,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
3340,GO:0006629,3.34014045446591e-15,1,73,1307,lipid metabolic process,BP,EBP;PDK4;PECR;WNT4;PHYH;DPM3;STRA6;ZFYVE21;ITGB8;FASN;DHH;HSD17B3;APOC1;HMGCS2;ADORA1;HSD17B11;DKK3;ACSF2;EDN1;ABCG1;BDH2;MBOAT2;ACADVL;ACSM5;RGN;FADS1;GHR;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;PDGFB;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;SESN2;RBP4;CYP17A1;FGF8;SDC4;ANG;HBEGF;BMP6;BMP2;ACAT1;ECHDC2;HEXB;FABP3;HSD3B2;NUDT7;CPT1C;AKT1;PON2;PTGES;KITLG;IDH1;DECR1;STAR;PIK3CA;PIK3CG;SIN3B;GLA;ECI1;CYP11A1;DHCR7;VDR;ACSL4;ELOVL6;ETFDH
2446,GO:0005102,3.68039258768627e-15,1,76,1400,receptor binding,MF,ITGA3;ITGA5;ARTN;PECR;LIF;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;TF;ITGB4;ITGB8;FADD;DHH;WNT6;WNT7A;WNT7B;MRAP;TRADD;ADORA1;EDN1;MFGE8;CCL20;PYCARD;FZD7;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;JAM3;HACL1;FGF8;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;IDUA;DLL1;MSN;NOL3;NUDT6;NUDT7;CTGF;NRTN;WNT2B;KITLG;IDH1;NPPC;JAG2;INHBB;PIK3CG;GAS6;GLA;S100B;SHC4;VDR;LAMA1;LAMA5;DOK1;GDNF;FZD8;CNIH4;EFNB2;LINGO1
7341,GO:0030258,1.06905320497786e-14,1,30,254,lipid modification,BP,PDK4;PHYH;ZFYVE21;APOC1;ABCG1;BDH2;ACADVL;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;CPT2;ETFB;HACL1;SESN2;FGF8;HBEGF;ACAT1;ECHDC2;FABP3;CPT1C;AKT1;KITLG;DECR1;PIK3CA;PIK3CG;ECI1;ETFDH
11894,GO:0044763,1.41437812464946e-14,1,280,10179,single-organism cellular process,BP,ITGA3;ITGA5;ARTN;TAGLN;PDK4;PECR;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;DPM3;STRA6;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;MRPL14;MRPL16;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;SALL4;TBC1D14;GUCY1B3;ADORA1;CASQ2;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;BDH2;SPTBN5;SPTBN4;PYCARD;MBOAT2;G0S2;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;RAB39B;RAB39A;PRND;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;REEP1;PDGFB;KCNH2;PLEKHH2;NNMT;FOXO4;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;KHK;HACL1;SESN2;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;SHPK;ESPN;HEXB;VAMP1;SFXN1;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB17;PON2;NRTN;WNT2B;TMEM176A;PTGES;KITLG;SEMA6C;IDH1;NPPC;DECR1;NAB2;JAG2;CDH1;MYO7A;BCAR1;INHBB;GJA3;RAB44;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;DHCR7;CYB5A;PTS;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;ACSL4;SLC1A3;FZD8;ELOVL6;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
4668,GO:0009888,3.37249267898919e-13,1,85,1837,tissue development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;SALL4;EDN1;PRKACB;BDH2;ACADVL;KRT10;FZD7;PSMB10;CDH2;FGF18;FGF10;PDGFB;PLA2G16;WNT5B;WNT5A;AXIN1;RBP4;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;CDKN1A;DLL1;WNK4;MSN;DDR1;DSG3;CTGF;GJB2;AKT1;PKP3;PKP1;NRTN;WNT2B;KITLG;NPPC;NAB2;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;S100B;DSC3;VDR;LAMA5;GDNF;DUSP5;HEY1;ACTA2;EFNB2
5888,GO:0016338,3.51956498790145e-13,1,11,23,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,BMP2;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
16787,GO:0072001,4.69895648440611e-13,1,29,278,renal system development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7B;RGN;FSTL3;FGF10;PDGFB;WNT5A;RBP4;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
11809,GO:0044444,5.72218124621401e-13,1,248,8745,cytoplasmic part,CC,ITGA3;ITGA5;EBP;PDK4;PECR;FHOD3;TMEM160;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT4;USE1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;IFI30;PNMT;DPM3;TF;ZFYVE21;ITGB5;FASN;PMAIP1;MSRA;CRISPLD2;SLC31A2;FBXO41;MRPL14;MRPL16;MRI1;FADD;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;TRADD;HMGCS2;RABIF;NMT2;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;RHPN1;ABCG1;PRKACB;BDH2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;ASAH2;PIK3R2;PIK3R1;TICAM1;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NPR1;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;BOLA1;ANG;FAM110C;SPTB;HBEGF;LGALS4;NMI;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;AOX1;PKN3;RAB20;ECHDC2;SARDH;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DSG3;CTGF;GJB1;GJB2;GJB6;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP1;RAB12;RAB17;PON2;CYTIP;PTGES;IDH1;NPPC;DECR1;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;LDHD;TMEM98;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;GAS6;ACP5;GLA;DTX4;ECI1;CYP11A1;RPH3AL;MYH11;DERA;S100B;DHCR7;CYB5A;PTS;GPSM1;AMOT;ARAF;SH3BP4;UNC119;RAB38;DOK1;RAB3D;LYPLAL1;ACSL4;MYZAP;FAM110B;FZD8;CNIH4;ELOVL6;ACTA2;RNF144A;PARVB;ETFDH;PDE4B;TMOD4
11868,GO:0044707,6.23099611417949e-13,1,187,5907,single-multicellular organism process,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;PDK4;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;ALG5;NOTCH1;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;APOC1;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EXTL1;EDN1;PLAU;PNP;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;SPTBN5;SPTBN4;PYCARD;ACADVL;KRT10;RRAS2;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FXYD1;RBP4;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;PKN3;DRP2;SLC2A14;HEXB;SFXN1;WNK4;CHGA;MSN;NOL3;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;FAM46A;TMEM176A;KITLG;SEMA6C;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;TFPI;TLE1;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;PEPD;HAPLN3;DTX4;MYH11;LZTS1;S100B;DHCR7;PTS;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;KCND1;TSPAN2;DOK1;RAB3D;GDNF;ACSL4;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;EFNB2;LINGO1;PDE4B
4247,GO:0008610,1.21881698087538e-12,1,44,628,lipid biosynthetic process,BP,EBP;PDK4;PECR;WNT4;DPM3;FASN;DHH;HSD17B3;APOC1;HMGCS2;HSD17B11;DKK3;EDN1;ABCG1;MBOAT2;ACADVL;ACSM5;RGN;FADS1;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PLA2G16;CYP17A1;FGF8;ANG;BMP6;BMP2;HEXB;FABP3;HSD3B2;AKT1;PTGES;IDH1;STAR;PIK3CA;PIK3CG;CYP11A1;DHCR7;VDR;ELOVL6
11692,GO:0044255,1.65702860494991e-12,1,58,1021,cellular lipid metabolic process,BP,PDK4;PECR;PHYH;DPM3;STRA6;ZFYVE21;ITGB8;FASN;APOC1;HMGCS2;ACSF2;EDN1;ABCG1;BDH2;MBOAT2;ACADVL;ACSM5;RGN;FADS1;GHR;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;PDGFB;CPT2;PLA2G16;ETFB;HACL1;SESN2;RBP4;FGF8;SDC4;ANG;HBEGF;ACAT1;ECHDC2;HEXB;FABP3;NUDT7;CPT1C;AKT1;PON2;PTGES;KITLG;IDH1;DECR1;STAR;PIK3CA;PIK3CG;SIN3B;GLA;ECI1;ACSL4;ELOVL6;ETFDH
3663,GO:0007155,1.73238991459413e-12,1,67,1311,cell adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;CDH23;ITGB5;ITGB4;ITGB8;FADD;DSC2;WNT7B;ACVR1;PLAU;PNP;MFGE8;PYCARD;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;RHOB;SDC4;LGALS4;BMP7;BMP4;BMP2;CAMSAP3;DLL1;RND3;MSN;DDR1;DSG3;CTGF;AKT1;PKP3;PKP1;CYTIP;KITLG;JAG2;CDH1;BCAR1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;CLDN23;DSC3;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
7112,GO:0022610,2.20762985889964e-12,1,67,1318,biological adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;CDH23;ITGB5;ITGB4;ITGB8;FADD;DSC2;WNT7B;ACVR1;PLAU;PNP;MFGE8;PYCARD;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;RHOB;SDC4;LGALS4;BMP7;BMP4;BMP2;CAMSAP3;DLL1;RND3;MSN;DDR1;DSG3;CTGF;AKT1;PKP3;PKP1;CYTIP;KITLG;JAG2;CDH1;BCAR1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;CLDN23;DSC3;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
11870,GO:0044710,2.2186445686412e-12,1,143,4067,single-organism metabolic process,BP,ARTN;EBP;PDK4;PECR;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;ACTN2;ALG5;PHYH;GLDC;IFI30;DPM3;STRA6;ZFYVE21;ITGB8;FASN;PMAIP1;GADD45A;MSRA;MRI1;DHH;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;SLC52A3;HMGCS2;ACVR1;GUCY1B3;ADORA1;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PNP;ABCG1;CCL20;BDH2;SPTBN5;SPTBN4;PYCARD;MBOAT2;ACADVL;MGST2;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;GHR;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;PDGFB;KCNH2;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HRAS;WNT5A;KHK;HACL1;SESN2;AXIN1;GALT;RBP4;RHOQ;NPR1;CYP17A1;PFKFB3;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;CHGA;HSD3B2;NUDT7;CTGF;CPT1C;PCBD1;MDH1;AKT1;PON2;NRTN;PTGES;KITLG;IDH1;NPPC;DECR1;INHBB;LDHD;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;VDR;ARAF;GDNF;ACSL4;SLC1A3;FZD8;ELOVL6;DUSP5;ETFDH;PDE4B
13381,GO:0048731,2.72314638334817e-12,1,148,4323,system development,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;DKK3;EXTL1;EDN1;PNP;PRKACB;MFGE8;SPTBN5;SPTBN4;KRT10;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;FSTL3;FGF18;FGF10;FGF17;PIK3R1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RBP4;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;WT1;CDKN1A;DLL1;DRP2;HEXB;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;TMEM176A;KITLG;SEMA6C;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;S100B;DHCR7;PTS;DSC3;GPSM1;VDR;AMOT;LAMA5;UNC119;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;FZD8;HEY1;ACTA2;CLDN11;CLDN18;EFNB2;LINGO1
13379,GO:0048729,3.82154532572775e-12,1,42,607,tissue morphogenesis,BP,ITGA3;ITGA5;ARTN;LIF;WNT3;WNT2;WNT4;NOTCH1;ITGB4;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;EDN1;PRKACB;FZD7;PSMB10;FGF10;WNT5A;AXIN1;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;WNT2B;JAG2;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
16771,GO:0071944,5.42091496917885e-12,1,164,5014,cell periphery,CC,ITGA3;ITGA5;CFB;EBP;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;SLC31A2;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;MRAP;TRADD;SLC52A3;ACVR1;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;ABCG1;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;FZD7;TYRO3;LPAR2;LIMS2;CDH2;GHR;FGF10;ASAH2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;PXK;HSD17B10;TJP3;HRAS;WNT5B;WNT5A;JAM3;SNX18;AXIN1;FXYD1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;FAM110C;SPTB;HBEGF;LGALS4;BMP2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;GRIA3;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;CASP4;AKT1;PKP3;PKP1;RAB17;PON2;CYTIP;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;RAB44;TFPI;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;RPH3AL;PRRT1;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;KCND1;TSPAN2;RAB38;RAB3D;MYZAP;SLC1A3;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;LINGO1;PDE4B
7211,GO:0030054,6.49172929272391e-12,1,61,1164,cell junction,CC,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;NOTCH1;IFI30;ZFYVE21;ITGB5;ITGB4;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;PIK3R1;CGN;TJP3;JAM3;RHOB;SDC4;CAMSAP3;DLL1;DRP2;VAMP1;WNK4;GRIA3;RND3;MSN;DSG3;GJB1;GJB2;GJB6;CPT1C;AKT1;PKP3;PKP1;CDH1;BCAR1;GJA3;CLDN1;CLDN2;CLDN3;CLDN5;PRRT1;LZTS1;CLDN23;SHC4;DSC3;AMOT;MYZAP;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
9759,GO:0035295,7.15732949314811e-12,1,40,566,tube development,BP,ITGA3;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB4;CRISPLD2;WNT6;WNT7A;WNT7B;ACVR1;SALL4;EDN1;PRKACB;FSTL3;FGF18;FGF10;WNT5A;RBP4;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;ACAT1;WT1;CDKN1A;DLL1;WNK4;DDR1;CTGF;WNT2B;DHCR7;VDR;LAMA5;GDNF;CLDN18;EFNB2
568,GO:0001655,9.31119131339269e-12,1,29,313,urogenital system development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7B;RGN;FSTL3;FGF10;PDGFB;WNT5A;RBP4;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
2856,GO:0005886,1.00862699185834e-11,1,161,4920,plasma membrane,CC,ITGA3;ITGA5;CFB;EBP;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;SLC31A2;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;MRAP;TRADD;SLC52A3;ACVR1;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;ABCG1;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;FZD7;TYRO3;LPAR2;LIMS2;CDH2;GHR;FGF10;ASAH2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;PXK;HSD17B10;TJP3;HRAS;WNT5B;WNT5A;JAM3;SNX18;AXIN1;FXYD1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;LGALS4;BMP2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;GRIA3;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;CASP4;AKT1;PKP3;PKP1;RAB17;PON2;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;GJA3;RAB44;TFPI;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;RPH3AL;PRRT1;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;KCND1;TSPAN2;RAB38;RAB3D;MYZAP;SLC1A3;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;LINGO1;PDE4B
13306,GO:0048608,2.39299227843641e-11,1,33,412,reproductive structure development,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;HSD17B3;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;RBP4;FGF8;ANG;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;IDH1;INHBB;STAR;VDR;HEY1
678,GO:0001822,2.61663590161514e-11,1,26,263,kidney development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;WNT6;WNT7B;RGN;FSTL3;FGF10;PDGFB;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
15512,GO:0061458,2.90769354624495e-11,1,33,415,reproductive system development,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;HSD17B3;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;RBP4;FGF8;ANG;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;IDH1;INHBB;STAR;VDR;HEY1
1447,GO:0003156,3.45137043885828e-11,1,11,33,regulation of animal organ formation,BP,WNT2;NOTCH1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;WNT2B;GDNF
16790,GO:0072006,5.37306800135398e-11,1,19,139,nephron development,BP,ITGA3;LIF;WNT4;NOTCH1;WNT6;WNT7B;PDGFB;FGF8;BMP7;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2
3341,GO:0006631,5.95877385132107e-11,1,29,330,fatty acid metabolic process,BP,PDK4;PECR;PHYH;FASN;APOC1;ACSF2;EDN1;BDH2;ACADVL;ACSM5;RGN;FADS1;GHR;CPT2;ETFB;HACL1;SESN2;ACAT1;ECHDC2;FABP3;CPT1C;AKT1;PON2;PTGES;DECR1;ECI1;ACSL4;ELOVL6;ETFDH
3674,GO:0007166,6.48632907838158e-11,1,99,2540,cell surface receptor signaling pathway,BP,ITGA3;ITGA5;PDK4;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;TSPAN15;TSPAN17;NOTCH1;IFI30;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;FADD;DHH;WNT6;P2RY14;WNT7A;WNT7B;TRADD;ACVR1;ADORA1;DKK3;EDN1;PRKACB;CCL20;PYCARD;G0S2;MPZL1;TSPAN13;MAPK12;FZD7;PSMB10;LIMS2;CDH2;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;AXIN1;RHOQ;NPR1;RNASEL;FGF8;CLCF1;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;DLL1;GRIA3;NOL3;DDR1;DEPTOR;CTGF;AKT1;IFI27;NRTN;WNT2B;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;TLE1;CLDN5;PIK3CA;GAS6;DTX4;ZCCHC12;SHC4;LAMA1;LAMA5;TSPAN2;DOK1;GDNF;FZD8;HEY1;CLDN18;EFNB2;PDE4B
11710,GO:0044281,6.8522044728484e-11,1,84,1974,small molecule metabolic process,BP,EBP;PDK4;PECR;WNT4;ACTN3;PHYH;GLDC;FASN;PMAIP1;MSRA;MRI1;HSD17B3;MRAP;APOC1;SLC52A3;HMGCS2;GUCY1B3;DKK3;EXTL1;ACSF2;EDN1;PNP;ABCG1;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;WNT5A;KHK;HACL1;SESN2;GALT;RBP4;RHOQ;NPR1;CYP17A1;PFKFB3;BMP6;BMP2;ACAT1;B3GNT2;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;CHGA;NUDT7;CPT1C;PCBD1;MDH1;AKT1;PON2;PTGES;IDH1;NPPC;DECR1;STAR;PIK3CA;PEPD;ACP5;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;VDR;ACSL4;SLC1A3;ELOVL6;ETFDH;PDE4B
768,GO:0001944,7.60202529425978e-11,1,39,587,vasculature development,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF18;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;ANG;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;DHCR7;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
13258,GO:0048513,8.72327882911189e-11,1,115,3169,animal organ development,BP,ITGA3;ARTN;TAGLN;EBP;FHOD3;LIF;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;CDH23;STRA6;IGSF8;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;PNP;KRT10;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;FSTL3;FGF18;FGF10;PIK3R1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RBP4;RHOJ;PFKFB3;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;CDKN1A;DLL1;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;NRTN;WNT2B;TMEM176A;KITLG;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;STAR;CLDN1;CLDN5;PIK3CA;GAS6;MYH11;S100B;DHCR7;DSC3;VDR;LAMA5;TSPAN2;GDNF;FZD8;HEY1;ACTA2;CLDN18;EFNB2
14949,GO:0060429,9.37136705246803e-11,1,60,1200,epithelium development,BP,ITGA5;TAGLN;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;STRA6;DSC2;WNT6;WNT7A;WNT7B;TRADD;ACVR1;SALL4;EDN1;PRKACB;BDH2;ACADVL;KRT10;FZD7;PSMB10;CDH2;FGF10;PDGFB;WNT5B;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;CDKN1A;DLL1;WNK4;MSN;DDR1;DSG3;AKT1;PKP3;PKP1;WNT2B;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;DSC3;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
3751,GO:0007275,9.41899495672083e-11,1,156,4864,multicellular organism development,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;ALG5;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;DKK3;EXTL1;EDN1;PNP;PRKACB;MFGE8;EBF1;SPTBN5;SPTBN4;KRT10;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;FSTL3;FGF18;FGF10;FGF17;PIK3R1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RBP4;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;HEXB;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;TMEM176A;KITLG;SEMA6C;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;S100B;DHCR7;PTS;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;EFNB2;LINGO1
6599,GO:0019395,1.13149915300006e-10,0.999999999990175,16,95,fatty acid oxidation,BP,PDK4;PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;SESN2;ACAT1;ECHDC2;FABP3;CPT1C;AKT1;DECR1;ECI1;ETFDH
17018,GO:0072358,1.18657787836628e-10,1,39,596,cardiovascular system development,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF18;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;ANG;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;DHCR7;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
4617,GO:0009653,1.23458082054743e-10,1,92,2328,anatomical structure morphogenesis,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;WNT3;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB5;ITGB4;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;FZD7;TYRO3;PSMB10;LIMS2;CDH2;FGF18;FGF10;PIK3R1;FOXO4;HRAS;WNT5A;JAM3;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;DLL1;HEXB;WNK4;MSN;DDR1;CTGF;GJB6;TPD52;NRTN;WNT2B;SEMA6C;NPPC;NAB2;JAG2;MYO7A;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;MYH11;LZTS1;S100B;VDR;AMOT;LAMA5;DOK1;GDNF;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;PARVB;EFNB2;LINGO1
4854,GO:0010562,1.43807997255526e-10,1,54,1022,positive regulation of phosphorus metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;MRAP;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;FZD7;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;FABP3;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
12436,GO:0045937,1.43807997255526e-10,1,54,1022,positive regulation of phosphate metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;MRAP;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;FZD7;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;FABP3;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
9447,GO:0034440,1.5772933540505e-10,0.99999999998598,16,97,lipid oxidation,BP,PDK4;PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;SESN2;ACAT1;ECHDC2;FABP3;CPT1C;AKT1;DECR1;ECI1;ETFDH
3928,GO:0008083,1.58561923010707e-10,0.999999999981004,20,159,growth factor activity,MF,ARTN;LIF;FGF18;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;NUDT6;CTGF;NRTN;KITLG;JAG2;INHBB;GDNF
8796,GO:0032879,1.62517680678582e-10,1,94,2401,regulation of localization,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;ACTN2;NOTCH1;RAB27A;TF;PMAIP1;SLC31A2;FADD;DSC2;WNT7A;APOC1;ACVR1;TBC1D14;ADORA1;CASQ2;EDN1;PLAU;ABCG1;KCNK6;MFGE8;CCL20;SPTBN4;PYCARD;TTYH1;RRAS2;TSPAN13;FZD7;RGN;CDH2;PRR5L;FGF18;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;SESN2;FXYD1;RBP4;RHOQ;RHOB;NPR1;RNASEL;SDC4;ANG;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;RAB20;WNK4;CHGA;MSN;NOL3;AKT1;IFI27;RAB17;KITLG;JAG2;CDH1;BCAR1;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;RPH3AL;AMOT;LAMA1;LAMA5;UNC119;KCND1;RAB3D;GDNF;CLDN18;PDE4B
11898,GO:0044767,2.235333153265e-10,1,172,5610,single-organism developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;ALG5;NOTCH1;MARK4;RAB27A;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EXTL1;EDN1;PNP;ABCG1;PRKACB;MFGE8;EBF1;BDH2;SPTBN5;SPTBN4;ACADVL;KRT10;RRAS2;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;FADS1;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;HEXB;SFXN1;WNK4;MSN;NUDT7;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;TMEM176A;KITLG;SEMA6C;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;S100B;DHCR7;PTS;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;RAB38;DOK1;GDNF;ACSL4;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2;LINGO1
17019,GO:0072359,2.35362708934588e-10,1,49,901,circulatory system development,BP,ITGA3;ITGA5;FHOD3;LIF;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;EDN1;MFGE8;FZD7;CDH2;FGF18;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RBP4;RHOJ;RHOB;NPR1;FGF8;ANG;BMP7;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;CLDN5;PIK3CA;PIK3CG;MYH11;DHCR7;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
525,GO:0001568,3.26066705272781e-10,1,37,564,blood vessel development,BP,ITGA5;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF18;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;ANG;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;DHCR7;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
3675,GO:0007167,3.34632518518243e-10,1,51,963,enzyme linked receptor protein signaling pathway,BP,ITGA3;ITGA5;PDK4;LIF;ADRA2B;ADRA2C;WNT4;NOTCH1;RASL11B;ITGB5;ACVR1;ADORA1;DKK3;MPZL1;MAPK12;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;FOXO4;HRAS;WNT5A;RHOQ;NPR1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;NPPC;EPN1;BCAR1;INHBB;CLDN5;PIK3CA;GAS6;ZCCHC12;SHC4;DOK1;EFNB2
8551,GO:0032502,3.9806289683162e-10,1,173,5693,developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;ALG5;NOTCH1;MARK4;RAB27A;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EXTL1;EDN1;PNP;ABCG1;PRKACB;MFGE8;EBF1;BDH2;SPTBN5;SPTBN4;ACADVL;KRT10;RRAS2;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;FADS1;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;CYP17A1;PFKFB3;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;HEXB;SFXN1;WNK4;MSN;NUDT7;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;TMEM176A;KITLG;SEMA6C;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;S100B;DHCR7;PTS;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;RAB38;DOK1;GDNF;ACSL4;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2;LINGO1
16837,GO:0072080,5.14413408729146e-10,0.999999999954735,15,92,nephron tubule development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
11322,GO:0043296,5.17841963207016e-10,0.999999999945516,17,123,apical junction complex,CC,CGN;TJP3;JAM3;CAMSAP3;WNK4;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
2871,GO:0005911,5.22482789645452e-10,1,30,394,cell-cell junction,CC,ITGA5;DSC2;CDH2;PIK3R1;CGN;TJP3;JAM3;CAMSAP3;WNK4;DSG3;GJB1;GJB2;GJB6;AKT1;PKP3;PKP1;CDH1;GJA3;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;DSC3;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
16830,GO:0072073,5.55025518110429e-10,0.99999999993689,18,140,kidney epithelium development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;SDC4;BMP7;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;EFNB2
8735,GO:0032787,6.5962716859206e-10,1,36,540,monocarboxylic acid metabolic process,BP,PDK4;PECR;ACTN3;PHYH;GLDC;FASN;APOC1;ACSF2;EDN1;BDH2;ACADVL;ACSM5;RGN;FADS1;GHR;CPT2;ETFB;HACL1;SESN2;PFKFB3;ACAT1;IDUA;ECHDC2;FABP3;CPT1C;AKT1;PON2;PTGES;IDH1;DECR1;STAR;ECI1;ACSL4;SLC1A3;ELOVL6;ETFDH
7621,GO:0030855,6.79053195834405e-10,1,42,708,epithelial cell differentiation,BP,TAGLN;LIF;WNT4;POU3F1;NOTCH1;DSC2;WNT7A;WNT7B;ACVR1;BDH2;ACADVL;KRT10;FZD7;CDH2;FGF10;PDGFB;WNT5B;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;MSN;DSG3;AKT1;PKP3;PKP1;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;DSC3;VDR;LAMA5;GDNF;HEY1;ACTA2
18089,GO:0098609,7.00043334790745e-10,1,44,771,cell-cell adhesion,BP,ITGA5;WNT4;CDH23;ITGB5;FADD;DSC2;WNT7B;ACVR1;PNP;PYCARD;TTYH1;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;BMP2;CAMSAP3;MSN;DSG3;AKT1;PKP3;PKP1;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;CLDN23;DSC3;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;EFNB2
15455,GO:0061326,7.00164498490334e-10,0.999999999936946,15,94,renal tubule development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
13236,GO:0048468,9.17262574303909e-10,1,76,1834,cell development,BP,ITGA3;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CDH23;DHH;WNT7A;WNT7B;ZFPM1;ACVR1;CASQ2;EDN1;SPTBN5;SPTBN4;FZD7;TYRO3;CDH2;FGF18;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;ANG;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HEXB;MSN;DDR1;AKT1;RAB17;NRTN;KITLG;SEMA6C;NPPC;CDH1;MYO7A;INHBB;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;MYH11;LZTS1;S100B;LAMA5;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;ACTA2;CLDN18;LINGO1
7263,GO:0030154,9.47503890627771e-10,1,125,3698,cell differentiation,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;CDH23;ITGB5;ITGB4;FASN;FADD;DHH;DSC2;WNT6;WNT7A;WNT7B;MRAP;ZFPM1;ACVR1;SALL4;CASQ2;EDN1;PNP;ABCG1;BDH2;SPTBN5;SPTBN4;ACADVL;KRT10;RRAS2;MAPK12;FZD7;TYRO3;CDH2;FADS1;FSTL3;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOB;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;SLC2A14;HEXB;SFXN1;MSN;NUDT7;DDR1;DSG3;CTGF;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;TMEM176A;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;INHBB;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;LZTS1;S100B;DHCR7;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;UNC119;TSPAN2;RAB38;DOK1;GDNF;ACSL4;SLC1A3;FZD8;HEY1;ACTA2;CLDN18;EFNB2;LINGO1
1379,GO:0003006,9.53752841020007e-10,1,38,607,developmental process involved in reproduction,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;HSD17B3;ACVR1;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;RBP4;CYP17A1;FGF8;ANG;BMP7;BMP6;BMP4;WT1;HEXB;GJB1;GJB2;AKT1;WNT2B;KITLG;IDH1;NPPC;INHBB;STAR;VDR;HEY1
759,GO:0001934,1.12313362725296e-09,1,47,868,positive regulation of protein phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;FZD7;CDH2;PRR5L;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
13330,GO:0048646,1.17451839437946e-09,1,49,941,anatomical structure formation involved in morphogenesis,BP,ITGA3;ITGA5;FHOD3;WNT3;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB5;ITGB4;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;CASQ2;EDN1;PRKACB;MFGE8;FZD7;FGF18;FGF10;FOXO4;WNT5A;JAM3;AXIN1;RBP4;RHOB;NPR1;FGF8;SDC4;ANG;BMP7;BMP4;WT1;DLL1;CTGF;WNT2B;PIK3CA;PIK3CG;MYH11;AMOT;LAMA5;GDNF;FZD8;DUSP5;HEY1;EFNB2
819,GO:0002009,1.18364101603545e-09,1,34,509,morphogenesis of an epithelium,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ACVR1;SALL4;EDN1;PRKACB;FZD7;PSMB10;FGF10;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;WNT2B;JAG2;VDR;LAMA5;GDNF;EFNB2
13440,GO:0048856,1.22251045239429e-09,1,162,5288,anatomical structure development,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;ALG5;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EXTL1;EDN1;PNP;PRKACB;MFGE8;EBF1;BDH2;SPTBN5;SPTBN4;ACADVL;KRT10;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;FSTL3;FGF18;FGF10;FGF17;PIK3R1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;HEXB;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;TMEM176A;KITLG;SEMA6C;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;S100B;DHCR7;PTS;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2;LINGO1
11862,GO:0044699,1.34973991618396e-09,1,311,12673,single-organism process,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;PDK4;PECR;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;DPM3;STRA6;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;MRPL14;MRPL16;SLC45A4;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;SALL4;TBC1D14;GUCY1B3;ADORA1;CASQ2;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;FLVCR2;SPTBN5;SPTBN4;PYCARD;MBOAT2;G0S2;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;NNMT;FOXO4;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;SHPK;ESPN;HEXB;VAMP1;SFXN1;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB17;PON2;NRTN;WNT2B;FAM46A;TMEM176A;PTGES;KITLG;SEMA6C;IDH1;NPPC;DECR1;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;LDHD;GJA3;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;PEPD;ACP5;GLA;HAPLN3;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;DHCR7;CYB5A;PTS;SHC4;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;ACSL4;MYZAP;SLC1A3;FZD8;ELOVL6;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
13395,GO:0048754,1.45028022060807e-09,0.999999999805691,18,148,branching morphogenesis of an epithelial tube,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
7159,GO:0023014,1.57946530515331e-09,1,47,880,signal transduction by protein phosphorylation,BP,ARTN;LIF;ADRA2B;ADRA2C;ACTN2;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;SPTBN5;SPTBN4;PYCARD;MAPK12;FZD7;TYRO3;PSMB10;CDH2;GHR;FGF18;FGF10;FGF17;PDGFB;KCNH2;HRAS;WNT5A;AXIN1;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CG;GAS6;ARAF;GDNF;FZD8;DUSP5
12859,GO:0046890,1.5891538569522e-09,0.999999999801722,17,129,regulation of lipid biosynthetic process,BP,PDK4;WNT4;DHH;APOC1;DKK3;ABCG1;ACADVL;RGN;PDGFB;BMP6;BMP2;FABP3;AKT1;IDH1;STAR;DHCR7;VDR
13450,GO:0048869,2.05607214599575e-09,1,128,3868,cellular developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;CDH23;ITGB5;ITGB4;FASN;FADD;DHH;DSC2;WNT6;WNT7A;WNT7B;MRAP;ZFPM1;ACVR1;SALL4;CASQ2;EDN1;PNP;ABCG1;BDH2;SPTBN5;SPTBN4;ACADVL;KRT10;RRAS2;MAPK12;FZD7;TYRO3;CDH2;FADS1;FSTL3;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;SLC2A14;HEXB;SFXN1;MSN;NUDT7;DDR1;DSG3;CTGF;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;TMEM176A;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;INHBB;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;LZTS1;S100B;DHCR7;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;UNC119;TSPAN2;RAB38;DOK1;GDNF;ACSL4;SLC1A3;FZD8;HEY1;ACTA2;CLDN18;PARVB;EFNB2;LINGO1
2449,GO:0005109,2.19282174856753e-09,0.999999999893113,10,36,frizzled binding,MF,WNT3;WNT2;WNT4;WNT6;WNT7A;WNT7B;FZD7;WNT5B;WNT5A;WNT2B
11863,GO:0044700,2.56401487314757e-09,1,176,5938,single organism signaling,BP,ITGA3;ITGA5;ARTN;EBP;PDK4;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;IFI30;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;FADD;DHH;DSC2;WNT6;P2RY14;WNT7A;WNT7B;TRADD;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;CCL20;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;FOXO4;RALB;PXK;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;RNASEL;FGF8;SDC4;CLCF1;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;GRIA3;RND3;CHGA;NOL3;DDR1;DEPTOR;CTGF;GJB1;GJB2;RRAD;CASP4;AKT1;IFI27;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;STAR;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;RPH3AL;LZTS1;S100B;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;GDNF;MYZAP;SLC1A3;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;LINGO1;PDE4B
15677,GO:0065008,2.71626919079767e-09,1,116,3394,regulation of biological quality,BP,PDK4;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;ACTN2;RAB27A;CDH23;IFI30;DPM3;TF;PMAIP1;SLC31A2;FADD;DSC2;SERPINA5;WNT7A;WNT7B;HSD17B3;ZFPM1;ADORA1;CASQ2;HSD17B11;DKK3;EDN1;PLAU;ABCG1;PRKACB;KCNK6;BDH2;SPTBN5;SPTBN4;PYCARD;ACADVL;RAB39A;PRND;TYRO3;PSMB10;LPAR2;RGN;CDH2;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;HRAS;WNT5A;JAM3;SESN2;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;CYP17A1;RNASEL;ANG;SPTB;BMP6;BMP4;BMP2;CDKN1A;DLL1;RAB20;HEXB;SFXN1;WNK4;FABP3;GRIA3;CHGA;MSN;NOL3;HSD3B2;DDR1;DEPTOR;CTGF;GJB6;AKT1;RAB17;FAM46A;KITLG;NPPC;INHBB;TFPI;STAR;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;CYP11A1;RPH3AL;LZTS1;S100B;DHCR7;HNF1A;VDR;RAB38;RAB3D;GDNF;SLC1A3;ACTA2;CLDN16;CLDN18;PIM2;PARVB;PDE4B;TMOD4
7172,GO:0023052,2.82158113488911e-09,1,176,5945,signaling,BP,ITGA3;ITGA5;ARTN;EBP;PDK4;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;IFI30;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;FADD;DHH;DSC2;WNT6;P2RY14;WNT7A;WNT7B;TRADD;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;CCL20;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;FOXO4;RALB;PXK;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;RNASEL;FGF8;SDC4;CLCF1;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;GRIA3;RND3;CHGA;NOL3;DDR1;DEPTOR;CTGF;GJB1;GJB2;RRAD;CASP4;AKT1;IFI27;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;STAR;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;RPH3AL;LZTS1;S100B;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;GDNF;MYZAP;SLC1A3;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;LINGO1;PDE4B
11682,GO:0044242,2.83191836840523e-09,0.999999999550035,20,189,cellular lipid catabolic process,BP,PHYH;APOC1;BDH2;ACADVL;CPT2;ETFB;HACL1;SESN2;ACAT1;ECHDC2;HEXB;FABP3;CPT1C;AKT1;IDH1;DECR1;PIK3CG;GLA;ECI1;ETFDH
3453,GO:0006793,2.87630633632828e-09,1,108,3069,phosphorus metabolic process,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;DPM3;ZFYVE21;FASN;GADD45A;WNT7A;WNT7B;MRAP;APOC1;ACVR1;GUCY1B3;ADORA1;ACSF2;EDN1;PNP;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;MBOAT2;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;NNMT;RALB;PLA2G16;HRAS;WNT5A;KHK;SESN2;AXIN1;GALT;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;CDKN1A;PKN3;SHPK;HEXB;WNK4;FABP3;CHGA;NUDT7;DDR1;DEPTOR;CTGF;MDH1;AKT1;NRTN;KITLG;IDH1;NPPC;INHBB;MDP1;PIK3CA;PIK3CG;GAS6;ACP5;DERA;ARAF;UNC119;GDNF;ACSL4;FZD8;ELOVL6;DUSP5;PIM2;PDE4B
13961,GO:0051239,2.95189423668368e-09,1,95,2576,regulation of multicellular organismal process,BP,ITGA3;ITGA5;PDK4;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;FADD;DSC2;WNT6;WNT7A;WNT7B;APOC1;ZFPM1;TRADD;ACVR1;ADORA1;CASQ2;EDN1;PLAU;PNP;PRKACB;KCNK6;CCL20;SPTBN4;PYCARD;FZD7;PSMB10;LIMS2;RGN;CDH2;GHR;FSTL3;FGF18;FGF10;PIK3R1;TICAM1;PDGFB;KCNH2;FOXO4;PLA2G16;HRAS;WNT5A;FXYD1;RBP4;RHOB;NPR1;FGF8;CLCF1;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;CHGA;NOL3;CTGF;AKT1;RAB17;WNT2B;FAM46A;TMEM176A;KITLG;NPPC;BCAR1;INHBB;STAR;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;LZTS1;S100B;VDR;AMOT;LAMA1;LAMA5;KCND1;GDNF;HEY1;CLDN18;EFNB2;LINGO1;PDE4B
11871,GO:0044711,2.98541899576432e-09,1,63,1404,single-organism biosynthetic process,BP,EBP;PDK4;PECR;WNT4;DPM3;FASN;MRI1;DHH;HSD17B3;MRAP;APOC1;HMGCS2;GUCY1B3;HSD17B11;DKK3;EXTL1;EDN1;PNP;ABCG1;BDH2;MBOAT2;ACADVL;MGST2;ACSM5;RGN;FADS1;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;NNMT;PLA2G16;WNT5A;SESN2;RBP4;NPR1;CYP17A1;FGF8;ANG;BMP6;BMP4;BMP2;ACAT1;B3GNT2;HEXB;FABP3;HSD3B2;CTGF;MDH1;AKT1;PTGES;IDH1;NPPC;STAR;PIK3CA;PIK3CG;CYP11A1;DHCR7;VDR;SLC1A3;ELOVL6
8214,GO:0031982,3.0231374360375e-09,1,133,4076,vesicle,CC,ITGA3;ITGA5;CFB;EBP;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;MSRA;CRISPLD2;SLC31A2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;TBC1D14;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PRKACB;MFGE8;BDH2;SPTBN5;SPTBN4;PYCARD;KRT10;RRAS2;RAB39B;RAB39A;SYCN;FZD7;LPAR2;CDH2;FSTL3;TICAM1;PDGFB;FRMPD1;RALB;ETFB;WNT5B;WNT5A;SNX18;KHK;AXIN1;RBP4;RHOQ;RHOJ;RHOB;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;ACAT1;B3GNT2;DAAM2;IDUA;DLL1;AOX1;RAB20;HEXB;VAMP1;CMBL;FABP3;GRIA3;RND3;CHGA;MSN;DDR1;DSG3;PCBD1;MDH1;AKT1;PKP1;RAB12;RAB17;CYTIP;IDH1;NPPC;DECR1;CDH1;MYO7A;MDP1;HPCAL1;RAB44;CLDN2;CLDN3;CLDN5;SNX21;RAB11FIP1;KCNG2;GAS6;PEPD;ACP5;GLA;ECI1;RPH3AL;MYH11;DERA;CYB5A;PM20D2;AMOT;LAMA5;SH3BP4;RAB38;RAB3D;LYPLAL1;ACSL4;ACTA2;CLDN11;RNF144A;PDE4B
15030,GO:0060541,3.31599130073411e-09,0.99999999946751,20,194,respiratory system development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF18;FGF10;WNT5A;AXIN1;RBP4;FGF8;BMP4;WT1;CTGF;WNT2B;DHCR7;LAMA5
5943,GO:0016477,3.41701071563019e-09,1,56,1193,cell migration,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;FADD;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;PYCARD;RRAS2;TYRO3;CDH2;PRR5L;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;ANG;FAM110C;HBEGF;BMP4;BMP2;PKN3;HEXB;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
15343,GO:0061061,3.75629618458464e-09,1,35,563,muscle structure development,BP,TAGLN;FHOD3;LIF;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ZFPM1;ACVR1;CASQ2;EDN1;MAPK12;FZD7;CDH2;FGF10;PDGFB;FOXO4;WNT5A;AXIN1;RBP4;FGF8;HBEGF;BMP4;BMP2;WT1;DLL1;AKT1;MYH11;S100B;LAMA5;HEY1;EFNB2
10767,GO:0042327,3.93525824434037e-09,1,47,904,positive regulation of phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;FZD7;CDH2;PRR5L;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
10583,GO:0040011,4.25458777441707e-09,1,66,1541,locomotion,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;NOTCH1;ITGB4;FADD;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;PYCARD;RRAS2;TYRO3;RGN;CDH2;PRR5L;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;ANG;FAM110C;SPTB;HBEGF;BMP7;BMP4;BMP2;B3GNT2;PKN3;HEXB;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;SEMA6C;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;DOK1;GDNF;EFNB2;PDE4B
15290,GO:0060993,4.81605830563544e-09,0.999999999506159,14,92,kidney morphogenesis,BP,LIF;WNT4;WNT6;WNT7B;FGF10;FGF8;BMP7;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
9895,GO:0035556,4.92292613894811e-09,1,93,2530,intracellular signal transduction,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;RAB6C;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;RABIF;GUCY1B3;ADORA1;CASQ2;EDN1;RAB40B;RAB40A;CCL20;SPTBN5;SPTBN4;PYCARD;RRAS2;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;KCNH2;RALB;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;CLCF1;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;RND3;NOL3;DEPTOR;CTGF;RRAD;CASP4;AKT1;NRTN;KITLG;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;S100B;SHC4;AMOT;ARAF;SH3BP4;RAB38;DOK1;GDNF;MYZAP;FZD8;DUSP5;PIM2
15047,GO:0060562,5.39667811827217e-09,0.999999999040835,25,309,epithelial tube morphogenesis,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;SALL4;EDN1;PRKACB;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;DDR1;WNT2B;VDR;LAMA5;GDNF;EFNB2
3537,GO:0006928,5.47615948037056e-09,1,72,1768,movement of cell or subcellular component,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;IGSF8;ITGB4;FADD;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;PYCARD;RRAS2;TYRO3;RGN;CDH2;PRR5L;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;ANG;FAM110C;SPTB;HBEGF;BMP7;BMP4;BMP2;B3GNT2;PKN3;HEXB;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;SEMA6C;JAG2;MYO7A;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;DOK1;GDNF;EFNB2;PDE4B
7401,GO:0030334,5.63572301210027e-09,1,38,653,regulation of cell migration,BP,ITGA3;ITGA5;WNT4;NOTCH1;FADD;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;PYCARD;RRAS2;PRR5L;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;FAM110C;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5
2977,GO:0006082,5.66394164837953e-09,1,51,1031,organic acid metabolic process,BP,PDK4;PECR;ACTN3;PHYH;GLDC;FASN;MSRA;MRI1;APOC1;EXTL1;ACSF2;EDN1;PNP;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;SESN2;PFKFB3;ACAT1;B3GNT2;IDUA;ECHDC2;SARDH;HEXB;FABP3;CPT1C;PCBD1;MDH1;AKT1;PON2;PTGES;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;ACSL4;SLC1A3;ELOVL6;ETFDH
5725,GO:0016020,5.76528048305208e-09,1,231,8566,membrane,CC,ITGA3;ITGA5;CFB;EBP;PDK4;PECR;TMEM160;TMEM163;TMEM164;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;ACTN2;TSPAN15;TSPAN17;ALG5;NOTCH1;GLDC;RAB27A;CDH23;DPM3;STRA6;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;MSRA;RHBDL3;SLC31A2;MRPL14;MRPL16;SLC45A4;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;TRADD;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;EXTL1;PLAU;RAB40B;RAB40A;ABCG1;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;CCDC51;MBOAT2;SLC25A53;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;SYCN;FZD7;TYRO3;LPAR2;LIMS2;CDH2;FADS1;GHR;HRCT1;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;TJP3;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;AXIN1;FXYD1;RHOQ;RHOJ;RHOB;NPR1;TMEM223;CYP17A1;FGF8;SDC4;SPTB;HBEGF;PGBD5;LGALS4;BMP2;ACAT1;B3GNT2;DLL1;RAB20;DRP2;SLC2A14;HEXB;VAMP1;SFXN1;WNK4;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;TMEM176A;PTGES;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;LDHD;GJA3;TPBGL;TMEM98;HPCAL1;RAB44;TFPI;STAR;CLDN1;CLDN2;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;ACP5;ECI1;CYP11A1;RPH3AL;PRRT1;LZTS1;CLDN23;DHCR7;CYB5A;SHC4;SLC18B1;DSC3;GPSM1;AMOT;LAMA1;SH3BP4;KCND1;TSPAN2;RAB38;RAB3D;ACSL4;MYZAP;SLC1A3;FZD8;CNIH4;ELOVL6;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;LINGO1;ETFDH;PDE4B
7402,GO:0030335,5.77211485178996e-09,0.999999998881078,28,379,positive regulation of cell migration,BP,ITGA3;ITGA5;NOTCH1;FADD;WNT7A;ACVR1;EDN1;PLAU;CCL20;PYCARD;RRAS2;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;FAM110C;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
13984,GO:0051270,5.81887141609426e-09,1,42,772,regulation of cellular component movement,BP,ITGA3;ITGA5;WNT3;WNT4;NOTCH1;FADD;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;PYCARD;RRAS2;RGN;PRR5L;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;FAM110C;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5;PDE4B
10584,GO:0040012,5.82620533870021e-09,1,42,770,regulation of locomotion,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;NOTCH1;FADD;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;PYCARD;RRAS2;RGN;PRR5L;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;FAM110C;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5;EFNB2
2879,GO:0005923,5.9209956983609e-09,0.999999999314623,15,109,bicellular tight junction,CC,CGN;TJP3;JAM3;WNK4;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
7792,GO:0031128,5.93812803831107e-09,0.999999999745577,9,30,developmental induction,BP,WNT3;WNT2;WNT4;FGF10;FGF8;BMP4;BMP2;WNT2B;GDNF
3662,GO:0007154,6.2904083054404e-09,1,175,5959,cell communication,BP,ITGA3;ITGA5;ARTN;EBP;PDK4;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;IFI30;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;FADD;DHH;DSC2;WNT6;P2RY14;WNT7A;WNT7B;TRADD;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;FOXO4;RALB;PXK;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;GRIA3;RND3;CHGA;NOL3;DDR1;DEPTOR;CTGF;GJB1;GJB2;GJB6;RRAD;CASP4;AKT1;IFI27;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;STAR;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;RPH3AL;LZTS1;S100B;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;DOK1;GDNF;MYZAP;SLC1A3;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;LINGO1;PDE4B
6685,GO:0019752,6.29120433259092e-09,1,47,909,carboxylic acid metabolic process,BP,PDK4;PECR;ACTN3;PHYH;GLDC;FASN;MSRA;MRI1;APOC1;ACSF2;EDN1;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;SESN2;PFKFB3;ACAT1;IDUA;ECHDC2;SARDH;FABP3;CPT1C;PCBD1;MDH1;AKT1;PON2;PTGES;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;ACSL4;SLC1A3;ELOVL6;ETFDH
4356,GO:0009062,6.54972291412116e-09,0.999999999311696,14,92,fatty acid catabolic process,BP,PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;SESN2;ACAT1;ECHDC2;CPT1C;AKT1;DECR1;ECI1;ETFDH
2756,GO:0005737,6.56879587372636e-09,1,270,10558,cytoplasm,CC,ITGA3;ITGA5;TAGLN;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;IFI30;PNMT;DPM3;TF;ZFYVE21;ITGB5;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;FBXO41;MRPL14;MRPL16;MRI1;FADD;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;RHPN1;ABCG1;PRKACB;BDH2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;ASAH2;PIK3R2;PIK3R1;TICAM1;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;BOLA1;ANG;FAM110C;SPTB;HBEGF;LGALS4;NMI;BMP6;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;AOX1;PKN3;RAB20;ECHDC2;SARDH;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP1;RAB12;RAB17;PON2;CYTIP;PTGES;KITLG;IDH1;NPPC;DECR1;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;LDHD;TMEM98;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;ACP5;GLA;DTX4;ECI1;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DSC3;GPSM1;AMOT;ARAF;SH3BP4;UNC119;RAB38;DOK1;RAB3D;LYPLAL1;ACSL4;MYZAP;FAM110B;FZD8;CNIH4;ELOVL6;HEY1;ACTA2;RNF144A;PIM2;PARVB;ETFDH;PDE4B;TMOD4
579,GO:0001667,6.57101729920496e-09,0.999999998821813,25,311,ameboidal-type cell migration,BP,ITGA3;NOTCH1;WNT7A;ACVR1;EDN1;PRR5L;FGF18;FGF10;PDGFB;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP4;PKN3;AKT1;NRTN;KITLG;BCAR1;PIK3CA;AMOT;LAMA5;GDNF;EFNB2
16793,GO:0072009,6.83470449848568e-09,0.999999999199702,15,110,nephron epithelium development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;ACAT1;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
4597,GO:0009611,7.02118469246111e-09,1,37,626,response to wounding,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;ITGB4;SERPINA5;WNT7A;ZFPM1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;NOL3;DDR1;CTGF;AKT1;FAM46A;TFPI;PIK3CA;PIK3CG;GAS6;SLC1A3
15765,GO:0070160,8.62649383079487e-09,0.999999998961023,15,112,occluding junction,CC,CGN;TJP3;JAM3;WNK4;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
7078,GO:0022008,8.99620867868193e-09,1,61,1405,neurogenesis,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SALL4;SPTBN5;SPTBN4;FZD7;CDH2;FGF10;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;HEXB;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;NAB2;JAG2;CDH1;MYO7A;STAR;PIK3CA;GAS6;LZTS1;S100B;UNC119;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;FZD8;LINGO1
8550,GO:0032501,9.38889952147826e-09,1,194,6860,multicellular organismal process,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;PDK4;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;ALG5;NOTCH1;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;APOC1;ZFPM1;TRADD;SLC52A3;ACVR1;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EXTL1;EDN1;PLAU;PNP;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;SPTBN5;SPTBN4;PYCARD;ACADVL;KRT10;RRAS2;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;NNMT;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FXYD1;RBP4;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;PKN3;DRP2;SLC2A14;ESPN;HEXB;SFXN1;WNK4;CHGA;MSN;NOL3;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;FAM46A;TMEM176A;KITLG;SEMA6C;IDH1;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;TFPI;TLE1;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;PEPD;HAPLN3;DTX4;MYH11;LZTS1;S100B;DHCR7;PTS;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;KCND1;TSPAN2;DOK1;RAB3D;GDNF;ACSL4;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;EFNB2;LINGO1;PDE4B;TMOD4
11406,GO:0043436,9.46512004349939e-09,1,50,1016,oxoacid metabolic process,BP,PDK4;PECR;ACTN3;PHYH;GLDC;FASN;MSRA;MRI1;APOC1;EXTL1;ACSF2;EDN1;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;SESN2;PFKFB3;ACAT1;B3GNT2;IDUA;ECHDC2;SARDH;HEXB;FABP3;CPT1C;PCBD1;MDH1;AKT1;PON2;PTGES;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;ACSL4;SLC1A3;ELOVL6;ETFDH
13382,GO:0048732,9.73444240471372e-09,0.999999998026232,29,415,gland development,BP,WNT3;WNT2;WNT4;NOTCH1;STRA6;FASN;FADD;SERPINA5;WNT7B;DKK3;LIMS2;RGN;FSTL3;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;ACAT1;WT1;MSN;DDR1;AKT1;CDH1;CLDN1;PIK3CA;VDR;LAMA5
12388,GO:0045860,1.18927548079079e-08,0.999999997465111,31,468,positive regulation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;SDC4;ANG;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
82,GO:0000165,1.20357054397463e-08,1,44,846,MAPK cascade,BP,ARTN;LIF;ADRA2B;ADRA2C;ACTN2;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;SPTBN5;SPTBN4;PYCARD;MAPK12;FZD7;PSMB10;CDH2;GHR;FGF18;FGF10;FGF17;PDGFB;HRAS;WNT5A;AXIN1;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CG;GAS6;ARAF;GDNF;FZD8;DUSP5
7392,GO:0030324,1.23886039146162e-08,0.999999998050258,18,169,lung development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF18;FGF10;WNT5A;RBP4;FGF8;BMP4;CTGF;WNT2B;DHCR7;LAMA5
9722,GO:0035239,1.25018120994348e-08,0.99999999721514,26,346,tube morphogenesis,BP,WNT2;WNT4;NOTCH1;STRA6;WNT6;ACVR1;SALL4;EDN1;PRKACB;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;DDR1;WNT2B;VDR;LAMA5;GDNF;EFNB2
4673,GO:0009893,1.2582332515039e-08,1,105,3038,positive regulation of metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;RAB27A;ITGB8;FASN;PMAIP1;GADD45A;FADD;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;EDN1;ABCG1;PRKACB;CCL20;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;CHGA;MSN;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;RAB12;KITLG;NPPC;CDH1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;RBMS3;HNF1A;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
15508,GO:0061448,1.3366420380298e-08,0.999999997540794,21,230,connective tissue development,BP,NOTCH1;ITGB8;WNT7A;WNT7B;EDN1;FGF18;PDGFB;PLA2G16;WNT5B;WNT5A;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;CTGF;WNT2B;NPPC;PIK3CA;ACTA2
21027,GO:2000147,1.35603590091386e-08,0.999999996784305,28,393,positive regulation of cell motility,BP,ITGA3;ITGA5;NOTCH1;FADD;WNT7A;ACVR1;EDN1;PLAU;CCL20;PYCARD;RRAS2;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;FAM110C;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
18906,GO:1901701,1.50551861831539e-08,1,47,948,cellular response to oxygen-containing compound,BP,PDK4;WNT3;WNT2;ACTN2;WNT6;WNT7B;GUCY1B3;EDN1;PRKACB;CCL20;PYCARD;FZD7;RGN;GHR;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;WNT5B;WNT5A;SESN2;RHOQ;RHOB;RNASEL;BMP7;BMP6;WT1;SHPK;MSN;GJB2;GJB6;CASP4;AKT1;CDH1;BCAR1;INHBB;TFPI;STAR;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;SH3BP4;PDE4B
16999,GO:0072329,1.51223487239831e-08,0.999999998095706,15,114,monocarboxylic acid catabolic process,BP,PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;SESN2;ACAT1;IDUA;ECHDC2;CPT1C;AKT1;DECR1;ECI1;ETFDH
10589,GO:0040017,1.55857691982712e-08,0.9999999961808,29,421,positive regulation of locomotion,BP,ITGA3;ITGA5;ARTN;NOTCH1;FADD;WNT7A;ACVR1;EDN1;PLAU;CCL20;PYCARD;RRAS2;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;FAM110C;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
13451,GO:0048870,1.58587355918663e-08,1,58,1317,cell motility,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;ITGB4;FADD;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;PYCARD;RRAS2;TYRO3;RGN;CDH2;PRR5L;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;ANG;FAM110C;HBEGF;BMP4;BMP2;PKN3;HEXB;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
14205,GO:0051674,1.58587355918663e-08,1,58,1317,localization of cell,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;ITGB4;FADD;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;PYCARD;RRAS2;TYRO3;RGN;CDH2;PRR5L;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;ANG;FAM110C;HBEGF;BMP4;BMP2;PKN3;HEXB;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
3343,GO:0006635,1.6662590451423e-08,0.999999998507439,12,69,fatty acid beta-oxidation,BP,BDH2;ACADVL;CPT2;ETFB;SESN2;ACAT1;ECHDC2;CPT1C;AKT1;DECR1;ECI1;ETFDH
13304,GO:0048598,1.69809453597502e-08,0.999999996131288,34,561,embryonic morphogenesis,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;NOTCH1;STRA6;ITGB5;ITGB4;WNT6;WNT7A;WNT7B;ACVR1;SALL4;EDN1;PRKACB;FZD7;FGF10;WNT5A;AXIN1;RBP4;FGF8;SDC4;BMP7;BMP4;DLL1;GJB6;WNT2B;JAG2;MYO7A;AMOT;LAMA5;GDNF;DUSP5
3208,GO:0006468,1.78498274416149e-08,1,72,1808,protein phosphorylation,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;DDR1;DEPTOR;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2
21025,GO:2000145,1.79698233143108e-08,0.999999995598086,39,704,regulation of cell motility,BP,ITGA3;ITGA5;WNT4;NOTCH1;FADD;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;PYCARD;RRAS2;RGN;PRR5L;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;FAM110C;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5
7391,GO:0030323,1.79878786679598e-08,0.99999999709401,18,173,respiratory tube development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF18;FGF10;WNT5A;RBP4;FGF8;BMP4;CTGF;WNT2B;DHCR7;LAMA5
4646,GO:0009790,1.88599471462862e-08,1,46,931,embryo development,BP,ITGA3;ITGA5;LIF;WNT3;WNT2;WNT4;NOTCH1;STRA6;ITGB5;ITGB4;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;EDN1;PRKACB;FZD7;FGF10;PDGFB;WNT5A;AXIN1;RBP4;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;GJB6;AKT1;WNT2B;KITLG;JAG2;EPN1;MYO7A;DSC3;AMOT;LAMA1;LAMA5;GDNF;ACSL4;DUSP5;HEY1
721,GO:0001882,2.10360775219817e-08,0.999999995049727,27,371,nucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;ADORA1;RAB40B;RAB40A;PNP;RRAS2;RAB39B;RAB39A;ACSM5;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
4667,GO:0009887,2.19186503618354e-08,1,47,966,animal organ morphogenesis,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;FZD7;PSMB10;LIMS2;CDH2;FGF18;FGF10;HRAS;WNT5A;AXIN1;RBP4;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;CTGF;GJB6;WNT2B;NPPC;NAB2;JAG2;MYO7A;TLE1;CLDN5;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
13986,GO:0051272,2.30567573040867e-08,0.999999994395464,28,403,positive regulation of cellular component movement,BP,ITGA3;ITGA5;NOTCH1;FADD;WNT7A;ACVR1;EDN1;PLAU;CCL20;PYCARD;RRAS2;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;FAM110C;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
13922,GO:0051179,2.70534437578055e-08,1,170,5858,localization,BP,ITGA3;ITGA5;ARTN;EBP;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;USE1;RIN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;ZFYVE21;ITGB4;PMAIP1;CRISPLD2;SLC31A2;SLC45A4;FADD;DSC2;SERPINA5;WNT7A;MRAP;APOC1;SLC52A3;ACVR1;RABIF;NMT2;TBC1D14;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PNP;ABCG1;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;PYCARD;SLC25A53;TTYH1;RRAS2;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;FOXO4;RALB;CPT2;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;GPRASP1;SESN2;FXYD1;RBP4;RHOQ;RHOB;NPR1;PSRC1;RNASEL;FGF8;SDC4;ANG;FAM110C;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;RAB20;SLC2A14;HEXB;VAMP1;SFXN1;WNK4;FABP3;GRIA3;CHGA;MSN;NOL3;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;NRTN;KITLG;IDH1;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;RAB44;STAR;CLDN1;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;GLA;RPH3AL;DERA;CYB5A;SLC18B1;HNF1A;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;SLC1A3;CNIH4;CLDN16;CLDN15;CLDN18;EFNB2;PDE4B
3542,GO:0006935,2.76906213134651e-08,0.999999992400673,33,539,chemotaxis,BP,ARTN;WNT3;NOTCH1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;FGF18;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;FGF8;SPTB;HBEGF;BMP7;BMP4;B3GNT2;CHGA;NRTN;SEMA6C;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;DOK1;GDNF;EFNB2;PDE4B
18905,GO:1901700,2.77397022648084e-08,1,62,1464,response to oxygen-containing compound,BP,PDK4;WNT3;WNT2;ACTN2;NOTCH1;FADD;DHH;WNT6;WNT7A;WNT7B;GUCY1B3;EDN1;PRKACB;CCL20;PYCARD;MGST2;FZD7;RGN;GHR;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;WNT5B;WNT5A;KHK;SESN2;RBP4;RHOQ;RHOB;RNASEL;BMP7;BMP6;WT1;CDKN1A;SHPK;FABP3;MSN;CTGF;GJB2;GJB6;CASP4;AKT1;PTGES;NPPC;CDH1;BCAR1;INHBB;TFPI;STAR;CLDN1;CLDN3;PIK3CA;PIK3CG;GAS6;VDR;SH3BP4;CLDN18;PDE4B
10769,GO:0042330,2.89876806119902e-08,0.99999999202984,33,540,taxis,BP,ARTN;WNT3;NOTCH1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;FGF18;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;FGF8;SPTB;HBEGF;BMP7;BMP4;B3GNT2;CHGA;NRTN;SEMA6C;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;DOK1;GDNF;EFNB2;PDE4B
12062,GO:0045165,2.94201071872498e-08,0.999999994326935,21,240,cell fate commitment,BP,WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;FZD7;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B;JAG2
8371,GO:0032270,2.99295472663421e-08,1,60,1396,positive regulation of cellular protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;IFI27;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;RBMS3;ARAF;UNC119;FZD8;DUSP5;RNF144A
15383,GO:0061138,3.36481062604373e-08,0.999999994305082,18,180,morphogenesis of a branching epithelium,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
4623,GO:0009719,3.49375916050046e-08,1,64,1551,response to endogenous stimulus,BP,ITGA3;PDK4;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;FADD;WNT7A;WNT7B;ACVR1;CASQ2;DKK3;EDN1;ABCG1;PRKACB;MGST2;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;NNMT;FOXO4;WNT5A;KHK;SESN2;RHOQ;RNASEL;FGF8;ANG;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;CDKN1A;FABP3;CTGF;GJB2;CASP4;AKT1;IDH1;CDH1;BCAR1;INHBB;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;ZCCHC12;S100B;VDR;SH3BP4;HEY1;PDE4B
3454,GO:0006796,3.97661086530743e-08,1,102,2984,phosphate-containing compound metabolic process,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;DPM3;ZFYVE21;GADD45A;WNT7A;WNT7B;MRAP;APOC1;ACVR1;GUCY1B3;ADORA1;EDN1;PNP;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;MBOAT2;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;NNMT;RALB;PLA2G16;HRAS;WNT5A;KHK;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;CDKN1A;PKN3;SHPK;HEXB;WNK4;FABP3;CHGA;NUDT7;DDR1;DEPTOR;CTGF;MDH1;AKT1;NRTN;KITLG;IDH1;NPPC;INHBB;MDP1;PIK3CA;PIK3CG;GAS6;ACP5;DERA;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2;PDE4B
10632,GO:0042060,4.54232663080057e-08,0.999999987523182,32,522,wound healing,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;SERPINA5;WNT7A;ZFPM1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;HRAS;WNT5B;WNT5A;RHOB;SDC4;HBEGF;DDR1;AKT1;FAM46A;TFPI;PIK3CA;PIK3CG;GAS6
16807,GO:0072028,4.7592989679407e-08,0.999999995245653,12,77,nephron morphogenesis,BP,LIF;WNT4;WNT6;FGF8;BMP7;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
5883,GO:0016331,4.94328535316506e-08,0.999999992521553,16,145,morphogenesis of embryonic epithelium,BP,WNT2;WNT4;WNT6;WNT7B;SALL4;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;WNT2B;JAG2;LAMA5;GDNF
1710,GO:0003924,4.99708369601999e-08,0.999999989355711,22,266,GTPase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
6534,GO:0019216,5.07158425275226e-08,0.99999998918327,22,269,regulation of lipid metabolic process,BP,PDK4;WNT4;DHH;APOC1;ADORA1;DKK3;ABCG1;ACADVL;RGN;PIK3R2;PIK3R1;PDGFB;SESN2;BMP6;BMP2;FABP3;AKT1;IDH1;STAR;PIK3CG;DHCR7;VDR
9161,GO:0033674,5.16932470613575e-08,0.999999986011405,31,498,positive regulation of kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;SDC4;ANG;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
7926,GO:0031401,5.17180925569605e-08,1,51,1114,positive regulation of protein modification process,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;FZD7;PSMB10;CDH2;PRR5L;GHR;FGF18;FGF10;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
722,GO:0001883,5.41189352840544e-08,0.999999986606259,26,363,purine nucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;ADORA1;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;ACSM5;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
11712,GO:0044283,6.18072523888395e-08,0.999999982439334,31,496,small molecule biosynthetic process,BP,EBP;PDK4;PECR;WNT4;FASN;MRI1;HSD17B3;APOC1;HMGCS2;DKK3;EDN1;PNP;ABCG1;BDH2;ACADVL;MGST2;ACSM5;RGN;FADS1;SESN2;RBP4;BMP6;BMP2;ACAT1;MDH1;PTGES;STAR;DHCR7;VDR;SLC1A3;ELOVL6
13364,GO:0048699,6.50200287762068e-08,1,56,1311,generation of neurons,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SPTBN5;SPTBN4;FZD7;CDH2;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;JAG2;CDH1;MYO7A;STAR;PIK3CA;GAS6;LZTS1;S100B;UNC119;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;FZD8;LINGO1
11792,GO:0044421,6.52266429200335e-08,1,119,3687,extracellular region part,CC,ITGA3;ARTN;CFB;LIF;WNT3;WNT2;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;MSRA;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;DKK3;EDN1;PLAU;PNP;PRKACB;MFGE8;CCL20;BDH2;SPTBN5;SPTBN4;KRT10;RRAS2;CDH2;GHR;FSTL3;FGF18;FGF10;FGF17;PDGFB;FRMPD1;RALB;ETFB;WNT5B;WNT5A;JAM3;SNX18;KHK;RBP4;RHOQ;RHOJ;RHOB;SDC4;CLCF1;ANG;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;DAAM2;IDUA;AOX1;HEXB;CMBL;FABP3;RND3;CHGA;MSN;DDR1;DSG3;CTGF;PCBD1;MDH1;PKP1;RAB17;WNT2B;KITLG;IDH1;NPPC;DECR1;CDH1;INHBB;MDP1;HPCAL1;TFPI;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;PEPD;ACP5;GLA;HAPLN3;ECI1;MYH11;DERA;S100B;CYB5A;PM20D2;LAMA1;LAMA5;SH3BP4;UNC119;RAB3D;LYPLAL1;ACSL4;ACTA2;CLDN11;LINGO1
632,GO:0001759,6.86841037381239e-08,0.99999999784629,7,19,organ induction,BP,WNT2;FGF10;FGF8;BMP4;BMP2;WNT2B;GDNF
5736,GO:0016042,6.92819614773908e-08,0.999999984328458,23,296,lipid catabolic process,BP,PHYH;APOC1;ADORA1;HSD17B11;BDH2;ACADVL;CPT2;PLA2G16;ETFB;HACL1;SESN2;ACAT1;ECHDC2;HEXB;FABP3;CPT1C;AKT1;IDH1;DECR1;PIK3CG;GLA;ECI1;ETFDH
13259,GO:0048514,7.17261171798113e-08,0.999999979934193,30,481,blood vessel morphogenesis,BP,ITGA5;WNT4;NOTCH1;STRA6;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF18;FGF10;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;ANG;BMP4;WT1;DLL1;CTGF;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;EFNB2
7883,GO:0031325,7.39406309434106e-08,1,97,2825,positive regulation of cellular metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;RAB27A;FASN;PMAIP1;GADD45A;FADD;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;EDN1;PRKACB;CCL20;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;CHGA;MSN;CTGF;PCBD1;AKT1;IFI27;RAB12;KITLG;NPPC;CDH1;INHBB;STAR;PIK3CA;PIK3CG;GAS6;RBMS3;HNF1A;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
4698,GO:0009967,7.49814698238503e-08,1,59,1402,positive regulation of signal transduction,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;ADORA1;EDN1;CCL20;PYCARD;G0S2;FZD7;PSMB10;LIMS2;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;S100B;ARAF;DOK1;FZD8;DUSP5;PIM2
10836,GO:0042446,9.16333821234096e-08,0.999999991536742,11,65,hormone biosynthetic process,BP,WNT4;HSD17B3;HSD17B11;DKK3;CYP17A1;BMP6;BMP2;HSD3B2;STAR;CYP11A1;DHCR7
3673,GO:0007165,9.29644943020799e-08,1,159,5449,signal transduction,BP,ITGA3;ITGA5;ARTN;EBP;PDK4;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;IFI30;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;FADD;DHH;WNT6;P2RY14;WNT7A;WNT7B;TRADD;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;RNASEL;FGF8;SDC4;CLCF1;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;GRIA3;RND3;CHGA;NOL3;DDR1;DEPTOR;CTGF;RRAD;CASP4;AKT1;IFI27;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;RPH3AL;S100B;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;DOK1;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;LINGO1;PDE4B
12884,GO:0046934,9.38130211629798e-08,0.999999991300771,11,66,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
4719,GO:0010033,9.51756395250122e-08,1,96,2793,response to organic substance,BP,ITGA3;ITGA5;PDK4;WNT3;WNT2;WNT4;ACTN2;NOTCH1;IFI30;RASL11B;ITGB5;FASN;PMAIP1;FADD;DHH;WNT6;WNT7A;WNT7B;TRADD;ACVR1;CASQ2;DKK3;EDN1;ABCG1;PRKACB;CCL20;PYCARD;ACADVL;MGST2;FZD7;PSMB10;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;PRKAR1B;NNMT;FOXO4;RALB;WNT5B;WNT5A;KHK;SESN2;RBP4;RHOQ;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;CDKN1A;DLL1;SHPK;FABP3;MSN;NOL3;CTGF;GJB2;GJB6;CASP4;AKT1;IFI27;PTGES;IDH1;NPPC;CDH1;BCAR1;INHBB;TFPI;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;S100B;VDR;SH3BP4;ACSL4;HEY1;CLDN18;PDE4B
10708,GO:0042221,9.64438240819878e-08,1,126,4006,response to chemical,BP,ITGA3;ITGA5;ARTN;EBP;PDK4;WNT3;WNT2;WNT4;ACTN2;RAB6C;NOTCH1;IFI30;RASL11B;TF;ITGB5;FASN;PMAIP1;FADD;DHH;WNT6;WNT7A;WNT7B;TRADD;ACVR1;GUCY1B3;CASQ2;DKK3;EDN1;PLAU;PNP;ABCG1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;ACADVL;MGST2;FZD7;PSMB10;RGN;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;PRKAR1B;NNMT;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;KHK;SESN2;RBP4;RHOQ;RHOB;RNASEL;FGF8;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;WT1;CDKN1A;DLL1;SHPK;CMBL;FABP3;CHGA;MSN;NOL3;CTGF;GJB2;GJB6;CASP4;AKT1;IFI27;PON2;NRTN;PTGES;SEMA6C;IDH1;NPPC;CDH1;BCAR1;INHBB;TFPI;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;RPH3AL;S100B;CYB5A;VDR;AMOT;SH3BP4;DOK1;GDNF;ACSL4;SLC1A3;HEY1;CLDN18;EFNB2;PDE4B
634,GO:0001763,9.65415086207511e-08,0.999999982380551,18,193,morphogenesis of a branching structure,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
13965,GO:0051247,1.09100301085807e-07,1,61,1485,positive regulation of protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;IFI27;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;RBMS3;ARAF;UNC119;FZD8;DUSP5;RNF144A
16174,GO:0070887,1.10313245393044e-07,1,92,2645,cellular response to chemical stimulus,BP,ITGA3;ITGA5;PDK4;WNT3;WNT2;WNT4;ACTN2;NOTCH1;IFI30;RASL11B;TF;ITGB5;FASN;PMAIP1;FADD;WNT6;WNT7A;WNT7B;TRADD;ACVR1;GUCY1B3;CASQ2;DKK3;EDN1;PRKACB;CCL20;PYCARD;ACADVL;MGST2;FZD7;PSMB10;RGN;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;JAM3;SESN2;RHOQ;RHOB;RNASEL;FGF8;CLCF1;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;SHPK;CMBL;CHGA;MSN;NOL3;CTGF;GJB2;GJB6;CASP4;AKT1;IFI27;CDH1;BCAR1;INHBB;TFPI;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;S100B;VDR;SH3BP4;HEY1;CLDN18;PDE4B
7286,GO:0030182,1.15999263428123e-07,1,52,1196,neuron differentiation,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SPTBN5;SPTBN4;FZD7;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;JAG2;CDH1;MYO7A;PIK3CA;LZTS1;S100B;UNC119;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;FZD8;LINGO1
3792,GO:0007399,1.16752463898649e-07,1,78,2141,nervous system development,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;MARK4;CDH23;IGSF8;DHH;WNT6;WNT7A;WNT7B;SALL4;ADORA1;PRKACB;SPTBN5;SPTBN4;FZD7;TYRO3;CDH2;FGF10;FGF17;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;DLL1;DRP2;HEXB;DDR1;GJB1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;NAB2;JAG2;CDH1;MYO7A;STAR;CLDN1;PIK3CA;GAS6;HAPLN3;LZTS1;S100B;PTS;GPSM1;UNC119;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;FZD8;CLDN11;EFNB2;LINGO1
12468,GO:0045995,1.16972408517442e-07,0.999999983994797,14,117,regulation of embryonic development,BP,WNT2;WNT4;NOTCH1;PRKACB;FZD7;WNT5A;BMP7;BMP4;DLL1;WNT2B;AMOT;LAMA1;LAMA5;GDNF
11391,GO:0043410,1.36771732051644e-07,0.999999961468162,29,463,positive regulation of MAPK cascade,BP,LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;PYCARD;FZD7;CDH2;GHR;FGF18;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;BMP4;BMP2;CTGF;KITLG;PIK3CG;GAS6;ARAF;FZD8;DUSP5
2649,GO:0005525,1.50889834867799e-07,0.99999996175439,25,357,GTP binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;ACSM5;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
14499,GO:0052813,1.51377868229484e-07,0.999999985196429,11,69,phosphatidylinositol bisphosphate kinase activity,MF,FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
18139,GO:0098742,1.58683505809587e-07,0.999999968376155,19,222,cell-cell adhesion via plasma-membrane adhesion molecules,BP,ITGA5;CDH23;DSC2;ACVR1;CDH2;BMP2;DSG3;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;DSC3;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
13664,GO:0050793,1.58745908201096e-07,1,79,2180,regulation of developmental process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;FADD;WNT6;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;EDN1;PNP;ABCG1;PRKACB;SPTBN4;MAPK12;FZD7;PSMB10;LIMS2;RGN;CDH2;FADS1;GHR;FSTL3;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;PLA2G16;WNT5B;WNT5A;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HEXB;MSN;CTGF;AKT1;RAB17;WNT2B;TMEM176A;KITLG;NPPC;NAB2;STAR;CLDN5;PIK3CA;GAS6;LZTS1;S100B;VDR;AMOT;LAMA1;LAMA5;GDNF;HEY1;CLDN18;PARVB;EFNB2;LINGO1
16520,GO:0071495,1.74035596260166e-07,1,52,1204,cellular response to endogenous stimulus,BP,ITGA3;PDK4;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;WNT7A;ACVR1;CASQ2;DKK3;EDN1;PRKACB;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;WNT5A;SESN2;RHOQ;RNASEL;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CTGF;GJB2;CASP4;AKT1;CDH1;BCAR1;INHBB;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;ZCCHC12;VDR;SH3BP4;HEY1;PDE4B
8575,GO:0032550,1.77578723318165e-07,0.999999954232841,25,360,purine ribonucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;ACSM5;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
11181,GO:0043085,1.85341617664046e-07,1,62,1554,positive regulation of catalytic activity,BP,ARTN;ADRA2B;ADRA2C;WNT4;RIN3;ACTN2;PMAIP1;GADD45A;FADD;WNT7B;APOC1;TRADD;RABIF;TBC1D14;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;MGST2;MAPK12;PSMB10;LPAR2;RGN;GHR;FGF18;FGF10;FGF17;PIK3R2;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;AXIN1;PSRC1;FGF8;SDC4;ANG;SPTB;HBEGF;BMP4;BMP2;CDKN1A;CTGF;AKT1;IFI27;NRTN;KITLG;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5
13919,GO:0051174,1.88671924976005e-07,1,63,1586,regulation of phosphorus metabolic process,BP,ITGA5;PDK4;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;MRAP;APOC1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;PYCARD;FZD7;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;FABP3;CHGA;DEPTOR;CTGF;AKT1;KITLG;IDH1;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
5871,GO:0016310,1.90922695474634e-07,1,78,2145,phosphorylation,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;ZFYVE21;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;RALB;HRAS;WNT5A;KHK;SESN2;AXIN1;NPR1;NUAK2;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;SHPK;WNK4;DDR1;DEPTOR;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2
13415,GO:0048806,2.04920724921567e-07,0.999999985572212,9,44,genitalia development,BP,STRA6;HSD17B3;TYRO3;FGF10;WNT5A;RBP4;FGF8;BMP6;WT1
8574,GO:0032549,2.17956732287267e-07,0.999999943173904,25,364,ribonucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;ACSM5;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
20958,GO:2000027,2.45019466987425e-07,0.999999947203393,20,247,regulation of organ morphogenesis,BP,LIF;WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FZD7;PSMB10;LIMS2;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;WNT2B;VDR;GDNF
16387,GO:0071310,2.46921435322928e-07,1,79,2192,cellular response to organic substance,BP,ITGA3;ITGA5;PDK4;WNT3;WNT2;WNT4;ACTN2;NOTCH1;IFI30;RASL11B;ITGB5;FASN;FADD;WNT6;WNT7A;WNT7B;TRADD;ACVR1;CASQ2;DKK3;EDN1;PRKACB;CCL20;PYCARD;ACADVL;FZD7;PSMB10;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;SESN2;RHOQ;RNASEL;FGF8;CLCF1;NMI;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;SHPK;MSN;NOL3;CTGF;GJB2;GJB6;CASP4;AKT1;IFI27;CDH1;BCAR1;INHBB;TFPI;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;SH3BP4;HEY1;CLDN18;PDE4B
13385,GO:0048738,2.54234023567592e-07,0.999999953106188,17,186,cardiac muscle tissue development,BP,FHOD3;WNT2;ACTN2;NOTCH1;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;RBP4;FGF8;BMP7;BMP4;BMP2;WT1;MYH11;EFNB2
4593,GO:0009605,2.54414355991733e-07,1,74,2000,response to external stimulus,BP,ARTN;CFB;PDK4;WNT3;WNT4;NOTCH1;STRA6;PMAIP1;GADD45A;FADD;DSC2;NMT2;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;PYCARD;MGST2;TYRO3;FADS1;FGF18;FGF10;PIK3R1;TICAM1;PDGFB;FOXO4;RALB;HRAS;WNT5A;JAM3;NUAK2;RNASEL;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;ACAT1;B3GNT2;CDKN1A;SHPK;CHGA;GJB2;GJB6;CASP4;AKT1;NRTN;WNT2B;FAM46A;PTGES;SEMA6C;BCAR1;INHBB;TFPI;STAR;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;AMOT;UNC119;RAB38;DOK1;GDNF;ACSL4;SLC1A3;ACTA2;PIM2;EFNB2;PDE4B
5746,GO:0016054,2.66181439903511e-07,0.99999994508306,19,224,organic acid catabolic process,BP,PHYH;GLDC;BDH2;ACADVL;CPT2;HSD17B10;ETFB;HACL1;SESN2;ACAT1;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;AKT1;DECR1;ECI1;ETFDH
12625,GO:0046395,2.66181439903511e-07,0.99999994508306,19,224,carboxylic acid catabolic process,BP,PHYH;GLDC;BDH2;ACADVL;CPT2;HSD17B10;ETFB;HACL1;SESN2;ACAT1;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;AKT1;DECR1;ECI1;ETFDH
4911,GO:0010647,2.74072702534463e-07,1,61,1530,positive regulation of cell communication,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;ADORA1;EDN1;CCL20;PYCARD;G0S2;FZD7;PSMB10;LIMS2;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;AXIN1;RBP4;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;S100B;ARAF;DOK1;SLC1A3;FZD8;DUSP5;PIM2
9748,GO:0035270,2.87781521214905e-07,0.99999995736134,14,124,endocrine system development,BP,WNT4;STRA6;DKK3;FSTL3;FGF10;WNT5A;FGF8;BMP6;BMP4;BMP2;WT1;DLL1;AKT1;CDH1
11616,GO:0044057,2.94341418960149e-07,0.999999912922841,29,484,regulation of system process,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;FGF10;PDGFB;KCNH2;FXYD1;NPR1;HBEGF;BMP6;WNK4;CHGA;NOL3;CTGF;AKT1;NPPC;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;KCND1;PDE4B
9641,GO:0035004,2.96943369573399e-07,0.99999996866686,11,74,phosphatidylinositol 3-kinase activity,MF,FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
3392,GO:0006694,3.01094336467192e-07,0.999999947447963,16,162,steroid biosynthetic process,BP,EBP;WNT4;DHH;HSD17B3;HMGCS2;HSD17B11;DKK3;ABCG1;CYP17A1;BMP6;BMP2;HSD3B2;STAR;CYP11A1;DHCR7;VDR
6538,GO:0019220,3.0885929783802e-07,1,62,1573,regulation of phosphate metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;MRAP;APOC1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;PYCARD;FZD7;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;FABP3;CHGA;DEPTOR;CTGF;AKT1;KITLG;IDH1;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
7173,GO:0023056,3.26929655974651e-07,1,61,1538,positive regulation of signaling,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;ADORA1;EDN1;CCL20;PYCARD;G0S2;FZD7;PSMB10;LIMS2;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;AXIN1;RBP4;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;S100B;ARAF;DOK1;SLC1A3;FZD8;DUSP5;PIM2
16841,GO:0072088,3.28620356697228e-07,0.999999964918912,11,75,nephron epithelium morphogenesis,BP,LIF;WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
12187,GO:0045446,3.28820631698337e-07,0.999999959957513,12,91,endothelial cell differentiation,BP,NOTCH1;WNT7A;WNT7B;ACVR1;BMP6;BMP4;DLL1;MSN;CLDN1;CLDN5;LAMA5;HEY1
16859,GO:0072109,3.30261696712285e-07,0.999999991186077,6,15,glomerular mesangium development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
9134,GO:0033612,3.3585865129348e-07,0.999999991010476,6,15,receptor serine/threonine kinase binding,MF,FADD;PYCARD;BMP7;BMP6;BMP4;BMP2
7932,GO:0031410,3.42330979413388e-07,1,76,2095,cytoplasmic vesicle,CC,ITGA5;EBP;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;ZFYVE21;ITGB5;FASN;CRISPLD2;SLC31A2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;TBC1D14;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PYCARD;RAB39A;SYCN;FZD7;LPAR2;FSTL3;TICAM1;PDGFB;WNT5B;WNT5A;SNX18;AXIN1;RHOQ;RHOB;ANG;HBEGF;IDUA;DLL1;RAB20;HEXB;VAMP1;GRIA3;CHGA;PKP1;RAB12;RAB17;CYTIP;IDH1;NPPC;CDH1;MYO7A;RAB44;SNX21;RAB11FIP1;GAS6;GLA;RPH3AL;MYH11;DERA;AMOT;SH3BP4;RAB38;RAB3D;RNF144A;PDE4B
18023,GO:0097708,3.61368701988962e-07,1,76,2098,intracellular vesicle,CC,ITGA5;EBP;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;ZFYVE21;ITGB5;FASN;CRISPLD2;SLC31A2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;TBC1D14;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PYCARD;RAB39A;SYCN;FZD7;LPAR2;FSTL3;TICAM1;PDGFB;WNT5B;WNT5A;SNX18;AXIN1;RHOQ;RHOB;ANG;HBEGF;IDUA;DLL1;RAB20;HEXB;VAMP1;GRIA3;CHGA;PKP1;RAB12;RAB17;CYTIP;IDH1;NPPC;CDH1;MYO7A;RAB44;SNX21;RAB11FIP1;GAS6;GLA;RPH3AL;MYH11;DERA;AMOT;SH3BP4;RAB38;RAB3D;RNF144A;PDE4B
1449,GO:0003158,3.66810043859602e-07,0.999999949518654,13,109,endothelium development,BP,NOTCH1;WNT7A;WNT7B;ACVR1;RHOB;BMP6;BMP4;DLL1;MSN;CLDN1;CLDN5;LAMA5;HEY1
13738,GO:0050896,3.67422402817746e-07,1,212,8010,response to stimulus,BP,ITGA3;ITGA5;ARTN;CFB;EBP;PDK4;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;IFI30;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;ZFPM1;TRADD;SLC52A3;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PNP;RHPN1;ABCG1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;MPZL1;RRAS2;TSPAN13;MGST2;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;PRKAR1B;NNMT;FOXO4;RALB;PXK;HRAS;WNT5B;WNT5A;JAM3;KHK;GPRASP1;SESN2;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;WT1;CDKN1A;DLL1;AOX1;PKN3;SHPK;HEXB;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;DDR1;DEPTOR;CTGF;GJB2;GJB6;RRAD;CASP4;AKT1;IFI27;PKP1;RAB17;PON2;NRTN;WNT2B;FAM46A;PTGES;KITLG;SEMA6C;IDH1;NPPC;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;GLA;DTX4;ZCCHC12;RPH3AL;PRRT1;DERA;S100B;CYB5A;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;DOK1;RAB3D;GDNF;ACSL4;MYZAP;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN18;PIM2;EFNB2;LINGO1;ETFDH;PDE4B
8586,GO:0032561,3.77553694836836e-07,0.999999898449149,25,375,guanyl ribonucleotide binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;ACSM5;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
6456,GO:0019001,3.96794536791436e-07,0.999999892971405,25,376,guanyl nucleotide binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;ACSM5;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
7171,GO:0023051,3.98395310033425e-07,1,99,3019,regulation of signaling,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;PYCARD;G0S2;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;PXK;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;NOL3;DEPTOR;CTGF;AKT1;WNT2B;KITLG;NPPC;JAG2;EPN1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;RPH3AL;LZTS1;S100B;GPSM1;AMOT;ARAF;SH3BP4;DOK1;GDNF;SLC1A3;FZD8;DUSP5;HEY1;PIM2
17400,GO:0090130,4.18677729502921e-07,0.999999910399556,19,235,tissue migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF18;FGF10;PDGFB;WNT5A;RHOB;FGF8;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;ACTA2;EFNB2
6536,GO:0019218,4.25015799228017e-07,0.999999953408057,11,75,regulation of steroid metabolic process,BP,WNT4;DHH;APOC1;DKK3;ABCG1;ACADVL;BMP6;BMP2;STAR;DHCR7;VDR
3840,GO:0007548,4.26604933979186e-07,0.999999904111297,20,257,sex differentiation,BP,WNT4;STRA6;DHH;WNT7A;HSD17B3;TYRO3;FSTL3;FGF10;WNT5A;RBP4;CYP17A1;FGF8;ANG;BMP6;WT1;WNT2B;KITLG;IDH1;INHBB;STAR
4876,GO:0010604,4.35418821681292e-07,1,94,2817,positive regulation of macromolecule metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;FADD;WNT6;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;EDN1;PRKACB;CCL20;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;HEXB;MSN;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;KITLG;CDH1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;RBMS3;HNF1A;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
7194,GO:0030029,4.45472147668188e-07,0.999999851096444,34,646,actin filament-based process,BP,FHOD3;WNT4;ACTN3;ACTN2;ITGB5;DSC2;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;FGF10;PIK3R1;KCNH2;PLEKHH2;HRAS;JAM3;RHOQ;RHOJ;NUAK2;SDC4;ANG;SPTB;DAAM2;ESPN;RND3;CTGF;MYO7A;BCAR1;MYH11;AMOT;PARVB;PDE4B;TMOD4
13266,GO:0048523,4.49963824288606e-07,1,127,4185,negative regulation of cellular process,BP,ITGA3;ITGA5;PDK4;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;IFI30;RASL11B;GADD45A;FADD;SERPINA5;WNT7A;APOC1;ZFPM1;TRADD;ACVR1;SALL4;TBC1D14;ADORA1;CASQ2;DKK3;EDN1;ABCG1;PRKACB;SPTBN5;SPTBN4;PYCARD;ACADVL;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;FSTL3;FGF10;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RBP4;RHOQ;RHOB;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;ESPN;FABP3;CHGA;NOL3;DDR1;DEPTOR;CTGF;GJB6;AKT1;IFI27;PKP3;PKP1;TMEM176A;PTGES;KITLG;NPPC;CST9L;NAB2;CDH1;EPN1;INHBB;TFPI;TLE1;STAR;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;GLA;RPH3AL;LZTS1;S100B;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;LINGO1;TMOD4
16091,GO:0070700,4.50026357889907e-07,0.999999993733084,5,9,BMP receptor binding,MF,PYCARD;BMP7;BMP6;BMP4;BMP2
2667,GO:0005576,4.7137222572085e-07,1,133,4413,extracellular region,CC,ITGA3;ARTN;CFB;LIF;WNT3;WNT2;WNT4;ACTN3;ACTN2;TSPAN15;NOTCH1;RAB27A;IFI30;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;MSRA;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;HSD17B11;DKK3;EDN1;PLAU;PNP;PRKACB;MFGE8;CCL20;BDH2;SPTBN5;SPTBN4;PYCARD;KRT10;RRAS2;PRND;CDH2;GHR;FSTL3;FGF18;FGF10;FGF17;PDGFB;FRMPD1;RALB;ETFB;WNT5B;WNT5A;JAM3;SNX18;KHK;RBP4;RHOQ;RHOJ;RHOB;FGF8;OLFML2B;SDC4;CLCF1;ANG;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;DAAM2;IDUA;DLL1;AOX1;HEXB;CMBL;FABP3;RND3;CHGA;MSN;DDR1;DSG3;CTGF;PCBD1;MDH1;CASP4;PKP1;RAB17;PON2;NRTN;WNT2B;KITLG;IDH1;NPPC;DECR1;CST9L;CDH1;INHBB;MDP1;HPCAL1;TFPI;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;PEPD;ACP5;GLA;HAPLN3;ECI1;MYH11;DERA;S100B;CYB5A;PM20D2;DSC3;LAMA1;LAMA5;SH3BP4;UNC119;RAB3D;GDNF;LYPLAL1;ACSL4;ACTA2;CLDN11;LINGO1
15766,GO:0070161,4.75943328278464e-07,0.999999855687235,29,498,anchoring junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;NOTCH1;ZFYVE21;ITGB5;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;JAM3;RHOB;SDC4;CAMSAP3;DLL1;RND3;MSN;DSG3;PKP3;PKP1;CDH1;BCAR1;DSC3;PARVB;EFNB2
19200,GO:1902533,4.87791094328307e-07,0.999999830474413,42,885,positive regulation of intracellular signal transduction,BP,LIF;ADRA2B;ADRA2C;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ADORA1;EDN1;CCL20;PYCARD;FZD7;CDH2;PRR5L;GHR;FGF18;FGF10;TICAM1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;FAM110C;HBEGF;BMP4;BMP2;CTGF;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;S100B;ARAF;FZD8;DUSP5;PIM2
5167,GO:0012501,4.92449621592779e-07,1,70,1885,programmed cell death,BP,ITGA5;PDK4;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;FADD;DSC2;WNT7A;TRADD;ACVR1;ADORA1;EDN1;PHLDA1;PYCARD;G0S2;KRT10;TYRO3;LIMS2;RGN;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;NOL3;DSG3;DEPTOR;CTGF;GJB6;CASP4;AKT1;IFI27;PKP3;PKP1;KITLG;JAG2;BCAR1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;S100B;SHC4;DSC3;VDR;ARAF;GDNF;PIM2
13836,GO:0051049,5.04861725692049e-07,1,66,1748,regulation of transport,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;TF;PMAIP1;SLC31A2;APOC1;TBC1D14;ADORA1;CASQ2;EDN1;ABCG1;KCNK6;MFGE8;SPTBN4;PYCARD;TTYH1;TSPAN13;FZD7;RGN;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;WNT5A;FXYD1;RBP4;RHOQ;NPR1;RNASEL;SDC4;ANG;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;WNK4;CHGA;MSN;NOL3;AKT1;IFI27;RAB17;CDH1;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;RPH3AL;UNC119;KCND1;RAB3D;GDNF;PDE4B
16750,GO:0071900,5.37790628527738e-07,0.999999839809703,28,467,regulation of protein serine/threonine kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PYCARD;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CG;ARAF;FZD8;DUSP5
13957,GO:0051234,5.75919214611949e-07,1,142,4853,establishment of localization,BP,ITGA3;EBP;LIF;ADRA2B;ADRA2C;SYT5;WNT4;USE1;RIN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;ZFYVE21;PMAIP1;CRISPLD2;SLC31A2;SLC45A4;SERPINA5;WNT7A;APOC1;SLC52A3;RABIF;NMT2;TBC1D14;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PNP;ABCG1;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;PYCARD;SLC25A53;TTYH1;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;CPT2;HRAS;WNT5A;SNX18;GPRASP1;SESN2;FXYD1;RBP4;RHOQ;RHOB;NPR1;PSRC1;RNASEL;SDC4;ANG;SPTB;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;SLC2A14;HEXB;VAMP1;SFXN1;WNK4;FABP3;GRIA3;CHGA;MSN;NOL3;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;IDH1;CDH1;EPN1;MYO7A;INHBB;GJA3;RAB44;STAR;CLDN1;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;GLA;RPH3AL;DERA;CYB5A;SLC18B1;HNF1A;VDR;LAMA5;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;SLC1A3;CNIH4;CLDN16;CLDN15;PDE4B
12836,GO:0046854,6.01630286315646e-07,0.999999922038409,12,96,phosphatidylinositol phosphorylation,BP,ZFYVE21;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
11233,GO:0043168,6.04856953448347e-07,1,87,2575,anion binding,MF,PDK4;SYT5;TUBG2;ACTN2;RAB6C;PHYH;GLDC;MARK4;RAB27A;RASL11B;FASN;CRISPLD2;SERPINA5;APOC1;ACVR1;GUCY1B3;ACSF2;RAB40B;RAB40A;PNP;ABCG1;PRKACB;MFGE8;SPTBN4;ACADVL;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;FZD7;TYRO3;FGF10;PRKAR1B;RALB;PXK;HRAS;SNX18;KHK;HACL1;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;ANG;HBEGF;BMP7;BMP4;AOX1;PKN3;RAB20;SHPK;WNK4;FABP3;RND3;DDR1;CTGF;ACCS;RRAD;AKT1;RAB12;RAB17;PTGES;DECR1;MYO7A;LDHD;RAB44;SNX21;PIK3CA;PIK3CG;GAS6;RPH3AL;MYH11;VDR;ARAF;RAB38;RAB3D;ACSL4;SLC1A3;ACTA2;PIM2;ETFDH;PDE4B
3828,GO:0007517,6.34636037921292e-07,0.999999834724159,23,343,muscle organ development,BP,TAGLN;LIF;WNT2;ACTN3;NOTCH1;STRA6;IGSF8;ZFPM1;EDN1;MAPK12;FZD7;FOXO4;WNT5A;RBP4;FGF8;HBEGF;BMP4;BMP2;WT1;DLL1;S100B;LAMA5;EFNB2
2698,GO:0005615,7.02315523519405e-07,0.999999781940643,56,1364,extracellular space,CC,ARTN;CFB;LIF;WNT3;WNT2;WNT4;TF;DHH;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;DKK3;EDN1;PLAU;MFGE8;CCL20;KRT10;GHR;FSTL3;FGF18;FGF10;FGF17;PDGFB;WNT5B;WNT5A;JAM3;RBP4;CLCF1;ANG;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;HEXB;FABP3;CHGA;MSN;DDR1;CTGF;MDH1;WNT2B;KITLG;NPPC;INHBB;TFPI;GAS6;HAPLN3;S100B;LAMA1;LAMA5;ACTA2;LINGO1
11711,GO:0044282,7.0408722919489e-07,0.999999815601316,23,336,small molecule catabolic process,BP,ACTN3;PHYH;GLDC;BDH2;ACADVL;CPT2;HSD17B10;ETFB;KHK;HACL1;SESN2;GALT;PFKFB3;ACAT1;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;AKT1;DECR1;ECI1;ETFDH
11475,GO:0043549,7.08916118113022e-07,0.999999742643304,38,772,regulation of kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;PYCARD;RGN;GHR;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;SDC4;ANG;BMP7;BMP4;BMP2;CDKN1A;DEPTOR;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
11175,GO:0043067,7.19323572011179e-07,0.999999776510522,56,1377,regulation of programmed cell death,BP,ITGA5;PDK4;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;FADD;WNT7A;TRADD;ACVR1;ADORA1;EDN1;PYCARD;G0S2;TYRO3;LIMS2;RGN;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;NOL3;DEPTOR;CTGF;CASP4;AKT1;IFI27;KITLG;BCAR1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;S100B;VDR;ARAF;GDNF;PIM2
19643,GO:1903522,7.77853613947179e-07,0.999999817846811,20,269,regulation of blood circulation,BP,ADRA2B;ADRA2C;DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;FXYD1;NPR1;HBEGF;CHGA;CTGF;AKT1;NPPC;PIK3CG;KCNG2;KCND1;PDE4B
7103,GO:0022414,7.95785178891657e-07,0.999999690622466,54,1304,reproductive process,BP,ITGA3;LIF;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;HSD17B3;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;RGN;FSTL3;FGF10;PDGFB;WNT5A;JAM3;RBP4;CYP17A1;FGF8;ANG;BMP7;BMP6;BMP4;WT1;SLC2A14;HEXB;DDR1;GJB1;GJB2;AKT1;WNT2B;KITLG;IDH1;NPPC;JAG2;EPN1;INHBB;STAR;VDR;ACSL4;HEY1;CLDN11;PIM2
15051,GO:0060572,8.02476824487702e-07,0.999999973761223,6,17,morphogenesis of an epithelial bud,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B
2,GO:0000003,8.15217850898603e-07,0.999999682843009,54,1305,reproduction,BP,ITGA3;LIF;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;HSD17B3;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;RGN;FSTL3;FGF10;PDGFB;WNT5A;JAM3;RBP4;CYP17A1;FGF8;ANG;BMP7;BMP6;BMP4;WT1;SLC2A14;HEXB;DDR1;GJB1;GJB2;AKT1;WNT2B;KITLG;IDH1;NPPC;JAG2;EPN1;INHBB;STAR;VDR;ACSL4;HEY1;CLDN11;PIM2
498,GO:0001525,9.38025250102899e-07,0.999999733451746,25,400,angiogenesis,BP,ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;MFGE8;FGF18;FGF10;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;ANG;BMP4;DLL1;CTGF;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;EFNB2
13677,GO:0050810,9.58039601602139e-07,0.999999917008087,9,51,regulation of steroid biosynthetic process,BP,WNT4;DHH;DKK3;ABCG1;BMP6;BMP2;STAR;DHCR7;VDR
13398,GO:0048762,1.06615909947699e-06,0.999999793719229,16,180,mesenchymal cell differentiation,BP,WNT2;WNT4;NOTCH1;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;NRTN;KITLG;LAMA5;GDNF;HEY1
12387,GO:0045859,1.08810839767e-06,0.999999608987012,36,723,regulation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;PYCARD;RGN;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;SDC4;ANG;BMP7;BMP4;BMP2;CDKN1A;DEPTOR;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
20957,GO:2000026,1.08908305559005e-06,0.999999647394917,63,1660,regulation of multicellular organismal development,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;EDN1;PNP;PRKACB;FZD7;PSMB10;LIMS2;RGN;CDH2;FSTL3;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;PLA2G16;WNT5A;RBP4;RHOB;NPR1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;RAB17;WNT2B;TMEM176A;KITLG;STAR;CLDN5;GAS6;LZTS1;S100B;VDR;AMOT;LAMA1;LAMA5;GDNF;HEY1;CLDN18;EFNB2;LINGO1
11864,GO:0044702,1.14859986630253e-06,0.999999560272697,50,1182,single organism reproductive process,BP,ITGA3;LIF;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;HSD17B3;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;RGN;FSTL3;FGF10;PDGFB;WNT5A;JAM3;RBP4;FGF8;ANG;BMP7;BMP6;BMP4;WT1;SLC2A14;HEXB;DDR1;GJB2;AKT1;WNT2B;KITLG;IDH1;NPPC;JAG2;INHBB;STAR;VDR;ACSL4;HEY1;CLDN11;PIM2
860,GO:0002065,1.14939871841005e-06,0.999999840807756,12,101,columnar/cuboidal epithelial cell differentiation,BP,WNT4;NOTCH1;CDH2;WNT5A;FGF8;BMP6;BMP4;BMP2;CDKN1A;DLL1;JAG2;MYO7A
679,GO:0001823,1.16301758591167e-06,0.999999838632454,12,102,mesonephros development,BP,WNT4;WNT6;FGF10;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
13962,GO:0051240,1.18637491326241e-06,0.99999962670773,56,1403,positive regulation of multicellular organismal process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;FADD;WNT6;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;EDN1;PNP;CCL20;SPTBN4;PYCARD;GHR;FGF18;FGF10;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;RHOB;NPR1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;NPPC;BCAR1;INHBB;STAR;GAS6;VDR;AMOT;GDNF;EFNB2;PDE4B
5221,GO:0014065,1.23234231803045e-06,0.99999977475402,15,161,phosphatidylinositol 3-kinase signaling,BP,EDN1;TYRO3;PRR5L;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
17402,GO:0090132,1.25748046701479e-06,0.99999972316209,18,229,epithelium migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF18;FGF10;PDGFB;WNT5A;RHOB;FGF8;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
4017,GO:0008219,1.27116267599339e-06,0.999999574093137,72,1990,cell death,BP,ITGA5;PDK4;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;FADD;DSC2;WNT7A;TRADD;ACVR1;ADORA1;EDN1;PHLDA1;PYCARD;G0S2;KRT10;RRAS2;TYRO3;LIMS2;RGN;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;NOL3;DSG3;DEPTOR;CTGF;GJB6;CASP4;AKT1;IFI27;PKP3;PKP1;KITLG;JAG2;BCAR1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;S100B;SHC4;DSC3;VDR;ARAF;GDNF;PIM2
14029,GO:0051347,1.31605845913766e-06,0.999999543251471,33,635,positive regulation of transferase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;PSMB10;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;SDC4;ANG;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
11111,GO:0042981,1.31840678018265e-06,0.999999476651145,55,1363,regulation of apoptotic process,BP,ITGA5;PDK4;WNT4;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;TRADD;ACVR1;ADORA1;EDN1;PYCARD;G0S2;TYRO3;LIMS2;RGN;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;NOL3;DEPTOR;CTGF;CASP4;AKT1;IFI27;KITLG;BCAR1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;S100B;VDR;ARAF;GDNF;PIM2
7629,GO:0030864,1.3196239769108e-06,0.999999880091964,9,55,cortical actin cytoskeleton,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;SPTB;CDH1;CLDN5;MYZAP
5120,GO:0010941,1.32820086554027e-06,0.999999463824878,58,1470,regulation of cell death,BP,ITGA5;PDK4;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;FADD;WNT7A;TRADD;ACVR1;ADORA1;EDN1;PYCARD;G0S2;RRAS2;TYRO3;LIMS2;RGN;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;NOL3;DEPTOR;CTGF;CASP4;AKT1;IFI27;KITLG;BCAR1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;S100B;VDR;ARAF;GDNF;PIM2
16427,GO:0071363,1.33342490930937e-06,0.999999545176059,32,610,cellular response to growth factor stimulus,BP,ITGA3;ITGA5;WNT2;WNT4;NOTCH1;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;FSTL3;FGF18;FGF10;FGF17;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;BCAR1;STAR;CLDN1;CLDN5;GAS6;ZCCHC12
19223,GO:1902578,1.53027244794806e-06,0.99999945434954,99,3072,single-organism localization,BP,ITGA3;EBP;LIF;ADRA2B;ADRA2C;SYT5;WNT4;USE1;ACTN2;TSPAN15;NOTCH1;RAB27A;STRA6;TF;PMAIP1;CRISPLD2;SLC45A4;SERPINA5;WNT7A;APOC1;SLC52A3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PNP;ABCG1;KCNK6;MFGE8;FLVCR2;SPTBN4;PYCARD;RAB39A;SYCN;FZD7;TYRO3;CDH2;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;CPT2;WNT5A;SESN2;RBP4;RHOQ;NPR1;RNASEL;SDC4;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;HEXB;VAMP1;WNK4;FABP3;CHGA;NOL3;DDR1;CTGF;GJB1;TPD52;AKT1;PKP3;PKP1;RAB17;IDH1;CDH1;MYO7A;INHBB;RAB44;STAR;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;GLA;RPH3AL;DERA;CYB5A;HNF1A;VDR;LAMA5;UNC119;KCND1;RAB3D;GDNF;ACSL4;SLC1A3
2757,GO:0005739,1.56090293861274e-06,0.999999357577308,61,1569,mitochondrion,CC,PDK4;PECR;TMEM160;PHYH;GLDC;FASN;PMAIP1;MSRA;MRPL14;MRPL16;HMGCS2;ACSF2;ABCG1;PYCARD;CCDC51;SLC25A53;G0S2;ACADVL;ACSM5;MAPK12;FADS1;PRR5L;ASAH2;REEP1;CPT2;HSD17B10;ETFB;SESN2;CYP17A1;RNASEL;BOLA1;ACAT1;TSFM;ECHDC2;SARDH;VAMP1;SFXN1;NOL3;HSD3B2;NUDT6;CPT1C;MDH1;CASP4;AKT1;IFI27;PON2;IDH1;DECR1;PUS1;LDHD;STAR;ECI1;CYP11A1;CYB5A;PTS;ARAF;RAB38;RAB3D;ACSL4;FAM110B;ETFDH
569,GO:0001656,1.65808873387991e-06,0.999999787827366,11,88,metanephros development,BP,LIF;WNT4;WNT7B;FGF10;PDGFB;FGF8;BMP7;BMP4;ACAT1;WT1;GDNF
4697,GO:0009966,1.68067854606444e-06,0.999999240915749,89,2670,regulation of signal transduction,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;PYCARD;G0S2;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;NOL3;DEPTOR;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;RPH3AL;S100B;GPSM1;AMOT;ARAF;SH3BP4;DOK1;GDNF;FZD8;DUSP5;HEY1;PIM2
480,GO:0001501,1.81637825568025e-06,0.999999434245108,27,473,skeletal system development,BP,EBP;ITGB8;WNT7A;WNT7B;ZFPM1;EXTL1;EDN1;RGN;FGF18;WNT5B;WNT5A;AXIN1;RBP4;FGF8;BMP7;BMP6;BMP4;BMP2;HEXB;CTGF;WNT2B;NPPC;NAB2;JAG2;HAPLN3;VDR;CLDN18
14995,GO:0060485,1.89176530645797e-06,0.999999570311992,18,234,mesenchyme development,BP,WNT2;WNT4;NOTCH1;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;NRTN;KITLG;LAMA5;GDNF;HEY1;ACTA2
859,GO:0002064,1.91408375906015e-06,0.999999611291411,16,190,epithelial cell development,BP,NOTCH1;WNT7A;WNT7B;PDGFB;WNT5B;WNT5A;BMP6;BMP4;CDKN1A;DLL1;MSN;MYO7A;CLDN1;CLDN3;CLDN5;ACTA2
3807,GO:0007423,1.92945565954785e-06,0.999999382423042,28,504,sensory organ development,BP,WNT2;NOTCH1;CDH23;STRA6;WNT6;WNT7A;WNT7B;EDN1;FGF10;WNT5B;WNT5A;AXIN1;RBP4;RHOJ;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;DDR1;GJB2;GJB6;WNT2B;JAG2;MYO7A
10765,GO:0042325,1.93579583835583e-06,0.999999227313457,54,1349,regulation of phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;PYCARD;FZD7;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DEPTOR;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
13862,GO:0051094,1.94862830818701e-06,0.99999919875441,48,1140,positive regulation of developmental process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;FADD;WNT6;WNT7A;WNT7B;TRADD;ACVR1;EDN1;PNP;SPTBN4;MAPK12;CDH2;GHR;FGF18;FGF10;PDGFB;WNT5B;WNT5A;RHOB;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;WNT2B;KITLG;NPPC;STAR;CLDN5;GAS6;VDR;AMOT;GDNF;EFNB2
10665,GO:0042127,2.01333057317463e-06,0.999999177615336,58,1489,regulation of cell proliferation,BP,LIF;WNT3;WNT2;NOTCH1;IFI30;FADD;WNT7A;ADORA1;EDN1;PLAU;PNP;PYCARD;FZD7;LIMS2;RGN;CDH2;FGF18;FGF10;FGF17;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;RBP4;NPR1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;FABP3;DDR1;CTGF;GJB6;AKT1;PTGES;KITLG;NPPC;JAG2;GAS6;S100B;DHCR7;SHC4;VDR;LAMA5;SH3BP4;GDNF;PIM2;EFNB2
4910,GO:0010646,2.06609099763661e-06,0.999999049293757,96,2967,regulation of cell communication,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;PYCARD;G0S2;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;PXK;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RBP4;RHOQ;RHOJ;RHOB;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;NOL3;DEPTOR;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;RPH3AL;LZTS1;S100B;GPSM1;AMOT;ARAF;SH3BP4;DOK1;GDNF;SLC1A3;FZD8;DUSP5;HEY1;PIM2
4703,GO:0009986,2.06721572565561e-06,0.999999254207467,34,682,cell surface,CC,ITGA3;ITGA5;WNT4;TSPAN15;NOTCH1;TF;ITGB5;ITGB4;ITGB8;SERPINA5;WNT6;WNT7A;TMEM206;PLAU;ABCG1;MFGE8;MPZL1;LPAR2;GHR;FGF10;PDGFB;KCNH2;WNT5B;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP2;VAMP1;MSN;TFPI;AMOT;SLC1A3
11389,GO:0043408,2.07395512335523e-06,0.999999264115755,33,649,regulation of MAPK cascade,BP,LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;PYCARD;FZD7;CDH2;GHR;FGF18;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;INHBB;PIK3CG;GAS6;ARAF;FZD8;DUSP5
5867,GO:0016303,2.10436542195e-06,0.999999835342566,8,43,1-phosphatidylinositol-3-kinase activity,MF,FGF18;FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
16835,GO:0072078,2.14322545196097e-06,0.999999754224989,10,73,nephron tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
12825,GO:0046834,2.15108906401515e-06,0.999999681809911,12,108,lipid phosphorylation,BP,ZFYVE21;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
4898,GO:0010634,2.44634026248787e-06,0.999999633302619,12,109,positive regulation of epithelial cell migration,BP,ITGA3;WNT7A;EDN1;FGF18;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;AKT1;BCAR1
9374,GO:0034330,2.47737400663268e-06,0.999999425458135,18,242,cell junction organization,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;LIMS2;CDH2;SDC4;ANG;CAMSAP3;GJB1;GJB2;PKP3;CDH1;CLDN1;CLDN3;CLDN5;LAMA5
13963,GO:0051241,2.50910177924432e-06,0.999998980969549,43,976,negative regulation of multicellular organismal process,BP,ADRA2C;WNT3;WNT4;NOTCH1;WNT7A;APOC1;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;SPTBN4;PYCARD;FZD7;LIMS2;RGN;FSTL3;PIK3R1;PDGFB;FOXO4;WNT5A;RBP4;NPR1;FGF8;NMI;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;NOL3;TMEM176A;NPPC;INHBB;PIK3CG;RAB11FIP1;GAS6;S100B;AMOT;CLDN18;LINGO1;PDE4B
14796,GO:0060231,2.52353770312983e-06,0.999999894032726,6,20,mesenchymal to epithelial transition,BP,LIF;WNT4;FZD7;BMP4;WT1;GDNF
15027,GO:0060537,2.61743859435072e-06,0.999999279707608,22,345,muscle tissue development,BP,FHOD3;WNT2;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;RBP4;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MYH11;S100B;EFNB2
3401,GO:0006705,2.67077745987498e-06,0.99999993507351,5,12,mineralocorticoid biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2;HSD3B2
4010,GO:0008212,2.67077745987498e-06,0.99999993507351,5,12,mineralocorticoid metabolic process,BP,WNT4;DKK3;BMP6;BMP2;HSD3B2
8412,GO:0032344,2.76289323654894e-06,0.99999997669565,4,6,regulation of aldosterone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
8415,GO:0032347,2.76289323654894e-06,0.99999997669565,4,6,regulation of aldosterone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
571,GO:0001658,2.91664027504634e-06,0.999999705492304,9,59,branching involved in ureteric bud morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
13329,GO:0048645,2.967031006666e-06,0.999999700252556,9,58,animal organ formation,BP,WNT2;FGF10;WNT5A;FGF8;BMP7;BMP4;WT1;WNT2B;GDNF
16151,GO:0070848,3.10248955132768e-06,0.999998894503302,32,635,response to growth factor,BP,ITGA3;ITGA5;WNT2;WNT4;NOTCH1;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;FSTL3;FGF18;FGF10;FGF17;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;BCAR1;STAR;CLDN1;CLDN5;GAS6;ZCCHC12
18088,GO:0098602,3.22311863306144e-06,0.99999884939592,32,633,single organism cell adhesion,BP,ITGA5;WNT4;ITGB5;FADD;DSC2;WNT7B;ACVR1;PNP;PYCARD;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;CAMSAP3;MSN;AKT1;PKP3;PKP1;CDH1;PIK3CA;PIK3CG;GAS6;LAMA5;EFNB2
757,GO:0001932,3.3517208085026e-06,0.99999852407026,51,1264,regulation of protein phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;PYCARD;FZD7;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DEPTOR;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
862,GO:0002067,3.40323787085067e-06,0.99999971392842,8,45,glandular epithelial cell differentiation,BP,WNT4;NOTCH1;WNT5A;FGF8;BMP6;BMP4;BMP2;DLL1
15456,GO:0061333,3.49476318134223e-06,0.999999574384846,10,77,renal tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
13072,GO:0048018,3.50144030362347e-06,0.999999842271904,6,21,receptor agonist activity,MF,WNT3;WNT2;WNT4;WNT7A;WNT5A;GAS6
4052,GO:0008283,3.62926156822417e-06,0.999998427352247,68,1890,cell proliferation,BP,ARTN;LIF;WNT3;WNT2;WNT4;NOTCH1;IFI30;IGSF8;FADD;WNT7A;WNT7B;SALL4;ADORA1;EDN1;PLAU;PNP;PYCARD;FZD7;LIMS2;RGN;CDH2;FGF18;FGF10;FGF17;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;RBP4;NPR1;FGF8;SDC4;CLCF1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;FABP3;MSN;DDR1;CTGF;GJB6;AKT1;WNT2B;PTGES;KITLG;NPPC;NAB2;JAG2;BCAR1;PIK3CG;GAS6;S100B;DHCR7;SHC4;VDR;LAMA5;SH3BP4;GDNF;PIM2;EFNB2
11386,GO:0043405,3.69234282215019e-06,0.999998997443459,21,321,regulation of MAP kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;GHR;FGF18;FGF10;PDGFB;HRAS;WNT5A;AXIN1;BMP7;BMP4;BMP2;KITLG;PIK3CG;ARAF;FZD8;DUSP5
3677,GO:0007169,3.70889355886486e-06,0.999998643294481,33,671,transmembrane receptor protein tyrosine kinase signaling pathway,BP,ITGA5;PDK4;ADRA2B;ADRA2C;WNT4;ADORA1;MPZL1;MAPK12;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;RHOQ;FGF8;HBEGF;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;EPN1;BCAR1;PIK3CA;SHC4;DOK1;EFNB2
1563,GO:0003338,3.72697990050371e-06,0.999999755023461,7,33,metanephros morphogenesis,BP,LIF;WNT4;WNT7B;FGF10;BMP4;WT1;GDNF
16872,GO:0072132,3.89492683653421e-06,0.999999665586271,8,46,mesenchyme morphogenesis,BP,NOTCH1;ACVR1;WNT5A;FGF8;BMP7;BMP2;HEY1;ACTA2
11174,GO:0043066,4.03027906078626e-06,0.999998431656826,37,795,negative regulation of apoptotic process,BP,ITGA5;PDK4;WNT4;NOTCH1;FADD;WNT7A;TRADD;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;RGN;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;NOL3;AKT1;KITLG;TLE1;STAR;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
9231,GO:0033993,4.05857015089296e-06,0.999998379062389,39,859,response to lipid,BP,PDK4;WNT3;WNT2;NOTCH1;DHH;WNT6;WNT7A;WNT7B;EDN1;ABCG1;CCL20;PYCARD;MGST2;FZD7;FGF10;TICAM1;WNT5B;WNT5A;RBP4;BMP7;BMP6;BMP4;CDKN1A;SHPK;FABP3;MSN;CTGF;GJB2;GJB6;AKT1;PTGES;IDH1;TFPI;STAR;CLDN1;S100B;VDR;HEY1;PDE4B
3891,GO:0008016,4.11929226542835e-06,0.999999056659709,17,225,regulation of heart contraction,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;FXYD1;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CG;KCNG2;KCND1;PDE4B
1468,GO:0003179,4.16277121562149e-06,0.999999720401022,7,34,heart valve morphogenesis,BP,NOTCH1;STRA6;ZFPM1;ACVR1;BMP4;BMP2;HEY1
5809,GO:0016202,4.20558892545703e-06,0.999999332634905,12,115,regulation of striated muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;RBP4;FGF8;BMP4;BMP2;DLL1;S100B;EFNB2
16752,GO:0071902,4.21029738778059e-06,0.999998890098878,20,297,positive regulation of protein serine/threonine kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;EDN1;GHR;FGF18;FGF10;PDGFB;RALB;HRAS;WNT5A;AXIN1;PSRC1;BMP2;AKT1;KITLG;PIK3CG;FZD8;DUSP5
16087,GO:0070696,4.21292915880018e-06,0.999999883311815,5,13,transmembrane receptor protein serine/threonine kinase binding,MF,PYCARD;BMP7;BMP6;BMP4;BMP2
11494,GO:0043583,4.21841137732832e-06,0.999999085573161,16,201,ear development,BP,NOTCH1;CDH23;STRA6;EDN1;FGF10;WNT5A;FGF8;SDC4;BMP4;BMP2;DLL1;DDR1;GJB2;GJB6;JAG2;MYO7A
5887,GO:0016337,4.60066005782333e-06,0.99999838816321,30,582,single organismal cell-cell adhesion,BP,ITGA5;WNT4;ITGB5;FADD;DSC2;WNT7B;ACVR1;PNP;PYCARD;TTYH1;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;CAMSAP3;MSN;AKT1;PKP3;PKP1;CDH1;PIK3CA;PIK3CG;GAS6;EFNB2
576,GO:0001664,4.63577893850108e-06,0.999998873362586,18,245,G-protein coupled receptor binding,MF,ADRA2C;WNT3;WNT2;WNT4;ITGB4;WNT6;WNT7A;WNT7B;MRAP;ADORA1;EDN1;CCL20;FZD7;REEP1;WNT5B;WNT5A;WNT2B;CNIH4
17327,GO:0090002,4.65243158186988e-06,0.999999180519319,13,136,establishment of protein localization to plasma membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
6140,GO:0016829,4.65356430614634e-06,0.999999111632375,14,154,lyase activity,MF,GLDC;FASN;GUCY1B3;MGST2;HACL1;NPR1;CYP17A1;ACAT1;ECHDC2;PCBD1;PUS1;ECI1;DERA;PTS
570,GO:0001657,4.74094748843619e-06,0.999999317308411,11,97,ureteric bud development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
4895,GO:0010631,4.77033491033663e-06,0.999998894785472,17,227,epithelial cell migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF18;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
10981,GO:0042692,4.78700441682956e-06,0.999998629429192,22,357,muscle cell differentiation,BP,FHOD3;WNT4;ACTN2;NOTCH1;ACVR1;CASQ2;EDN1;MAPK12;FZD7;CDH2;FGF10;PDGFB;FOXO4;AXIN1;BMP4;BMP2;WT1;DLL1;AKT1;MYH11;HEY1;EFNB2
5233,GO:0014706,4.79859273661099e-06,0.99999867306906,21,331,striated muscle tissue development,BP,FHOD3;WNT2;ACTN3;ACTN2;NOTCH1;IGSF8;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;RBP4;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MYH11;S100B;EFNB2
7200,GO:0030036,4.91599921961938e-06,0.999998305373132,29,562,actin cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;ITGB5;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;RHOJ;NUAK2;SDC4;ANG;SPTB;DAAM2;ESPN;RND3;CTGF;BCAR1;MYH11;AMOT;PARVB;TMOD4
18944,GO:1901861,4.99693478641717e-06,0.999999192495447,12,117,regulation of muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;RBP4;FGF8;BMP4;BMP2;DLL1;S100B;EFNB2
16888,GO:0072163,5.08876944318707e-06,0.999999261170705,11,98,mesonephric epithelium development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
16889,GO:0072164,5.08876944318707e-06,0.999999261170705,11,98,mesonephric tubule development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
14677,GO:0060047,5.34334087977374e-06,0.999998685944699,18,255,heart contraction,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;FXYD1;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CA;PIK3CG;KCNG2;KCND1;PDE4B
11177,GO:0043069,5.51226227024936e-06,0.999997818278172,37,806,negative regulation of programmed cell death,BP,ITGA5;PDK4;WNT4;NOTCH1;FADD;WNT7A;TRADD;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;RGN;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;NOL3;AKT1;KITLG;TLE1;STAR;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
15036,GO:0060548,5.54774882765729e-06,0.999997753149198,39,872,negative regulation of cell death,BP,ITGA5;PDK4;WNT4;NOTCH1;FADD;WNT7A;TRADD;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;RGN;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;CHGA;NOL3;CTGF;AKT1;KITLG;TLE1;STAR;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
15048,GO:0060563,5.56184665533e-06,0.99999949592018,8,48,neuroepithelial cell differentiation,BP,WNT4;NOTCH1;CDH2;FGF8;BMP2;DLL1;JAG2;MYO7A
4006,GO:0008207,5.60975146319994e-06,0.999999605366329,7,34,C21-steroid hormone metabolic process,BP,WNT4;DKK3;CYP17A1;BMP6;BMP2;STAR;CYP11A1
4912,GO:0010648,5.6331428852882e-06,0.999997528957644,48,1182,negative regulation of cell communication,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;NOTCH1;RASL11B;FADD;TRADD;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;PYCARD;TYRO3;PSMB10;CDH2;PRR5L;FSTL3;FGF10;TICAM1;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;NOL3;DEPTOR;AKT1;EPN1;INHBB;TLE1;RAB11FIP1;GAS6;RPH3AL;ARAF;SH3BP4;GDNF;DUSP5;HEY1
15110,GO:0060675,5.67380430163814e-06,0.999999372647822,9,64,ureteric bud morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
599,GO:0001704,5.68528816068845e-06,0.999999068850684,12,118,formation of primary germ layer,BP,ITGA3;ITGA5;WNT3;ITGB5;ITGB4;ACVR1;FZD7;WNT5A;AXIN1;BMP7;BMP4;DUSP5
7010,GO:0021871,5.7178791683111e-06,0.999999713157957,6,23,forebrain regionalization,BP,WNT7B;AXIN1;FGF8;BMP4;BMP2;WNT2B
3396,GO:0006700,5.99029810985234e-06,0.999999696996225,6,23,C21-steroid hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2;STAR;CYP11A1
14485,GO:0052742,6.02085950889753e-06,0.999999447059674,8,49,phosphatidylinositol kinase activity,MF,FGF18;FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
13319,GO:0048634,6.09787902827267e-06,0.999998993763083,12,119,regulation of muscle organ development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;RBP4;FGF8;BMP4;BMP2;DLL1;S100B;EFNB2
7174,GO:0023057,6.17476273389918e-06,0.999997281891643,48,1186,negative regulation of signaling,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;NOTCH1;RASL11B;FADD;TRADD;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;PYCARD;TYRO3;PSMB10;CDH2;PRR5L;FSTL3;FGF10;TICAM1;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;NOL3;DEPTOR;AKT1;EPN1;INHBB;TLE1;RAB11FIP1;GAS6;RPH3AL;ARAF;SH3BP4;GDNF;DUSP5;HEY1
1388,GO:0003015,6.21686575344368e-06,0.999998453189224,18,258,heart process,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;FXYD1;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CA;PIK3CG;KCNG2;KCND1;PDE4B
14225,GO:0051716,6.36863204132404e-06,0.999996470215171,177,6569,cellular response to stimulus,BP,ITGA3;ITGA5;ARTN;EBP;PDK4;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;IFI30;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;FADD;DHH;DSC2;WNT6;P2RY14;WNT7A;WNT7B;TRADD;SLC52A3;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;MPZL1;RRAS2;TSPAN13;MGST2;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;RNASEL;FGF8;SDC4;CLCF1;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;PKN3;SHPK;CMBL;WNK4;GRIA3;RND3;CHGA;MSN;NOL3;DDR1;DEPTOR;CTGF;GJB2;GJB6;RRAD;CASP4;AKT1;IFI27;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;RPH3AL;S100B;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;DOK1;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;LINGO1;PDE4B
16896,GO:0072171,6.50340840637681e-06,0.999999267473368,9,65,mesonephric tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
10227,GO:0036092,6.72069076029913e-06,0.999999371960317,8,50,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF18;FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
7113,GO:0022612,6.88232424058644e-06,0.999998849879042,12,120,gland morphogenesis,BP,WNT4;NOTCH1;LIMS2;FGF10;WNT5A;FGF8;BMP7;BMP4;MSN;DDR1;VDR;LAMA5
14577,GO:0055024,7.33189820530547e-06,0.999999160482645,9,66,regulation of cardiac muscle tissue development,BP,WNT2;NOTCH1;EDN1;FZD7;RBP4;FGF8;BMP4;BMP2;EFNB2
16796,GO:0072012,7.34749930501866e-06,0.999999611205881,6,24,glomerulus vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
11051,GO:0042802,7.67481970785418e-06,0.999996493021145,52,1331,identical protein binding,MF,ADRA2C;ACTN3;ACTN2;FASN;GADD45A;MRI1;FADD;TRADD;ACVR1;CASQ2;ABCG1;PYCARD;GHR;PDGFB;KCNH2;PLEKHH2;FOXO4;JAM3;HACL1;AXIN1;ANG;NMI;ACAT1;HEXB;NOL3;GJB1;ACCS;TPD52;PCBD1;AKT1;PON2;IDH1;NPPC;NAB2;MYO7A;INHBB;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;GLA;S100B;CLDN23;PTS;SH3BP4;GDNF;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
15405,GO:0061180,7.77517681617342e-06,0.999999103082845,9,66,mammary gland epithelium development,BP,WNT3;WNT2;WNT4;WNT7B;FGF10;WNT5A;DDR1;AKT1;VDR
13898,GO:0051145,7.86067722827915e-06,0.999999249213464,8,50,smooth muscle cell differentiation,BP,WNT4;NOTCH1;ACVR1;FGF10;PDGFB;FOXO4;BMP4;HEY1
4009,GO:0008211,8.02727947199903e-06,0.999999568485163,6,24,glucocorticoid metabolic process,BP,WNT4;DKK3;CYP17A1;BMP2;HSD3B2;STAR
8869,GO:0032989,8.50861471929595e-06,0.99999640671588,41,973,cellular component morphogenesis,BP,ARTN;FHOD3;WNT3;ACTN2;NOTCH1;WNT7A;WNT7B;ZFPM1;CASQ2;EDN1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;RHOQ;RHOJ;FGF8;SPTB;BMP7;B3GNT2;HEXB;MSN;DDR1;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;MYH11;LZTS1;S100B;VDR;LAMA5;DOK1;GDNF;SLC1A3;PARVB;LINGO1
7214,GO:0030057,8.62113502996251e-06,0.99999952690621,6,25,desmosome,CC,DSC2;JAM3;DSG3;PKP3;PKP1;DSC3
12094,GO:0045216,8.74401755526492e-06,0.999997984098645,16,214,cell-cell junction organization,BP,WNT4;ACTN3;ACTN2;LIMS2;CDH2;SDC4;ANG;CAMSAP3;GJB1;GJB2;PKP3;CDH1;CLDN1;CLDN3;CLDN5;LAMA5
427,GO:0001101,9.14561507810303e-06,0.999997451871256,20,313,response to acid chemical,BP,PDK4;WNT3;WNT2;WNT6;WNT7B;EDN1;FZD7;PDGFB;WNT5B;WNT5A;SESN2;RBP4;BMP6;FABP3;CTGF;GJB2;AKT1;PTGES;CLDN1;SH3BP4
15709,GO:0070062,9.19267288881876e-06,0.999995121907801,87,2675,extracellular exosome,CC,ITGA3;CFB;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;MSRA;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;PLAU;PNP;PRKACB;MFGE8;BDH2;SPTBN5;SPTBN4;KRT10;RRAS2;CDH2;FRMPD1;RALB;ETFB;WNT5B;WNT5A;SNX18;KHK;RBP4;RHOQ;RHOJ;RHOB;SDC4;CLCF1;ANG;ACAT1;B3GNT2;DAAM2;IDUA;AOX1;HEXB;CMBL;FABP3;RND3;MSN;DDR1;DSG3;PCBD1;MDH1;PKP1;RAB17;IDH1;DECR1;CDH1;MDP1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;PEPD;ACP5;GLA;ECI1;MYH11;DERA;CYB5A;PM20D2;LAMA5;SH3BP4;RAB3D;LYPLAL1;ACSL4;ACTA2;CLDN11
7488,GO:0030546,9.27623957594181e-06,0.999999285874244,7,37,receptor activator activity,MF,WNT3;WNT2;WNT4;ACTN2;WNT7A;WNT5A;GAS6
14734,GO:0060129,9.33680792110562e-06,1,3,3,thyroid-stimulating hormone-secreting cell differentiation,BP,WNT4;FGF8;BMP2
1461,GO:0003170,9.37633529135562e-06,0.999999274471491,7,38,heart valve development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;BMP4;BMP2;HEY1
19198,GO:1902531,9.52151849586455e-06,0.999995382486663,61,1683,regulation of intracellular signal transduction,BP,ITGA3;LIF;ADRA2B;ADRA2C;ACTN3;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ADORA1;CASQ2;EDN1;CCL20;PYCARD;FZD7;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;NOL3;DEPTOR;CTGF;AKT1;KITLG;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;S100B;AMOT;ARAF;SH3BP4;FZD8;DUSP5;PIM2
8562,GO:0032526,9.53199875775805e-06,0.999998514710725,11,103,response to retinoic acid,BP,WNT3;WNT2;WNT6;WNT7B;FZD7;WNT5B;WNT5A;RBP4;BMP6;GJB2;PTGES
3799,GO:0007411,9.55302549361402e-06,0.999997780156386,16,218,axon guidance,BP,ARTN;WNT3;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;DOK1;GDNF
5882,GO:0016328,9.62428988187422e-06,0.999999050694734,8,52,lateral plasma membrane,CC,AXIN1;GJB1;GJB2;CDH1;CLDN1;CLDN3;CLDN12;CLDN15
13296,GO:0048584,9.70892798829762e-06,0.999995139906701,68,1941,positive regulation of response to stimulus,BP,ITGA5;ARTN;CFB;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;G0S2;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;AXIN1;RNASEL;FGF8;CLCF1;FAM110C;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;BCAR1;INHBB;PIK3CA;PIK3CG;GAS6;S100B;ARAF;DOK1;FZD8;DUSP5;PIM2;PDE4B
2451,GO:0005111,9.82269206158753e-06,1,3,3,type 2 fibroblast growth factor receptor binding,MF,FGF18;FGF10;FGF17
3890,GO:0008015,9.87082458450417e-06,0.999996686257971,26,487,blood circulation,BP,ADRA2B;ADRA2C;DSC2;GUCY1B3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;PDGFB;KCNH2;FXYD1;NPR1;HBEGF;DLL1;CHGA;CTGF;AKT1;NPPC;PIK3CA;PIK3CG;KCNG2;GAS6;KCND1;ACTA2;PDE4B
15050,GO:0060571,9.88219208289629e-06,0.999999444326995,6,25,morphogenesis of an epithelial fold,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B
21078,GO:2000242,1.01390103677912e-05,0.999998994522142,8,51,negative regulation of reproductive process,BP,LIF;WNT4;PRKACB;WNT5A;BMP7;BMP4;WT1;NPPC
11387,GO:0043406,1.02779980944909e-05,0.999997598767894,16,214,positive regulation of MAP kinase activity,BP,ADRA2B;ADRA2C;WNT7B;EDN1;GHR;FGF18;FGF10;PDGFB;HRAS;WNT5A;AXIN1;BMP2;KITLG;PIK3CG;FZD8;DUSP5
18903,GO:1901698,1.04772929439762e-05,0.999995619141192,39,900,response to nitrogen compound,BP,PDK4;ACTN2;NOTCH1;PMAIP1;FADD;GUCY1B3;CASQ2;EDN1;PRKACB;MGST2;GHR;PIK3R2;PIK3R1;TICAM1;PRKAR1B;NNMT;FOXO4;RALB;KHK;SESN2;RHOQ;RNASEL;BMP7;BMP4;WT1;CDKN1A;FABP3;CTGF;GJB2;CASP4;AKT1;CDH1;BCAR1;INHBB;STAR;PIK3CA;PIK3CG;SH3BP4;PDE4B
17944,GO:0097485,1.07526167857039e-05,0.999997476213181,16,220,neuron projection guidance,BP,ARTN;WNT3;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;DOK1;GDNF
14020,GO:0051338,1.12387109004976e-05,0.999995231787334,40,933,regulation of transferase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;PYCARD;PSMB10;RGN;GHR;FGF18;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;SDC4;ANG;BMP7;BMP4;BMP2;CDKN1A;DEPTOR;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
1386,GO:0003013,1.12474527015985e-05,0.999996194238981,26,491,circulatory system process,BP,ADRA2B;ADRA2C;DSC2;GUCY1B3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;PDGFB;KCNH2;FXYD1;NPR1;HBEGF;DLL1;CHGA;CTGF;AKT1;NPPC;PIK3CA;PIK3CG;KCNG2;GAS6;KCND1;ACTA2;PDE4B
4873,GO:0010595,1.13274793245175e-05,0.999998624467615,9,69,positive regulation of endothelial cell migration,BP,WNT7A;EDN1;FGF18;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1
19669,GO:1903561,1.13895082337608e-05,0.999993921613785,87,2690,extracellular vesicle,CC,ITGA3;CFB;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;MSRA;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;PLAU;PNP;PRKACB;MFGE8;BDH2;SPTBN5;SPTBN4;KRT10;RRAS2;CDH2;FRMPD1;RALB;ETFB;WNT5B;WNT5A;SNX18;KHK;RBP4;RHOQ;RHOJ;RHOB;SDC4;CLCF1;ANG;ACAT1;B3GNT2;DAAM2;IDUA;AOX1;HEXB;CMBL;FABP3;RND3;MSN;DDR1;DSG3;PCBD1;MDH1;PKP1;RAB17;IDH1;DECR1;CDH1;MDP1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;PEPD;ACP5;GLA;ECI1;MYH11;DERA;CYB5A;PM20D2;LAMA5;SH3BP4;RAB3D;LYPLAL1;ACSL4;ACTA2;CLDN11
11277,GO:0043230,1.15575223192531e-05,0.999993829537208,87,2691,extracellular organelle,CC,ITGA3;CFB;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;MSRA;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;PLAU;PNP;PRKACB;MFGE8;BDH2;SPTBN5;SPTBN4;KRT10;RRAS2;CDH2;FRMPD1;RALB;ETFB;WNT5B;WNT5A;SNX18;KHK;RBP4;RHOQ;RHOJ;RHOB;SDC4;CLCF1;ANG;ACAT1;B3GNT2;DAAM2;IDUA;AOX1;HEXB;CMBL;FABP3;RND3;MSN;DDR1;DSG3;PCBD1;MDH1;PKP1;RAB17;IDH1;DECR1;CDH1;MDP1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;PEPD;ACP5;GLA;ECI1;MYH11;DERA;CYB5A;PM20D2;LAMA5;SH3BP4;RAB3D;LYPLAL1;ACSL4;ACTA2;CLDN11
8314,GO:0032148,1.17953962327141e-05,0.999999310509567,6,26,activation of protein kinase B activity,BP,ADRA2B;ADRA2C;PDGFB;WNT5A;ANG;GAS6
3461,GO:0006810,1.19716055266354e-05,0.999993125082691,135,4735,transport,BP,EBP;LIF;ADRA2B;ADRA2C;SYT5;USE1;RIN3;ACTN2;RAB6C;NOTCH1;RAB27A;CDH23;STRA6;TF;ZFYVE21;PMAIP1;CRISPLD2;SLC31A2;SLC45A4;SERPINA5;WNT7A;APOC1;SLC52A3;RABIF;NMT2;TBC1D14;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PNP;ABCG1;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;PYCARD;SLC25A53;TTYH1;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;CPT2;HRAS;WNT5A;SNX18;GPRASP1;SESN2;FXYD1;RBP4;RHOQ;RHOB;NPR1;RNASEL;SDC4;ANG;SPTB;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;SLC2A14;HEXB;VAMP1;SFXN1;WNK4;FABP3;GRIA3;CHGA;MSN;NOL3;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;IFI27;PKP1;RAB12;RAB17;IDH1;CDH1;EPN1;MYO7A;INHBB;GJA3;RAB44;STAR;CLDN1;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;GLA;RPH3AL;DERA;CYB5A;SLC18B1;HNF1A;VDR;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;SLC1A3;CNIH4;CLDN16;CLDN15;PDE4B
15446,GO:0061311,1.20365290420792e-05,0.999999293860961,6,26,cell surface receptor signaling pathway involved in heart development,BP,NOTCH1;ACVR1;WNT5A;BMP4;BMP2;HEY1
4625,GO:0009725,1.20859486733711e-05,0.999995035169312,37,837,response to hormone,BP,ITGA3;PDK4;ACTN2;NOTCH1;WNT7B;EDN1;ABCG1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;RNASEL;ANG;BMP7;BMP6;BMP4;ACAT1;WT1;CDKN1A;FABP3;CTGF;GJB2;AKT1;IDH1;BCAR1;INHBB;STAR;CLDN1;PIK3CA;S100B;VDR;HEY1
3532,GO:0006915,1.21287923117572e-05,0.999994015045902,63,1763,apoptotic process,BP,ITGA5;PDK4;WNT4;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;FADD;WNT7A;TRADD;ACVR1;ADORA1;EDN1;PHLDA1;PYCARD;G0S2;TYRO3;LIMS2;RGN;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;NOL3;DEPTOR;CTGF;GJB6;CASP4;AKT1;IFI27;KITLG;JAG2;BCAR1;INHBB;TLE1;STAR;PIK3CA;PIK3CG;GAS6;S100B;SHC4;VDR;ARAF;GDNF;PIM2
15500,GO:0061437,1.21495350834451e-05,0.999999286037777,6,26,renal system vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
15503,GO:0061440,1.21495350834451e-05,0.999999286037777,6,26,kidney vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
1480,GO:0003197,1.21738016517481e-05,0.999999015515116,7,39,endocardial cushion development,BP,NOTCH1;ACVR1;FGF8;BMP7;BMP4;BMP2;HEY1
15774,GO:0070169,1.25434775783613e-05,0.999998980845826,7,39,positive regulation of biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2
8313,GO:0032147,1.26048198299722e-05,0.999996542920915,19,294,activation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;PRKACB;GHR;FGF10;PDGFB;PRKAR1B;WNT5A;AXIN1;ANG;BMP4;BMP2;PIK3CA;GAS6;ARAF;DUSP5
8024,GO:0031589,1.28761890138957e-05,0.999996461695943,19,298,cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;ITGB5;ITGB4;PLAU;TTYH1;FZD7;TYRO3;PIK3R1;JAM3;SDC4;DDR1;CTGF;GAS6;LAMA5
21475,GO:2000811,1.30531980499639e-05,0.999999507702531,5,16,negative regulation of anoikis,BP,ITGA5;PDK4;NOTCH1;TLE1;PIK3CA
18176,GO:0098805,1.31445234483428e-05,0.999993723423721,56,1511,whole membrane,CC,PECR;TMEM163;SYT5;WNT3;WNT4;TSPAN15;RAB27A;TF;ZFYVE21;PMAIP1;FADD;SERPINA5;WNT6;WNT7A;WNT7B;TRADD;PXMP2;PXMP4;PLAU;RAB39A;SYCN;FZD7;CDH2;TICAM1;PLA2G16;WNT5B;WNT5A;SNX18;RHOQ;RHOB;SDC4;HBEGF;DLL1;RAB20;VAMP1;GRIA3;CHGA;CPT1C;IFI27;PKP1;RAB12;RAB17;CDH1;EPN1;MYO7A;RAB44;SNX21;RAB11FIP1;RPH3AL;DHCR7;CYB5A;SH3BP4;RAB38;RAB3D;ACSL4;RNF144A
7254,GO:0030139,1.39145113494254e-05,0.999996315533969,18,270,endocytic vesicle,CC,WNT3;WNT4;TF;ITGB5;WNT6;WNT7A;WNT7B;RAB39A;LPAR2;WNT5B;WNT5A;HBEGF;RAB20;GRIA3;RAB17;RAB11FIP1;AMOT;RAB38
1387,GO:0003014,1.39738809712379e-05,0.999997725056721,11,107,renal system process,BP,ITGA3;ADORA1;EDN1;PRKACB;PDGFB;PRKAR1B;NPR1;BMP4;WNK4;GAS6;HNF1A
13662,GO:0050790,1.40107572501024e-05,0.99999268206999,77,2320,regulation of catalytic activity,BP,ARTN;ADRA2B;ADRA2C;WNT4;RIN3;ACTN2;NOTCH1;PMAIP1;GADD45A;FADD;SERPINA5;WNT7B;APOC1;TRADD;RABIF;TBC1D14;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;MGST2;MAPK12;PSMB10;LPAR2;RGN;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;SESN2;AXIN1;PSRC1;FGF8;SDC4;ANG;SPTB;HBEGF;BMP7;BMP4;BMP2;CAMSAP3;CDKN1A;NOL3;DEPTOR;CTGF;AKT1;IFI27;NRTN;KITLG;CST9L;TFPI;PIK3CA;PIK3CG;GAS6;GLA;PTS;GPSM1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5
3543,GO:0006936,1.40926481665497e-05,0.999995947200138,20,326,muscle contraction,BP,ADRA2B;ADRA2C;ACTN3;ACTN2;ITGB5;DSC2;ADORA1;CASQ2;EDN1;KCNH2;FXYD1;CHGA;CTGF;PIK3CA;PIK3CG;MYH11;GDNF;ACTA2;PDE4B;TMOD4
3744,GO:0007267,1.45534996910951e-05,0.999993025613498,56,1519,cell-cell signaling,BP,ITGA3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;NOTCH1;DHH;WNT6;WNT7A;WNT7B;ADORA1;CASQ2;DKK3;EDN1;CCL20;MPZL1;FZD7;PSMB10;CDH2;FADS1;FGF18;FGF10;FGF17;PDGFB;PXK;HRAS;WNT5B;WNT5A;AXIN1;RBP4;FGF8;BMP6;BMP4;BMP2;DLL1;GRIA3;GJB1;GJB2;AKT1;WNT2B;INHBB;GJA3;TLE1;STAR;RAB11FIP1;KCNG2;LZTS1;S100B;UNC119;GDNF;SLC1A3;FZD8;EFNB2
13724,GO:0050878,1.45998230758298e-05,0.999994981877838,26,495,regulation of body fluid levels,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;RHOB;NPR1;WNK4;DDR1;AKT1;FAM46A;TFPI;CLDN1;PIK3CA;PIK3CG;GAS6;VDR
13262,GO:0048519,1.56083855417397e-05,0.999990798873313,132,4623,negative regulation of biological process,BP,ITGA3;ITGA5;PDK4;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;IFI30;RASL11B;ITGB8;GADD45A;FADD;SERPINA5;WNT7A;APOC1;ZFPM1;TRADD;ACVR1;SALL4;TBC1D14;ADORA1;CASQ2;DKK3;EDN1;PLAU;ABCG1;PRKACB;SPTBN5;SPTBN4;PYCARD;ACADVL;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;FSTL3;FGF10;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;PLA2G16;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RBP4;RHOQ;RHOB;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;ESPN;WNK4;FABP3;CHGA;NOL3;DDR1;DEPTOR;CTGF;GJB6;AKT1;IFI27;PKP3;PKP1;TMEM176A;PTGES;KITLG;NPPC;CST9L;NAB2;CDH1;EPN1;INHBB;TFPI;TLE1;STAR;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;GLA;RPH3AL;LZTS1;S100B;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;LINGO1;PDE4B;TMOD4
12763,GO:0046660,1.60209486204126e-05,0.999997349809715,11,109,female sex differentiation,BP,WNT4;STRA6;TYRO3;FGF10;WNT5A;RBP4;ANG;WT1;KITLG;IDH1;INHBB
14626,GO:0055114,1.66509387195872e-05,0.99999280826127,40,940,oxidation-reduction process,BP,PDK4;PECR;ACTN3;PHYH;GLDC;IFI30;FASN;MSRA;HSD17B3;HSD17B11;BDH2;ACADVL;FADS1;CPT2;HSD17B10;ETFB;HACL1;SESN2;CYP17A1;PFKFB3;BMP2;ACAT1;AOX1;ECHDC2;SARDH;FABP3;HSD3B2;CPT1C;PCBD1;MDH1;AKT1;IDH1;DECR1;LDHD;PIK3CA;ECI1;CYP11A1;DHCR7;CYB5A;ETFDH
12372,GO:0045833,1.67579699096749e-05,0.999997855845941,9,71,negative regulation of lipid metabolic process,BP,WNT4;APOC1;ADORA1;DKK3;ACADVL;PDGFB;BMP2;AKT1;PIK3CG
17437,GO:0090183,1.68450845597319e-05,0.999998193015418,8,55,regulation of kidney development,BP,LIF;WNT4;PDGFB;BMP7;BMP4;WT1;WNT2B;GDNF
3784,GO:0007369,1.68482573659476e-05,0.999996367041228,14,176,gastrulation,BP,ITGA3;ITGA5;WNT3;ITGB5;ITGB4;ACVR1;FZD7;WNT5A;AXIN1;FGF8;BMP7;BMP4;AMOT;DUSP5
17438,GO:0090184,1.7199416086395e-05,0.999998526932055,7,40,positive regulation of kidney development,BP,LIF;WNT4;PDGFB;BMP4;WT1;WNT2B;GDNF
15302,GO:0061005,1.72770393701501e-05,0.999998137062017,8,56,cell differentiation involved in kidney development,BP,LIF;WNT4;NOTCH1;PDGFB;BMP4;WT1;GDNF;ACTA2
11468,GO:0043542,1.75788915222161e-05,0.999996465674735,13,153,endothelial cell migration,BP,NOTCH1;WNT7A;EDN1;FGF18;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
13945,GO:0051216,1.75889441743476e-05,0.999996192320807,14,176,cartilage development,BP,ITGB8;WNT7A;WNT7B;EDN1;FGF18;WNT5B;WNT5A;BMP7;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC
13069,GO:0048015,1.76194323797933e-05,0.999995928841206,15,201,phosphatidylinositol-mediated signaling,BP,EDN1;TYRO3;PRR5L;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
2640,GO:0005515,1.76848765791517e-05,0.999989725318752,255,10444,protein binding,MF,ITGA3;ITGA5;ARTN;CFB;TAGLN;EBP;PECR;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;RIN3;ACTN3;ACTN2;TSPAN15;TSPAN17;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;DPM3;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;MRAP;ZFPM1;TRADD;ACVR1;RABIF;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;ACSF2;EDN1;PLAU;PHLDA1;RHPN1;ABCG1;PRKACB;MFGE8;CCL20;EBF1;SPTBN5;SPTBN4;PYCARD;G0S2;LAGE3;MPZL1;RRAS2;RAB39B;RAB39A;MGST2;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;MB21D2;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;PKN3;ESPN;HEXB;VAMP1;WNK4;FABP3;RND3;MSN;NOL3;NUDT6;NUDT7;DDR1;DEPTOR;CTGF;GJB1;ACCS;CPT1C;RRAD;TPD52;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;FAM46A;CYTIP;KITLG;IDH1;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;LDHD;SPSB1;HPCAL1;TLE1;STAR;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;WBP1;SIN3B;PEPD;GLA;ZCCHC12;RPH3AL;MYH11;LZTS1;S100B;CLDN23;CYB5A;PTS;SHC4;HNF1A;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;DOK1;RAB3D;GDNF;MYZAP;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;PDE4B;TMOD4
18874,GO:1901652,1.80114071539651e-05,0.999994030880077,24,442,response to peptide,BP,PDK4;ACTN2;NOTCH1;EDN1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;RNASEL;BMP7;FABP3;CTGF;GJB2;CASP4;AKT1;BCAR1;INHBB;STAR;PIK3CA
7485,GO:0030540,1.81930956195461e-05,0.999999251720233,5,17,female genitalia development,BP,STRA6;TYRO3;FGF10;WNT5A;RBP4
12293,GO:0045669,1.95727668797273e-05,0.999997848661953,8,57,positive regulation of osteoblast differentiation,BP,WNT4;WNT7B;ACVR1;BMP7;BMP6;BMP4;BMP2;NPPC
13291,GO:0048568,1.95798827097753e-05,0.999993651147494,23,417,embryonic organ development,BP,LIF;WNT2;NOTCH1;STRA6;WNT7B;ZFPM1;ACVR1;EDN1;FGF10;PDGFB;WNT5A;AXIN1;RBP4;FGF8;BMP7;BMP4;DLL1;GJB6;AKT1;KITLG;EPN1;MYO7A;HEY1
3400,GO:0006704,1.96835065198212e-05,0.999999176843219,5,17,glucocorticoid biosynthetic process,BP,WNT4;DKK3;CYP17A1;BMP2;HSD3B2
2872,GO:0005912,1.98079557843107e-05,0.999993223914496,25,479,adherens junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;NOTCH1;ZFYVE21;ITGB5;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;CAMSAP3;DLL1;RND3;MSN;PKP3;CDH1;BCAR1;PARVB;EFNB2
10229,GO:0036094,2.00996663658415e-05,0.999989231084676,76,2314,small molecule binding,MF,PDK4;TUBG2;RAB6C;PHYH;GLDC;MARK4;RAB27A;RASL11B;FASN;SERPINA5;APOC1;ACVR1;GUCY1B3;ADORA1;ACSF2;RAB40B;RAB40A;PNP;ABCG1;PRKACB;BDH2;ACADVL;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;HACL1;SESN2;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;AOX1;PKN3;RAB20;SHPK;WNK4;FABP3;RND3;DDR1;ACCS;RRAD;MDH1;AKT1;RAB12;RAB17;IDH1;DECR1;MYO7A;LDHD;RAB44;STAR;PIK3CA;PIK3CG;MYH11;DHCR7;VDR;ARAF;RAB38;RAB3D;ACSL4;SLC1A3;ACTA2;PIM2;ETFDH;PDE4B
13261,GO:0048518,2.05179652861795e-05,0.999987725831154,142,5094,positive regulation of biological process,BP,ITGA3;ITGA5;ARTN;CFB;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;STRA6;TF;ITGB8;FASN;PMAIP1;GADD45A;FADD;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;CASQ2;EDN1;PLAU;PNP;ABCG1;PRKACB;MFGE8;CCL20;SPTBN4;PYCARD;G0S2;RRAS2;MAPK12;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;FXYD1;RBP4;RHOQ;RHOB;NPR1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;ESPN;HEXB;FABP3;CHGA;MSN;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;RAB12;WNT2B;KITLG;NPPC;JAG2;CDH1;BCAR1;INHBB;TLE1;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;RPH3AL;S100B;SHC4;RBMS3;HNF1A;VDR;AMOT;ARAF;SH3BP4;UNC119;DOK1;RAB3D;GDNF;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;EFNB2;PDE4B
9599,GO:0034754,2.05795843918264e-05,0.999996498956023,11,110,cellular hormone metabolic process,BP,WNT4;HSD17B3;HSD17B11;DKK3;RBP4;CYP17A1;BMP6;BMP2;HSD3B2;STAR;CYP11A1
8410,GO:0032341,2.0765936714748e-05,0.999999569850051,4,9,aldosterone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
8411,GO:0032342,2.0765936714748e-05,0.999999569850051,4,9,aldosterone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
11630,GO:0044093,2.08164287596938e-05,0.99998933096025,64,1841,positive regulation of molecular function,BP,ARTN;ADRA2B;ADRA2C;WNT2;WNT4;RIN3;ACTN2;PMAIP1;GADD45A;FADD;WNT7B;APOC1;TRADD;RABIF;TBC1D14;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;MGST2;MAPK12;PSMB10;LPAR2;RGN;GHR;FGF18;FGF10;FGF17;PIK3R2;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;AXIN1;PSRC1;FGF8;SDC4;ANG;SPTB;HBEGF;BMP4;BMP2;CDKN1A;CTGF;AKT1;IFI27;NRTN;KITLG;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5
13071,GO:0048017,2.10262834390696e-05,0.999995063417055,15,204,inositol lipid-mediated signaling,BP,EDN1;TYRO3;PRR5L;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
1529,GO:0003279,2.14320613589406e-05,0.999996729460653,10,95,cardiac septum development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;FGF8;BMP7;BMP4;HEY1
17339,GO:0090030,2.1927530703496e-05,0.999999539341007,4,9,regulation of steroid hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
16864,GO:0072124,2.25791303300307e-05,0.999999522039847,4,9,regulation of glomerular mesangial cell proliferation,BP,PDGFB;BMP7;BMP4;WT1
1483,GO:0003203,2.27102576951449e-05,0.999998479665784,6,29,endocardial cushion morphogenesis,BP,NOTCH1;ACVR1;FGF8;BMP7;BMP2;HEY1
18904,GO:1901699,2.27342731226779e-05,0.999991620640156,28,574,cellular response to nitrogen compound,BP,PDK4;ACTN2;GUCY1B3;CASQ2;EDN1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RALB;SESN2;RHOQ;RNASEL;BMP4;WT1;GJB2;CASP4;AKT1;CDH1;BCAR1;INHBB;STAR;PIK3CA;PIK3CG;SH3BP4;PDE4B
3684,GO:0007178,2.27395981872152e-05,0.999993476727697,19,309,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ITGA3;NOTCH1;RASL11B;ITGB5;ACVR1;DKK3;FSTL3;FGF10;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;INHBB;CLDN5;ZCCHC12
7066,GO:0021983,2.3444411738252e-05,0.999997879583487,7,42,pituitary gland development,BP,WNT4;FGF10;WNT5A;FGF8;BMP4;BMP2;CDH1
4736,GO:0010092,2.48918836994853e-05,0.999998305795812,6,29,specification of animal organ identity,BP,WNT2;FGF10;FGF8;BMP4;WNT2B;GDNF
13579,GO:0050679,2.51201063920893e-05,0.999994764054288,13,158,positive regulation of epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;FGF10;PDGFB;HRAS;WNT5A;ANG;BMP6;BMP4;BMP2;AKT1
13457,GO:0048878,2.53760799908786e-05,0.999988706245126,41,1004,chemical homeostasis,BP,PDK4;CDH23;TF;SLC31A2;WNT7B;ADORA1;CASQ2;EDN1;ABCG1;PRKACB;BDH2;RAB39A;PRND;LPAR2;RGN;PIK3R2;PIK3R1;KCNH2;PRKAR1B;SESN2;RBP4;NPR1;BMP6;RAB20;HEXB;SFXN1;WNK4;FABP3;NOL3;GJB6;AKT1;STAR;CLDN1;PIK3CA;PIK3CG;GAS6;RPH3AL;HNF1A;VDR;RAB38;CLDN16
14697,GO:0060070,2.64907097305214e-05,0.999992619306142,18,283,canonical Wnt signaling pathway,BP,WNT3;WNT2;WNT4;NOTCH1;WNT7A;WNT7B;DKK3;FZD7;PSMB10;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;FZD8
14562,GO:0055007,2.65432923580512e-05,0.999995840203945,10,97,cardiac muscle cell differentiation,BP,FHOD3;ACTN2;ACVR1;EDN1;FZD7;BMP4;BMP2;WT1;MYH11;EFNB2
8791,GO:0032874,2.75390982299467e-05,0.999994662323869,12,137,positive regulation of stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;FZD8
13740,GO:0050900,2.77603879657645e-05,0.999991049779528,22,391,leukocyte migration,BP,ITGA3;ITGA5;ARTN;FADD;ADORA1;EDN1;CCL20;PYCARD;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;SDC4;CHGA;MSN;KITLG;PIK3CA;PIK3CG;GAS6;PDE4B
12596,GO:0046330,2.79233949055607e-05,0.99999507326946,11,116,positive regulation of JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;CTGF;FZD8
7628,GO:0030863,2.79306503489395e-05,0.999996154768112,9,79,cortical cytoskeleton,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;SPTB;CDH1;CLDN5;MYZAP
11404,GO:0043434,2.8051440790396e-05,0.999990947088024,22,396,response to peptide hormone,BP,PDK4;ACTN2;EDN1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;RNASEL;BMP7;FABP3;CTGF;GJB2;AKT1;BCAR1;INHBB;STAR;PIK3CA
2806,GO:0005796,2.8250581300801e-05,0.999995539573196,10,97,Golgi lumen,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;PDGFB;WNT5B;WNT5A;SDC4;GAS6
7108,GO:0022603,2.84435774932037e-05,0.999987659380637,38,911,regulation of anatomical structure morphogenesis,BP,ITGA5;LIF;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;ACVR1;EDN1;FZD7;PSMB10;LIMS2;FGF10;FOXO4;WNT5A;RHOQ;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;HEXB;MSN;WNT2B;LZTS1;S100B;VDR;AMOT;GDNF;HEY1;PARVB;EFNB2;LINGO1
11896,GO:0044765,2.86948015433998e-05,0.9999838337442,91,2931,single-organism transport,BP,EBP;LIF;ADRA2B;ADRA2C;SYT5;USE1;ACTN2;NOTCH1;RAB27A;STRA6;TF;CRISPLD2;SLC45A4;SERPINA5;WNT7A;APOC1;SLC52A3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PNP;ABCG1;KCNK6;MFGE8;FLVCR2;PYCARD;RAB39A;SYCN;FZD7;TYRO3;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;CPT2;WNT5A;SESN2;RBP4;RHOQ;NPR1;RNASEL;SDC4;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;HEXB;VAMP1;WNK4;FABP3;CHGA;NOL3;DDR1;CTGF;GJB1;TPD52;AKT1;PKP1;RAB17;IDH1;CDH1;MYO7A;INHBB;RAB44;STAR;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;GLA;RPH3AL;DERA;CYB5A;HNF1A;VDR;UNC119;KCND1;RAB3D;GDNF;ACSL4;SLC1A3
6026,GO:0016614,2.92768529805444e-05,0.99999429292189,12,135,oxidoreductase activity, acting on CH-OH group of donors,MF,FASN;HSD17B3;HSD17B11;BDH2;HSD17B10;BMP2;AOX1;HSD3B2;MDH1;IDH1;LDHD;CYB5A
15863,GO:0070304,2.96398909688379e-05,0.999994209208559,12,138,positive regulation of stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;FZD8
16463,GO:0071417,3.12520681456442e-05,0.999988995845572,25,491,cellular response to organonitrogen compound,BP,PDK4;ACTN2;CASQ2;EDN1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;SESN2;RHOQ;RNASEL;WT1;GJB2;CASP4;AKT1;CDH1;BCAR1;INHBB;STAR;PIK3CA;PIK3CG;SH3BP4;PDE4B
1530,GO:0003281,3.20100585831609e-05,0.999996200982907,8,62,ventricular septum development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;BMP4;HEY1
16559,GO:0071560,3.29368669476418e-05,0.999991944218342,15,212,cellular response to transforming growth factor beta stimulus,BP,ITGA3;WNT2;WNT4;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;CGN;PDGFB;WNT5A;STAR;CLDN1;CLDN5
9664,GO:0035051,3.36334771007811e-05,0.999993931870436,11,120,cardiocyte differentiation,BP,FHOD3;ACTN2;NOTCH1;ACVR1;EDN1;FZD7;BMP4;BMP2;WT1;MYH11;EFNB2
15118,GO:0060686,3.36460009644332e-05,0.999999826327133,3,4,negative regulation of prostatic bud formation,BP,WNT5A;BMP7;BMP4
17147,GO:0072659,3.40239500823324e-05,0.999991654290334,15,212,protein localization to plasma membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
15678,GO:0065009,3.40823848713419e-05,0.999980587578303,89,2865,regulation of molecular function,BP,ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;RIN3;ACTN2;NOTCH1;PMAIP1;GADD45A;FADD;SERPINA5;WNT7B;APOC1;ZFPM1;TRADD;RABIF;TBC1D14;ADORA1;CASQ2;EDN1;PLAU;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;TSPAN13;MGST2;MAPK12;PSMB10;LPAR2;RGN;GHR;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;SESN2;AXIN1;FXYD1;PSRC1;FGF8;SDC4;ANG;SPTB;HBEGF;BMP7;BMP4;BMP2;CAMSAP3;CDKN1A;WNK4;NOL3;DEPTOR;CTGF;PCBD1;AKT1;IFI27;NRTN;KITLG;CST9L;TFPI;PIK3CA;PIK3CG;GAS6;GLA;PTS;GPSM1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;PDE4B
15011,GO:0060513,3.42978623909631e-05,0.999999146393297,4,10,prostatic bud formation,BP,FGF10;WNT5A;BMP7;BMP4
18776,GO:1901343,3.53235994713754e-05,0.999994986318033,9,79,negative regulation of vasculature development,BP,WNT4;NOTCH1;PDGFB;FOXO4;NPR1;BMP7;BMP4;WT1;AMOT
14669,GO:0060039,3.54695119144718e-05,0.999998254875912,5,20,pericardium development,BP,NOTCH1;WNT5A;BMP7;BMP2;WT1
14858,GO:0060317,3.59245223091435e-05,0.999997361596288,6,31,cardiac epithelial to mesenchymal transition,BP,WNT2;NOTCH1;ACVR1;FGF8;BMP2;HEY1
16558,GO:0071559,3.61388932540193e-05,0.999991085213619,15,214,response to transforming growth factor beta,BP,ITGA3;WNT2;WNT4;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;CGN;PDGFB;WNT5A;STAR;CLDN1;CLDN5
14934,GO:0060411,3.61581343543082e-05,0.999995633303907,8,62,cardiac septum morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;HEY1
16860,GO:0072110,3.61919630502358e-05,0.999999086580199,4,10,glomerular mesangial cell proliferation,BP,PDGFB;BMP7;BMP4;WT1
3342,GO:0006633,3.64490157471685e-05,0.999993369874621,11,118,fatty acid biosynthetic process,BP,PDK4;PECR;FASN;APOC1;EDN1;ACADVL;ACSM5;RGN;FADS1;PTGES;ELOVL6
15333,GO:0061047,3.66312509562555e-05,0.999999805366144,3,4,positive regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4;WNT2B
9701,GO:0035148,3.6730906031369e-05,0.999992652432765,12,142,tube formation,BP,WNT4;NOTCH1;WNT6;SALL4;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;GDNF
16865,GO:0072125,3.69897142300309e-05,0.99999980280865,3,4,negative regulation of glomerular mesangial cell proliferation,BP,BMP7;BMP4;WT1
17448,GO:0090194,3.69897142300309e-05,0.99999980280865,3,4,negative regulation of glomerulus development,BP,BMP7;BMP4;WT1
9373,GO:0034329,3.70732304797136e-05,0.999991375079076,14,191,cell junction assembly,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;LIMS2;SDC4;GJB1;GJB2;PKP3;CLDN1;CLDN3;CLDN5;LAMA5
4002,GO:0008202,3.73707278008776e-05,0.999989299442662,18,288,steroid metabolic process,BP,EBP;WNT4;DHH;HSD17B3;APOC1;HMGCS2;HSD17B11;DKK3;ABCG1;ACADVL;CYP17A1;BMP6;BMP2;HSD3B2;STAR;CYP11A1;DHCR7;VDR
13626,GO:0050731,3.8239033598385e-05,0.999991683440477,13,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;GHR;FGF10;PDGFB;CLCF1;HBEGF;KITLG;GAS6;UNC119
10083,GO:0035850,3.83929823195555e-05,0.999996208666707,7,46,epithelial cell differentiation involved in kidney development,BP,LIF;NOTCH1;PDGFB;BMP4;WT1;GDNF;ACTA2
4520,GO:0009267,3.95199616810944e-05,0.999992740206988,11,120,cellular response to starvation,BP,PDK4;WNT4;PMAIP1;DSC2;FADS1;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6
10933,GO:0042592,3.98936854039079e-05,0.999979743815666,56,1571,homeostatic process,BP,PDK4;CDH23;TF;PMAIP1;SLC31A2;FADD;WNT7B;ZFPM1;ADORA1;CASQ2;EDN1;ABCG1;PRKACB;BDH2;ACADVL;RAB39A;PRND;TYRO3;LPAR2;RGN;CDH2;PIK3R2;PIK3R1;KCNH2;PRKAR1B;JAM3;SESN2;RBP4;NPR1;ANG;BMP6;BMP4;DLL1;RAB20;HEXB;SFXN1;WNK4;FABP3;NOL3;CTGF;GJB6;AKT1;KITLG;STAR;CLDN1;PIK3CA;PIK3CG;GAS6;RPH3AL;HNF1A;VDR;RAB38;RAB3D;CLDN16;CLDN18;PDE4B
2460,GO:0005126,4.01181080553725e-05,0.999988942248321,17,260,cytokine receptor binding,MF,ITGA5;LIF;RASL11B;FADD;TRADD;CCL20;PYCARD;PIK3R1;CLCF1;BMP7;BMP6;BMP4;BMP2;NOL3;KITLG;INHBB;CNIH4
10850,GO:0042475,4.07821030436251e-05,0.999994092764776,9,81,odontogenesis of dentin-containing tooth,BP,ITGB4;WNT6;FGF10;FGF8;BMP7;BMP4;BMP2;JAG2;LAMA5
7538,GO:0030666,4.09764196349907e-05,0.999991022832949,13,165,endocytic vesicle membrane,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;RAB39A;WNT5B;WNT5A;HBEGF;RAB20;GRIA3;RAB11FIP1;RAB38
5222,GO:0014066,4.1455205906496e-05,0.99999159907508,12,143,regulation of phosphatidylinositol 3-kinase signaling,BP,PRR5L;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA
16343,GO:0071229,4.14699456627296e-05,0.999990252016933,14,190,cellular response to acid chemical,BP,PDK4;WNT3;WNT2;WNT6;WNT7B;EDN1;FZD7;PDGFB;WNT5B;WNT5A;SESN2;AKT1;CLDN1;SH3BP4
3680,GO:0007173,4.20066450138342e-05,0.999992227495577,11,121,epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PIK3R1;HRAS;HBEGF;AKT1;EPN1;BCAR1;PIK3CA;DOK1
11312,GO:0043276,4.28397690467615e-05,0.999996737454943,6,32,anoikis,BP,ITGA5;PDK4;NOTCH1;AKT1;TLE1;PIK3CA
17356,GO:0090066,4.29102086314438e-05,0.999985330326626,23,439,regulation of anatomical structure size,BP,FHOD3;ADRA2B;ADRA2C;WNT3;ACTN2;WNT7A;WNT7B;ADORA1;EDN1;SPTBN5;SPTBN4;PYCARD;PLEKHH2;WNT5A;NPR1;SPTB;CHGA;MSN;DEPTOR;AKT1;NPPC;ACTA2;TMOD4
7393,GO:0030325,4.29929169490778e-05,0.999997796349051,5,20,adrenal gland development,BP,WNT4;STRA6;DKK3;FSTL3;WT1
20468,GO:1905332,4.37545154407227e-05,0.999996654951644,6,32,positive regulation of morphogenesis of an epithelium,BP,LIF;WNT2;WNT4;BMP4;WNT2B;GDNF
5805,GO:0016192,4.40584770694806e-05,0.999976958922905,61,1770,vesicle-mediated transport,BP,SYT5;USE1;RIN3;ACTN2;RAB6C;NOTCH1;RAB27A;TF;ZFYVE21;CRISPLD2;WNT7A;APOC1;RABIF;TBC1D14;ADORA1;PLAU;RAB40B;RAB40A;PNP;MFGE8;SPTBN5;SPTBN4;PYCARD;RAB39B;RAB39A;SYCN;TYRO3;GHR;PIK3R2;PIK3R1;PDGFB;RALB;HRAS;WNT5A;SNX18;SDC4;SPTB;DLL1;RAB20;HEXB;VAMP1;CHGA;MSN;PKP1;RAB17;IDH1;EPN1;MYO7A;RAB44;PIK3CA;PIK3CG;RAB11FIP1;GAS6;GLA;RPH3AL;DERA;SH3BP4;UNC119;RAB38;RAB3D;CNIH4
12231,GO:0045595,4.44380557402525e-05,0.999977734555638,53,1471,regulation of cell differentiation,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;FADD;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;PNP;ABCG1;MAPK12;FZD7;CDH2;FADS1;FSTL3;FGF18;FGF10;PIK3R1;PDGFB;FOXO4;WNT5B;WNT5A;AXIN1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;RAB17;TMEM176A;KITLG;NPPC;STAR;CLDN5;GAS6;LZTS1;S100B;VDR;GDNF;HEY1;CLDN18;EFNB2;LINGO1
4054,GO:0008285,4.49814694748058e-05,0.999982417100472,29,623,negative regulation of cell proliferation,BP,LIF;NOTCH1;IFI30;ADORA1;LIMS2;RGN;FGF10;FOXO4;HRAS;WNT5A;RBP4;NPR1;SDC4;ANG;BMP7;BMP4;BMP2;WT1;CDKN1A;DLL1;FABP3;DDR1;GJB6;PTGES;NPPC;VDR;SH3BP4;PIM2;EFNB2
12346,GO:0045778,4.62642268859314e-05,0.999993182078651,9,82,positive regulation of ossification,BP,WNT4;WNT7B;ACVR1;WNT5A;BMP7;BMP6;BMP4;BMP2;NPPC
16861,GO:0072111,4.63414333172467e-05,0.99999758643967,5,20,cell proliferation involved in kidney development,BP,PDGFB;BMP7;BMP4;BMP2;WT1
11872,GO:0044712,4.75011499672301e-05,0.99997886875861,38,922,single-organism catabolic process,BP,ACTN3;PHYH;GLDC;APOC1;ADORA1;HSD17B11;PNP;BDH2;ACADVL;CPT2;PLA2G16;HSD17B10;ETFB;KHK;HACL1;SESN2;GALT;PFKFB3;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;AKT1;IDH1;DECR1;PIK3CG;PEPD;GLA;ECI1;DERA;ETFDH;PDE4B
4761,GO:0010243,4.75498310151608e-05,0.999979847611286,34,792,response to organonitrogen compound,BP,PDK4;ACTN2;NOTCH1;FADD;CASQ2;EDN1;PRKACB;MGST2;GHR;PIK3R2;PIK3R1;PRKAR1B;NNMT;FOXO4;KHK;SESN2;RHOQ;RNASEL;BMP7;WT1;CDKN1A;FABP3;CTGF;GJB2;CASP4;AKT1;CDH1;BCAR1;INHBB;STAR;PIK3CA;PIK3CG;SH3BP4;PDE4B
1470,GO:0003181,4.89011360050207e-05,0.999997398760189,5,21,atrioventricular valve morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;BMP2;HEY1
3790,GO:0007389,5.06772279652411e-05,0.99998295286792,22,413,pattern specification process,BP,WNT3;WNT2;ALG5;NOTCH1;WNT6;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FGF10;WNT5A;AXIN1;FGF8;BMP7;BMP4;BMP2;DAAM2;WT1;DLL1;WNT2B;GDNF
820,GO:0002011,5.20341453483883e-05,0.999994573388545,7,49,morphogenesis of an epithelial sheet,BP,ITGA5;NOTCH1;WNT7A;WNT5A;HBEGF;BMP7;DDR1
15550,GO:0061564,5.28437106168283e-05,0.999981670912082,23,450,axon development,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;S100B;TSPAN2;DOK1;GDNF;LINGO1
13374,GO:0048711,5.39977524091411e-05,0.999998425669675,4,11,positive regulation of astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
3398,GO:0006702,5.53194324856367e-05,0.999998376929881,4,11,androgen biosynthetic process,BP,WNT4;HSD17B3;CYP17A1;HSD3B2
4896,GO:0010632,6.00959775580372e-05,0.999986299336179,13,173,regulation of epithelial cell migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF18;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;AKT1;BCAR1
3825,GO:0007507,6.10137208778833e-05,0.999978080358759,24,488,heart development,BP,ITGA3;FHOD3;WNT2;ACTN2;NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PDGFB;WNT5A;RBP4;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;CLDN5;MYH11;HEY1;EFNB2
13265,GO:0048522,6.13148676226869e-05,0.999962015677448,128,4576,positive regulation of cellular process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;TF;FASN;PMAIP1;GADD45A;FADD;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;CASQ2;EDN1;PLAU;PNP;PRKACB;MFGE8;CCL20;PYCARD;G0S2;RRAS2;MAPK12;FZD7;PSMB10;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;RBP4;RHOQ;RHOB;NPR1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;ESPN;HEXB;FABP3;CHGA;MSN;CTGF;PCBD1;AKT1;IFI27;RAB12;WNT2B;KITLG;NPPC;JAG2;CDH1;BCAR1;INHBB;STAR;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;RPH3AL;S100B;SHC4;RBMS3;HNF1A;VDR;ARAF;SH3BP4;UNC119;DOK1;RAB3D;GDNF;SLC1A3;FZD8;DUSP5;HEY1;RNF144A;PIM2;EFNB2
4699,GO:0009968,6.20365241098661e-05,0.999970891127076,42,1080,negative regulation of signal transduction,BP,ITGA3;LIF;WNT4;ACTN3;NOTCH1;RASL11B;FADD;TRADD;ACVR1;CASQ2;DKK3;PRKACB;PYCARD;TYRO3;PSMB10;CDH2;PRR5L;FSTL3;FGF10;TICAM1;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;NOL3;DEPTOR;AKT1;EPN1;TLE1;GAS6;RPH3AL;ARAF;SH3BP4;GDNF;DUSP5;HEY1
328,GO:0000902,6.23819196862668e-05,0.999972484754128,36,883,cell morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;ZFPM1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;RHOQ;RHOJ;FGF8;SPTB;BMP7;B3GNT2;HEXB;MSN;DDR1;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;LZTS1;S100B;VDR;LAMA5;DOK1;GDNF;SLC1A3;PARVB;LINGO1
8545,GO:0032496,6.33859006257184e-05,0.999981057036794,18,299,response to lipopolysaccharide,BP,NOTCH1;EDN1;CCL20;PYCARD;MGST2;FGF10;TICAM1;WNT5A;BMP6;SHPK;GJB2;GJB6;AKT1;PTGES;TFPI;STAR;CLDN1;PDE4B
16900,GO:0072175,6.64485029204691e-05,0.999987020357926,11,128,epithelial tube formation,BP,WNT4;WNT6;SALL4;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;GDNF
13427,GO:0048839,6.7323412279437e-05,0.999984469812953,13,175,inner ear development,BP,NOTCH1;CDH23;FGF10;WNT5A;FGF8;SDC4;BMP4;BMP2;DLL1;GJB2;GJB6;JAG2;MYO7A
1484,GO:0003205,6.81278475392378e-05,0.999985411054505,12,153,cardiac chamber development,BP,WNT2;NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;RBP4;FGF8;BMP7;BMP4;HEY1
7459,GO:0030501,6.86360671781614e-05,0.999994239129769,6,35,positive regulation of bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
1524,GO:0003272,6.87925342316095e-05,0.999996029716217,5,22,endocardial cushion formation,BP,NOTCH1;ACVR1;FGF8;BMP7;HEY1
7638,GO:0030879,6.91811078876845e-05,0.999986420181732,11,129,mammary gland development,BP,WNT3;WNT2;WNT4;FASN;WNT7B;FGF10;WNT5A;BMP4;DDR1;AKT1;VDR
1467,GO:0003177,7.04052600455269e-05,0.999997730242456,4,12,pulmonary valve development,BP,NOTCH1;STRA6;BMP4;HEY1
1472,GO:0003184,7.04052600455269e-05,0.999997730242456,4,12,pulmonary valve morphogenesis,BP,NOTCH1;STRA6;BMP4;HEY1
3933,GO:0008092,7.25066401909028e-05,0.999968561055491,34,823,cytoskeletal protein binding,MF,TAGLN;FHOD3;ACTN3;ACTN2;MARK4;RAB27A;SPTBN5;SPTBN4;PYCARD;RAB39B;CGN;REEP1;PLEKHH2;PXK;PSTPIP2;PSRC1;ANG;FAM110C;SPTB;CAMSAP3;DAAM2;ESPN;FABP3;MSN;CDH1;MYO7A;RPH3AL;MYH11;LZTS1;S100B;RAB3D;PARVB;PDE4B;TMOD4
7484,GO:0030539,7.33799857424167e-05,0.999995705941291,5,22,male genitalia development,BP,HSD17B3;FGF10;FGF8;BMP6;WT1
763,GO:0001938,7.34770025742119e-05,0.999990106289812,8,68,positive regulation of endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;ANG;BMP6;BMP4;BMP2;AKT1
3415,GO:0006732,7.45668990515587e-05,0.999977416739461,18,303,coenzyme metabolic process,BP,PDK4;ACTN3;FASN;ACSF2;PNP;ACSM5;NNMT;PFKFB3;ACAT1;SHPK;NUDT7;PCBD1;MDH1;IDH1;DERA;PTS;ACSL4;ELOVL6
21638,GO:2001236,7.46302588378648e-05,0.999983870643057,12,151,regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;FADD;TRADD;ACVR1;PYCARD;G0S2;FGF10;BMP4;NOL3;DEPTOR;AKT1;GDNF
562,GO:0001649,7.51385777242328e-05,0.999981281572928,14,201,osteoblast differentiation,BP,WNT3;WNT4;NOTCH1;FASN;DHH;WNT7B;ACVR1;RRAS2;BMP7;BMP6;BMP4;BMP2;AKT1;NPPC
1385,GO:0003012,7.63582831411135e-05,0.999974302784204,21,397,muscle system process,BP,ADRA2B;ADRA2C;ACTN3;ACTN2;ITGB5;DSC2;ADORA1;CASQ2;EDN1;KCNH2;FXYD1;CHGA;NOL3;CTGF;PIK3CA;PIK3CG;MYH11;GDNF;ACTA2;PDE4B;TMOD4
602,GO:0001707,7.76597622144616e-05,0.999989458670908,8,68,mesoderm formation,BP,ITGA3;WNT3;ITGB4;ACVR1;WNT5A;AXIN1;BMP7;BMP4
6103,GO:0016773,7.80106371366792e-05,0.999966959467044,32,752,phosphotransferase activity, alcohol group as acceptor,MF,PDK4;MARK4;ZFYVE21;ACVR1;PRKACB;MAPK12;TYRO3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;RNASEL;FGF8;HBEGF;CDKN1A;PKN3;SHPK;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
14935,GO:0060412,7.90640544673053e-05,0.999993167318337,6,36,ventricular septum morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;WNT5A;BMP4;HEY1
4858,GO:0010566,8.12869435702804e-05,0.999997279042876,4,12,regulation of ketone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
16882,GO:0072144,8.14822014108837e-05,0.999999164369689,3,5,glomerular mesangial cell development,BP,NOTCH1;PDGFB;ACTA2
14721,GO:0060113,8.25573298256986e-05,0.999990677559153,7,52,inner ear receptor cell differentiation,BP,NOTCH1;CDH23;SDC4;BMP4;DLL1;JAG2;MYO7A
4650,GO:0009798,8.25574986123034e-05,0.999986814371025,9,88,axis specification,BP,WNT3;NOTCH1;WNT6;WNT7A;FGF10;WNT5A;BMP4;WT1;DLL1
20875,GO:1990778,8.28049910906047e-05,0.999977944761444,15,229,protein localization to cell periphery,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
18010,GO:0097651,8.30950451004574e-05,0.999999142102305,3,5,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1;PIK3CA;PIK3CG
13578,GO:0050678,8.3494353928319e-05,0.999975495129166,17,282,regulation of epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;LIMS2;RGN;FGF10;PDGFB;HRAS;WNT5A;ANG;BMP6;BMP4;BMP2;AKT1;VDR;EFNB2
3727,GO:0007229,8.59198313380435e-05,0.999986195866812,9,89,integrin-mediated signaling pathway,BP,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;LIMS2;CTGF;BCAR1;LAMA5
16935,GO:0072215,8.88664565090424e-05,0.999994539626534,5,23,regulation of metanephros development,BP,LIF;PDGFB;BMP4;WT1;GDNF
17125,GO:0072593,9.07247037365077e-05,0.999975635526595,15,228,reactive oxygen species metabolic process,BP,PDK4;RAB27A;PMAIP1;GADD45A;EDN1;RGN;TICAM1;PDGFB;SESN2;BMP7;CDKN1A;AOX1;CTGF;AKT1;GLA
14946,GO:0060425,9.17381650928808e-05,0.999989462295497,7,52,lung morphogenesis,BP,LIF;WNT2;WNT7B;FGF10;FGF8;BMP4;WNT2B
21062,GO:2000209,9.18118960355122e-05,0.999994318944322,5,23,regulation of anoikis,BP,ITGA5;PDK4;NOTCH1;TLE1;PIK3CA
16450,GO:0071396,9.32800881046019e-05,0.99996473693923,25,522,cellular response to lipid,BP,PDK4;WNT3;WNT2;WNT6;WNT7B;EDN1;CCL20;PYCARD;FZD7;TICAM1;WNT5B;WNT5A;BMP7;BMP6;BMP4;SHPK;MSN;GJB2;AKT1;TFPI;STAR;CLDN1;VDR;HEY1;PDE4B
18775,GO:1901342,9.43453286139978e-05,0.999974566015245,15,230,regulation of vasculature development,BP,ITGA5;WNT4;NOTCH1;PDGFB;FOXO4;WNT5A;RHOB;NPR1;BMP7;BMP4;WT1;DLL1;AMOT;HEY1;EFNB2
13203,GO:0048332,9.43768372530461e-05,0.999986795257446,8,70,mesoderm morphogenesis,BP,ITGA3;WNT3;ITGB4;ACVR1;WNT5A;AXIN1;BMP7;BMP4
4053,GO:0008284,9.44366253574961e-05,0.999958464736861,34,816,positive regulation of cell proliferation,BP,LIF;WNT2;NOTCH1;FADD;WNT7A;EDN1;PNP;PYCARD;FZD7;FGF18;FGF10;FGF17;TICAM1;PDGFB;HRAS;WNT5A;FGF8;CLCF1;ANG;HBEGF;BMP6;BMP4;BMP2;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;GAS6;S100B;SHC4;GDNF;EFNB2
12764,GO:0046661,9.45926577591636e-05,0.999979010618912,12,155,male sex differentiation,BP,WNT4;DHH;HSD17B3;FSTL3;FGF10;WNT5A;FGF8;BMP6;WT1;WNT2B;KITLG;STAR
10701,GO:0042181,9.46667633017757e-05,0.999991543259407,6,36,ketone biosynthetic process,BP,WNT4;HSD17B3;DKK3;BMP6;BMP2;STAR
8858,GO:0032970,9.79273336459202e-05,0.999969649417968,18,318,regulation of actin filament-based process,BP,FHOD3;WNT4;ACTN2;DSC2;EDN1;SPTBN5;SPTBN4;PYCARD;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;SDC4;SPTB;CTGF;PDE4B;TMOD4
12439,GO:0045940,9.90527640072561e-05,0.99999376992705,5,23,positive regulation of steroid metabolic process,BP,WNT4;APOC1;ABCG1;BMP6;STAR
10935,GO:0042594,9.99700904582649e-05,0.999977679980902,12,156,response to starvation,BP,PDK4;WNT4;PMAIP1;DSC2;FADS1;RALB;NUAK2;ACAT1;CDKN1A;WNT2B;INHBB;GAS6
1462,GO:0003171,0.000100489514955941,0.999993615932514,5,24,atrioventricular valve development,BP,NOTCH1;ZFPM1;ACVR1;BMP2;HEY1
12233,GO:0045597,0.000100559046639594,0.999955616197702,34,824,positive regulation of cell differentiation,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;FADD;WNT7B;ACVR1;EDN1;PNP;MAPK12;CDH2;FGF18;WNT5B;WNT5A;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;NPPC;STAR;CLDN5;GAS6;VDR;GDNF;EFNB2
15363,GO:0061098,0.000101591775902606,0.999990777855194,6,37,positive regulation of protein tyrosine kinase activity,BP,ADRA2B;ADRA2C;ADORA1;PDGFB;GAS6;UNC119
857,GO:0002062,0.000102918101439707,0.999983042474198,9,91,chondrocyte differentiation,BP,WNT7A;FGF18;WNT5B;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC
15077,GO:0060601,0.00010314500895066,0.999996231919933,4,13,lateral sprouting from an epithelium,BP,FGF10;WNT5A;BMP7;BMP4
18875,GO:1901653,0.000103181466438159,0.999967891812013,18,315,cellular response to peptide,BP,PDK4;ACTN2;EDN1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;RNASEL;GJB2;CASP4;AKT1;BCAR1;INHBB;STAR;PIK3CA
7487,GO:0030545,0.000107836434216469,0.99998726359012,7,53,receptor regulator activity,MF,WNT3;WNT2;WNT4;ACTN2;WNT7A;WNT5A;GAS6
329,GO:0000904,0.000108333371377671,0.999956122409919,28,634,cell morphogenesis involved in differentiation,BP,ARTN;WNT3;NOTCH1;WNT7A;ZFPM1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;LZTS1;S100B;LAMA5;DOK1;GDNF;SLC1A3;LINGO1
4857,GO:0010565,0.000109070287662584,0.999975418630817,12,156,regulation of cellular ketone metabolic process,BP,PDK4;WNT4;APOC1;DKK3;ACADVL;PSMB10;RGN;BMP6;BMP2;FABP3;AKT1;STAR
3855,GO:0007596,0.0001106806692339,0.999964079581544,19,343,blood coagulation,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;FAM46A;TFPI;PIK3CA;PIK3CG;GAS6
2976,GO:0006081,0.000113383935160519,0.999981085906514,9,90,cellular aldehyde metabolic process,BP,WNT4;GLDC;DKK3;KHK;BMP6;BMP2;SHPK;IDH1;DERA
955,GO:0002237,0.000117389411388956,0.999963087938814,18,314,response to molecule of bacterial origin,BP,NOTCH1;EDN1;CCL20;PYCARD;MGST2;FGF10;TICAM1;WNT5A;BMP6;SHPK;GJB2;GJB6;AKT1;PTGES;TFPI;STAR;CLDN1;PDE4B
18910,GO:1901722,0.000119234557902487,0.999995475130687,4,13,regulation of cell proliferation involved in kidney development,BP,PDGFB;BMP7;BMP4;WT1
12382,GO:0045843,0.000119468118625585,0.999988793584806,6,38,negative regulation of striated muscle tissue development,BP,FZD7;RBP4;FGF8;BMP4;BMP2;S100B
7624,GO:0030858,0.000120031042686878,0.999985552167244,7,54,positive regulation of epithelial cell differentiation,BP,LIF;NOTCH1;BMP6;BMP4;CLDN5;VDR;GDNF
11805,GO:0044438,0.000121205017198613,0.999979587899713,9,91,microbody part,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1;ACSL4
11806,GO:0044439,0.000121205017198613,0.999979587899713,9,91,peroxisomal part,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1;ACSL4
12594,GO:0046328,0.000121650028358947,0.99997223339033,12,160,regulation of JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;CTGF;AKT1;FZD8
15120,GO:0060688,0.000122982111371114,0.999985138161759,7,54,regulation of morphogenesis of a branching structure,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B;GDNF
17797,GO:0097191,0.000123020034443073,0.999967826547613,14,209,extrinsic apoptotic signaling pathway,BP,PMAIP1;FADD;TRADD;ACVR1;PYCARD;G0S2;FGF10;PIK3R1;BMP4;NOL3;DEPTOR;AKT1;KITLG;GDNF
13682,GO:0050817,0.000128708356906184,0.999957719750841,19,347,coagulation,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;FAM46A;TFPI;PIK3CA;PIK3CG;GAS6
10851,GO:0042476,0.000129443721704808,0.999975200561081,10,115,odontogenesis,BP,ITGB4;WNT6;EDN1;FGF10;FGF8;BMP7;BMP4;BMP2;JAG2;LAMA5
15772,GO:0070167,0.000129603283768312,0.999980953769907,8,73,regulation of biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2;GAS6
16433,GO:0071375,0.000131683494746247,0.999959800587143,17,293,cellular response to peptide hormone stimulus,BP,PDK4;ACTN2;EDN1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;RNASEL;GJB2;AKT1;BCAR1;INHBB;STAR;PIK3CA
1381,GO:0003008,0.000132371339981804,0.999926772029754,63,1906,system process,BP,ITGA3;ITGA5;ADRA2B;ADRA2C;ACTN3;ACTN2;CDH23;STRA6;ITGB5;DSC2;SLC52A3;GUCY1B3;ADORA1;CASQ2;EDN1;PRKACB;KCNK6;SPTBN4;FGF10;PDGFB;KCNH2;PRKAR1B;JAM3;FXYD1;RBP4;NPR1;HBEGF;BMP6;BMP4;B3GNT2;DLL1;ESPN;HEXB;WNK4;CHGA;NOL3;CTGF;GJB2;GJB6;AKT1;NPPC;JAG2;MYO7A;INHBB;GJA3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;MYH11;S100B;HNF1A;VDR;UNC119;KCND1;GDNF;SLC1A3;ACTA2;CLDN16;PDE4B;TMOD4
4872,GO:0010594,0.000132696022613352,0.999974499150565,10,115,regulation of endothelial cell migration,BP,NOTCH1;WNT7A;EDN1;FGF18;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1
3858,GO:0007599,0.00013400903461708,0.999955835388792,19,348,hemostasis,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;FAM46A;TFPI;PIK3CA;PIK3CG;GAS6
10858,GO:0042490,0.000134202257721837,0.999983503330409,7,56,mechanoreceptor differentiation,BP,NOTCH1;CDH23;SDC4;BMP4;DLL1;JAG2;MYO7A
4893,GO:0010628,0.000138208972709498,0.999925509537507,57,1687,positive regulation of gene expression,BP,ITGA3;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;FADD;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;MSN;CTGF;PCBD1;AKT1;PKP3;PKP1;CDH1;TLE1;STAR;GAS6;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
17000,GO:0072330,0.000140597190255985,0.99996498690295,13,185,monocarboxylic acid biosynthetic process,BP,PDK4;PECR;FASN;APOC1;EDN1;ACADVL;ACSM5;RGN;FADS1;PTGES;STAR;SLC1A3;ELOVL6
13445,GO:0048863,0.00014106855729395,0.999967265829373,12,162,stem cell differentiation,BP,LIF;WNT3;NOTCH1;WNT7A;ACVR1;EDN1;FOXO4;NRTN;KITLG;SHC4;LAMA5;GDNF
12668,GO:0046488,0.000141184971743296,0.999962557866855,14,213,phosphatidylinositol metabolic process,BP,DPM3;ZFYVE21;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PLA2G16;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
1654,GO:0003824,0.000142282884996363,0.99990763787807,147,5495,catalytic activity,MF,CFB;EBP;PDK4;PECR;TUBG2;RAB6C;TSPAN17;ALG5;PHYH;GLDC;MARK4;RAB27A;IFI30;PNMT;DPM3;RASL11B;ZFYVE21;FASN;MSRA;RHBDL3;FBXO41;MRI1;DHH;HSD17B3;HMGCS2;ACVR1;NMT2;GUCY1B3;ADORA1;HSD17B11;EXTL1;ACSF2;PLAU;RAB40B;RAB40A;PNP;ABCG1;PRKACB;BDH2;PYCARD;MBOAT2;ACADVL;RRAS2;RAB39B;RAB39A;MGST2;ACSM5;MAPK12;TYRO3;PSMB10;RGN;FADS1;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PTPN7;NNMT;RALB;CPT2;PLA2G16;HSD17B10;HRAS;KHK;HACL1;SESN2;GALT;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;RNASEL;FGF8;ANG;HBEGF;BMP2;ACAT1;B3GNT2;IDUA;CDKN1A;AOX1;PKN3;RAB20;ECHDC2;SARDH;SHPK;HEXB;CMBL;WNK4;RND3;HSD3B2;NUDT6;NUDT7;DDR1;CPT1C;RRAD;PCBD1;MDH1;CASP4;AKT1;RAB12;RAB17;PON2;PTGES;KITLG;IDH1;DECR1;PUS1;MYO7A;LDHD;MDP1;SPSB1;RAB44;PIK3CA;PIK3CG;SIN3B;PEPD;ACP5;GLA;DTX4;ECI1;CYP11A1;MYH11;DERA;DHCR7;CYB5A;PTS;PM20D2;ARAF;RAB38;RAB3D;LYPLAL1;ACSL4;ELOVL6;DUSP5;RNF144A;PIM2;ETFDH;PDE4B
4271,GO:0008654,0.000145054423662954,0.999957247442659,16,266,phospholipid biosynthetic process,BP,DPM3;MBOAT2;FADS1;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PLA2G16;FGF8;HEXB;FABP3;IDH1;PIK3CA;PIK3CG
1485,GO:0003206,0.000145985663696884,0.999971589526486,10,117,cardiac chamber morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A;RBP4;FGF8;BMP7;BMP4;HEY1
5226,GO:0014070,0.000147930847692098,0.999931706394584,36,908,response to organic cyclic compound,BP,NOTCH1;PMAIP1;FADD;DHH;WNT7A;WNT7B;CASQ2;EDN1;PRKACB;FGF10;TICAM1;PDGFB;RALB;FGF8;BMP7;BMP6;BMP4;BMP2;ACAT1;WT1;CDKN1A;MSN;CTGF;GJB2;AKT1;PTGES;IDH1;CDH1;TFPI;STAR;CLDN1;PIK3CG;S100B;VDR;HEY1;PDE4B
18534,GO:1900180,0.000148852626881893,0.999960315088321,14,214,regulation of protein localization to nucleus,BP,LIF;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6;CLDN18
10852,GO:0042481,0.000149330323275503,0.999989600757196,5,25,regulation of odontogenesis,BP,WNT6;EDN1;FGF8;BMP4;BMP2
6034,GO:0016628,0.000150539635699458,0.99998949820089,5,25,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,PECR;FASN;BDH2;DECR1;DHCR7
16932,GO:0072210,0.000151547098999537,0.999985066149844,6,40,metanephric nephron development,BP,LIF;WNT4;PDGFB;BMP4;WT1;GDNF
11813,GO:0044448,0.000154142115025099,0.999969776862392,10,119,cell cortex part,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;SPTB;CDH1;CLDN5;MYZAP
16929,GO:0072207,0.000156472715919044,0.999988929721131,5,26,metanephric epithelium development,BP,LIF;WNT4;WNT7B;ACAT1;WT1
16521,GO:0071496,0.000157878612798301,0.99995310681325,16,268,cellular response to external stimulus,BP,PDK4;WNT4;PMAIP1;GADD45A;FADD;DSC2;FADS1;RALB;NUAK2;BMP6;CDKN1A;AKT1;WNT2B;INHBB;GAS6;VDR
16967,GO:0072273,0.000158134317466566,0.999988786511982,5,26,metanephric nephron morphogenesis,BP,LIF;WNT4;BMP4;WT1;GDNF
5082,GO:0010893,0.000158643924049871,0.999993375295466,4,14,positive regulation of steroid biosynthetic process,BP,WNT4;ABCG1;BMP6;STAR
11825,GO:0044464,0.000158804494517446,0.999932853357584,342,15425,cell part,CC,ITGA3;ITGA5;ARTN;CFB;TAGLN;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;PNMT;DPM3;STRA6;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;FBXO41;MRPL14;MRPL16;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;FLVCR2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;HBEGF;LGALS4;NMI;BMP6;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;F8A1;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;IDH1;NPPC;DECR1;NAB2;JAG2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;PTMS;LDHD;GJA3;TMEM98;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN2;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;PRRT1;LZTS1;DERA;S100B;CLDN23;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;SLC18B1;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;LYPLAL1;ACSL4;MYZAP;FAM110B;SLC1A3;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
16936,GO:0072216,0.000158846431896109,0.999993364607492,4,14,positive regulation of metanephros development,BP,LIF;PDGFB;WT1;GDNF
18945,GO:1901862,0.000159876646273171,0.999984087786175,6,40,negative regulation of muscle tissue development,BP,FZD7;RBP4;FGF8;BMP4;BMP2;S100B
15162,GO:0060740,0.000160746756359022,0.999988560683376,5,26,prostate gland epithelium morphogenesis,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
13320,GO:0048635,0.000161451272299782,0.999983901732574,6,40,negative regulation of muscle organ development,BP,FZD7;RBP4;FGF8;BMP4;BMP2;S100B
15220,GO:0060842,0.000161845120256331,0.999997505678155,3,6,arterial endothelial cell differentiation,BP,NOTCH1;DLL1;HEY1
17446,GO:0090192,0.000162404328684595,0.99999317623877,4,14,regulation of glomerulus development,BP,PDGFB;BMP7;BMP4;WT1
16792,GO:0072008,0.000162832402787168,0.999997485219504,3,6,glomerular mesangial cell differentiation,BP,NOTCH1;PDGFB;ACTA2
1378,GO:0003002,0.000163579649104304,0.999947098588905,18,327,regionalization,BP,WNT3;WNT2;NOTCH1;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FGF10;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B;GDNF
16881,GO:0072143,0.000164026015096826,0.999997460427939,3,6,mesangial cell development,BP,NOTCH1;PDGFB;ACTA2
6028,GO:0016616,0.000165222675459818,0.999967370499906,10,115,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,FASN;HSD17B3;HSD17B11;BDH2;HSD17B10;BMP2;HSD3B2;MDH1;IDH1;CYB5A
3668,GO:0007160,0.000165615981995279,0.99995800117801,13,193,cell-matrix adhesion,BP,ITGA3;WNT4;ACTN3;ACTN2;ITGB5;ITGB4;PLAU;PIK3R1;JAM3;SDC4;DDR1;CTGF;LAMA5
16924,GO:0072202,0.000166678360905584,0.999988044944921,5,26,cell differentiation involved in metanephros development,BP,LIF;WNT4;PDGFB;BMP4;GDNF
12465,GO:0045992,0.000167734884599761,0.99998795265373,5,26,negative regulation of embryonic development,BP,PRKACB;FZD7;WNT5A;BMP7;BMP4
15117,GO:0060685,0.000168462173242362,0.999997367742926,3,6,regulation of prostatic bud formation,BP,WNT5A;BMP7;BMP4
7924,GO:0031399,0.000172472041395365,0.999907153258074,55,1619,regulation of protein modification process,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;PYCARD;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CDKN1A;DEPTOR;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
4651,GO:0009799,0.000172647469206144,0.999965666429332,10,119,specification of symmetry,BP,ALG5;NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;BMP4;DAAM2;DLL1
20984,GO:2000064,0.000173445988772928,0.999997262604741,3,6,regulation of cortisol biosynthetic process,BP,WNT4;DKK3;BMP2
18911,GO:1901723,0.000177531940015666,0.999997175623234,3,6,negative regulation of cell proliferation involved in kidney development,BP,BMP7;BMP4;WT1
15332,GO:0061046,0.000177857172589127,0.999997168669675,3,6,regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4;WNT2B
15478,GO:0061370,0.000178009859708198,0.999997165403665,3,6,testosterone biosynthetic process,BP,WNT4;HSD17B3;STAR
2438,GO:0005088,0.000178387337570231,0.999948881166363,15,249,Ras guanyl-nucleotide exchange factor activity,MF,ARTN;RIN3;ACTN2;SPTBN5;SPTBN4;FGF18;FGF10;FGF17;PDGFB;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
10498,GO:0038127,0.000181622447453692,0.999960000911287,11,143,ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PIK3R1;HRAS;HBEGF;AKT1;EPN1;BCAR1;PIK3CA;DOK1
14027,GO:0051345,0.000183752088952209,0.999914163050431,36,925,positive regulation of hydrolase activity,BP,ARTN;WNT4;RIN3;ACTN2;PMAIP1;FADD;TRADD;RABIF;TBC1D14;CCL20;SPTBN5;SPTBN4;PYCARD;MAPK12;LPAR2;RGN;FGF18;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;ANG;SPTB;HBEGF;BMP2;CTGF;AKT1;IFI27;NRTN;KITLG;GDNF
567,GO:0001654,0.000185077140356711,0.999939509276916,18,333,eye development,BP,WNT2;STRA6;WNT6;WNT7A;WNT7B;FGF10;WNT5B;WNT5A;AXIN1;RBP4;RHOJ;BMP7;BMP6;BMP4;WT1;DLL1;WNT2B;MYO7A
729,GO:0001890,0.000188046543083432,0.999958417781014,11,143,placenta development,BP,LIF;WNT2;ITGB8;WNT7B;PDGFB;ANG;BMP7;GJB2;AKT1;VDR;HEY1
10629,GO:0042056,0.000188199058427773,0.999986140454785,5,26,chemoattractant activity,MF,FGF10;PDGFB;WNT5A;FGF8;BMP4
7296,GO:0030198,0.000194755845973856,0.999938460368566,17,306,extracellular matrix organization,BP,ITGA3;ITGA5;NOTCH1;ITGB5;ITGB4;ITGB8;CRISPLD2;PDGFB;JAM3;WT1;DDR1;CTGF;CDH1;GAS6;MYH11;LAMA1;LAMA5
9569,GO:0034698,0.000197307720434558,0.999985243185855,5,27,response to gonadotropin,BP,ITGA3;NOTCH1;WT1;GJB2;STAR
11171,GO:0043062,0.00020244784913266,0.999935811083239,17,307,extracellular structure organization,BP,ITGA3;ITGA5;NOTCH1;ITGB5;ITGB4;ITGB8;CRISPLD2;PDGFB;JAM3;WT1;DDR1;CTGF;CDH1;GAS6;MYH11;LAMA1;LAMA5
10700,GO:0042180,0.000203357700763389,0.999944076971889,14,217,cellular ketone metabolic process,BP,PDK4;WNT4;HSD17B3;APOC1;DKK3;ACADVL;PSMB10;RGN;CYP17A1;BMP6;BMP2;FABP3;AKT1;STAR
13901,GO:0051148,0.000203557515640889,0.999973104163951,7,59,negative regulation of muscle cell differentiation,BP,NOTCH1;FZD7;PDGFB;FOXO4;BMP4;BMP2;DLL1
12561,GO:0046184,0.000204095173018999,0.999990734276089,4,15,aldehyde biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
8846,GO:0032956,0.000204357914619844,0.999937827913725,16,278,regulation of actin cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;EDN1;SPTBN5;SPTBN4;PYCARD;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;SDC4;SPTB;CTGF;TMOD4
7465,GO:0030509,0.000205445136161808,0.999954063602559,11,146,BMP signaling pathway,BP,ITGA3;NOTCH1;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
17162,GO:0072678,0.000206274513611668,0.999978419337217,6,41,T cell migration,BP,FADD;CCL20;PYCARD;WNT5A;MSN;PIK3CG
13837,GO:0051050,0.000207876553917124,0.999903330057902,35,889,positive regulation of transport,BP,ACTN2;RAB27A;TF;PMAIP1;ADORA1;EDN1;ABCG1;MFGE8;PYCARD;RGN;CDH2;PRR5L;PIK3R2;PIK3R1;PDGFB;KCNH2;WNT5A;FXYD1;RBP4;RHOQ;NPR1;RNASEL;SDC4;ANG;BMP6;BMP4;DLL1;MSN;AKT1;CDH1;INHBB;GAS6;RPH3AL;RAB3D;GDNF
16883,GO:0072148,0.000209652392447466,0.999990414107185,4,15,epithelial cell fate commitment,BP,NOTCH1;ACVR1;DLL1;JAG2
8071,GO:0031669,0.000211320128385187,0.999948676316929,12,169,cellular response to nutrient levels,BP,PDK4;WNT4;PMAIP1;DSC2;FADS1;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6;VDR
11823,GO:0044459,0.000215237146675073,0.999872901247005,76,2478,plasma membrane part,CC,ITGA3;ITGA5;EBP;ADRA2B;ADRA2C;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;ITGB5;ITGB4;ITGB8;SLC31A2;FADD;SERPINA5;P2RY14;TRADD;SLC52A3;ACVR1;ADORA1;CASQ2;ABCG1;KCNK6;MFGE8;SPTBN5;TTYH1;MPZL1;TSPAN13;TYRO3;LPAR2;CDH2;GHR;PDGFB;KCNH2;PTPN7;SNX18;AXIN1;FXYD1;NPR1;FGF8;SDC4;SPTB;HBEGF;BMP2;DLL1;DRP2;VAMP1;GRIA3;MSN;DDR1;GJB1;GJB2;GJB6;CPT1C;RAB17;JAG2;CDH1;MYO7A;GJA3;CLDN1;CLDN3;CLDN5;KCNG2;LZTS1;SHC4;SLC18B1;AMOT;KCND1;TSPAN2;MYZAP;FZD8;CLDN12;CLDN15;EFNB2;PDE4B
13322,GO:0048638,0.000215330025243086,0.999934169668185,16,280,regulation of developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;GHR;WNT5A;RBP4;FGF8;BMP4;WT1;DLL1;AKT1;NPPC;PIK3CA
4648,GO:0009792,0.000216209188142883,0.999913494650981,25,555,embryo development ending in birth or egg hatching,BP,LIF;WNT2;NOTCH1;WNT7B;ACVR1;SALL4;EDN1;PRKACB;PDGFB;WNT5A;AXIN1;RBP4;FGF8;SDC4;BMP7;BMP4;BMP2;DLL1;AKT1;JAG2;EPN1;DSC3;AMOT;ACSL4;HEY1
3544,GO:0006937,0.000218705629924321,0.999950738872923,11,146,regulation of muscle contraction,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;CHGA;CTGF;PIK3CG;PDE4B
482,GO:0001503,0.000225161505195705,0.999922580684648,19,366,ossification,BP,WNT3;WNT4;NOTCH1;FASN;DHH;WNT7B;ACVR1;RRAS2;FSTL3;FGF18;WNT5A;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NPPC;NAB2
2700,GO:0005623,0.0002260918532092,0.999895657141336,342,15450,cell,CC,ITGA3;ITGA5;ARTN;CFB;TAGLN;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;PNMT;DPM3;STRA6;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;FBXO41;MRPL14;MRPL16;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;FLVCR2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;HBEGF;LGALS4;NMI;BMP6;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;F8A1;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;IDH1;NPPC;DECR1;NAB2;JAG2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;PTMS;LDHD;GJA3;TMEM98;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN2;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;PRRT1;LZTS1;DERA;S100B;CLDN23;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;SLC18B1;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;LYPLAL1;ACSL4;MYZAP;FAM110B;SLC1A3;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
5531,GO:0015629,0.000227994722541775,0.99991667404009,21,433,actin cytoskeleton,CC,FHOD3;ACTN3;ACTN2;MSRA;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;RHOQ;SPTB;ESPN;CDH1;MYO7A;BCAR1;CLDN5;MYH11;AMOT;MYZAP;ACTA2;TMOD4
17882,GO:0097367,0.00023354073173063,0.999865583360495,67,2130,carbohydrate derivative binding,MF,ITGA3;PDK4;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;CRISPLD2;SERPINA5;ACVR1;GUCY1B3;ADORA1;ACSF2;RAB40B;RAB40A;PNP;ABCG1;PRKACB;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;FGF10;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;ANG;HBEGF;LGALS4;BMP7;BMP4;PKN3;RAB20;SHPK;WNK4;RND3;DDR1;CTGF;RRAD;AKT1;RAB12;RAB17;CDH1;MYO7A;RAB44;PIK3CA;PIK3CG;GLA;HAPLN3;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
15010,GO:0060512,0.00023530811205898,0.99998162522729,5,28,prostate gland morphogenesis,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
1476,GO:0003190,0.00023743189577841,0.999995388892646,3,7,atrioventricular valve formation,BP,NOTCH1;ZFPM1;HEY1
9694,GO:0035116,0.000238672752674803,0.9999813046289,5,28,embryonic hindlimb morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF8;BMP4
20463,GO:1905314,0.000238839167969977,0.999988531663507,4,16,semi-lunar valve development,BP,NOTCH1;STRA6;BMP4;HEY1
2885,GO:0005938,0.000244050074970524,0.999931566571627,14,229,cell cortex,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;FAM110C;SPTB;CTGF;CYTIP;CDH1;MYO7A;CLDN5;MYZAP
12858,GO:0046889,0.000245473044277179,0.999966506693208,7,60,positive regulation of lipid biosynthetic process,BP,WNT4;ABCG1;RGN;BMP6;FABP3;AKT1;STAR
12373,GO:0045834,0.000246462825200632,0.999948677115126,10,123,positive regulation of lipid metabolic process,BP,WNT4;APOC1;ABCG1;RGN;PDGFB;SESN2;BMP6;FABP3;AKT1;STAR
8789,GO:0032872,0.000250381238981183,0.999933670783262,13,198,regulation of stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
12734,GO:0046622,0.000250713235241627,0.999972619582635,6,44,positive regulation of organ growth,BP,WNT2;NOTCH1;EDN1;FGF8;WT1;AKT1
13297,GO:0048585,0.000256272527304922,0.999866071500681,47,1339,negative regulation of response to stimulus,BP,ITGA3;LIF;WNT3;WNT4;ACTN3;NOTCH1;RASL11B;FADD;TRADD;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;PYCARD;TYRO3;PSMB10;CDH2;PRR5L;FSTL3;FGF10;TICAM1;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;NMI;BMP7;BMP4;BMP2;NOL3;DEPTOR;AKT1;EPN1;TLE1;GAS6;RPH3AL;ARAF;SH3BP4;GDNF;DUSP5;HEY1
4007,GO:0008209,0.000257117744063498,0.999979529536044,5,28,androgen metabolic process,BP,WNT4;HSD17B3;HSD17B11;CYP17A1;HSD3B2
12865,GO:0046903,0.000259118833309014,0.999861040993119,51,1489,secretion,BP,LIF;ADRA2B;ADRA2C;SYT5;USE1;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;ADORA1;EDN1;PLAU;RAB40B;RAB40A;PNP;PYCARD;SYCN;TYRO3;FGF10;PDGFB;RALB;WNT5A;RBP4;NPR1;SDC4;ANG;BMP6;HEXB;VAMP1;WNK4;CHGA;DDR1;CTGF;TPD52;PKP1;IDH1;INHBB;RAB44;PIK3CG;RAB11FIP1;KCNG2;GAS6;GLA;RPH3AL;DERA;VDR;RAB3D;GDNF;SLC1A3
13861,GO:0051093,0.000260444234911462,0.99988175552552,32,796,negative regulation of developmental process,BP,WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;ABCG1;PRKACB;FZD7;LIMS2;RGN;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;AXIN1;RBP4;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;TMEM176A;NPPC;GAS6;S100B;AMOT;CLDN18;LINGO1
15861,GO:0070302,0.00026315715647277,0.999929912139088,13,199,regulation of stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
21415,GO:2000725,0.000263334285787059,0.999978832549848,5,29,regulation of cardiac muscle cell differentiation,BP,EDN1;FZD7;BMP4;BMP2;EFNB2
12239,GO:0045603,0.000272357441998575,0.99998645872557,4,16,positive regulation of endothelial cell differentiation,BP,NOTCH1;BMP6;BMP4;CLDN5
21077,GO:2000241,0.000273502210223871,0.999942273207777,10,124,regulation of reproductive process,BP,LIF;WNT4;NOTCH1;PRKACB;WNT5A;BMP7;BMP4;WT1;NPPC;INHBB
13371,GO:0048708,0.000273739150231032,0.999961884588093,7,62,astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2;DLL1;S100B;TSPAN2
15323,GO:0061036,0.000276710958717531,0.999977514832566,5,29,positive regulation of cartilage development,BP,FGF18;WNT5A;BMP6;BMP4;BMP2
5190,GO:0014031,0.00027865253768984,0.999961085507746,7,62,mesenchymal cell development,BP,NOTCH1;ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
13446,GO:0048864,0.000279833859987248,0.999960893026222,7,62,stem cell development,BP,WNT7A;ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
21092,GO:2000270,0.000281540581397572,0.999994201900955,3,7,negative regulation of fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
16791,GO:0072007,0.000285273765744685,0.999994098286135,3,7,mesangial cell differentiation,BP,NOTCH1;PDGFB;ACTA2
13295,GO:0048583,0.00028734739315514,0.999819086741388,100,3506,regulation of response to stimulus,BP,ITGA3;ITGA5;ARTN;CFB;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;TRADD;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;PYCARD;G0S2;FZD7;TYRO3;PSMB10;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;RNASEL;FGF8;CLCF1;FAM110C;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;DLL1;SHPK;CHGA;NOL3;DEPTOR;CTGF;CASP4;AKT1;WNT2B;FAM46A;KITLG;JAG2;EPN1;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;RPH3AL;S100B;GPSM1;AMOT;ARAF;SH3BP4;DOK1;GDNF;FZD8;DUSP5;HEY1;PIM2;EFNB2;PDE4B
880,GO:0002088,0.000287915772617489,0.999959530604838,7,63,lens development in camera-type eye,BP,WNT2;WNT7A;WNT7B;WNT5B;WNT5A;BMP4;WNT2B
12383,GO:0045844,0.000287982834218542,0.99995951960962,7,63,positive regulation of striated muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
13321,GO:0048636,0.000287982834218542,0.99995951960962,7,63,positive regulation of muscle organ development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
20389,GO:1905114,0.000289512272700813,0.999881815359952,25,565,cell surface receptor signaling pathway involved in cell-cell signaling,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ADORA1;DKK3;FZD7;PSMB10;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP4;BMP2;GRIA3;AKT1;WNT2B;TLE1;FZD8
18856,GO:1901617,0.000290552624375368,0.999921807083701,13,199,organic hydroxy compound biosynthetic process,BP,EBP;WNT4;PNMT;HSD17B3;HMGCS2;DKK3;ABCG1;WNT5A;BMP6;BMP2;STAR;DHCR7;VDR
10443,GO:0038030,0.000291157020531415,0.999993934038501,3,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,WNT4;FZD7;WNT5A
13338,GO:0048666,0.000294617199748648,0.999858739754566,36,954,neuron development,BP,ITGA3;ARTN;LIF;WNT3;NOTCH1;CDH23;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SDC4;SPTB;BMP7;CAMSAP3;B3GNT2;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;MYO7A;PIK3CA;LZTS1;S100B;TSPAN2;DOK1;GDNF;ACSL4;SLC1A3;LINGO1
13086,GO:0048037,0.000296367103132941,0.999910874768258,15,252,cofactor binding,MF,PHYH;GLDC;FASN;BDH2;ACADVL;HACL1;ACAT1;AOX1;ACCS;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
13842,GO:0051055,0.000296633414253477,0.999966563246955,6,44,negative regulation of lipid biosynthetic process,BP,WNT4;APOC1;DKK3;ACADVL;PDGFB;BMP2
8195,GO:0031946,0.000298795380079511,0.99999371906633,3,7,regulation of glucocorticoid biosynthetic process,BP,WNT4;DKK3;BMP2
14963,GO:0060443,0.000303253906333982,0.999965609042279,6,45,mammary gland morphogenesis,BP,WNT4;FGF10;WNT5A;BMP4;DDR1;VDR
3548,GO:0006942,0.000308641481198151,0.999947992021158,8,84,regulation of striated muscle contraction,BP,ACTN3;DSC2;ADORA1;CASQ2;CHGA;CTGF;PIK3CG;PDE4B
1488,GO:0003209,0.000308937224213986,0.99997417891846,5,30,cardiac atrium morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A
14684,GO:0060054,0.000313693026184357,0.999993294293118,3,7,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A;FZD7;FGF10
3932,GO:0008091,0.000316335868096287,0.999992761594208,3,8,spectrin,CC,SPTBN5;SPTBN4;SPTB
18946,GO:1901863,0.000316369572109741,0.999954782126583,7,64,positive regulation of muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
15909,GO:0070374,0.000317336515916108,0.999919301172393,12,174,positive regulation of ERK1 and ERK2 cascade,BP,CCL20;PYCARD;FGF18;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
7606,GO:0030834,0.000318493916612301,0.999963478993397,6,46,regulation of actin filament depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
18169,GO:0098797,0.000320373665047047,0.999907682876064,14,230,plasma membrane protein complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;FADD;TRADD;CDH2;GJB1;GJB2;GJB6;CDH1;GJA3;FZD8
13323,GO:0048639,0.000323738722820563,0.999923469454484,11,155,positive regulation of developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;GHR;FGF8;WT1;DLL1;AKT1
12917,GO:0046983,0.000324061222757087,0.999834905011123,42,1157,protein dimerization activity,MF,ITGA3;ADRA2C;SYT5;ACTN3;ACTN2;NOTCH1;GLDC;FASN;GADD45A;ACVR1;ADORA1;CASQ2;ABCG1;PYCARD;TYRO3;GHR;PIK3R2;PIK3R1;PDGFB;KCNH2;JAM3;AXIN1;RBP4;CLCF1;ANG;BMP6;BMP2;ACAT1;HEXB;GJB1;ACCS;TPD52;IDH1;NPPC;MYO7A;INHBB;GLA;S100B;PTS;HNF1A;GDNF;HEY1
7264,GO:0030155,0.000324416744896254,0.99986150677011,27,634,regulation of cell adhesion,BP,ITGA3;ITGA5;WNT4;NOTCH1;FADD;PLAU;PNP;PYCARD;FZD7;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;BMP4;BMP2;DLL1;DDR1;AKT1;CYTIP;JAG2;CDH1;PIK3CA;PIK3CG;LAMA1;LAMA5;EFNB2
4711,GO:0010001,0.000327242147471939,0.999916438219183,12,178,glial cell differentiation,BP,LIF;POU3F1;NOTCH1;CDH2;FGF10;CLCF1;BMP2;DLL1;AKT1;NAB2;S100B;TSPAN2
12857,GO:0046888,0.000328282754834402,0.999952836079952,7,63,negative regulation of hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;INHBB;RAB11FIP1
1481,GO:0003198,0.000337366711867368,0.999982023195417,4,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,NOTCH1;ACVR1;FGF8;HEY1
3590,GO:0007010,0.000337462106342201,0.999830600578252,40,1111,cytoskeleton organization,BP,FHOD3;WNT4;TUBG2;ACTN2;RAB6C;MARK4;ITGB5;GADD45A;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;PSTPIP2;AXIN1;RHOQ;RHOJ;NUAK2;PSRC1;SDC4;ANG;SPTB;CAMSAP3;DAAM2;ESPN;RND3;MSN;CTGF;PKP1;BCAR1;MYH11;AMOT;LAMA5;PARVB;TMOD4
13109,GO:0048144,0.000340814344765681,0.999941707197307,8,84,fibroblast proliferation,BP,WNT2;IFI30;WNT7B;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
13339,GO:0048667,0.000342656590833034,0.999864280236763,23,512,cell morphogenesis involved in neuron differentiation,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;MYO7A;PIK3CA;LZTS1;S100B;DOK1;GDNF;SLC1A3;LINGO1
1491,GO:0003213,0.000342707461699402,1,2,2,cardiac right atrium morphogenesis,BP,NOTCH1;WNT5A
12854,GO:0046885,0.000344873128029056,0.999981515199178,4,17,regulation of hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
3519,GO:0006897,0.000348658216885202,0.99985307172208,26,603,endocytosis,BP,SYT5;RIN3;RAB27A;TF;APOC1;ADORA1;MFGE8;PYCARD;RAB39A;TYRO3;GHR;PIK3R2;PIK3R1;HRAS;WNT5A;SNX18;DLL1;RAB20;RAB17;EPN1;MYO7A;PIK3CA;PIK3CG;GAS6;SH3BP4;UNC119
5866,GO:0016301,0.000349729488274397,0.999838391181501,32,816,kinase activity,MF,PDK4;MARK4;ZFYVE21;ACVR1;PRKACB;MAPK12;TYRO3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;RNASEL;FGF8;HBEGF;CDKN1A;PKN3;SHPK;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
17379,GO:0090092,0.000350580581626857,0.999903672067214,13,206,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ITGA3;NOTCH1;RASL11B;ACVR1;DKK3;FSTL3;FGF10;WNT5A;BMP7;BMP6;BMP4;BMP2;INHBB
13929,GO:0051186,0.000353160585019354,0.999873998395331,19,373,cofactor metabolic process,BP,PDK4;ACTN3;FASN;ACSF2;PNP;BDH2;ACSM5;NNMT;PFKFB3;ACAT1;SHPK;NUDT7;PCBD1;MDH1;IDH1;DERA;PTS;ACSL4;ELOVL6
3798,GO:0007409,0.000354388217232519,0.99986960793912,20,416,axonogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;S100B;DOK1;GDNF;LINGO1
14107,GO:0051493,0.000355621503153254,0.999869134220871,20,413,regulation of cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;RAB6C;EDN1;SPTBN5;SPTBN4;PYCARD;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;PSRC1;SDC4;SPTB;CAMSAP3;ESPN;CTGF;TMOD4
12291,GO:0045667,0.000359000786206947,0.999929381571198,9,107,regulation of osteoblast differentiation,BP,WNT4;NOTCH1;WNT7B;ACVR1;BMP7;BMP6;BMP4;BMP2;NPPC
19812,GO:1903847,0.000361141392177253,1,2,2,regulation of aorta morphogenesis,BP,NOTCH1;EFNB2
19813,GO:1903849,0.000361141392177253,1,2,2,positive regulation of aorta morphogenesis,BP,NOTCH1;EFNB2
20581,GO:1905651,0.000361141392177253,1,2,2,regulation of artery morphogenesis,BP,NOTCH1;EFNB2
20582,GO:1905653,0.000361141392177253,1,2,2,positive regulation of artery morphogenesis,BP,NOTCH1;EFNB2
21181,GO:2000379,0.000365236985350014,0.999936874183363,8,84,positive regulation of reactive oxygen species metabolic process,BP,RAB27A;GADD45A;EDN1;RGN;TICAM1;PDGFB;CDKN1A;AKT1
13564,GO:0050662,0.000367523860212981,0.999904940700688,12,177,coenzyme binding,MF,FASN;BDH2;ACADVL;HACL1;ACAT1;AOX1;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
16673,GO:0071772,0.000369430593657944,0.999911265630391,11,156,response to BMP,BP,ITGA3;NOTCH1;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
16674,GO:0071773,0.000369430593657944,0.999911265630391,11,156,cellular response to BMP stimulus,BP,ITGA3;NOTCH1;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
17160,GO:0072676,0.000372331886450238,0.999935500251707,8,83,lymphocyte migration,BP,ARTN;FADD;CCL20;PYCARD;WNT5A;MSN;PIK3CG;GAS6
10581,GO:0040008,0.000383923867112583,0.999837141507499,26,607,regulation of growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;GHR;WNT5A;SESN2;RBP4;NPR1;PSRC1;FGF8;HBEGF;BMP4;WT1;CDKN1A;DLL1;DDR1;CTGF;AKT1;NPPC;BCAR1;PIK3CA;GAS6;SH3BP4
15079,GO:0060603,0.000389007656336265,0.999965669158232,5,31,mammary gland duct morphogenesis,BP,WNT4;FGF10;WNT5A;DDR1;VDR
13899,GO:0051146,0.000405547662933075,0.999880230806705,14,238,striated muscle cell differentiation,BP,FHOD3;ACTN2;NOTCH1;ACVR1;CASQ2;EDN1;FZD7;CDH2;BMP4;BMP2;WT1;AKT1;MYH11;EFNB2
7533,GO:0030659,0.000409227734613622,0.999816838833114,29,711,cytoplasmic vesicle membrane,CC,TMEM163;SYT5;WNT3;WNT4;RAB27A;TF;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;WNT5B;WNT5A;SNX18;HBEGF;RAB20;VAMP1;GRIA3;CHGA;PKP1;RAB44;SNX21;RAB11FIP1;RPH3AL;RAB38;RAB3D;RNF144A
2888,GO:0005943,0.000414230899180762,1,2,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1;PIK3CA
16382,GO:0071300,0.000415261158588096,0.999937764684227,7,66,cellular response to retinoic acid,BP,WNT3;WNT2;WNT6;WNT7B;FZD7;WNT5B;WNT5A
1649,GO:0003779,0.000416718157599003,0.999849141361359,19,393,actin binding,MF,TAGLN;FHOD3;ACTN3;ACTN2;SPTBN5;SPTBN4;CGN;PLEKHH2;PXK;PSTPIP2;ANG;SPTB;DAAM2;ESPN;MSN;MYO7A;MYH11;PARVB;TMOD4
13299,GO:0048589,0.000424752479022076,0.999825389909815,24,551,developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;STRA6;WNT7A;WNT7B;SALL4;EDN1;SPTBN4;FZD7;GHR;FGF10;WNT5A;RBP4;FGF8;BMP4;WT1;DLL1;DDR1;AKT1;NPPC;PIK3CA;DHCR7
11803,GO:0044433,0.000434145225389681,0.999767258280859,47,1367,cytoplasmic vesicle part,CC,TMEM163;SYT5;WNT3;WNT4;ACTN2;TSPAN15;RAB27A;TF;ZFYVE21;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;PNP;PYCARD;RAB39A;SYCN;FZD7;TICAM1;PDGFB;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;RAB20;HEXB;VAMP1;GRIA3;CHGA;PKP1;RAB12;RAB17;IDH1;RAB44;SNX21;RAB11FIP1;GAS6;GLA;RPH3AL;DERA;RAB38;RAB3D;RNF144A
5169,GO:0012505,0.000434215292404382,0.999718228864641,111,4018,endomembrane system,CC,ITGA5;EBP;TMEM163;ADRA2C;SYT5;WNT3;WNT4;USE1;RIN3;ACTN2;RAB6C;TSPAN15;ALG5;NOTCH1;RAB27A;DPM3;TF;ZFYVE21;FASN;CRISPLD2;SLC31A2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;NMT2;TBC1D14;ADORA1;CASQ2;EXTL1;EDN1;PLAU;RAB40B;RAB40A;PNP;ABCG1;PYCARD;MBOAT2;TTYH1;RRAS2;RAB39B;RAB39A;MGST2;SYCN;FZD7;TYRO3;FADS1;FSTL3;PIK3R1;TICAM1;REEP1;PDGFB;PLA2G16;HRAS;WNT5B;WNT5A;SNX18;GALT;RHOQ;RHOB;CYP17A1;SDC4;SPTB;B3GNT2;PKN3;RAB20;HEXB;VAMP1;RND3;CHGA;NOL3;HSD3B2;CTGF;GJB1;CPT1C;TPD52;CASP4;IFI27;PKP1;RAB12;RAB17;CYTIP;PTGES;IDH1;NPPC;CDH1;EPN1;TMEM98;RAB44;TFPI;SNX21;RAB11FIP1;GAS6;GLA;RPH3AL;DERA;DHCR7;CYB5A;GPSM1;SH3BP4;RAB38;RAB3D;ACSL4;FZD8;CNIH4;ELOVL6;RNF144A;PDE4B
3783,GO:0007368,0.000434894073340508,0.999912048263528,9,110,determination of left/right symmetry,BP,ALG5;NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;DAAM2;DLL1
8414,GO:0032346,0.000436498874933937,1,2,2,positive regulation of aldosterone metabolic process,BP,WNT4;BMP6
8417,GO:0032349,0.000436498874933937,1,2,2,positive regulation of aldosterone biosynthetic process,BP,WNT4;BMP6
16831,GO:0072074,0.000439866001286384,0.999974571230023,4,18,kidney mesenchyme development,BP,WNT4;BMP7;BMP4;WT1
4069,GO:0008305,0.00044062082417957,0.999959892215902,5,32,integrin complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8
1430,GO:0003130,0.000445304956740428,1,2,2,BMP signaling pathway involved in heart induction,BP,BMP4;BMP2
1432,GO:0003133,0.000445304956740428,1,2,2,endodermal-mesodermal cell signaling,BP,BMP4;BMP2
1433,GO:0003134,0.000445304956740428,1,2,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP4;BMP2
15095,GO:0060638,0.000447455585158478,0.999988458660365,3,8,mesenchymal-epithelial cell signaling,BP,FGF10;WNT5A;WNT2B
14733,GO:0060128,0.000448959209483534,1,2,2,corticotropin hormone secreting cell differentiation,BP,FGF8;BMP2
7204,GO:0030042,0.000449442097771444,0.999944716080633,6,49,actin filament depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
15215,GO:0060837,0.000451239134904311,0.999988327099568,3,8,blood vessel endothelial cell differentiation,BP,NOTCH1;DLL1;HEY1
19990,GO:1904238,0.000451868564025279,0.999988305175658,3,8,pericyte cell differentiation,BP,NOTCH1;PDGFB;ACTA2
17809,GO:0097205,0.00045250648208219,0.999973641528342,4,18,renal filtration,BP,ITGA3;ADORA1;PDGFB;GAS6
12609,GO:0046356,0.000454373037343659,1,2,2,acetyl-CoA catabolic process,BP,ACAT1;NUDT7
5054,GO:0010862,0.000456678611068946,0.999943742779725,6,48,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
11137,GO:0043009,0.000480799691326023,0.999800584547397,24,552,chordate embryonic development,BP,LIF;WNT2;NOTCH1;WNT7B;ACVR1;SALL4;EDN1;PRKACB;PDGFB;WNT5A;AXIN1;RBP4;FGF8;SDC4;BMP7;BMP4;BMP2;DLL1;AKT1;JAG2;EPN1;DSC3;AMOT;HEY1
15366,GO:0061101,0.000488011346320668,0.999987028652346,3,8,neuroendocrine cell differentiation,BP,WNT4;FGF8;BMP2
9094,GO:0033539,0.000488317743035104,0.999987017685141,3,8,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACADVL;ETFB;ETFDH
7212,GO:0030055,0.000495787814943153,0.999817927364749,19,391,cell-substrate junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;ZFYVE21;ITGB5;ITGB4;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
2887,GO:0005942,0.00050529906034959,0.99996939853776,4,19,phosphatidylinositol 3-kinase complex,CC,PIK3R2;PIK3R1;PIK3CA;PIK3CG
10591,GO:0040019,0.000515658456345019,0.999951243554567,5,33,positive regulation of embryonic development,BP,WNT2;WNT4;WNT2B;AMOT;GDNF
2491,GO:0005160,0.000518469711733344,0.999934464383199,6,49,transforming growth factor beta receptor binding,MF,RASL11B;BMP7;BMP6;BMP4;BMP2;INHBB
8204,GO:0031960,0.00052231504446409,0.999869136510343,11,159,response to corticosteroid,BP,NOTCH1;WNT7B;EDN1;BMP6;CDKN1A;CTGF;GJB2;STAR;CLDN1;S100B;HEY1
1552,GO:0003323,0.000523630050025323,0.999967984104614,4,19,type B pancreatic cell development,BP,WNT5A;BMP6;BMP4;DLL1
19802,GO:1903827,0.000534504331715432,0.999776609749439,24,553,regulation of cellular protein localization,BP,ITGA3;LIF;ACTN2;PMAIP1;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;NOL3;AKT1;IFI27;CDH1;GAS6;CLDN18
16834,GO:0072077,0.000537446021874438,0.99996690908788,4,19,renal vesicle morphogenesis,BP,LIF;WNT4;BMP4;GDNF
6353,GO:0018108,0.000541444984745135,0.999805905063352,18,360,peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;TYRO3;GHR;FGF18;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;DDR1;KITLG;GAS6;UNC119
12299,GO:0045684,0.000548999560472032,0.999947364732825,5,33,positive regulation of epidermis development,BP,NOTCH1;TRADD;WNT5A;BMP4;VDR
10835,GO:0042445,0.000551210426157389,0.999850553768228,12,185,hormone metabolic process,BP,WNT4;HSD17B3;HSD17B11;DKK3;RBP4;CYP17A1;BMP6;BMP2;HSD3B2;STAR;CYP11A1;DHCR7
1503,GO:0003230,0.000555016423115336,0.999946499106207,5,34,cardiac atrium development,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A
12297,GO:0045682,0.000557296975251161,0.999911998631863,7,69,regulation of epidermis development,BP,NOTCH1;TRADD;WNT5A;BMP4;DLL1;NAB2;VDR
12666,GO:0046486,0.000561919095249927,0.999785403180285,20,423,glycerolipid metabolic process,BP,DPM3;ZFYVE21;APOC1;MBOAT2;RGN;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PLA2G16;FGF8;ANG;HBEGF;FABP3;KITLG;PIK3CA;PIK3CG;ACSL4
17636,GO:0090596,0.000562440532316998,0.999828154429071,14,245,sensory organ morphogenesis,BP,WNT2;STRA6;EDN1;FGF10;WNT5A;AXIN1;RBP4;FGF8;BMP7;BMP4;DLL1;GJB6;WNT2B;MYO7A
13300,GO:0048592,0.000562716970200471,0.999869178732392,10,139,eye morphogenesis,BP,WNT2;STRA6;WNT5A;AXIN1;RBP4;BMP7;BMP4;DLL1;WNT2B;MYO7A
8786,GO:0032868,0.000567519658142358,0.999826459172812,14,244,response to insulin,BP,PDK4;PIK3R2;PIK3R1;FOXO4;KHK;SESN2;RHOQ;RNASEL;FABP3;AKT1;BCAR1;INHBB;STAR;PIK3CA
3589,GO:0007009,0.000577179426783797,0.999814512820641,15,275,plasma membrane organization,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
6387,GO:0018212,0.000578645739898846,0.999791349891836,18,362,peptidyl-tyrosine modification,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;TYRO3;GHR;FGF18;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;DDR1;KITLG;GAS6;UNC119
1569,GO:0003344,0.000580814301935592,0.999982829452146,3,9,pericardium morphogenesis,BP,NOTCH1;WNT5A;BMP7
13900,GO:0051147,0.000582596493460728,0.999851976082523,11,163,regulation of muscle cell differentiation,BP,NOTCH1;EDN1;MAPK12;FZD7;CDH2;PDGFB;FOXO4;BMP4;BMP2;DLL1;EFNB2
5170,GO:0012506,0.000582795529079521,0.999733115787797,29,727,vesicle membrane,CC,TMEM163;SYT5;WNT3;WNT4;RAB27A;TF;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;WNT5B;WNT5A;SNX18;HBEGF;RAB20;VAMP1;GRIA3;CHGA;PKP1;RAB44;SNX21;RAB11FIP1;RPH3AL;RAB38;RAB3D;RNF144A
7234,GO:0030111,0.00058958106806989,0.999801924096804,16,303,regulation of Wnt signaling pathway,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT7A;DKK3;PSMB10;CDH2;FGF10;WNT5B;WNT5A;AXIN1;BMP2;WNT2B;TLE1
14693,GO:0060065,0.000598515948160509,0.999961754115277,4,20,uterus development,BP,STRA6;WNT7A;WNT5A;RBP4
13064,GO:0048010,0.000599569351303393,0.9998878215218,8,91,vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;MAPK12;FGF18;FGF10;PIK3R2;PIK3R1;BCAR1;PIK3CA
14019,GO:0051336,0.000599710672837603,0.999677580467498,45,1321,regulation of hydrolase activity,BP,ARTN;WNT4;RIN3;ACTN2;PMAIP1;FADD;SERPINA5;APOC1;TRADD;RABIF;TBC1D14;CCL20;SPTBN5;SPTBN4;PYCARD;MAPK12;LPAR2;RGN;FGF18;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;ANG;SPTB;HBEGF;BMP2;CAMSAP3;NOL3;CTGF;AKT1;IFI27;NRTN;KITLG;CST9L;TFPI;GAS6;AMOT;SH3BP4;GDNF
3733,GO:0007254,0.000604715543090329,0.999834182151199,12,190,JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;CTGF;AKT1;FZD8
13111,GO:0048146,0.000608968250333856,0.999920387152819,6,51,positive regulation of fibroblast proliferation,BP,WNT2;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
4671,GO:0009891,0.000609727184045817,0.999651005930387,56,1746,positive regulation of biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;FADD;WNT6;WNT7A;MRAP;ZFPM1;ACVR1;SALL4;EDN1;ABCG1;CCL20;FZD7;RGN;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;FABP3;CTGF;PCBD1;AKT1;KITLG;NPPC;CDH1;STAR;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
5747,GO:0016055,0.000611735696693086,0.999758492564562,21,461,Wnt signaling pathway,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;DKK3;FZD7;PSMB10;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;TLE1;FZD8
7804,GO:0031175,0.000615603980091625,0.999709222390146,31,811,neuron projection development,BP,ITGA3;ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SPTB;BMP7;CAMSAP3;B3GNT2;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;PIK3CA;LZTS1;S100B;TSPAN2;DOK1;GDNF;ACSL4;LINGO1
18077,GO:0098588,0.000616112033978737,0.999642336152541,59,1865,bounding membrane of organelle,CC,PECR;TMEM163;SYT5;WNT3;WNT4;TSPAN15;NOTCH1;RAB27A;TF;ZFYVE21;PMAIP1;SERPINA5;WNT6;WNT7A;WNT7B;PXMP2;PXMP4;CASQ2;PLAU;ABCG1;SPTBN5;TTYH1;RAB39A;SYCN;FZD7;TICAM1;PDGFB;PLA2G16;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;B3GNT2;RAB20;VAMP1;GRIA3;RND3;CHGA;HSD3B2;CPT1C;IFI27;PKP1;RAB12;RAB17;MYO7A;RAB44;SNX21;RAB11FIP1;RPH3AL;DHCR7;CYB5A;GPSM1;RAB38;RAB3D;ACSL4;RNF144A
18854,GO:1901615,0.000620273105629129,0.999754886919349,21,457,organic hydroxy compound metabolic process,BP,EBP;PECR;WNT4;ACTN3;PNMT;HSD17B3;APOC1;HMGCS2;DKK3;ABCG1;ACADVL;WNT5A;RBP4;NPR1;CYP17A1;BMP6;BMP2;STAR;CYP11A1;DHCR7;VDR
13625,GO:0050730,0.000620570082988517,0.999818515470554,13,216,regulation of peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;GHR;FGF10;PDGFB;CLCF1;HBEGF;KITLG;GAS6;UNC119
14627,GO:0055117,0.000629532137021292,0.999898275469189,7,72,regulation of cardiac muscle contraction,BP,DSC2;ADORA1;CASQ2;CHGA;CTGF;PIK3CG;PDE4B
18426,GO:0198738,0.000629611108108059,0.999750861496061,21,462,cell-cell signaling by wnt,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;DKK3;FZD7;PSMB10;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;TLE1;FZD8
8877,GO:0033002,0.000630386976580472,0.999838261781573,11,164,muscle cell proliferation,BP,WNT2;NOTCH1;EDN1;PDGFB;RBP4;NPR1;ANG;HBEGF;BMP4;AKT1;NPPC
12327,GO:0045742,0.000637618014116634,0.999936611320134,5,34,positive regulation of epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1;DOK1
13574,GO:0050673,0.000640352816387948,0.999774820531995,17,335,epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;LIMS2;RGN;FGF10;PDGFB;HRAS;WNT5A;ANG;BMP6;BMP4;BMP2;AKT1;VDR;EFNB2
3351,GO:0006644,0.000641133803592009,0.999752474102491,20,427,phospholipid metabolic process,BP,DPM3;ZFYVE21;APOC1;MBOAT2;FADS1;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PLA2G16;FGF8;HBEGF;HEXB;FABP3;KITLG;IDH1;PIK3CA;PIK3CG
597,GO:0001701,0.000641264897057429,0.999782793903279,16,307,in utero embryonic development,BP,LIF;WNT2;NOTCH1;WNT7B;ACVR1;SALL4;EDN1;PDGFB;BMP7;BMP2;AKT1;JAG2;EPN1;DSC3;AMOT;HEY1
3363,GO:0006661,0.000651522813586349,0.999845580777137,10,140,phosphatidylinositol biosynthetic process,BP,DPM3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
861,GO:0002066,0.000659421469526809,0.99991234483692,6,52,columnar/cuboidal epithelial cell development,BP,WNT5A;BMP6;BMP4;CDKN1A;DLL1;MYO7A
16840,GO:0072087,0.00066508546540419,0.999956277652794,4,20,renal vesicle development,BP,LIF;WNT4;BMP4;GDNF
9537,GO:0034650,0.000665769404360614,0.999979362415388,3,9,cortisol metabolic process,BP,WNT4;DKK3;BMP2
9538,GO:0034651,0.000665769404360614,0.999979362415388,3,9,cortisol biosynthetic process,BP,WNT4;DKK3;BMP2
17914,GO:0097435,0.000676310905534197,0.999718195497714,23,534,supramolecular fiber organization,BP,FHOD3;WNT4;TUBG2;ACTN2;ITGB5;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;PIK3R1;PLEKHH2;AXIN1;PSRC1;SDC4;ANG;SPTB;ESPN;CTGF;PKP1;BCAR1;MYH11;TMOD4
18173,GO:0098801,0.000678785641798114,0.99993157109302,5,34,regulation of renal system process,BP,ADORA1;EDN1;PDGFB;NPR1;GAS6
13790,GO:0050995,0.000680526370307214,0.999954985244846,4,20,negative regulation of lipid catabolic process,BP,APOC1;ADORA1;AKT1;PIK3CG
14696,GO:0060068,0.000680770526177861,0.999978733300805,3,9,vagina development,BP,TYRO3;WNT5A;RBP4
18098,GO:0098636,0.000683909110511611,0.999930745888318,5,35,protein complex involved in cell adhesion,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8
645,GO:0001775,0.000692244203553399,0.99962770809265,44,1279,cell activation,BP,ADRA2B;ADRA2C;WNT4;RAB27A;CRISPLD2;FADD;WNT7A;ZFPM1;EDN1;PLAU;PNP;PYCARD;FZD7;TYRO3;FGF10;PIK3R1;TICAM1;PDGFB;WNT5A;RHOB;SDC4;CLCF1;BMP4;CDKN1A;DLL1;SHPK;HEXB;CHGA;MSN;CTGF;TPD52;AKT1;PKP1;IDH1;JAG2;RAB44;PIK3CA;PIK3CG;GAS6;GLA;DERA;RAB3D;FZD8;EFNB2
9744,GO:0035265,0.00069452563414523,0.999833930786439,10,142,organ growth,BP,WNT2;NOTCH1;EDN1;FGF10;RBP4;FGF8;WT1;DLL1;AKT1;NPPC
13756,GO:0050918,0.000694797227414191,0.999906709566075,6,52,positive chemotaxis,BP,ARTN;FGF10;PDGFB;WNT5A;FGF8;BMP4
3354,GO:0006650,0.00069618671458166,0.999753295343277,17,337,glycerophospholipid metabolic process,BP,DPM3;ZFYVE21;APOC1;MBOAT2;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PLA2G16;FGF8;HBEGF;FABP3;KITLG;PIK3CA;PIK3CG
628,GO:0001755,0.000699680168865839,0.999928787610968,5,35,neural crest cell migration,BP,ACVR1;NRTN;KITLG;LAMA5;GDNF
8192,GO:0031943,0.000706504728065743,0.99997764270593,3,9,regulation of glucocorticoid metabolic process,BP,WNT4;DKK3;BMP2
12894,GO:0046951,0.000708315011011857,0.999977565454237,3,9,ketone body biosynthetic process,BP,HMGCS2;BDH2;ACAT1
16078,GO:0070673,0.00070982601703752,0.99997750092066,3,9,response to interleukin-18,BP,PDGFB;AKT1;CLDN1
2878,GO:0005922,0.000715773698742683,0.999952005072314,4,20,connexin complex,CC,GJB1;GJB2;GJB6;GJA3
21202,GO:2000406,0.000728677914941982,0.99995090381431,4,20,positive regulation of T cell migration,BP,FADD;CCL20;PYCARD;WNT5A
3345,GO:0006637,0.000732114102757945,0.999858609915497,8,93,acyl-CoA metabolic process,BP,PDK4;FASN;ACSF2;ACSM5;ACAT1;NUDT7;ACSL4;ELOVL6
9805,GO:0035383,0.000732114102757945,0.999858609915497,8,93,thioester metabolic process,BP,PDK4;FASN;ACSF2;ACSM5;ACAT1;NUDT7;ACSL4;ELOVL6
8369,GO:0032268,0.000733330148520108,0.99955498941881,69,2281,regulation of cellular protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;FADD;SERPINA5;WNT7A;WNT7B;TRADD;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;CDKN1A;MSN;NOL3;DEPTOR;CTGF;AKT1;IFI27;KITLG;CST9L;INHBB;TFPI;PIK3CA;PIK3CG;GAS6;PM20D2;RBMS3;ARAF;UNC119;FZD8;DUSP5;RNF144A
4662,GO:0009855,0.000735696058634641,0.999839397561456,9,118,determination of bilateral symmetry,BP,ALG5;NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;DAAM2;DLL1
8838,GO:0032940,0.000739642427091672,0.999595449776083,46,1364,secretion by cell,BP,LIF;ADRA2B;ADRA2C;SYT5;USE1;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;ADORA1;EDN1;PLAU;RAB40B;RAB40A;PNP;PYCARD;SYCN;TYRO3;FGF10;PDGFB;RALB;WNT5A;RBP4;SDC4;ANG;BMP6;HEXB;VAMP1;CHGA;CTGF;PKP1;IDH1;INHBB;RAB44;PIK3CG;RAB11FIP1;KCNG2;GAS6;GLA;RPH3AL;DERA;RAB3D;GDNF;SLC1A3
19907,GO:1904031,0.000746878566720451,0.999922867461979,5,35,positive regulation of cyclin-dependent protein kinase activity,BP,FGF10;PDGFB;PSRC1;CDKN1A;AKT1
8568,GO:0032535,0.000755893839893641,0.9997398555318,16,313,regulation of cellular component size,BP,FHOD3;WNT3;ACTN2;WNT7A;WNT7B;EDN1;SPTBN5;SPTBN4;PYCARD;PLEKHH2;WNT5A;SPTB;MSN;DEPTOR;AKT1;TMOD4
18155,GO:0098772,0.000765072382547097,0.999580810586711,46,1372,molecular function regulator,MF,ARTN;WNT3;WNT2;WNT4;RIN3;ACTN2;NOTCH1;SERPINA5;WNT7A;APOC1;RABIF;TBC1D14;SPTBN5;SPTBN4;PYCARD;TSPAN13;MGST2;RGN;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;WNT5A;SESN2;AXIN1;FXYD1;FGF8;SPTB;HBEGF;BMP2;CDKN1A;WNK4;NOL3;AKT1;NRTN;KITLG;CST9L;TFPI;PIK3CA;GAS6;GPSM1;SH3BP4;GDNF
761,GO:0001936,0.00076530669466979,0.999851044841766,8,95,regulation of endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;ANG;BMP6;BMP4;BMP2;AKT1
9699,GO:0035137,0.000771618766513385,0.999919519725711,5,36,hindlimb morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF8;BMP4
12589,GO:0046323,0.000792746593221023,0.999866570399284,7,74,glucose import,BP,PIK3R2;PIK3R1;SESN2;RHOQ;RNASEL;AKT1;HNF1A
1471,GO:0003183,0.000808927738902674,0.999972231544455,3,10,mitral valve morphogenesis,BP,NOTCH1;ZFPM1;ACVR1
5737,GO:0016043,0.000808935136782791,0.999446972052212,147,5728,cellular component organization,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;MARK4;RAB27A;CDH23;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRISPLD2;MRPL14;MRPL16;FADD;SERPINA5;WNT7A;WNT7B;APOC1;ZFPM1;TRADD;RABIF;TBC1D14;CASQ2;EDN1;RAB40B;RAB40A;ABCG1;MFGE8;SPTBN5;SPTBN4;PYCARD;TTYH1;RAB39B;RAB39A;PRND;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;PLA2G16;HSD17B10;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;HACL1;SESN2;AXIN1;RHOQ;RHOJ;NPR1;NUAK2;PSRC1;FGF8;SDC4;ANG;FAM110C;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;RAB20;DRP2;ESPN;HEXB;VAMP1;RND3;CHGA;MSN;NOL3;DDR1;DEPTOR;CTGF;GJB1;GJB2;PCBD1;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;SEMA6C;DECR1;CDH1;PUS1;EPN1;MYO7A;BCAR1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;KCNG2;GAS6;SIN3B;MYH11;LZTS1;S100B;HNF1A;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;GDNF;ACSL4;SLC1A3;PIM2;PARVB;LINGO1;TMOD4
13789,GO:0050994,0.000809669569593541,0.999887745016251,6,54,regulation of lipid catabolic process,BP,APOC1;ADORA1;SESN2;AKT1;IDH1;PIK3CG
2459,GO:0005125,0.000814830780271378,0.999754475761166,13,218,cytokine activity,MF,LIF;WNT2;WNT7A;EDN1;CCL20;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;KITLG;INHBB
693,GO:0001838,0.000820254936578471,0.999818043615091,9,120,embryonic epithelial tube formation,BP,WNT4;WNT6;SALL4;PRKACB;WNT5A;SDC4;BMP7;BMP4;GDNF
1380,GO:0003007,0.000823566147002565,0.999751286409043,13,228,heart morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A;RBP4;FGF8;BMP7;BMP4;BMP2;DLL1;CLDN5;HEY1
83,GO:0000166,0.00083213439457307,0.999504605308418,62,2024,nucleotide binding,MF,PDK4;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;FASN;ACVR1;GUCY1B3;ACSF2;RAB40B;RAB40A;ABCG1;PRKACB;BDH2;ACADVL;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;AOX1;PKN3;RAB20;SHPK;WNK4;RND3;DDR1;RRAD;MDH1;AKT1;RAB12;RAB17;IDH1;DECR1;MYO7A;LDHD;RAB44;PIK3CA;PIK3CG;MYH11;DHCR7;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;ETFDH;PDE4B
18706,GO:1901186,0.000838113191175079,0.999910951447511,5,36,positive regulation of ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1;DOK1
18748,GO:1901265,0.00084304202156772,0.999497827998004,62,2025,nucleoside phosphate binding,MF,PDK4;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;FASN;ACVR1;GUCY1B3;ACSF2;RAB40B;RAB40A;ABCG1;PRKACB;BDH2;ACADVL;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;AOX1;PKN3;RAB20;SHPK;WNK4;RND3;DDR1;RRAD;MDH1;AKT1;RAB12;RAB17;IDH1;DECR1;MYO7A;LDHD;RAB44;PIK3CA;PIK3CG;MYH11;DHCR7;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;ETFDH;PDE4B
12325,GO:0045740,0.00084404330514776,0.99988203467222,6,54,positive regulation of DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
13758,GO:0050920,0.000846294470963378,0.999774695550846,11,169,regulation of chemotaxis,BP,ARTN;WNT3;NOTCH1;EDN1;FGF18;FGF10;PDGFB;WNT5A;JAM3;GAS6;EFNB2
7607,GO:0030835,0.000853795673554744,0.99990868390012,5,37,negative regulation of actin filament depolymerization,BP,SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
14678,GO:0060048,0.00085795833376066,0.999808346522043,9,122,cardiac muscle contraction,BP,DSC2;ADORA1;CASQ2;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;PDE4B
2435,GO:0005085,0.000861347117514064,0.999699728622871,16,320,guanyl-nucleotide exchange factor activity,MF,ARTN;RIN3;ACTN2;RABIF;SPTBN5;SPTBN4;FGF18;FGF10;FGF17;PDGFB;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
11052,GO:0042803,0.000862242560764376,0.999600630849907,28,705,protein homodimerization activity,MF,ADRA2C;ACTN3;ACTN2;FASN;GADD45A;ACVR1;CASQ2;ABCG1;PYCARD;GHR;PDGFB;KCNH2;JAM3;AXIN1;ANG;ACAT1;HEXB;GJB1;ACCS;TPD52;IDH1;NPPC;MYO7A;INHBB;GLA;S100B;PTS;GDNF
4386,GO:0009108,0.000880993193176878,0.999782610361999,10,143,coenzyme biosynthetic process,BP,PDK4;FASN;ACSF2;PNP;NNMT;ACAT1;PCBD1;PTS;ACSL4;ELOVL6
19225,GO:1902580,0.000882445793062627,0.999563405893683,33,894,single-organism cellular localization,BP,ITGA3;SYT5;WNT4;ACTN2;TSPAN15;RAB27A;PMAIP1;WNT7A;RAB40B;RAB40A;ABCG1;SPTBN4;FZD7;CDH2;PIK3R2;PIK3R1;CPT2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;CHGA;NOL3;AKT1;PKP3;RAB17;CDH1;MYO7A;STAR;PIK3CG;GAS6;LAMA5
8070,GO:0031668,0.000886323824364578,0.999745742652333,12,198,cellular response to extracellular stimulus,BP,PDK4;WNT4;PMAIP1;DSC2;FADS1;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6;VDR
8181,GO:0031929,0.000899065059014353,0.999820350381764,8,98,TOR signaling,BP,PRR5L;SESN2;DEPTOR;AKT1;PIK3CA;GAS6;ARAF;SH3BP4
5951,GO:0016491,0.00090028279487013,0.999581824273352,28,701,oxidoreductase activity,MF,PECR;PHYH;GLDC;IFI30;FASN;MSRA;HSD17B3;HSD17B11;BDH2;ACADVL;MGST2;FADS1;HSD17B10;SESN2;CYP17A1;BMP2;AOX1;SARDH;HSD3B2;PCBD1;MDH1;IDH1;DECR1;LDHD;CYP11A1;DHCR7;CYB5A;ETFDH
2669,GO:0005578,0.000904553387853532,0.999671448683687,17,351,proteinaceous extracellular matrix,CC,WNT3;WNT2;WNT4;CRISPLD2;WNT6;WNT7A;WNT7B;WNT5B;WNT5A;ANG;BMP4;CTGF;WNT2B;HAPLN3;LAMA1;LAMA5;LINGO1
16895,GO:0072170,0.000909710958481468,0.999934009721342,4,22,metanephric tubule development,BP,LIF;WNT4;WNT7B;ACAT1
11138,GO:0043010,0.000913084603733486,0.999692650608504,15,288,camera-type eye development,BP,WNT2;STRA6;WNT6;WNT7A;WNT7B;FGF10;WNT5B;WNT5A;RBP4;RHOJ;BMP7;BMP4;WT1;DLL1;WNT2B
15089,GO:0060627,0.000915454355655971,0.999635874328922,20,441,regulation of vesicle-mediated transport,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;APOC1;TBC1D14;MFGE8;PYCARD;RALB;WNT5A;SDC4;DLL1;RAB20;MSN;RAB17;GAS6;RPH3AL;UNC119;RAB3D
17488,GO:0090257,0.000922172692093726,0.999734135489192,12,201,regulation of muscle system process,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;CHGA;NOL3;CTGF;PIK3CG;PDE4B
11282,GO:0043235,0.000955305006842433,0.99966365673521,16,320,receptor complex,CC,ITGA3;ITGA5;NOTCH1;TF;ITGB5;ITGB4;ITGB8;TRADD;ACVR1;GHR;NPR1;BMP2;GRIA3;DDR1;CPT1C;VDR
13432,GO:0048844,0.000962226975746155,0.999861582793178,6,57,artery morphogenesis,BP,NOTCH1;STRA6;FGF8;BMP4;HEY1;EFNB2
1477,GO:0003192,0.000974165879339515,0.999994065232824,2,3,mitral valve formation,BP,NOTCH1;ZFPM1
6834,GO:0021536,0.000978346208358867,0.999829039475498,7,76,diencephalon development,BP,WNT4;FGF10;WNT5A;FGF8;BMP4;BMP2;CDH1
20416,GO:1905207,0.000993128572960977,0.999889859893142,5,38,regulation of cardiocyte differentiation,BP,EDN1;FZD7;BMP4;BMP2;EFNB2
10853,GO:0042482,0.000995886133198161,0.99996324196705,3,10,positive regulation of odontogenesis,BP,WNT6;EDN1;BMP2
5745,GO:0016053,0.00101504955606791,0.999654757528377,15,285,organic acid biosynthetic process,BP,PDK4;PECR;FASN;MRI1;APOC1;EDN1;ACADVL;MGST2;ACSM5;RGN;FADS1;PTGES;STAR;SLC1A3;ELOVL6
12624,GO:0046394,0.00101504955606791,0.999654757528377,15,285,carboxylic acid biosynthetic process,BP,PDK4;PECR;FASN;MRI1;APOC1;EDN1;ACADVL;MGST2;ACSM5;RGN;FADS1;PTGES;STAR;SLC1A3;ELOVL6
6657,GO:0019637,0.00102168879525451,0.999459858769592,39,1112,organophosphate metabolic process,BP,ACTN3;DPM3;ZFYVE21;MRAP;APOC1;GUCY1B3;EDN1;PNP;MBOAT2;FADS1;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;NNMT;PLA2G16;WNT5A;KHK;RHOQ;NPR1;PFKFB3;FGF8;HBEGF;ACAT1;SHPK;HEXB;FABP3;CHGA;NUDT7;MDH1;KITLG;IDH1;NPPC;PIK3CA;PIK3CG;DERA;PDE4B
2507,GO:0005178,0.00102536515911411,0.99979070142841,8,100,integrin binding,MF,ITGA3;ITGA5;ACTN3;ACTN2;MFGE8;JAM3;CTGF;LAMA5
15315,GO:0061028,0.00103121568428281,0.999884662786526,5,38,establishment of endothelial barrier,BP,WNT7A;WNT7B;MSN;CLDN1;CLDN5
4350,GO:0009056,0.00103279970147314,0.999368343152475,67,2223,catabolic process,BP,USE1;ACTN3;PHYH;GLDC;ITGB4;PMAIP1;APOC1;WDR45;TBC1D14;ADORA1;HSD17B11;PNP;BDH2;ACADVL;RAB39A;PSMB10;RGN;PRR5L;PIK3R2;TICAM1;RALB;CPT2;PLA2G16;HSD17B10;ETFB;WNT5A;MAGEC2;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;PFKFB3;SDC4;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;MSN;NUDT7;CPT1C;PCBD1;AKT1;PKP3;PKP1;RAB12;PON2;IDH1;DECR1;PIK3CA;PIK3CG;PEPD;GLA;ECI1;LZTS1;DERA;ARAF;SH3BP4;LYPLAL1;RNF144A;PIM2;ETFDH;PDE4B
692,GO:0001837,0.00103347605281782,0.999762855342676,9,123,epithelial to mesenchymal transition,BP,WNT2;WNT4;NOTCH1;ACVR1;WNT5A;FGF8;BMP7;BMP2;HEY1
14347,GO:0051953,0.00103628512286279,0.999922125445477,4,22,negative regulation of amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA
2881,GO:0005925,0.00105053229117224,0.99960036441814,18,384,focal adhesion,CC,ITGA3;ITGA5;ACTN3;ACTN2;ZFYVE21;ITGB5;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
6033,GO:0016627,0.00109690344563644,0.99983831277037,6,56,oxidoreductase activity, acting on the CH-CH group of donors,MF,PECR;FASN;BDH2;ACADVL;DECR1;DHCR7
2666,GO:0005575,0.00109926498298812,1,363,16973,cellular_component,CC,ITGA3;ITGA5;ARTN;CFB;TAGLN;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;TMEM164;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;PNMT;DPM3;STRA6;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;RHBDL3;SLC31A2;FBXO41;MRPL14;MRPL16;SLC45A4;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;FLVCR2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;HRCT1;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;TMEM223;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;OLFML2B;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;HBEGF;PGBD5;LGALS4;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;F8A1;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;TMEM176A;CYTIP;PTGES;KITLG;SEMA6C;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;PTMS;LDHD;GJA3;TPBGL;TMEM98;MDP1;SPSB1;HPCAL1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN2;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;WBP1;SIN3B;PEPD;ACP5;GLA;HAPLN3;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;PRRT1;LZTS1;DERA;S100B;CLDN23;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;SLC18B1;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;LYPLAL1;ACSL4;MYZAP;FAM110B;SLC1A3;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
11183,GO:0043087,0.00110412295369587,0.999487444761819,27,695,regulation of GTPase activity,BP,ARTN;WNT4;RIN3;ACTN2;RABIF;TBC1D14;CCL20;SPTBN5;SPTBN4;RGN;FGF18;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;NRTN;KITLG;AMOT;SH3BP4;GDNF
9760,GO:0035296,0.00110989829755747,0.999742699614614,9,123,regulation of tube diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
18038,GO:0097746,0.00110989829755747,0.999742699614614,9,123,regulation of blood vessel diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
14965,GO:0060445,0.00111237900851301,0.99991427973874,4,23,branching involved in salivary gland morphogenesis,BP,FGF10;FGF8;BMP7;LAMA5
16337,GO:0071222,0.001112604066675,0.999716523976734,10,148,cellular response to lipopolysaccharide,BP,CCL20;PYCARD;TICAM1;WNT5A;BMP6;SHPK;AKT1;TFPI;STAR;PDE4B
1464,GO:0003174,0.00111582322021781,0.999955995066284,3,11,mitral valve development,BP,NOTCH1;ZFPM1;ACVR1
10580,GO:0040007,0.00111868234270648,0.999438305200234,33,907,growth,BP,WNT3;WNT2;ACTN3;NOTCH1;STRA6;WNT7A;WNT7B;SALL4;EDN1;SPTBN4;FZD7;GHR;FGF10;WNT5A;SESN2;RBP4;NPR1;PSRC1;FGF8;HBEGF;BMP4;WT1;CDKN1A;DLL1;DDR1;CTGF;AKT1;NPPC;BCAR1;PIK3CA;GAS6;DHCR7;SH3BP4
21639,GO:2001237,0.00112110007636173,0.999767942881858,8,100,negative regulation of extrinsic apoptotic signaling pathway,BP,FADD;TRADD;ACVR1;FGF10;BMP4;NOL3;AKT1;GDNF
863,GO:0002068,0.00112164125805504,0.999913370899452,4,23,glandular epithelial cell development,BP,WNT5A;BMP6;BMP4;DLL1
3820,GO:0007498,0.00112178934461424,0.999739471076036,9,124,mesoderm development,BP,ITGA3;WNT3;ITGB4;ACVR1;WNT5A;AXIN1;FGF8;BMP7;BMP4
12756,GO:0046649,0.00112813403686264,0.99949250861515,25,613,lymphocyte activation,BP,WNT4;RAB27A;FADD;ZFPM1;PNP;PYCARD;FZD7;TYRO3;FGF10;PIK3R1;TICAM1;SDC4;CLCF1;BMP4;CDKN1A;DLL1;MSN;TPD52;AKT1;JAG2;PIK3CA;PIK3CG;GAS6;FZD8;EFNB2
1545,GO:0003309,0.00113933240428044,0.999911629219922,4,23,type B pancreatic cell differentiation,BP,WNT5A;BMP6;BMP4;DLL1
2880,GO:0005924,0.00114893824507845,0.999559355562887,18,387,cell-substrate adherens junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;ZFYVE21;ITGB5;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
14964,GO:0060444,0.00115744228291263,0.999909838540249,4,23,branching involved in mammary gland duct morphogenesis,BP,WNT4;WNT5A;DDR1;VDR
14579,GO:0055026,0.00116220069630795,0.999909366740455,4,23,negative regulation of cardiac muscle tissue development,BP,FZD7;RBP4;FGF8;BMP2
12244,GO:0045608,0.00116624845107036,0.999992212465604,2,3,negative regulation of auditory receptor cell differentiation,BP,NOTCH1;DLL1
9086,GO:0033500,0.00117895895224163,0.999650070772574,12,204,carbohydrate homeostasis,BP,PDK4;PIK3R2;PIK3R1;SESN2;RBP4;GJB6;AKT1;STAR;PIK3CA;GAS6;RPH3AL;HNF1A
10934,GO:0042593,0.00117895895224163,0.999650070772574,12,204,glucose homeostasis,BP,PDK4;PIK3R2;PIK3R1;SESN2;RBP4;GJB6;AKT1;STAR;PIK3CA;GAS6;RPH3AL;HNF1A
2790,GO:0005777,0.00118348709609182,0.999723016969498,9,124,peroxisome,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1;ACSL4
10922,GO:0042579,0.00118348709609182,0.999723016969498,9,124,microbody,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1;ACSL4
2773,GO:0005759,0.00118630342204097,0.999530433823126,19,410,mitochondrial matrix,CC,PDK4;GLDC;MRPL14;MRPL16;HMGCS2;ACSF2;ACADVL;ACSM5;HSD17B10;ETFB;RNASEL;ACAT1;TSFM;SARDH;DECR1;PUS1;ECI1;CYP11A1;ETFDH
13418,GO:0048812,0.00120638253693365,0.999474380642761,23,561,neuron projection morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;S100B;DOK1;GDNF;LINGO1
14578,GO:0055025,0.00120645407613016,0.999859607274597,5,40,positive regulation of cardiac muscle tissue development,BP,WNT2;NOTCH1;EDN1;BMP4;EFNB2
7284,GO:0030177,0.00121178018598501,0.999687527185499,10,151,positive regulation of Wnt signaling pathway,BP,WNT3;WNT2;WNT4;WNT7A;PSMB10;FGF10;WNT5A;AXIN1;BMP2;WNT2B
6458,GO:0019003,0.00121331355732128,0.999817395823598,6,57,GDP binding,MF,RAB27A;RALB;HRAS;RHOB;RAB12;RAB17
14083,GO:0051445,0.00122158985418118,0.999857735228029,5,39,regulation of meiotic cell cycle,BP,LIF;WNT4;PRKACB;WNT5A;NPPC
21179,GO:2000377,0.0012236744519882,0.999684110954861,10,150,regulation of reactive oxygen species metabolic process,BP,RAB27A;GADD45A;EDN1;RGN;TICAM1;PDGFB;BMP7;CDKN1A;AKT1;GLA
13301,GO:0048593,0.00122569897417267,0.999742414417966,8,103,camera-type eye morphogenesis,BP,WNT2;STRA6;WNT5A;RBP4;BMP7;BMP4;DLL1;WNT2B
5191,GO:0014032,0.00122630828740695,0.999814860773091,6,58,neural crest cell development,BP,ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
15210,GO:0060828,0.00122962813663981,0.999611607778346,13,234,regulation of canonical Wnt signaling pathway,BP,WNT2;WNT4;NOTCH1;WNT7A;DKK3;PSMB10;CDH2;FGF10;WNT5B;WNT5A;AXIN1;BMP2;WNT2B
20466,GO:1905330,0.00124595035859862,0.999651481841284,11,178,regulation of morphogenesis of an epithelium,BP,LIF;WNT2;WNT4;FZD7;PSMB10;FGF10;WNT5A;BMP7;BMP4;WNT2B;GDNF
1041,GO:0002376,0.00124719739944135,0.999211042213489,76,2604,immune system process,BP,ITGA3;ITGA5;ARTN;CFB;EBP;LIF;WNT4;NOTCH1;RAB27A;IFI30;ITGB5;PMAIP1;CRISPLD2;FADD;ZFPM1;ADORA1;EDN1;PLAU;PNP;PRKACB;CCL20;PYCARD;FZD7;TYRO3;PSMB10;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;JAM3;RBP4;RNASEL;SDC4;CLCF1;NMI;BMP6;BMP4;CDKN1A;DLL1;SHPK;HEXB;SFXN1;CHGA;MSN;TPD52;CASP4;AKT1;IFI27;PKP1;RAB17;WNT2B;TMEM176A;KITLG;IDH1;JAG2;BCAR1;PTMS;RAB44;STAR;CLDN1;PIK3CA;PIK3CG;GAS6;GLA;DERA;S100B;TSPAN2;RAB3D;FZD8;CLDN18;EFNB2;PDE4B
12592,GO:0046326,0.00125953992860682,0.999851994486209,5,40,positive regulation of glucose import,BP,PIK3R2;PIK3R1;RHOQ;RNASEL;AKT1
3592,GO:0007015,0.00127034508140743,0.999540041096282,16,328,actin filament organization,BP,FHOD3;WNT4;ACTN2;ITGB5;SPTBN5;SPTBN4;PYCARD;PIK3R1;PLEKHH2;SDC4;ANG;SPTB;ESPN;CTGF;BCAR1;TMOD4
700,GO:0001845,0.0012847433094947,0.99994676928531,3,11,phagolysosome assembly,BP,RAB39A;RAB20;MYO7A
17340,GO:0090031,0.00129628306324028,0.999990864279815,2,3,positive regulation of steroid hormone biosynthetic process,BP,WNT4;BMP6
15420,GO:0061205,0.00130066279346986,0.999990817607912,2,3,paramesonephric duct development,BP,WNT4;STRA6
14944,GO:0060423,0.00130218055749742,0.999990801415214,2,3,foregut regionalization,BP,WNT2;WNT2B
14945,GO:0060424,0.00130218055749742,0.999990801415214,2,3,lung field specification,BP,WNT2;WNT2B
15002,GO:0060492,0.00130218055749742,0.999990801415214,2,3,lung induction,BP,WNT2;WNT2B
14667,GO:0060037,0.00130509087571853,0.999894397182004,4,24,pharyngeal system development,BP,ACVR1;FGF8;BMP7;BMP4
21197,GO:2000401,0.00130511643390628,0.999845713599551,5,39,regulation of lymphocyte migration,BP,FADD;CCL20;PYCARD;WNT5A;MSN
2346,GO:0004938,0.00130537111461613,0.999990767344187,2,3,alpha2-adrenergic receptor activity,MF,ADRA2B;ADRA2C
14948,GO:0060428,0.00130747057305371,0.999845056690765,5,40,lung epithelium development,BP,WNT2;STRA6;WNT7B;FGF10;BMP4
9083,GO:0033489,0.00131308318712487,0.999990684812277,2,3,cholesterol biosynthetic process via desmosterol,BP,EBP;DHCR7
9084,GO:0033490,0.00131308318712487,0.999990684812277,2,3,cholesterol biosynthetic process via lathosterol,BP,EBP;DHCR7
16878,GO:0072138,0.00131679071406427,0.999990645046675,2,3,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP4;BMP2
14737,GO:0060135,0.0013209694840329,0.999797438849845,6,59,maternal process involved in female pregnancy,BP,ITGA3;LIF;WNT4;GJB2;AKT1;VDR
4128,GO:0008406,0.00132661601351277,0.999600587914152,12,207,gonad development,BP,WNT4;DHH;FSTL3;WNT5A;FGF8;ANG;WT1;WNT2B;KITLG;IDH1;INHBB;STAR
13416,GO:0048807,0.0013296059285651,0.999990507151763,2,3,female genitalia morphogenesis,BP,FGF10;RBP4
12326,GO:0045741,0.00133448609263145,0.999943966635089,3,11,positive regulation of epidermal growth factor-activated receptor activity,BP,ADRA2B;ADRA2C;ADORA1
12893,GO:0046950,0.00135036939517449,0.999943063805267,3,11,cellular ketone body metabolic process,BP,HMGCS2;BDH2;ACAT1
2228,GO:0004769,0.00135046592162573,0.999990281228088,2,3,steroid delta-isomerase activity,MF,EBP;HSD3B2
12732,GO:0046620,0.00135860128464823,0.999747918756213,7,81,regulation of organ growth,BP,WNT2;NOTCH1;EDN1;RBP4;FGF8;WT1;AKT1
18041,GO:0097756,0.001373001136159,0.999744924604237,7,80,negative regulation of blood vessel diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;CHGA;AKT1;ACTA2
15046,GO:0060561,0.00138086301458198,0.999886531320496,4,24,apoptotic process involved in morphogenesis,BP,NOTCH1;BMP7;JAG2;VDR
19751,GO:1903725,0.00138446063549263,0.999785737828238,6,59,regulation of phospholipid metabolic process,BP,APOC1;PIK3R2;PIK3R1;PDGFB;FABP3;IDH1
7464,GO:0030507,0.00139276277618139,0.9998847302413,4,25,spectrin binding,MF,SPTBN5;SPTBN4;CAMSAP3;MYO7A
15322,GO:0061035,0.00142296914695188,0.999778372621839,6,60,regulation of cartilage development,BP,FGF18;WNT5A;BMP6;BMP4;BMP2;CTGF
10633,GO:0042063,0.00143445447643993,0.999538815225693,13,239,gliogenesis,BP,LIF;POU3F1;NOTCH1;CDH2;FGF10;CLCF1;BMP2;DLL1;HEXB;AKT1;NAB2;S100B;TSPAN2
18291,GO:0099068,0.00146602650908706,0.999935022972457,3,12,postsynapse assembly,BP,WNT7A;CDH2;WNT5A
3527,GO:0006909,0.00147093565917513,0.999551582430073,12,209,phagocytosis,BP,RAB27A;ADORA1;MFGE8;PYCARD;RAB39A;TYRO3;PIK3R2;PIK3R1;RAB20;MYO7A;PIK3CA;GAS6
3452,GO:0006790,0.0014833200429948,0.999435635674888,17,358,sulfur compound metabolic process,BP,PDK4;FASN;MSRA;MRI1;EXTL1;ACSF2;MGST2;ACSM5;GHR;ACAT1;B3GNT2;IDUA;HEXB;NUDT7;IDH1;ACSL4;ELOVL6
3863,GO:0007605,0.00149081992441276,0.999638576892859,9,131,sensory perception of sound,BP,CDH23;SLC52A3;SPTBN4;ESPN;HEXB;GJB2;GJB6;MYO7A;SLC1A3
16334,GO:0071219,0.00149773976618917,0.999602413920276,10,154,cellular response to molecule of bacterial origin,BP,CCL20;PYCARD;TICAM1;WNT5A;BMP6;SHPK;AKT1;TFPI;STAR;PDE4B
7195,GO:0030030,0.00151459179595134,0.999162230286649,42,1276,cell projection organization,BP,ITGA3;ARTN;WNT3;ACTN2;NOTCH1;MARK4;CDH23;WNT7A;WNT7B;SPTBN5;SPTBN4;TTYH1;PIK3R1;HRAS;WNT5A;JAM3;RHOQ;FGF8;SDC4;FAM110C;SPTB;BMP7;CAMSAP3;B3GNT2;ESPN;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;MYO7A;PIK3CA;LZTS1;S100B;LAMA5;TSPAN2;DOK1;GDNF;ACSL4;PARVB;LINGO1
11867,GO:0044706,0.00153230713421202,0.999530545149402,12,210,multi-multicellular organism process,BP,ITGA3;LIF;ADRA2C;WNT4;EDN1;HEXB;DDR1;GJB2;AKT1;EPN1;VDR;ACSL4
14920,GO:0060393,0.00153274015595793,0.999757758385288,6,60,regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
11473,GO:0043547,0.00154705471028848,0.999287299702652,25,640,positive regulation of GTPase activity,BP,ARTN;WNT4;RIN3;ACTN2;RABIF;TBC1D14;CCL20;SPTBN5;SPTBN4;RGN;FGF18;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
19343,GO:1902903,0.00156883440695094,0.999465048382728,14,272,regulation of supramolecular fiber organization,BP,FHOD3;WNT4;ACTN2;EDN1;SPTBN5;SPTBN4;PYCARD;PIK3R1;PLEKHH2;PSRC1;SDC4;SPTB;CTGF;TMOD4
13373,GO:0048710,0.00157328138706563,0.999865375888188,4,25,regulation of astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
3615,GO:0007044,0.00157610033150476,0.999699228169968,7,85,cell-substrate junction assembly,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;SDC4;LAMA5
15311,GO:0061024,0.0015858738198573,0.999169489333302,35,1001,membrane organization,BP,ITGA3;SYT5;WNT4;RIN3;ACTN2;TSPAN15;RAB27A;TF;PMAIP1;SERPINA5;RABIF;TBC1D14;RAB40B;RAB40A;MFGE8;SPTBN4;RAB39A;CDH2;PIK3R1;REEP1;WNT5A;SNX18;RHOQ;RAB20;VAMP1;NOL3;AKT1;PKP3;RAB12;CDH1;EPN1;GAS6;LAMA5;RAB38;GDNF
7275,GO:0030168,0.0015967724719122,0.999572206387776,10,157,platelet activation,BP,ADRA2B;ADRA2C;TYRO3;PIK3R1;PDGFB;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
8466,GO:0032403,0.00162385850224975,0.999225220625501,27,710,protein complex binding,MF,ITGA3;ITGA5;TAGLN;ACTN3;ACTN2;FADD;TRADD;ACVR1;ADORA1;MFGE8;FSTL3;PIK3R1;PDGFB;JAM3;SPTB;MB21D2;CDKN1A;ESPN;DDR1;CTGF;PKP1;MYO7A;MYH11;LAMA5;RAB38;DOK1;TMOD4
12049,GO:0045137,0.00162935072935137,0.99949703658748,12,212,development of primary sexual characteristics,BP,WNT4;DHH;FSTL3;WNT5A;FGF8;ANG;WT1;WNT2B;KITLG;IDH1;INHBB;STAR
16153,GO:0070851,0.00163101850877731,0.999599478017502,9,130,growth factor receptor binding,MF,ITGA5;PYCARD;FGF18;FGF10;FGF17;PDGFB;FGF8;HBEGF;LINGO1
13110,GO:0048145,0.00163455630005904,0.999686401404316,7,83,regulation of fibroblast proliferation,BP,WNT2;IFI30;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
4663,GO:0009880,0.00164938304010028,0.999735038366552,6,62,embryonic pattern specification,BP,WNT7A;FGF10;WNT5A;BMP7;WT1;DLL1
15907,GO:0070372,0.00166042942705633,0.999457236464014,13,240,regulation of ERK1 and ERK2 cascade,BP,LIF;CCL20;PYCARD;FGF18;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
20323,GO:1904953,0.00166300416980528,0.999922951744866,3,12,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A
1120,GO:0002521,0.00166453306827159,0.999303234405864,20,462,leukocyte differentiation,BP,LIF;WNT4;FADD;ZFPM1;PNP;FZD7;TYRO3;FSTL3;PIK3R1;CLCF1;BMP4;DLL1;TPD52;TMEM176A;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
13442,GO:0048858,0.00166482601772922,0.99925598984695,23,575,cell projection morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;S100B;DOK1;GDNF;LINGO1
13726,GO:0050880,0.00173783257890262,0.999569168141937,9,131,regulation of blood vessel size,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
9130,GO:0033604,0.00174091822133489,0.999918030694308,3,12,negative regulation of catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA
21200,GO:2000404,0.001755459147934,0.999845203196281,4,25,regulation of T cell migration,BP,FADD;CCL20;PYCARD;WNT5A
11734,GO:0044319,0.00175625762908558,0.999844432512316,4,26,wound healing, spreading of cells,BP,ITGA5;WNT7A;HBEGF;DDR1
17610,GO:0090505,0.00175625762908558,0.999844432512316,4,26,epiboly involved in wound healing,BP,ITGA5;WNT7A;HBEGF;DDR1
21199,GO:2000403,0.00176110054312268,0.999844568776195,4,25,positive regulation of lymphocyte migration,BP,FADD;CCL20;PYCARD;WNT5A
1417,GO:0003093,0.00176360507377025,0.999916582772484,3,12,regulation of glomerular filtration,BP,ADORA1;PDGFB;GAS6
16286,GO:0071071,0.00176382746573863,0.999916568545839,3,12,regulation of phospholipid biosynthetic process,BP,PDGFB;FABP3;IDH1
1205,GO:0002685,0.00176928969348717,0.999519435288436,10,156,regulation of leukocyte migration,BP,FADD;ADORA1;EDN1;CCL20;PYCARD;WNT5A;JAM3;MSN;KITLG;GAS6
19078,GO:1902224,0.00177010599011583,0.999916166637614,3,12,ketone body metabolic process,BP,HMGCS2;BDH2;ACAT1
14823,GO:0060272,0.00177060626005436,0.999916134591792,3,12,embryonic skeletal joint morphogenesis,BP,AXIN1;BMP7;BMP4
14561,GO:0055006,0.0017734214798369,0.999710504177046,6,64,cardiac cell development,BP,FHOD3;ACTN2;NOTCH1;EDN1;BMP4;MYH11
13931,GO:0051188,0.00178506676144086,0.999477054702229,11,184,cofactor biosynthetic process,BP,PDK4;FASN;ACSF2;PNP;BDH2;NNMT;ACAT1;PCBD1;PTS;ACSL4;ELOVL6
8775,GO:0032835,0.00179517953559119,0.999706489844919,6,63,glomerulus development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
9190,GO:0033764,0.00180566214813231,0.999839537522676,4,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B3;HSD17B11;HSD17B10;HSD3B2
5016,GO:0010817,0.00181218738395383,0.999235802811711,20,465,regulation of hormone levels,BP,LIF;ADRA2B;ADRA2C;WNT4;HSD17B3;ADORA1;HSD17B11;DKK3;EDN1;RBP4;CYP17A1;BMP6;BMP2;HSD3B2;INHBB;STAR;RAB11FIP1;KCNG2;CYP11A1;DHCR7
15457,GO:0061337,0.00181443855859011,0.99954679459237,9,136,cardiac conduction,BP,DSC2;CASQ2;KCNK6;SPTBN4;KCNH2;FXYD1;NPR1;NPPC;KCND1
6163,GO:0016863,0.0018247272180737,0.999912648754139,3,12,intramolecular oxidoreductase activity, transposing C=C bonds,MF,EBP;HSD3B2;ECI1
3749,GO:0007272,0.00182531541608885,0.999590429231963,8,110,ensheathment of neurons,BP,POU3F1;DHH;JAM3;HEXB;AKT1;NAB2;TSPAN2;CLDN11
4104,GO:0008366,0.00182531541608885,0.999590429231963,8,110,axon ensheathment,BP,POU3F1;DHH;JAM3;HEXB;AKT1;NAB2;TSPAN2;CLDN11
13833,GO:0051046,0.00182909861098381,0.999132987320547,26,673,regulation of secretion,BP,LIF;ADRA2B;ADRA2C;SYT5;NOTCH1;RAB27A;ADORA1;EDN1;PYCARD;FGF10;RALB;WNT5A;RBP4;NPR1;SDC4;ANG;BMP6;WNK4;CHGA;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL;RAB3D;GDNF
10107,GO:0035883,0.00183009273481796,0.999836047351049,4,26,enteroendocrine cell differentiation,BP,WNT5A;BMP6;BMP4;DLL1
9702,GO:0035150,0.00183389840863239,0.999541643695724,9,132,regulation of tube size,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
790,GO:0001968,0.00185415431849504,0.999833294005691,4,26,fibronectin binding,MF,ITGA3;FSTL3;SDC4;CTGF
11273,GO:0043226,0.00188176540027208,0.998734660635671,284,12482,organelle,CC,ITGA3;ITGA5;CFB;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;ADRA2C;SYT5;WNT3;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;DPM3;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;MRPL14;MRPL16;MRI1;FADD;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;ABCG1;PRKACB;MFGE8;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;F8A1;ESPN;HEXB;VAMP1;SFXN1;CMBL;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DDR1;DSG3;CTGF;GJB1;GJB2;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;WNT2B;CYTIP;PTGES;KITLG;IDH1;NPPC;DECR1;NAB2;CDH1;PUS1;EPN1;MYO7A;BCAR1;PTMS;LDHD;TMEM98;MDP1;HPCAL1;RAB44;TFPI;TLE1;STAR;CLDN2;CLDN3;CLDN5;SNX21;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;PEPD;ACP5;GLA;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;DHCR7;CYB5A;PTS;PM20D2;HNF1A;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;DOK1;RAB3D;LYPLAL1;ACSL4;MYZAP;FAM110B;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN11;RNF144A;PARVB;ETFDH;PDE4B;TMOD4
781,GO:0001958,0.00188511767802164,0.999829736116261,4,26,endochondral ossification,BP,FGF18;BMP6;BMP4;NAB2
10219,GO:0036075,0.00188511767802164,0.999829736116261,4,26,replacement ossification,BP,FGF18;BMP6;BMP4;NAB2
7721,GO:0031032,0.00188914149633943,0.999481568734258,10,164,actomyosin structure organization,BP,FHOD3;WNT4;ACTN2;ITGB5;CASQ2;EDN1;PIK3R1;SDC4;CTGF;MYH11
2512,GO:0005198,0.00191487147070111,0.999089208695708,26,677,structural molecule activity,MF,TUBG2;ACTN3;ACTN2;MRPL14;MRPL16;SPTBN4;MPZL1;KRT10;AXIN1;SPTB;MSN;PKP1;CLDN1;CLDN2;CLDN3;CLDN5;HAPLN3;MYH11;CLDN23;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
6145,GO:0016835,0.00192248323028543,0.999681650593497,6,62,carbon-oxygen lyase activity,MF,FASN;ECHDC2;PCBD1;PUS1;ECI1;PTS
3547,GO:0006941,0.00192977540026011,0.999468966570428,10,163,striated muscle contraction,BP,ACTN3;DSC2;ADORA1;CASQ2;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;PDE4B
8418,GO:0032350,0.00193604738587665,0.999823848246855,4,26,regulation of hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
2447,GO:0005104,0.00193720609261976,0.999823713779625,4,26,fibroblast growth factor receptor binding,MF,FGF18;FGF10;FGF17;FGF8
13384,GO:0048736,0.00194276677249739,0.999464814010026,10,164,appendage development,BP,WNT3;NOTCH1;ITGB4;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
14764,GO:0060173,0.00194276677249739,0.999464814010026,10,164,limb development,BP,WNT3;NOTCH1;ITGB4;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
16814,GO:0072044,0.00194404118481384,0.999903187400663,3,13,collecting duct development,BP,NOTCH1;WNT7B;BMP4
9806,GO:0035384,0.00195615561874058,0.999674674255766,6,63,thioester biosynthetic process,BP,PDK4;FASN;ACSF2;ACAT1;ACSL4;ELOVL6
16596,GO:0071616,0.00195615561874058,0.999674674255766,6,63,acyl-CoA biosynthetic process,BP,PDK4;FASN;ACSF2;ACAT1;ACSL4;ELOVL6
5027,GO:0010828,0.00195813710958579,0.999743750223776,5,44,positive regulation of glucose transport,BP,PIK3R2;PIK3R1;RHOQ;RNASEL;AKT1
14916,GO:0060389,0.00196001801019028,0.999673904101459,6,63,pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
17609,GO:0090504,0.00197327902040745,0.999818790244079,4,27,epiboly,BP,ITGA5;WNT7A;HBEGF;DDR1
15426,GO:0061217,0.00197915899162946,0.99981883000468,4,26,regulation of mesonephros development,BP,BMP4;WT1;WNT2B;GDNF
502,GO:0001533,0.00198599021245593,0.999668717234407,6,63,cornified envelope,CC,DSC2;KRT10;DSG3;PKP3;PKP1;DSC3
14059,GO:0051403,0.0019922543807272,0.999334741570744,13,247,stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
17077,GO:0072524,0.00199608267085558,0.999494619524234,9,134,pyridine-containing compound metabolic process,BP,ACTN3;PNP;NNMT;PFKFB3;AOX1;SHPK;MDH1;IDH1;DERA
1475,GO:0003188,0.00199610980269245,0.999899662672529,3,13,heart valve formation,BP,NOTCH1;ZFPM1;HEY1
7886,GO:0031328,0.00200553579200053,0.998801686132284,53,1717,positive regulation of cellular biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;MRAP;ZFPM1;ACVR1;SALL4;EDN1;CCL20;FZD7;RGN;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;FABP3;PCBD1;AKT1;KITLG;NPPC;CDH1;STAR;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
12586,GO:0046320,0.00201700002664262,0.999813653603515,4,27,regulation of fatty acid oxidation,BP,PDK4;ACADVL;FABP3;AKT1
7717,GO:0031018,0.00201718519874456,0.99973421723961,5,44,endocrine pancreas development,BP,WNT5A;BMP6;BMP4;DLL1;AKT1
8797,GO:0032880,0.00202788731120116,0.998942510495103,33,937,regulation of protein localization,BP,ITGA3;LIF;ADRA2C;ACTN2;PMAIP1;WNT7A;PYCARD;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;RALB;WNT5A;SESN2;RBP4;RHOQ;ANG;BMP7;BMP6;BMP4;CDKN1A;MSN;NOL3;AKT1;IFI27;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL;CLDN18
6146,GO:0016836,0.00203464306089603,0.999731823721733,5,43,hydro-lyase activity,MF,FASN;ECHDC2;PCBD1;PUS1;ECI1
11880,GO:0044723,0.00203510792507568,0.99915443781311,19,436,single-organism carbohydrate metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;PDGFB;KHK;SESN2;GALT;RBP4;PFKFB3;B3GNT2;IDUA;HEXB;MDH1;AKT1;IDH1;PIK3CA;GLA;CYB5A
8694,GO:0032729,0.00203784379653213,0.999658320121588,6,63,positive regulation of interferon-gamma production,BP,FADD;ZFPM1;PYCARD;HRAS;WNT5A;PDE4B
15362,GO:0061097,0.00203863242259617,0.999657876364663,6,64,regulation of protein tyrosine kinase activity,BP,ADRA2B;ADRA2C;ADORA1;PDGFB;GAS6;UNC119
8069,GO:0031667,0.00204006578476654,0.999175046258764,18,403,response to nutrient levels,BP,PDK4;WNT4;PMAIP1;DSC2;FADS1;FOXO4;RALB;NUAK2;BMP7;ACAT1;CDKN1A;AKT1;WNT2B;INHBB;STAR;GAS6;VDR;ACSL4
4239,GO:0008593,0.00204058091185373,0.999657484258974,6,64,regulation of Notch signaling pathway,BP,NOTCH1;FGF10;BMP7;DLL1;JAG2;HEY1
13964,GO:0051246,0.00204727546451533,0.998694958366164,71,2455,regulation of protein metabolic process,BP,ITGA5;CFB;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;FADD;SERPINA5;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;TICAM1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;CDKN1A;MSN;NOL3;DEPTOR;CTGF;AKT1;IFI27;KITLG;CST9L;INHBB;TFPI;PIK3CA;PIK3CG;GAS6;PM20D2;RBMS3;ARAF;UNC119;FZD8;DUSP5;RNF144A
8787,GO:0032869,0.00205871807979033,0.99938523813102,11,191,cellular response to insulin stimulus,BP,PDK4;PIK3R2;PIK3R1;FOXO4;RHOQ;RNASEL;AKT1;BCAR1;INHBB;STAR;PIK3CA
14865,GO:0060326,0.00208733604386067,0.999299383610142,13,245,cell chemotaxis,BP,NOTCH1;EDN1;CCL20;FGF18;PDGFB;WNT5A;JAM3;HBEGF;CHGA;BCAR1;PIK3CG;GAS6;PDE4B
13271,GO:0048534,0.00212202792414392,0.99895335688166,28,752,hematopoietic or lymphoid organ development,BP,ARTN;EBP;LIF;WNT4;NOTCH1;FADD;ZFPM1;PNP;FZD7;TYRO3;FSTL3;FGF10;PIK3R1;WNT5A;JAM3;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;TMEM176A;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
3853,GO:0007589,0.00212754093236092,0.999571525940976,7,87,body fluid secretion,BP,ADORA1;EDN1;FGF10;NPR1;WNK4;DDR1;VDR
760,GO:0001935,0.00212787089611578,0.999510512440837,8,111,endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;ANG;BMP6;BMP4;BMP2;AKT1
18721,GO:1901213,0.00213068887191014,0.999890400368342,3,13,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,NOTCH1;ACVR1;BMP4
14023,GO:0051341,0.00214606887384234,0.999567339054566,7,86,regulation of oxidoreductase activity,BP,EDN1;RGN;AKT1;GLA;PTS;VDR;GDNF
10861,GO:0042493,0.00217365158444132,0.999115777451878,18,405,response to drug,BP,ITGA3;EBP;RAB6C;EDN1;PNP;KCNH2;NNMT;FGF8;CDKN1A;FABP3;NPPC;CDH1;STAR;CLDN1;GAS6;RPH3AL;SLC1A3;PDE4B
12434,GO:0045935,0.00218859365183543,0.99869894835944,51,1645,positive regulation of nucleobase-containing compound metabolic process,BP,LIF;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;FADD;WNT6;WNT7A;MRAP;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;CHGA;PCBD1;AKT1;KITLG;NPPC;CDH1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
7458,GO:0030500,0.00220123917188527,0.999624592843897,6,65,regulation of bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
16735,GO:0071883,0.00220145702943847,0.99997131146958,2,4,activation of MAPK activity by adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C
18951,GO:1901879,0.00223114659682484,0.999618169074015,6,66,regulation of protein depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
731,GO:0001892,0.00223472197612705,0.999545782932517,7,88,embryonic placenta development,BP,LIF;WNT2;WNT7B;PDGFB;BMP7;AKT1;HEY1
15866,GO:0070307,0.00223623757845602,0.999882986925245,3,13,lens fiber cell development,BP,WNT7A;WNT7B;WNT5B
10855,GO:0042487,0.00224281414585381,0.999882520767858,3,13,regulation of odontogenesis of dentin-containing tooth,BP,FGF8;BMP4;BMP2
7616,GO:0030850,0.00224417550039107,0.999696498712832,5,45,prostate gland development,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
1562,GO:0003337,0.00226024695921274,0.99988128272589,3,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;BMP4;GDNF
13835,GO:0051048,0.00227790890087754,0.999310890910386,11,191,negative regulation of secretion,BP,LIF;ADRA2B;ADRA2C;NOTCH1;ADORA1;EDN1;WNK4;CHGA;INHBB;RAB11FIP1;GAS6
13286,GO:0048562,0.00228806367234454,0.99918660092933,14,283,embryonic organ morphogenesis,BP,NOTCH1;STRA6;ACVR1;EDN1;FGF10;WNT5A;AXIN1;RBP4;FGF8;BMP7;BMP4;DLL1;GJB6;MYO7A
18352,GO:0099568,0.00228809277548714,0.999186380062062,14,287,cytoplasmic region,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;FAM110C;SPTB;CTGF;CYTIP;CDH1;MYO7A;CLDN5;MYZAP
9376,GO:0034332,0.00229490871129261,0.999465137609748,8,114,adherens junction organization,BP,WNT4;ACTN3;ACTN2;CDH2;SDC4;ANG;CDH1;LAMA5
5779,GO:0016125,0.00231543171859611,0.999400368314861,9,137,sterol metabolic process,BP,EBP;APOC1;HMGCS2;ABCG1;ACADVL;CYP17A1;STAR;CYP11A1;DHCR7
10752,GO:0042306,0.00232700897836082,0.999342704464167,10,166,regulation of protein import into nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;CDH1;GAS6
2794,GO:0005783,0.00233662412670814,0.998613022877442,50,1601,endoplasmic reticulum,CC,ITGA5;EBP;WNT3;WNT4;USE1;ALG5;NOTCH1;DPM3;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ADORA1;CASQ2;EXTL1;EDN1;ABCG1;PYCARD;MBOAT2;TTYH1;RRAS2;MGST2;TYRO3;FADS1;PIK3R1;REEP1;PDGFB;PLA2G16;WNT5B;WNT5A;CYP17A1;NOL3;HSD3B2;GJB1;CPT1C;TPD52;CASP4;PTGES;TMEM98;TFPI;GAS6;DHCR7;CYB5A;GPSM1;RAB38;ACSL4;CNIH4;ELOVL6
16348,GO:0071241,0.00233954711282226,0.999338779106114,10,165,cellular response to inorganic substance,BP,TF;GUCY1B3;EDN1;FSTL3;WNT5A;BMP6;AKT1;CDH1;STAR;CLDN1
13332,GO:0048660,0.00234900459144041,0.999450801414884,8,112,regulation of smooth muscle cell proliferation,BP,EDN1;PDGFB;NPR1;ANG;HBEGF;BMP4;AKT1;NPPC
2159,GO:0004672,0.00234914742251668,0.998901298432612,24,624,protein kinase activity,MF,PDK4;MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF18;FGF10;FGF17;KCNH2;NPR1;NUAK2;RNASEL;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;PIK3CA;PIK3CG;ARAF;PIM2
5192,GO:0014033,0.00234969477684432,0.999593699820627,6,66,neural crest cell differentiation,BP,ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
4221,GO:0008544,0.00235609650269195,0.999007978160981,19,440,epidermis development,BP,POU3F1;NOTCH1;DSC2;TRADD;KRT10;FGF10;WNT5A;BMP4;DLL1;DSG3;CTGF;PKP3;PKP1;NAB2;JAG2;MYO7A;DSC3;VDR;LAMA5
877,GO:0002085,0.00237861160470489,0.999967748085733,2,4,inhibition of neuroepithelial cell differentiation,BP,NOTCH1;DLL1
12400,GO:0045893,0.00238491867243597,0.998637808624024,43,1335,positive regulation of transcription, DNA-templated,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;PCBD1;AKT1;CDH1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
19633,GO:1903508,0.00238491867243597,0.998637808624024,43,1335,positive regulation of nucleic acid-templated transcription,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;PCBD1;AKT1;CDH1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
12262,GO:0045632,0.00239342765189148,0.999967443652383,2,4,negative regulation of mechanoreceptor differentiation,BP,NOTCH1;DLL1
21528,GO:2000981,0.00239342765189148,0.999967443652383,2,4,negative regulation of inner ear receptor cell differentiation,BP,NOTCH1;DLL1
12133,GO:0045321,0.00240886015654937,0.998671769956669,38,1129,leukocyte activation,BP,WNT4;RAB27A;CRISPLD2;FADD;ZFPM1;EDN1;PLAU;PNP;PYCARD;FZD7;TYRO3;FGF10;PIK3R1;TICAM1;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;DLL1;SHPK;HEXB;CHGA;MSN;TPD52;AKT1;PKP1;IDH1;JAG2;RAB44;PIK3CA;PIK3CG;GAS6;GLA;DERA;RAB3D;FZD8;EFNB2
14861,GO:0060322,0.00241406410702511,0.998831489004997,26,699,head development,BP,WNT3;WNT2;WNT4;POU3F1;NOTCH1;STRA6;CRISPLD2;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;BMP7;BMP4;BMP2;ACAT1;DLL1;WNT2B;CDH1;STAR;CLDN5;TSPAN2
5820,GO:0016229,0.00241453476790061,0.999765559079586,4,27,steroid dehydrogenase activity,MF,HSD17B3;HSD17B11;HSD17B10;HSD3B2
9689,GO:0035107,0.00244264985379344,0.999361709540962,9,142,appendage morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
9690,GO:0035108,0.00244264985379344,0.999361709540962,9,142,limb morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
5280,GO:0014834,0.0024477516106817,0.999966319093468,2,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A;FZD7
7712,GO:0031012,0.00245520437544147,0.998912318691575,21,517,extracellular matrix,CC,WNT3;WNT2;WNT4;CRISPLD2;WNT6;WNT7A;WNT7B;MFGE8;FGF10;PDGFB;WNT5B;WNT5A;ANG;BMP7;BMP4;CTGF;WNT2B;HAPLN3;LAMA1;LAMA5;LINGO1
7766,GO:0031098,0.00245647299856766,0.999159356937576,13,253,stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
6102,GO:0016772,0.00247497312747121,0.998692405120426,33,955,transferase activity, transferring phosphorus-containing groups,MF,PDK4;MARK4;ZFYVE21;ACVR1;PRKACB;MAPK12;TYRO3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;GALT;NPR1;NUAK2;PFKFB3;RNASEL;FGF8;HBEGF;CDKN1A;PKN3;SHPK;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
1504,GO:0003231,0.00248485423981187,0.999413043198377,8,116,cardiac ventricle development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;BMP4;HEY1
8870,GO:0032990,0.0024894815662995,0.998850867028382,23,593,cell part morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;S100B;DOK1;GDNF;LINGO1
6160,GO:0016860,0.00250092008843311,0.999653215448857,5,45,intramolecular oxidoreductase activity,MF,EBP;MRI1;HSD3B2;PTGES;ECI1
13318,GO:0048633,0.00250717314729933,0.999965074132756,2,4,positive regulation of skeletal muscle tissue growth,BP,ACTN3;DLL1
2799,GO:0005788,0.00252892520486836,0.999224088679644,11,196,endoplasmic reticulum lumen,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;CASQ2;EDN1;PDGFB;WNT5B;WNT5A;GAS6
10102,GO:0035877,0.00254080920121752,0.999964362586127,2,4,death effector domain binding,MF,FADD;NOL3
11802,GO:0044432,0.0025483306813939,0.99859000348528,38,1135,endoplasmic reticulum part,CC,EBP;WNT3;WNT4;USE1;ALG5;NOTCH1;DPM3;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;CASQ2;EXTL1;EDN1;ABCG1;MBOAT2;TTYH1;MGST2;TYRO3;FADS1;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;CYP17A1;HSD3B2;GJB1;CPT1C;CASP4;PTGES;GAS6;DHCR7;CYB5A;GPSM1;ACSL4;ELOVL6
1826,GO:0004095,0.00255339842909058,0.999964095009131,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1C
1424,GO:0003104,0.00255892377992307,0.999963977354708,2,4,positive regulation of glomerular filtration,BP,PDGFB;GAS6
17587,GO:0090407,0.00256065642670704,0.998794449936658,24,615,organophosphate biosynthetic process,BP,DPM3;MRAP;GUCY1B3;EDN1;PNP;MBOAT2;FADS1;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;NNMT;PLA2G16;NPR1;FGF8;ACAT1;HEXB;FABP3;IDH1;NPPC;PIK3CA;PIK3CG
8413,GO:0032345,0.0025664477421302,0.999963816930986,2,4,negative regulation of aldosterone metabolic process,BP,DKK3;BMP2
8416,GO:0032348,0.0025664477421302,0.999963816930986,2,4,negative regulation of aldosterone biosynthetic process,BP,DKK3;BMP2
20985,GO:2000065,0.0025664477421302,0.999963816930986,2,4,negative regulation of cortisol biosynthetic process,BP,DKK3;BMP2
11969,GO:0045017,0.00256732015230998,0.999116861324665,13,254,glycerolipid biosynthetic process,BP,DPM3;RGN;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;ANG;FABP3;PIK3CA;PIK3CG
9951,GO:0035625,0.00256805503021894,0.999963782629236,2,4,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C
10636,GO:0042074,0.00257103549205446,0.999856624432951,3,14,cell migration involved in gastrulation,BP,WNT5A;FGF8;AMOT
3803,GO:0007417,0.0025714234998781,0.99866634792734,31,886,central nervous system development,BP,LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;SPTBN4;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;CLCF1;BMP7;BMP4;BMP2;ACAT1;DLL1;DRP2;AKT1;WNT2B;CDH1;STAR;HAPLN3;S100B;PTS;TSPAN2
5202,GO:0014045,0.00257339987441842,0.999963668482881,2,4,establishment of endothelial blood-brain barrier,BP,WNT7A;WNT7B
7079,GO:0022009,0.00257339987441842,0.999963668482881,2,4,central nervous system vasculogenesis,BP,WNT7A;WNT7B
21671,GO:2001275,0.0025754904393319,0.999856287765188,3,14,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1;RNASEL
16858,GO:0072108,0.00257856172669786,0.999963558127897,2,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;GDNF
6568,GO:0019318,0.00258141955526154,0.999156603231644,12,224,hexose metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;KHK;SESN2;GALT;RBP4;PFKFB3;MDH1;AKT1;PIK3CA
15422,GO:0061209,0.00258519280313063,0.999963416194392,2,4,cell proliferation involved in mesonephros development,BP,BMP4;BMP2
20324,GO:1904954,0.00259193519006219,0.999963271684807,2,4,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
15970,GO:0070482,0.00259285119782659,0.998991312289286,16,349,response to oxygen levels,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;PSMB10;ANG;BMP7;BMP2;CDKN1A;NOL3;CTGF;AKT1;NPPC;CLDN3;S100B
8758,GO:0032811,0.00260052925664992,0.999963087205613,2,4,negative regulation of epinephrine secretion,BP,ADRA2B;ADRA2C
10119,GO:0035909,0.00260515204979634,0.999739833415225,4,29,aorta morphogenesis,BP,NOTCH1;FGF8;HEY1;EFNB2
16710,GO:0071840,0.00261864930659322,0.998139689650183,148,5922,cellular component organization or biogenesis,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;MARK4;RAB27A;CDH23;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRISPLD2;MRPL14;MRPL16;FADD;SERPINA5;WNT7A;WNT7B;APOC1;ZFPM1;TRADD;RABIF;TBC1D14;CASQ2;EDN1;RAB40B;RAB40A;ABCG1;MFGE8;SPTBN5;SPTBN4;PYCARD;TTYH1;RAB39B;RAB39A;PRND;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;PLA2G16;HSD17B10;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;HACL1;SESN2;AXIN1;RHOQ;RHOJ;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;ANG;FAM110C;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;ACAT1;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;RAB20;DRP2;ESPN;HEXB;VAMP1;RND3;CHGA;MSN;NOL3;DDR1;DEPTOR;CTGF;GJB1;GJB2;PCBD1;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;SEMA6C;DECR1;CDH1;PUS1;EPN1;MYO7A;BCAR1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;KCNG2;GAS6;SIN3B;MYH11;LZTS1;S100B;HNF1A;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;GDNF;ACSL4;SLC1A3;PIM2;PARVB;LINGO1;TMOD4
20628,GO:1905867,0.00261989207269658,0.999962670407648,2,4,epididymis development,BP,GJB1;GJB2
3969,GO:0008150,0.00262332328404389,0.998703517605878,348,16026,biological_process,BP,ITGA3;ITGA5;ARTN;CFB;TAGLN;EBP;PDK4;PECR;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;PNMT;DPM3;STRA6;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;RHBDL3;SLC31A2;FBXO41;MRPL14;MRPL16;SLC45A4;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;WDR45;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;FLVCR2;SPTBN5;SPTBN4;PYCARD;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;LGALS4;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;F8A1;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;ACCS;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;FAM46A;TMEM176A;CYTIP;PTGES;KITLG;SEMA6C;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;PTMS;LDHD;GJA3;MDP1;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN2;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;WBP1;SIN3B;PEPD;ACP5;GLA;HAPLN3;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;PRRT1;LZTS1;DERA;S100B;CLDN23;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;SLC18B1;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;LYPLAL1;ACSL4;MYZAP;SLC1A3;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
2448,GO:0005105,0.00262403362568642,0.999962581050002,2,4,type 1 fibroblast growth factor receptor binding,MF,FGF18;FGF17
7609,GO:0030837,0.00263542637726101,0.999629045187339,5,47,negative regulation of actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;SPTB;TMOD4
16732,GO:0071880,0.00264987466990411,0.999850635558876,3,14,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
6208,GO:0016936,0.00265571218842126,0.99996189514201,2,4,galactoside binding,MF,LGALS4;GLA
20141,GO:1904589,0.00265722500713184,0.999235198961643,10,169,regulation of protein import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;CDH1;GAS6
11865,GO:0044703,0.0026573828466395,0.99860394145744,32,909,multi-organism reproductive process,BP,ITGA3;LIF;ADRA2C;WNT3;WNT4;NOTCH1;IGSF8;DHH;SERPINA5;ACVR1;EDN1;MFGE8;SPTBN4;TYRO3;RGN;FSTL3;JAM3;ANG;BMP4;WT1;SLC2A14;HEXB;DDR1;GJB2;AKT1;NPPC;JAG2;EPN1;INHBB;VDR;ACSL4;CLDN11
7888,GO:0031330,0.00266872381935418,0.999293530334534,9,141,negative regulation of cellular catabolic process,BP,APOC1;TBC1D14;RGN;AKT1;PKP3;PKP1;PIK3CA;PIK3CG;LZTS1
3806,GO:0007422,0.00266923295099888,0.999525462676286,6,69,peripheral nervous system development,BP,ARTN;POU3F1;AKT1;NAB2;CLDN1;GDNF
17785,GO:0097169,0.00268113779115662,0.999961341544624,2,4,AIM2 inflammasome complex,CC,PYCARD;CASP4
14581,GO:0055037,0.00268695198658199,0.999287837215256,9,142,recycling endosome,CC,SYT5;TF;SLC31A2;TBC1D14;ABCG1;FZD7;RAB12;RAB17;RAB11FIP1
11624,GO:0044087,0.00268857017289575,0.998650982946677,28,771,regulation of cellular component biogenesis,BP,FHOD3;WNT4;NOTCH1;PMAIP1;WNT7A;TBC1D14;EDN1;SPTBN5;SPTBN4;PYCARD;PIK3R1;RALB;HRAS;WNT5A;RHOQ;PSRC1;SDC4;FAM110C;SPTB;BMP7;ESPN;CHGA;MSN;CTGF;RAB17;CLDN1;HNF1A;TMOD4
4805,GO:0010463,0.00268948362565385,0.999619651713205,5,47,mesenchymal cell proliferation,BP,WNT2;WNT5A;BMP7;BMP4;BMP2
2905,GO:0005975,0.002709428037876,0.998764620215132,22,549,carbohydrate metabolic process,BP,PDK4;ACTN3;DPM3;PMAIP1;RGN;PDGFB;KHK;SESN2;GALT;RBP4;PFKFB3;B3GNT2;IDUA;SHPK;HEXB;MDH1;AKT1;IDH1;PIK3CA;GLA;DERA;CYB5A
18174,GO:0098802,0.00272332048324468,0.999213501834224,10,169,plasma membrane receptor complex,CC,ITGA3;ITGA5;TF;ITGB5;ITGB4;ITGB8;ACVR1;BMP2;GRIA3;CPT1C
15109,GO:0060674,0.00273130754372582,0.999723630149487,4,29,placenta blood vessel development,BP,WNT2;ITGB8;AKT1;HEY1
4675,GO:0009895,0.00275240189624393,0.999145999135994,11,198,negative regulation of catabolic process,BP,ACTN3;APOC1;TBC1D14;ADORA1;RGN;AKT1;PKP3;PKP1;PIK3CA;PIK3CG;LZTS1
18704,GO:1901184,0.00275577071376201,0.999417756002161,7,91,regulation of ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;HBEGF;AKT1;EPN1;DOK1
15140,GO:0060711,0.00276040446984456,0.999607259535352,5,47,labyrinthine layer development,BP,WNT2;WNT7B;BMP7;AKT1;HEY1
4704,GO:0009987,0.00276229048436353,0.998297549246061,323,14598,cellular process,BP,ITGA3;ITGA5;ARTN;TAGLN;EBP;PDK4;PECR;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;PNMT;DPM3;STRA6;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;FBXO41;MRPL14;MRPL16;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;WDR45;RABIF;NMT2;SALL4;TBC1D14;GUCY1B3;ADORA1;CASQ2;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;MBOAT2;G0S2;LAGE3;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;TMEM176A;PTGES;KITLG;SEMA6C;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;PTMS;GJA3;MDP1;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;PEPD;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;LYPLAL1;ACSL4;MYZAP;SLC1A3;FZD8;ELOVL6;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
13331,GO:0048659,0.00276455074685522,0.999335774982393,8,115,smooth muscle cell proliferation,BP,EDN1;PDGFB;NPR1;ANG;HBEGF;BMP4;AKT1;NPPC
8919,GO:0033077,0.00277607225613228,0.999502906998971,6,68,T cell differentiation in thymus,BP,WNT4;FADD;FZD7;BMP4;JAG2;FZD8
19287,GO:1902742,0.00278353069128426,0.999716859572741,4,29,apoptotic process involved in development,BP,NOTCH1;BMP7;JAG2;VDR
2533,GO:0005243,0.00279179215253096,0.999839692870785,3,14,gap junction channel activity,MF,GJB1;GJB2;GJA3
2441,GO:0005092,0.00279812126972528,0.999839200083069,3,14,GDP-dissociation inhibitor activity,MF,SESN2;GPSM1;SH3BP4
13452,GO:0048871,0.00280534971841779,0.998938190490645,15,320,multicellular organismal homeostasis,BP,PDK4;CDH23;TF;ADORA1;PRKACB;ACADVL;PRKAR1B;RBP4;BMP6;DLL1;CTGF;CLDN1;PIK3CA;RAB3D;CLDN18
14961,GO:0060441,0.0028184620642623,0.999712310563989,4,29,epithelial tube branching involved in lung morphogenesis,BP,WNT2;FGF10;BMP4;WNT2B
17059,GO:0072498,0.00284681022806871,0.999835395703751,3,14,embryonic skeletal joint development,BP,AXIN1;BMP7;BMP4
16353,GO:0071248,0.00285178037519338,0.999237396633576,9,142,cellular response to metal ion,BP,TF;EDN1;FSTL3;WNT5A;BMP6;AKT1;CDH1;STAR;CLDN1
7067,GO:0021984,0.00285979296263791,0.999834377283229,3,14,adenohypophysis development,BP,WNT4;FGF8;BMP2
2699,GO:0005622,0.00286766772259189,0.998111745390842,303,13536,intracellular,CC,ITGA3;ITGA5;ARTN;TAGLN;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;IFI30;PNMT;DPM3;TF;ZFYVE21;ITGB5;ITGB4;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;FBXO41;MRPL14;MRPL16;MRI1;FADD;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;RHPN1;ABCG1;PRKACB;CCL20;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;HBEGF;LGALS4;NMI;BMP6;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;ECHDC2;SLC2A14;SARDH;F8A1;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;CYTIP;PTGES;KITLG;IDH1;NPPC;DECR1;NAB2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;PTMS;LDHD;TMEM98;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;DOK1;RAB3D;GDNF;LYPLAL1;ACSL4;MYZAP;FAM110B;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PARVB;ETFDH;PDE4B;TMOD4
19605,GO:1903426,0.00286920532537719,0.999482804176563,6,68,regulation of reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;RGN;TICAM1;AKT1;GLA
14035,GO:0051353,0.00286923584371235,0.999588095382501,5,47,positive regulation of oxidoreductase activity,BP,EDN1;RGN;AKT1;VDR;GDNF
15906,GO:0070371,0.00288902900098685,0.998992327030804,13,256,ERK1 and ERK2 cascade,BP,LIF;CCL20;PYCARD;FGF18;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
4691,GO:0009952,0.00291101937777482,0.999089966379788,11,200,anterior/posterior pattern specification,BP,WNT3;WNT2;NOTCH1;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B
13669,GO:0050801,0.00291233887113896,0.99857031152803,26,698,ion homeostasis,BP,PDK4;CDH23;TF;SLC31A2;ADORA1;CASQ2;EDN1;ABCG1;BDH2;RAB39A;PRND;LPAR2;RGN;KCNH2;NPR1;BMP6;RAB20;HEXB;SFXN1;WNK4;FABP3;NOL3;PIK3CG;VDR;RAB38;CLDN16
19650,GO:1903531,0.00292978156765193,0.999145241117267,10,169,negative regulation of secretion by cell,BP,LIF;ADRA2B;ADRA2C;NOTCH1;ADORA1;EDN1;CHGA;INHBB;RAB11FIP1;GAS6
13918,GO:0051173,0.00297194680584792,0.998188563037385,53,1750,positive regulation of nitrogen compound metabolic process,BP,LIF;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;FADD;WNT6;WNT7A;MRAP;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;CHGA;PCBD1;AKT1;KITLG;NPPC;CDH1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
12185,GO:0045444,0.00299426898537477,0.999060598946693,11,199,fat cell differentiation,BP,MRAP;ZFPM1;FGF10;WNT5B;WNT5A;AXIN1;RNASEL;BMP2;NUDT7;AKT1;INHBB
7767,GO:0031099,0.00299588858277147,0.999123103009038,10,170,regeneration,BP,NOTCH1;WNT7A;FZD7;RGN;FGF10;NNMT;JAM3;CDKN1A;CLDN1;GAS6
14886,GO:0060350,0.00300623748201172,0.999563141876231,5,48,endochondral bone morphogenesis,BP,FGF18;BMP6;BMP4;NPPC;NAB2
13279,GO:0048546,0.00312741337097769,0.999540750030556,5,49,digestive tract morphogenesis,BP,NOTCH1;STRA6;FGF10;WNT5A;BMP4
98,GO:0000187,0.00312797184915579,0.999151526264612,9,144,activation of MAPK activity,BP,ADRA2B;ADRA2C;WNT7B;GHR;FGF10;WNT5A;AXIN1;BMP2;DUSP5
13774,GO:0050954,0.00313352434447167,0.999149466876027,9,146,sensory perception of mechanical stimulus,BP,CDH23;SLC52A3;SPTBN4;ESPN;HEXB;GJB2;GJB6;MYO7A;SLC1A3
8952,GO:0033138,0.00313516750735891,0.999321776851692,7,92,positive regulation of peptidyl-serine phosphorylation,BP,LIF;WNT5A;AXIN1;AKT1;PIK3CA;GAS6;ARAF
11687,GO:0044248,0.00315840452426531,0.998044607833707,56,1867,cellular catabolic process,BP,PHYH;GLDC;ITGB4;PMAIP1;APOC1;WDR45;TBC1D14;PNP;BDH2;ACADVL;RAB39A;PSMB10;RGN;PRR5L;PIK3R2;TICAM1;RALB;CPT2;HSD17B10;ETFB;MAGEC2;HACL1;GPRASP1;SESN2;AXIN1;GALT;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;MSN;NUDT7;CPT1C;PCBD1;AKT1;PKP3;PKP1;RAB12;PON2;IDH1;DECR1;PIK3CA;PIK3CG;GLA;ECI1;LZTS1;DERA;ARAF;SH3BP4;RNF144A;PIM2;ETFDH;PDE4B
14884,GO:0060348,0.0031686685582375,0.999064704106987,10,174,bone development,BP,ZFPM1;RGN;FGF18;FGF8;BMP6;BMP4;BMP2;NPPC;NAB2;CLDN18
12237,GO:0045601,0.00317220350176799,0.999664311857553,4,30,regulation of endothelial cell differentiation,BP,NOTCH1;BMP6;BMP4;CLDN5
7760,GO:0031090,0.00317297476602347,0.99791263694375,76,2705,organelle membrane,CC,PDK4;PECR;TMEM163;SYT5;WNT3;WNT4;TSPAN15;NOTCH1;RAB27A;TF;ZFYVE21;PMAIP1;MRPL14;MRPL16;SERPINA5;WNT6;WNT7A;WNT7B;HMGCS2;PXMP2;PXMP4;CASQ2;PLAU;ABCG1;SPTBN5;SLC25A53;ACADVL;TTYH1;RAB39A;MGST2;SYCN;FZD7;TICAM1;REEP1;PDGFB;CPT2;PLA2G16;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;ACAT1;B3GNT2;RAB20;VAMP1;SFXN1;GRIA3;RND3;CHGA;HSD3B2;CPT1C;IFI27;PKP1;RAB12;RAB17;MYO7A;LDHD;RAB44;TFPI;STAR;SNX21;RAB11FIP1;ECI1;CYP11A1;RPH3AL;DHCR7;CYB5A;GPSM1;RAB38;RAB3D;ACSL4;RNF144A;ETFDH
19263,GO:1902680,0.00323797320004575,0.998118013766212,43,1357,positive regulation of RNA biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;PCBD1;AKT1;CDH1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
527,GO:0001570,0.00325735595608636,0.999396364508589,6,71,vasculogenesis,BP,NOTCH1;WNT7A;WNT7B;WT1;AMOT;HEY1
8646,GO:0032649,0.00327369510505594,0.999286264890852,7,92,regulation of interferon-gamma production,BP,FADD;ZFPM1;PYCARD;HRAS;WNT5A;GAS6;PDE4B
16832,GO:0072075,0.00328834327182112,0.999797435726918,3,15,metanephric mesenchyme development,BP,WNT4;BMP7;WT1
14047,GO:0051384,0.00330592805084375,0.999095755174665,9,144,response to glucocorticoid,BP,WNT7B;EDN1;BMP6;CDKN1A;GJB2;STAR;CLDN1;S100B;HEY1
21091,GO:2000269,0.00330964186114162,0.999795653820003,3,15,regulation of fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
4055,GO:0008286,0.00334155382500517,0.999170769328755,8,120,insulin receptor signaling pathway,BP,PDK4;PIK3R2;PIK3R1;FOXO4;RHOQ;AKT1;BCAR1;PIK3CA
17514,GO:0090287,0.00338017017013971,0.998857373771743,12,234,regulation of cellular response to growth factor stimulus,BP,ITGA3;ITGA5;WNT4;NOTCH1;RASL11B;DKK3;FSTL3;FGF18;FGF10;WNT5A;BMP4;DLL1
3545,GO:0006939,0.00338306523411007,0.999257422177555,7,94,smooth muscle contraction,BP,ADRA2B;ADRA2C;ADORA1;EDN1;MYH11;GDNF;ACTA2
4692,GO:0009953,0.00339126645854,0.99925529609053,7,94,dorsal/ventral pattern formation,BP,WNT3;WNT7A;ACVR1;EDN1;PRKACB;FGF8;BMP4
2877,GO:0005921,0.00339653408903479,0.999633647028012,4,30,gap junction,CC,GJB1;GJB2;GJB6;GJA3
18156,GO:0098773,0.00339896619110033,0.999253004973083,7,95,skin epidermis development,BP,NOTCH1;TRADD;KRT10;FGF10;WNT5A;DLL1;LAMA5
4003,GO:0008203,0.00342942429053463,0.999145557723874,8,119,cholesterol metabolic process,BP,EBP;APOC1;HMGCS2;ABCG1;ACADVL;STAR;CYP11A1;DHCR7
7681,GO:0030949,0.00343084022758537,0.99978543512169,3,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;FGF18;FGF10
15855,GO:0070293,0.00344476909982222,0.999784252210733,3,15,renal absorption,BP,WNK4;GAS6;HNF1A
8902,GO:0033036,0.00344632301154338,0.997719378993766,77,2775,macromolecule localization,BP,ITGA3;LIF;ADRA2C;WNT4;USE1;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;SERPINA5;WNT7A;MRAP;APOC1;RABIF;TBC1D14;ADORA1;EDN1;RAB40B;RAB40A;PNP;ABCG1;SPTBN4;PYCARD;RAB39B;RAB39A;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;CPT2;WNT5A;SNX18;SESN2;RBP4;RHOQ;RHOB;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;HEXB;WNK4;FABP3;MSN;NOL3;AKT1;IFI27;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;STAR;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;AMOT;LAMA5;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;CNIH4;CLDN18
2921,GO:0005996,0.00344921963128593,0.998771176933809,13,262,monosaccharide metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;KHK;SESN2;GALT;RBP4;PFKFB3;MDH1;AKT1;PIK3CA;CYB5A
17493,GO:0090263,0.00344946669168212,0.999139741449565,8,119,positive regulation of canonical Wnt signaling pathway,BP,WNT2;WNT4;WNT7A;PSMB10;FGF10;WNT5A;AXIN1;WNT2B
6717,GO:0019827,0.00346110826963991,0.999046015232741,9,148,stem cell population maintenance,BP,LIF;NOTCH1;WNT7A;SALL4;FZD7;CDH2;FGF10;BMP7;DLL1
7394,GO:0030326,0.00347125439395298,0.999132737327482,8,122,embryonic limb morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;WNT5A;FGF8;BMP7;BMP4
9692,GO:0035113,0.00347125439395298,0.999132737327482,8,122,embryonic appendage morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;WNT5A;FGF8;BMP7;BMP4
13972,GO:0051254,0.00349504384225393,0.997947233630044,44,1403,positive regulation of RNA metabolic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;PCBD1;AKT1;CDH1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
10859,GO:0042491,0.00353920181204137,0.999612718108216,4,31,auditory receptor cell differentiation,BP,NOTCH1;DLL1;JAG2;MYO7A
13091,GO:0048048,0.00357698370464901,0.999606357694306,4,32,embryonic eye morphogenesis,BP,STRA6;WNT5A;AXIN1;BMP7
7226,GO:0030100,0.00359922002153679,0.998842578566947,11,204,regulation of endocytosis,BP,RAB27A;TF;APOC1;MFGE8;PYCARD;WNT5A;DLL1;RAB20;RAB17;GAS6;UNC119
732,GO:0001893,0.00361152626890584,0.999602559036639,4,31,maternal placenta development,BP,LIF;GJB2;AKT1;VDR
5592,GO:0015758,0.00361852669479034,0.998995894885884,9,148,glucose transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;RNASEL;SLC2A14;AKT1;HNF1A
7715,GO:0031016,0.00362674480938148,0.999312659786468,6,72,pancreas development,BP,FGF10;WNT5A;BMP6;BMP4;DLL1;AKT1
7622,GO:0030856,0.0036386277592138,0.9990840874571,8,121,regulation of epithelial cell differentiation,BP,LIF;NOTCH1;BMP6;BMP4;DLL1;CLDN5;VDR;GDNF
12428,GO:0045927,0.00364301552956821,0.998756704589151,12,237,positive regulation of growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;GHR;FGF8;HBEGF;WT1;DLL1;AKT1
9769,GO:0035313,0.00364492817110557,0.999764665929848,3,16,wound healing, spreading of epidermal cells,BP,ITGA5;WNT7A;HBEGF
12232,GO:0045596,0.00366911357926339,0.998251632655402,23,603,negative regulation of cell differentiation,BP,WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;ABCG1;FZD7;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;AXIN1;BMP7;BMP4;BMP2;DLL1;TMEM176A;NPPC;S100B;CLDN18;LINGO1
12816,GO:0046822,0.00367327574503982,0.998815335616567,11,206,regulation of nucleocytoplasmic transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;IFI27;CDH1;GAS6
11799,GO:0044429,0.00369525626704767,0.99801489472643,32,919,mitochondrial part,CC,PDK4;GLDC;PMAIP1;MRPL14;MRPL16;HMGCS2;ACSF2;SLC25A53;ACADVL;ACSM5;REEP1;CPT2;HSD17B10;ETFB;RNASEL;ACAT1;TSFM;SARDH;VAMP1;SFXN1;HSD3B2;CPT1C;IFI27;DECR1;PUS1;LDHD;STAR;ECI1;CYP11A1;CYB5A;ACSL4;ETFDH
16797,GO:0072014,0.00372133875119256,0.999926355718246,2,5,proximal tubule development,BP,ACAT1;DLL1
13716,GO:0050867,0.00374669849836291,0.998592133550603,14,294,positive regulation of cell activation,BP,FADD;PNP;PYCARD;FGF10;PIK3R1;TICAM1;WNT5A;CLCF1;CDKN1A;CTGF;AKT1;PIK3CA;GAS6;EFNB2
16331,GO:0071216,0.00375086112887753,0.998866175078578,10,175,cellular response to biotic stimulus,BP,CCL20;PYCARD;TICAM1;WNT5A;BMP6;SHPK;AKT1;TFPI;STAR;PDE4B
8949,GO:0033135,0.00376228607661319,0.99904773101471,8,121,regulation of peptidyl-serine phosphorylation,BP,LIF;SPTBN4;WNT5A;AXIN1;AKT1;PIK3CA;GAS6;ARAF
18132,GO:0098727,0.0037731258584148,0.998945956247213,9,150,maintenance of cell number,BP,LIF;NOTCH1;WNT7A;SALL4;FZD7;CDH2;FGF10;BMP7;DLL1
14941,GO:0060420,0.00377563350728853,0.999419234605705,5,51,regulation of heart growth,BP,WNT2;NOTCH1;EDN1;RBP4;WT1
17796,GO:0097190,0.00381019133810323,0.998211612895443,22,565,apoptotic signaling pathway,BP,WNT4;PMAIP1;FADD;TRADD;ACVR1;ADORA1;PYCARD;G0S2;FGF10;PIK3R1;TICAM1;HRAS;BMP4;CDKN1A;NOL3;DEPTOR;CASP4;AKT1;IFI27;KITLG;INHBB;GDNF
5095,GO:0010907,0.003818529568186,0.999572009888073,4,32,positive regulation of glucose metabolic process,BP,ACTN3;PMAIP1;RGN;AKT1
14048,GO:0051385,0.00382271180452484,0.999572562139419,4,31,response to mineralocorticoid,BP,EDN1;CDKN1A;CTGF;STAR
15167,GO:0060745,0.00383048755202077,0.999923057964836,2,5,mammary gland branching involved in pregnancy,BP,WNT4;VDR
17412,GO:0090150,0.00383796447626401,0.998445119148434,16,359,establishment of protein localization to membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;PMAIP1;ADORA1;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
5868,GO:0016307,0.0038492528340898,0.999746580066969,3,16,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21;PIK3CA;PIK3CG
2628,GO:0005488,0.00385430422584995,0.997425937518865,302,13522,binding,MF,ITGA3;ITGA5;ARTN;CFB;TAGLN;EBP;PDK4;PECR;FHOD3;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;DPM3;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;RHBDL3;MRPL14;MRPL16;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;RABIF;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;RHPN1;ABCG1;PRKACB;MFGE8;CCL20;EBF1;BDH2;FLVCR2;SPTBN5;SPTBN4;PYCARD;G0S2;LAGE3;ACADVL;TTYH1;MPZL1;RRAS2;RAB39B;RAB39A;PRND;MGST2;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;MB21D2;HBEGF;LGALS4;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;SHPK;ESPN;HEXB;VAMP1;WNK4;FABP3;RND3;MSN;NOL3;NUDT6;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;ACCS;CPT1C;RRAD;TPD52;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;FAM46A;CYTIP;PTGES;KITLG;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;LDHD;MDP1;SPSB1;HPCAL1;RAB44;TLE1;STAR;CLDN1;CLDN2;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;GAS6;WBP1;SIN3B;PEPD;ACP5;GLA;HAPLN3;DTX4;ZCCHC12;CYP11A1;RPH3AL;MYH11;LZTS1;S100B;CLDN23;DHCR7;CYB5A;PTS;SHC4;RBMS3;HNF1A;DSC3;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;ACSL4;MYZAP;SLC1A3;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
13885,GO:0051128,0.00386605668857498,0.997521872645773,63,2195,regulation of cellular component organization,BP,ITGA3;FHOD3;LIF;WNT3;WNT4;ACTN2;RAB6C;NOTCH1;RAB27A;TF;PMAIP1;WNT7A;APOC1;TBC1D14;EDN1;MFGE8;SPTBN5;SPTBN4;PYCARD;CDH2;PIK3R1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;SESN2;RHOQ;RHOJ;NPR1;PSRC1;FGF8;SDC4;FAM110C;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;WT1;CDKN1A;DLL1;RAB20;ESPN;HEXB;MSN;NOL3;DDR1;CTGF;AKT1;RAB17;BCAR1;CLDN1;GAS6;LZTS1;S100B;HNF1A;SH3BP4;UNC119;PARVB;LINGO1;TMOD4
7223,GO:0030097,0.00388747108997463,0.99804869503993,26,712,hemopoiesis,BP,EBP;LIF;WNT4;NOTCH1;FADD;ZFPM1;PNP;FZD7;TYRO3;FSTL3;PIK3R1;WNT5A;JAM3;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;TMEM176A;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
8933,GO:0033093,0.00389630451114444,0.999921045541575,2,5,Weibel-Palade body,CC,RAB27A;EDN1
16974,GO:0072283,0.00394619949060545,0.999737874463393,3,16,metanephric renal vesicle morphogenesis,BP,LIF;BMP4;GDNF
3787,GO:0007386,0.00394664089906191,0.999919494441367,2,5,compartment pattern specification,BP,NOTCH1;DLL1
4267,GO:0008645,0.00396104224433,0.998885260525114,9,150,hexose transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;RNASEL;SLC2A14;AKT1;HNF1A
14628,GO:0055118,0.00399246166850635,0.999918073493631,2,5,negative regulation of cardiac muscle contraction,BP,ADORA1;PIK3CG
7887,GO:0031329,0.00400253286923148,0.998078868313575,23,606,regulation of cellular catabolic process,BP,APOC1;TBC1D14;PSMB10;RGN;PRR5L;PIK3R2;TICAM1;RALB;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;IDH1;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2
9950,GO:0035624,0.00400253513788881,0.999917759960523,2,5,receptor transactivation,BP,ADRA2B;ADRA2C
14750,GO:0060157,0.00402838822541069,0.99991695340992,2,5,urinary bladder development,BP,WNT5A;RBP4
21487,GO:2000826,0.00404350670698824,0.999539449605842,4,32,regulation of heart morphogenesis,BP,NOTCH1;ACVR1;BMP4;BMP2
12302,GO:0045687,0.0041068063993345,0.99953019255319,4,32,positive regulation of glial cell differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
15397,GO:0061156,0.00411000248436382,0.999914389554012,2,5,pulmonary artery morphogenesis,BP,STRA6;BMP4
1119,GO:0002520,0.0041152823866621,0.997869445314642,28,789,immune system development,BP,ARTN;EBP;LIF;WNT4;NOTCH1;FADD;ZFPM1;PNP;FZD7;TYRO3;FSTL3;FGF10;PIK3R1;WNT5A;JAM3;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;TMEM176A;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
16941,GO:0072223,0.00411616460815286,0.999914194888315,2,5,metanephric glomerular mesangium development,BP,PDGFB;WT1
7355,GO:0030278,0.00413105896933834,0.998733406116516,10,179,regulation of ossification,BP,WNT4;NOTCH1;WNT7B;ACVR1;WNT5A;BMP7;BMP6;BMP4;BMP2;NPPC
2992,GO:0006103,0.00415152979190037,0.999719178821671,3,16,2-oxoglutarate metabolic process,BP,PHYH;GHR;IDH1
5912,GO:0016416,0.00416203062009012,0.999912741178563,2,5,O-palmitoyltransferase activity,MF,CPT2;CPT1C
8788,GO:0032870,0.00416867762223113,0.997992202389899,23,610,cellular response to hormone stimulus,BP,PDK4;ACTN2;NOTCH1;EDN1;PRKACB;GHR;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;RNASEL;BMP7;BMP4;WT1;GJB2;AKT1;BCAR1;INHBB;STAR;PIK3CA;VDR;HEY1
3272,GO:0006549,0.00417841081862007,0.999912219979542,2,5,isoleucine metabolic process,BP,GHR;ACAT1
13288,GO:0048565,0.00419057079404587,0.998919186082996,8,125,digestive tract development,BP,NOTCH1;STRA6;ITGB4;FGF10;WNT5A;BMP4;CDKN1A;CLDN18
14942,GO:0060421,0.00419527297802307,0.999515973542367,4,33,positive regulation of heart growth,BP,WNT2;NOTCH1;EDN1;WT1
20659,GO:1905940,0.00419722961719809,0.999911619869927,2,5,negative regulation of gonad development,BP,WNT4;WT1
8193,GO:0031944,0.00421175602375978,0.999911155678264,2,5,negative regulation of glucocorticoid metabolic process,BP,DKK3;BMP2
8196,GO:0031947,0.00421175602375978,0.999911155678264,2,5,negative regulation of glucocorticoid biosynthetic process,BP,DKK3;BMP2
8421,GO:0032353,0.00421175602375978,0.999911155678264,2,5,negative regulation of hormone biosynthetic process,BP,DKK3;BMP2
17341,GO:0090032,0.00421175602375978,0.999911155678264,2,5,negative regulation of steroid hormone biosynthetic process,BP,DKK3;BMP2
10300,GO:0036293,0.00421334041143507,0.998333069507336,15,334,response to decreased oxygen levels,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;PSMB10;ANG;BMP7;BMP2;NOL3;CTGF;AKT1;NPPC;CLDN3;S100B
12322,GO:0045737,0.00421476166928991,0.999514309961775,4,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,FGF10;PDGFB;PSRC1;AKT1
9970,GO:0035655,0.0042384466775878,0.999910300598958,2,5,interleukin-18-mediated signaling pathway,BP,PDGFB;AKT1
14951,GO:0060431,0.00424052928906926,0.999910233760552,2,5,primary lung bud formation,BP,WNT2;WNT2B
14211,GO:0051693,0.00427449652339668,0.99950422968742,4,33,actin filament capping,BP,SPTBN5;SPTBN4;SPTB;TMOD4
15440,GO:0061302,0.00427568338021543,0.999909102958157,2,5,smooth muscle cell-matrix adhesion,BP,PLAU;DDR1
11499,GO:0043588,0.00428947292414968,0.998187553973955,17,398,skin development,BP,ITGA3;POU3F1;NOTCH1;ITGB4;DSC2;TRADD;KRT10;FGF10;WNT5A;DLL1;DSG3;PKP3;PKP1;CLDN1;DSC3;VDR;LAMA5
1429,GO:0003129,0.00429749157393682,0.999908399007785,2,5,heart induction,BP,BMP4;BMP2
5216,GO:0014060,0.00430308619125301,0.999908218117021,2,5,regulation of epinephrine secretion,BP,ADRA2B;ADRA2C
13150,GO:0048242,0.00430308619125301,0.999908218117021,2,5,epinephrine secretion,BP,ADRA2B;ADRA2C
15487,GO:0061384,0.00430585638267219,0.999499563520809,4,33,heart trabecula morphogenesis,BP,NOTCH1;RBP4;BMP7;HEY1
5590,GO:0015749,0.0043103242561915,0.998770808152034,9,152,monosaccharide transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;RNASEL;SLC2A14;AKT1;HNF1A
17383,GO:0090100,0.00434522276631364,0.998999950402347,7,99,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,NOTCH1;ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
4706,GO:0009991,0.00435289685833358,0.998106937970419,18,433,response to extracellular stimulus,BP,PDK4;WNT4;PMAIP1;DSC2;FADS1;FOXO4;RALB;NUAK2;BMP7;ACAT1;CDKN1A;AKT1;WNT2B;INHBB;STAR;GAS6;VDR;ACSL4
18952,GO:1901880,0.00435487137191561,0.999305772699805,5,53,negative regulation of protein depolymerization,BP,SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
18536,GO:1900182,0.00440751591581359,0.998853668914494,8,125,positive regulation of protein localization to nucleus,BP,LIF;PIK3R2;PIK3R1;SESN2;BMP6;BMP4;AKT1;CDH1
12183,GO:0045428,0.00441115057697174,0.999295414933506,5,52,regulation of nitric oxide biosynthetic process,BP,EDN1;RGN;TICAM1;AKT1;GLA
19254,GO:1902652,0.00441284982335985,0.99885232556093,8,124,secondary alcohol metabolic process,BP,EBP;APOC1;HMGCS2;ABCG1;ACADVL;STAR;CYP11A1;DHCR7
14862,GO:0060323,0.00441902864784315,0.999482642651615,4,33,head morphogenesis,BP,WNT3;STRA6;CRISPLD2;CLDN5
12332,GO:0045747,0.00443629727683616,0.999480049615661,4,33,positive regulation of Notch signaling pathway,BP,NOTCH1;FGF10;DLL1;JAG2
16066,GO:0070661,0.00446094710223312,0.998360855357707,13,268,leukocyte proliferation,BP,WNT4;FADD;PNP;PYCARD;FGF10;TICAM1;SDC4;CLCF1;BMP4;CDKN1A;MSN;KITLG;PIK3CG
4266,GO:0008643,0.00447683316880573,0.99861127003985,10,181,carbohydrate transport,BP,SLC45A4;EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;RNASEL;SLC2A14;AKT1;HNF1A
7183,GO:0030010,0.00448920023612213,0.998959914319976,7,101,establishment of cell polarity,BP,MARK4;WNT7A;FGF10;WNT5A;JAM3;MSN;AMOT
13307,GO:0048609,0.00451442598315732,0.997676239927499,27,755,multicellular organismal reproductive process,BP,ITGA3;LIF;WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;EDN1;TYRO3;RGN;FSTL3;JAM3;ANG;BMP4;WT1;SLC2A14;HEXB;GJB2;AKT1;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;CLDN11
18840,GO:1901575,0.00452128758838083,0.997171620956615,54,1816,organic substance catabolic process,BP,USE1;ACTN3;PHYH;GLDC;PMAIP1;APOC1;ADORA1;HSD17B11;PNP;BDH2;ACADVL;PSMB10;RGN;PRR5L;CPT2;PLA2G16;HSD17B10;ETFB;WNT5A;MAGEC2;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;PFKFB3;SDC4;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;MSN;NUDT7;CPT1C;PCBD1;AKT1;PKP3;PKP1;RAB12;IDH1;DECR1;PIK3CG;GLA;ECI1;DERA;ARAF;LYPLAL1;RNF144A;ETFDH;PDE4B
15466,GO:0061351,0.00456589440267503,0.998804925649121,8,127,neural precursor cell proliferation,BP,ARTN;WNT2;NOTCH1;WNT7A;LIMS2;CDH2;WNT5A;FGF8
724,GO:0001885,0.0045688051197225,0.999263379533085,5,53,endothelial cell development,BP,WNT7A;WNT7B;MSN;CLDN1;CLDN5
4674,GO:0009894,0.00459217551999588,0.997664660923957,26,723,regulation of catabolic process,BP,ACTN3;APOC1;TBC1D14;ADORA1;PSMB10;RGN;PRR5L;PIK3R2;TICAM1;RALB;WNT5A;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;IDH1;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2
15218,GO:0060840,0.00462800193164007,0.999074913212485,6,78,artery development,BP,NOTCH1;STRA6;FGF8;BMP4;HEY1;EFNB2
1391,GO:0003018,0.00467105344897618,0.998651442928382,9,152,vascular process in circulatory system,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
7815,GO:0031214,0.00471503593152597,0.998759548232887,8,126,biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2;GAS6
12441,GO:0045944,0.00474050725504038,0.997360021899696,34,1031,positive regulation of transcription from RNA polymerase II promoter,BP,LIF;WNT2;POU3F1;NOTCH1;FADD;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;RHOQ;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HEXB;AKT1;HNF1A;VDR;GDNF;FZD8;HEY1
18789,GO:1901380,0.00476837250452322,0.99965799693296,3,17,negative regulation of potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2
4849,GO:0010557,0.004775698654441,0.997082605226334,48,1587,positive regulation of macromolecule biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;CCL20;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;KITLG;CDH1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
3434,GO:0006766,0.00479714600361951,0.998734305464963,8,126,vitamin metabolic process,BP,FASN;SLC52A3;RGN;AOX1;ACP5;CYP11A1;CYB5A;VDR
3815,GO:0007492,0.00482015256310735,0.999028919741713,6,77,endoderm development,BP,ITGA5;NOTCH1;ITGB5;FGF8;BMP4;DUSP5
3842,GO:0007565,0.00485783240917552,0.998475224400369,10,182,female pregnancy,BP,ITGA3;LIF;ADRA2C;WNT4;DDR1;GJB2;AKT1;EPN1;VDR;ACSL4
13328,GO:0048644,0.00489177736636593,0.999010969882886,6,78,muscle organ morphogenesis,BP,LIF;WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
1418,GO:0003094,0.00494563963578775,0.999640593496992,3,17,glomerular filtration,BP,ADORA1;PDGFB;GAS6
3810,GO:0007435,0.00497803040843044,0.999395846687277,4,34,salivary gland morphogenesis,BP,FGF10;FGF8;BMP7;LAMA5
7796,GO:0031143,0.00500747945526229,0.999634467747137,3,17,pseudopodium,CC,ACTN3;ACTN2;MSN
2979,GO:0006084,0.00501484700557948,0.999390107880393,4,34,acetyl-CoA metabolic process,BP,PDK4;FASN;ACAT1;NUDT7
7976,GO:0031489,0.00503905890489471,0.999631328774998,3,17,myosin V binding,MF,RAB27A;RAB39B;RAB3D
19649,GO:1903530,0.00504770407552882,0.997529223237975,23,617,regulation of secretion by cell,BP,LIF;ADRA2B;ADRA2C;SYT5;NOTCH1;RAB27A;ADORA1;EDN1;PYCARD;RALB;WNT5A;RBP4;SDC4;ANG;BMP6;CHGA;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL;RAB3D;GDNF
799,GO:0001977,0.00506281556381691,0.999628962607602,3,17,renal system process involved in regulation of blood volume,BP,ADORA1;PDGFB;GAS6
10982,GO:0042693,0.00509383141066026,0.999625867274898,3,17,muscle cell fate commitment,BP,ACVR1;FGF10;WT1
14085,GO:0051447,0.00509925106186433,0.999625325689178,3,17,negative regulation of meiotic cell cycle,BP,LIF;PRKACB;NPPC
784,GO:0001961,0.00513077308503877,0.999371957921602,4,34,positive regulation of cytokine-mediated signaling pathway,BP,FADD;EDN1;WNT5A;GAS6
7463,GO:0030506,0.00522171798725846,0.99960737873372,3,19,ankyrin binding,MF,SPTBN4;SPTB;CDH1
7747,GO:0031076,0.00524759872634578,0.999352130859829,4,35,embryonic camera-type eye development,BP,STRA6;FGF10;WNT5A;BMP7
15325,GO:0061038,0.00525764449805592,0.99986481231142,2,6,uterus morphogenesis,BP,STRA6;WNT7A
8552,GO:0032504,0.00528920633388382,0.997243875057481,27,764,multicellular organism reproduction,BP,ITGA3;LIF;WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;EDN1;TYRO3;RGN;FSTL3;JAM3;ANG;BMP4;WT1;SLC2A14;HEXB;GJB2;AKT1;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;CLDN11
2820,GO:0005829,0.00532993893320056,0.996194165377987,118,4626,cytosol,CC,LIF;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;NOTCH1;MARK4;RAB27A;IFI30;PNMT;ZFYVE21;FASN;PMAIP1;MSRA;FBXO41;MRI1;FADD;TRADD;RABIF;NMT2;TBC1D14;GUCY1B3;HSD17B11;PHLDA1;PNP;RHPN1;PRKACB;BDH2;SPTBN5;SPTBN4;PYCARD;ACADVL;KRT10;RAB39A;MAPK12;PSMB10;LIMS2;RGN;GHR;PIK3R2;PIK3R1;TICAM1;PRKAR1B;PTPN7;NNMT;FOXO4;FRMPD1;PXK;PLA2G16;ETFB;HRAS;MAGEC2;PSTPIP2;KHK;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;PSRC1;RNASEL;SPTB;LGALS4;NMI;WT1;CDKN1A;AOX1;VAMP1;CMBL;WNK4;FABP3;MSN;NOL3;DSG3;CTGF;GJB2;GJB6;PCBD1;MDH1;CASP4;AKT1;RAB12;CYTIP;IDH1;DECR1;EPN1;MYO7A;BCAR1;SPSB1;TLE1;STAR;PIK3CA;PIK3CG;RAB11FIP1;ACP5;DTX4;MYH11;DERA;DHCR7;CYB5A;PTS;GPSM1;AMOT;ARAF;UNC119;RAB38;DOK1;LYPLAL1;FAM110B;ACTA2;PARVB;PDE4B
7768,GO:0031100,0.00534278679505743,0.998900509974372,6,77,animal organ regeneration,BP,NOTCH1;RGN;NNMT;CDKN1A;CLDN1;GAS6
21417,GO:2000727,0.00534665679612095,0.999597290291456,3,18,positive regulation of cardiac muscle cell differentiation,BP,EDN1;BMP4;EFNB2
14257,GO:0051785,0.00536155347502019,0.99910037721757,5,55,positive regulation of nuclear division,BP,WNT4;EDN1;PDGFB;WNT5A;FGF8
9958,GO:0035637,0.00538927957840555,0.998281393845224,10,190,multicellular organismal signaling,BP,DSC2;CASQ2;KCNK6;SPTBN4;KCNH2;JAM3;FXYD1;NPR1;NPPC;KCND1
13838,GO:0051051,0.00541211073514383,0.997595047730133,18,442,negative regulation of transport,BP,LIF;ADRA2B;ADRA2C;ACTN2;NOTCH1;APOC1;ADORA1;CASQ2;EDN1;KCNH2;BMP7;WNK4;CHGA;AKT1;INHBB;RAB11FIP1;GAS6;UNC119
11289,GO:0043244,0.00547277086789082,0.998866969684281,6,79,regulation of protein complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
8618,GO:0032609,0.00547602219991193,0.998684023266846,7,101,interferon-gamma production,BP,FADD;ZFPM1;PYCARD;HRAS;WNT5A;GAS6;PDE4B
6535,GO:0019217,0.00549191957233604,0.998862762582538,6,78,regulation of fatty acid metabolic process,BP,PDK4;APOC1;ACADVL;RGN;FABP3;AKT1
11287,GO:0043242,0.00551644706181037,0.999067226258541,5,56,negative regulation of protein complex disassembly,BP,SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
3937,GO:0008104,0.0055235414896998,0.996336666028297,69,2482,protein localization,BP,ITGA3;LIF;ADRA2C;WNT4;USE1;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;WNT7A;MRAP;RABIF;TBC1D14;ADORA1;RAB40B;RAB40A;PNP;ABCG1;SPTBN4;PYCARD;RAB39B;RAB39A;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SNX18;SESN2;RBP4;RHOQ;RHOB;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;WNK4;MSN;NOL3;AKT1;IFI27;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;AMOT;LAMA5;SH3BP4;UNC119;RAB38;RAB3D;CNIH4;CLDN18
16003,GO:0070542,0.00553337846087484,0.998852390307089,6,78,response to fatty acid,BP,PDK4;EDN1;FABP3;CTGF;AKT1;CLDN1
20467,GO:1905331,0.00556287514072078,0.999574968482353,3,18,negative regulation of morphogenesis of an epithelium,BP,WNT5A;BMP7;BMP4
14939,GO:0060416,0.00559646923794491,0.999296321966196,4,35,response to growth hormone,BP,GHR;PIK3R1;AKT1;STAR
1571,GO:0003348,0.00561847322835441,0.999850484194017,2,6,cardiac endothelial cell differentiation,BP,NOTCH1;ACVR1
15265,GO:0060956,0.00561847322835441,0.999850484194017,2,6,endocardial cell differentiation,BP,NOTCH1;ACVR1
6242,GO:0017046,0.00563532235086337,0.999290042265131,4,35,peptide hormone binding,MF,ACVR1;GHR;PIK3R1;NPR1
11758,GO:0044346,0.00564251556710898,0.999566664991616,3,18,fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
16429,GO:0071371,0.00564934013430102,0.999565951424641,3,18,cellular response to gonadotropin stimulus,BP,NOTCH1;WT1;STAR
6582,GO:0019362,0.0056762865742782,0.99845844620773,8,129,pyridine nucleotide metabolic process,BP,ACTN3;PNP;NNMT;PFKFB3;SHPK;MDH1;IDH1;DERA
12673,GO:0046496,0.0056762865742782,0.99845844620773,8,129,nicotinamide nucleotide metabolic process,BP,ACTN3;PNP;NNMT;PFKFB3;SHPK;MDH1;IDH1;DERA
10630,GO:0042058,0.00567674710382806,0.998816393320961,6,78,regulation of epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1;EPN1;DOK1
3551,GO:0006950,0.00569605107678561,0.996036544603974,93,3506,response to stress,BP,ITGA5;CFB;PDK4;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;IFI30;ITGB4;PMAIP1;GADD45A;MSRA;FADD;DSC2;SERPINA5;WNT7A;WNT7B;ZFPM1;SLC52A3;ACVR1;GUCY1B3;ADORA1;EDN1;PLAU;PRKACB;CCL20;PYCARD;ACADVL;MAPK12;FZD7;TYRO3;PSMB10;RGN;FADS1;PRR5L;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;PXK;HRAS;WNT5B;WNT5A;JAM3;SESN2;AXIN1;RHOB;NUAK2;RNASEL;FGF8;SDC4;ANG;HBEGF;NMI;BMP7;BMP6;BMP2;ACAT1;CDKN1A;AOX1;SHPK;CHGA;NOL3;DDR1;CTGF;GJB2;CASP4;AKT1;IFI27;PON2;WNT2B;FAM46A;PTGES;IDH1;NPPC;INHBB;TFPI;STAR;CLDN1;CLDN3;PIK3CA;PIK3CG;GAS6;S100B;TSPAN2;SLC1A3;FZD8;ETFDH
14600,GO:0055080,0.00569748313594908,0.997182063996645,23,624,cation homeostasis,BP,PDK4;CDH23;TF;SLC31A2;ADORA1;CASQ2;EDN1;BDH2;RAB39A;PRND;LPAR2;RGN;KCNH2;NPR1;BMP6;RAB20;HEXB;SFXN1;NOL3;PIK3CG;VDR;RAB38;CLDN16
3671,GO:0007163,0.0057099677022214,0.998297178234796,9,161,establishment or maintenance of cell polarity,BP,MARK4;WNT7A;WNT7B;FGF10;WNT5A;JAM3;MSN;AMOT;PARVB
15177,GO:0060760,0.00572128134601814,0.999276104013611,4,35,positive regulation of response to cytokine stimulus,BP,FADD;EDN1;WNT5A;GAS6
5133,GO:0010959,0.0057247267540952,0.997739919351847,14,313,regulation of metal ion transport,BP,ACTN2;SLC31A2;ADORA1;CASQ2;SPTBN4;TSPAN13;RGN;PDGFB;KCNH2;FXYD1;WNK4;AKT1;PIK3CG;PDE4B
20319,GO:1904948,0.00573868920827129,0.99955657994629,3,18,midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A
13063,GO:0048009,0.00575057911395904,0.999269845020891,4,36,insulin-like growth factor receptor signaling pathway,BP,GHR;PIK3R1;BMP2;AKT1
2930,GO:0006006,0.00576842130749966,0.998143013668938,10,187,glucose metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;SESN2;RBP4;PFKFB3;MDH1;AKT1;PIK3CA
3719,GO:0007219,0.00580836721946371,0.998263758053934,9,159,Notch signaling pathway,BP,NOTCH1;FGF10;BMP7;BMP2;DLL1;JAG2;EPN1;DTX4;HEY1
14922,GO:0060395,0.00582469387007899,0.999002261653978,5,56,SMAD protein signal transduction,BP,BMP7;BMP6;BMP4;BMP2;INHBB
13714,GO:0050865,0.00585322056933673,0.997315300439141,19,479,regulation of cell activation,BP,FADD;PNP;PYCARD;TYRO3;FGF10;PIK3R1;TICAM1;PDGFB;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;SHPK;CTGF;AKT1;PIK3CA;GAS6;EFNB2
12461,GO:0045988,0.0058773072381694,0.99983990302293,2,6,negative regulation of striated muscle contraction,BP,ADORA1;PIK3CG
3753,GO:0007281,0.00587784427095875,0.997979129516846,11,217,germ cell development,BP,WNT4;DHH;ACVR1;JAM3;ANG;BMP4;WT1;HEXB;AKT1;NPPC;INHBB
7351,GO:0030274,0.00592941977232141,0.999837742569274,2,6,LIM domain binding,MF,ACTN2;RPH3AL
13316,GO:0048631,0.00596127108122279,0.999836417172841,2,6,regulation of skeletal muscle tissue growth,BP,ACTN3;DLL1
4679,GO:0009912,0.00596743319941112,0.999836160324707,2,6,auditory receptor cell fate commitment,BP,NOTCH1;JAG2
14726,GO:0060120,0.00596743319941112,0.999836160324707,2,6,inner ear receptor cell fate commitment,BP,NOTCH1;JAG2
13179,GO:0048286,0.00596995327065611,0.999233872110694,4,36,lung alveolus development,BP,LIF;STRA6;FGF10;BMP4
17439,GO:0090185,0.00597712927567653,0.999531307726597,3,18,negative regulation of kidney development,BP,BMP7;BMP4;WT1
1466,GO:0003176,0.00601874923698264,0.999834015976401,2,6,aortic valve development,BP,NOTCH1;BMP4
1469,GO:0003180,0.00601874923698264,0.999834015976401,2,6,aortic valve morphogenesis,BP,NOTCH1;BMP4
12885,GO:0046935,0.0060208344971899,0.999833928635718,2,6,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R2;PIK3R1
10444,GO:0038031,0.00607424901360476,0.999831685971227,2,6,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7;WNT5A
16975,GO:0072284,0.00610320348685054,0.999830465944996,2,6,metanephric S-shaped body morphogenesis,BP,BMP4;WT1
10904,GO:0042552,0.00619031394061113,0.99847526960231,7,107,myelination,BP,POU3F1;DHH;JAM3;HEXB;AKT1;NAB2;TSPAN2
19739,GO:1903707,0.00619925666254447,0.998290443217002,8,131,negative regulation of hemopoiesis,BP,NOTCH1;ZFPM1;FSTL3;PIK3R1;BMP4;DLL1;TMEM176A;CLDN18
5902,GO:0016406,0.00620788480766692,0.999826029737243,2,6,carnitine O-acyltransferase activity,MF,CPT2;CPT1C
15217,GO:0060839,0.00622507573467328,0.999825297433189,2,6,endothelial cell fate commitment,BP,ACVR1;DLL1
15139,GO:0060710,0.00623378585270008,0.99982492599098,2,6,chorio-allantoic fusion,BP,WNT7B;BMP7
11796,GO:0044425,0.00624026709368489,0.995424708290128,152,6187,membrane part,CC,ITGA3;ITGA5;EBP;TMEM160;TMEM163;TMEM164;ADRA2B;ADRA2C;SYT5;USE1;TSPAN15;TSPAN17;ALG5;NOTCH1;RAB27A;CDH23;DPM3;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;RHBDL3;SLC31A2;SLC45A4;FADD;DSC2;SERPINA5;P2RY14;HSD17B3;MRAP;TRADD;SLC52A3;TMEM206;ACVR1;NMT2;PXMP2;PXMP4;ADORA1;CASQ2;EXTL1;ABCG1;KCNK6;MFGE8;FLVCR2;SPTBN5;CCDC51;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;PRND;MGST2;FZD7;TYRO3;LPAR2;CDH2;FADS1;GHR;HRCT1;ASAH2;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PTPN7;PLA2G16;JAM3;SNX18;AXIN1;FXYD1;RHOQ;NPR1;TMEM223;CYP17A1;FGF8;SDC4;SPTB;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;DRP2;SLC2A14;VAMP1;SFXN1;GRIA3;MSN;HSD3B2;DDR1;DSG3;GJB1;GJB2;GJB6;CPT1C;CASP4;IFI27;RAB17;TMEM176A;PTGES;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;GJA3;TPBGL;TMEM98;TFPI;STAR;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;ACP5;PRRT1;LZTS1;CLDN23;DHCR7;CYB5A;SHC4;SLC18B1;DSC3;GPSM1;AMOT;SH3BP4;KCND1;TSPAN2;ACSL4;MYZAP;SLC1A3;FZD8;CNIH4;ELOVL6;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;LINGO1;ETFDH;PDE4B
6234,GO:0017022,0.00624552229945453,0.998911223522622,5,57,myosin binding,MF,RAB27A;SPTBN5;PYCARD;RAB39B;RAB3D
19356,GO:1902936,0.00624744299872035,0.998669855373916,6,80,phosphatidylinositol bisphosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;AKT1;SNX21
7224,GO:0030098,0.00625282607696228,0.99750590661144,14,314,lymphocyte differentiation,BP,WNT4;FADD;ZFPM1;PNP;FZD7;TYRO3;PIK3R1;CLCF1;BMP4;DLL1;TPD52;JAG2;GAS6;FZD8
14043,GO:0051379,0.00626619818025533,0.999823541374246,2,6,epinephrine binding,MF,ADRA2B;ADRA2C
16842,GO:0072089,0.00626803115426179,0.998452996720135,7,106,stem cell proliferation,BP,ARTN;WNT3;NOTCH1;WNT7B;WNT5A;WNT2B;KITLG
15127,GO:0060696,0.00627338464120887,0.999823233866085,2,6,regulation of phospholipid catabolic process,BP,APOC1;IDH1
2344,GO:0004936,0.00627735264358854,0.999823063996157,2,6,alpha-adrenergic receptor activity,MF,ADRA2B;ADRA2C
8419,GO:0032351,0.00627737465704332,0.999823063053605,2,6,negative regulation of hormone metabolic process,BP,DKK3;BMP2
14947,GO:0060426,0.00628278113271151,0.999822831511431,2,6,lung vasculature development,BP,LIF;STRA6
16416,GO:0071351,0.00631041456540992,0.999821646423825,2,6,cellular response to interleukin-18,BP,PDGFB;AKT1
17101,GO:0072559,0.00631264154821733,0.999821550798403,2,6,NLRP3 inflammasome complex,CC,PYCARD;CASP4
8719,GO:0032768,0.00631672488490004,0.998896803257536,5,56,regulation of monooxygenase activity,BP,AKT1;GLA;PTS;VDR;GDNF
15447,GO:0061312,0.00632676524020068,0.999820943921902,2,6,BMP signaling pathway involved in heart development,BP,ACVR1;BMP4
18833,GO:1901565,0.00636040171892349,0.997365637488177,15,346,organonitrogen compound catabolic process,BP,GLDC;APOC1;PNP;HSD17B10;SDC4;ACAT1;IDUA;AOX1;SARDH;HEXB;NUDT7;PCBD1;GLA;DERA;PDE4B
8580,GO:0032555,0.00636936483796932,0.995974011061189,52,1791,purine ribonucleotide binding,MF,PDK4;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;ACSF2;RAB40B;RAB40A;ABCG1;PRKACB;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;PKN3;RAB20;SHPK;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
13149,GO:0048241,0.00637248723568857,0.999818974422593,2,6,epinephrine transport,BP,ADRA2B;ADRA2C
17326,GO:0089720,0.00637720292340187,0.999818770867835,2,6,caspase binding,MF,FADD;NOL3
7331,GO:0030239,0.00638834590905977,0.998878390522656,5,59,myofibril assembly,BP,FHOD3;ACTN2;CASQ2;EDN1;MYH11
4220,GO:0008543,0.00643642007138795,0.99840356852259,7,106,fibroblast growth factor receptor signaling pathway,BP,WNT4;FGF18;FGF10;FGF17;WNT5A;FGF8;CTGF
21669,GO:2001273,0.0064718548403477,0.999474139883296,3,19,regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1;RNASEL
2661,GO:0005546,0.0064854255793049,0.998859149403957,5,57,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;SNX21
6756,GO:0019898,0.00651026723722854,0.997605633717567,12,254,extrinsic component of membrane,CC,TF;NMT2;MFGE8;CDH2;PIK3R2;PIK3R1;SNX18;MSN;CDH1;PIK3CA;PIK3CG;MYZAP
2791,GO:0005778,0.0065246928260391,0.998850579788437,5,57,peroxisomal membrane,CC,PECR;PXMP2;PXMP4;PLA2G16;ACSL4
8174,GO:0031903,0.0065246928260391,0.998850579788437,5,57,microbody membrane,CC,PECR;PXMP2;PXMP4;PLA2G16;ACSL4
11756,GO:0044344,0.00653291156250098,0.998181597688661,8,133,cellular response to fibroblast growth factor stimulus,BP,WNT4;FGF18;FGF10;FGF17;WNT5A;FGF8;CTGF;STAR
4234,GO:0008584,0.00654872914571277,0.998176446480966,8,133,male gonad development,BP,WNT4;DHH;FSTL3;WNT5A;WT1;WNT2B;KITLG;STAR
12703,GO:0046546,0.00654872914571277,0.998176446480966,8,133,development of primary male sexual characteristics,BP,WNT4;DHH;FSTL3;WNT5A;WT1;WNT2B;KITLG;STAR
7322,GO:0030225,0.00660379266744993,0.999127776527161,4,36,macrophage differentiation,BP,LIF;FADD;BMP4;TSPAN2
17377,GO:0090090,0.0066061107754696,0.997984666358616,9,161,negative regulation of canonical Wnt signaling pathway,BP,WNT4;NOTCH1;DKK3;PSMB10;CDH2;WNT5B;WNT5A;AXIN1;BMP2
14568,GO:0055013,0.00660785820917464,0.998830419807358,5,59,cardiac muscle cell development,BP,FHOD3;ACTN2;EDN1;BMP4;MYH11
17767,GO:0097150,0.00666484719108316,0.999449359775951,3,20,neuronal stem cell population maintenance,BP,NOTCH1;CDH2;DLL1
8373,GO:0032272,0.00672807591177407,0.998804966279608,5,58,negative regulation of protein polymerization,BP,FHOD3;SPTBN5;SPTBN4;SPTB;TMOD4
2452,GO:0005112,0.00687788737959271,0.999425234034284,3,20,Notch binding,MF,NOTCH1;DLL1;JAG2
40,GO:0000079,0.0069697353697978,0.998481015691175,6,81,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,GADD45A;FGF10;PDGFB;PSRC1;CDKN1A;AKT1
14631,GO:0055123,0.00698605681410494,0.998031989473708,8,136,digestive system development,BP,NOTCH1;STRA6;ITGB4;FGF10;WNT5A;BMP4;CDKN1A;CLDN18
7658,GO:0030900,0.00703240946648939,0.997052732718621,15,360,forebrain development,BP,WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;FGF8;BMP4;BMP2;WNT2B;CDH1
7102,GO:0022412,0.00707074956859943,0.997371590561994,12,254,cellular process involved in reproduction in multicellular organism,BP,WNT4;DHH;SERPINA5;ACVR1;JAM3;ANG;BMP4;WT1;HEXB;AKT1;NPPC;INHBB
16070,GO:0070665,0.00708065901699784,0.998001949722896,8,133,positive regulation of leukocyte proliferation,BP,FADD;PNP;PYCARD;FGF10;TICAM1;CLCF1;CDKN1A;KITLG
16544,GO:0071542,0.00708865329064933,0.999042719183286,4,37,dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A;FGF8
8230,GO:0032006,0.0071146233310333,0.998441302227257,6,83,regulation of TOR signaling,BP,SESN2;DEPTOR;PIK3CA;GAS6;ARAF;SH3BP4
7285,GO:0030178,0.00716761097434114,0.997616937372898,10,193,negative regulation of Wnt signaling pathway,BP,WNT4;NOTCH1;DKK3;PSMB10;CDH2;WNT5B;WNT5A;AXIN1;BMP2;TLE1
16946,GO:0072234,0.0072009117905306,0.999388122096196,3,20,metanephric nephron tubule development,BP,LIF;WNT7B;ACAT1
10751,GO:0042304,0.00722825482804949,0.999018392466984,4,37,regulation of fatty acid biosynthetic process,BP,PDK4;APOC1;ACADVL;RGN
2692,GO:0005605,0.00729642733811775,0.999373679548718,3,21,basal lamina,CC,ANG;LAMA1;LAMA5
12757,GO:0046651,0.00733126258008124,0.997262113012563,12,253,lymphocyte proliferation,BP,WNT4;FADD;PNP;PYCARD;FGF10;TICAM1;SDC4;CLCF1;BMP4;CDKN1A;MSN;PIK3CG
6260,GO:0017076,0.00734011577294325,0.995323827054177,52,1804,purine nucleotide binding,MF,PDK4;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;ACSF2;RAB40B;RAB40A;ABCG1;PRKACB;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;PKN3;RAB20;SHPK;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
18154,GO:0098771,0.00734299308770269,0.996287301332693,23,638,inorganic ion homeostasis,BP,PDK4;CDH23;TF;SLC31A2;ADORA1;CASQ2;EDN1;BDH2;RAB39A;PRND;LPAR2;RGN;KCNH2;NPR1;BMP6;RAB20;HEXB;SFXN1;NOL3;PIK3CG;VDR;RAB38;CLDN16
9770,GO:0035315,0.00735893136474843,0.998993681379196,4,38,hair cell differentiation,BP,NOTCH1;DLL1;JAG2;MYO7A
3809,GO:0007431,0.00739743557392241,0.998986899491187,4,38,salivary gland development,BP,FGF10;FGF8;BMP7;LAMA5
11176,GO:0043068,0.00745954320053999,0.996351286499289,21,566,positive regulation of programmed cell death,BP,NOTCH1;MARK4;PMAIP1;GADD45A;FADD;TRADD;PYCARD;G0S2;PIK3R2;WNT5A;RHOB;BMP7;BMP4;BMP2;CDKN1A;CTGF;AKT1;IFI27;INHBB;S100B;VDR
10499,GO:0038128,0.00746132746998711,0.998975622896198,4,38,ERBB2 signaling pathway,BP,PIK3R1;HRAS;HBEGF;PIK3CA
1216,GO:0002696,0.00748864603407694,0.997066430342577,13,286,positive regulation of leukocyte activation,BP,FADD;PNP;PYCARD;FGF10;PIK3R1;TICAM1;WNT5A;CLCF1;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
12242,GO:0045606,0.00753366659136776,0.999349238947025,3,20,positive regulation of epidermal cell differentiation,BP,NOTCH1;BMP4;VDR
15078,GO:0060602,0.00758974240358695,0.999342622317948,3,20,branch elongation of an epithelium,BP,FGF10;WNT5A;BMP4
11922,GO:0044802,0.00759079974364057,0.996034436101197,25,717,single-organism membrane organization,BP,ITGA3;SYT5;WNT4;ACTN2;TSPAN15;PMAIP1;SERPINA5;TBC1D14;RAB40B;RAB40A;SPTBN4;RAB39A;CDH2;PIK3R1;REEP1;RHOQ;RAB20;VAMP1;NOL3;AKT1;PKP3;CDH1;GAS6;LAMA5;GDNF
12366,GO:0045822,0.00760877736786652,0.99934037214469,3,20,negative regulation of heart contraction,BP,ADORA1;SPTBN4;PIK3CG
12431,GO:0045932,0.00762750755944582,0.999338155948707,3,20,negative regulation of muscle contraction,BP,ADRA2C;ADORA1;PIK3CG
646,GO:0001776,0.00762796300601512,0.998304187388568,6,83,leukocyte homeostasis,BP,PMAIP1;FADD;JAM3;AKT1;KITLG;PDE4B
3206,GO:0006464,0.00762916367550223,0.994596562877046,97,3744,cellular protein modification process,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;ALG5;MARK4;DPM3;GADD45A;MSRA;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EXTL1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;KRT10;PRND;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;ETFB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;DEPTOR;CTGF;AKT1;NRTN;KITLG;INHBB;MDP1;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;FZD8;DUSP5;RNF144A;PIM2
10278,GO:0036211,0.00762916367550223,0.994596562877046,97,3744,protein modification process,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;ALG5;MARK4;DPM3;GADD45A;MSRA;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EXTL1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;KRT10;PRND;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;ETFB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;DEPTOR;CTGF;AKT1;NRTN;KITLG;INHBB;MDP1;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;FZD8;DUSP5;RNF144A;PIM2
8578,GO:0032553,0.0076447258020353,0.995118701496075,52,1808,ribonucleotide binding,MF,PDK4;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;ACSF2;RAB40B;RAB40A;ABCG1;PRKACB;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;PKN3;RAB20;SHPK;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
17145,GO:0072657,0.0076628462206153,0.996391349499613,19,493,protein localization to membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;PMAIP1;ADORA1;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5;RAB38
9642,GO:0035005,0.0077418329287801,0.999743265344246,2,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3CA;PIK3CG
12782,GO:0046697,0.00776034443266982,0.999322380290517,3,20,decidualization,BP,LIF;GJB2;VDR
8840,GO:0032943,0.00778344880015826,0.997070101535865,12,255,mononuclear cell proliferation,BP,WNT4;FADD;PNP;PYCARD;FGF10;TICAM1;SDC4;CLCF1;BMP4;CDKN1A;MSN;PIK3CG
16469,GO:0071425,0.00782439028312222,0.999314738028043,3,20,hematopoietic stem cell proliferation,BP,WNT5A;WNT2B;KITLG
8062,GO:0031659,0.00783231583588187,0.999738688647588,2,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,FGF10;AKT1
4015,GO:0008217,0.00786876138776109,0.997531074242042,9,165,regulation of blood pressure,BP,ADORA1;EDN1;KCNK6;PDGFB;NPR1;DLL1;CHGA;GAS6;ACTA2
12659,GO:0046474,0.00787014319755691,0.997181395987604,11,227,glycerophospholipid biosynthetic process,BP,DPM3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;FABP3;PIK3CA;PIK3CG
3435,GO:0006767,0.00787361857845023,0.998237067505702,6,84,water-soluble vitamin metabolic process,BP,FASN;SLC52A3;RGN;AOX1;ACP5;CYB5A
14563,GO:0055008,0.00790049766712306,0.998536791206399,5,62,cardiac muscle tissue morphogenesis,BP,WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
15144,GO:0060716,0.0079252862843536,0.999302651202925,3,20,labyrinthine layer blood vessel development,BP,WNT2;AKT1;HEY1
19032,GO:1902106,0.00795817971018972,0.998214113802024,6,84,negative regulation of leukocyte differentiation,BP,ZFPM1;FSTL3;PIK3R1;BMP4;TMEM176A;CLDN18
11814,GO:0044449,0.00796372925352721,0.997308219315726,10,203,contractile fiber part,CC,FHOD3;ACTN2;CASQ2;SDC4;MYH11;MYZAP;ACTA2;PARVB;PDE4B;TMOD4
1264,GO:0002761,0.00797653832155827,0.997937961844057,7,110,regulation of myeloid leukocyte differentiation,BP,LIF;FADD;ZFPM1;FSTL3;PIK3R1;KITLG;CLDN18
11736,GO:0044321,0.0079866098224238,0.999295276766786,3,20,response to leptin,BP,EDN1;INHBB;STAR
6666,GO:0019682,0.00807187313285324,0.999284988259402,3,20,glyceraldehyde-3-phosphate metabolic process,BP,KHK;SHPK;DERA
8828,GO:0032924,0.00809191104379701,0.998860882849495,4,39,activin receptor signaling pathway,BP,ACVR1;FSTL3;FGF10;INHBB
13776,GO:0050957,0.00811992520282401,0.999723955861414,2,7,equilibrioception,BP,CDH23;MYO7A
12072,GO:0045184,0.00815703428428572,0.994657314635032,58,2049,establishment of protein localization,BP,ITGA3;ADRA2C;WNT4;USE1;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;RABIF;TBC1D14;ADORA1;RAB40B;RAB40A;PNP;ABCG1;SPTBN4;PYCARD;RAB39B;RAB39A;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;REEP1;WNT5A;SNX18;RBP4;RHOQ;RHOB;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;NOL3;AKT1;IFI27;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;LAMA5;UNC119;RAB38;RAB3D;CNIH4
14950,GO:0060430,0.00820252361396315,0.999719673100984,2,7,lung saccule development,BP,STRA6;FGF10
12590,GO:0046324,0.00821729892652541,0.998464699587294,5,61,regulation of glucose import,BP,PIK3R2;PIK3R1;RHOQ;RNASEL;AKT1
16728,GO:0071875,0.008271243423664,0.99925681338105,3,21,adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
19174,GO:1902473,0.0082767379696523,0.999715805555328,2,7,regulation of protein localization to synapse,BP,WNT7A;WNT5A
19175,GO:1902474,0.0082767379696523,0.999715805555328,2,7,positive regulation of protein localization to synapse,BP,WNT7A;WNT5A
578,GO:0001666,0.0082808051025738,0.996584246486153,14,326,response to hypoxia,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;PSMB10;ANG;BMP7;BMP2;NOL3;AKT1;NPPC;CLDN3;S100B
15070,GO:0060592,0.00830015681559775,0.999714581305766,2,7,mammary gland formation,BP,FGF10;BMP4
19905,GO:1904029,0.0083035583512002,0.99811980782242,6,84,regulation of cyclin-dependent protein kinase activity,BP,GADD45A;FGF10;PDGFB;PSRC1;CDKN1A;AKT1
18960,GO:1901897,0.00831796718905704,0.999713649022121,2,7,regulation of relaxation of cardiac muscle,BP,CHGA;PDE4B
15081,GO:0060606,0.00831914690961834,0.99811393825946,6,86,tube closure,BP,SALL4;PRKACB;FGF10;WNT5A;SDC4;BMP4
15119,GO:0060687,0.00832186923890493,0.999713444628275,2,7,regulation of branching involved in prostate gland morphogenesis,BP,BMP7;BMP4
3511,GO:0006887,0.00833444944931488,0.995444855831742,28,833,exocytosis,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;PLAU;RAB40B;RAB40A;PNP;PYCARD;SYCN;PDGFB;RALB;SDC4;HEXB;VAMP1;CHGA;PKP1;IDH1;RAB44;PIK3CG;RAB11FIP1;GAS6;GLA;RPH3AL;DERA;RAB3D
12243,GO:0045607,0.00834265267252104,0.999712355114367,2,7,regulation of auditory receptor cell differentiation,BP,NOTCH1;DLL1
12261,GO:0045631,0.00834265267252104,0.999712355114367,2,7,regulation of mechanoreceptor differentiation,BP,NOTCH1;DLL1
21527,GO:2000980,0.00834265267252104,0.999712355114367,2,7,regulation of inner ear receptor cell differentiation,BP,NOTCH1;DLL1
9643,GO:0035014,0.00835108792191118,0.999711912509828,2,7,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R2;PIK3R1
13305,GO:0048599,0.00838360179773339,0.998807709282246,4,39,oocyte development,BP,WNT4;ANG;NPPC;INHBB
3437,GO:0006771,0.00842249567169346,0.999708156219262,2,7,riboflavin metabolic process,BP,SLC52A3;ACP5
18318,GO:0099503,0.00843316464497674,0.995287320970777,30,905,secretory vesicle,CC,TMEM163;SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;SERPINA5;EDN1;PLAU;RAB40B;RAB40A;PNP;PYCARD;SYCN;FSTL3;PDGFB;HEXB;VAMP1;CHGA;PKP1;IDH1;NPPC;RAB44;GAS6;GLA;RPH3AL;DERA;RAB3D;PDE4B
16675,GO:0071774,0.00844247552658884,0.997541893453093,8,139,response to fibroblast growth factor,BP,WNT4;FGF18;FGF10;FGF17;WNT5A;FGF8;CTGF;STAR
17577,GO:0090385,0.00844755353778636,0.999706834084046,2,7,phagosome-lysosome fusion,BP,RAB39A;RAB20
7193,GO:0030027,0.00852751010569793,0.997287537123368,9,172,lamellipodium,CC,CDH2;PLEKHH2;KITLG;CDH1;BCAR1;PIK3CA;AMOT;ACTA2;PARVB
12082,GO:0045198,0.00853850874156937,0.999702017557605,2,7,establishment of epithelial cell apical/basal polarity,BP,WNT5A;MSN
17868,GO:0097342,0.00856368313276774,0.999700679631771,2,7,ripoptosome,CC,FADD;TICAM1
7633,GO:0030868,0.00856656525615914,0.999700526324584,2,7,smooth endoplasmic reticulum membrane,CC,TTYH1;HSD3B2
17909,GO:0097425,0.00856656525615914,0.999700526324584,2,7,smooth endoplasmic reticulum part,CC,TTYH1;HSD3B2
2892,GO:0005952,0.0085770572494248,0.999699967999206,2,7,cAMP-dependent protein kinase complex,CC,PRKACB;PRKAR1B
8922,GO:0033080,0.00860631525538884,0.999698409141295,2,7,immature T cell proliferation in thymus,BP,WNT4;BMP4
14255,GO:0051783,0.00862188274811922,0.997253420009101,9,170,regulation of nuclear division,BP,LIF;WNT4;EDN1;PDGFB;WNT5A;PSRC1;FGF8;BMP7;BMP4
19752,GO:1903726,0.00862200539698593,0.999697572018086,2,7,negative regulation of phospholipid metabolic process,BP,APOC1;PDGFB
14969,GO:0060449,0.00863048315557301,0.999697119364544,2,7,bud elongation involved in lung branching,BP,FGF10;BMP4
11956,GO:0044877,0.00863524962395915,0.99521487627348,29,880,macromolecular complex binding,MF,ITGA3;ITGA5;TAGLN;ACTN3;ACTN2;FADD;TRADD;ACVR1;ADORA1;MFGE8;FSTL3;PIK3R1;PDGFB;JAM3;RNASEL;SPTB;MB21D2;CDKN1A;HMGN5;ESPN;DDR1;CTGF;PKP1;MYO7A;MYH11;LAMA5;RAB38;DOK1;TMOD4
11774,GO:0044381,0.0086679666979302,0.999207720667802,3,21,glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1;RNASEL
14108,GO:0051494,0.00869694499940631,0.99771282881321,7,113,negative regulation of cytoskeleton organization,BP,FHOD3;SPTBN5;SPTBN4;PLEKHH2;SPTB;ESPN;TMOD4
522,GO:0001561,0.00870526595523048,0.999693116291976,2,7,fatty acid alpha-oxidation,BP,PHYH;HACL1
4937,GO:0010700,0.00871252157461572,0.999692726930989,2,7,negative regulation of norepinephrine secretion,BP,ADRA2B;ADRA2C
1755,GO:0003996,0.00873521655735616,0.999691507933042,2,7,acyl-CoA ligase activity,MF,ACSF2;ACSM5
15116,GO:0060684,0.0087358531934059,0.999691473713689,2,7,epithelial-mesenchymal cell signaling,BP,WNT6;BMP4
12359,GO:0045807,0.00874964434466869,0.99769693012629,7,112,positive regulation of endocytosis,BP,RAB27A;TF;MFGE8;PYCARD;WNT5A;DLL1;GAS6
3413,GO:0006729,0.00884902983901676,0.999685369488445,2,7,tetrahydrobiopterin biosynthetic process,BP,PCBD1;PTS
12548,GO:0046146,0.00884902983901676,0.999685369488445,2,7,tetrahydrobiopterin metabolic process,BP,PCBD1;PTS
12414,GO:0045913,0.00885263046797405,0.998314591076046,5,62,positive regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1;RGN;PDGFB;AKT1
19594,GO:1903409,0.00886722799054208,0.997962322834233,6,86,reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;RGN;TICAM1;AKT1;GLA
12286,GO:0045662,0.00892868429344548,0.999174993802312,3,21,negative regulation of myoblast differentiation,BP,NOTCH1;BMP4;DLL1
4600,GO:0009617,0.00895576538152879,0.995717007682421,19,497,response to bacterium,BP,NOTCH1;EDN1;CCL20;PYCARD;MGST2;FGF10;TICAM1;WNT5A;BMP6;SHPK;CHGA;GJB2;GJB6;AKT1;PTGES;TFPI;STAR;CLDN1;PDE4B
6278,GO:0017111,0.0089830886396915,0.995176924769139,26,772,nucleoside-triphosphatase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;ABCG1;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
11298,GO:0043256,0.00913000973042348,0.999657476466038,2,8,laminin complex,CC,LAMA1;LAMA5
13969,GO:0051251,0.00913899396409999,0.996485225663486,12,261,positive regulation of lymphocyte activation,BP,FADD;PNP;PYCARD;FGF10;PIK3R1;TICAM1;CLCF1;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
7130,GO:0022829,0.00926266862087242,0.99913254371637,3,21,wide pore channel activity,MF,GJB1;GJB2;GJA3
7600,GO:0030825,0.00928341625080287,0.999129887402328,3,21,positive regulation of cGMP metabolic process,BP,WNT5A;NPR1;NPPC
5083,GO:0010894,0.00932190928049097,0.999124953234248,3,21,negative regulation of steroid biosynthetic process,BP,WNT4;DKK3;BMP2
13979,GO:0051261,0.00933040822859684,0.997830822920603,6,88,protein depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
11440,GO:0043507,0.00935755918465079,0.998192959447157,5,63,positive regulation of JUN kinase activity,BP,WNT7B;EDN1;WNT5A;AXIN1;FZD8
10068,GO:0035812,0.00940648623272155,0.999114084952908,3,21,renal sodium excretion,BP,ADORA1;EDN1;NPR1
10069,GO:0035813,0.00940648623272155,0.999114084952908,3,21,regulation of renal sodium excretion,BP,ADORA1;EDN1;NPR1
12916,GO:0046982,0.00949186780810991,0.995534501547564,18,466,protein heterodimerization activity,MF,ITGA3;ADRA2C;SYT5;NOTCH1;GADD45A;ADORA1;ABCG1;TYRO3;PIK3R2;PIK3R1;PDGFB;JAM3;RBP4;CLCF1;BMP6;BMP2;HEXB;TPD52
14602,GO:0055082,0.00950328161890322,0.995010278418604,24,690,cellular chemical homeostasis,BP,CDH23;TF;SLC31A2;CASQ2;EDN1;RAB39A;PRND;LPAR2;RGN;PIK3R2;PIK3R1;SESN2;BMP6;RAB20;HEXB;NOL3;GJB6;STAR;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
3570,GO:0006979,0.00953991761601358,0.995734534001686,16,397,response to oxidative stress,BP,MSRA;GUCY1B3;EDN1;RGN;PRR5L;SESN2;RHOB;FGF8;BMP7;NOL3;GJB2;AKT1;PON2;IDH1;STAR;ETFDH
5009,GO:0010810,0.00956086352177266,0.996902068589131,9,174,regulation of cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;NOTCH1;PLAU;FZD7;PIK3R1;SDC4;DDR1
18690,GO:1901136,0.00967046553580386,0.996862005167428,9,171,carbohydrate derivative catabolic process,BP,PNP;GALT;SDC4;IDUA;HEXB;NUDT7;GLA;DERA;PDE4B
13103,GO:0048103,0.00967396092115301,0.999075057812438,3,22,somatic stem cell division,BP,NOTCH1;WNT7A;FZD7
3460,GO:0006809,0.00972266696072958,0.998104834040715,5,63,nitric oxide biosynthetic process,BP,EDN1;RGN;TICAM1;AKT1;GLA
11698,GO:0044262,0.00972645650939948,0.996410383908278,11,234,cellular carbohydrate metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;KHK;SESN2;PFKFB3;B3GNT2;IDUA;AKT1;IDH1
14590,GO:0055067,0.00975938291115162,0.997084712539195,8,142,monovalent inorganic cation homeostasis,BP,PDK4;ADORA1;EDN1;RAB39A;KCNH2;NPR1;RAB20;RAB38
3805,GO:0007420,0.00985802277878654,0.994882995291295,23,666,brain development,BP,WNT3;WNT2;WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;BMP7;BMP4;BMP2;ACAT1;DLL1;WNT2B;CDH1;STAR;TSPAN2
9960,GO:0035639,0.00986069960385628,0.993663716978971,50,1749,purine ribonucleoside triphosphate binding,MF,PDK4;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;ACSF2;RAB40B;RAB40A;ABCG1;PRKACB;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;RNASEL;PKN3;RAB20;SHPK;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2
5094,GO:0010906,0.00991147441704313,0.997664970649235,6,89,regulation of glucose metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;SESN2;AKT1
13238,GO:0048471,0.00997212122356705,0.994900771129445,22,621,perinuclear region of cytoplasm,CC,ITGA3;SYT5;TF;RAB40B;PRKACB;PIK3R1;KCNH2;PLA2G16;HRAS;AXIN1;CDKN1A;PKN3;CHGA;MSN;CTGF;GJB2;TPD52;PTGES;CDH1;INHBB;S100B;DOK1
19645,GO:1903524,0.0100281231744364,0.998030455359696,5,63,positive regulation of blood circulation,BP,ADRA2C;EDN1;CHGA;CTGF;AKT1
4708,GO:0009994,0.0100374144103261,0.998491408625253,4,41,oocyte differentiation,BP,WNT4;ANG;NPPC;INHBB
1440,GO:0003143,0.0100513792859418,0.998023423483318,5,64,embryonic heart tube morphogenesis,BP,NOTCH1;ACVR1;WNT5A;FGF8;DLL1
11274,GO:0043227,0.0100971344252115,0.992601059519129,262,11597,membrane-bounded organelle,CC,ITGA3;ITGA5;CFB;EBP;PDK4;PECR;BEX4;TMEM160;TMEM163;ADRA2C;SYT5;WNT3;WNT4;USE1;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;RAB27A;IFI30;DPM3;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;MRPL14;MRPL16;MRI1;FADD;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;ADORA1;CASQ2;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;ABCG1;PRKACB;MFGE8;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;FSTL3;FGF18;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;REEP1;ARL6IP4;PDGFB;FOXO4;FRMPD1;RALB;CPT2;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;KHK;HACL1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP2;ACAT1;B3GNT2;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;ECHDC2;SLC2A14;SARDH;F8A1;HEXB;VAMP1;SFXN1;CMBL;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DDR1;DSG3;CTGF;GJB1;GJB2;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;WNT2B;CYTIP;PTGES;IDH1;NPPC;DECR1;NAB2;CDH1;PUS1;EPN1;MYO7A;PTMS;LDHD;TMEM98;MDP1;HPCAL1;RAB44;TFPI;TLE1;STAR;CLDN2;CLDN3;CLDN5;SNX21;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;PEPD;ACP5;GLA;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;DERA;S100B;DHCR7;CYB5A;PTS;PM20D2;HNF1A;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;RAB38;DOK1;RAB3D;LYPLAL1;ACSL4;FAM110B;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN11;RNF144A;ETFDH;PDE4B
16927,GO:0072205,0.0101341272526986,0.999598501786145,2,8,metanephric collecting duct development,BP,WNT7B;BMP4
1207,GO:0002687,0.0101361380392651,0.997255430391885,7,113,positive regulation of leukocyte migration,BP,FADD;EDN1;CCL20;PYCARD;WNT5A;KITLG;GAS6
13431,GO:0048843,0.0101640399129966,0.999596695286263,2,8,negative regulation of axon extension involved in axon guidance,BP,WNT3;WNT5A
11429,GO:0043491,0.0102049065749436,0.996926793974389,8,144,protein kinase B signaling,BP,TYRO3;SESN2;FAM110C;HBEGF;AKT1;PIK3CA;PIK3CG;GAS6
12423,GO:0045922,0.0102166620108028,0.999003387724741,3,22,negative regulation of fatty acid metabolic process,BP,APOC1;ACADVL;AKT1
3971,GO:0008154,0.0102288952482281,0.996649489464357,9,174,actin polymerization or depolymerization,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PYCARD;PLEKHH2;ANG;SPTB;TMOD4
3998,GO:0008198,0.0102300606791336,0.999001599714309,3,22,ferrous iron binding,MF,PHYH;TF;ACP5
12093,GO:0045214,0.0102426580535083,0.998447142368931,4,43,sarcomere organization,BP,FHOD3;ACTN2;CASQ2;EDN1
15352,GO:0061082,0.0102486128998424,0.998999122518098,3,22,myeloid leukocyte cytokine production,BP,WNT5A;CHGA;GAS6
13405,GO:0048771,0.0102590497107429,0.996907636597338,8,144,tissue remodeling,BP,PDK4;LIF;FGF10;FGF8;NOL3;VDR;RAB3D;CLDN18
14878,GO:0060341,0.0102822350530433,0.994349769082752,27,811,regulation of cellular localization,BP,ITGA3;LIF;ACTN2;PMAIP1;CASQ2;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;NOL3;AKT1;IFI27;CDH1;GAS6;GDNF;CLDN18
13302,GO:0048596,0.0102856599030011,0.998989815731371,3,23,embryonic camera-type eye morphogenesis,BP,STRA6;WNT5A;BMP7
796,GO:0001974,0.0102884641150506,0.998440294150658,4,42,blood vessel remodeling,BP,LIF;FGF10;FGF8;NOL3
16068,GO:0070663,0.0103106692421944,0.996378894693162,10,202,regulation of leukocyte proliferation,BP,FADD;PNP;PYCARD;FGF10;TICAM1;SDC4;CLCF1;BMP4;CDKN1A;KITLG
8060,GO:0031657,0.0103110454622639,0.999587776232024,2,8,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,FGF10;AKT1
16550,GO:0071548,0.010365700519374,0.998427411847826,4,41,response to dexamethasone,BP,EDN1;GJB2;STAR;CLDN1
17575,GO:0090382,0.0103704375003191,0.998426483883977,4,41,phagosome maturation,BP,RAB39A;RAB20;MYO7A;RAB38
8856,GO:0032967,0.0103788573365406,0.998981683952836,3,22,positive regulation of collagen biosynthetic process,BP,WNT4;BMP4;CTGF
9781,GO:0035338,0.0103899730512127,0.998422655562963,4,41,long-chain fatty-acyl-CoA biosynthetic process,BP,FASN;ACSF2;ACSL4;ELOVL6
3614,GO:0007043,0.0104109741469815,0.997520446212463,6,90,cell-cell junction assembly,BP,GJB1;GJB2;PKP3;CLDN1;CLDN3;CLDN5
11626,GO:0044089,0.0104173248251964,0.995168510121139,17,441,positive regulation of cellular component biogenesis,BP,WNT4;PMAIP1;WNT7A;EDN1;PYCARD;RALB;HRAS;RHOQ;PSRC1;SDC4;BMP7;ESPN;CHGA;MSN;CTGF;CLDN1;HNF1A
552,GO:0001618,0.0104194295550267,0.99793292206059,5,64,virus receptor activity,MF,ITGA5;ITGB5;TYRO3;CLDN1;EFNB2
3416,GO:0006733,0.010428295460966,0.996848165198372,8,143,oxidoreduction coenzyme metabolic process,BP,ACTN3;PNP;NNMT;PFKFB3;SHPK;MDH1;IDH1;DERA
15423,GO:0061213,0.0104539338545821,0.998971594174122,3,22,positive regulation of mesonephros development,BP,WT1;WNT2B;GDNF
3741,GO:0007264,0.0104567753558526,0.995029391540277,18,482,small GTPase mediated signal transduction,BP,ITGA3;RAB6C;RABIF;RRAS2;FGF10;PIK3R2;RALB;HRAS;RHOQ;RHOJ;RHOB;CDKN1A;RND3;RRAD;KITLG;AMOT;RAB38;DOK1
9839,GO:0035457,0.0105782444189073,0.999571391372918,2,8,cellular response to interferon-alpha,BP,STAR;GAS6
19405,GO:1903011,0.0106843005922697,0.999564826317134,2,8,negative regulation of bone development,BP,RGN;CLDN18
7282,GO:0030175,0.0107166290455966,0.997429920760166,6,92,filopodium,CC,ITGA3;ACTN2;TTYH1;MSN;KITLG;ACTA2
18206,GO:0098858,0.0107295368954621,0.99645665289722,9,178,actin-based cell projection,CC,ITGA3;ACTN2;CDH23;TTYH1;ESPN;MSN;KITLG;MYO7A;ACTA2
11795,GO:0044424,0.0107440019365001,0.992399249617257,294,13251,intracellular part,CC,ITGA3;ITGA5;TAGLN;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;IFI30;PNMT;DPM3;TF;ZFYVE21;ITGB5;ITGB4;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;FBXO41;MRPL14;MRPL16;MRI1;FADD;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;RHPN1;ABCG1;PRKACB;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;BOLA1;ANG;FAM110C;SPTB;HBEGF;LGALS4;NMI;BMP6;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;ECHDC2;SLC2A14;SARDH;F8A1;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DSG3;DEPTOR;CTGF;GJB1;GJB2;GJB6;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;WNT2B;CYTIP;PTGES;KITLG;IDH1;NPPC;DECR1;NAB2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;PTMS;LDHD;TMEM98;SPSB1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;DHCR7;CYB5A;PTS;PM20D2;RBMS3;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;DOK1;RAB3D;LYPLAL1;ACSL4;MYZAP;FAM110B;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PARVB;ETFDH;PDE4B;TMOD4
16952,GO:0072243,0.0107774384877996,0.998923169838613,3,23,metanephric nephron epithelium development,BP,LIF;WNT7B;ACAT1
12588,GO:0046322,0.010796485822531,0.999557844013296,2,8,negative regulation of fatty acid oxidation,BP,ACADVL;AKT1
13906,GO:0051153,0.0108255600359395,0.997400034264445,6,90,regulation of striated muscle cell differentiation,BP,NOTCH1;EDN1;FZD7;BMP4;BMP2;EFNB2
5186,GO:0014020,0.0108367803037223,0.997395811474971,6,91,primary neural tube formation,BP,SALL4;PRKACB;WNT5A;SDC4;BMP7;BMP4
15441,GO:0061303,0.0108643245092298,0.999553602990085,2,8,cornea development in camera-type eye,BP,WNT6;WNT2B
19146,GO:1902373,0.0108816855274978,0.999552515371774,2,8,negative regulation of mRNA catabolic process,BP,PKP3;PKP1
9388,GO:0034350,0.0108981799093827,0.999551481189222,2,8,regulation of glial cell apoptotic process,BP,DLL1;GAS6
9389,GO:0034351,0.0108981799093827,0.999551481189222,2,8,negative regulation of glial cell apoptotic process,BP,DLL1;GAS6
16923,GO:0072201,0.0109025949506441,0.999551204228685,2,8,negative regulation of mesenchymal cell proliferation,BP,WNT5A;BMP4
14134,GO:0051549,0.0109052858476207,0.999551035396367,2,8,positive regulation of keratinocyte migration,BP,FGF10;HBEGF
20418,GO:1905209,0.0109724800288945,0.998896414530238,3,23,positive regulation of cardiocyte differentiation,BP,EDN1;BMP4;EFNB2
16950,GO:0072239,0.0109893636296417,0.999545749019322,2,8,metanephric glomerulus vasculature development,BP,PDGFB;WT1
13386,GO:0048739,0.011016935748654,0.999531273683136,2,9,cardiac muscle fiber development,BP,BMP4;MYH11
12855,GO:0046886,0.011022983033539,0.999543629157483,2,8,positive regulation of hormone biosynthetic process,BP,WNT4;BMP6
13315,GO:0048630,0.0110255166262436,0.99954346926276,2,8,skeletal muscle tissue growth,BP,ACTN3;DLL1
15870,GO:0070316,0.0110283514810856,0.999543290332211,2,8,regulation of G0 to G1 transition,BP,FOXO4;CTGF
10999,GO:0042726,0.0110962629020563,0.999538996574617,2,8,flavin-containing compound metabolic process,BP,SLC52A3;ACP5
6663,GO:0019674,0.0110993057289837,0.997763599280102,5,64,NAD metabolic process,BP,ACTN3;PNP;NNMT;PFKFB3;MDH1
12153,GO:0045350,0.0111237893556841,0.999537252193568,2,8,interferon-beta biosynthetic process,BP,TICAM1;NMI
12160,GO:0045357,0.0111237893556841,0.999537252193568,2,8,regulation of interferon-beta biosynthetic process,BP,TICAM1;NMI
5880,GO:0016324,0.0111804990996021,0.995579867652102,12,274,apical plasma membrane,CC,NOTCH1;RAB27A;TF;SLC52A3;CDH2;DLL1;MSN;GJB6;RAB17;MYO7A;CLDN1;LZTS1
14557,GO:0055001,0.0111856093326461,0.996574206799471,8,149,muscle cell development,BP,FHOD3;ACTN2;NOTCH1;CASQ2;EDN1;AXIN1;BMP4;MYH11
7671,GO:0030916,0.0111884207050132,0.999533147390607,2,8,otic vesicle formation,BP,FGF10;FGF8
9032,GO:0033278,0.0112040822670492,0.999532150801949,2,8,cell proliferation in midbrain,BP,WNT2;WNT5A
21003,GO:2000107,0.0112189710599234,0.998255745223188,4,42,negative regulation of leukocyte apoptotic process,BP,FADD;BMP4;KITLG;GAS6
8829,GO:0032925,0.011224014683568,0.99886164303328,3,23,regulation of activin receptor signaling pathway,BP,ACVR1;FSTL3;FGF10
14830,GO:0060284,0.0112480679947861,0.993923731892341,25,747,regulation of cell development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;EDN1;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;NPPC;STAR;CLDN5;LZTS1;CLDN18;LINGO1
16819,GO:0072050,0.0112583423355722,0.999528692340072,2,8,S-shaped body morphogenesis,BP,BMP4;WT1
12892,GO:0046949,0.0113166926541344,0.998236086868913,4,42,fatty-acyl-CoA biosynthetic process,BP,FASN;ACSF2;ACSL4;ELOVL6
16436,GO:0071378,0.0113187150501511,0.998848474801213,3,23,cellular response to growth hormone stimulus,BP,GHR;PIK3R1;STAR
15029,GO:0060539,0.0113287700999851,0.999524190102402,2,8,diaphragm development,BP,STRA6;WT1
21403,GO:2000698,0.0113367034351466,0.999523682010096,2,8,positive regulation of epithelial cell differentiation involved in kidney development,BP,LIF;GDNF
15251,GO:0060923,0.0113930351751938,0.999520068779016,2,8,cardiac muscle cell fate commitment,BP,ACVR1;WT1
16886,GO:0072161,0.0114113951143962,0.999518889072672,2,8,mesenchymal cell differentiation involved in kidney development,BP,WNT4;BMP4
21533,GO:2001012,0.0114113951143962,0.999518889072672,2,8,mesenchymal cell differentiation involved in renal system development,BP,WNT4;BMP4
4370,GO:0009081,0.0114290065109406,0.99883308585045,3,23,branched-chain amino acid metabolic process,BP,GHR;HSD17B10;ACAT1
1564,GO:0003339,0.0114560972577462,0.999516012530247,2,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;GDNF
18723,GO:1901215,0.0114633829578154,0.996174027566832,9,177,negative regulation of neuron death,BP,TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;STAR;PIK3CA;GDNF
4235,GO:0008585,0.0114814409519409,0.9972064074043,6,91,female gonad development,BP,WNT4;ANG;WT1;KITLG;IDH1;INHBB
8407,GO:0032330,0.0114819351506923,0.998200294889359,4,43,regulation of chondrocyte differentiation,BP,FGF18;BMP6;BMP4;CTGF
17435,GO:0090181,0.0114951492506783,0.998823829858144,3,23,regulation of cholesterol metabolic process,BP,ABCG1;ACADVL;DHCR7
1890,GO:0004300,0.0115268606212094,0.999511446719689,2,8,enoyl-CoA hydratase activity,MF,ECHDC2;ECI1
14320,GO:0051904,0.0115399383693349,0.998817550585998,3,23,pigment granule transport,BP,RAB27A;RAB17;MYO7A
9356,GO:0034260,0.0115738128624833,0.998181659482008,4,43,negative regulation of GTPase activity,BP,RGN;HRAS;AMOT;SH3BP4
4680,GO:0009913,0.0115807111520756,0.995024714898433,14,335,epidermal cell differentiation,BP,POU3F1;NOTCH1;DSC2;KRT10;WNT5A;BMP4;DLL1;DSG3;PKP3;PKP1;JAG2;MYO7A;DSC3;VDR
3837,GO:0007530,0.0116388085451121,0.99880365658888,3,23,sex determination,BP,WNT4;DHH;WT1
14218,GO:0051704,0.0117117587576689,0.992083979811786,62,2241,multi-organism process,BP,ITGA3;ITGA5;LIF;ADRA2C;WNT3;WNT4;NOTCH1;IGSF8;ITGB5;PMAIP1;FADD;DHH;SERPINA5;ACVR1;NMT2;EDN1;RAB40B;MFGE8;CCL20;SPTBN4;PYCARD;MGST2;TYRO3;PSMB10;RGN;FSTL3;FGF10;PIK3R1;TICAM1;HRAS;WNT5A;JAM3;RNASEL;ANG;BMP6;BMP4;WT1;SLC2A14;SHPK;HEXB;CHGA;DDR1;GJB2;GJB6;AKT1;PTGES;NPPC;JAG2;CDH1;EPN1;INHBB;TFPI;STAR;CLDN1;GAS6;VDR;ACSL4;ACTA2;CLDN11;PIM2;EFNB2;PDE4B
19031,GO:1902105,0.0117245629313949,0.995555690101496,11,239,regulation of leukocyte differentiation,BP,LIF;FADD;ZFPM1;PNP;FSTL3;PIK3R1;BMP4;TMEM176A;KITLG;GAS6;CLDN18
4001,GO:0008201,0.0117796321479079,0.996360476969376,8,147,heparin binding,MF,CRISPLD2;SERPINA5;FGF10;ANG;HBEGF;BMP7;BMP4;CTGF
4944,GO:0010714,0.0117958151143928,0.998781500621774,3,23,positive regulation of collagen metabolic process,BP,WNT4;BMP4;CTGF
11690,GO:0044253,0.0117958151143928,0.998781500621774,3,23,positive regulation of multicellular organismal metabolic process,BP,WNT4;BMP4;CTGF
17443,GO:0090189,0.011873580099383,0.998770485150714,3,23,regulation of branching involved in ureteric bud morphogenesis,BP,BMP4;WNT2B;GDNF
13335,GO:0048663,0.011968655387942,0.997540033695686,5,66,neuron fate commitment,BP,NOTCH1;AXIN1;BMP4;DLL1;JAG2
1203,GO:0002683,0.0119916208160743,0.9946551389815,15,373,negative regulation of immune system process,BP,NOTCH1;FADD;ZFPM1;ADORA1;TYRO3;FSTL3;PIK3R1;TICAM1;SDC4;NMI;BMP4;DLL1;TMEM176A;KITLG;CLDN18
12438,GO:0045939,0.0120352143875587,0.998747501762484,3,23,negative regulation of steroid metabolic process,BP,WNT4;DKK3;BMP2
2638,GO:0005509,0.0120373019463938,0.993638080492245,23,676,calcium ion binding,MF,SYT5;ACTN3;ACTN2;NOTCH1;CDH23;RHBDL3;DHH;DSC2;CASQ2;TTYH1;RGN;CDH2;DLL1;NOL3;DSG3;TPD52;JAG2;CDH1;HPCAL1;GAS6;RPH3AL;S100B;DSC3
843,GO:0002040,0.0120678102205652,0.997513074239282,5,67,sprouting angiogenesis,BP,ITGA5;NOTCH1;BMP4;DLL1;EFNB2
15676,GO:0065007,0.0121291743092682,0.990968951962276,249,10987,biological regulation,BP,ITGA3;ITGA5;ARTN;CFB;EBP;PDK4;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;CDH23;IFI30;DPM3;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;SLC31A2;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;ACVR1;RABIF;NMT2;SALL4;TBC1D14;GUCY1B3;ADORA1;CASQ2;HSD17B11;DKK3;EDN1;PLAU;RAB40B;RAB40A;PNP;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39A;PRND;MGST2;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;PXK;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;SNX18;GPRASP1;SESN2;AXIN1;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;TSFM;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SHPK;ESPN;HEXB;SFXN1;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;DDR1;DEPTOR;CTGF;GJB6;RRAD;PCBD1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;FAM46A;TMEM176A;CYTIP;PTGES;KITLG;IDH1;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;GLA;DTX4;ZCCHC12;CYP11A1;RPH3AL;LZTS1;S100B;DHCR7;PTS;PM20D2;SHC4;RBMS3;HNF1A;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;MYZAP;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN16;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;PDE4B;TMOD4
3347,GO:0006639,0.0122877524683492,0.996542236590096,7,119,acylglycerol metabolic process,BP,APOC1;RGN;PLA2G16;ANG;FABP3;PIK3CG;ACSL4
5832,GO:0016242,0.0122976720126214,0.998704885196034,3,24,negative regulation of macroautophagy,BP,AKT1;PIK3CA;LZTS1
14727,GO:0060122,0.0123087775591797,0.9987032825867,3,24,inner ear receptor stereocilium organization,BP,CDH23;SDC4;MYO7A
11706,GO:0044272,0.0123148997966731,0.995554641333397,10,209,sulfur compound biosynthetic process,BP,PDK4;FASN;MRI1;EXTL1;ACSF2;MGST2;ACAT1;B3GNT2;ACSL4;ELOVL6
13278,GO:0048545,0.0123276884174054,0.994486987530531,15,376,response to steroid hormone,BP,NOTCH1;WNT7B;EDN1;BMP7;BMP6;BMP4;CDKN1A;CTGF;GJB2;IDH1;STAR;CLDN1;S100B;VDR;HEY1
4723,GO:0010038,0.0124193604904388,0.994809341502633,13,308,response to metal ion,BP,TF;CASQ2;EDN1;FSTL3;WNT5A;KHK;BMP6;AKT1;PTGES;CDH1;STAR;CLDN1;CYB5A
17453,GO:0090199,0.0124266471279898,0.998006564054266,4,43,regulation of release of cytochrome c from mitochondria,BP,PMAIP1;PYCARD;NOL3;AKT1
12567,GO:0046209,0.0124587556278576,0.997412190813602,5,67,nitric oxide metabolic process,BP,EDN1;RGN;TICAM1;AKT1;GLA
2793,GO:0005782,0.0124634973037702,0.997998913698604,4,43,peroxisomal matrix,CC,PHYH;HACL1;NUDT7;IDH1
8178,GO:0031907,0.0124634973037702,0.997998913698604,4,43,microbody lumen,CC,PHYH;HACL1;NUDT7;IDH1
1265,GO:0002762,0.0125317501723437,0.997982139821287,4,44,negative regulation of myeloid leukocyte differentiation,BP,ZFPM1;FSTL3;PIK3R1;CLDN18
10658,GO:0042110,0.012700766393319,0.993981411232644,17,446,T cell activation,BP,WNT4;RAB27A;FADD;ZFPM1;PNP;PYCARD;FZD7;PIK3R1;SDC4;BMP4;MSN;AKT1;JAG2;PIK3CA;PIK3CG;FZD8;EFNB2
12644,GO:0046456,0.0127351017955855,0.997942314671659,4,43,icosanoid biosynthetic process,BP,EDN1;MGST2;FADS1;PTGES
18838,GO:1901570,0.0127351017955855,0.997942314671659,4,43,fatty acid derivative biosynthetic process,BP,EDN1;MGST2;FADS1;PTGES
3616,GO:0007045,0.0127750009311102,0.997326873368658,5,69,cell-substrate adherens junction assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
13090,GO:0048041,0.0127750009311102,0.997326873368658,5,69,focal adhesion assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
3346,GO:0006638,0.0128263790607906,0.996359696253828,7,120,neutral lipid metabolic process,BP,APOC1;RGN;PLA2G16;ANG;FABP3;PIK3CG;ACSL4
18832,GO:1901564,0.012829113292668,0.991335980393903,60,2159,organonitrogen compound metabolic process,BP,ACTN3;GLDC;PNMT;ITGB8;FASN;MSRA;MRPL14;MRPL16;MRI1;MRAP;APOC1;SLC52A3;GUCY1B3;EXTL1;EDN1;PNP;BDH2;MBOAT2;MGST2;PSMB10;GHR;ASAH2;PDGFB;NNMT;PLA2G16;HSD17B10;WNT5A;SESN2;RHOQ;NPR1;PFKFB3;SDC4;ANG;BMP4;ACAT1;B3GNT2;TSFM;IDUA;AOX1;SARDH;SHPK;HEXB;FABP3;CHGA;NUDT7;CPT1C;PCBD1;MDH1;AKT1;IDH1;NPPC;GAS6;PEPD;ACP5;GLA;DERA;PTS;RBMS3;SLC1A3;PDE4B
14321,GO:0051905,0.0128395347591938,0.99862605350023,3,24,establishment of pigment granule localization,BP,RAB27A;RAB17;MYO7A
15344,GO:0061072,0.0128598097617958,0.999406606342486,2,9,iris morphogenesis,BP,WNT2;WNT2B
1214,GO:0002694,0.0128600876622486,0.993897641088199,17,446,regulation of leukocyte activation,BP,FADD;PNP;PYCARD;TYRO3;FGF10;PIK3R1;TICAM1;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;SHPK;AKT1;PIK3CA;GAS6;EFNB2
17328,GO:0090003,0.0128933735882689,0.997906482749584,4,44,regulation of establishment of protein localization to plasma membrane,BP,ITGA3;PIK3R1;RHOQ;AKT1
17007,GO:0072341,0.0128940954690299,0.997298884397537,5,67,modified amino acid binding,MF,SYT5;FASN;MFGE8;PTGES;GAS6
20271,GO:1904861,0.0129328965094268,0.999401452786947,2,9,excitatory synapse assembly,BP,WNT7A;WNT5A
11319,GO:0043292,0.0129541831868278,0.995284163285825,10,218,contractile fiber,CC,FHOD3;ACTN2;CASQ2;SDC4;MYH11;MYZAP;ACTA2;PARVB;PDE4B;TMOD4
5891,GO:0016342,0.0129652365434304,0.999399167415043,2,9,catenin complex,CC,CDH2;CDH1
15448,GO:0061314,0.0129820298458555,0.999397979478971,2,9,Notch signaling involved in heart development,BP,NOTCH1;HEY1
1611,GO:0003674,0.0130450311100818,0.99247839059406,345,16005,molecular_function,MF,ITGA3;ITGA5;ARTN;CFB;TAGLN;EBP;PDK4;PECR;FHOD3;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;PNMT;DPM3;STRA6;RASL11B;TF;ZFYVE21;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;RHBDL3;SLC31A2;FBXO41;MRPL14;MRPL16;SLC45A4;MRI1;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;GUCY1B3;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;BDH2;FLVCR2;SPTBN5;SPTBN4;PYCARD;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;MPZL1;KRT10;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MGST2;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;NNMT;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;BOLA1;ANG;FAM110C;SPTB;MB21D2;HBEGF;LGALS4;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;DAAM2;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;DRP2;ECHDC2;SLC2A14;SARDH;F8A1;SHPK;ESPN;HEXB;VAMP1;SFXN1;CMBL;WNK4;FABP3;GRIA3;RND3;MSN;NOL3;HSD3B2;NUDT6;NUDT7;DDR1;DSG3;DEPTOR;CTGF;GJB1;GJB2;ACCS;CPT1C;RRAD;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;NRTN;WNT2B;FAM46A;CYTIP;PTGES;KITLG;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;EPN1;MYO7A;BCAR1;INHBB;LDHD;GJA3;MDP1;SPSB1;HPCAL1;RAB44;TFPI;TLE1;STAR;CLDN1;CLDN2;CLDN3;CLDN5;SNX21;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;WBP1;SIN3B;PEPD;ACP5;GLA;HAPLN3;DTX4;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;LZTS1;DERA;S100B;CLDN23;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;SLC18B1;HNF1A;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;LYPLAL1;ACSL4;MYZAP;SLC1A3;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;ETFDH;PDE4B;TMOD4
5806,GO:0016197,0.0131935493506604,0.994911415986884,11,246,endosomal transport,BP,ACTN2;RAB6C;ZFYVE21;TBC1D14;SNX18;GPRASP1;RHOB;MSN;RAB12;RAB17;RAB38
13926,GO:0051183,0.0132108136339525,0.998571297860216,3,24,vitamin transporter activity,MF,STRA6;SLC52A3;RBP4
5121,GO:0010942,0.0134055315045379,0.99306797483529,21,598,positive regulation of cell death,BP,NOTCH1;MARK4;PMAIP1;GADD45A;FADD;TRADD;PYCARD;G0S2;PIK3R2;WNT5A;RHOB;BMP7;BMP4;BMP2;CDKN1A;CTGF;AKT1;IFI27;INHBB;S100B;VDR
20703,GO:1990124,0.0134116024378925,0.9993673136402,2,9,messenger ribonucleoprotein complex,CC,PKP3;PKP1
1409,GO:0003071,0.0135236234275913,0.998524705736261,3,24,renal system process involved in regulation of systemic arterial blood pressure,BP,ADORA1;PDGFB;GAS6
13518,GO:0050433,0.0135658069835487,0.997764077022584,4,44,regulation of catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA;GDNF
11619,GO:0044062,0.0135980801476985,0.998513554377197,3,24,regulation of excretion,BP,ADORA1;EDN1;NPR1
3917,GO:0008064,0.0136023802816007,0.995685700068481,8,152,regulation of actin polymerization or depolymerization,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PYCARD;PLEKHH2;SPTB;TMOD4
1446,GO:0003151,0.0136886482167001,0.997086157081132,5,69,outflow tract morphogenesis,BP,ZFPM1;WNT5A;FGF8;BMP4;CLDN5
14610,GO:0055091,0.013737681290351,0.999343681040518,2,9,phospholipid homeostasis,BP,ABCG1;FABP3
7604,GO:0030832,0.0137975736251507,0.995612049109801,8,153,regulation of actin filament length,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PYCARD;PLEKHH2;SPTB;TMOD4
21095,GO:2000273,0.0138371579522741,0.99770053396712,4,46,positive regulation of receptor activity,BP,ADRA2B;ADRA2C;ACTN2;ADORA1
13643,GO:0050766,0.0138497509091915,0.99770049159218,4,45,positive regulation of phagocytosis,BP,RAB27A;MFGE8;PYCARD;GAS6
12295,GO:0045671,0.0138900821216813,0.998464155331576,3,25,negative regulation of osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
6641,GO:0019538,0.0139558115182967,0.989570764722317,129,5268,protein metabolic process,BP,ITGA5;ARTN;CFB;PDK4;LIF;ADRA2B;ADRA2C;USE1;ACTN2;TSPAN15;TSPAN17;ALG5;MARK4;DPM3;PMAIP1;GADD45A;MSRA;RHBDL3;FBXO41;MRPL14;MRPL16;FADD;DHH;SERPINA5;WNT7A;WNT7B;APOC1;ZFPM1;TRADD;ACVR1;NMT2;ADORA1;EXTL1;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;ABCG1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PYCARD;KRT10;PRND;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;ETFB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;TSFM;IDUA;CDKN1A;DLL1;PKN3;HEXB;WNK4;MSN;NOL3;DDR1;DEPTOR;CTGF;CASP4;AKT1;IFI27;RAB12;NRTN;KITLG;CST9L;JAG2;INHBB;MDP1;SPSB1;TFPI;PIK3CA;PIK3CG;GAS6;SIN3B;PEPD;DTX4;PM20D2;RBMS3;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;FZD8;DUSP5;RNF144A;PIM2
5262,GO:0014807,0.0139925719107632,0.999324996808477,2,9,regulation of somitogenesis,BP,NOTCH1;DLL1
8830,GO:0032926,0.0140323829287515,0.999322061932669,2,9,negative regulation of activin receptor signaling pathway,BP,ACVR1;FSTL3
12702,GO:0046545,0.0140369239176066,0.996427786712217,6,95,development of primary female sexual characteristics,BP,WNT4;ANG;WT1;KITLG;IDH1;INHBB
14651,GO:0060019,0.0141121753217639,0.999316166161625,2,9,radial glial cell differentiation,BP,CDH2;FGF10
13563,GO:0050661,0.0141144417770645,0.997643409760822,4,45,NADP binding,MF,FASN;IDH1;DECR1;DHCR7
4749,GO:0010171,0.0141335441592529,0.997636541097,4,46,body morphogenesis,BP,WNT3;STRA6;CRISPLD2;CLDN5
18467,GO:1900078,0.0141913881012824,0.998418265758808,3,25,positive regulation of cellular response to insulin stimulus,BP,PIK3R2;PIK3R1;RNASEL
6726,GO:0019842,0.0141945790937054,0.995889239262445,7,122,vitamin binding,MF,PHYH;GLDC;FASN;HACL1;RBP4;ACCS;VDR
14863,GO:0060324,0.0142503452613663,0.997611208609176,4,46,face development,BP,STRA6;CRISPLD2;WNT5A;CLDN5
20953,GO:2000018,0.0142671153777893,0.999304666656866,2,9,regulation of male gonad development,BP,WNT4;WT1
7038,GO:0021915,0.0142717456331227,0.995432552186943,8,155,neural tube development,BP,NOTCH1;SALL4;PRKACB;WNT5A;FGF8;SDC4;BMP7;BMP4
7256,GO:0030141,0.0142914747951529,0.992021008582046,26,787,secretory granule,CC,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;SERPINA5;EDN1;PLAU;PNP;PYCARD;SYCN;FSTL3;PDGFB;HEXB;VAMP1;CHGA;PKP1;IDH1;NPPC;RAB44;GAS6;GLA;RPH3AL;DERA;RAB3D
9779,GO:0035336,0.0143091049887792,0.99760121900812,4,45,long-chain fatty-acyl-CoA metabolic process,BP,FASN;ACSF2;ACSL4;ELOVL6
14574,GO:0055021,0.0143099875881221,0.997598248375701,4,46,regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1;RBP4
7842,GO:0031264,0.0143280517701176,0.999300125566655,2,9,death-inducing signaling complex,CC,FADD;TRADD
7177,GO:0030001,0.0143319783456896,0.991995669248582,26,797,metal ion transport,BP,ACTN2;CDH23;TF;SLC31A2;ADORA1;CASQ2;KCNK6;SPTBN4;TTYH1;TSPAN13;RGN;PDGFB;KCNH2;FXYD1;SFXN1;WNK4;NOL3;CTGF;AKT1;PIK3CG;KCNG2;GAS6;VDR;KCND1;CLDN16;PDE4B
2601,GO:0005381,0.0143336873864861,0.999299705065325,2,9,iron ion transmembrane transporter activity,MF,TF;TTYH1
3683,GO:0007176,0.0143616427635706,0.998392169396018,3,25,regulation of epidermal growth factor-activated receptor activity,BP,ADRA2B;ADRA2C;ADORA1
10446,GO:0038034,0.0143635808534554,0.996905612252749,5,69,signal transduction in absence of ligand,BP,FADD;FGF10;AKT1;KITLG;GDNF
17798,GO:0097192,0.0143635808534554,0.996905612252749,5,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,FADD;FGF10;AKT1;KITLG;GDNF
16937,GO:0072217,0.0143699598953496,0.999296996468251,2,9,negative regulation of metanephros development,BP,BMP4;WT1
11305,GO:0043267,0.0143899850712724,0.998387813556977,3,25,negative regulation of potassium ion transport,BP,ACTN2;CASQ2;KCNH2
8921,GO:0033079,0.0144055075438237,0.999294338432814,2,9,immature T cell proliferation,BP,WNT4;BMP4
6143,GO:0016832,0.0144445227826268,0.999291417052969,2,9,aldehyde-lyase activity,MF,CYP17A1;DERA
13903,GO:0051150,0.014468298571015,0.998375760689349,3,25,regulation of smooth muscle cell differentiation,BP,PDGFB;FOXO4;BMP4
18898,GO:1901681,0.0145111524553898,0.994626102060647,10,215,sulfur compound binding,MF,CRISPLD2;SERPINA5;FGF10;HACL1;ANG;HBEGF;BMP7;BMP4;CTGF;PTGES
16186,GO:0070900,0.0145142585407472,0.999286184817509,2,9,mitochondrial tRNA modification,BP,HSD17B10;PUS1
18646,GO:1900864,0.0145142585407472,0.999286184817509,2,9,mitochondrial RNA modification,BP,HSD17B10;PUS1
16552,GO:0071550,0.0146075974192461,0.999279160485722,2,9,death-inducing signaling complex assembly,BP,FADD;TRADD
19332,GO:1902882,0.0146815742122639,0.996819771393592,5,69,regulation of response to oxidative stress,BP,RGN;SESN2;BMP7;NOL3;AKT1
7358,GO:0030282,0.0147120630233848,0.996216173581692,6,96,bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
2658,GO:0005543,0.0148052457430525,0.993439898977698,14,353,phospholipid binding,MF,SYT5;ACTN2;SERPINA5;APOC1;ABCG1;MFGE8;SPTBN4;FZD7;PXK;SNX18;AKT1;SNX21;GAS6;RPH3AL
5183,GO:0014015,0.0148679106592553,0.997476213032795,4,46,positive regulation of gliogenesis,BP,LIF;NOTCH1;CLCF1;BMP2
15486,GO:0061383,0.0148708710291654,0.997472774945819,4,47,trabecula morphogenesis,BP,NOTCH1;RBP4;BMP7;HEY1
587,GO:0001678,0.0148765999121603,0.995650135702418,7,124,cellular glucose homeostasis,BP,PIK3R2;PIK3R1;SESN2;GJB6;STAR;PIK3CA;GAS6
21563,GO:2001057,0.0149009712071776,0.99675847734328,5,70,reactive nitrogen species metabolic process,BP,EDN1;RGN;TICAM1;AKT1;GLA
7343,GO:0030260,0.0149777536237447,0.995614732844784,7,124,entry into host cell,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
11785,GO:0044409,0.0149777536237447,0.995614732844784,7,124,entry into host,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
14274,GO:0051806,0.0149777536237447,0.995614732844784,7,124,entry into cell of other organism involved in symbiotic interaction,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
14281,GO:0051828,0.0149777536237447,0.995614732844784,7,124,entry into other organism involved in symbiotic interaction,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
6172,GO:0016878,0.0150297800099074,0.998288615855387,3,25,acid-thiol ligase activity,MF,ACSF2;ACSM5;ACSL4
1202,GO:0002682,0.0150976034267983,0.990563757710228,39,1306,regulation of immune system process,BP,CFB;LIF;NOTCH1;FADD;ZFPM1;ADORA1;EDN1;PNP;PRKACB;CCL20;PYCARD;TYRO3;PSMB10;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;HRAS;WNT5A;JAM3;RBP4;SDC4;CLCF1;NMI;BMP4;CDKN1A;DLL1;SHPK;MSN;AKT1;TMEM176A;KITLG;BCAR1;PIK3CA;GAS6;CLDN18;EFNB2;PDE4B
18811,GO:1901522,0.0152075332996778,0.998255115669855,3,26,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,NOTCH1;SESN2;BMP2
1146,GO:0002573,0.0152937464295132,0.994644086827416,9,185,myeloid leukocyte differentiation,BP,LIF;FADD;ZFPM1;FSTL3;PIK3R1;BMP4;KITLG;TSPAN2;CLDN18
12127,GO:0045295,0.0153921209023153,0.999202540830963,2,10,gamma-catenin binding,MF,CDH2;CDH1
9485,GO:0034504,0.0154188481901155,0.993133183484917,14,354,protein localization to nucleus,BP,LIF;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6;CLDN18
10116,GO:0035904,0.0155105241513346,0.997328148750475,4,48,aorta development,BP,NOTCH1;FGF8;HEY1;EFNB2
8207,GO:0031966,0.0155463574628222,0.991713261859721,22,634,mitochondrial membrane,CC,PDK4;PMAIP1;MRPL14;MRPL16;HMGCS2;SLC25A53;ACADVL;REEP1;CPT2;ACAT1;VAMP1;SFXN1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;CYB5A;ACSL4;ETFDH
8245,GO:0032029,0.015589091131519,1,1,1,myosin tail binding,MF,SPTBN5
14938,GO:0060415,0.0156922776487853,0.996536461577578,5,73,muscle tissue morphogenesis,BP,WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
11528,GO:0043648,0.0157211284510882,0.99589745843973,6,96,dicarboxylic acid metabolic process,BP,PHYH;GHR;MDH1;IDH1;STAR;SLC1A3
6141,GO:0016830,0.0158760513107091,0.997252121824671,4,46,carbon-carbon lyase activity,MF,HACL1;CYP17A1;ACAT1;DERA
15327,GO:0061041,0.0159310151184331,0.995276798778285,7,126,regulation of wound healing,BP,WNT4;EDN1;PLAU;PDGFB;HRAS;HBEGF;FAM46A
5939,GO:0016462,0.0159716866774509,0.990995251271166,26,810,pyrophosphatase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;ABCG1;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
6762,GO:0019904,0.0159844422294436,0.991455110637511,22,652,protein domain specific binding,MF,ITGA3;WNT3;ACTN2;RAB27A;FADD;TRADD;EBF1;PYCARD;FZD7;KCNH2;WNT5A;AXIN1;RHOQ;WT1;ESPN;NOL3;MYO7A;BCAR1;WBP1;RPH3AL;SHC4;FZD8
8423,GO:0032355,0.0159891490664538,0.995257101391497,7,125,response to estradiol,BP,DHH;WNT7A;FGF10;BMP7;CTGF;GJB2;TFPI
7379,GO:0030308,0.0159994801475928,0.994773771113804,8,155,negative regulation of cell growth,BP,WNT3;WNT5A;SESN2;NPR1;PSRC1;WT1;CDKN1A;SH3BP4
14295,GO:0051875,0.016054920533949,0.998120200544677,3,26,pigment granule localization,BP,RAB27A;RAB17;MYO7A
13759,GO:0050921,0.0160614153295424,0.995231427274637,7,125,positive regulation of chemotaxis,BP,ARTN;EDN1;FGF18;FGF10;PDGFB;WNT5A;GAS6
11702,GO:0044267,0.0161043603707185,0.988001316423879,116,4698,cellular protein metabolic process,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;ALG5;MARK4;DPM3;PMAIP1;GADD45A;MSRA;FBXO41;MRPL14;MRPL16;FADD;SERPINA5;WNT7A;WNT7B;TRADD;ACVR1;NMT2;ADORA1;EXTL1;EDN1;RAB40B;RAB40A;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PYCARD;KRT10;PRND;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;ETFB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;TSFM;CDKN1A;DLL1;PKN3;HEXB;WNK4;MSN;NOL3;DDR1;DEPTOR;CTGF;AKT1;IFI27;RAB12;NRTN;KITLG;CST9L;JAG2;INHBB;MDP1;SPSB1;TFPI;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;PM20D2;RBMS3;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;FZD8;DUSP5;RNF144A;PIM2
16739,GO:0071887,0.0161434694436433,0.995761314828722,6,97,leukocyte apoptotic process,BP,FADD;WNT5A;BMP4;AKT1;KITLG;GAS6
19260,GO:1902668,0.0161608783626646,0.999140869681956,2,10,negative regulation of axon guidance,BP,WNT3;WNT5A
19607,GO:1903428,0.0162001834003906,0.997176018948081,4,47,positive regulation of reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;TICAM1;AKT1
7679,GO:0030947,0.0162139952073973,0.998094561610008,3,26,regulation of vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;FGF18;FGF10
12427,GO:0045926,0.0162250651920871,0.993885439627608,10,218,negative regulation of growth,BP,WNT3;WNT5A;SESN2;RBP4;NPR1;PSRC1;BMP4;WT1;CDKN1A;SH3BP4
14765,GO:0060174,0.0162727568895568,0.999131760244957,2,10,limb bud formation,BP,WNT3;FGF10
2782,GO:0005768,0.0163029286480931,0.990792750556734,26,803,endosome,CC,TMEM163;ADRA2C;SYT5;RIN3;TSPAN15;RAB27A;TF;ZFYVE21;SLC31A2;TBC1D14;RAB40B;RAB40A;ABCG1;FZD7;TICAM1;SNX18;RHOB;RAB20;RAB12;RAB17;CYTIP;CDH1;SNX21;RAB11FIP1;RAB38;RNF144A
21043,GO:2000181,0.0163316258993319,0.996360863260975,5,72,negative regulation of blood vessel morphogenesis,BP,WNT4;NOTCH1;FOXO4;NPR1;AMOT
19230,GO:1902589,0.0163327632804834,0.989458909880343,44,1542,single-organism organelle organization,BP,FHOD3;SYT5;WNT4;TUBG2;ACTN2;NOTCH1;MARK4;ITGB5;PMAIP1;TBC1D14;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;RAB39A;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;AXIN1;RHOQ;RHOJ;NUAK2;PSRC1;SDC4;ANG;SPTB;DAAM2;RAB20;ESPN;VAMP1;RND3;NOL3;CTGF;PKP1;RAB17;BCAR1;MYH11;AMOT;LAMA5;PARVB;TMOD4
10620,GO:0042035,0.0163552478943417,0.995693377379045,6,97,regulation of cytokine biosynthetic process,BP,ZFPM1;CCL20;TICAM1;WNT5A;NMI;INHBB
21079,GO:2000243,0.0163804111428085,0.997135187209267,4,47,positive regulation of reproductive process,BP,WNT4;WNT5A;WT1;INHBB
13433,GO:0048845,0.016383457504193,0.99912271341132,2,10,venous blood vessel morphogenesis,BP,NOTCH1;EFNB2
14877,GO:0060340,0.0164360278942364,0.999118405604333,2,10,positive regulation of type I interferon-mediated signaling pathway,BP,FADD;WNT5A
6135,GO:0016818,0.0164498899971313,0.990701741307066,26,812,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;ABCG1;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
11392,GO:0043412,0.0165012389195304,0.987872244560977,100,3985,macromolecule modification,BP,ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;ALG5;MARK4;DPM3;GADD45A;MSRA;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EXTL1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PYCARD;KRT10;PRND;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;PRR5L;GHR;FGF18;FGF10;FGF17;PIK3R1;TICAM1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HSD17B10;ETFB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;HMGN5;PKN3;WNK4;DDR1;DEPTOR;CTGF;AKT1;NRTN;KITLG;PUS1;INHBB;MDP1;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;FZD8;DUSP5;RNF144A;PIM2
12126,GO:0045294,0.0165556003369961,0.999108579717715,2,10,alpha-catenin binding,MF,CDH2;PKP3
696,GO:0001841,0.0165652494874272,0.995621905826091,6,100,neural tube formation,BP,SALL4;PRKACB;WNT5A;SDC4;BMP7;BMP4
4825,GO:0010508,0.0166221899449723,0.995603534916568,6,100,positive regulation of autophagy,BP,TICAM1;RALB;SESN2;RAB12;SH3BP4;PIM2
14132,GO:0051547,0.0166525762567585,0.999100582518155,2,10,regulation of keratinocyte migration,BP,FGF10;HBEGF
9749,GO:0035272,0.0166576167629268,0.997069041333148,4,48,exocrine system development,BP,FGF10;FGF8;BMP7;LAMA5
4931,GO:0010676,0.0167120946329448,0.997056594496892,4,48,positive regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1;RGN;AKT1
11972,GO:0045023,0.0167364946196033,0.999093641797203,2,10,G0 to G1 transition,BP,FOXO4;CTGF
13517,GO:0050432,0.0167988195917609,0.997039857422562,4,47,catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA;GDNF
13333,GO:0048661,0.0168495384286791,0.996215857148829,5,72,positive regulation of smooth muscle cell proliferation,BP,EDN1;PDGFB;HBEGF;BMP4;AKT1
14346,GO:0051952,0.0168523235203861,0.996217021697553,5,71,regulation of amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA;GDNF
19145,GO:1902369,0.0168775840933419,0.999081930179251,2,10,negative regulation of RNA catabolic process,BP,PKP3;PKP1
14589,GO:0055065,0.0168858673003104,0.99138090484422,19,537,metal ion homeostasis,BP,CDH23;TF;SLC31A2;ADORA1;CASQ2;EDN1;BDH2;PRND;LPAR2;RGN;KCNH2;NPR1;BMP6;HEXB;SFXN1;NOL3;PIK3CG;VDR;CLDN16
13241,GO:0048477,0.0169151212934275,0.996197410217157,5,72,oogenesis,BP,WNT4;ANG;HEXB;NPPC;INHBB
6134,GO:0016817,0.0169356706884719,0.990402747544551,26,814,hydrolase activity, acting on acid anhydrides,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;ABCG1;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
14940,GO:0060419,0.0169515795657677,0.996185241386065,5,73,heart growth,BP,WNT2;NOTCH1;EDN1;RBP4;WT1
10576,GO:0039706,0.0169594735868935,0.999075108341092,2,10,co-receptor binding,MF,BMP4;BMP2
5118,GO:0010939,0.0170947122667527,0.997950864338214,3,26,regulation of necrotic cell death,BP,FADD;TRADD;NOL3
12240,GO:0045604,0.0171634496032222,0.996952988493959,4,48,regulation of epidermal cell differentiation,BP,NOTCH1;BMP4;DLL1;VDR
3408,GO:0006720,0.0171915790017213,0.994824789971141,7,127,isoprenoid metabolic process,BP,PECR;PHYH;STRA6;HMGCS2;RBP4;SDC4;STAR
16925,GO:0072203,0.0171987364575328,0.99905507449981,2,10,cell proliferation involved in metanephros development,BP,BMP7;WT1
1523,GO:0003270,0.0172579615390709,1,1,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
15221,GO:0060843,0.0172579615390709,1,1,1,venous endothelial cell differentiation,BP,NOTCH1
15006,GO:0060502,0.0172579743550016,0.999050091033238,2,10,epithelial cell proliferation involved in lung morphogenesis,BP,WNT2;BMP4
16372,GO:0071281,0.0173761685215868,0.99904012014764,2,10,cellular response to iron ion,BP,TF;BMP6
11676,GO:0044233,0.0173892022846046,0.99903901836535,2,10,ER-mitochondrion membrane contact site,CC,RAB38;ACSL4
7111,GO:0022607,0.0174123520324777,0.987797003624395,68,2570,cellular component assembly,BP,ITGA5;FHOD3;WNT4;TUBG2;ACTN3;ACTN2;NOTCH1;MARK4;ITGB5;ITGB4;PMAIP1;FADD;WNT7A;APOC1;TRADD;TBC1D14;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;TTYH1;RAB39A;PRND;LIMS2;CDH2;PIK3R1;RALB;HRAS;WNT5A;HACL1;AXIN1;RHOQ;PSRC1;SDC4;ANG;FAM110C;SPTB;BMP7;ACAT1;RAB20;ESPN;VAMP1;MSN;NOL3;CTGF;GJB1;GJB2;PCBD1;PKP3;PKP1;RAB17;DECR1;CDH1;MYO7A;TLE1;CLDN1;CLDN3;CLDN5;KCNG2;GAS6;MYH11;HNF1A;LAMA5;KCND1;RAB38;PARVB;TMOD4
16584,GO:0071600,0.0175089904652957,0.999028871419028,2,10,otic vesicle morphogenesis,BP,FGF10;FGF8
19134,GO:1902337,0.0175735621099386,0.999023386109749,2,10,regulation of apoptotic process involved in morphogenesis,BP,BMP7;VDR
20221,GO:1904748,0.0175735621099386,0.999023386109749,2,10,regulation of apoptotic process involved in development,BP,BMP7;VDR
1542,GO:0003306,0.0175819804991638,0.999022670169726,2,10,Wnt signaling pathway involved in heart development,BP,WNT5A;BMP2
5002,GO:0010800,0.0176684480574954,0.997849323454016,3,27,positive regulation of peptidyl-threonine phosphorylation,BP,WNT5A;AXIN1;BMP7
13967,GO:0051249,0.0176894666799675,0.991738299267841,15,390,regulation of lymphocyte activation,BP,FADD;PNP;PYCARD;TYRO3;FGF10;PIK3R1;TICAM1;SDC4;CLCF1;BMP4;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
15228,GO:0060856,0.0177542870561029,0.9990079756981,2,10,establishment of blood-brain barrier,BP,WNT7A;WNT7B
13572,GO:0050671,0.0177884347605626,0.99460874090191,7,127,positive regulation of lymphocyte proliferation,BP,FADD;PNP;PYCARD;FGF10;TICAM1;CLCF1;CDKN1A
9780,GO:0035337,0.0178303878646901,0.996798341979343,4,48,fatty-acyl-CoA metabolic process,BP,FASN;ACSF2;ACSL4;ELOVL6
3999,GO:0008199,0.0178392715601237,0.999000699618141,2,10,ferric iron binding,MF,TF;ACP5
1901,GO:0004313,0.0178444278441788,1,1,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,FASN
1904,GO:0004316,0.0178444278441788,1,1,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,FASN
1905,GO:0004317,0.0178444278441788,1,1,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,FASN
1906,GO:0004319,0.0178444278441788,1,1,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,FASN
6514,GO:0019171,0.0178444278441788,1,1,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,FASN
12939,GO:0047117,0.0178444278441788,1,1,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,FASN
12990,GO:0047451,0.0178444278441788,1,1,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,FASN
18400,GO:0102132,0.0178444278441788,1,1,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,FASN
15812,GO:0070231,0.0178626148617591,0.996790823004985,4,48,T cell apoptotic process,BP,FADD;WNT5A;BMP4;AKT1
2343,GO:0004935,0.0178634345071647,0.998998627437825,2,10,adrenergic receptor activity,MF,ADRA2B;ADRA2C
7509,GO:0030595,0.0178839046637326,0.993570365299481,9,187,leukocyte chemotaxis,BP,EDN1;CCL20;PDGFB;WNT5A;JAM3;CHGA;PIK3CG;GAS6;PDE4B
3676,GO:0007168,0.017922118471076,0.998993588464811,2,10,receptor guanylyl cyclase signaling pathway,BP,NPR1;NPPC
12011,GO:0045080,0.0179228370630609,0.998993526706557,2,10,positive regulation of chemokine biosynthetic process,BP,TICAM1;WNT5A
21016,GO:2000121,0.0179303671450633,0.998992879464902,2,10,regulation of removal of superoxide radicals,BP,RGN;BMP7
15838,GO:0070265,0.0180682742422063,0.996742740471462,4,48,necrotic cell death,BP,FADD;TRADD;TICAM1;NOL3
728,GO:0001889,0.0181132425840339,0.994487422948047,7,130,liver development,BP,WNT4;NOTCH1;LIMS2;RGN;ACAT1;CLDN1;PIK3CA
5831,GO:0016241,0.0181290538830044,0.994481653573837,7,130,regulation of macroautophagy,BP,TBC1D14;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1
9663,GO:0035050,0.0181450349083768,0.995843934441781,5,74,embryonic heart tube development,BP,NOTCH1;ACVR1;WNT5A;FGF8;DLL1
598,GO:0001702,0.0183273218152483,0.997732030373004,3,28,gastrulation with mouth forming second,BP,ACVR1;WNT5A;AMOT
19738,GO:1903706,0.0183325876355324,0.991933898544825,13,323,regulation of hemopoiesis,BP,LIF;NOTCH1;FADD;ZFPM1;PNP;FSTL3;PIK3R1;BMP4;DLL1;TMEM176A;KITLG;GAS6;CLDN18
11307,GO:0043269,0.0183352839852657,0.990384403057022,20,582,regulation of ion transport,BP,ACTN2;SLC31A2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;RGN;PDGFB;KCNH2;FXYD1;WNK4;AKT1;PIK3CG;KCNG2;KCND1;GDNF;PDE4B
13834,GO:0051047,0.018358521214406,0.99164177473746,14,358,positive regulation of secretion,BP,RAB27A;ADORA1;EDN1;PYCARD;WNT5A;RBP4;NPR1;SDC4;ANG;BMP6;INHBB;RPH3AL;RAB3D;GDNF
8843,GO:0032946,0.0184930361574778,0.994350644439168,7,128,positive regulation of mononuclear cell proliferation,BP,FADD;PNP;PYCARD;FGF10;TICAM1;CLCF1;CDKN1A
20912,GO:1990909,0.0186248465055722,0.998914626801921,2,11,Wnt signalosome,CC,WNT3;WNT2
905,GO:0002140,0.0186523586632343,1,1,1,stereocilia tip link,CC,MYO7A
7975,GO:0031477,0.0186523586632343,1,1,1,myosin VII complex,CC,MYO7A
20778,GO:1990427,0.0186523586632343,1,1,1,stereocilia tip-link density,CC,MYO7A
20782,GO:1990435,0.0186523586632343,1,1,1,upper tip-link density,CC,MYO7A
19644,GO:1903523,0.0187089573396258,0.997666785977547,3,28,negative regulation of blood circulation,BP,ADORA1;SPTBN4;PIK3CG
17576,GO:0090383,0.0187525815061278,0.997665675349752,3,27,phagosome acidification,BP,RAB39A;RAB20;RAB38
14864,GO:0060325,0.0187768070449942,0.997655131763995,3,28,face morphogenesis,BP,STRA6;CRISPLD2;CLDN5
2655,GO:0005539,0.0188823628625487,0.993145841474459,9,192,glycosaminoglycan binding,MF,CRISPLD2;SERPINA5;FGF10;ANG;HBEGF;BMP7;BMP4;CTGF;HAPLN3
5035,GO:0010837,0.0188952286707369,0.997634751760717,3,28,regulation of keratinocyte proliferation,BP,FGF10;VDR;EFNB2
4950,GO:0010720,0.0189185819381558,0.990847736971773,16,437,positive regulation of cell development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;EDN1;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;STAR;CLDN5
10756,GO:0042310,0.0189424823689439,0.995613760964367,5,74,vasoconstriction,BP,ADRA2B;ADRA2C;EDN1;AKT1;ACTA2
6570,GO:0019320,0.0189788548070442,0.996524348400549,4,49,hexose catabolic process,BP,ACTN3;KHK;GALT;PFKFB3
8914,GO:0033059,0.0191915316140596,0.99647026453786,4,50,cellular pigmentation,BP,RAB27A;RAB17;MYO7A;RAB38
11483,GO:0043560,0.0192588032091228,0.998857557525939,2,11,insulin receptor substrate binding,MF,PIK3R1;PIK3CA
13453,GO:0048872,0.0192792361885414,0.992532137703035,10,225,homeostasis of number of cells,BP,PMAIP1;FADD;ZFPM1;CDH2;JAM3;BMP4;SFXN1;AKT1;KITLG;PDE4B
19723,GO:1903670,0.0194111718271764,0.997545380411347,3,28,regulation of sprouting angiogenesis,BP,ITGA5;NOTCH1;DLL1
17076,GO:0072523,0.0195640175011575,0.99638092445663,4,50,purine-containing compound catabolic process,BP,PNP;AOX1;NUDT7;PDE4B
13731,GO:0050885,0.0196435342121659,0.996358461698514,4,51,neuromuscular process controlling balance,BP,CDH23;HEXB;MYO7A;SLC1A3
11317,GO:0043281,0.0196857088546414,0.992803878364207,9,192,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;FADD;TRADD;PYCARD;NOL3;CTGF;AKT1;IFI27;GAS6
12830,GO:0046847,0.0197497688726803,0.996332828160939,4,51,filopodium assembly,BP,TTYH1;RHOQ;ESPN;RAB17
20718,GO:1990172,0.0197849299030455,1,1,1,G-protein coupled receptor catabolic process,BP,GPRASP1
4688,GO:0009948,0.0197896455663423,0.996326546976863,4,50,anterior/posterior axis specification,BP,WNT3;WNT5A;BMP4;WT1
2455,GO:0005115,0.0198148209182957,1,1,1,receptor tyrosine kinase-like orphan receptor binding,MF,WNT5A
10418,GO:0036517,0.0198148209182957,1,1,1,chemoattraction of serotonergic neuron axon,BP,WNT5A
15462,GO:0061347,0.0198148209182957,1,1,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,WNT5A
15463,GO:0061348,0.0198148209182957,1,1,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,WNT5A
15464,GO:0061349,0.0198148209182957,1,1,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,WNT5A
15465,GO:0061350,0.0198148209182957,1,1,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,WNT5A
15467,GO:0061354,0.0198148209182957,1,1,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,WNT5A
15586,GO:0061642,0.0198148209182957,1,1,1,chemoattraction of axon,BP,WNT5A
19148,GO:1902379,0.0198148209182957,1,1,1,chemoattractant activity involved in axon guidance,MF,WNT5A
20314,GO:1904934,0.0198148209182957,1,1,1,negative regulation of cell proliferation in midbrain,BP,WNT5A
20325,GO:1904955,0.0198148209182957,1,1,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
4764,GO:0010256,0.0198335721376236,0.989700806392361,19,553,endomembrane system organization,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB27A;RAB40B;RAB40A;SPTBN5;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5;RAB38
20812,GO:1990578,0.0198355319680699,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
21640,GO:2001238,0.019953917278746,0.996286833789464,4,50,positive regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;FADD;PYCARD;G0S2
21416,GO:2000726,0.0199671546844109,0.998792575027916,2,11,negative regulation of cardiac muscle cell differentiation,BP,FZD7;BMP2
1448,GO:0003157,0.0200141087270339,0.998788222656996,2,11,endocardium development,BP,NOTCH1;ACVR1
16828,GO:0072070,0.0200443797458073,0.99878541376216,2,11,loop of Henle development,BP,WNT7B;DLL1
11707,GO:0044273,0.0200987653404231,0.996251730887138,4,50,sulfur compound catabolic process,BP,ACAT1;IDUA;HEXB;NUDT7
13976,GO:0051258,0.0201179018750224,0.992153695649075,10,227,protein polymerization,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;PYCARD;PSRC1;ANG;SPTB;TMOD4
15303,GO:0061008,0.0201568866630351,0.993729796765742,7,133,hepaticobiliary system development,BP,WNT4;NOTCH1;LIMS2;RGN;ACAT1;CLDN1;PIK3CA
3393,GO:0006695,0.0201591832348385,0.996237065461437,4,50,cholesterol biosynthetic process,BP,EBP;HMGCS2;ABCG1;DHCR7
14576,GO:0055023,0.0201846160980276,0.997403129488956,3,29,positive regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1
17239,GO:0085029,0.0202008258636294,0.997400256077671,3,29,extracellular matrix assembly,BP,NOTCH1;GAS6;MYH11
7598,GO:0030823,0.0202360860733557,0.997400558915399,3,28,regulation of cGMP metabolic process,BP,WNT5A;NPR1;NPPC
16430,GO:0071372,0.0202801042247293,0.998763461706504,2,11,cellular response to follicle-stimulating hormone stimulus,BP,NOTCH1;STAR
13014,GO:0047676,0.020299862566856,1,1,1,arachidonate-CoA ligase activity,MF,ACSL4
12352,GO:0045792,0.0203289069578407,0.998758899490857,2,11,negative regulation of cell size,BP,DEPTOR;AKT1
10592,GO:0040020,0.020362531635934,0.997378153085298,3,28,regulation of meiotic nuclear division,BP,LIF;WNT4;WNT5A
20707,GO:1990134,0.020404178002552,1,1,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,JAG2
11460,GO:0043534,0.0204101639915438,0.995178952024861,5,76,blood vessel endothelial cell migration,BP,NOTCH1;PDGFB;AKT1;AMOT;EFNB2
21635,GO:2001233,0.020497220416711,0.990535156585953,14,362,regulation of apoptotic signaling pathway,BP,WNT4;PMAIP1;FADD;TRADD;ACVR1;PYCARD;G0S2;FGF10;BMP4;NOL3;DEPTOR;AKT1;INHBB;GDNF
4721,GO:0010035,0.020537664754034,0.989727569179452,17,473,response to inorganic substance,BP,TF;GUCY1B3;CASQ2;EDN1;RGN;FSTL3;WNT5A;KHK;RHOB;BMP7;BMP6;AKT1;PTGES;CDH1;STAR;CLDN1;CYB5A
5004,GO:0010803,0.0205700510108355,0.996136968385,4,50,regulation of tumor necrosis factor-mediated signaling pathway,BP,TRADD;PYCARD;NOL3;GAS6
10621,GO:0042036,0.0205843950256161,0.997338707811262,3,28,negative regulation of cytokine biosynthetic process,BP,ZFPM1;NMI;INHBB
13904,GO:0051151,0.0206011100143862,0.998733343999922,2,11,negative regulation of smooth muscle cell differentiation,BP,PDGFB;FOXO4
4147,GO:0008434,0.0206047894234466,1,1,1,calcitriol receptor activity,MF,VDR
10529,GO:0038186,0.0206047894234466,1,1,1,lithocholic acid receptor activity,MF,VDR
19025,GO:1902098,0.0206047894234466,1,1,1,calcitriol binding,MF,VDR
19041,GO:1902121,0.0206047894234466,1,1,1,lithocholic acid binding,MF,VDR
14213,GO:0051695,0.0206971414502002,1,1,1,actin filament uncapping,BP,ACTN2
14959,GO:0060439,0.0207460970117505,0.998719656700421,2,11,trachea morphogenesis,BP,WNT7B;BMP4
122,GO:0000248,0.020754549157232,1,1,1,C-5 sterol desaturase activity,MF,FADS1
12194,GO:0045485,0.020754549157232,1,1,1,omega-6 fatty acid desaturase activity,MF,FADS1
16095,GO:0070704,0.020754549157232,1,1,1,sterol desaturase activity,MF,FADS1
7930,GO:0031406,0.0207831589445653,0.992874344481864,8,162,carboxylic acid binding,MF,PHYH;GLDC;SERPINA5;APOC1;SESN2;FABP3;VDR;SLC1A3
11454,GO:0043524,0.0207965756682781,0.993490125833272,7,133,negative regulation of neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;STAR;PIK3CA;GDNF
13255,GO:0048505,0.0208602879704771,0.998708839919552,2,11,regulation of timing of cell differentiation,BP,NOTCH1;DLL1
18893,GO:1901676,0.020904534458708,1,1,1,positive regulation of histone H3-K27 acetylation,BP,LIF
5884,GO:0016332,0.0209054081072927,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
16825,GO:0072060,0.0209054081072927,1,1,1,outer medullary collecting duct development,BP,WNT7B
8194,GO:0031945,0.0209065423711004,1,1,1,positive regulation of glucocorticoid metabolic process,BP,WNT4
8197,GO:0031948,0.0209065423711004,1,1,1,positive regulation of glucocorticoid biosynthetic process,BP,WNT4
15477,GO:0061369,0.0209065423711004,1,1,1,negative regulation of testicular blood vessel morphogenesis,BP,WNT4
20954,GO:2000019,0.0209065423711004,1,1,1,negative regulation of male gonad development,BP,WNT4
20986,GO:2000066,0.0209065423711004,1,1,1,positive regulation of cortisol biosynthetic process,BP,WNT4
21068,GO:2000225,0.0209065423711004,1,1,1,negative regulation of testosterone biosynthetic process,BP,WNT4
609,GO:0001715,0.0209135464671459,1,1,1,ectodermal cell fate specification,BP,FZD7
10973,GO:0042665,0.0209135464671459,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
10974,GO:0042666,0.0209135464671459,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
21185,GO:2000383,0.0209135464671459,1,1,1,regulation of ectoderm development,BP,FZD7
21186,GO:2000384,0.0209135464671459,1,1,1,negative regulation of ectoderm development,BP,FZD7
13497,GO:0050277,0.0209143122643918,1,1,1,sedoheptulokinase activity,MF,SHPK
1950,GO:0004375,0.0209156731993065,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
6040,GO:0016642,0.0209156731993065,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
17407,GO:0090138,0.0209266813402236,1,1,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,JAM3
18995,GO:1902010,0.0209304645275276,1,1,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
15647,GO:0061772,0.0209306544736591,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
19660,GO:1903544,0.0209306544736591,1,1,1,response to butyrate,BP,CLDN1
19661,GO:1903545,0.0209306544736591,1,1,1,cellular response to butyrate,BP,CLDN1
7016,GO:0021881,0.0209306602870674,1,1,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,AXIN1
6910,GO:0021679,0.0209307222059978,1,1,1,cerebellar molecular layer development,BP,DLL1
6918,GO:0021687,0.0209307222059978,1,1,1,cerebellar molecular layer morphogenesis,BP,DLL1
6919,GO:0021688,0.0209307222059978,1,1,1,cerebellar molecular layer formation,BP,DLL1
15227,GO:0060853,0.0209307222059978,1,1,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,DLL1
4176,GO:0008480,0.0209307289434604,1,1,1,sarcosine dehydrogenase activity,MF,SARDH
18664,GO:1901052,0.0209307289434604,1,1,1,sarcosine metabolic process,BP,SARDH
18665,GO:1901053,0.0209307289434604,1,1,1,sarcosine catabolic process,BP,SARDH
12171,GO:0045403,0.0209311337567727,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
14906,GO:0060377,0.0209311337567727,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
9949,GO:0035623,0.0209311755381261,1,1,1,renal glucose absorption,BP,HNF1A
5175,GO:0014004,0.0209315386855278,1,1,1,microglia differentiation,BP,TSPAN2
5176,GO:0014005,0.0209315386855278,1,1,1,microglia development,BP,TSPAN2
8614,GO:0032605,0.0209317534894602,1,1,1,hepatocyte growth factor production,BP,INHBB
8643,GO:0032646,0.0209317534894602,1,1,1,regulation of hepatocyte growth factor production,BP,INHBB
8668,GO:0032686,0.0209317534894602,1,1,1,negative regulation of hepatocyte growth factor production,BP,INHBB
12809,GO:0046789,0.0209317534894602,1,1,1,host cell surface receptor binding,MF,INHBB
12813,GO:0046812,0.0209317534894602,1,1,1,host cell surface binding,MF,INHBB
13125,GO:0048175,0.0209317534894602,1,1,1,hepatocyte growth factor biosynthetic process,BP,INHBB
13126,GO:0048176,0.0209317534894602,1,1,1,regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
13127,GO:0048178,0.0209317534894602,1,1,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
13829,GO:0051042,0.0209329601448924,1,1,1,negative regulation of calcium-independent cell-cell adhesion,BP,BMP2
15200,GO:0060804,0.0209329601448924,1,1,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,BMP2
12688,GO:0046523,0.0209343936129752,1,1,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,MRI1
16981,GO:0072299,0.0209402626718547,1,1,1,negative regulation of metanephric glomerulus development,BP,WT1
16984,GO:0072302,0.0209402626718547,1,1,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
4624,GO:0009720,0.0209416878807729,1,1,1,detection of hormone stimulus,BP,ABCG1
15266,GO:0060957,0.0209438917358582,1,1,1,endocardial cell fate commitment,BP,ACVR1
15507,GO:0061445,0.0209438917358582,1,1,1,endocardial cushion cell fate commitment,BP,ACVR1
8420,GO:0032352,0.0209440576168739,0.998700884269209,2,11,positive regulation of hormone metabolic process,BP,WNT4;BMP6
4501,GO:0009237,0.0209476088567761,1,1,1,siderophore metabolic process,BP,BDH2
6564,GO:0019290,0.0209476088567761,1,1,1,siderophore biosynthetic process,BP,BDH2
16957,GO:0072255,0.0209531418965841,1,1,1,metanephric glomerular mesangial cell development,BP,PDGFB
17668,GO:0090677,0.0209531418965841,1,1,1,reversible differentiation,BP,PDGFB
17669,GO:0090678,0.0209531418965841,1,1,1,cell dedifferentiation involved in phenotypic switching,BP,PDGFB
18568,GO:1900241,0.0209531418965841,1,1,1,positive regulation of phenotypic switching,BP,PDGFB
20409,GO:1905174,0.0209531418965841,1,1,1,regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
20410,GO:1905176,0.0209531418965841,1,1,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
20926,GO:1990936,0.0209531418965841,1,1,1,vascular smooth muscle cell dedifferentiation,BP,PDGFB
3002,GO:0006113,0.0209538825928377,1,1,1,fermentation,BP,ACTN3
6659,GO:0019659,0.0209538825928377,1,1,1,glucose catabolic process to lactate,BP,ACTN3
6660,GO:0019660,0.0209538825928377,1,1,1,glycolytic fermentation,BP,ACTN3
6661,GO:0019661,0.0209538825928377,1,1,1,glucose catabolic process to lactate via pyruvate,BP,ACTN3
11414,GO:0043465,0.0209538825928377,1,1,1,regulation of fermentation,BP,ACTN3
19269,GO:1902690,0.0209538825928377,1,1,1,positive regulation of NAD metabolic process,BP,ACTN3
19901,GO:1904023,0.0209538825928377,1,1,1,regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
19902,GO:1904025,0.0209538825928377,1,1,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
15138,GO:0060709,0.0209549887438663,1,1,1,glycogen cell differentiation involved in embryonic placenta development,BP,AKT1
18383,GO:0100002,0.0209549887438663,1,1,1,negative regulation of protein kinase activity by protein phosphorylation,BP,AKT1
15386,GO:0061143,0.0209574547938936,1,1,1,alveolar primary septum development,BP,STRA6
8361,GO:0032242,0.0209586707744186,1,1,1,regulation of nucleoside transport,BP,ADORA1
8362,GO:0032244,0.0209586707744186,1,1,1,positive regulation of nucleoside transport,BP,ADORA1
8808,GO:0032900,0.0209586707744186,1,1,1,negative regulation of neurotrophin production,BP,ADORA1
19614,GO:1903435,0.0209648625238748,1,1,1,positive regulation of constitutive secretory pathway,BP,RAB27A
15823,GO:0070243,0.020971194292071,0.998698303361736,2,11,regulation of thymocyte apoptotic process,BP,WNT5A;BMP4
13907,GO:0051154,0.0209919736817084,0.997258925339196,3,29,negative regulation of striated muscle cell differentiation,BP,NOTCH1;FZD7;BMP2
12375,GO:0045836,0.0209952854891748,0.998696010577735,2,11,positive regulation of meiotic nuclear division,BP,WNT4;WNT5A
4683,GO:0009918,0.0209974420809107,1,1,1,sterol delta7 reductase activity,MF,DHCR7
5784,GO:0016131,0.0209974420809107,1,1,1,brassinosteroid metabolic process,BP,DHCR7
5785,GO:0016132,0.0209974420809107,1,1,1,brassinosteroid biosynthetic process,BP,DHCR7
13004,GO:0047598,0.0209974420809107,1,1,1,7-dehydrocholesterol reductase activity,MF,DHCR7
9676,GO:0035089,0.021011975619621,0.998694421320157,2,11,establishment of apical/basal cell polarity,BP,WNT5A;MSN
18509,GO:1900141,0.0210422249026758,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
18510,GO:1900142,0.0210422249026758,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
21282,GO:2000533,0.0210422249026758,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
1900,GO:0004312,0.0210639393208126,0.998689468860176,2,11,fatty acid synthase activity,MF,FASN;ELOVL6
1992,GO:0004454,0.0210734816532361,1,1,1,ketohexokinase activity,MF,KHK
3017,GO:0006148,0.0210749496994542,1,1,1,inosine catabolic process,BP,PNP
3419,GO:0006738,0.0210749496994542,1,1,1,nicotinamide riboside catabolic process,BP,PNP
12672,GO:0046495,0.0210749496994542,1,1,1,nicotinamide riboside metabolic process,BP,PNP
16055,GO:0070637,0.0210749496994542,1,1,1,pyridine nucleoside metabolic process,BP,PNP
16056,GO:0070638,0.0210749496994542,1,1,1,pyridine nucleoside catabolic process,BP,PNP
19344,GO:1902904,0.0210889520569739,0.994111338676518,6,105,negative regulation of supramolecular fiber organization,BP,FHOD3;SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
14129,GO:0051543,0.0210959928783754,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
14130,GO:0051545,0.0210959928783754,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
6290,GO:0017133,0.021097528523393,1,1,1,mitochondrial electron transfer flavoprotein complex,CC,ETFDH
11549,GO:0043783,0.021097528523393,1,1,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,ETFDH
12109,GO:0045251,0.021097528523393,1,1,1,electron transfer flavoprotein complex,CC,ETFDH
9391,GO:0034356,0.0211059053592693,0.998685464376546,2,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,PNP;NNMT
10188,GO:0036024,0.0211134891443042,1,1,1,protein C inhibitor-TMPRSS7 complex,CC,SERPINA5
10189,GO:0036025,0.0211134891443042,1,1,1,protein C inhibitor-TMPRSS11E complex,CC,SERPINA5
10190,GO:0036026,0.0211134891443042,1,1,1,protein C inhibitor-PLAT complex,CC,SERPINA5
10191,GO:0036027,0.0211134891443042,1,1,1,protein C inhibitor-PLAU complex,CC,SERPINA5
10192,GO:0036028,0.0211134891443042,1,1,1,protein C inhibitor-thrombin complex,CC,SERPINA5
10193,GO:0036029,0.0211134891443042,1,1,1,protein C inhibitor-KLK3 complex,CC,SERPINA5
10194,GO:0036030,0.0211134891443042,1,1,1,protein C inhibitor-plasma kallikrein complex,CC,SERPINA5
17789,GO:0097179,0.0211134891443042,1,1,1,protease inhibitor complex,CC,SERPINA5
17790,GO:0097180,0.0211134891443042,1,1,1,serine protease inhibitor complex,CC,SERPINA5
17791,GO:0097181,0.0211134891443042,1,1,1,protein C inhibitor-coagulation factor V complex,CC,SERPINA5
17792,GO:0097182,0.0211134891443042,1,1,1,protein C inhibitor-coagulation factor Xa complex,CC,SERPINA5
17793,GO:0097183,0.0211134891443042,1,1,1,protein C inhibitor-coagulation factor XI complex,CC,SERPINA5
13661,GO:0050789,0.0211282711223378,0.983815058465692,235,10394,regulation of biological process,BP,ITGA3;ITGA5;ARTN;CFB;EBP;PDK4;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;IFI30;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;SLC31A2;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;RABIF;NMT2;SALL4;TBC1D14;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PNP;RHPN1;ABCG1;PRKACB;KCNK6;MFGE8;CCL20;EBF1;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;TTYH1;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;PXK;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;GPRASP1;SESN2;AXIN1;FXYD1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;TSFM;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SHPK;ESPN;HEXB;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;DDR1;DEPTOR;CTGF;GJB6;RRAD;PCBD1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;FAM46A;TMEM176A;CYTIP;PTGES;KITLG;IDH1;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;GLA;DTX4;ZCCHC12;RPH3AL;LZTS1;S100B;DHCR7;PTS;PM20D2;SHC4;RBMS3;HNF1A;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;DOK1;RAB3D;GDNF;MYZAP;SLC1A3;FZD8;DUSP5;HEY1;ACTA2;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;PDE4B;TMOD4
755,GO:0001928,0.0211354449239067,1,1,1,regulation of exocyst assembly,BP,RALB
14768,GO:0060178,0.0211354449239067,1,1,1,regulation of exocyst localization,BP,RALB
3970,GO:0008152,0.0211396392857926,0.983839751410214,240,10623,metabolic process,BP,ITGA3;ITGA5;ARTN;CFB;EBP;PDK4;PECR;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;USE1;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;IFI30;PNMT;DPM3;STRA6;ZFYVE21;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;RHBDL3;FBXO41;MRPL14;MRPL16;MRI1;FADD;DHH;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;WDR45;NMT2;SALL4;TBC1D14;GUCY1B3;ADORA1;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PRKACB;MFGE8;CCL20;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;MBOAT2;LAGE3;ACADVL;KRT10;RAB39A;PRND;MGST2;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PTPN7;NNMT;FOXO4;RALB;CPT2;PLA2G16;HSD17B10;ETFB;HRAS;WNT5A;MAGEC2;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;ECHDC2;SARDH;SHPK;HEXB;CMBL;WNK4;FABP3;CHGA;MSN;NOL3;HSD3B2;NUDT7;DDR1;DEPTOR;CTGF;ACCS;CPT1C;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;PON2;NRTN;FAM46A;PTGES;KITLG;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;INHBB;PTMS;LDHD;MDP1;SPSB1;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;PEPD;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;LZTS1;DERA;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;HNF1A;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;LYPLAL1;ACSL4;SLC1A3;FZD8;ELOVL6;DUSP5;HEY1;ACTA2;RNF144A;PIM2;ETFDH;PDE4B
1716,GO:0003940,0.021161583370058,1,1,1,L-iduronidase activity,MF,IDUA
7307,GO:0030209,0.021161583370058,1,1,1,dermatan sulfate catabolic process,BP,IDUA
3535,GO:0006924,0.0211753423875791,0.998678829024118,2,11,activation-induced cell death of T cells,BP,FADD;AKT1
16801,GO:0072019,0.0211843694233187,1,1,1,proximal convoluted tubule development,BP,ACAT1
16944,GO:0072229,0.0211843694233187,1,1,1,metanephric proximal convoluted tubule development,BP,ACAT1
19323,GO:1902858,0.0211843694233187,1,1,1,propionyl-CoA metabolic process,BP,ACAT1
19324,GO:1902860,0.0211843694233187,1,1,1,propionyl-CoA biosynthetic process,BP,ACAT1
8019,GO:0031583,0.0212016567448982,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
8096,GO:0031707,0.0212016567448982,1,1,1,endothelin A receptor binding,MF,EDN1
9568,GO:0034696,0.0212016567448982,1,1,1,response to prostaglandin F,BP,EDN1
10758,GO:0042313,0.0212016567448982,1,1,1,protein kinase C deactivation,BP,EDN1
11243,GO:0043179,0.0212016567448982,1,1,1,rhythmic excitation,BP,EDN1
17268,GO:0086030,0.0212239394708733,1,1,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,CHGA
13571,GO:0050670,0.0212516288045574,0.992128628651977,9,194,regulation of lymphocyte proliferation,BP,FADD;PNP;PYCARD;FGF10;TICAM1;SDC4;CLCF1;BMP4;CDKN1A
4115,GO:0008386,0.0212538830432065,1,1,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,CYP11A1
15964,GO:0070473,0.0212618451428601,1,1,1,negative regulation of uterine smooth muscle contraction,BP,ADRA2C
1923,GO:0004341,0.021271773470759,1,1,1,gluconolactonase activity,MF,RGN
19695,GO:1903610,0.021271773470759,1,1,1,regulation of calcium-dependent ATPase activity,BP,RGN
19696,GO:1903611,0.021271773470759,1,1,1,negative regulation of calcium-dependent ATPase activity,BP,RGN
19705,GO:1903627,0.021271773470759,1,1,1,regulation of dUTP diphosphatase activity,BP,RGN
19706,GO:1903629,0.021271773470759,1,1,1,positive regulation of dUTP diphosphatase activity,BP,RGN
19708,GO:1903631,0.021271773470759,1,1,1,negative regulation of aminoacyl-tRNA ligase activity,BP,RGN
19710,GO:1903633,0.021271773470759,1,1,1,regulation of leucine-tRNA ligase activity,BP,RGN
19711,GO:1903634,0.021271773470759,1,1,1,negative regulation of leucine-tRNA ligase activity,BP,RGN
13665,GO:0050794,0.0212727068867289,0.983635710362097,223,9810,regulation of cellular process,BP,ITGA3;ITGA5;ARTN;EBP;PDK4;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;IFI30;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;FADD;DHH;DSC2;SERPINA5;WNT6;P2RY14;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;RABIF;NMT2;SALL4;TBC1D14;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PNP;RHPN1;ABCG1;PRKACB;MFGE8;CCL20;EBF1;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;PXK;PLA2G16;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;GPRASP1;SESN2;AXIN1;RBP4;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;TSFM;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SHPK;ESPN;HEXB;WNK4;FABP3;GRIA3;RND3;CHGA;MSN;NOL3;DDR1;DEPTOR;CTGF;GJB6;RRAD;PCBD1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;TMEM176A;PTGES;KITLG;IDH1;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TFPI;TLE1;STAR;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;GLA;DTX4;ZCCHC12;RPH3AL;LZTS1;S100B;DHCR7;PM20D2;SHC4;RBMS3;HNF1A;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;DOK1;RAB3D;GDNF;MYZAP;SLC1A3;FZD8;DUSP5;HEY1;CLDN18;RNF144A;PIM2;PARVB;EFNB2;LINGO1;PDE4B;TMOD4
3910,GO:0008049,0.0212796068676757,1,1,1,male courtship behavior,BP,HEXB
18396,GO:0102009,0.0212847914012248,1,1,1,proline dipeptidase activity,MF,PEPD
2036,GO:0004508,0.0212942754603314,1,1,1,steroid 17-alpha-monooxygenase activity,MF,CYP17A1
12988,GO:0047442,0.0212942754603314,1,1,1,17-alpha-hydroxyprogesterone aldolase activity,MF,CYP17A1
21228,GO:2000454,0.021302472182877,1,1,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
6728,GO:0019852,0.0213255671018695,0.998664433065512,2,11,L-ascorbic acid metabolic process,BP,RGN;CYB5A
13229,GO:0048390,0.0213278818950141,1,1,1,intermediate mesoderm morphogenesis,BP,BMP4
13230,GO:0048391,0.0213278818950141,1,1,1,intermediate mesoderm formation,BP,BMP4
13231,GO:0048392,0.0213278818950141,1,1,1,intermediate mesodermal cell differentiation,BP,BMP4
14572,GO:0055018,0.0213278818950141,1,1,1,regulation of cardiac muscle fiber development,BP,BMP4
14573,GO:0055020,0.0213278818950141,1,1,1,positive regulation of cardiac muscle fiber development,BP,BMP4
15007,GO:0060503,0.0213278818950141,1,1,1,bud dilation involved in lung branching,BP,BMP4
15390,GO:0061149,0.0213278818950141,1,1,1,BMP signaling pathway involved in ureter morphogenesis,BP,BMP4
15391,GO:0061150,0.0213278818950141,1,1,1,renal system segmentation,BP,BMP4
15392,GO:0061151,0.0213278818950141,1,1,1,BMP signaling pathway involved in renal system segmentation,BP,BMP4
15396,GO:0061155,0.0213278818950141,1,1,1,pulmonary artery endothelial tube morphogenesis,BP,BMP4
15425,GO:0061216,0.0213278818950141,1,1,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,BMP4
16743,GO:0071893,0.0213278818950141,1,1,1,BMP signaling pathway involved in nephric duct formation,BP,BMP4
16847,GO:0072096,0.0213278818950141,1,1,1,negative regulation of branch elongation involved in ureteric bud branching,BP,BMP4
16848,GO:0072097,0.0213278818950141,1,1,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,BMP4
16850,GO:0072099,0.0213278818950141,1,1,1,anterior/posterior pattern specification involved in ureteric bud development,BP,BMP4
16851,GO:0072100,0.0213278818950141,1,1,1,specification of ureteric bud anterior/posterior symmetry,BP,BMP4
16852,GO:0072101,0.0213278818950141,1,1,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,BMP4
16915,GO:0072192,0.0213278818950141,1,1,1,ureter epithelial cell differentiation,BP,BMP4
16922,GO:0072200,0.0213278818950141,1,1,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
18971,GO:1901964,0.0213278818950141,1,1,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
20942,GO:2000004,0.0213278818950141,1,1,1,regulation of metanephric S-shaped body morphogenesis,BP,BMP4
20943,GO:2000005,0.0213278818950141,1,1,1,negative regulation of metanephric S-shaped body morphogenesis,BP,BMP4
20944,GO:2000006,0.0213278818950141,1,1,1,regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
20945,GO:2000007,0.0213278818950141,1,1,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
19129,GO:1902311,0.0213319320127507,1,1,1,regulation of copper ion transmembrane transport,BP,SLC31A2
20934,GO:1990967,0.0213366697131893,1,1,1,multi-organism toxin transport,BP,RAB40B
1856,GO:0004139,0.0213480935107447,1,1,1,deoxyribose-phosphate aldolase activity,MF,DERA
9971,GO:0035659,0.0213529787567093,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
20291,GO:1904889,0.0213529787567093,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
20292,GO:1904891,0.0213529787567093,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
2202,GO:0004730,0.021368506517494,1,1,1,pseudouridylate synthase activity,MF,PUS1
16188,GO:0070902,0.021368506517494,1,1,1,mitochondrial tRNA pseudouridine synthesis,BP,PUS1
13152,GO:0048244,0.0213691624608113,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
3944,GO:0008112,0.021396651164964,1,1,1,nicotinamide N-methyltransferase activity,MF,NNMT
7571,GO:0030760,0.021396651164964,1,1,1,pyridine N-methyltransferase activity,MF,NNMT
14692,GO:0060064,0.0214186155799917,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
20523,GO:1905474,0.0214186155799917,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
12161,GO:0045358,0.0214222035301432,1,1,1,negative regulation of interferon-beta biosynthetic process,BP,NMI
14472,GO:0052692,0.0214372116851362,1,1,1,raffinose alpha-galactosidase activity,MF,GLA
5303,GO:0014876,0.0214459368908806,1,1,1,response to injury involved in regulation of muscle adaptation,BP,NOL3
3941,GO:0008108,0.0214549405175325,1,1,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,GALT
15611,GO:0061702,0.0214567566352885,0.998651815925172,2,11,inflammasome complex,CC,PYCARD;CASP4
13041,GO:0047860,0.0214675524328202,1,1,1,diiodophenylpyruvate reductase activity,MF,MDH1
11241,GO:0043177,0.0214742507670023,0.99259211229401,8,163,organic acid binding,MF,PHYH;GLDC;SERPINA5;APOC1;SESN2;FABP3;VDR;SLC1A3
2090,GO:0004581,0.0214842627526979,1,1,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,ALG5
121,GO:0000247,0.0214865437733198,1,1,1,C-8 sterol isomerase activity,MF,EBP
2107,GO:0004603,0.0214865437733198,1,1,1,phenylethanolamine N-methyltransferase activity,MF,PNMT
14269,GO:0051798,0.0214979666179348,0.998647843856967,2,11,positive regulation of hair follicle development,BP,TRADD;WNT5A
17403,GO:0090133,0.0215008753761968,1,1,1,mesendoderm migration,BP,FGF8
17404,GO:0090134,0.0215008753761968,1,1,1,cell migration involved in mesendoderm migration,BP,FGF8
5700,GO:0015938,0.0215045878340806,1,1,1,coenzyme A catabolic process,BP,NUDT7
9213,GO:0033869,0.0215045878340806,1,1,1,nucleoside bisphosphate catabolic process,BP,NUDT7
9235,GO:0034031,0.0215045878340806,1,1,1,ribonucleoside bisphosphate catabolic process,BP,NUDT7
9238,GO:0034034,0.0215045878340806,1,1,1,purine nucleoside bisphosphate catabolic process,BP,NUDT7
4279,GO:0008709,0.0215106016364221,1,1,1,cholate 7-alpha-dehydrogenase activity,MF,HSD17B10
12924,GO:0047015,0.0215106016364221,1,1,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,HSD17B10
1683,GO:0003874,0.0215121825299,1,1,1,6-pyruvoyltetrahydropterin synthase activity,MF,PTS
6147,GO:0016838,0.0215121825299,1,1,1,carbon-oxygen lyase activity, acting on phosphates,MF,PTS
9524,GO:0034632,0.0215125342143951,1,1,1,retinol transporter activity,MF,RBP4
9525,GO:0034633,0.0215125342143951,1,1,1,retinol transport,BP,RBP4
12839,GO:0046864,0.0215125342143951,1,1,1,isoprenoid transport,BP,RBP4
12840,GO:0046865,0.0215125342143951,1,1,1,terpenoid transport,BP,RBP4
6235,GO:0017024,0.0215154617198034,1,1,1,myosin I binding,MF,PYCARD
13616,GO:0050719,0.0215195066730411,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
13618,GO:0050721,0.0215195066730411,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
13621,GO:0050726,0.0215195066730411,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
13575,GO:0050674,0.0215301771828067,1,1,1,urothelial cell proliferation,BP,FGF10
13576,GO:0050675,0.0215301771828067,1,1,1,regulation of urothelial cell proliferation,BP,FGF10
13577,GO:0050677,0.0215301771828067,1,1,1,positive regulation of urothelial cell proliferation,BP,FGF10
14952,GO:0060432,0.0215301771828067,1,1,1,lung pattern specification process,BP,FGF10
14956,GO:0060436,0.0215301771828067,1,1,1,bronchiole morphogenesis,BP,FGF10
15003,GO:0060495,0.0215301771828067,1,1,1,cell-cell signaling involved in lung development,BP,FGF10
15004,GO:0060496,0.0215301771828067,1,1,1,mesenchymal-epithelial cell signaling involved in lung development,BP,FGF10
15234,GO:0060879,0.0215301771828067,1,1,1,semicircular canal fusion,BP,FGF10
15377,GO:0061115,0.0215301771828067,1,1,1,lung proximal/distal axis specification,BP,FGF10
7064,GO:0021978,0.0215317288413399,0.998644586552574,2,11,telencephalon regionalization,BP,BMP4;BMP2
5088,GO:0010900,0.0215339678630132,1,1,1,negative regulation of phosphatidylcholine catabolic process,BP,APOC1
14953,GO:0060433,0.0215513888788567,0.998642688511771,2,11,bronchus development,BP,WNT7B;BMP4
19255,GO:1902653,0.0215625307987615,0.995888853948095,4,51,secondary alcohol biosynthetic process,BP,EBP;HMGCS2;ABCG1;DHCR7
14971,GO:0060452,0.0215771510384079,0.998640199923359,2,11,positive regulation of cardiac muscle contraction,BP,CHGA;CTGF
3685,GO:0007179,0.0215957580253268,0.992538894328223,8,167,transforming growth factor beta receptor signaling pathway,BP,ITGA3;RASL11B;ITGB5;ACVR1;DKK3;CGN;PDGFB;CLDN5
7694,GO:0030971,0.0215972509105826,0.995876643533812,4,52,receptor tyrosine kinase binding,MF,PIK3R2;PIK3R1;GAS6;SHC4
16452,GO:0071398,0.0216170917127749,0.995871710228884,4,52,cellular response to fatty acid,BP,PDK4;EDN1;AKT1;CLDN1
17363,GO:0090075,0.0216514799065166,0.997139501332014,3,29,relaxation of muscle,BP,ADORA1;CHGA;PDE4B
17329,GO:0090004,0.0216858773504576,0.997133232957903,3,29,positive regulation of establishment of protein localization to plasma membrane,BP,ITGA3;PIK3R1;AKT1
3348,GO:0006641,0.0217821551138395,0.993875087529629,6,104,triglyceride metabolic process,BP,APOC1;RGN;PLA2G16;FABP3;PIK3CG;ACSL4
10845,GO:0042470,0.0217936467011105,0.993871130527918,6,104,melanosome,CC,RAB27A;FASN;RAB17;MYO7A;MYH11;RAB38
13404,GO:0048770,0.0217936467011105,0.993871130527918,6,104,pigment granule,CC,RAB27A;FASN;RAB17;MYO7A;MYH11;RAB38
5062,GO:0010872,0.0218627390500702,0.998612504095483,2,11,regulation of cholesterol esterification,BP,APOC1;ABCG1
8841,GO:0032944,0.0218899239050587,0.991850549244671,9,195,regulation of mononuclear cell proliferation,BP,FADD;PNP;PYCARD;FGF10;TICAM1;SDC4;CLCF1;BMP4;CDKN1A
4986,GO:0010762,0.0219054535565847,0.997093126830657,3,29,regulation of fibroblast migration,BP,PRR5L;SDC4;AKT1
9377,GO:0034333,0.0219226635807073,0.994719493243142,5,79,adherens junction assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
7816,GO:0031223,0.022043106989039,0.99857583096578,2,12,auditory behavior,BP,STRA6;SLC1A3
12351,GO:0045787,0.022077252649362,0.990037910964592,13,334,positive regulation of cell cycle,BP,WNT4;GADD45A;EDN1;FGF10;PDGFB;FOXO4;WNT5A;PSRC1;FGF8;CDKN1A;HMGN5;CTGF;AKT1
6758,GO:0019900,0.0221392143367639,0.988159534385823,20,596,kinase binding,MF,GADD45A;TRADD;TBC1D14;CDH2;GHR;PIK3R2;PIK3R1;TICAM1;PRKAR1B;AXIN1;NPR1;SDC4;CDKN1A;MSN;AKT1;BCAR1;GAS6;SHC4;ARAF;ACTA2
13805,GO:0051015,0.0222075902926702,0.99294898575491,7,139,actin filament binding,MF,TAGLN;ACTN2;SPTB;ESPN;MYO7A;MYH11;TMOD4
8429,GO:0032365,0.0222360360717894,0.997025527300007,3,30,intracellular lipid transport,BP,ABCG1;CPT2;STAR
8854,GO:0032965,0.022273390144033,0.997025567756319,3,29,regulation of collagen biosynthetic process,BP,WNT4;BMP4;CTGF
19897,GO:1904018,0.0223131118554627,0.992913272393833,7,135,positive regulation of vasculature development,BP,ITGA5;NOTCH1;PDGFB;WNT5A;RHOB;DLL1;EFNB2
4676,GO:0009896,0.0224269019459234,0.989212789501152,15,406,positive regulation of catabolic process,BP,ACTN3;PSMB10;RGN;PRR5L;TICAM1;RALB;WNT5A;SESN2;AXIN1;MSN;AKT1;RAB12;SH3BP4;RNF144A;PIM2
16800,GO:0072017,0.0224474844479461,0.998535570876556,2,12,distal tubule development,BP,NOTCH1;WNK4
4057,GO:0008289,0.0224491052619119,0.987780154729408,21,631,lipid binding,MF,SYT5;ACTN2;SERPINA5;APOC1;ABCG1;MFGE8;SPTBN4;FZD7;LPAR2;PXK;SNX18;RBP4;FABP3;AKT1;EPN1;STAR;SNX21;GAS6;RPH3AL;VDR;UNC119
3612,GO:0007041,0.0224851369551286,0.994548743805359,5,79,lysosomal transport,BP,USE1;SPTBN5;GPRASP1;RHOB;RAB12
18956,GO:1901890,0.0226530752553372,0.996948296734505,3,30,positive regulation of cell junction assembly,BP,WNT4;SDC4;CLDN1
12067,GO:0045177,0.0227277393610118,0.989702265572124,13,339,apical part of cell,CC,NOTCH1;RAB27A;TF;SLC52A3;ACVR1;CDH2;DLL1;MSN;GJB6;RAB17;MYO7A;CLDN1;LZTS1
6117,GO:0016790,0.0227425902994786,0.996938776307682,3,29,thiolester hydrolase activity,MF,FASN;NUDT7;LYPLAL1
5037,GO:0010839,0.022749976569391,0.998505194220031,2,12,negative regulation of keratinocyte proliferation,BP,VDR;EFNB2
21636,GO:2001234,0.0227665066767749,0.991465709603473,9,197,negative regulation of apoptotic signaling pathway,BP,WNT4;FADD;TRADD;ACVR1;FGF10;BMP4;NOL3;AKT1;GDNF
3323,GO:0006606,0.0227913541629117,0.990464281233695,11,267,protein import into nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6
11889,GO:0044744,0.0227913541629117,0.990464281233695,11,267,protein targeting to nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6
8281,GO:0032092,0.0229289664197732,0.994413191263748,5,79,positive regulation of protein binding,BP,TICAM1;RALB;WNT5A;BMP4;BMP2
4823,GO:0010506,0.0230584619734059,0.990335635620272,11,267,regulation of autophagy,BP,TBC1D14;PIK3R2;TICAM1;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1;SH3BP4;PIM2
15237,GO:0060900,0.0232438268759598,0.99845512571393,2,12,embryonic camera-type eye formation,BP,STRA6;WNT5A
2998,GO:0006109,0.0232928986680718,0.992535046227431,7,137,regulation of carbohydrate metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;PDGFB;SESN2;AKT1
14332,GO:0051930,0.0233323764840137,0.996821297533116,3,30,regulation of sensory perception of pain,BP,ADRA2C;ADORA1;EDN1
14333,GO:0051931,0.0233323764840137,0.996821297533116,3,30,regulation of sensory perception,BP,ADRA2C;ADORA1;EDN1
15865,GO:0070306,0.0234300108692222,0.996802923053666,3,30,lens fiber cell differentiation,BP,WNT7A;WNT7B;WNT5B
520,GO:0001558,0.0234781642179689,0.98896387391296,14,373,regulation of cell growth,BP,WNT3;EDN1;WNT5A;SESN2;NPR1;PSRC1;HBEGF;WT1;CDKN1A;DDR1;CTGF;AKT1;BCAR1;SH3BP4
526,GO:0001569,0.0236229103469643,0.996766531123998,3,30,branching involved in blood vessel morphogenesis,BP,ACVR1;EDN1;FGF8
16654,GO:0071704,0.0236338507933597,0.981781392114748,230,10155,organic substance metabolic process,BP,ITGA3;ITGA5;ARTN;CFB;EBP;PDK4;PECR;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;USE1;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;PNMT;DPM3;STRA6;ZFYVE21;ITGB8;FASN;PMAIP1;GADD45A;MSRA;RHBDL3;FBXO41;MRPL14;MRPL16;MRI1;FADD;DHH;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;ADORA1;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PRKACB;MFGE8;CCL20;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;MBOAT2;LAGE3;ACADVL;KRT10;PRND;MGST2;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PTPN7;NNMT;FOXO4;RALB;CPT2;PLA2G16;HSD17B10;ETFB;HRAS;WNT5A;MAGEC2;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;ECHDC2;SARDH;SHPK;HEXB;WNK4;FABP3;CHGA;MSN;NOL3;HSD3B2;NUDT7;DDR1;DEPTOR;CTGF;CPT1C;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;PON2;NRTN;FAM46A;PTGES;KITLG;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;INHBB;PTMS;MDP1;SPSB1;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;PEPD;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;LZTS1;DERA;DHCR7;CYB5A;PTS;PM20D2;SHC4;RBMS3;HNF1A;VDR;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;ACSL4;SLC1A3;FZD8;ELOVL6;DUSP5;HEY1;ACTA2;RNF144A;PIM2;ETFDH;PDE4B
4916,GO:0010656,0.0236681478940937,0.996757979684388,3,30,negative regulation of muscle cell apoptotic process,BP,EDN1;BMP7;NOL3
8907,GO:0033043,0.0236760557366131,0.985291286962768,33,1117,regulation of organelle organization,BP,FHOD3;LIF;WNT4;ACTN2;RAB6C;PMAIP1;TBC1D14;EDN1;SPTBN5;SPTBN4;PYCARD;CDH2;PIK3R1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;RHOQ;PSRC1;FGF8;SDC4;SPTB;BMP7;BMP4;CAMSAP3;ESPN;MSN;NOL3;CTGF;AKT1;TMOD4
13130,GO:0048185,0.0238515646551199,0.998392708152216,2,12,activin binding,MF,ACVR1;FSTL3
15798,GO:0070201,0.0238767857085681,0.986204518529186,25,791,regulation of establishment of protein localization,BP,ITGA3;ADRA2C;PMAIP1;PYCARD;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;RBP4;RHOQ;ANG;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;IFI27;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL
8184,GO:0031932,0.0241314557649903,0.998363666474285,2,12,TORC2 complex,CC,PRR5L;SESN2
16410,GO:0071345,0.0241400303009026,0.986379973122448,23,704,cellular response to cytokine stimulus,BP,IFI30;FASN;FADD;TRADD;EDN1;CCL20;PYCARD;PSMB10;GHR;PDGFB;WNT5A;RNASEL;CLCF1;NMI;SHPK;NOL3;AKT1;IFI27;TFPI;STAR;CLDN1;GAS6;CLDN18
9180,GO:0033700,0.0241586338283249,0.998360836584859,2,12,phospholipid efflux,BP,APOC1;ABCG1
14918,GO:0060391,0.0243373140970864,0.998342188263083,2,12,positive regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
10717,GO:0042246,0.0243935505147734,0.99516356553729,4,53,tissue regeneration,BP,NOTCH1;WNT7A;FZD7;FGF10
7625,GO:0030859,0.0244128701859881,0.998334280065205,2,12,polarized epithelial cell differentiation,BP,WNT5A;MSN
19233,GO:1902593,0.024432163537394,0.989668626780138,11,270,single-organism nuclear import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6
11970,GO:0045019,0.0244424651548361,0.998331178799401,2,12,negative regulation of nitric oxide biosynthetic process,BP,RGN;GLA
20064,GO:1904406,0.0244424651548361,0.998331178799401,2,12,negative regulation of nitric oxide metabolic process,BP,RGN;GLA
14962,GO:0060442,0.0244681779426312,0.998328482676462,2,12,branching involved in prostate gland morphogenesis,BP,BMP7;BMP4
13646,GO:0050769,0.0245000485494469,0.988417986421542,14,378,positive regulation of neurogenesis,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;STAR
11439,GO:0043506,0.0245375558281582,0.99391354369518,5,80,regulation of JUN kinase activity,BP,WNT7B;EDN1;WNT5A;AXIN1;FZD8
16903,GO:0072178,0.0246086657512073,0.998313724357387,2,12,nephric duct morphogenesis,BP,BMP4;EFNB2
10601,GO:0040037,0.0246933054168227,0.998304810566535,2,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,WNT4;WNT5A
11173,GO:0043065,0.024704124820051,0.986864950474282,19,560,positive regulation of apoptotic process,BP,NOTCH1;PMAIP1;GADD45A;FADD;TRADD;PYCARD;G0S2;PIK3R2;WNT5A;RHOB;BMP7;BMP4;BMP2;CTGF;AKT1;IFI27;INHBB;S100B;VDR
11678,GO:0044237,0.0247157542714928,0.980878002991644,224,9871,cellular metabolic process,BP,ITGA3;ITGA5;ARTN;PDK4;PECR;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;PNMT;DPM3;STRA6;ZFYVE21;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;MSRA;FBXO41;MRPL14;MRPL16;MRI1;FADD;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;WDR45;NMT2;SALL4;TBC1D14;GUCY1B3;ADORA1;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PRKACB;MFGE8;CCL20;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;MBOAT2;LAGE3;ACADVL;KRT10;RAB39A;PRND;MGST2;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PTPN7;NNMT;FOXO4;RALB;CPT2;PLA2G16;HSD17B10;ETFB;HRAS;WNT5A;MAGEC2;KHK;HACL1;GPRASP1;SESN2;AXIN1;GALT;RBP4;RHOQ;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;ECHDC2;SARDH;SHPK;HEXB;CMBL;WNK4;FABP3;CHGA;MSN;NOL3;HSD3B2;NUDT7;DDR1;DEPTOR;CTGF;CPT1C;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;RAB12;PON2;NRTN;PTGES;KITLG;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;INHBB;PTMS;MDP1;SPSB1;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;PEPD;ACP5;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;LZTS1;DERA;CYB5A;PTS;PM20D2;RBMS3;HNF1A;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;LYPLAL1;ACSL4;SLC1A3;FZD8;ELOVL6;DUSP5;HEY1;RNF144A;PIM2;ETFDH;PDE4B
5845,GO:0016264,0.0247514442841776,0.998298677975004,2,12,gap junction assembly,BP,GJB1;GJB2
3533,GO:0006919,0.0248177916175544,0.993828440882691,5,79,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;FADD;TRADD;PYCARD;IFI27
21002,GO:2000106,0.0248253130040508,0.993826087421394,5,79,regulation of leukocyte apoptotic process,BP,FADD;WNT5A;BMP4;KITLG;GAS6
10599,GO:0040034,0.0248258043244146,0.998290822820469,2,12,regulation of development, heterochronic,BP,NOTCH1;DLL1
8670,GO:0032688,0.0248258866696812,0.998290814114615,2,12,negative regulation of interferon-beta production,BP,PYCARD;NMI
7466,GO:0030510,0.0248346214686694,0.993818278180256,5,81,regulation of BMP signaling pathway,BP,ITGA3;NOTCH1;FSTL3;WNT5A;BMP4
12154,GO:0045351,0.0248983979698395,0.998283141797507,2,12,type I interferon biosynthetic process,BP,TICAM1;NMI
1590,GO:0003401,0.0249065176965477,0.996513889543428,3,31,axis elongation,BP,FGF10;WNT5A;BMP4
8290,GO:0032101,0.0249481609544195,0.986069365912672,22,672,regulation of response to external stimulus,BP,ARTN;CFB;WNT3;WNT4;NOTCH1;NMT2;ADORA1;EDN1;PLAU;TYRO3;FGF18;FGF10;PDGFB;WNT5A;JAM3;BMP6;SHPK;CASP4;FAM46A;PIK3CG;GAS6;EFNB2
18674,GO:1901077,0.0249606423352838,0.998276546020667,2,12,regulation of relaxation of muscle,BP,CHGA;PDE4B
7832,GO:0031252,0.025035048869709,0.988503889837512,13,347,cell leading edge,CC,ITGA5;ITGB4;ADORA1;CDH2;PLEKHH2;KITLG;CDH1;BCAR1;PIK3CA;S100B;AMOT;ACTA2;PARVB
11203,GO:0043122,0.025061381644903,0.989872571269562,10,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;PYCARD;TICAM1;BMP7;NOL3;AKT1;TLE1;S100B;PIM2
2873,GO:0005913,0.0251039000980466,0.993733820664997,5,81,cell-cell adherens junction,CC,DSC2;CDH2;CAMSAP3;PKP3;CDH1
2854,GO:0005884,0.0251083836264255,0.993732412331861,5,81,actin filament,CC,ACTN3;ACTN2;RHOQ;ESPN;AMOT
16411,GO:0071346,0.0252248879042006,0.991785162908849,7,136,cellular response to interferon-gamma,BP,IFI30;EDN1;CCL20;WNT5A;NMI;STAR;CLDN1
7202,GO:0030038,0.0252432738134024,0.993690009509537,5,81,contractile actin filament bundle assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;CTGF
11223,GO:0043149,0.0252432738134024,0.993690009509537,5,81,stress fiber assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;CTGF
4387,GO:0009109,0.0252514277512943,0.99824561315848,2,12,coenzyme catabolic process,BP,ACAT1;NUDT7
6350,GO:0018105,0.0253303550535652,0.989229065995932,11,272,peptidyl-serine phosphorylation,BP,LIF;SPTBN4;MAPK12;PDGFB;WNT5A;AXIN1;PKN3;AKT1;PIK3CA;GAS6;ARAF
14597,GO:0055076,0.0253406935591761,0.992619503644727,6,108,transition metal ion homeostasis,BP,TF;SLC31A2;BDH2;PRND;BMP6;SFXN1
2996,GO:0006107,0.0253910032352798,0.998230695781021,2,12,oxaloacetate metabolic process,BP,GHR;MDH1
13768,GO:0050930,0.0253977100021771,0.998229977846571,2,12,induction of positive chemotaxis,BP,ARTN;FGF10
10959,GO:0042635,0.0254064581771972,0.998229041230436,2,12,positive regulation of hair cycle,BP,TRADD;WNT5A
6759,GO:0019901,0.0254385555638547,0.98668317660753,18,528,protein kinase binding,MF,TBC1D14;CDH2;GHR;PIK3R2;PIK3R1;TICAM1;PRKAR1B;AXIN1;NPR1;SDC4;CDKN1A;MSN;AKT1;BCAR1;GAS6;SHC4;ARAF;ACTA2
13369,GO:0048705,0.0254560603753235,0.990267001946019,9,204,skeletal system morphogenesis,BP,WNT7A;FGF18;AXIN1;BMP7;BMP6;BMP4;CTGF;NPPC;NAB2
17650,GO:0090646,0.0254664017862119,0.998222618651759,2,12,mitochondrial tRNA processing,BP,HSD17B10;PUS1
15242,GO:0060911,0.0254669854722201,0.998222556072621,2,12,cardiac cell fate commitment,BP,ACVR1;WT1
13995,GO:0051287,0.0254904844344969,0.994877854218178,4,53,NAD binding,MF,BDH2;AOX1;MDH1;IDH1
13644,GO:0050767,0.0255040346122163,0.985932894412338,21,647,regulation of neurogenesis,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;STAR;LZTS1;LINGO1
15035,GO:0060547,0.0255060505819443,0.99821836596651,2,12,negative regulation of necrotic cell death,BP,FADD;NOL3
5635,GO:0015837,0.0255490275476486,0.993598729985194,5,79,amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA;GDNF
12663,GO:0046479,0.025577808933699,0.998210660007428,2,12,glycosphingolipid catabolic process,BP,HEXB;GLA
8972,GO:0033162,0.0257160566947158,0.998195780399184,2,12,melanosome membrane,CC,RAB27A;RAB38
11964,GO:0045009,0.0257160566947158,0.998195780399184,2,12,chitosome,CC,RAB27A;RAB38
3399,GO:0006703,0.0258437938957619,0.998181992896339,2,12,estrogen biosynthetic process,BP,HSD17B11;STAR
3546,GO:0006940,0.0259018030806528,0.994765536049987,4,54,regulation of smooth muscle contraction,BP,ADRA2B;ADRA2C;ADORA1;EDN1
12502,GO:0046068,0.0259996865721079,0.994735676197975,4,55,cGMP metabolic process,BP,GUCY1B3;WNT5A;NPR1;NPPC
3611,GO:0007040,0.0260135814293481,0.994732002790329,4,55,lysosome organization,BP,RAB39A;RAB20;HEXB;MYO7A
17234,GO:0080171,0.0260135814293481,0.994732002790329,4,55,lytic vacuole organization,BP,RAB39A;RAB20;HEXB;MYO7A
4594,GO:0009607,0.0262302381817312,0.984543913946424,26,827,response to biotic stimulus,BP,NOTCH1;PMAIP1;FADD;EDN1;CCL20;PYCARD;MGST2;FGF10;TICAM1;HRAS;WNT5A;RNASEL;BMP6;SHPK;CHGA;GJB2;GJB6;AKT1;PTGES;TFPI;STAR;CLDN1;PRRT1;ACTA2;PIM2;PDE4B
10641,GO:0042089,0.0262875147398383,0.99227961719859,6,108,cytokine biosynthetic process,BP,ZFPM1;CCL20;TICAM1;WNT5A;NMI;INHBB
15307,GO:0061013,0.0262974777789372,0.996234432097752,3,32,regulation of mRNA catabolic process,BP,PRR5L;PKP3;PKP1
12794,GO:0046718,0.0264735518841809,0.992210655916833,6,109,viral entry into host cell,BP,ITGA5;ITGB5;TYRO3;CLDN1;GAS6;EFNB2
16725,GO:0071872,0.0264889114498412,0.99809066776906,2,13,cellular response to epinephrine stimulus,BP,STAR;PDE4B
6676,GO:0019725,0.0265843570388339,0.984485665687911,25,797,cellular homeostasis,BP,CDH23;TF;SLC31A2;CASQ2;EDN1;RAB39A;PRND;TYRO3;LPAR2;RGN;PIK3R2;PIK3R1;SESN2;BMP6;RAB20;HEXB;NOL3;GJB6;STAR;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
2758,GO:0005740,0.02672910522376,0.984972266814676,22,669,mitochondrial envelope,CC,PDK4;PMAIP1;MRPL14;MRPL16;HMGCS2;SLC25A53;ACADVL;REEP1;CPT2;ACAT1;VAMP1;SFXN1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;CYB5A;ACSL4;ETFDH
691,GO:0001836,0.0268426943490946,0.994515856684917,4,54,release of cytochrome c from mitochondria,BP,PMAIP1;PYCARD;NOL3;AKT1
3420,GO:0006739,0.0268485651064246,0.996132646377507,3,31,NADP metabolic process,BP,SHPK;IDH1;DERA
12234,GO:0045598,0.0270245471554562,0.992009268892491,6,110,regulation of fat cell differentiation,BP,ZFPM1;WNT5B;WNT5A;AXIN1;BMP2;AKT1
12349,GO:0045785,0.0271065540764264,0.987015529006897,14,378,positive regulation of cell adhesion,BP,ITGA3;ITGA5;WNT4;FADD;PNP;PYCARD;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;AKT1;PIK3CA;EFNB2
14220,GO:0051707,0.0271252586490458,0.984141209926372,25,790,response to other organism,BP,NOTCH1;PMAIP1;FADD;EDN1;CCL20;PYCARD;MGST2;FGF10;TICAM1;HRAS;WNT5A;RNASEL;BMP6;SHPK;CHGA;GJB2;GJB6;AKT1;PTGES;TFPI;STAR;CLDN1;ACTA2;PIM2;PDE4B
3083,GO:0006275,0.0271614405602963,0.991957714787884,6,111,regulation of DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
16239,GO:0070986,0.0272697021621383,0.998003489209135,2,13,left/right axis specification,BP,NOTCH1;DLL1
3554,GO:0006954,0.0272872694286,0.984846632427236,21,635,inflammatory response,BP,CFB;NOTCH1;ACVR1;ADORA1;CCL20;PYCARD;TYRO3;TICAM1;PXK;WNT5A;JAM3;NMI;BMP6;BMP2;AOX1;SHPK;CASP4;AKT1;PTGES;PIK3CG;TSPAN2
3209,GO:0006469,0.0273306643111468,0.988796946741882,10,238,negative regulation of protein kinase activity,BP,GADD45A;PYCARD;RGN;PRKAR1B;BMP7;BMP4;CDKN1A;DEPTOR;AKT1;DUSP5
2487,GO:0005154,0.0273744543507755,0.996019507280945,3,32,epidermal growth factor receptor binding,MF,ITGA5;HBEGF;LINGO1
11262,GO:0043207,0.0274841315948423,0.983911493623031,25,791,response to external biotic stimulus,BP,NOTCH1;PMAIP1;FADD;EDN1;CCL20;PYCARD;MGST2;FGF10;TICAM1;HRAS;WNT5A;RNASEL;BMP6;SHPK;CHGA;GJB2;GJB6;AKT1;PTGES;TFPI;STAR;CLDN1;ACTA2;PIM2;PDE4B
15400,GO:0061162,0.0276614585883466,0.997959224703984,2,13,establishment of monopolar cell polarity,BP,WNT5A;MSN
15458,GO:0061339,0.0276614585883466,0.997959224703984,2,13,establishment or maintenance of monopolar cell polarity,BP,WNT5A;MSN
5195,GO:0014037,0.0276644333431735,0.995953483227861,3,33,Schwann cell differentiation,BP,POU3F1;AKT1;NAB2
3752,GO:0007276,0.0277234441448305,0.984816774238853,20,603,gamete generation,BP,WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;TYRO3;RGN;FSTL3;JAM3;ANG;BMP4;WT1;SLC2A14;HEXB;AKT1;NPPC;JAG2;INHBB;CLDN11
5780,GO:0016126,0.0277317308046274,0.994272979558232,4,55,sterol biosynthetic process,BP,EBP;HMGCS2;ABCG1;DHCR7
9691,GO:0035112,0.0278550173450085,0.997937226320483,2,13,genitalia morphogenesis,BP,FGF10;RBP4
10649,GO:0042098,0.0279079877499959,0.989882653054331,8,171,T cell proliferation,BP,WNT4;FADD;PNP;PYCARD;SDC4;BMP4;MSN;PIK3CG
12207,GO:0045540,0.0280284263281603,0.997917446250246,2,13,regulation of cholesterol biosynthetic process,BP,ABCG1;DHCR7
4903,GO:0010639,0.0281305461205144,0.987334106213679,12,311,negative regulation of organelle organization,BP,FHOD3;LIF;SPTBN5;SPTBN4;PLEKHH2;SPTB;BMP7;BMP4;ESPN;NOL3;AKT1;TMOD4
13204,GO:0048333,0.0282611149966751,0.995840007404709,3,32,mesodermal cell differentiation,BP,ITGA3;ITGB4;BMP4
18877,GO:1901655,0.0283659717482753,0.992686021032405,5,83,cellular response to ketone,BP,MSN;GJB2;AKT1;STAR;GAS6
9037,GO:0033293,0.0283888588687716,0.99409494971164,4,55,monocarboxylic acid binding,MF,SERPINA5;APOC1;FABP3;VDR
18660,GO:1901031,0.0284470919150499,0.995802068565134,3,32,regulation of response to reactive oxygen species,BP,RGN;SESN2;BMP7
12300,GO:0045685,0.0284477748604387,0.994074594683234,4,56,regulation of glial cell differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
10655,GO:0042107,0.0284746692241191,0.991479262139153,6,110,cytokine metabolic process,BP,ZFPM1;CCL20;TICAM1;WNT5A;NMI;INHBB
7189,GO:0030018,0.0285718540752699,0.991430777417195,6,117,Z disc,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
15841,GO:0070268,0.0286458012221546,0.991416272539636,6,110,cornification,BP,DSC2;KRT10;DSG3;PKP3;PKP1;DSC3
19725,GO:1903672,0.0286547807629836,0.997845438277861,2,13,positive regulation of sprouting angiogenesis,BP,ITGA5;DLL1
5310,GO:0014889,0.0286901955347027,0.997841340665221,2,13,muscle atrophy,BP,ACTN3;NOL3
19039,GO:1902117,0.0287071090562116,0.993999651687482,4,57,positive regulation of organelle assembly,BP,EDN1;RALB;SDC4;MSN
782,GO:0001959,0.0288221986437163,0.990345951836884,7,141,regulation of cytokine-mediated signaling pathway,BP,FADD;TRADD;EDN1;PYCARD;WNT5A;NOL3;GAS6
8569,GO:0032536,0.0288444318569268,0.997823462403416,2,13,regulation of cell projection size,BP,WNT7A;WNT7B
3503,GO:0006878,0.0288709090059579,0.997820387987494,2,13,cellular copper ion homeostasis,BP,SLC31A2;PRND
12241,GO:0045605,0.0289473598985034,0.997811502083338,2,13,negative regulation of epidermal cell differentiation,BP,NOTCH1;DLL1
12276,GO:0045651,0.0289859424224353,0.997807012698222,2,13,positive regulation of macrophage differentiation,BP,LIF;FADD
13438,GO:0048854,0.0289932989716211,0.995682011999375,3,33,brain morphogenesis,BP,CDH2;WNT5A;FGF8
13580,GO:0050680,0.0289992537816787,0.991280135641603,6,113,negative regulation of epithelial cell proliferation,BP,LIMS2;RGN;WNT5A;BMP4;VDR;EFNB2
650,GO:0001780,0.0290789752915196,0.997796173992149,2,13,neutrophil homeostasis,BP,JAM3;PDE4B
15922,GO:0070402,0.0291976909804478,0.997782315269157,2,13,NADPH binding,MF,FASN;DECR1
13601,GO:0050704,0.0292172924576831,0.995643895525842,3,32,regulation of interleukin-1 secretion,BP,PYCARD;WNT5A;GAS6
11306,GO:0043268,0.0292326996042396,0.99563256707953,3,33,positive regulation of potassium ion transport,BP,ACTN2;ADORA1;KCNH2
21011,GO:2000116,0.0293618820940163,0.988490056146134,9,206,regulation of cysteine-type endopeptidase activity,BP,PMAIP1;FADD;TRADD;PYCARD;NOL3;CTGF;AKT1;IFI27;GAS6
14582,GO:0055038,0.0293677239128874,0.993822777161131,4,56,recycling endosome membrane,CC,SYT5;FZD7;RAB12;RAB17
10066,GO:0035810,0.0293765030890055,0.997761382094956,2,13,positive regulation of urine volume,BP,EDN1;NPR1
17852,GO:0097296,0.0294628589334162,0.997751247294766,2,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
3887,GO:0007638,0.02958469646137,0.997715681982989,2,14,mechanosensory behavior,BP,STRA6;SLC1A3
5901,GO:0016405,0.0297174841755735,0.997721268557459,2,13,CoA-ligase activity,MF,ACSF2;ACSM5
10071,GO:0035815,0.0297548710061046,0.997716854742977,2,13,positive regulation of renal sodium excretion,BP,EDN1;NPR1
12818,GO:0046824,0.0297942278465026,0.990983364603338,6,114,positive regulation of nucleocytoplasmic transport,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1;GAS6
15991,GO:0070525,0.0298042330511516,0.997711022454095,2,13,tRNA threonylcarbamoyladenosine metabolic process,BP,HSD17B10;PUS1
21248,GO:2000484,0.0298361276955242,0.997707251150576,2,13,positive regulation of interleukin-8 secretion,BP,PYCARD;WNT5A
12684,GO:0046514,0.0298827270682567,0.997701737108483,2,13,ceramide catabolic process,BP,HEXB;GLA
698,GO:0001843,0.0299759897880574,0.992153079864713,5,85,neural tube closure,BP,SALL4;PRKACB;WNT5A;SDC4;BMP4
9263,GO:0034097,0.0299833920460975,0.982303190951756,25,798,response to cytokine,BP,IFI30;FASN;FADD;TRADD;EDN1;CCL20;PYCARD;PSMB10;GHR;PDGFB;WNT5A;RNASEL;CLCF1;NMI;SHPK;NOL3;AKT1;IFI27;PTGES;TFPI;STAR;CLDN1;GAS6;ACSL4;CLDN18
12004,GO:0045073,0.0299887367533295,0.99768917538225,2,13,regulation of chemokine biosynthetic process,BP,TICAM1;WNT5A
12367,GO:0045823,0.0301674611462975,0.995437954894369,3,33,positive regulation of heart contraction,BP,EDN1;CHGA;CTGF
4930,GO:0010675,0.0304891527580814,0.990723968432039,6,114,regulation of cellular carbohydrate metabolic process,BP,PDK4;ACTN3;PMAIP1;RGN;SESN2;AKT1
12852,GO:0046883,0.0305329203316052,0.987252318621819,10,243,regulation of hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;RBP4;BMP6;INHBB;RAB11FIP1;KCNG2
11005,GO:0042733,0.0307029658097403,0.993443711550749,4,58,embryonic digit morphogenesis,BP,NOTCH1;WNT7A;WNT5A;BMP4
8712,GO:0032760,0.0307646622243119,0.993430894596523,4,57,positive regulation of tumor necrosis factor production,BP,FADD;PYCARD;PIK3R1;TICAM1
1411,GO:0003073,0.0309316464658407,0.991838884396397,5,84,regulation of systemic arterial blood pressure,BP,ADORA1;EDN1;KCNK6;PDGFB;GAS6
8741,GO:0032794,0.0310947426945445,0.997533766041645,2,14,GTPase activating protein binding,MF,AKT1;CDH1
13155,GO:0048247,0.0311150182691158,0.993337447138038,4,56,lymphocyte chemotaxis,BP,CCL20;WNT5A;PIK3CG;GAS6
14885,GO:0060349,0.0311326983446597,0.991769000217003,5,85,bone morphogenesis,BP,FGF18;BMP6;BMP4;NPPC;NAB2
11316,GO:0043280,0.0311942825251155,0.990461279262926,6,113,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;FADD;TRADD;PYCARD;CTGF;IFI27
15813,GO:0070232,0.0313356365592078,0.995191324768754,3,33,regulation of T cell apoptotic process,BP,FADD;WNT5A;BMP4
13769,GO:0050931,0.0313992734526352,0.995169366502001,3,34,pigment cell differentiation,BP,RAB27A;KITLG;RAB38
18425,GO:0120025,0.0317441489563053,0.978475931809757,45,1661,plasma membrane bounded cell projection,CC,ITGA3;ITGA5;ADRA2C;SYT5;ACTN3;ACTN2;MARK4;RAB27A;CDH23;FADD;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;RAB39B;CDH2;FSTL3;PRKAR1B;PLEKHH2;CYP17A1;ANG;DRP2;ESPN;VAMP1;MSN;GJB2;CPT1C;AKT1;RAB17;NRTN;KITLG;CDH1;MYO7A;BCAR1;STAR;PIK3CA;LZTS1;S100B;AMOT;KCND1;SLC1A3;ACTA2;PARVB;PDE4B
18687,GO:1901099,0.0317816229931066,0.995096177659253,3,33,negative regulation of signal transduction in absence of ligand,BP,FGF10;AKT1;GDNF
21642,GO:2001240,0.0317816229931066,0.995096177659253,3,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;GDNF
767,GO:0001942,0.0318398049202496,0.991529367842895,5,86,hair follicle development,BP,NOTCH1;TRADD;FGF10;WNT5A;LAMA5
13437,GO:0048853,0.0319193502686831,0.997432322396458,2,14,forebrain morphogenesis,BP,WNT5A;FGF8
771,GO:0001947,0.0319853759665476,0.993082855050724,4,58,heart looping,BP,NOTCH1;WNT5A;FGF8;DLL1
14673,GO:0060043,0.0320356838944558,0.995033091794984,3,34,regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1;RBP4
10846,GO:0042471,0.0320680569817801,0.990127181076125,6,115,ear morphogenesis,BP,EDN1;FGF10;WNT5A;FGF8;GJB6;MYO7A
6296,GO:0017145,0.0321237874272292,0.995014139483827,3,34,stem cell division,BP,NOTCH1;WNT7A;FZD7
12248,GO:0045618,0.0321790137964988,0.99740007422197,2,14,positive regulation of keratinocyte differentiation,BP,NOTCH1;VDR
7203,GO:0030041,0.0321942552276263,0.98895850479085,7,146,actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;PYCARD;ANG;SPTB;TMOD4
21001,GO:2000105,0.0322194289575861,0.997395041930151,2,14,positive regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
7305,GO:0030207,0.0323028660419053,0.997384641666642,2,14,chondroitin sulfate catabolic process,BP,IDUA;HEXB
7208,GO:0030048,0.0323051492928638,0.990029363668321,6,119,actin filament-based movement,BP,ACTN3;ACTN2;DSC2;KCNH2;MYO7A;PDE4B
7889,GO:0031331,0.0323473070211902,0.98460883365723,13,352,positive regulation of cellular catabolic process,BP,PSMB10;RGN;PRR5L;TICAM1;RALB;SESN2;AXIN1;MSN;AKT1;RAB12;SH3BP4;RNF144A;PIM2
12267,GO:0045638,0.0324085897473262,0.991340709064474,5,85,negative regulation of myeloid cell differentiation,BP,ZFPM1;FSTL3;PIK3R1;DLL1;CLDN18
3735,GO:0007257,0.0324417296671058,0.994945571296895,3,34,activation of JUN kinase activity,BP,WNT7B;WNT5A;AXIN1
6544,GO:0019229,0.0324451047651525,0.992952327565618,4,58,regulation of vasoconstriction,BP,ADRA2B;ADRA2C;EDN1;AKT1
2492,GO:0005161,0.0325246983451211,0.997356918086597,2,14,platelet-derived growth factor receptor binding,MF,ITGA5;PDGFB
18651,GO:1901017,0.0325275748801268,0.997356557898048,2,14,negative regulation of potassium ion transmembrane transporter activity,BP,ACTN2;CASQ2
16441,GO:0071385,0.0325500574956601,0.992922443868547,4,58,cellular response to glucocorticoid stimulus,BP,EDN1;GJB2;STAR;HEY1
15083,GO:0060612,0.0325735329481911,0.994917066466515,3,34,adipose tissue development,BP,PLA2G16;ACAT1;PIK3CA
9615,GO:0034774,0.0325910301597973,0.985006532046234,12,312,secretory granule lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PNP;PYCARD;PDGFB;HEXB;IDH1;GAS6;GLA;DERA
14084,GO:0051446,0.0327077483556762,0.997333962000065,2,14,positive regulation of meiotic cell cycle,BP,WNT4;WNT5A
7099,GO:0022409,0.0327449364490053,0.986169823440791,10,244,positive regulation of cell-cell adhesion,BP,FADD;PNP;PYCARD;FSTL3;PIK3R1;WNT5A;BMP7;AKT1;PIK3CA;EFNB2
4824,GO:0010507,0.0328372049856619,0.992835883810972,4,59,negative regulation of autophagy,BP,TBC1D14;AKT1;PIK3CA;LZTS1
17228,GO:0080135,0.0328440058555631,0.981976546447594,19,579,regulation of cellular response to stress,BP,PMAIP1;GADD45A;WNT7A;WNT7B;EDN1;PYCARD;FZD7;RGN;FGF10;PIK3R1;HRAS;WNT5A;AXIN1;BMP7;BMP2;NOL3;CTGF;AKT1;FZD8
20876,GO:1990782,0.0328507411361438,0.992832013827848,4,59,protein tyrosine kinase binding,MF,PIK3R2;PIK3R1;GAS6;SHC4
12459,GO:0045986,0.0329170655400725,0.997307624070422,2,14,negative regulation of smooth muscle contraction,BP,ADRA2C;ADORA1
21243,GO:2000479,0.0329219873384449,0.997307003646836,2,14,regulation of cAMP-dependent protein kinase activity,BP,PRKAR1B;SESN2
5115,GO:0010934,0.0329342413848793,0.997305458723122,2,14,macrophage cytokine production,BP,WNT5A;GAS6
13886,GO:0051129,0.0329631798830088,0.981903317229615,19,581,negative regulation of cellular component organization,BP,ITGA3;FHOD3;LIF;WNT3;APOC1;SPTBN5;SPTBN4;PLEKHH2;WNT5A;RHOQ;SPTB;BMP7;BMP4;ESPN;NOL3;AKT1;UNC119;LINGO1;TMOD4
11675,GO:0044232,0.0329753447201888,0.997300274301618,2,14,organelle membrane contact site,CC,RAB38;ACSL4
3779,GO:0007351,0.0330976291235436,0.997284829132046,2,14,tripartite regional subdivision,BP,WNT5A;WT1
4241,GO:0008595,0.0330976291235436,0.997284829132046,2,14,anterior/posterior axis specification, embryo,BP,WNT5A;WT1
5643,GO:0015850,0.0332099402282299,0.98669062896008,9,212,organic hydroxy compound transport,BP,ADRA2B;ADRA2C;APOC1;ABCG1;RBP4;BMP6;CHGA;STAR;GDNF
12613,GO:0046365,0.0332114496666635,0.992733398890931,4,58,monosaccharide catabolic process,BP,ACTN3;KHK;GALT;PFKFB3
7357,GO:0030280,0.0332634750870438,0.997263831109785,2,14,structural constituent of epidermis,MF,KRT10;PKP1
2647,GO:0005523,0.0332810872933849,0.997261597769556,2,14,tropomyosin binding,MF,PYCARD;TMOD4
11376,GO:0043393,0.0333439522902827,0.987485864439604,8,180,regulation of protein binding,BP,ZFPM1;TICAM1;PDGFB;RALB;WNT5A;BMP4;BMP2;PCBD1
19353,GO:1902930,0.0333714628735768,0.994743507378334,3,34,regulation of alcohol biosynthetic process,BP,ABCG1;DHCR7;VDR
8649,GO:0032652,0.0334343968201186,0.992669394311883,4,58,regulation of interleukin-1 production,BP,CCL20;PYCARD;WNT5A;GAS6
16714,GO:0071850,0.0334823151876506,0.997236034099996,2,14,mitotic cell cycle arrest,BP,GADD45A;CDKN1A
14883,GO:0060347,0.0335034308976063,0.997233346621,2,14,heart trabecula formation,BP,RBP4;HEY1
12308,GO:0045717,0.0336158250748942,0.99721902590023,2,14,negative regulation of fatty acid biosynthetic process,BP,APOC1;ACADVL
17227,GO:0080134,0.0336742290265364,0.978061447942098,36,1266,regulation of response to stress,BP,CFB;WNT4;PMAIP1;GADD45A;FADD;WNT7A;WNT7B;ADORA1;EDN1;PLAU;PRKACB;PYCARD;FZD7;TYRO3;PSMB10;RGN;FGF10;PIK3R1;TICAM1;PDGFB;HRAS;WNT5A;SESN2;AXIN1;HBEGF;NMI;BMP7;BMP2;SHPK;NOL3;CTGF;CASP4;AKT1;FAM46A;PIK3CG;FZD8
4942,GO:0010712,0.0339815007736962,0.994609677155143,3,34,regulation of collagen metabolic process,BP,WNT4;BMP4;CTGF
831,GO:0002027,0.0340224469909894,0.990783105100715,5,88,regulation of heart rate,BP,DSC2;CASQ2;EDN1;SPTBN4;KCNH2
7097,GO:0022407,0.0341449382709706,0.983129609737833,14,389,regulation of cell-cell adhesion,BP,WNT4;FADD;PNP;PYCARD;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;BMP4;AKT1;CDH1;PIK3CA;EFNB2
2925,GO:0006000,0.0342297785697568,0.997140328499654,2,14,fructose metabolic process,BP,KHK;PFKFB3
12462,GO:0045989,0.0342475561225291,0.997138037934417,2,14,positive regulation of striated muscle contraction,BP,CHGA;CTGF
5698,GO:0015936,0.0342780369100012,0.997134109065585,2,14,coenzyme A metabolic process,BP,ACAT1;NUDT7
2990,GO:0006101,0.0342979000845604,0.994539879825373,3,34,citrate metabolic process,BP,GHR;MDH1;IDH1
6595,GO:0019377,0.0343149193958535,0.99712935243346,2,14,glycolipid catabolic process,BP,HEXB;GLA
19668,GO:1903557,0.0343567521615926,0.992398211779546,4,59,positive regulation of tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;PIK3R1;TICAM1
18876,GO:1901654,0.0343572634492728,0.987031497077696,8,180,response to ketone,BP,EDN1;CDKN1A;MSN;GJB2;AKT1;STAR;CLDN1;GAS6
11313,GO:0043277,0.0344907280788377,0.994488242551479,3,35,apoptotic cell clearance,BP,MFGE8;TYRO3;GAS6
10619,GO:0042033,0.0345634627797606,0.997097224147309,2,14,chemokine biosynthetic process,BP,TICAM1;WNT5A
245,GO:0000578,0.0345952404994021,0.994465040952928,3,35,embryonic axis specification,BP,WNT7A;WNT5A;WT1
9441,GO:0034433,0.0346415066807262,0.997087109029465,2,14,steroid esterification,BP,APOC1;ABCG1
9442,GO:0034434,0.0346415066807262,0.997087109029465,2,14,sterol esterification,BP,APOC1;ABCG1
9443,GO:0034435,0.0346415066807262,0.997087109029465,2,14,cholesterol esterification,BP,APOC1;ABCG1
7094,GO:0022404,0.0347012856664817,0.990549947399977,5,88,molting cycle process,BP,NOTCH1;TRADD;FGF10;WNT5A;LAMA5
7095,GO:0022405,0.0347012856664817,0.990549947399977,5,88,hair cycle process,BP,NOTCH1;TRADD;FGF10;WNT5A;LAMA5
6090,GO:0016746,0.0347260487524043,0.985187241799058,10,247,transferase activity, transferring acyl groups,MF,FASN;HMGCS2;NMT2;MBOAT2;ACSM5;CPT2;PLA2G16;ACAT1;CPT1C;ELOVL6
13760,GO:0050922,0.0347289084242184,0.994435325394357,3,35,negative regulation of chemotaxis,BP,WNT3;NOTCH1;WNT5A
7309,GO:0030212,0.0348741345607724,0.994402987669321,3,35,hyaluronan metabolic process,BP,PDGFB;HEXB;AKT1
19804,GO:1903829,0.0349289766190346,0.983197667423076,13,357,positive regulation of cellular protein localization,BP,ITGA3;LIF;PMAIP1;PRR5L;PIK3R2;PIK3R1;SESN2;BMP6;BMP4;MSN;AKT1;CDH1;GAS6
16949,GO:0072237,0.0349593950477601,0.999689849951179,1,2,metanephric proximal tubule development,BP,ACAT1
14356,GO:0051962,0.0350219167798028,0.982166858285258,15,434,positive regulation of nervous system development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;STAR
15176,GO:0060759,0.0350649985984873,0.987755639160697,7,147,regulation of response to cytokine stimulus,BP,FADD;TRADD;EDN1;PYCARD;WNT5A;NOL3;GAS6
5302,GO:0014874,0.0353033821088053,0.996976940632039,2,15,response to stimulus involved in regulation of muscle adaptation,BP,ACTN3;NOL3
4806,GO:0010464,0.0354785409795181,0.994267816862806,3,35,regulation of mesenchymal cell proliferation,BP,WNT2;WNT5A;BMP4
19419,GO:1903034,0.0355458002728836,0.987548923273158,7,149,regulation of response to wounding,BP,WNT4;EDN1;PLAU;PDGFB;HRAS;HBEGF;FAM46A
8853,GO:0032964,0.0355638400612723,0.994248664509637,3,35,collagen biosynthetic process,BP,WNT4;BMP4;CTGF
12350,GO:0045786,0.0356650281593384,0.980590408075537,18,544,negative regulation of cell cycle,BP,LIF;GADD45A;PRKACB;MAPK12;PSMB10;FGF10;FOXO4;PLA2G16;HRAS;RHOB;BMP7;BMP4;BMP2;CDKN1A;HMGN5;AKT1;NPPC;GAS6
11056,GO:0042813,0.0357855897500475,0.996913005875019,2,15,Wnt-activated receptor activity,MF,FZD7;FZD8
7507,GO:0030593,0.0358532365476165,0.990157708765437,5,86,neutrophil chemotaxis,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
11718,GO:0044297,0.0358822117350865,0.981233456237098,16,472,cell body,CC,SYT5;FADD;ADORA1;SPTBN4;CYP17A1;ANG;DRP2;GJB2;RAB17;STAR;LZTS1;S100B;KCND1;ACSL4;SLC1A3;ACTA2
2645,GO:0005521,0.0359497365925373,0.996891131647362,2,15,lamin binding,MF,IFI27;PKP1
14936,GO:0060413,0.0360071908309001,0.99688346207443,2,15,atrial septum morphogenesis,BP,ZFPM1;ACVR1
14109,GO:0051495,0.036085167115653,0.986247732264996,8,182,positive regulation of cytoskeleton organization,BP,WNT4;ACTN2;EDN1;PYCARD;HRAS;PSRC1;SDC4;CTGF
16901,GO:0072176,0.0361940518681754,0.996858470657822,2,15,nephric duct development,BP,BMP4;EFNB2
1582,GO:0003365,0.0362814025788931,0.999665721874119,1,2,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT
9563,GO:0034686,0.0362821511351314,0.999665707951371,1,2,integrin alphav-beta8 complex,CC,ITGB8
11495,GO:0043584,0.0363079478476498,0.996843202372855,2,15,nose development,BP,STRA6;AXIN1
11308,GO:0043270,0.036391084147267,0.985172611184693,9,216,positive regulation of ion transport,BP,ACTN2;ADORA1;EDN1;RGN;PDGFB;KCNH2;FXYD1;AKT1;GDNF
21020,GO:2000137,0.0363988385047017,0.999663534016615,1,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
10539,GO:0038201,0.0364815637867731,0.996819876765462,2,15,TOR complex,CC,PRR5L;SESN2
6384,GO:0018209,0.0365189784212079,0.983557867145365,11,288,peptidyl-serine modification,BP,LIF;SPTBN4;MAPK12;PDGFB;WNT5A;AXIN1;PKN3;AKT1;PIK3CA;GAS6;ARAF
8481,GO:0032420,0.0365313742880759,0.994020990898886,3,36,stereocilium,CC,CDH23;ESPN;MYO7A
2695,GO:0005608,0.0365649361111821,0.999660427166655,1,2,laminin-3 complex,CC,LAMA1
15141,GO:0060712,0.0365662231642864,0.996808480061902,2,15,spongiotrophoblast layer development,BP,LIF;AKT1
13429,GO:0048841,0.036571409717902,0.99678586445618,2,16,regulation of axon extension involved in axon guidance,BP,WNT3;WNT5A
11685,GO:0044246,0.0365878780368684,0.99401728224138,3,35,regulation of multicellular organismal metabolic process,BP,WNT4;BMP4;CTGF
4607,GO:0009636,0.0366384200754935,0.985055882706862,9,214,response to toxic substance,BP,MGST2;RGN;SESN2;BMP7;CDKN1A;PON2;CDH1;STAR;CLDN1
5674,GO:0015908,0.036650762839994,0.989873251751017,5,88,fatty acid transport,BP,EDN1;CPT2;FABP3;AKT1;ACSL4
20417,GO:1905208,0.0367361754997675,0.996785556768674,2,15,negative regulation of cardiocyte differentiation,BP,FZD7;BMP2
11120,GO:0042990,0.0367606423530272,0.989831639693236,5,89,regulation of transcription factor import into nucleus,BP,PIK3R2;PIK3R1;BMP7;NOL3;CDH1
3417,GO:0006734,0.0368473703009679,0.993958226392495,3,35,NADH metabolic process,BP,ACTN3;PFKFB3;MDH1
528,GO:0001573,0.0369883787479009,0.996751429879591,2,15,ganglioside metabolic process,BP,ITGB8;HEXB
16110,GO:0070742,0.0370378938077371,0.996744714403011,2,15,C2H2 zinc finger domain binding,MF,EBF1;WT1
13915,GO:0051170,0.0370413963510798,0.983285376553701,11,288,nuclear import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6
14131,GO:0051546,0.0371004758496378,0.996736219521159,2,15,keratinocyte migration,BP,FGF10;HBEGF
10656,GO:0042108,0.0371172669466138,0.991581590971701,4,60,positive regulation of cytokine biosynthetic process,BP,ZFPM1;CCL20;TICAM1;WNT5A
14338,GO:0051937,0.0372649486689267,0.991537578035587,4,60,catecholamine transport,BP,ADRA2B;ADRA2C;CHGA;GDNF
9160,GO:0033673,0.0373324409224559,0.983878720483726,10,251,negative regulation of kinase activity,BP,GADD45A;PYCARD;RGN;PRKAR1B;BMP7;BMP4;CDKN1A;DEPTOR;AKT1;DUSP5
9387,GO:0034349,0.0373548552853151,0.996701607462928,2,15,glial cell apoptotic process,BP,DLL1;GAS6
13902,GO:0051149,0.037472209134453,0.989581780038044,5,89,positive regulation of muscle cell differentiation,BP,EDN1;MAPK12;CDH2;BMP4;EFNB2
14184,GO:0051641,0.0375211884797554,0.972839921488971,63,2455,cellular localization,BP,ITGA3;LIF;SYT5;WNT4;ACTN2;RAB6C;TSPAN15;TSPAN17;RAB27A;ZFYVE21;PMAIP1;WNT7A;MRAP;NMT2;TBC1D14;ADORA1;CASQ2;RAB40B;RAB40A;ABCG1;SPTBN5;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;CPT2;WNT5A;GPRASP1;SESN2;RHOQ;RHOB;PSRC1;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;NOL3;AKT1;IFI27;PKP3;RAB12;RAB17;CDH1;MYO7A;STAR;PIK3CG;GAS6;RPH3AL;AMOT;LAMA5;SH3BP4;RAB38;GDNF;CNIH4;CLDN18
18880,GO:1901658,0.0376331699817706,0.99377835815765,3,35,glycosyl compound catabolic process,BP,PNP;GLA;DERA
17406,GO:0090136,0.0376720600153638,0.99665826172561,2,15,epithelial cell-cell adhesion,BP,ITGB5;CAMSAP3
1460,GO:0003169,0.0378279433928015,0.999636326469022,1,2,coronary vein morphogenesis,BP,NOTCH1
16583,GO:0071599,0.0379048973995108,0.996626314117049,2,15,otic vesicle development,BP,FGF10;FGF8
13694,GO:0050839,0.0380523642821491,0.980412031944484,15,438,cell adhesion molecule binding,MF,ITGA3;ITGA5;ACTN3;ACTN2;FASN;MFGE8;CGN;JAM3;MB21D2;MSN;CTGF;PKP3;IDH1;CDH1;LAMA5
16833,GO:0072076,0.0381599406806509,0.999629851467093,1,2,nephrogenic mesenchyme development,BP,BMP7
16874,GO:0072134,0.0381599406806509,0.999629851467093,1,2,nephrogenic mesenchyme morphogenesis,BP,BMP7
5914,GO:0016418,0.0382576818130752,0.999627934103182,1,2,S-acetyltransferase activity,MF,FASN
2457,GO:0005123,0.0382591925090006,0.996577489816108,2,15,death receptor binding,MF,FADD;NOL3
11121,GO:0042991,0.0382788421522034,0.989293663662644,5,90,transcription factor import into nucleus,BP,PIK3R2;PIK3R1;BMP7;NOL3;CDH1
16440,GO:0071384,0.0383192779245976,0.991216449071542,4,61,cellular response to corticosteroid stimulus,BP,EDN1;GJB2;STAR;HEY1
1281,GO:0002790,0.0383329424548411,0.979356447007378,17,511,peptide secretion,BP,ADRA2C;NOTCH1;ADORA1;EDN1;RAB40B;RAB40A;PNP;PYCARD;WNT5A;RBP4;ANG;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL
11743,GO:0044331,0.038453274577057,0.996550636046657,2,15,cell-cell adhesion mediated by cadherin,BP,CDH2;WNT5A
21410,GO:2000707,0.0384902517607881,0.999623351524945,1,2,positive regulation of dense core granule biogenesis,BP,CHGA
1450,GO:0003159,0.0385129344416365,0.996542366010417,2,15,morphogenesis of an endothelium,BP,RHOB;BMP4
15395,GO:0061154,0.0385129344416365,0.996542366010417,2,15,endothelial tube morphogenesis,BP,RHOB;BMP4
18961,GO:1901898,0.0385450151920445,0.999622268300513,1,2,negative regulation of relaxation of cardiac muscle,BP,PDE4B
14128,GO:0051542,0.0385579732810631,0.999622011756528,1,2,elastin biosynthetic process,BP,HBEGF
11259,GO:0043202,0.0386218940817668,0.989171953631465,5,90,lysosomal lumen,CC,IFI30;SDC4;IDUA;HEXB;GLA
5247,GO:0014736,0.0387118210226602,0.99961895909392,1,2,negative regulation of muscle atrophy,BP,NOL3
1902,GO:0004314,0.0387292811184094,0.999618611857668,1,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,FASN
5915,GO:0016419,0.0387292811184094,0.999618611857668,1,2,S-malonyltransferase activity,MF,FASN
5916,GO:0016420,0.0387292811184094,0.999618611857668,1,2,malonyltransferase activity,MF,FASN
352,GO:0000963,0.0387351685155601,0.996511496671282,2,15,mitochondrial RNA processing,BP,HSD17B10;PUS1
1907,GO:0004320,0.0388017313277586,0.999617169286521,1,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
5861,GO:0016295,0.0388017313277586,0.999617169286521,1,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
5862,GO:0016296,0.0388017313277586,0.999617169286521,1,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
5863,GO:0016297,0.0388017313277586,0.999617169286521,1,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
8697,GO:0032732,0.0388769670834945,0.993480595053694,3,36,positive regulation of interleukin-1 production,BP,CCL20;PYCARD;WNT5A
9409,GO:0034375,0.0389079573070767,0.996487426638117,2,15,high-density lipoprotein particle remodeling,BP,APOC1;ABCG1
1903,GO:0004315,0.0389292178194038,0.999614624132035,1,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,FASN
5217,GO:0014061,0.0389424023322451,0.996482621142803,2,15,regulation of norepinephrine secretion,BP,ADRA2B;ADRA2C
15219,GO:0060841,0.0389556294323158,0.99645667543288,2,16,venous blood vessel development,BP,NOTCH1;EFNB2
15839,GO:0070266,0.0389615705001076,0.993460848095129,3,36,necroptotic process,BP,FADD;TRADD;TICAM1
7805,GO:0031177,0.0389900723237658,0.999613406192825,1,2,phosphopantetheine binding,MF,FASN
12266,GO:0045637,0.0389962081572027,0.98491108631926,8,184,regulation of myeloid cell differentiation,BP,LIF;FADD;ZFPM1;FSTL3;PIK3R1;DLL1;KITLG;CLDN18
16777,GO:0071955,0.0390830489318854,0.999611541577737,1,2,recycling endosome to Golgi transport,BP,TBC1D14
10908,GO:0042559,0.039200615254153,0.996446521301026,2,15,pteridine-containing compound biosynthetic process,BP,PCBD1;PTS
6922,GO:0021693,0.0392522377322094,0.999608136810525,1,2,cerebellar Purkinje cell layer structural organization,BP,DLL1
6927,GO:0021698,0.0392522377322094,0.999608136810525,1,2,cerebellar cortex structural organization,BP,DLL1
14103,GO:0051489,0.0392532773207813,0.993383144996412,3,37,regulation of filopodium assembly,BP,RHOQ;ESPN;RAB17
17770,GO:0097153,0.0392908411962458,0.996433875535446,2,15,cysteine-type endopeptidase activity involved in apoptotic process,MF,PYCARD;CASP4
13636,GO:0050755,0.0393950643383301,0.996419247632125,2,15,chemokine metabolic process,BP,TICAM1;WNT5A
12089,GO:0045210,0.0394727357843119,0.999603676740373,1,2,FasL biosynthetic process,BP,PHLDA1
9561,GO:0034684,0.0395108312615969,0.999602903564394,1,2,integrin alphav-beta5 complex,CC,ITGB5
15459,GO:0061341,0.0396018827053092,0.99960105249287,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,WNT5A
15461,GO:0061346,0.0396018827053092,0.99960105249287,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,WNT5A
10910,GO:0042562,0.0396039222750855,0.990822141200761,4,62,hormone binding,MF,ACVR1;GHR;PIK3R1;NPR1
11586,GO:0043974,0.0396689971042433,0.999599685248118,1,2,histone H3-K27 acetylation,BP,LIF
18891,GO:1901674,0.0396689971042433,0.999599685248118,1,2,regulation of histone H3-K27 acetylation,BP,LIF
11309,GO:0043271,0.0397152733805571,0.98713429180783,6,120,negative regulation of ion transport,BP,ACTN2;ADORA1;CASQ2;KCNH2;WNK4;AKT1
10879,GO:0042517,0.0397309219782873,0.993280472009555,3,36,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,LIF;GHR;CLCF1
16724,GO:0071871,0.0397653138113844,0.996342249828546,2,16,response to epinephrine,BP,STAR;PDE4B
7249,GO:0030133,0.0398358294222766,0.980473866468236,13,361,transport vesicle,CC,TMEM163;SYT5;RAB27A;CRISPLD2;EDN1;RAB40B;RAB40A;SYCN;VAMP1;CHGA;RPH3AL;RAB3D;PDE4B
18992,GO:1902001,0.0398902720488268,0.996324472943429,2,16,fatty acid transmembrane transport,BP,CPT2;AKT1
2291,GO:0004854,0.0399335788251678,0.999594271972915,1,2,xanthine dehydrogenase activity,MF,AOX1
4392,GO:0009115,0.0399335788251678,0.999594271972915,1,2,xanthine catabolic process,BP,AOX1
6080,GO:0016726,0.0399335788251678,0.999594271972915,1,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,AOX1
7333,GO:0030241,0.0400783682667627,0.999456298079702,1,3,skeletal muscle myosin thick filament assembly,BP,MYH11
5241,GO:0014728,0.0401846744932574,0.999589100297568,1,2,regulation of the force of skeletal muscle contraction,BP,ACTN3
5298,GO:0014862,0.0401846744932574,0.999589100297568,1,2,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,ACTN3
15505,GO:0061443,0.0402167126725276,0.999588438020235,1,2,endocardial cushion cell differentiation,BP,ACVR1
15075,GO:0060599,0.0403386611423348,0.999585912182095,1,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,WNT5A
18287,GO:0099054,0.0403449170572696,0.996259529692784,2,16,presynapse assembly,BP,WNT7A;WNT5A
10419,GO:0036518,0.0403462463643844,0.999585754813812,1,2,chemorepulsion of dopaminergic neuron axon,BP,WNT5A
2450,GO:0005110,0.0403477194267169,0.999585724249099,1,2,frizzled-2 binding,MF,WNT5A
17861,GO:0097325,0.0403658115424079,0.999585348760152,1,2,melanocyte proliferation,BP,WNT5A
15203,GO:0060809,0.0403784342479078,0.999585086682074,1,2,mesodermal to mesenchymal transition involved in gastrulation,BP,WNT5A
6777,GO:0019953,0.0404312184843972,0.975976312479492,23,747,sexual reproduction,BP,WNT3;WNT4;NOTCH1;IGSF8;DHH;SERPINA5;ACVR1;MFGE8;SPTBN4;TYRO3;RGN;FSTL3;JAM3;ANG;BMP4;WT1;SLC2A14;HEXB;AKT1;NPPC;JAG2;INHBB;CLDN11
2969,GO:0006066,0.0404513417193488,0.981490008930024,11,289,alcohol metabolic process,BP,EBP;PECR;APOC1;HMGCS2;ABCG1;ACADVL;RBP4;STAR;CYP11A1;DHCR7;VDR
10126,GO:0035924,0.0405007234302478,0.99308866490636,3,37,cellular response to vascular endothelial growth factor stimulus,BP,NOTCH1;DLL1;AKT1
1954,GO:0004379,0.040507745012672,0.999582397007428,1,2,glycylpeptide N-tetradecanoyltransferase activity,MF,NMT2
6329,GO:0018008,0.040507745012672,0.999582397007428,1,2,N-terminal peptidyl-glycine N-myristoylation,BP,NMT2
6502,GO:0019107,0.040507745012672,0.999582397007428,1,2,myristoyltransferase activity,MF,NMT2
14695,GO:0060067,0.0405227388598984,0.999582084560164,1,2,cervix development,BP,WNT5A
14304,GO:0051885,0.04052784796507,0.999581978067516,1,2,positive regulation of timing of anagen,BP,WNT5A
15028,GO:0060538,0.0405534579498507,0.985384394884054,7,154,skeletal muscle organ development,BP,ACTN3;NOTCH1;STRA6;IGSF8;WT1;DLL1;S100B
17613,GO:0090526,0.0405957565909756,0.999580561284991,1,2,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,SESN2
8422,GO:0032354,0.0406088685230366,0.996221636121958,2,16,response to follicle-stimulating hormone,BP,NOTCH1;STAR
14662,GO:0060031,0.0406668161931345,0.999579076143188,1,2,mediolateral intercalation,BP,WNT5A
15188,GO:0060775,0.0406668161931345,0.999579076143188,1,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,WNT5A
16071,GO:0070666,0.0406671428980114,0.999579069308885,1,2,regulation of mast cell proliferation,BP,KITLG
16073,GO:0070668,0.0406671428980114,0.999579069308885,1,2,positive regulation of mast cell proliferation,BP,KITLG
5323,GO:0014909,0.0407190678991808,0.99047042776775,4,64,smooth muscle cell migration,BP,PLAU;PDGFB;FOXO4;DDR1
5111,GO:0010927,0.0407480666090834,0.988397603468891,5,94,cellular component assembly involved in morphogenesis,BP,FHOD3;ACTN2;CASQ2;EDN1;MYH11
11623,GO:0044085,0.0407842437305693,0.969855586384739,71,2815,cellular component biogenesis,BP,ITGA5;FHOD3;WNT4;TUBG2;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;ITGB5;ITGB4;PMAIP1;FADD;WNT7A;APOC1;TRADD;TBC1D14;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;TTYH1;RAB39A;PRND;LIMS2;CDH2;PIK3R1;RALB;HRAS;WNT5A;HACL1;AXIN1;RHOQ;PSRC1;RNASEL;SDC4;ANG;FAM110C;SPTB;BMP7;ACAT1;RAB20;ESPN;VAMP1;CHGA;MSN;NOL3;CTGF;GJB1;GJB2;PCBD1;PKP3;PKP1;RAB17;DECR1;CDH1;MYO7A;TLE1;CLDN1;CLDN3;CLDN5;KCNG2;GAS6;MYH11;HNF1A;LAMA5;KCND1;RAB38;PARVB;TMOD4
20507,GO:1905438,0.0408183373294186,0.999575900409603,1,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
20313,GO:1904933,0.0408356632926598,0.99957553649805,1,2,regulation of cell proliferation in midbrain,BP,WNT5A
5362,GO:0015091,0.040856942358831,0.999575089338151,1,2,ferric iron transmembrane transporter activity,MF,TF
17067,GO:0072510,0.040856942358831,0.999575089338151,1,2,trivalent inorganic cation transmembrane transporter activity,MF,TF
21019,GO:2000136,0.0408833755103869,0.996182079770687,2,16,regulation of cell proliferation involved in heart morphogenesis,BP,NOTCH1;BMP4
14905,GO:0060375,0.0409345111442666,0.99957345726647,1,2,regulation of mast cell differentiation,BP,ZFPM1
9549,GO:0034667,0.0409411457618059,0.99957331752372,1,2,integrin alpha3-beta1 complex,CC,ITGA3
656,GO:0001786,0.0410177463982024,0.992965509491664,3,37,phosphatidylserine binding,MF,SYT5;MFGE8;GAS6
305,GO:0000806,0.0410455629480772,0.999571115140519,1,2,Y chromosome,CC,SIN3B
19010,GO:1902043,0.041083375368761,0.996153165439882,2,16,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;FADD
2203,GO:0004731,0.0411256848030836,0.999569421272229,1,2,purine-nucleoside phosphorylase activity,MF,PNP
1779,GO:0004031,0.0411841341892022,0.99956818343404,1,2,aldehyde oxidase activity,MF,AOX1
17855,GO:0097305,0.0412005002978626,0.983882498384282,8,187,response to alcohol,BP,RBP4;AKT1;NPPC;CDH1;STAR;CLDN1;CLDN3;CLDN18
17865,GO:0097338,0.0412193520480078,0.999567436715893,1,2,response to clozapine,BP,PRKACB
7615,GO:0030849,0.0412439371717841,0.999566915051283,1,2,autosome,CC,SIN3B
8894,GO:0033026,0.0412500551806962,0.999566785185135,1,2,negative regulation of mast cell apoptotic process,BP,KITLG
15479,GO:0061371,0.0412626859406129,0.990307921492396,4,63,determination of heart left/right asymmetry,BP,NOTCH1;WNT5A;FGF8;DLL1
17694,GO:0097018,0.041290273128286,0.999565930989211,1,2,renal albumin absorption,BP,GAS6
21281,GO:2000532,0.041290273128286,0.999565930989211,1,2,regulation of renal albumin absorption,BP,GAS6
18613,GO:1900453,0.0412985703136072,0.999565754656937,1,2,negative regulation of long term synaptic depression,BP,ADORA1
15207,GO:0060823,0.0413691530426598,0.999564253149631,1,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,AXIN1
17315,GO:0086097,0.0413698105519264,0.999564239149985,1,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,ACTN2
11606,GO:0044028,0.0413993320241175,0.999563610343941,1,2,DNA hypomethylation,BP,PIK3CA
11607,GO:0044029,0.0413993320241175,0.999563610343941,1,2,hypomethylation of CpG island,BP,PIK3CA
16821,GO:0072053,0.0413996603006267,0.999563603349063,1,2,renal inner medulla development,BP,WNT7B
16822,GO:0072054,0.0413996603006267,0.999563603349063,1,2,renal outer medulla development,BP,WNT7B
15169,GO:0060748,0.0414075842783566,0.999563434488479,1,2,tertiary branching involved in mammary gland duct morphogenesis,BP,WNT4
10462,GO:0038062,0.0414097535059781,0.999563388256252,1,2,protein tyrosine kinase collagen receptor activity,MF,DDR1
7329,GO:0030237,0.0414187080531015,0.999563197383678,1,2,female sex determination,BP,WNT4
10460,GO:0038060,0.0414247629580603,0.999563068294905,1,2,nitric oxide-cGMP-mediated signaling pathway,BP,GUCY1B3
13827,GO:0051040,0.0414269121730625,0.999563022469595,1,2,regulation of calcium-independent cell-cell adhesion,BP,BMP2
9244,GO:0034041,0.0414281520500153,0.999562996031968,1,2,sterol-transporting ATPase activity,MF,ABCG1
12921,GO:0046997,0.0414286774893802,0.999562984827893,1,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,SARDH
8807,GO:0032899,0.0414302003568471,0.999562952354577,1,2,regulation of neurotrophin production,BP,ADORA1
19121,GO:1902303,0.0414310881835454,0.999562933422173,1,2,negative regulation of potassium ion export,BP,KCNH2
9445,GO:0034437,0.041433319555241,0.99956288583758,1,2,glycoprotein transporter activity,MF,ABCG1
8487,GO:0032427,0.0414343679650679,0.999562863479049,1,2,GBD domain binding,MF,RHOQ
16983,GO:0072301,0.0414365060216456,0.999562817880752,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
20952,GO:2000017,0.0414373405450522,0.999562800082226,1,2,positive regulation of determination of dorsal identity,BP,ACVR1
19612,GO:1903433,0.0414397897626699,0.999562747843732,1,2,regulation of constitutive secretory pathway,BP,RAB27A
1674,GO:0003858,0.0414409917923803,0.9995627222049,1,2,3-hydroxybutyrate dehydrogenase activity,MF,BDH2
16529,GO:0071505,0.041449116344023,0.999562548891204,1,2,response to mycophenolic acid,BP,PDGFB
16530,GO:0071506,0.041449116344023,0.999562548891204,1,2,cellular response to mycophenolic acid,BP,PDGFB
11341,GO:0043316,0.041457768855845,0.999562364276443,1,2,cytotoxic T cell degranulation,BP,RAB27A
21507,GO:2000857,0.0414792297009148,0.999561906204313,1,2,positive regulation of mineralocorticoid secretion,BP,BMP6
21509,GO:2000860,0.0414792297009148,0.999561906204313,1,2,positive regulation of aldosterone secretion,BP,BMP6
4829,GO:0010512,0.0414854392247592,0.999561773619154,1,2,negative regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
1479,GO:0003195,0.041486292868501,0.999561755390632,1,2,tricuspid valve formation,BP,ZFPM1
19108,GO:1902271,0.0414932988766638,0.999561605771236,1,2,D3 vitamins binding,MF,VDR
16931,GO:0072209,0.0414970011715261,0.999561526694975,1,2,metanephric mesangial cell differentiation,BP,PDGFB
16956,GO:0072254,0.0414970011715261,0.999561526694975,1,2,metanephric glomerular mesangial cell differentiation,BP,PDGFB
8571,GO:0032542,0.0415166420270783,0.999561107069716,1,2,sulfiredoxin activity,MF,SESN2
16386,GO:0071307,0.0415342987362458,0.999560729660588,1,2,cellular response to vitamin K,BP,GAS6
17740,GO:0097102,0.0415409960725773,0.999560586462831,1,2,endothelial tip cell fate specification,BP,DLL1
6294,GO:0017143,0.0415639541362312,0.999560095408666,1,2,insecticide metabolic process,BP,STAR
1976,GO:0004421,0.0415682116574903,0.999560004312985,1,2,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS2
15222,GO:0060844,0.0415861507321537,0.999559620375324,1,2,arterial endothelial cell fate commitment,BP,DLL1
1877,GO:0004174,0.041588254888492,0.999559575330307,1,2,electron-transferring-flavoprotein dehydrogenase activity,MF,ETFDH
6044,GO:0016649,0.041588254888492,0.999559575330307,1,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,ETFDH
15319,GO:0061032,0.0415930565083783,0.999559472530156,1,2,visceral serous pericardium development,BP,WT1
20379,GO:1905069,0.0416140078536529,0.999559023829503,1,2,allantois development,BP,BMP7
1048,GO:0002386,0.0416433260275716,0.99955839555051,1,2,immune response in mucosal-associated lymphoid tissue,BP,RAB17
1055,GO:0002415,0.0416433260275716,0.99955839555051,1,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,RAB17
19651,GO:1903532,0.0416583670963829,0.980110315726555,12,327,positive regulation of secretion by cell,BP,RAB27A;EDN1;PYCARD;WNT5A;RBP4;SDC4;ANG;BMP6;INHBB;RPH3AL;RAB3D;GDNF
14825,GO:0060279,0.0416608734270053,0.999558019296846,1,2,positive regulation of ovulation,BP,INHBB
3720,GO:0007220,0.041668984640975,0.996068046560107,2,16,Notch receptor processing,BP,DLL1;JAG2
10308,GO:0036304,0.0416706371994043,0.999557809869871,1,2,umbilical cord morphogenesis,BP,HEY1
15314,GO:0061027,0.0416706371994043,0.999557809869871,1,2,umbilical cord development,BP,HEY1
14376,GO:0051990,0.0416788994953345,0.999557632609067,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,IDH1
14725,GO:0060119,0.0416790545683271,0.992797341004928,3,38,inner ear receptor cell development,BP,CDH23;SDC4;MYO7A
16997,GO:0072320,0.0416807641482833,0.999557592599443,1,2,volume-sensitive chloride channel activity,MF,TTYH1
17831,GO:0097241,0.0417217409735272,0.999556712898257,1,2,hematopoietic stem cell migration to bone marrow,BP,GAS6
11750,GO:0044338,0.0417609187886048,0.99955587098398,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
15721,GO:0070080,0.0417629457071299,0.999555827404178,1,2,titin Z domain binding,MF,ACTN2
9041,GO:0033306,0.0417686015986573,0.999555705788018,1,2,phytol metabolic process,BP,PECR
19475,GO:1903173,0.0417686015986573,0.999555705788018,1,2,fatty alcohol metabolic process,BP,PECR
14034,GO:0051352,0.0417779474251832,0.999555504791532,1,2,negative regulation of ligase activity,BP,RGN
16891,GO:0072166,0.0417820890650442,0.999555415704298,1,2,posterior mesonephric tubule development,BP,WT1
1404,GO:0003064,0.0417922957328081,0.999555196118561,1,2,regulation of heart rate by hormone,BP,KCNH2
1994,GO:0004458,0.0417973486094857,0.999555087390729,1,2,D-lactate dehydrogenase (cytochrome) activity,MF,LDHD
6190,GO:0016898,0.0417973486094857,0.999555087390729,1,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,LDHD
20869,GO:1990769,0.0417986496007445,0.999555059393793,1,2,proximal neuron projection,CC,SYT5
9435,GO:0034418,0.041806727995387,0.999554885529058,1,2,urate biosynthetic process,BP,PNP
15291,GO:0060994,0.0418077040589581,0.999554864519684,1,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,BMP4
19703,GO:1903625,0.0418095290905776,0.999554825235257,1,2,negative regulation of DNA catabolic process,BP,RGN
18970,GO:1901963,0.0418133145219316,0.999554743746912,1,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
6767,GO:0019912,0.0418195190262352,0.999554610167112,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
10061,GO:0035801,0.0418205458473803,0.999554588058205,1,2,adrenal cortex development,BP,WT1
10062,GO:0035802,0.0418205458473803,0.999554588058205,1,2,adrenal cortex formation,BP,WT1
21567,GO:2001074,0.0418216362403808,0.999554564579892,1,2,regulation of metanephric ureteric bud development,BP,WT1
21568,GO:2001076,0.0418216362403808,0.999554564579892,1,2,positive regulation of metanephric ureteric bud development,BP,WT1
16100,GO:0070724,0.0418218683535449,0.999554559581956,1,2,BMP receptor complex,CC,BMP2
19242,GO:1902612,0.041826712159474,0.999554455277018,1,2,regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
19243,GO:1902613,0.041826712159474,0.999554455277018,1,2,negative regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
20741,GO:1990262,0.041826712159474,0.999554455277018,1,2,anti-Mullerian hormone signaling pathway,BP,DKK3
2479,GO:0005146,0.0418299334914819,0.999554385902997,1,2,leukemia inhibitory factor receptor binding,MF,LIF
775,GO:0001952,0.0418377300558408,0.988002619720456,5,94,regulation of cell-matrix adhesion,BP,WNT4;PLAU;PIK3R1;SDC4;DDR1
20490,GO:1905384,0.0418535332980889,0.999553877493571,1,2,regulation of protein localization to presynapse,BP,WNT7A
20491,GO:1905386,0.0418535332980889,0.999553877493571,1,2,positive regulation of protein localization to presynapse,BP,WNT7A
15793,GO:0070195,0.0418598480211064,0.999553741405594,1,2,growth hormone receptor complex,CC,GHR
18962,GO:1901899,0.0418640842232978,0.999553650099733,1,2,positive regulation of relaxation of cardiac muscle,BP,CHGA
21675,GO:2001287,0.0418807590643057,0.999553290602389,1,2,negative regulation of caveolin-mediated endocytosis,BP,UNC119
2898,GO:0005960,0.0418850728263127,0.999553197576772,1,2,glycine cleavage complex,CC,GLDC
5181,GO:0014013,0.0418952639392964,0.98798834409862,5,92,regulation of gliogenesis,BP,LIF;NOTCH1;CDH2;CLCF1;BMP2
19193,GO:1902524,0.0418980765991917,0.999552917092526,1,2,positive regulation of protein K48-linked ubiquitination,BP,NMI
21204,GO:2000409,0.0418999436895403,0.999552876813029,1,2,positive regulation of T cell extravasation,BP,FADD
21226,GO:2000451,0.0418999436895403,0.999552876813029,1,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
11977,GO:0045029,0.0419081874568614,0.999552698944735,1,2,UDP-activated nucleotide receptor activity,MF,P2RY14
12063,GO:0045168,0.0419130233201607,0.999552594588879,1,2,cell-cell signaling involved in cell fate commitment,BP,DLL1
12597,GO:0046331,0.0419130233201607,0.999552594588879,1,2,lateral inhibition,BP,DLL1
2069,GO:0004557,0.0419134561149173,0.999552585248747,1,2,alpha-galactosidase activity,MF,GLA
13362,GO:0048697,0.0419180073887959,0.999552487021802,1,2,positive regulation of collateral sprouting in absence of injury,BP,WNT3
10763,GO:0042323,0.0419185951379988,0.99955247433602,1,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
15833,GO:0070256,0.0419185951379988,0.99955247433602,1,2,negative regulation of mucus secretion,BP,ADORA1
21067,GO:2000224,0.0419342760102294,0.999552135817518,1,2,regulation of testosterone biosynthetic process,BP,WNT4
15072,GO:0060595,0.041950050948438,0.999551795136378,1,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,FGF10
15085,GO:0060615,0.041950050948438,0.999551795136378,1,2,mammary gland bud formation,BP,FGF10
15103,GO:0060667,0.041950050948438,0.999551795136378,1,2,branch elongation involved in salivary gland morphogenesis,BP,FGF10
15246,GO:0060915,0.041950050948438,0.999551795136378,1,2,mesenchymal cell differentiation involved in lung development,BP,FGF10
19268,GO:1902688,0.0419761046592183,0.999551232181453,1,2,regulation of NAD metabolic process,BP,ACTN3
15320,GO:0061033,0.041983304468006,0.999551076548095,1,2,secretion by lung epithelial cell involved in lung growth,BP,FGF10
8279,GO:0032090,0.0419964489846154,0.999550792340929,1,2,Pyrin domain binding,MF,PYCARD
1990,GO:0004450,0.0420016206312448,0.999550680495802,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH1
2987,GO:0006097,0.0420016206312448,0.999550680495802,1,2,glyoxylate cycle,BP,IDH1
6965,GO:0021784,0.0420094924724515,0.999550510227346,1,2,postganglionic parasympathetic fiber development,BP,GDNF
10167,GO:0035993,0.0420228880974818,0.999550220403312,1,2,deltoid tuberosity development,BP,BMP4
17734,GO:0097089,0.0420319062684921,0.999550025234907,1,2,methyl-branched fatty acid metabolic process,BP,PHYH
12523,GO:0046102,0.042032391329489,0.999550014736145,1,2,inosine metabolic process,BP,PNP
3273,GO:0006550,0.0421159050981758,0.99954820528087,1,2,isoleucine catabolic process,BP,ACAT1
17722,GO:0097059,0.0421181667191995,0.99954815622775,1,2,CNTFR-CLCF1 complex,CC,CLCF1
7359,GO:0030283,0.0421224227197702,0.999548063910429,1,2,testosterone dehydrogenase [NAD(P)] activity,MF,HSD17B10
9993,GO:0035698,0.0421232986724584,0.999548044908859,1,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
21227,GO:2000452,0.0421232986724584,0.999548044908859,1,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
3954,GO:0008124,0.042142039526793,0.999547638275809,1,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,PCBD1
15233,GO:0060876,0.0421429893150668,0.999547617662633,1,2,semicircular canal formation,BP,FGF10
16015,GO:0070557,0.0421603876791063,0.999547239982477,1,2,PCNA-p21 complex,CC,CDKN1A
13228,GO:0048389,0.04216147880945,0.999547216291074,1,2,intermediate mesoderm development,BP,BMP4
15428,GO:0061227,0.04216147880945,0.999547216291074,1,2,pattern specification involved in mesonephros development,BP,BMP4
16849,GO:0072098,0.04216147880945,0.999547216291074,1,2,anterior/posterior pattern specification involved in kidney development,BP,BMP4
3068,GO:0006258,0.0421673471852062,0.99954708886184,1,2,UDP-glucose catabolic process,BP,GALT
4811,GO:0010469,0.0422213790210571,0.986113384847431,6,124,regulation of receptor activity,BP,ADRA2B;ADRA2C;ACTN2;ADORA1;CASQ2;PLAU
8136,GO:0031780,0.0422223783606007,0.999545892992265,1,2,corticotropin hormone receptor binding,MF,MRAP
8139,GO:0031783,0.0422223783606007,0.999545892992265,1,2,type 5 melanocortin receptor binding,MF,MRAP
14483,GO:0052740,0.0422323796604394,0.999545675483346,1,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,PLA2G16
6729,GO:0019853,0.0422413547190054,0.999545480247882,1,2,L-ascorbic acid biosynthetic process,BP,RGN
15098,GO:0060661,0.0422478768223145,0.999545338344943,1,2,submandibular salivary gland formation,BP,FGF10
16404,GO:0071335,0.0422478768223145,0.999545338344943,1,2,hair follicle cell proliferation,BP,FGF10
16405,GO:0071336,0.0422478768223145,0.999545338344943,1,2,regulation of hair follicle cell proliferation,BP,FGF10
16406,GO:0071338,0.0422478768223145,0.999545338344943,1,2,positive regulation of hair follicle cell proliferation,BP,FGF10
16942,GO:0072224,0.0422734353462243,0.995979478497305,2,16,metanephric glomerulus development,BP,PDGFB;WT1
19707,GO:1903630,0.0422931339271431,0.999544353052029,1,2,regulation of aminoacyl-tRNA ligase activity,BP,RGN
14592,GO:0055070,0.0423063122103979,0.995974640540532,2,16,copper ion homeostasis,BP,SLC31A2;PRND
10819,GO:0042418,0.0423109265390625,0.999543965390433,1,2,epinephrine biosynthetic process,BP,PNMT
15822,GO:0070242,0.0423173247634314,0.995973019526233,2,16,thymocyte apoptotic process,BP,WNT5A;BMP4
8403,GO:0032311,0.042335512183628,0.999543429446502,1,2,angiogenin-PRI complex,CC,ANG
11511,GO:0043616,0.0423405412314742,0.992637595106527,3,38,keratinocyte proliferation,BP,FGF10;VDR;EFNB2
14917,GO:0060390,0.042341751173508,0.995969423182712,2,16,regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
12158,GO:0045355,0.0423460835041996,0.999543198902772,1,2,negative regulation of interferon-alpha biosynthetic process,BP,NMI
16779,GO:0071963,0.042355106186572,0.999543002085345,1,2,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
4275,GO:0008670,0.0424060158735959,0.999541890748586,1,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR1
3945,GO:0008113,0.0424191000365503,0.999541604904091,1,2,peptide-methionine (S)-S-oxide reductase activity,MF,MSRA
10371,GO:0036461,0.042460672112946,0.999540696090867,1,2,BLOC-2 complex binding,MF,RAB38
16000,GO:0070538,0.0424720356415595,0.999540447511035,1,2,oleic acid binding,MF,FABP3
12634,GO:0046434,0.0425101040885242,0.986000659028472,6,122,organophosphate catabolic process,BP,APOC1;PNP;NUDT7;IDH1;DERA;PDE4B
13028,GO:0047750,0.0425338112969897,0.999539094951774,1,2,cholestenol delta-isomerase activity,MF,EBP
15895,GO:0070352,0.04253444026696,0.999539081170221,1,2,positive regulation of white fat cell proliferation,BP,FGF10
1153,GO:0002582,0.0425542314575753,0.999538647411838,1,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
1156,GO:0002585,0.0425542314575753,0.999538647411838,1,2,positive regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
1159,GO:0002588,0.0425542314575753,0.999538647411838,1,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
1999,GO:0004464,0.0425887898264219,0.999537889505141,1,2,leukotriene-C4 synthase activity,MF,MGST2
15716,GO:0070075,0.0426009730352572,0.99953762216111,1,2,tear secretion,BP,FGF10
18604,GO:1900407,0.0426597169213126,0.989873778334662,4,63,regulation of cellular response to oxidative stress,BP,RGN;BMP7;NOL3;AKT1
4985,GO:0010761,0.0426915352717402,0.992552411506204,3,38,fibroblast migration,BP,PRR5L;SDC4;AKT1
11679,GO:0044238,0.0427922430891429,0.966089125394036,220,9787,primary metabolic process,BP,ITGA3;ITGA5;ARTN;CFB;EBP;PDK4;PECR;LIF;ADRA2B;ADRA2C;WNT2;WNT4;USE1;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;ALG5;PHYH;NOTCH1;GLDC;MARK4;DPM3;STRA6;ZFYVE21;ITGB8;FASN;PMAIP1;GADD45A;MSRA;RHBDL3;FBXO41;MRPL14;MRPL16;MRI1;FADD;DHH;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;ADORA1;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;ABCG1;PRKACB;MFGE8;CCL20;EBF1;BDH2;SPTBN5;SPTBN4;PYCARD;MBOAT2;LAGE3;ACADVL;KRT10;PRND;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;ASAH2;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PTPN7;NNMT;FOXO4;RALB;CPT2;PLA2G16;HSD17B10;ETFB;HRAS;WNT5A;MAGEC2;KHK;HACL1;SESN2;AXIN1;GALT;RBP4;RHOQ;NPR1;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;ECHDC2;SARDH;SHPK;HEXB;WNK4;FABP3;CHGA;MSN;NOL3;HSD3B2;NUDT7;DDR1;DEPTOR;CTGF;CPT1C;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;PON2;NRTN;PTGES;KITLG;IDH1;NPPC;DECR1;CST9L;NAB2;JAG2;CDH1;PUS1;INHBB;PTMS;MDP1;SPSB1;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;PEPD;GLA;DTX4;ECI1;ZCCHC12;CYP11A1;LZTS1;DERA;DHCR7;CYB5A;PTS;PM20D2;RBMS3;HNF1A;VDR;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;ACSL4;SLC1A3;FZD8;ELOVL6;DUSP5;HEY1;RNF144A;PIM2;ETFDH;PDE4B
21562,GO:2001056,0.0428243639179245,0.985872499790443,6,122,positive regulation of cysteine-type endopeptidase activity,BP,PMAIP1;FADD;TRADD;PYCARD;CTGF;IFI27
17455,GO:0090201,0.0428628495952215,0.995892422161611,2,16,negative regulation of release of cytochrome c from mitochondria,BP,NOL3;AKT1
16653,GO:0071702,0.0428950456887182,0.968499095674311,66,2596,organic substance transport,BP,ADRA2B;ADRA2C;USE1;NOTCH1;RAB27A;TF;SLC45A4;SERPINA5;APOC1;SLC52A3;RABIF;TBC1D14;ADORA1;EDN1;RAB40B;RAB40A;PNP;ABCG1;FLVCR2;PYCARD;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;CPT2;WNT5A;SNX18;SESN2;RBP4;RHOQ;RHOB;RNASEL;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;FABP3;CHGA;NOL3;GJB1;AKT1;IFI27;RAB12;RAB17;CDH1;MYO7A;INHBB;STAR;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;HNF1A;UNC119;RAB38;RAB3D;GDNF;ACSL4;SLC1A3;CNIH4
20663,GO:1905953,0.0429697058382506,0.992484695708536,3,38,negative regulation of lipid localization,BP,APOC1;ABCG1;AKT1
5127,GO:0010952,0.0430055116046439,0.984305333154584,7,154,positive regulation of peptidase activity,BP,PMAIP1;FADD;TRADD;PYCARD;MAPK12;CTGF;IFI27
16509,GO:0071479,0.0430988111361092,0.989730845724425,4,64,cellular response to ionizing radiation,BP,GADD45A;HRAS;RHOB;CDKN1A
8763,GO:0032816,0.0431809826432902,0.99584515148931,2,16,positive regulation of natural killer cell activation,BP,TICAM1;GAS6
13977,GO:0051259,0.0431812926696764,0.976879897161323,16,478,protein oligomerization,BP,ACTN2;PMAIP1;TRADD;SPTBN5;PRND;HRAS;HACL1;ACAT1;NOL3;GJB1;PCBD1;DECR1;CLDN1;CLDN3;KCNG2;KCND1
7996,GO:0031527,0.0432324826559527,0.995812722837071,2,17,filopodium membrane,CC,ITGA3;TTYH1
19446,GO:1903078,0.0432477274735475,0.992416834874455,3,38,positive regulation of protein localization to plasma membrane,BP,ITGA3;PIK3R1;AKT1
20043,GO:1904377,0.0432477274735475,0.992416834874455,3,38,positive regulation of protein localization to cell periphery,BP,ITGA3;PIK3R1;AKT1
5001,GO:0010799,0.0433357210298788,0.992395319325193,3,38,regulation of peptidyl-threonine phosphorylation,BP,WNT5A;AXIN1;BMP7
6830,GO:0021532,0.0433497778422222,0.992391880579661,3,38,neural tube patterning,BP,PRKACB;FGF8;BMP4
16751,GO:0071901,0.0435117867727118,0.98558881427807,6,123,negative regulation of protein serine/threonine kinase activity,BP,PYCARD;PRKAR1B;BMP7;BMP4;CDKN1A;DUSP5
15331,GO:0061045,0.0435134559776121,0.989600550954362,4,64,negative regulation of wound healing,BP,WNT4;EDN1;PLAU;PDGFB
6127,GO:0016805,0.0435480412779344,0.995790365871603,2,16,dipeptidase activity,MF,PEPD;PM20D2
2988,GO:0006098,0.0435853964276021,0.995784775701535,2,16,pentose-phosphate shunt,BP,SHPK;DERA
13151,GO:0048243,0.043695237925517,0.995768322295179,2,16,norepinephrine secretion,BP,ADRA2B;ADRA2C
4048,GO:0008277,0.0438768252544104,0.985439013632225,6,123,regulation of G-protein coupled receptor protein signaling pathway,BP,NMT2;EDN1;GPRASP1;CHGA;RPH3AL;GPSM1
4603,GO:0009628,0.0439640413918035,0.971449468839755,32,1129,response to abiotic stimulus,BP,NOTCH1;STRA6;PMAIP1;GADD45A;FADD;SLC52A3;NMT2;ADORA1;EDN1;PLAU;ACADVL;PSMB10;PIK3R1;HRAS;RHOB;ANG;BMP7;BMP6;BMP2;CDKN1A;NOL3;CTGF;GJB6;AKT1;NPPC;INHBB;STAR;CLDN1;CLDN3;S100B;UNC119;SLC1A3
10753,GO:0042307,0.0439715116739367,0.987220599725809,5,94,positive regulation of protein import into nucleus,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1
4439,GO:0009166,0.0440998960876587,0.989415558337088,4,64,nucleotide catabolic process,BP,PNP;NUDT7;DERA;PDE4B
12873,GO:0046915,0.04412917627694,0.992200495011415,3,38,transition metal ion transmembrane transporter activity,MF,TF;SLC31A2;TTYH1
13641,GO:0050764,0.0441351385993989,0.989404414543122,4,64,regulation of phagocytosis,BP,RAB27A;MFGE8;PYCARD;GAS6
4948,GO:0010718,0.0441518210920442,0.992184984661264,3,39,positive regulation of epithelial to mesenchymal transition,BP,NOTCH1;ACVR1;BMP2
16250,GO:0070997,0.0441654057412152,0.979499272267091,11,296,neuron death,BP,FADD;RRAS2;TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;STAR;PIK3CA;GDNF
2842,GO:0005865,0.0442155822216824,0.995690060739772,2,16,striated muscle thin filament,CC,FHOD3;TMOD4
5005,GO:0010804,0.0442429019040081,0.995685937282681,2,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,NOL3;GAS6
10586,GO:0040014,0.0445000761912942,0.989283320714892,4,65,regulation of multicellular organism growth,BP,SPTBN4;GHR;NPPC;PIK3CA
18977,GO:1901981,0.0445137956141832,0.985171834824367,6,125,phosphatidylinositol phosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;AKT1;SNX21
6539,GO:0019221,0.0446287921180515,0.975058770770496,18,552,cytokine-mediated signaling pathway,BP,IFI30;FADD;TRADD;EDN1;CCL20;PYCARD;PSMB10;GHR;PDGFB;WNT5A;RNASEL;CLCF1;NMI;NOL3;AKT1;IFI27;GAS6;CLDN18
8839,GO:0032941,0.0447060898069864,0.992057924619043,3,38,secretion by tissue,BP,ADORA1;FGF10;WNK4
967,GO:0002262,0.0447533356597535,0.985075470581993,6,124,myeloid cell homeostasis,BP,ZFPM1;JAM3;BMP4;SFXN1;KITLG;PDE4B
7649,GO:0030890,0.0448834949616467,0.992013929088233,3,38,positive regulation of B cell proliferation,BP,TICAM1;CLCF1;CDKN1A
1958,GO:0004383,0.0450863158255365,0.995531559462236,2,17,guanylate cyclase activity,MF,GUCY1B3;NPR1
3922,GO:0008074,0.0450863158255365,0.995531559462236,2,17,guanylate cyclase complex, soluble,CC,GUCY1B3;NPR1
14354,GO:0051960,0.0452677853206487,0.973108185081722,22,729,regulation of nervous system development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;PRKACB;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;STAR;LZTS1;LINGO1
9325,GO:0034199,0.0454579717579427,0.995474390666151,2,17,activation of protein kinase A activity,BP,PRKACB;PRKAR1B
17013,GO:0072350,0.0455723196332413,0.991842420808341,3,38,tricarboxylic acid metabolic process,BP,GHR;MDH1;IDH1
11232,GO:0043167,0.0456036246060941,0.96401138133169,136,5840,ion binding,MF,ITGA3;ITGA5;PDK4;TMEM163;SYT5;TUBG2;ACTN3;ACTN2;RAB6C;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;RASL11B;TF;ZFYVE21;FASN;CRISPLD2;RHBDL3;DHH;DSC2;SERPINA5;APOC1;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;CASQ2;ACSF2;RAB40B;RAB40A;PNP;ABCG1;PRKACB;MFGE8;EBF1;SPTBN4;ACADVL;TTYH1;RRAS2;RAB39B;RAB39A;PRND;ACSM5;MAPK12;FZD7;TYRO3;LIMS2;RGN;CDH2;FGF10;PRKAR1B;RALB;PXK;HRAS;SNX18;KHK;HACL1;SESN2;GALT;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;RNASEL;ANG;HBEGF;BMP7;BMP4;ACAT1;WT1;CDKN1A;DLL1;AOX1;PKN3;RAB20;DRP2;SHPK;WNK4;FABP3;RND3;NOL3;NUDT7;DDR1;DSG3;CTGF;ACCS;RRAD;TPD52;AKT1;RAB12;RAB17;PON2;PTGES;IDH1;DECR1;JAG2;CDH1;MYO7A;LDHD;MDP1;HPCAL1;RAB44;SNX21;PIK3CA;PIK3CG;GAS6;PEPD;ACP5;DTX4;ZCCHC12;CYP11A1;RPH3AL;MYH11;S100B;CYB5A;PTS;DSC3;VDR;ARAF;KCND1;RAB38;RAB3D;ACSL4;SLC1A3;ACTA2;RNF144A;PIM2;ETFDH;PDE4B
3344,GO:0006636,0.0456059763352434,0.991834012970669,3,38,unsaturated fatty acid biosynthetic process,BP,EDN1;FADS1;PTGES
14782,GO:0060205,0.0456097150204682,0.977920701712337,12,329,cytoplasmic vesicle lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PNP;PYCARD;PDGFB;HEXB;IDH1;GAS6;GLA;DERA
11418,GO:0043473,0.0457634095427185,0.986551745756206,5,95,pigmentation,BP,RAB27A;RAB17;KITLG;MYO7A;RAB38
16458,GO:0071407,0.0458412126422192,0.97475921870365,17,527,cellular response to organic cyclic compound,BP,CASQ2;EDN1;PDGFB;RALB;BMP7;BMP4;BMP2;WT1;MSN;GJB2;AKT1;CDH1;STAR;PIK3CG;VDR;HEY1;PDE4B
8430,GO:0032366,0.0459086419475825,0.995404711314791,2,17,intracellular sterol transport,BP,ABCG1;STAR
8431,GO:0032367,0.0459086419475825,0.995404711314791,2,17,intracellular cholesterol transport,BP,ABCG1;STAR
9755,GO:0035282,0.0459775741746471,0.986471700121306,5,95,segmentation,BP,NOTCH1;WNT5A;BMP4;WT1;DLL1
13807,GO:0051017,0.0460722873693833,0.98452360310325,6,126,actin filament bundle assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;ESPN;CTGF
15551,GO:0061572,0.0460722873693833,0.98452360310325,6,126,actin filament bundle organization,BP,WNT4;ITGB5;PIK3R1;SDC4;ESPN;CTGF
18722,GO:1901214,0.0460944762905002,0.979360943468351,10,262,regulation of neuron death,BP,RRAS2;TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;STAR;PIK3CA;GDNF
3729,GO:0007249,0.0461416977699571,0.979338200141358,10,260,I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;PYCARD;TICAM1;BMP7;NOL3;AKT1;TLE1;S100B;PIM2
11477,GO:0043551,0.046216768001052,0.991670433853119,3,39,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R2;PIK3R1;PDGFB
14629,GO:0055119,0.0463502744175036,0.995336051551882,2,17,relaxation of cardiac muscle,BP,CHGA;PDE4B
8075,GO:0031674,0.0463642065784063,0.984389787063432,6,131,I band,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
2857,GO:0005887,0.0464217216147248,0.968185567649711,41,1513,integral component of plasma membrane,CC,ITGA3;ITGA5;EBP;ADRA2B;ADRA2C;TSPAN15;TSPAN17;ITGB5;ITGB4;ITGB8;SLC31A2;P2RY14;SLC52A3;ACVR1;ADORA1;ABCG1;KCNK6;MPZL1;TSPAN13;TYRO3;LPAR2;GHR;KCNH2;FXYD1;NPR1;SDC4;HBEGF;BMP2;DLL1;VAMP1;GRIA3;DDR1;CPT1C;JAG2;CLDN1;CLDN3;KCNG2;SLC18B1;KCND1;TSPAN2;EFNB2
16435,GO:0071377,0.0464671613463793,0.991607379251347,3,39,cellular response to glucagon stimulus,BP,PRKACB;PRKAR1B;GJB2
8215,GO:0031983,0.0464810904749256,0.977432988943261,12,330,vesicle lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PNP;PYCARD;PDGFB;HEXB;IDH1;GAS6;GLA;DERA
6287,GO:0017127,0.0464909836252735,0.995314097419607,2,17,cholesterol transporter activity,MF,ABCG1;STAR
9985,GO:0035690,0.046861214370795,0.988527541056317,4,65,cellular response to drug,BP,EDN1;KCNH2;GAS6;PDE4B
7301,GO:0030203,0.0468851289683048,0.982558986267352,7,159,glycosaminoglycan metabolic process,BP,EXTL1;PDGFB;SDC4;B3GNT2;IDUA;HEXB;AKT1
8432,GO:0032368,0.0468989895090592,0.986126080220479,5,95,regulation of lipid transport,BP,APOC1;EDN1;ABCG1;BMP6;AKT1
4457,GO:0009187,0.0471565023156137,0.981048886996985,8,192,cyclic nucleotide metabolic process,BP,MRAP;GUCY1B3;EDN1;WNT5A;NPR1;CHGA;NPPC;PDE4B
3778,GO:0007350,0.0474301044120274,0.995166605509673,2,17,blastoderm segmentation,BP,WNT5A;WT1
20743,GO:1990266,0.0474454000942097,0.985927727839655,5,93,neutrophil migration,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
20143,GO:1904591,0.0474590655130101,0.985911373678614,5,96,positive regulation of protein import,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1
8803,GO:0032891,0.0475211957408271,0.995152210222865,2,17,negative regulation of organic acid transport,BP,ADORA1;AKT1
11989,GO:0045055,0.0475364300545526,0.971613875779422,22,723,regulated exocytosis,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;PLAU;PNP;PYCARD;PDGFB;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;RAB11FIP1;GAS6;GLA;RPH3AL;DERA;RAB3D
19444,GO:1903076,0.0478082802824054,0.988214864243904,4,66,regulation of protein localization to plasma membrane,BP,ITGA3;PIK3R1;RHOQ;AKT1
15814,GO:0070233,0.0478313999520114,0.995103070429898,2,17,negative regulation of T cell apoptotic process,BP,FADD;BMP4
12298,GO:0045683,0.0478844356622386,0.995094650774674,2,17,negative regulation of epidermis development,BP,NOTCH1;DLL1
6171,GO:0016877,0.0479215400486533,0.991238346083244,3,39,ligase activity, forming carbon-sulfur bonds,MF,ACSF2;ACSM5;ACSL4
12432,GO:0045933,0.0479599755091631,0.991228529351517,3,39,positive regulation of muscle contraction,BP,EDN1;CHGA;CTGF
20658,GO:1905939,0.0479839180320854,0.995078843179943,2,17,regulation of gonad development,BP,WNT4;WT1
19345,GO:1902905,0.048048263744594,0.982031414124621,7,159,positive regulation of supramolecular fiber organization,BP,WNT4;ACTN2;EDN1;PYCARD;PSRC1;SDC4;CTGF
8231,GO:0032007,0.0481463765536574,0.991170310891246,3,40,negative regulation of TOR signaling,BP,SESN2;DEPTOR;SH3BP4
14247,GO:0051767,0.0481760683981424,0.995048257921429,2,17,nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
14248,GO:0051769,0.0481760683981424,0.995048257921429,2,17,regulation of nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
9572,GO:0034703,0.0481935367951508,0.980540894178357,8,197,cation channel complex,CC,CASQ2;KCNK6;KCNH2;GRIA3;CPT1C;KCNG2;KCND1;PDE4B
13165,GO:0048261,0.0484392454673732,0.99500625420097,2,17,negative regulation of receptor-mediated endocytosis,BP,APOC1;UNC119
13744,GO:0050905,0.0484642788830794,0.985526998946173,5,97,neuromuscular process,BP,CDH23;STRA6;HEXB;MYO7A;SLC1A3
14571,GO:0055017,0.0485336884755445,0.987972559765857,4,67,cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1;RBP4
4713,GO:0010008,0.0485769445690357,0.974796372224432,14,411,endosome membrane,CC,TMEM163;SYT5;TSPAN15;RAB27A;TF;ZFYVE21;FZD7;TICAM1;SNX18;RHOB;RAB12;RAB17;SNX21;RNF144A
21665,GO:2001269,0.0487683066575434,0.994953551970393,2,17,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
11518,GO:0043624,0.0488662652719735,0.980222675075703,8,192,cellular protein complex disassembly,BP,ACTN2;MRPL14;MRPL16;SPTBN5;SPTBN4;PLEKHH2;SPTB;TMOD4
11286,GO:0043241,0.0488941506066245,0.978968208688017,9,227,protein complex disassembly,BP,ACTN2;MRPL14;MRPL16;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SPTB;TMOD4
15914,GO:0070382,0.0489094086322097,0.981638875323471,7,159,exocytic vesicle,CC,TMEM163;SYT5;RAB27A;RAB40B;RAB40A;VAMP1;PDE4B
6515,GO:0019184,0.0490227233426497,0.99491266546543,2,17,nonribosomal peptide biosynthetic process,BP,BDH2;MGST2
3852,GO:0007588,0.0490328064538943,0.987814885093861,4,66,excretion,BP,ADORA1;EDN1;NPR1;CLDN16
4856,GO:0010564,0.0491211826511213,0.972223624263999,18,568,regulation of cell cycle process,BP,LIF;WNT4;RAB6C;GADD45A;EDN1;PSMB10;FGF10;PDGFB;FOXO4;WNT5A;PSRC1;FGF8;BMP7;BMP4;CDKN1A;HMGN5;CTGF;AKT1
5271,GO:0014821,0.0491793108662458,0.99488744049621,2,17,phasic smooth muscle contraction,BP,EDN1;GDNF
11276,GO:0043229,0.0493267072027108,0.961181418796643,255,11553,intracellular organelle,CC,ITGA5;EBP;PDK4;PECR;FHOD3;BEX4;TMEM160;TMEM163;ADRA2C;SYT5;WNT3;WNT4;USE1;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;IFI30;DPM3;TF;ZFYVE21;ITGB5;ITGB4;FASN;PMAIP1;GADD45A;MSRA;CRISPLD2;SLC31A2;MRPL14;MRPL16;MRI1;FADD;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;ADORA1;CASQ2;HSD17B11;EXTL1;ACSF2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PNP;MRO;ABCG1;PRKACB;EBF1;SPTBN5;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;LPAR2;LIMS2;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;CPT2;PXK;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;HACL1;SESN2;AXIN1;GALT;RHOQ;RHOB;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;BOLA1;ANG;FAM110C;SPTB;HBEGF;NMI;BMP2;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;PKN3;RAB20;ECHDC2;SLC2A14;SARDH;F8A1;ESPN;HEXB;VAMP1;SFXN1;GRIA3;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;CTGF;GJB1;GJB2;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;PON2;WNT2B;CYTIP;PTGES;KITLG;IDH1;NPPC;DECR1;NAB2;CDH1;PUS1;EPN1;MYO7A;BCAR1;PTMS;LDHD;TMEM98;RAB44;TFPI;TLE1;STAR;CLDN5;SNX21;PIK3CG;RAB11FIP1;GAS6;SIN3B;ACP5;GLA;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;DERA;S100B;DHCR7;CYB5A;PTS;PM20D2;HNF1A;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;DOK1;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;ACTA2;RNF144A;PARVB;ETFDH;PDE4B;TMOD4
5768,GO:0016101,0.0496216834275951,0.985089442519425,5,96,diterpenoid metabolic process,BP,PECR;STRA6;RBP4;SDC4;STAR
8639,GO:0032642,0.0498027990204352,0.987561619856601,4,66,regulation of chemokine production,BP,ZFPM1;PYCARD;TICAM1;WNT5A
20041,GO:1904375,0.0500733755642129,0.987466303787528,4,67,regulation of protein localization to cell periphery,BP,ITGA3;PIK3R1;RHOQ;AKT1
11153,GO:0043029,0.0502516096256558,0.990626153469636,3,40,T cell homeostasis,BP,PMAIP1;FADD;AKT1
12184,GO:0045429,0.0503056764342074,0.990612050465777,3,40,positive regulation of nitric oxide biosynthetic process,BP,EDN1;TICAM1;AKT1
20065,GO:1904407,0.0503056764342074,0.990612050465777,3,40,positive regulation of nitric oxide metabolic process,BP,EDN1;TICAM1;AKT1
9382,GO:0034341,0.0503165556418845,0.980996037667655,7,158,response to interferon-gamma,BP,IFI30;EDN1;CCL20;WNT5A;NMI;STAR;CLDN1
13598,GO:0050701,0.0505447156996517,0.990549622336488,3,40,interleukin-1 secretion,BP,PYCARD;WNT5A;GAS6
10696,GO:0042175,0.0508151639025638,0.967546398448418,28,971,nuclear outer membrane-endoplasmic reticulum membrane network,CC,EBP;USE1;ALG5;NOTCH1;DPM3;HSD17B3;MRAP;CASQ2;EXTL1;ABCG1;MBOAT2;TTYH1;MGST2;TYRO3;FADS1;PIK3R1;REEP1;CYP17A1;HSD3B2;GJB1;CPT1C;CASP4;PTGES;DHCR7;CYB5A;GPSM1;ACSL4;ELOVL6
19227,GO:1902582,0.0508515459844683,0.96979526872856,21,694,single-organism intracellular transport,BP,SYT5;RAB27A;WNT7A;ABCG1;FZD7;PIK3R2;PIK3R1;CPT2;BMP7;BMP6;BMP4;CDKN1A;CHGA;NOL3;AKT1;RAB17;CDH1;MYO7A;STAR;PIK3CG;GAS6
11125,GO:0042995,0.0509565969866662,0.964120633985373,46,1762,cell projection,CC,ITGA3;ITGA5;ADRA2C;SYT5;ACTN3;ACTN2;MARK4;RAB27A;CDH23;MRI1;FADD;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;RAB39B;CDH2;FSTL3;PRKAR1B;PLEKHH2;CYP17A1;ANG;DRP2;ESPN;VAMP1;MSN;GJB2;CPT1C;AKT1;RAB17;NRTN;KITLG;CDH1;MYO7A;BCAR1;STAR;PIK3CA;LZTS1;S100B;AMOT;KCND1;SLC1A3;ACTA2;PARVB;PDE4B
5066,GO:0010876,0.0512751393431184,0.97471788953299,12,341,lipid localization,BP,SERPINA5;APOC1;EDN1;ABCG1;CPT2;RBP4;BMP6;HEXB;FABP3;AKT1;STAR;ACSL4
6305,GO:0017157,0.0513230658096418,0.980523754623061,7,162,regulation of exocytosis,BP,SYT5;NOTCH1;RAB27A;RALB;SDC4;RPH3AL;RAB3D
20451,GO:1905276,0.0513547996904766,0.99450387487565,2,18,regulation of epithelial tube formation,BP,WNT5A;GDNF
21401,GO:2000696,0.0514884106245854,0.994481664604469,2,18,regulation of epithelial cell differentiation involved in kidney development,BP,LIF;GDNF
21041,GO:2000178,0.0519786161446502,0.994399894802179,2,18,negative regulation of neural precursor cell proliferation,BP,LIMS2;WNT5A
13698,GO:0050849,0.0522852443483223,0.994348521787125,2,18,negative regulation of calcium-mediated signaling,BP,ACTN3;CASQ2
19780,GO:1903779,0.0524804965235681,0.986646195508527,4,70,regulation of cardiac conduction,BP,CASQ2;FXYD1;NPR1;NPPC
9837,GO:0035455,0.0525948339540151,0.994296477188262,2,18,response to interferon-alpha,BP,STAR;GAS6
10108,GO:0035886,0.0527206549062728,0.994275275341704,2,18,vascular smooth muscle cell differentiation,BP,NOTCH1;PDGFB
5026,GO:0010827,0.0527888399626156,0.983854795628171,5,99,regulation of glucose transport,BP,PIK3R2;PIK3R1;RHOQ;RNASEL;AKT1
3034,GO:0006182,0.0528022054342203,0.98994263402592,3,41,cGMP biosynthetic process,BP,GUCY1B3;NPR1;NPPC
11300,GO:0043259,0.0528752693472946,0.999048060606192,1,3,laminin-10 complex,CC,LAMA5
11301,GO:0043260,0.05290563679755,0.999046953438762,1,3,laminin-11 complex,CC,LAMA5
18635,GO:1900745,0.0529116903490164,0.994243028833897,2,18,positive regulation of p38MAPK cascade,BP,GADD45A;BMP2
4773,GO:0010288,0.0530113648392907,0.994226177382866,2,18,response to lead ion,BP,STAR;CLDN1
6371,GO:0018193,0.0530365378471315,0.964983668358716,32,1149,peptidyl-amino acid modification,BP,ITGA5;LIF;ADRA2B;ADRA2C;ALG5;DPM3;ACVR1;NMT2;ADORA1;SPTBN4;MAPK12;TYRO3;GHR;FGF18;FGF10;FGF17;PDGFB;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;PKN3;DDR1;AKT1;KITLG;PIK3CA;GAS6;ARAF;UNC119;RAB3D
16884,GO:0072156,0.0530378710469546,0.999042124621467,1,3,distal tubule morphogenesis,BP,WNK4
5881,GO:0016327,0.0530904619991453,0.994212791893563,2,18,apicolateral plasma membrane,CC,CLDN3;CLDN5
14593,GO:0055072,0.0531175296699112,0.986443456761605,4,68,iron ion homeostasis,BP,TF;BDH2;BMP6;SFXN1
14268,GO:0051797,0.0531859229415615,0.994196621945506,2,18,regulation of hair follicle development,BP,TRADD;WNT5A
11152,GO:0043028,0.0532213983504021,0.989830709254472,3,41,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PYCARD;NOL3;GAS6
2696,GO:0005610,0.0538457547376627,0.9990123513835,1,3,laminin-5 complex,CC,LAMA5
2939,GO:0006022,0.0538983977830243,0.979322288526528,7,164,aminoglycan metabolic process,BP,EXTL1;PDGFB;SDC4;B3GNT2;IDUA;HEXB;AKT1
904,GO:0002139,0.0539319992562005,0.999009145389721,1,3,stereocilia coupling link,CC,MYO7A
13676,GO:0050808,0.0539426286734043,0.976355789620525,9,238,synapse organization,BP,WNT7A;WNT7B;RAB39B;CDH2;WNT5A;DRP2;RAB17;CDH1;GDNF
20723,GO:1990182,0.0541075564280738,0.994039652839177,2,18,exosomal secretion,BP,RAB27A;SDC4
2693,GO:0005606,0.0541343134238002,0.999001603803599,1,3,laminin-1 complex,CC,LAMA1
17854,GO:0097300,0.0541868719329717,0.989571512756215,3,41,programmed necrotic cell death,BP,FADD;TRADD;TICAM1
8621,GO:0032612,0.0542328716187792,0.986065724692122,4,68,interleukin-1 production,BP,CCL20;PYCARD;WNT5A;GAS6
4087,GO:0008333,0.0543794508415024,0.989508365568495,3,42,endosome to lysosome transport,BP,GPRASP1;RHOB;RAB12
18959,GO:1901896,0.0544272879303239,0.998990630744871,1,3,positive regulation of calcium-transporting ATPase activity,BP,RGN
12458,GO:0045981,0.0544407260970831,0.980950093286929,6,130,positive regulation of nucleotide metabolic process,BP,ACTN3;MRAP;WNT5A;NPR1;CHGA;NPPC
18621,GO:1900544,0.0544407260970831,0.980950093286929,6,130,positive regulation of purine nucleotide metabolic process,BP,ACTN3;MRAP;WNT5A;NPR1;CHGA;NPPC
7819,GO:0031226,0.0545833188892243,0.961958147476847,42,1576,intrinsic component of plasma membrane,CC,ITGA3;ITGA5;EBP;ADRA2B;ADRA2C;TSPAN15;TSPAN17;ITGB5;ITGB4;ITGB8;SLC31A2;P2RY14;SLC52A3;ACVR1;ADORA1;ABCG1;KCNK6;MPZL1;TSPAN13;TYRO3;LPAR2;GHR;KCNH2;FXYD1;NPR1;SDC4;SPTB;HBEGF;BMP2;DLL1;VAMP1;GRIA3;DDR1;CPT1C;JAG2;CLDN1;CLDN3;KCNG2;SLC18B1;KCND1;TSPAN2;EFNB2
15829,GO:0070252,0.054788350242845,0.983059305177133,5,102,actin-mediated cell contraction,BP,ACTN3;ACTN2;DSC2;KCNH2;PDE4B
12191,GO:0045471,0.0548673989297477,0.980764316153511,6,130,response to ethanol,BP,RBP4;NPPC;STAR;CLDN1;CLDN3;CLDN18
14106,GO:0051492,0.0548772023146015,0.985833830204304,4,70,regulation of stress fiber assembly,BP,WNT4;PIK3R1;SDC4;CTGF
8363,GO:0032252,0.0548865917244233,0.998973304206358,1,3,secretory granule localization,BP,PIK3CG
1531,GO:0003283,0.0549582813449502,0.99386536765798,2,19,atrial septum development,BP,ZFPM1;ACVR1
9106,GO:0033563,0.0553131425889352,0.99895707777438,1,3,dorsal/ventral axon guidance,BP,FGF8
3509,GO:0006885,0.0553394560528144,0.982853440633121,5,99,regulation of pH,BP,PDK4;EDN1;RAB39A;RAB20;RAB38
12235,GO:0045599,0.055674762696798,0.989156669042935,3,42,negative regulation of fat cell differentiation,BP,ZFPM1;WNT5A;AXIN1
8969,GO:0033158,0.0557551665708115,0.993726562515208,2,19,regulation of protein import into nucleus, translocation,BP,CDKN1A;GAS6
1005,GO:0002320,0.0557599170947788,0.993725731603152,2,19,lymphoid progenitor cell differentiation,BP,NOTCH1;BMP4
4349,GO:0009055,0.0558135720559006,0.982674148381372,5,97,electron carrier activity,MF,GLDC;ETFB;AOX1;CYB5A;ETFDH
21543,GO:2001026,0.0559963125009599,0.993684332343893,2,19,regulation of endothelial cell chemotaxis,BP,NOTCH1;FGF18
14558,GO:0055002,0.0560399770363682,0.980240339182678,6,134,striated muscle cell development,BP,FHOD3;ACTN2;CASQ2;EDN1;BMP4;MYH11
3498,GO:0006869,0.0561285151260872,0.972897342514931,11,309,lipid transport,BP,SERPINA5;APOC1;EDN1;ABCG1;CPT2;RBP4;BMP6;FABP3;AKT1;STAR;ACSL4
5973,GO:0016525,0.0561887618235124,0.985384030432759,4,70,negative regulation of angiogenesis,BP,NOTCH1;FOXO4;NPR1;AMOT
7541,GO:0030670,0.056219748956154,0.985379677409832,4,69,phagocytic vesicle membrane,CC,RAB39A;RAB20;RAB11FIP1;RAB38
17970,GO:0097529,0.0562901387741808,0.978202372766776,7,162,myeloid leukocyte migration,BP,EDN1;CCL20;PDGFB;JAM3;CHGA;PIK3CG;PDE4B
20524,GO:1905475,0.0563622221692252,0.980107503889014,6,131,regulation of protein localization to membrane,BP,ITGA3;PMAIP1;CDH2;PIK3R1;RHOQ;AKT1
13390,GO:0048745,0.0564318726892378,0.993607790166407,2,19,smooth muscle tissue development,BP,STRA6;BMP4
15281,GO:0060979,0.0564596598134419,0.998912815965738,1,3,vasculogenesis involved in coronary vascular morphogenesis,BP,NOTCH1
15808,GO:0070227,0.0564736584820898,0.985292194220063,4,69,lymphocyte apoptotic process,BP,FADD;WNT5A;BMP4;AKT1
9571,GO:0034702,0.0564850732767857,0.973787487137118,10,275,ion channel complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;FXYD1;GRIA3;CPT1C;KCNG2;KCND1;PDE4B
11543,GO:0043696,0.0567032241413189,0.998903291470676,1,3,dedifferentiation,BP,PDGFB
11544,GO:0043697,0.0567032241413189,0.998903291470676,1,3,cell dedifferentiation,BP,PDGFB
4598,GO:0009612,0.0567159575664683,0.976333019776471,8,202,response to mechanical stimulus,BP,STRA6;GADD45A;FADD;EDN1;BMP6;AKT1;INHBB;SLC1A3
3607,GO:0007034,0.0568303206931739,0.982253499179367,5,101,vacuolar transport,BP,USE1;SPTBN5;GPRASP1;RHOB;RAB12
8409,GO:0032332,0.0570084881844045,0.993505935321724,2,19,positive regulation of chondrocyte differentiation,BP,FGF18;BMP6
5277,GO:0014829,0.0570117346272898,0.993505360172957,2,19,vascular smooth muscle contraction,BP,EDN1;ACTA2
338,GO:0000930,0.0570321739135943,0.993501738658915,2,19,gamma-tubulin complex,CC,TUBG2;PDE4B
935,GO:0002193,0.0571403659381674,0.998886090247607,1,3,MAML1-RBP-Jkappa- ICN1 complex,CC,NOTCH1
20878,GO:1990785,0.0571675129618126,0.998885017499596,1,3,response to water-immersion restraint stress,BP,FOXO4
1453,GO:0003162,0.0573123980032336,0.998879283224989,1,3,atrioventricular node development,BP,NOTCH1
8372,GO:0032271,0.057318987695001,0.977706214433836,7,166,regulation of protein polymerization,BP,FHOD3;SPTBN5;SPTBN4;PYCARD;PSRC1;SPTB;TMOD4
15451,GO:0061318,0.0573203832299699,0.993450592930525,2,19,renal filtration cell differentiation,BP,BMP4;WT1
16862,GO:0072112,0.0573203832299699,0.993450592930525,2,19,glomerular visceral epithelial cell differentiation,BP,BMP4;WT1
10274,GO:0036166,0.0573740874320758,0.998876837091007,1,3,phenotypic switching,BP,PDGFB
18567,GO:1900239,0.0573740874320758,0.998876837091007,1,3,regulation of phenotypic switching,BP,PDGFB
14958,GO:0060438,0.0575102979154371,0.993416809372925,2,19,trachea development,BP,WNT7B;BMP4
17384,GO:0090101,0.0575318308257453,0.981969294497986,5,102,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,NOTCH1;RASL11B;ACVR1;FSTL3;WNT5A
19404,GO:1903010,0.0576031702633735,0.993400265022018,2,19,regulation of bone development,BP,RGN;CLDN18
1595,GO:0003408,0.0576204944372122,0.998867039149561,1,3,optic cup formation involved in camera-type eye development,BP,WNT5A
4626,GO:0009726,0.0576388613338133,0.998866307072386,1,3,detection of endogenous stimulus,BP,ABCG1
11496,GO:0043585,0.0577677708715716,0.998861162097474,1,3,nose morphogenesis,BP,STRA6
19339,GO:1902895,0.0578188048847108,0.99336179231984,2,19,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
7605,GO:0030833,0.0579267337835535,0.979412180567148,6,133,regulation of actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;PYCARD;SPTB;TMOD4
15264,GO:0060948,0.0580293108795633,0.998850686881836,1,3,cardiac vascular smooth muscle cell development,BP,NOTCH1
19104,GO:1902263,0.0581074723660718,0.998847546793982,1,3,apoptotic process involved in embryonic digit morphogenesis,BP,NOTCH1
9269,GO:0034109,0.0581314835172968,0.984704683950898,4,71,homotypic cell-cell adhesion,BP,DSC2;TYRO3;PIK3CG;GAS6
12435,GO:0045936,0.0583540881226306,0.966871893976028,17,541,negative regulation of phosphate metabolic process,BP,LIF;ACTN3;GADD45A;APOC1;EDN1;PYCARD;RGN;PRR5L;PDGFB;PRKAR1B;BMP7;BMP4;CAMSAP3;CDKN1A;DEPTOR;AKT1;DUSP5
19606,GO:1903427,0.0583816992501939,0.993260972324642,2,19,negative regulation of reactive oxygen species biosynthetic process,BP,RGN;GLA
7812,GO:0031210,0.0584022866233462,0.993257274232178,2,19,phosphatidylcholine binding,MF,SERPINA5;APOC1
13792,GO:0050997,0.0584022866233462,0.993257274232178,2,19,quaternary ammonium group binding,MF,SERPINA5;APOC1
9243,GO:0034040,0.058439005443682,0.998834178746265,1,3,lipid-transporting ATPase activity,MF,ABCG1
16374,GO:0071284,0.0585259685961275,0.998830659115455,1,3,cellular response to lead ion,BP,CLDN1
2503,GO:0005173,0.0585375403943208,0.998830190363077,1,3,stem cell factor receptor binding,MF,KITLG
8664,GO:0032680,0.0585584248432973,0.981565701306249,5,100,regulation of tumor necrosis factor production,BP,FADD;PYCARD;PIK3R1;TICAM1;GAS6
15374,GO:0061110,0.0586139049525269,0.998827094554779,1,3,dense core granule biogenesis,BP,CHGA
21408,GO:2000705,0.0586139049525269,0.998827094554779,1,3,regulation of dense core granule biogenesis,BP,CHGA
15142,GO:0060713,0.0586653746986199,0.993209949644323,2,19,labyrinthine layer morphogenesis,BP,WNT7B;BMP7
7187,GO:0030016,0.0587377498958853,0.975304916735531,8,208,myofibril,CC,FHOD3;ACTN2;CASQ2;SDC4;MYZAP;PARVB;PDE4B;TMOD4
6520,GO:0019200,0.0587378131008602,0.993196897763991,2,19,carbohydrate kinase activity,MF,KHK;PFKFB3
14110,GO:0051496,0.0587460392758509,0.988297091501653,3,43,positive regulation of stress fiber assembly,BP,WNT4;SDC4;CTGF
13128,GO:0048179,0.0587846303774852,0.998820158167967,1,3,activin receptor complex,CC,ACVR1
20517,GO:1905457,0.0589603546127597,0.998812996740833,1,3,negative regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
21523,GO:2000974,0.0589603546127597,0.998812996740833,1,3,negative regulation of pro-B cell differentiation,BP,NOTCH1
13076,GO:0048022,0.0590583461089596,0.998808993546787,1,3,negative regulation of melanin biosynthetic process,BP,WNT5A
18598,GO:1900377,0.0590583461089596,0.998808993546787,1,3,negative regulation of secondary metabolite biosynthetic process,BP,WNT5A
17444,GO:0090190,0.0591245817993543,0.993127052706839,2,19,positive regulation of branching involved in ureteric bud morphogenesis,BP,WNT2B;GDNF
4855,GO:0010563,0.0591728045537203,0.966346686670077,17,542,negative regulation of phosphorus metabolic process,BP,LIF;ACTN3;GADD45A;APOC1;EDN1;PYCARD;RGN;PRR5L;PDGFB;PRKAR1B;BMP7;BMP4;CAMSAP3;CDKN1A;DEPTOR;AKT1;DUSP5
5246,GO:0014735,0.0592312548433158,0.998801912907949,1,3,regulation of muscle atrophy,BP,NOL3
15071,GO:0060594,0.0592358616169961,0.998801723964939,1,3,mammary gland specification,BP,FGF10
9250,GO:0034059,0.0592990514792272,0.99879913073981,1,3,response to anoxia,BP,CTGF
10815,GO:0042414,0.0593954808558468,0.998795167858485,1,3,epinephrine metabolic process,BP,PNMT
13435,GO:0048850,0.0594343864106863,0.998793567088401,1,3,hypophysis morphogenesis,BP,WNT5A
6926,GO:0021697,0.0594373917202653,0.993042094429939,2,20,cerebellar cortex formation,BP,WNT7A;DLL1
6757,GO:0019899,0.059439461703548,0.957666603925326,46,1773,enzyme binding,MF,ITGA3;RIN3;TSPAN15;TSPAN17;NOTCH1;GLDC;GADD45A;FADD;SERPINA5;TRADD;TBC1D14;PRKACB;SPTBN4;PYCARD;CDH2;PRR5L;GHR;PIK3R2;PIK3R1;TICAM1;KCNH2;PRKAR1B;FOXO4;RALB;MAGEC2;AXIN1;NPR1;SDC4;ACAT1;DAAM2;CDKN1A;MSN;NOL3;AKT1;PKP3;BCAR1;RAB11FIP1;GAS6;RPH3AL;CYB5A;SHC4;ARAF;SH3BP4;FZD8;ACTA2;RNF144A
16836,GO:0072079,0.0596102682779246,0.993038969490676,2,19,nephron tubule formation,BP,WNT6;GDNF
18036,GO:0097734,0.0596382698382298,0.993033878471305,2,19,extracellular exosome biogenesis,BP,RAB27A;SDC4
625,GO:0001743,0.0596802340018228,0.998783426423308,1,3,optic placode formation,BP,AXIN1
3874,GO:0007619,0.0597170790372784,0.998781902888932,1,3,courtship behavior,BP,HEXB
5904,GO:0016408,0.0597332790683502,0.993016594341193,2,19,C-acyltransferase activity,MF,ACSM5;ACAT1
20168,GO:1904646,0.0598121388568231,0.99877796765987,1,3,cellular response to beta-amyloid,BP,CASP4
15032,GO:0060544,0.0599325226899144,0.992980296131069,2,19,regulation of necroptotic process,BP,FADD;TRADD
10344,GO:0036379,0.0599389674540729,0.992979120855309,2,19,myofilament,CC,FHOD3;TMOD4
7603,GO:0030828,0.0599681568163723,0.992973796928025,2,19,positive regulation of cGMP biosynthetic process,BP,NPR1;NPPC
21040,GO:2000177,0.0600500103697565,0.984025665592352,4,72,regulation of neural precursor cell proliferation,BP,NOTCH1;LIMS2;CDH2;WNT5A
3524,GO:0006904,0.0600958592901845,0.987918074398438,3,43,vesicle docking involved in exocytosis,BP,RAB40B;RAB40A;RALB
20272,GO:1904862,0.0601469051273551,0.998764057260366,1,3,inhibitory synapse assembly,BP,WNT5A
16067,GO:0070662,0.0601480613287132,0.99876400907698,1,3,mast cell proliferation,BP,KITLG
19055,GO:1902176,0.060160967285887,0.992938592006556,2,19,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,NOL3;AKT1
14967,GO:0060447,0.0601627917404231,0.99876339511919,1,3,bud outgrowth involved in lung branching,BP,FGF10
16059,GO:0070644,0.0602228304947849,0.99876089110614,1,3,vitamin D response element binding,MF,VDR
18752,GO:1901292,0.0603475739500064,0.983927136983086,4,71,nucleoside phosphate catabolic process,BP,PNP;NUDT7;DERA;PDE4B
15587,GO:0061643,0.0604346626024691,0.998752035503874,1,3,chemorepulsion of axon,BP,WNT5A
12527,GO:0046110,0.0604883614720753,0.99874978548127,1,3,xanthine metabolic process,BP,AOX1
16961,GO:0072262,0.0605104360761123,0.998748859934563,1,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,WT1
14691,GO:0060061,0.0605505199941618,0.998747178390831,1,3,Spemann organizer formation,BP,WNT3
10056,GO:0035793,0.0605583981846845,0.998746847759607,1,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
18566,GO:1900238,0.0605583981846845,0.998746847759607,1,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
21327,GO:2000591,0.0605583981846845,0.998746847759607,1,3,positive regulation of metanephric mesenchymal cell migration,BP,PDGFB
21481,GO:2000820,0.0605676564984519,0.998746459150158,1,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,HEY1
2889,GO:0005944,0.0605687979229612,0.998746411235594,1,3,phosphatidylinositol 3-kinase complex, class IB,CC,PIK3CG
18771,GO:1901338,0.0605693288178027,0.992863814057758,2,19,catecholamine binding,MF,ADRA2B;ADRA2C
1526,GO:0003274,0.0606084408627384,0.998744746525359,1,3,endocardial cushion fusion,BP,ACVR1
11618,GO:0044060,0.0606272376026405,0.987767863850227,3,43,regulation of endocrine process,BP,BMP6;INHBB;RAB11FIP1
3667,GO:0007159,0.060637136497434,0.969303191375416,12,346,leukocyte cell-cell adhesion,BP,ITGA5;FADD;PNP;PYCARD;PIK3R1;SDC4;BMP7;BMP4;MSN;AKT1;PIK3CA;EFNB2
6379,GO:0018201,0.0606833844173393,0.998741596346951,1,3,peptidyl-glycine modification,BP,NMT2
14599,GO:0055078,0.0607023608167095,0.987746582395667,3,43,sodium ion homeostasis,BP,ADORA1;EDN1;NPR1
1204,GO:0002684,0.0607078099535404,0.961211557565873,26,904,positive regulation of immune system process,BP,CFB;LIF;FADD;EDN1;PNP;PRKACB;CCL20;PYCARD;TYRO3;PSMB10;FGF10;PIK3R2;PIK3R1;TICAM1;HRAS;WNT5A;RBP4;CLCF1;CDKN1A;AKT1;KITLG;BCAR1;PIK3CA;GAS6;EFNB2;PDE4B
9512,GO:0034613,0.0608114347497117,0.95692497470582,44,1682,cellular protein localization,BP,ITGA3;LIF;WNT4;ACTN2;TSPAN15;TSPAN17;RAB27A;PMAIP1;MRAP;TBC1D14;ADORA1;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;MSN;NOL3;AKT1;IFI27;PKP3;CDH1;MYO7A;GAS6;RPH3AL;AMOT;LAMA5;SH3BP4;RAB38;CLDN18
10648,GO:0042097,0.0608484555622616,0.998734643424078,1,3,interleukin-4 biosynthetic process,BP,ZFPM1
12170,GO:0045402,0.0608484555622616,0.998734643424078,1,3,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
8710,GO:0032757,0.0608970446646911,0.987691378522431,3,43,positive regulation of interleukin-8 production,BP,FADD;PYCARD;WNT5A
14442,GO:0052547,0.0609051359363314,0.96820836882186,13,384,regulation of peptidase activity,BP,PMAIP1;FADD;SERPINA5;TRADD;PYCARD;MAPK12;NOL3;CTGF;AKT1;IFI27;CST9L;TFPI;GAS6
754,GO:0001927,0.0609604760589069,0.998729913814118,1,3,exocyst assembly,BP,RALB
8482,GO:0032421,0.0610014479249264,0.987649895664375,3,44,stereocilium bundle,CC,CDH23;ESPN;MYO7A
19559,GO:1903348,0.0610522005320873,0.998726034364164,1,3,positive regulation of bicellular tight junction assembly,BP,CLDN1
975,GO:0002277,0.0610567032002852,0.998725843768938,1,3,myeloid dendritic cell activation involved in immune response,BP,PYCARD
6154,GO:0016849,0.0611273450981555,0.992731668226948,2,20,phosphorus-oxygen lyase activity,MF,GUCY1B3;NPR1
12085,GO:0045202,0.0611363802655414,0.962039905364595,23,797,synapse,CC,ITGA3;ITGA5;TMEM163;ADRA2C;SYT5;ACTN2;RAB27A;WNT7A;ADORA1;RAB40B;RAB40A;CDH2;DRP2;VAMP1;GRIA3;CPT1C;AKT1;MYO7A;PRRT1;LZTS1;SHC4;LAMA5;PDE4B
14668,GO:0060038,0.0611708828420835,0.987601711083832,3,44,cardiac muscle cell proliferation,BP,WNT2;NOTCH1;RBP4
4701,GO:0009975,0.0611748126880763,0.992722876293867,2,20,cyclase activity,MF,GUCY1B3;NPR1
13841,GO:0051054,0.0612032957092523,0.974063135299376,8,202,positive regulation of DNA metabolic process,BP,FGF10;PDGFB;HRAS;CLCF1;BMP6;BMP4;AKT1;KITLG
12096,GO:0045218,0.0612102248772285,0.998719336515527,1,3,zonula adherens maintenance,BP,CAMSAP3
4580,GO:0009449,0.0612127841355904,0.998719227892939,1,3,gamma-aminobutyric acid biosynthetic process,BP,SLC1A3
13434,GO:0048846,0.0612340242491745,0.992685230796028,2,21,axon extension involved in axon guidance,BP,WNT3;WNT5A
19112,GO:1902284,0.0612340242491745,0.992685230796028,2,21,neuron projection extension involved in neuron projection guidance,BP,WNT3;WNT5A
21381,GO:2000669,0.0612976755839105,0.998715622160387,1,3,negative regulation of dendritic cell apoptotic process,BP,GAS6
5148,GO:0010979,0.0612984051251684,0.998715591150799,1,3,regulation of vitamin D 24-hydroxylase activity,BP,VDR
5149,GO:0010980,0.0612984051251684,0.998715591150799,1,3,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
18537,GO:1900186,0.0613090292151833,0.998715139523868,1,3,negative regulation of clathrin-dependent endocytosis,BP,UNC119
8891,GO:0033023,0.0613186313002232,0.99871473127181,1,3,mast cell homeostasis,BP,KITLG
8892,GO:0033024,0.0613186313002232,0.99871473127181,1,3,mast cell apoptotic process,BP,KITLG
8893,GO:0033025,0.0613186313002232,0.99871473127181,1,3,regulation of mast cell apoptotic process,BP,KITLG
16284,GO:0071062,0.0613753025895574,0.998712320418676,1,3,alphav-beta3 integrin-vitronectin complex,CC,ITGA5
17693,GO:0097017,0.061404442062307,0.998711079891846,1,3,renal protein absorption,BP,GAS6
19341,GO:1902897,0.0614265321905874,0.998710139060566,1,3,regulation of postsynaptic density protein 95 clustering,BP,CDH2
18676,GO:1901079,0.0614345672456261,0.998709796755369,1,3,positive regulation of relaxation of muscle,BP,CHGA
13530,GO:0050508,0.0614418937674268,0.998709484594012,1,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,EXTL1
16809,GO:0072034,0.0614475937223464,0.998709241708979,1,3,renal vesicle induction,BP,WNT4
15389,GO:0061146,0.0614512695314756,0.998709085063863,1,3,Peyer's patch morphogenesis,BP,ARTN
5087,GO:0010899,0.061463320155281,0.998708571456289,1,3,regulation of phosphatidylcholine catabolic process,BP,APOC1
11886,GO:0044729,0.0614648736691467,0.998708505236594,1,3,hemi-methylated DNA-binding,MF,WT1
6211,GO:0016941,0.0614683031969337,0.998708359044213,1,3,natriuretic peptide receptor activity,MF,NPR1
8970,GO:0033159,0.0615069138842107,0.998706712577721,1,3,negative regulation of protein import into nucleus, translocation,BP,GAS6
13361,GO:0048696,0.061510451137836,0.998706561685497,1,3,regulation of collateral sprouting in absence of injury,BP,WNT3
10878,GO:0042516,0.0615199303099286,0.987514248299261,3,43,regulation of tyrosine phosphorylation of Stat3 protein,BP,LIF;GHR;CLCF1
3421,GO:0006740,0.061532434454475,0.998705623717799,1,3,NADPH regeneration,BP,IDH1
4744,GO:0010159,0.0615382783927256,0.998705374314171,1,3,specification of animal organ position,BP,BMP4
17374,GO:0090087,0.0615397357322886,0.962192624562403,22,747,regulation of peptide transport,BP,ADRA2C;ADORA1;PYCARD;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;RBP4;ANG;BMP7;BMP6;BMP4;CDKN1A;NOL3;IFI27;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL
20374,GO:1905064,0.0615698587391457,0.998704026121908,1,3,negative regulation of vascular smooth muscle cell differentiation,BP,PDGFB
4071,GO:0008307,0.0615746039604811,0.987464284460939,3,46,structural constituent of muscle,MF,ACTN3;ACTN2;MYH11
16431,GO:0071373,0.0615880002543243,0.998703251318531,1,3,cellular response to luteinizing hormone stimulus,BP,STAR
607,GO:0001712,0.0616209015861136,0.998701845532502,1,3,ectodermal cell fate commitment,BP,FZD7
6807,GO:0021502,0.0616363285464209,0.998701186109871,1,3,neural fold elevation formation,BP,BMP7
1872,GO:0004165,0.0616470379086001,0.998700728238819,1,3,dodecenoyl-CoA delta-isomerase activity,MF,ECI1
6031,GO:0016623,0.0616478494582978,0.998700693538214,1,3,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
14687,GO:0060057,0.0616561079056673,0.998700340392711,1,3,apoptotic process involved in mammary gland involution,BP,VDR
14688,GO:0060058,0.0616561079056673,0.998700340392711,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
19136,GO:1902339,0.0616561079056673,0.998700340392711,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
19641,GO:1903519,0.0616561079056673,0.998700340392711,1,3,regulation of mammary gland involution,BP,VDR
19642,GO:1903521,0.0616561079056673,0.998700340392711,1,3,positive regulation of mammary gland involution,BP,VDR
20220,GO:1904747,0.0616561079056673,0.998700340392711,1,3,positive regulation of apoptotic process involved in development,BP,VDR
11891,GO:0044752,0.0616585451568805,0.998700236162197,1,3,response to human chorionic gonadotropin,BP,GJB2
10140,GO:0035939,0.0616675342573514,0.998699851700731,1,3,microsatellite binding,MF,HEY1
15408,GO:0061184,0.0616697781650455,0.998699755720266,1,3,positive regulation of dermatome development,BP,WNT4
17833,GO:0097252,0.0616766916236703,0.998699459982436,1,3,oligodendrocyte apoptotic process,BP,GAS6
17696,GO:0097021,0.0616812410444073,0.998699265352458,1,3,lymphocyte migration into lymphoid organs,BP,ARTN
4192,GO:0008506,0.061694991096353,0.998698677016757,1,3,sucrose:proton symporter activity,MF,SLC45A4
4200,GO:0008515,0.061694991096353,0.998698677016757,1,3,sucrose transmembrane transporter activity,MF,SLC45A4
5396,GO:0015154,0.061694991096353,0.998698677016757,1,3,disaccharide transmembrane transporter activity,MF,SLC45A4
5397,GO:0015157,0.061694991096353,0.998698677016757,1,3,oligosaccharide transmembrane transporter activity,MF,SLC45A4
5595,GO:0015766,0.061694991096353,0.998698677016757,1,3,disaccharide transport,BP,SLC45A4
5596,GO:0015770,0.061694991096353,0.998698677016757,1,3,sucrose transport,BP,SLC45A4
5597,GO:0015772,0.061694991096353,0.998698677016757,1,3,oligosaccharide transport,BP,SLC45A4
9665,GO:0035054,0.0617198261209436,0.998697614031632,1,3,embryonic heart tube anterior/posterior pattern specification,BP,BMP2
13199,GO:0048320,0.0617242172506247,0.998697426036684,1,3,axial mesoderm formation,BP,AXIN1
8343,GO:0032217,0.0617618009033794,0.998695816418016,1,3,riboflavin transporter activity,MF,SLC52A3
8344,GO:0032218,0.0617618009033794,0.998695816418016,1,3,riboflavin transport,BP,SLC52A3
15223,GO:0060846,0.0617627691356691,0.998695774937413,1,3,blood vessel endothelial cell fate commitment,BP,DLL1
15224,GO:0060847,0.0617627691356691,0.998695774937413,1,3,endothelial cell fate specification,BP,DLL1
17739,GO:0097101,0.0617627691356691,0.998695774937413,1,3,blood vessel endothelial cell fate specification,BP,DLL1
16159,GO:0070859,0.0617829519110071,0.998694910120863,1,3,positive regulation of bile acid biosynthetic process,BP,STAR
19998,GO:1904253,0.0617829519110071,0.998694910120863,1,3,positive regulation of bile acid metabolic process,BP,STAR
10241,GO:0036118,0.0618054295861239,0.998693946622489,1,3,hyaluranon cable assembly,BP,BMP7
18481,GO:1900104,0.0618054295861239,0.998693946622489,1,3,regulation of hyaluranon cable assembly,BP,BMP7
18482,GO:1900106,0.0618054295861239,0.998693946622489,1,3,positive regulation of hyaluranon cable assembly,BP,BMP7
3918,GO:0008065,0.0618159160874427,0.998693496996819,1,3,establishment of blood-nerve barrier,BP,CLDN1
16919,GO:0072197,0.0618515330023895,0.998691969269655,1,3,ureter morphogenesis,BP,BMP4
7030,GO:0021898,0.0618588902720104,0.99869165357759,1,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,AXIN1
21647,GO:2001245,0.0618723276925414,0.99869107689201,1,3,regulation of phosphatidylcholine biosynthetic process,BP,FABP3
10524,GO:0038181,0.0618860399679064,0.998690488275871,1,3,bile acid receptor activity,MF,VDR
10526,GO:0038183,0.0618860399679064,0.998690488275871,1,3,bile acid signaling pathway,BP,VDR
16875,GO:0072135,0.0618912833867517,0.998690263159739,1,3,kidney mesenchymal cell proliferation,BP,BMP7
16876,GO:0072136,0.0618912833867517,0.998690263159739,1,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,BMP7
14824,GO:0060278,0.0618940634259091,0.998690143796015,1,3,regulation of ovulation,BP,INHBB
20773,GO:1990418,0.0619078827183267,0.998689550368005,1,3,response to insulin-like growth factor stimulus,BP,AKT1
10784,GO:0042359,0.0619116766703262,0.992585887742009,2,20,vitamin D metabolic process,BP,CYP11A1;VDR
10146,GO:0035963,0.0619200283911945,0.998689028694382,1,3,cellular response to interleukin-13,BP,SHPK
14776,GO:0060197,0.0619281786297376,0.998688678570356,1,3,cloacal septation,BP,BMP4
16826,GO:0072061,0.0619701464700618,0.998686874923008,1,3,inner medullary collecting duct development,BP,WNT7B
6449,GO:0018963,0.0620133479424116,0.998685016925706,1,3,phthalate metabolic process,BP,STAR
15372,GO:0061107,0.0620252325046071,0.998684505560592,1,3,seminal vesicle development,BP,SERPINA5
8760,GO:0032813,0.0620296849845361,0.987368716326243,3,43,tumor necrosis factor receptor superfamily binding,MF,FADD;TRADD;NOL3
7483,GO:0030538,0.0620324170679773,0.998684196375902,1,3,embryonic genitalia morphogenesis,BP,FGF10
12141,GO:0045335,0.0620382138583403,0.980145073977573,5,102,phagocytic vesicle,CC,ITGB5;RAB39A;RAB20;RAB11FIP1;RAB38
9444,GO:0034436,0.0620513470419458,0.998683381553349,1,3,glycoprotein transport,BP,ABCG1
20950,GO:2000015,0.0620625185064632,0.998682900566611,1,3,regulation of determination of dorsal identity,BP,ACVR1
14617,GO:0055099,0.0620699338559555,0.998682581249268,1,3,response to high density lipoprotein particle,BP,ABCG1
15062,GO:0060584,0.0620704420506916,0.998682559364095,1,3,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
15063,GO:0060585,0.0620704420506916,0.998682559364095,1,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
18541,GO:1900194,0.0620747827006241,0.998682372428377,1,3,negative regulation of oocyte maturation,BP,NPPC
14694,GO:0060066,0.0620817733199882,0.998682071339603,1,3,oviduct development,BP,WNT7A
3822,GO:0007500,0.062098073769216,0.99868136913524,1,3,mesodermal cell fate determination,BP,BMP4
20996,GO:2000097,0.0621302572536031,0.998679982143123,1,3,regulation of smooth muscle cell-matrix adhesion,BP,PLAU
7452,GO:0030485,0.062137215971132,0.998679682148845,1,3,smooth muscle contractile fiber,CC,ACTA2
16913,GO:0072190,0.0621859716942442,0.998677579278011,1,3,ureter urothelium development,BP,BMP4
1746,GO:0003985,0.0621926260050002,0.998677292139062,1,3,acetyl-CoA C-acetyltransferase activity,MF,ACAT1
12851,GO:0046882,0.0622073477832687,0.998676656768309,1,3,negative regulation of follicle-stimulating hormone secretion,BP,INHBB
3269,GO:0006546,0.0622112239386938,0.998676489452911,1,3,glycine catabolic process,BP,GLDC
6619,GO:0019464,0.0622112239386938,0.998676489452911,1,3,glycine decarboxylation via glycine cleavage system,BP,GLDC
7547,GO:0030678,0.0622125093242803,0.998676433966458,1,3,mitochondrial ribonuclease P complex,CC,HSD17B10
19746,GO:1903719,0.0622186878006028,0.998676167242441,1,3,regulation of I-kappaB phosphorylation,BP,AKT1
19747,GO:1903721,0.0622186878006028,0.998676167242441,1,3,positive regulation of I-kappaB phosphorylation,BP,AKT1
855,GO:0002060,0.0622305883332198,0.998675653420069,1,3,purine nucleobase binding,MF,PNP
4494,GO:0009227,0.0622343001862744,0.998675493134559,1,3,nucleotide-sugar catabolic process,BP,GALT
2033,GO:0004505,0.0622487386889727,0.998674869555152,1,3,phenylalanine 4-monooxygenase activity,MF,PCBD1
15737,GO:0070101,0.0622562841613399,0.998674543616317,1,3,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
5782,GO:0016128,0.0622688980221205,0.998673998648168,1,3,phytosteroid metabolic process,BP,DHCR7
5783,GO:0016129,0.0622688980221205,0.998673998648168,1,3,phytosteroid biosynthetic process,BP,DHCR7
9992,GO:0035697,0.0622837476188033,0.998673356939747,1,3,CD8-positive, alpha-beta T cell extravasation,BP,FADD
21203,GO:2000407,0.0622837476188033,0.998673356939747,1,3,regulation of T cell extravasation,BP,FADD
21225,GO:2000449,0.0622837476188033,0.998673356939747,1,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
6357,GO:0018125,0.0622907395651955,0.998673054735421,1,3,peptidyl-cysteine methylation,BP,RAB3D
8097,GO:0031708,0.0623498582340332,0.998670498105823,1,3,endothelin B receptor binding,MF,EDN1
12532,GO:0046121,0.0623502135254345,0.998670482733334,1,3,deoxyribonucleoside catabolic process,BP,DERA
14250,GO:0051771,0.0623517447937384,0.99867041647849,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
15097,GO:0060648,0.0623560149496847,0.998670231708609,1,3,mammary gland bud morphogenesis,BP,FGF10
7289,GO:0030185,0.0623665694140486,0.998669774959676,1,3,nitric oxide transport,BP,EDN1
16920,GO:0072198,0.0623754171198689,0.998669392009251,1,3,mesenchymal cell proliferation involved in ureter development,BP,BMP4
16921,GO:0072199,0.0623754171198689,0.998669392009251,1,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
5349,GO:0015065,0.0623934026187765,0.998668613377864,1,3,uridine nucleotide receptor activity,MF,P2RY14
16553,GO:0071553,0.0623934026187765,0.998668613377864,1,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,P2RY14
9969,GO:0035651,0.0624199886943711,0.998667461979467,1,3,AP-3 adaptor complex binding,MF,RAB38
16670,GO:0071733,0.0624300250890693,0.998667027186853,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
17456,GO:0090202,0.0624300250890693,0.998667027186853,1,3,gene looping,BP,ZFPM1
17634,GO:0090579,0.0624300250890693,0.998667027186853,1,3,dsDNA loop formation,BP,ZFPM1
6513,GO:0019166,0.0624323841860124,0.998666924976419,1,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,PECR
4687,GO:0009946,0.0624331248603219,0.998666892885069,1,3,proximal/distal axis specification,BP,FGF10
20489,GO:1905383,0.062470871551228,0.998665256899951,1,3,protein localization to presynapse,BP,WNT7A
5945,GO:0016480,0.0624927745221654,0.998664307126525,1,3,negative regulation of transcription from RNA polymerase III promoter,BP,NAB2
19259,GO:1902667,0.0625279991043156,0.99244305658582,2,21,regulation of axon guidance,BP,WNT3;WNT5A
9644,GO:0035019,0.0625283053091221,0.983145400438111,4,72,somatic stem cell population maintenance,BP,WNT7A;SALL4;FGF10;BMP7
9968,GO:0035650,0.0625287865214131,0.998662744790841,1,3,AP-1 adaptor complex binding,MF,RAB38
17099,GO:0072557,0.0625373407765945,0.998662373536999,1,3,IPAF inflammasome complex,CC,CASP4
17721,GO:0097058,0.0625802648962976,0.99866050983363,1,3,CRLF-CLCF1 complex,CC,CLCF1
18631,GO:1900738,0.0625997795092096,0.998659662095711,1,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
13146,GO:0048237,0.062613508410281,0.998659065530569,1,3,rough endoplasmic reticulum lumen,CC,EDN1
12163,GO:0045360,0.0626163620167083,0.998658941514993,1,3,regulation of interleukin-1 biosynthetic process,BP,CCL20
12164,GO:0045362,0.0626163620167083,0.998658941514993,1,3,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
3388,GO:0006690,0.0626228865613255,0.979909849794002,5,101,icosanoid metabolic process,BP,EDN1;MGST2;FADS1;PON2;PTGES
18836,GO:1901568,0.0626228865613255,0.979909849794002,5,101,fatty acid derivative metabolic process,BP,EDN1;MGST2;FADS1;PON2;PTGES
13490,GO:0050220,0.0626447297001843,0.998657708355948,1,3,prostaglandin-E synthase activity,MF,PTGES
12553,GO:0046165,0.0626501142250922,0.979894212325173,5,102,alcohol biosynthetic process,BP,EBP;HMGCS2;ABCG1;DHCR7;VDR
14482,GO:0052739,0.0626710205311087,0.998656564958016,1,3,phosphatidylserine 1-acylhydrolase activity,MF,PLA2G16
10165,GO:0035990,0.0626734859546281,0.998656457710142,1,3,tendon cell differentiation,BP,BMP4
10166,GO:0035992,0.0626734859546281,0.998656457710142,1,3,tendon formation,BP,BMP4
8637,GO:0032640,0.0627490112648821,0.979853597576405,5,102,tumor necrosis factor production,BP,FADD;PYCARD;PIK3R1;TICAM1;GAS6
19035,GO:1902109,0.0627645068108868,0.998652495146565,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,NOL3
14955,GO:0060435,0.0627741271729554,0.99865207597625,1,3,bronchiole development,BP,FGF10
16249,GO:0070996,0.0627865120928975,0.998651536252154,1,3,type 1 melanocortin receptor binding,MF,MRAP
18889,GO:1901671,0.0627943016972522,0.998651196730966,1,3,positive regulation of superoxide dismutase activity,BP,RGN
20258,GO:1904833,0.0627943016972522,0.998651196730966,1,3,positive regulation of removal of superoxide radicals,BP,RGN
12709,GO:0046573,0.0628364830425623,0.998649357431805,1,3,lactonohydrolase activity,MF,PON2
18394,GO:0102007,0.0628364830425623,0.998649357431805,1,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,PON2
16992,GO:0072311,0.0629623343674224,0.992388921022526,2,20,glomerular epithelial cell differentiation,BP,BMP4;WT1
12933,GO:0047045,0.0630666601592782,0.998639297929409,1,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B3
2091,GO:0004582,0.0630691136980052,0.99863919049467,1,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,DPM3
8987,GO:0033185,0.0630691136980052,0.99863919049467,1,3,dolichol-phosphate-mannose synthase complex,CC,DPM3
8111,GO:0031731,0.0632116743536418,0.998632940598258,1,3,CCR6 chemokine receptor binding,MF,CCL20
15285,GO:0060986,0.0633373263769503,0.986980598110376,3,44,endocrine hormone secretion,BP,BMP6;INHBB;RAB11FIP1
2541,GO:0005251,0.0633849742955782,0.992309146609893,2,20,delayed rectifier potassium channel activity,MF,KCNH2;KCNG2
4372,GO:0009083,0.0634638897787703,0.992294216734281,2,20,branched-chain amino acid catabolic process,BP,HSD17B10;ACAT1
7055,GO:0021953,0.0635539324400261,0.974694325961361,7,172,central nervous system neuron differentiation,BP,WNT3;WNT2;WNT7A;SPTBN4;WNT5A;AXIN1;FGF8
2980,GO:0006085,0.0637398920129877,0.992241915434352,2,20,acetyl-CoA biosynthetic process,BP,PDK4;ACAT1
3278,GO:0006555,0.0637882085661568,0.992232746065596,2,20,methionine metabolic process,BP,MSRA;MRI1
11432,GO:0043496,0.063839558655283,0.992222996569621,2,20,regulation of protein homodimerization activity,BP,TICAM1;PCBD1
5266,GO:0014812,0.0638676887422126,0.982651152695366,4,74,muscle cell migration,BP,PLAU;PDGFB;FOXO4;DDR1
2800,GO:0005789,0.0638702365647399,0.958627743222091,27,951,endoplasmic reticulum membrane,CC,EBP;USE1;ALG5;NOTCH1;DPM3;HSD17B3;MRAP;CASQ2;EXTL1;ABCG1;MBOAT2;TTYH1;MGST2;TYRO3;FADS1;REEP1;CYP17A1;HSD3B2;GJB1;CPT1C;CASP4;PTGES;DHCR7;CYB5A;GPSM1;ACSL4;ELOVL6
16308,GO:0071157,0.0640181510652448,0.992189052884857,2,20,negative regulation of cell cycle arrest,BP,FGF10;HMGN5
12633,GO:0046427,0.0640654901291394,0.982593196045546,4,72,positive regulation of JAK-STAT cascade,BP,LIF;NOTCH1;GHR;CLCF1
20295,GO:1904894,0.0640654901291394,0.982593196045546,4,72,positive regulation of STAT cascade,BP,LIF;NOTCH1;GHR;CLCF1
7470,GO:0030514,0.064114712319851,0.986743399445523,3,45,negative regulation of BMP signaling pathway,BP,NOTCH1;FSTL3;WNT5A
4924,GO:0010664,0.0642971909388888,0.992135907488972,2,20,negative regulation of striated muscle cell apoptotic process,BP,BMP7;NOL3
13701,GO:0050852,0.0643303540425541,0.974325145978955,7,168,T cell receptor signaling pathway,BP,PSMB10;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
4634,GO:0009749,0.064440688612233,0.974266446985015,7,170,response to glucose,BP,KHK;SESN2;CTGF;GJB6;STAR;PIK3CA;GAS6
12379,GO:0045840,0.0645846476474884,0.986606622528963,3,45,positive regulation of mitotic nuclear division,BP,EDN1;PDGFB;FGF8
6238,GO:0017038,0.0646317200985297,0.968042420339322,11,316,protein import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6
13094,GO:0048066,0.0646752898804251,0.986580191274697,3,45,developmental pigmentation,BP,RAB27A;KITLG;RAB38
5639,GO:0015844,0.0647509251908975,0.982345453096233,4,72,monoamine transport,BP,ADRA2B;ADRA2C;CHGA;GDNF
12274,GO:0045649,0.0647731812224392,0.99204494098681,2,20,regulation of macrophage differentiation,BP,LIF;FADD
9765,GO:0035306,0.0648017898857245,0.986543277239831,3,45,positive regulation of dephosphorylation,BP,ADORA1;RGN;BMP2
649,GO:0001779,0.0648278545238612,0.992034467355234,2,20,natural killer cell differentiation,BP,TYRO3;GAS6
3845,GO:0007568,0.0648628930055738,0.969151469798145,10,278,aging,BP,EDN1;RGN;FOXO4;HRAS;CDKN1A;CTGF;GJB2;GJB6;AKT1;CLDN1
12712,GO:0046579,0.0648718126258016,0.986522830517942,3,45,positive regulation of Ras protein signal transduction,BP,FGF10;HRAS;KITLG
19666,GO:1903555,0.0648838184030906,0.978967631361327,5,103,regulation of tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;PIK3R1;TICAM1;GAS6
9506,GO:0034599,0.0649233001167791,0.970529847613232,9,240,cellular response to oxidative stress,BP,GUCY1B3;RGN;PRR5L;SESN2;RHOB;BMP7;NOL3;GJB2;AKT1
10869,GO:0042503,0.0650153859433355,0.986493177158482,3,44,tyrosine phosphorylation of Stat3 protein,BP,LIF;GHR;CLCF1
5539,GO:0015645,0.0651742048988941,0.991967998266939,2,20,fatty acid ligase activity,MF,ACSM5;ACSL4
3463,GO:0006812,0.0651843392075212,0.957028357298964,29,1043,cation transport,BP,ACTN2;CDH23;TF;SLC31A2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;RGN;PDGFB;KCNH2;FXYD1;SFXN1;WNK4;NOL3;CTGF;AKT1;PIK3CG;KCNG2;GAS6;CYB5A;VDR;KCND1;GDNF;CLDN16;PDE4B
9610,GO:0034766,0.065205180733608,0.982173806892878,4,73,negative regulation of ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2;AKT1
3761,GO:0007292,0.0652449484824452,0.97881312467635,5,104,female gamete generation,BP,WNT4;ANG;HEXB;NPPC;INHBB
10065,GO:0035809,0.0653341991855069,0.991937223620942,2,20,regulation of urine volume,BP,EDN1;NPR1
13324,GO:0048640,0.0653375624546405,0.98211894227323,4,74,negative regulation of developmental growth,BP,WNT3;WNT5A;RBP4;BMP4
5658,GO:0015874,0.0654904373836284,0.991907128999333,2,20,norepinephrine transport,BP,ADRA2B;ADRA2C
3245,GO:0006520,0.065519614744739,0.966418265543079,12,349,cellular amino acid metabolic process,BP,GLDC;MSRA;MRI1;PSMB10;GHR;HSD17B10;ACAT1;SARDH;PCBD1;PEPD;PTS;SLC1A3
16101,GO:0070727,0.0655905104928435,0.953266176422296,44,1692,cellular macromolecule localization,BP,ITGA3;LIF;WNT4;ACTN2;TSPAN15;TSPAN17;RAB27A;PMAIP1;MRAP;TBC1D14;ADORA1;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;MSN;NOL3;AKT1;IFI27;PKP3;CDH1;MYO7A;GAS6;RPH3AL;AMOT;LAMA5;SH3BP4;RAB38;CLDN18
5017,GO:0010818,0.0657461086313196,0.991857791164713,2,20,T cell chemotaxis,BP,WNT5A;PIK3CG
13562,GO:0050660,0.0657583018071121,0.981972646198794,4,73,flavin adenine dinucleotide binding,MF,ACADVL;AOX1;LDHD;ETFDH
5125,GO:0010950,0.0658748747315561,0.975823919479906,6,136,positive regulation of endopeptidase activity,BP,PMAIP1;FADD;TRADD;PYCARD;CTGF;IFI27
13930,GO:0051187,0.0658759663066293,0.991832689107419,2,20,cofactor catabolic process,BP,ACAT1;NUDT7
4120,GO:0008395,0.0659231513615592,0.991823560870017,2,20,steroid hydroxylase activity,MF,CYP17A1;CYP11A1
8968,GO:0033157,0.06611237339088,0.966059091486196,12,356,regulation of intracellular protein transport,BP,FZD7;PRR5L;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;IFI27;CDH1;GAS6
8645,GO:0032648,0.0661550568487048,0.986146442983724,3,45,regulation of interferon-beta production,BP,PYCARD;TICAM1;NMI
9609,GO:0034765,0.0662384290453482,0.964971378162879,13,397,regulation of ion transmembrane transport,BP,ACTN2;SLC31A2;CASQ2;KCNK6;TSPAN13;RGN;KCNH2;FXYD1;AKT1;PIK3CG;KCNG2;KCND1;PDE4B
7576,GO:0030801,0.0664164479385663,0.978324656616592,5,104,positive regulation of cyclic nucleotide metabolic process,BP,MRAP;WNT5A;NPR1;CHGA;NPPC
12340,GO:0045765,0.0667076626926542,0.971217830846319,8,207,regulation of angiogenesis,BP,ITGA5;NOTCH1;FOXO4;WNT5A;RHOB;NPR1;DLL1;AMOT
19925,GO:1904062,0.0668732807814219,0.969465138484582,9,245,regulation of cation transmembrane transport,BP,ACTN2;SLC31A2;CASQ2;TSPAN13;RGN;KCNH2;FXYD1;PIK3CG;PDE4B
15274,GO:0060972,0.0669127080972129,0.991600780324577,2,21,left/right pattern formation,BP,NOTCH1;DLL1
4107,GO:0008375,0.0672344083822214,0.985827407636938,3,45,acetylglucosaminyltransferase activity,MF,EXTL1;B3GNT2;HEXB
6085,GO:0016740,0.0672492613741845,0.950140001516832,57,2269,transferase activity,MF,PDK4;TSPAN17;ALG5;MARK4;PNMT;DPM3;ZFYVE21;FASN;FBXO41;HMGCS2;ACVR1;NMT2;EXTL1;PNP;PRKACB;MBOAT2;MGST2;ACSM5;MAPK12;TYRO3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;NNMT;CPT2;PLA2G16;KHK;GALT;NPR1;NUAK2;PFKFB3;RNASEL;FGF8;HBEGF;ACAT1;B3GNT2;CDKN1A;PKN3;SHPK;HEXB;WNK4;DDR1;CPT1C;AKT1;KITLG;SPSB1;PIK3CA;PIK3CG;DTX4;ARAF;ELOVL6;RNF144A;PIM2
8611,GO:0032602,0.0675425024336547,0.981319696893013,4,73,chemokine production,BP,ZFPM1;PYCARD;TICAM1;WNT5A
17422,GO:0090162,0.067551267377685,0.99147535686462,2,21,establishment of epithelial cell polarity,BP,WNT5A;MSN
11840,GO:0044550,0.0678953491879134,0.991407485195585,2,21,secondary metabolite biosynthetic process,BP,BDH2;WNT5A
13794,GO:0050999,0.0680760779768592,0.985577083304726,3,45,regulation of nitric-oxide synthase activity,BP,AKT1;GLA;PTS
9703,GO:0035162,0.0682486926141962,0.991337576884218,2,21,embryonic hemopoiesis,BP,ZFPM1;KITLG
16360,GO:0071260,0.068504160234816,0.980958035375499,4,74,cellular response to mechanical stimulus,BP,GADD45A;FADD;BMP6;AKT1
16307,GO:0071156,0.0685576309575204,0.9774204103345,5,105,regulation of cell cycle arrest,BP,GADD45A;FGF10;FOXO4;CDKN1A;HMGN5
3374,GO:0006672,0.068617383739136,0.980916167974666,4,74,ceramide metabolic process,BP,ITGB8;ASAH2;HEXB;GLA
12068,GO:0045178,0.0687900506649803,0.985338916682373,3,47,basal part of cell,CC,TF;EDN1;CLDN11
18847,GO:1901605,0.0687969278121098,0.970128999764266,8,206,alpha-amino acid metabolic process,BP,GLDC;MSRA;MRI1;GHR;ACAT1;SARDH;PCBD1;SLC1A3
481,GO:0001502,0.0688706350200463,0.991214011574672,2,21,cartilage condensation,BP,WNT7A;CTGF
3040,GO:0006195,0.0691308875160133,0.98524872875803,3,46,purine nucleotide catabolic process,BP,PNP;NUDT7;PDE4B
13325,GO:0048641,0.069288502484261,0.985201349720846,3,46,regulation of skeletal muscle tissue development,BP,ACTN3;DLL1;S100B
7081,GO:0022011,0.0693716499776073,0.99108483664018,2,22,myelination in peripheral nervous system,BP,POU3F1;AKT1
8389,GO:0032292,0.0693716499776073,0.99108483664018,2,22,peripheral nervous system axon ensheathment,BP,POU3F1;AKT1
519,GO:0001556,0.0695578487893627,0.991076716188083,2,21,oocyte maturation,BP,ANG;NPPC
2804,GO:0005794,0.0696974076756978,0.951531239200664,37,1399,Golgi apparatus,CC,ITGA5;WNT3;WNT4;RAB6C;NOTCH1;RAB27A;FASN;WNT6;WNT7A;WNT7B;NMT2;TBC1D14;ABCG1;RAB39B;RAB39A;FSTL3;PDGFB;HRAS;WNT5B;WNT5A;GALT;RHOQ;SDC4;SPTB;B3GNT2;PKN3;RAB20;RND3;CTGF;RAB12;CDH1;GAS6;GLA;GPSM1;RAB38;FZD8;RNF144A
4102,GO:0008360,0.0697005552086172,0.974041324461357,6,141,regulation of cell shape,BP,RHOQ;RHOJ;HEXB;MSN;S100B;PARVB
8209,GO:0031968,0.0697491672662735,0.971636993924889,7,174,organelle outer membrane,CC,PMAIP1;VAMP1;CPT1C;IFI27;DHCR7;CYB5A;ACSL4
16395,GO:0071320,0.0700203592306938,0.984968347637103,3,47,cellular response to cAMP,BP,WT1;STAR;PIK3CG
19420,GO:1903035,0.0700274135520438,0.980385549609261,4,75,negative regulation of response to wounding,BP,WNT4;EDN1;PLAU;PDGFB
17357,GO:0090068,0.0700537928468705,0.967725263758376,9,246,positive regulation of cell cycle process,BP,WNT4;GADD45A;EDN1;PDGFB;FOXO4;WNT5A;FGF8;CDKN1A;CTGF
12826,GO:0046835,0.0700625137075925,0.990975383257221,2,21,carbohydrate phosphorylation,BP,KHK;PFKFB3
3409,GO:0006721,0.0703632041701342,0.976650241546007,5,106,terpenoid metabolic process,BP,PECR;STRA6;RBP4;SDC4;STAR
14062,GO:0051412,0.0705560526215909,0.99087586919769,2,21,response to corticosterone,BP,CDKN1A;STAR
12769,GO:0046677,0.0706370524734127,0.984794067924841,3,46,response to antibiotic,BP,GJB2;STAR;SLC1A3
4106,GO:0008374,0.0706481246261663,0.984790709878129,3,46,O-acyltransferase activity,MF,MBOAT2;CPT2;CPT1C
6352,GO:0018107,0.0706957175723067,0.97649936712793,5,108,peptidyl-threonine phosphorylation,BP,ACVR1;WNT5A;AXIN1;BMP7;AKT1
13949,GO:0051223,0.0710753620960457,0.956133004618813,21,719,regulation of protein transport,BP,ADRA2C;PYCARD;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;RBP4;ANG;BMP7;BMP6;BMP4;CDKN1A;NOL3;IFI27;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL
825,GO:0002020,0.0711995518675497,0.976284260530838,5,108,protease binding,MF,ITGA3;FADD;SERPINA5;PYCARD;NOL3
21246,GO:2000482,0.0712142896322366,0.990742509175013,2,21,regulation of interleukin-8 secretion,BP,PYCARD;WNT5A
7260,GO:0030149,0.0713543109811037,0.990714046819023,2,21,sphingolipid catabolic process,BP,HEXB;GLA
7252,GO:0030136,0.0717194021362601,0.970646643401892,7,176,clathrin-coated vesicle,CC,RAB27A;TF;EDN1;WNT5A;SNX18;HBEGF;SH3BP4
7179,GO:0030003,0.0717630171050873,0.958143435351255,17,556,cellular cation homeostasis,BP,CDH23;TF;SLC31A2;CASQ2;EDN1;RAB39A;PRND;LPAR2;RGN;BMP6;RAB20;HEXB;NOL3;PIK3CG;VDR;RAB38;CLDN16
19652,GO:1903533,0.0719012127949712,0.965157992926761,10,284,regulation of protein targeting,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;CDH1;GAS6
14232,GO:0051726,0.072014236253077,0.952780021456019,27,969,regulation of cell cycle,BP,LIF;WNT4;RAB6C;GADD45A;EDN1;PRKACB;MAPK12;PSMB10;FGF10;PDGFB;FOXO4;PLA2G16;HRAS;WNT5A;RHOB;PSRC1;FGF8;BMP7;BMP4;BMP2;CDKN1A;HMGN5;CTGF;AKT1;NPPC;GAS6;PIM2
8291,GO:0032102,0.0720644751174607,0.966617535495985,9,246,negative regulation of response to external stimulus,BP,WNT3;WNT4;NOTCH1;ADORA1;EDN1;PLAU;TYRO3;PDGFB;WNT5A
16599,GO:0071621,0.0722369492345094,0.975854198037231,5,105,granulocyte chemotaxis,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
3889,GO:0008013,0.0722730069175916,0.979522681771878,4,78,beta-catenin binding,MF,CDH2;FOXO4;AXIN1;CDH1
10750,GO:0042303,0.0723023415491883,0.975811801047204,5,108,molting cycle,BP,NOTCH1;TRADD;FGF10;WNT5A;LAMA5
10957,GO:0042633,0.0723023415491883,0.975811801047204,5,108,hair cycle,BP,NOTCH1;TRADD;FGF10;WNT5A;LAMA5
12848,GO:0046879,0.0724264126993704,0.964855958626975,10,285,hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;RBP4;BMP6;INHBB;RAB11FIP1;KCNG2
12390,GO:0045862,0.0724428182655796,0.962257426670612,12,357,positive regulation of proteolysis,BP,PMAIP1;FADD;TRADD;PYCARD;MAPK12;PSMB10;RGN;AXIN1;CTGF;AKT1;IFI27;RNF144A
19754,GO:1903729,0.0727039973710728,0.979373945331786,4,76,regulation of plasma membrane organization,BP,ITGA3;PIK3R1;RHOQ;AKT1
14798,GO:0060235,0.0727817711879811,0.997956250860999,1,4,lens induction in camera-type eye,BP,BMP4
14675,GO:0060045,0.0727869758109515,0.990389606736132,2,22,positive regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
6741,GO:0019867,0.0728702487775008,0.970067876692085,7,176,outer membrane,CC,PMAIP1;VAMP1;CPT1C;IFI27;DHCR7;CYB5A;ACSL4
4633,GO:0009746,0.0728776254511007,0.970066707295633,7,175,response to hexose,BP,KHK;SESN2;CTGF;GJB6;STAR;PIK3CA;GAS6
3531,GO:0006914,0.0729183548763852,0.95987029375238,14,438,autophagy,BP,ITGB4;WDR45;TBC1D14;RAB39A;PIK3R2;TICAM1;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1;SH3BP4;PIM2
13978,GO:0051260,0.0729196435071023,0.964575897941491,10,283,protein homooligomerization,BP,ACTN2;SPTBN5;PRND;ACAT1;PCBD1;DECR1;CLDN1;CLDN3;KCNG2;KCND1
32,GO:0000060,0.0731232777668983,0.984021187644599,3,47,protein import into nucleus, translocation,BP,CDKN1A;AKT1;GAS6
11123,GO:0042993,0.073387716539393,0.983939644224385,3,47,positive regulation of transcription factor import into nucleus,BP,PIK3R2;PIK3R1;CDH1
8617,GO:0032608,0.0735375213034467,0.98389339279949,3,47,interferon-beta production,BP,PYCARD;TICAM1;NMI
1525,GO:0003273,0.0735548671475424,0.997911890896828,1,4,cell migration involved in endocardial cushion formation,BP,NOTCH1
19540,GO:1903305,0.0737642105914052,0.975182069951667,5,108,regulation of regulated secretory pathway,BP,SYT5;NOTCH1;RAB27A;RPH3AL;RAB3D
16656,GO:0071706,0.0739318887865835,0.975114400031851,5,107,tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;PIK3R1;TICAM1;GAS6
13120,GO:0048168,0.073932725682707,0.983758432020402,3,48,regulation of neuronal synaptic plasticity,BP,HRAS;STAR;S100B
10417,GO:0036515,0.0742189250750766,0.997873394761832,1,4,serotonergic neuron axon guidance,BP,WNT5A
17755,GO:0097118,0.0742452102955978,0.997871863507755,1,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,CDH2
5011,GO:0010812,0.0742667310562366,0.98365484369381,3,48,negative regulation of cell-substrate adhesion,BP,NOTCH1;FZD7;PIK3R1
4920,GO:0010660,0.0742681441870217,0.983667227187745,3,47,regulation of muscle cell apoptotic process,BP,EDN1;BMP7;NOL3
6091,GO:0016747,0.0743087474735517,0.967204861257181,8,211,transferase activity, transferring acyl groups other than amino-acyl groups,MF,FASN;NMT2;MBOAT2;ACSM5;CPT2;ACAT1;CPT1C;ELOVL6
1443,GO:0003148,0.0743911159470107,0.990056325431536,2,22,outflow tract septum morphogenesis,BP,FGF8;BMP4
14443,GO:0052548,0.0744470342356372,0.961040260316046,12,358,regulation of endopeptidase activity,BP,PMAIP1;FADD;SERPINA5;TRADD;PYCARD;NOL3;CTGF;AKT1;IFI27;CST9L;TFPI;GAS6
14923,GO:0060396,0.0745140405490892,0.990030609830233,2,22,growth hormone receptor signaling pathway,BP,GHR;PIK3R1
483,GO:0001504,0.0745522415006896,0.990022613159748,2,22,neurotransmitter uptake,BP,GDNF;SLC1A3
18140,GO:0098743,0.0749369167038629,0.989941953720715,2,22,cell aggregation,BP,WNT7A;CTGF
21641,GO:2001239,0.0751385091668102,0.983396531174927,3,47,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;GDNF
7862,GO:0031295,0.0752891376929294,0.978390988974319,4,76,T cell costimulation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
15105,GO:0060669,0.0754330736796084,0.989837557082374,2,22,embryonic placenta morphogenesis,BP,WNT7B;BMP7
10954,GO:0042629,0.0754910770050325,0.98982532602086,2,22,mast cell granule,CC,CHGA;PIK3CG
4529,GO:0009306,0.0756976774044817,0.957172846397502,15,480,protein secretion,BP,ADRA2C;NOTCH1;RAB40B;RAB40A;PNP;PYCARD;WNT5A;RBP4;ANG;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL
13765,GO:0050927,0.0758445963594117,0.989750659972316,2,22,positive regulation of positive chemotaxis,BP,ARTN;FGF10
16119,GO:0070777,0.0759075587061424,0.997773865698641,1,4,D-aspartate transport,BP,SLC1A3
16121,GO:0070779,0.0759075587061424,0.997773865698641,1,4,D-aspartate import,BP,SLC1A3
2532,GO:0005242,0.0760790646573786,0.98970102479037,2,22,inward rectifier potassium channel activity,MF,KCNK6;KCNH2
8465,GO:0032402,0.0761607459433736,0.989683712206188,2,22,melanosome transport,BP,RAB27A;RAB17
19380,GO:1902965,0.076401914571774,0.997744282773853,1,4,regulation of protein localization to early endosome,BP,MSN
19381,GO:1902966,0.076401914571774,0.997744282773853,1,4,positive regulation of protein localization to early endosome,BP,MSN
20586,GO:1905666,0.076401914571774,0.997744282773853,1,4,regulation of protein localization to endosome,BP,MSN
20587,GO:1905668,0.076401914571774,0.997744282773853,1,4,positive regulation of protein localization to endosome,BP,MSN
21577,GO:2001137,0.0764106264479555,0.997743759633173,1,4,positive regulation of endocytic recycling,BP,ACTN2
12285,GO:0045661,0.0764225039562581,0.982981362980757,3,48,regulation of myoblast differentiation,BP,NOTCH1;BMP4;DLL1
15171,GO:0060750,0.0765144435458363,0.997737520679029,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,WNT5A
13839,GO:0051052,0.0766289802594106,0.95970321274297,12,364,regulation of DNA metabolic process,BP,RGN;FGF10;PDGFB;HRAS;CLCF1;BMP6;BMP4;CDKN1A;AKT1;KITLG;NPPC;PIK3CA
20899,GO:1990851,0.0766389288446821,0.997730027913143,1,4,Wnt-Frizzled-LRP5/6 complex,CC,FZD8
20781,GO:1990430,0.0767124599372948,0.997725596062094,1,4,extracellular matrix protein binding,MF,ITGB8
9189,GO:0033762,0.0767212197678656,0.98288737736907,3,48,response to glucagon,BP,PRKACB;PRKAR1B;GJB2
4388,GO:0009110,0.0768211011468368,0.989543344980041,2,22,vitamin biosynthetic process,BP,RGN;VDR
8226,GO:0031999,0.0768244229589953,0.997718839265817,1,4,negative regulation of fatty acid beta-oxidation,BP,AKT1
13615,GO:0050718,0.0769476608524053,0.989516361221755,2,22,positive regulation of interleukin-1 beta secretion,BP,PYCARD;WNT5A
5053,GO:0010861,0.0769692008478497,0.99771008677755,1,4,thyroid hormone receptor activator activity,MF,ACTN2
7419,GO:0030375,0.0769692008478497,0.99771008677755,1,4,thyroid hormone receptor coactivator activity,MF,ACTN2
15021,GO:0060528,0.0770023786962834,0.9977080785833,1,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,NOTCH1
4357,GO:0009063,0.0770196291999557,0.97376586140803,5,108,cellular amino acid catabolic process,BP,GLDC;HSD17B10;ACAT1;SARDH;PCBD1
7227,GO:0030101,0.0770512708315202,0.977713953238931,4,76,natural killer cell activation,BP,RAB27A;TYRO3;TICAM1;GAS6
11476,GO:0043550,0.0771220639130207,0.982761006165908,3,48,regulation of lipid kinase activity,BP,PIK3R2;PIK3R1;PDGFB
11629,GO:0044092,0.0772352003825293,0.948230109635121,29,1056,negative regulation of molecular function,BP,ACTN2;NOTCH1;GADD45A;SERPINA5;APOC1;ZFPM1;CASQ2;PYCARD;PSMB10;RGN;PDGFB;PRKAR1B;RALB;HRAS;BMP7;BMP4;CAMSAP3;CDKN1A;NOL3;DEPTOR;AKT1;CST9L;TFPI;GAS6;GLA;AMOT;SH3BP4;DUSP5;HEY1
21544,GO:2001027,0.0774905076030938,0.997678427802696,1,4,negative regulation of endothelial cell chemotaxis,BP,NOTCH1
13444,GO:0048861,0.0775184671294053,0.997676723467353,1,4,leukemia inhibitory factor signaling pathway,BP,LIF
4972,GO:0010746,0.0776174426258281,0.997670684996651,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
4973,GO:0010748,0.0776174426258281,0.997670684996651,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
15025,GO:0060535,0.0776590952349067,0.997668141357365,1,4,trachea cartilage morphogenesis,BP,WNT7B
3231,GO:0006499,0.0777192640016421,0.997664464438999,1,4,N-terminal protein myristoylation,BP,NMT2
6611,GO:0019430,0.0777430324154712,0.989346179113045,2,22,removal of superoxide radicals,BP,RGN;BMP7
21663,GO:2001267,0.0777567401428064,0.989343237050395,2,22,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
7601,GO:0030826,0.0777736221788541,0.989339613269691,2,22,regulation of cGMP biosynthetic process,BP,NPR1;NPPC
4677,GO:0009897,0.0777938529816707,0.965331622517545,8,213,external side of plasma membrane,CC,ITGA3;ITGA5;TF;SERPINA5;ABCG1;MFGE8;FGF8;AMOT
15495,GO:0061419,0.077806088446343,0.997659153307823,1,4,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
6155,GO:0016853,0.0778269388298149,0.97020026390592,6,141,isomerase activity,MF,EBP;MRI1;HSD3B2;PTGES;PUS1;ECI1
12288,GO:0045664,0.0778314251062683,0.95490935716326,16,529,regulation of neuron differentiation,BP,ITGA3;ADRA2B;ADRA2C;WNT3;NOTCH1;WNT7A;WNT5A;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;LZTS1;LINGO1
14310,GO:0051894,0.0778848727175928,0.989284135275971,2,23,positive regulation of focal adhesion assembly,BP,WNT4;SDC4
5163,GO:0010996,0.0779078363957144,0.989279187177114,2,23,response to auditory stimulus,BP,STRA6;SLC1A3
917,GO:0002159,0.077929024607848,0.997651622515779,1,4,desmosome assembly,BP,PKP3
10464,GO:0038064,0.0781470897097574,0.997638233553811,1,4,collagen receptor activity,MF,DDR1
16172,GO:0070885,0.078170876334004,0.997636770698656,1,4,negative regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
97,GO:0000186,0.0782728490209945,0.982383437068287,3,49,activation of MAPKK activity,BP,ADORA1;BMP4;ARAF
15460,GO:0061343,0.0782777070749512,0.997630194929095,1,4,cell adhesion involved in heart morphogenesis,BP,ACVR1
8802,GO:0032890,0.0782990868872682,0.982388266754306,3,48,regulation of organic acid transport,BP,ADORA1;EDN1;AKT1
13648,GO:0050771,0.0783206142334613,0.982368250067479,3,49,negative regulation of axonogenesis,BP,WNT3;WNT5A;LINGO1
2375,GO:0004971,0.0784017934163359,0.997622545154885,1,4,AMPA glutamate receptor activity,MF,GRIA3
5894,GO:0016361,0.0784019235306351,0.997622537126799,1,4,activin receptor activity, type I,MF,ACVR1
16871,GO:0072131,0.0784969815451301,0.997616668274542,1,4,kidney mesenchyme morphogenesis,BP,BMP7
16873,GO:0072133,0.0784969815451301,0.997616668274542,1,4,metanephric mesenchyme morphogenesis,BP,BMP7
1495,GO:0003219,0.0786390822308643,0.997607881059807,1,4,cardiac right ventricle formation,BP,NOTCH1
1507,GO:0003241,0.0786407013581648,0.997607780839876,1,4,growth involved in heart morphogenesis,BP,NOTCH1
2188,GO:0004713,0.0786727247997455,0.967104565919382,7,180,protein tyrosine kinase activity,MF,TYRO3;FGF18;FGF10;FGF17;FGF8;HBEGF;DDR1
2413,GO:0005025,0.0787933931311302,0.99759831983653,1,4,transforming growth factor beta receptor activity, type I,MF,ACVR1
14088,GO:0051452,0.0788219503074434,0.982221891295167,3,48,intracellular pH reduction,BP,RAB39A;RAB20;RAB38
3015,GO:0006145,0.0789479450964571,0.997588723891645,1,4,purine nucleobase catabolic process,BP,AOX1
2209,GO:0004740,0.0789952048548137,0.997585785636614,1,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK4
14058,GO:0051402,0.0790763201098616,0.964634568518934,8,215,neuron apoptotic process,BP,FADD;TYRO3;HRAS;FGF8;CLCF1;STAR;PIK3CA;GDNF
11807,GO:0044440,0.0790980703645271,0.955935955364929,14,443,endosomal part,CC,TMEM163;SYT5;TSPAN15;RAB27A;TF;ZFYVE21;FZD7;TICAM1;SNX18;RHOB;RAB12;RAB17;SNX21;RNF144A
15872,GO:0070318,0.0792014191408499,0.997572943116919,1,4,positive regulation of G0 to G1 transition,BP,CTGF
14841,GO:0060298,0.0792698502016939,0.997568673604815,1,4,positive regulation of sarcomere organization,BP,EDN1
18675,GO:1901078,0.079298409547014,0.997566890597463,1,4,negative regulation of relaxation of muscle,BP,PDE4B
13436,GO:0048852,0.0793528104960797,0.997563492384002,1,4,diencephalon morphogenesis,BP,WNT5A
12642,GO:0046449,0.0794040008881885,0.997560292479376,1,4,creatinine metabolic process,BP,GHR
7294,GO:0030195,0.0794708744852089,0.982014725844739,3,48,negative regulation of blood coagulation,BP,EDN1;PLAU;PDGFB
18456,GO:1900047,0.0794708744852089,0.982014725844739,3,48,negative regulation of hemostasis,BP,EDN1;PLAU;PDGFB
20267,GO:1904849,0.079539724216425,0.997551797908388,1,4,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
21294,GO:2000546,0.079539724216425,0.997551797908388,1,4,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
7199,GO:0030035,0.0795708708150822,0.997549846367303,1,4,microspike assembly,BP,ACTN2
15769,GO:0070164,0.0796485583847953,0.99754497521737,1,4,negative regulation of adiponectin secretion,BP,RAB11FIP1
14829,GO:0060283,0.0796564751112086,0.997544478543218,1,4,negative regulation of oocyte development,BP,NPPC
20634,GO:1905880,0.0796564751112086,0.997544478543218,1,4,negative regulation of oogenesis,BP,NPPC
15856,GO:0070294,0.079670684389191,0.99754358696082,1,4,renal sodium ion absorption,BP,WNK4
14303,GO:0051884,0.0797053158912659,0.997541413253533,1,4,regulation of timing of anagen,BP,WNT5A
9570,GO:0034699,0.0797634789890583,0.997537760304345,1,4,response to luteinizing hormone,BP,STAR
13198,GO:0048319,0.0798043552702319,0.997535191378238,1,4,axial mesoderm morphogenesis,BP,AXIN1
14656,GO:0060024,0.0798083129927309,0.99753494257608,1,4,rhythmic synaptic transmission,BP,EDN1
7666,GO:0030910,0.0798817910661369,0.997530321016624,1,4,olfactory placode formation,BP,AXIN1
16650,GO:0071698,0.0798817910661369,0.997530321016624,1,4,olfactory placode development,BP,AXIN1
16651,GO:0071699,0.0798817910661369,0.997530321016624,1,4,olfactory placode morphogenesis,BP,AXIN1
10052,GO:0035788,0.0799912823371786,0.997523426014812,1,4,cell migration involved in metanephros development,BP,PDGFB
10053,GO:0035789,0.0799912823371786,0.997523426014812,1,4,metanephric mesenchymal cell migration,BP,PDGFB
21325,GO:2000589,0.0799912823371786,0.997523426014812,1,4,regulation of metanephric mesenchymal cell migration,BP,PDGFB
13672,GO:0050804,0.0800033707525388,0.96045973257687,10,292,modulation of synaptic transmission,BP,WNT7A;ADORA1;EDN1;PXK;HRAS;STAR;LZTS1;S100B;GDNF;SLC1A3
6385,GO:0018210,0.0800202238963257,0.972423736395085,5,112,peptidyl-threonine modification,BP,ACVR1;WNT5A;AXIN1;BMP7;AKT1
1534,GO:0003289,0.0801604264955807,0.997512754921017,1,4,atrial septum primum morphogenesis,BP,ACVR1
6074,GO:0016717,0.0802708464851497,0.997505775843661,1,4,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,FADS1
16846,GO:0072095,0.0802825836309002,0.997505033403854,1,4,regulation of branch elongation involved in ureteric bud branching,BP,BMP4
2540,GO:0005250,0.0803344346459643,0.997501752169146,1,4,A-type (transient outward) potassium channel activity,MF,KCND1
16856,GO:0072106,0.0804435498699752,0.99749483984689,1,4,regulation of ureteric bud formation,BP,GDNF
16857,GO:0072107,0.0804435498699752,0.99749483984689,1,4,positive regulation of ureteric bud formation,BP,GDNF
20453,GO:1905278,0.0804435498699752,0.99749483984689,1,4,positive regulation of epithelial tube formation,BP,GDNF
10058,GO:0035795,0.0804461744919853,0.997494673458323,1,4,negative regulation of mitochondrial membrane permeability,BP,NOL3
20596,GO:1905709,0.0804461744919853,0.997494673458323,1,4,negative regulation of membrane permeability,BP,NOL3
11206,GO:0043125,0.080460073160534,0.997493792253363,1,4,ErbB-3 class receptor binding,MF,PIK3R1
18436,GO:1900019,0.080476839019204,0.997492729048917,1,4,regulation of protein kinase C activity,BP,WNT5A
18437,GO:1900020,0.080476839019204,0.997492729048917,1,4,positive regulation of protein kinase C activity,BP,WNT5A
3689,GO:0007184,0.0804814276051227,0.988719185015884,2,23,SMAD protein import into nucleus,BP,BMP6;BMP4
15817,GO:0070236,0.0805077647100086,0.997490767288102,1,4,negative regulation of activation-induced cell death of T cells,BP,FADD
142,GO:0000285,0.0805183042945764,0.997490098531536,1,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
19665,GO:1903553,0.0805481886410814,0.997488201811368,1,4,positive regulation of extracellular exosome assembly,BP,SDC4
11751,GO:0044339,0.080659687175408,0.997481118596417,1,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
10442,GO:0038028,0.0806742089990627,0.99748019530193,1,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,PIK3CA
11458,GO:0043532,0.0806876742353466,0.997479339028449,1,4,angiostatin binding,MF,AMOT
18501,GO:1900127,0.0806931035282242,0.997478993729383,1,4,positive regulation of hyaluronan biosynthetic process,BP,PDGFB
1682,GO:0003873,0.0806969428638539,0.997478749535651,1,4,6-phosphofructo-2-kinase activity,MF,PFKFB3
1914,GO:0004331,0.0806969428638539,0.997478749535651,1,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,PFKFB3
2928,GO:0006003,0.0806969428638539,0.997478749535651,1,4,fructose 2,6-bisphosphate metabolic process,BP,PFKFB3
16972,GO:0072278,0.0807037170184588,0.997478318648393,1,4,metanephric comma-shaped body morphogenesis,BP,BMP4
3355,GO:0006651,0.0807051435668539,0.997478227904309,1,4,diacylglycerol biosynthetic process,BP,ANG
10078,GO:0035844,0.0807235249667427,0.997477058494877,1,4,cloaca development,BP,BMP4
3924,GO:0008078,0.0807332924561094,0.99747643698104,1,4,mesodermal cell migration,BP,FGF8
127,GO:0000255,0.0808028269695191,0.997472010147911,1,4,allantoin metabolic process,BP,GHR
7033,GO:0021904,0.0808604830928891,0.988635793590608,2,23,dorsal/ventral neural tube patterning,BP,PRKACB;BMP4
19785,GO:1903792,0.0808694508029244,0.988633817892272,2,23,negative regulation of anion transport,BP,ADORA1;AKT1
8929,GO:0033088,0.08095866994746,0.997462073989538,1,4,negative regulation of immature T cell proliferation in thymus,BP,BMP4
9273,GO:0034113,0.0810266982460719,0.981501218244076,3,49,heterotypic cell-cell adhesion,BP,ITGA5;DSC2;BMP7
16794,GO:0072010,0.0810280827068597,0.988598847769364,2,23,glomerular epithelium development,BP,BMP4;WT1
16812,GO:0072039,0.0810445094126672,0.997456592456257,1,4,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
16813,GO:0072040,0.0810445094126672,0.997456592456257,1,4,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
18694,GO:1901145,0.0810445094126672,0.997456592456257,1,4,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
20177,GO:1904673,0.0810445094126672,0.997456592456257,1,4,negative regulation of somatic stem cell population maintenance,BP,BMP7
15101,GO:0060665,0.0810556838219433,0.997455878430574,1,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGF10
8806,GO:0032898,0.08105908590116,0.9974556610229,1,4,neurotrophin production,BP,ADORA1
15703,GO:0070053,0.0810835713773049,0.997454096010477,1,4,thrombospondin receptor activity,MF,SDC4
16712,GO:0071847,0.0811263478003899,0.997451360718569,1,4,TNFSF11-mediated signaling pathway,BP,CLDN18
16287,GO:0071072,0.0811651844329694,0.997448876034402,1,4,negative regulation of phospholipid biosynthetic process,BP,PDGFB
13417,GO:0048808,0.0811785011054973,0.997448023773571,1,4,male genitalia morphogenesis,BP,FGF10
17637,GO:0090598,0.0811785011054973,0.997448023773571,1,4,male anatomical structure morphogenesis,BP,FGF10
21054,GO:2000195,0.0812448983002918,0.997443772183163,1,4,negative regulation of female gonad development,BP,WT1
7188,GO:0030017,0.0812529671922568,0.965757416442095,7,186,sarcomere,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B;TMOD4
19635,GO:1903510,0.0812744310841314,0.971866140658157,5,112,mucopolysaccharide metabolic process,BP,PDGFB;B3GNT2;IDUA;HEXB;AKT1
5085,GO:0010897,0.081289300652376,0.997440926935597,1,4,negative regulation of triglyceride catabolic process,BP,PIK3CG
4953,GO:0010724,0.0813719662367506,0.997435625459043,1,4,regulation of definitive erythrocyte differentiation,BP,ZFPM1
6442,GO:0018894,0.0813986733537991,0.99743391147386,1,4,dibenzo-p-dioxin metabolic process,BP,STAR
4394,GO:0009117,0.0814021150555913,0.950231843691174,19,641,nucleotide metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;PNP;NNMT;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;SHPK;CHGA;NUDT7;MDH1;IDH1;NPPC;DERA;PDE4B
15871,GO:0070317,0.0814200917894325,0.997432536472139,1,4,negative regulation of G0 to G1 transition,BP,FOXO4
600,GO:0001705,0.0814479303697222,0.997430748745286,1,4,ectoderm formation,BP,FZD7
16187,GO:0070901,0.0814705732418811,0.997429294198869,1,4,mitochondrial tRNA methylation,BP,HSD17B10
8360,GO:0032241,0.0814797427945518,0.997428705038294,1,4,positive regulation of nucleobase-containing compound transport,BP,ADORA1
21366,GO:2000653,0.0815490375278671,0.997424250462716,1,4,regulation of genetic imprinting,BP,PIK3CA
12186,GO:0045445,0.0815570986995393,0.975933464529089,4,79,myoblast differentiation,BP,NOTCH1;MAPK12;BMP4;DLL1
20631,GO:1905874,0.0815818484538111,0.997422139835794,1,4,regulation of postsynaptic density organization,BP,CDH2
15340,GO:0061054,0.0816100040862443,0.997420327955552,1,4,dermatome development,BP,WNT4
15407,GO:0061183,0.0816100040862443,0.997420327955552,1,4,regulation of dermatome development,BP,WNT4
10173,GO:0036003,0.0816179606894866,0.988468452881144,2,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1;SESN2
2004,GO:0004470,0.0816180618231107,0.997419809300092,1,4,malic enzyme activity,MF,MDH1
8464,GO:0032401,0.0816413693625507,0.988463266692807,2,23,establishment of melanosome localization,BP,RAB27A;RAB17
2926,GO:0006001,0.0816539581494991,0.997417498090909,1,4,fructose catabolic process,BP,KHK
15576,GO:0061624,0.0816539581494991,0.997417498090909,1,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,KHK
4212,GO:0008532,0.0816829020433899,0.997415633737892,1,4,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT2
15916,GO:0070384,0.0817014527014892,0.997414438474161,1,4,Harderian gland development,BP,FGF10
6440,GO:0018879,0.0817056094745425,0.997414170603951,1,4,biphenyl metabolic process,BP,STAR
21050,GO:2000191,0.0817120766769463,0.988447596120851,2,23,regulation of fatty acid transport,BP,EDN1;AKT1
8276,GO:0032079,0.0817184950020017,0.997413340145143,1,4,positive regulation of endodeoxyribonuclease activity,BP,AKT1
12895,GO:0046952,0.0817341605111392,0.997412330333294,1,4,ketone body catabolic process,BP,ACAT1
9362,GO:0034284,0.0817431828318259,0.965519044556085,7,180,response to monosaccharide,BP,KHK;SESN2;CTGF;GJB6;STAR;PIK3CA;GAS6
10429,GO:0038001,0.0817654792752441,0.997410310887165,1,4,paracrine signaling,BP,PDGFB
17445,GO:0090191,0.0817656313551334,0.997410301079002,1,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,BMP4
21152,GO:2000346,0.0817781491364848,0.997409493697634,1,4,negative regulation of hepatocyte proliferation,BP,LIMS2
13764,GO:0050926,0.0817996405337644,0.988428178509047,2,23,regulation of positive chemotaxis,BP,ARTN;FGF10
15454,GO:0061325,0.0818636290054518,0.997403976865894,1,4,cell proliferation involved in outflow tract morphogenesis,BP,BMP4
5275,GO:0014826,0.0818650879674585,0.997403882652361,1,4,vein smooth muscle contraction,BP,EDN1
17100,GO:0072558,0.0819316403317189,0.997399583101078,1,4,NLRP1 inflammasome complex,CC,PYCARD
13222,GO:0048382,0.0819377976583112,0.997399185126585,1,4,mesendoderm development,BP,FGF8
2001,GO:0004466,0.0819528955652412,0.997398209150363,1,4,long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
16914,GO:0072191,0.0819784462103898,0.997396557043913,1,4,ureter smooth muscle development,BP,BMP4
16916,GO:0072193,0.0819784462103898,0.997396557043913,1,4,ureter smooth muscle cell differentiation,BP,BMP4
20796,GO:1990481,0.0819828760632383,0.997396270554043,1,4,mRNA pseudouridine synthesis,BP,PUS1
15137,GO:0060708,0.0820115896955406,0.997394413174117,1,4,spongiotrophoblast differentiation,BP,LIF
13185,GO:0048295,0.0820171184117236,0.997394055462864,1,4,positive regulation of isotype switching to IgE isotypes,BP,CLCF1
7381,GO:0030311,0.0820261283783524,0.997393472458087,1,4,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT2
11988,GO:0045054,0.0820319317577912,0.997393096905044,1,4,constitutive secretory pathway,BP,RAB27A
7314,GO:0030217,0.0820369932413192,0.963022839689048,8,216,T cell differentiation,BP,WNT4;FADD;ZFPM1;PNP;FZD7;BMP4;JAG2;FZD8
17930,GO:0097460,0.0820420770966721,0.997392440304204,1,4,ferrous iron import into cell,BP,TF
11411,GO:0043457,0.0820521016795254,0.988372125009178,2,23,regulation of cellular respiration,BP,ACTN3;PIK3CA
10145,GO:0035962,0.0821044701463213,0.997388400375579,1,4,response to interleukin-13,BP,SHPK
851,GO:0002054,0.0821047663115236,0.997388381191254,1,4,nucleobase binding,MF,PNP
8084,GO:0031694,0.0821174453603304,0.997387559827764,1,4,alpha-2A adrenergic receptor binding,MF,ADRA2C
876,GO:0002084,0.0821348883981809,0.997386429628776,1,4,protein depalmitoylation,BP,LYPLAL1
3404,GO:0006710,0.0821830342934545,0.997383308763177,1,4,androgen catabolic process,BP,HSD17B11
1544,GO:0003308,0.0821859940432257,0.997383116846222,1,4,negative regulation of Wnt signaling pathway involved in heart development,BP,BMP2
8742,GO:0032795,0.0821987208122125,0.997382291530243,1,4,heterotrimeric G-protein binding,MF,ADORA1
9606,GO:0034762,0.0821994267840394,0.955041955312693,13,411,regulation of transmembrane transport,BP,ACTN2;SLC31A2;CASQ2;KCNK6;TSPAN13;RGN;KCNH2;FXYD1;AKT1;PIK3CG;KCNG2;KCND1;PDE4B
1054,GO:0002414,0.0822168080905544,0.997381118359466,1,4,immunoglobulin transcytosis in epithelial cells,BP,RAB17
9607,GO:0034763,0.0822174759136665,0.975672762620022,4,79,negative regulation of transmembrane transport,BP,ACTN2;CASQ2;KCNH2;AKT1
18629,GO:1900736,0.0822235764846329,0.997380679280183,1,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
15053,GO:0060574,0.0822403183782464,0.997379593036098,1,4,intestinal epithelial cell maturation,BP,CDKN1A
12656,GO:0046470,0.0822586532458312,0.975664325693185,4,78,phosphatidylcholine metabolic process,BP,APOC1;MBOAT2;PLA2G16;FABP3
18767,GO:1901318,0.0822589678707441,0.997378382748723,1,4,negative regulation of flagellated sperm motility,BP,RGN
5933,GO:0016453,0.0822598433197594,0.997378325928,1,4,C-acetyltransferase activity,MF,ACAT1
17847,GO:0097278,0.0823132623460797,0.997374857576298,1,4,complement-dependent cytotoxicity,BP,RAB27A
1603,GO:0003419,0.0823344168403268,0.997373483415683,1,4,growth plate cartilage chondrocyte proliferation,BP,NPPC
19520,GO:1903273,0.0823872302280137,0.997370051119229,1,4,regulation of sodium ion export,BP,FXYD1
19521,GO:1903275,0.0823872302280137,0.997370051119229,1,4,positive regulation of sodium ion export,BP,FXYD1
19522,GO:1903276,0.0823872302280137,0.997370051119229,1,4,regulation of sodium ion export from cell,BP,FXYD1
19523,GO:1903278,0.0823872302280137,0.997370051119229,1,4,positive regulation of sodium ion export from cell,BP,FXYD1
7784,GO:0031119,0.0823946822049775,0.997369566634634,1,4,tRNA pseudouridine synthesis,BP,PUS1
16141,GO:0070838,0.0824316645147305,0.954894954901565,13,411,divalent metal ion transport,BP,CDH23;TF;CASQ2;TSPAN13;RGN;PDGFB;NOL3;CTGF;PIK3CG;GAS6;VDR;CLDN16;PDE4B
3782,GO:0007356,0.0824365095028447,0.997366846406244,1,4,thorax and anterior abdomen determination,BP,WT1
17167,GO:0072683,0.0824718329183118,0.997364548021149,1,4,T cell extravasation,BP,FADD
18888,GO:1901668,0.0825025597006324,0.997362547879312,1,4,regulation of superoxide dismutase activity,BP,RGN
8095,GO:0031705,0.0825158670902929,0.997361681398501,1,4,bombesin receptor binding,MF,EDN1
13887,GO:0051130,0.0825192402750681,0.943945439175969,30,1116,positive regulation of cellular component organization,BP,ITGA3;LIF;WNT3;WNT4;ACTN2;RAB27A;TF;PMAIP1;WNT7A;EDN1;MFGE8;PYCARD;PIK3R1;PDGFB;RALB;HRAS;WNT5A;RHOQ;PSRC1;FGF8;SDC4;BMP7;DLL1;ESPN;MSN;CTGF;AKT1;CLDN1;GAS6;HNF1A
7215,GO:0030060,0.0825857172457422,0.997357130842591,1,4,L-malate dehydrogenase activity,MF,MDH1
8491,GO:0032431,0.0825988403684932,0.997356275451649,1,4,activation of phospholipase A2 activity,BP,ANG
15887,GO:0070343,0.0826324787887023,0.997354082177928,1,4,white fat cell proliferation,BP,FGF10
15893,GO:0070350,0.0826324787887023,0.997354082177928,1,4,regulation of white fat cell proliferation,BP,FGF10
7225,GO:0030099,0.0826605119446647,0.957356980111582,11,329,myeloid cell differentiation,BP,LIF;FADD;ZFPM1;FSTL3;PIK3R1;BMP4;DLL1;SFXN1;KITLG;TSPAN2;CLDN18
1157,GO:0002586,0.0827052163616307,0.99734933635893,1,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
8065,GO:0031663,0.0827668114822906,0.980936856213291,3,49,lipopolysaccharide-mediated signaling pathway,BP,TICAM1;BMP6;AKT1
12385,GO:0045851,0.0827728964226027,0.9809348734108,3,49,pH reduction,BP,RAB39A;RAB20;RAB38
21601,GO:2001181,0.0827863635023624,0.997344036647849,1,4,positive regulation of interleukin-10 secretion,BP,PYCARD
3894,GO:0008021,0.0827942020525301,0.967781118538384,6,145,synaptic vesicle,CC,TMEM163;SYT5;RAB40B;RAB40A;VAMP1;PDE4B
10709,GO:0042222,0.0827952078318167,0.997343458693963,1,4,interleukin-1 biosynthetic process,BP,CCL20
4257,GO:0008625,0.0827985899653668,0.975442720172355,4,79,extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;FADD;TRADD;PIK3R1
15890,GO:0070346,0.082817123777861,0.997342026263048,1,4,positive regulation of fat cell proliferation,BP,FGF10
7984,GO:0031501,0.0828362777273954,0.997340774028976,1,4,mannosyltransferase complex,CC,DPM3
1747,GO:0003986,0.0828825042044421,0.997337750605744,1,4,acetyl-CoA hydrolase activity,MF,NUDT7
8135,GO:0031779,0.082969622725638,0.997332047813741,1,4,melanocortin receptor binding,MF,MRAP
8137,GO:0031781,0.082969622725638,0.997332047813741,1,4,type 3 melanocortin receptor binding,MF,MRAP
8138,GO:0031782,0.082969622725638,0.997332047813741,1,4,type 4 melanocortin receptor binding,MF,MRAP
7313,GO:0030216,0.083019160833517,0.958696845060698,10,287,keratinocyte differentiation,BP,POU3F1;NOTCH1;DSC2;KRT10;WNT5A;DSG3;PKP3;PKP1;DSC3;VDR
4567,GO:0009435,0.0832326197160532,0.98810865354574,2,23,NAD biosynthetic process,BP,PNP;NNMT
5100,GO:0010915,0.0832643293731144,0.997312709360593,1,4,regulation of very-low-density lipoprotein particle clearance,BP,APOC1
5101,GO:0010916,0.0832643293731144,0.997312709360593,1,4,negative regulation of very-low-density lipoprotein particle clearance,BP,APOC1
4103,GO:0008361,0.0832842923544908,0.967527239597861,6,149,regulation of cell size,BP,WNT3;EDN1;WNT5A;MSN;DEPTOR;AKT1
7817,GO:0031224,0.0833115249796692,0.93279785806785,119,5117,intrinsic component of membrane,CC,ITGA3;ITGA5;EBP;TMEM160;TMEM163;TMEM164;ADRA2B;ADRA2C;SYT5;USE1;TSPAN15;TSPAN17;ALG5;NOTCH1;CDH23;DPM3;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;RHBDL3;SLC31A2;SLC45A4;DSC2;P2RY14;MRAP;SLC52A3;TMEM206;ACVR1;PXMP2;PXMP4;ADORA1;CASQ2;EXTL1;ABCG1;KCNK6;FLVCR2;CCDC51;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;PRND;MGST2;FZD7;TYRO3;LPAR2;CDH2;FADS1;GHR;HRCT1;ASAH2;REEP1;KCNH2;PLA2G16;JAM3;FXYD1;NPR1;TMEM223;SDC4;SPTB;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;SLC2A14;VAMP1;SFXN1;GRIA3;HSD3B2;DDR1;DSG3;GJB1;GJB2;GJB6;CPT1C;IFI27;TMEM176A;PTGES;KITLG;SEMA6C;JAG2;CDH1;GJA3;TPBGL;TMEM98;TFPI;CLDN1;CLDN2;CLDN3;CLDN5;KCNG2;ACP5;PRRT1;CLDN23;DHCR7;CYB5A;SLC18B1;DSC3;KCND1;TSPAN2;ACSL4;SLC1A3;FZD8;CNIH4;ELOVL6;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;LINGO1;ETFDH;PDE4B
11182,GO:0043086,0.0833875698774325,0.9464048168398,23,811,negative regulation of catalytic activity,BP,NOTCH1;GADD45A;SERPINA5;APOC1;PYCARD;PSMB10;RGN;PRKAR1B;HRAS;BMP7;BMP4;CAMSAP3;CDKN1A;NOL3;DEPTOR;AKT1;CST9L;TFPI;GAS6;GLA;AMOT;SH3BP4;DUSP5
7387,GO:0030318,0.0833899319025125,0.988041377368214,2,24,melanocyte differentiation,BP,RAB27A;KITLG
13732,GO:0050886,0.0835205011372666,0.975156120476511,4,79,endocrine process,BP,EDN1;BMP6;INHBB;RAB11FIP1
19206,GO:1902554,0.0835470098849418,0.975137789484022,4,80,serine/threonine protein kinase complex,CC,ACVR1;PYCARD;SESN2;CDKN1A
9920,GO:0035588,0.0835718285154872,0.988032533419366,2,23,G-protein coupled purinergic receptor signaling pathway,BP,P2RY14;ADORA1
3638,GO:0007088,0.0840536601311077,0.967153810875991,6,148,regulation of mitotic nuclear division,BP,EDN1;PDGFB;PSRC1;FGF8;BMP7;BMP4
5744,GO:0016052,0.0840837487030399,0.967146298518281,6,146,carbohydrate catabolic process,BP,ACTN3;KHK;GALT;PFKFB3;HEXB;DERA
4008,GO:0008210,0.0841295078775036,0.987906986218958,2,23,estrogen metabolic process,BP,HSD17B11;STAR
16490,GO:0071456,0.0842065992440859,0.964233128826454,7,181,cellular response to hypoxia,BP,NOTCH1;PMAIP1;EDN1;PSMB10;BMP7;AKT1;S100B
7861,GO:0031294,0.0843241644361745,0.974835999801774,4,79,lymphocyte costimulation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
491,GO:0001516,0.0843261310092633,0.987862602751996,2,23,prostaglandin biosynthetic process,BP,EDN1;PTGES
12645,GO:0046457,0.0843261310092633,0.987862602751996,2,23,prostanoid biosynthetic process,BP,EDN1;PTGES
7494,GO:0030552,0.0847205903316298,0.987740610748775,2,24,cAMP binding,MF,PRKAR1B;PDE4B
6755,GO:0019897,0.0850160850466469,0.966684558865027,6,147,extrinsic component of plasma membrane,CC,TF;MFGE8;CDH2;SNX18;CDH1;MYZAP
5173,GO:0014002,0.0852279300054105,0.987625190119304,2,24,astrocyte development,BP,DLL1;TSPAN2
3499,GO:0006873,0.0852519227520439,0.949112038656627,17,570,cellular ion homeostasis,BP,CDH23;TF;SLC31A2;CASQ2;EDN1;RAB39A;PRND;LPAR2;RGN;BMP6;RAB20;HEXB;NOL3;PIK3CG;VDR;RAB38;CLDN16
6727,GO:0019843,0.0855949991460258,0.980008344122526,3,49,rRNA binding,MF,MRPL16;RNASEL;ANG
1266,GO:0002763,0.0857583728093093,0.979940046913918,3,50,positive regulation of myeloid leukocyte differentiation,BP,LIF;FADD;KITLG
7473,GO:0030517,0.0860825258966856,0.987429838065329,2,24,negative regulation of axon extension,BP,WNT3;WNT5A
11304,GO:0043266,0.0862200251629392,0.974060425589401,4,81,regulation of potassium ion transport,BP,ACTN2;ADORA1;CASQ2;KCNH2
19199,GO:1902532,0.0865745764500851,0.951104046278917,14,451,negative regulation of intracellular signal transduction,BP,ITGA3;LIF;ACTN3;CASQ2;PYCARD;SESN2;BMP7;BMP4;NOL3;DEPTOR;AKT1;TLE1;SH3BP4;DUSP5
14256,GO:0051784,0.0868501375129595,0.979563478551412,3,51,negative regulation of nuclear division,BP,LIF;BMP7;BMP4
8688,GO:0032722,0.0868858989632516,0.979565459615044,3,50,positive regulation of chemokine production,BP,PYCARD;TICAM1;WNT5A
5201,GO:0014044,0.0870073481904366,0.987185819011153,2,25,Schwann cell development,BP,POU3F1;AKT1
8354,GO:0032231,0.0870368348056291,0.973723298645801,4,82,regulation of actin filament bundle assembly,BP,WNT4;PIK3R1;SDC4;CTGF
14313,GO:0051897,0.0871915288716431,0.97366857808918,4,81,positive regulation of protein kinase B signaling,BP,FAM110C;HBEGF;PIK3CG;GAS6
3430,GO:0006753,0.0872398907764678,0.946189771775739,19,647,nucleoside phosphate metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;PNP;NNMT;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;SHPK;CHGA;NUDT7;MDH1;IDH1;NPPC;DERA;PDE4B
2944,GO:0006029,0.0872858960352455,0.97362262128259,4,82,proteoglycan metabolic process,BP,EXTL1;BMP2;IDUA;HEXB
11142,GO:0043015,0.0873632431776563,0.987134900190495,2,24,gamma-tubulin binding,MF,MARK4;PDE4B
17068,GO:0072511,0.0874032489195146,0.951726785292646,13,415,divalent inorganic cation transport,BP,CDH23;TF;CASQ2;TSPAN13;RGN;PDGFB;NOL3;CTGF;PIK3CG;GAS6;VDR;CLDN16;PDE4B
7569,GO:0030742,0.0874990255255206,0.987103477871439,2,24,GTP-dependent protein binding,MF,RAB38;RAB3D
3664,GO:0007156,0.0875620736913743,0.965408096259675,6,152,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH23;DSC2;CDH2;DSG3;CDH1;DSC3
7891,GO:0031333,0.0876972712519492,0.968958060352769,5,114,negative regulation of protein complex assembly,BP,FHOD3;SPTBN5;SPTBN4;SPTB;TMOD4
14874,GO:0060337,0.0878333981328562,0.97341687326476,4,80,type I interferon signaling pathway,BP,FADD;WNT5A;RNASEL;IFI27
16422,GO:0071357,0.0878333981328562,0.97341687326476,4,80,cellular response to type I interferon,BP,FADD;WNT5A;RNASEL;IFI27
8356,GO:0032233,0.0881159115622353,0.979140180682593,3,51,positive regulation of actin filament bundle assembly,BP,WNT4;SDC4;CTGF
832,GO:0002028,0.0882275192195216,0.973241038318738,4,82,regulation of sodium ion transport,BP,SPTBN4;FXYD1;WNK4;AKT1
13327,GO:0048643,0.0883786979679711,0.986899198811888,2,24,positive regulation of skeletal muscle tissue development,BP,ACTN3;DLL1
7637,GO:0030878,0.0887266151943224,0.986818066826667,2,24,thyroid gland development,BP,FGF10;FGF8
2636,GO:0005506,0.0889322497759416,0.964744999243901,6,147,iron ion binding,MF,PHYH;TF;CYP17A1;AOX1;ACP5;CYP11A1
12189,GO:0045453,0.089341754239482,0.978727636189464,3,51,bone resorption,BP,PDK4;RAB3D;CLDN18
5726,GO:0016021,0.0893656826165637,0.927757188989702,116,4993,integral component of membrane,CC,ITGA3;ITGA5;EBP;TMEM160;TMEM163;TMEM164;ADRA2B;ADRA2C;SYT5;USE1;TSPAN15;TSPAN17;ALG5;NOTCH1;CDH23;DPM3;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;RHBDL3;SLC31A2;SLC45A4;DSC2;P2RY14;MRAP;SLC52A3;TMEM206;ACVR1;PXMP2;PXMP4;ADORA1;CASQ2;EXTL1;ABCG1;KCNK6;FLVCR2;CCDC51;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;MGST2;FZD7;TYRO3;LPAR2;CDH2;FADS1;GHR;HRCT1;ASAH2;REEP1;KCNH2;PLA2G16;JAM3;FXYD1;NPR1;TMEM223;SDC4;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;SLC2A14;VAMP1;SFXN1;GRIA3;HSD3B2;DDR1;DSG3;GJB1;GJB2;GJB6;CPT1C;IFI27;TMEM176A;PTGES;KITLG;SEMA6C;JAG2;CDH1;GJA3;TPBGL;TMEM98;CLDN1;CLDN2;CLDN3;CLDN5;KCNG2;ACP5;PRRT1;CLDN23;DHCR7;CYB5A;SLC18B1;DSC3;KCND1;TSPAN2;ACSL4;SLC1A3;FZD8;CNIH4;ELOVL6;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;LINGO1;ETFDH;PDE4B
13844,GO:0051057,0.0895043312608838,0.978658844743415,3,52,positive regulation of small GTPase mediated signal transduction,BP,FGF10;HRAS;KITLG
13613,GO:0050716,0.0896445670991615,0.986603088955891,2,24,positive regulation of interleukin-1 secretion,BP,PYCARD;WNT5A
4681,GO:0009914,0.0896597520420004,0.954736617666518,10,297,hormone transport,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;RBP4;BMP6;INHBB;RAB11FIP1;KCNG2
4917,GO:0010657,0.0896911725210529,0.978609576574409,3,51,muscle cell apoptotic process,BP,EDN1;BMP7;NOL3
12653,GO:0046466,0.0898980516508181,0.986543490557974,2,24,membrane lipid catabolic process,BP,HEXB;GLA
13670,GO:0050802,0.0899123101823547,0.986540135136154,2,24,circadian sleep/wake cycle, sleep,BP,ADORA1;STAR
18062,GO:0098552,0.0900971974289723,0.950001352415954,13,412,side of membrane,CC,ITGA3;ITGA5;TF;SERPINA5;ABCG1;MFGE8;PTPN7;SNX18;FGF8;SPTB;CDH1;AMOT;MYZAP
19585,GO:1903393,0.090210189280707,0.986436921352026,2,25,positive regulation of adherens junction organization,BP,WNT4;SDC4
2789,GO:0005776,0.0903488395559326,0.972375904627164,4,82,autophagosome,CC,TBC1D14;TICAM1;RALB;RAB12
17544,GO:0090322,0.0904937392784733,0.986403036526042,2,24,regulation of superoxide metabolic process,BP,RGN;BMP7
16485,GO:0071450,0.0906057042937879,0.986376574602582,2,24,cellular response to oxygen radical,BP,RGN;BMP7
16486,GO:0071451,0.0906057042937879,0.986376574602582,2,24,cellular response to superoxide,BP,RGN;BMP7
7270,GO:0030162,0.0907377302113405,0.943020167094011,20,693,regulation of proteolysis,BP,CFB;PMAIP1;FADD;SERPINA5;TRADD;PRKACB;PYCARD;MAPK12;PSMB10;RGN;AXIN1;NOL3;CTGF;AKT1;IFI27;CST9L;TFPI;GAS6;ARAF;RNF144A
6963,GO:0021782,0.0911125742208271,0.972054558462482,4,83,glial cell development,BP,POU3F1;DLL1;AKT1;TSPAN2
9425,GO:0034394,0.0912597223015569,0.978062820271136,3,52,protein localization to cell surface,BP,ACTN2;MRAP;FGF10
8866,GO:0032984,0.0913089737427946,0.955669960136422,9,258,macromolecular complex disassembly,BP,ACTN2;MRPL14;MRPL16;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SPTB;TMOD4
14703,GO:0060076,0.0915027472503975,0.986130104182756,2,25,excitatory synapse,CC,ITGA3;PDE4B
13684,GO:0050819,0.0916531121075206,0.977942863595223,3,51,negative regulation of coagulation,BP,EDN1;PLAU;PDGFB
12874,GO:0046916,0.0921054253259495,0.971653812119402,4,82,cellular transition metal ion homeostasis,BP,TF;SLC31A2;PRND;BMP6
14880,GO:0060343,0.0923778951680468,0.985920879183492,2,25,trabecula formation,BP,RBP4;HEY1
15339,GO:0061053,0.0924354638907693,0.971501434387249,4,84,somite development,BP,WNT4;NOTCH1;WNT5A;DLL1
12845,GO:0046875,0.0928091147297489,0.985817344777584,2,25,ephrin receptor binding,MF,PIK3CG;EFNB2
20104,GO:1904502,0.0930344591243072,0.996411610194878,1,5,regulation of lipophagy,BP,SESN2
20105,GO:1904504,0.0930344591243072,0.996411610194878,1,5,positive regulation of lipophagy,BP,SESN2
12265,GO:0045636,0.0933003050201786,0.996390661279864,1,5,positive regulation of melanocyte differentiation,BP,KITLG
10958,GO:0042634,0.0934156661724342,0.985671221857176,2,25,regulation of hair cycle,BP,TRADD;WNT5A
10416,GO:0036514,0.0936137652013114,0.996365878817563,1,5,dopaminergic neuron axon guidance,BP,WNT5A
20317,GO:1904938,0.0936137652013114,0.996365878817563,1,5,planar cell polarity pathway involved in axon guidance,BP,WNT5A
8292,GO:0032103,0.0937954115654323,0.954217842809295,9,258,positive regulation of response to external stimulus,BP,ARTN;EDN1;FGF18;FGF10;PDGFB;WNT5A;BMP6;PIK3CG;GAS6
14605,GO:0055086,0.0938527091863574,0.940814211780239,20,695,nucleobase-containing small molecule metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;PNP;NNMT;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;AOX1;SHPK;CHGA;NUDT7;MDH1;IDH1;NPPC;DERA;PDE4B
14358,GO:0051964,0.0939976380929386,0.996335409272582,1,5,negative regulation of synapse assembly,BP,WNT5A
4951,GO:0010721,0.0941161351729987,0.954018444308371,9,264,negative regulation of cell development,BP,WNT3;NOTCH1;WNT7A;WNT5A;BMP7;DLL1;NPPC;CLDN18;LINGO1
16948,GO:0072236,0.0941738234584156,0.996321380407238,1,5,metanephric loop of Henle development,BP,WNT7B
20287,GO:1904885,0.0942138142901553,0.996318192229291,1,5,beta-catenin destruction complex assembly,BP,AXIN1
8433,GO:0032369,0.0943235140340196,0.98545144199494,2,25,negative regulation of lipid transport,BP,APOC1;AKT1
17442,GO:0090188,0.0944055426553206,0.99630288715867,1,5,negative regulation of pancreatic juice secretion,BP,WNK4
8463,GO:0032400,0.0944158459196473,0.985429017560367,2,25,melanosome localization,BP,RAB27A;RAB17
6683,GO:0019748,0.0944804607053048,0.976955826830383,3,52,secondary metabolic process,BP,BDH2;WNT5A;STAR
5743,GO:0016051,0.0947231447599809,0.958632890761127,7,186,carbohydrate biosynthetic process,BP,RGN;PDGFB;SESN2;RBP4;B3GNT2;MDH1;AKT1
11151,GO:0043027,0.0947633341592572,0.985344505028934,2,25,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,NOL3;GAS6
1474,GO:0003186,0.0950712702583578,0.996249487616119,1,5,tricuspid valve morphogenesis,BP,ZFPM1
9401,GO:0034367,0.0951940372209102,0.985239493406643,2,25,macromolecular complex remodeling,BP,APOC1;ABCG1
9402,GO:0034368,0.0951940372209102,0.985239493406643,2,25,protein-lipid complex remodeling,BP,APOC1;ABCG1
9403,GO:0034369,0.0951940372209102,0.985239493406643,2,25,plasma lipoprotein particle remodeling,BP,APOC1;ABCG1
6041,GO:0016645,0.0952703077723988,0.985220867525146,2,25,oxidoreductase activity, acting on the CH-NH group of donors,MF,SARDH;ETFDH
15312,GO:0061025,0.0954223225979864,0.955561019715228,8,223,membrane fusion,BP,SYT5;SERPINA5;RABIF;TBC1D14;RAB39A;RAB20;VAMP1;GAS6
21621,GO:2001205,0.0954586440778098,0.996218231985451,1,5,negative regulation of osteoclast development,BP,CLDN18
7292,GO:0030193,0.0955025687611332,0.970234338486947,4,83,regulation of blood coagulation,BP,EDN1;PLAU;PDGFB;FAM46A
18455,GO:1900046,0.0955025687611332,0.970234338486947,4,83,regulation of hemostasis,BP,EDN1;PLAU;PDGFB;FAM46A
9423,GO:0034392,0.095565697236099,0.996209570478861,1,5,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
13909,GO:0051156,0.0957478900833389,0.985104032922681,2,25,glucose 6-phosphate metabolic process,BP,SHPK;DERA
19473,GO:1903169,0.0958513495566763,0.965158023573783,5,118,regulation of calcium ion transmembrane transport,BP,CASQ2;TSPAN13;RGN;PIK3CG;PDE4B
16854,GO:0072103,0.0958538008810843,0.996186209205565,1,5,glomerulus vasculature morphogenesis,BP,BMP4
16855,GO:0072104,0.0958538008810843,0.996186209205565,1,5,glomerular capillary formation,BP,BMP4
18689,GO:1901135,0.0959157573032673,0.93307430578747,32,1210,carbohydrate derivative metabolic process,BP,ACTN3;ALG5;DPM3;ITGB8;MRAP;GUCY1B3;EXTL1;EDN1;PHLDA1;PNP;PDGFB;WNT5A;KHK;GALT;RHOQ;NPR1;PFKFB3;SDC4;HBEGF;BMP2;ACAT1;B3GNT2;IDUA;SHPK;HEXB;CHGA;NUDT7;AKT1;NPPC;GLA;DERA;PDE4B
15992,GO:0070527,0.096005369307836,0.976411061779289,3,53,platelet aggregation,BP,TYRO3;PIK3CG;GAS6
6640,GO:0019534,0.0960232044976954,0.996172437986113,1,5,toxin transporter activity,MF,ABCG1
15172,GO:0060751,0.096058393470763,0.99616957414905,1,5,branch elongation involved in mammary gland duct branching,BP,WNT5A
15531,GO:0061515,0.0961293415963735,0.976367770066556,3,53,myeloid cell development,BP,ZFPM1;TSPAN2;CLDN18
20322,GO:1904951,0.0961326939259789,0.943675086807276,15,498,positive regulation of establishment of protein localization,BP,ITGA3;PMAIP1;PYCARD;PRR5L;PIK3R2;PIK3R1;WNT5A;RBP4;ANG;BMP6;BMP4;AKT1;CDH1;GAS6;RPH3AL
10502,GO:0038132,0.0962358864887047,0.996155111963585,1,5,neuregulin binding,MF,ITGB4
8434,GO:0032370,0.0963456302193165,0.976292180537055,3,53,positive regulation of lipid transport,BP,EDN1;ABCG1;BMP6
17133,GO:0072606,0.0963752378958419,0.984950022997348,2,25,interleukin-8 secretion,BP,PYCARD;WNT5A
1052,GO:0002407,0.0964879700621182,0.984922283398578,2,25,dendritic cell chemotaxis,BP,PIK3CG;GAS6
10164,GO:0035989,0.0966374640864183,0.996122286519501,1,5,tendon development,BP,BMP4
4647,GO:0009791,0.0967309434370561,0.969686867764335,4,87,post-embryonic development,BP,BMP4;NPPC;MYO7A;DHCR7
10301,GO:0036294,0.0968463299526746,0.957478583236638,7,188,cellular response to decreased oxygen levels,BP,NOTCH1;PMAIP1;EDN1;PSMB10;BMP7;AKT1;S100B
6416,GO:0018377,0.0970267766858939,0.996090324836874,1,5,protein myristoylation,BP,NMT2
5677,GO:0015911,0.0970760312404305,0.996086271408543,1,5,plasma membrane long-chain fatty acid transport,BP,AKT1
17971,GO:0097530,0.0971142420844708,0.964579834792815,5,115,granulocyte migration,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
18790,GO:1901381,0.0972145343335283,0.984708989395355,2,26,positive regulation of potassium ion transmembrane transport,BP,ACTN2;KCNH2
17130,GO:0072602,0.0972183770497128,0.996074544686682,1,5,interleukin-4 secretion,BP,NOTCH1
10226,GO:0036091,0.0972877511849918,0.996068822885989,1,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
9918,GO:0035586,0.0974005499098481,0.984697005200013,2,25,purinergic receptor activity,MF,P2RY14;ADORA1
2461,GO:0005127,0.0974979655662897,0.996051458424877,1,5,ciliary neurotrophic factor receptor binding,MF,CLCF1
8884,GO:0033010,0.0975339123428878,0.996048485099288,1,5,paranodal junction,CC,JAM3
5123,GO:0010948,0.0976645840174225,0.9519329637438,9,262,negative regulation of cell cycle process,BP,LIF;GADD45A;PSMB10;FGF10;FOXO4;BMP7;BMP4;CDKN1A;HMGN5
21556,GO:2001046,0.0977046635491086,0.996034345540851,1,5,positive regulation of integrin-mediated signaling pathway,BP,LIMS2
8590,GO:0032571,0.0977412816805317,0.996031309840603,1,5,response to vitamin K,BP,GAS6
21473,GO:2000809,0.0977661282869664,0.99602924932872,1,5,positive regulation of synaptic vesicle clustering,BP,CDH2
17731,GO:0097070,0.097839074061963,0.996023196765531,1,5,ductus arteriosus closure,BP,STRA6
10984,GO:0042695,0.0979078189051318,0.996017488370379,1,5,thelarche,BP,WNT5A
15166,GO:0060744,0.0979078189051318,0.996017488370379,1,5,mammary gland branching involved in thelarche,BP,WNT5A
21536,GO:2001015,0.0979220634058896,0.996016305009863,1,5,negative regulation of skeletal muscle cell differentiation,BP,S100B
6349,GO:0018103,0.0980134938417568,0.996008705072336,1,5,protein C-linked glycosylation,BP,DPM3
6386,GO:0018211,0.0980134938417568,0.996008705072336,1,5,peptidyl-tryptophan modification,BP,DPM3
6407,GO:0018317,0.0980134938417568,0.996008705072336,1,5,protein C-linked glycosylation via tryptophan,BP,DPM3
6422,GO:0018406,0.0980134938417568,0.996008705072336,1,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPM3
7794,GO:0031133,0.0980615887869729,0.996004704263996,1,5,regulation of axon diameter,BP,WNT7A
16639,GO:0071680,0.0980842571238651,0.996002817859652,1,5,response to indole-3-methanol,BP,CDH1
16640,GO:0071681,0.0980842571238651,0.996002817859652,1,5,cellular response to indole-3-methanol,BP,CDH1
601,GO:0001706,0.0981361159461321,0.975648994502088,3,54,endoderm formation,BP,ITGA5;ITGB5;DUSP5
20349,GO:1905007,0.0981381123931699,0.995998334292638,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,ACVR1
7206,GO:0030046,0.0982392159614754,0.995989910126563,1,5,parallel actin filament bundle assembly,BP,ESPN
11057,GO:0042816,0.098368073364636,0.995979160065301,1,5,vitamin B6 metabolic process,BP,AOX1
8669,GO:0032687,0.0983836472292655,0.995977859783399,1,5,negative regulation of interferon-alpha production,BP,NMI
21674,GO:2001286,0.0984496361180223,0.995972347854682,1,5,regulation of caveolin-mediated endocytosis,BP,UNC119
733,GO:0001894,0.0984876689327075,0.956583234030923,7,189,tissue homeostasis,BP,PDK4;CDH23;TF;RBP4;CTGF;RAB3D;CLDN18
10051,GO:0035787,0.0985667330593824,0.995962557278047,1,5,cell migration involved in kidney development,BP,PDGFB
14904,GO:0060374,0.098603000421316,0.995959522418888,1,5,mast cell differentiation,BP,ZFPM1
19956,GO:1904177,0.0986725756943574,0.995953697019648,1,5,regulation of adipose tissue development,BP,PLA2G16
10040,GO:0035767,0.0987033455520259,0.98433835208586,2,26,endothelial cell chemotaxis,BP,NOTCH1;FGF18
14127,GO:0051541,0.098725924958396,0.995949227227706,1,5,elastin metabolic process,BP,HBEGF
7115,GO:0022614,0.0987462729069983,0.995947521726024,1,5,membrane to membrane docking,BP,MSN
2635,GO:0005504,0.0987890559017199,0.984351777399133,2,25,fatty acid binding,MF,APOC1;FABP3
16510,GO:0071480,0.0988362169332515,0.984305107881039,2,26,cellular response to gamma radiation,BP,HRAS;CDKN1A
154,GO:0000302,0.098884535965515,0.953589553682149,8,224,response to reactive oxygen species,BP,GUCY1B3;EDN1;RGN;SESN2;RHOB;BMP7;AKT1;STAR
10962,GO:0042640,0.0989684201303583,0.995928877683936,1,5,anagen,BP,WNT5A
15009,GO:0060510,0.0990034052380594,0.995925937438429,1,5,Type II pneumocyte differentiation,BP,FGF10
17144,GO:0072656,0.0990883921586573,0.995918790291095,1,5,maintenance of protein location in mitochondrion,BP,AKT1
14859,GO:0060318,0.0991652861726103,0.995912318103693,1,5,definitive erythrocyte differentiation,BP,ZFPM1
1420,GO:0003096,0.0992233289637923,0.995907429085773,1,5,renal sodium ion transport,BP,WNK4
14738,GO:0060136,0.0992448145464315,0.995905618555001,1,5,embryonic process involved in female pregnancy,BP,ACSL4
14026,GO:0051344,0.0993147449413622,0.995899722821758,1,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,RGN
5237,GO:0014719,0.0993544470061263,0.995896373627464,1,5,skeletal muscle satellite cell activation,BP,WNT7A
14105,GO:0051491,0.0993885526547304,0.984166623260224,2,26,positive regulation of filopodium assembly,BP,RHOQ;ESPN
12871,GO:0046912,0.0994011045057558,0.995892435862356,1,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS2
9099,GO:0033554,0.0994161928996744,0.926744887689645,44,1745,cellular response to stress,BP,PDK4;WNT4;NOTCH1;PMAIP1;GADD45A;DSC2;WNT7A;WNT7B;SLC52A3;GUCY1B3;EDN1;PYCARD;ACADVL;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FGF10;PIK3R2;PIK3R1;FOXO4;RALB;HRAS;WNT5A;JAM3;SESN2;AXIN1;RHOB;NUAK2;BMP7;BMP2;CDKN1A;NOL3;CTGF;GJB2;CASP4;AKT1;WNT2B;INHBB;GAS6;S100B;FZD8
1532,GO:0003284,0.0994193411561084,0.99589089620361,1,5,septum primum development,BP,ACVR1
12209,GO:0045542,0.0995037903609065,0.995883762519049,1,5,positive regulation of cholesterol biosynthetic process,BP,ABCG1
15114,GO:0060681,0.0995243032614548,0.995882028756885,1,5,branch elongation involved in ureteric bud branching,BP,BMP4
5292,GO:0014855,0.0995640197248006,0.975143587843269,3,54,striated muscle cell proliferation,BP,WNT2;NOTCH1;RBP4
4787,GO:0010385,0.0995890522758756,0.995876553634697,1,5,double-stranded methylated DNA binding,MF,WT1
7216,GO:0030061,0.0996047365631908,0.995875226813654,1,5,mitochondrial crista,CC,STAR
16421,GO:0071356,0.099618782296576,0.950779022645924,9,260,cellular response to tumor necrosis factor,BP,TRADD;EDN1;CCL20;PYCARD;PSMB10;NOL3;CLDN1;GAS6;CLDN18
7213,GO:0030056,0.0996219573607611,0.995706837264349,1,6,hemidesmosome,CC,ITGB4
10766,GO:0042326,0.0996522050206719,0.943787193965557,13,421,negative regulation of phosphorylation,BP,LIF;ACTN3;GADD45A;PYCARD;RGN;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;DEPTOR;AKT1;DUSP5
15973,GO:0070487,0.0996664965900238,0.995870000025065,1,5,monocyte aggregation,BP,BMP7
2759,GO:0005741,0.0996997893977621,0.959262572927832,6,153,mitochondrial outer membrane,CC,PMAIP1;VAMP1;CPT1C;IFI27;CYB5A;ACSL4
13422,GO:0048818,0.099701933052286,0.995866999456863,1,5,positive regulation of hair follicle maturation,BP,WNT5A
13341,GO:0048669,0.0997297923037417,0.995864639687803,1,5,collateral sprouting in absence of injury,BP,WNT3
4579,GO:0009448,0.0998296697468988,0.995856173969101,1,5,gamma-aminobutyric acid metabolic process,BP,SLC1A3
12814,GO:0046813,0.0998492152944471,0.995854516210979,1,5,receptor-mediated virion attachment to host cell,BP,GAS6
5829,GO:0016239,0.100100421826397,0.97493855128745,3,55,positive regulation of macroautophagy,BP,RALB;SESN2;RAB12
7697,GO:0030976,0.100104631993039,0.995832821213712,1,5,thiamine pyrophosphate binding,MF,HACL1
19120,GO:1902302,0.10011267167014,0.995832137367485,1,5,regulation of potassium ion export,BP,KCNH2
11579,GO:0043954,0.100170182080704,0.983969847913897,2,26,cellular component maintenance,BP,ITGA3;CAMSAP3
15825,GO:0070245,0.100194430506317,0.995825179724423,1,5,positive regulation of thymocyte apoptotic process,BP,WNT5A
14957,GO:0060437,0.100196900839783,0.995824969405832,1,5,lung growth,BP,FGF10
13798,GO:0051005,0.100208459514231,0.995823985253047,1,5,negative regulation of lipoprotein lipase activity,BP,APOC1
20699,GO:1990111,0.100338020096761,0.995812945653959,1,5,spermatoproteasome complex,CC,PSMB10
12612,GO:0046364,0.100361428863611,0.968174260021786,4,84,monosaccharide biosynthetic process,BP,RGN;SESN2;RBP4;MDH1
19004,GO:1902035,0.100396056770829,0.995807995532634,1,5,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
11461,GO:0043535,0.100433337323866,0.974834271474467,3,54,regulation of blood vessel endothelial cell migration,BP,NOTCH1;PDGFB;AKT1
2074,GO:0004563,0.100472885480268,0.995801437888218,1,5,beta-N-acetylhexosaminidase activity,MF,HEXB
8928,GO:0033087,0.100587723403273,0.995791626029124,1,5,negative regulation of immature T cell proliferation,BP,BMP4
630,GO:0001757,0.100602200224699,0.995790388267714,1,5,somite specification,BP,DLL1
9381,GO:0034340,0.10062879657381,0.968060255424248,4,84,response to type I interferon,BP,FADD;WNT5A;RNASEL;IFI27
14653,GO:0060021,0.100633089588452,0.968033171453605,4,87,palate development,BP,WNT7A;WNT5A;JAG2;CLDN5
17546,GO:0090324,0.100644923306022,0.99578673435695,1,5,negative regulation of oxidative phosphorylation,BP,ACTN3
11351,GO:0043331,0.100651722665665,0.968041852578356,4,85,response to dsRNA,BP,PMAIP1;TICAM1;RALB;BMP4
7743,GO:0031069,0.100709083679134,0.983833633592111,2,26,hair follicle morphogenesis,BP,NOTCH1;FGF10
21349,GO:2000630,0.100714812614206,0.99578075347555,1,5,positive regulation of miRNA metabolic process,BP,HRAS
1423,GO:0003100,0.1007736061851,0.995775718699318,1,5,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
16887,GO:0072162,0.100813567280459,0.995772294849788,1,5,metanephric mesenchymal cell differentiation,BP,WNT4
14860,GO:0060319,0.100831058847039,0.995770795724329,1,5,primitive erythrocyte differentiation,BP,ZFPM1
10600,GO:0040036,0.100906236324539,0.983783689583514,2,26,regulation of fibroblast growth factor receptor signaling pathway,BP,WNT4;WNT5A
1151,GO:0002580,0.100907301585691,0.995764258053913,1,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
16866,GO:0072126,0.100909774176585,0.995764045945694,1,5,positive regulation of glomerular mesangial cell proliferation,BP,PDGFB
18826,GO:1901552,0.100916476936556,0.995763470929657,1,5,positive regulation of endothelial cell development,BP,CLDN5
19467,GO:1903142,0.100916476936556,0.995763470929657,1,5,positive regulation of establishment of endothelial barrier,BP,CLDN5
15777,GO:0070172,0.100926530979884,0.995762608337511,1,5,positive regulation of tooth mineralization,BP,WNT6
2571,GO:0005324,0.100932378401909,0.995762106612586,1,5,long-chain fatty acid transporter activity,MF,FABP3
6239,GO:0017040,0.100998052932922,0.995756469427226,1,5,ceramidase activity,MF,ASAH2
5207,GO:0014050,0.101001138591157,0.995756204472991,1,5,negative regulation of glutamate secretion,BP,ADORA1
3857,GO:0007598,0.101095839452325,0.995748068655985,1,5,blood coagulation, extrinsic pathway,BP,TFPI
6628,GO:0019509,0.101141166937007,0.995744171662026,1,5,L-methionine salvage from methylthioadenosine,BP,MRI1
16904,GO:0072179,0.101171050923234,0.995741601391123,1,5,nephric duct formation,BP,BMP4
6971,GO:0021797,0.101180967323038,0.995740748319428,1,5,forebrain anterior/posterior pattern specification,BP,AXIN1
16051,GO:0070627,0.101183048892556,0.995740569238271,1,5,ferrous iron import,BP,TF
14040,GO:0051373,0.101204891829486,0.995738689814245,1,5,FATZ binding,MF,ACTN2
15993,GO:0070528,0.101242869795694,0.983698273885194,2,26,protein kinase C signaling,BP,PDGFB;WNT5A
7380,GO:0030309,0.101244410873689,0.99573528839142,1,5,poly-N-acetyllactosamine metabolic process,BP,B3GNT2
16194,GO:0070915,0.101296726017237,0.995730783423228,1,5,lysophosphatidic acid receptor activity,MF,LPAR2
3555,GO:0006955,0.101399805684927,0.92469124174239,46,1821,immune response,BP,CFB;LIF;NOTCH1;RAB27A;IFI30;CRISPLD2;FADD;ZFPM1;EDN1;PLAU;PNP;PRKACB;CCL20;PYCARD;TYRO3;PSMB10;PIK3R2;PIK3R1;TICAM1;HRAS;WNT5A;JAM3;RNASEL;CLCF1;NMI;BMP6;DLL1;HEXB;CHGA;CASP4;IFI27;PKP1;RAB17;IDH1;BCAR1;RAB44;STAR;CLDN1;PIK3CA;PIK3CG;GAS6;GLA;DERA;S100B;RAB3D;PDE4B
8274,GO:0032077,0.101424788643075,0.995719745200267,1,5,positive regulation of deoxyribonuclease activity,BP,AKT1
6996,GO:0021846,0.101505085834502,0.983598063815782,2,27,cell proliferation in forebrain,BP,WNT7A;FGF8
14215,GO:0051701,0.101506389076059,0.954928681442972,7,190,interaction with host,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
8695,GO:0032730,0.101524458562656,0.995711143959449,1,5,positive regulation of interleukin-1 alpha production,BP,CCL20
1543,GO:0003307,0.101552491562215,0.995708723164196,1,5,regulation of Wnt signaling pathway involved in heart development,BP,BMP2
4348,GO:0009052,0.101619992575893,0.995702891174649,1,5,pentose-phosphate shunt, non-oxidative branch,BP,SHPK
3781,GO:0007354,0.101646260790693,0.995700620521321,1,5,zygotic determination of anterior/posterior axis, embryo,BP,WT1
17163,GO:0072679,0.101660983502504,0.995699347600081,1,5,thymocyte migration,BP,CCL20
21615,GO:2001199,0.101692452276231,0.995696626159702,1,5,negative regulation of dendritic cell differentiation,BP,TMEM176A
4171,GO:0008474,0.101723928704227,0.995693903158209,1,5,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1
18086,GO:0098599,0.101723928704227,0.995693903158209,1,5,palmitoyl hydrolase activity,MF,LYPLAL1
18135,GO:0098734,0.101723928704227,0.995693903158209,1,5,macromolecule depalmitoylation,BP,LYPLAL1
4754,GO:0010193,0.101749097061172,0.995691725216044,1,5,response to ozone,BP,EDN1
17079,GO:0072526,0.101760297648282,0.995690755789071,1,5,pyridine-containing compound catabolic process,BP,PNP
15135,GO:0060706,0.10176444362304,0.983565590172591,2,26,cell differentiation involved in embryonic placenta development,BP,LIF;AKT1
17401,GO:0090131,0.101814672729121,0.99568604792899,1,5,mesenchyme migration,BP,ACTA2
2991,GO:0006102,0.101817836392494,0.995685773932576,1,5,isocitrate metabolic process,BP,IDH1
1672,GO:0003854,0.101822879979916,0.995685337102184,1,5,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,HSD3B2
19505,GO:1903232,0.101826291885115,0.995685041580404,1,5,melanosome assembly,BP,RAB38
1988,GO:0004448,0.101835557605196,0.995684238977797,1,5,isocitrate dehydrogenase activity,MF,IDH1
10761,GO:0042321,0.101938639582627,0.995675304693869,1,5,negative regulation of circadian sleep/wake cycle, sleep,BP,ADORA1
14731,GO:0060126,0.101967931927706,0.995672764118038,1,5,somatotropin secreting cell differentiation,BP,WNT4
8490,GO:0032430,0.101968198521072,0.995672740992356,1,5,positive regulation of phospholipase A2 activity,BP,ANG
13998,GO:0051291,0.102014514639436,0.962230832793037,5,118,protein heterooligomerization,BP,TRADD;HRAS;PCBD1;CLDN1;CLDN3
10070,GO:0035814,0.102059480586367,0.995664818921678,1,5,negative regulation of renal sodium excretion,BP,ADORA1
8325,GO:0032190,0.102064572756706,0.995664376766117,1,5,acrosin binding,MF,SERPINA5
8151,GO:0031849,0.102121634780343,0.99565942043319,1,5,olfactory receptor binding,MF,REEP1
12236,GO:0045600,0.102150637742647,0.974219642512758,3,54,positive regulation of fat cell differentiation,BP,WNT5B;BMP2;AKT1
461,GO:0001191,0.102292176678005,0.967322685148273,4,87,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1;TLE1;SIN3B
19432,GO:1903053,0.102662079459923,0.983302137895876,2,27,regulation of extracellular matrix organization,BP,NOTCH1;DDR1
11453,GO:0043523,0.10271616620318,0.954260010536705,7,191,regulation of neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;STAR;PIK3CA;GDNF
6581,GO:0019359,0.102764874791263,0.98330992736044,2,26,nicotinamide nucleotide biosynthetic process,BP,PNP;NNMT
6583,GO:0019363,0.102764874791263,0.98330992736044,2,26,pyridine nucleotide biosynthetic process,BP,PNP;NNMT
12679,GO:0046503,0.102889022161311,0.97395391349901,3,54,glycerolipid catabolic process,BP,APOC1;FABP3;PIK3CG
7100,GO:0022410,0.103044499797443,0.983238195707417,2,26,circadian sleep/wake cycle process,BP,ADORA1;STAR
3705,GO:0007202,0.103100788251912,0.983223741749339,2,26,activation of phospholipase C activity,BP,LPAR2;ANG
4533,GO:0009311,0.10323576867769,0.97382882521784,3,54,oligosaccharide metabolic process,BP,IDUA;HEXB;GLA
3456,GO:0006801,0.103271056529249,0.973816084391342,3,54,superoxide metabolic process,BP,EDN1;RGN;BMP7
5107,GO:0010922,0.103523141547746,0.983080576793687,2,27,positive regulation of phosphatase activity,BP,RGN;BMP2
5324,GO:0014910,0.103581319467937,0.973674570514268,3,56,regulation of smooth muscle cell migration,BP,PLAU;PDGFB;FOXO4
15809,GO:0070228,0.10364761715446,0.973680001621736,3,54,regulation of lymphocyte apoptotic process,BP,FADD;WNT5A;BMP4
7015,GO:0021879,0.103684048666752,0.973651827749839,3,55,forebrain neuron differentiation,BP,WNT5A;AXIN1;FGF8
10266,GO:0036152,0.103880620773606,0.983022997647979,2,26,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2;PLA2G16
19337,GO:1902893,0.103888895003798,0.982986122540326,2,27,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
2761,GO:0005743,0.104013205826157,0.939571000201032,14,454,mitochondrial inner membrane,CC,PDK4;MRPL14;MRPL16;HMGCS2;SLC25A53;ACADVL;CPT2;ACAT1;SFXN1;HSD3B2;LDHD;STAR;ECI1;ETFDH
18747,GO:1901264,0.104978678153758,0.973197165107213,3,54,carbohydrate derivative transport,BP,ADORA1;ABCG1;GJB1
6052,GO:0016667,0.105185735765816,0.973121802419486,3,54,oxidoreductase activity, acting on a sulfur group of donors,MF,IFI30;MSRA;SESN2
9144,GO:0033627,0.105201400163169,0.9731008143698,3,55,cell adhesion mediated by integrin,BP,ITGA5;PLAU;PIK3CG
13370,GO:0048706,0.105356645056876,0.960601489183044,5,121,embryonic skeletal system development,BP,WNT5A;AXIN1;RBP4;BMP7;BMP4
3923,GO:0008076,0.105558322965897,0.965911295588975,4,87,voltage-gated potassium channel complex,CC,KCNK6;KCNH2;KCNG2;KCND1
17780,GO:0097164,0.105580127871286,0.952679249927278,7,190,ammonium ion metabolic process,BP,APOC1;MBOAT2;PLA2G16;NPR1;SARDH;FABP3;CPT1C
19183,GO:1902495,0.105704605991568,0.944930866308984,10,310,transmembrane transporter complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;FXYD1;GRIA3;CPT1C;KCNG2;KCND1;PDE4B
3606,GO:0007033,0.105760901515562,0.956095008289718,6,157,vacuole organization,BP,TBC1D14;RAB39A;RALB;RAB20;HEXB;MYO7A
14028,GO:0051346,0.105837502738658,0.941231455486975,12,384,negative regulation of hydrolase activity,BP,SERPINA5;APOC1;RGN;HRAS;CAMSAP3;NOL3;AKT1;CST9L;TFPI;GAS6;AMOT;SH3BP4
8054,GO:0031647,0.106146295862638,0.949389647974917,8,230,regulation of protein stability,BP,IFI30;DPM3;TF;PYCARD;PIK3R1;BMP2;CDKN1A;PIM2
13908,GO:0051155,0.106312687556232,0.972694938196138,3,55,positive regulation of striated muscle cell differentiation,BP,EDN1;BMP4;EFNB2
17928,GO:0097458,0.106515675304004,0.924501153108248,33,1285,neuron part,CC,ITGA3;TMEM163;ADRA2C;SYT5;ACTN2;MARK4;RAB27A;CDH23;FADD;WNT7A;ADORA1;RAB40B;RAB40A;SPTBN5;SPTBN4;RAB39B;FSTL3;CYP17A1;ANG;DRP2;ESPN;VAMP1;CPT1C;RAB17;NRTN;MYO7A;STAR;LZTS1;S100B;KCND1;ACSL4;SLC1A3;PDE4B
508,GO:0001541,0.106662986852729,0.972566592743307,3,55,ovarian follicle development,BP,ANG;KITLG;INHBB
17262,GO:0086023,0.106671129660126,0.995063171730537,1,6,adrenergic receptor signaling pathway involved in heart process,BP,CHGA
11462,GO:0043536,0.106820484966916,0.982221716172805,2,27,positive regulation of blood vessel endothelial cell migration,BP,PDGFB;AKT1
17243,GO:0086003,0.10710827924992,0.972373552093536,3,57,cardiac muscle cell contraction,BP,DSC2;KCNH2;PDE4B
6925,GO:0021696,0.107311257913435,0.982058678177582,2,28,cerebellar cortex morphogenesis,BP,WNT7A;DLL1
17980,GO:0097546,0.107338322127153,0.982085339800448,2,27,ciliary base,CC,PRKACB;PRKAR1B
850,GO:0002053,0.107661451086073,0.982000036366868,2,27,positive regulation of mesenchymal cell proliferation,BP,WNT2;WNT5A
432,GO:0001106,0.107693018839615,0.981991694295878,2,27,RNA polymerase II transcription corepressor activity,MF,TLE1;SIN3B
8382,GO:0032281,0.108083071117945,0.981888495495832,2,27,AMPA glutamate receptor complex,CC,GRIA3;CPT1C
4922,GO:0010662,0.108161625219214,0.981867684182582,2,27,regulation of striated muscle cell apoptotic process,BP,BMP7;NOL3
11205,GO:0043124,0.108332474235038,0.97193695092158,3,56,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,PYCARD;BMP7;TLE1
10660,GO:0042116,0.108595631607784,0.971839665146861,3,56,macrophage activation,BP,TICAM1;WNT5A;SHPK
13683,GO:0050818,0.108666452352352,0.964552730497967,4,87,regulation of coagulation,BP,EDN1;PLAU;PDGFB;FAM46A
12331,GO:0045746,0.10876143986113,0.981708469359588,2,27,negative regulation of Notch signaling pathway,BP,BMP7;HEY1
2786,GO:0005773,0.109161821084817,0.92981667876067,20,715,vacuole,CC,RAB27A;IFI30;TBC1D14;PYCARD;RAB39A;TICAM1;RALB;SDC4;IDUA;HEXB;CHGA;RAB12;PON2;MYO7A;RAB44;PIK3CG;ACP5;GLA;RAB38;RAB3D
14030,GO:0051348,0.109287060293673,0.940731434311167,11,345,negative regulation of transferase activity,BP,GADD45A;PYCARD;PSMB10;RGN;PRKAR1B;BMP7;BMP4;CDKN1A;DEPTOR;AKT1;DUSP5
17267,GO:0086029,0.109502898694636,0.994791358802825,1,6,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,CASQ2
17297,GO:0086068,0.109502898694636,0.994791358802825,1,6,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,CASQ2
8761,GO:0032814,0.109738699199522,0.981447907598335,2,27,regulation of natural killer cell activation,BP,TICAM1;GAS6
10653,GO:0042104,0.10980021630518,0.981431457647756,2,27,positive regulation of activated T cell proliferation,BP,FADD;PYCARD
12774,GO:0046686,0.10985299633621,0.971388917898139,3,55,response to cadmium ion,BP,AKT1;STAR;CYB5A
155,GO:0000303,0.110008698778436,0.981375666297196,2,27,response to superoxide,BP,RGN;BMP7
10265,GO:0036151,0.110064414206086,0.981360745431146,2,27,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2;PLA2G16
11482,GO:0043559,0.11015306113929,0.994727875390993,1,6,insulin binding,MF,PIK3R1
8721,GO:0032770,0.110287972716718,0.981300828583439,2,27,positive regulation of monooxygenase activity,BP,AKT1;GDNF
7647,GO:0030888,0.110644752529974,0.971078420653578,3,56,regulation of B cell proliferation,BP,TICAM1;CLCF1;CDKN1A
17515,GO:0090288,0.110688687003078,0.957976471948643,5,124,negative regulation of cellular response to growth factor stimulus,BP,WNT4;NOTCH1;RASL11B;FSTL3;WNT5A
2539,GO:0005249,0.110860245936118,0.963575830363633,4,88,voltage-gated potassium channel activity,MF,KCNK6;KCNH2;KCNG2;KCND1
19008,GO:1902041,0.110899651082691,0.970983267607342,3,56,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;FADD;TRADD
5263,GO:0014808,0.110922275709553,0.981061901340776,2,29,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CASQ2;NOL3
5273,GO:0014823,0.11101423700819,0.970925228245407,3,57,response to activity,BP,EDN1;BMP6;STAR
3618,GO:0007050,0.111042098675276,0.946519550750417,8,233,cell cycle arrest,BP,GADD45A;MAPK12;FGF10;FOXO4;HRAS;CDKN1A;HMGN5;GAS6
758,GO:0001933,0.111135635287269,0.937762408234872,12,389,negative regulation of protein phosphorylation,BP,LIF;GADD45A;PYCARD;RGN;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;DEPTOR;AKT1;DUSP5
20662,GO:1905952,0.111265695158678,0.957697473322699,5,123,regulation of lipid localization,BP,APOC1;EDN1;ABCG1;BMP6;AKT1
2644,GO:0005520,0.11163461306423,0.980902476774018,2,28,insulin-like growth factor binding,MF,ITGB4;CTGF
4437,GO:0009164,0.111742340084112,0.980909211579813,2,27,nucleoside catabolic process,BP,PNP;DERA
3687,GO:0007182,0.111976080420784,0.994547722902517,1,6,common-partner SMAD protein phosphorylation,BP,BMP4
16715,GO:0071855,0.111999915776023,0.980839524800148,2,27,neuropeptide receptor binding,MF,MRAP;EDN1
7574,GO:0030799,0.112144783510497,0.952713187041739,6,158,regulation of cyclic nucleotide metabolic process,BP,MRAP;EDN1;WNT5A;NPR1;CHGA;NPPC
15619,GO:0061724,0.112217835472256,0.994523594284143,1,6,lipophagy,BP,SESN2
5077,GO:0010887,0.112477635988011,0.994497602386971,1,6,negative regulation of cholesterol storage,BP,ABCG1
21522,GO:2000973,0.112676795861425,0.994477633650609,1,6,regulation of pro-B cell differentiation,BP,NOTCH1
5447,GO:0015248,0.112807556063893,0.980583963013156,2,28,sterol transporter activity,MF,ABCG1;STAR
20750,GO:1990316,0.112894166172295,0.99445579577947,1,6,ATG1/ULK1 kinase complex,CC,SESN2
5741,GO:0016049,0.113017588244114,0.933457553127392,14,473,cell growth,BP,WNT3;EDN1;WNT5A;SESN2;NPR1;PSRC1;HBEGF;WT1;CDKN1A;DDR1;CTGF;AKT1;BCAR1;SH3BP4
9281,GO:0034122,0.113143286637699,0.980492417100114,2,28,negative regulation of toll-like receptor signaling pathway,BP,TYRO3;TICAM1
16380,GO:0071295,0.1132720736727,0.980457255285364,2,28,cellular response to vitamin,BP,GAS6;VDR
18957,GO:1901894,0.113485808159717,0.994396128276228,1,6,regulation of calcium-transporting ATPase activity,BP,RGN
16412,GO:0071347,0.11366532890684,0.962327287969018,4,88,cellular response to interleukin-1,BP,EDN1;CCL20;PYCARD;TFPI
5889,GO:0016339,0.113673753784708,0.980347428689282,2,28,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH23;CDH2
19362,GO:1902946,0.114192881832845,0.994324380089306,1,6,protein localization to early endosome,BP,MSN
18634,GO:1900744,0.114233753166432,0.980193913929746,2,28,regulation of p38MAPK cascade,BP,GADD45A;BMP2
1465,GO:0003175,0.114432650392434,0.994299941607875,1,6,tricuspid valve development,BP,ZFPM1
3501,GO:0006875,0.114528744012824,0.93242678931336,14,472,cellular metal ion homeostasis,BP,CDH23;TF;SLC31A2;CASQ2;EDN1;PRND;LPAR2;RGN;BMP6;HEXB;NOL3;PIK3CG;VDR;CLDN16
11097,GO:0042940,0.114574610415088,0.994285446335386,1,6,D-amino acid transport,BP,SLC1A3
17301,GO:0086073,0.114578557384104,0.994285043041882,1,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,DSC2
17309,GO:0086083,0.114578557384104,0.994285043041882,1,6,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,DSC2
16389,GO:0071313,0.114720263654995,0.994112526112675,1,7,cellular response to caffeine,BP,CASQ2
14848,GO:0060306,0.114980833385066,0.97995356362882,2,29,regulation of membrane repolarization,BP,CASQ2;KCNH2
15810,GO:0070229,0.115037529812577,0.979972756772998,2,28,negative regulation of lymphocyte apoptotic process,BP,FADD;BMP4
2498,GO:0005168,0.11525996146048,0.994215194722108,1,6,neurotrophin TRKA receptor binding,MF,PIK3R1
2932,GO:0006011,0.115422989038817,0.994198417345376,1,6,UDP-glucose metabolic process,BP,GALT
2600,GO:0005375,0.115575731743162,0.994182675265848,1,6,copper ion transmembrane transporter activity,MF,SLC31A2
9829,GO:0035434,0.115575731743162,0.994182675265848,1,6,copper ion transmembrane transport,BP,SLC31A2
14702,GO:0060075,0.115683577774363,0.994171546878645,1,6,regulation of resting membrane potential,BP,KCNK6
11752,GO:0044340,0.115706010164283,0.994169230729165,1,6,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
9574,GO:0034705,0.115909381108077,0.961301503410872,4,90,potassium channel complex,CC,KCNK6;KCNH2;KCNG2;KCND1
3473,GO:0006826,0.115930126082979,0.969068686680244,3,57,iron ion transport,BP,TF;TTYH1;SFXN1
11385,GO:0043403,0.116045199432797,0.979694144434119,2,28,skeletal muscle tissue regeneration,BP,WNT7A;FZD7
7075,GO:0021999,0.116049993934199,0.994133653842786,1,6,neural plate anterior/posterior regionalization,BP,AXIN1
10929,GO:0042587,0.116103305969822,0.994128129823319,1,6,glycogen granule,CC,FASN
16077,GO:0070672,0.116115342921736,0.994126882215976,1,6,response to interleukin-15,BP,ACSL4
78,GO:0000155,0.116171566885536,0.994121052865839,1,6,phosphorelay sensor kinase activity,MF,KCNH2
1591,GO:0003402,0.11622348940718,0.994115666797218,1,6,planar cell polarity pathway involved in axis elongation,BP,WNT5A
16487,GO:0071453,0.116243813443116,0.946657561843221,7,197,cellular response to oxygen levels,BP,NOTCH1;PMAIP1;EDN1;PSMB10;BMP7;AKT1;S100B
11869,GO:0044708,0.116269566161001,0.934366353974011,12,396,single-organism behavior,BP,ITGA3;ITGA5;STRA6;FADD;ADORA1;SPTBN4;PRKAR1B;STAR;CLDN5;S100B;GDNF;SLC1A3
15289,GO:0060992,0.116426916144809,0.994094539830419,1,6,response to fungicide,BP,STAR
12667,GO:0046487,0.116443843895726,0.979583507152881,2,28,glyoxylate metabolic process,BP,GLDC;IDH1
16444,GO:0071389,0.116445120309871,0.994092647291975,1,6,cellular response to mineralocorticoid stimulus,BP,EDN1
16102,GO:0070728,0.116447177760112,0.994092433375647,1,6,leucine binding,MF,SESN2
3230,GO:0006498,0.116510921954771,0.994085803777275,1,6,N-terminal protein lipidation,BP,NMT2
4798,GO:0010453,0.116514719152329,0.979563812248607,2,28,regulation of cell fate commitment,BP,FZD7;BMP4
12694,GO:0046533,0.116555318439636,0.994081184096126,1,6,negative regulation of photoreceptor cell differentiation,BP,NOTCH1
13603,GO:0050706,0.116562028956518,0.979550661604504,2,28,regulation of interleukin-1 beta secretion,BP,PYCARD;WNT5A
780,GO:0001957,0.116674305361068,0.994068793560663,1,6,intramembranous ossification,BP,FGF18
10218,GO:0036072,0.116674305361068,0.994068793560663,1,6,direct ossification,BP,FGF18
1403,GO:0003062,0.116752725488592,0.994060619954249,1,6,regulation of heart rate by chemical signal,BP,KCNH2
11012,GO:0042745,0.116785109273638,0.979488607642833,2,28,circadian sleep/wake cycle,BP,ADORA1;STAR
15045,GO:0060560,0.116898139382503,0.946268076384826,7,202,developmental growth involved in morphogenesis,BP,WNT3;NOTCH1;WNT7B;FGF10;WNT5A;BMP4;DDR1
12849,GO:0046880,0.116943411240942,0.994040720422842,1,6,regulation of follicle-stimulating hormone secretion,BP,INHBB
12850,GO:0046881,0.116943411240942,0.994040720422842,1,6,positive regulation of follicle-stimulating hormone secretion,BP,INHBB
743,GO:0001913,0.116977782290743,0.979434952804128,2,28,T cell mediated cytotoxicity,BP,RAB27A;FADD
15950,GO:0070444,0.117010916546359,0.99403366734704,1,6,oligodendrocyte progenitor proliferation,BP,CDH2
15951,GO:0070445,0.117010916546359,0.99403366734704,1,6,regulation of oligodendrocyte progenitor proliferation,BP,CDH2
672,GO:0001816,0.117022989639921,0.925946318223864,18,635,cytokine production,BP,NOTCH1;FADD;ZFPM1;PNP;CCL20;PYCARD;PIK3R1;TICAM1;HRAS;WNT5A;NMI;DLL1;CHGA;INHBB;PIK3CG;GAS6;DTX4;PDE4B
1451,GO:0003160,0.117023427028311,0.994032359748263,1,6,endocardium morphogenesis,BP,NOTCH1
6805,GO:0020037,0.117068757895231,0.95480645740089,5,123,heme binding,MF,GUCY1B3;FLVCR2;CYP17A1;CYP11A1;CYB5A
9976,GO:0035666,0.117138259019201,0.979390221971895,2,28,TRIF-dependent toll-like receptor signaling pathway,BP,FADD;TICAM1
21021,GO:2000138,0.117202348148767,0.994013642403626,1,6,positive regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
697,GO:0001842,0.117272036083448,0.994006343862066,1,6,neural fold formation,BP,BMP7
3742,GO:0007265,0.117288822159217,0.937644979153704,10,318,Ras protein signal transduction,BP,ITGA3;RRAS2;FGF10;RALB;HRAS;RHOJ;RHOB;CDKN1A;KITLG;DOK1
20347,GO:1905005,0.117341906540089,0.993999021516495,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,ACVR1
17005,GO:0072338,0.11743530764309,0.99398922585291,1,6,cellular lactam metabolic process,BP,GHR
6972,GO:0021798,0.117496850391173,0.993982766824774,1,6,forebrain dorsal/ventral pattern formation,BP,FGF8
17454,GO:0090200,0.117544877065834,0.979276712037649,2,28,positive regulation of release of cytochrome c from mitochondria,BP,PMAIP1;PYCARD
12530,GO:0046113,0.117555288206448,0.993976630293231,1,6,nucleobase catabolic process,BP,AOX1
2303,GO:0004869,0.117558699435066,0.968445440804637,3,57,cysteine-type endopeptidase inhibitor activity,MF,NOL3;CST9L;GAS6
14769,GO:0060179,0.117589266039429,0.993973060784355,1,6,male mating behavior,BP,HEXB
17712,GO:0097048,0.117741078496612,0.993957098704136,1,6,dendritic cell apoptotic process,BP,GAS6
21380,GO:2000668,0.117741078496612,0.993957098704136,1,6,regulation of dendritic cell apoptotic process,BP,GAS6
8755,GO:0032808,0.117743141215683,0.993956881670121,1,6,lacrimal gland development,BP,FGF10
15767,GO:0070162,0.117863752289549,0.993944184163531,1,6,adiponectin secretion,BP,RAB11FIP1
15768,GO:0070163,0.117863752289549,0.993944184163531,1,6,regulation of adiponectin secretion,BP,RAB11FIP1
19637,GO:1903514,0.117891762841761,0.979109851521875,2,30,calcium ion transport from endoplasmic reticulum to cytosol,BP,CASQ2;NOL3
7761,GO:0031091,0.117919459916291,0.960392357375861,4,90,platelet alpha granule,CC,ACTN2;SERPINA5;PDGFB;GAS6
17156,GO:0072672,0.11793727481669,0.993936437104716,1,6,neutrophil extravasation,BP,PIK3CG
20753,GO:1990351,0.118041216213924,0.937168702118764,10,317,transporter complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;FXYD1;GRIA3;CPT1C;KCNG2;KCND1;PDE4B
11472,GO:0043546,0.11806277419729,0.993923201232269,1,6,molybdopterin cofactor binding,MF,AOX1
15824,GO:0070244,0.118142867047466,0.993914746263575,1,6,negative regulation of thymocyte apoptotic process,BP,BMP4
20167,GO:1904645,0.118150390194413,0.993913951768405,1,6,response to beta-amyloid,BP,CASP4
8428,GO:0032364,0.118321231867841,0.993895895064156,1,6,oxygen homeostasis,BP,WNT7B
14661,GO:0060029,0.118323985015309,0.993895603846698,1,6,convergent extension involved in organogenesis,BP,WNT5A
15816,GO:0070235,0.118341485816012,0.993893752507962,1,6,regulation of activation-induced cell death of T cells,BP,FADD
17458,GO:0090205,0.11837110779533,0.993890618246823,1,6,positive regulation of cholesterol metabolic process,BP,ABCG1
16980,GO:0072298,0.118562980382665,0.993870296006522,1,6,regulation of metanephric glomerulus development,BP,WT1
9995,GO:0035701,0.118611160528231,0.993865187422687,1,6,hematopoietic stem cell migration,BP,GAS6
5299,GO:0014866,0.118708435650346,0.993685596846767,1,7,skeletal myofibril assembly,BP,MYH11
15760,GO:0070141,0.118739247150509,0.993851595409199,1,6,response to UV-A,BP,AKT1
9129,GO:0033603,0.118763671817723,0.993849001771913,1,6,positive regulation of dopamine secretion,BP,GDNF
12031,GO:0045110,0.118764161747326,0.993848949740772,1,6,intermediate filament bundle assembly,BP,PKP1
18859,GO:1901621,0.118796302823139,0.993845535812765,1,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
15111,GO:0060676,0.118801142271164,0.993845021694994,1,6,ureteric bud formation,BP,GDNF
1602,GO:0003418,0.118836751594284,0.993841238051915,1,6,growth plate cartilage chondrocyte differentiation,BP,NPPC
20176,GO:1904672,0.118880332558062,0.993836605725136,1,6,regulation of somatic stem cell population maintenance,BP,BMP7
17116,GO:0072583,0.118934796863745,0.967884063816535,3,59,clathrin-dependent endocytosis,BP,SYT5;DLL1;UNC119
6740,GO:0019866,0.118980789542742,0.928004189415678,15,506,organelle inner membrane,CC,PDK4;MRPL14;MRPL16;HMGCS2;SLC25A53;ACADVL;CPT2;ACAT1;SFXN1;HSD3B2;IFI27;LDHD;STAR;ECI1;ETFDH
4632,GO:0009744,0.119011493853861,0.993822653228239,1,6,response to sucrose,BP,KHK
9363,GO:0034285,0.119011493853861,0.993822653228239,1,6,response to disaccharide,BP,KHK
7843,GO:0031265,0.119066328306313,0.993816815209171,1,6,CD95 death-inducing signaling complex,CC,FADD
19664,GO:1903551,0.119084715561968,0.993814856937993,1,6,regulation of extracellular exosome assembly,BP,SDC4
10824,GO:0042426,0.119099066808467,0.9938133282816,1,6,choline catabolic process,BP,SARDH
12095,GO:0045217,0.119137957030705,0.99380918480121,1,6,cell-cell junction maintenance,BP,CAMSAP3
3261,GO:0006537,0.1192983060079,0.993792085343441,1,6,glutamate biosynthetic process,BP,SLC1A3
16477,GO:0071438,0.119338837583025,0.993787759171092,1,6,invadopodium membrane,CC,ITGA3
10114,GO:0035900,0.11934631254528,0.9937869611516,1,6,response to isolation stress,BP,HRAS
9861,GO:0035502,0.119416845094894,0.993779428514479,1,6,metanephric part of ureteric bud development,BP,WT1
15179,GO:0060762,0.119429132543829,0.993778115765947,1,6,regulation of branching involved in mammary gland duct morphogenesis,BP,WNT5A
15005,GO:0060501,0.11944766844977,0.993776135178406,1,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
972,GO:0002274,0.11948411639385,0.925232605840446,17,596,myeloid leukocyte activation,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;TICAM1;WNT5A;SHPK;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;GLA;DERA;RAB3D
19135,GO:1902338,0.119511910429088,0.993769268268654,1,6,negative regulation of apoptotic process involved in morphogenesis,BP,BMP7
20219,GO:1904746,0.119511910429088,0.993769268268654,1,6,negative regulation of apoptotic process involved in development,BP,BMP7
12152,GO:0045349,0.119516265640024,0.993768802590361,1,6,interferon-alpha biosynthetic process,BP,NMI
12157,GO:0045354,0.119516265640024,0.993768802590361,1,6,regulation of interferon-alpha biosynthetic process,BP,NMI
16899,GO:0072174,0.119538132786454,0.993766464182457,1,6,metanephric tubule formation,BP,WNT4
19167,GO:1902455,0.11960830142782,0.993758957441318,1,6,negative regulation of stem cell population maintenance,BP,BMP7
4828,GO:0010511,0.119612071019908,0.993758554030575,1,6,regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
8926,GO:0033084,0.119614644212121,0.993758278647183,1,6,regulation of immature T cell proliferation in thymus,BP,BMP4
14960,GO:0060440,0.119694845764019,0.993749692264007,1,6,trachea formation,BP,BMP4
2631,GO:0005499,0.119712897067977,0.993747758834831,1,6,vitamin D binding,MF,VDR
16818,GO:0072049,0.119720742906123,0.993746918389091,1,6,comma-shaped body morphogenesis,BP,BMP4
16811,GO:0072038,0.119791019375254,0.993739387729416,1,6,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,BMP7
15427,GO:0061218,0.11984772172685,0.993733308166729,1,6,negative regulation of mesonephros development,BP,BMP4
10476,GO:0038095,0.119868638044669,0.953387883666766,5,124,Fc-epsilon receptor signaling pathway,BP,PSMB10;PIK3R2;PIK3R1;HRAS;PIK3CA
10541,GO:0038203,0.119869512144134,0.99373097099743,1,6,TORC2 signaling,BP,PRR5L
10133,GO:0035931,0.119962407698928,0.993721002182254,1,6,mineralocorticoid secretion,BP,BMP6
10134,GO:0035932,0.119962407698928,0.993721002182254,1,6,aldosterone secretion,BP,BMP6
21506,GO:2000855,0.119962407698928,0.993721002182254,1,6,regulation of mineralocorticoid secretion,BP,BMP6
21508,GO:2000858,0.119962407698928,0.993721002182254,1,6,regulation of aldosterone secretion,BP,BMP6
15847,GO:0070278,0.119973285985945,0.993719834265977,1,6,extracellular matrix constituent secretion,BP,CTGF
11834,GO:0044539,0.120012851678925,0.993715585445096,1,6,long-chain fatty acid import,BP,FABP3
8683,GO:0032713,0.120018483404748,0.993714980551005,1,6,negative regulation of interleukin-4 production,BP,ZFPM1
6479,GO:0019064,0.120051118391924,0.993711474679924,1,6,fusion of virus membrane with host plasma membrane,BP,GAS6
10570,GO:0039663,0.120051118391924,0.993711474679924,1,6,membrane fusion involved in viral entry into host cell,BP,GAS6
11920,GO:0044800,0.120051118391924,0.993711474679924,1,6,multi-organism membrane fusion,BP,GAS6
17245,GO:0086005,0.12005647467066,0.978498428911329,2,30,ventricular cardiac muscle cell action potential,BP,DSC2;KCNH2
14634,GO:0055131,0.120188436236944,0.993696711805743,1,6,C3HC4-type RING finger domain binding,MF,KCNH2
8352,GO:0032229,0.120215670345489,0.993693781737056,1,6,negative regulation of synaptic transmission, GABAergic,BP,ADORA1
12662,GO:0046477,0.120233940823196,0.993691815647982,1,6,glycosylceramide catabolic process,BP,GLA
14712,GO:0060087,0.120310457782231,0.993683578144685,1,6,relaxation of vascular smooth muscle,BP,ADORA1
17969,GO:0097527,0.120337922103952,0.993680620069439,1,6,necroptotic signaling pathway,BP,FADD
8110,GO:0031730,0.120385528798362,0.993675490812292,1,6,CCR5 chemokine receptor binding,MF,CNIH4
18540,GO:1900193,0.120392421221424,0.993674748025089,1,6,regulation of oocyte maturation,BP,NPPC
1908,GO:0004321,0.120427735697281,0.993670941511712,1,6,fatty-acyl-CoA synthase activity,MF,ACSM5
4396,GO:0009120,0.120464812275209,0.993666943767191,1,6,deoxyribonucleoside metabolic process,BP,DERA
3387,GO:0006689,0.120470409431148,0.99366634014419,1,6,ganglioside catabolic process,BP,HEXB
4709,GO:0009996,0.120496126248359,0.993663566335687,1,6,negative regulation of cell fate specification,BP,FZD7
3018,GO:0006152,0.120556203371891,0.993657083945669,1,6,purine nucleoside catabolic process,BP,PNP
12539,GO:0046130,0.120556203371891,0.993657083945669,1,6,purine ribonucleoside catabolic process,BP,PNP
5672,GO:0015893,0.120647955625197,0.978365028878309,2,29,drug transport,BP,EBP;CLDN1
1749,GO:0003988,0.120720258200247,0.993639364486351,1,6,acetyl-CoA C-acyltransferase activity,MF,ACAT1
864,GO:0002069,0.120774083458579,0.993633545189884,1,6,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
8647,GO:0032650,0.120788313747393,0.993632006220069,1,6,regulation of interleukin-1 alpha production,BP,CCL20
3772,GO:0007341,0.120810243688736,0.993629634169218,1,6,penetration of zona pellucida,BP,HEXB
14993,GO:0060482,0.120955368534453,0.993613925036973,1,6,lobar bronchus development,BP,WNT7B
5879,GO:0016323,0.120961193258451,0.943940814470051,7,201,basolateral plasma membrane,CC,ITGA3;TF;ADORA1;CDH2;PDGFB;MSN;RAB17
15100,GO:0060664,0.121001933027614,0.993608880321147,1,6,epithelial cell proliferation involved in salivary gland morphogenesis,BP,FGF10
13380,GO:0048730,0.121287812681325,0.97818269758935,2,29,epidermis morphogenesis,BP,NOTCH1;FGF10
13088,GO:0048039,0.121301372236984,0.993576389534483,1,6,ubiquinone binding,MF,ETFDH
1154,GO:0002583,0.121356994274094,0.993570344695123,1,6,regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
1804,GO:0004064,0.121433758065451,0.993561997319508,1,6,arylesterase activity,MF,PON2
1389,GO:0003016,0.121470624027014,0.978130493960077,2,29,respiratory system process,BP,ADORA1;JAG2
13536,GO:0050543,0.121671244524364,0.993536136708827,1,6,icosatetraenoic acid binding,MF,FABP3
9454,GO:0034447,0.121742649090858,0.993528350586324,1,6,very-low-density lipoprotein particle clearance,BP,APOC1
10748,GO:0042297,0.121785326587953,0.993345485143215,1,7,vocal learning,BP,STRA6
18083,GO:0098596,0.121785326587953,0.993345485143215,1,7,imitative learning,BP,STRA6
11714,GO:0044291,0.121880162850811,0.966723989214236,3,60,cell-cell contact zone,CC,DSC2;CDH2;JAM3
348,GO:0000959,0.121889317517622,0.9780107470918,2,29,mitochondrial RNA metabolic process,BP,HSD17B10;PUS1
12931,GO:0047035,0.121945400868823,0.993506215168148,1,6,testosterone dehydrogenase (NAD+) activity,MF,HSD17B3
14793,GO:0060228,0.122072385790313,0.9934923313378,1,6,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOC1
8208,GO:0031967,0.122232766512522,0.91462315479036,28,1063,organelle envelope,CC,EBP;PDK4;PMAIP1;MRPL14;MRPL16;HMGCS2;RAB40B;SLC25A53;ACADVL;MGST2;TYRO3;REEP1;CPT2;ACAT1;VAMP1;SFXN1;HSD3B2;CPT1C;IFI27;PTGES;LDHD;STAR;ECI1;CYP11A1;DHCR7;CYB5A;ACSL4;ETFDH
8212,GO:0031975,0.122232766512522,0.91462315479036,28,1063,envelope,CC,EBP;PDK4;PMAIP1;MRPL14;MRPL16;HMGCS2;RAB40B;SLC25A53;ACADVL;MGST2;TYRO3;REEP1;CPT2;ACAT1;VAMP1;SFXN1;HSD3B2;CPT1C;IFI27;PTGES;LDHD;STAR;ECI1;CYP11A1;DHCR7;CYB5A;ACSL4;ETFDH
5242,GO:0014731,0.122315986335723,0.993285878958475,1,7,spectrin-associated cytoskeleton,CC,SPTB
18209,GO:0098869,0.122338976640656,0.958372371717194,4,90,cellular oxidant detoxification,BP,MGST2;RGN;SESN2;BMP7
17078,GO:0072525,0.1225887031346,0.977810148893015,2,29,pyridine-containing compound biosynthetic process,BP,PNP;NNMT
10890,GO:0042531,0.122677767488539,0.966443418880571,3,58,positive regulation of tyrosine phosphorylation of STAT protein,BP,LIF;GHR;CLCF1
3297,GO:0006575,0.12328246546686,0.946669137167684,6,161,cellular modified amino acid metabolic process,BP,FASN;MGST2;GHR;PLA2G16;SARDH;IDH1
4631,GO:0009743,0.123329003462536,0.942576124604383,7,200,response to carbohydrate,BP,KHK;SESN2;CTGF;GJB6;STAR;PIK3CA;GAS6
7105,GO:0022600,0.123420895152187,0.957863910740941,4,91,digestive system process,BP,FGF10;RBP4;WNK4;VDR
3462,GO:0006811,0.123660980096333,0.909067341158288,38,1514,ion transport,BP,ACTN2;CDH23;TF;SLC31A2;APOC1;SLC52A3;ADORA1;CASQ2;EDN1;ABCG1;KCNK6;SPTBN4;TTYH1;TSPAN13;RGN;PDGFB;KCNH2;CPT2;FXYD1;SFXN1;WNK4;FABP3;GRIA3;NOL3;CTGF;AKT1;PIK3CG;KCNG2;GAS6;CYB5A;VDR;KCND1;GDNF;ACSL4;SLC1A3;CLDN16;CLDN15;PDE4B
16655,GO:0071705,0.123970384174064,0.904486782685412,54,2230,nitrogen compound transport,BP,ADRA2B;ADRA2C;USE1;NOTCH1;RAB27A;TF;SLC52A3;RABIF;TBC1D14;ADORA1;EDN1;RAB40B;RAB40A;PNP;ABCG1;FLVCR2;PYCARD;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RBP4;RHOB;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;CHGA;NOL3;GJB1;AKT1;IFI27;RAB12;RAB17;CDH1;MYO7A;INHBB;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;UNC119;RAB38;RAB3D;GDNF;SLC1A3;CNIH4
17132,GO:0072604,0.12412216473088,0.977367815616061,2,29,interleukin-6 secretion,BP,PYCARD;GAS6
9566,GO:0034694,0.124130999010414,0.977328882332306,2,30,response to prostaglandin,BP,EDN1;AKT1
8450,GO:0032386,0.124293761250395,0.925691731401372,14,480,regulation of intracellular transport,BP,FZD7;PRR5L;PIK3R2;PIK3R1;REEP1;BMP7;BMP6;BMP4;CDKN1A;MSN;NOL3;IFI27;CDH1;GAS6
15568,GO:0061614,0.124366276835831,0.977260605764776,2,30,pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
19054,GO:1902175,0.12445564239818,0.977271167878016,2,29,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,NOL3;AKT1
13866,GO:0051098,0.124611802708562,0.932963650236789,10,318,regulation of binding,BP,LIF;ZFPM1;TICAM1;PDGFB;RALB;WNT5A;BMP4;BMP2;PCBD1;HEY1
766,GO:0001941,0.124686352021308,0.977167591564202,2,30,postsynaptic membrane organization,BP,CDH2;GDNF
6223,GO:0017002,0.1250859009172,0.992970207418306,1,7,activin-activated receptor activity,MF,ACVR1
8384,GO:0032287,0.125403486759241,0.992933526059898,1,7,peripheral nervous system myelin maintenance,BP,AKT1
11154,GO:0043030,0.125416961226551,0.976954715533717,2,30,regulation of macrophage activation,BP,WNT5A;SHPK
16508,GO:0071478,0.125607047284792,0.945375151491526,6,164,cellular response to radiation,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;CDKN1A
2943,GO:0006027,0.125655155965343,0.965237277395242,3,60,glycosaminoglycan catabolic process,BP,SDC4;IDUA;HEXB
6448,GO:0018958,0.125941333255329,0.956675887856216,4,93,phenol-containing compound metabolic process,BP,PNMT;WNT5A;NPR1;STAR
3466,GO:0006816,0.125968126757328,0.929852178796671,11,362,calcium ion transport,BP,CDH23;CASQ2;TSPAN13;RGN;PDGFB;NOL3;CTGF;PIK3CG;GAS6;VDR;PDE4B
2489,GO:0005158,0.126212696198789,0.976687147632307,2,31,insulin receptor binding,MF,PIK3R1;DOK1
12018,GO:0045087,0.126417251456266,0.915426065170773,22,808,innate immune response,BP,CFB;RAB27A;IFI30;FADD;EDN1;PRKACB;CCL20;PYCARD;TYRO3;PSMB10;TICAM1;HRAS;WNT5A;RNASEL;NMI;CHGA;CASP4;IFI27;STAR;CLDN1;PIK3CG;S100B
9824,GO:0035418,0.126439093393578,0.976620669338121,2,31,protein localization to synapse,BP,WNT7A;WNT5A
6298,GO:0017147,0.126637924435306,0.976597229631794,2,30,Wnt-protein binding,MF,FZD7;FZD8
9693,GO:0035115,0.126778480505032,0.976555936923204,2,30,embryonic forelimb morphogenesis,BP,WNT3;WNT7A
586,GO:0001676,0.126994160980887,0.956194136072666,4,92,long-chain fatty acid metabolic process,BP,FADS1;PTGES;ACSL4;ELOVL6
12081,GO:0045197,0.12725073999766,0.976416985623075,2,30,establishment or maintenance of epithelial cell apical/basal polarity,BP,WNT5A;MSN
2788,GO:0005775,0.12778955542236,0.944166367888247,6,164,vacuolar lumen,CC,IFI30;PYCARD;SDC4;IDUA;HEXB;GLA
11677,GO:0044236,0.127868653294909,0.949258774383076,5,129,multicellular organism metabolic process,BP,WNT4;GHR;BMP4;CTGF;PEPD
19348,GO:1902911,0.128285567670463,0.955570517777795,4,94,protein kinase complex,CC,ACVR1;PYCARD;SESN2;CDKN1A
4918,GO:0010658,0.128420196878767,0.976071505894517,2,30,striated muscle cell apoptotic process,BP,BMP7;NOL3
20526,GO:1905477,0.129131046006878,0.955182694189086,4,93,positive regulation of protein localization to membrane,BP,ITGA3;PMAIP1;PIK3R1;AKT1
7141,GO:0022843,0.129251285171335,0.94853506776282,5,130,voltage-gated cation channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
16958,GO:0072257,0.129395131166808,0.992463903510136,1,7,metanephric nephron tubule epithelial cell differentiation,BP,LIF
16988,GO:0072307,0.129395131166808,0.992463903510136,1,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,LIF
14840,GO:0060297,0.129466933533394,0.9924553099582,1,7,regulation of sarcomere organization,BP,EDN1
8999,GO:0033209,0.129495213186307,0.943226738182962,6,162,tumor necrosis factor-mediated signaling pathway,BP,TRADD;PYCARD;PSMB10;NOL3;GAS6;CLDN18
3721,GO:0007221,0.129498284468414,0.992451556151348,1,7,positive regulation of transcription of Notch receptor target,BP,NOTCH1
16346,GO:0071233,0.129537835099084,0.992446819148341,1,7,cellular response to leucine,BP,SESN2
12060,GO:0045162,0.129621748635665,0.99243676358233,1,7,clustering of voltage-gated sodium channels,BP,SPTBN4
20863,GO:1990748,0.129684182552295,0.954931996946299,4,92,cellular detoxification,BP,MGST2;RGN;SESN2;BMP7
8696,GO:0032731,0.129761078905673,0.975672943408459,2,30,positive regulation of interleukin-1 beta production,BP,PYCARD;WNT5A
2642,GO:0005518,0.129815132535402,0.963558120530159,3,61,collagen binding,MF,ITGA3;PDGFB;DDR1
10325,GO:0036336,0.130013859465142,0.975597515541246,2,30,dendritic cell migration,BP,PIK3CG;GAS6
11296,GO:0043254,0.130064358161972,0.927141273426088,11,360,regulation of protein complex assembly,BP,FHOD3;PMAIP1;SPTBN5;SPTBN4;PYCARD;RALB;PSRC1;SPTB;MSN;HNF1A;TMOD4
15337,GO:0061051,0.130283802910463,0.992357180454758,1,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
13158,GO:0048251,0.130435654345845,0.992338864978157,1,7,elastic fiber assembly,BP,MYH11
7383,GO:0030314,0.130470495686534,0.992334659346526,1,7,junctional membrane complex,CC,CASQ2
2931,GO:0006007,0.130656228889889,0.975405421488056,2,30,glucose catabolic process,BP,ACTN3;PFKFB3
18612,GO:1900452,0.130660255360288,0.992311732437613,1,7,regulation of long term synaptic depression,BP,ADORA1
16154,GO:0070852,0.130805913171634,0.992294109435584,1,7,cell body fiber,CC,SPTBN4
156,GO:0000305,0.130950230160315,0.975317304495583,2,30,response to oxygen radical,BP,RGN;BMP7
8662,GO:0032677,0.130989656427897,0.963100225821395,3,60,regulation of interleukin-8 production,BP,FADD;PYCARD;WNT5A
13771,GO:0050942,0.131037274734733,0.992266073439093,1,7,positive regulation of pigment cell differentiation,BP,KITLG
2171,GO:0004691,0.131087389138386,0.992259993580955,1,7,cAMP-dependent protein kinase activity,MF,PRKACB
15858,GO:0070296,0.131173871216743,0.975178769434427,2,32,sarcoplasmic reticulum calcium ion transport,BP,CASQ2;NOL3
12264,GO:0045634,0.131494092823701,0.992210559172943,1,7,regulation of melanocyte differentiation,BP,KITLG
2989,GO:0006099,0.131671783440647,0.975100514229777,2,30,tricarboxylic acid cycle,BP,MDH1;IDH1
21471,GO:2000807,0.13193989471866,0.99215618151018,1,7,regulation of synaptic vesicle clustering,BP,CDH2
4989,GO:0010765,0.131979848568184,0.974970502234234,2,31,positive regulation of sodium ion transport,BP,FXYD1;AKT1
16462,GO:0071415,0.132222925235443,0.991964164624857,1,8,cellular response to purine-containing compound,BP,CASQ2
7018,GO:0021884,0.132317925197414,0.974868376868172,2,31,forebrain neuron development,BP,WNT5A;FGF8
10847,GO:0042472,0.132603995934003,0.953521008234265,4,95,inner ear morphogenesis,BP,FGF10;WNT5A;FGF8;MYO7A
2494,GO:0005164,0.132628621878416,0.974811874712922,2,30,tumor necrosis factor receptor binding,MF,FADD;TRADD
13734,GO:0050891,0.132648046719027,0.962394460496013,3,62,multicellular organismal water homeostasis,BP,PRKACB;PRKAR1B;CLDN1
13075,GO:0048021,0.13270785305713,0.992062039548931,1,7,regulation of melanin biosynthetic process,BP,WNT5A
18597,GO:1900376,0.13270785305713,0.992062039548931,1,7,regulation of secondary metabolite biosynthetic process,BP,WNT5A
957,GO:0002244,0.132709663796619,0.953470750970029,4,95,hematopoietic progenitor cell differentiation,BP,NOTCH1;FSTL3;JAM3;BMP4
17440,GO:0090186,0.132713465870123,0.992061349305399,1,7,regulation of pancreatic juice secretion,BP,WNK4
5798,GO:0016176,0.132763895995547,0.992055146168167,1,7,superoxide-generating NADPH oxidase activator activity,MF,PDGFB
1516,GO:0003256,0.132832392813982,0.992046716645816,1,7,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,NOTCH1
15501,GO:0061438,0.13294158477671,0.992033269235003,1,7,renal system vasculature morphogenesis,BP,BMP4
15502,GO:0061439,0.13294158477671,0.992033269235003,1,7,kidney vasculature morphogenesis,BP,BMP4
13393,GO:0048752,0.133036078576183,0.992021622273062,1,7,semicircular canal morphogenesis,BP,FGF10
3813,GO:0007442,0.133087160043677,0.992015322414348,1,7,hindgut morphogenesis,BP,WNT5A
18848,GO:1901606,0.133196042499758,0.953258659322485,4,93,alpha-amino acid catabolic process,BP,GLDC;ACAT1;SARDH;PCBD1
15263,GO:0060947,0.133202331608313,0.992001108708674,1,7,cardiac vascular smooth muscle cell differentiation,BP,NOTCH1
17274,GO:0086042,0.133226496705936,0.991998124718544,1,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,DSC2
2567,GO:0005314,0.133508909919206,0.991963207758628,1,7,high-affinity glutamate transmembrane transporter activity,MF,SLC1A3
5306,GO:0014883,0.133555113061304,0.991957487655636,1,7,transition between fast and slow fiber,BP,ACTN3
9511,GO:0034612,0.13358770492246,0.929820832229587,9,278,response to tumor necrosis factor,BP,TRADD;EDN1;CCL20;PYCARD;PSMB10;NOL3;CLDN1;GAS6;CLDN18
6915,GO:0021684,0.133668932347727,0.991943387274365,1,7,cerebellar granular layer formation,BP,WNT7A
6932,GO:0021707,0.133668932347727,0.991943387274365,1,7,cerebellar granule cell differentiation,BP,WNT7A
2497,GO:0005167,0.133745514619538,0.991933892615617,1,7,neurotrophin TRK receptor binding,MF,PIK3R1
15577,GO:0061626,0.13382669872098,0.991923820969799,1,7,pharyngeal arch artery morphogenesis,BP,BMP4
18095,GO:0098632,0.133904742662602,0.974386833758104,2,31,protein binding involved in cell-cell adhesion,MF,DSC2;PKP3
1004,GO:0002318,0.133960661690216,0.991907187089943,1,7,myeloid progenitor cell differentiation,BP,JAM3
21051,GO:2000192,0.134041523881318,0.991897137859839,1,7,negative regulation of fatty acid transport,BP,AKT1
7824,GO:0031232,0.134098537313048,0.991890048496404,1,7,extrinsic component of external side of plasma membrane,CC,TF
14165,GO:0051597,0.134150437648023,0.991883592074321,1,7,response to methylmercury,BP,S100B
18788,GO:1901379,0.134274087267169,0.961730245515174,3,62,regulation of potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2
21290,GO:2000542,0.134434335821346,0.991848226969403,1,7,negative regulation of gastrulation,BP,FZD7
15236,GO:0060897,0.134555735353984,0.991833079458389,1,7,neural plate regionalization,BP,AXIN1
18499,GO:1900125,0.1346476522009,0.991821600732472,1,7,regulation of hyaluronan biosynthetic process,BP,PDGFB
80,GO:0000160,0.134671570716723,0.991818612351668,1,7,phosphorelay signal transduction system,BP,KCNH2
11489,GO:0043569,0.134723669095737,0.991812101179312,1,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
12700,GO:0046543,0.134864427673001,0.991794495701806,1,7,development of secondary female sexual characteristics,BP,WNT5A
12693,GO:0046532,0.13488033223268,0.991792505170757,1,7,regulation of photoreceptor cell differentiation,BP,NOTCH1
4693,GO:0009954,0.13495811259288,0.974065172195296,2,31,proximal/distal pattern formation,BP,FGF10;DLL1
973,GO:0002275,0.135011449168623,0.916665679079753,15,524,myeloid cell activation involved in immune response,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;TICAM1;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;GLA;DERA;RAB3D
621,GO:0001738,0.135101906008628,0.945463406120034,5,131,morphogenesis of a polarized epithelium,BP,FZD7;PSMB10;WNT5A;MSN;LAMA5
18084,GO:0098597,0.135122275373565,0.991597789145055,1,8,observational learning,BP,STRA6
12853,GO:0046884,0.135125419876834,0.991761799011477,1,7,follicle-stimulating hormone secretion,BP,INHBB
2160,GO:0004673,0.135203112244782,0.99175205255444,1,7,protein histidine kinase activity,MF,KCNH2
2875,GO:0005915,0.135288329500379,0.99174135509731,1,7,zonula adherens,CC,CAMSAP3
14212,GO:0051694,0.135366333952828,0.99173155664713,1,7,pointed-end actin filament capping,BP,TMOD4
10907,GO:0042558,0.135419177891805,0.973923877757398,2,31,pteridine-containing compound metabolic process,BP,PCBD1;PTS
304,GO:0000805,0.135516527600483,0.991712672919101,1,7,X chromosome,CC,SIN3B
17269,GO:0086036,0.135560151262213,0.991707183881207,1,7,regulation of cardiac muscle cell membrane potential,BP,FXYD1
13796,GO:0051001,0.135564198722615,0.99170667450365,1,7,negative regulation of nitric-oxide synthase activity,BP,GLA
11474,GO:0043548,0.135690338110628,0.973804319963589,2,32,phosphatidylinositol 3-kinase binding,MF,TYRO3;PIK3R1
20373,GO:1905063,0.135902018652326,0.991664101141893,1,7,regulation of vascular smooth muscle cell differentiation,BP,PDGFB
1623,GO:0003696,0.135914482743092,0.991662528163814,1,7,satellite DNA binding,MF,HEY1
8379,GO:0032278,0.135959174056723,0.991656886794171,1,7,positive regulation of gonadotropin secretion,BP,INHBB
18818,GO:1901533,0.13597357397078,0.991655068667856,1,7,negative regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
5325,GO:0014911,0.136032900170677,0.973698873932639,2,32,positive regulation of smooth muscle cell migration,BP,PDGFB;FOXO4
9286,GO:0034128,0.136038821025793,0.991646827979697,1,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
5701,GO:0015939,0.136057773757047,0.991644433447642,1,7,pantothenate metabolic process,BP,FASN
12665,GO:0046485,0.136246693278001,0.991620545069379,1,7,ether lipid metabolic process,BP,PLA2G16
12162,GO:0045359,0.136324629101669,0.99161067977638,1,7,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
694,GO:0001839,0.136461210850545,0.991593376137164,1,7,neural plate morphogenesis,BP,FGF8
14660,GO:0060028,0.136504971316177,0.991587828102359,1,7,convergent extension involved in axis elongation,BP,WNT5A
11344,GO:0043320,0.136505714711386,0.991587733836576,1,7,natural killer cell degranulation,BP,RAB27A
4928,GO:0010668,0.136535404939587,0.99158396852811,1,7,ectodermal cell differentiation,BP,FZD7
7469,GO:0030513,0.136557530043396,0.973537058112072,2,32,positive regulation of BMP signaling pathway,BP,NOTCH1;BMP4
16024,GO:0070569,0.136654072023431,0.991568910290717,1,7,uridylyltransferase activity,MF,GALT
13801,GO:0051011,0.136678472630585,0.99156581221474,1,7,microtubule minus-end binding,MF,CAMSAP3
11760,GO:0044351,0.136867206958877,0.991541828804917,1,7,macropinocytosis,BP,PYCARD
15241,GO:0060907,0.136891347892476,0.991538758496768,1,7,positive regulation of macrophage cytokine production,BP,WNT5A
11821,GO:0044456,0.136948975091973,0.911386059122707,18,663,synapse part,CC,ITGA3;TMEM163;ADRA2C;SYT5;ACTN2;WNT7A;ADORA1;RAB40B;RAB40A;CDH2;DRP2;VAMP1;GRIA3;AKT1;LZTS1;SHC4;LAMA5;PDE4B
14981,GO:0060462,0.136984436670991,0.991526913697158,1,7,lung lobe development,BP,LIF
14982,GO:0060463,0.136984436670991,0.991526913697158,1,7,lung lobe morphogenesis,BP,LIF
10224,GO:0036089,0.137080188154014,0.991514720940763,1,7,cleavage furrow formation,BP,SNX18
10039,GO:0035766,0.137105377911362,0.991511511797912,1,7,cell chemotaxis to fibroblast growth factor,BP,FGF18
10041,GO:0035768,0.137105377911362,0.991511511797912,1,7,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
20265,GO:1904847,0.137105377911362,0.991511511797912,1,7,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
21292,GO:2000544,0.137105377911362,0.991511511797912,1,7,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
4152,GO:0008443,0.137304403104198,0.991486133658646,1,7,phosphofructokinase activity,MF,PFKFB3
8768,GO:0032825,0.137362634171957,0.991478700904858,1,7,positive regulation of natural killer cell differentiation,BP,GAS6
13209,GO:0048341,0.137383889841764,0.991475986924661,1,7,paraxial mesoderm formation,BP,WNT5A
20969,GO:2000049,0.137406370872152,0.991473115989413,1,7,positive regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
16418,GO:0071353,0.137450355327224,0.973297789612862,2,31,cellular response to interleukin-4,BP,FASN;SHPK
7176,GO:0023061,0.137484463351862,0.920042549626006,12,407,signal release,BP,LIF;ADRA2B;ADRA2C;SYT5;WNT7A;ADORA1;EDN1;RBP4;BMP6;INHBB;RAB11FIP1;KCNG2
17803,GO:0097197,0.137489778976081,0.991462459903624,1,7,tetraspanin-enriched microdomain,CC,TSPAN15
1255,GO:0002741,0.137495770682866,0.991461694141555,1,7,positive regulation of cytokine secretion involved in immune response,BP,WNT5A
1501,GO:0003228,0.137515811776723,0.991459132552205,1,7,atrial cardiac muscle tissue development,BP,WNT2
14564,GO:0055009,0.137515811776723,0.991459132552205,1,7,atrial cardiac muscle tissue morphogenesis,BP,WNT2
3694,GO:0007189,0.137533909326283,0.96038706483554,3,62,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
19743,GO:1903715,0.137554544170332,0.991454180747269,1,7,regulation of aerobic respiration,BP,ACTN3
16781,GO:0071971,0.137574691833047,0.991451604336348,1,7,extracellular exosome assembly,BP,SDC4
10372,GO:0036462,0.137610774600101,0.991446989173954,1,7,TRAIL-activated apoptotic signaling pathway,BP,FADD
6637,GO:0019530,0.137612525748282,0.991446765159987,1,7,taurine metabolic process,BP,GHR
6669,GO:0019694,0.137612525748282,0.991446765159987,1,7,alkanesulfonate metabolic process,BP,GHR
8714,GO:0032762,0.137675784521268,0.991438670758931,1,7,mast cell cytokine production,BP,CHGA
19003,GO:1902033,0.137719395487534,0.991433088071367,1,7,regulation of hematopoietic stem cell proliferation,BP,KITLG
18443,GO:1900029,0.13774307428241,0.991430056115916,1,7,positive regulation of ruffle assembly,BP,HRAS
6115,GO:0016787,0.137787408432037,0.89229647081836,57,2385,hydrolase activity,MF,CFB;TUBG2;RAB6C;RAB27A;RASL11B;FASN;RHBDL3;DHH;ADORA1;PLAU;RAB40B;RAB40A;ABCG1;PYCARD;RRAS2;RAB39B;RAB39A;PSMB10;RGN;ASAH2;CGN;PTPN7;RALB;PLA2G16;HRAS;RHOQ;RHOJ;RHOB;PFKFB3;RNASEL;ANG;IDUA;RAB20;HEXB;CMBL;RND3;NUDT6;NUDT7;RRAD;CASP4;RAB12;RAB17;PON2;MYO7A;MDP1;RAB44;SIN3B;PEPD;ACP5;GLA;MYH11;PM20D2;RAB38;RAB3D;LYPLAL1;DUSP5;PDE4B
12139,GO:0045333,0.137815570974015,0.938528114103693,6,165,cellular respiration,BP,ACTN3;ETFB;MDH1;IDH1;PIK3CA;ETFDH
5634,GO:0015833,0.137863855447384,0.894621942054966,47,1934,peptide transport,BP,ADRA2C;USE1;NOTCH1;RAB27A;TF;RABIF;TBC1D14;ADORA1;EDN1;RAB40B;RAB40A;PNP;ABCG1;PYCARD;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RBP4;RHOB;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;NOL3;AKT1;IFI27;RAB12;RAB17;CDH1;MYO7A;INHBB;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;UNC119;RAB38;RAB3D;CNIH4
17993,GO:0097623,0.137907151784447,0.991409031179106,1,7,potassium ion export across plasma membrane,BP,KCNH2
18121,GO:0098668,0.137907151784447,0.991409031179106,1,7,potassium ion export from cell,BP,KCNH2
11246,GO:0043184,0.137911960243768,0.991408414610417,1,7,vascular endothelial growth factor receptor 2 binding,MF,ITGA5
17713,GO:0097049,0.137974538730847,0.991400388295558,1,7,motor neuron apoptotic process,BP,FADD
2632,GO:0005501,0.138028672052534,0.973118449513725,2,31,retinoid binding,MF,SERPINA5;RBP4
21348,GO:2000628,0.138061134503438,0.991389274979523,1,7,regulation of miRNA metabolic process,BP,HRAS
9529,GO:0034638,0.138073355023486,0.991387706040501,1,7,phosphatidylcholine catabolic process,BP,APOC1
9919,GO:0035587,0.138082229010323,0.97310181692991,2,31,purinergic receptor signaling pathway,BP,P2RY14;ADORA1
5554,GO:0015684,0.138151381104613,0.991377685045662,1,7,ferrous iron transport,BP,TF
8890,GO:0033018,0.138153150884815,0.99137745767884,1,7,sarcoplasmic reticulum lumen,CC,CASQ2
13274,GO:0048537,0.138230181024013,0.991367558403177,1,7,mucosal-associated lymphoid tissue development,BP,ARTN
13277,GO:0048541,0.138230181024013,0.991367558403177,1,7,Peyer's patch development,BP,ARTN
12410,GO:0045907,0.13823852502309,0.973053254390915,2,31,positive regulation of vasoconstriction,BP,ADRA2C;AKT1
2472,GO:0005138,0.13824806848308,0.991365258794577,1,7,interleukin-6 receptor binding,MF,PYCARD
11260,GO:0043203,0.138311924608608,0.991357046816652,1,7,axon hillock,CC,SPTBN4
13175,GO:0048278,0.138331576118847,0.960056049377712,3,62,vesicle docking,BP,RAB40B;RAB40A;RALB
18912,GO:1901724,0.138391968239689,0.991346747266843,1,7,positive regulation of cell proliferation involved in kidney development,BP,PDGFB
15963,GO:0070472,0.138435043033136,0.991341201964115,1,7,regulation of uterine smooth muscle contraction,BP,ADRA2C
4684,GO:0009922,0.138501045290872,0.991332701407644,1,7,fatty acid elongase activity,MF,ELOVL6
6585,GO:0019367,0.138501045290872,0.991332701407644,1,7,fatty acid elongation, saturated fatty acid,BP,ELOVL6
18403,GO:0102336,0.138501045290872,0.991332701407644,1,7,3-oxo-arachidoyl-CoA synthase activity,MF,ELOVL6
18404,GO:0102337,0.138501045290872,0.991332701407644,1,7,3-oxo-cerotoyl-CoA synthase activity,MF,ELOVL6
18405,GO:0102338,0.138501045290872,0.991332701407644,1,7,3-oxo-lignoceronyl-CoA synthase activity,MF,ELOVL6
5274,GO:0014824,0.138533113804342,0.991328569648237,1,7,artery smooth muscle contraction,BP,EDN1
7011,GO:0021872,0.138536591833199,0.959954288853042,3,63,forebrain generation of neurons,BP,WNT5A;AXIN1;FGF8
16288,GO:0071073,0.138589239116016,0.9913213358621,1,7,positive regulation of phospholipid biosynthetic process,BP,FABP3
13180,GO:0048289,0.138628283136821,0.991316301736946,1,7,isotype switching to IgE isotypes,BP,CLCF1
13183,GO:0048293,0.138628283136821,0.991316301736946,1,7,regulation of isotype switching to IgE isotypes,BP,CLCF1
4243,GO:0008603,0.138736860780978,0.991302294193911,1,7,cAMP-dependent protein kinase regulator activity,MF,PRKAR1B
15043,GO:0060558,0.138756757356563,0.991299726051124,1,7,regulation of calcidiol 1-monooxygenase activity,BP,VDR
11192,GO:0043102,0.138762511221124,0.991298983298432,1,7,amino acid salvage,BP,MRI1
16365,GO:0071267,0.138762511221124,0.991298983298432,1,7,L-methionine salvage,BP,MRI1
18145,GO:0098751,0.138823822694729,0.972833516194401,2,32,bone cell development,BP,ZFPM1;CLDN18
11457,GO:0043531,0.138829519525743,0.972831738426294,2,32,ADP binding,MF,ABCG1;MYO7A
13032,GO:0047760,0.138844152333372,0.991288440822559,1,7,butyrate-CoA ligase activity,MF,ACSM5
6070,GO:0016713,0.138847261995226,0.991288039132191,1,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,CYP11A1
16368,GO:0071276,0.138859312390534,0.972860025730074,2,31,cellular response to cadmium ion,BP,AKT1;STAR
8378,GO:0032277,0.138978123023097,0.991271126274304,1,7,negative regulation of gonadotropin secretion,BP,INHBB
549,GO:0001609,0.139014065884008,0.991266477873475,1,7,G-protein coupled adenosine receptor activity,MF,ADORA1
4606,GO:0009635,0.139174330173424,0.991245735336993,1,7,response to herbicide,BP,STAR
6071,GO:0016714,0.139219169911982,0.991239927194532,1,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,PCBD1
5675,GO:0015909,0.139223777937513,0.959684716245984,3,62,long-chain fatty acid transport,BP,CPT2;FABP3;AKT1
6596,GO:0019388,0.13928036995866,0.991231996589273,1,7,galactose catabolic process,BP,GALT
21599,GO:2001179,0.139532727925933,0.991199254630109,1,7,regulation of interleukin-10 secretion,BP,PYCARD
10590,GO:0040018,0.139593821097608,0.972592808103783,2,32,positive regulation of multicellular organism growth,BP,SPTBN4;GHR
1993,GO:0004457,0.139702415116682,0.991177202359211,1,7,lactate dehydrogenase activity,MF,LDHD
8619,GO:0032610,0.139724991973502,0.991174266103548,1,7,interleukin-1 alpha production,BP,CCL20
21500,GO:2000848,0.139743848550941,0.991171813295769,1,7,positive regulation of corticosteroid hormone secretion,BP,BMP6
5153,GO:0010985,0.13975312261283,0.991170606820764,1,7,negative regulation of lipoprotein particle clearance,BP,APOC1
7222,GO:0030091,0.139808036667215,0.99116346118852,1,7,protein repair,BP,MSRA
10682,GO:0042157,0.139962244738259,0.932738309624272,7,207,lipoprotein metabolic process,BP,DPM3;APOC1;NMT2;ABCG1;PRKACB;PRND;LYPLAL1
12246,GO:0045616,0.140015811174896,0.972460531317276,2,32,regulation of keratinocyte differentiation,BP,NOTCH1;VDR
2942,GO:0006026,0.140063326528635,0.95931747917321,3,63,aminoglycan catabolic process,BP,SDC4;IDUA;HEXB
6153,GO:0016846,0.140085956043145,0.991127250244332,1,7,carbon-sulfur lyase activity,MF,MGST2
9415,GO:0034382,0.140366385645572,0.991090632682383,1,7,chylomicron remnant clearance,BP,APOC1
16706,GO:0071830,0.140366385645572,0.991090632682383,1,7,triglyceride-rich lipoprotein particle clearance,BP,APOC1
8232,GO:0032008,0.140434702255513,0.972328974689291,2,32,positive regulation of TOR signaling,BP,PIK3CA;GAS6
17333,GO:0090022,0.140461398676756,0.972358813291992,2,31,regulation of neutrophil chemotaxis,BP,EDN1;JAM3
8512,GO:0032456,0.140603685548826,0.972275833093768,2,32,endocytic recycling,BP,ACTN2;RAB17
13700,GO:0050851,0.140817997894913,0.932231504392965,7,205,antigen receptor-mediated signaling pathway,BP,PSMB10;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
12294,GO:0045670,0.14090545335517,0.958964789027395,3,63,regulation of osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
1367,GO:0002931,0.141202644177513,0.972087145796519,2,32,response to ischemia,BP,NOL3;GJB2
1125,GO:0002526,0.14138668812059,0.94211902097579,5,131,acute inflammatory response,BP,CFB;ACVR1;ADORA1;PTGES;PIK3CG
15606,GO:0061695,0.141642223536435,0.927889661366671,8,248,transferase complex, transferring phosphorus-containing groups,CC,ACVR1;PYCARD;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG
14689,GO:0060059,0.141803089126645,0.990720623835773,1,8,embryonic retina morphogenesis in camera-type eye,BP,RBP4
19927,GO:1904064,0.141896748260525,0.949011489524572,4,98,positive regulation of cation transmembrane transport,BP,ACTN2;RGN;KCNH2;FXYD1
8799,GO:0032885,0.141974768980383,0.971806709762093,2,33,regulation of polysaccharide biosynthetic process,BP,PDGFB;AKT1
19033,GO:1902107,0.14246103377686,0.941535304648001,5,132,positive regulation of leukocyte differentiation,BP,LIF;FADD;PNP;KITLG;GAS6
966,GO:0002260,0.142477237455667,0.958303792369864,3,63,lymphocyte homeostasis,BP,PMAIP1;FADD;AKT1
9678,GO:0035091,0.142579809859809,0.931147931919238,7,211,phosphatidylinositol binding,MF,SYT5;ACTN2;FZD7;PXK;SNX18;AKT1;SNX21
3802,GO:0007416,0.142642285718731,0.941411741580674,5,136,synapse assembly,BP,WNT7A;CDH2;WNT5A;RAB17;CDH1
3204,GO:0006461,0.142684317792569,0.895837636412056,33,1312,protein complex assembly,BP,FHOD3;TUBG2;ACTN2;PMAIP1;FADD;TRADD;CASQ2;SPTBN5;SPTBN4;PYCARD;PRND;RALB;HRAS;HACL1;AXIN1;PSRC1;ANG;SPTB;ACAT1;VAMP1;MSN;NOL3;GJB1;PCBD1;DECR1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;HNF1A;KCND1;TMOD4
15843,GO:0070271,0.142684317792569,0.895837636412056,33,1312,protein complex biogenesis,BP,FHOD3;TUBG2;ACTN2;PMAIP1;FADD;TRADD;CASQ2;SPTBN5;SPTBN4;PYCARD;PRND;RALB;HRAS;HACL1;AXIN1;PSRC1;ANG;SPTB;ACAT1;VAMP1;MSN;NOL3;GJB1;PCBD1;DECR1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;HNF1A;KCND1;TMOD4
4724,GO:0010039,0.142859728075215,0.971562461205313,2,32,response to iron ion,BP,TF;BMP6
2801,GO:0005790,0.143039283855689,0.97146852414223,2,33,smooth endoplasmic reticulum,CC,TTYH1;HSD3B2
3385,GO:0006687,0.143125311195597,0.958030223239408,3,63,glycosphingolipid metabolic process,BP,ITGB8;HEXB;GLA
11150,GO:0043025,0.143251447199303,0.916062667200413,12,412,neuronal cell body,CC,SYT5;ADORA1;SPTBN4;CYP17A1;ANG;DRP2;RAB17;STAR;S100B;KCND1;ACSL4;SLC1A3
16721,GO:0071868,0.143362199838865,0.971365618401926,2,33,cellular response to monoamine stimulus,BP,STAR;PDE4B
16723,GO:0071870,0.143362199838865,0.971365618401926,2,33,cellular response to catecholamine stimulus,BP,STAR;PDE4B
3776,GO:0007346,0.14345431544699,0.912193232350654,14,492,regulation of mitotic cell cycle,BP,GADD45A;EDN1;PSMB10;FGF10;PDGFB;FOXO4;HRAS;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;PIM2
12867,GO:0046906,0.143609927197994,0.940916570319877,5,132,tetrapyrrole binding,MF,GUCY1B3;FLVCR2;CYP17A1;CYP11A1;CYB5A
19926,GO:1904063,0.143877109593333,0.957712118259732,3,63,negative regulation of cation transmembrane transport,BP,ACTN2;CASQ2;KCNH2
8632,GO:0032633,0.14425573740072,0.971117412689296,2,32,interleukin-4 production,BP,NOTCH1;ZFPM1
14355,GO:0051961,0.144630370736533,0.926004611530973,8,251,negative regulation of nervous system development,BP,WNT3;NOTCH1;WNT7A;PRKACB;WNT5A;BMP7;DLL1;LINGO1
18146,GO:0098754,0.144711339196245,0.947650454169744,4,96,detoxification,BP,MGST2;RGN;SESN2;BMP7
7539,GO:0030667,0.144959975337215,0.922482168632676,9,288,secretory granule membrane,CC,RAB27A;SERPINA5;PLAU;SYCN;VAMP1;PKP1;RAB44;RPH3AL;RAB3D
5974,GO:0016528,0.145084640722684,0.957150088070894,3,66,sarcoplasm,CC,CASQ2;FABP3;NOL3
10801,GO:0042391,0.145360015104734,0.916823018719691,11,373,regulation of membrane potential,BP,ACTN2;PMAIP1;DSC2;WNT7A;ADORA1;CASQ2;EDN1;KCNK6;KCNH2;FXYD1;GRIA3
13843,GO:0051056,0.1457153976227,0.921974454921491,9,295,regulation of small GTPase mediated signal transduction,BP,ITGA3;FGF10;PIK3R2;HRAS;RHOQ;RHOJ;RHOB;KITLG;AMOT
17907,GO:0097421,0.145799704790244,0.970621976688576,2,32,liver regeneration,BP,RGN;CLDN1
21323,GO:2000587,0.145820075448718,0.990170956411415,1,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
16329,GO:0071214,0.146125472228769,0.921724213643411,9,288,cellular response to abiotic stimulus,BP,GADD45A;FADD;NMT2;PIK3R1;HRAS;RHOB;BMP6;CDKN1A;AKT1
17686,GO:0097009,0.146253226076698,0.970437721820288,2,33,energy homeostasis,BP,DLL1;PIK3CA
17741,GO:0097104,0.146330595076308,0.990099896280701,1,8,postsynaptic membrane assembly,BP,CDH2
4428,GO:0009154,0.146491836581027,0.970360608818919,2,33,purine ribonucleotide catabolic process,BP,NUDT7;PDE4B
5338,GO:0015031,0.146729516079564,0.887531199502172,46,1900,protein transport,BP,ADRA2C;USE1;NOTCH1;RAB27A;TF;RABIF;TBC1D14;ADORA1;RAB40B;RAB40A;PNP;ABCG1;PYCARD;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RBP4;RHOB;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;NOL3;AKT1;IFI27;RAB12;RAB17;CDH1;MYO7A;INHBB;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;UNC119;RAB38;RAB3D;CNIH4
18079,GO:0098590,0.147160603798147,0.897903244660944,24,932,plasma membrane region,CC,ITGA3;ITGA5;NOTCH1;RAB27A;TF;SLC52A3;ADORA1;SPTBN5;TTYH1;CDH2;PDGFB;DLL1;DRP2;GRIA3;MSN;GJB6;RAB17;CDH1;MYO7A;CLDN1;CLDN3;CLDN5;LZTS1;SHC4
12200,GO:0045505,0.147250556055935,0.989971158835172,1,8,dynein intermediate chain binding,MF,SPTBN5
13719,GO:0050870,0.147332516695513,0.928276521314722,7,208,positive regulation of T cell activation,BP,FADD;PNP;PYCARD;PIK3R1;AKT1;PIK3CA;EFNB2
3850,GO:0007585,0.147343092324471,0.956217841945021,3,64,respiratory gaseous exchange,BP,ADORA1;EDN1;JAG2
15112,GO:0060677,0.147494825525606,0.989936827816841,1,8,ureteric bud elongation,BP,BMP4
18619,GO:1900542,0.147593721429966,0.928109745696676,7,210,regulation of purine nucleotide metabolic process,BP,ACTN3;MRAP;EDN1;WNT5A;NPR1;CHGA;NPPC
17313,GO:0086091,0.14769042776967,0.969935711249429,2,34,regulation of heart rate by cardiac conduction,BP,DSC2;KCNH2
6872,GO:0021587,0.147841254741421,0.969886615504895,2,34,cerebellum morphogenesis,BP,WNT7A;DLL1
4354,GO:0009060,0.147964984855943,0.955968375422386,3,63,aerobic respiration,BP,ACTN3;MDH1;IDH1
13289,GO:0048566,0.148018361531929,0.969865368335949,2,33,embryonic digestive tract development,BP,STRA6;FGF10
867,GO:0002072,0.148141538767712,0.989845634038985,1,8,optic cup morphogenesis involved in camera-type eye development,BP,WNT5A
845,GO:0002042,0.148169117738662,0.969816280824465,2,33,cell migration involved in sprouting angiogenesis,BP,NOTCH1;EFNB2
16808,GO:0072033,0.148253800112868,0.98982975940551,1,8,renal vesicle formation,BP,WNT4
5256,GO:0014745,0.148314842217008,0.989821122042793,1,8,negative regulation of muscle adaptation,BP,NOL3
15284,GO:0060982,0.148986574956967,0.989725815450313,1,8,coronary artery morphogenesis,BP,NOTCH1
2707,GO:0005641,0.149159218094728,0.989701244268965,1,8,nuclear envelope lumen,CC,PTGES
20516,GO:1905456,0.1494150502524,0.989664775947057,1,8,regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
6306,GO:0017158,0.149426489557897,0.955304455044806,3,65,regulation of calcium ion-dependent exocytosis,BP,SYT5;NOTCH1;RPH3AL
10771,GO:0042339,0.149428656602735,0.969404910671559,2,33,keratan sulfate metabolic process,BP,B3GNT2;HEXB
16853,GO:0072102,0.149749118228652,0.989617052078077,1,8,glomerulus morphogenesis,BP,BMP4
6178,GO:0016885,0.149800674141982,0.989609676552943,1,8,ligase activity, forming carbon-carbon bonds,MF,ACAT1
7532,GO:0030658,0.15000647002515,0.931468741054722,6,172,transport vesicle membrane,CC,TMEM163;SYT5;SYCN;VAMP1;CHGA;RPH3AL
17626,GO:0090557,0.150275632400171,0.989541598567711,1,8,establishment of endothelial intestinal barrier,BP,CLDN1
9720,GO:0035234,0.150295818967468,0.989538699893675,1,8,ectopic germ cell programmed cell death,BP,KITLG
13287,GO:0048563,0.150461240517717,0.989514930219914,1,8,post-embryonic animal organ morphogenesis,BP,MYO7A
15536,GO:0061525,0.150558708295961,0.989500911490687,1,8,hindgut development,BP,WNT5A
7365,GO:0030291,0.150832373800928,0.968943816296012,2,33,protein serine/threonine kinase inhibitor activity,MF,PRKAR1B;CDKN1A
629,GO:0001756,0.151022579812284,0.954596636385158,3,66,somitogenesis,BP,NOTCH1;WNT5A;DLL1
1282,GO:0002791,0.151059218557945,0.910630344477199,12,412,regulation of peptide secretion,BP,ADRA2C;ADORA1;PYCARD;WNT5A;RBP4;ANG;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL
17244,GO:0086004,0.151168520884302,0.968759976041034,2,35,regulation of cardiac muscle cell contraction,BP,DSC2;PDE4B
17058,GO:0072497,0.151239731303608,0.989402682256313,1,8,mesenchymal stem cell differentiation,BP,WNT3
9412,GO:0034379,0.151252970573132,0.989400767830208,1,8,very-low-density lipoprotein particle assembly,BP,APOC1
7023,GO:0021891,0.151338565935099,0.989388386120532,1,8,olfactory bulb interneuron development,BP,WNT5A
18465,GO:1900076,0.151430981418657,0.954436048429035,3,65,regulation of cellular response to insulin stimulus,BP,PIK3R2;PIK3R1;RNASEL
10925,GO:0042583,0.1515200051702,0.989362114775558,1,8,chromaffin granule,CC,CHGA
8454,GO:0032391,0.151565684963049,0.96866408773084,2,34,photoreceptor connecting cilium,CC,SPTBN5;MYO7A
10625,GO:0042045,0.151569339840115,0.989354965424255,1,8,epithelial fluid transport,BP,EDN1
7229,GO:0030104,0.151573982201916,0.954356999360103,3,66,water homeostasis,BP,PRKACB;PRKAR1B;CLDN1
6613,GO:0019433,0.151586757389071,0.968694869764319,2,33,triglyceride catabolic process,BP,FABP3;PIK3CG
8051,GO:0031644,0.151655720649099,0.95433833283295,3,65,regulation of neurological system process,BP,ADRA2C;ADORA1;EDN1
16551,GO:0071549,0.151718545367166,0.968651297617989,2,33,cellular response to dexamethasone stimulus,BP,GJB2;STAR
4143,GO:0008429,0.151813892887459,0.989319488184817,1,8,phosphatidylethanolamine binding,MF,MFGE8
1259,GO:0002756,0.151868132918238,0.968601810937309,2,33,MyD88-independent toll-like receptor signaling pathway,BP,FADD;TICAM1
3567,GO:0006975,0.152000421013132,0.989292386363575,1,8,DNA damage induced protein phosphorylation,BP,MAPK12
2525,GO:0005225,0.152064948625849,0.989283002236879,1,8,volume-sensitive anion channel activity,MF,TTYH1
9210,GO:0033865,0.152257061260219,0.968472998156637,2,33,nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
9216,GO:0033875,0.152257061260219,0.968472998156637,2,33,ribonucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
9236,GO:0034032,0.152257061260219,0.968472998156637,2,33,purine nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
8068,GO:0031666,0.15236951868605,0.98923865011649,1,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
15024,GO:0060534,0.152396569352128,0.989234706227262,1,8,trachea cartilage development,BP,WNT7B
6724,GO:0019840,0.152563409292743,0.968371386291867,2,33,isoprenoid binding,MF,SERPINA5;RBP4
17460,GO:0090207,0.152573476878411,0.968368044760761,2,33,regulation of triglyceride metabolic process,BP,RGN;PIK3CG
3390,GO:0006692,0.152583444566261,0.968364736246494,2,33,prostanoid metabolic process,BP,EDN1;PTGES
3391,GO:0006693,0.152583444566261,0.968364736246494,2,33,prostaglandin metabolic process,BP,EDN1;PTGES
7368,GO:0030295,0.15293745264251,0.953779689127923,3,65,protein kinase activator activity,MF,CDKN1A;PIK3CA;GAS6
19820,GO:1903867,0.153051111092579,0.989139041795736,1,8,extraembryonic membrane development,BP,BMP7
2870,GO:0005905,0.153096755272124,0.953676415770338,3,67,clathrin-coated pit,CC,TF;EPN1;SH3BP4
11187,GO:0043094,0.153282213927321,0.968132450317673,2,33,cellular metabolic compound salvage,BP,MRI1;PNP
21218,GO:2000427,0.153356717642424,0.989094221547471,1,8,positive regulation of apoptotic cell clearance,BP,MFGE8
21637,GO:2001235,0.153369408650276,0.929497985315931,6,172,positive regulation of apoptotic signaling pathway,BP,PMAIP1;FADD;TRADD;PYCARD;G0S2;INHBB
21458,GO:2000785,0.153426360714561,0.968046011730376,2,34,regulation of autophagosome assembly,BP,TBC1D14;RALB
21463,GO:2000794,0.153457712386411,0.989079388046103,1,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
6668,GO:0019693,0.153579460543787,0.903228792885448,15,535,ribose phosphate metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;SHPK;CHGA;NUDT7;NPPC;DERA;PDE4B
15735,GO:0070099,0.153631436867483,0.989053847310306,1,8,regulation of chemokine-mediated signaling pathway,BP,EDN1
14749,GO:0060155,0.153638639855623,0.989052787650582,1,8,platelet dense granule organization,BP,RAB38
14659,GO:0060027,0.153648654002173,0.989051314339594,1,8,convergent extension involved in gastrulation,BP,WNT5A
11436,GO:0043502,0.153650193009312,0.953434208656826,3,67,regulation of muscle adaptation,BP,ACTN3;EDN1;NOL3
2429,GO:0005057,0.153653914978824,0.935392331005896,5,138,signal transducer activity, downstream of receptor,MF,ACVR1;MAPK12;TYRO3;ARAF;DOK1
2783,GO:0005769,0.15375831335651,0.916710871619488,9,293,early endosome,CC,TMEM163;RIN3;TF;RHOB;RAB20;RAB17;CYTIP;SNX21;RAB38
4514,GO:0009261,0.153798718824044,0.967921738403132,2,34,ribonucleotide catabolic process,BP,NUDT7;PDE4B
17732,GO:0097084,0.153869528183817,0.989018791815274,1,8,vascular smooth muscle cell development,BP,NOTCH1
10394,GO:0036490,0.153890001641782,0.989015774607051,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
6016,GO:0016597,0.154055304249022,0.953290597268139,3,65,amino acid binding,MF,GLDC;SESN2;SLC1A3
1033,GO:0002366,0.154222366800554,0.898489223345161,18,663,leukocyte activation involved in immune response,BP,RAB27A;CRISPLD2;ZFPM1;PLAU;PNP;PYCARD;TICAM1;CLCF1;DLL1;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;GLA;DERA;RAB3D
19352,GO:1902916,0.15429674218597,0.988955741010144,1,8,positive regulation of protein polyubiquitination,BP,NMI
11076,GO:0042886,0.154320440798714,0.880871827267585,47,1954,amide transport,BP,ADRA2C;USE1;NOTCH1;RAB27A;TF;RABIF;TBC1D14;ADORA1;EDN1;RAB40B;RAB40A;PNP;ABCG1;PYCARD;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RBP4;RHOB;ANG;BMP7;BMP6;BMP4;CDKN1A;RAB20;NOL3;AKT1;IFI27;RAB12;RAB17;CDH1;MYO7A;INHBB;SNX21;RAB11FIP1;KCNG2;GAS6;RPH3AL;UNC119;RAB38;RAB3D;CNIH4
9953,GO:0035630,0.154323596827179,0.988951771215196,1,8,bone mineralization involved in bone maturation,BP,BMP2
9285,GO:0034127,0.154406641389975,0.988939490318522,1,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
21357,GO:2000643,0.154439855647267,0.988934576451953,1,8,positive regulation of early endosome to late endosome transport,BP,MSN
13423,GO:0048819,0.154445374694057,0.988933759826663,1,8,regulation of hair follicle maturation,BP,WNT5A
5270,GO:0014820,0.154484419369044,0.988927981667343,1,8,tonic smooth muscle contraction,BP,EDN1
14182,GO:0051639,0.154535964498865,0.988920351123827,1,8,actin filament network formation,BP,FHOD3
166,GO:0000323,0.154540307956766,0.899552527865629,17,624,lytic vacuole,CC,RAB27A;IFI30;PYCARD;RAB39A;SDC4;IDUA;HEXB;CHGA;RAB12;PON2;MYO7A;RAB44;PIK3CG;ACP5;GLA;RAB38;RAB3D
2778,GO:0005764,0.154540307956766,0.899552527865629,17,624,lysosome,CC,RAB27A;IFI30;PYCARD;RAB39A;SDC4;IDUA;HEXB;CHGA;RAB12;PON2;MYO7A;RAB44;PIK3CG;ACP5;GLA;RAB38;RAB3D
10860,GO:0042492,0.154619453844743,0.988907985736781,1,8,gamma-delta T cell differentiation,BP,JAG2
2453,GO:0005113,0.154683072660517,0.988898558386726,1,8,patched binding,MF,DHH
5441,GO:0015232,0.154690869631239,0.988897402699496,1,8,heme transporter activity,MF,FLVCR2
9375,GO:0034331,0.154713537231656,0.988894042484784,1,8,cell junction maintenance,BP,CAMSAP3
20792,GO:1990459,0.154722693571744,0.988892685007529,1,8,transferrin receptor binding,MF,TF
438,GO:0001135,0.15495560445886,0.988858124964533,1,8,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,LIF
17345,GO:0090037,0.155095206634807,0.988837382926071,1,8,positive regulation of protein kinase C signaling,BP,WNT5A
4635,GO:0009750,0.155162792877973,0.988827333599366,1,8,response to fructose,BP,KHK
19609,GO:1903430,0.15516362409154,0.988827209977096,1,8,negative regulation of cell maturation,BP,NPPC
5243,GO:0014732,0.155196721757268,0.988822286932868,1,8,skeletal muscle atrophy,BP,ACTN3
11841,GO:0044557,0.155232198277931,0.988817008766971,1,8,relaxation of smooth muscle,BP,ADORA1
14024,GO:0051342,0.155256763397676,0.988813353211452,1,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,RGN
18411,GO:0102391,0.155265990493365,0.988811979955259,1,8,decanoate--CoA ligase activity,MF,ACSL4
8781,GO:0032845,0.155340387303697,0.928311495613287,6,177,negative regulation of homeostatic process,BP,FADD;ADORA1;CASQ2;NOL3;KITLG;CLDN18
18527,GO:1900165,0.155344935370586,0.988800227022093,1,8,negative regulation of interleukin-6 secretion,BP,GAS6
13070,GO:0048016,0.155455352372712,0.967329575960658,2,35,inositol phosphate-mediated signaling,BP,ACTN3;EDN1
18858,GO:1901620,0.155514569598326,0.988774950437748,1,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
6478,GO:0019062,0.155541179455129,0.988770982642284,1,8,virion attachment to host cell,BP,GAS6
11858,GO:0044650,0.155541179455129,0.988770982642284,1,8,adhesion of symbiont to host cell,BP,GAS6
20848,GO:1990712,0.155578041772559,0.988765484867261,1,8,HFE-transferrin receptor complex,CC,TF
13197,GO:0048318,0.15559905760349,0.988762349850486,1,8,axial mesoderm development,BP,AXIN1
18662,GO:1901033,0.155645857994099,0.988755366770554,1,8,positive regulation of response to reactive oxygen species,BP,RGN
17584,GO:0090400,0.155681658415574,0.98875002343309,1,8,stress-induced premature senescence,BP,CDKN1A
20955,GO:2000020,0.155708144036752,0.988746069490869,1,8,positive regulation of male gonad development,BP,WT1
12041,GO:0045124,0.155709354320954,0.967281010916245,2,34,regulation of bone resorption,BP,PDK4;CLDN18
5230,GO:0014701,0.155717417807095,0.988574910475847,1,9,junctional sarcoplasmic reticulum membrane,CC,CASQ2
10681,GO:0042149,0.155848039206377,0.967234304112438,2,34,cellular response to glucose starvation,BP,PMAIP1;NUAK2
10121,GO:0035912,0.155872823374642,0.988721468485364,1,8,dorsal aorta morphogenesis,BP,HEY1
1437,GO:0003139,0.155937435590722,0.988711808414643,1,8,secondary heart field specification,BP,BMP4
1200,GO:0002679,0.156101750136522,0.988687222134798,1,8,respiratory burst involved in defense response,BP,PIK3CG
8486,GO:0032426,0.156107562693197,0.98868635188325,1,8,stereocilium tip,CC,ESPN
19702,GO:1903624,0.156154509302593,0.988679321764062,1,8,regulation of DNA catabolic process,BP,RGN
14171,GO:0051604,0.156228065392156,0.918624885423896,8,251,protein maturation,BP,CFB;TSPAN15;RHBDL3;FADD;PLAU;PRKACB;NOL3;GAS6
10466,GO:0038066,0.156231923918398,0.96710487759159,2,34,p38MAPK cascade,BP,GADD45A;BMP2
19110,GO:1902282,0.156448442499799,0.988635253169008,1,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,KCNH2
15610,GO:0061700,0.156489425518178,0.988629101443345,1,8,GATOR2 complex,CC,SESN2
8925,GO:0033083,0.156534407143985,0.98862234746558,1,8,regulation of immature T cell proliferation,BP,BMP4
17462,GO:0090209,0.156543613456134,0.98862096487682,1,8,negative regulation of triglyceride metabolic process,BP,PIK3CG
15962,GO:0070471,0.156551739600082,0.988619744431479,1,8,uterine smooth muscle contraction,BP,ADRA2C
10342,GO:0036376,0.15664427739426,0.988605841485611,1,8,sodium ion export from cell,BP,FXYD1
16518,GO:0071493,0.156661758750536,0.988603214057,1,8,cellular response to UV-B,BP,CDKN1A
8927,GO:0033085,0.156690043336869,0.988598962230356,1,8,negative regulation of T cell differentiation in thymus,BP,BMP4
10034,GO:0035754,0.156706188629882,0.988596534840596,1,8,B cell chemotaxis,BP,GAS6
5647,GO:0015858,0.156729485225803,0.988593031790955,1,8,nucleoside transport,BP,ADORA1
5689,GO:0015925,0.156740723592994,0.988591341701147,1,8,galactosidase activity,MF,GLA
8709,GO:0032755,0.156777227044143,0.952092395508756,3,65,positive regulation of interleukin-6 production,BP,PYCARD;TICAM1;WNT5A
15700,GO:0070050,0.156808613947246,0.98858112912134,1,8,neuron cellular homeostasis,BP,TYRO3
19792,GO:1903800,0.156903518422063,0.988566844702761,1,8,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
21244,GO:2000480,0.156908045650412,0.988566163055035,1,8,negative regulation of cAMP-dependent protein kinase activity,BP,PRKAR1B
12076,GO:0045188,0.156920249215568,0.988564325502185,1,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
11510,GO:0043615,0.156996878926693,0.98855278337636,1,8,astrocyte cell migration,BP,HEXB
7457,GO:0030497,0.157017215225209,0.988549719237871,1,8,fatty acid elongation,BP,ELOVL6
968,GO:0002263,0.157035743771055,0.89636278731775,18,665,cell activation involved in immune response,BP,RAB27A;CRISPLD2;ZFPM1;PLAU;PNP;PYCARD;TICAM1;CLCF1;DLL1;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;GLA;DERA;RAB3D
13167,GO:0048263,0.157086522720772,0.988539273157736,1,8,determination of dorsal identity,BP,ACVR1
20642,GO:1905898,0.157127946235177,0.966801981828301,2,34,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R1
3552,GO:0006952,0.157149801130793,0.882632599814682,36,1444,defense response,BP,CFB;NOTCH1;RAB27A;IFI30;PMAIP1;FADD;ACVR1;ADORA1;EDN1;PRKACB;CCL20;PYCARD;TYRO3;PSMB10;TICAM1;PXK;HRAS;WNT5A;JAM3;RNASEL;NMI;BMP6;BMP2;AOX1;SHPK;CHGA;CASP4;AKT1;IFI27;PTGES;INHBB;STAR;CLDN1;PIK3CG;S100B;TSPAN2
16363,GO:0071265,0.157150346394821,0.988529649108273,1,8,L-methionine biosynthetic process,BP,MRI1
5787,GO:0016139,0.157157580560731,0.988528557987626,1,8,glycoside catabolic process,BP,GLA
8269,GO:0032071,0.157178401589512,0.988525417267537,1,8,regulation of endodeoxyribonuclease activity,BP,AKT1
13608,GO:0050711,0.157217792277299,0.98851947417726,1,8,negative regulation of interleukin-1 secretion,BP,GAS6
10897,GO:0042538,0.157282807815369,0.988509661332715,1,8,hyperosmotic salinity response,BP,CLDN1
13923,GO:0051180,0.157351268507989,0.966726314089766,2,34,vitamin transport,BP,STRA6;SLC52A3
6027,GO:0016615,0.157436643046658,0.988486425047809,1,8,malate dehydrogenase activity,MF,MDH1
2997,GO:0006108,0.157515060089001,0.98847457078271,1,8,malate metabolic process,BP,MDH1
17134,GO:0072608,0.157569468176047,0.988466342113975,1,8,interleukin-10 secretion,BP,PYCARD
3866,GO:0007610,0.157665865728826,0.900218358491605,15,547,behavior,BP,ITGA3;ITGA5;CDH23;STRA6;FADD;ADORA1;SPTBN4;PRKAR1B;ESPN;HEXB;STAR;CLDN5;S100B;GDNF;SLC1A3
14022,GO:0051340,0.157668387228318,0.988451373586021,1,8,regulation of ligase activity,BP,RGN
12846,GO:0046877,0.157697287105105,0.988446998472622,1,8,regulation of saliva secretion,BP,FGF10
14153,GO:0051584,0.157766566405821,0.988436506771219,1,8,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
14341,GO:0051940,0.157766566405821,0.988436506771219,1,8,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
11622,GO:0044070,0.157886041604694,0.940990485997059,4,101,regulation of anion transport,BP,ADORA1;EDN1;TTYH1;AKT1
6161,GO:0016861,0.157991174506568,0.988402457021464,1,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MRI1
9266,GO:0034103,0.158229485727354,0.951431051173198,3,66,regulation of tissue remodeling,BP,PDK4;VDR;CLDN18
654,GO:0001784,0.158303082243853,0.966365117085193,2,35,phosphotyrosine binding,MF,PIK3R2;PIK3R1
134,GO:0000271,0.158358599267902,0.95135636131533,3,67,polysaccharide biosynthetic process,BP,PDGFB;B3GNT2;AKT1
13876,GO:0051119,0.158520753743526,0.966328922309555,2,34,sugar transmembrane transporter activity,MF,SLC45A4;SLC2A14
5936,GO:0016459,0.158538527224744,0.951227344284821,3,70,myosin complex,CC,CGN;MYO7A;MYH11
9743,GO:0035264,0.15876068073991,0.932540060542081,5,140,multicellular organism growth,BP,SPTBN4;GHR;NPPC;PIK3CA;DHCR7
10679,GO:0042147,0.15883592425427,0.951143997370949,3,67,retrograde transport, endosome to Golgi,BP,RAB6C;ZFYVE21;TBC1D14
18085,GO:0098598,0.159019398467797,0.988068813625378,1,9,learned vocalization behavior or vocal learning,BP,STRA6
7763,GO:0031093,0.159118257617774,0.951035664002091,3,66,platelet alpha granule lumen,CC,ACTN2;PDGFB;GAS6
16075,GO:0070670,0.15950907563819,0.96599160134974,2,34,response to interleukin-4,BP,FASN;SHPK
11881,GO:0044724,0.159596078715496,0.932086197619118,5,138,single-organism carbohydrate catabolic process,BP,ACTN3;KHK;GALT;PFKFB3;HEXB
2646,GO:0005522,0.159914331366207,0.987929629827114,1,9,profilin binding,MF,RHOQ
1416,GO:0003091,0.160344604082911,0.965666726163743,2,35,renal water homeostasis,BP,PRKACB;PRKAR1B
18114,GO:0098657,0.160576749312073,0.950366828967759,3,67,import into cell,BP,TF;GDNF;SLC1A3
8635,GO:0032637,0.160584043288958,0.950381197356972,3,66,interleukin-8 production,BP,FADD;PYCARD;WNT5A
5709,GO:0015980,0.160831775621286,0.915650523576809,8,252,energy derivation by oxidation of organic compounds,BP,ACTN3;ACADVL;ETFB;MDH1;AKT1;IDH1;PIK3CA;ETFDH
9458,GO:0034452,0.161248458765108,0.987720539861457,1,9,dynactin binding,MF,SPTBN5
17318,GO:0086103,0.162075875122852,0.98758989973623,1,9,G-protein coupled receptor signaling pathway involved in heart process,BP,CHGA
19247,GO:1902622,0.162257393890976,0.965046426046924,2,34,regulation of neutrophil migration,BP,EDN1;JAM3
5055,GO:0010863,0.162306039717304,0.964990258617906,2,35,positive regulation of phospholipase C activity,BP,LPAR2;ANG
8661,GO:0032675,0.163022814683278,0.938350054016173,4,101,regulation of interleukin-6 production,BP,PYCARD;TICAM1;WNT5A;GAS6
16705,GO:0071827,0.163228230868926,0.964670359080381,2,35,plasma lipoprotein particle organization,BP,APOC1;ABCG1
7251,GO:0030135,0.163288405488924,0.914039619255191,8,257,coated vesicle,CC,RAB27A;TF;EDN1;WNT5A;SNX18;HBEGF;IDUA;SH3BP4
19037,GO:1902115,0.163355764995916,0.929950417288572,5,141,regulation of organelle assembly,BP,TBC1D14;EDN1;RALB;SDC4;MSN
2191,GO:0004716,0.163515027099768,0.987360912140034,1,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,TYRO3
7444,GO:0030431,0.163574997098179,0.96454976320392,2,35,sleep,BP,ADORA1;STAR
17756,GO:0097119,0.163812891503821,0.987313238438701,1,9,postsynaptic density protein 95 clustering,BP,CDH2
10463,GO:0038063,0.164019602524035,0.987280097569028,1,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,DDR1
8798,GO:0032881,0.164243843048577,0.964278911452281,2,36,regulation of polysaccharide metabolic process,BP,PDGFB;AKT1
9033,GO:0033280,0.164297624054199,0.964297916329387,2,35,response to vitamin D,BP,BMP7;VDR
10684,GO:0042159,0.164427560999873,0.987214556070961,1,9,lipoprotein catabolic process,BP,LYPLAL1
13599,GO:0050702,0.164719964905727,0.964150388124055,2,35,interleukin-1 beta secretion,BP,PYCARD;WNT5A
14339,GO:0051938,0.164732929858521,0.987165378412124,1,9,L-glutamate import,BP,SLC1A3
12329,GO:0045744,0.164828739050565,0.964112352047074,2,35,negative regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1;RPH3AL
16720,GO:0071867,0.165106263500136,0.963977165892804,2,36,response to monoamine,BP,STAR;PDE4B
16722,GO:0071869,0.165106263500136,0.963977165892804,2,36,response to catecholamine,BP,STAR;PDE4B
5010,GO:0010811,0.165358591000426,0.937106320567379,4,104,positive regulation of cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;SDC4
8852,GO:0032963,0.165803390491175,0.936874590990149,4,104,collagen metabolic process,BP,WNT4;BMP4;CTGF;PEPD
7398,GO:0030330,0.165856034872982,0.936847147494313,4,104,DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1;GADD45A;SESN2;CDKN1A
1001,GO:0002315,0.166191299525258,0.986929123615079,1,9,marginal zone B cell differentiation,BP,DLL1
3013,GO:0006140,0.166286522844483,0.916480736251492,7,217,regulation of nucleotide metabolic process,BP,ACTN3;MRAP;EDN1;WNT5A;NPR1;CHGA;NPPC
11179,GO:0043083,0.16639473734521,0.986895983473453,1,9,synaptic cleft,CC,LAMA5
1208,GO:0002688,0.166474158920076,0.936556523363382,4,101,regulation of leukocyte chemotaxis,BP,EDN1;WNT5A;JAM3;GAS6
15230,GO:0060872,0.166509053131058,0.986877341646763,1,9,semicircular canal development,BP,FGF10
10874,GO:0042509,0.166657990883358,0.94761923874385,3,67,regulation of tyrosine phosphorylation of STAT protein,BP,LIF;GHR;CLCF1
6018,GO:0016600,0.166860968547519,0.986819864629438,1,9,flotillin complex,CC,CDH1
15235,GO:0060896,0.166955046980836,0.986804476365735,1,9,neural plate pattern specification,BP,AXIN1
1369,GO:0002934,0.166956385677306,0.986804257327838,1,9,desmosome organization,BP,PKP3
15195,GO:0060795,0.16695943221848,0.963363983600933,2,35,cell fate commitment involved in formation of primary germ layer,BP,FZD7;BMP4
2811,GO:0005811,0.167011350919051,0.947440039060394,3,68,lipid particle,CC,HSD17B11;G0S2;ACSL4
2170,GO:0004690,0.167082840733587,0.986783557936152,1,9,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB
10985,GO:0042698,0.167110834307912,0.936202414278913,4,103,ovulation cycle,BP,TYRO3;ANG;KITLG;INHBB
13099,GO:0048087,0.1674383690027,0.986725268501526,1,9,positive regulation of developmental pigmentation,BP,KITLG
19868,GO:1903960,0.167533527293119,0.986709643835742,1,9,negative regulation of anion transmembrane transport,BP,AKT1
13770,GO:0050932,0.167645580287326,0.986691232494183,1,9,regulation of pigment cell differentiation,BP,KITLG
6914,GO:0021683,0.167860320663956,0.986655910508104,1,9,cerebellar granular layer morphogenesis,BP,WNT7A
6742,GO:0019869,0.167921829191682,0.986645783917831,1,9,chloride channel inhibitor activity,MF,WNK4
17736,GO:0097091,0.167993572104643,0.986633967167214,1,9,synaptic vesicle clustering,BP,CDH2
11793,GO:0044422,0.168012816037913,0.857136434673844,185,8458,organelle part,CC,EBP;PDK4;PECR;FHOD3;TMEM163;SYT5;WNT3;WNT4;USE1;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;CDH23;IFI30;DPM3;TF;ZFYVE21;PMAIP1;GADD45A;MSRA;CRISPLD2;MRPL14;MRPL16;MRI1;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;ZFPM1;HMGCS2;SALL4;TBC1D14;PXMP2;PXMP4;CASQ2;EXTL1;ACSF2;EDN1;PLAU;RAB40B;PHLDA1;PNP;MRO;ABCG1;PRKACB;SPTBN5;SPTBN4;PYCARD;MBOAT2;SLC25A53;LAGE3;ACADVL;TTYH1;KRT10;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;CDH2;FADS1;FSTL3;FGF18;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;PRKAR1B;PLEKHH2;FOXO4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;HACL1;RHOQ;RHOB;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;ANG;FAM110C;SPTB;HBEGF;NMI;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;HMGN5;AOX1;RAB20;SARDH;ESPN;HEXB;VAMP1;SFXN1;GRIA3;RND3;CHGA;NOL3;HSD3B2;NUDT7;GJB1;CPT1C;PCBD1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;CYTIP;PTGES;IDH1;DECR1;CDH1;PUS1;MYO7A;LDHD;RAB44;TFPI;TLE1;STAR;CLDN5;SNX21;RAB11FIP1;GAS6;SIN3B;GLA;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;DERA;DHCR7;CYB5A;PM20D2;GPSM1;VDR;AMOT;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;ELOVL6;DUSP5;HEY1;ACTA2;RNF144A;PARVB;ETFDH;PDE4B;TMOD4
19720,GO:1903651,0.168086006106544,0.986618734138888,1,9,positive regulation of cytoplasmic transport,BP,MSN
15001,GO:0060491,0.168112873803969,0.927241642709456,5,142,regulation of cell projection assembly,BP,HRAS;RHOQ;FAM110C;ESPN;RAB17
12289,GO:0045665,0.168314596640294,0.920526620401487,6,181,negative regulation of neuron differentiation,BP,WNT3;NOTCH1;WNT5A;BMP7;DLL1;LINGO1
5619,GO:0015810,0.168655579692247,0.986524663808248,1,9,aspartate transport,BP,SLC1A3
21575,GO:2001135,0.16880863642167,0.986499324867545,1,9,regulation of endocytic recycling,BP,ACTN2
13273,GO:0048536,0.168855434840321,0.962653406246293,2,36,spleen development,BP,FADD;FGF10
1172,GO:0002639,0.168948149830313,0.962659808139322,2,35,positive regulation of immunoglobulin production,BP,RBP4;CLCF1
21362,GO:2000648,0.168961830150763,0.962615556047069,2,36,positive regulation of stem cell proliferation,BP,NOTCH1;KITLG
11204,GO:0043123,0.168991687922597,0.92013137590497,6,178,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;TICAM1;AKT1;S100B;PIM2
2412,GO:0005024,0.169018303301917,0.986464572550808,1,9,transforming growth factor beta-activated receptor activity,MF,ACVR1
7608,GO:0030836,0.169380967600488,0.986404347811713,1,9,positive regulation of actin filament depolymerization,BP,ACTN2
15437,GO:0061299,0.169462966238917,0.986390711088709,1,9,retina vasculature morphogenesis in camera-type eye,BP,RHOJ
2161,GO:0004674,0.16952011990697,0.897518043567002,12,431,protein serine/threonine kinase activity,MF,MARK4;ACVR1;PRKACB;MAPK12;NUAK2;PKN3;WNK4;AKT1;PIK3CA;PIK3CG;ARAF;PIM2
7328,GO:0030235,0.170020385149565,0.986297815631164,1,9,nitric-oxide synthase regulator activity,MF,AKT1
9732,GO:0035251,0.170237156124379,0.986261598598229,1,9,UDP-glucosyltransferase activity,MF,ALG5
16783,GO:0071985,0.170690351828019,0.986185715192161,1,9,multivesicular body sorting pathway,BP,RAB27A
16017,GO:0070561,0.170802119627645,0.986166966243641,1,9,vitamin D receptor signaling pathway,BP,VDR
19424,GO:1903039,0.170875974365877,0.913570839549531,7,217,positive regulation of leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD;PIK3R1;AKT1;PIK3CA;EFNB2
14827,GO:0060281,0.171008771314862,0.986132264675055,1,9,regulation of oocyte development,BP,NPPC
20633,GO:1905879,0.171008771314862,0.986132264675055,1,9,regulation of oogenesis,BP,NPPC
12944,GO:0047144,0.171072391641927,0.986121571968451,1,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
12048,GO:0045136,0.171138556468053,0.986110446915592,1,9,development of secondary sexual characteristics,BP,WNT5A
9675,GO:0035088,0.171190911465224,0.961818960518055,2,36,establishment or maintenance of apical/basal cell polarity,BP,WNT5A;MSN
15431,GO:0061245,0.171190911465224,0.961818960518055,2,36,establishment or maintenance of bipolar cell polarity,BP,WNT5A;MSN
3134,GO:0006357,0.171195603015777,0.867637578418873,44,1840,regulation of transcription from RNA polymerase II promoter,BP,ITGA3;LIF;WNT2;POU3F1;NOTCH1;FADD;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;PSMB10;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RNASEL;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;HEXB;AKT1;IFI27;TLE1;SIN3B;ZCCHC12;HNF1A;VDR;GDNF;FZD8;HEY1
963,GO:0002252,0.171294812101526,0.876406342102244,27,1065,immune effector process,BP,CFB;RAB27A;PMAIP1;CRISPLD2;FADD;ZFPM1;PLAU;PNP;PYCARD;PIK3R2;PIK3R1;TICAM1;WNT5A;RBP4;RNASEL;CLCF1;DLL1;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CA;PIK3CG;GLA;DERA;RAB3D
10789,GO:0042364,0.171381607324406,0.98606953892057,1,9,water-soluble vitamin biosynthetic process,BP,RGN
1522,GO:0003266,0.171415659414084,0.986063802442554,1,9,regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
7672,GO:0030917,0.171509651591654,0.986047961769037,1,9,midbrain-hindbrain boundary development,BP,FGF8
19803,GO:1903828,0.171510397206972,0.925294797203457,5,142,negative regulation of cellular protein localization,BP,ACTN2;RHOQ;BMP7;GAS6;CLDN18
3295,GO:0006573,0.171525433902813,0.986045301000388,1,9,valine metabolic process,BP,GHR
13119,GO:0048167,0.17155723648516,0.925253823947559,5,144,regulation of synaptic plasticity,BP,ADORA1;HRAS;STAR;LZTS1;S100B
12368,GO:0045824,0.171653214474783,0.961652890317555,2,36,negative regulation of innate immune response,BP,TYRO3;NMI
7056,GO:0021954,0.171721506190713,0.945238658493968,3,70,central nervous system neuron development,BP,SPTBN4;WNT5A;FGF8
15064,GO:0060586,0.171851989926906,0.985990185211681,1,9,multicellular organismal iron ion homeostasis,BP,BMP6
11015,GO:0042748,0.171854000970976,0.985989845428471,1,9,circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
11940,GO:0044851,0.172148102834185,0.985940106758844,1,9,hair cycle phase,BP,WNT5A
14787,GO:0060215,0.172224884132068,0.985927105886818,1,9,primitive hemopoiesis,BP,ZFPM1
6615,GO:0019439,0.172305134764492,0.895534010755679,12,420,aromatic compound catabolic process,BP,PNP;RGN;PRR5L;GALT;AOX1;NUDT7;PCBD1;PKP3;PKP1;PON2;DERA;PDE4B
10383,GO:0036477,0.1723305017183,0.886098044485085,17,644,somatodendritic compartment,CC,SYT5;ACTN2;RAB27A;ADORA1;SPTBN4;CYP17A1;ANG;DRP2;CPT1C;RAB17;STAR;LZTS1;S100B;KCND1;ACSL4;SLC1A3;PDE4B
17929,GO:0097459,0.172516199640122,0.985877720676243,1,9,iron ion import into cell,BP,TF
6014,GO:0016595,0.17253208873995,0.985875024408162,1,9,glutamate binding,MF,SLC1A3
18864,GO:1901626,0.172541071537371,0.985873499968566,1,9,regulation of postsynaptic membrane organization,BP,CDH2
14894,GO:0060363,0.172621512034296,0.985859844751821,1,9,cranial suture morphogenesis,BP,BMP4
18991,GO:1901998,0.172665500443367,0.961288223414843,2,36,toxin transport,BP,RAB40B;ABCG1
5667,GO:0015886,0.172671499604654,0.985851355518028,1,9,heme transport,BP,FLVCR2
16388,GO:0071312,0.17282999612784,0.961190345387893,2,37,cellular response to alkaloid,BP,CASQ2;STAR
9080,GO:0033483,0.172864116601929,0.98581861838899,1,9,gas homeostasis,BP,WNT7B
13996,GO:0051289,0.172922243379475,0.944699158489921,3,69,protein homotetramerization,BP,ACTN2;PCBD1;DECR1
5311,GO:0014891,0.172927126064294,0.98580790049992,1,9,striated muscle atrophy,BP,ACTN3
978,GO:0002281,0.17298609796296,0.985797865459877,1,9,macrophage activation involved in immune response,BP,TICAM1
14584,GO:0055056,0.173008830373552,0.985793996148559,1,9,D-glucose transmembrane transporter activity,MF,SLC2A14
15775,GO:0070170,0.17304621528968,0.985787631585516,1,9,regulation of tooth mineralization,BP,WNT6
16448,GO:0071394,0.173077463192515,0.985782310638411,1,9,cellular response to testosterone stimulus,BP,MSN
1444,GO:0003149,0.173142708194324,0.985771197157994,1,9,membranous septum morphogenesis,BP,BMP4
15124,GO:0060693,0.173215469276243,0.985758797928704,1,9,regulation of branching involved in salivary gland morphogenesis,BP,FGF10
14686,GO:0060056,0.173321210393581,0.98574076822513,1,9,mammary gland involution,BP,VDR
6670,GO:0019695,0.173420019654296,0.985723909384421,1,9,choline metabolic process,BP,SARDH
5036,GO:0010838,0.173468413754108,0.985715648477255,1,9,positive regulation of keratinocyte proliferation,BP,FGF10
11740,GO:0044325,0.173547547094369,0.932767391068078,4,107,ion channel binding,MF,ACTN3;ACTN2;FXYD1;PDE4B
10118,GO:0035907,0.173549219104302,0.985701849225301,1,9,dorsal aorta development,BP,HEY1
14739,GO:0060137,0.173549947699438,0.985701724769449,1,9,maternal process involved in parturition,BP,EDN1
8260,GO:0032055,0.173740368858593,0.985669177799875,1,9,negative regulation of translation in response to stress,BP,SESN2
15832,GO:0070255,0.173746373831253,0.985668150777527,1,9,regulation of mucus secretion,BP,ADORA1
16897,GO:0072172,0.173753521266313,0.985666928309845,1,9,mesonephric tubule formation,BP,GDNF
15034,GO:0060546,0.173761024088098,0.985665644998031,1,9,negative regulation of necroptotic process,BP,FADD
13344,GO:0048672,0.173824131532989,0.985654848412254,1,9,positive regulation of collateral sprouting,BP,WNT3
14168,GO:0051601,0.17383859762928,0.985652372899627,1,9,exocyst localization,BP,RALB
3593,GO:0007016,0.17391989962017,0.985469117183307,1,10,cytoskeletal anchoring at plasma membrane,BP,SPTBN4
17921,GO:0097449,0.173959052737315,0.98563175109228,1,9,astrocyte projection,CC,GJB2
4551,GO:0009395,0.17400688305367,0.960802826131197,2,36,phospholipid catabolic process,BP,APOC1;IDH1
1752,GO:0003993,0.174057923768725,0.985614812568211,1,9,acid phosphatase activity,MF,ACP5
16157,GO:0070857,0.174088022368939,0.985609653965692,1,9,regulation of bile acid biosynthetic process,BP,STAR
6523,GO:0019203,0.174230416179554,0.985585235602091,1,9,carbohydrate phosphatase activity,MF,PFKFB3
13501,GO:0050308,0.174230416179554,0.985585235602091,1,9,sugar-phosphatase activity,MF,PFKFB3
13334,GO:0048662,0.174276959476056,0.960704795579551,2,36,negative regulation of smooth muscle cell proliferation,BP,NPR1;ANG
5102,GO:0010917,0.174388732300812,0.98555806068892,1,9,negative regulation of mitochondrial membrane potential,BP,PMAIP1
17688,GO:0097011,0.174609064821259,0.985520194901959,1,9,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,AKT1
17689,GO:0097012,0.174609064821259,0.985520194901959,1,9,response to granulocyte macrophage colony-stimulating factor,BP,AKT1
11025,GO:0042761,0.174696839892449,0.985505095258791,1,9,very long-chain fatty acid biosynthetic process,BP,ELOVL6
19009,GO:1902042,0.174720137625407,0.960543716106734,2,36,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD;TRADD
13166,GO:0048262,0.174745139774393,0.985496782788783,1,9,determination of dorsal/ventral asymmetry,BP,ACVR1
8596,GO:0032585,0.174760835210564,0.985494081033228,1,9,multivesicular body membrane,CC,RAB27A
12290,GO:0045666,0.174825261471395,0.902552517024002,9,305,positive regulation of neuron differentiation,BP,ITGA3;ADRA2B;ADRA2C;WNT3;WNT5A;BMP7;BMP6;BMP4;BMP2
15919,GO:0070391,0.17490111221594,0.985469922245634,1,9,response to lipoteichoic acid,BP,CCL20
16338,GO:0071223,0.17490111221594,0.985469922245634,1,9,cellular response to lipoteichoic acid,BP,CCL20
2298,GO:0004862,0.174947043878224,0.985462007106541,1,9,cAMP-dependent protein kinase inhibitor activity,MF,PRKAR1B
15041,GO:0060556,0.175039962003902,0.985445987975987,1,9,regulation of vitamin D biosynthetic process,BP,VDR
15301,GO:0061004,0.175089518675194,0.985437440504055,1,9,pattern specification involved in kidney development,BP,BMP4
16817,GO:0072048,0.175089518675194,0.985437440504055,1,9,renal system pattern specification,BP,BMP4
2860,GO:0005891,0.175147485815026,0.960311735541619,2,38,voltage-gated calcium channel complex,CC,CASQ2;PDE4B
7445,GO:0030432,0.175151645930227,0.98542672106293,1,9,peristalsis,BP,GDNF
1673,GO:0003857,0.175376569872876,0.98538787720405,1,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HSD17B10
21614,GO:2001198,0.175422085545953,0.985380009987221,1,9,regulation of dendritic cell differentiation,BP,TMEM176A
4803,GO:0010459,0.175426129153468,0.985379310954413,1,9,negative regulation of heart rate,BP,SPTBN4
15988,GO:0070513,0.175479493207597,0.985370084037294,1,9,death domain binding,MF,TRADD
7764,GO:0031094,0.175635971692574,0.985170299317128,1,10,platelet dense tubular network,CC,SERPINA5
1150,GO:0002579,0.175638162555039,0.985342630810014,1,9,positive regulation of antigen processing and presentation,BP,PYCARD
7493,GO:0030551,0.175660399521633,0.960161648357334,2,37,cyclic nucleotide binding,MF,PRKAR1B;PDE4B
11014,GO:0042747,0.175687899199702,0.985334019598486,1,9,circadian sleep/wake cycle, REM sleep,BP,STAR
21493,GO:2000833,0.175902078597,0.98529690632874,1,9,positive regulation of steroid hormone secretion,BP,BMP6
21265,GO:2000510,0.175993170240174,0.985281106568341,1,9,positive regulation of dendritic cell chemotaxis,BP,GAS6
8258,GO:0032052,0.176164731447082,0.985251324657978,1,9,bile acid binding,MF,VDR
11257,GO:0043200,0.176254933569008,0.931334247560102,4,106,response to amino acid,BP,EDN1;SESN2;CTGF;SH3BP4
5063,GO:0010873,0.176469140236669,0.985198401574963,1,9,positive regulation of cholesterol esterification,BP,APOC1
13720,GO:0050871,0.176478187569654,0.943038014488123,3,69,positive regulation of B cell activation,BP,TICAM1;CLCF1;CDKN1A
18583,GO:1900274,0.176902588729668,0.959706698010422,2,37,regulation of phospholipase C activity,BP,LPAR2;ANG
5938,GO:0016461,0.177186168181239,0.984897553746788,1,10,unconventional myosin complex,CC,MYO7A
9611,GO:0034767,0.177458442868967,0.93067898648804,4,107,positive regulation of ion transmembrane transport,BP,ACTN2;RGN;KCNH2;FXYD1
6867,GO:0021575,0.177638277992058,0.95939832229365,2,38,hindbrain morphogenesis,BP,WNT7A;DLL1
411,GO:0001076,0.177665065823113,0.921703402723491,5,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,LIF;POU3F1;NOTCH1;TLE1;SIN3B
3812,GO:0007440,0.177973945748932,0.984757925608505,1,10,foregut morphogenesis,BP,NOTCH1
14604,GO:0055085,0.178275335843787,0.866727538590154,33,1348,transmembrane transport,BP,EBP;ACTN2;SLC31A2;CASQ2;ABCG1;KCNK6;FLVCR2;SLC25A53;TTYH1;TSPAN13;PSMB10;RGN;KCNH2;CPT2;FXYD1;RNASEL;SLC2A14;SFXN1;GRIA3;NOL3;GJB1;GJB2;AKT1;GJA3;PIK3CG;KCNG2;GAS6;CYB5A;SLC18B1;KCND1;SLC1A3;CLDN16;PDE4B
4755,GO:0010212,0.178585360070128,0.9211808473396,5,144,response to ionizing radiation,BP,GADD45A;HRAS;RHOB;CDKN1A;STAR
7623,GO:0030857,0.178701892875856,0.959043943822649,2,37,negative regulation of epithelial cell differentiation,BP,NOTCH1;DLL1
1011,GO:0002328,0.178898381305137,0.984593194035845,1,10,pro-B cell differentiation,BP,NOTCH1
5905,GO:0016409,0.179107616307713,0.958893885697644,2,37,palmitoyltransferase activity,MF,CPT2;CPT1C
21322,GO:2000586,0.179207594298131,0.984537880538994,1,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
13074,GO:0048020,0.179675713768524,0.958724151750206,2,36,CCR chemokine receptor binding,MF,CCL20;CNIH4
1194,GO:0002673,0.1799573922647,0.941377627476657,3,70,regulation of acute inflammatory response,BP,CFB;ADORA1;PIK3CG
3670,GO:0007162,0.180156390985334,0.907590098299361,7,223,negative regulation of cell adhesion,BP,NOTCH1;FZD7;PIK3R1;SDC4;BMP4;BMP2;CDH1
5300,GO:0014870,0.180199575908315,0.984359709717495,1,10,response to muscle inactivity,BP,ACTN3
5304,GO:0014877,0.180199575908315,0.984359709717495,1,10,response to muscle inactivity involved in regulation of muscle adaptation,BP,ACTN3
5312,GO:0014894,0.180199575908315,0.984359709717495,1,10,response to denervation involved in regulation of muscle adaptation,BP,ACTN3
13605,GO:0050708,0.180742141168098,0.892063943428319,11,386,regulation of protein secretion,BP,ADRA2C;PYCARD;WNT5A;RBP4;ANG;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6;RPH3AL
572,GO:0001659,0.180747837124734,0.958284942761146,2,37,temperature homeostasis,BP,ADORA1;ACADVL
11023,GO:0042759,0.180786438613796,0.984253785130319,1,10,long-chain fatty acid biosynthetic process,BP,ELOVL6
22,GO:0000041,0.180805085978331,0.928887244552163,4,106,transition metal ion transport,BP,TF;SLC31A2;TTYH1;SFXN1
9698,GO:0035136,0.181155017068989,0.958094159804595,2,38,forelimb morphogenesis,BP,WNT3;WNT7A
19453,GO:1903115,0.181294399756533,0.958005073820063,2,39,regulation of actin filament-based movement,BP,DSC2;PDE4B
10313,GO:0036312,0.181378729681961,0.984146490251833,1,10,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1
19338,GO:1902894,0.181525304919436,0.984119877221647,1,10,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB
12598,GO:0046332,0.181529228442214,0.940576972580544,3,73,SMAD binding,MF,ACVR1;AXIN1;BMP2
8776,GO:0032836,0.181870335411931,0.984057136586728,1,10,glomerular basement membrane development,BP,WT1
11390,GO:0043409,0.181920803955914,0.919219665589636,5,145,negative regulation of MAPK cascade,BP,LIF;BMP7;BMP4;AKT1;DUSP5
12819,GO:0046825,0.182122397515045,0.957732436780052,2,38,regulation of protein export from nucleus,BP,IFI27;GAS6
9513,GO:0034614,0.182365988101847,0.918965205878348,5,144,cellular response to reactive oxygen species,BP,GUCY1B3;RGN;RHOB;BMP7;AKT1
6674,GO:0019722,0.18276474399175,0.918708716157818,5,147,calcium-mediated signaling,BP,ACTN3;CASQ2;EDN1;CCL20;RGN
5947,GO:0016485,0.182913727103833,0.905806223110044,7,222,protein processing,BP,CFB;RHBDL3;FADD;PLAU;PRKACB;NOL3;GAS6
1067,GO:0002433,0.183414114806359,0.939711461671769,3,71,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R2;PIK3R1;PIK3CA
10477,GO:0038096,0.183414114806359,0.939711461671769,3,71,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R2;PIK3R1;PIK3CA
7209,GO:0030049,0.183425153902628,0.957205593330249,2,39,muscle filament sliding,BP,ACTN3;ACTN2
9029,GO:0033275,0.183425153902628,0.957205593330249,2,39,actin-myosin filament sliding,BP,ACTN3;ACTN2
18118,GO:0098662,0.183441868157559,0.877569978752953,17,648,inorganic cation transmembrane transport,BP,ACTN2;SLC31A2;CASQ2;KCNK6;TTYH1;TSPAN13;RGN;KCNH2;FXYD1;NOL3;PIK3CG;KCNG2;GAS6;CYB5A;KCND1;CLDN16;PDE4B
13712,GO:0050863,0.183467155118844,0.896632546043742,9,302,regulation of T cell activation,BP,FADD;PNP;PYCARD;PIK3R1;SDC4;BMP4;AKT1;PIK3CA;EFNB2
3464,GO:0006813,0.18392382694166,0.905140830575653,7,224,potassium ion transport,BP,ACTN2;ADORA1;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
18094,GO:0098631,0.184192438996414,0.956954100636135,2,38,protein binding involved in cell adhesion,MF,DSC2;PKP3
11388,GO:0043407,0.184374108968373,0.939250947261699,3,71,negative regulation of MAP kinase activity,BP,BMP7;BMP4;DUSP5
1490,GO:0003211,0.184984035732204,0.983484900684639,1,10,cardiac ventricle formation,BP,NOTCH1
21459,GO:2000786,0.184997232892348,0.983482452137762,1,10,positive regulation of autophagosome assembly,BP,RALB
16225,GO:0070970,0.185493268147747,0.983390277719427,1,10,interleukin-2 secretion,BP,PNP
16898,GO:0072173,0.185622893824063,0.983366144747152,1,10,metanephric tubule morphogenesis,BP,WNT4
11696,GO:0044259,0.185656622024756,0.926216404603034,4,109,multicellular organismal macromolecule metabolic process,BP,WNT4;BMP4;CTGF;PEPD
16703,GO:0071825,0.185769619938158,0.956357145127633,2,38,protein-lipid complex subunit organization,BP,APOC1;ABCG1
13208,GO:0048340,0.185791674566591,0.983334693760449,1,10,paraxial mesoderm morphogenesis,BP,WNT5A
14713,GO:0060088,0.186004370165316,0.983295013902946,1,10,auditory receptor cell stereocilium organization,BP,MYO7A
695,GO:0001840,0.186195830032829,0.983259252148151,1,10,neural plate development,BP,FGF8
18954,GO:1901888,0.186360547595569,0.938257844884454,3,73,regulation of cell junction assembly,BP,WNT4;SDC4;CLDN1
8489,GO:0032429,0.186441889651223,0.983213231362368,1,10,regulation of phospholipase A2 activity,BP,ANG
19413,GO:1903025,0.186475070996466,0.983207020200878,1,10,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,LIF
2876,GO:0005916,0.186618293515863,0.983180196376272,1,10,fascia adherens,CC,CDH2
21216,GO:2000425,0.186872175380378,0.983132590590394,1,10,regulation of apoptotic cell clearance,BP,MFGE8
8634,GO:0032635,0.186874619436342,0.925571115454453,4,107,interleukin-6 production,BP,PYCARD;TICAM1;WNT5A;GAS6
688,GO:0001833,0.186934437295862,0.983120904665146,1,10,inner cell mass cell proliferation,BP,SALL4
15689,GO:0070016,0.186948474017533,0.983118269512119,1,10,armadillo repeat domain binding,MF,AXIN1
3830,GO:0007519,0.187119705904663,0.916132671808942,5,147,skeletal muscle tissue development,BP,ACTN3;NOTCH1;IGSF8;DLL1;S100B
8023,GO:0031588,0.187251760932226,0.983061278341746,1,10,nucleotide-activated protein kinase complex,CC,SESN2
3738,GO:0007260,0.18730600063849,0.937836932819262,3,71,tyrosine phosphorylation of STAT protein,BP,LIF;GHR;CLCF1
18605,GO:1900408,0.187312723448613,0.955769797931285,2,38,negative regulation of cellular response to oxidative stress,BP,NOL3;AKT1
19333,GO:1902883,0.187312723448613,0.955769797931285,2,38,negative regulation of response to oxidative stress,BP,NOL3;AKT1
19489,GO:1903202,0.187312723448613,0.955769797931285,2,38,negative regulation of oxidative stress-induced cell death,BP,NOL3;AKT1
45,GO:0000096,0.187382178777346,0.955743284872437,2,38,sulfur amino acid metabolic process,BP,MSRA;MRI1
13293,GO:0048570,0.187597861706993,0.982996115168978,1,10,notochord morphogenesis,BP,WNT5A
17074,GO:0072521,0.187735990682507,0.87770383646496,15,555,purine-containing compound metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;PNP;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;AOX1;CHGA;NUDT7;NPPC;PDE4B
12448,GO:0045955,0.187854754043901,0.982947660573388,1,10,negative regulation of calcium ion-dependent exocytosis,BP,NOTCH1
1597,GO:0003413,0.188114951881428,0.982898506546503,1,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,NPPC
6064,GO:0016705,0.188135228256256,0.915536131242991,5,146,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,PHYH;FADS1;CYP17A1;PCBD1;CYP11A1
12832,GO:0046849,0.188195074392893,0.937387249706047,3,72,bone remodeling,BP,PDK4;RAB3D;CLDN18
8732,GO:0032784,0.188389033058264,0.955358200707306,2,38,regulation of DNA-templated transcription, elongation,BP,AXIN1;TSFM
19544,GO:1903312,0.188432030461548,0.955341725010896,2,38,negative regulation of mRNA metabolic process,BP,PKP3;PKP1
20668,GO:1990001,0.188480150845791,0.982829387751262,1,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,NOL3
5572,GO:0015718,0.188513391145917,0.915310939668569,5,146,monocarboxylic acid transport,BP,EDN1;CPT2;FABP3;AKT1;ACSL4
18350,GO:0099565,0.188604028040555,0.92458798413912,4,110,chemical synaptic transmission, postsynaptic,BP,WNT7A;ADORA1;GRIA3;AKT1
18653,GO:1901019,0.188691320325981,0.937127958465685,3,73,regulation of calcium ion transmembrane transporter activity,BP,CASQ2;RGN;PDE4B
6761,GO:0019903,0.188717510974699,0.924536235121025,4,109,protein phosphatase binding,MF,CDH2;PIK3R2;PIK3R1;AKT1
6528,GO:0019209,0.188773589886997,0.937106141390302,3,72,kinase activator activity,MF,CDKN1A;PIK3CA;GAS6
1521,GO:0003264,0.188811745952325,0.982766498393872,1,10,regulation of cardioblast proliferation,BP,NOTCH1
7014,GO:0021877,0.188832353152962,0.982762585990556,1,10,forebrain neuron fate commitment,BP,AXIN1
18636,GO:1900746,0.188847876315399,0.982759638506012,1,10,regulation of vascular endothelial growth factor signaling pathway,BP,DLL1
4947,GO:0010717,0.189160406388387,0.936899692083987,3,73,regulation of epithelial to mesenchymal transition,BP,NOTCH1;ACVR1;BMP2
15185,GO:0060768,0.189163913524972,0.982699571209646,1,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
6530,GO:0019211,0.189184202090407,0.98269571122538,1,10,phosphatase activator activity,MF,BMP2
428,GO:0001102,0.18918852831524,0.955011989760913,2,39,RNA polymerase II activating transcription factor binding,MF,ZFPM1;IFI27
9049,GO:0033327,0.189459689843468,0.982643252443515,1,10,Leydig cell differentiation,BP,DHH
11617,GO:0044058,0.189478655233296,0.954939902864542,2,38,regulation of digestive system process,BP,FGF10;WNK4
17117,GO:0072584,0.189521792292703,0.982631414944179,1,10,caveolin-mediated endocytosis,BP,UNC119
3665,GO:0007157,0.189785711840263,0.954782101438747,2,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ITGA5;CDH2
6079,GO:0016725,0.189840741299976,0.982570550523256,1,10,oxidoreductase activity, acting on CH or CH2 groups,MF,AOX1
6265,GO:0017085,0.189911087672586,0.982557110961683,1,10,response to insecticide,BP,STAR
10103,GO:0035878,0.190010216130727,0.982538163118442,1,10,nail development,BP,ITGB4
16687,GO:0071803,0.19009577154057,0.982521800740584,1,10,positive regulation of podosome assembly,BP,MSN
4853,GO:0010561,0.190204762082662,0.98250094441307,1,10,negative regulation of glycoprotein biosynthetic process,BP,HBEGF
16475,GO:0071436,0.190339855285014,0.982475074430871,1,10,sodium ion export,BP,FXYD1
9967,GO:0035646,0.19035188102996,0.982472770531224,1,10,endosome to melanosome transport,BP,RAB38
11423,GO:0043485,0.19035188102996,0.982472770531224,1,10,endosome to pigment granule transport,BP,RAB38
13397,GO:0048757,0.19035188102996,0.982472770531224,1,10,pigment granule maturation,BP,RAB38
2994,GO:0006105,0.19060465374695,0.982424306259967,1,10,succinate metabolic process,BP,GHR
14674,GO:0060044,0.190651110274922,0.982415391244684,1,10,negative regulation of cardiac muscle cell proliferation,BP,RBP4
17808,GO:0097202,0.190657890742011,0.982414089867398,1,10,activation of cysteine-type endopeptidase activity,BP,FADD
2941,GO:0006024,0.190750148918993,0.923403122210844,4,110,glycosaminoglycan biosynthetic process,BP,EXTL1;PDGFB;SDC4;B3GNT2
8201,GO:0031957,0.190853261987529,0.982376569817316,1,10,very long-chain fatty acid-CoA ligase activity,MF,ACSL4
2502,GO:0005172,0.190857299726779,0.982375793933765,1,10,vascular endothelial growth factor receptor binding,MF,ITGA5
2914,GO:0005984,0.190863539645911,0.982374594847572,1,10,disaccharide metabolic process,BP,IDUA
17447,GO:0090193,0.190871351762519,0.982373093579807,1,10,positive regulation of glomerulus development,BP,PDGFB
20664,GO:1905954,0.190905627472824,0.936047884696809,3,73,positive regulation of lipid localization,BP,EDN1;ABCG1;BMP6
11811,GO:0044446,0.191191207579696,0.836227155101999,180,8256,intracellular organelle part,CC,EBP;PDK4;PECR;FHOD3;TMEM163;SYT5;WNT3;WNT4;USE1;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;ALG5;PHYH;NOTCH1;GLDC;MARK4;RAB27A;IFI30;DPM3;TF;ZFYVE21;PMAIP1;GADD45A;MSRA;CRISPLD2;MRPL14;MRPL16;MRI1;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;ZFPM1;HMGCS2;SALL4;TBC1D14;PXMP2;PXMP4;CASQ2;EXTL1;ACSF2;EDN1;PLAU;RAB40B;PHLDA1;PNP;MRO;ABCG1;PRKACB;SPTBN5;SPTBN4;PYCARD;MBOAT2;SLC25A53;LAGE3;ACADVL;TTYH1;KRT10;RAB39A;MGST2;SYCN;ACSM5;MAPK12;FZD7;TYRO3;PSMB10;CDH2;FADS1;FSTL3;FGF18;PIK3R1;TICAM1;CGN;REEP1;ARL6IP4;PDGFB;PLEKHH2;FOXO4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;HACL1;RHOQ;RHOB;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;ANG;FAM110C;SPTB;HBEGF;NMI;CAMSAP3;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;HMGN5;AOX1;RAB20;SARDH;ESPN;HEXB;VAMP1;SFXN1;GRIA3;RND3;CHGA;NOL3;HSD3B2;NUDT7;GJB1;CPT1C;PCBD1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;RAB17;CYTIP;PTGES;IDH1;DECR1;CDH1;PUS1;MYO7A;LDHD;RAB44;TLE1;STAR;CLDN5;SNX21;RAB11FIP1;GAS6;SIN3B;GLA;ECI1;ZCCHC12;CYP11A1;RPH3AL;MYH11;DERA;DHCR7;CYB5A;PM20D2;GPSM1;VDR;AMOT;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;ELOVL6;DUSP5;HEY1;RNF144A;ETFDH;PDE4B;TMOD4
15384,GO:0061140,0.191214861115819,0.982307012384161,1,10,lung secretory cell differentiation,BP,FGF10
1428,GO:0003128,0.191253670911439,0.982299538096374,1,10,heart field specification,BP,BMP4
7688,GO:0030957,0.191280110447232,0.982294445189609,1,10,Tat protein binding,MF,DLL1
10837,GO:0042447,0.191379328780595,0.982275326219949,1,10,hormone catabolic process,BP,HSD17B11
14350,GO:0051956,0.191401926905782,0.982270970091627,1,10,negative regulation of amino acid transport,BP,ADORA1
9349,GO:0034244,0.191554364015786,0.982241570411133,1,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
10514,GO:0038166,0.19155857936714,0.982240757045603,1,10,angiotensin-activated signaling pathway,BP,ACTN2
13115,GO:0048156,0.191565689321049,0.982239385111562,1,10,tau protein binding,MF,S100B
20660,GO:1905941,0.191621038460554,0.982228703000851,1,10,positive regulation of gonad development,BP,WT1
18935,GO:1901841,0.191642744071374,0.982224512976109,1,10,regulation of high voltage-gated calcium channel activity,BP,PDE4B
19996,GO:1904251,0.19171781789353,0.982210016693835,1,10,regulation of bile acid metabolic process,BP,STAR
21560,GO:2001054,0.191871158888294,0.982180387636083,1,10,negative regulation of mesenchymal cell apoptotic process,BP,BMP7
4334,GO:0008970,0.191872162425881,0.982180193641297,1,10,phosphatidylcholine 1-acylhydrolase activity,MF,PLA2G16
5019,GO:0010820,0.191990365657639,0.982157335665914,1,10,positive regulation of T cell chemotaxis,BP,WNT5A
19090,GO:1902237,0.192147950227558,0.98212683750969,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
11242,GO:0043178,0.192375156239446,0.935327526082028,3,73,alcohol binding,MF,ABCG1;RBP4;STAR
15055,GO:0060576,0.192502088346883,0.982058196418415,1,10,intestinal epithelial cell development,BP,CDKN1A
8268,GO:0032070,0.19258374255128,0.98204234951699,1,10,regulation of deoxyribonuclease activity,BP,AKT1
677,GO:0001821,0.192698058789047,0.982020151058201,1,10,histamine secretion,BP,EDN1
5699,GO:0015937,0.192762773695695,0.982007577833,1,10,coenzyme A biosynthetic process,BP,ACAT1
7546,GO:0030677,0.19303152162099,0.981955312835805,1,10,ribonuclease P complex,CC,HSD17B10
2086,GO:0004576,0.193039278593993,0.981953803072202,1,10,oligosaccharyl transferase activity,MF,ALG5
3854,GO:0007595,0.193102378611662,0.953457903780596,2,40,lactation,BP,DDR1;VDR
4365,GO:0009071,0.193220691905779,0.981918474527343,1,10,serine family amino acid catabolic process,BP,GLDC
3281,GO:0006558,0.193474988474715,0.981868889640968,1,10,L-phenylalanine metabolic process,BP,PCBD1
3282,GO:0006559,0.193474988474715,0.981868889640968,1,10,L-phenylalanine catabolic process,BP,PCBD1
19076,GO:1902221,0.193474988474715,0.981868889640968,1,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,PCBD1
19077,GO:1902222,0.193474988474715,0.981868889640968,1,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,PCBD1
8399,GO:0032306,0.193506943456253,0.98186265358669,1,10,regulation of prostaglandin secretion,BP,EDN1
8400,GO:0032308,0.193506943456253,0.98186265358669,1,10,positive regulation of prostaglandin secretion,BP,EDN1
8072,GO:0031670,0.193626592389779,0.95329192391844,2,39,cellular response to nutrient,BP,GAS6;VDR
21264,GO:2000508,0.19373925811695,0.981817282163599,1,10,regulation of dendritic cell chemotaxis,BP,GAS6
1222,GO:0002702,0.194056137706629,0.934518881670969,3,72,positive regulation of production of molecular mediator of immune response,BP,WNT5A;RBP4;CLCF1
1892,GO:0004303,0.194114508339206,0.981743865449517,1,10,estradiol 17-beta-dehydrogenase activity,MF,HSD17B11
10201,GO:0036041,0.194187054110106,0.981729653567877,1,10,long-chain fatty acid binding,MF,FABP3
4995,GO:0010771,0.19421198900992,0.934404776965243,3,74,negative regulation of cell morphogenesis involved in differentiation,BP,WNT3;WNT5A;LINGO1
9902,GO:0035567,0.194933900978344,0.911439143305591,5,149,non-canonical Wnt signaling pathway,BP,WNT4;WNT7A;FZD7;PSMB10;WNT5A
2940,GO:0006023,0.195080677463594,0.920983839121458,4,111,aminoglycan biosynthetic process,BP,EXTL1;PDGFB;SDC4;B3GNT2
13722,GO:0050873,0.195086281248513,0.952720331178787,2,39,brown fat cell differentiation,BP,MRAP;NUDT7
2809,GO:0005801,0.19517028362236,0.95264815217931,2,40,cis-Golgi network,CC,PIK3R1;CTGF
8018,GO:0031581,0.195263922555209,0.981343433289121,1,11,hemidesmosome assembly,BP,ITGB4
19568,GO:1903364,0.19527977338481,0.903732273935538,6,186,positive regulation of cellular protein catabolic process,BP,PSMB10;RGN;AXIN1;MSN;AKT1;RNF144A
12648,GO:0046461,0.195385765206284,0.952602699511377,2,39,neutral lipid catabolic process,BP,FABP3;PIK3CG
12651,GO:0046464,0.195385765206284,0.952602699511377,2,39,acylglycerol catabolic process,BP,FABP3;PIK3CG
9026,GO:0033270,0.195519671140414,0.981292510731998,1,11,paranode region of axon,CC,SPTBN4
20227,GO:1904754,0.195552280720357,0.981286012373358,1,11,positive regulation of vascular associated smooth muscle cell migration,BP,PDGFB
17249,GO:0086009,0.195582182836057,0.952486165686119,2,40,membrane repolarization,BP,CASQ2;KCNH2
16403,GO:0071333,0.195693489261894,0.920652144700382,4,110,cellular response to glucose stimulus,BP,GJB6;STAR;PIK3CA;GAS6
18078,GO:0098589,0.195842730493723,0.884317728436687,10,355,membrane region,CC,TF;FADD;TRADD;CDH2;RHOQ;SDC4;DLL1;CDH1;EPN1;SH3BP4
11521,GO:0043627,0.195946286091602,0.933565147752598,3,73,response to estrogen,BP,DHH;WNT7A;STAR
10465,GO:0038065,0.196069734808171,0.981182731639916,1,11,collagen-activated signaling pathway,BP,DDR1
9145,GO:0033628,0.196101538293364,0.952321063533254,2,39,regulation of cell adhesion mediated by integrin,BP,PLAU;PIK3CG
9054,GO:0033344,0.196162935795936,0.952257382664829,2,40,cholesterol efflux,BP,APOC1;ABCG1
12470,GO:0046006,0.196293813524028,0.952245290193176,2,39,regulation of activated T cell proliferation,BP,FADD;PYCARD
10667,GO:0042129,0.196636814463779,0.910425157491502,5,147,regulation of T cell proliferation,BP,FADD;PNP;PYCARD;SDC4;BMP4
11324,GO:0043299,0.197347282750411,0.872395795389334,14,519,leukocyte degranulation,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;GLA;DERA;RAB3D
21421,GO:2000736,0.197590749379857,0.951692958257391,2,40,regulation of stem cell differentiation,BP,NOTCH1;GDNF
16688,GO:0071804,0.198064403767603,0.901937111251711,6,189,cellular potassium ion transport,BP,ACTN2;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
16689,GO:0071805,0.198064403767603,0.901937111251711,6,189,potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
14357,GO:0051963,0.198334440191906,0.932340078939149,3,75,regulation of synapse assembly,BP,WNT7A;WNT5A;RAB17
11258,GO:0043201,0.198456638336139,0.980702326990054,1,11,response to leucine,BP,SESN2
13645,GO:0050768,0.198581151902367,0.895448508561102,7,232,negative regulation of neurogenesis,BP,WNT3;NOTCH1;WNT7A;WNT5A;BMP7;DLL1;LINGO1
13234,GO:0048407,0.198706623191484,0.980651633087942,1,11,platelet-derived growth factor binding,MF,PDGFB
3487,GO:0006853,0.198801741939671,0.980632325199383,1,11,carnitine shuttle,BP,CPT2
9608,GO:0034764,0.198879875387674,0.918840641238536,4,112,positive regulation of transmembrane transport,BP,ACTN2;RGN;KCNH2;FXYD1
17307,GO:0086080,0.198881011578098,0.980616226492066,1,11,protein binding involved in heterotypic cell-cell adhesion,MF,DSC2
7542,GO:0030672,0.198973494552883,0.932039200789812,3,74,synaptic vesicle membrane,CC,TMEM163;SYT5;VAMP1
18317,GO:0099501,0.198973494552883,0.932039200789812,3,74,exocytic vesicle membrane,CC,TMEM163;SYT5;VAMP1
15930,GO:0070411,0.199566450416627,0.980476719234745,1,11,I-SMAD binding,MF,AXIN1
2430,GO:0005068,0.199596139987798,0.980470664247341,1,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
18281,GO:0099024,0.199773561718041,0.950824726796749,2,40,plasma membrane invagination,BP,MFGE8;SNX18
7327,GO:0030234,0.199971089769523,0.855711876631941,24,961,enzyme regulator activity,MF,RIN3;NOTCH1;SERPINA5;APOC1;TBC1D14;PYCARD;MGST2;RGN;PIK3R2;PIK3R1;PDGFB;PRKAR1B;SESN2;AXIN1;BMP2;CDKN1A;NOL3;AKT1;CST9L;TFPI;PIK3CA;GAS6;GPSM1;SH3BP4
3693,GO:0007188,0.200206663272939,0.908241461169686,5,149,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PRKACB;CHGA
143,GO:0000287,0.200261777199307,0.900522016679812,6,190,magnesium ion binding,MF,PRKACB;MAPK12;HACL1;NUAK2;NUDT7;IDH1
13859,GO:0051091,0.200867658691364,0.893929526542754,7,230,positive regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;TRADD;EDN1;PYCARD;TICAM1;WNT5A;AKT1
15018,GO:0060525,0.201025950608321,0.98017785650985,1,11,prostate glandular acinus development,BP,NOTCH1
12496,GO:0046058,0.201221853070215,0.907614449403194,5,150,cAMP metabolic process,BP,MRAP;EDN1;CHGA;NPPC;PDE4B
15278,GO:0060976,0.201285063596344,0.95014365542377,2,42,coronary vasculature development,BP,NOTCH1;BMP4
12364,GO:0045820,0.201321231296985,0.980117091644011,1,11,negative regulation of glycolytic process,BP,ACTN3
13936,GO:0051195,0.201321231296985,0.980117091644011,1,11,negative regulation of cofactor metabolic process,BP,ACTN3
13939,GO:0051198,0.201321231296985,0.980117091644011,1,11,negative regulation of coenzyme metabolic process,BP,ACTN3
14160,GO:0051592,0.201467823465065,0.917366914302467,4,113,response to calcium ion,BP,CASQ2;EDN1;WNT5A;PTGES
12563,GO:0046189,0.201562086992016,0.950108508423002,2,40,phenol-containing compound biosynthetic process,BP,PNMT;WNT5A
13675,GO:0050807,0.202175482360421,0.916965463277867,4,113,regulation of synapse organization,BP,WNT7A;CDH2;WNT5A;RAB17
13378,GO:0048715,0.202268460627233,0.979921481948514,1,11,negative regulation of oligodendrocyte differentiation,BP,NOTCH1
7636,GO:0030877,0.202447683144493,0.979884354072279,1,11,beta-catenin destruction complex,CC,AXIN1
11134,GO:0043005,0.202506218291595,0.854675028631823,23,931,neuron projection,CC,ITGA3;ADRA2C;SYT5;ACTN2;MARK4;RAB27A;FADD;ADORA1;SPTBN4;RAB39B;FSTL3;CYP17A1;ANG;DRP2;VAMP1;CPT1C;RAB17;NRTN;STAR;LZTS1;KCND1;SLC1A3;PDE4B
3366,GO:0006664,0.202844779939269,0.916607572108604,4,111,glycolipid metabolic process,BP,DPM3;ITGB8;HEXB;GLA
14875,GO:0060338,0.203063604386654,0.949503875180167,2,40,regulation of type I interferon-mediated signaling pathway,BP,FADD;WNT5A
12378,GO:0045839,0.203190949363401,0.949412932319558,2,41,negative regulation of mitotic nuclear division,BP,BMP7;BMP4
846,GO:0002043,0.203195897808062,0.979728950386307,1,11,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,BMP4
14908,GO:0060379,0.203295483691871,0.979708217414665,1,11,cardiac muscle cell myoblast differentiation,BP,NOTCH1
18650,GO:1901016,0.20331588616843,0.949362427716812,2,41,regulation of potassium ion transmembrane transporter activity,BP,ACTN2;CASQ2
11513,GO:0043619,0.203452004013951,0.97967560785661,1,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
16198,GO:0070925,0.203952156649924,0.861565056567125,17,664,organelle assembly,BP,FHOD3;ACTN2;NOTCH1;MARK4;TBC1D14;CASQ2;EDN1;RAB39A;RALB;SDC4;RAB20;MSN;RAB17;MYO7A;MYH11;LAMA5;RAB38
10151,GO:0035970,0.204180948448462,0.979523363714887,1,11,peptidyl-threonine dephosphorylation,BP,DUSP5
17353,GO:0090051,0.204365367821695,0.979484748696729,1,11,negative regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
20001,GO:1904262,0.204513883367221,0.979453622692576,1,11,negative regulation of TORC1 signaling,BP,SESN2
17709,GO:0097038,0.204535098265331,0.979449174361413,1,11,perinuclear endoplasmic reticulum,CC,PIK3R1
12353,GO:0045793,0.204545987418631,0.97944689092467,1,11,positive regulation of cell size,BP,EDN1
11409,GO:0043455,0.20455207719658,0.979445613848495,1,11,regulation of secondary metabolic process,BP,WNT5A
7302,GO:0030204,0.204568391588179,0.948854945019276,2,41,chondroitin sulfate metabolic process,BP,IDUA;HEXB
21620,GO:2001204,0.204681775791029,0.979418404739525,1,11,regulation of osteoclast development,BP,CLDN18
17331,GO:0090009,0.204789940149712,0.979395698256233,1,11,primitive streak formation,BP,WNT5A
11108,GO:0042977,0.204977145561816,0.979356366815732,1,11,activation of JAK2 kinase activity,BP,GHR
13326,GO:0048642,0.204995960530125,0.979352411574777,1,11,negative regulation of skeletal muscle tissue development,BP,S100B
10475,GO:0038094,0.205165980111294,0.928899338557714,3,75,Fc-gamma receptor signaling pathway,BP,PIK3R2;PIK3R1;PIK3CA
5269,GO:0014819,0.20520885621517,0.979307628374439,1,11,regulation of skeletal muscle contraction,BP,ACTN3
21554,GO:2001044,0.205321929848229,0.979283821542604,1,11,regulation of integrin-mediated signaling pathway,BP,LIMS2
17866,GO:0097340,0.205347261333964,0.979278486139002,1,11,inhibition of cysteine-type endopeptidase activity,BP,NOL3
17867,GO:0097341,0.205347261333964,0.979278486139002,1,11,zymogen inhibition,BP,NOL3
4987,GO:0010763,0.20539807902583,0.979267780488524,1,11,positive regulation of fibroblast migration,BP,AKT1
19204,GO:1902547,0.205443902764358,0.979258124321802,1,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DLL1
2495,GO:0005165,0.205484803513378,0.97924950347997,1,11,neurotrophin receptor binding,MF,PIK3R1
11270,GO:0043220,0.205493994854838,0.979247565909614,1,11,Schmidt-Lanterman incisure,CC,JAM3
13244,GO:0048484,0.205583441511084,0.979228705064598,1,11,enteric nervous system development,BP,GDNF
10374,GO:0036465,0.205674549816251,0.948404992123212,2,41,synaptic vesicle recycling,BP,SYT5;WNT7A
20972,GO:2000052,0.205788635470486,0.979185402332033,1,11,positive regulation of non-canonical Wnt signaling pathway,BP,WNT5A
8720,GO:0032769,0.205818316429991,0.979179134599521,1,11,negative regulation of monooxygenase activity,BP,GLA
3817,GO:0007494,0.206014686862258,0.979137641135269,1,11,midgut development,BP,WNT5A
15184,GO:0060767,0.206122802915974,0.979114776792929,1,11,epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
7032,GO:0021903,0.206224529919338,0.979093251149206,1,11,rostrocaudal neural tube patterning,BP,FGF8
9174,GO:0033690,0.206308686228498,0.979075434371918,1,11,positive regulation of osteoblast proliferation,BP,BMP2
20947,GO:2000009,0.206310601774849,0.979075028734353,1,11,negative regulation of protein localization to cell surface,BP,ACTN2
11938,GO:0044848,0.206314698466141,0.979074161201485,1,11,biological phase,BP,WNT5A
7374,GO:0030301,0.206318386196166,0.928294190014364,3,76,cholesterol transport,BP,APOC1;ABCG1;STAR
21053,GO:2000194,0.206435662867794,0.979048536432825,1,11,regulation of female gonad development,BP,WT1
9600,GO:0034755,0.206455566170983,0.979044318534857,1,11,iron ion transmembrane transport,BP,TTYH1
4114,GO:0008385,0.206485050480995,0.979038069384725,1,11,IkappaB kinase complex,CC,PYCARD
17701,GO:0097028,0.206548404792558,0.948088847966161,2,40,dendritic cell differentiation,BP,TMEM176A;GAS6
14601,GO:0055081,0.206676957936108,0.947995811576167,2,41,anion homeostasis,BP,ABCG1;FABP3
8377,GO:0032276,0.206707511222135,0.978990886481136,1,11,regulation of gonadotropin secretion,BP,INHBB
13690,GO:0050829,0.206787290021907,0.947991245299563,2,40,defense response to Gram-negative bacterium,BP,PYCARD;CHGA
6760,GO:0019902,0.206915814572643,0.904095287484324,5,153,phosphatase binding,MF,SPTBN4;CDH2;PIK3R2;PIK3R1;AKT1
19634,GO:1903509,0.207176386171535,0.914122397204881,4,112,liposaccharide metabolic process,BP,DPM3;ITGB8;HEXB;GLA
7287,GO:0030183,0.207230216005508,0.91408015182259,4,113,B cell differentiation,BP,PIK3R1;CLCF1;DLL1;TPD52
3021,GO:0006163,0.207266944492498,0.864800420819297,14,523,purine nucleotide metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;PNP;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;CHGA;NUDT7;NPPC;PDE4B
15351,GO:0061081,0.20734510438832,0.978855335614636,1,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,WNT5A
9747,GO:0035269,0.207448145746264,0.978833384661822,1,11,protein O-linked mannosylation,BP,DPM3
15972,GO:0070486,0.207464591053686,0.978829880161046,1,11,leukocyte aggregation,BP,BMP7
12856,GO:0046887,0.207737440287116,0.913800293545969,4,112,positive regulation of hormone secretion,BP,EDN1;RBP4;BMP6;INHBB
11251,GO:0043194,0.207741463727201,0.9786063307812,1,12,axon initial segment,CC,SPTBN4
11783,GO:0044406,0.20774455552721,0.978770171118474,1,11,adhesion of symbiont to host,BP,GAS6
17248,GO:0086008,0.20785596996137,0.978746383858688,1,11,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNH2
15885,GO:0070341,0.207961520869426,0.978723835082238,1,11,fat cell proliferation,BP,FGF10
15888,GO:0070344,0.207961520869426,0.978723835082238,1,11,regulation of fat cell proliferation,BP,FGF10
3364,GO:0006662,0.208038201798724,0.978707445607849,1,11,glycerol ether metabolic process,BP,PLA2G16
2985,GO:0006094,0.208151759440799,0.927376519953275,3,75,gluconeogenesis,BP,SESN2;RBP4;MDH1
5057,GO:0010867,0.208154815628702,0.978682507848257,1,11,positive regulation of triglyceride biosynthetic process,BP,RGN
5060,GO:0010870,0.20823282100404,0.978665817588242,1,11,positive regulation of receptor biosynthetic process,BP,EDN1
9131,GO:0033605,0.208294616700003,0.978652590543607,1,11,positive regulation of catecholamine secretion,BP,GDNF
17451,GO:0090197,0.208343142122616,0.978642200798446,1,11,positive regulation of chemokine secretion,BP,PYCARD
1139,GO:0002551,0.20841643295337,0.978626503323277,1,11,mast cell chemotaxis,BP,CHGA
20967,GO:2000047,0.208419503833875,0.97862584546295,1,11,regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
10749,GO:0042301,0.208501020518495,0.978608378489737,1,11,phosphate ion binding,MF,PNP
16401,GO:0071331,0.208713759283824,0.913227420661913,4,113,cellular response to hexose stimulus,BP,GJB6;STAR;PIK3CA;GAS6
2859,GO:0005890,0.208763383745924,0.978552107835769,1,11,sodium:potassium-exchanging ATPase complex,CC,FXYD1
14174,GO:0051608,0.208832716892129,0.978537224063368,1,11,histamine transport,BP,EDN1
604,GO:0001709,0.208883750987578,0.947090215109836,2,41,cell fate determination,BP,BMP4;DLL1
15831,GO:0070254,0.208938812377119,0.978514437605266,1,11,mucus secretion,BP,ADORA1
12629,GO:0046415,0.209004900075218,0.978500237079039,1,11,urate metabolic process,BP,PNP
96,GO:0000185,0.209044573967223,0.978491709734263,1,11,activation of MAPKKK activity,BP,GADD45A
6589,GO:0019371,0.209203015473751,0.978457636571829,1,11,cyclooxygenase pathway,BP,PTGES
12374,GO:0045835,0.209219060612803,0.978454184392234,1,11,negative regulation of meiotic nuclear division,BP,LIF
2780,GO:0005766,0.209222619546256,0.90268343828376,5,151,primary lysosome,CC,PYCARD;HEXB;RAB44;GLA;RAB3D
10924,GO:0042582,0.209222619546256,0.90268343828376,5,151,azurophil granule,CC,PYCARD;HEXB;RAB44;GLA;RAB3D
14856,GO:0060315,0.209253731226997,0.978446723832445,1,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,CASQ2
3319,GO:0006600,0.209315832250484,0.978433357167053,1,11,creatine metabolic process,BP,GHR
7656,GO:0030898,0.209345508548439,0.978259911088309,1,12,actin-dependent ATPase activity,MF,MYO7A
5018,GO:0010819,0.209359648855695,0.978423923332113,1,11,regulation of T cell chemotaxis,BP,WNT5A
19753,GO:1903727,0.209369269431999,0.946890090598674,2,41,positive regulation of phospholipid metabolic process,BP,PDGFB;FABP3
12376,GO:0045837,0.209436793663376,0.978407308374772,1,11,negative regulation of membrane potential,BP,PMAIP1
3439,GO:0006775,0.209550144760739,0.946815454664117,2,41,fat-soluble vitamin metabolic process,BP,CYP11A1;VDR
10791,GO:0042368,0.209629482394967,0.978365777824956,1,11,vitamin D biosynthetic process,BP,VDR
11297,GO:0043255,0.209781862719439,0.92650245118023,3,77,regulation of carbohydrate biosynthetic process,BP,PDGFB;SESN2;AKT1
10876,GO:0042511,0.209793939274535,0.978330297700511,1,11,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,LIF
14152,GO:0051583,0.209837176032147,0.978320964484576,1,11,dopamine uptake involved in synaptic transmission,BP,GDNF
14336,GO:0051934,0.209837176032147,0.978320964484576,1,11,catecholamine uptake involved in synaptic transmission,BP,GDNF
17602,GO:0090493,0.209837176032147,0.978320964484576,1,11,catecholamine uptake,BP,GDNF
17603,GO:0090494,0.209837176032147,0.978320964484576,1,11,dopamine uptake,BP,GDNF
13948,GO:0051222,0.20987267354122,0.867808439708474,12,443,positive regulation of protein transport,BP,PYCARD;PRR5L;PIK3R2;PIK3R1;WNT5A;RBP4;ANG;BMP6;BMP4;CDH1;GAS6;RPH3AL
10028,GO:0035747,0.209895152583887,0.978308446051091,1,11,natural killer cell chemotaxis,BP,PIK3CG
3525,GO:0006906,0.210012716016751,0.902185459655375,5,152,vesicle fusion,BP,SYT5;TBC1D14;RAB39A;RAB20;VAMP1
17799,GO:0097193,0.210069749794809,0.882390657089446,8,273,intrinsic apoptotic signaling pathway,BP,PMAIP1;PYCARD;PIK3R1;HRAS;CDKN1A;NOL3;CASP4;AKT1
13697,GO:0050848,0.210070857478784,0.926353771257826,3,77,regulation of calcium-mediated signaling,BP,ACTN3;CASQ2;RGN
4799,GO:0010454,0.21033280323819,0.978213820245117,1,11,negative regulation of cell fate commitment,BP,FZD7
18535,GO:1900181,0.210539989034949,0.926112186593129,3,77,negative regulation of protein localization to nucleus,BP,BMP7;GAS6;CLDN18
8728,GO:0032780,0.210621644895903,0.978151245750305,1,11,negative regulation of ATPase activity,BP,RGN
11321,GO:0043295,0.210650647032182,0.978144957332273,1,11,glutathione binding,MF,PTGES
6055,GO:0016671,0.210724459627602,0.978128948384427,1,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRA
18766,GO:1901317,0.211051295766824,0.978057985170962,1,11,regulation of flagellated sperm motility,BP,RGN
13867,GO:0051099,0.211318555863301,0.901365947599165,5,153,positive regulation of binding,BP,TICAM1;RALB;WNT5A;BMP4;BMP2
13814,GO:0051024,0.211333960783,0.977996511256661,1,11,positive regulation of immunoglobulin secretion,BP,RBP4
7882,GO:0031324,0.211347374760754,0.829687905805029,54,2336,negative regulation of cellular metabolic process,BP,LIF;WNT4;ACTN3;NOTCH1;GADD45A;SERPINA5;APOC1;ZFPM1;SALL4;TBC1D14;DKK3;EDN1;PYCARD;ACADVL;PSMB10;RGN;PRR5L;PDGFB;PRKAR1B;WNT5A;SESN2;AXIN1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;NOL3;DEPTOR;AKT1;IFI27;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TFPI;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;GLA;LZTS1;VDR;FZD8;DUSP5;HEY1
2295,GO:0004859,0.211479993485726,0.977964715312584,1,11,phospholipase inhibitor activity,MF,APOC1
16014,GO:0070555,0.211649536710243,0.911532090520478,4,113,response to interleukin-1,BP,EDN1;CCL20;PYCARD;TFPI
14463,GO:0052652,0.211854268232975,0.901040105895308,5,152,cyclic purine nucleotide metabolic process,BP,MRAP;GUCY1B3;EDN1;NPR1;NPPC
5392,GO:0015144,0.211931916345981,0.945828524690468,2,41,carbohydrate transmembrane transporter activity,MF,SLC45A4;SLC2A14
18804,GO:1901476,0.211931916345981,0.945828524690468,2,41,carbohydrate transporter activity,MF,SLC45A4;SLC2A14
1284,GO:0002793,0.212216479057715,0.88625935427399,7,232,positive regulation of peptide secretion,BP,ADORA1;PYCARD;WNT5A;RBP4;ANG;BMP6;RPH3AL
13659,GO:0050786,0.212330880438038,0.977778951488968,1,11,RAGE receptor binding,MF,S100B
12059,GO:0045161,0.212376413851483,0.977597044981993,1,12,neuronal ion channel clustering,BP,SPTBN4
11921,GO:0044801,0.212460620426396,0.892589077670544,6,192,single-organism membrane fusion,BP,SYT5;SERPINA5;TBC1D14;RAB39A;RAB20;VAMP1
13556,GO:0050654,0.21246681859375,0.945565671270237,2,42,chondroitin sulfate proteoglycan metabolic process,BP,IDUA;HEXB
11267,GO:0043217,0.212761407529259,0.977512067869809,1,12,myelin maintenance,BP,AKT1
4264,GO:0008637,0.212915211195499,0.910797983229904,4,113,apoptotic mitochondrial changes,BP,PMAIP1;PYCARD;NOL3;AKT1
12358,GO:0045806,0.212995440332987,0.945385361113568,2,41,negative regulation of endocytosis,BP,APOC1;UNC119
16399,GO:0071326,0.213087008699073,0.910686667998053,4,114,cellular response to monosaccharide stimulus,BP,GJB6;STAR;PIK3CA;GAS6
5204,GO:0014047,0.213579027552715,0.945101073300693,2,42,glutamate secretion,BP,ADORA1;SLC1A3
12422,GO:0045921,0.213596823562462,0.92453109519247,3,77,positive regulation of exocytosis,BP,RAB27A;SDC4;RAB3D
8045,GO:0031638,0.213689788615684,0.945095207231144,2,41,zymogen activation,BP,FADD;PLAU
8221,GO:0031994,0.214225760464126,0.977187245048811,1,12,insulin-like growth factor I binding,MF,ITGB4
18711,GO:1901201,0.214457783208289,0.977135544132981,1,12,regulation of extracellular matrix assembly,BP,NOTCH1
8435,GO:0032371,0.214493294239344,0.944717910725147,2,42,regulation of sterol transport,BP,APOC1;ABCG1
8438,GO:0032374,0.214493294239344,0.944717910725147,2,42,regulation of cholesterol transport,BP,APOC1;ABCG1
9453,GO:0034446,0.215032881056111,0.923765427903253,3,78,substrate adhesion-dependent cell spreading,BP,FZD7;TYRO3;LAMA5
1077,GO:0002444,0.215144804231783,0.85870919324755,14,528,myeloid leukocyte mediated immunity,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;GLA;DERA;RAB3D
4460,GO:0009190,0.215619480428482,0.898678427237421,5,153,cyclic nucleotide biosynthetic process,BP,MRAP;GUCY1B3;EDN1;NPR1;NPPC
8210,GO:0031970,0.215623553543496,0.923495499600499,3,76,organelle envelope lumen,CC,HSD3B2;PTGES;STAR
1065,GO:0002431,0.215707916495853,0.923432159619015,3,77,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R2;PIK3R1;PIK3CA
626,GO:0001750,0.215774386336053,0.923378638339816,3,78,photoreceptor outer segment,CC,RAB27A;SPTBN5;MYO7A
12833,GO:0046850,0.215931422238344,0.944112919908232,2,42,regulation of bone remodeling,BP,PDK4;CLDN18
8530,GO:0032479,0.21596578841152,0.908997476230652,4,115,regulation of type I interferon production,BP,PYCARD;TICAM1;NMI;DTX4
2434,GO:0005080,0.216088411025305,0.944046709113671,2,42,protein kinase C binding,MF,SDC4;AKT1
6929,GO:0021700,0.21618472903874,0.883527001822654,7,237,developmental maturation,BP,SPTBN4;WNT5A;ANG;BMP2;CDKN1A;NPPC;RAB38
603,GO:0001708,0.21646952628292,0.923034297930089,3,77,cell fate specification,BP,NOTCH1;FZD7;DLL1
12647,GO:0046460,0.216626477684944,0.943819524743845,2,42,neutral lipid biosynthetic process,BP,RGN;ANG
12650,GO:0046463,0.216626477684944,0.943819524743845,2,42,acylglycerol biosynthetic process,BP,RGN;ANG
2570,GO:0005319,0.216665468376408,0.908576832078499,4,116,lipid transporter activity,MF,ABCG1;RBP4;FABP3;STAR
17583,GO:0090399,0.217891434546554,0.976362945566545,1,12,replicative senescence,BP,CDKN1A
16798,GO:0072015,0.217905327647367,0.976359790964125,1,12,glomerular visceral epithelial cell development,BP,BMP4
2868,GO:0005902,0.217965326767083,0.922231665536264,3,78,microvillus,CC,ESPN;MSN;MYO7A
11420,GO:0043476,0.218218084154336,0.976288714693145,1,12,pigment accumulation,BP,RAB38
11421,GO:0043482,0.218218084154336,0.976288714693145,1,12,cellular pigment accumulation,BP,RAB38
783,GO:0001960,0.218263670058232,0.943125863642143,2,42,negative regulation of cytokine-mediated signaling pathway,BP,NOL3;GAS6
15336,GO:0061050,0.218347781919975,0.976259205632478,1,12,regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
4913,GO:0010649,0.218459743604631,0.976233715755071,1,12,regulation of cell communication by electrical coupling,BP,CASQ2
8452,GO:0032388,0.218480832341959,0.876457129674021,8,278,positive regulation of intracellular transport,BP,PRR5L;PIK3R2;PIK3R1;BMP6;BMP4;MSN;CDH1;GAS6
16700,GO:0071822,0.218699168272027,0.830849505571074,36,1516,protein complex subunit organization,BP,FHOD3;TUBG2;ACTN2;PMAIP1;MRPL14;MRPL16;FADD;TRADD;CASQ2;SPTBN5;SPTBN4;PYCARD;PRND;PLEKHH2;RALB;HRAS;HACL1;AXIN1;PSRC1;ANG;SPTB;ACAT1;VAMP1;MSN;NOL3;GJB1;PCBD1;DECR1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;HNF1A;KCND1;TMOD4
1486,GO:0003207,0.219130531661183,0.976080686324735,1,12,cardiac chamber formation,BP,NOTCH1
6519,GO:0019199,0.219327795257944,0.921478331102984,3,80,transmembrane receptor protein kinase activity,MF,ACVR1;TYRO3;DDR1
13671,GO:0050803,0.219383016648988,0.906970044867769,4,117,regulation of synapse structure or activity,BP,WNT7A;CDH2;WNT5A;RAB17
20618,GO:1905809,0.219501455376932,0.975995835075214,1,12,negative regulation of synapse organization,BP,WNT5A
11990,GO:0045056,0.21959524490204,0.975974354030254,1,12,transcytosis,BP,RAB17
6912,GO:0021681,0.219619302861585,0.975968842229151,1,12,cerebellar granular layer development,BP,WNT7A
5583,GO:0015740,0.220041490631717,0.97587200410986,1,12,C4-dicarboxylate transport,BP,SLC1A3
15164,GO:0060742,0.220344646960263,0.975802336845472,1,12,epithelial cell differentiation involved in prostate gland development,BP,NOTCH1
19422,GO:1903037,0.220358041561437,0.870461618032976,9,317,regulation of leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD;PIK3R1;SDC4;BMP4;AKT1;PIK3CA;EFNB2
7725,GO:0031045,0.220474662454432,0.975772424722871,1,12,dense core granule,CC,SYT5
4827,GO:0010510,0.22047679727546,0.975771933404503,1,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
8615,GO:0032606,0.220486050870557,0.906331222394373,4,116,type I interferon production,BP,PYCARD;TICAM1;NMI;DTX4
16643,GO:0071688,0.22065506088781,0.975573988644734,1,13,striated muscle myosin thick filament assembly,BP,MYH11
16677,GO:0071786,0.221105808252449,0.975626931780244,1,12,endoplasmic reticulum tubular network organization,BP,REEP1
1195,GO:0002674,0.221108870838863,0.975626224622674,1,12,negative regulation of acute inflammatory response,BP,ADORA1
16424,GO:0071360,0.221328578734116,0.975575464263159,1,12,cellular response to exogenous dsRNA,BP,RALB
10772,GO:0042340,0.221330950047169,0.975574916089449,1,12,keratan sulfate catabolic process,BP,HEXB
5116,GO:0010935,0.221363132860874,0.975567475758441,1,12,regulation of macrophage cytokine production,BP,WNT5A
15026,GO:0060536,0.221395874107984,0.975559905048439,1,12,cartilage morphogenesis,BP,WNT7B
17550,GO:0090329,0.221546445200934,0.941683436524626,2,43,regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
8650,GO:0032653,0.221554750769175,0.94172054327901,2,42,regulation of interleukin-10 production,BP,PYCARD;DLL1
9408,GO:0034374,0.221914243501869,0.975439871863142,1,12,low-density lipoprotein particle remodeling,BP,ABCG1
4375,GO:0009086,0.222103307292598,0.975396012135353,1,12,methionine biosynthetic process,BP,MRI1
13985,GO:0051271,0.222134594519688,0.879424038713344,7,239,negative regulation of cellular component movement,BP,WNT3;WNT4;NOTCH1;ADORA1;RGN;WNT5A;RHOB
13504,GO:0050321,0.222294987666936,0.975351501582633,1,12,tau-protein kinase activity,MF,MARK4
16476,GO:0071437,0.22231226554167,0.975347487278344,1,12,invadopodium,CC,ITGA3
8531,GO:0032480,0.222375815516676,0.941326774145827,2,43,negative regulation of type I interferon production,BP,PYCARD;NMI
7310,GO:0030213,0.222423137413179,0.975321719012086,1,12,hyaluronan biosynthetic process,BP,PDGFB
6921,GO:0021692,0.222481330184412,0.975148676831728,1,13,cerebellar Purkinje cell layer morphogenesis,BP,DLL1
14329,GO:0051924,0.222789110788981,0.88572715723419,6,197,regulation of calcium ion transport,BP,CASQ2;TSPAN13;RGN;PDGFB;PIK3CG;PDE4B
18824,GO:1901550,0.222896612970187,0.975211510049443,1,12,regulation of endothelial cell development,BP,CLDN5
19465,GO:1903140,0.222896612970187,0.975211510049443,1,12,regulation of establishment of endothelial barrier,BP,CLDN5
14149,GO:0051580,0.222936550859191,0.975202201548152,1,12,regulation of neurotransmitter uptake,BP,GDNF
8246,GO:0032036,0.222957424244437,0.975197335732454,1,12,myosin heavy chain binding,MF,SPTBN5
17725,GO:0097062,0.223159982784923,0.975150089899659,1,12,dendritic spine maintenance,BP,ITGA3
11031,GO:0042771,0.223246698723349,0.94095126293791,2,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,PYCARD;CDKN1A
17850,GO:0097286,0.223302866099979,0.975116733355376,1,12,iron ion import,BP,TF
11030,GO:0042770,0.22337194665987,0.904600541787236,4,118,signal transduction in response to DNA damage,BP,PMAIP1;GADD45A;SESN2;CDKN1A
17330,GO:0090005,0.223588058835202,0.975050080813717,1,12,negative regulation of establishment of protein localization to plasma membrane,BP,RHOQ
5455,GO:0015271,0.223800062236251,0.975000469970345,1,12,outward rectifier potassium channel activity,MF,KCND1
5516,GO:0015485,0.223836620575361,0.940696317967282,2,43,cholesterol binding,MF,ABCG1;STAR
9148,GO:0033631,0.224016415538929,0.974949785430149,1,12,cell-cell adhesion mediated by integrin,BP,ITGA5
6773,GO:0019934,0.224138756667701,0.974921099938759,1,12,cGMP-mediated signaling,BP,GUCY1B3
795,GO:0001973,0.224143785082418,0.974919920533869,1,12,adenosine receptor signaling pathway,BP,ADORA1
18895,GO:1901678,0.224301117979208,0.974883003026284,1,12,iron coordination entity transport,BP,FLVCR2
18239,GO:0098915,0.224334506672216,0.974875164673779,1,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,KCNH2
7786,GO:0031122,0.224335943789486,0.940440652602286,2,44,cytoplasmic microtubule organization,BP,TUBG2;AXIN1
4558,GO:0009404,0.224344437452911,0.974872833057775,1,12,toxin metabolic process,BP,STAR
18302,GO:0099094,0.224399876404207,0.918771291247303,3,81,ligand-gated cation channel activity,MF,KCNK6;KCNH2;GRIA3
5022,GO:0010823,0.22441335239863,0.940446620603729,2,43,negative regulation of mitochondrion organization,BP,NOL3;AKT1
2982,GO:0006089,0.224471656610818,0.97484295317177,1,12,lactate metabolic process,BP,ACTN3
12347,GO:0045779,0.224492556106082,0.974838042655305,1,12,negative regulation of bone resorption,BP,CLDN18
15136,GO:0060707,0.224494271945537,0.974837639480666,1,12,trophoblast giant cell differentiation,BP,LIF
13132,GO:0048193,0.224527158535697,0.867401193978126,9,326,Golgi vesicle transport,BP,USE1;RAB6C;RABIF;TBC1D14;SPTBN5;SPTBN4;SPTB;GAS6;CNIH4
11415,GO:0043467,0.224552810349134,0.918708021968792,3,80,regulation of generation of precursor metabolites and energy,BP,ACTN3;AKT1;PIK3CA
6569,GO:0019319,0.224653416370267,0.918692449302617,3,78,hexose biosynthetic process,BP,SESN2;RBP4;MDH1
10932,GO:0042590,0.224754804226195,0.918658180375108,3,77,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,IFI30;ITGB5;PSMB10
2933,GO:0006012,0.224831326804723,0.974758372145633,1,12,galactose metabolic process,BP,GALT
17450,GO:0090196,0.224941238072664,0.974732494006995,1,12,regulation of chemokine secretion,BP,PYCARD
1034,GO:0002367,0.22498161174869,0.91851730635421,3,78,cytokine production involved in immune response,BP,WNT5A;CHGA;GAS6
7109,GO:0022604,0.225042003101762,0.859387732615,11,414,regulation of cell morphogenesis,BP,WNT3;WNT7A;WNT5A;RHOQ;RHOJ;HEXB;MSN;LZTS1;S100B;PARVB;LINGO1
8733,GO:0032785,0.225046684320025,0.974707653449278,1,12,negative regulation of DNA-templated transcription, elongation,BP,AXIN1
8900,GO:0033033,0.225059462016838,0.974704642425596,1,12,negative regulation of myeloid cell apoptotic process,BP,KITLG
10089,GO:0035859,0.225069961222802,0.9747021681737,1,12,Seh1-associated complex,CC,SESN2
16474,GO:0071435,0.225112256337223,0.974692199524391,1,12,potassium ion export,BP,KCNH2
8766,GO:0032823,0.225162432850195,0.97468037048936,1,12,regulation of natural killer cell differentiation,BP,GAS6
12344,GO:0045776,0.225397234033437,0.940019613930424,2,43,negative regulation of blood pressure,BP,ADORA1;KCNK6
9113,GO:0033574,0.225490609924468,0.939979020944935,2,43,response to testosterone,BP,EDN1;MSN
12009,GO:0045078,0.225729219283286,0.974546540554548,1,12,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
9276,GO:0034116,0.225802343167581,0.974529246269298,1,12,positive regulation of heterotypic cell-cell adhesion,BP,BMP7
21559,GO:2001053,0.225814553828266,0.974526357737916,1,12,regulation of mesenchymal cell apoptotic process,BP,BMP7
14773,GO:0060191,0.225816971452951,0.918051467808944,3,79,regulation of lipase activity,BP,APOC1;LPAR2;ANG
12132,GO:0045309,0.225942410940691,0.939742523022908,2,44,protein phosphorylated amino acid binding,MF,PIK3R2;PIK3R1
6526,GO:0019207,0.225980157262423,0.883598691085484,6,196,kinase regulator activity,MF,PIK3R2;PIK3R1;PRKAR1B;CDKN1A;PIK3CA;GAS6
12064,GO:0045171,0.2261336238846,0.939699167232533,2,43,intercellular bridge,CC,PRKACB;UNC119
2297,GO:0004861,0.226349534799557,0.974399626899209,1,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A
5084,GO:0010896,0.22642626919694,0.974381421057202,1,12,regulation of triglyceride catabolic process,BP,PIK3CG
12268,GO:0045639,0.226553998553308,0.917656787750769,3,79,positive regulation of myeloid cell differentiation,BP,LIF;FADD;KITLG
8436,GO:0032372,0.226555233316042,0.974350807275976,1,12,negative regulation of sterol transport,BP,APOC1
8439,GO:0032375,0.226555233316042,0.974350807275976,1,12,negative regulation of cholesterol transport,BP,APOC1
7531,GO:0030656,0.226659651139715,0.974326005624045,1,12,regulation of vitamin metabolic process,BP,VDR
5986,GO:0016556,0.226705916627435,0.974315012286464,1,12,mRNA modification,BP,PUS1
13668,GO:0050798,0.226722837173081,0.939442240546949,2,43,activated T cell proliferation,BP,FADD;PYCARD
1293,GO:0002821,0.226766116366402,0.917562599885821,3,78,positive regulation of adaptive immune response,BP,FADD;PYCARD;CLCF1
3773,GO:0007342,0.227225842652823,0.974191292536381,1,12,fusion of sperm to egg plasma membrane,BP,SERPINA5
18639,GO:1900750,0.227247551166401,0.974186119746527,1,12,oligopeptide binding,MF,PTGES
11625,GO:0044088,0.22737137061956,0.939118615881184,2,44,regulation of vacuole organization,BP,TBC1D14;RALB
8729,GO:0032781,0.228363835595724,0.938724222235647,2,43,positive regulation of ATPase activity,BP,RGN;FGF10
17429,GO:0090174,0.228515277695535,0.890462701797583,5,157,organelle membrane fusion,BP,SYT5;TBC1D14;RAB39A;RAB20;VAMP1
16439,GO:0071383,0.228643466597816,0.874899728482592,7,240,cellular response to steroid hormone stimulus,BP,EDN1;BMP7;BMP4;GJB2;STAR;VDR;HEY1
3723,GO:0007224,0.228941697020626,0.901264335651583,4,119,smoothened signaling pathway,BP,DHH;PRKACB;FGF10;BMP4
6399,GO:0018279,0.229158850173444,0.938375062240613,2,43,protein N-linked glycosylation via asparagine,BP,ALG5;DPM3
13163,GO:0048259,0.229171969523537,0.916229991233842,3,80,regulation of receptor-mediated endocytosis,BP,TF;APOC1;UNC119
10055,GO:0035791,0.229329850894543,0.973517789639558,1,13,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
5075,GO:0010885,0.229490036603929,0.973478961017802,1,13,regulation of cholesterol storage,BP,ABCG1
17743,GO:0097106,0.229740482573736,0.973418190805217,1,13,postsynaptic density organization,BP,CDH2
18300,GO:0099084,0.229740482573736,0.973418190805217,1,13,postsynaptic specialization organization,BP,CDH2
4902,GO:0010638,0.230035430459637,0.844762437690283,15,584,positive regulation of organelle organization,BP,LIF;WNT4;ACTN2;PMAIP1;EDN1;PYCARD;PDGFB;RALB;HRAS;WNT5A;PSRC1;FGF8;SDC4;MSN;CTGF
15279,GO:0060977,0.230058752565377,0.97334085279159,1,13,coronary vasculature morphogenesis,BP,NOTCH1
18321,GO:0099512,0.230133456556115,0.834413513497155,21,861,supramolecular fiber,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;KRT10;RHOQ;PSRC1;SDC4;FAM110C;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B;TMOD4
8493,GO:0032433,0.230294588449815,0.973283466091465,1,13,filopodium tip,CC,TTYH1
11254,GO:0043197,0.230316108458756,0.900426822973601,4,120,dendritic spine,CC,ACTN2;ADORA1;LZTS1;PDE4B
4945,GO:0010715,0.230660680444015,0.973194249196553,1,13,regulation of extracellular matrix disassembly,BP,DDR1
4666,GO:0009886,0.230773918507926,0.973166619839941,1,13,post-embryonic animal morphogenesis,BP,MYO7A
17002,GO:0072332,0.230793890015162,0.915353458513681,3,80,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1;PYCARD;CDKN1A
17540,GO:0090316,0.230856708968105,0.873348661622952,7,241,positive regulation of intracellular protein transport,BP,PRR5L;PIK3R2;PIK3R1;BMP6;BMP4;CDH1;GAS6
4971,GO:0010745,0.230993322562135,0.973113042071909,1,13,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1
5291,GO:0014854,0.231187398510095,0.97306560030095,1,13,response to inactivity,BP,ACTN3
6924,GO:0021695,0.231507843489897,0.937257589430058,2,45,cerebellar cortex development,BP,WNT7A;DLL1
19542,GO:1903307,0.231766534594215,0.937182406103774,2,44,positive regulation of regulated secretory pathway,BP,RAB27A;RAB3D
777,GO:0001954,0.231859380520029,0.937101639501721,2,45,positive regulation of cell-matrix adhesion,BP,WNT4;SDC4
14809,GO:0060253,0.2328082287773,0.972667589524213,1,13,negative regulation of glial cell proliferation,BP,NOTCH1
7303,GO:0030205,0.232946092565289,0.972633587253291,1,13,dermatan sulfate metabolic process,BP,IDUA
5244,GO:0014733,0.232980442183889,0.972625111751166,1,13,regulation of skeletal muscle adaptation,BP,ACTN3
7022,GO:0021889,0.233011669573243,0.972617405379809,1,13,olfactory bulb interneuron differentiation,BP,WNT5A
19350,GO:1902914,0.233193206324774,0.972572581621481,1,13,regulation of protein polyubiquitination,BP,NMI
13257,GO:0048512,0.233240620485089,0.936527210785991,2,44,circadian behavior,BP,ADORA1;STAR
21180,GO:2000378,0.233267213587875,0.936515363993385,2,44,negative regulation of reactive oxygen species metabolic process,BP,RGN;GLA
8358,GO:0032239,0.233505456194023,0.972495388579325,1,13,regulation of nucleobase-containing compound transport,BP,ADORA1
12341,GO:0045766,0.233591062332085,0.898460578404939,4,119,positive regulation of angiogenesis,BP,ITGA5;WNT5A;RHOB;DLL1
10162,GO:0035987,0.233644720422638,0.936307058031788,2,45,endodermal cell differentiation,BP,ITGA5;ITGB5
11102,GO:0042953,0.233703196910088,0.9722957145147,1,14,lipoprotein transport,BP,UNC119
11955,GO:0044872,0.233703196910088,0.9722957145147,1,14,lipoprotein localization,BP,UNC119
21545,GO:2001028,0.233770057228706,0.972429881455345,1,13,positive regulation of endothelial cell chemotaxis,BP,FGF18
4082,GO:0008328,0.233794443268996,0.936240227888615,2,45,ionotropic glutamate receptor complex,CC,GRIA3;CPT1C
16907,GO:0072182,0.233816521434312,0.97241836947158,1,13,regulation of nephron tubule epithelial cell differentiation,BP,LIF
6004,GO:0016580,0.233852405899329,0.972409476913845,1,13,Sin3 complex,CC,SIN3B
11449,GO:0043517,0.234031005796052,0.972365194422987,1,13,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
17434,GO:0090179,0.234280929587823,0.972303161972808,1,13,planar cell polarity pathway involved in neural tube closure,BP,WNT5A
16991,GO:0072310,0.23434232455023,0.972287911672725,1,13,glomerular epithelial cell development,BP,BMP4
15213,GO:0060831,0.234403749593844,0.972272649267797,1,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
7093,GO:0022402,0.234427861544556,0.821474685644086,30,1261,cell cycle process,BP,LIF;WNT4;RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;MAPK12;PSMB10;FGF10;PDGFB;FOXO4;RALB;HRAS;WNT5A;SNX18;RHOB;PSRC1;FGF8;BMP7;BMP4;CDKN1A;HMGN5;CTGF;AKT1;GAS6;LZTS1;PIM2
10178,GO:0036010,0.234523511378303,0.972242878488258,1,13,protein localization to endosome,BP,MSN
6533,GO:0019215,0.234685266518981,0.972202640890781,1,13,intermediate filament binding,MF,PKP1
13275,GO:0048538,0.235015698444584,0.935693984933009,2,45,thymus development,BP,FADD;FGF10
13674,GO:0050806,0.235059318729636,0.897546823900691,4,121,positive regulation of synaptic transmission,BP,WNT7A;ADORA1;S100B;SLC1A3
2639,GO:0005513,0.23523139109915,0.972066551449303,1,13,detection of calcium ion,BP,CASQ2
15316,GO:0061029,0.235375641279511,0.972030544353939,1,13,eyelid development in camera-type eye,BP,STRA6
19724,GO:1903671,0.235756354966292,0.97193538935538,1,13,negative regulation of sprouting angiogenesis,BP,NOTCH1
11838,GO:0044548,0.235978279486571,0.971879839594031,1,13,S100 protein binding,MF,S100B
6374,GO:0018196,0.236205304451921,0.935200643371169,2,44,peptidyl-asparagine modification,BP,ALG5;DPM3
885,GO:0002093,0.236217029956607,0.971820010444762,1,13,auditory receptor cell morphogenesis,BP,MYO7A
7266,GO:0030157,0.236339155666407,0.971789379486868,1,13,pancreatic juice secretion,BP,WNK4
8280,GO:0032091,0.236390088227481,0.912283999679693,3,81,negative regulation of protein binding,BP,ZFPM1;PDGFB;RALB
14312,GO:0051896,0.23639050819801,0.896748407030782,4,120,regulation of protein kinase B signaling,BP,FAM110C;HBEGF;PIK3CG;GAS6
11350,GO:0043330,0.2364080027118,0.935109513649219,2,44,response to exogenous dsRNA,BP,TICAM1;RALB
7107,GO:0022602,0.236561408773641,0.912189988623406,3,81,ovulation cycle process,BP,ANG;KITLG;INHBB
1452,GO:0003161,0.236564669368431,0.971732768990898,1,13,cardiac conduction system development,BP,NOTCH1
4890,GO:0010623,0.236614219992222,0.971720321948384,1,13,programmed cell death involved in cell development,BP,KITLG
4262,GO:0008631,0.236656090195853,0.934997902626257,2,44,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,NOL3;AKT1
11434,GO:0043500,0.236701162660208,0.912094175554729,3,82,muscle adaptation,BP,ACTN3;EDN1;NOL3
13679,GO:0050812,0.236805061523337,0.971672354577074,1,13,regulation of acyl-CoA biosynthetic process,BP,PDK4
4990,GO:0010766,0.236971638239758,0.971630449396861,1,13,negative regulation of sodium ion transport,BP,WNK4
7723,GO:0031034,0.23697426711027,0.971474807951272,1,14,myosin filament assembly,BP,MYH11
8622,GO:0032613,0.237082428043341,0.934805906302558,2,44,interleukin-10 production,BP,PYCARD;DLL1
13721,GO:0050872,0.237565185046929,0.971480854554555,1,13,white fat cell differentiation,BP,FGF10
3530,GO:0006913,0.237668364524241,0.846518950191111,12,457,nucleocytoplasmic transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;IFI27;CDH1;GAS6
16912,GO:0072189,0.237680413834059,0.971451762443985,1,13,ureter development,BP,BMP4
11107,GO:0042976,0.237819066856345,0.971416734637126,1,13,activation of Janus kinase activity,BP,GHR
13733,GO:0050890,0.238055772191514,0.868261804653588,7,246,cognition,BP,ITGA3;ITGA5;STRA6;ADORA1;PRKAR1B;CLDN5;S100B
16137,GO:0070830,0.238070264535814,0.934318967557936,2,45,bicellular tight junction assembly,BP,CLDN1;CLDN3
756,GO:0001931,0.238348881312285,0.971282669420488,1,13,uropod,CC,MSN
7834,GO:0031254,0.238348881312285,0.971282669420488,1,13,cell trailing edge,CC,MSN
6105,GO:0016775,0.238448732593704,0.97125736404965,1,13,phosphotransferase activity, nitrogenous group as acceptor,MF,KCNH2
11729,GO:0044309,0.238654972836658,0.89534297546198,4,122,neuron spine,CC,ACTN2;ADORA1;LZTS1;PDE4B
641,GO:0001771,0.238817080032447,0.971163907000564,1,13,immunological synapse formation,BP,MSN
5231,GO:0014704,0.238913342147261,0.933897723227611,2,46,intercalated disc,CC,DSC2;CDH2
10967,GO:0042659,0.238920928408267,0.971137528308562,1,13,regulation of cell fate specification,BP,FZD7
5589,GO:0015748,0.238948532655162,0.910856894351346,3,82,organophosphate ester transport,BP,APOC1;ABCG1;GJB1
879,GO:0002087,0.239024444514181,0.971111220749801,1,13,regulation of respiratory gaseous exchange by neurological system process,BP,ADORA1
18480,GO:1900103,0.239031577804908,0.97110940740909,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
11019,GO:0042754,0.23925631684255,0.971052244695392,1,13,negative regulation of circadian rhythm,BP,ADORA1
10952,GO:0042627,0.239266048994506,0.971049767896935,1,13,chylomicron,CC,APOC1
11226,GO:0043154,0.2393254615333,0.91066811676414,3,81,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NOL3;AKT1;GAS6
18781,GO:1901361,0.239548474796961,0.845067342874141,12,452,organic cyclic compound catabolic process,BP,HSD17B11;PNP;RGN;PRR5L;GALT;AOX1;NUDT7;PCBD1;PKP3;PKP1;DERA;PDE4B
14672,GO:0060042,0.239555760738765,0.933606061005936,2,46,retina morphogenesis in camera-type eye,BP,RBP4;DLL1
865,GO:0002070,0.239652170711272,0.970951406743985,1,13,epithelial cell maturation,BP,CDKN1A
12741,GO:0046629,0.239959844942081,0.970872897339543,1,13,gamma-delta T cell activation,BP,JAG2
2002,GO:0004467,0.240375929114054,0.970766538497902,1,13,long-chain fatty acid-CoA ligase activity,MF,ACSL4
10234,GO:0036109,0.240418758316275,0.97075557838736,1,13,alpha-linolenic acid metabolic process,BP,FADS1
18298,GO:0099081,0.240513797820688,0.825804756769464,21,868,supramolecular polymer,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;KRT10;RHOQ;PSRC1;SDC4;FAM110C;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B;TMOD4
17972,GO:0097531,0.240583362560079,0.970713434559282,1,13,mast cell migration,BP,CHGA
1213,GO:0002693,0.240615822643276,0.970705119801329,1,13,positive regulation of cellular extravasation,BP,FADD
18236,GO:0098911,0.240644361170498,0.970537987769141,1,14,regulation of ventricular cardiac muscle cell action potential,BP,DSC2
3877,GO:0007622,0.241018095191662,0.932980118814848,2,45,rhythmic behavior,BP,ADORA1;STAR
17769,GO:0097152,0.24108129481903,0.970585743933073,1,13,mesenchymal cell apoptotic process,BP,BMP7
6443,GO:0018904,0.241134428296934,0.970572100141458,1,13,ether metabolic process,BP,PLA2G16
17449,GO:0090195,0.241174097305537,0.970561911518664,1,13,chemokine secretion,BP,PYCARD
977,GO:0002279,0.241177191086283,0.932907528733647,2,45,mast cell activation involved in immune response,BP,CHGA;PIK3CG
11328,GO:0043303,0.241177191086283,0.932907528733647,2,45,mast cell degranulation,BP,CHGA;PIK3CG
19411,GO:1903019,0.241201785772622,0.970554798832208,1,13,negative regulation of glycoprotein metabolic process,BP,HBEGF
624,GO:0001741,0.241267683553936,0.970537867012177,1,13,XY body,CC,SIN3B
4569,GO:0009437,0.241416748206474,0.970499546368695,1,13,carnitine metabolic process,BP,CPT1C
5445,GO:0015245,0.241518644865258,0.970473335527926,1,13,fatty acid transporter activity,MF,FABP3
15753,GO:0070129,0.241610765141948,0.970449628374935,1,13,regulation of mitochondrial translation,BP,TSFM
5693,GO:0015929,0.241740798971957,0.970416146245854,1,13,hexosaminidase activity,MF,HEXB
16046,GO:0070613,0.24178180657342,0.909287979761979,3,82,regulation of protein processing,BP,CFB;PRKACB;NOL3
18297,GO:0099080,0.241877246787169,0.82466876539951,21,869,supramolecular complex,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;KRT10;RHOQ;PSRC1;SDC4;FAM110C;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B;TMOD4
17242,GO:0086002,0.242112852657787,0.932401075967611,2,47,cardiac muscle cell action potential involved in contraction,BP,DSC2;KCNH2
4535,GO:0009313,0.242114635151708,0.970319771074622,1,13,oligosaccharide catabolic process,BP,HEXB
16375,GO:0071285,0.242121746291198,0.970317936137321,1,13,cellular response to lithium ion,BP,CDH1
13989,GO:0051280,0.242151893632446,0.970310156309567,1,13,negative regulation of release of sequestered calcium ion into cytosol,BP,CASQ2
6231,GO:0017017,0.242283028004964,0.970276302619497,1,13,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP5
7827,GO:0031235,0.242685625601673,0.970009689282734,1,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB
10787,GO:0042362,0.242724506332795,0.970162173420849,1,13,fat-soluble vitamin biosynthetic process,BP,VDR
8402,GO:0032310,0.242893911500755,0.970118315178714,1,13,prostaglandin secretion,BP,EDN1
17806,GO:0097200,0.242913470809037,0.970113249063893,1,13,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
4702,GO:0009982,0.243000633569121,0.970090666994912,1,13,pseudouridine synthase activity,MF,PUS1
10773,GO:0042345,0.243155107256771,0.932002236169473,2,45,regulation of NF-kappaB import into nucleus,BP,BMP7;NOL3
10776,GO:0042348,0.243155107256771,0.932002236169473,2,45,NF-kappaB import into nucleus,BP,BMP7;NOL3
12699,GO:0046541,0.243265201175579,0.970022065143253,1,13,saliva secretion,BP,FGF10
13264,GO:0048521,0.243274444240771,0.970019666861173,1,13,negative regulation of behavior,BP,ADORA1
5065,GO:0010875,0.243313751031057,0.969846078709683,1,14,positive regulation of cholesterol efflux,BP,ABCG1
20215,GO:1904738,0.243955588780908,0.969678387236766,1,14,vascular associated smooth muscle cell migration,BP,PDGFB
20225,GO:1904752,0.243955588780908,0.969678387236766,1,14,regulation of vascular associated smooth muscle cell migration,BP,PDGFB
16397,GO:0071322,0.244197409982763,0.891945247026298,4,121,cellular response to carbohydrate stimulus,BP,GJB6;STAR;PIK3CA;GAS6
6199,GO:0016918,0.244268108738706,0.969761222402324,1,13,retinal binding,MF,RBP4
5683,GO:0015918,0.244315245018576,0.907857166196782,3,83,sterol transport,BP,APOC1;ABCG1;STAR
6725,GO:0019841,0.244450409296956,0.969713673973473,1,13,retinol binding,MF,RBP4
8038,GO:0031625,0.244693547370509,0.857554499138355,8,286,ubiquitin protein ligase binding,MF,PRKACB;PRR5L;KCNH2;RALB;MAGEC2;AXIN1;CDKN1A;FZD8
13941,GO:0051205,0.244704685107233,0.931289326762223,2,45,protein insertion into membrane,BP,PMAIP1;REEP1
1073,GO:0002440,0.244789277920127,0.879844671530336,5,160,production of molecular mediator of immune response,BP,WNT5A;RBP4;CLCF1;CHGA;GAS6
1492,GO:0003214,0.245969032902136,0.969148994362058,1,14,cardiac left ventricle morphogenesis,BP,NOTCH1
13062,GO:0048008,0.246832250557665,0.930224156409291,2,47,platelet-derived growth factor receptor signaling pathway,BP,PDGFB;BCAR1
2659,GO:0005544,0.247104728372756,0.930137275091923,2,46,calcium-dependent phospholipid binding,MF,SYT5;RPH3AL
19547,GO:1903317,0.247387772403023,0.906134279755813,3,83,regulation of protein maturation,BP,CFB;PRKACB;NOL3
11991,GO:0045058,0.247430149311623,0.929986023147907,2,46,T cell selection,BP,ZFPM1;JAG2
18652,GO:1901018,0.247579595035303,0.968721871651041,1,14,positive regulation of potassium ion transmembrane transporter activity,BP,ACTN2
11517,GO:0043623,0.247765097092745,0.832971024780021,14,548,cellular protein complex assembly,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;PYCARD;RALB;AXIN1;PSRC1;ANG;SPTB;VAMP1;MYH11;TMOD4
16309,GO:0071158,0.248182926522951,0.905686477488763,3,83,positive regulation of cell cycle arrest,BP,GADD45A;FOXO4;CDKN1A
17527,GO:0090303,0.248351861754988,0.929556850538971,2,46,positive regulation of wound healing,BP,HRAS;HBEGF
3504,GO:0006879,0.248954784030157,0.929275498019852,2,46,cellular iron ion homeostasis,BP,TF;BMP6
6540,GO:0019222,0.249106920718574,0.784487742664969,133,6101,regulation of metabolic process,BP,ITGA3;ITGA5;CFB;PDK4;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;RAB27A;ITGB8;FASN;PMAIP1;GADD45A;FADD;DHH;SERPINA5;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;TBC1D14;ADORA1;DKK3;EDN1;ABCG1;PRKACB;CCL20;EBF1;SPTBN4;PYCARD;ACADVL;MAPK12;FZD7;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;CHGA;MSN;NOL3;DEPTOR;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;RAB12;FAM46A;KITLG;IDH1;NPPC;CST9L;NAB2;CDH1;INHBB;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;GLA;ZCCHC12;LZTS1;DHCR7;PTS;PM20D2;SHC4;RBMS3;HNF1A;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
12040,GO:0045123,0.249305772295769,0.929111485420738,2,46,cellular extravasation,BP,FADD;PIK3CG
9342,GO:0034236,0.249326777434859,0.968254829756087,1,14,protein kinase A catalytic subunit binding,MF,PRKAR1B
7945,GO:0031432,0.249432591313223,0.968226421051031,1,14,titin binding,MF,ACTN2
15178,GO:0060761,0.24953702673954,0.929003332675298,2,46,negative regulation of response to cytokine stimulus,BP,NOL3;GAS6
18215,GO:0098878,0.249562037602908,0.928951338583962,2,47,neurotransmitter receptor complex,CC,GRIA3;CPT1C
13935,GO:0051194,0.249593746572306,0.968183127286938,1,14,positive regulation of cofactor metabolic process,BP,ACTN3
13938,GO:0051197,0.249593746572306,0.968183127286938,1,14,positive regulation of coenzyme metabolic process,BP,ACTN3
17298,GO:0086069,0.249656648932504,0.968166219917661,1,14,bundle of His cell to Purkinje myocyte communication,BP,DSC2
2566,GO:0005313,0.249809753148876,0.968125046567436,1,14,L-glutamate transmembrane transporter activity,MF,SLC1A3
5402,GO:0015172,0.249809753148876,0.968125046567436,1,14,acidic amino acid transmembrane transporter activity,MF,SLC1A3
17322,GO:0089711,0.249809753148876,0.968125046567436,1,14,L-glutamate transmembrane transport,BP,SLC1A3
19740,GO:1903708,0.249990761075693,0.876380587281183,5,162,positive regulation of hemopoiesis,BP,LIF;FADD;PNP;KITLG;GAS6
17433,GO:0090178,0.250114358673161,0.968043043015838,1,14,regulation of establishment of planar polarity involved in neural tube closure,BP,WNT5A
7706,GO:0031000,0.250134142800811,0.967888204293972,1,15,response to caffeine,BP,CASQ2
15275,GO:0060973,0.250296377989235,0.96799398531074,1,14,cell migration involved in heart development,BP,NOTCH1
3643,GO:0007095,0.250375938811758,0.967972529009303,1,14,mitotic G2 DNA damage checkpoint,BP,FOXO4
19790,GO:1903798,0.251639101945953,0.967630802945074,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
8648,GO:0032651,0.251790861747088,0.927945505298578,2,46,regulation of interleukin-1 beta production,BP,PYCARD;WNT5A
13993,GO:0051284,0.251796011612376,0.967588213072922,1,14,positive regulation of sequestering of calcium ion,BP,CASQ2
21388,GO:2000677,0.252052344586617,0.92778146044879,2,47,regulation of transcription regulatory region DNA binding,BP,LIF;HEY1
8544,GO:0032495,0.252138410096112,0.967495168002539,1,14,response to muramyl dipeptide,BP,NOTCH1
2851,GO:0005881,0.252221638902035,0.927701628512124,2,47,cytoplasmic microtubule,CC,TUBG2;RAB3D
4678,GO:0009898,0.252416536006686,0.874746221326529,5,164,cytoplasmic side of plasma membrane,CC,PTPN7;SNX18;SPTB;CDH1;MYZAP
11726,GO:0044306,0.252418196852738,0.886786698018387,4,124,neuron projection terminus,CC,ADRA2C;ADORA1;FSTL3;VAMP1
2836,GO:0005856,0.252599696510299,0.797052201736725,44,1934,cytoskeleton,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;MSRA;TRADD;PNP;PRKACB;SPTBN5;SPTBN4;KRT10;CDH2;CGN;PLEKHH2;PTPN7;FRMPD1;PXK;PSTPIP2;RHOQ;PSRC1;FAM110C;SPTB;CAMSAP3;ESPN;MSN;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;MYH11;AMOT;UNC119;RAB3D;MYZAP;FAM110B;ACTA2;PARVB;PDE4B;TMOD4
10163,GO:0035988,0.252676944152394,0.967348523928595,1,14,chondrocyte proliferation,BP,CTGF
6061,GO:0016684,0.252685024238299,0.92752394606476,2,46,oxidoreductase activity, acting on peroxide as acceptor,MF,MGST2;SESN2
7258,GO:0030145,0.252931884585134,0.92736628799933,2,47,manganese ion binding,MF,NUDT7;PEPD
18953,GO:1901881,0.253068807189444,0.967241587909607,1,14,positive regulation of protein depolymerization,BP,ACTN2
11268,GO:0043218,0.253154055331923,0.96721829867136,1,14,compact myelin,CC,JAM3
7722,GO:0031033,0.253160143005022,0.967063488669876,1,15,myosin filament organization,BP,MYH11
21625,GO:2001212,0.253215932820548,0.967201388376321,1,14,regulation of vasculogenesis,BP,HEY1
8000,GO:0031532,0.253240066376713,0.902780866759793,3,85,actin cytoskeleton reorganization,BP,FGF10;HRAS;PARVB
2691,GO:0005604,0.253330050672134,0.902656706704743,3,89,basement membrane,CC,ANG;LAMA1;LAMA5
7330,GO:0030238,0.253387740423505,0.967154410203195,1,14,male sex determination,BP,DHH
437,GO:0001134,0.253539366878168,0.967112919178448,1,14,transcription factor activity, transcription factor recruiting,MF,LIF
7311,GO:0030214,0.253721311966682,0.967063093298301,1,14,hyaluronan catabolic process,BP,HEXB
8375,GO:0032274,0.253782773147618,0.967046252595505,1,14,gonadotropin secretion,BP,INHBB
11571,GO:0043931,0.253956931629095,0.966844394517742,1,15,ossification involved in bone maturation,BP,BMP2
1415,GO:0003085,0.254364955179419,0.966886493835313,1,14,negative regulation of systemic arterial blood pressure,BP,KCNK6
3557,GO:0006957,0.254461092585109,0.966860071032057,1,14,complement activation, alternative pathway,BP,CFB
9681,GO:0035094,0.25458131558385,0.926584902504043,2,47,response to nicotine,BP,EDN1;STAR
5946,GO:0016482,0.255062440417469,0.885098617403794,4,126,cytosolic transport,BP,RAB6C;ZFYVE21;TBC1D14;MSN
14249,GO:0051770,0.255305343865589,0.966627529403061,1,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
17849,GO:0097284,0.255731502890229,0.966509803639789,1,14,hepatocyte apoptotic process,BP,PIK3CG
13914,GO:0051169,0.255923070883022,0.832196900188951,12,465,nuclear transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;IFI27;CDH1;GAS6
16685,GO:0071801,0.255998975937023,0.966435796663013,1,14,regulation of podosome assembly,BP,MSN
21151,GO:2000345,0.256085891595741,0.966411728422558,1,14,regulation of hepatocyte proliferation,BP,LIMS2
14361,GO:0051967,0.256107362413829,0.966405781352712,1,14,negative regulation of synaptic transmission, glutamatergic,BP,ADORA1
3427,GO:0006749,0.256220636169336,0.925846551895578,2,46,glutathione metabolic process,BP,MGST2;IDH1
9024,GO:0033268,0.256303502197945,0.966194455200356,1,15,node of Ranvier,CC,SPTBN4
7947,GO:0031434,0.256387655515403,0.966328090869457,1,14,mitogen-activated protein kinase kinase binding,MF,ARAF
12834,GO:0046851,0.256436104674988,0.966314651795197,1,14,negative regulation of bone remodeling,BP,CLDN18
1081,GO:0002448,0.256859586624464,0.925499612959855,2,47,mast cell mediated immunity,BP,CHGA;PIK3CG
18606,GO:1900409,0.257150905926156,0.966116029200289,1,14,positive regulation of cellular response to oxidative stress,BP,RGN
5205,GO:0014048,0.257361523308354,0.966057380555847,1,14,regulation of glutamate secretion,BP,ADORA1
2183,GO:0004707,0.257462057595267,0.966029365779721,1,14,MAP kinase activity,MF,MAPK12
11530,GO:0043650,0.257544675661559,0.966006333872229,1,14,dicarboxylic acid biosynthetic process,BP,SLC1A3
13778,GO:0050961,0.257546765026291,0.966005751295325,1,14,detection of temperature stimulus involved in sensory perception,BP,ADORA1
13780,GO:0050965,0.257546765026291,0.966005751295325,1,14,detection of temperature stimulus involved in sensory perception of pain,BP,ADORA1
3375,GO:0006677,0.257575401095083,0.965997766148389,1,14,glycosylceramide metabolic process,BP,GLA
964,GO:0002253,0.257645798107349,0.827769439177414,13,507,activation of immune response,BP,CFB;FADD;PRKACB;PYCARD;TYRO3;PSMB10;PIK3R2;PIK3R1;TICAM1;HRAS;BCAR1;PIK3CA;PDE4B
12868,GO:0046907,0.257688597209458,0.795726087455419,38,1646,intracellular transport,BP,SYT5;RAB6C;RAB27A;ZFYVE21;WNT7A;NMT2;TBC1D14;ADORA1;ABCG1;SPTBN5;SPTBN4;FZD7;PRR5L;PIK3R2;PIK3R1;REEP1;CPT2;GPRASP1;RHOB;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;NOL3;AKT1;IFI27;RAB12;RAB17;CDH1;MYO7A;STAR;PIK3CG;GAS6;RPH3AL;CNIH4
4188,GO:0008499,0.25772494031199,0.965956050257628,1,14,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT2
1253,GO:0002739,0.257752346993999,0.96594840171819,1,14,regulation of cytokine secretion involved in immune response,BP,WNT5A
10132,GO:0035930,0.257758661138681,0.965946639457949,1,14,corticosteroid hormone secretion,BP,BMP6
21498,GO:2000846,0.257758661138681,0.965946639457949,1,14,regulation of corticosteroid hormone secretion,BP,BMP6
9096,GO:0033549,0.258102652057739,0.96585055568461,1,14,MAP kinase phosphatase activity,MF,DUSP5
5654,GO:0015868,0.25833918112311,0.96578440061873,1,14,purine ribonucleotide transport,BP,GJB1
19017,GO:1902074,0.25836567892258,0.965776984972796,1,14,response to salt,BP,EDN1
8225,GO:0031998,0.258596520803075,0.96555255282503,1,15,regulation of fatty acid beta-oxidation,BP,AKT1
746,GO:0001916,0.258786508256314,0.96565909193868,1,14,positive regulation of T cell mediated cytotoxicity,BP,FADD
548,GO:0001608,0.258961325932166,0.965610051223417,1,14,G-protein coupled nucleotide receptor activity,MF,P2RY14
9921,GO:0035589,0.258961325932166,0.965610051223417,1,14,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,P2RY14
11976,GO:0045028,0.258961325932166,0.965610051223417,1,14,G-protein coupled purinergic nucleotide receptor activity,MF,P2RY14
7277,GO:0030170,0.259047194704354,0.924450957675675,2,47,pyridoxal phosphate binding,MF,GLDC;ACCS
15848,GO:0070279,0.259047194704354,0.924450957675675,2,47,vitamin B6 binding,MF,GLDC;ACCS
2548,GO:0005267,0.259153805702434,0.882530016905601,4,124,potassium channel activity,MF,KCNK6;KCNH2;KCNG2;KCND1
1122,GO:0002523,0.259397046677397,0.965487650717453,1,14,leukocyte migration involved in inflammatory response,BP,JAM3
11777,GO:0044389,0.259498452419217,0.846590790841968,8,291,ubiquitin-like protein ligase binding,MF,PRKACB;PRR5L;KCNH2;RALB;MAGEC2;AXIN1;CDKN1A;FZD8
12313,GO:0045723,0.259621510755728,0.96542450066215,1,14,positive regulation of fatty acid biosynthetic process,BP,RGN
12430,GO:0045931,0.260127205288751,0.88188673718669,4,126,positive regulation of mitotic cell cycle,BP,EDN1;FGF10;PDGFB;FGF8
18165,GO:0098793,0.26018805837857,0.840771060870819,9,337,presynapse,CC,TMEM163;ADRA2C;SYT5;WNT7A;ADORA1;RAB40B;RAB40A;VAMP1;PDE4B
7385,GO:0030316,0.26039207210114,0.898651486891181,3,86,osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
12315,GO:0045725,0.260618952815991,0.964980805063362,1,15,positive regulation of glycogen biosynthetic process,BP,AKT1
8836,GO:0032934,0.260912443813787,0.923510598656031,2,48,sterol binding,MF,ABCG1;STAR
6723,GO:0019838,0.261205298707088,0.881187567047921,4,127,growth factor binding,MF,ITGB4;ACVR1;PDGFB;CTGF
13966,GO:0051248,0.261445102774482,0.803101022659325,25,1048,negative regulation of protein metabolic process,BP,LIF;GADD45A;SERPINA5;ZFPM1;EDN1;PYCARD;PSMB10;RGN;PRR5L;PRKAR1B;SESN2;ANG;HBEGF;NMI;BMP7;BMP4;CDKN1A;NOL3;DEPTOR;AKT1;CST9L;INHBB;TFPI;GAS6;DUSP5
4777,GO:0010324,0.261475972648308,0.923237885130328,2,48,membrane invagination,BP,MFGE8;SNX18
5068,GO:0010878,0.261582629596414,0.964706521962678,1,15,cholesterol storage,BP,ABCG1
2301,GO:0004866,0.261717555572021,0.868482826794045,5,164,endopeptidase inhibitor activity,MF,SERPINA5;NOL3;CST9L;TFPI;GAS6
11186,GO:0043092,0.263175657034705,0.964250489784442,1,15,L-amino acid import,BP,SLC1A3
9280,GO:0034121,0.263288309567336,0.922357934836361,2,48,regulation of toll-like receptor signaling pathway,BP,TYRO3;TICAM1
1839,GO:0004115,0.263365463972195,0.964195936036421,1,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE4B
16600,GO:0071622,0.263527510722709,0.922283222100743,2,47,regulation of granulocyte chemotaxis,BP,EDN1;JAM3
12902,GO:0046965,0.263623494725142,0.964121699027409,1,15,retinoid X receptor binding,MF,VDR
1210,GO:0002690,0.263659036797817,0.896792746819529,3,84,positive regulation of leukocyte chemotaxis,BP,EDN1;WNT5A;GAS6
1147,GO:0002576,0.263671583239779,0.879621428140601,4,126,platelet degranulation,BP,ACTN2;TF;PDGFB;GAS6
4424,GO:0009150,0.263746485703634,0.82287132143386,13,507,purine ribonucleotide metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;CHGA;NUDT7;NPPC;PDE4B
18386,GO:0101002,0.264005269920422,0.87943160331202,4,124,ficolin-1-rich granule,CC,CRISPLD2;PNP;IDH1;DERA
20249,GO:1904813,0.264005269920422,0.87943160331202,4,124,ficolin-1-rich granule lumen,CC,CRISPLD2;PNP;IDH1;DERA
16885,GO:0072160,0.264090848584595,0.963987019616274,1,15,nephron tubule epithelial cell differentiation,BP,LIF
3843,GO:0007566,0.264117386556134,0.92195392028942,2,48,embryo implantation,BP,LIF;DDR1
13292,GO:0048569,0.264281884755558,0.963931886643454,1,15,post-embryonic animal organ development,BP,MYO7A
2178,GO:0004702,0.265354078579246,0.895742679001748,3,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,ACVR1;MAPK12;ARAF
10088,GO:0035855,0.265568016816678,0.963559481074248,1,15,megakaryocyte development,BP,ZFPM1
15380,GO:0061134,0.266220830012692,0.855706929122394,6,207,peptidase regulator activity,MF,SERPINA5;PYCARD;NOL3;CST9L;TFPI;GAS6
17432,GO:0090177,0.266232149156015,0.963366340161932,1,15,establishment of planar polarity involved in neural tube closure,BP,WNT5A
10585,GO:0040013,0.266535603963336,0.847695728178528,7,253,negative regulation of locomotion,BP,WNT3;WNT4;NOTCH1;ADORA1;RGN;WNT5A;RHOB
10016,GO:0035729,0.266641653377678,0.963246964536446,1,15,cellular response to hepatocyte growth factor stimulus,BP,BCAR1
15750,GO:0070125,0.266799361513529,0.894955577112717,3,84,mitochondrial translational elongation,BP,MRPL14;MRPL16;TSFM
7881,GO:0031323,0.266928524010516,0.768556554608047,124,5697,regulation of cellular metabolic process,BP,ITGA3;ITGA5;PDK4;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;RAB27A;FASN;PMAIP1;GADD45A;FADD;SERPINA5;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;TBC1D14;ADORA1;DKK3;EDN1;ABCG1;PRKACB;CCL20;EBF1;SPTBN4;PYCARD;ACADVL;MAPK12;FZD7;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;CHGA;MSN;NOL3;DEPTOR;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;RAB12;KITLG;IDH1;NPPC;CST9L;NAB2;CDH1;INHBB;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;GLA;ZCCHC12;LZTS1;PM20D2;RBMS3;HNF1A;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
5031,GO:0010832,0.266967107375869,0.96315193551644,1,15,negative regulation of myotube differentiation,BP,NOTCH1
16196,GO:0070920,0.26728392260491,0.963059296921445,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,BMP4
3737,GO:0007259,0.267443071820515,0.86456396535227,5,166,JAK-STAT cascade,BP,LIF;NOTCH1;GHR;CLCF1;NMI
18021,GO:0097696,0.267443071820515,0.86456396535227,5,166,STAT cascade,BP,LIF;NOTCH1;GHR;CLCF1;NMI
14309,GO:0051893,0.267523623960496,0.920204203568831,2,50,regulation of focal adhesion assembly,BP,WNT4;SDC4
17390,GO:0090109,0.267523623960496,0.920204203568831,2,50,regulation of cell-substrate junction assembly,BP,WNT4;SDC4
13391,GO:0048747,0.267693684314705,0.920120366602428,2,50,muscle fiber development,BP,BMP4;MYH11
21012,GO:2000117,0.267756238033654,0.89435245281185,3,86,negative regulation of cysteine-type endopeptidase activity,BP,NOL3;AKT1;GAS6
16347,GO:0071236,0.267806039709525,0.962906342564613,1,15,cellular response to antibiotic,BP,STAR
14924,GO:0060397,0.267859093066861,0.962890780752993,1,15,JAK-STAT cascade involved in growth hormone signaling pathway,BP,GHR
17344,GO:0090036,0.267865620374177,0.962888865885886,1,15,regulation of protein kinase C signaling,BP,WNT5A
4584,GO:0009566,0.267872749241844,0.864269699187341,5,166,fertilization,BP,IGSF8;SERPINA5;MFGE8;SPTBN4;HEXB
3512,GO:0006888,0.267893601706583,0.864230674489023,5,169,ER to Golgi vesicle-mediated transport,BP,SPTBN5;SPTBN4;SPTB;GAS6;CNIH4
14658,GO:0060026,0.267954670647274,0.962862736347494,1,15,convergent extension,BP,WNT5A
6076,GO:0016722,0.268604151494935,0.962671851006599,1,15,oxidoreductase activity, oxidizing metal ions,MF,ETFDH
5827,GO:0016236,0.268955445258695,0.845919655487066,7,252,macroautophagy,BP,TBC1D14;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1
2981,GO:0006086,0.268967709492687,0.962564760215542,1,15,acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
17893,GO:0097386,0.268988992544032,0.962558485684713,1,15,glial cell projection,CC,GJB2
3731,GO:0007252,0.268993146483757,0.962557260978461,1,15,I-kappaB phosphorylation,BP,AKT1
17747,GO:0097110,0.269252530538516,0.919350070501876,2,50,scaffold protein binding,MF,KCNH2;DLL1
7096,GO:0022406,0.269347542229839,0.863233301100216,5,169,membrane docking,BP,MARK4;RAB40B;RAB40A;RALB;MSN
15193,GO:0060788,0.269511273316216,0.962404325505994,1,15,ectodermal placode formation,BP,AXIN1
16649,GO:0071697,0.269511273316216,0.962404325505994,1,15,ectodermal placode morphogenesis,BP,AXIN1
14596,GO:0055075,0.269773746952937,0.96232671778231,1,15,potassium ion homeostasis,BP,KCNH2
9421,GO:0034390,0.269793027996423,0.962321013260468,1,15,smooth muscle cell apoptotic process,BP,EDN1
9422,GO:0034391,0.269793027996423,0.962321013260468,1,15,regulation of smooth muscle cell apoptotic process,BP,EDN1
14190,GO:0051648,0.269972130869512,0.845155733903526,7,255,vesicle localization,BP,SYT5;RAB27A;WNT7A;CDH2;RAB17;MYO7A;PIK3CG
4273,GO:0008656,0.270067545977429,0.962239741366059,1,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,PYCARD
12602,GO:0046339,0.270252784222504,0.962184845516189,1,15,diacylglycerol metabolic process,BP,ANG
6293,GO:0017137,0.270462742836093,0.875204854707372,4,129,Rab GTPase binding,MF,RIN3;TBC1D14;RAB11FIP1;RPH3AL
12320,GO:0045732,0.270576833266406,0.844728155337067,7,251,positive regulation of protein catabolic process,BP,PSMB10;RGN;WNT5A;AXIN1;MSN;AKT1;RNF144A
7418,GO:0030374,0.270673198453815,0.918645210729928,2,50,ligand-dependent nuclear receptor transcription coactivator activity,MF,ACTN2;ZCCHC12
6013,GO:0016594,0.270733971169991,0.96204203541553,1,15,glycine binding,MF,GLDC
11620,GO:0044065,0.270815031543288,0.962017948015122,1,15,regulation of respiratory system process,BP,ADORA1
7543,GO:0030673,0.270977760144992,0.961816198275274,1,16,axolemma,CC,ADORA1
7361,GO:0030285,0.271052009716973,0.961947479870525,1,15,integral component of synaptic vesicle membrane,CC,TMEM163
19898,GO:1904019,0.271070372936492,0.892356152655928,3,88,epithelial cell apoptotic process,BP,JAG2;PIK3CG;GAS6
10930,GO:0042588,0.271182585221228,0.961908620445737,1,15,zymogen granule,CC,RAB3D
3528,GO:0006910,0.271281130683121,0.961879278461774,1,15,phagocytosis, recognition,BP,MFGE8
2590,GO:0005351,0.271284319416092,0.96187832880241,1,15,sugar:proton symporter activity,MF,SLC45A4
2607,GO:0005402,0.271284319416092,0.96187832880241,1,15,cation:sugar symporter activity,MF,SLC45A4
11264,GO:0043209,0.271932370474229,0.86147124066433,5,167,myelin sheath,CC,JAM3;MSN;MDH1;TSPAN2;CLDN11
8559,GO:0032515,0.271955231614764,0.961678224296281,1,15,negative regulation of phosphoprotein phosphatase activity,BP,RGN
874,GO:0002082,0.271991411342379,0.961667416713716,1,15,regulation of oxidative phosphorylation,BP,ACTN3
19566,GO:1903362,0.272215959845245,0.843516279331744,7,251,regulation of cellular protein catabolic process,BP,PSMB10;RGN;AXIN1;MSN;AKT1;ARAF;RNF144A
3306,GO:0006584,0.272265396368835,0.917892276796923,2,49,catecholamine metabolic process,BP,PNMT;NPR1
4621,GO:0009712,0.272265396368835,0.917892276796923,2,49,catechol-containing compound metabolic process,BP,PNMT;NPR1
1601,GO:0003417,0.272298586964831,0.961575588494675,1,15,growth plate cartilage development,BP,NPPC
1643,GO:0003746,0.272480412007492,0.961521174914669,1,15,translation elongation factor activity,MF,TSFM
3867,GO:0007611,0.272498937926021,0.851173427699794,6,214,learning or memory,BP,ITGA3;ITGA5;STRA6;PRKAR1B;CLDN5;S100B
14575,GO:0055022,0.272617740926324,0.961480048733181,1,15,negative regulation of cardiac muscle tissue growth,BP,RBP4
15378,GO:0061117,0.272617740926324,0.961480048733181,1,15,negative regulation of heart growth,BP,RBP4
14774,GO:0060192,0.272784174536871,0.961430173438256,1,15,negative regulation of lipase activity,BP,APOC1
19334,GO:1902884,0.272846151425741,0.961411591512249,1,15,positive regulation of response to oxidative stress,BP,RGN
19657,GO:1903541,0.272926558255335,0.961387476425638,1,15,regulation of exosomal secretion,BP,SDC4
19659,GO:1903543,0.272926558255335,0.961387476425638,1,15,positive regulation of exosomal secretion,BP,SDC4
11801,GO:0044431,0.273091058630081,0.798351992656038,21,878,Golgi apparatus part,CC,WNT3;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ABCG1;RAB39A;PDGFB;HRAS;WNT5B;WNT5A;RHOQ;SDC4;B3GNT2;RND3;RAB12;CDH1;GAS6;GPSM1;RAB38
17616,GO:0090533,0.273127950019096,0.961327039193491,1,15,cation-transporting ATPase complex,CC,FXYD1
14018,GO:0051321,0.27324161149243,0.850657556904683,6,211,meiotic cell cycle,BP,LIF;WNT4;PRKACB;WNT5A;NPPC;PIM2
2162,GO:0004675,0.273367890008003,0.96109888343279,1,16,transmembrane receptor protein serine/threonine kinase activity,MF,ACVR1
6546,GO:0019233,0.273596361204506,0.890855177655097,3,88,sensory perception of pain,BP,ADRA2C;ADORA1;EDN1
11156,GO:0043032,0.273622795823013,0.961178311476659,1,15,positive regulation of macrophage activation,BP,WNT5A
5651,GO:0015865,0.273680329816167,0.961160998610163,1,15,purine nucleotide transport,BP,GJB1
8272,GO:0032075,0.273771495931603,0.961133556437587,1,15,positive regulation of nuclease activity,BP,AKT1
5580,GO:0015732,0.273794228358498,0.961126711988455,1,15,prostaglandin transport,BP,EDN1
16038,GO:0070588,0.273806693907907,0.842300119317908,7,259,calcium ion transmembrane transport,BP,CASQ2;TSPAN13;RGN;NOL3;PIK3CG;GAS6;PDE4B
989,GO:0002295,0.273872348369807,0.961103185868551,1,15,T-helper cell lineage commitment,BP,ZFPM1
13797,GO:0051004,0.27396055400485,0.961076612812945,1,15,regulation of lipoprotein lipase activity,BP,APOC1
3428,GO:0006750,0.274140390779849,0.961022403130854,1,15,glutathione biosynthetic process,BP,MGST2
3267,GO:0006544,0.274181989765595,0.961009857567081,1,15,glycine metabolic process,BP,GLDC
3141,GO:0006366,0.274205536746145,0.776831790149276,46,2029,transcription from RNA polymerase II promoter,BP,ITGA3;LIF;WNT2;POU3F1;NOTCH1;FADD;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;PSMB10;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RNASEL;FGF8;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;AKT1;IFI27;TLE1;SIN3B;ZCCHC12;HNF1A;VDR;GDNF;FZD8;HEY1
15436,GO:0061298,0.27421031373746,0.960844271622409,1,16,retina vasculature development in camera-type eye,BP,RHOJ
8398,GO:0032305,0.274251026904993,0.960989032103813,1,15,positive regulation of icosanoid secretion,BP,EDN1
21052,GO:2000193,0.274251026904993,0.960989032103813,1,15,positive regulation of fatty acid transport,BP,EDN1
15815,GO:0070234,0.274343392747293,0.960961159623556,1,15,positive regulation of T cell apoptotic process,BP,WNT5A
11191,GO:0043101,0.274564570861705,0.96089437104353,1,15,purine-containing compound salvage,BP,PNP
12042,GO:0045125,0.274570805181626,0.960892487552218,1,15,bioactive lipid receptor activity,MF,LPAR2
21081,GO:2000251,0.27475427786398,0.960837034581308,1,15,positive regulation of actin cytoskeleton reorganization,BP,HRAS
1498,GO:0003222,0.27499693136609,0.96060568372673,1,16,ventricular trabecula myocardium morphogenesis,BP,NOTCH1
5152,GO:0010984,0.275350717150282,0.960656460868416,1,15,regulation of lipoprotein particle clearance,BP,APOC1
16166,GO:0070875,0.276086050855838,0.960273999058584,1,16,positive regulation of glycogen metabolic process,BP,AKT1
7540,GO:0030669,0.276833207190852,0.915557559136027,2,50,clathrin-coated endocytic vesicle membrane,CC,WNT5A;HBEGF
13424,GO:0048820,0.277178593880045,0.959939699792331,1,16,hair follicle maturation,BP,WNT5A
14559,GO:0055003,0.277217229708365,0.959786353171611,1,17,cardiac myofibril assembly,BP,FHOD3
4832,GO:0010518,0.277651758798875,0.915143426736317,2,50,positive regulation of phospholipase activity,BP,LPAR2;ANG
4690,GO:0009950,0.278460728924922,0.959545377247442,1,16,dorsal/ventral axis specification,BP,WNT3
9911,GO:0035579,0.278767617175415,0.887737900065555,3,89,specific granule membrane,CC,PLAU;VAMP1;RAB44
4906,GO:0010642,0.278881254961659,0.959415570165735,1,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
9576,GO:0034707,0.27905705855421,0.914430337054512,2,50,chloride channel complex,CC,TTYH1;FXYD1
14118,GO:0051531,0.279317088196275,0.959280790924026,1,16,NFAT protein import into nucleus,BP,PIK3R1
16369,GO:0071277,0.279827144893976,0.913998238637163,2,51,cellular response to calcium ion,BP,EDN1;WNT5A
9762,GO:0035303,0.279882049081031,0.869016104706211,4,131,regulation of dephosphorylation,BP,ADORA1;RGN;BMP2;CAMSAP3
2066,GO:0004553,0.280322295471466,0.886820000179081,3,88,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,IDUA;HEXB;GLA
13557,GO:0050655,0.280486025146812,0.958918059520249,1,16,dermatan sulfate proteoglycan metabolic process,BP,IDUA
497,GO:0001523,0.280869274095436,0.886469404968855,3,89,retinoid metabolic process,BP,STRA6;RBP4;SDC4
10650,GO:0042100,0.280908232948887,0.886465820251235,3,88,B cell proliferation,BP,TICAM1;CLCF1;CDKN1A
66,GO:0000132,0.280991197499126,0.958760738895716,1,16,establishment of mitotic spindle orientation,BP,FGF10
17294,GO:0086065,0.281273947452212,0.913220588823388,2,52,cell communication involved in cardiac conduction,BP,DSC2;CASQ2
16132,GO:0070822,0.281381152267916,0.95863906742919,1,16,Sin3-type complex,CC,SIN3B
163,GO:0000315,0.281421057781758,0.91326699972857,2,49,organellar large ribosomal subunit,CC,MRPL14;MRPL16
2776,GO:0005762,0.281421057781758,0.91326699972857,2,49,mitochondrial large ribosomal subunit,CC,MRPL14;MRPL16
18817,GO:1901532,0.281641377794454,0.958557760888636,1,16,regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
13096,GO:0048070,0.281833133853293,0.958497789760991,1,16,regulation of developmental pigmentation,BP,KITLG
12691,GO:0046527,0.281860942959669,0.958489088486139,1,16,glucosyltransferase activity,MF,ALG5
9910,GO:0035578,0.281865298204653,0.885886392783457,3,88,azurophil granule lumen,CC,PYCARD;HEXB;GLA
2490,GO:0005159,0.282122938933001,0.95840706126886,1,16,insulin-like growth factor receptor binding,MF,PIK3R1
2175,GO:0004697,0.282129075899821,0.958405138776912,1,16,protein kinase C activity,MF,PKN3
687,GO:0001832,0.282350209887113,0.958335831971062,1,16,blastocyst growth,BP,SALL4
9916,GO:0035584,0.282370459888611,0.958329482054583,1,16,calcium-mediated signaling using intracellular calcium source,BP,CCL20
15452,GO:0061323,0.282697496012183,0.958226855728389,1,16,cell proliferation involved in heart morphogenesis,BP,BMP4
14191,GO:0051649,0.283098788990078,0.769787737160263,44,1947,establishment of localization in cell,BP,SYT5;RAB6C;RAB27A;ZFYVE21;PMAIP1;WNT7A;NMT2;TBC1D14;ADORA1;CASQ2;ABCG1;SPTBN5;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;CPT2;GPRASP1;RHOB;PSRC1;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;NOL3;AKT1;IFI27;RAB12;RAB17;CDH1;MYO7A;STAR;PIK3CG;GAS6;RPH3AL;GDNF;CNIH4
7901,GO:0031344,0.283359934233832,0.806899631114469,13,527,regulation of cell projection organization,BP,ITGA3;WNT3;WNT7A;HRAS;WNT5A;RHOQ;FAM110C;BMP7;ESPN;AKT1;RAB17;LZTS1;LINGO1
10885,GO:0042523,0.284000263856366,0.957816622912031,1,16,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,GHR
21535,GO:2001014,0.284015725393423,0.95781174058651,1,16,regulation of skeletal muscle cell differentiation,BP,S100B
21474,GO:2000810,0.284122767201713,0.957777930995141,1,16,regulation of bicellular tight junction assembly,BP,CLDN1
9746,GO:0035268,0.284458777393175,0.957671701439853,1,16,protein mannosylation,BP,DPM3
17075,GO:0072522,0.284801715229123,0.83411169705718,7,254,purine-containing compound biosynthetic process,BP,MRAP;GUCY1B3;EDN1;PNP;NPR1;ACAT1;NPPC
16648,GO:0071696,0.284900853574707,0.957531709448327,1,16,ectodermal placode development,BP,AXIN1
14976,GO:0060457,0.28517345034398,0.957445256236835,1,16,negative regulation of digestive system process,BP,WNK4
16232,GO:0070977,0.285228929285503,0.95727788037498,1,17,bone maturation,BP,BMP2
16669,GO:0071732,0.28525939704829,0.957417977912159,1,16,cellular response to nitric oxide,BP,GUCY1B3
3938,GO:0008105,0.28571943993552,0.957121515848057,1,17,asymmetric protein localization,BP,WNT7A
46,GO:0000097,0.285911652406999,0.957210638873862,1,16,sulfur amino acid biosynthetic process,BP,MRI1
1754,GO:0003995,0.286117411715695,0.957145113957815,1,16,acyl-CoA dehydrogenase activity,MF,ACADVL
13066,GO:0048012,0.286122675193139,0.957143437037894,1,16,hepatocyte growth factor receptor signaling pathway,BP,BCAR1
15381,GO:0061135,0.286222532105729,0.851484244486699,5,170,endopeptidase regulator activity,MF,SERPINA5;NOL3;CST9L;TFPI;GAS6
4778,GO:0010332,0.28628425255817,0.910639589962446,2,52,response to gamma radiation,BP,HRAS;CDKN1A
8251,GO:0032042,0.286411013089669,0.957051517222183,1,16,mitochondrial DNA metabolic process,BP,SESN2
13272,GO:0048535,0.28675946749076,0.956940284143877,1,16,lymph node development,BP,FADD
14089,GO:0051453,0.286759468565192,0.882865138768751,3,90,regulation of intracellular pH,BP,RAB39A;RAB20;RAB38
980,GO:0002283,0.2869961428716,0.807226232254583,12,474,neutrophil activation involved in immune response,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;HEXB;PKP1;IDH1;RAB44;GLA;DERA;RAB3D
11337,GO:0043312,0.2869961428716,0.807226232254583,12,474,neutrophil degranulation,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;HEXB;PKP1;IDH1;RAB44;GLA;DERA;RAB3D
17941,GO:0097479,0.287073591229946,0.864228508643655,4,132,synaptic vesicle localization,BP,SYT5;RAB27A;WNT7A;CDH2
11735,GO:0044320,0.287429787142486,0.956725848096702,1,16,cellular response to leptin stimulus,BP,INHBB
9211,GO:0033866,0.287505481221592,0.956701595609133,1,16,nucleoside bisphosphate biosynthetic process,BP,ACAT1
9234,GO:0034030,0.287505481221592,0.956701595609133,1,16,ribonucleoside bisphosphate biosynthetic process,BP,ACAT1
9237,GO:0034033,0.287505481221592,0.956701595609133,1,16,purine nucleoside bisphosphate biosynthetic process,BP,ACAT1
16676,GO:0071782,0.287518597756613,0.956697392271828,1,16,endoplasmic reticulum tubular network,CC,REEP1
9854,GO:0035493,0.287751890117353,0.956622592615025,1,16,SNARE complex assembly,BP,VAMP1
5056,GO:0010866,0.287836899384412,0.956595318256194,1,16,regulation of triglyceride biosynthetic process,BP,RGN
8348,GO:0032225,0.288288073532504,0.956450401240239,1,16,regulation of synaptic transmission, dopaminergic,BP,GDNF
20050,GO:1904385,0.288465362852527,0.956393381142938,1,16,cellular response to angiotensin,BP,ACTN2
16647,GO:0071695,0.288689871792842,0.909349481957785,2,53,anatomical structure maturation,BP,WNT5A;BMP2
10668,GO:0042130,0.288715247939164,0.909415517649479,2,51,negative regulation of T cell proliferation,BP,SDC4;BMP4
10838,GO:0042448,0.288718697180403,0.956311830034867,1,16,progesterone metabolic process,BP,CYP17A1
2849,GO:0005876,0.28884791330159,0.909305867665537,2,52,spindle microtubule,CC,TUBG2;PSRC1
13611,GO:0050714,0.288938139944231,0.839225904916916,6,214,positive regulation of protein secretion,BP,PYCARD;WNT5A;RBP4;ANG;BMP6;RPH3AL
16423,GO:0071359,0.288986838338499,0.909233339998809,2,52,cellular response to dsRNA,BP,RALB;BMP4
13269,GO:0048531,0.289025478873892,0.956212958157511,1,16,beta-1,3-galactosyltransferase activity,MF,B3GNT2
9027,GO:0033273,0.289083676479807,0.881438847465436,3,90,response to vitamin,BP,BMP7;GAS6;VDR
11362,GO:0043373,0.289210406818596,0.956153297079839,1,16,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
8675,GO:0032693,0.28922666384689,0.956148050071108,1,16,negative regulation of interleukin-10 production,BP,DLL1
13934,GO:0051193,0.289266563476076,0.909087226796089,2,52,regulation of cofactor metabolic process,BP,PDK4;ACTN3
13937,GO:0051196,0.289266563476076,0.909087226796089,2,52,regulation of coenzyme metabolic process,BP,PDK4;ACTN3
12003,GO:0045072,0.289280953679564,0.956130525275386,1,16,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
3849,GO:0007584,0.289436974948594,0.849196436322419,5,172,response to nutrient,BP,BMP7;STAR;GAS6;VDR;ACSL4
2984,GO:0006091,0.289556516768437,0.818012301919733,9,342,generation of precursor metabolites and energy,BP,ACTN3;ACADVL;ETFB;PFKFB3;MDH1;AKT1;IDH1;PIK3CA;ETFDH
1148,GO:0002577,0.289558263080289,0.956040947755482,1,16,regulation of antigen processing and presentation,BP,PYCARD
10263,GO:0036149,0.289712875457122,0.955990959357359,1,16,phosphatidylinositol acyl-chain remodeling,BP,PLA2G16
6590,GO:0019372,0.290253881273345,0.955815791100516,1,16,lipoxygenase pathway,BP,PON2
1170,GO:0002637,0.290421853355053,0.908523406090717,2,51,regulation of immunoglobulin production,BP,RBP4;CLCF1
19583,GO:1903391,0.290519590246211,0.908392202703984,2,53,regulation of adherens junction organization,BP,WNT4;SDC4
6588,GO:0019370,0.291094620105715,0.955542791952482,1,16,leukotriene biosynthetic process,BP,MGST2
3569,GO:0006978,0.29138009701303,0.955293600461028,1,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A
16171,GO:0070884,0.291421727108282,0.955279997310799,1,17,regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
11627,GO:0044090,0.291584503186886,0.95522678569658,1,17,positive regulation of vacuole organization,BP,RALB
19431,GO:1903052,0.291692849189425,0.847596255384102,5,172,positive regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN;AXIN1;AKT1;RNF144A
18705,GO:1901185,0.291892643411354,0.907710358552838,2,52,negative regulation of ERBB signaling pathway,BP,HBEGF;EPN1
2629,GO:0005496,0.292134628355611,0.879536422517333,3,91,steroid binding,MF,ABCG1;STAR;VDR
14619,GO:0055102,0.292243386523383,0.955168230576009,1,16,lipase inhibitor activity,MF,APOC1
7434,GO:0030414,0.292325978008548,0.847146189367305,5,172,peptidase inhibitor activity,MF,SERPINA5;NOL3;CST9L;TFPI;GAS6
11184,GO:0043090,0.293714624541562,0.954527139284025,1,17,amino acid import,BP,SLC1A3
3796,GO:0007405,0.293927830389926,0.906597020344987,2,53,neuroblast proliferation,BP,ARTN;NOTCH1
10663,GO:0042119,0.294079588247806,0.801428447445499,12,477,neutrophil activation,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;HEXB;PKP1;IDH1;RAB44;GLA;DERA;RAB3D
13516,GO:0050431,0.294178505268154,0.954373959727622,1,17,transforming growth factor beta binding,MF,ACVR1
11800,GO:0044430,0.294560036033762,0.766471653268403,33,1452,cytoskeletal part,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;PRKACB;SPTBN5;SPTBN4;KRT10;CDH2;CGN;PLEKHH2;PXK;RHOQ;PSRC1;FAM110C;SPTB;CAMSAP3;ESPN;AKT1;PKP1;CDH1;MYO7A;CLDN5;MYH11;AMOT;UNC119;RAB3D;MYZAP;FAM110B;PDE4B;TMOD4
9649,GO:0035024,0.294611710502088,0.954230645630768,1,17,negative regulation of Rho protein signal transduction,BP,ITGA3
5078,GO:0010888,0.294781377016992,0.954174446585652,1,17,negative regulation of lipid storage,BP,ABCG1
8780,GO:0032844,0.295073842373183,0.804378645481473,11,439,regulation of homeostatic process,BP,PDK4;FADD;ZFPM1;ADORA1;CASQ2;EDN1;NPR1;DLL1;NOL3;KITLG;CLDN18
17737,GO:0097094,0.295214669137292,0.95403074854,1,17,craniofacial suture morphogenesis,BP,BMP4
10015,GO:0035728,0.295285559977811,0.954007213816739,1,17,response to hepatocyte growth factor,BP,BCAR1
16438,GO:0071380,0.295438190702829,0.953956519430722,1,17,cellular response to prostaglandin E stimulus,BP,AKT1
9957,GO:0035635,0.295473277165265,0.95394486141869,1,17,entry of bacterium into host cell,BP,CDH1
430,GO:0001104,0.295572911025005,0.877361691235021,3,93,RNA polymerase II transcription cofactor activity,MF,POU3F1;TLE1;SIN3B
10719,GO:0042249,0.296140517652061,0.953722841529667,1,17,establishment of planar polarity of embryonic epithelium,BP,WNT5A
1666,GO:0003841,0.296448707992123,0.95362008843548,1,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
10695,GO:0042171,0.296448707992123,0.95362008843548,1,17,lysophosphatidic acid acyltransferase activity,MF,MBOAT2
16597,GO:0071617,0.296448707992123,0.95362008843548,1,17,lysophospholipid acyltransferase activity,MF,MBOAT2
3908,GO:0008047,0.297032915303764,0.798988212945913,12,484,enzyme activator activity,MF,RIN3;APOC1;TBC1D14;PYCARD;MGST2;PIK3R2;PDGFB;AXIN1;BMP2;CDKN1A;PIK3CA;GAS6
9459,GO:0034453,0.297105382819373,0.953256429434982,1,18,microtubule anchoring,BP,CAMSAP3
4360,GO:0009066,0.297321299747845,0.904834570857457,2,52,aspartate family amino acid metabolic process,BP,MSRA;MRI1
10198,GO:0036035,0.297403594142873,0.953300899452414,1,17,osteoclast development,BP,CLDN18
999,GO:0002313,0.29794116085286,0.95312065993098,1,17,mature B cell differentiation involved in immune response,BP,DLL1
4512,GO:0009259,0.297949080561741,0.79486983871257,13,522,ribonucleotide metabolic process,BP,ACTN3;MRAP;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;ACAT1;CHGA;NUDT7;NPPC;PDE4B
15096,GO:0060644,0.297955242960282,0.953115933067331,1,17,mammary gland epithelial cell differentiation,BP,AKT1
13860,GO:0051092,0.298002681922618,0.856858038409348,4,132,positive regulation of NF-kappaB transcription factor activity,BP,TRADD;PYCARD;TICAM1;WNT5A
2026,GO:0004497,0.298081595227357,0.875833736101755,3,91,monooxygenase activity,MF,CYP17A1;PCBD1;CYP11A1
7526,GO:0030641,0.29809870943751,0.875802936204768,3,92,regulation of cellular pH,BP,RAB39A;RAB20;RAB38
8081,GO:0031690,0.298324835588421,0.952991777042646,1,17,adrenergic receptor binding,MF,ADRA2C
6263,GO:0017081,0.298566655693873,0.952910442155176,1,17,chloride channel regulator activity,MF,WNK4
7369,GO:0030296,0.298907516798095,0.952795659537502,1,17,protein tyrosine kinase activator activity,MF,GAS6
7589,GO:0030814,0.298909709270634,0.856227935002858,4,133,regulation of cAMP metabolic process,BP,MRAP;EDN1;CHGA;NPPC
7354,GO:0030277,0.298968810659449,0.952775002391419,1,17,maintenance of gastrointestinal epithelium,BP,RBP4
9573,GO:0034704,0.299022860545629,0.90380689671166,2,55,calcium channel complex,CC,CASQ2;PDE4B
15170,GO:0060749,0.299117756419334,0.952724783533654,1,17,mammary gland alveolus development,BP,DDR1
15482,GO:0061377,0.299117756419334,0.952724783533654,1,17,mammary gland lobule development,BP,DDR1
17856,GO:0097306,0.299201318139279,0.903749089022021,2,54,cellular response to alcohol,BP,AKT1;CDH1
7659,GO:0030901,0.299216176094853,0.875102200525936,3,92,midbrain development,BP,WNT3;WNT2;WNT5A
18179,GO:0098810,0.299568507525173,0.952572622335104,1,17,neurotransmitter reuptake,BP,GDNF
13270,GO:0048532,0.299699305993903,0.952528416276247,1,17,anatomical structure arrangement,BP,DLL1
4847,GO:0010544,0.299739195279442,0.952514930200081,1,17,negative regulation of platelet activation,BP,PDGFB
14159,GO:0051591,0.300121078043366,0.874513826216862,3,93,response to cAMP,BP,WT1;STAR;PIK3CG
13565,GO:0050663,0.300367907013403,0.841375468921989,5,174,cytokine secretion,BP,NOTCH1;PNP;PYCARD;WNT5A;GAS6
13368,GO:0048704,0.300472361264352,0.874292807347912,3,93,embryonic skeletal system morphogenesis,BP,AXIN1;BMP7;BMP4
9005,GO:0033218,0.30076900734203,0.821954830394669,7,260,amide binding,MF,FASN;ACVR1;GHR;PIK3R1;NPR1;ANG;PTGES
5365,GO:0015095,0.300782894790527,0.952161293108894,1,17,magnesium ion transmembrane transporter activity,MF,CLDN16
19805,GO:1903830,0.300782894790527,0.952161293108894,1,17,magnesium ion transmembrane transport,BP,CLDN16
11542,GO:0043691,0.300793915712639,0.952157550914355,1,17,reverse cholesterol transport,BP,ABCG1
21355,GO:2000641,0.300805091440717,0.952153755984668,1,17,regulation of early endosome to late endosome transport,BP,MSN
3769,GO:0007338,0.300874453203728,0.8548989166312,4,132,single fertilization,BP,IGSF8;SERPINA5;MFGE8;HEXB
4927,GO:0010667,0.300976269854376,0.952095607698987,1,17,negative regulation of cardiac muscle cell apoptotic process,BP,NOL3
794,GO:0001972,0.301008331182588,0.952084712185178,1,17,retinoic acid binding,MF,SERPINA5
20197,GO:1904707,0.301232316099623,0.952008555236558,1,17,positive regulation of vascular smooth muscle cell proliferation,BP,PDGFB
4867,GO:0010586,0.30127196737639,0.951995066258084,1,17,miRNA metabolic process,BP,HRAS
14471,GO:0052689,0.302033997120786,0.85410523556625,4,132,carboxylic ester hydrolase activity,MF,RGN;PLA2G16;PON2;LYPLAL1
10659,GO:0042113,0.302090905596966,0.829448681627269,6,218,B cell activation,BP,PIK3R1;TICAM1;CLCF1;CDKN1A;DLL1;TPD52
19421,GO:1903036,0.302100535856425,0.902228367638306,2,53,positive regulation of response to wounding,BP,HRAS;HBEGF
17110,GO:0072574,0.302140256241523,0.951699141291703,1,17,hepatocyte proliferation,BP,LIMS2
17111,GO:0072575,0.302140256241523,0.951699141291703,1,17,epithelial cell proliferation involved in liver morphogenesis,BP,LIMS2
12660,GO:0046475,0.302198549697334,0.951679236946378,1,17,glycerophospholipid catabolic process,BP,APOC1
15054,GO:0060575,0.302395605084675,0.951611917631294,1,17,intestinal epithelial cell differentiation,BP,CDKN1A
4837,GO:0010523,0.302553963142139,0.951557779632916,1,17,negative regulation of calcium ion transport into cytosol,BP,CASQ2
4757,GO:0010224,0.302607956416457,0.951539313020478,1,17,response to UV-B,BP,CDKN1A
4018,GO:0008227,0.302617977557694,0.90199030814372,2,52,G-protein coupled amine receptor activity,MF,ADRA2B;ADRA2C
3299,GO:0006577,0.303091430936694,0.951373777735429,1,17,amino-acid betaine metabolic process,BP,CPT1C
17218,GO:0080090,0.303182000209071,0.735037125092477,120,5552,regulation of primary metabolic process,BP,ITGA3;ITGA5;CFB;PDK4;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;FADD;DHH;SERPINA5;WNT6;WNT7A;WNT7B;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;DKK3;EDN1;ABCG1;PRKACB;CCL20;EBF1;SPTBN4;PYCARD;ACADVL;MAPK12;FZD7;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;CHGA;MSN;NOL3;DEPTOR;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;KITLG;IDH1;NPPC;CST9L;NAB2;CDH1;INHBB;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;DHCR7;PM20D2;RBMS3;HNF1A;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
3996,GO:0008194,0.303292867434001,0.853229313450965,4,133,UDP-glycosyltransferase activity,MF,ALG5;EXTL1;B3GNT2;HEXB
4373,GO:0009084,0.303417036955762,0.951262113161534,1,17,glutamine family amino acid biosynthetic process,BP,SLC1A3
5071,GO:0010881,0.303512973033701,0.951078636581893,1,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,CASQ2
1040,GO:0002374,0.303695971241866,0.951166338208066,1,17,cytokine secretion involved in immune response,BP,WNT5A
8396,GO:0032303,0.30398289884763,0.951067706769454,1,17,regulation of icosanoid secretion,BP,EDN1
21491,GO:2000831,0.304081508089832,0.951033783607109,1,17,regulation of steroid hormone secretion,BP,BMP6
1032,GO:0002363,0.304089263530821,0.951031115042091,1,17,alpha-beta T cell lineage commitment,BP,ZFPM1
3786,GO:0007379,0.304094668077685,0.951029255345769,1,17,segment specification,BP,DLL1
18067,GO:0098562,0.304249068207013,0.838548666561773,5,177,cytoplasmic side of membrane,CC,PTPN7;SNX18;SPTB;CDH1;MYZAP
3869,GO:0007613,0.304278248261942,0.871849502769965,3,95,memory,BP,ITGA3;ITGA5;S100B
11531,GO:0043651,0.304396030388435,0.950925493273257,1,17,linoleic acid metabolic process,BP,FADS1
10647,GO:0042095,0.304566824878118,0.950866631381445,1,17,interferon-gamma biosynthetic process,BP,ZFPM1
8242,GO:0032026,0.304780584331642,0.950641103404348,1,18,response to magnesium ion,BP,BMP6
11158,GO:0043034,0.305007165046449,0.950426740455124,1,19,costamere,CC,SDC4
10875,GO:0042510,0.305324236173775,0.950605115044575,1,17,regulation of tyrosine phosphorylation of Stat1 protein,BP,LIF
13087,GO:0048038,0.305711846847176,0.950470975602611,1,17,quinone binding,MF,ETFDH
460,GO:0001190,0.305847554760181,0.900115462095963,2,55,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1
18180,GO:0098811,0.305847554760181,0.900115462095963,2,55,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,POU3F1;NOTCH1
3367,GO:0006665,0.305912558197621,0.85141430445902,4,134,sphingolipid metabolic process,BP,ITGB8;ASAH2;HEXB;GLA
10841,GO:0042454,0.30615190208117,0.950318435011816,1,17,ribonucleoside catabolic process,BP,PNP
3042,GO:0006198,0.306371388160885,0.950088869268529,1,18,cAMP catabolic process,BP,PDE4B
10285,GO:0036230,0.306425784997005,0.791233230415001,12,482,granulocyte activation,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;HEXB;PKP1;IDH1;RAB44;GLA;DERA;RAB3D
13813,GO:0051023,0.306531071028657,0.950186785147839,1,17,regulation of immunoglobulin secretion,BP,RBP4
11032,GO:0042772,0.306621701575785,0.950001655656735,1,18,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A
674,GO:0001818,0.306710361281574,0.825983128363383,6,218,negative regulation of cytokine production,BP,ZFPM1;PYCARD;NMI;DLL1;INHBB;GAS6
11323,GO:0043297,0.306735319240971,0.899669925273797,2,54,apical junction assembly,BP,CLDN1;CLDN3
881,GO:0002089,0.306775912341677,0.94994788262312,1,18,lens morphogenesis in camera-type eye,BP,BMP4
3692,GO:0007187,0.30745781432528,0.836229207926766,5,176,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,ADRA2B;ADRA2C;ADORA1;PRKACB;CHGA
15711,GO:0070064,0.307591638176124,0.949662891120876,1,18,proline-rich region binding,MF,GHR
17582,GO:0090398,0.307745700646433,0.899117021621409,2,54,cellular senescence,BP,HRAS;CDKN1A
11903,GO:0044773,0.307816113809356,0.869617507416753,3,94,mitotic DNA damage checkpoint,BP,GADD45A;FOXO4;CDKN1A
7315,GO:0030218,0.30785803289935,0.869590740311456,3,94,erythrocyte differentiation,BP,ZFPM1;BMP4;SFXN1
9365,GO:0034308,0.308263226670883,0.898874366686159,2,53,primary alcohol metabolic process,BP,PECR;RBP4
20966,GO:2000045,0.30877482213961,0.849411258072367,4,136,regulation of G1/S transition of mitotic cell cycle,BP,GADD45A;FGF10;CDKN1A;AKT1
19125,GO:1902307,0.309090574150652,0.949136793640687,1,18,positive regulation of sodium ion transmembrane transport,BP,FXYD1
14849,GO:0060307,0.309202987351265,0.949097212719597,1,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,KCNH2
7317,GO:0030220,0.309766681902672,0.948898469156964,1,18,platelet formation,BP,ZFPM1
14723,GO:0060117,0.309787343964091,0.948891175853429,1,18,auditory receptor cell development,BP,MYO7A
10831,GO:0042438,0.310170509191138,0.948755818122146,1,18,melanin biosynthetic process,BP,WNT5A
13342,GO:0048670,0.31024585034938,0.948729178855597,1,18,regulation of collateral sprouting,BP,WNT3
21422,GO:2000737,0.310257793633091,0.948724955199878,1,18,negative regulation of stem cell differentiation,BP,NOTCH1
21099,GO:2000278,0.310286424185669,0.868036416863882,3,94,regulation of DNA biosynthetic process,BP,RGN;PDGFB;CDKN1A
7923,GO:0031398,0.310295994474456,0.834161173417951,5,176,positive regulation of protein ubiquitination,BP,PSMB10;TICAM1;MAGEC2;AXIN1;NMI
13283,GO:0048557,0.310671535614925,0.948578515437971,1,18,embryonic digestive tract morphogenesis,BP,FGF10
12429,GO:0045930,0.310706680542221,0.814267285592806,7,264,negative regulation of mitotic cell cycle,BP,GADD45A;PSMB10;FOXO4;HRAS;BMP7;BMP4;CDKN1A
10168,GO:0035994,0.310964204528061,0.948333531743577,1,19,response to muscle stretch,BP,EDN1
13207,GO:0048339,0.311002877499724,0.948461068000122,1,18,paraxial mesoderm development,BP,WNT5A
11426,GO:0043488,0.31105163368136,0.847830708252806,4,136,regulation of mRNA stability,BP,PSMB10;RNASEL;AKT1;GDNF
12692,GO:0046530,0.311269647668064,0.89713767872888,2,55,photoreceptor cell differentiation,BP,NOTCH1;MYO7A
19488,GO:1903201,0.311315970662249,0.897152193691041,2,54,regulation of oxidative stress-induced cell death,BP,NOL3;AKT1
10328,GO:0036342,0.311592360865107,0.948251740529235,1,18,post-anal tail morphogenesis,BP,WNT5A
16053,GO:0070633,0.312171628048363,0.94804556752766,1,18,transepithelial transport,BP,EDN1
3472,GO:0006825,0.313243262539855,0.947662912648762,1,18,copper ion transport,BP,SLC31A2
2637,GO:0005507,0.313411638891634,0.895990821811923,2,54,copper ion binding,MF,PRND;ANG
6771,GO:0019932,0.313585363233353,0.820742490314515,6,225,second-messenger-mediated signaling,BP,ACTN3;GUCY1B3;CASQ2;EDN1;CCL20;RGN
13246,GO:0048486,0.313877690698474,0.947435615136892,1,18,parasympathetic nervous system development,BP,GDNF
4261,GO:0008630,0.31413029443175,0.86554121319354,3,95,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PYCARD;PIK3R1;CDKN1A
1092,GO:0002474,0.31433252755456,0.865451025473893,3,93,antigen processing and presentation of peptide antigen via MHC class I,BP,IFI30;ITGB5;PSMB10
70,GO:0000145,0.314342948509758,0.947268567597242,1,18,exocyst,CC,RALB
6229,GO:0017015,0.314465526448319,0.865285585382894,3,97,regulation of transforming growth factor beta receptor signaling pathway,BP,ITGA3;RASL11B;DKK3
11315,GO:0043279,0.314470665599613,0.845433994737686,4,137,response to alkaloid,BP,FADD;CASQ2;EDN1;STAR
5964,GO:0016505,0.314811338516627,0.947100088423015,1,18,peptidase activator activity involved in apoptotic process,MF,PYCARD
5559,GO:0015693,0.314893836894023,0.947070381956055,1,18,magnesium ion transport,BP,CLDN16
8408,GO:0032331,0.315415640883883,0.946882266287817,1,18,negative regulation of chondrocyte differentiation,BP,BMP4
3844,GO:0007567,0.315485795587529,0.946856945601234,1,18,parturition,BP,EDN1
7161,GO:0023019,0.31571753303915,0.946773256220214,1,18,signal transduction involved in regulation of gene expression,BP,FGF8
5740,GO:0016048,0.315892555391022,0.946709998771665,1,18,detection of temperature stimulus,BP,ADORA1
13868,GO:0051100,0.316140379633029,0.844264682426339,4,137,negative regulation of binding,BP,ZFPM1;PDGFB;RALB;HEY1
20873,GO:1990776,0.316354830697132,0.946542713558705,1,18,response to angiotensin,BP,ACTN2
1079,GO:0002446,0.316539987044216,0.782796526460222,12,486,neutrophil mediated immunity,BP,RAB27A;CRISPLD2;PLAU;PNP;PYCARD;HEXB;PKP1;IDH1;RAB44;GLA;DERA;RAB3D
18068,GO:0098563,0.31656904740502,0.946465092143982,1,18,intrinsic component of synaptic vesicle membrane,CC,TMEM163
3526,GO:0006907,0.31678228310792,0.946387761979627,1,18,pinocytosis,BP,PYCARD
7937,GO:0031418,0.316938784731844,0.946330965712321,1,18,L-ascorbic acid binding,MF,PHYH
2374,GO:0004970,0.3175228429449,0.945971463127846,1,19,ionotropic glutamate receptor activity,MF,GRIA3
3745,GO:0007268,0.317567544772792,0.775263207055764,14,584,chemical synaptic transmission,BP,SYT5;WNT7A;ADORA1;EDN1;PXK;HRAS;GRIA3;AKT1;STAR;LZTS1;S100B;UNC119;GDNF;SLC1A3
18240,GO:0098916,0.317567544772792,0.775263207055764,14,584,anterograde trans-synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;PXK;HRAS;GRIA3;AKT1;STAR;LZTS1;S100B;UNC119;GDNF;SLC1A3
2530,GO:0005234,0.317632826274851,0.945931336250104,1,19,extracellular-glutamate-gated ion channel activity,MF,GRIA3
15706,GO:0070059,0.317972253314131,0.893401440570658,2,55,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1;CASP4
10097,GO:0035869,0.31800031856398,0.893345807125868,2,56,ciliary transition zone,CC,SPTBN5;MYO7A
6831,GO:0021533,0.318092389158933,0.945763481880929,1,19,cell differentiation in hindbrain,BP,WNT7A
18040,GO:0097755,0.318163375546066,0.893294006768425,2,55,positive regulation of blood vessel diameter,BP,ADORA1;NPPC
673,GO:0001817,0.318165200208841,0.774767735713441,14,576,regulation of cytokine production,BP,FADD;ZFPM1;CCL20;PYCARD;PIK3R1;TICAM1;HRAS;WNT5A;NMI;DLL1;INHBB;GAS6;DTX4;PDE4B
12036,GO:0045117,0.318439918468745,0.945784431411392,1,18,azole transport,BP,EDN1
15773,GO:0070168,0.318440684530227,0.945784151690628,1,18,negative regulation of biomineral tissue development,BP,GAS6
2121,GO:0004620,0.318548724643697,0.862673266110817,3,95,phospholipase activity,MF,ADORA1;PLA2G16;LYPLAL1
12217,GO:0045576,0.319055824213673,0.892791684101832,2,55,mast cell activation,BP,CHGA;PIK3CG
18102,GO:0098641,0.319329528642858,0.945459038933363,1,18,cadherin binding involved in cell-cell adhesion,MF,PKP3
9778,GO:0035335,0.319479165168238,0.862026640398807,3,97,peptidyl-tyrosine dephosphorylation,BP,PTPN7;MDP1;DUSP5
8674,GO:0032692,0.319829179507117,0.945275790720893,1,18,negative regulation of interleukin-1 production,BP,GAS6
15499,GO:0061436,0.319847588768393,0.945119646451101,1,19,establishment of skin barrier,BP,CLDN1
8437,GO:0032373,0.319915512185486,0.94509464326495,1,19,positive regulation of sterol transport,BP,ABCG1
8440,GO:0032376,0.319915512185486,0.94509464326495,1,19,positive regulation of cholesterol transport,BP,ABCG1
8474,GO:0032413,0.320219765142872,0.892134918952901,2,55,negative regulation of ion transmembrane transporter activity,BP,ACTN2;CASQ2
4517,GO:0009264,0.320283028310939,0.94510903410726,1,18,deoxyribonucleotide catabolic process,BP,DERA
5786,GO:0016137,0.320835839819225,0.944905521501115,1,18,glycoside metabolic process,BP,GLA
496,GO:0001522,0.320896807348542,0.944883050318623,1,18,pseudouridine synthesis,BP,PUS1
2214,GO:0004745,0.321180453709458,0.94477843567092,1,18,retinol dehydrogenase activity,MF,BMP2
12807,GO:0046785,0.321575163074062,0.891327296188776,2,56,microtubule polymerization,BP,TUBG2;PSRC1
18335,GO:0099536,0.321763030133107,0.771685043837226,14,586,synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;PXK;HRAS;GRIA3;AKT1;STAR;LZTS1;S100B;UNC119;GDNF;SLC1A3
18336,GO:0099537,0.321763030133107,0.771685043837226,14,586,trans-synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;PXK;HRAS;GRIA3;AKT1;STAR;LZTS1;S100B;UNC119;GDNF;SLC1A3
12020,GO:0045089,0.322468585037912,0.797740376792243,8,313,positive regulation of innate immune response,BP,FADD;PRKACB;PYCARD;TYRO3;PSMB10;TICAM1;HRAS;WNT5A
10652,GO:0042102,0.322477937696891,0.860102673477224,3,95,positive regulation of T cell proliferation,BP,FADD;PNP;PYCARD
4438,GO:0009165,0.323005158807334,0.79732591296212,8,309,nucleotide biosynthetic process,BP,MRAP;GUCY1B3;EDN1;PNP;NNMT;NPR1;ACAT1;NPPC
7579,GO:0030804,0.323292854875843,0.859546843204237,3,96,positive regulation of cyclic nucleotide biosynthetic process,BP,MRAP;NPR1;NPPC
6811,GO:0021510,0.32385490559078,0.859137534568009,3,98,spinal cord development,BP,NOTCH1;DLL1;AKT1
18925,GO:1901798,0.323921174714249,0.943608522527777,1,19,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
19718,GO:1903649,0.324005350187618,0.943577047693147,1,19,regulation of cytoplasmic transport,BP,MSN
5680,GO:0015914,0.324373722288167,0.889695404804297,2,57,phospholipid transport,BP,APOC1;ABCG1
7577,GO:0030802,0.324475265487122,0.838368315625499,4,138,regulation of cyclic nucleotide biosynthetic process,BP,MRAP;EDN1;NPR1;NPPC
10330,GO:0036344,0.324496032858736,0.943393370491197,1,19,platelet morphogenesis,BP,ZFPM1
7940,GO:0031424,0.324598852090232,0.812353281658681,6,220,keratinization,BP,DSC2;KRT10;DSG3;PKP3;PKP1;DSC3
3304,GO:0006582,0.324611781385617,0.94334999219956,1,19,melanin metabolic process,BP,WNT5A
21261,GO:2000505,0.324627694266006,0.943344027139619,1,19,regulation of energy homeostasis,BP,DLL1
1493,GO:0003215,0.324853165261466,0.943259468774718,1,19,cardiac right ventricle morphogenesis,BP,NOTCH1
2197,GO:0004725,0.325242187351794,0.858222738397884,3,98,protein tyrosine phosphatase activity,MF,PTPN7;MDP1;DUSP5
14788,GO:0060216,0.325360517847089,0.943068930482768,1,19,definitive hemopoiesis,BP,ZFPM1
703,GO:0001848,0.325463976481478,0.94303003096466,1,19,complement binding,MF,CFB
1538,GO:0003298,0.325472805899037,0.943026710473301,1,19,physiological muscle hypertrophy,BP,EDN1
1541,GO:0003301,0.325472805899037,0.943026710473301,1,19,physiological cardiac muscle hypertrophy,BP,EDN1
15335,GO:0061049,0.325472805899037,0.943026710473301,1,19,cell growth involved in cardiac muscle cell development,BP,EDN1
14706,GO:0060079,0.325525554285752,0.858035590148293,3,98,excitatory postsynaptic potential,BP,WNT7A;ADORA1;GRIA3
19809,GO:1903844,0.326087028955748,0.857645203398822,3,99,regulation of cellular response to transforming growth factor beta stimulus,BP,ITGA3;RASL11B;DKK3
5533,GO:0015631,0.326176174524387,0.802095731211054,7,275,tubulin binding,MF,MARK4;REEP1;PSRC1;FAM110C;CAMSAP3;LZTS1;PDE4B
11026,GO:0042762,0.326382495613103,0.942684003844847,1,19,regulation of sulfur metabolic process,BP,PDK4
19681,GO:1903579,0.326391361988117,0.94268065778803,1,19,negative regulation of ATP metabolic process,BP,ACTN3
8473,GO:0032412,0.327114590397001,0.821664235415379,5,184,regulation of ion transmembrane transporter activity,BP,ACTN2;CASQ2;RGN;FXYD1;PDE4B
7781,GO:0031116,0.32723008053938,0.942363626326953,1,19,positive regulation of microtubule polymerization,BP,PSRC1
17112,GO:0072576,0.327240440016245,0.942359704185479,1,19,liver morphogenesis,BP,LIMS2
4712,GO:0010002,0.327260227062627,0.942352212298428,1,19,cardioblast differentiation,BP,NOTCH1
16384,GO:0071305,0.327294593363668,0.942339198993019,1,19,cellular response to vitamin D,BP,VDR
14814,GO:0060261,0.327496330101086,0.942262774217115,1,19,positive regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
10884,GO:0042522,0.327574222094076,0.94223325042767,1,19,regulation of tyrosine phosphorylation of Stat5 protein,BP,GHR
17889,GO:0097381,0.327583308887234,0.942229805647717,1,19,photoreceptor disc membrane,CC,SPTBN5
8553,GO:0032506,0.327643538028834,0.942206969936608,1,19,cytokinetic process,BP,SNX18
8620,GO:0032611,0.327693842821543,0.887831957015361,2,56,interleukin-1 beta production,BP,PYCARD;WNT5A
19050,GO:1902170,0.32775387417302,0.942165122778578,1,19,cellular response to reactive nitrogen species,BP,GUCY1B3
7661,GO:0030903,0.328069506764916,0.942045316305895,1,19,notochord development,BP,WNT5A
17724,GO:0097061,0.32839232510979,0.887350624773644,2,58,dendritic spine organization,BP,ITGA3;WNT7A
16668,GO:0071731,0.328406944261225,0.941917074842121,1,19,response to nitric oxide,BP,GUCY1B3
19445,GO:1903077,0.328695580216812,0.941807250227263,1,19,negative regulation of protein localization to plasma membrane,BP,RHOQ
944,GO:0002218,0.328812479620849,0.800027906632798,7,271,activation of innate immune response,BP,FADD;PRKACB;PYCARD;TYRO3;PSMB10;TICAM1;HRAS
17351,GO:0090049,0.328883298828794,0.941735759858917,1,19,regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
3881,GO:0007626,0.32892853808235,0.820289368365315,5,186,locomotory behavior,BP,CDH23;SPTBN4;ESPN;HEXB;GDNF
10303,GO:0036296,0.329305269698983,0.941574872188406,1,19,response to increased oxygen levels,BP,CDKN1A
14612,GO:0055093,0.329305269698983,0.941574872188406,1,19,response to hyperoxia,BP,CDKN1A
8066,GO:0031664,0.329679750781558,0.941431876504949,1,19,regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
11066,GO:0042832,0.329906961113613,0.941345017696664,1,19,defense response to protozoan,BP,HRAS
9103,GO:0033559,0.330139359194148,0.855014873020012,3,96,unsaturated fatty acid metabolic process,BP,EDN1;FADS1;PTGES
9267,GO:0034104,0.330182086011889,0.941239742314638,1,19,negative regulation of tissue remodeling,BP,CLDN18
2592,GO:0005355,0.330523620840386,0.941108903581046,1,19,glucose transmembrane transporter activity,MF,SLC2A14
9828,GO:0035428,0.330523620840386,0.941108903581046,1,19,hexose transmembrane transport,BP,SLC2A14
20172,GO:1904659,0.330523620840386,0.941108903581046,1,19,glucose transmembrane transport,BP,SLC2A14
20661,GO:1905950,0.330523620840386,0.941108903581046,1,19,monosaccharide transmembrane transport,BP,SLC2A14
116,GO:0000242,0.330676022448628,0.940906935374495,1,20,pericentriolar material,CC,TUBG2
9395,GO:0034361,0.330712661928646,0.941036411386505,1,19,very-low-density lipoprotein particle,CC,APOC1
9418,GO:0034385,0.330712661928646,0.941036411386505,1,19,triglyceride-rich plasma lipoprotein particle,CC,APOC1
9909,GO:0035577,0.331040854935781,0.885857597115184,2,57,azurophil granule membrane,CC,RAB44;RAB3D
13927,GO:0051184,0.331229598805023,0.940837916519049,1,19,cofactor transporter activity,MF,FLVCR2
10131,GO:0035929,0.331549900406269,0.940714732544469,1,19,steroid hormone secretion,BP,BMP6
3014,GO:0006144,0.331566296565633,0.940708422798726,1,19,purine nucleobase metabolic process,BP,AOX1
5975,GO:0016529,0.331587572663415,0.885462813893492,2,59,sarcoplasmic reticulum,CC,CASQ2;NOL3
13113,GO:0048148,0.3317816499122,0.940625512146258,1,19,behavioral response to cocaine,BP,FADD
2123,GO:0004622,0.331837070314799,0.940604164543397,1,19,lysophospholipase activity,MF,LYPLAL1
5126,GO:0010951,0.33200315180691,0.806592895635259,6,225,negative regulation of endopeptidase activity,BP,SERPINA5;NOL3;AKT1;CST9L;TFPI;GAS6
8516,GO:0032461,0.332168899852664,0.940476252903683,1,19,positive regulation of protein oligomerization,BP,PMAIP1
5228,GO:0014074,0.332317690444852,0.83271100992072,4,142,response to purine-containing compound,BP,CASQ2;WT1;STAR;PIK3CG
18753,GO:1901293,0.332496771996127,0.78965605953898,8,312,nucleoside phosphate biosynthetic process,BP,MRAP;GUCY1B3;EDN1;PNP;NNMT;NPR1;ACAT1;NPPC
605,GO:0001710,0.332895240702009,0.940195711363856,1,19,mesodermal cell fate commitment,BP,BMP4
6037,GO:0016638,0.332903798566558,0.940192401425656,1,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLDC
17461,GO:0090208,0.333296129316254,0.940040545145924,1,19,positive regulation of triglyceride metabolic process,BP,RGN
17685,GO:0097006,0.333848146010552,0.884223422916693,2,57,regulation of plasma lipoprotein particle levels,BP,APOC1;ABCG1
2906,GO:0005976,0.334214360600925,0.852229252162752,3,99,polysaccharide metabolic process,BP,PDGFB;B3GNT2;AKT1
5064,GO:0010874,0.334255040690967,0.939521819637339,1,20,regulation of cholesterol efflux,BP,ABCG1
14069,GO:0051428,0.334277824720308,0.939659590529449,1,19,peptide hormone receptor binding,MF,NPPC
8628,GO:0032623,0.334350528076696,0.883929837107154,2,57,interleukin-2 production,BP,PNP;PDE4B
21452,GO:2000778,0.33439277191672,0.939614892922035,1,19,positive regulation of interleukin-6 secretion,BP,PYCARD
3207,GO:0006465,0.334441445484184,0.939595960259337,1,19,signal peptide processing,BP,GAS6
12621,GO:0046386,0.334525075277794,0.93956342256543,1,19,deoxyribose phosphate catabolic process,BP,DERA
10896,GO:0042537,0.334562751332413,0.939548760692208,1,19,benzene-containing compound metabolic process,BP,STAR
7902,GO:0031345,0.334760394691902,0.830949850119064,4,142,negative regulation of cell projection organization,BP,ITGA3;WNT3;WNT5A;LINGO1
9176,GO:0033692,0.334929580126595,0.883551089950683,2,58,cellular polysaccharide biosynthetic process,BP,B3GNT2;AKT1
5859,GO:0016289,0.334942916002146,0.939400701865251,1,19,CoA hydrolase activity,MF,NUDT7
16843,GO:0072091,0.335088906699186,0.883457755679763,2,58,regulation of stem cell proliferation,BP,NOTCH1;KITLG
12821,GO:0046827,0.33594398653782,0.938861719107248,1,20,positive regulation of protein export from nucleus,BP,GAS6
5225,GO:0014069,0.336010909565019,0.814920395208234,5,190,postsynaptic density,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
10579,GO:0040001,0.336418466319079,0.938675527660006,1,20,establishment of mitotic spindle localization,BP,FGF10
13858,GO:0051090,0.336986632559807,0.779674462720071,9,362,regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;TRADD;EDN1;PYCARD;TICAM1;WNT5A;BMP7;AKT1;GAS6
20970,GO:2000050,0.336997331840711,0.938447929207972,1,20,regulation of non-canonical Wnt signaling pathway,BP,WNT5A
2656,GO:0005540,0.337105102579217,0.938405501873182,1,20,hyaluronic acid binding,MF,HAPLN3
14001,GO:0051294,0.337526655000974,0.938239381551713,1,20,establishment of spindle orientation,BP,FGF10
18033,GO:0097731,0.338194814342655,0.849527311344398,3,100,9+0 non-motile cilium,CC,RAB27A;SPTBN5;MYO7A
18035,GO:0097733,0.338194814342655,0.849527311344398,3,100,photoreceptor cell cilium,CC,RAB27A;SPTBN5;MYO7A
4352,GO:0009058,0.338227897512443,0.701201312854501,130,6057,biosynthetic process,BP,ITGA3;EBP;PDK4;PECR;LIF;WNT2;WNT4;POU3F1;ACTN2;ALG5;NOTCH1;RAB27A;PNMT;DPM3;FASN;MRPL14;MRPL16;MRI1;FADD;DHH;WNT6;WNT7A;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PHLDA1;PNP;ABCG1;CCL20;EBF1;BDH2;PYCARD;MBOAT2;ACADVL;PRND;MGST2;ACSM5;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5A;SESN2;AXIN1;RBP4;RHOQ;NPR1;CYP17A1;PSRC1;RNASEL;FGF8;SDC4;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;HSD3B2;CTGF;ACCS;PCBD1;MDH1;AKT1;IFI27;PTGES;KITLG;IDH1;NPPC;NAB2;CDH1;INHBB;PTMS;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;GLA;ZCCHC12;CYP11A1;LZTS1;DHCR7;PTS;RBMS3;HNF1A;VDR;GDNF;ACSL4;SLC1A3;FZD8;ELOVL6;HEY1;PIM2
5106,GO:0010921,0.338305134054368,0.849433353873534,3,101,regulation of phosphatase activity,BP,RGN;BMP2;CAMSAP3
19608,GO:1903429,0.338391571452035,0.937897732364462,1,20,regulation of cell maturation,BP,NPPC
849,GO:0002052,0.338430234688018,0.937882434511971,1,20,positive regulation of neuroblast proliferation,BP,NOTCH1
9410,GO:0034377,0.339366735684128,0.937511221262019,1,20,plasma lipoprotein particle assembly,BP,APOC1
18879,GO:1901657,0.339495508231798,0.82754180096411,4,140,glycosyl compound metabolic process,BP,PNP;RHOQ;GLA;DERA
5059,GO:0010869,0.33954759916221,0.937439381968872,1,20,regulation of receptor biosynthetic process,BP,EDN1
4672,GO:0009892,0.339742976520641,0.711871613863437,58,2643,negative regulation of metabolic process,BP,LIF;WNT4;ACTN3;NOTCH1;ITGB8;GADD45A;SERPINA5;APOC1;ZFPM1;SALL4;TBC1D14;ADORA1;DKK3;EDN1;PYCARD;ACADVL;PSMB10;RGN;PRR5L;PDGFB;PRKAR1B;HRAS;WNT5A;SESN2;AXIN1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;NOL3;DEPTOR;CTGF;AKT1;IFI27;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TFPI;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;GLA;LZTS1;VDR;FZD8;DUSP5;HEY1
16684,GO:0071800,0.340299452123365,0.937140230387176,1,20,podosome assembly,BP,MSN
18186,GO:0098827,0.341036942134669,0.936845987434821,1,20,endoplasmic reticulum subcompartment,CC,REEP1
1063,GO:0002429,0.341123221663601,0.782604202112835,8,318,immune response-activating cell surface receptor signaling pathway,BP,PRKACB;PSMB10;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
5742,GO:0016050,0.341263520372808,0.776121559716858,9,365,vesicle organization,BP,SYT5;RAB27A;TBC1D14;RAB39A;SDC4;RAB20;VAMP1;MYO7A;RAB38
2185,GO:0004709,0.341464220328484,0.936675146792598,1,20,MAP kinase kinase kinase activity,MF,ARAF
13772,GO:0050951,0.342019993129841,0.936452527760865,1,20,sensory perception of temperature stimulus,BP,ADORA1
18168,GO:0098796,0.342674810922259,0.750723675215683,15,631,membrane protein complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;FADD;TRADD;CDH2;VAMP1;GJB1;GJB2;GJB6;CDH1;GJA3;FZD8
11608,GO:0044030,0.34274729892341,0.936160512986326,1,20,regulation of DNA methylation,BP,PIK3CA
20042,GO:1904376,0.342761530384561,0.936154791252095,1,20,negative regulation of protein localization to cell periphery,BP,RHOQ
13414,GO:0048799,0.342941089819795,0.935943087229131,1,21,animal organ maturation,BP,BMP2
13686,GO:0050821,0.343058658532454,0.824904569595115,4,143,protein stabilization,BP,IFI30;PIK3R1;CDKN1A;PIM2
1260,GO:0002757,0.343095087249368,0.764427737707315,11,454,immune response-activating signal transduction,BP,FADD;PRKACB;TYRO3;PSMB10;PIK3R2;PIK3R1;TICAM1;HRAS;BCAR1;PIK3CA;PDE4B
21352,GO:2000637,0.343357297711634,0.935914996155443,1,20,positive regulation of gene silencing by miRNA,BP,BMP4
17253,GO:0086013,0.343397341357645,0.935898859898691,1,20,membrane repolarization during cardiac muscle cell action potential,BP,KCNH2
20362,GO:1905039,0.343962529591104,0.845585962479569,3,101,carboxylic acid transmembrane transport,BP,CPT2;AKT1;SLC1A3
20956,GO:2000021,0.344025795466676,0.808826619618068,5,189,regulation of ion homeostasis,BP,ADORA1;CASQ2;EDN1;NPR1;NOL3
7565,GO:0030728,0.344030547217866,0.935643384453623,1,20,ovulation,BP,INHBB
12783,GO:0046700,0.344040146416698,0.768365715202151,10,406,heterocycle catabolic process,BP,PNP;RGN;PRR5L;GALT;AOX1;NUDT7;PKP3;PKP1;DERA;PDE4B
10798,GO:0042379,0.344211108765732,0.878097204254706,2,57,chemokine receptor binding,MF,CCL20;CNIH4
18355,GO:0099572,0.344473453108236,0.808459244699116,5,192,postsynaptic specialization,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
5394,GO:0015149,0.344638150570971,0.935397682013854,1,20,hexose transmembrane transporter activity,MF,SLC2A14
5444,GO:0015238,0.344645651119584,0.935394645535696,1,20,drug transmembrane transporter activity,MF,EBP
3350,GO:0006643,0.344660168084977,0.808374915682606,5,185,membrane lipid metabolic process,BP,DPM3;ITGB8;ASAH2;HEXB;GLA
11724,GO:0044304,0.344967805566028,0.877485883745898,2,61,main axon,CC,ADORA1;SPTBN4
19429,GO:1903050,0.3450778158176,0.79632259608574,6,229,regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN;AXIN1;AKT1;ARAF;RNF144A
11358,GO:0043369,0.345130697878684,0.935198105422743,1,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
71,GO:0000146,0.3453066529948,0.93485686253083,1,22,microfilament motor activity,MF,MYO7A
10474,GO:0038093,0.345415240398185,0.807796222558222,5,185,Fc receptor signaling pathway,BP,PSMB10;PIK3R2;PIK3R1;HRAS;PIK3CA
4616,GO:0009651,0.345882932617808,0.934892612656162,1,20,response to salt stress,BP,CLDN1
8078,GO:0031683,0.346029425057395,0.934833022611626,1,20,G-protein beta/gamma-subunit complex binding,MF,ADORA1
13795,GO:0051000,0.346152932236481,0.934782757786212,1,20,positive regulation of nitric-oxide synthase activity,BP,AKT1
3568,GO:0006977,0.346293760447128,0.876765901991369,2,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,GADD45A;CDKN1A
12371,GO:0045830,0.346628888284298,0.934588842247583,1,20,positive regulation of isotype switching,BP,CLCF1
4622,GO:0009713,0.346715059068369,0.934553698361975,1,20,catechol-containing compound biosynthetic process,BP,PNMT
10822,GO:0042423,0.346715059068369,0.934553698361975,1,20,catecholamine biosynthetic process,BP,PNMT
15811,GO:0070230,0.346873004882971,0.934489253159587,1,20,positive regulation of lymphocyte apoptotic process,BP,WNT5A
19355,GO:1902932,0.346934119626808,0.934464307133249,1,20,positive regulation of alcohol biosynthetic process,BP,ABCG1
3492,GO:0006862,0.347083615130942,0.934403262186166,1,20,nucleotide transport,BP,GJB1
9274,GO:0034114,0.347189284523525,0.934360093173103,1,20,regulation of heterotypic cell-cell adhesion,BP,BMP7
10849,GO:0042474,0.34731634918662,0.934308161622771,1,20,middle ear morphogenesis,BP,EDN1
4481,GO:0009214,0.347640465367718,0.934032289172338,1,21,cyclic nucleotide catabolic process,BP,PDE4B
11904,GO:0044774,0.347677524074554,0.843038042704756,3,101,mitotic DNA integrity checkpoint,BP,GADD45A;FOXO4;CDKN1A
10873,GO:0042508,0.347914633261318,0.934063319669301,1,20,tyrosine phosphorylation of Stat1 protein,BP,LIF
9105,GO:0033561,0.348060726921622,0.933859811310034,1,21,regulation of water loss via skin,BP,CLDN1
21173,GO:2000369,0.348213867812406,0.933796896022318,1,21,regulation of clathrin-dependent endocytosis,BP,UNC119
12075,GO:0045187,0.348312893920711,0.933900040500301,1,20,regulation of circadian sleep/wake cycle, sleep,BP,ADORA1
7147,GO:0022857,0.348432300691257,0.729161522573981,23,1011,transmembrane transporter activity,MF,EBP;TF;SLC31A2;SLC45A4;ABCG1;KCNK6;SLC25A53;TTYH1;KCNH2;FXYD1;SLC2A14;SFXN1;GRIA3;GJB1;GJB2;GJA3;KCNG2;GAS6;CYB5A;SLC18B1;KCND1;SLC1A3;CLDN16
18861,GO:1901623,0.348500200783632,0.933823166771351,1,20,regulation of lymphocyte chemotaxis,BP,WNT5A
11425,GO:0043487,0.348500396103289,0.820893858555674,4,144,regulation of RNA stability,BP,PSMB10;RNASEL;AKT1;GDNF
19428,GO:1903047,0.348586944080606,0.734052236556033,20,874,mitotic cell cycle process,BP,MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;PSMB10;FGF10;PDGFB;FOXO4;HRAS;SNX18;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;LZTS1;PIM2
11810,GO:0044445,0.350299489705643,0.792191618415148,6,228,cytosolic part,CC,FADD;GUCY1B3;PYCARD;TICAM1;NPR1;CASP4
5453,GO:0015267,0.350699487209049,0.757929115617935,11,461,channel activity,MF,KCNK6;TTYH1;KCNH2;FXYD1;GRIA3;GJB1;GJB2;GJA3;KCNG2;GAS6;KCND1
9541,GO:0034655,0.351264201027782,0.76778187857789,9,364,nucleobase-containing compound catabolic process,BP,PNP;RGN;PRR5L;GALT;NUDT7;PKP3;PKP1;DERA;PDE4B
17052,GO:0072431,0.351560353703364,0.873538942552009,2,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
19151,GO:1902400,0.351560353703364,0.873538942552009,2,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
2106,GO:0004602,0.351626541680703,0.932532349721486,1,20,glutathione peroxidase activity,MF,MGST2
13245,GO:0048485,0.351826815735826,0.932302430139524,1,21,sympathetic nervous system development,BP,GDNF
8380,GO:0032279,0.351903746271544,0.802722873295125,5,194,asymmetric synapse,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
11117,GO:0042987,0.352075208756847,0.932198967504826,1,21,amyloid precursor protein catabolic process,BP,ABCG1
4831,GO:0010517,0.352207271767668,0.873144709038374,2,60,regulation of phospholipase activity,BP,LPAR2;ANG
7156,GO:0022898,0.352306710593942,0.802444024182337,5,190,regulation of transmembrane transporter activity,BP,ACTN2;CASQ2;RGN;FXYD1;PDE4B
10737,GO:0042277,0.352371094505131,0.79052315165303,6,231,peptide binding,MF,ACVR1;GHR;PIK3R1;NPR1;ANG;PTGES
11704,GO:0044270,0.352431565374092,0.761263738324657,10,409,cellular nitrogen compound catabolic process,BP,PNP;RGN;PRR5L;GALT;AOX1;NUDT7;PKP3;PKP1;DERA;PDE4B
13596,GO:0050699,0.352901946780844,0.931853941937248,1,21,WW domain binding,MF,WBP1
19034,GO:1902108,0.352969723352505,0.872719429203579,2,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1;NOL3
21389,GO:2000678,0.353043119965089,0.931794923158697,1,21,negative regulation of transcription regulatory region DNA binding,BP,HEY1
3861,GO:0007602,0.35311175112363,0.872632671916563,2,59,phototransduction,BP,NMT2;UNC119
11288,GO:0043243,0.353228185004441,0.931717509675631,1,21,positive regulation of protein complex disassembly,BP,ACTN2
7125,GO:0022803,0.35334086636169,0.755665087274905,11,462,passive transmembrane transporter activity,MF,KCNK6;TTYH1;KCNH2;FXYD1;GRIA3;GJB1;GJB2;GJA3;KCNG2;GAS6;KCND1
17794,GO:0097186,0.353454633877902,0.931622715219271,1,21,amelogenesis,BP,ITGB4
9486,GO:0034505,0.353521420615584,0.931594742715659,1,21,tooth mineralization,BP,WNT6
734,GO:0001895,0.353556762438848,0.872320458263821,2,60,retina homeostasis,BP,CDH23;TF
8644,GO:0032647,0.353593232673894,0.931564657967167,1,21,regulation of interferon-alpha production,BP,NMI
2517,GO:0005215,0.353997622513562,0.716464667526316,29,1294,transporter activity,MF,EBP;STRA6;TF;SLC31A2;SLC45A4;SLC52A3;ABCG1;KCNK6;FLVCR2;SLC25A53;TTYH1;KCNH2;FXYD1;RBP4;SLC2A14;SFXN1;FABP3;GRIA3;GJB1;GJB2;GJA3;STAR;KCNG2;GAS6;CYB5A;SLC18B1;KCND1;SLC1A3;CLDN16
11348,GO:0043325,0.354002871774702,0.931392896739204,1,21,phosphatidylinositol-3,4-bisphosphate binding,MF,AKT1
9265,GO:0034101,0.35442073145728,0.83834964434919,3,102,erythrocyte homeostasis,BP,ZFPM1;BMP4;SFXN1
1600,GO:0003416,0.354558684098577,0.931159441953699,1,21,endochondral bone growth,BP,NPPC
1016,GO:0002335,0.35479368069531,0.931060597873521,1,21,mature B cell differentiation,BP,DLL1
11252,GO:0043195,0.355405075066801,0.871148286065587,2,61,terminal bouton,CC,ADORA1;VAMP1
2534,GO:0005244,0.355595076075946,0.799876299374845,5,192,voltage-gated ion channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
7131,GO:0022832,0.355595076075946,0.799876299374845,5,192,voltage-gated channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
11994,GO:0045061,0.355646315641772,0.93070126522553,1,21,thymic T cell selection,BP,JAG2
8479,GO:0032418,0.35615426493372,0.870726824576858,2,60,lysosome localization,BP,CHGA;PIK3CG
19541,GO:1903306,0.356178355609588,0.93047648843422,1,21,negative regulation of regulated secretory pathway,BP,NOTCH1
13647,GO:0050770,0.35621692562061,0.815106127595539,4,149,regulation of axonogenesis,BP,WNT3;WNT7A;WNT5A;LINGO1
523,GO:0001562,0.356495285188058,0.930342388810386,1,21,response to protozoan,BP,HRAS
3791,GO:0007398,0.356499799004898,0.930340477824179,1,21,ectoderm development,BP,FZD7
14744,GO:0060148,0.356606899708888,0.93029512625338,1,21,positive regulation of posttranscriptional gene silencing,BP,BMP4
19611,GO:1903432,0.356854860252955,0.930190061427912,1,21,regulation of TORC1 signaling,BP,SESN2
8864,GO:0032982,0.357029756107057,0.929978668440404,1,22,myosin filament,CC,MYH11
11480,GO:0043555,0.357409906521699,0.92995454294114,1,21,regulation of translation in response to stress,BP,SESN2
3872,GO:0007617,0.357815779822751,0.929782027169744,1,21,mating behavior,BP,HEXB
4361,GO:0009067,0.357852545408139,0.929766387715503,1,21,aspartate family amino acid biosynthetic process,BP,MRI1
7054,GO:0021952,0.358088726514208,0.929527834898427,1,22,central nervous system projection neuron axonogenesis,BP,SPTBN4
3565,GO:0006972,0.358665691897406,0.929419966195587,1,21,hyperosmotic response,BP,CLDN1
9763,GO:0035304,0.358740873521564,0.869090895432684,2,61,regulation of protein dephosphorylation,BP,ADORA1;RGN
5893,GO:0016358,0.358970553497652,0.797229436781655,5,194,dendrite development,BP,WNT7A;BMP7;RAB17;LZTS1;ACSL4
14123,GO:0051537,0.358984730300372,0.929283774108401,1,21,2 iron, 2 sulfur cluster binding,MF,AOX1
3470,GO:0006821,0.359027879942657,0.835107503536403,3,103,chloride transport,BP,TTYH1;FXYD1;WNK4
6304,GO:0017156,0.359087080782779,0.835046380153285,3,104,calcium ion regulated exocytosis,BP,SYT5;NOTCH1;RPH3AL
17045,GO:0072413,0.359154334684129,0.868834810424503,2,61,signal transduction involved in mitotic cell cycle checkpoint,BP,GADD45A;CDKN1A
19152,GO:1902402,0.359154334684129,0.868834810424503,2,61,signal transduction involved in mitotic DNA damage checkpoint,BP,GADD45A;CDKN1A
19153,GO:1902403,0.359154334684129,0.868834810424503,2,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,GADD45A;CDKN1A
21644,GO:2001242,0.359158280745471,0.81296637219276,4,144,regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1;PYCARD;NOL3;AKT1
1138,GO:0002548,0.359173191570266,0.868903949570143,2,59,monocyte chemotaxis,BP,CCL20;PDGFB
10706,GO:0042219,0.359728389495094,0.928965719728601,1,21,cellular modified amino acid catabolic process,BP,SARDH
10264,GO:0036150,0.359870166944896,0.928904987971655,1,21,phosphatidylserine acyl-chain remodeling,BP,PLA2G16
12039,GO:0045121,0.360285649408558,0.774572466204482,7,281,membrane raft,CC,FADD;TRADD;CDH2;RHOQ;SDC4;DLL1;CDH1
18270,GO:0098984,0.360295298136269,0.796177555267468,5,196,neuron to neuron synapse,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
18441,GO:1900027,0.360308287527007,0.928717121940907,1,21,regulation of ruffle assembly,BP,HRAS
16437,GO:0071379,0.360356908013137,0.928556485824356,1,22,cellular response to prostaglandin stimulus,BP,AKT1
13757,GO:0050919,0.361101571828299,0.928235879039951,1,22,negative chemotaxis,BP,WNT5A
580,GO:0001669,0.361108220698197,0.833663841299166,3,102,acrosomal vesicle,CC,NOTCH1;SERPINA5;HEXB
744,GO:0001914,0.361384629884602,0.928254348426311,1,21,regulation of T cell mediated cytotoxicity,BP,FADD
12631,GO:0046425,0.361460053071557,0.811224861826028,4,145,regulation of JAK-STAT cascade,BP,LIF;NOTCH1;GHR;CLCF1
20293,GO:1904892,0.361460053071557,0.811224861826028,4,145,regulation of STAT cascade,BP,LIF;NOTCH1;GHR;CLCF1
2514,GO:0005200,0.36168251514343,0.833219048699258,3,104,structural constituent of cytoskeleton,MF,SPTBN4;SPTB;MSN
2983,GO:0006090,0.361881336019909,0.833098445972501,3,103,pyruvate metabolic process,BP,PDK4;ACTN3;PFKFB3
13192,GO:0048306,0.361942544514331,0.86714181951575,2,60,calcium-dependent protein binding,MF,CASQ2;S100B
17509,GO:0090281,0.361955448137186,0.928008210107096,1,21,negative regulation of calcium ion import,BP,CASQ2
18370,GO:0099623,0.362023979753258,0.927837575798186,1,22,regulation of cardiac muscle cell membrane repolarization,BP,KCNH2
550,GO:0001614,0.362080436834428,0.927954248460256,1,21,purinergic nucleotide receptor activity,MF,P2RY14
5961,GO:0016502,0.362080436834428,0.927954248460256,1,21,nucleotide receptor activity,MF,P2RY14
3641,GO:0007093,0.362466131275696,0.810442380063824,4,147,mitotic cell cycle checkpoint,BP,GADD45A;FOXO4;HRAS;CDKN1A
41,GO:0000082,0.362474791464126,0.782389614990898,6,236,G1/S transition of mitotic cell cycle,BP,GADD45A;ACVR1;FGF10;CDKN1A;AKT1;PIM2
4367,GO:0009074,0.362825458602404,0.927632104821722,1,21,aromatic amino acid family catabolic process,BP,PCBD1
13191,GO:0048305,0.363116807001263,0.927505897099777,1,21,immunoglobulin secretion,BP,RBP4
7585,GO:0030810,0.363174589313855,0.8321845707019,3,103,positive regulation of nucleotide biosynthetic process,BP,MRAP;NPR1;NPPC
18596,GO:1900373,0.363174589313855,0.8321845707019,3,103,positive regulation of purine nucleotide biosynthetic process,BP,MRAP;NPR1;NPPC
3070,GO:0006260,0.363253932948359,0.772129943107264,7,281,DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG;PTMS
4904,GO:0010640,0.363403907620878,0.927239288937783,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
18205,GO:0098857,0.363688240168882,0.771766916825729,7,282,membrane microdomain,CC,FADD;TRADD;CDH2;RHOQ;SDC4;DLL1;CDH1
18116,GO:0098660,0.363718727738043,0.726878096909812,17,744,inorganic ion transmembrane transport,BP,ACTN2;SLC31A2;CASQ2;KCNK6;TTYH1;TSPAN13;RGN;KCNH2;FXYD1;NOL3;PIK3CG;KCNG2;GAS6;CYB5A;KCND1;CLDN16;PDE4B
13655,GO:0050778,0.363816658044448,0.732107757264959,15,643,positive regulation of immune response,BP,CFB;FADD;PRKACB;PYCARD;TYRO3;PSMB10;PIK3R2;PIK3R1;TICAM1;HRAS;WNT5A;CLCF1;BCAR1;PIK3CA;PDE4B
2825,GO:0005839,0.364228510974382,0.927023133436129,1,21,proteasome core complex,CC,PSMB10
13121,GO:0048169,0.364255135213727,0.926868776581665,1,22,regulation of long-term neuronal synaptic plasticity,BP,HRAS
18849,GO:1901607,0.364574171912773,0.865455897941361,2,61,alpha-amino acid biosynthetic process,BP,MRI1;SLC1A3
19307,GO:1902806,0.364661386745743,0.808773023634636,4,148,regulation of cell cycle G1/S phase transition,BP,GADD45A;FGF10;CDKN1A;AKT1
20288,GO:1904886,0.36476376415009,0.926646857385921,1,22,beta-catenin destruction complex disassembly,BP,AXIN1
9961,GO:0035640,0.365220363479979,0.926447301641412,1,22,exploration behavior,BP,ITGA3
16344,GO:0071230,0.36522408592253,0.865008629773553,2,62,cellular response to amino acid stimulus,BP,SESN2;SH3BP4
8955,GO:0033141,0.365233783204851,0.926584962159175,1,21,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
18372,GO:0099625,0.365477300970861,0.92633486717359,1,22,ventricular cardiac muscle cell membrane repolarization,BP,KCNH2
4804,GO:0010460,0.365490606900966,0.926329041813223,1,22,positive regulation of heart rate,BP,EDN1
12030,GO:0045109,0.365505620044634,0.926322468705651,1,22,intermediate filament organization,BP,PKP1
6768,GO:0019915,0.365585976760053,0.864781171368688,2,62,lipid storage,BP,ABCG1;HEXB
1889,GO:0004298,0.366039405341016,0.926232696421793,1,21,threonine-type endopeptidase activity,MF,PSMB10
15682,GO:0070003,0.366039405341016,0.926232696421793,1,21,threonine-type peptidase activity,MF,PSMB10
17241,GO:0086001,0.36631053271049,0.864249971406453,2,64,cardiac muscle cell action potential,BP,DSC2;KCNH2
6842,GO:0021544,0.366325124631339,0.925963145685588,1,22,subpallium development,BP,FGF8
10122,GO:0035914,0.367065594463835,0.863849285261982,2,62,skeletal muscle cell differentiation,BP,NOTCH1;S100B
18594,GO:1900371,0.367069587304583,0.806961280017085,4,147,regulation of purine nucleotide biosynthetic process,BP,MRAP;EDN1;NPR1;NPPC
368,GO:0000983,0.367447596647383,0.925469308452221,1,22,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,HEY1
8616,GO:0032607,0.367462579157036,0.925462703719919,1,22,interferon-alpha production,BP,NMI
8748,GO:0032801,0.367706755626626,0.92535501484193,1,22,receptor catabolic process,BP,GPRASP1
11492,GO:0043576,0.367927481708383,0.925257589292101,1,22,regulation of respiratory gaseous exchange,BP,ADORA1
4808,GO:0010466,0.367936976693001,0.777975329422469,6,235,negative regulation of peptidase activity,BP,SERPINA5;NOL3;AKT1;CST9L;TFPI;GAS6
13666,GO:0050795,0.368017319604596,0.863248254853151,2,62,regulation of behavior,BP,STRA6;ADORA1
18112,GO:0098655,0.368213511382885,0.722851803502395,17,745,cation transmembrane transport,BP,ACTN2;SLC31A2;CASQ2;KCNK6;TTYH1;TSPAN13;RGN;KCNH2;FXYD1;NOL3;PIK3CG;KCNG2;GAS6;CYB5A;KCND1;CLDN16;PDE4B
11928,GO:0044818,0.368282853993785,0.925100575077735,1,22,mitotic G2/M transition checkpoint,BP,FOXO4
11413,GO:0043462,0.368661884587904,0.862880333895284,2,61,regulation of ATPase activity,BP,RGN;FGF10
7537,GO:0030665,0.368804923772141,0.828141783942606,3,105,clathrin-coated vesicle membrane,CC,TF;WNT5A;HBEGF
7777,GO:0031112,0.36907070925964,0.924751782824852,1,22,positive regulation of microtubule polymerization or depolymerization,BP,PSRC1
20960,GO:2000036,0.369231009505784,0.924680698937642,1,22,regulation of stem cell population maintenance,BP,BMP7
3488,GO:0006855,0.369531982761177,0.924547127586786,1,22,drug transmembrane transport,BP,EBP
10872,GO:0042506,0.369547233997366,0.924540355395328,1,22,tyrosine phosphorylation of Stat5 protein,BP,GHR
5072,GO:0010882,0.369863113696802,0.924265748243964,1,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,CASQ2
13622,GO:0050727,0.370318501015399,0.766289815458603,7,280,regulation of inflammatory response,BP,CFB;ADORA1;TYRO3;WNT5A;SHPK;CASP4;PIK3CG
3457,GO:0006805,0.370324819375227,0.827094417624701,3,103,xenobiotic metabolic process,BP,MGST2;CMBL;STAR
140,GO:0000280,0.370456106226076,0.732708029334654,13,560,nuclear division,BP,LIF;WNT4;MARK4;EDN1;TTYH1;PDGFB;WNT5A;SNX18;PSRC1;FGF8;BMP7;BMP4;PIM2
5393,GO:0015145,0.37065836661589,0.924045998983096,1,22,monosaccharide transmembrane transporter activity,MF,SLC2A14
10775,GO:0042347,0.370689617602862,0.924032067445936,1,22,negative regulation of NF-kappaB import into nucleus,BP,BMP7
7997,GO:0031528,0.370808443630644,0.923979081591024,1,22,microvillus membrane,CC,MSN
14036,GO:0051354,0.370989072606715,0.92389849526677,1,22,negative regulation of oxidoreductase activity,BP,GLA
14613,GO:0055094,0.371055813380668,0.923868706574157,1,22,response to lipoprotein particle,BP,ABCG1
9767,GO:0035308,0.37135603573926,0.923734621786396,1,22,negative regulation of protein dephosphorylation,BP,RGN
18478,GO:1900101,0.371364792865303,0.923730708599346,1,22,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
2706,GO:0005640,0.371482970591746,0.92354246370906,1,23,nuclear outer membrane,CC,DHCR7
11141,GO:0043014,0.371498241993641,0.923671061166872,1,22,alpha-tubulin binding,MF,FAM110C
7583,GO:0030808,0.371947358110294,0.803234244022025,4,148,regulation of nucleotide biosynthetic process,BP,MRAP;EDN1;NPR1;NPPC
19552,GO:1903322,0.372090737758333,0.78691968517833,5,191,positive regulation of protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;MAGEC2;AXIN1;NMI
5224,GO:0014068,0.372226830526202,0.860535561983865,2,63,positive regulation of phosphatidylinositol 3-kinase signaling,BP,PRR5L;PDGFB
14122,GO:0051536,0.372623784947254,0.860321249906944,2,62,iron-sulfur cluster binding,MF,AOX1;ETFDH
14126,GO:0051540,0.372623784947254,0.860321249906944,2,62,metal cluster binding,MF,AOX1;ETFDH
6486,GO:0019079,0.372983887863596,0.825144792644837,3,105,viral genome replication,BP,NOTCH1;RNASEL;GAS6
15245,GO:0060914,0.374072190362685,0.922515185483498,1,22,heart formation,BP,BMP4
2189,GO:0004714,0.374163885748276,0.859258506527506,2,64,transmembrane receptor protein tyrosine kinase activity,MF,TYRO3;DDR1
9135,GO:0033613,0.374205320744921,0.859231941445094,2,64,activating transcription factor binding,MF,ZFPM1;IFI27
17043,GO:0072401,0.374298018264701,0.859210646648862,2,63,signal transduction involved in DNA integrity checkpoint,BP,GADD45A;CDKN1A
17047,GO:0072422,0.374298018264701,0.859210646648862,2,63,signal transduction involved in DNA damage checkpoint,BP,GADD45A;CDKN1A
7378,GO:0030307,0.374738212393199,0.801059949437348,4,151,positive regulation of cell growth,BP,WNT3;EDN1;HBEGF;AKT1
21230,GO:2000463,0.374763613977159,0.922065142929867,1,23,positive regulation of excitatory postsynaptic potential,BP,WNT7A
8046,GO:0031639,0.3749067369777,0.922138207695564,1,22,plasminogen activation,BP,PLAU
9922,GO:0035590,0.375215187059223,0.921998601440908,1,22,purinergic nucleotide receptor signaling pathway,BP,P2RY14
1136,GO:0002544,0.375344681137178,0.921939947498082,1,22,chronic inflammatory response,BP,PTGES
11016,GO:0042749,0.375439566910693,0.92189695268542,1,22,regulation of circadian sleep/wake cycle,BP,ADORA1
3597,GO:0007020,0.375610508909951,0.921681052601703,1,23,microtubule nucleation,BP,TUBG2
13606,GO:0050709,0.375772000684577,0.82313318534346,3,105,negative regulation of protein secretion,BP,INHBB;RAB11FIP1;GAS6
4536,GO:0009314,0.375781278109159,0.741201707889378,10,421,response to radiation,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;CDKN1A;AKT1;STAR;UNC119;SLC1A3
14081,GO:0051443,0.375902114627748,0.823059291434127,3,104,positive regulation of ubiquitin-protein transferase activity,BP,PSMB10;MAGEC2;AXIN1
3159,GO:0006400,0.375914456408738,0.858212066001908,2,62,tRNA modification,BP,HSD17B10;PUS1
858,GO:0002063,0.376366219570385,0.921337371427314,1,23,chondrocyte development,BP,FGF18
7180,GO:0030004,0.376563375851781,0.822540577232768,3,106,cellular monovalent inorganic cation homeostasis,BP,RAB39A;RAB20;RAB38
14835,GO:0060292,0.376714660102705,0.921178607400979,1,23,long term synaptic depression,BP,ADORA1
2294,GO:0004857,0.37674437859612,0.746125308690216,9,373,enzyme inhibitor activity,MF,NOTCH1;SERPINA5;APOC1;PRKAR1B;CDKN1A;NOL3;CST9L;TFPI;GAS6
5622,GO:0015813,0.376780376110634,0.921148643165698,1,23,L-glutamate transport,BP,SLC1A3
14607,GO:0055088,0.376989556300609,0.822231791589298,3,106,lipid homeostasis,BP,ABCG1;SESN2;FABP3
5549,GO:0015672,0.377153109098357,0.73065931941706,12,513,monovalent inorganic cation transport,BP,ACTN2;ADORA1;CASQ2;KCNK6;SPTBN4;KCNH2;FXYD1;WNK4;AKT1;KCNG2;CYB5A;KCND1
6097,GO:0016758,0.377251510949667,0.782788214294855,5,193,transferase activity, transferring hexosyl groups,MF,ALG5;DPM3;EXTL1;B3GNT2;HEXB
8494,GO:0032434,0.378161300492708,0.821381647222206,3,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,AKT1;ARAF;RNF144A
16741,GO:0071889,0.378194359770897,0.920502277493666,1,23,14-3-3 protein binding,MF,AKT1
13237,GO:0048469,0.37874277125583,0.797989598081429,4,150,cell maturation,BP,SPTBN4;ANG;CDKN1A;NPPC
14775,GO:0060193,0.378743021284004,0.856346843782938,2,63,positive regulation of lipase activity,BP,LPAR2;ANG
14799,GO:0060236,0.37884128811476,0.920205506179268,1,23,regulation of mitotic spindle organization,BP,PSRC1
7196,GO:0030031,0.378908962456588,0.733473765351611,11,474,cell projection assembly,BP,ACTN2;NOTCH1;MARK4;TTYH1;HRAS;RHOQ;FAM110C;ESPN;RAB17;LAMA5;PARVB
12733,GO:0046621,0.379190507782279,0.920045032457713,1,23,negative regulation of organ growth,BP,RBP4
998,GO:0002312,0.379238366166041,0.856025980435722,2,63,B cell activation involved in immune response,BP,CLCF1;DLL1
18901,GO:1901685,0.379508073404703,0.9200401892283,1,22,glutathione derivative metabolic process,BP,MGST2
18902,GO:1901687,0.379508073404703,0.9200401892283,1,22,glutathione derivative biosynthetic process,BP,MGST2
11435,GO:0043501,0.379698555526361,0.919811231826938,1,23,skeletal muscle adaptation,BP,ACTN3
15674,GO:0065005,0.380086133461367,0.919632597860286,1,23,protein-lipid complex assembly,BP,APOC1
10754,GO:0042308,0.380539875708109,0.855142237566906,2,64,negative regulation of protein import into nucleus,BP,BMP7;GAS6
20142,GO:1904590,0.380539875708109,0.855142237566906,2,64,negative regulation of protein import,BP,BMP7;GAS6
17041,GO:0072395,0.380625277833731,0.855086713569809,2,64,signal transduction involved in cell cycle checkpoint,BP,GADD45A;CDKN1A
10468,GO:0038084,0.380804713131865,0.919300780454844,1,23,vascular endothelial growth factor signaling pathway,BP,DLL1
532,GO:0001578,0.380986288089179,0.854814016230408,2,65,microtubule bundle formation,BP,MARK4;PSRC1
8471,GO:0032410,0.380990121210239,0.854888488473385,2,63,negative regulation of transporter activity,BP,ACTN2;CASQ2
6911,GO:0021680,0.381075044740687,0.919045283524152,1,24,cerebellar Purkinje cell layer development,BP,DLL1
13713,GO:0050864,0.381101376280431,0.819240976123311,3,106,regulation of B cell activation,BP,TICAM1;CLCF1;CDKN1A
18208,GO:0098868,0.381255180982836,0.919092353954929,1,23,bone growth,BP,NPPC
11487,GO:0043567,0.381430355449567,0.919011216300165,1,23,regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
16512,GO:0071482,0.381727167351995,0.818764140162059,3,107,cellular response to light stimulus,BP,NMT2;PIK3R1;CDKN1A
12019,GO:0045088,0.382008776287319,0.741577682468421,9,377,regulation of innate immune response,BP,FADD;PRKACB;PYCARD;TYRO3;PSMB10;TICAM1;HRAS;WNT5A;NMI
9172,GO:0033688,0.382081887873346,0.918709013477522,1,23,regulation of osteoblast proliferation,BP,BMP2
12301,GO:0045686,0.382507688708651,0.918511150616116,1,23,negative regulation of glial cell differentiation,BP,NOTCH1
4759,GO:0010226,0.382924505093992,0.918317185292992,1,23,response to lithium ion,BP,CDH1
14887,GO:0060351,0.382944807437027,0.918307730593957,1,23,cartilage development involved in endochondral bone morphogenesis,BP,NPPC
18055,GO:0098533,0.383299021758855,0.918142669893101,1,23,ATPase dependent transmembrane transport complex,CC,FXYD1
3740,GO:0007263,0.383449751551618,0.918072370973762,1,23,nitric oxide mediated signal transduction,BP,GUCY1B3
17149,GO:0072661,0.383781059231015,0.917785440629143,1,24,protein targeting to plasma membrane,BP,GAS6
17251,GO:0086011,0.383879024581557,0.91787196518771,1,23,membrane repolarization during action potential,BP,KCNH2
612,GO:0001726,0.383924785385426,0.793925221891657,4,154,ruffle,CC,ITGA5;BCAR1;S100B;AMOT
13263,GO:0048520,0.384048598114136,0.91779271953476,1,23,positive regulation of behavior,BP,STRA6
17601,GO:0090484,0.384224021604866,0.91771069213547,1,23,drug transporter activity,MF,EBP
17386,GO:0090103,0.384266965799478,0.9176906041555,1,23,cochlea morphogenesis,BP,WNT5A
769,GO:0001945,0.384281393834148,0.917551229663594,1,24,lymph vessel development,BP,EFNB2
1211,GO:0002691,0.384591266346727,0.91753881192385,1,23,regulation of cellular extravasation,BP,FADD
9348,GO:0034243,0.384609209116158,0.917530408758304,1,23,regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
5108,GO:0010923,0.384947091649748,0.852225003396626,2,65,negative regulation of phosphatase activity,BP,RGN;CAMSAP3
3500,GO:0006874,0.384985987079304,0.738996778943251,9,379,cellular calcium ion homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;RGN;HEXB;NOL3;PIK3CG;VDR
8277,GO:0032088,0.38547871744916,0.851914301758316,2,64,negative regulation of NF-kappaB transcription factor activity,BP,PYCARD;BMP7
4426,GO:0009152,0.385556545060145,0.763493450931354,6,239,purine ribonucleotide biosynthetic process,BP,MRAP;GUCY1B3;EDN1;NPR1;ACAT1;NPPC
16,GO:0000030,0.385747829510277,0.916996112403114,1,23,mannosyltransferase activity,MF,DPM3
8842,GO:0032945,0.385952771921581,0.851602650609918,2,64,negative regulation of mononuclear cell proliferation,BP,SDC4;BMP4
13573,GO:0050672,0.385952771921581,0.851602650609918,2,64,negative regulation of lymphocyte proliferation,BP,SDC4;BMP4
12412,GO:0045911,0.386223022753857,0.916772519704517,1,23,positive regulation of DNA recombination,BP,CLCF1
14807,GO:0060251,0.386746527480189,0.916391475793421,1,24,regulation of glial cell proliferation,BP,NOTCH1
7268,GO:0030159,0.387589274966683,0.915992776514792,1,24,receptor signaling complex scaffold activity,MF,AXIN1
737,GO:0001906,0.388043888267515,0.814143295784733,3,106,cell killing,BP,RAB27A;FADD;CHGA
8475,GO:0032414,0.388595752631048,0.84978261517305,2,66,positive regulation of ion transmembrane transporter activity,BP,ACTN2;RGN
8978,GO:0033173,0.388721715601237,0.915455240922481,1,24,calcineurin-NFAT signaling cascade,BP,ACTN3
11105,GO:0042974,0.388964531098315,0.915339717010624,1,24,retinoic acid receptor binding,MF,VDR
9821,GO:0035412,0.389192904865925,0.915230978001489,1,24,regulation of catenin import into nucleus,BP,FZD7
13340,GO:0048668,0.389247648495677,0.915204899707843,1,24,collateral sprouting,BP,WNT3
4885,GO:0010613,0.389329391461862,0.915165950782853,1,24,positive regulation of cardiac muscle hypertrophy,BP,EDN1
5253,GO:0014742,0.389329391461862,0.915165950782853,1,24,positive regulation of muscle hypertrophy,BP,EDN1
5329,GO:0015012,0.390623190539535,0.914548056383204,1,24,heparan sulfate proteoglycan biosynthetic process,BP,EXTL1
18620,GO:1900543,0.390704545095434,0.848421906275162,2,65,negative regulation of purine nucleotide metabolic process,BP,ACTN3;EDN1
1838,GO:0004114,0.390775416562891,0.914475179724784,1,24,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
7400,GO:0030332,0.390778831142631,0.914473544603415,1,24,cyclin binding,MF,CDKN1A
11538,GO:0043679,0.391026332654886,0.811874913384259,3,109,axon terminus,CC,ADRA2C;ADORA1;VAMP1
12140,GO:0045334,0.391298750274666,0.848026718601405,2,65,clathrin-coated endocytic vesicle,CC,WNT5A;HBEGF
8953,GO:0033139,0.391811939370852,0.914115750294828,1,23,regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
4237,GO:0008589,0.392335670186588,0.847297662408535,2,66,regulation of smoothened signaling pathway,BP,PRKACB;FGF10
5070,GO:0010880,0.392875399029993,0.913338673948331,1,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CASQ2
1942,GO:0004364,0.392949773744644,0.913568738537827,1,23,glutathione transferase activity,MF,MGST2
16497,GO:0071466,0.393108826941775,0.81036572603273,3,107,cellular response to xenobiotic stimulus,BP,MGST2;CMBL;STAR
9567,GO:0034695,0.393365375507638,0.913229560649029,1,24,response to prostaglandin E,BP,AKT1
8747,GO:0032800,0.393798620415055,0.913020141540011,1,24,receptor biosynthetic process,BP,EDN1
12330,GO:0045745,0.393951086830883,0.912946371349178,1,24,positive regulation of G-protein coupled receptor protein signaling pathway,BP,CHGA
14698,GO:0060071,0.394109891211556,0.809579342961283,3,109,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7;PSMB10;WNT5A
11791,GO:0044420,0.394181041907234,0.809414831014507,3,115,extracellular matrix component,CC,ANG;LAMA1;LAMA5
12537,GO:0046128,0.394527745071778,0.845870410725818,2,65,purine ribonucleoside metabolic process,BP,PNP;RHOQ
1029,GO:0002360,0.394643787148199,0.912610739270017,1,24,T cell lineage commitment,BP,ZFPM1
12321,GO:0045736,0.394911679382699,0.912480730557566,1,24,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
4929,GO:0010669,0.395111137020437,0.912383858037228,1,24,epithelial structure maintenance,BP,RBP4
4406,GO:0009132,0.395552329910827,0.808501416615278,3,109,nucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3;NUDT7
20320,GO:1904949,0.396211512560024,0.911848271968221,1,24,ATPase complex,CC,FXYD1
8923,GO:0033081,0.396515136867079,0.911700143967347,1,24,regulation of T cell differentiation in thymus,BP,BMP4
3022,GO:0006164,0.396881644668943,0.754024328492896,6,242,purine nucleotide biosynthetic process,BP,MRAP;GUCY1B3;EDN1;NPR1;ACAT1;NPPC
15324,GO:0061037,0.397325344877106,0.911304139672241,1,24,negative regulation of cartilage development,BP,BMP4
18841,GO:1901576,0.397343133778134,0.644790555475554,127,5982,organic substance biosynthetic process,BP,ITGA3;EBP;PDK4;PECR;LIF;WNT2;WNT4;POU3F1;ACTN2;ALG5;NOTCH1;PNMT;DPM3;FASN;MRPL14;MRPL16;MRI1;FADD;DHH;WNT6;WNT7A;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PHLDA1;PNP;ABCG1;CCL20;EBF1;BDH2;PYCARD;MBOAT2;ACADVL;PRND;MGST2;ACSM5;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5A;SESN2;AXIN1;RBP4;RHOQ;NPR1;CYP17A1;PSRC1;RNASEL;FGF8;SDC4;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;HSD3B2;CTGF;PCBD1;MDH1;AKT1;IFI27;PTGES;KITLG;IDH1;NPPC;NAB2;CDH1;INHBB;PTMS;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;CYP11A1;LZTS1;DHCR7;PTS;RBMS3;HNF1A;VDR;GDNF;ACSL4;SLC1A3;FZD8;ELOVL6;HEY1;PIM2
20195,GO:1904705,0.397630627802807,0.911154650978466,1,24,regulation of vascular smooth muscle cell proliferation,BP,PDGFB
20903,GO:1990874,0.397630627802807,0.911154650978466,1,24,vascular smooth muscle cell proliferation,BP,PDGFB
8899,GO:0033032,0.397715996662958,0.911112821129153,1,24,regulation of myeloid cell apoptotic process,BP,KITLG
12457,GO:0045980,0.398308971521404,0.843287357553963,2,66,negative regulation of nucleotide metabolic process,BP,ACTN3;EDN1
10115,GO:0035902,0.398371468384507,0.910791252653592,1,24,response to immobilization stress,BP,FOXO4
3900,GO:0008033,0.398957921900011,0.805966128433234,3,108,tRNA processing,BP,LAGE3;HSD17B10;PUS1
17430,GO:0090175,0.399684765874977,0.805379063406704,3,110,regulation of establishment of planar polarity,BP,FZD7;PSMB10;WNT5A
10905,GO:0042554,0.399972370127628,0.91000292861267,1,24,superoxide anion generation,BP,EDN1
12843,GO:0046873,0.400628883666816,0.719380867378933,10,436,metal ion transmembrane transporter activity,MF,TF;SLC31A2;KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1;SLC1A3;CLDN16
6541,GO:0019226,0.400938686416001,0.841430400672493,2,68,transmission of nerve impulse,BP,SPTBN4;JAM3
3906,GO:0008045,0.401024063242134,0.909350175973312,1,25,motor neuron axon guidance,BP,FGF8
10833,GO:0042440,0.401024199996902,0.84144753930777,2,66,pigment metabolic process,BP,BDH2;WNT5A
19800,GO:1903825,0.401576584225488,0.803931939723185,3,111,organic acid transmembrane transport,BP,CPT2;AKT1;SLC1A3
18027,GO:0097720,0.401830155488969,0.908949749307147,1,25,calcineurin-mediated signaling,BP,ACTN3
8173,GO:0031902,0.401856619032321,0.803759563592029,3,109,late endosome membrane,CC,TSPAN15;RAB27A;RHOB
10807,GO:0042402,0.401897416332588,0.909049457072947,1,24,cellular biogenic amine catabolic process,BP,SARDH
5610,GO:0015800,0.402225592196461,0.908752927380262,1,25,acidic amino acid transport,BP,SLC1A3
3135,GO:0006359,0.402424698420118,0.90865372873682,1,25,regulation of transcription from RNA polymerase III promoter,BP,NAB2
5145,GO:0010975,0.402937695224903,0.723282720511861,9,391,regulation of neuron projection development,BP,ITGA3;WNT3;WNT7A;WNT5A;BMP7;AKT1;RAB17;LZTS1;LINGO1
1836,GO:0004112,0.403145908057532,0.908293864201332,1,25,cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
17470,GO:0090224,0.403559232464943,0.908087241843202,1,25,regulation of spindle organization,BP,PSRC1
8498,GO:0032438,0.404526501995834,0.90760260427288,1,25,melanosome organization,BP,RAB38
3704,GO:0007200,0.404566732926222,0.801705735279937,3,109,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,ACTN2;EDN1;CHGA
11512,GO:0043618,0.404956894797185,0.801389262992886,3,110,regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1;PSMB10;SESN2
2986,GO:0006096,0.405350320875122,0.838455537043568,2,67,glycolytic process,BP,ACTN3;PFKFB3
3432,GO:0006757,0.405350320875122,0.838455537043568,2,67,ATP generation from ADP,BP,ACTN3;PFKFB3
14855,GO:0060314,0.405913065492761,0.906905201936021,1,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,CASQ2
12396,GO:0045879,0.405998504381725,0.906862125045769,1,25,negative regulation of smoothened signaling pathway,BP,PRKACB
8938,GO:0033120,0.40606761511823,0.906827271741714,1,25,positive regulation of RNA splicing,BP,PIK3R1
8470,GO:0032409,0.406407775107873,0.758939642733406,5,203,regulation of transporter activity,BP,ACTN2;CASQ2;RGN;FXYD1;PDE4B
14227,GO:0051721,0.406442551707009,0.906638049868121,1,25,protein phosphatase 2A binding,MF,AKT1
981,GO:0002285,0.406577469668339,0.776000408138248,4,155,lymphocyte activation involved in immune response,BP,RAB27A;ZFPM1;CLCF1;DLL1
11463,GO:0043537,0.406968049090992,0.906372453182851,1,25,negative regulation of blood vessel endothelial cell migration,BP,NOTCH1
21540,GO:2001022,0.406998731565347,0.83732293611881,2,67,positive regulation of response to DNA damage stimulus,BP,PMAIP1;FGF10
1220,GO:0002700,0.407124002958629,0.799739088624479,3,110,regulation of production of molecular mediator of immune response,BP,WNT5A;RBP4;CLCF1
8200,GO:0031954,0.407379582284531,0.906164137959575,1,25,positive regulation of protein autophosphorylation,BP,PDGFB
19906,GO:1904030,0.40783952230871,0.905930988440358,1,25,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
16069,GO:0070664,0.408220538255634,0.836480917576437,2,67,negative regulation of leukocyte proliferation,BP,SDC4;BMP4
16531,GO:0071514,0.408306929684368,0.905693695297857,1,25,genetic imprinting,BP,PIK3CA
139,GO:0000278,0.408496245132024,0.677480939383188,21,952,mitotic cell cycle,BP,RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;PSMB10;FGF10;PDGFB;FOXO4;HRAS;SNX18;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;LZTS1;PIM2
10923,GO:0042581,0.408611082086584,0.774351498811877,4,156,specific granule,CC,RAB27A;PLAU;VAMP1;RAB44
5872,GO:0016311,0.408619563853787,0.718273834493252,9,389,dephosphorylation,BP,ADORA1;RGN;PTPN7;PFKFB3;BMP2;CAMSAP3;MDP1;ACP5;DUSP5
3469,GO:0006820,0.408951692417621,0.698223888431292,13,573,anion transport,BP,APOC1;SLC52A3;ADORA1;EDN1;ABCG1;TTYH1;CPT2;FXYD1;WNK4;FABP3;AKT1;ACSL4;SLC1A3
2909,GO:0005979,0.40915084905799,0.905137101300164,1,26,regulation of glycogen biosynthetic process,BP,AKT1
5136,GO:0010962,0.40915084905799,0.905137101300164,1,26,regulation of glucan biosynthetic process,BP,AKT1
9721,GO:0035235,0.409204963105928,0.905109496788262,1,26,ionotropic glutamate receptor signaling pathway,BP,GRIA3
1,GO:0000002,0.409322372832506,0.905176929423032,1,25,mitochondrial genome maintenance,BP,SESN2
4925,GO:0010665,0.409424568837874,0.905124826567119,1,25,regulation of cardiac muscle cell apoptotic process,BP,NOL3
1283,GO:0002792,0.409887897344036,0.797605937287034,3,111,negative regulation of peptide secretion,BP,INHBB;RAB11FIP1;GAS6
12793,GO:0046717,0.410038113445101,0.797490800068573,3,111,acid secretion,BP,ADORA1;EDN1;SLC1A3
12460,GO:0045987,0.410091495114133,0.904784380430957,1,25,positive regulation of smooth muscle contraction,BP,EDN1
11937,GO:0044843,0.410167420212164,0.742735662893298,6,249,cell cycle G1/S phase transition,BP,GADD45A;ACVR1;FGF10;CDKN1A;AKT1;PIM2
3892,GO:0008017,0.410173839252887,0.755764182598095,5,208,microtubule binding,MF,MARK4;REEP1;PSRC1;CAMSAP3;LZTS1
8012,GO:0031571,0.410382272282398,0.834947603249469,2,68,mitotic G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
11929,GO:0044819,0.410382272282398,0.834947603249469,2,68,mitotic G1/S transition checkpoint,BP,GADD45A;CDKN1A
12319,GO:0045730,0.410670777043115,0.904488075008901,1,25,respiratory burst,BP,PIK3CG
1882,GO:0004181,0.411227076682158,0.904203000291016,1,25,metallocarboxypeptidase activity,MF,PEPD
15308,GO:0061014,0.411267779152167,0.904053592805093,1,26,positive regulation of mRNA catabolic process,BP,PRR5L
18226,GO:0098901,0.411654686160558,0.903735591459933,1,27,regulation of cardiac muscle cell action potential,BP,DSC2
19207,GO:1902555,0.411662463910699,0.903979527862142,1,25,endoribonuclease complex,CC,HSD17B10
20476,GO:1905348,0.411662463910699,0.903979527862142,1,25,endonuclease complex,CC,HSD17B10
13924,GO:0051181,0.412440911736729,0.903579185162064,1,25,cofactor transport,BP,FLVCR2
4532,GO:0009310,0.412440963949357,0.903579158276097,1,25,amine catabolic process,BP,SARDH
872,GO:0002080,0.41290518437446,0.903339936737259,1,25,acrosomal membrane,CC,SERPINA5
11824,GO:0044463,0.41327516952549,0.673016615592475,21,964,cell projection part,CC,ITGA3;ITGA5;ADRA2C;ACTN2;MARK4;RAB27A;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;FSTL3;PRKAR1B;ANG;ESPN;VAMP1;MSN;AKT1;MYO7A;LZTS1;PDE4B
4066,GO:0008299,0.413387069451115,0.903091231977981,1,25,isoprenoid biosynthetic process,BP,HMGCS2
5356,GO:0015079,0.413406982613388,0.770460976184292,4,157,potassium ion transmembrane transporter activity,MF,KCNK6;KCNH2;KCNG2;KCND1
3223,GO:0006487,0.413550628987612,0.832782369557861,2,67,protein N-linked glycosylation,BP,ALG5;DPM3
10956,GO:0042632,0.413621779988826,0.832694059043251,2,68,cholesterol homeostasis,BP,ABCG1;FABP3
14611,GO:0055092,0.413621779988826,0.832694059043251,2,68,sterol homeostasis,BP,ABCG1;FABP3
7869,GO:0031304,0.413868155970467,0.902842552603422,1,25,intrinsic component of mitochondrial inner membrane,CC,ETFDH
7870,GO:0031305,0.413868155970467,0.902842552603422,1,25,integral component of mitochondrial inner membrane,CC,ETFDH
9820,GO:0035411,0.414581548154069,0.902342516359351,1,26,catenin import into nucleus,BP,FZD7
24,GO:0000045,0.414608571169478,0.831966930362375,2,69,autophagosome assembly,BP,TBC1D14;RALB
7559,GO:0030695,0.415864375882149,0.727421266251772,7,300,GTPase regulator activity,MF,RIN3;TBC1D14;PIK3R2;SESN2;AXIN1;GPSM1;SH3BP4
3579,GO:0006996,0.416143678255612,0.634446537006489,74,3492,organelle organization,BP,FHOD3;LIF;SYT5;WNT4;TUBG2;ACTN2;RAB6C;NOTCH1;MARK4;RAB27A;ITGB5;PMAIP1;GADD45A;ZFPM1;TBC1D14;CASQ2;EDN1;SPTBN5;SPTBN4;PYCARD;TTYH1;RAB39A;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;PLA2G16;HSD17B10;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOJ;NUAK2;PSRC1;FGF8;SDC4;ANG;SPTB;BMP7;BMP4;CAMSAP3;DAAM2;HMGN5;RAB20;ESPN;HEXB;VAMP1;RND3;CHGA;MSN;NOL3;CTGF;AKT1;PKP1;RAB17;PUS1;MYO7A;BCAR1;SIN3B;MYH11;AMOT;LAMA5;RAB38;PIM2;PARVB;TMOD4
2838,GO:0005859,0.416247243243169,0.901353712615698,1,27,muscle myosin complex,CC,MYH11
9532,GO:0034644,0.416373724042395,0.830729848559816,2,69,cellular response to UV,BP,PIK3R1;CDKN1A
21024,GO:2000144,0.416415616035403,0.901387590759056,1,26,positive regulation of DNA-templated transcription, initiation,BP,HNF1A
1781,GO:0004033,0.416615694326647,0.901414895197267,1,25,aldo-keto reductase (NADP) activity,MF,CYB5A
10738,GO:0042278,0.416653680253612,0.83057112735671,2,68,purine nucleoside metabolic process,BP,PNP;RHOQ
13394,GO:0048753,0.416997418284846,0.901083489861416,1,26,pigment granule organization,BP,RAB38
11908,GO:0044783,0.417666316569902,0.829821076502381,2,69,G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
14997,GO:0060487,0.418286136685815,0.900407864715226,1,26,lung epithelial cell differentiation,BP,FGF10
19682,GO:1903580,0.418808518738892,0.900133203023636,1,26,positive regulation of ATP metabolic process,BP,ACTN3
675,GO:0001819,0.419245259330945,0.708831135304189,9,387,positive regulation of cytokine production,BP,FADD;ZFPM1;CCL20;PYCARD;PIK3R1;TICAM1;HRAS;WNT5A;PDE4B
4908,GO:0010644,0.419513994153538,0.89963788977076,1,27,cell communication by electrical coupling,BP,CASQ2
15925,GO:0070405,0.419722061721982,0.828409019702344,2,68,ammonium ion binding,MF,SERPINA5;APOC1
13177,GO:0048284,0.419790726297495,0.747727444063873,5,204,organelle fusion,BP,SYT5;TBC1D14;RAB39A;RAB20;VAMP1
13065,GO:0048011,0.419825159212994,0.89959734635875,1,26,neurotrophin TRK receptor signaling pathway,BP,BCAR1
14813,GO:0060260,0.419855644084827,0.89958125125614,1,26,regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
5907,GO:0016411,0.420185000288378,0.899407260822566,1,26,acylglycerol O-acyltransferase activity,MF,MBOAT2
3919,GO:0008066,0.42030070270919,0.899221988782252,1,27,glutamate receptor activity,MF,GRIA3
9171,GO:0033687,0.420580965389841,0.899197839723305,1,26,osteoblast proliferation,BP,BMP2
12888,GO:0046942,0.420615772529433,0.723283669116959,7,297,carboxylic acid transport,BP,ADORA1;EDN1;CPT2;FABP3;AKT1;ACSL4;SLC1A3
21158,GO:2000352,0.420624414067706,0.899174844095062,1,26,negative regulation of endothelial cell apoptotic process,BP,GAS6
2508,GO:0005179,0.4208968659309,0.789092010757301,3,111,hormone activity,MF,EDN1;NPPC;INHBB
3146,GO:0006376,0.421062789411386,0.898942650942236,1,26,mRNA splice site selection,BP,NOL3
5570,GO:0015711,0.421120415593965,0.701057729058416,10,437,organic anion transport,BP,APOC1;SLC52A3;ADORA1;EDN1;ABCG1;CPT2;FABP3;AKT1;ACSL4;SLC1A3
20525,GO:1905476,0.421862644939289,0.898518154419179,1,26,negative regulation of protein localization to membrane,BP,RHOQ
303,GO:0000803,0.421964687117611,0.898463920919126,1,26,sex chromosome,CC,SIN3B
20641,GO:1905897,0.422126287821466,0.826666721500567,2,69,regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R1
20321,GO:1904950,0.422263582035594,0.745628248060041,5,205,negative regulation of establishment of protein localization,BP,RHOQ;BMP7;INHBB;RAB11FIP1;GAS6
10624,GO:0042044,0.422485872528545,0.898186645023346,1,26,fluid transport,BP,EDN1
9268,GO:0034105,0.422804890782528,0.898016696502413,1,26,positive regulation of tissue remodeling,BP,VDR
4766,GO:0010259,0.423402908160501,0.897571752195527,1,27,multicellular organism aging,BP,EDN1
14595,GO:0055074,0.423708853458059,0.70481729455404,9,392,calcium ion homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;RGN;HEXB;NOL3;PIK3CG;VDR
7453,GO:0030488,0.423734492240196,0.89752048934934,1,26,tRNA methylation,BP,HSD17B10
9334,GO:0034219,0.423780448744867,0.897495920326506,1,26,carbohydrate transmembrane transport,BP,SLC2A14
10379,GO:0036473,0.42390300559454,0.825402017280385,2,69,cell death in response to oxidative stress,BP,NOL3;AKT1
21,GO:0000038,0.423986999764536,0.897385450717245,1,26,very long-chain fatty acid metabolic process,BP,ELOVL6
12487,GO:0046039,0.424155903356651,0.897295062071048,1,26,GTP metabolic process,BP,RHOQ
2772,GO:0005758,0.424275715593859,0.825174967291362,2,68,mitochondrial intermembrane space,CC,HSD3B2;STAR
19271,GO:1902692,0.424299749742134,0.897091623206012,1,27,regulation of neuroblast proliferation,BP,NOTCH1
99,GO:0000188,0.424471404978279,0.897126091398715,1,26,inactivation of MAPK activity,BP,DUSP5
3978,GO:0008170,0.424498112649939,0.824939631050589,2,70,N-methyltransferase activity,MF,PNMT;NNMT
8267,GO:0032069,0.424522296479839,0.897098819956778,1,26,regulation of nuclease activity,BP,AKT1
6122,GO:0016798,0.424863828780345,0.785945935684533,3,113,hydrolase activity, acting on glycosyl bonds,MF,IDUA;HEXB;GLA
3418,GO:0006735,0.424870071087586,0.896912338329032,1,26,NADH regeneration,BP,PFKFB3
15573,GO:0061621,0.424870071087586,0.896912338329032,1,26,canonical glycolysis,BP,PFKFB3
15617,GO:0061718,0.424870071087586,0.896912338329032,1,26,glucose catabolic process to pyruvate,BP,PFKFB3
3860,GO:0007601,0.425003781776019,0.743295576870217,5,206,visual perception,BP,CDH23;RBP4;MYO7A;GJA3;UNC119
6165,GO:0016866,0.425177758487915,0.89674718002539,1,26,intramolecular transferase activity,MF,PUS1
1487,GO:0003208,0.425979501677029,0.823843299296791,2,71,cardiac ventricle morphogenesis,BP,NOTCH1;HEY1
9124,GO:0033598,0.426103404639982,0.896121871838954,1,27,mammary gland epithelial cell proliferation,BP,WNT5A
830,GO:0002026,0.426110565218467,0.896118010810156,1,27,regulation of the force of heart contraction,BP,CHGA
9398,GO:0034364,0.426479903572566,0.896046433762711,1,26,high-density lipoprotein particle,CC,APOC1
12864,GO:0046902,0.426540747846118,0.823515877629424,2,69,regulation of mitochondrial membrane permeability,BP,PMAIP1;NOL3
8191,GO:0031941,0.426671707370191,0.895815166576275,1,27,filamentous actin,CC,ESPN
13791,GO:0050996,0.42690638054831,0.895688355334911,1,27,positive regulation of lipid catabolic process,BP,SESN2
18166,GO:0098794,0.426965419728992,0.70186445110501,9,400,postsynapse,CC,ACTN2;ADORA1;CDH2;DRP2;GRIA3;AKT1;LZTS1;SHC4;PDE4B
4562,GO:0009410,0.427241582535275,0.784074540370676,3,113,response to xenobiotic stimulus,BP,MGST2;CMBL;STAR
4381,GO:0009100,0.427634241241348,0.701275568632974,9,396,glycoprotein metabolic process,BP,ALG5;DPM3;EXTL1;PHLDA1;HBEGF;BMP2;B3GNT2;IDUA;HEXB
7903,GO:0031346,0.428913711125369,0.715943078045448,7,305,positive regulation of cell projection organization,BP,ITGA3;WNT3;HRAS;WNT5A;RHOQ;BMP7;ESPN
7925,GO:0031400,0.428924307910804,0.679929114464101,13,580,negative regulation of protein modification process,BP,LIF;GADD45A;PYCARD;PSMB10;RGN;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;DEPTOR;AKT1;DUSP5
15515,GO:0061462,0.429090477953556,0.894503595619496,1,27,protein localization to lysosome,BP,SH3BP4
17334,GO:0090023,0.429269188681396,0.894535616356888,1,26,positive regulation of neutrophil chemotaxis,BP,EDN1
6908,GO:0021675,0.429270432635565,0.821477686038499,2,71,nerve development,BP,NRTN;SLC1A3
1076,GO:0002443,0.429553890924414,0.669384955923318,16,717,leukocyte mediated immunity,BP,RAB27A;CRISPLD2;FADD;PLAU;PNP;PYCARD;CLCF1;HEXB;CHGA;PKP1;IDH1;RAB44;PIK3CG;GLA;DERA;RAB3D
1848,GO:0004129,0.43001657616903,0.894128523993744,1,26,cytochrome-c oxidase activity,MF,CYB5A
5328,GO:0015002,0.43001657616903,0.894128523993744,1,26,heme-copper terminal oxidase activity,MF,CYB5A
6058,GO:0016676,0.43001657616903,0.894128523993744,1,26,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,CYB5A
10540,GO:0038202,0.430204306154927,0.893896244443118,1,27,TORC1 signaling,BP,SESN2
14990,GO:0060479,0.430479584527593,0.893745810563901,1,27,lung cell differentiation,BP,FGF10
1267,GO:0002764,0.431108592399422,0.686684539592027,11,487,immune response-regulating signaling pathway,BP,FADD;PRKACB;TYRO3;PSMB10;PIK3R2;PIK3R1;TICAM1;HRAS;BCAR1;PIK3CA;PDE4B
11514,GO:0043620,0.431796521949942,0.780429730887991,3,115,regulation of DNA-templated transcription in response to stress,BP,NOTCH1;PSMB10;SESN2
16130,GO:0070820,0.431854414322446,0.755248869385478,4,161,tertiary granule,CC,PLAU;VAMP1;PKP1;IDH1
16131,GO:0070821,0.431891725284694,0.819582006667473,2,71,tertiary granule membrane,CC,PLAU;VAMP1
14000,GO:0051293,0.43305734771166,0.892208670120658,1,28,establishment of spindle localization,BP,FGF10
17001,GO:0072331,0.433108993383887,0.722880323911348,6,255,signal transduction by p53 class mediator,BP,PMAIP1;GADD45A;PYCARD;SESN2;CDKN1A;AKT1
17103,GO:0072562,0.433206747459918,0.779327760766826,3,114,blood microparticle,CC,CFB;TF;MSN
6376,GO:0018198,0.433365019956435,0.892161104597218,1,27,peptidyl-cysteine modification,BP,RAB3D
9629,GO:0034976,0.433703367459912,0.722366501291671,6,254,response to endoplasmic reticulum stress,BP,PMAIP1;ACADVL;PIK3R2;PIK3R1;SESN2;CASP4
7152,GO:0022890,0.433847716412839,0.67949492796306,12,540,inorganic cation transmembrane transporter activity,MF,TF;SLC31A2;KCNK6;TTYH1;KCNH2;GRIA3;KCNG2;GAS6;CYB5A;KCND1;SLC1A3;CLDN16
13715,GO:0050866,0.433899510820812,0.753543800955013,4,161,negative regulation of cell activation,BP,TYRO3;PDGFB;SDC4;BMP4
4513,GO:0009260,0.434062565918067,0.722064895113868,6,252,ribonucleotide biosynthetic process,BP,MRAP;GUCY1B3;EDN1;NPR1;ACAT1;NPPC
7057,GO:0021955,0.434392836622176,0.891470305797176,1,28,central nervous system neuron axonogenesis,BP,SPTBN4
16658,GO:0071709,0.434444320487456,0.891441779428752,1,28,membrane assembly,BP,CDH2
3882,GO:0007628,0.434632313190828,0.891337576617505,1,28,adult walking behavior,BP,SPTBN4
11897,GO:0044766,0.434713760091582,0.817529800641036,2,71,multi-organism transport,BP,NMT2;RAB40B
19224,GO:1902579,0.434713760091582,0.817529800641036,2,71,multi-organism localization,BP,NMT2;RAB40B
9335,GO:0034220,0.434743679385062,0.651006868591882,22,1015,ion transmembrane transport,BP,ACTN2;SLC31A2;CASQ2;KCNK6;TTYH1;TSPAN13;RGN;KCNH2;CPT2;FXYD1;SFXN1;GRIA3;NOL3;AKT1;PIK3CG;KCNG2;GAS6;CYB5A;KCND1;SLC1A3;CLDN16;PDE4B
20360,GO:1905037,0.435434561138722,0.816966863639898,2,72,autophagosome organization,BP,TBC1D14;RALB
14349,GO:0051955,0.435500027403989,0.890979253810431,1,27,regulation of amino acid transport,BP,ADORA1
18319,GO:0099504,0.435779547671039,0.777197504619925,3,118,synaptic vesicle cycle,BP,SYT5;WNT7A;CDH2
5147,GO:0010977,0.436083235795451,0.776954567096093,3,118,negative regulation of neuron projection development,BP,WNT3;WNT5A;LINGO1
17031,GO:0072378,0.436126113399477,0.890631175941497,1,27,blood coagulation, fibrin clot formation,BP,TFPI
18655,GO:1901021,0.436253323633215,0.890436512400452,1,28,positive regulation of calcium ion transmembrane transporter activity,BP,RGN
3402,GO:0006706,0.436268876893396,0.890551709759805,1,27,steroid catabolic process,BP,HSD17B11
5203,GO:0014046,0.436854924692106,0.890225126754026,1,27,dopamine secretion,BP,GDNF
5215,GO:0014059,0.436854924692106,0.890225126754026,1,27,regulation of dopamine secretion,BP,GDNF
9523,GO:0034629,0.436875678811643,0.89021355025997,1,27,cellular protein complex localization,BP,RALB
13773,GO:0050953,0.436953343863936,0.733042834079917,5,209,sensory perception of light stimulus,BP,CDH23;RBP4;MYO7A;GJA3;UNC119
9731,GO:0035250,0.437207682408728,0.890028258924211,1,27,UDP-galactosyltransferase activity,MF,B3GNT2
15569,GO:0061615,0.437224883395484,0.890018653804561,1,27,glycolytic process through fructose-6-phosphate,BP,PFKFB3
15572,GO:0061620,0.437224883395484,0.890018653804561,1,27,glycolytic process through glucose-6-phosphate,BP,PFKFB3
776,GO:0001953,0.437323783395821,0.889838969221667,1,28,negative regulation of cell-matrix adhesion,BP,PIK3R1
8659,GO:0032673,0.437786458109379,0.889704783765223,1,27,regulation of interleukin-4 production,BP,ZFPM1
11002,GO:0042730,0.437938840570094,0.88961952055202,1,27,fibrinolysis,BP,PLAU
1196,GO:0002675,0.437946274388245,0.889615360037425,1,27,positive regulation of acute inflammatory response,BP,PIK3CG
8572,GO:0032543,0.43852599187607,0.775074072142811,3,114,mitochondrial translation,BP,MRPL14;MRPL16;TSFM
3389,GO:0006691,0.438604233114184,0.88924673481839,1,27,leukotriene metabolic process,BP,MGST2
3650,GO:0007126,0.438971262661557,0.749270091053814,4,163,meiotic nuclear division,BP,LIF;WNT4;WNT5A;PIM2
9528,GO:0034637,0.43912658058393,0.814259796738002,2,72,cellular carbohydrate biosynthetic process,BP,B3GNT2;AKT1
17259,GO:0086019,0.439326036692993,0.888599068425772,1,29,cell-cell signaling involved in cardiac conduction,BP,CASQ2
13667,GO:0050796,0.439658547824099,0.748679921588425,4,164,regulation of insulin secretion,BP,ADRA2C;RBP4;INHBB;KCNG2
3617,GO:0007049,0.439974694197787,0.629846199119737,35,1635,cell cycle,BP,LIF;WNT4;RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;PRKACB;TTYH1;MAPK12;PSMB10;FGF10;PDGFB;FOXO4;RALB;PLA2G16;HRAS;WNT5A;SNX18;RHOB;PSRC1;FGF8;BMP7;BMP4;BMP2;CDKN1A;HMGN5;CTGF;AKT1;NPPC;JAG2;GAS6;LZTS1;PIM2
3707,GO:0007205,0.440257287490375,0.888191179629226,1,28,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1
2515,GO:0005201,0.440849139689456,0.812883449877704,2,75,extracellular matrix structural constituent,MF,HAPLN3;LAMA1
13160,GO:0048255,0.441065312320286,0.887734648848613,1,28,mRNA stabilization,BP,GDNF
4393,GO:0009116,0.441352087823205,0.772759350419059,3,116,nucleoside metabolic process,BP,PNP;RHOQ;DERA
7631,GO:0030866,0.441632211597553,0.887413667452091,1,28,cortical actin cytoskeleton organization,BP,RHOQ
7908,GO:0031365,0.441771556784319,0.887334682821233,1,28,N-terminal protein amino acid modification,BP,NMT2
12479,GO:0046031,0.441835630953887,0.81226055844187,2,72,ADP metabolic process,BP,ACTN3;PFKFB3
6057,GO:0016675,0.442028097993469,0.887316242456605,1,27,oxidoreductase activity, acting on a heme group of donors,MF,CYB5A
1270,GO:0002768,0.442116576298254,0.695453591036049,8,350,immune response-regulating cell surface receptor signaling pathway,BP,PRKACB;PSMB10;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
11283,GO:0043236,0.44214438843018,0.887123183502117,1,28,laminin binding,MF,ITGA3
13956,GO:0051233,0.442342065789462,0.887010946017282,1,28,spindle midzone,CC,UNC119
11448,GO:0043516,0.44250750553482,0.886916959470581,1,28,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
20895,GO:1990841,0.442689791933251,0.886813346405497,1,28,promoter-specific chromatin binding,MF,FOXO4
7892,GO:0031334,0.442731105224747,0.728035519518273,5,210,positive regulation of protein complex assembly,BP,PMAIP1;PYCARD;PSRC1;MSN;HNF1A
1219,GO:0002699,0.442900210225748,0.745970047307777,4,162,positive regulation of immune effector process,BP,FADD;WNT5A;RBP4;CLCF1
7885,GO:0031327,0.443746948579279,0.630080364467315,31,1445,negative regulation of cellular biosynthetic process,BP,WNT4;NOTCH1;APOC1;ZFPM1;SALL4;DKK3;EDN1;ACADVL;RGN;PDGFB;WNT5A;SESN2;AXIN1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;NAB2;INHBB;TLE1;GAS6;SIN3B;GLA;VDR;FZD8;HEY1
6360,GO:0018146,0.444014557082267,0.88605857626167,1,28,keratan sulfate biosynthetic process,BP,B3GNT2
4685,GO:0009925,0.444095017394151,0.885893317516965,1,29,basal plasma membrane,CC,TF
12817,GO:0046823,0.444775882778273,0.810041412204481,2,73,negative regulation of nucleocytoplasmic transport,BP,BMP7;GAS6
4919,GO:0010659,0.444969038213815,0.885512847386588,1,28,cardiac muscle cell apoptotic process,BP,NOL3
17657,GO:0090659,0.445082351805701,0.88532811984251,1,29,walking behavior,BP,SPTBN4
12622,GO:0046390,0.445311637689466,0.7121316389689,6,255,ribose phosphate biosynthetic process,BP,MRAP;GUCY1B3;EDN1;NPR1;ACAT1;NPPC
947,GO:0002223,0.445359484335924,0.769457701448008,3,119,stimulatory C-type lectin receptor signaling pathway,BP,PRKACB;PSMB10;HRAS
12421,GO:0045920,0.445522209952376,0.885195830113003,1,28,negative regulation of exocytosis,BP,NOTCH1
17957,GO:0097502,0.445782601342987,0.885046414488315,1,28,mannosylation,BP,DPM3
16164,GO:0070873,0.446009680014634,0.884795698103639,1,29,regulation of glycogen metabolic process,BP,AKT1
5468,GO:0015295,0.446278722815949,0.884761401042349,1,28,solute:proton symporter activity,MF,SLC45A4
4526,GO:0009303,0.446375956119967,0.884705490906204,1,28,rRNA transcription,BP,ANG
8472,GO:0032411,0.447231817788593,0.808172281331359,2,74,positive regulation of transporter activity,BP,ACTN2;RGN
8895,GO:0033028,0.4475110390281,0.884051563127328,1,28,myeloid cell apoptotic process,BP,KITLG
7471,GO:0030515,0.447786755340056,0.883892375226063,1,28,snoRNA binding,MF,NUDT7
7472,GO:0030516,0.447888585108578,0.807645268120808,2,75,regulation of axon extension,BP,WNT3;WNT5A
1587,GO:0003382,0.447973199754639,0.883663305412238,1,29,epithelial cell morphogenesis,BP,CLDN3
5642,GO:0015849,0.448226065715754,0.698708538981583,7,305,organic acid transport,BP,ADORA1;EDN1;CPT2;FABP3;AKT1;ACSL4;SLC1A3
12079,GO:0045191,0.44829778294768,0.883596969501212,1,28,regulation of isotype switching,BP,CLCF1
7091,GO:0022400,0.448917044345789,0.883238373740219,1,28,regulation of rhodopsin mediated signaling pathway,BP,NMT2
14102,GO:0051482,0.44898054571337,0.883201563304674,1,28,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
9764,GO:0035305,0.449030117349615,0.806824178467799,2,74,negative regulation of dephosphorylation,BP,RGN;CAMSAP3
9057,GO:0033363,0.44925436095519,0.882920734714536,1,29,secretory granule organization,BP,RAB38
8368,GO:0032266,0.449355382114715,0.882862057381976,1,29,phosphatidylinositol-3-phosphate binding,MF,SNX21
8804,GO:0032892,0.449585440762256,0.882850556991131,1,28,positive regulation of organic acid transport,BP,EDN1
10916,GO:0042572,0.44990932418391,0.882662346250085,1,28,retinol metabolic process,BP,RBP4
4969,GO:0010743,0.450119122340821,0.882417854319929,1,29,regulation of macrophage derived foam cell differentiation,BP,ABCG1
14806,GO:0060249,0.45133122780241,0.687063126333942,8,354,anatomical structure homeostasis,BP,PDK4;CDH23;TF;TYRO3;RBP4;CTGF;RAB3D;CLDN18
19176,GO:1902475,0.451340701794456,0.881705193132739,1,29,L-alpha-amino acid transmembrane transport,BP,SLC1A3
7985,GO:0031503,0.451435850576024,0.764498676364542,3,119,protein complex localization,BP,RALB;BMP7;NOL3
13650,GO:0050773,0.452128672814036,0.763874280247715,3,122,regulation of dendrite development,BP,BMP7;RAB17;LZTS1
15267,GO:0060964,0.452901731025115,0.8807906007336,1,29,regulation of gene silencing by miRNA,BP,BMP4
12090,GO:0045211,0.453275907393322,0.718762992503391,5,217,postsynaptic membrane,CC,ADORA1;DRP2;GRIA3;LZTS1;SHC4
620,GO:0001736,0.453359631540738,0.762899628511029,3,120,establishment of planar polarity,BP,FZD7;PSMB10;WNT5A
3672,GO:0007164,0.453359631540738,0.762899628511029,3,120,establishment of tissue polarity,BP,FZD7;PSMB10;WNT5A
10867,GO:0042501,0.453439733828442,0.880598607471682,1,28,serine phosphorylation of STAT protein,BP,LIF
4519,GO:0009266,0.453553837084286,0.718543237232536,5,214,response to temperature stimulus,BP,SLC52A3;ADORA1;ACADVL;CDKN1A;AKT1
5864,GO:0016298,0.454399967092169,0.762062185273493,3,119,lipase activity,MF,ADORA1;PLA2G16;LYPLAL1
4587,GO:0009583,0.454412878945725,0.802796758374886,2,73,detection of light stimulus,BP,NMT2;UNC119
8693,GO:0032728,0.454681410643345,0.879742551730796,1,29,positive regulation of interferon-beta production,BP,TICAM1
4846,GO:0010543,0.454823235544791,0.879658785559967,1,29,regulation of platelet activation,BP,PDGFB
2784,GO:0005770,0.455321148575984,0.716995315807021,5,213,late endosome,CC,TSPAN15;RAB27A;TF;SLC31A2;RHOB
9670,GO:0035066,0.455843586059422,0.879055063304461,1,29,positive regulation of histone acetylation,BP,LIF
17062,GO:0072503,0.455918874109622,0.675458087805044,9,403,cellular divalent inorganic cation homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;RGN;HEXB;NOL3;PIK3CG;VDR
1228,GO:0002708,0.456080587687981,0.801528826071018,2,73,positive regulation of lymphocyte mediated immunity,BP,FADD;CLCF1
37,GO:0000075,0.456287769076309,0.716134264660503,5,214,cell cycle checkpoint,BP,GADD45A;FOXO4;HRAS;CDKN1A;AKT1
945,GO:0002220,0.456514176264468,0.760279322674102,3,121,innate immune response activating cell surface receptor signaling pathway,BP,PRKACB;PSMB10;HRAS
11198,GO:0043114,0.456575627430098,0.87862076740192,1,29,regulation of vascular permeability,BP,NPR1
6496,GO:0019098,0.457373285558608,0.878146437385534,1,29,reproductive behavior,BP,HEXB
14007,GO:0051301,0.457851165077926,0.657150016345735,12,547,cell division,BP,NOTCH1;MARK4;WNT7A;FZD7;PDGFB;RALB;SNX18;RHOB;PSRC1;FGF8;DLL1;BCAR1
19088,GO:1902235,0.458603016397688,0.877412910371705,1,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
12773,GO:0046685,0.459061587978568,0.87713867116988,1,29,response to arsenic-containing substance,BP,CDKN1A
10693,GO:0042168,0.459614028545267,0.876807786951401,1,29,heme metabolic process,BP,BDH2
7617,GO:0030851,0.459876447801025,0.876650416078469,1,29,granulocyte differentiation,BP,ZFPM1
3260,GO:0006536,0.460078584368658,0.87652911064561,1,29,glutamate metabolic process,BP,SLC1A3
4366,GO:0009072,0.46013768428062,0.876493629744909,1,29,aromatic amino acid family metabolic process,BP,PCBD1
17628,GO:0090559,0.460539052050691,0.798080834729063,2,74,regulation of membrane permeability,BP,PMAIP1;NOL3
21656,GO:2001257,0.460699151641197,0.756789111325217,3,122,regulation of cation channel activity,BP,ACTN2;CASQ2;PDE4B
18632,GO:1900739,0.460856126589175,0.876061799696433,1,29,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
18633,GO:1900740,0.460856126589175,0.876061799696433,1,29,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
13406,GO:0048786,0.461213062498812,0.87561515016768,1,31,presynaptic active zone,CC,ADORA1
8698,GO:0032733,0.461268268298291,0.875813650330204,1,29,positive regulation of interleukin-10 production,BP,PYCARD
643,GO:0001773,0.461545314716467,0.875646666869099,1,29,myeloid dendritic cell activation,BP,PYCARD
7101,GO:0022411,0.461763653519807,0.658249794192416,11,500,cellular component disassembly,BP,ACTN2;MRPL14;MRPL16;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SPTB;DDR1;CDH1;TMOD4
8496,GO:0032436,0.462106820952368,0.796837524291362,2,75,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,AKT1;RNF144A
5981,GO:0016538,0.462671386327712,0.874966506253202,1,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A
6096,GO:0016757,0.462714000159225,0.696512700521644,6,261,transferase activity, transferring glycosyl groups,MF,ALG5;DPM3;EXTL1;PNP;B3GNT2;HEXB
7299,GO:0030201,0.463008357566989,0.874641849811881,1,30,heparan sulfate proteoglycan metabolic process,BP,EXTL1
8048,GO:0031641,0.463024077859446,0.87463232049337,1,30,regulation of myelination,BP,AKT1
6667,GO:0019692,0.463475063149584,0.874479654128671,1,29,deoxyribose phosphate metabolic process,BP,DERA
13178,GO:0048285,0.464126124452122,0.64700204922842,13,599,organelle fission,BP,LIF;WNT4;MARK4;EDN1;TTYH1;PDGFB;WNT5A;SNX18;PSRC1;FGF8;BMP7;BMP4;PIM2
1647,GO:0003774,0.464134138685603,0.753782184380434,3,130,motor activity,MF,CGN;MYO7A;MYH11
19249,GO:1902624,0.464183026766162,0.874049800478235,1,29,positive regulation of neutrophil migration,BP,EDN1
13411,GO:0048791,0.464185646519872,0.873926945124897,1,30,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT5
6230,GO:0017016,0.464435651580065,0.694911507855046,6,268,Ras GTPase binding,MF,RIN3;TBC1D14;DAAM2;RAB11FIP1;RPH3AL;SH3BP4
1296,GO:0002824,0.464491763347917,0.795031522869319,2,74,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD;CLCF1
1261,GO:0002758,0.464775787793263,0.694628086603442,6,264,innate immune response-activating signal transduction,BP,FADD;PRKACB;TYRO3;PSMB10;TICAM1;HRAS
13376,GO:0048713,0.465011026880574,0.873424215235866,1,30,regulation of oligodendrocyte differentiation,BP,NOTCH1
17127,GO:0072595,0.465092840790844,0.873374314939265,1,30,maintenance of protein localization in organelle,BP,AKT1
11478,GO:0043552,0.465314921262559,0.873238800441315,1,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,PDGFB
16602,GO:0071624,0.465378872010376,0.873321625828769,1,29,positive regulation of granulocyte chemotaxis,BP,EDN1
2125,GO:0004629,0.465550412628318,0.873095003197136,1,30,phospholipase C activity,MF,ADORA1
8704,GO:0032743,0.465905703218492,0.872877859737216,1,30,positive regulation of interleukin-2 production,BP,PDE4B
60,GO:0000122,0.466017055280306,0.634948254283943,16,742,negative regulation of transcription from RNA polymerase II promoter,BP,NOTCH1;ZFPM1;SALL4;EDN1;PDGFB;AXIN1;BMP6;BMP4;BMP2;WT1;IFI27;TLE1;SIN3B;VDR;FZD8;HEY1
12424,GO:0045923,0.466571421304686,0.872470364274414,1,30,positive regulation of fatty acid metabolic process,BP,RGN
5913,GO:0016417,0.466663329209048,0.872414041806542,1,30,S-acyltransferase activity,MF,FASN
4269,GO:0008652,0.466898792842516,0.793125701604382,2,75,cellular amino acid biosynthetic process,BP,MRI1;SLC1A3
21436,GO:2000758,0.467024066712805,0.872192825762382,1,30,positive regulation of peptidyl-lysine acetylation,BP,LIF
3851,GO:0007586,0.467783797620306,0.72451413531811,4,167,digestion,BP,FGF10;RBP4;WNK4;VDR
7979,GO:0031492,0.467894392119748,0.871658122188945,1,30,nucleosomal DNA binding,MF,HMGN5
1097,GO:0002479,0.468476264413315,0.791933480047703,2,74,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5;PSMB10
7906,GO:0031349,0.469211699624397,0.663100113360515,9,406,positive regulation of defense response,BP,FADD;PRKACB;PYCARD;TYRO3;PSMB10;TICAM1;HRAS;WNT5A;PIK3CG
13946,GO:0051219,0.469359999334242,0.791133598502622,2,77,phosphoprotein binding,MF,PIK3R2;PIK3R1
4563,GO:0009411,0.469390771369943,0.749486646018815,3,123,response to UV,BP,PIK3R1;CDKN1A;AKT1
21004,GO:2000108,0.46954257463907,0.870641676290739,1,30,positive regulation of leukocyte apoptotic process,BP,WNT5A
10757,GO:0042311,0.470853357009288,0.869829702383547,1,30,vasodilation,BP,ADORA1
13337,GO:0048665,0.471179824833194,0.869626971571391,1,30,neuron fate specification,BP,DLL1
4599,GO:0009615,0.471213411898716,0.677725895231321,7,310,response to virus,BP,PMAIP1;FADD;PYCARD;TICAM1;RNASEL;ACTA2;PIM2
17788,GO:0097178,0.471607665057261,0.869360989254423,1,30,ruffle assembly,BP,HRAS
14348,GO:0051954,0.471813771498283,0.869232733798088,1,30,positive regulation of amine transport,BP,GDNF
3360,GO:0006658,0.471931198169305,0.869159626315519,1,30,phosphatidylserine metabolic process,BP,PLA2G16
13248,GO:0048488,0.472464988815994,0.86870965753511,1,31,synaptic vesicle endocytosis,BP,SYT5
1234,GO:0002714,0.473031065348841,0.868473619771348,1,30,positive regulation of B cell mediated immunity,BP,CLCF1
1346,GO:0002891,0.473031065348841,0.868473619771348,1,30,positive regulation of immunoglobulin mediated immune response,BP,CLCF1
18654,GO:1901020,0.47347534150493,0.868195875009347,1,30,negative regulation of calcium ion transmembrane transporter activity,BP,CASQ2
785,GO:0001963,0.47388866287993,0.867937149927334,1,30,synaptic transmission, dopaminergic,BP,GDNF
6168,GO:0016874,0.473970805759268,0.719045614176208,4,170,ligase activity,MF,ACSF2;ACSM5;ACAT1;ACSL4
8351,GO:0032228,0.474137358093867,0.8676632037407,1,31,regulation of synaptic transmission, GABAergic,BP,ADORA1
15494,GO:0061418,0.475034486709087,0.786705978803041,2,76,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1;PSMB10
13968,GO:0051250,0.475065580550854,0.744677017756454,3,123,negative regulation of lymphocyte activation,BP,TYRO3;SDC4;BMP4
3529,GO:0006911,0.475185972396739,0.867004376245188,1,31,phagocytosis, engulfment,BP,MFGE8
1084,GO:0002456,0.475283458946439,0.786509015216922,2,76,T cell mediated immunity,BP,RAB27A;FADD
4000,GO:0008200,0.475702225429766,0.866679263279994,1,31,ion channel inhibitor activity,MF,WNK4
13249,GO:0048489,0.475727966570364,0.744075696606218,3,125,synaptic vesicle transport,BP,SYT5;RAB27A;WNT7A
17942,GO:0097480,0.475727966570364,0.744075696606218,3,125,establishment of synaptic vesicle localization,BP,SYT5;RAB27A;WNT7A
18276,GO:0099003,0.475727966570364,0.744075696606218,3,125,vesicle-mediated transport in synapse,BP,SYT5;RAB27A;WNT7A
11427,GO:0043489,0.475749064115855,0.866649741558538,1,31,RNA stabilization,BP,GDNF
4670,GO:0009890,0.475762411304069,0.599080555976949,31,1465,negative regulation of biosynthetic process,BP,WNT4;NOTCH1;APOC1;ZFPM1;SALL4;DKK3;EDN1;ACADVL;RGN;PDGFB;WNT5A;SESN2;AXIN1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;NAB2;INHBB;TLE1;GAS6;SIN3B;GLA;VDR;FZD8;HEY1
1007,GO:0002323,0.475858436125956,0.866699733075872,1,30,natural killer cell activation involved in immune response,BP,RAB27A
1047,GO:0002385,0.47596613801801,0.866631864100838,1,30,mucosal immune response,BP,RAB17
20946,GO:2000008,0.476082517701557,0.86643945135101,1,31,regulation of protein localization to cell surface,BP,ACTN2
11112,GO:0042982,0.476488209657365,0.866183321992628,1,31,amyloid precursor protein metabolic process,BP,ABCG1
10844,GO:0042462,0.476652451842966,0.866079541167352,1,31,eye photoreceptor cell development,BP,MYO7A
8047,GO:0031640,0.476697041769789,0.86617070351911,1,30,killing of cells of other organism,BP,CHGA
11767,GO:0044364,0.476697041769789,0.86617070351911,1,30,disruption of cells of other organism,BP,CHGA
4092,GO:0008344,0.476949754696556,0.78511674077962,2,78,adult locomotory behavior,BP,SPTBN4;GDNF
5835,GO:0016247,0.477032503014316,0.742981226169029,3,124,channel regulator activity,MF,TSPAN13;FXYD1;WNK4
21100,GO:2000279,0.477955813450023,0.865254171739938,1,31,negative regulation of DNA biosynthetic process,BP,RGN
7778,GO:0031113,0.478510404438116,0.864901996440617,1,31,regulation of microtubule polymerization,BP,PSRC1
3142,GO:0006367,0.478526900192409,0.714980847362448,4,173,transcription initiation from RNA polymerase II promoter,BP,NOTCH1;CTGF;HNF1A;VDR
7447,GO:0030449,0.478962804258104,0.864614283149658,1,31,regulation of complement activation,BP,CFB
13112,GO:0048147,0.479132674568989,0.864506150373967,1,31,negative regulation of fibroblast proliferation,BP,IFI30
3604,GO:0007031,0.479213620330862,0.864454604235518,1,31,peroxisome organization,BP,PLA2G16
11357,GO:0043368,0.479426093079237,0.864319242806296,1,31,positive T cell selection,BP,ZFPM1
5227,GO:0014072,0.479930838535585,0.863997337865487,1,31,response to isoquinoline alkaloid,BP,FADD
11314,GO:0043278,0.479930838535585,0.863997337865487,1,31,response to morphine,BP,FADD
18973,GO:1901976,0.480001549476284,0.863952202851017,1,31,regulation of cell cycle checkpoint,BP,AKT1
6955,GO:0021772,0.480626346741661,0.863439366097227,1,32,olfactory bulb development,BP,WNT5A
14077,GO:0051438,0.480647075901851,0.739904753518091,3,123,regulation of ubiquitin-protein transferase activity,BP,PSMB10;MAGEC2;AXIN1
11628,GO:0044091,0.48091492092546,0.863254596192159,1,32,membrane biogenesis,BP,CDH2
5937,GO:0016460,0.481311734496642,0.862893288758577,1,33,myosin II complex,CC,MYH11
6116,GO:0016788,0.481566361162428,0.623128509544663,15,697,hydrolase activity, acting on ester bonds,MF,FASN;ADORA1;RGN;PTPN7;PLA2G16;PFKFB3;RNASEL;ANG;NUDT7;PON2;MDP1;ACP5;LYPLAL1;DUSP5;PDE4B
8370,GO:0032269,0.482122302863924,0.607426643995985,21,986,negative regulation of cellular protein metabolic process,BP,LIF;GADD45A;SERPINA5;EDN1;PYCARD;PSMB10;RGN;PRR5L;PRKAR1B;SESN2;ANG;BMP7;BMP4;CDKN1A;NOL3;DEPTOR;AKT1;CST9L;TFPI;GAS6;DUSP5
3108,GO:0006308,0.482130626113662,0.862588753673106,1,31,DNA catabolic process,BP,RGN
15734,GO:0070098,0.482317062536387,0.780904865814505,2,76,chemokine-mediated signaling pathway,BP,EDN1;CCL20
18032,GO:0097730,0.482341958674779,0.738391314606353,3,126,non-motile cilium,CC,RAB27A;SPTBN5;MYO7A
2999,GO:0006110,0.482397843055953,0.862302600747012,1,32,regulation of glycolytic process,BP,ACTN3
1231,GO:0002711,0.483017056402988,0.862018541861768,1,31,positive regulation of T cell mediated immunity,BP,FADD
4109,GO:0008378,0.48317772137969,0.861915030685048,1,31,galactosyltransferase activity,MF,B3GNT2
10289,GO:0036257,0.4834252161893,0.861755481365943,1,31,multivesicular body organization,BP,RAB27A
699,GO:0001844,0.483615474049011,0.861632750644347,1,31,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
11923,GO:0044803,0.483858149580895,0.861476106077442,1,31,multi-organism membrane organization,BP,GAS6
18369,GO:0099622,0.484177818526916,0.861154361205376,1,32,cardiac muscle cell membrane repolarization,BP,KCNH2
8671,GO:0032689,0.484280990913546,0.861202897048723,1,31,negative regulation of interferon-gamma production,BP,GAS6
14743,GO:0060147,0.485298123099647,0.860428556333424,1,32,regulation of posttranscriptional gene silencing,BP,BMP4
15269,GO:0060966,0.485298123099647,0.860428556333424,1,32,regulation of gene silencing by RNA,BP,BMP4
4515,GO:0009262,0.485502723433429,0.860411578077665,1,31,deoxyribonucleotide metabolic process,BP,DERA
12001,GO:0045070,0.485972469987889,0.859990509958289,1,32,positive regulation of viral genome replication,BP,NOTCH1
2565,GO:0005310,0.486091489978374,0.859913105492836,1,32,dicarboxylic acid transmembrane transporter activity,MF,SLC1A3
19867,GO:1903959,0.486186834630159,0.859851078596445,1,32,regulation of anion transmembrane transport,BP,AKT1
14196,GO:0051656,0.486580936694808,0.646713306033711,9,416,establishment of organelle localization,BP,SYT5;RAB27A;WNT7A;FGF10;PSRC1;CHGA;RAB17;MYO7A;PIK3CG
5836,GO:0016248,0.486686287556705,0.859525871468015,1,32,channel inhibitor activity,MF,WNK4
14194,GO:0051653,0.487568988681807,0.858840290927243,1,33,spindle localization,BP,FGF10
19427,GO:1903046,0.4878203496626,0.706673428838946,4,174,meiotic cell cycle process,BP,LIF;WNT4;WNT5A;PIM2
13692,GO:0050832,0.488485415225806,0.858467628933483,1,31,defense response to fungus,BP,CHGA
21080,GO:2000249,0.488677017229942,0.858224877505626,1,32,regulation of actin cytoskeleton reorganization,BP,HRAS
16633,GO:0071674,0.488805135655924,0.775629361123556,2,77,mononuclear cell migration,BP,CCL20;PDGFB
15293,GO:0060996,0.489030852613486,0.775305470948579,2,81,dendritic spine development,BP,WNT7A;ACSL4
12595,GO:0046329,0.489121512576068,0.857933343071651,1,32,negative regulation of JNK cascade,BP,AKT1
3646,GO:0007098,0.489253746701132,0.775157958639617,2,80,centrosome cycle,BP,RAB6C;GADD45A
3987,GO:0008180,0.489643229357545,0.857590673184574,1,32,COP9 signalosome,CC,AMOT
948,GO:0002224,0.489781462040253,0.731947906435384,3,126,toll-like receptor signaling pathway,BP,FADD;TYRO3;TICAM1
21087,GO:2000257,0.490127158979104,0.857272351096899,1,32,regulation of protein activation cascade,BP,CFB
18793,GO:1901385,0.490783964484028,0.856839587338225,1,32,regulation of voltage-gated calcium channel activity,BP,PDE4B
21026,GO:2000146,0.490900291910142,0.684862332726812,5,224,negative regulation of cell motility,BP,WNT4;NOTCH1;ADORA1;RGN;RHOB
7071,GO:0021988,0.491516411523468,0.856244636039109,1,33,olfactory lobe development,BP,WNT5A
12000,GO:0045069,0.491536713886286,0.773331462161102,2,79,regulation of viral genome replication,BP,NOTCH1;RNASEL
18183,GO:0098815,0.491621200277323,0.856175319641143,1,33,modulation of excitatory postsynaptic potential,BP,WNT7A
8037,GO:0031624,0.49177265555358,0.856075096197905,1,33,ubiquitin conjugating enzyme binding,MF,RNF144A
14609,GO:0055090,0.4922212000517,0.855889681838104,1,32,acylglycerol homeostasis,BP,SESN2
15878,GO:0070328,0.4922212000517,0.855889681838104,1,32,triglyceride homeostasis,BP,SESN2
9414,GO:0034381,0.492434459569402,0.855748390844177,1,32,plasma lipoprotein particle clearance,BP,APOC1
5177,GO:0014009,0.492911152954889,0.855320281447506,1,33,glial cell proliferation,BP,NOTCH1
3235,GO:0006506,0.493106954208045,0.855302262154874,1,32,GPI anchor biosynthetic process,BP,DPM3
11403,GO:0043433,0.493178406896335,0.728962514765826,3,127,negative regulation of sequence-specific DNA binding transcription factor activity,BP,PYCARD;BMP7;GAS6
742,GO:0001912,0.493694305555492,0.854911895386907,1,32,positive regulation of leukocyte mediated cytotoxicity,BP,FADD
18834,GO:1901566,0.493780537399646,0.584966310663376,28,1317,organonitrogen compound biosynthetic process,BP,PNMT;MRPL14;MRPL16;MRI1;MRAP;GUCY1B3;EXTL1;EDN1;PNP;BDH2;MGST2;PDGFB;NNMT;SESN2;NPR1;SDC4;ANG;BMP4;ACAT1;B3GNT2;TSFM;FABP3;PCBD1;AKT1;NPPC;PTS;RBMS3;SLC1A3
5748,GO:0016056,0.493832546531647,0.854819919450603,1,32,rhodopsin mediated signaling pathway,BP,NMT2
14928,GO:0060401,0.494190886556196,0.728021246665149,3,130,cytosolic calcium ion transport,BP,CASQ2;NOL3;CTGF
13940,GO:0051204,0.494327297174,0.854490440821807,1,32,protein insertion into mitochondrial membrane,BP,PMAIP1
11974,GO:0045026,0.49527183061345,0.853860100358729,1,32,plasma membrane fusion,BP,SERPINA5
2124,GO:0004623,0.495350656223171,0.853807416610511,1,32,phospholipase A2 activity,MF,PLA2G16
2544,GO:0005254,0.495850488094463,0.769756913343803,2,80,chloride channel activity,MF,TTYH1;FXYD1
17029,GO:0072376,0.496057940600248,0.769621225524851,2,79,protein activation cascade,BP,CFB;TFPI
11255,GO:0043198,0.4964791256762,0.852938341216049,1,33,dendritic shaft,CC,LZTS1
1885,GO:0004197,0.49678942410219,0.768982549409888,2,80,cysteine-type endopeptidase activity,MF,PYCARD;CASP4
7630,GO:0030865,0.497246270355361,0.852422943103734,1,33,cortical cytoskeleton organization,BP,RHOQ
962,GO:0002251,0.497957883610536,0.852057981679627,1,32,organ or tissue specific immune response,BP,RAB17
7321,GO:0030224,0.498124274636228,0.851831643900376,1,33,monocyte differentiation,BP,BMP4
19462,GO:1903131,0.498124274636228,0.851831643900376,1,33,mononuclear cell differentiation,BP,BMP4
11941,GO:0044853,0.498150830042126,0.76778895115911,2,82,plasma membrane raft,CC,CDH2;CDH1
9766,GO:0035307,0.498157702955327,0.851809101311561,1,33,positive regulation of protein dephosphorylation,BP,ADORA1
17466,GO:0090218,0.49884479475957,0.851345268603477,1,33,positive regulation of lipid kinase activity,BP,PDGFB
17800,GO:0097194,0.49894695235276,0.767197857562557,2,80,execution phase of apoptosis,BP,CASP4;AKT1
3000,GO:0006111,0.49936922597093,0.850990615534241,1,33,regulation of gluconeogenesis,BP,SESN2
161,GO:0000313,0.499538968613558,0.766778967186731,2,78,organellar ribosome,CC,MRPL14;MRPL16
2775,GO:0005761,0.499538968613558,0.766778967186731,2,78,mitochondrial ribosome,CC,MRPL14;MRPL16
5813,GO:0016209,0.49965940723229,0.766642496642694,2,79,antioxidant activity,MF,MGST2;SESN2
12771,GO:0046683,0.500020548157634,0.722902279737907,3,129,response to organophosphorus,BP,WT1;STAR;PIK3CG
15983,GO:0070507,0.50038843565042,0.722558659600678,3,130,regulation of microtubule cytoskeleton organization,BP,RAB6C;PSRC1;CAMSAP3
6763,GO:0019905,0.50044132304705,0.765922578574449,2,81,syntaxin binding,MF,SYT5;VAMP1
2536,GO:0005246,0.500839729730625,0.849993268527155,1,33,calcium channel regulator activity,MF,TSPAN13
4585,GO:0009581,0.50157390244148,0.721507827417576,3,130,detection of external stimulus,BP,NMT2;ADORA1;UNC119
6751,GO:0019887,0.502148492602342,0.693657816853039,4,176,protein kinase regulator activity,MF,PRKAR1B;CDKN1A;PIK3CA;GAS6
12195,GO:0045494,0.503148880414035,0.848308920520492,1,34,photoreceptor cell maintenance,BP,CDH23
9774,GO:0035329,0.503413252302992,0.848024489842084,1,35,hippo signaling,BP,AMOT
1206,GO:0002686,0.503434079648516,0.848223229146402,1,33,negative regulation of leukocyte migration,BP,ADORA1
17647,GO:0090630,0.503491463372241,0.763345065135229,2,82,activation of GTPase activity,BP,TBC1D14;WNT5A
9714,GO:0035196,0.503654532718532,0.847962448713854,1,34,production of miRNAs involved in gene silencing by miRNA,BP,BMP4
13735,GO:0050892,0.503661550390245,0.848067394762088,1,33,intestinal absorption,BP,VDR
19474,GO:1903170,0.50373278498516,0.848018572552133,1,33,negative regulation of calcium ion transmembrane transport,BP,CASQ2
4747,GO:0010165,0.503814160431454,0.847852966287069,1,34,response to X-ray,BP,CDKN1A
3234,GO:0006505,0.503833581362447,0.847949472227988,1,33,GPI anchor metabolic process,BP,DPM3
4968,GO:0010742,0.50398733459458,0.847734135383155,1,34,macrophage derived foam cell differentiation,BP,ABCG1
17365,GO:0090077,0.50398733459458,0.847734135383155,1,34,foam cell differentiation,BP,ABCG1
5144,GO:0010972,0.504908982115183,0.762227371697927,2,80,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB10;FOXO4
6746,GO:0019882,0.505307399334012,0.671507049382417,5,223,antigen processing and presentation,BP,RAB27A;IFI30;ITGB5;PYCARD;PSMB10
1291,GO:0002819,0.505347239309068,0.718186742713806,3,128,regulation of adaptive immune response,BP,FADD;PYCARD;CLCF1
11971,GO:0045022,0.505371837928393,0.846781944824195,1,34,early endosome to late endosome transport,BP,MSN
10522,GO:0038179,0.505929450868009,0.846397363933461,1,34,neurotrophin signaling pathway,BP,BCAR1
13298,GO:0048588,0.506085154820292,0.689976550041377,4,182,developmental cell growth,BP,WNT3;EDN1;WNT5A;DDR1
12803,GO:0046777,0.506206404101635,0.670608692228044,5,230,protein autophosphorylation,BP,TYRO3;PDGFB;DDR1;AKT1;PIM2
14705,GO:0060078,0.506826750828972,0.716775670357555,3,133,regulation of postsynaptic membrane potential,BP,WNT7A;ADORA1;GRIA3
9431,GO:0034405,0.507115175715583,0.845577507436055,1,34,response to fluid shear stress,BP,AKT1
13372,GO:0048709,0.507206426122309,0.760226864573485,2,82,oligodendrocyte differentiation,BP,NOTCH1;TSPAN2
8013,GO:0031572,0.507821127779879,0.845088043600311,1,34,G2 DNA damage checkpoint,BP,FOXO4
13917,GO:0051172,0.508268619910989,0.567113491510121,31,1487,negative regulation of nitrogen compound metabolic process,BP,WNT4;ACTN3;NOTCH1;APOC1;ZFPM1;SALL4;DKK3;EDN1;RGN;PDGFB;WNT5A;SESN2;AXIN1;ANG;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;PKP3;PKP1;NPPC;NAB2;TLE1;GAS6;SIN3B;GLA;VDR;FZD8;HEY1
21094,GO:2000272,0.508376231947195,0.84470246430615,1,34,negative regulation of receptor activity,BP,CASQ2
4932,GO:0010677,0.508380353781039,0.844699598930447,1,34,negative regulation of cellular carbohydrate metabolic process,BP,ACTN3
18115,GO:0098659,0.508444388300167,0.844655079651055,1,34,inorganic cation import into cell,BP,TF
18358,GO:0099587,0.508444388300167,0.844655079651055,1,34,inorganic ion import into cell,BP,TF
336,GO:0000922,0.50863677751603,0.715189355470673,3,131,spindle pole,CC,PSRC1;FAM110C;UNC119
484,GO:0001505,0.50865198541866,0.687632788604753,4,180,regulation of neurotransmitter levels,BP,SYT5;WNT7A;GDNF;SLC1A3
10697,GO:0042176,0.509393348940534,0.632535125155643,8,371,regulation of protein catabolic process,BP,PSMB10;RGN;WNT5A;AXIN1;MSN;AKT1;ARAF;RNF144A
3902,GO:0008037,0.50945592104028,0.714454172045626,3,131,cell recognition,BP,MFGE8;MSN;LAMA5
10818,GO:0042417,0.509953393799304,0.843603567068377,1,34,dopamine metabolic process,BP,NPR1
18980,GO:1901985,0.510204734647659,0.843427979811285,1,34,positive regulation of protein acetylation,BP,LIF
739,GO:0001909,0.510509819096114,0.75747018887981,2,81,leukocyte mediated cytotoxicity,BP,RAB27A;FADD
12222,GO:0045581,0.510560401883555,0.843179291623749,1,34,negative regulation of T cell differentiation,BP,BMP4
17065,GO:0072507,0.510584268880116,0.623682045199196,9,422,divalent inorganic cation homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;RGN;HEXB;NOL3;PIK3CG;VDR
4492,GO:0009225,0.511635585756708,0.842425948597594,1,34,nucleotide-sugar metabolic process,BP,GALT
7272,GO:0030165,0.511885760864984,0.756200162489475,2,84,PDZ domain binding,MF,FZD7;FZD8
14253,GO:0051781,0.512530811540806,0.755718867001035,2,82,positive regulation of cell division,BP,PDGFB;FGF8
12345,GO:0045777,0.51261133877934,0.841740243950852,1,34,positive regulation of blood pressure,BP,ADORA1
14008,GO:0051302,0.51276484488404,0.711475002726252,3,131,regulation of cell division,BP,PDGFB;FGF8;DLL1
8514,GO:0032459,0.512952996236179,0.841499689014311,1,34,regulation of protein oligomerization,BP,PMAIP1
19543,GO:1903311,0.513019601309706,0.711245008432519,3,131,regulation of mRNA metabolic process,BP,PRR5L;PKP3;PKP1
7904,GO:0031347,0.513422539465277,0.595587608952546,14,661,regulation of defense response,BP,CFB;FADD;ADORA1;PRKACB;PYCARD;TYRO3;PSMB10;TICAM1;HRAS;WNT5A;NMI;SHPK;CASP4;PIK3CG
7729,GO:0031050,0.514042354470052,0.840623576098925,1,35,dsRNA fragmentation,BP,BMP4
16195,GO:0070918,0.514042354470052,0.840623576098925,1,35,production of small RNA involved in gene silencing by RNA,BP,BMP4
6753,GO:0019894,0.514114780229468,0.840572362552288,1,35,kinesin binding,MF,SPTBN5
3395,GO:0006699,0.51431732137497,0.840536723334376,1,34,bile acid biosynthetic process,BP,STAR
7774,GO:0031109,0.514364748930808,0.754121194212179,2,83,microtubule polymerization or depolymerization,BP,TUBG2;PSRC1
2662,GO:0005547,0.514485751131878,0.840309874645704,1,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,AKT1
21657,GO:2001258,0.515092520804089,0.839987882556257,1,34,negative regulation of cation channel activity,BP,CASQ2
3513,GO:0006890,0.515590986575549,0.753072680673385,2,83,retrograde vesicle-mediated transport, Golgi to ER,BP,USE1;RAB6C
13058,GO:0048002,0.516014539329614,0.680824943530786,4,178,antigen processing and presentation of peptide antigen,BP,IFI30;ITGB5;PYCARD;PSMB10
4586,GO:0009582,0.517174167816698,0.707445964954112,3,133,detection of abiotic stimulus,BP,NMT2;ADORA1;UNC119
21022,GO:2000142,0.517473404060241,0.838185641687261,1,35,regulation of DNA-templated transcription, initiation,BP,HNF1A
3023,GO:0006165,0.517819965003789,0.751160460445735,2,83,nucleoside diphosphate phosphorylation,BP,ACTN3;PFKFB3
19295,GO:1902750,0.518178846704604,0.750886402534334,2,82,negative regulation of cell cycle G2/M phase transition,BP,PSMB10;FOXO4
6129,GO:0016811,0.518588729872869,0.750499055855678,2,83,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,ASAH2;SIN3B
7220,GO:0030072,0.519364635981839,0.658183005881732,5,231,peptide hormone secretion,BP,ADRA2C;EDN1;RBP4;INHBB;KCNG2
3478,GO:0006836,0.520154509450041,0.676897641776206,4,183,neurotransmitter transport,BP,SYT5;WNT7A;GDNF;SLC1A3
8554,GO:0032507,0.520163475128082,0.749074181985186,2,85,maintenance of protein location in cell,BP,SPTBN4;AKT1
13958,GO:0051235,0.520381672884708,0.642593633938236,6,284,maintenance of location,BP,CASQ2;ABCG1;SPTBN4;HEXB;NOL3;AKT1
2641,GO:0005516,0.520922822253035,0.676112249400964,4,189,calmodulin binding,MF,CAMSAP3;RRAD;MYO7A;MYH11
14671,GO:0060041,0.520962273815036,0.703958572973864,3,135,retina development in camera-type eye,BP,RBP4;RHOJ;DLL1
6835,GO:0021537,0.521033794236397,0.656562697765367,5,235,telencephalon development,BP,CDH2;WNT5A;FGF8;BMP4;BMP2
7118,GO:0022617,0.521156741185971,0.748215460198046,2,85,extracellular matrix disassembly,BP,DDR1;CDH1
3171,GO:0006414,0.522130966054784,0.702978545868998,3,130,translational elongation,BP,MRPL14;MRPL16;TSFM
8599,GO:0032589,0.522309975424881,0.834603279834059,1,36,neuron projection membrane,CC,ADORA1
9112,GO:0033572,0.522375395453408,0.834660531864889,1,35,transferrin transport,BP,TF
141,GO:0000281,0.522545382345937,0.834432686459191,1,36,mitotic cytokinesis,BP,SNX18
17723,GO:0097060,0.523559381522969,0.639526830522582,6,285,synaptic membrane,CC,ITGA3;ADORA1;DRP2;GRIA3;LZTS1;SHC4
8889,GO:0033017,0.523734058553846,0.833470083853814,1,37,sarcoplasmic reticulum membrane,CC,CASQ2
1240,GO:0002720,0.52397303747331,0.833500886777862,1,35,positive regulation of cytokine production involved in immune response,BP,WNT5A
7591,GO:0030816,0.524045500502489,0.745742165794021,2,84,positive regulation of cAMP metabolic process,BP,MRAP;CHGA
20709,GO:1990138,0.525144263613353,0.700089448400212,3,137,neuron projection extension,BP,WNT3;WNT5A;DDR1
3358,GO:0006656,0.525396336505408,0.832463310658521,1,35,phosphatidylcholine biosynthetic process,BP,FABP3
12251,GO:0045621,0.52700945385762,0.743156092805388,2,84,positive regulation of lymphocyte differentiation,BP,PNP;GAS6
5023,GO:0010824,0.527010967195831,0.83117472351072,1,36,regulation of centrosome duplication,BP,RAB6C
18304,GO:0099106,0.528123407682858,0.742146655720037,2,85,ion channel regulator activity,MF,TSPAN13;WNK4
18207,GO:0098862,0.528466409878951,0.697042227435683,3,136,cluster of actin-based cell projections,CC,CDH23;ESPN;MYO7A
4812,GO:0010470,0.528628096540404,0.829984618655468,1,36,regulation of gastrulation,BP,FZD7
6262,GO:0017080,0.528920893852746,0.829768550447807,1,36,sodium channel regulator activity,MF,FXYD1
13971,GO:0051253,0.529242684390493,0.554001364528693,25,1206,negative regulation of RNA metabolic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;RGN;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;PKP3;PKP1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
21645,GO:2001243,0.529417464045801,0.741044338483775,2,84,negative regulation of intrinsic apoptotic signaling pathway,BP,NOL3;AKT1
431,GO:0001105,0.529580168708711,0.829179840409618,1,37,RNA polymerase II transcription coactivator activity,MF,POU3F1
14870,GO:0060333,0.529651459651449,0.740838616193988,2,84,interferon-gamma-mediated signaling pathway,BP,IFI30;NMI
12768,GO:0046676,0.529992663761276,0.828976102697428,1,36,negative regulation of insulin secretion,BP,INHBB
19909,GO:1904036,0.530097202799141,0.82889867867807,1,36,negative regulation of epithelial cell apoptotic process,BP,GAS6
4851,GO:0010559,0.530811371869034,0.828369131066846,1,36,regulation of glycoprotein biosynthetic process,BP,HBEGF
14183,GO:0051640,0.531121236911026,0.596984785950246,10,482,organelle localization,BP,SYT5;RAB27A;WNT7A;CDH2;FGF10;PSRC1;CHGA;RAB17;MYO7A;PIK3CG
5963,GO:0016504,0.531553695286233,0.8278175641099,1,36,peptidase activator activity,MF,PYCARD
8283,GO:0032094,0.531832068227099,0.827610424444149,1,36,response to food,BP,AKT1
14173,GO:0051607,0.531853984964425,0.646218941169351,5,231,defense response to virus,BP,PMAIP1;FADD;PYCARD;TICAM1;RNASEL
11699,GO:0044264,0.531857172885802,0.738827671860817,2,86,cellular polysaccharide metabolic process,BP,B3GNT2;AKT1
3477,GO:0006835,0.532169979298005,0.738551316792881,2,86,dicarboxylic acid transport,BP,ADORA1;SLC1A3
9324,GO:0034198,0.532239549055669,0.827306918306235,1,36,cellular response to amino acid starvation,BP,CDKN1A
3442,GO:0006778,0.532910051885244,0.826806737264153,1,36,porphyrin-containing compound metabolic process,BP,BDH2
8685,GO:0032715,0.532927936193299,0.826793382873932,1,36,negative regulation of interleukin-6 production,BP,GAS6
18247,GO:0098927,0.533474911666413,0.826281674404352,1,37,vesicle-mediated transport between endosomal compartments,BP,MSN
11537,GO:0043666,0.53376027393519,0.826068064310879,1,37,regulation of phosphoprotein phosphatase activity,BP,RGN
330,GO:0000910,0.534159475780717,0.691738044656122,3,137,cytokinesis,BP,RALB;SNX18;RHOB
16428,GO:0071364,0.534282108824098,0.825676992381208,1,37,cellular response to epidermal growth factor stimulus,BP,AKT1
7900,GO:0031343,0.535379223575597,0.824956540944713,1,36,positive regulation of cell killing,BP,FADD
8055,GO:0031648,0.536172266985754,0.824255612240898,1,37,protein destabilization,BP,BMP2
15672,GO:0065003,0.536544920079495,0.53583453037998,34,1645,macromolecular complex assembly,BP,FHOD3;TUBG2;ACTN2;PMAIP1;FADD;APOC1;TRADD;CASQ2;SPTBN5;SPTBN4;PYCARD;PRND;RALB;HRAS;HACL1;AXIN1;PSRC1;ANG;SPTB;ACAT1;VAMP1;MSN;NOL3;GJB1;PCBD1;DECR1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;HNF1A;KCND1;TMOD4
7844,GO:0031267,0.536744197799062,0.626692339095392,6,289,small GTPase binding,MF,RIN3;TBC1D14;DAAM2;RAB11FIP1;RPH3AL;SH3BP4
5129,GO:0010955,0.536957814102741,0.823662641058862,1,37,negative regulation of protein processing,BP,NOL3
19548,GO:1903318,0.536957814102741,0.823662641058862,1,37,negative regulation of protein maturation,BP,NOL3
12413,GO:0045912,0.537281545039781,0.823417887525027,1,37,negative regulation of carbohydrate metabolic process,BP,ACTN3
7977,GO:0031490,0.538231551676682,0.733130723381409,2,87,chromatin DNA binding,MF,NOTCH1;HMGN5
15489,GO:0061387,0.538867976389378,0.732497713880238,2,89,regulation of extent of cell growth,BP,WNT3;WNT5A
9392,GO:0034358,0.5391731183181,0.82198328169624,1,37,plasma lipoprotein particle,CC,APOC1
20874,GO:1990777,0.5391731183181,0.82198328169624,1,37,lipoprotein particle,CC,APOC1
18857,GO:1901618,0.539919767303448,0.821414888243452,1,37,organic hydroxy compound transmembrane transporter activity,MF,ABCG1
11688,GO:0044249,0.540170402640077,0.504408065397354,122,5897,cellular biosynthetic process,BP,ITGA3;PDK4;PECR;LIF;WNT2;WNT4;POU3F1;ACTN2;ALG5;NOTCH1;PNMT;DPM3;FASN;MRPL14;MRPL16;MRI1;FADD;WNT6;WNT7A;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;HSD17B11;DKK3;EXTL1;ACSF2;EDN1;PHLDA1;PNP;ABCG1;CCL20;EBF1;BDH2;PYCARD;MBOAT2;ACADVL;PRND;MGST2;ACSM5;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;PLA2G16;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;CYP17A1;PSRC1;RNASEL;FGF8;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;HSD3B2;CTGF;PCBD1;AKT1;IFI27;PTGES;KITLG;IDH1;NPPC;NAB2;CDH1;INHBB;PTMS;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;GLA;ZCCHC12;CYP11A1;LZTS1;PTS;RBMS3;HNF1A;VDR;GDNF;ACSL4;SLC1A3;FZD8;ELOVL6;HEY1;PIM2
4390,GO:0009112,0.540425399498011,0.821029287863186,1,37,nucleobase metabolic process,BP,AOX1
1382,GO:0003009,0.540780023302505,0.820758518504236,1,37,skeletal muscle contraction,BP,ACTN3
6847,GO:0021549,0.541586999864942,0.730057314677484,2,89,cerebellum development,BP,WNT7A;DLL1
13067,GO:0048013,0.542516360992003,0.729284533015894,2,87,ephrin receptor signaling pathway,BP,HRAS;EFNB2
15067,GO:0060589,0.543399135494169,0.60857894116474,7,338,nucleoside-triphosphatase regulator activity,MF,RIN3;TBC1D14;PIK3R2;SESN2;AXIN1;GPSM1;SH3BP4
11778,GO:0044390,0.543713882871186,0.818406923081817,1,38,ubiquitin-like protein conjugating enzyme binding,MF,RNF144A
1881,GO:0004180,0.544209915854977,0.818125591967412,1,37,carboxypeptidase activity,MF,PEPD
15751,GO:0070126,0.544561556828678,0.72750528336838,2,85,mitochondrial translational termination,BP,MRPL14;MRPL16
18659,GO:1901030,0.544822918737158,0.817652331057438,1,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
14192,GO:0051650,0.545470680098517,0.632911701484017,5,239,establishment of vesicle localization,BP,SYT5;RAB27A;WNT7A;RAB17;MYO7A
4409,GO:0009135,0.545832876051453,0.726253357855437,2,88,purine nucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
4449,GO:0009179,0.545832876051453,0.726253357855437,2,88,purine ribonucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
14334,GO:0051932,0.545849304764384,0.816756319637666,1,38,synaptic transmission, GABAergic,BP,ADORA1
4669,GO:0009889,0.546004925828746,0.503521305034676,86,4178,regulation of biosynthetic process,BP,ITGA3;PDK4;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;FADD;DHH;WNT6;WNT7A;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;CCL20;EBF1;PYCARD;ACADVL;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;CTGF;PCBD1;AKT1;IFI27;KITLG;IDH1;NPPC;NAB2;CDH1;INHBB;TLE1;STAR;GAS6;SIN3B;GLA;ZCCHC12;LZTS1;DHCR7;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
7098,GO:0022408,0.546073695890804,0.680524323045683,3,137,negative regulation of cell-cell adhesion,BP,SDC4;BMP4;CDH1
3629,GO:0007067,0.546988296173116,0.587804341801788,9,438,mitotic nuclear division,BP,MARK4;EDN1;TTYH1;PDGFB;SNX18;PSRC1;FGF8;BMP7;BMP4
7482,GO:0030534,0.547422086605161,0.679191199332014,3,140,adult behavior,BP,FADD;SPTBN4;GDNF
5182,GO:0014014,0.54828804715078,0.814859055501315,1,38,negative regulation of gliogenesis,BP,NOTCH1
12271,GO:0045646,0.548359229768084,0.814803481521167,1,38,regulation of erythrocyte differentiation,BP,ZFPM1
1225,GO:0002705,0.54876624552708,0.723618348300228,2,87,positive regulation of leukocyte mediated immunity,BP,FADD;CLCF1
4874,GO:0010596,0.548932627094963,0.814355409691801,1,38,negative regulation of endothelial cell migration,BP,NOTCH1
1305,GO:0002833,0.549547234731922,0.81387433042231,1,38,positive regulation of response to biotic stimulus,BP,BMP6
12886,GO:0046939,0.549735760728137,0.722700380249791,2,88,nucleotide phosphorylation,BP,ACTN3;PFKFB3
4522,GO:0009295,0.550537197871538,0.813097691872976,1,38,nucleoid,CC,ACADVL
10965,GO:0042645,0.550537197871538,0.813097691872976,1,38,mitochondrial nucleoid,CC,ACADVL
5553,GO:0015682,0.551169825690811,0.812600252804021,1,38,ferric iron transport,BP,TF
17069,GO:0072512,0.551169825690811,0.812600252804021,1,38,trivalent inorganic cation transport,BP,TF
12324,GO:0045739,0.551681773959767,0.812197056075697,1,38,positive regulation of DNA repair,BP,FGF10
3722,GO:0007223,0.551824696152006,0.811985902024319,1,39,Wnt signaling pathway, calcium modulating pathway,BP,WNT5A
1042,GO:0002377,0.551985728328714,0.72064022643398,2,88,immunoglobulin production,BP,RBP4;CLCF1
2785,GO:0005771,0.55228482970592,0.811721360124764,1,38,multivesicular body,CC,RAB27A
7660,GO:0030902,0.552530050085449,0.674294111143367,3,141,hindbrain development,BP,WNT7A;BMP7;DLL1
3862,GO:0007603,0.552641413223075,0.811439703975255,1,38,phototransduction, visible light,BP,NMT2
3873,GO:0007618,0.552764152852862,0.811342689751,1,38,mating,BP,HEXB
7283,GO:0030176,0.553627308081963,0.673309290104026,3,137,integral component of endoplasmic reticulum membrane,CC,DPM3;DHCR7;ELOVL6
12749,GO:0046638,0.55364874204368,0.810642513747738,1,38,positive regulation of alpha-beta T cell differentiation,BP,PNP
4993,GO:0010769,0.554101684940242,0.624369439168577,5,244,regulation of cell morphogenesis involved in differentiation,BP,WNT3;WNT7A;WNT5A;LZTS1;LINGO1
18809,GO:1901505,0.554374693465954,0.810066602034407,1,38,carbohydrate derivative transporter activity,MF,ABCG1
2626,GO:0005484,0.554465648338665,0.809994362888505,1,38,SNAP receptor activity,MF,VAMP1
806,GO:0001990,0.554712512881205,0.809798202457747,1,38,regulation of systemic arterial blood pressure by hormone,BP,EDN1
12292,GO:0045668,0.554909710251464,0.809541896689081,1,39,negative regulation of osteoblast differentiation,BP,NOTCH1
10640,GO:0042088,0.555140420614951,0.809457861384378,1,38,T-helper 1 type immune response,BP,HRAS
4566,GO:0009416,0.555187525995067,0.608468774812458,6,289,response to light stimulus,BP,NMT2;PIK3R1;CDKN1A;AKT1;UNC119;SLC1A3
16747,GO:0071897,0.555378178652126,0.643028475413396,4,190,DNA biosynthetic process,BP,RGN;PDGFB;CDKN1A;CTGF
4363,GO:0009069,0.55557329362482,0.80911315478208,1,38,serine family amino acid metabolic process,BP,GLDC
3210,GO:0006470,0.555734226916486,0.622773935821898,5,241,protein dephosphorylation,BP,ADORA1;RGN;PTPN7;MDP1;DUSP5
10921,GO:0042578,0.556105952936786,0.595906422812834,7,340,phosphoric ester hydrolase activity,MF,ADORA1;PTPN7;PFKFB3;MDP1;ACP5;DUSP5;PDE4B
5458,GO:0015276,0.557623196561954,0.669373456598225,3,142,ligand-gated ion channel activity,MF,KCNK6;KCNH2;GRIA3
7133,GO:0022834,0.557623196561954,0.669373456598225,3,142,ligand-gated channel activity,MF,KCNK6;KCNH2;GRIA3
3927,GO:0008081,0.557662197180377,0.715338829575849,2,90,phosphoric diester hydrolase activity,MF,ADORA1;PDE4B
17541,GO:0090317,0.557946965801306,0.715074616639164,2,90,negative regulation of intracellular protein transport,BP,BMP7;GAS6
14100,GO:0051480,0.558068073871625,0.605578609564152,6,291,regulation of cytosolic calcium ion concentration,BP,CDH23;CASQ2;EDN1;LPAR2;NOL3;PIK3CG
158,GO:0000307,0.558215911308483,0.806899057165897,1,39,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A
4455,GO:0009185,0.558345793908994,0.714704339653755,2,90,ribonucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
4894,GO:0010629,0.558369471654698,0.51476986716774,33,1614,negative regulation of gene expression,BP,WNT4;NOTCH1;ITGB8;ZFPM1;SALL4;DKK3;EDN1;PRR5L;PDGFB;HRAS;WNT5A;SESN2;AXIN1;ANG;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;NOL3;CTGF;AKT1;IFI27;PKP3;PKP1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
8873,GO:0032994,0.558400907370463,0.806750453833826,1,39,protein-lipid complex,CC,APOC1
21157,GO:2000351,0.55888916326116,0.806357878215369,1,39,regulation of endothelial cell apoptotic process,BP,GAS6
17504,GO:0090276,0.559439854100782,0.639020154291022,4,191,regulation of peptide hormone secretion,BP,ADRA2C;RBP4;INHBB;KCNG2
370,GO:0000988,0.559549989985927,0.557812442754599,12,590,transcription factor activity, protein binding,MF,LIF;WNT4;POU3F1;ACTN2;NOTCH1;NMI;PCBD1;NAB2;TLE1;SIN3B;ZCCHC12;HEY1
18927,GO:1901800,0.560648957798991,0.71256061639205,2,90,positive regulation of proteasomal protein catabolic process,BP,AKT1;RNF144A
13980,GO:0051262,0.561110224896204,0.66602765707762,3,140,protein tetramerization,BP,ACTN2;PCBD1;DECR1
2535,GO:0005245,0.561268966820949,0.80424842529016,1,41,voltage-gated calcium channel activity,MF,GAS6
4850,GO:0010558,0.561598308210946,0.517153486975041,28,1374,negative regulation of macromolecule biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;RGN;PDGFB;WNT5A;SESN2;AXIN1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
12743,GO:0046632,0.561934547265476,0.711359984164584,2,90,alpha-beta T cell differentiation,BP,ZFPM1;PNP
2187,GO:0004712,0.562294606838526,0.803507950029944,1,40,protein serine/threonine/tyrosine kinase activity,MF,AKT1
747,GO:0001917,0.563025857189983,0.80291311810964,1,40,photoreceptor inner segment,CC,MYO7A
5371,GO:0015108,0.563217151421383,0.710127523851418,2,91,chloride transmembrane transporter activity,MF,TTYH1;FXYD1
19177,GO:1902476,0.563217151421383,0.710127523851418,2,91,chloride transmembrane transport,BP,TTYH1;FXYD1
7221,GO:0030073,0.563396883322209,0.635083752161068,4,193,insulin secretion,BP,ADRA2C;RBP4;INHBB;KCNG2
2062,GO:0004540,0.563433928575596,0.709956021408192,2,90,ribonuclease activity,MF,RNASEL;ANG
7833,GO:0031253,0.563522909013748,0.600080528187689,6,295,cell projection membrane,CC,ITGA3;ITGA5;ADORA1;SPTBN5;TTYH1;MSN
1968,GO:0004407,0.563539545182831,0.802494533289505,1,40,histone deacetylase activity,MF,SIN3B
9102,GO:0033558,0.563539545182831,0.802494533289505,1,40,protein deacetylase activity,MF,SIN3B
5309,GO:0014888,0.563777773727989,0.802300205777889,1,40,striated muscle adaptation,BP,ACTN3
5657,GO:0015872,0.563962697621932,0.802246646719076,1,39,dopamine transport,BP,GDNF
9059,GO:0033365,0.564180211177138,0.532522697113143,18,884,protein localization to organelle,BP,LIF;TSPAN17;PMAIP1;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;MSN;NOL3;AKT1;CDH1;GAS6;SH3BP4;CLDN18
10843,GO:0042461,0.564778699149716,0.80148231672645,1,40,photoreceptor cell development,BP,MYO7A
10214,GO:0036064,0.564928386088794,0.708489756984352,2,92,ciliary basal body,CC,MARK4;AKT1
7770,GO:0031103,0.564982456820895,0.801315539217058,1,40,axon regeneration,BP,JAM3
10805,GO:0042398,0.56512592369072,0.801295800148428,1,39,cellular modified amino acid biosynthetic process,BP,MGST2
3656,GO:0007140,0.565143178342899,0.801183920193475,1,40,male meiosis,BP,PIM2
3754,GO:0007283,0.565582085191686,0.562414268506261,10,488,spermatogenesis,BP,NOTCH1;DHH;SERPINA5;TYRO3;RGN;FSTL3;JAM3;SLC2A14;JAG2;CLDN11
961,GO:0002250,0.565835934767415,0.586112108741566,7,338,adaptive immune response,BP,RAB27A;FADD;PYCARD;HRAS;JAM3;CLCF1;PIK3CG
3229,GO:0006497,0.565846345373375,0.66139217441492,3,141,protein lipidation,BP,DPM3;NMT2;PRND
17152,GO:0072665,0.565900202441552,0.800563178266835,1,40,protein localization to vacuole,BP,SH3BP4
8198,GO:0031952,0.565971760289166,0.800504434596331,1,40,regulation of protein autophosphorylation,BP,PDGFB
3602,GO:0007029,0.566547801037625,0.800031120174663,1,40,endoplasmic reticulum organization,BP,REEP1
5562,GO:0015696,0.566624209326211,0.706955582781173,2,90,ammonium transport,BP,EDN1;GDNF
10631,GO:0042059,0.567216983915936,0.799480317200061,1,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,EPN1
12073,GO:0045185,0.56742987296786,0.706101099105522,2,93,maintenance of protein location,BP,SPTBN4;AKT1
3228,GO:0006493,0.567640905720786,0.705871676771642,2,94,protein O-linked glycosylation,BP,DPM3;B3GNT2
4883,GO:0010611,0.567858767963241,0.798857323068797,1,41,regulation of cardiac muscle hypertrophy,BP,EDN1
7593,GO:0030818,0.567993400137849,0.798839960118209,1,40,negative regulation of cAMP biosynthetic process,BP,EDN1
13145,GO:0048232,0.568211441781752,0.559734764958532,10,489,male gamete generation,BP,NOTCH1;DHH;SERPINA5;TYRO3;RGN;FSTL3;JAM3;SLC2A14;JAG2;CLDN11
6612,GO:0019432,0.568805387774022,0.798168779465718,1,40,triglyceride biosynthetic process,BP,RGN
13808,GO:0051018,0.568931572211922,0.797880647462991,1,42,protein kinase A binding,MF,PRKAR1B
6475,GO:0019058,0.569035611554872,0.565552614812839,9,438,viral life cycle,BP,ITGA5;NOTCH1;ITGB5;NMT2;TYRO3;RNASEL;CLDN1;GAS6;EFNB2
21018,GO:2000134,0.569160433437147,0.704493905676396,2,92,negative regulation of G1/S transition of mitotic cell cycle,BP,GADD45A;CDKN1A
13717,GO:0050868,0.569226987134588,0.704462226066843,2,91,negative regulation of T cell activation,BP,SDC4;BMP4
6065,GO:0016706,0.5692473761319,0.797708599003574,1,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,PHYH
20980,GO:2000060,0.569424158536571,0.70430740655969,2,90,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10;AXIN1
14169,GO:0051602,0.569576971438147,0.797529586216019,1,40,response to electrical stimulus,BP,GJB6
21658,GO:2001259,0.570153104132408,0.796956936689951,1,41,positive regulation of cation channel activity,BP,ACTN2
14125,GO:0051539,0.570346273998517,0.796890912069866,1,40,4 iron, 4 sulfur cluster binding,MF,ETFDH
16152,GO:0070849,0.57061578199261,0.796572228149416,1,41,response to epidermal growth factor,BP,AKT1
19786,GO:1903793,0.570848735005632,0.796473029443175,1,40,positive regulation of anion transport,BP,EDN1
3636,GO:0007080,0.57118352337931,0.796194270372986,1,40,mitotic metaphase plate congression,BP,PSRC1
13950,GO:0051224,0.571322367821933,0.627181670626065,4,193,negative regulation of protein transport,BP,BMP7;INHBB;RAB11FIP1;GAS6
1880,GO:0004177,0.57143033890414,0.795988594643642,1,40,aminopeptidase activity,MF,PEPD
11122,GO:0042992,0.571545243493114,0.795797896648436,1,41,negative regulation of transcription factor import into nucleus,BP,BMP7
940,GO:0002204,0.57207656786374,0.795449410202256,1,40,somatic recombination of immunoglobulin genes involved in immune response,BP,CLCF1
941,GO:0002208,0.57207656786374,0.795449410202256,1,40,somatic diversification of immunoglobulins involved in immune response,BP,CLCF1
12078,GO:0045190,0.57207656786374,0.795449410202256,1,40,isotype switching,BP,CLCF1
14315,GO:0051899,0.572318924134848,0.701400161886104,2,95,membrane depolarization,BP,EDN1;KCNH2
11416,GO:0043470,0.572612586389792,0.794906220160542,1,41,regulation of carbohydrate catabolic process,BP,ACTN3
15382,GO:0061136,0.572989545343565,0.654329727885812,3,143,regulation of proteasomal protein catabolic process,BP,AKT1;ARAF;RNF144A
627,GO:0001754,0.573771246205778,0.793935251518714,1,41,eye photoreceptor cell differentiation,BP,MYO7A
2302,GO:0004867,0.57392126552493,0.699992426436655,2,91,serine-type endopeptidase inhibitor activity,MF,SERPINA5;TFPI
3846,GO:0007569,0.573978963150892,0.699874498162365,2,93,cell aging,BP,HRAS;CDKN1A
12711,GO:0046578,0.574394850975726,0.624033412106989,4,199,regulation of Ras protein signal transduction,BP,ITGA3;FGF10;HRAS;KITLG
2296,GO:0004860,0.575219019065983,0.698717978197638,2,92,protein kinase inhibitor activity,MF,PRKAR1B;CDKN1A
18333,GO:0099531,0.575488554150527,0.651819711553258,3,145,presynaptic process involved in chemical synaptic transmission,BP,SYT5;WNT7A;GDNF
20697,GO:1990090,0.576563936065559,0.791490235686166,1,42,cellular response to nerve growth factor stimulus,BP,AKT1
1215,GO:0002695,0.576817940736067,0.650531223847341,3,143,negative regulation of leukocyte activation,BP,TYRO3;SDC4;BMP4
18986,GO:1901991,0.576954769653685,0.621505402138595,4,194,negative regulation of mitotic cell cycle phase transition,BP,GADD45A;PSMB10;FOXO4;CDKN1A
11895,GO:0044764,0.577070942593497,0.516907893681246,19,934,multi-organism cellular process,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;FADD;NMT2;MFGE8;PYCARD;TYRO3;PSMB10;PIK3R1;TICAM1;RNASEL;INHBB;CLDN1;GAS6;ACTA2;PIM2;EFNB2
17506,GO:0090278,0.57732108536227,0.790940889495803,1,41,negative regulation of peptide hormone secretion,BP,INHBB
982,GO:0002286,0.577368248113231,0.696653207932166,2,92,T cell activation involved in immune response,BP,RAB27A;ZFPM1
17126,GO:0072594,0.577406477611254,0.535177344597073,13,641,establishment of protein localization to organelle,BP,TSPAN17;PMAIP1;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6
12249,GO:0045619,0.577462069645462,0.649889963621371,3,143,regulation of lymphocyte differentiation,BP,PNP;BMP4;GAS6
7820,GO:0031227,0.577621779594772,0.64974778027528,3,142,intrinsic component of endoplasmic reticulum membrane,CC,DPM3;DHCR7;ELOVL6
8790,GO:0032873,0.577655777961123,0.790657041698632,1,41,negative regulation of stress-activated MAPK cascade,BP,AKT1
15862,GO:0070303,0.577655777961123,0.790657041698632,1,41,negative regulation of stress-activated protein kinase signaling cascade,BP,AKT1
10903,GO:0042551,0.578388733890373,0.78994217061502,1,42,neuron maturation,BP,SPTBN4
19410,GO:1903018,0.578838871641102,0.789651558889304,1,41,regulation of glycoprotein metabolic process,BP,HBEGF
11504,GO:0043603,0.578911209952195,0.51745503987691,18,882,cellular amide metabolic process,BP,ITGB8;FASN;MRPL14;MRPL16;BDH2;MGST2;GHR;ASAH2;SESN2;ANG;BMP4;TSFM;HEXB;AKT1;IDH1;GAS6;GLA;RBMS3
1103,GO:0002495,0.579427559745835,0.694635640290484,2,93,antigen processing and presentation of peptide antigen via MHC class II,BP,IFI30;PYCARD
8589,GO:0032570,0.580054518792617,0.788614961417926,1,41,response to progesterone,BP,GJB2
39,GO:0000077,0.5803361199111,0.646987852109323,3,145,DNA damage checkpoint,BP,GADD45A;FOXO4;CDKN1A
6118,GO:0016791,0.580409691659873,0.597892605371044,5,247,phosphatase activity,MF,PTPN7;PFKFB3;MDP1;ACP5;DUSP5
7905,GO:0031348,0.580572950396831,0.646767395325258,3,144,negative regulation of defense response,BP,ADORA1;TYRO3;NMI
1070,GO:0002437,0.580758529790582,0.78801304030133,1,41,inflammatory response to antigenic stimulus,BP,NOTCH1
7998,GO:0031529,0.580774099027753,0.787999715484204,1,41,ruffle organization,BP,HRAS
5073,GO:0010883,0.581753102525767,0.787067363091147,1,42,regulation of lipid storage,BP,ABCG1
2543,GO:0005253,0.58321169903605,0.690934656826177,2,94,anion channel activity,MF,TTYH1;FXYD1
12128,GO:0045296,0.583361169734195,0.57987702714431,6,299,cadherin binding,MF,FASN;CGN;MB21D2;PKP3;IDH1;CDH1
4395,GO:0009119,0.583502031859639,0.690682919686299,2,93,ribonucleoside metabolic process,BP,PNP;RHOQ
4080,GO:0008324,0.583623160321229,0.528761947325569,13,649,cation transmembrane transporter activity,MF,TF;SLC31A2;SLC45A4;KCNK6;TTYH1;KCNH2;GRIA3;KCNG2;GAS6;CYB5A;KCND1;SLC1A3;CLDN16
7439,GO:0030425,0.58388374985645,0.550276180841662,9,454,dendrite,CC,ACTN2;RAB27A;ADORA1;DRP2;CPT1C;RAB17;LZTS1;KCND1;PDE4B
1107,GO:0002504,0.584991434416112,0.689199452209917,2,94,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,IFI30;PYCARD
15985,GO:0070509,0.585044331109022,0.642196691022752,3,149,calcium ion import,BP,CASQ2;PDGFB;NOL3
5254,GO:0014743,0.585211051244449,0.783994575309388,1,43,regulation of muscle hypertrophy,BP,EDN1
7578,GO:0030803,0.586226217935084,0.78320335191682,1,42,negative regulation of cyclic nucleotide biosynthetic process,BP,EDN1
12713,GO:0046580,0.586647986673021,0.782746219501435,1,43,negative regulation of Ras protein signal transduction,BP,ITGA3
19308,GO:1902807,0.587078004914858,0.687127224793826,2,95,negative regulation of cell cycle G1/S phase transition,BP,GADD45A;CDKN1A
12026,GO:0045104,0.587468839938688,0.782030859582355,1,43,intermediate filament cytoskeleton organization,BP,PKP1
17507,GO:0090279,0.587518723356066,0.686665057638482,2,96,regulation of calcium ion import,BP,CASQ2;PDGFB
21009,GO:2000113,0.588073621831084,0.492769238806953,26,1293,negative regulation of cellular macromolecule biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;RGN;PDGFB;WNT5A;SESN2;AXIN1;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
14331,GO:0051928,0.588103844718872,0.686120437204943,2,95,positive regulation of calcium ion transport,BP,RGN;PDGFB
12250,GO:0045620,0.588128188309534,0.78154580162287,1,42,negative regulation of lymphocyte differentiation,BP,BMP4
8584,GO:0032559,0.588378254756319,0.488478825832087,29,1461,adenyl ribonucleotide binding,MF,PDK4;MARK4;ACVR1;ACSF2;ABCG1;PRKACB;ACSM5;MAPK12;TYRO3;PRKAR1B;KHK;NPR1;NUAK2;PFKFB3;RNASEL;PKN3;SHPK;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2;PDE4B
8687,GO:0032720,0.590316122884339,0.779628205977018,1,42,negative regulation of tumor necrosis factor production,BP,GAS6
13243,GO:0048483,0.590700068911124,0.779199047941913,1,43,autonomic nervous system development,BP,GDNF
21042,GO:2000179,0.590990177773291,0.778943558792678,1,43,positive regulation of neural precursor cell proliferation,BP,NOTCH1
4880,GO:0010608,0.59107185163567,0.542846068594036,9,450,posttranscriptional regulation of gene expression,BP,PSMB10;SESN2;RNASEL;ANG;BMP4;TSFM;AKT1;RBMS3;GDNF
11902,GO:0044772,0.591435423243395,0.535806655293395,10,501,mitotic cell cycle phase transition,BP,GADD45A;ACVR1;PHLDA1;PSMB10;FGF10;FOXO4;CDKN1A;AKT1;LZTS1;PIM2
6299,GO:0017148,0.591933697549632,0.635202767310001,3,150,negative regulation of translation,BP,SESN2;ANG;BMP4
20260,GO:1904837,0.593589518990294,0.77664523466525,1,43,beta-catenin-TCF complex assembly,BP,TLE1
13947,GO:0051220,0.593781575274963,0.776474763141059,1,43,cytoplasmic sequestering of protein,BP,AKT1
13346,GO:0048675,0.594259426165062,0.679921091825964,2,99,axon extension,BP,WNT3;WNT5A
9929,GO:0035601,0.594491724170306,0.679747600203104,2,97,protein deacylation,BP,SIN3B;LYPLAL1
13845,GO:0051058,0.595118049908216,0.775197531767556,1,44,negative regulation of small GTPase mediated signal transduction,BP,ITGA3
7089,GO:0022037,0.595702557504477,0.678513212806509,2,98,metencephalon development,BP,WNT7A;DLL1
5932,GO:0016447,0.5959649184694,0.774530424668887,1,43,somatic recombination of immunoglobulin gene segments,BP,CLCF1
15584,GO:0061640,0.596011496162659,0.774400127822821,1,44,cytoskeleton-dependent cytokinesis,BP,SNX18
12025,GO:0045103,0.596124009293545,0.774299569835334,1,44,intermediate filament-based process,BP,PKP1
13943,GO:0051209,0.596363266187644,0.677825805256976,2,99,release of sequestered calcium ion into cytosol,BP,CASQ2;NOL3
13992,GO:0051283,0.596363266187644,0.677825805256976,2,99,negative regulation of sequestering of calcium ion,BP,CASQ2;NOL3
6529,GO:0019210,0.597586023040374,0.676691819877858,2,96,kinase inhibitor activity,MF,PRKAR1B;CDKN1A
1232,GO:0002712,0.598760657226636,0.772023539111881,1,43,regulation of B cell mediated immunity,BP,CLCF1
1344,GO:0002889,0.598760657226636,0.772023539111881,1,43,regulation of immunoglobulin mediated immune response,BP,CLCF1
4093,GO:0008347,0.598772149007594,0.77192376353748,1,44,glial cell migration,BP,HEXB
12433,GO:0045934,0.59912279833817,0.47995025723591,27,1347,negative regulation of nucleobase-containing compound metabolic process,BP,WNT4;ACTN3;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;RGN;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;PKP3;PKP1;NPPC;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
3966,GO:0008144,0.599280657970348,0.674994459504207,2,96,drug binding,MF,FASN;PNP
2105,GO:0004601,0.600042176230201,0.770867939130727,1,43,peroxidase activity,MF,MGST2
18134,GO:0098732,0.60031527748687,0.673896228412923,2,98,macromolecule deacylation,BP,SIN3B;LYPLAL1
8401,GO:0032309,0.60119155494059,0.769828011691817,1,43,icosanoid secretion,BP,EDN1
13991,GO:0051282,0.60205558030054,0.67208685359379,2,100,regulation of sequestering of calcium ion,BP,CASQ2;NOL3
7590,GO:0030815,0.602630876805523,0.768430620966124,1,44,negative regulation of cAMP metabolic process,BP,EDN1
20696,GO:1990089,0.602660747702729,0.76831700658668,1,45,response to nerve growth factor,BP,AKT1
4561,GO:0009409,0.603343748524209,0.767781207911374,1,44,response to cold,BP,ACADVL
12399,GO:0045892,0.603958811319645,0.48284033250214,22,1103,negative regulation of transcription, DNA-templated,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
8800,GO:0032886,0.604251971883159,0.622511523838043,3,152,regulation of microtubule-based process,BP,RAB6C;PSRC1;CAMSAP3
13365,GO:0048701,0.605582740609849,0.765646023320455,1,45,embryonic cranial skeleton morphogenesis,BP,BMP4
7496,GO:0030554,0.605594957727116,0.470663061153188,29,1472,adenyl nucleotide binding,MF,PDK4;MARK4;ACVR1;ACSF2;ABCG1;PRKACB;ACSM5;MAPK12;TYRO3;PRKAR1B;KHK;NPR1;NUAK2;PFKFB3;RNASEL;PKN3;SHPK;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2;PDE4B
13702,GO:0050853,0.605634453556301,0.765685751882017,1,44,B cell receptor signaling pathway,BP,BCAR1
3961,GO:0008138,0.605860037426329,0.765478678792945,1,44,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP5
6194,GO:0016903,0.606668989658229,0.76473504685742,1,44,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,AOX1
15294,GO:0060997,0.607155209764013,0.764115952810939,1,46,dendritic spine morphogenesis,BP,WNT7A
10683,GO:0042158,0.607299810890457,0.619373785044222,3,150,lipoprotein biosynthetic process,BP,DPM3;NMT2;PRND
13256,GO:0048511,0.607513170877995,0.554688064655962,6,306,rhythmic process,BP,ADORA1;TYRO3;ANG;KITLG;INHBB;STAR
19667,GO:1903556,0.607583220862338,0.763892638019241,1,44,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6
5896,GO:0016363,0.607642299181898,0.666450850854143,2,99,nuclear matrix,CC,SPTBN4;RNASEL
17385,GO:0090102,0.608257361542555,0.763182227681896,1,45,cochlea development,BP,WNT5A
7921,GO:0031396,0.608434150616649,0.568770109504459,5,252,regulation of protein ubiquitination,BP,PSMB10;TICAM1;MAGEC2;AXIN1;NMI
19423,GO:1903038,0.609331255814937,0.664755965935823,2,98,negative regulation of leukocyte cell-cell adhesion,BP,SDC4;BMP4
18983,GO:1901988,0.609493978551064,0.58786284321044,4,202,negative regulation of cell cycle phase transition,BP,GADD45A;PSMB10;FOXO4;CDKN1A
17250,GO:0086010,0.610142822536854,0.761191608933447,1,48,membrane depolarization during action potential,BP,KCNH2
4025,GO:0008238,0.610974430349229,0.663073446785615,2,98,exopeptidase activity,MF,PEPD;PM20D2
5903,GO:0016407,0.611002506046715,0.663015357676916,2,99,acetyltransferase activity,MF,FASN;ACAT1
3559,GO:0006959,0.611164688022816,0.58613222538072,4,199,humoral immune response,BP,CFB;NOTCH1;PSMB10;CHGA
13164,GO:0048260,0.611252014631973,0.760401990226084,1,45,positive regulation of receptor-mediated endocytosis,BP,TF
772,GO:0001948,0.611449998670927,0.662527478527719,2,100,glycoprotein binding,MF,ITGA3;CDH1
12389,GO:0045861,0.611677660199928,0.550296713617894,6,304,negative regulation of proteolysis,BP,SERPINA5;NOL3;AKT1;CST9L;TFPI;GAS6
7584,GO:0030809,0.611753600467173,0.759934070742688,1,45,negative regulation of nucleotide biosynthetic process,BP,EDN1
18595,GO:1900372,0.611753600467173,0.759934070742688,1,45,negative regulation of purine nucleotide biosynthetic process,BP,EDN1
2304,GO:0004871,0.612655048831228,0.458975198047471,33,1637,signal transducer activity,MF,EBP;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;P2RY14;WNT7A;TRADD;ACVR1;ADORA1;MAPK12;FZD7;TYRO3;LPAR2;GHR;PIK3R1;TICAM1;KCNH2;WNT5A;AXIN1;NPR1;SDC4;GRIA3;DDR1;PKP1;BCAR1;CLDN3;GAS6;VDR;ARAF;DOK1;FZD8
2908,GO:0005978,0.613079577792772,0.758608762747594,1,46,glycogen biosynthetic process,BP,AKT1
4506,GO:0009250,0.613079577792772,0.758608762747594,1,46,glucan biosynthetic process,BP,AKT1
21363,GO:2000649,0.614303174454874,0.757460089233027,1,46,regulation of sodium ion transmembrane transporter activity,BP,FXYD1
7158,GO:0022904,0.614748942039018,0.659218981727317,2,97,respiratory electron transport chain,BP,ETFB;ETFDH
11573,GO:0043933,0.615366052892912,0.451752753032181,38,1895,macromolecular complex subunit organization,BP,FHOD3;TUBG2;ACTN2;PMAIP1;MRPL14;MRPL16;FADD;APOC1;TRADD;CASQ2;ABCG1;SPTBN5;SPTBN4;PYCARD;PRND;PLEKHH2;RALB;HRAS;HACL1;AXIN1;PSRC1;ANG;SPTB;ACAT1;VAMP1;MSN;NOL3;GJB1;PCBD1;DECR1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;HNF1A;KCND1;TMOD4
4005,GO:0008206,0.615628861760354,0.756297042474785,1,45,bile acid metabolic process,BP,STAR
19262,GO:1902679,0.615798093612671,0.468678296073027,23,1159,negative regulation of RNA biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;RGN;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
17113,GO:0072577,0.615819200209312,0.756031514546799,1,46,endothelial cell apoptotic process,BP,GAS6
2546,GO:0005261,0.616060163378521,0.545599065613965,6,312,cation channel activity,MF,KCNK6;KCNH2;GRIA3;KCNG2;GAS6;KCND1
13623,GO:0050728,0.616342859397,0.657510642776307,2,99,negative regulation of inflammatory response,BP,ADORA1;TYRO3
18657,GO:1901028,0.616591825591206,0.755387240330977,1,45,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
13604,GO:0050707,0.616813973569775,0.609370816416721,3,151,regulation of cytokine secretion,BP,PYCARD;WNT5A;GAS6
2312,GO:0004879,0.617123865754817,0.754797325520714,1,46,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,VDR
18053,GO:0098531,0.617123865754817,0.754797325520714,1,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,VDR
14565,GO:0055010,0.617206905403332,0.754636084354512,1,47,ventricular cardiac muscle tissue morphogenesis,BP,NOTCH1
11278,GO:0043231,0.617281763670617,0.423811664854634,204,9934,intracellular membrane-bounded organelle,CC,ITGA5;EBP;PDK4;PECR;BEX4;TMEM160;WNT3;WNT4;USE1;POU3F1;RAB6C;ALG5;PHYH;NOTCH1;GLDC;RAB27A;IFI30;DPM3;ITGB4;FASN;PMAIP1;GADD45A;MSRA;MRPL14;MRPL16;MRI1;FADD;SERPINA5;WNT6;WNT7A;WNT7B;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;HMGCS2;NMT2;SALL4;TBC1D14;PXMP2;PXMP4;ADORA1;CASQ2;EXTL1;ACSF2;EDN1;RAB40B;PHLDA1;PNP;MRO;ABCG1;PRKACB;EBF1;SPTBN4;PYCARD;CCDC51;MBOAT2;SLC25A53;G0S2;LAGE3;ACADVL;TTYH1;KRT10;RRAS2;RAB39B;RAB39A;MGST2;ACSM5;MAPK12;TYRO3;PSMB10;LIMS2;RGN;FADS1;PRR5L;FSTL3;FGF18;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;REEP1;ARL6IP4;PDGFB;FOXO4;RALB;CPT2;PLA2G16;HSD17B10;ETFB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;HACL1;SESN2;AXIN1;GALT;RHOQ;RHOB;NUAK2;CYP17A1;PFKFB3;PSRC1;RNASEL;SDC4;BOLA1;ANG;FAM110C;SPTB;NMI;BMP2;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;HMGN5;AOX1;PKN3;RAB20;ECHDC2;SLC2A14;SARDH;F8A1;HEXB;VAMP1;SFXN1;RND3;CHGA;MSN;NOL3;HSD3B2;NUDT6;NUDT7;CTGF;GJB1;GJB2;CPT1C;TPD52;PCBD1;MDH1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;PON2;WNT2B;CYTIP;PTGES;IDH1;DECR1;NAB2;CDH1;PUS1;EPN1;MYO7A;PTMS;LDHD;TMEM98;RAB44;TFPI;TLE1;STAR;PIK3CG;RAB11FIP1;GAS6;SIN3B;ACP5;GLA;ECI1;ZCCHC12;CYP11A1;DERA;S100B;DHCR7;CYB5A;PTS;PM20D2;HNF1A;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;RAB38;DOK1;RAB3D;ACSL4;FAM110B;FZD8;CNIH4;ELOVL6;DUSP5;HEY1;RNF144A;ETFDH
16662,GO:0071715,0.617496278125833,0.754530519633465,1,45,icosanoid transport,BP,EDN1
18839,GO:1901571,0.617496278125833,0.754530519633465,1,45,fatty acid derivative transport,BP,EDN1
3706,GO:0007204,0.617700871180823,0.558897591169057,5,258,positive regulation of cytosolic calcium ion concentration,BP,CASQ2;EDN1;LPAR2;NOL3;PIK3CG
2663,GO:0005548,0.617888982731452,0.753988776265329,1,47,phospholipid transporter activity,MF,ABCG1
13942,GO:0051208,0.618473965055295,0.655185628931004,2,103,sequestering of calcium ion,BP,CASQ2;NOL3
14193,GO:0051651,0.618786599409451,0.65488770009049,2,102,maintenance of location in cell,BP,SPTBN4;AKT1
112,GO:0000226,0.619312324260835,0.520935774944396,8,418,microtubule cytoskeleton organization,BP,TUBG2;RAB6C;MARK4;GADD45A;FGF10;AXIN1;PSRC1;CAMSAP3
7575,GO:0030800,0.619405559200952,0.752628204012395,1,46,negative regulation of cyclic nucleotide metabolic process,BP,EDN1
11808,GO:0044441,0.619650385721221,0.530047158020851,7,364,ciliary part,CC,MARK4;RAB27A;PRKACB;SPTBN5;PRKAR1B;AKT1;MYO7A
3514,GO:0006891,0.619832830141195,0.752137338357419,1,47,intra-Golgi vesicle-mediated transport,BP,RAB6C
18666,GO:1901068,0.62025031376227,0.751821665617985,1,46,guanosine-containing compound metabolic process,BP,RHOQ
11197,GO:0043113,0.620481638285809,0.751517166675493,1,47,receptor clustering,BP,CDH2
13725,GO:0050879,0.621084193355288,0.750940214226058,1,47,multicellular organismal movement,BP,ACTN3
13727,GO:0050881,0.621084193355288,0.750940214226058,1,47,musculoskeletal movement,BP,ACTN3
18225,GO:0098900,0.621174211440655,0.750773964404428,1,48,regulation of action potential,BP,DSC2
3322,GO:0006605,0.621440374070334,0.489168842908527,13,662,protein targeting,BP,RAB27A;ADORA1;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;CDH1;GAS6
14811,GO:0060255,0.62225236381449,0.421552379223268,115,5664,regulation of macromolecule metabolic process,BP,ITGA3;ITGA5;CFB;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;FADD;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;SALL4;ADORA1;DKK3;EDN1;ABCG1;PRKACB;CCL20;EBF1;SPTBN4;PYCARD;MAPK12;FZD7;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;MSN;NOL3;DEPTOR;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;FAM46A;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;SHC4;RBMS3;HNF1A;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
18985,GO:1901990,0.622446589023071,0.538793571909705,6,309,regulation of mitotic cell cycle phase transition,BP,GADD45A;PSMB10;FGF10;FOXO4;CDKN1A;AKT1
12727,GO:0046605,0.622906172158506,0.749189821483289,1,47,regulation of centrosome cycle,BP,RAB6C
1045,GO:0002381,0.623738857295455,0.748471010633258,1,46,immunoglobulin production involved in immunoglobulin mediated immune response,BP,CLCF1
13624,GO:0050729,0.624803120846149,0.648646936840127,2,100,positive regulation of inflammatory response,BP,WNT5A;PIK3CG
7157,GO:0022900,0.62571938466631,0.6477111009352,2,99,electron transport chain,BP,ETFB;ETFDH
8011,GO:0031570,0.625984183646372,0.599544647328789,3,155,DNA integrity checkpoint,BP,GADD45A;FOXO4;CDKN1A
6715,GO:0019825,0.626801964005419,0.745502339546907,1,46,oxygen binding,MF,CYP17A1
6098,GO:0016763,0.628138342495392,0.744114174758588,1,47,transferase activity, transferring pentosyl groups,MF,PNP
4601,GO:0009620,0.628172138385322,0.744166286766307,1,46,response to fungus,BP,CHGA
13810,GO:0051020,0.628253250801735,0.532508046895864,6,317,GTPase binding,MF,RIN3;TBC1D14;DAAM2;RAB11FIP1;RPH3AL;SH3BP4
17982,GO:0097553,0.628816376240418,0.644267327814485,2,105,calcium ion transmembrane import into cytosol,BP,CASQ2;NOL3
19256,GO:1902656,0.628816376240418,0.644267327814485,2,105,calcium ion import into cytosol,BP,CASQ2;NOL3
7403,GO:0030336,0.629453813862417,0.56647845201139,4,210,negative regulation of cell migration,BP,WNT4;NOTCH1;ADORA1;RHOB
18113,GO:0098656,0.629677698149035,0.546006088870716,5,262,anion transmembrane transport,BP,TTYH1;CPT2;FXYD1;AKT1;SLC1A3
13612,GO:0050715,0.630142679736539,0.642969284936189,2,101,positive regulation of cytokine secretion,BP,PYCARD;WNT5A
5467,GO:0015294,0.630308042763559,0.642737023823639,2,103,solute:cation symporter activity,MF,SLC45A4;SLC1A3
7316,GO:0030219,0.630780150148543,0.741523508474661,1,47,megakaryocyte differentiation,BP,ZFPM1
8316,GO:0032154,0.630869824442148,0.741353063166336,1,48,cleavage furrow,CC,RHOB
17991,GO:0097610,0.630869824442148,0.741353063166336,1,48,cell surface furrow,CC,RHOB
3172,GO:0006415,0.630875687232744,0.642218470495619,2,100,translational termination,BP,MRPL14;MRPL16
4560,GO:0009408,0.631060132803345,0.594050720284962,3,157,response to heat,BP,SLC52A3;CDKN1A;AKT1
13695,GO:0050840,0.631393236354249,0.740837299120282,1,48,extracellular matrix binding,MF,ITGA3
2529,GO:0005231,0.632233381198443,0.740007876129608,1,48,excitatory extracellular ligand-gated ion channel activity,MF,GRIA3
12738,GO:0046626,0.633259633125392,0.738992117161971,1,48,regulation of insulin receptor signaling pathway,BP,PIK3R1
6843,GO:0021545,0.633610025928043,0.738644649838182,1,48,cranial nerve development,BP,SLC1A3
11804,GO:0044437,0.634095975334808,0.490653664327238,10,517,vacuolar part,CC,IFI30;PYCARD;SDC4;IDUA;HEXB;RAB12;MYO7A;RAB44;GLA;RAB3D
8364,GO:0032259,0.634301021601501,0.52598498992463,6,313,methylation,BP,PNMT;NNMT;HSD17B10;ETFB;PIK3CA;RAB3D
8374,GO:0032273,0.634699885912581,0.638046213222553,2,103,positive regulation of protein polymerization,BP,PYCARD;PSRC1
5930,GO:0016445,0.6355853618915,0.736679528118499,1,48,somatic diversification of immunoglobulins,BP,CLCF1
16205,GO:0070936,0.63588689485484,0.736378613830207,1,48,protein K48-linked ubiquitination,BP,NMI
6279,GO:0017112,0.6365818288428,0.735604110357503,1,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN3
14015,GO:0051310,0.636966742810525,0.735298931559076,1,48,metaphase plate congression,BP,PSRC1
13607,GO:0050710,0.638603562436018,0.733656234948695,1,48,negative regulation of cytokine secretion,BP,GAS6
3888,GO:0008009,0.639027965133246,0.733313130288127,1,47,chemokine activity,MF,CCL20
19545,GO:1903313,0.639228612221249,0.732946365386212,1,49,positive regulation of mRNA metabolic process,BP,PRR5L
1397,GO:0003044,0.639511369293809,0.732741974210829,1,48,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,EDN1
7129,GO:0022824,0.639689386499792,0.732481701964902,1,49,transmitter-gated ion channel activity,MF,GRIA3
7134,GO:0022835,0.639689386499792,0.732481701964902,1,49,transmitter-gated channel activity,MF,GRIA3
11782,GO:0044403,0.639902361870254,0.451139176186368,19,968,symbiosis, encompassing mutualism through parasitism,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;FADD;NMT2;MFGE8;PYCARD;TYRO3;PSMB10;PIK3R1;TICAM1;RNASEL;CDH1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
3586,GO:0007006,0.640404897151948,0.631894613397326,2,103,mitochondrial membrane organization,BP,PMAIP1;NOL3
7978,GO:0031491,0.641027677599357,0.731128770306382,1,49,nucleosome binding,MF,HMGN5
7769,GO:0031102,0.641144756134355,0.731010173820012,1,49,neuron projection regeneration,BP,JAM3
2518,GO:0005216,0.641388906083669,0.497141688726992,8,423,ion channel activity,MF,KCNK6;TTYH1;KCNH2;FXYD1;GRIA3;KCNG2;GAS6;KCND1
18691,GO:1901137,0.64167437056286,0.463658799581082,14,723,carbohydrate derivative biosynthetic process,BP,ALG5;DPM3;MRAP;GUCY1B3;EXTL1;EDN1;PHLDA1;PDGFB;NPR1;SDC4;HBEGF;ACAT1;B3GNT2;NPPC
17508,GO:0090280,0.642489733276076,0.729645014668942,1,49,positive regulation of calcium ion import,BP,PDGFB
11790,GO:0044419,0.643308584253601,0.447500311848896,19,970,interspecies interaction between organisms,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;FADD;NMT2;MFGE8;PYCARD;TYRO3;PSMB10;PIK3R1;TICAM1;RNASEL;CDH1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
402,GO:0001047,0.643486014498728,0.580436105500355,3,161,core promoter binding,MF,NOTCH1;GADD45A;ZFPM1
9353,GO:0034249,0.644310300313305,0.579513375286219,3,162,negative regulation of cellular amide metabolic process,BP,SESN2;ANG;BMP4
7826,GO:0031234,0.645144161571653,0.62667824923895,2,105,extrinsic component of cytoplasmic side of plasma membrane,CC,SNX18;MYZAP
12993,GO:0047485,0.645866831531077,0.625860170023794,2,106,protein N-terminus binding,MF,GADD45A;MYO7A
5020,GO:0010821,0.646108475297871,0.548247541511149,4,212,regulation of mitochondrion organization,BP,PMAIP1;PYCARD;NOL3;AKT1
11562,GO:0043902,0.646604531984907,0.577022367059036,3,159,positive regulation of multi-organism process,BP,NOTCH1;BMP6;INHBB
1360,GO:0002920,0.646686899051516,0.725352232431662,1,49,regulation of humoral immune response,BP,CFB
3298,GO:0006576,0.648812632756188,0.723159074900401,1,49,cellular biogenic amine metabolic process,BP,SARDH
9669,GO:0035065,0.650028419689181,0.721819309336809,1,50,regulation of histone acetylation,BP,LIF
7534,GO:0030660,0.650238435119106,0.721601161857036,1,50,Golgi-associated vesicle membrane,CC,RHOQ
10707,GO:0042220,0.650647187424334,0.721176220196189,1,50,response to cocaine,BP,FADD
10645,GO:0042093,0.650937429493619,0.72087419196851,1,50,T-helper cell differentiation,BP,ZFPM1
7438,GO:0030424,0.651624896997765,0.495302523972636,7,378,axon,CC,ADRA2C;ADORA1;SPTBN4;CYP17A1;VAMP1;CPT1C;NRTN
8656,GO:0032663,0.651943168177476,0.719825742041749,1,50,regulation of interleukin-2 production,BP,PDE4B
20978,GO:2000058,0.652364604231375,0.618725465027093,2,105,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10;AXIN1
12002,GO:0045071,0.652841496058312,0.718886804879691,1,50,negative regulation of viral genome replication,BP,RNASEL
3743,GO:0007266,0.65393153284689,0.568782005344828,3,165,Rho protein signal transduction,BP,ITGA3;RHOJ;RHOB
1087,GO:0002460,0.654821227101079,0.53854890272253,4,213,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RAB27A;FADD;HRAS;CLCF1
12746,GO:0046635,0.654908497688737,0.716717515724518,1,50,positive regulation of alpha-beta T cell activation,BP,PNP
11375,GO:0043392,0.654908953983312,0.716639568430035,1,51,negative regulation of DNA binding,BP,HEY1
1502,GO:0003229,0.655439437911185,0.716006160691902,1,52,ventricular cardiac muscle tissue development,BP,NOTCH1
740,GO:0001910,0.655505137456218,0.716089048513419,1,50,regulation of leukocyte mediated cytotoxicity,BP,FADD
2048,GO:0004521,0.655693972832096,0.715889924341074,1,50,endoribonuclease activity,MF,RNASEL
1631,GO:0003714,0.656054759098122,0.537139670983154,4,216,transcription corepressor activity,MF,WNT4;NAB2;TLE1;SIN3B
2703,GO:0005637,0.656304666668034,0.715167499438508,1,51,nuclear inner membrane,CC,IFI27
13869,GO:0051101,0.656949055729209,0.613538480083837,2,108,regulation of DNA binding,BP,LIF;HEY1
14004,GO:0051297,0.656997088030731,0.613458810619102,2,109,centrosome organization,BP,RAB6C;GADD45A
371,GO:0000989,0.657271107439914,0.459807544541869,11,582,transcription factor activity, transcription factor binding,MF,LIF;WNT4;POU3F1;ACTN2;NOTCH1;NMI;PCBD1;NAB2;TLE1;SIN3B;ZCCHC12
12549,GO:0046148,0.657332123354929,0.714080207475245,1,51,pigment biosynthetic process,BP,WNT5A
4877,GO:0010605,0.657343059028952,0.401326909519645,48,2423,negative regulation of macromolecule metabolic process,BP,LIF;WNT4;NOTCH1;ITGB8;GADD45A;SERPINA5;ZFPM1;SALL4;DKK3;EDN1;PYCARD;PSMB10;RGN;PRR5L;PDGFB;PRKAR1B;HRAS;WNT5A;SESN2;AXIN1;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;NOL3;DEPTOR;CTGF;AKT1;IFI27;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TFPI;TLE1;GAS6;SIN3B;VDR;FZD8;DUSP5;HEY1
3150,GO:0006383,0.657398084977656,0.7140102992078,1,51,transcription from RNA polymerase III promoter,BP,NAB2
5730,GO:0016032,0.65755651442171,0.434556323691231,18,928,viral process,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;FADD;NMT2;MFGE8;PYCARD;TYRO3;PSMB10;PIK3R1;TICAM1;RNASEL;CLDN1;GAS6;ACTA2;PIM2;EFNB2
10467,GO:0038083,0.658804785465167,0.712441183519167,1,52,peptidyl-tyrosine autophosphorylation,BP,DDR1
11515,GO:0043621,0.65989914482944,0.711202199111274,1,53,protein self-association,MF,SPTBN5
7535,GO:0030662,0.660358008671892,0.56158131856343,3,163,coated vesicle membrane,CC,TF;WNT5A;HBEGF
9510,GO:0034605,0.660611894159254,0.609374630437741,2,110,cellular response to heat,BP,SLC52A3;CDKN1A
6816,GO:0021515,0.661214123795133,0.709868525753641,1,52,cell differentiation in spinal cord,BP,NOTCH1
6532,GO:0019213,0.661526097171335,0.709534152585428,1,52,deacetylase activity,MF,SIN3B
20074,GO:1904427,0.661748486028114,0.709295620315871,1,52,positive regulation of calcium ion transmembrane transport,BP,RGN
19680,GO:1903578,0.661836723031464,0.709200937530071,1,52,regulation of ATP metabolic process,BP,ACTN3
487,GO:0001510,0.661885350083677,0.709224558200338,1,51,RNA methylation,BP,HSD17B10
11900,GO:0044770,0.662028919535452,0.460194116206846,10,530,cell cycle phase transition,BP,GADD45A;ACVR1;PHLDA1;PSMB10;FGF10;FOXO4;CDKN1A;AKT1;LZTS1;PIM2
7807,GO:0031201,0.662259654319162,0.708822672262244,1,51,SNARE complex,CC,VAMP1
2803,GO:0005793,0.66235930888633,0.607428242576686,2,109,endoplasmic reticulum-Golgi intermediate compartment,CC,GJB2;CNIH4
1229,GO:0002709,0.662684179376123,0.708366361902564,1,51,regulation of T cell mediated immunity,BP,FADD
3465,GO:0006814,0.663174852962202,0.529087390537853,4,220,sodium ion transport,BP,SPTBN4;FXYD1;WNK4;AKT1
1142,GO:0002562,0.663289709270075,0.707638488353188,1,52,somatic diversification of immune receptors via germline recombination within a single locus,BP,CLCF1
5929,GO:0016444,0.663289709270075,0.707638488353188,1,52,somatic cell DNA recombination,BP,CLCF1
6587,GO:0019369,0.663358663295135,0.707640276647715,1,51,arachidonic acid metabolic process,BP,PTGES
5406,GO:0015179,0.663770150432732,0.707120471985062,1,52,L-amino acid transmembrane transporter activity,MF,SLC1A3
7135,GO:0022836,0.664117337081912,0.493013735376887,6,327,gated channel activity,MF,KCNK6;KCNH2;GRIA3;KCNG2;GAS6;KCND1
988,GO:0002294,0.665774870850689,0.704951529360775,1,52,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ZFPM1
5029,GO:0010830,0.666250965221745,0.704434666841387,1,52,regulation of myotube differentiation,BP,NOTCH1
17818,GO:0097223,0.667703922262522,0.55322984932366,3,163,sperm part,CC,NOTCH1;SERPINA5;HEXB
7136,GO:0022838,0.667728895913163,0.468083051051669,8,433,substrate-specific channel activity,MF,KCNK6;TTYH1;KCNH2;FXYD1;GRIA3;KCNG2;GAS6;KCND1
946,GO:0002221,0.668346234147774,0.552466709892271,3,165,pattern recognition receptor signaling pathway,BP,FADD;TYRO3;TICAM1
4728,GO:0010043,0.668537024514415,0.701943355512477,1,52,response to zinc ion,BP,KHK
19632,GO:1903507,0.670978458206572,0.411642105838835,22,1143,negative regulation of nucleic acid-templated transcription,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;IFI27;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
5846,GO:0016266,0.671157685675199,0.698852232418681,1,55,O-glycan processing,BP,B3GNT2
7775,GO:0031110,0.671226886232904,0.698917092548176,1,53,regulation of microtubule polymerization or depolymerization,BP,PSRC1
983,GO:0002287,0.672807052617919,0.697172597679827,1,53,alpha-beta T cell activation involved in immune response,BP,ZFPM1
987,GO:0002293,0.672807052617919,0.697172597679827,1,53,alpha-beta T cell differentiation involved in immune response,BP,ZFPM1
12748,GO:0046637,0.673935618846534,0.695921986542566,1,53,regulation of alpha-beta T cell differentiation,BP,PNP
10727,GO:0042267,0.675197002983925,0.69451955972471,1,53,natural killer cell mediated cytotoxicity,BP,RAB27A
14330,GO:0051926,0.675426781131334,0.694263560544234,1,53,negative regulation of calcium ion transport,BP,CASQ2
5490,GO:0015370,0.675556886859622,0.694045900372685,1,54,solute:sodium symporter activity,MF,SLC1A3
17871,GO:0097345,0.676241927020792,0.693354078385583,1,53,mitochondrial outer membrane permeabilization,BP,PMAIP1
4897,GO:0010633,0.676438532901331,0.693061620730697,1,54,negative regulation of epithelial cell migration,BP,NOTCH1
1096,GO:0002478,0.676760180589808,0.54277305827592,3,165,antigen processing and presentation of exogenous peptide antigen,BP,IFI30;ITGB5;PSMB10
3173,GO:0006417,0.676939075591358,0.478521383403305,6,329,regulation of translation,BP,SESN2;ANG;BMP4;TSFM;AKT1;RBMS3
5564,GO:0015698,0.677554331286855,0.541809937665575,3,168,inorganic anion transport,BP,TTYH1;FXYD1;WNK4
21646,GO:2001244,0.678022108251992,0.691360717138467,1,53,positive regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
21434,GO:2000756,0.678025414514427,0.691283934773087,1,54,regulation of peptidyl-lysine acetylation,BP,LIF
4789,GO:0010389,0.678108010148487,0.589303772523938,2,111,regulation of G2/M transition of mitotic cell cycle,BP,PSMB10;FOXO4
15908,GO:0070373,0.678111181399504,0.691187632385478,1,54,negative regulation of ERK1 and ERK2 cascade,BP,LIF
11580,GO:0043966,0.678188326510129,0.691100991287007,1,54,histone H3 acetylation,BP,LIF
6099,GO:0016765,0.678462434542021,0.690866140665123,1,53,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,MGST2
4382,GO:0009101,0.678988292444717,0.476172995755111,6,332,glycoprotein biosynthetic process,BP,ALG5;DPM3;EXTL1;PHLDA1;HBEGF;B3GNT2
4588,GO:0009584,0.680346326811373,0.688669826444809,1,54,detection of visible light,BP,NMT2
7197,GO:0030032,0.680622138417154,0.68828721482458,1,55,lamellipodium assembly,BP,PARVB
19550,GO:1903320,0.680859373536298,0.488841102215093,5,274,regulation of protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;MAGEC2;AXIN1;NMI
418,GO:0001085,0.680990639465394,0.585861423415999,2,114,RNA polymerase II transcription factor binding,MF,ZFPM1;IFI27
14834,GO:0060291,0.681121163971429,0.687654057668882,1,56,long-term synaptic potentiation,BP,S100B
5146,GO:0010976,0.681714250050454,0.507789581667243,4,227,positive regulation of neuron projection development,BP,ITGA3;WNT3;WNT5A;BMP7
3520,GO:0006898,0.682029649276026,0.487468536795244,5,278,receptor-mediated endocytosis,BP,SYT5;TF;APOC1;DLL1;UNC119
3158,GO:0006399,0.682949477802731,0.535546392982599,3,166,tRNA metabolic process,BP,LAGE3;HSD17B10;PUS1
19036,GO:1902110,0.683124254261605,0.685518740283074,1,54,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
19267,GO:1902686,0.683124254261605,0.685518740283074,1,54,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PMAIP1
2194,GO:0004721,0.683224129695146,0.535170007496465,3,170,phosphoprotein phosphatase activity,MF,PTPN7;MDP1;DUSP5
18322,GO:0099513,0.683224888654113,0.426250564256531,12,647,polymeric cytoskeletal fiber,CC,TUBG2;ACTN3;ACTN2;KRT10;RHOQ;PSRC1;FAM110C;CAMSAP3;ESPN;PKP1;AMOT;RAB3D
10800,GO:0042383,0.683989431060878,0.582266794299857,2,117,sarcolemma,CC,CDH2;FXYD1
8602,GO:0032592,0.684244932237562,0.684240619328443,1,54,integral component of mitochondrial membrane,CC,ETFDH
7720,GO:0031023,0.684481374620349,0.581733773297761,2,115,microtubule organizing center organization,BP,RAB6C;GADD45A
2648,GO:0005524,0.684666410212675,0.389223348649841,27,1426,ATP binding,MF,PDK4;MARK4;ACVR1;ACSF2;ABCG1;PRKACB;ACSM5;MAPK12;TYRO3;KHK;NPR1;NUAK2;PFKFB3;RNASEL;PKN3;SHPK;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2
18982,GO:1901987,0.684726356733738,0.469619040895503,6,330,regulation of cell cycle phase transition,BP,GADD45A;PSMB10;FGF10;FOXO4;CDKN1A;AKT1
5696,GO:0015934,0.685288142591627,0.580906598737114,2,110,large ribosomal subunit,CC,MRPL14;MRPL16
19123,GO:1902305,0.685629924120439,0.68251474775813,1,56,regulation of sodium ion transmembrane transport,BP,FXYD1
4504,GO:0009247,0.687163209211076,0.680821655562558,1,55,glycolipid biosynthetic process,BP,DPM3
72,GO:0000149,0.687276825627637,0.578451721465831,2,114,SNARE binding,MF,SYT5;VAMP1
4022,GO:0008235,0.687687470390705,0.680217396670319,1,55,metalloexopeptidase activity,MF,PEPD
119,GO:0000245,0.688176165249438,0.679653336142396,1,55,spliceosomal complex assembly,BP,NOL3
9023,GO:0033267,0.688231371891138,0.529228156772785,3,174,axon part,CC,ADORA1;SPTBN4;VAMP1
3556,GO:0006956,0.689133825276358,0.678545758012875,1,55,complement activation,BP,CFB
7884,GO:0031326,0.689878078646175,0.355850495840607,82,4131,regulation of cellular biosynthetic process,BP,ITGA3;PDK4;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;CCL20;EBF1;PYCARD;ACADVL;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;PCBD1;AKT1;IFI27;KITLG;IDH1;NPPC;NAB2;CDH1;INHBB;TLE1;STAR;GAS6;SIN3B;GLA;ZCCHC12;LZTS1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
8172,GO:0031901,0.690086511192465,0.57508636121501,2,115,early endosome membrane,CC,TMEM163;SNX21
18069,GO:0098573,0.69078868341362,0.676624855620774,1,55,intrinsic component of mitochondrial membrane,CC,ETFDH
20210,GO:1904724,0.691960266416437,0.675259552044155,1,55,tertiary granule lumen,CC,IDH1
13419,GO:0048813,0.693299193024686,0.571172983762056,2,118,dendrite morphogenesis,BP,WNT7A;LZTS1
8315,GO:0032153,0.694205850017218,0.672491646625708,1,57,cell division site,CC,RHOB
8317,GO:0032155,0.694205850017218,0.672491646625708,1,57,cell division site part,CC,RHOB
43,GO:0000086,0.694436058788794,0.492903571624428,4,227,G2/M transition of mitotic cell cycle,BP,PHLDA1;PSMB10;FOXO4;CDKN1A
14359,GO:0051965,0.695005875973954,0.671550632490419,1,57,positive regulation of synapse assembly,BP,WNT7A
1640,GO:0003730,0.69551544266629,0.670950167480882,1,57,mRNA 3'-UTR binding,MF,RBMS3
12742,GO:0046631,0.695720489222006,0.56833157610448,2,115,alpha-beta T cell activation,BP,ZFPM1;PNP
10057,GO:0035794,0.696379557531812,0.669998294747352,1,56,positive regulation of mitochondrial membrane permeability,BP,PMAIP1
6284,GO:0017124,0.696467928079592,0.567358979577796,2,118,SH3 domain binding,MF,ESPN;BCAR1
14360,GO:0051966,0.696601404805614,0.669601626418828,1,58,regulation of synaptic transmission, glutamatergic,BP,ADORA1
7273,GO:0030166,0.69700623649218,0.669122455953123,1,58,proteoglycan biosynthetic process,BP,EXTL1
8886,GO:0033013,0.698681140957175,0.667200527458324,1,57,tetrapyrrole metabolic process,BP,BDH2
7019,GO:0021885,0.698827288417076,0.666960281714153,1,58,forebrain cell migration,BP,TYRO3
1627,GO:0003707,0.699356454513676,0.666329921769944,1,58,steroid hormone receptor activity,MF,VDR
3129,GO:0006352,0.700044408335686,0.486240761921384,4,229,DNA-templated transcription, initiation,BP,NOTCH1;CTGF;HNF1A;VDR
3895,GO:0008022,0.701278327433468,0.513635141165877,3,176,protein C-terminus binding,MF,HRAS;CTGF;LAMA1
951,GO:0002228,0.701767140878768,0.663513150719022,1,57,natural killer cell mediated immunity,BP,RAB27A
13723,GO:0050877,0.702063233294808,0.375976047212685,23,1203,neurological system process,BP,ITGA3;ITGA5;ADRA2C;CDH23;STRA6;SLC52A3;ADORA1;EDN1;SPTBN4;PRKAR1B;JAM3;RBP4;B3GNT2;ESPN;HEXB;GJB2;GJB6;MYO7A;GJA3;CLDN5;S100B;UNC119;SLC1A3
939,GO:0002200,0.702196738852207,0.662930462301381,1,58,somatic diversification of immune receptors,BP,CLCF1
7353,GO:0030276,0.702493239257253,0.66257402562926,1,58,clathrin binding,MF,SYT5
18782,GO:1901362,0.70288259638767,0.341136188309093,87,4382,organic cyclic compound biosynthetic process,BP,ITGA3;EBP;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;FADD;DHH;WNT6;WNT7A;HSD17B3;MRAP;ZFPM1;TRADD;HMGCS2;ACVR1;SALL4;GUCY1B3;HSD17B11;DKK3;EDN1;PNP;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;CYP17A1;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;HSD3B2;CTGF;PCBD1;AKT1;IFI27;NPPC;NAB2;CDH1;TLE1;STAR;GAS6;SIN3B;ZCCHC12;CYP11A1;LZTS1;DHCR7;PTS;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
20597,GO:1905710,0.702938004703349,0.662105745308885,1,57,positive regulation of membrane permeability,BP,PMAIP1
13960,GO:0051238,0.703358848308712,0.558937416462867,2,120,sequestering of metal ion,BP,CASQ2;NOL3
6748,GO:0019884,0.703750778273879,0.510699990070911,3,172,antigen processing and presentation of exogenous antigen,BP,IFI30;ITGB5;PSMB10
7898,GO:0031341,0.70376327538776,0.661110967608115,1,57,regulation of cell killing,BP,FADD
1226,GO:0002706,0.703841244131397,0.558439676495239,2,116,regulation of lymphocyte mediated immunity,BP,FADD;CLCF1
101,GO:0000209,0.704068336021423,0.461699438095147,5,284,protein polyubiquitination,BP,FBXO41;PSMB10;NMI;SPSB1;RNF144A
4582,GO:0009451,0.704120620227784,0.558097397923649,2,116,RNA modification,BP,HSD17B10;PUS1
6774,GO:0019935,0.704142338159159,0.66052130925619,1,59,cyclic-nucleotide-mediated signaling,BP,GUCY1B3
8451,GO:0032387,0.704610880732526,0.557449027586161,2,118,negative regulation of intracellular transport,BP,BMP7;GAS6
680,GO:0001824,0.705094629933286,0.659434020084861,1,58,blastocyst development,BP,SALL4
4288,GO:0008757,0.705542890152601,0.556304668346884,2,118,S-adenosylmethionine-dependent methyltransferase activity,MF,PNMT;NNMT
13840,GO:0051053,0.705623021549564,0.556183123027941,2,119,negative regulation of DNA metabolic process,BP,RGN;NPPC
364,GO:0000979,0.705980180020083,0.65829477108423,1,59,RNA polymerase II core promoter sequence-specific DNA binding,MF,ZFPM1
7592,GO:0030817,0.707368293572496,0.554057286287351,2,118,regulation of cAMP biosynthetic process,BP,MRAP;EDN1
9713,GO:0035195,0.707373889291372,0.656535503071285,1,60,gene silencing by miRNA,BP,BMP4
1294,GO:0002822,0.707528217022326,0.553883513414932,2,117,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD;CLCF1
3105,GO:0006305,0.708104347597816,0.655706972549684,1,59,DNA alkylation,BP,PIK3CA
3106,GO:0006306,0.708104347597816,0.655706972549684,1,59,DNA methylation,BP,PIK3CA
12221,GO:0045580,0.709330692022195,0.551632224321647,2,118,regulation of T cell differentiation,BP,PNP;BMP4
986,GO:0002292,0.711362065981645,0.651708003740124,1,59,T cell differentiation involved in immune response,BP,ZFPM1
11383,GO:0043401,0.711438332718392,0.501260289307449,3,178,steroid hormone mediated signaling pathway,BP,BMP7;BMP4;VDR
14715,GO:0060090,0.711748981113271,0.500879489174639,3,178,binding, bridging,MF,TRADD;PIK3R1;GAS6
7691,GO:0030968,0.711957831204684,0.54834777257166,2,119,endoplasmic reticulum unfolded protein response,BP,ACADVL;PIK3R1
57,GO:0000118,0.712861262973216,0.649729687827465,1,61,histone deacetylase complex,CC,SIN3B
10461,GO:0038061,0.713049163962694,0.547011259192119,2,118,NIK/NF-kappaB signaling,BP,PSMB10;AKT1
18387,GO:0101003,0.713629349184619,0.648839090775152,1,60,ficolin-1-rich granule membrane,CC,PKP1
9429,GO:0034399,0.713751873064885,0.546065586866354,2,121,nuclear periphery,CC,SPTBN4;RNASEL
6361,GO:0018149,0.714503679919362,0.647816574014796,1,59,peptide cross-linking,BP,KRT10
19294,GO:1902749,0.714931304105258,0.544636058015775,2,119,regulation of cell cycle G2/M phase transition,BP,PSMB10;FOXO4
1636,GO:0003725,0.715109851353473,0.646997574260695,1,60,double-stranded RNA binding,MF,MSN
20290,GO:1904888,0.715148043598648,0.646887914074418,1,61,cranial skeletal system development,BP,BMP4
11632,GO:0044106,0.715731710143127,0.543656490448669,2,118,cellular amine metabolic process,BP,PSMB10;SARDH
14005,GO:0051298,0.717090317229113,0.644459777049726,1,61,centrosome duplication,BP,RAB6C
13653,GO:0050776,0.719111695126058,0.371745053768855,16,860,regulation of immune response,BP,CFB;FADD;PRKACB;PYCARD;TYRO3;PSMB10;PIK3R2;PIK3R1;TICAM1;HRAS;WNT5A;CLCF1;NMI;BCAR1;PIK3CA;PDE4B
13654,GO:0050777,0.719152392798269,0.539306285574024,2,120,negative regulation of immune response,BP,TYRO3;NMI
3028,GO:0006171,0.72049894443164,0.537581344173726,2,121,cAMP biosynthetic process,BP,MRAP;EDN1
14929,GO:0060402,0.720720119821751,0.537235613903786,2,124,calcium ion transport into cytosol,BP,CASQ2;NOL3
9912,GO:0035580,0.721100213635587,0.639467133787114,1,60,specific granule lumen,CC,RAB27A
14300,GO:0051881,0.721251363365417,0.639275463430058,1,60,regulation of mitochondrial membrane potential,BP,PMAIP1
18978,GO:1901983,0.722782362058914,0.63726632909537,1,61,regulation of protein acetylation,BP,LIF
11936,GO:0044839,0.723550552955608,0.457754914556442,4,236,cell cycle G2/M phase transition,BP,PHLDA1;PSMB10;FOXO4;CDKN1A
14156,GO:0051588,0.724028409281656,0.635614860703632,1,62,regulation of neurotransmitter transport,BP,GDNF
18117,GO:0098661,0.72437462494968,0.532611727161397,2,123,inorganic anion transmembrane transport,BP,TTYH1;FXYD1
3246,GO:0006521,0.724629792663291,0.634969749082382,1,60,regulation of cellular amino acid metabolic process,BP,PSMB10
11281,GO:0043234,0.725636199300422,0.324769021176445,56,2889,protein complex,CC,ITGA3;ITGA5;WNT3;WNT2;POU3F1;TUBG2;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;FADD;SERPINA5;ZFPM1;TRADD;SALL4;PXMP2;GUCY1B3;CASQ2;PYCARD;PSMB10;CDH2;PRR5L;PIK3R1;CGN;RALB;PXK;SESN2;AXIN1;RBP4;NPR1;CLCF1;ANG;SPTB;CDKN1A;ESPN;VAMP1;GJB1;GJB2;GJB6;CASP4;AKT1;NPPC;CDH1;MYO7A;GJA3;MYH11;HNF1A;VDR;AMOT;LAMA1;LAMA5;FZD8;ACTA2;ETFDH;PDE4B
3131,GO:0006354,0.726130000218457,0.530390286288369,2,122,DNA-templated transcription, elongation,BP,AXIN1;TSFM
2816,GO:0005819,0.728451086997438,0.432325117939664,5,295,spindle,CC,TUBG2;PSRC1;FAM110C;AKT1;UNC119
13348,GO:0048678,0.728568015264019,0.629772430833177,1,62,response to axon injury,BP,JAM3
9517,GO:0034620,0.729073899643233,0.526588095030275,2,123,cellular response to unfolded protein,BP,ACADVL;PIK3R1
7468,GO:0030512,0.730564143714675,0.62706125204729,1,64,negative regulation of transforming growth factor beta receptor signaling pathway,BP,RASL11B
10900,GO:0042542,0.730568607588123,0.52466019459996,2,123,response to hydrogen peroxide,BP,RHOB;STAR
18280,GO:0099023,0.731163089021441,0.626338320235066,1,63,tethering complex,CC,RALB
9712,GO:0035194,0.731232307358771,0.626189794058215,1,64,posttranscriptional gene silencing by RNA,BP,BMP4
2814,GO:0005815,0.731241481631733,0.376173831476789,11,620,microtubule organizing center,CC,TUBG2;RAB6C;MARK4;PRKACB;PXK;FAM110C;CAMSAP3;AKT1;UNC119;FAM110B;PDE4B
13082,GO:0048029,0.731595421329172,0.625833830598757,1,62,monosaccharide binding,MF,PHYH
5616,GO:0015807,0.73195920187032,0.625298100372063,1,63,L-amino acid transport,BP,SLC1A3
19908,GO:1904035,0.733511914165104,0.62326244076219,1,63,regulation of epithelial cell apoptotic process,BP,GAS6
9,GO:0000018,0.734371873865467,0.622131091483773,1,63,regulation of DNA recombination,BP,CLCF1
1540,GO:0003300,0.734638149866196,0.621609868348102,1,66,cardiac muscle hypertrophy,BP,EDN1
21318,GO:2000573,0.734992241526638,0.621313207297787,1,63,positive regulation of DNA biosynthetic process,BP,PDGFB
11356,GO:0043367,0.735465383021223,0.620688442235208,1,63,CD4-positive, alpha-beta T cell differentiation,BP,ZFPM1
18059,GO:0098542,0.735569887356895,0.3897331896097,8,451,defense response to other organism,BP,PMAIP1;FADD;CCL20;PYCARD;TICAM1;HRAS;RNASEL;CHGA
5927,GO:0016441,0.736160516450504,0.619653334769876,1,65,posttranscriptional gene silencing,BP,BMP4
18430,GO:1900006,0.737261668479705,0.618192839443341,1,65,positive regulation of dendrite development,BP,BMP7
1238,GO:0002718,0.737512328723358,0.617975700824123,1,63,regulation of cytokine production involved in immune response,BP,WNT5A
15271,GO:0060968,0.737614275376492,0.617781267681749,1,64,regulation of gene silencing,BP,BMP4
8240,GO:0032024,0.737679256736255,0.617753770727553,1,63,positive regulation of insulin secretion,BP,RBP4
3868,GO:0007612,0.738313610638934,0.514470942243762,2,128,learning,BP,STRA6;CLDN5
3756,GO:0007286,0.738500956407006,0.514287536977612,2,125,spermatid development,BP,DHH;JAM3
10401,GO:0036498,0.738884567630146,0.616089086520524,1,64,IRE1-mediated unfolded protein response,BP,ACADVL
14009,GO:0051303,0.739955848620031,0.614657180296751,1,64,establishment of chromosome localization,BP,PSRC1
11006,GO:0042734,0.740435191242219,0.613902006688746,1,66,presynaptic membrane,CC,ADORA1
2046,GO:0004519,0.740613288863653,0.511508685275372,2,125,endonuclease activity,MF,RNASEL;ANG
3958,GO:0008134,0.740685875986828,0.376371362174481,9,517,transcription factor binding,MF,ZFPM1;PIK3R1;FOXO4;DLL1;IFI27;NAB2;TLE1;VDR;HEY1
19810,GO:1903845,0.741903402892895,0.611929285051214,1,66,negative regulation of cellular response to transforming growth factor beta stimulus,BP,RASL11B
7499,GO:0030574,0.742098592159108,0.611666392585666,1,66,collagen catabolic process,BP,PEPD
486,GO:0001508,0.742460420257124,0.508946434668023,2,131,action potential,BP,DSC2;KCNH2
17607,GO:0090502,0.742589564851105,0.611117958183766,1,64,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,RNASEL
635,GO:0001764,0.743212244824842,0.50797029649595,2,130,neuron migration,BP,ITGA3;GAS6
17209,GO:0075733,0.743981915829925,0.60917818099077,1,65,intracellular transport of virus,BP,NMT2
4705,GO:0009988,0.744051867864846,0.609141204940446,1,64,cell-cell recognition,BP,MSN
4530,GO:0009308,0.744925331987641,0.505798680973101,2,125,amine metabolic process,BP,PSMB10;SARDH
13465,GO:0050000,0.745244619756709,0.607464695503093,1,65,chromosome localization,BP,PSRC1
5315,GO:0014897,0.745376013209371,0.607122544032845,1,68,striated muscle hypertrophy,BP,EDN1
2305,GO:0004872,0.745801835594804,0.319490332840903,29,1537,receptor activity,MF,ITGA5;EBP;ADRA2B;ADRA2C;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;P2RY14;ACVR1;GUCY1B3;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;GHR;KCNH2;NPR1;SDC4;GRIA3;DDR1;CLDN1;CLDN3;VDR;AMOT;FZD8;EFNB2
14714,GO:0060089,0.745801835594804,0.319490332840903,29,1537,molecular transducer activity,MF,ITGA5;EBP;ADRA2B;ADRA2C;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;P2RY14;ACVR1;GUCY1B3;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;GHR;KCNH2;NPR1;SDC4;GRIA3;DDR1;CLDN1;CLDN3;VDR;AMOT;FZD8;EFNB2
13673,GO:0050805,0.74601944783815,0.606353912906363,1,66,negative regulation of synaptic transmission,BP,ADORA1
17606,GO:0090501,0.746394678013849,0.50379918498375,2,127,RNA phosphodiester bond hydrolysis,BP,RNASEL;ANG
5354,GO:0015077,0.74701385821578,0.39540700900132,6,354,monovalent inorganic cation transmembrane transporter activity,MF,KCNK6;KCNH2;KCNG2;CYB5A;KCND1;SLC1A3
2702,GO:0005635,0.747109449283334,0.384483486402671,7,412,nuclear envelope,CC,EBP;RAB40B;MGST2;TYRO3;IFI27;PTGES;DHCR7
19226,GO:1902581,0.749415489429824,0.601703314342426,1,66,multi-organism cellular localization,BP,NMT2
19228,GO:1902583,0.749415489429824,0.601703314342426,1,66,multi-organism intracellular transport,BP,NMT2
8844,GO:0032947,0.750159729541746,0.600569696322924,1,68,protein complex scaffold,MF,AXIN1
7895,GO:0031338,0.750172580908991,0.600660246087863,1,66,regulation of vesicle fusion,BP,TBC1D14
243,GO:0000502,0.751742771417707,0.598546390374287,1,65,proteasome complex,CC,PSMB10
1629,GO:0003712,0.751858224562412,0.362977378899237,9,521,transcription cofactor activity,MF,WNT4;POU3F1;ACTN2;NMI;PCBD1;NAB2;TLE1;SIN3B;ZCCHC12
13988,GO:0051279,0.752298795876334,0.597609825678147,1,68,regulation of release of sequestered calcium ion into cytosol,BP,CASQ2
1558,GO:0003333,0.752651015297036,0.597174236399967,1,67,amino acid transmembrane transport,BP,SLC1A3
13691,GO:0050830,0.753311541434684,0.596367855591665,1,65,defense response to Gram-positive bacterium,BP,CHGA
1888,GO:0004252,0.755416558322519,0.445269411988807,3,186,serine-type endopeptidase activity,MF,CFB;RHBDL3;PLAU
5314,GO:0014896,0.756119611262889,0.592173362442918,1,70,muscle hypertrophy,BP,EDN1
3747,GO:0007270,0.756330912092549,0.49030564964311,2,132,neuron-neuron synaptic transmission,BP,ADORA1;GDNF
2867,GO:0005901,0.756372417798293,0.591869155474495,1,69,caveola,CC,CDH1
20485,GO:1905369,0.756995152950124,0.59115550481467,1,66,endopeptidase complex,CC,PSMB10
13260,GO:0048515,0.757849135217011,0.488274025168889,2,130,spermatid differentiation,BP,DHH;JAM3
6537,GO:0019219,0.758129162228701,0.283713671555004,77,3966,regulation of nucleobase-containing compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;CLCF1;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CHGA;PCBD1;AKT1;IFI27;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
7356,GO:0030279,0.759261663097549,0.587845498717491,1,68,negative regulation of ossification,BP,NOTCH1
3563,GO:0006970,0.759540482753844,0.587450312931728,1,68,response to osmotic stress,BP,CLDN1
12811,GO:0046794,0.759704914479191,0.587217102547611,1,68,transport of virus,BP,NMT2
18780,GO:1901360,0.760202840467986,0.276158178870276,117,5915,organic cyclic compound metabolic process,BP,ITGA3;EBP;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PNMT;GADD45A;FADD;DHH;WNT6;WNT7A;HSD17B3;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;HMGCS2;ACVR1;SALL4;GUCY1B3;HSD17B11;DKK3;EDN1;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;GHR;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;NNMT;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;GALT;RHOQ;NPR1;CYP17A1;PFKFB3;PSRC1;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;AOX1;SHPK;HEXB;CHGA;NOL3;HSD3B2;NUDT7;CTGF;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;KITLG;IDH1;NPPC;NAB2;CDH1;PUS1;PTMS;TLE1;STAR;PIK3CA;GAS6;SIN3B;ACP5;ZCCHC12;CYP11A1;LZTS1;DERA;DHCR7;PTS;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
7835,GO:0031256,0.76137381309065,0.483363180637241,2,134,leading edge membrane,CC,ITGA5;ADORA1
2802,GO:0005791,0.762923221760399,0.582629720635218,1,68,rough endoplasmic reticulum,CC,EDN1
3071,GO:0006261,0.763212837223243,0.480865342110204,2,132,DNA-dependent DNA replication,BP,BMP6;BMP4
3605,GO:0007032,0.76495932637206,0.579651640778545,1,69,endosome organization,BP,RAB27A
11394,GO:0043414,0.765932586648588,0.403886836244978,4,251,macromolecule methylation,BP,HSD17B10;ETFB;PIK3CA;RAB3D
13916,GO:0051171,0.766330135867625,0.273847386107747,82,4223,regulation of nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;FADD;WNT6;WNT7A;MRAP;APOC1;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;FABP3;CHGA;PCBD1;AKT1;IFI27;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;GLA;ZCCHC12;LZTS1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
17986,GO:0097581,0.766371466161706,0.577560770608695,1,70,lamellipodium organization,BP,PARVB
3746,GO:0007269,0.767733637788405,0.474531991719212,2,135,neurotransmitter secretion,BP,SYT5;WNT7A
18380,GO:0099643,0.767733637788405,0.474531991719212,2,135,signal release from synapse,BP,SYT5;WNT7A
3233,GO:0006501,0.768057334240461,0.575166778538549,1,69,C-terminal protein lipidation,BP,PRND
7154,GO:0022892,0.769238585496008,0.305212671908078,20,1110,substrate-specific transporter activity,MF,TF;SLC31A2;SLC45A4;ABCG1;KCNK6;TTYH1;KCNH2;FXYD1;RBP4;SLC2A14;SFXN1;FABP3;GRIA3;STAR;KCNG2;GAS6;CYB5A;KCND1;SLC1A3;CLDN16
3859,GO:0007600,0.771286588059649,0.311468154639444,16,886,sensory perception,BP,ADRA2C;CDH23;SLC52A3;ADORA1;EDN1;SPTBN4;RBP4;B3GNT2;ESPN;HEXB;GJB2;GJB6;MYO7A;GJA3;UNC119;SLC1A3
9352,GO:0034248,0.771496801385506,0.36468348983269,6,366,regulation of cellular amide metabolic process,BP,SESN2;ANG;BMP4;TSFM;AKT1;RBMS3
3495,GO:0006865,0.771679268030125,0.469004676619554,2,135,amino acid transport,BP,ADORA1;SLC1A3
5368,GO:0015103,0.771894658885449,0.468701600841871,2,135,inorganic anion transmembrane transporter activity,MF,TTYH1;FXYD1
10000,GO:0035710,0.772311114649478,0.5688884798983,1,70,CD4-positive, alpha-beta T cell activation,BP,ZFPM1
4358,GO:0009064,0.772454956848036,0.568676539846994,1,70,glutamine family amino acid metabolic process,BP,SLC1A3
292,GO:0000792,0.773085054240539,0.567696271633645,1,71,heterochromatin,CC,SALL4
13649,GO:0050772,0.773517281686585,0.566960182050817,1,73,positive regulation of axonogenesis,BP,WNT3
8532,GO:0032481,0.774259752585116,0.56595862431315,1,71,positive regulation of type I interferon production,BP,TICAM1
20806,GO:1990542,0.775560475852707,0.564078351930271,1,70,mitochondrial transmembrane transport,BP,CPT2
2907,GO:0005977,0.77645957717099,0.562638350650757,1,72,glycogen metabolic process,BP,AKT1
7386,GO:0030317,0.778035920802965,0.560281149446955,1,72,flagellated sperm motility,BP,RGN
2975,GO:0006073,0.780789398011083,0.556088003790504,1,73,cellular glucan metabolic process,BP,AKT1
11614,GO:0044042,0.780789398011083,0.556088003790504,1,73,glucan metabolic process,BP,AKT1
13420,GO:0048814,0.781009307910584,0.555708207543486,1,74,regulation of dendrite morphogenesis,BP,LZTS1
7798,GO:0031146,0.781034613280559,0.555815768749045,1,71,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB10
9730,GO:0035249,0.782604758880167,0.553288934178256,1,74,synaptic transmission, glutamatergic,BP,ADORA1
7440,GO:0030426,0.782676243961686,0.453242552857409,2,141,growth cone,CC,ITGA3;ANG
11683,GO:0044243,0.782692807381024,0.553155078201841,1,74,multicellular organismal catabolic process,BP,PEPD
14075,GO:0051436,0.783119341706035,0.552652419916172,1,71,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
10150,GO:0035967,0.785062113562922,0.449849030740789,2,138,cellular response to topologically incorrect protein,BP,ACADVL;PIK3R1
18028,GO:0097722,0.786218294159477,0.547765726535075,1,74,sperm motility,BP,RGN
5353,GO:0015075,0.786660774458395,0.295825561684688,15,861,ion transmembrane transporter activity,MF,TF;SLC31A2;SLC45A4;KCNK6;TTYH1;KCNH2;FXYD1;SFXN1;GRIA3;KCNG2;GAS6;CYB5A;KCND1;SLC1A3;CLDN16
11885,GO:0044728,0.78686411240748,0.546772148147658,1,74,DNA methylation or demethylation,BP,PIK3CA
12223,GO:0045582,0.786903051736866,0.54675985569678,1,73,positive regulation of T cell differentiation,BP,PNP
3222,GO:0006486,0.78723048374455,0.375481296429441,4,261,protein glycosylation,BP,ALG5;DPM3;EXTL1;B3GNT2
11393,GO:0043413,0.78723048374455,0.375481296429441,4,261,macromolecule glycosylation,BP,ALG5;DPM3;EXTL1;B3GNT2
14078,GO:0051439,0.787729620777868,0.54553428729021,1,72,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
3697,GO:0007193,0.788109076936355,0.54485121909827,1,74,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,ADORA1
13875,GO:0051117,0.788144807803233,0.544795979108464,1,74,ATPase binding,MF,RALB
11040,GO:0042787,0.788500594321615,0.400212695181429,3,200,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10;AXIN1;RNF144A
3715,GO:0007215,0.789632853325239,0.542398128401591,1,76,glutamate receptor signaling pathway,BP,GRIA3
6128,GO:0016810,0.790415639122617,0.442032866095073,2,139,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,ASAH2;SIN3B
2528,GO:0005230,0.791476884764126,0.53957102491786,1,75,extracellular ligand-gated ion channel activity,MF,GRIA3
12745,GO:0046634,0.791855471708395,0.539025987854954,1,74,regulation of alpha-beta T cell activation,BP,PNP
7456,GO:0030496,0.793051195928981,0.43810778512511,2,142,midbody,CC,RALB;PSRC1
5466,GO:0015293,0.793052911733113,0.438122299294768,2,141,symporter activity,MF,SLC45A4;SLC1A3
8782,GO:0032846,0.7967891836592,0.388508852676434,3,203,positive regulation of homeostatic process,BP,CASQ2;EDN1;NPR1
7441,GO:0030427,0.797375209739185,0.431637841597198,2,146,site of polarized growth,CC,ITGA3;ANG
6423,GO:0018410,0.800180188604221,0.52574328411075,1,76,C-terminal protein amino acid modification,BP,PRND
3086,GO:0006282,0.800740238242258,0.524798669611033,1,77,regulation of DNA repair,BP,FGF10
13970,GO:0051252,0.801238271212683,0.238048228937664,69,3624,regulation of RNA metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;PCBD1;AKT1;IFI27;PKP3;PKP1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
9923,GO:0035591,0.802335464904979,0.52218313748879,1,78,signaling adaptor activity,MF,PIK3R1
7153,GO:0022891,0.803539368350363,0.272905835440985,16,925,substrate-specific transmembrane transporter activity,MF,TF;SLC31A2;SLC45A4;KCNK6;TTYH1;KCNH2;FXYD1;SLC2A14;SFXN1;GRIA3;KCNG2;GAS6;CYB5A;KCND1;SLC1A3;CLDN16
9012,GO:0033238,0.804160021332877,0.519314409668669,1,76,regulation of cellular amine metabolic process,BP,PSMB10
11815,GO:0044450,0.804223970598498,0.421350092294202,2,147,microtubule organizing center part,CC,TUBG2;PDE4B
14076,GO:0051437,0.804482486946956,0.518789955696041,1,76,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,PSMB10
5401,GO:0015171,0.804534175862808,0.518616970690224,1,78,amino acid transmembrane transporter activity,MF,SLC1A3
7594,GO:0030819,0.806217002726509,0.515870676966942,1,78,positive regulation of cAMP biosynthetic process,BP,MRAP
15724,GO:0070085,0.806824825379756,0.348498678806577,4,269,glycosylation,BP,ALG5;DPM3;EXTL1;B3GNT2
2445,GO:0005096,0.806835778040064,0.348471522374748,4,271,GTPase activator activity,MF,RIN3;TBC1D14;PIK3R2;AXIN1
8597,GO:0032587,0.809491670543718,0.510399269333426,1,80,ruffle membrane,CC,ITGA5
20174,GO:1904667,0.809647110675621,0.51027117571445,1,77,negative regulation of ubiquitin protein ligase activity,BP,PSMB10
5760,GO:0016079,0.809730581450069,0.510004046504853,1,80,synaptic vesicle exocytosis,BP,SYT5
3069,GO:0006259,0.809824575973984,0.265270983173089,16,927,DNA metabolic process,BP,GADD45A;RGN;FGF10;PDGFB;HRAS;SESN2;CLCF1;BMP6;BMP4;CDKN1A;CTGF;AKT1;KITLG;NPPC;PTMS;PIK3CA
5999,GO:0016575,0.81011889898673,0.509361018341794,1,80,histone deacetylation,BP,SIN3B
1217,GO:0002697,0.810636952392789,0.326045263563165,5,324,regulation of immune effector process,BP,CFB;FADD;WNT5A;RBP4;CLCF1
14203,GO:0051668,0.811629660909449,0.506851650459756,1,80,localization within membrane,BP,CDH2
12872,GO:0046914,0.811845952320275,0.25052826133898,23,1303,transition metal ion binding,MF,TMEM163;PHYH;TF;DHH;RABIF;PRND;LIMS2;RGN;GALT;CYP17A1;ANG;WT1;AOX1;DRP2;NUDT7;PEPD;ACP5;DTX4;ZCCHC12;CYP11A1;S100B;VDR;RNF144A
15860,GO:0070301,0.81425572425302,0.502460584864403,1,80,cellular response to hydrogen peroxide,BP,RHOB
4023,GO:0008236,0.814746865952109,0.362547423155363,3,207,serine-type peptidase activity,MF,CFB;RHBDL3;PLAU
3959,GO:0008135,0.814912464141913,0.501356600949983,1,80,translation factor activity, RNA binding,MF,TSFM
14762,GO:0060170,0.815760173322952,0.49988697772156,1,81,ciliary membrane,CC,SPTBN5
7736,GO:0031058,0.816041029046265,0.499412823460378,1,81,positive regulation of histone modification,BP,LIF
6527,GO:0019208,0.816404437613097,0.498798656387124,1,81,phosphatase regulator activity,MF,BMP2
3585,GO:0007005,0.816465561634976,0.288580875728328,8,495,mitochondrion organization,BP,PMAIP1;PYCARD;HSD17B10;SESN2;NOL3;AKT1;PUS1;RAB38
11196,GO:0043112,0.816692654564888,0.402199207155806,2,149,receptor metabolic process,BP,EDN1;GPRASP1
6243,GO:0017048,0.817546577297914,0.49678425751898,1,83,Rho GTPase binding,MF,DAAM2
6677,GO:0019730,0.818389439951372,0.495514644246532,1,79,antimicrobial humoral response,BP,CHGA
11163,GO:0043043,0.818799956171123,0.274104132992216,10,605,peptide biosynthetic process,BP,MRPL14;MRPL16;BDH2;MGST2;SESN2;ANG;BMP4;TSFM;AKT1;RBMS3
13944,GO:0051213,0.818946221138191,0.494442337940703,1,82,dioxygenase activity,MF,PHYH
7797,GO:0031145,0.8207870133241,0.491375700606198,1,80,anaphase-promoting complex-dependent catabolic process,BP,PSMB10
6314,GO:0017171,0.82228139746283,0.351373746991241,3,210,serine hydrolase activity,MF,CFB;RHBDL3;PLAU
6246,GO:0017053,0.823844205826075,0.485907409457103,1,85,transcriptional repressor complex,CC,ZFPM1
2808,GO:0005798,0.824121876221388,0.485502130722167,1,83,Golgi-associated vesicle,CC,RHOQ
1082,GO:0002449,0.825009140375078,0.347279802224223,3,212,lymphocyte mediated immunity,BP,RAB27A;FADD;CLCF1
8211,GO:0031974,0.82550271851547,0.207511068224282,90,4694,membrane-enclosed lumen,CC,PDK4;WNT3;WNT4;POU3F1;ACTN2;PHYH;NOTCH1;GLDC;RAB27A;IFI30;TF;GADD45A;MSRA;CRISPLD2;MRPL14;MRPL16;MRI1;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;TBC1D14;CASQ2;ACSF2;EDN1;PHLDA1;PNP;MRO;PRKACB;SPTBN4;PYCARD;LAGE3;ACADVL;ACSM5;MAPK12;PSMB10;FSTL3;FGF18;ARL6IP4;PDGFB;FOXO4;CPT2;HSD17B10;ETFB;WNT5B;WNT5A;MAGEC2;HACL1;PFKFB3;PSRC1;RNASEL;SDC4;ANG;NMI;ACAT1;TSFM;WT1;IDUA;CDKN1A;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;AKT1;PKP3;PKP1;CYTIP;PTGES;IDH1;DECR1;PUS1;TLE1;STAR;GAS6;SIN3B;GLA;ECI1;ZCCHC12;CYP11A1;DERA;PM20D2;VDR;DUSP5;HEY1;ETFDH
11280,GO:0043233,0.82550271851547,0.207511068224282,90,4694,organelle lumen,CC,PDK4;WNT3;WNT4;POU3F1;ACTN2;PHYH;NOTCH1;GLDC;RAB27A;IFI30;TF;GADD45A;MSRA;CRISPLD2;MRPL14;MRPL16;MRI1;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;TBC1D14;CASQ2;ACSF2;EDN1;PHLDA1;PNP;MRO;PRKACB;SPTBN4;PYCARD;LAGE3;ACADVL;ACSM5;MAPK12;PSMB10;FSTL3;FGF18;ARL6IP4;PDGFB;FOXO4;CPT2;HSD17B10;ETFB;WNT5B;WNT5A;MAGEC2;HACL1;PFKFB3;PSRC1;RNASEL;SDC4;ANG;NMI;ACAT1;TSFM;WT1;IDUA;CDKN1A;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;AKT1;PKP3;PKP1;CYTIP;PTGES;IDH1;DECR1;PUS1;TLE1;STAR;GAS6;SIN3B;GLA;ECI1;ZCCHC12;CYP11A1;DERA;PM20D2;VDR;DUSP5;HEY1;ETFDH
15688,GO:0070013,0.82550271851547,0.207511068224282,90,4694,intracellular organelle lumen,CC,PDK4;WNT3;WNT4;POU3F1;ACTN2;PHYH;NOTCH1;GLDC;RAB27A;IFI30;TF;GADD45A;MSRA;CRISPLD2;MRPL14;MRPL16;MRI1;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;TBC1D14;CASQ2;ACSF2;EDN1;PHLDA1;PNP;MRO;PRKACB;SPTBN4;PYCARD;LAGE3;ACADVL;ACSM5;MAPK12;PSMB10;FSTL3;FGF18;ARL6IP4;PDGFB;FOXO4;CPT2;HSD17B10;ETFB;WNT5B;WNT5A;MAGEC2;HACL1;PFKFB3;PSRC1;RNASEL;SDC4;ANG;NMI;ACAT1;TSFM;WT1;IDUA;CDKN1A;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;AKT1;PKP3;PKP1;CYTIP;PTGES;IDH1;DECR1;PUS1;TLE1;STAR;GAS6;SIN3B;GLA;ECI1;ZCCHC12;CYP11A1;DERA;PM20D2;VDR;DUSP5;HEY1;ETFDH
4810,GO:0010468,0.825787653890772,0.208446512333026,81,4258,regulation of gene expression,BP,ITGA3;CFB;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;PRKACB;EBF1;PYCARD;MAPK12;FZD7;PSMB10;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;MSN;NOL3;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;FAM46A;NAB2;CDH1;TLE1;STAR;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;SHC4;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
21580,GO:2001141,0.826406075929281,0.210544549603734,66,3508,regulation of RNA biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;PCBD1;AKT1;IFI27;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
7610,GO:0030838,0.826558660919758,0.481258391186555,1,83,positive regulation of actin filament polymerization,BP,PYCARD
4351,GO:0009057,0.826734640044092,0.236989069274714,20,1153,macromolecule catabolic process,BP,USE1;PMAIP1;PSMB10;RGN;PRR5L;WNT5A;MAGEC2;GPRASP1;AXIN1;SDC4;IDUA;HEXB;MSN;AKT1;PKP3;PKP1;RAB12;ARAF;LYPLAL1;RNF144A
4836,GO:0010522,0.828036631094284,0.478591227548201,1,85,regulation of calcium ion transport into cytosol,BP,CASQ2
17505,GO:0090277,0.829155474259304,0.476697843110256,1,83,positive regulation of peptide hormone secretion,BP,RBP4
3001,GO:0006112,0.830195917261482,0.474782908365645,1,85,energy reserve metabolic process,BP,AKT1
4638,GO:0009755,0.8306627227039,0.338709413132784,3,218,hormone-mediated signaling pathway,BP,BMP7;BMP4;VDR
7818,GO:0031225,0.830765600495763,0.379888686000328,2,152,anchored component of membrane,CC,PRND;TFPI
3515,GO:0006892,0.831382101771619,0.472605991240752,1,87,post-Golgi vesicle-mediated transport,BP,RABIF
14082,GO:0051444,0.832076411767086,0.471520329908766,1,83,negative regulation of ubiquitin-protein transferase activity,BP,PSMB10
3458,GO:0006807,0.834117146839889,0.194768191807342,128,6563,nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GLDC;PNMT;ITGB8;FASN;GADD45A;MSRA;MRPL14;MRPL16;MRI1;FADD;WNT6;WNT7A;MRAP;APOC1;ZFPM1;TRADD;SLC52A3;ACVR1;SALL4;GUCY1B3;DKK3;EXTL1;EDN1;PNP;ABCG1;EBF1;BDH2;PYCARD;MBOAT2;LAGE3;MGST2;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;GHR;FSTL3;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;NNMT;FOXO4;PLA2G16;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;GALT;RHOQ;NPR1;PFKFB3;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;AOX1;SARDH;SHPK;HEXB;FABP3;CHGA;NOL3;NUDT7;CTGF;CPT1C;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;KITLG;IDH1;NPPC;NAB2;CDH1;PUS1;PTMS;TLE1;PIK3CA;GAS6;SIN3B;PEPD;ACP5;GLA;ZCCHC12;LZTS1;DERA;PTS;RBMS3;HNF1A;VDR;GDNF;SLC1A3;FZD8;HEY1;PIM2;PDE4B
1223,GO:0002703,0.834214305046006,0.374301069176221,2,153,regulation of leukocyte mediated immunity,BP,FADD;CLCF1
3161,GO:0006402,0.834293221481752,0.333194356201964,3,217,mRNA catabolic process,BP,PRR5L;PKP3;PKP1
3510,GO:0006886,0.834450424111108,0.229190100361069,19,1108,intracellular protein transport,BP,RAB27A;TBC1D14;ADORA1;FZD7;PRR5L;PIK3R2;PIK3R1;RHOB;BMP7;BMP6;BMP4;CDKN1A;NOL3;AKT1;IFI27;CDH1;MYO7A;GAS6;RPH3AL
20175,GO:1904668,0.83484966037894,0.466518188857761,1,84,positive regulation of ubiquitin protein ligase activity,BP,PSMB10
3620,GO:0007052,0.835033278705466,0.466076704444337,1,87,mitotic spindle organization,BP,PSRC1
19319,GO:1902850,0.835033278705466,0.466076704444337,1,87,microtubule cytoskeleton organization involved in mitosis,BP,PSRC1
21538,GO:2001020,0.835410062333892,0.372329159119675,2,155,regulation of response to DNA damage stimulus,BP,PMAIP1;FGF10
11561,GO:0043901,0.836306423080509,0.370882720279023,2,154,negative regulation of multi-organism process,BP,RNASEL;NPPC
14068,GO:0051427,0.836524747006787,0.37049836772255,2,156,hormone receptor binding,MF,NPPC;VDR
19837,GO:1903901,0.838536032521282,0.459772325637408,1,86,negative regulation of viral life cycle,BP,RNASEL
4820,GO:0010498,0.838894045942428,0.274818044473216,6,398,proteasomal protein catabolic process,BP,PMAIP1;PSMB10;AXIN1;AKT1;ARAF;RNF144A
20447,GO:1905269,0.840451489984342,0.45620078262546,1,88,positive regulation of chromatin organization,BP,LIF
7271,GO:0030163,0.840899913589882,0.234416701579176,13,792,protein catabolic process,BP,USE1;PMAIP1;PSMB10;RGN;WNT5A;MAGEC2;AXIN1;MSN;AKT1;RAB12;ARAF;LYPLAL1;RNF144A
6841,GO:0021543,0.84121821570312,0.362725789121416,2,161,pallium development,BP,CDH2;FGF8
3218,GO:0006479,0.841355878456465,0.362524687660935,2,159,protein methylation,BP,ETFB;RAB3D
4011,GO:0008213,0.841355878456465,0.362524687660935,2,159,protein alkylation,BP,ETFB;RAB3D
20484,GO:1905368,0.84167803139713,0.454019403895201,1,86,peptidase complex,CC,PSMB10
2319,GO:0004896,0.844529738223688,0.448671402105648,1,88,cytokine receptor activity,MF,GHR
1641,GO:0003735,0.845691562781265,0.355390973402291,2,154,structural constituent of ribosome,MF,MRPL14;MRPL16
2812,GO:0005813,0.846852479244608,0.254899262547675,7,467,centrosome,CC,TUBG2;RAB6C;MARK4;PRKACB;CAMSAP3;UNC119;PDE4B
19631,GO:1903506,0.846882206943032,0.187537783578877,65,3489,regulation of nucleic acid-templated transcription,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;PCBD1;AKT1;IFI27;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
3244,GO:0006518,0.848538931925521,0.227682804274246,12,735,peptide metabolic process,BP,MRPL14;MRPL16;BDH2;MGST2;SESN2;ANG;BMP4;TSFM;AKT1;IDH1;GAS6;RBMS3
5992,GO:0016567,0.849500548540444,0.223348907640079,13,800,protein ubiquitination,BP,TSPAN17;FBXO41;RAB40B;RAB40A;PSMB10;TICAM1;MAGEC2;AXIN1;NMI;AKT1;SPSB1;DTX4;RNF144A
6750,GO:0019886,0.849835551936383,0.438644178361072,1,90,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,IFI30
11009,GO:0042742,0.85007114510816,0.308660025791892,3,222,defense response to bacterium,BP,CCL20;PYCARD;CHGA
3215,GO:0006476,0.851532546155723,0.43535338701967,1,92,protein deacetylation,BP,SIN3B
7867,GO:0031301,0.85183782859994,0.344961088500677,2,160,integral component of organelle membrane,CC,TMEM163;ETFDH
3691,GO:0007186,0.852506065734774,0.205343624103949,20,1157,G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;ACTN2;P2RY14;NMT2;ADORA1;EDN1;PRKACB;CCL20;FZD7;LPAR2;GPRASP1;NPR1;CHGA;AKT1;BCAR1;PIK3CG;RPH3AL;GPSM1;FZD8
3574,GO:0006986,0.852743171385904,0.343409829878421,2,161,response to unfolded protein,BP,ACADVL;PIK3R1
6778,GO:0019955,0.852979650642802,0.43262053277466,1,91,cytokine binding,MF,ACVR1
18923,GO:1901796,0.853382414216268,0.342296087703691,2,163,regulation of signal transduction by p53 class mediator,BP,PMAIP1;AKT1
5021,GO:0010822,0.853776137814719,0.341637428468649,2,162,positive regulation of mitochondrion organization,BP,PMAIP1;PYCARD
18025,GO:0097711,0.853910120374053,0.430770169183664,1,93,ciliary basal body docking,BP,MARK4
1878,GO:0004175,0.85458490539111,0.252608479722959,6,405,endopeptidase activity,MF,CFB;RHBDL3;PLAU;PYCARD;PSMB10;CASP4
1630,GO:0003713,0.858162599502026,0.273334507440171,4,294,transcription coactivator activity,MF,POU3F1;ACTN2;PCBD1;ZCCHC12
7745,GO:0031072,0.860784030473258,0.417357663416547,1,94,heat shock protein binding,MF,ADORA1
20173,GO:1904666,0.861129158672545,0.416740192419997,1,92,regulation of ubiquitin protein ligase activity,BP,PSMB10
6024,GO:0016607,0.861628041604801,0.253200127333018,5,355,nuclear speck,CC,GADD45A;ARL6IP4;FOXO4;WT1;ZCCHC12
6023,GO:0016605,0.861827050556887,0.415266967872144,1,95,PML body,CC,SPTBN4
4228,GO:0008565,0.861835980448445,0.415249296247948,1,95,protein transporter activity,MF,ABCG1
19838,GO:1903902,0.862422985279389,0.414117022048609,1,94,positive regulation of viral life cycle,BP,NOTCH1
11017,GO:0042752,0.86429077445339,0.410339114346871,1,96,regulation of circadian rhythm,BP,ADORA1
3104,GO:0006304,0.864476363895756,0.409998353481832,1,95,DNA modification,BP,PIK3CA
2883,GO:0005929,0.864487615621684,0.230112755638315,7,479,cilium,CC,MARK4;RAB27A;PRKACB;SPTBN5;PRKAR1B;AKT1;MYO7A
7508,GO:0030594,0.865367988385381,0.408213453663191,1,95,neurotransmitter receptor activity,MF,GRIA3
18159,GO:0098781,0.866103355782851,0.40673685640127,1,95,ncRNA transcription,BP,ANG
3603,GO:0007030,0.866230985117988,0.406391969286105,1,98,Golgi organization,BP,SPTBN5
11235,GO:0043170,0.866831337419588,0.157242202771231,169,8633,macromolecule metabolic process,BP,ITGA3;ITGA5;ARTN;CFB;PDK4;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;USE1;POU3F1;ACTN2;TSPAN15;TSPAN17;ALG5;NOTCH1;MARK4;RAB27A;DPM3;ITGB8;PMAIP1;GADD45A;MSRA;RHBDL3;FBXO41;MRPL14;MRPL16;FADD;DHH;SERPINA5;WNT6;WNT7A;WNT7B;APOC1;ZFPM1;TRADD;ACVR1;NMT2;SALL4;ADORA1;DKK3;EXTL1;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;ABCG1;PRKACB;MFGE8;CCL20;EBF1;SPTBN5;SPTBN4;PYCARD;LAGE3;KRT10;PRND;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HSD17B10;ETFB;HRAS;WNT5A;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;PKN3;HEXB;WNK4;MSN;NOL3;DDR1;DEPTOR;CTGF;PCBD1;CASP4;AKT1;IFI27;PKP3;PKP1;RAB12;NRTN;FAM46A;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;PUS1;INHBB;PTMS;MDP1;SPSB1;TFPI;TLE1;STAR;PIK3CA;PIK3CG;GAS6;SIN3B;PEPD;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;RBMS3;HNF1A;VDR;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
17066,GO:0072509,0.868325422378341,0.316188740828385,2,174,divalent inorganic cation transmembrane transporter activity,MF,GAS6;CLDN16
8871,GO:0032991,0.868485219302929,0.159574053948017,86,4576,macromolecular complex,CC,ITGA3;ITGA5;WNT3;WNT2;POU3F1;TUBG2;TSPAN17;NOTCH1;GLDC;DPM3;STRA6;TF;ITGB5;ITGB4;ITGB8;MRPL14;MRPL16;FADD;SERPINA5;APOC1;ZFPM1;TRADD;ACVR1;SALL4;PXMP2;GUCY1B3;CASQ2;PRKACB;KCNK6;PYCARD;TTYH1;PSMB10;CDH2;PRR5L;GHR;PIK3R2;PIK3R1;TICAM1;CGN;KCNH2;PRKAR1B;RALB;PXK;HSD17B10;SESN2;AXIN1;FXYD1;RBP4;NPR1;CLCF1;ANG;SPTB;BMP2;CDKN1A;ESPN;VAMP1;GRIA3;DDR1;GJB1;GJB2;GJB6;CPT1C;CASP4;AKT1;PKP3;PKP1;NPPC;CDH1;MYO7A;GJA3;PIK3CA;PIK3CG;KCNG2;SIN3B;MYH11;HNF1A;VDR;AMOT;LAMA1;LAMA5;KCND1;FZD8;ACTA2;RNF144A;ETFDH;PDE4B
2869,GO:0005903,0.868589717306128,0.401625672592724,1,98,brush border,CC,ESPN
5319,GO:0014902,0.869965303581186,0.398826264825958,1,98,myotube differentiation,BP,NOTCH1
3143,GO:0006368,0.87101685383468,0.39670513335722,1,97,transcription elongation from RNA polymerase II promoter,BP,AXIN1
3480,GO:0006839,0.871724896016434,0.252259330495917,4,296,mitochondrial transport,BP,PMAIP1;SLC25A53;CPT2;NOL3
11694,GO:0044257,0.871954076400718,0.203624469724598,10,652,cellular protein catabolic process,BP,PMAIP1;PSMB10;RGN;MAGEC2;AXIN1;MSN;AKT1;RAB12;ARAF;RNF144A
20730,GO:1990204,0.873008019101171,0.392639665449572,1,96,oxidoreductase complex,CC,GLDC
14822,GO:0060271,0.873233501401633,0.249841034177788,4,305,cilium assembly,BP,NOTCH1;MARK4;RAB17;LAMA5
7866,GO:0031300,0.8745466890126,0.305096861105255,2,170,intrinsic component of organelle membrane,CC,TMEM163;ETFDH
11541,GO:0043687,0.874673868109761,0.389131404071538,1,98,post-translational protein modification,BP,PRND
18011,GO:0097659,0.875292750057433,0.154478677681296,67,3636,nucleic acid-templated transcription,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
5750,GO:0016064,0.876012004128929,0.386343762283729,1,98,immunoglobulin mediated immune response,BP,CLCF1
11146,GO:0043021,0.876802211252795,0.384662554583286,1,99,ribonucleoprotein complex binding,MF,RNASEL
5906,GO:0016410,0.877609727497805,0.382940408443423,1,100,N-acyltransferase activity,MF,NMT2
340,GO:0000932,0.878388154663077,0.381274755723606,1,101,P-body,CC,GHR
4848,GO:0010556,0.87853722510665,0.149743792759165,73,3946,regulation of macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;CCL20;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;KITLG;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
12317,GO:0045727,0.87862119609261,0.380810238275088,1,100,positive regulation of translation,BP,RBMS3
6045,GO:0016651,0.878641469419981,0.380823170697288,1,98,oxidoreductase activity, acting on NAD(P)H,MF,DECR1
11907,GO:0044782,0.879507016140389,0.239846832441043,4,309,cilium organization,BP,NOTCH1;MARK4;RAB17;LAMA5
11210,GO:0043130,0.88076364520702,0.376242883884233,1,101,ubiquitin binding,MF,MARK4
6675,GO:0019724,0.881202624781339,0.375334786962089,1,100,B cell mediated immunity,BP,CLCF1
2847,GO:0005874,0.881203479586369,0.223450727237316,5,376,microtubule,CC,TUBG2;PSRC1;FAM110C;CAMSAP3;RAB3D
3006,GO:0006119,0.88141853855693,0.374901794447385,1,99,oxidative phosphorylation,BP,ACTN3
3326,GO:0006611,0.881870443688986,0.291665418475378,2,176,protein export from nucleus,BP,IFI27;GAS6
20732,GO:1990234,0.882785211271166,0.18514318274305,11,719,transferase complex,CC,TSPAN17;DPM3;ACVR1;PYCARD;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG;RNF144A
19836,GO:1903900,0.883584899155648,0.288504808864037,2,175,regulation of viral life cycle,BP,NOTCH1;RNASEL
3976,GO:0008168,0.884232340522083,0.287292791620107,2,176,methyltransferase activity,MF,PNMT;NNMT
11422,GO:0043484,0.884267615919255,0.368680376317146,1,103,regulation of RNA splicing,BP,PIK3R1
5355,GO:0015078,0.885325210568424,0.36644492309017,1,101,hydrogen ion transmembrane transporter activity,MF,CYB5A
4021,GO:0008234,0.886382732307242,0.283254547835148,2,179,cysteine-type peptidase activity,MF,PYCARD;CASP4
11261,GO:0043204,0.88653827530605,0.363731019506907,1,104,perikaryon,CC,DRP2
11229,GO:0043161,0.887265647882433,0.214043315850755,5,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,PSMB10;AXIN1;AKT1;ARAF;RNF144A
7070,GO:0021987,0.888296618099251,0.359813254097693,1,107,cerebral cortex development,BP,CDH2
10149,GO:0035966,0.888829104318423,0.278672727125968,2,178,response to topologically incorrect protein,BP,ACADVL;PIK3R1
5422,GO:0015197,0.89038768727056,0.355228529391079,1,106,peptide transporter activity,MF,ABCG1
3160,GO:0006401,0.890661292506211,0.241340764658577,3,246,RNA catabolic process,BP,PRR5L;PKP3;PKP1
3132,GO:0006355,0.890910386873098,0.136970363305442,63,3465,regulation of transcription, DNA-templated,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;PCBD1;AKT1;IFI27;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
9518,GO:0034622,0.891519515779322,0.163389267082256,15,947,cellular macromolecular complex assembly,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;PYCARD;RALB;AXIN1;PSRC1;ANG;SPTB;VAMP1;NOL3;MYH11;TMOD4
3128,GO:0006351,0.891617649482701,0.13561858564958,66,3617,transcription, DNA-templated,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
3327,GO:0006612,0.89181668504159,0.273017983135638,2,178,protein targeting to membrane,BP,ADORA1;GAS6
19237,GO:1902600,0.892355493524753,0.350903659832151,1,104,hydrogen ion transmembrane transport,BP,CYB5A
13267,GO:0048524,0.892910853341734,0.349613589808945,1,106,positive regulation of viral process,BP,NOTCH1
11560,GO:0043900,0.893082563751751,0.204880323394575,5,373,regulation of multi-organism process,BP,NOTCH1;RNASEL;BMP6;NPPC;INHBB
2810,GO:0005802,0.893836816955766,0.269116691924513,2,183,trans-Golgi network,CC,CDH1;RAB38
13268,GO:0048525,0.894283136209844,0.346534528681046,1,106,negative regulation of viral process,BP,RNASEL
11779,GO:0044391,0.894827683395344,0.267274969004576,2,177,ribosomal subunit,CC,MRPL14;MRPL16
401,GO:0001046,0.894978275414169,0.34489789673424,1,109,core promoter sequence-specific DNA binding,MF,ZFPM1
10951,GO:0042626,0.895364588551192,0.344025289641376,1,109,ATPase activity, coupled to transmembrane movement of substances,MF,ABCG1
11820,GO:0044455,0.896292385220704,0.264437026629635,2,179,mitochondrial membrane part,CC,STAR;ETFDH
4473,GO:0009205,0.896334048621414,0.231396491024593,3,248,purine ribonucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
3883,GO:0007631,0.897390973899295,0.339470360798585,1,107,feeding behavior,BP,STRA6
4020,GO:0008233,0.897727658422574,0.171378848766952,9,614,peptidase activity,MF,CFB;RHBDL3;DHH;PLAU;PYCARD;PSMB10;CASP4;PEPD;PM20D2
2547,GO:0005262,0.899608732486741,0.334234150188795,1,114,calcium channel activity,MF,GAS6
17143,GO:0072655,0.899698393088396,0.257794144301512,2,183,establishment of protein localization to mitochondrion,BP,PMAIP1;AKT1
6136,GO:0016820,0.899809361431301,0.333835533390667,1,111,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,ABCG1
11275,GO:0043228,0.900147025191814,0.125276042818647,68,3749,non-membrane-bounded organelle,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;MSRA;MRPL14;MRPL16;MRI1;TRADD;SALL4;CASQ2;HSD17B11;PHLDA1;PNP;MRO;PRKACB;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;KRT10;CDH2;GHR;FGF18;CGN;ARL6IP4;PLEKHH2;PTPN7;FRMPD1;CPT2;PXK;MAGEC2;PSTPIP2;RHOQ;PSRC1;SDC4;ANG;FAM110C;SPTB;CAMSAP3;WT1;CDKN1A;HMGN5;ESPN;MSN;NOL3;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;SIN3B;MYH11;AMOT;UNC119;RAB3D;ACSL4;MYZAP;FAM110B;ACTA2;PARVB;PDE4B;TMOD4
11279,GO:0043232,0.900147025191814,0.125276042818647,68,3749,intracellular non-membrane-bounded organelle,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;MSRA;MRPL14;MRPL16;MRI1;TRADD;SALL4;CASQ2;HSD17B11;PHLDA1;PNP;MRO;PRKACB;SPTBN5;SPTBN4;PYCARD;G0S2;ACADVL;KRT10;CDH2;GHR;FGF18;CGN;ARL6IP4;PLEKHH2;PTPN7;FRMPD1;CPT2;PXK;MAGEC2;PSTPIP2;RHOQ;PSRC1;SDC4;ANG;FAM110C;SPTB;CAMSAP3;WT1;CDKN1A;HMGN5;ESPN;MSN;NOL3;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;SIN3B;MYH11;AMOT;UNC119;RAB3D;ACSL4;MYZAP;FAM110B;ACTA2;PARVB;PDE4B;TMOD4
16035,GO:0070585,0.903030273312059,0.251243068904442,2,185,protein localization to mitochondrion,BP,PMAIP1;AKT1
11234,GO:0043169,0.903252416143072,0.120928210511178,73,4015,cation binding,MF,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;PHYH;NOTCH1;GLDC;CDH23;TF;ZFYVE21;RHBDL3;DHH;DSC2;SERPINA5;APOC1;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;CASQ2;PRKACB;EBF1;TTYH1;PRND;ACSM5;MAPK12;LIMS2;RGN;CDH2;HACL1;SESN2;GALT;NUAK2;CYP17A1;RNASEL;ANG;ACAT1;WT1;CDKN1A;DLL1;AOX1;DRP2;NOL3;NUDT7;DDR1;DSG3;TPD52;PON2;IDH1;JAG2;CDH1;MDP1;HPCAL1;GAS6;PEPD;ACP5;DTX4;ZCCHC12;CYP11A1;RPH3AL;S100B;CYB5A;PTS;DSC3;VDR;ARAF;KCND1;RNF144A;ETFDH;PDE4B
2779,GO:0005765,0.903315724454264,0.200626814017575,4,322,lysosomal membrane,CC,RAB12;MYO7A;RAB44;RAB3D
18202,GO:0098852,0.903315724454264,0.200626814017575,4,322,lytic vacuole membrane,CC,RAB12;MYO7A;RAB44;RAB3D
3878,GO:0007623,0.903602301470217,0.250079608470958,2,189,circadian rhythm,BP,ADORA1;STAR
6086,GO:0016741,0.903657396984033,0.249987851510022,2,187,transferase activity, transferring one-carbon groups,MF,PNMT;NNMT
11505,GO:0043604,0.904679791292425,0.15762362491007,10,676,amide biosynthetic process,BP,MRPL14;MRPL16;BDH2;MGST2;SESN2;ANG;BMP4;TSFM;AKT1;RBMS3
19759,GO:1903749,0.90508074895684,0.321543226957076,1,111,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
4467,GO:0009199,0.905090085740202,0.215729173568158,3,254,ribonucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
4418,GO:0009144,0.906615788085652,0.212960136702996,3,255,purine nucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
8724,GO:0032774,0.90812218003262,0.115852067871954,68,3751,RNA biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
10072,GO:0035821,0.908354628197455,0.313717964167852,1,113,modification of morphology or physiology of other organism,BP,CHGA
13913,GO:0051168,0.909051760735404,0.23919038326204,2,192,nuclear export,BP,IFI27;GAS6
2752,GO:0005730,0.910276375618761,0.141721971260299,13,861,nucleolus,CC,MRI1;PHLDA1;MRO;PYCARD;ACADVL;FGF18;ARL6IP4;CPT2;MAGEC2;ANG;WT1;CDKN1A;NOL3
2852,GO:0005882,0.91066099116453,0.235967256073557,2,189,intermediate filament,CC,KRT10;PKP1
17632,GO:0090575,0.910930516526719,0.307470550449464,1,115,RNA polymerase II transcription factor complex,CC,VDR
5501,GO:0015399,0.911999329323226,0.304834045033165,1,117,primary active transmembrane transporter activity,MF,ABCG1
5503,GO:0015405,0.911999329323226,0.304834045033165,1,117,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCG1
14893,GO:0060359,0.913474339989221,0.301247182813869,1,116,response to ammonium ion,BP,FADD
9354,GO:0034250,0.913740642368256,0.300593393717845,1,116,positive regulation of cellular amide metabolic process,BP,RBMS3
12654,GO:0046467,0.914110966962043,0.29968283378651,1,116,membrane lipid biosynthetic process,BP,DPM3
413,GO:0001078,0.91502761648887,0.297402719729421,1,117,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,ZFPM1
11697,GO:0044260,0.915904844376935,0.101782978219415,153,7982,cellular macromolecule metabolic process,BP,ITGA3;ITGA5;ARTN;PDK4;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN2;TSPAN17;ALG5;NOTCH1;MARK4;DPM3;PMAIP1;GADD45A;MSRA;FBXO41;MRPL14;MRPL16;FADD;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;TRADD;ACVR1;NMT2;SALL4;ADORA1;DKK3;EXTL1;EDN1;RAB40B;RAB40A;PHLDA1;ABCG1;PRKACB;MFGE8;CCL20;EBF1;SPTBN5;SPTBN4;PYCARD;LAGE3;KRT10;PRND;MAPK12;FZD7;TYRO3;PSMB10;RGN;CDH2;FADS1;PRR5L;GHR;FSTL3;FGF18;FGF10;FGF17;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HSD17B10;ETFB;HRAS;WNT5A;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PSRC1;RNASEL;FGF8;SDC4;CLCF1;ANG;SPTB;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;TSFM;WT1;IDUA;CDKN1A;DLL1;HMGN5;PKN3;HEXB;WNK4;MSN;NOL3;DDR1;DEPTOR;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;RAB12;NRTN;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;PUS1;INHBB;PTMS;MDP1;SPSB1;TFPI;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;RBMS3;HNF1A;VDR;ARAF;UNC119;RAB3D;GDNF;LYPLAL1;FZD8;DUSP5;HEY1;RNF144A;PIM2
3237,GO:0006508,0.916824011419374,0.117115844676685,27,1634,proteolysis,BP,CFB;PMAIP1;RHBDL3;FADD;DHH;SERPINA5;TRADD;PLAU;PRKACB;PYCARD;MAPK12;PSMB10;RGN;FOXO4;AXIN1;NOL3;CTGF;CASP4;AKT1;IFI27;CST9L;TFPI;GAS6;PEPD;PM20D2;ARAF;RNF144A
9648,GO:0035023,0.919440375132626,0.286268622601007,1,123,regulation of Rho protein signal transduction,BP,ITGA3
8321,GO:0032182,0.920610951363517,0.283337869882064,1,121,ubiquitin-like protein binding,MF,MARK4
563,GO:0001650,0.920826760132465,0.282789243345501,1,121,fibrillar center,CC,MRI1
2045,GO:0004518,0.921551688784061,0.213411021072927,2,199,nuclease activity,MF,RNASEL;ANG
11430,GO:0043492,0.922626125169179,0.27814024340593,1,124,ATPase activity, coupled to movement of substances,MF,ABCG1
3169,GO:0006412,0.92320816568928,0.137370627127554,8,581,translation,BP,MRPL14;MRPL16;SESN2;ANG;BMP4;TSFM;AKT1;RBMS3
6108,GO:0016779,0.923651885503083,0.275534134160555,1,122,nucleotidyltransferase activity,MF,GALT
8503,GO:0032446,0.92440348601122,0.121700021692199,13,882,protein modification by small protein conjugation,BP,TSPAN17;FBXO41;RAB40B;RAB40A;PSMB10;TICAM1;MAGEC2;AXIN1;NMI;AKT1;SPSB1;DTX4;RNF144A
6003,GO:0016579,0.925643233208934,0.17730973797432,3,276,protein deubiquitination,BP,PSMB10;FOXO4;AXIN1
11469,GO:0043543,0.926031168756615,0.203860687266048,2,204,protein acylation,BP,LIF;NMT2
19757,GO:1903747,0.926314929036333,0.268597491609344,1,123,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
6614,GO:0019438,0.927160598468113,0.0921423565570398,77,4252,aromatic compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;PTS;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
4210,GO:0008528,0.928327546163516,0.263303138139422,1,123,G-protein coupled peptide receptor activity,MF,NPR1
566,GO:0001653,0.929838390908317,0.259274595686369,1,124,peptide receptor activity,MF,NPR1
7734,GO:0031056,0.930325311075528,0.257911547162809,1,128,regulation of histone modification,BP,LIF
36,GO:0000070,0.930441418106681,0.257585934024674,1,129,mitotic sister chromatid segregation,BP,PSRC1
3594,GO:0007017,0.930632190561007,0.125738106686964,8,608,microtubule-based process,BP,TUBG2;RAB6C;MARK4;GADD45A;FGF10;AXIN1;PSRC1;CAMSAP3
4994,GO:0010770,0.930692455772436,0.256899090697792,1,130,positive regulation of cell morphogenesis involved in differentiation,BP,WNT3
4415,GO:0009141,0.930930643123875,0.167038723528952,3,275,nucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
5358,GO:0015085,0.931764173749159,0.253976870740462,1,133,calcium ion transmembrane transporter activity,MF,GAS6
15686,GO:0070011,0.932972592727138,0.122049727536,8,596,peptidase activity, acting on L-amino acid peptides,MF,CFB;RHBDL3;PLAU;PYCARD;PSMB10;CASP4;PEPD;PM20D2
12664,GO:0046483,0.934852426874131,0.0811135293303992,105,5674,heterocycle metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GADD45A;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;SLC52A3;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;GHR;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;NNMT;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;GALT;RHOQ;NPR1;PFKFB3;PSRC1;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;AOX1;SHPK;HEXB;CHGA;NOL3;NUDT7;CTGF;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;KITLG;IDH1;NPPC;NAB2;CDH1;PUS1;PTMS;TLE1;STAR;PIK3CA;GAS6;SIN3B;ACP5;ZCCHC12;LZTS1;DERA;PTS;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
12889,GO:0046943,0.936437565132517,0.241247073580192,1,131,carboxylic acid transmembrane transporter activity,MF,SLC1A3
21008,GO:2000112,0.937189128285895,0.0809568496501229,68,3834,regulation of cellular macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;HBEGF;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;PCBD1;AKT1;IFI27;KITLG;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
9540,GO:0034654,0.937692961616389,0.0796615967740108,75,4183,nucleobase-containing compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
2284,GO:0004842,0.937961525557688,0.12979489371811,5,423,ubiquitin-protein transferase activity,MF,TSPAN17;FBXO41;SPSB1;DTX4;RNF144A
9738,GO:0035257,0.93796219367274,0.236982530435775,1,133,nuclear hormone receptor binding,MF,VDR
9530,GO:0034641,0.939355039528262,0.0754164881879863,114,6132,cellular nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;ITGB8;FASN;GADD45A;MRPL14;MRPL16;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;SLC52A3;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;MGST2;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;GHR;FSTL3;FGF10;ASAH2;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;NNMT;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;GALT;RHOQ;NPR1;PFKFB3;PSRC1;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;AOX1;SARDH;SHPK;HEXB;CHGA;NOL3;NUDT7;CTGF;CPT1C;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;KITLG;IDH1;NPPC;NAB2;CDH1;PUS1;PTMS;TLE1;PIK3CA;GAS6;SIN3B;ACP5;GLA;ZCCHC12;LZTS1;DERA;PTS;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
18170,GO:0098798,0.940027809892718,0.231223361422857,1,130,mitochondrial protein complex,CC,ETFDH
16060,GO:0070646,0.940906751389559,0.147059460986101,3,291,protein modification by small protein removal,BP,PSMB10;FOXO4;AXIN1
1303,GO:0002831,0.94104127798098,0.228295821187774,1,134,regulation of response to biotic stimulus,BP,BMP6
6359,GO:0018130,0.941582040300552,0.0748634332061096,76,4246,heterocycle biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;PYCARD;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;PTS;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
7922,GO:0031397,0.942577431317527,0.223908077617232,1,134,negative regulation of protein ubiquitination,BP,PSMB10
3619,GO:0007051,0.942974155716962,0.222704644289456,1,139,spindle organization,BP,PSRC1
5997,GO:0016573,0.943693493010748,0.220643066996487,1,138,histone acetylation,BP,LIF
69,GO:0000139,0.944085404966487,0.101122079432035,9,678,Golgi membrane,CC,NOTCH1;ABCG1;RAB39A;PDGFB;HRAS;B3GNT2;RND3;RAB12;GPSM1
12842,GO:0046872,0.945230488518636,0.0710296912201793,69,3929,metal ion binding,MF,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;PHYH;NOTCH1;CDH23;TF;ZFYVE21;RHBDL3;DHH;DSC2;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;CASQ2;PRKACB;EBF1;TTYH1;PRND;ACSM5;MAPK12;LIMS2;RGN;CDH2;HACL1;GALT;NUAK2;CYP17A1;RNASEL;ANG;ACAT1;WT1;CDKN1A;DLL1;AOX1;DRP2;NOL3;NUDT7;DDR1;DSG3;TPD52;PON2;IDH1;JAG2;CDH1;MDP1;HPCAL1;GAS6;PEPD;ACP5;DTX4;ZCCHC12;CYP11A1;RPH3AL;S100B;CYB5A;PTS;DSC3;VDR;ARAF;KCND1;RNF144A;ETFDH;PDE4B
11919,GO:0044798,0.947499772345872,0.209486557358083,1,140,nuclear transcription factor complex,CC,VDR
6022,GO:0016604,0.947620993616671,0.0954570347995144,9,686,nuclear body,CC,GADD45A;SPTBN4;LAGE3;ARL6IP4;FOXO4;WT1;CDKN1A;AOX1;ZCCHC12
5694,GO:0015931,0.94816815683425,0.153993324609763,2,224,nucleobase-containing compound transport,BP,ADORA1;GJB1
2787,GO:0005774,0.948275735750064,0.11937790702214,4,367,vacuolar membrane,CC,RAB12;MYO7A;RAB44;RAB3D
12032,GO:0045111,0.948507132729338,0.15320067851172,2,222,intermediate filament cytoskeleton,CC,KRT10;PKP1
2583,GO:0005342,0.94877329087827,0.205688518960116,1,141,organic acid transmembrane transporter activity,MF,SLC1A3
8216,GO:0031984,0.948789914387968,0.130731939224674,3,300,organelle subcompartment,CC,REEP1;CDH1;RAB38
10012,GO:0035725,0.948855791015307,0.20540835648914,1,144,sodium ion transmembrane transport,BP,FXYD1
2826,GO:0005840,0.949066574909773,0.151888244698649,2,219,ribosome,CC,MRPL14;MRPL16
6417,GO:0018393,0.94946322829879,0.203601216917886,1,143,internal peptidyl-lysine acetylation,BP,LIF
5464,GO:0015291,0.950954700884933,0.147343094016459,2,227,secondary active transmembrane transporter activity,MF,SLC45A4;SLC1A3
12482,GO:0046034,0.951148802653867,0.146891003550412,2,224,ATP metabolic process,BP,ACTN3;PFKFB3
3566,GO:0006974,0.951318564027516,0.0871708575473077,10,751,cellular response to DNA damage stimulus,BP,PMAIP1;GADD45A;PYCARD;MAPK12;FGF10;PIK3R1;FOXO4;SESN2;CDKN1A;AKT1
11700,GO:0044265,0.95155979346447,0.0816830119825299,13,927,cellular macromolecule catabolic process,BP,PMAIP1;PSMB10;RGN;PRR5L;MAGEC2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;ARAF;RNF144A
6701,GO:0019787,0.952360536994375,0.103624393190208,5,443,ubiquitin-like protein transferase activity,MF,TSPAN17;FBXO41;SPSB1;DTX4;RNF144A
19551,GO:1903321,0.952681500508089,0.193841563371907,1,143,negative regulation of protein modification by small protein conjugation or removal,BP,PSMB10
4809,GO:0010467,0.95294114609804,0.0601030983004347,91,5049,gene expression,BP,ITGA3;CFB;LIF;WNT3;WNT2;WNT4;POU3F1;TSPAN15;NOTCH1;RAB27A;ITGB8;RHBDL3;MRPL14;MRPL16;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;PLAU;ABCG1;PRKACB;EBF1;PYCARD;LAGE3;MAPK12;FZD7;PSMB10;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;MSN;NOL3;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;FAM46A;NAB2;CDH1;PUS1;TLE1;STAR;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;SHC4;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
4195,GO:0008509,0.952975322891227,0.121840741805537,3,304,anion transmembrane transporter activity,MF,TTYH1;FXYD1;SLC1A3
2721,GO:0005667,0.953267255562273,0.121215017779189,3,304,transcription factor complex,CC,POU3F1;ZFPM1;VDR
6418,GO:0018394,0.954535528394487,0.188066747334248,1,148,peptidyl-lysine acetylation,BP,LIF
3214,GO:0006475,0.954651465510458,0.187706393555811,1,148,internal protein amino acid acetylation,BP,LIF
21653,GO:2001252,0.954936898221847,0.186817926373571,1,148,positive regulation of chromosome organization,BP,LIF
9470,GO:0034470,0.955392605320172,0.105363829272889,4,372,ncRNA processing,BP,LAGE3;HSD17B10;RNASEL;PUS1
5357,GO:0015081,0.956226675517772,0.182750978759222,1,151,sodium ion transmembrane transporter activity,MF,SLC1A3
3411,GO:0006725,0.956599719823154,0.0551249226868907,104,5710,cellular aromatic compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PNMT;GADD45A;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;NNMT;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;GALT;RHOQ;NPR1;PFKFB3;PSRC1;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;AOX1;SHPK;HEXB;CHGA;NOL3;NUDT7;CTGF;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;PON2;KITLG;IDH1;NPPC;NAB2;CDH1;PUS1;PTMS;TLE1;STAR;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;DERA;PTS;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
19109,GO:1902275,0.959200561684291,0.173264441468655,1,154,regulation of chromatin organization,BP,LIF
5714,GO:0015992,0.961513545280922,0.165773323271452,1,152,proton transport,BP,CYB5A
3468,GO:0006818,0.963060305806722,0.160655647322718,1,154,hydrogen transport,BP,CYB5A
7726,GO:0031047,0.963600918766615,0.158824440118049,1,158,gene silencing by RNA,BP,BMP4
7544,GO:0030674,0.965371774533518,0.152854053883512,1,161,protein binding, bridging,MF,PIK3R1
3012,GO:0006139,0.966467640554842,0.0432399120467388,99,5512,nucleobase-containing compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GADD45A;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;PYCARD;LAGE3;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;NNMT;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;GALT;RHOQ;NPR1;PFKFB3;PSRC1;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;AOX1;SHPK;HEXB;CHGA;NOL3;NUDT7;CTGF;PCBD1;MDH1;AKT1;IFI27;PKP3;PKP1;KITLG;IDH1;NPPC;NAB2;CDH1;PUS1;PTMS;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;DERA;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
11817,GO:0044452,0.966483764932743,0.149072984453183,1,161,nucleolar part,CC,MRI1
19182,GO:1902494,0.966782707645299,0.0540989603605834,18,1259,catalytic complex,CC,TSPAN17;GLDC;DPM3;FADD;ACVR1;PYCARD;PSMB10;PIK3R2;PIK3R1;TICAM1;HSD17B10;SESN2;FXYD1;CDKN1A;PIK3CA;PIK3CG;SIN3B;RNF144A
9544,GO:0034660,0.9681306531943,0.0690953981146248,6,529,ncRNA metabolic process,BP,LAGE3;HSD17B10;HRAS;RNASEL;ANG;PUS1
412,GO:0001077,0.969401995154064,0.100531544397869,2,255,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,WT1;HNF1A
4111,GO:0008380,0.969640154824385,0.0759013548078447,4,401,RNA splicing,BP,PIK3R1;ARL6IP4;WT1;NOL3
7335,GO:0030246,0.97189927251457,0.0937544576134992,2,256,carbohydrate binding,MF,PHYH;LGALS4
13663,GO:0050792,0.972671378860071,0.09162792976587,2,258,regulation of viral process,BP,NOTCH1;RNASEL
3212,GO:0006473,0.973392603060826,0.124605116773544,1,173,protein acetylation,BP,LIF
14170,GO:0051603,0.973554273982248,0.0558912926149946,7,617,proteolysis involved in cellular protein catabolic process,BP,PMAIP1;PSMB10;RGN;AXIN1;AKT1;ARAF;RNF144A
10373,GO:0036464,0.973707581548854,0.123447107696407,1,174,cytoplasmic ribonucleoprotein granule,CC,GHR
11705,GO:0044271,0.975348145346559,0.0327325930220557,82,4709,cellular nitrogen compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;MRPL14;MRPL16;FADD;WNT6;WNT7A;MRAP;ZFPM1;TRADD;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;PNP;ABCG1;EBF1;BDH2;PYCARD;MGST2;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;NNMT;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;ACAT1;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;GLA;ZCCHC12;LZTS1;PTS;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
1639,GO:0003729,0.975473527813645,0.116903639377568,1,176,mRNA binding,MF,RBMS3
471,GO:0001227,0.976828762755165,0.111787226737026,1,179,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,ZFPM1
7126,GO:0022804,0.977016403863325,0.0667793679789749,3,350,active transmembrane transporter activity,MF,SLC45A4;ABCG1;SLC1A3
4440,GO:0009167,0.977351059526146,0.0784532750977099,2,267,purine ribonucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
4400,GO:0009126,0.977771693603886,0.0772419182911022,2,268,purine nucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
17529,GO:0090305,0.97808922768337,0.0763195585719292,2,271,nucleic acid phosphodiester bond hydrolysis,BP,RNASEL;ANG
16061,GO:0070647,0.978122001943087,0.0390100387921017,14,1072,protein modification by small protein conjugation or removal,BP,TSPAN17;FBXO41;RAB40B;RAB40A;PSMB10;TICAM1;FOXO4;MAGEC2;AXIN1;NMI;AKT1;SPSB1;DTX4;RNF144A
10437,GO:0038023,0.978130654590412,0.0368210823726654,18,1290,signaling receptor activity,MF,EBP;ADRA2B;ADRA2C;P2RY14;ACVR1;ADORA1;FZD7;TYRO3;LPAR2;GHR;KCNH2;NPR1;SDC4;GRIA3;DDR1;CLDN3;VDR;FZD8
17776,GO:0097159,0.978840384500206,0.027794003199333,101,5716,organic cyclic compound binding,MF,PDK4;ADRA2B;ADRA2C;POU3F1;TUBG2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;RASL11B;FASN;GADD45A;MRPL14;MRPL16;ZFPM1;ACVR1;SALL4;GUCY1B3;ADORA1;ACSF2;RAB40B;RAB40A;PNP;ABCG1;PRKACB;EBF1;BDH2;FLVCR2;ACADVL;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;ARL6IP4;PRKAR1B;FOXO4;RALB;HSD17B10;HRAS;WNT5A;KHK;HACL1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;RNASEL;ANG;TSFM;WT1;HMGN5;AOX1;PKN3;RAB20;SHPK;WNK4;RND3;MSN;NOL3;NUDT7;DDR1;ACCS;RRAD;MDH1;AKT1;RAB12;RAB17;FAM46A;IDH1;DECR1;PUS1;MYO7A;LDHD;RAB44;STAR;PIK3CA;PIK3CG;ZCCHC12;CYP11A1;MYH11;LZTS1;DHCR7;CYB5A;RBMS3;HNF1A;VDR;ARAF;RAB38;RAB3D;ACSL4;HEY1;ACTA2;PIM2;ETFDH;PDE4B
7119,GO:0022618,0.978845446941734,0.104026644582884,1,183,ribonucleoprotein complex assembly,BP,NOL3
18361,GO:0099600,0.97885222574742,0.0361507678033593,17,1234,transmembrane receptor activity,MF,EBP;ADRA2B;ADRA2C;P2RY14;ACVR1;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;GHR;KCNH2;NPR1;GRIA3;DDR1;CLDN3;FZD8
4024,GO:0008237,0.978917961076828,0.103744768229784,1,183,metallopeptidase activity,MF,PEPD
10043,GO:0035770,0.979136808312039,0.102883182790024,1,185,ribonucleoprotein granule,CC,GHR
5752,GO:0016070,0.979364432880719,0.0278223166751847,76,4437,RNA metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;LAGE3;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;NOL3;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;NAB2;CDH1;PUS1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
5754,GO:0016072,0.979990603562745,0.0707716422420926,2,273,rRNA metabolic process,BP,RNASEL;ANG
8206,GO:0031965,0.98002702335195,0.0706509594089851,2,280,nuclear membrane,CC,IFI27;DHCR7
4199,GO:0008514,0.980216592255893,0.0986390671244002,1,186,organic anion transmembrane transporter activity,MF,SLC1A3
18163,GO:0098791,0.981130042331945,0.0673812630158154,2,282,Golgi subcompartment,CC,CDH1;RAB38
5532,GO:0015630,0.98113071594905,0.0346975135223885,13,1035,microtubule cytoskeleton,CC,TUBG2;RAB6C;MARK4;PRKACB;PXK;PSRC1;FAM110C;CAMSAP3;AKT1;UNC119;RAB3D;FAM110B;PDE4B
11563,GO:0043903,0.981738189857935,0.0655676723479515,2,280,regulation of symbiosis, encompassing mutualism through parasitism,BP,NOTCH1;RNASEL
4434,GO:0009161,0.981830559940471,0.0652923909539655,2,279,ribonucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
367,GO:0000982,0.982348549994058,0.053300396295912,3,366,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,ZFPM1;WT1;HNF1A
74,GO:0000151,0.982989945937239,0.0617785221322068,2,286,ubiquitin ligase complex,CC,TSPAN17;RNF144A
15581,GO:0061630,0.983191227026374,0.0866014687947738,1,195,ubiquitin protein ligase activity,MF,RNF144A
16704,GO:0071826,0.983647332018433,0.0847160966081798,1,195,ribonucleoprotein complex subunit organization,BP,NOL3
15593,GO:0061659,0.984900316255122,0.0794512544696927,1,200,ubiquitin-like protein ligase activity,MF,RNF144A
4397,GO:0009123,0.985482217808914,0.0540788855193363,2,291,nucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
18783,GO:1901363,0.985599254603596,0.0192627816007573,98,5633,heterocyclic compound binding,MF,PDK4;POU3F1;TUBG2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;RASL11B;FASN;GADD45A;MRPL14;MRPL16;ZFPM1;ACVR1;SALL4;GUCY1B3;ADORA1;ACSF2;RAB40B;RAB40A;PNP;ABCG1;PRKACB;EBF1;BDH2;FLVCR2;ACADVL;RRAS2;RAB39B;RAB39A;ACSM5;MAPK12;TYRO3;ARL6IP4;PRKAR1B;FOXO4;RALB;HSD17B10;HRAS;WNT5A;KHK;HACL1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;CYP17A1;PFKFB3;RNASEL;ANG;TSFM;WT1;HMGN5;AOX1;PKN3;RAB20;SHPK;WNK4;RND3;MSN;NOL3;NUDT7;DDR1;ACCS;RRAD;MDH1;AKT1;RAB12;RAB17;FAM46A;IDH1;DECR1;PUS1;MYO7A;LDHD;RAB44;PIK3CA;PIK3CG;ZCCHC12;CYP11A1;MYH11;LZTS1;DHCR7;CYB5A;RBMS3;HNF1A;VDR;ARAF;RAB38;RAB3D;ACSL4;HEY1;ACTA2;PIM2;ETFDH;PDE4B
312,GO:0000819,0.986396045689452,0.0730288468279532,1,206,sister chromatid segregation,BP,PSRC1
4041,GO:0008270,0.986725586318084,0.0251333282637621,13,1061,zinc ion binding,MF,TMEM163;DHH;RABIF;LIMS2;RGN;GALT;WT1;DRP2;DTX4;ZCCHC12;S100B;VDR;RNF144A
10948,GO:0042623,0.987171643808506,0.0487038645897066,2,305,ATPase activity, coupled,MF,ABCG1;MYO7A
1616,GO:0003682,0.98816568265687,0.0334762623044935,4,470,chromatin binding,MF,NOTCH1;FOXO4;HMGN5;SIN3B
5753,GO:0016071,0.988243383978036,0.0270837715862943,7,674,mRNA metabolic process,BP,PRR5L;ARL6IP4;RNASEL;NOL3;PKP3;PKP1;PUS1
4353,GO:0009059,0.988278656222444,0.016032139873548,84,4943,macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;ALG5;NOTCH1;DPM3;MRPL14;MRPL16;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;NMT2;SALL4;DKK3;EXTL1;EDN1;PHLDA1;ABCG1;CCL20;EBF1;PYCARD;PRND;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;SDC4;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;KITLG;NAB2;CDH1;INHBB;PTMS;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
3239,GO:0006511,0.989462248173835,0.0276932380707536,5,548,ubiquitin-dependent protein catabolic process,BP,PSMB10;AXIN1;AKT1;ARAF;RNF144A
2317,GO:0004888,0.989576764236928,0.0193763955646534,15,1184,transmembrane signaling receptor activity,MF,EBP;ADRA2B;ADRA2C;P2RY14;ACVR1;ADORA1;FZD7;TYRO3;LPAR2;GHR;NPR1;GRIA3;DDR1;CLDN3;FZD8
6775,GO:0019941,0.990513902522284,0.0252188021540337,5,555,modification-dependent protein catabolic process,BP,PSMB10;AXIN1;AKT1;ARAF;RNF144A
11663,GO:0044212,0.990990803518896,0.0203635789518837,8,771,transcription regulatory region DNA binding,MF,NOTCH1;GADD45A;ZFPM1;SALL4;WNT5A;WT1;HNF1A;VDR
3202,GO:0006457,0.991107522955835,0.051615478029956,1,221,protein folding,BP,NPPC
9533,GO:0034645,0.991142768231946,0.0123144110833533,80,4781,cellular macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ALG5;NOTCH1;DPM3;MRPL14;MRPL16;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;NMT2;SALL4;DKK3;EXTL1;EDN1;PHLDA1;ABCG1;EBF1;PYCARD;PRND;MAPK12;FZD7;PSMB10;RGN;FADS1;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;ANG;HBEGF;NMI;BMP7;BMP6;BMP4;BMP2;B3GNT2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;CTGF;PCBD1;AKT1;IFI27;KITLG;NAB2;CDH1;PTMS;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;RBMS3;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
360,GO:0000975,0.991227400639239,0.0198771835002409,8,773,regulatory region DNA binding,MF,NOTCH1;GADD45A;ZFPM1;SALL4;WNT5A;WT1;HNF1A;VDR
406,GO:0001067,0.991339023162317,0.0196472281905181,8,774,regulatory region nucleic acid binding,MF,NOTCH1;GADD45A;ZFPM1;SALL4;WNT5A;WT1;HNF1A;VDR
11524,GO:0043632,0.991339229139794,0.0232525875779527,5,561,modification-dependent macromolecule catabolic process,BP,PSMB10;AXIN1;AKT1;ARAF;RNF144A
17528,GO:0090304,0.992629356920622,0.0102954862466694,82,4910,nucleic acid metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;GADD45A;FADD;WNT6;WNT7A;ZFPM1;TRADD;ACVR1;SALL4;DKK3;EDN1;ABCG1;EBF1;PYCARD;LAGE3;MAPK12;FZD7;PSMB10;RGN;FADS1;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;TICAM1;ARL6IP4;PDGFB;FOXO4;HSD17B10;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;RNASEL;FGF8;CLCF1;ANG;NMI;BMP7;BMP6;BMP4;BMP2;TSFM;WT1;CDKN1A;DLL1;HMGN5;HEXB;NOL3;CTGF;PCBD1;AKT1;IFI27;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;PUS1;PTMS;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;HNF1A;VDR;GDNF;FZD8;HEY1;PIM2
2341,GO:0004930,0.993852826905295,0.0143805895996774,8,775,G-protein coupled receptor activity,MF,ADRA2B;ADRA2C;P2RY14;ADORA1;FZD7;LPAR2;NPR1;FZD8
3140,GO:0006364,0.994445582704912,0.0349197138283016,1,242,rRNA processing,BP,RNASEL
5935,GO:0016458,0.994569810896891,0.0342585263431588,1,248,gene silencing,BP,BMP4
472,GO:0001228,0.994848342356485,0.022285147390067,2,352,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,WT1;HNF1A
3110,GO:0006310,0.994879068260762,0.0326162232542151,1,250,DNA recombination,BP,CLCF1
3155,GO:0006396,0.995063451396298,0.0113039879152201,9,872,RNA processing,BP,LAGE3;PIK3R1;ARL6IP4;HSD17B10;RNASEL;BMP4;WT1;NOL3;PUS1
366,GO:0000981,0.99530870266625,0.0124818701372665,6,676,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,ZFPM1;FOXO4;WT1;HNF1A;VDR;HEY1
7477,GO:0030522,0.995920335424459,0.0269343007053979,1,262,intracellular receptor signaling pathway,BP,VDR
10594,GO:0040029,0.995959431971651,0.0267165154728232,1,262,regulation of gene expression, epigenetic,BP,BMP4
18181,GO:0098813,0.996137376404861,0.0257176997640834,1,265,nuclear chromosome segregation,BP,PSRC1
286,GO:0000785,0.996431379587172,0.013184553057006,3,459,chromatin,CC,SALL4;HMGN5;SIN3B
3156,GO:0006397,0.996738750062289,0.0121714748462027,3,461,mRNA processing,BP,ARL6IP4;RNASEL;NOL3
8908,GO:0033044,0.997217715221199,0.0194615424579187,1,281,regulation of chromosome organization,BP,LIF
14172,GO:0051606,0.997460287076763,0.00770288539213572,5,625,detection of stimulus,BP,NMT2;ADORA1;CASQ2;ABCG1;UNC119
11816,GO:0044451,0.99770969522882,0.00536701891360075,10,1010,nucleoplasm part,CC,GADD45A;SPTBN4;LAGE3;ARL6IP4;FOXO4;WT1;CDKN1A;AOX1;SIN3B;ZCCHC12
6180,GO:0016887,0.997838841950965,0.0104246487472977,2,406,ATPase activity,MF,ABCG1;MYO7A
10721,GO:0042254,0.998099231043749,0.0140428011276742,1,292,ribosome biogenesis,BP,RNASEL
5994,GO:0016570,0.998164837412634,0.00902440394528985,2,410,histone modification,BP,LIF;SIN3B
11486,GO:0043565,0.99819468935201,0.0044664221522633,9,957,sequence-specific DNA binding,MF,POU3F1;NOTCH1;ZFPM1;SALL4;FOXO4;WT1;HNF1A;VDR;HEY1
290,GO:0000790,0.998240573811299,0.0131366150310731,1,300,nuclear chromatin,CC,SIN3B
3623,GO:0007059,0.998435769248949,0.0118675519383933,1,308,chromosome segregation,BP,PSRC1
178,GO:0000377,0.99854613811428,0.0111414507740344,1,306,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,NOL3
190,GO:0000398,0.99854613811428,0.0111414507740344,1,306,mRNA splicing, via spliceosome,BP,NOL3
5993,GO:0016569,0.998549824791342,0.00589569140678957,3,516,covalent chromatin modification,BP,LIF;HMGN5;SIN3B
177,GO:0000375,0.998638084097995,0.010528425676896,1,309,RNA splicing, via transesterification reactions,BP,NOL3
7114,GO:0022613,0.998728461947399,0.00651993499927021,2,420,ribonucleoprotein complex biogenesis,BP,RNASEL;NOL3
7480,GO:0030529,0.998766949769989,0.00368181618561657,6,756,intracellular ribonucleoprotein complex,CC,MRPL14;MRPL16;GHR;HSD17B10;PKP3;PKP1
20910,GO:1990904,0.99878494171428,0.00363236275611471,6,757,ribonucleoprotein complex,CC,MRPL14;MRPL16;GHR;HSD17B10;PKP3;PKP1
6381,GO:0018205,0.999233778596171,0.00637626535139587,1,342,peptidyl-lysine modification,BP,LIF
1625,GO:0003700,0.999456922919198,0.00135333037028354,11,1183,transcription factor activity, sequence-specific DNA binding,MF,POU3F1;NOTCH1;ZFPM1;SALL4;FOXO4;WNT5A;WT1;LZTS1;HNF1A;VDR;HEY1
409,GO:0001071,0.999464485017703,0.00133562262356131,11,1184,nucleic acid binding transcription factor activity,MF,POU3F1;NOTCH1;ZFPM1;SALL4;FOXO4;WNT5A;WT1;LZTS1;HNF1A;VDR;HEY1
4590,GO:0009593,0.999471579667879,0.00297359851356461,2,454,detection of chemical stimulus,BP,CASQ2;ABCG1
1634,GO:0003723,0.999620348878041,0.000849300675516689,16,1541,RNA binding,MF,FASN;MRPL14;MRPL16;ARL6IP4;HSD17B10;RNASEL;ANG;TSFM;WT1;HMGN5;MSN;NOL3;NUDT7;FAM46A;PUS1;RBMS3
3085,GO:0006281,0.999667306836283,0.00195869187864641,2,493,DNA repair,BP,GADD45A;FGF10
3115,GO:0006325,0.999786543737123,0.000885139674816496,4,709,chromatin organization,BP,LIF;ZFPM1;HMGN5;SIN3B
1620,GO:0003690,0.999834261196601,0.000700578246815762,4,723,double-stranded DNA binding,MF,ZFPM1;WT1;HNF1A;HEY1
3865,GO:0007608,0.999852115408929,0.00148259929296165,1,402,sensory perception of smell,BP,B3GNT2
362,GO:0000977,0.99987001196442,0.000834147939058153,2,542,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ZFPM1;HNF1A
388,GO:0001012,0.999872354891892,0.000820418638036354,2,543,RNA polymerase II regulatory region DNA binding,MF,ZFPM1;HNF1A
20893,GO:1990837,0.999888499261116,0.000568863003368932,3,653,sequence-specific double-stranded DNA binding,MF,ZFPM1;HNF1A;HEY1
11819,GO:0044454,0.999959928347828,0.000455895250268745,1,476,nuclear chromosome part,CC,SIN3B
13745,GO:0050906,0.999964926398979,0.00040400721145691,1,468,detection of stimulus involved in sensory perception,BP,ADORA1
3864,GO:0007606,0.999969002610277,0.000361042146833162,1,473,sensory perception of chemical stimulus,BP,B3GNT2
361,GO:0000976,0.999970502830804,0.000213849625943769,2,618,transcription regulatory region sequence-specific DNA binding,MF,ZFPM1;HNF1A
113,GO:0000228,0.999979290740622,0.0002498243455827,1,508,nuclear chromosome,CC,SIN3B
11798,GO:0044428,0.999982153062461,3.25585160564681e-05,53,4050,nuclear part,CC,EBP;POU3F1;NOTCH1;GADD45A;MSRA;MRI1;ZFPM1;SALL4;TBC1D14;RAB40B;PHLDA1;MRO;PRKACB;SPTBN4;PYCARD;LAGE3;ACADVL;MGST2;MAPK12;TYRO3;PSMB10;FSTL3;FGF18;ARL6IP4;FOXO4;CPT2;MAGEC2;PFKFB3;PSRC1;RNASEL;ANG;NMI;WT1;CDKN1A;AOX1;NOL3;PCBD1;AKT1;IFI27;PKP3;PKP1;CYTIP;PTGES;DECR1;TLE1;SIN3B;ZCCHC12;DHCR7;PM20D2;VDR;AMOT;DUSP5;HEY1
11797,GO:0044427,0.999992734239397,4.49312119555671e-05,3,793,chromosomal part,CC,SALL4;HMGN5;SIN3B
2711,GO:0005654,0.999994810232904,1.07866835018176e-05,36,3159,nucleoplasm,CC,POU3F1;NOTCH1;GADD45A;MSRA;MRI1;ZFPM1;SALL4;TBC1D14;PRKACB;SPTBN4;LAGE3;MAPK12;PSMB10;FSTL3;ARL6IP4;FOXO4;CPT2;PFKFB3;PSRC1;NMI;WT1;CDKN1A;AOX1;PCBD1;AKT1;PKP3;PKP1;CYTIP;DECR1;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
8213,GO:0031981,0.999995699242378,8.48197530895282e-06,45,3713,nuclear lumen,CC,POU3F1;NOTCH1;GADD45A;MSRA;MRI1;ZFPM1;SALL4;TBC1D14;PHLDA1;MRO;PRKACB;SPTBN4;PYCARD;LAGE3;ACADVL;MAPK12;PSMB10;FSTL3;FGF18;ARL6IP4;FOXO4;CPT2;MAGEC2;PFKFB3;PSRC1;RNASEL;ANG;NMI;WT1;CDKN1A;AOX1;NOL3;PCBD1;AKT1;PKP3;PKP1;CYTIP;DECR1;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
2742,GO:0005694,0.999999021266369,6.82211358171099e-06,3,897,chromosome,CC,SALL4;HMGN5;SIN3B
13987,GO:0051276,0.999999169030221,4.27523749510865e-06,5,1106,chromosome organization,BP,LIF;ZFPM1;PSRC1;HMGN5;SIN3B
2701,GO:0005634,0.999999873351508,2.337309714903e-07,93,6684,nucleus,CC,EBP;BEX4;POU3F1;RAB6C;NOTCH1;GLDC;ITGB4;PMAIP1;GADD45A;MSRA;MRI1;FADD;ZFPM1;TRADD;SALL4;TBC1D14;RAB40B;PHLDA1;PNP;MRO;PRKACB;EBF1;SPTBN4;PYCARD;LAGE3;ACADVL;KRT10;MGST2;MAPK12;TYRO3;PSMB10;LIMS2;RGN;FSTL3;FGF18;FGF10;PIK3R2;PIK3R1;ARL6IP4;FOXO4;CPT2;TJP3;HRAS;MAGEC2;SESN2;AXIN1;RHOB;NUAK2;PFKFB3;PSRC1;RNASEL;ANG;FAM110C;NMI;TSFM;WT1;CDKN1A;HMGN5;AOX1;PKN3;SLC2A14;F8A1;MSN;NOL3;NUDT6;PCBD1;AKT1;IFI27;PKP3;PKP1;PON2;CYTIP;PTGES;DECR1;NAB2;PUS1;EPN1;PTMS;TLE1;SIN3B;ZCCHC12;DERA;S100B;DHCR7;PM20D2;HNF1A;VDR;AMOT;LAMA5;SH3BP4;DOK1;DUSP5;HEY1
1613,GO:0003677,0.999999999674418,1.29220051435229e-09,15,2382,DNA binding,MF,POU3F1;NOTCH1;GADD45A;ZFPM1;SALL4;EBF1;FOXO4;WNT5A;ANG;WT1;HMGN5;LZTS1;HNF1A;VDR;HEY1
3,GO:0000009,1,0.978910866225711,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.958133986410002,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.843342562884877,0,8,single strand break repair,BP,
6,GO:0000014,1,0.864502339177674,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.91782900054146,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000016,1,0.980527527997882,0,1,lactase activity,MF,
10,GO:0000019,1,0.900334131441321,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.80925297189889,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.940336854957939,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.939762480928384,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.629376220468097,0,22,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.722369146492373,0,15,ribosomal small subunit assembly,BP,
17,GO:0000032,1,0.978668801600268,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.937625029727558,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.957982772018758,0,2,acyl binding,MF,
20,GO:0000036,1,0.978471214322306,0,1,ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process,MF,
23,GO:0000042,1,0.686166914525999,0,19,protein targeting to Golgi,BP,
25,GO:0000049,1,0.352863468963191,0,49,tRNA binding,MF,
26,GO:0000050,1,0.790527645974523,0,11,urea cycle,BP,
27,GO:0000052,1,0.848759594523133,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.978688479522968,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.773488846066112,0,12,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.861112396734245,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.879608342414769,0,6,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.709864775101596,0,16,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.940380176930877,0,3,L-ornithine transmembrane transporter activity,MF,
35,GO:0000066,1,0.958121710814489,0,2,mitochondrial ornithine transport,BP,
38,GO:0000076,1,0.695776999521167,0,17,DNA replication checkpoint,BP,
42,GO:0000083,1,0.589670558323904,0,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
44,GO:0000095,1,0.978852367704527,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
47,GO:0000098,1,0.808581327283841,0,10,sulfur amino acid catabolic process,BP,
48,GO:0000099,1,0.865444438174052,0,7,sulfur amino acid transmembrane transporter activity,MF,
49,GO:0000101,1,0.880440338734416,0,6,sulfur amino acid transport,BP,
50,GO:0000103,1,0.937910805375977,0,3,sulfate assimilation,BP,
51,GO:0000104,1,0.917663598579391,0,4,succinate dehydrogenase activity,MF,
52,GO:0000105,1,0.958414588555189,0,2,histidine biosynthetic process,BP,
53,GO:0000109,1,0.729155761857567,0,15,nucleotide-excision repair complex,CC,
54,GO:0000110,1,0.939809995334268,0,3,nucleotide-excision repair factor 1 complex,CC,
55,GO:0000111,1,0.979071537988483,0,1,nucleotide-excision repair factor 2 complex,CC,
56,GO:0000117,1,0.980033286583452,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
58,GO:0000120,1,0.898614886059065,0,5,RNA polymerase I transcription factor complex,CC,
59,GO:0000121,1,0.979066574543881,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.195276528443774,0,78,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.790954695723087,0,11,SAGA complex,CC,
63,GO:0000125,1,0.903949058308469,0,5,PCAF complex,CC,
64,GO:0000126,1,0.963370202897237,0,2,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.882056501465006,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000137,1,0.880884098409961,0,6,Golgi cis cisterna,CC,
68,GO:0000138,1,0.898907081885199,0,5,Golgi trans cisterna,CC,
73,GO:0000150,1,0.843059221369725,0,8,recombinase activity,MF,
75,GO:0000152,1,0.449598966792636,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.776358838266931,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.560680701056746,0,27,rRNA modification,BP,
79,GO:0000159,1,0.654930043329021,0,20,protein phosphatase type 2A complex,CC,
81,GO:0000164,1,0.809842415347362,0,10,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.978558918485875,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.958765184612199,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.958765184612199,0,2,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.978626132147022,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.556460009945911,0,28,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.790662703949847,0,11,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.807884604662991,0,10,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.626173135770431,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.917811775442796,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.817892109999959,0,10,rDNA binding,MF,
94,GO:0000183,1,0.433033803835653,0,39,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.0779904623458819,0,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
100,GO:0000189,1,0.941974460301878,0,3,MAPK import into nucleus,BP,
102,GO:0000210,1,0.979069535472492,0,1,NAD+ diphosphatase activity,MF,
103,GO:0000212,1,0.802060539461015,0,11,meiotic spindle organization,BP,
104,GO:0000213,1,0.917810650896593,0,4,tRNA-intron endonuclease activity,MF,
105,GO:0000214,1,0.917735270238224,0,4,tRNA-intron endonuclease complex,CC,
106,GO:0000215,1,0.97849493469943,0,1,tRNA 2'-phosphotransferase activity,MF,
107,GO:0000217,1,0.614656792405103,0,23,DNA secondary structure binding,MF,
108,GO:0000220,1,0.881246676490753,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
109,GO:0000221,1,0.939228434929412,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
110,GO:0000224,1,0.978967955395732,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
111,GO:0000225,1,0.978513166931619,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
114,GO:0000229,1,0.957573788800649,0,2,cytoplasmic chromosome,CC,
115,GO:0000235,1,0.904398655404739,0,5,astral microtubule,CC,
117,GO:0000243,1,0.842147139035107,0,8,commitment complex,CC,
118,GO:0000244,1,0.77706250743919,0,12,spliceosomal tri-snRNP complex assembly,BP,
120,GO:0000246,1,0.97919254046201,0,1,delta24(24-1) sterol reductase activity,MF,
123,GO:0000250,1,0.979181173777904,0,1,lanosterol synthase activity,MF,
124,GO:0000252,1,0.978610437250493,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
125,GO:0000253,1,0.936996650270355,0,3,3-keto sterol reductase activity,MF,
126,GO:0000254,1,0.97897493185122,0,1,C-4 methylsterol oxidase activity,MF,
128,GO:0000256,1,0.97856963137963,0,1,allantoin catabolic process,BP,
129,GO:0000257,1,0.978550427424545,0,1,nitrilase activity,MF,
130,GO:0000262,1,0.978608941058058,0,1,mitochondrial chromosome,CC,
131,GO:0000266,1,0.507019891818822,0,33,mitochondrial fission,BP,
132,GO:0000268,1,0.898840138574465,0,5,peroxisome targeting sequence binding,MF,
133,GO:0000270,1,0.859161291047345,0,7,peptidoglycan metabolic process,BP,
135,GO:0000272,1,0.54477668584181,0,29,polysaccharide catabolic process,BP,
136,GO:0000274,1,0.978468652759428,0,1,mitochondrial proton-transporting ATP synthase, stator stalk,CC,
137,GO:0000275,1,0.91686909719335,0,4,mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),CC,
138,GO:0000276,1,0.805190421086691,0,10,mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),CC,
144,GO:0000288,1,0.223712777685023,0,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
145,GO:0000289,1,0.498067348758672,0,34,nuclear-transcribed mRNA poly(A) tail shortening,BP,
146,GO:0000290,1,0.829858063533331,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
147,GO:0000291,1,0.477887633109059,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
148,GO:0000293,1,0.938548685736323,0,3,ferric-chelate reductase activity,MF,
149,GO:0000294,1,0.959264607043302,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
150,GO:0000295,1,0.790657977848439,0,11,adenine nucleotide transmembrane transporter activity,MF,
151,GO:0000296,1,0.978877397748273,0,1,spermine transport,BP,
152,GO:0000298,1,0.918287180998757,0,4,endopolyphosphatase activity,MF,
153,GO:0000301,1,0.617062911514614,0,24,retrograde transport, vesicle recycling within Golgi,BP,
157,GO:0000306,1,0.939225143227265,0,3,extrinsic component of vacuolar membrane,CC,
159,GO:0000308,1,0.959071390522475,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
160,GO:0000309,1,0.939027367313167,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
162,GO:0000314,1,0.569113293447374,0,26,organellar small ribosomal subunit,CC,
164,GO:0000320,1,0.94073452565351,0,3,re-entry into mitotic cell cycle,BP,
165,GO:0000322,1,0.938527946946019,0,3,storage vacuole,CC,
167,GO:0000333,1,0.959953011544867,0,2,telomerase catalytic core complex,CC,
168,GO:0000334,1,0.978535374216238,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
169,GO:0000338,1,0.806672649989078,0,10,protein deneddylation,BP,
170,GO:0000339,1,0.729472076840019,0,15,RNA cap binding,MF,
171,GO:0000340,1,0.863310103419597,0,7,RNA 7-methylguanosine cap binding,MF,
172,GO:0000346,1,0.758480901853997,0,13,transcription export complex,CC,
173,GO:0000347,1,0.880020771367027,0,6,THO complex,CC,
174,GO:0000349,1,0.978900931820457,0,1,generation of catalytic spliceosome for first transesterification step,BP,
175,GO:0000350,1,0.937470362137009,0,3,generation of catalytic spliceosome for second transesterification step,BP,
176,GO:0000354,1,0.960708534125679,0,2,cis assembly of pre-catalytic spliceosome,BP,
179,GO:0000379,1,0.937751280934829,0,3,tRNA-type intron splice site recognition and cleavage,BP,
180,GO:0000380,1,0.36297743868368,0,48,alternative mRNA splicing, via spliceosome,BP,
181,GO:0000381,1,0.458039042152486,0,37,regulation of alternative mRNA splicing, via spliceosome,BP,
182,GO:0000384,1,0.9577105789769,0,2,first spliceosomal transesterification activity,MF,
183,GO:0000386,1,0.958161824972738,0,2,second spliceosomal transesterification activity,MF,
184,GO:0000387,1,0.444300225773155,0,38,spliceosomal snRNP assembly,BP,
185,GO:0000389,1,0.880464153955096,0,6,mRNA 3'-splice site recognition,BP,
186,GO:0000390,1,0.958018289075364,0,2,spliceosomal complex disassembly,BP,
187,GO:0000393,1,0.917687168781743,0,4,spliceosomal conformational changes to generate catalytic conformation,BP,
188,GO:0000394,1,0.694277370701914,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
189,GO:0000395,1,0.880020643699346,0,6,mRNA 5'-splice site recognition,BP,
191,GO:0000400,1,0.712446594730509,0,16,four-way junction DNA binding,MF,
192,GO:0000403,1,0.921029516479837,0,4,Y-form DNA binding,MF,
193,GO:0000404,1,0.979071537988483,0,1,heteroduplex DNA loop binding,MF,
194,GO:0000405,1,0.86343945544605,0,7,bubble DNA binding,MF,
195,GO:0000407,1,0.570646297333046,0,27,pre-autophagosomal structure,CC,
196,GO:0000408,1,0.937883830743433,0,3,EKC/KEOPS complex,CC,
197,GO:0000409,1,0.980995364013494,0,1,regulation of transcription by galactose,BP,
198,GO:0000411,1,0.980995364013494,0,1,positive regulation of transcription by galactose,BP,
199,GO:0000413,1,0.444613266360977,0,38,protein peptidyl-prolyl isomerization,BP,
200,GO:0000414,1,0.925813902478437,0,4,regulation of histone H3-K36 methylation,BP,
201,GO:0000415,1,0.980593034323631,0,1,negative regulation of histone H3-K36 methylation,BP,
202,GO:0000416,1,0.979076285535164,0,1,positive regulation of histone H3-K36 methylation,BP,
203,GO:0000421,1,0.552532525494514,0,28,autophagosome membrane,CC,
204,GO:0000422,1,0.199987123600749,0,77,mitophagy,BP,
205,GO:0000423,1,0.704067574141097,0,17,macromitophagy,BP,
206,GO:0000428,1,0.0716459990814387,0,125,DNA-directed RNA polymerase complex,CC,
207,GO:0000429,1,0.919734571664721,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000430,1,0.937555577532064,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000431,1,0.980995364013494,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000432,1,0.937555577532064,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
211,GO:0000433,1,0.978924682514653,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
212,GO:0000435,1,0.980995364013494,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
213,GO:0000436,1,0.919734571664721,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
214,GO:0000437,1,0.978924682514653,0,1,carbon catabolite repression of transcription from RNA polymerase II promoter,BP,
215,GO:0000438,1,0.937331089607673,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
216,GO:0000439,1,0.844777305300372,0,8,core TFIIH complex,CC,
217,GO:0000444,1,0.923879258782324,0,4,MIS12/MIND type complex,CC,
218,GO:0000445,1,0.880020771367027,0,6,THO complex part of transcription export complex,CC,
219,GO:0000447,1,0.827690104592237,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
220,GO:0000448,1,0.960169048875492,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
221,GO:0000451,1,0.958796990139584,0,2,rRNA 2'-O-methylation,BP,
222,GO:0000453,1,0.958796990139584,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
223,GO:0000454,1,0.937013325033001,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
224,GO:0000459,1,0.898668375786624,0,5,exonucleolytic trimming involved in rRNA processing,BP,
225,GO:0000460,1,0.541894495663696,0,29,maturation of 5.8S rRNA,BP,
226,GO:0000461,1,0.957435425388051,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000462,1,0.465890930061192,0,36,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000463,1,0.825616519554506,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000466,1,0.684246249743184,0,18,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000467,1,0.898668375786624,0,5,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000469,1,0.616736682139421,0,23,cleavage involved in rRNA processing,BP,
232,GO:0000470,1,0.640152520355901,0,21,maturation of LSU-rRNA,BP,
233,GO:0000472,1,0.941642422121791,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000478,1,0.748252446125627,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
235,GO:0000479,1,0.748252446125627,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
236,GO:0000480,1,0.883386431356153,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
237,GO:0000481,1,0.979071454232573,0,1,maturation of 5S rRNA,BP,
238,GO:0000491,1,0.880639140603304,0,6,small nucleolar ribonucleoprotein complex assembly,BP,
239,GO:0000492,1,0.919105879158149,0,4,box C/D snoRNP assembly,BP,
240,GO:0000493,1,0.958157066047111,0,2,box H/ACA snoRNP assembly,BP,
241,GO:0000494,1,0.978515364646893,0,1,box C/D snoRNA 3'-end processing,BP,
242,GO:0000495,1,0.978980630239622,0,1,box H/ACA snoRNA 3'-end processing,BP,
244,GO:0000506,1,0.841975414342501,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
246,GO:0000700,1,0.917903379358158,0,4,mismatch base pair DNA N-glycosylase activity,MF,
247,GO:0000701,1,0.957695851150971,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
248,GO:0000702,1,0.937185598710953,0,3,oxidized base lesion DNA N-glycosylase activity,MF,
249,GO:0000703,1,0.957562029489311,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
250,GO:0000706,1,0.918593837879289,0,4,meiotic DNA double-strand break processing,BP,
251,GO:0000707,1,0.879935527917662,0,6,meiotic DNA recombinase assembly,BP,
252,GO:0000710,1,0.958709154650792,0,2,meiotic mismatch repair,BP,
253,GO:0000711,1,0.958079662431075,0,2,meiotic DNA repair synthesis,BP,
254,GO:0000712,1,0.779665257700059,0,12,resolution of meiotic recombination intermediates,BP,
255,GO:0000715,1,0.611284060471339,0,23,nucleotide-excision repair, DNA damage recognition,BP,
256,GO:0000717,1,0.626758418495901,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
257,GO:0000718,1,0.978651906489294,0,1,nucleotide-excision repair, DNA damage removal,BP,
258,GO:0000720,1,0.938015734869102,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
259,GO:0000722,1,0.471862977543978,0,36,telomere maintenance via recombination,BP,
260,GO:0000723,1,0.0457238328495422,0,147,telomere maintenance,BP,
261,GO:0000724,1,0.131062246942249,0,97,double-strand break repair via homologous recombination,BP,
262,GO:0000725,1,0.12829151674376,0,98,recombinational repair,BP,
263,GO:0000726,1,0.213181814051806,0,74,non-recombinational repair,BP,
264,GO:0000727,1,0.898683674381635,0,5,double-strand break repair via break-induced replication,BP,
265,GO:0000729,1,0.619414156138128,0,23,DNA double-strand break processing,BP,
266,GO:0000730,1,0.808050622448838,0,10,DNA recombinase assembly,BP,
267,GO:0000731,1,0.24272163994324,0,68,DNA synthesis involved in DNA repair,BP,
268,GO:0000732,1,0.597511043986638,0,25,strand displacement,BP,
269,GO:0000733,1,0.826357070373395,0,9,DNA strand renaturation,BP,
270,GO:0000737,1,0.614521658452093,0,23,DNA catabolic process, endonucleolytic,BP,
271,GO:0000738,1,0.958008249584726,0,2,DNA catabolic process, exonucleolytic,BP,
272,GO:0000741,1,0.978659005690316,0,1,karyogamy,BP,
273,GO:0000768,1,0.377590975780315,0,47,syncytium formation by plasma membrane fusion,BP,
274,GO:0000773,1,0.978493531868126,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
275,GO:0000774,1,0.80802640075801,0,10,adenyl-nucleotide exchange factor activity,MF,
276,GO:0000775,1,0.0253740013814,0,176,chromosome, centromeric region,CC,
277,GO:0000776,1,0.0796859555039165,0,121,kinetochore,CC,
278,GO:0000777,1,0.138862834294271,0,94,condensed chromosome kinetochore,CC,
279,GO:0000778,1,0.842966516168764,0,8,condensed nuclear chromosome kinetochore,CC,
280,GO:0000779,1,0.112769751591985,0,104,condensed chromosome, centromeric region,CC,
281,GO:0000780,1,0.745325704563348,0,14,condensed nuclear chromosome, centromeric region,CC,
282,GO:0000781,1,0.0337795891368902,0,161,chromosome, telomeric region,CC,
283,GO:0000782,1,0.791358447827099,0,11,telomere cap complex,CC,
284,GO:0000783,1,0.791358447827099,0,11,nuclear telomere cap complex,CC,
285,GO:0000784,1,0.0701436994205374,0,126,nuclear chromosome, telomeric region,CC,
287,GO:0000786,1,0.111570636343491,0,101,nucleosome,CC,
288,GO:0000788,1,0.447947776518616,0,37,nuclear nucleosome,CC,
289,GO:0000789,1,0.978506299962292,0,1,cytoplasmic chromatin,CC,
291,GO:0000791,1,0.507619966401506,0,32,euchromatin,CC,
293,GO:0000793,1,0.0179411697892452,0,192,condensed chromosome,CC,
294,GO:0000794,1,0.19827304881057,0,78,condensed nuclear chromosome,CC,
295,GO:0000795,1,0.510352731987791,0,32,synaptonemal complex,CC,
296,GO:0000796,1,0.865698807952626,0,7,condensin complex,CC,
297,GO:0000797,1,0.979463225419922,0,1,condensin core heterodimer,CC,
298,GO:0000798,1,0.899278937509999,0,5,nuclear cohesin complex,CC,
299,GO:0000799,1,0.940016206665214,0,3,nuclear condensin complex,CC,
300,GO:0000800,1,0.781349236325241,0,12,lateral element,CC,
301,GO:0000801,1,0.842815430923031,0,8,central element,CC,
302,GO:0000802,1,0.979069722034358,0,1,transverse filament,CC,
306,GO:0000808,1,0.825938687923209,0,9,origin recognition complex,CC,
307,GO:0000811,1,0.937995926784732,0,3,GINS complex,CC,
308,GO:0000812,1,0.834652408313939,0,9,Swr1 complex,CC,
309,GO:0000813,1,0.807903781196578,0,10,ESCRT I complex,CC,
310,GO:0000814,1,0.937618169742792,0,3,ESCRT II complex,CC,
311,GO:0000815,1,0.790000650345899,0,11,ESCRT III complex,CC,
313,GO:0000820,1,0.902244724882338,0,5,regulation of glutamine family amino acid metabolic process,BP,
314,GO:0000821,1,0.961636151162695,0,2,regulation of arginine metabolic process,BP,
315,GO:0000822,1,0.944740691575503,0,3,inositol hexakisphosphate binding,MF,
316,GO:0000823,1,0.978676204711141,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
317,GO:0000824,1,0.978676204711141,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
318,GO:0000825,1,0.978676204711141,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
319,GO:0000827,1,0.900761433003902,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
320,GO:0000828,1,0.900761433003902,0,5,inositol hexakisphosphate kinase activity,MF,
321,GO:0000829,1,0.900761433003902,0,5,inositol heptakisphosphate kinase activity,MF,
322,GO:0000831,1,0.979027088264401,0,1,inositol hexakisphosphate 6-kinase activity,MF,
323,GO:0000832,1,0.900761433003902,0,5,inositol hexakisphosphate 5-kinase activity,MF,
324,GO:0000835,1,0.882929600404697,0,6,ER ubiquitin ligase complex,CC,
325,GO:0000836,1,0.90155356932901,0,5,Hrd1p ubiquitin ligase complex,CC,
326,GO:0000839,1,0.939686750918288,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
327,GO:0000900,1,0.76402377637849,0,13,translation repressor activity, nucleic acid binding,MF,
331,GO:0000912,1,0.939420341287481,0,3,assembly of actomyosin apparatus involved in cytokinesis,BP,
332,GO:0000915,1,0.939420341287481,0,3,actomyosin contractile ring assembly,BP,
333,GO:0000917,1,0.978697140030716,0,1,barrier septum assembly,BP,
334,GO:0000920,1,0.695623240332379,0,17,cell separation after cytokinesis,BP,
335,GO:0000921,1,0.979435559037729,0,1,septin ring assembly,BP,
337,GO:0000923,1,0.881869171698195,0,6,equatorial microtubule organizing center,CC,
339,GO:0000931,1,0.865061341025235,0,7,gamma-tubulin large complex,CC,
341,GO:0000938,1,0.920322010710672,0,4,GARP complex,CC,
342,GO:0000939,1,0.957979975014448,0,2,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.781119483288942,0,12,condensed chromosome outer kinetochore,CC,
344,GO:0000942,1,0.918160831967419,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.0149733464050748,0,198,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.920536936528295,0,4,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.958716191718372,0,2,mitochondrial mRNA catabolic process,BP,
349,GO:0000960,1,0.920536936528295,0,4,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.960181170951621,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.958716191718372,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000964,1,0.958740636326964,0,2,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.93845794318097,0,3,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.883897762008361,0,6,RNA 5'-end processing,BP,
356,GO:0000967,1,0.941642422121791,0,3,rRNA 5'-end processing,BP,
357,GO:0000972,1,0.881001016125561,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
358,GO:0000973,1,0.938741209250006,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000974,1,0.79150059331898,0,11,Prp19 complex,CC,
363,GO:0000978,1,0.000956329680596697,0,330,RNA polymerase II core promoter proximal region sequence-specific DNA binding,MF,
365,GO:0000980,1,0.257065683902832,0,65,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
369,GO:0000987,1,0.000746345376184683,0,342,core promoter proximal region sequence-specific DNA binding,MF,
372,GO:0000990,1,0.8508386128244,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.959232735346083,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.960494890391269,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.615025149039231,0,23,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.978670272541697,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.925423695937229,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0000997,1,0.979083236024535,0,1,mitochondrial RNA polymerase core promoter sequence-specific DNA binding,MF,
379,GO:0000999,1,0.978932700990815,0,1,RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly,BP,
380,GO:0001002,1,0.960494890391269,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
381,GO:0001003,1,0.960494890391269,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
382,GO:0001004,1,0.978932700990815,0,1,transcription factor activity, RNA polymerase III promoter sequence-specific binding, TFIIIB recruiting,MF,
383,GO:0001005,1,0.978932700990815,0,1,transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIB recruiting,MF,
384,GO:0001007,1,0.905639170731162,0,5,transcription factor activity, RNA polymerase III transcription factor binding,MF,
385,GO:0001009,1,0.978932700990815,0,1,transcription from RNA polymerase III type 2 promoter,BP,
386,GO:0001010,1,0.938092837871815,0,3,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
387,GO:0001011,1,0.982045076660238,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
389,GO:0001013,1,0.847123480992029,0,8,RNA polymerase I regulatory region DNA binding,MF,
390,GO:0001016,1,0.867344232741346,0,7,RNA polymerase III regulatory region DNA binding,MF,
391,GO:0001018,1,0.979083236024535,0,1,mitochondrial RNA polymerase regulatory region DNA binding,MF,
392,GO:0001022,1,0.978932700990815,0,1,transcription initiation from RNA polymerase III type 1 promoter,BP,
393,GO:0001025,1,0.912653912145872,0,5,RNA polymerase III transcription factor binding,MF,
394,GO:0001026,1,0.963370202897237,0,2,TFIIIB-type transcription factor activity,MF,
395,GO:0001030,1,0.905683864934098,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
396,GO:0001031,1,0.905683864934098,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
397,GO:0001032,1,0.922897717598886,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
398,GO:0001034,1,0.958060793794095,0,2,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
399,GO:0001042,1,0.901355132257135,0,5,RNA polymerase I core binding,MF,
400,GO:0001044,1,0.979083236024535,0,1,mitochondrial RNA polymerase regulatory region sequence-specific DNA binding,MF,
403,GO:0001054,1,0.826581581246291,0,9,RNA polymerase I activity,MF,
404,GO:0001055,1,0.808004631141018,0,10,RNA polymerase II activity,MF,
405,GO:0001056,1,0.741770191742505,0,14,RNA polymerase III activity,MF,
407,GO:0001069,1,0.979749114423447,0,1,regulatory region RNA binding,MF,
408,GO:0001070,1,0.978971470207301,0,1,RNA binding transcription factor activity,MF,
410,GO:0001075,1,0.830580407314431,0,9,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
414,GO:0001079,1,0.978819787817556,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
415,GO:0001080,1,0.978819787817556,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
416,GO:0001082,1,0.978884143808707,0,1,transcription factor activity, RNA polymerase I transcription factor binding,MF,
417,GO:0001083,1,0.906093494825868,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
419,GO:0001087,1,0.982045076660238,0,1,transcription factor activity, TFIIB-class binding,MF,
420,GO:0001091,1,0.798304827501542,0,11,RNA polymerase II basal transcription factor binding,MF,
421,GO:0001093,1,0.942432087277352,0,3,TFIIB-class transcription factor binding,MF,
422,GO:0001094,1,0.865204209707352,0,7,TFIID-class transcription factor binding,MF,
423,GO:0001096,1,0.979073619960208,0,1,TFIIF-class transcription factor binding,MF,
424,GO:0001098,1,0.480268846884942,0,35,basal transcription machinery binding,MF,
425,GO:0001099,1,0.480268846884942,0,35,basal RNA polymerase II transcription machinery binding,MF,
426,GO:0001100,1,0.97897493185122,0,1,negative regulation of exit from mitosis,BP,
429,GO:0001103,1,0.557581301831571,0,28,RNA polymerase II repressing transcription factor binding,MF,
433,GO:0001128,1,0.97854668659798,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
434,GO:0001129,1,0.922663455300534,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
435,GO:0001132,1,0.922663455300534,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
436,GO:0001133,1,0.978787297703884,0,1,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
439,GO:0001147,1,0.963320128272797,0,2,transcription termination site sequence-specific DNA binding,MF,
440,GO:0001153,1,0.978932700990815,0,1,transcription factor activity, RNA polymerase III transcription factor recruiting,MF,
441,GO:0001156,1,0.948041413684899,0,3,TFIIIC-class transcription factor binding,MF,
442,GO:0001158,1,0.176004453811874,0,83,enhancer sequence-specific DNA binding,MF,
443,GO:0001159,1,0.00070207574633183,0,345,core promoter proximal region DNA binding,MF,
444,GO:0001160,1,0.963320128272797,0,2,transcription termination site DNA binding,MF,
445,GO:0001161,1,0.792244201332426,0,11,intronic transcription regulatory region sequence-specific DNA binding,MF,
446,GO:0001162,1,0.843780584910571,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
447,GO:0001163,1,0.847123480992029,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
448,GO:0001164,1,0.847123480992029,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
449,GO:0001165,1,0.979324049461949,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
450,GO:0001167,1,0.978884143808707,0,1,RNA polymerase I transcription factor activity, sequence-specific DNA binding,MF,
451,GO:0001169,1,0.978884143808707,0,1,transcription factor activity, RNA polymerase I CORE element sequence-specific binding,MF,
452,GO:0001172,1,0.960279199070421,0,2,transcription, RNA-templated,BP,
453,GO:0001179,1,0.978701808882628,0,1,RNA polymerase I transcription factor binding,MF,
454,GO:0001180,1,0.937988434677769,0,3,transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript,BP,
455,GO:0001181,1,0.979078276997789,0,1,transcription factor activity, core RNA polymerase I binding,MF,
456,GO:0001186,1,0.978884143808707,0,1,transcription factor activity, RNA polymerase I transcription factor recruiting,MF,
457,GO:0001187,1,0.978884143808707,0,1,transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting,MF,
458,GO:0001188,1,0.958034483210773,0,2,RNA polymerase I transcriptional preinitiation complex assembly,BP,
459,GO:0001189,1,0.958034483210773,0,2,RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript,BP,
462,GO:0001205,1,0.579924344985793,0,26,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
463,GO:0001206,1,0.818147878082498,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
464,GO:0001207,1,0.979068973647465,0,1,histone displacement,BP,
465,GO:0001221,1,0.498612065374145,0,34,transcription cofactor binding,MF,
466,GO:0001222,1,0.811616095704305,0,10,transcription corepressor binding,MF,
467,GO:0001223,1,0.681866259500339,0,19,transcription coactivator binding,MF,
468,GO:0001224,1,0.942444859282162,0,3,RNA polymerase II transcription cofactor binding,MF,
469,GO:0001225,1,0.962594820040804,0,2,RNA polymerase II transcription coactivator binding,MF,
470,GO:0001226,1,0.979069191768179,0,1,RNA polymerase II transcription corepressor binding,MF,
473,GO:0001300,1,0.958571131607175,0,2,chronological cell aging,BP,
474,GO:0001302,1,0.881139789312282,0,6,replicative cell aging,BP,
475,GO:0001306,1,0.960087405950105,0,2,age-dependent response to oxidative stress,BP,
476,GO:0001315,1,0.978496709782108,0,1,age-dependent response to reactive oxygen species,BP,
477,GO:0001325,1,0.729223009032794,0,15,formation of extrachromosomal circular DNA,BP,
478,GO:0001401,1,0.978665510226433,0,1,mitochondrial sorting and assembly machinery complex,CC,
479,GO:0001405,1,0.938014498231285,0,3,presequence translocase-associated import motor,CC,
485,GO:0001507,1,0.958480536499977,0,2,acetylcholine catabolic process in synaptic cleft,BP,
488,GO:0001512,1,0.978511455072996,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
489,GO:0001514,1,0.828594342314179,0,9,selenocysteine incorporation,BP,
490,GO:0001515,1,0.917450936130919,0,4,opioid peptide activity,MF,
492,GO:0001517,1,0.865331553384266,0,7,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
493,GO:0001518,1,0.763982237526615,0,14,voltage-gated sodium channel complex,CC,
494,GO:0001519,1,0.958229609826683,0,2,peptide amidation,BP,
495,GO:0001520,1,0.843051547494735,0,8,outer dense fiber,CC,
499,GO:0001527,1,0.820109820754619,0,10,microfibril,CC,
500,GO:0001530,1,0.63933952671821,0,21,lipopolysaccharide binding,MF,
501,GO:0001532,1,0.979069056272352,0,1,interleukin-21 receptor activity,MF,
503,GO:0001534,1,0.938390490573464,0,3,radial spoke,CC,
504,GO:0001536,1,0.958492790009789,0,2,radial spoke stalk,CC,
505,GO:0001537,1,0.899601754368111,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
506,GO:0001539,1,0.626604470939403,0,24,cilium or flagellum-dependent cell motility,BP,
507,GO:0001540,1,0.501232800668741,0,33,beta-amyloid binding,MF,
509,GO:0001542,1,0.848202149442316,0,8,ovulation from ovarian follicle,BP,
510,GO:0001543,1,0.98147414157751,0,1,ovarian follicle rupture,BP,
511,GO:0001544,1,0.981305595465867,0,1,initiation of primordial ovarian follicle growth,BP,
512,GO:0001545,1,0.958525730167023,0,2,primary ovarian follicle growth,BP,
513,GO:0001546,1,0.937621452110082,0,3,preantral ovarian follicle growth,BP,
514,GO:0001547,1,0.884597237320983,0,6,antral ovarian follicle growth,BP,
515,GO:0001550,1,0.95973080078005,0,2,ovarian cumulus expansion,BP,
516,GO:0001553,1,0.812998326975871,0,10,luteinization,BP,
517,GO:0001554,1,0.901917224003608,0,5,luteolysis,BP,
518,GO:0001555,1,0.958259559357877,0,2,oocyte growth,BP,
521,GO:0001560,1,0.942086309464693,0,3,regulation of cell growth by extracellular stimulus,BP,
524,GO:0001567,1,0.957710665443349,0,2,cholesterol 25-hydroxylase activity,MF,
529,GO:0001574,1,0.866229370823424,0,7,ganglioside biosynthetic process,BP,
530,GO:0001575,1,0.957963858833561,0,2,globoside metabolic process,BP,
531,GO:0001576,1,0.978794799674675,0,1,globoside biosynthetic process,BP,
533,GO:0001579,1,0.958562959671042,0,2,medium-chain fatty acid transport,BP,
534,GO:0001580,1,0.488904912526644,0,33,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
535,GO:0001581,1,0.959207365765717,0,2,detection of chemical stimulus involved in sensory perception of sour taste,BP,
536,GO:0001582,1,0.958378506568461,0,2,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
537,GO:0001587,1,0.979415015266058,0,1,Gq/11-coupled serotonin receptor activity,MF,
538,GO:0001588,1,0.917712722218918,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
539,GO:0001591,1,0.840918195585753,0,8,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
540,GO:0001594,1,0.858925853059152,0,7,trace-amine receptor activity,MF,
541,GO:0001595,1,0.91763390021763,0,4,angiotensin receptor activity,MF,
542,GO:0001596,1,0.978891613116959,0,1,angiotensin type I receptor activity,MF,
543,GO:0001601,1,0.93811065029805,0,3,peptide YY receptor activity,MF,
544,GO:0001602,1,0.917429525351638,0,4,pancreatic polypeptide receptor activity,MF,
545,GO:0001604,1,0.978514919917225,0,1,urotensin II receptor activity,MF,
546,GO:0001605,1,0.979572130115318,0,1,adrenomedullin receptor activity,MF,
547,GO:0001607,1,0.958295936471188,0,2,neuromedin U receptor activity,MF,
551,GO:0001616,1,0.978492371447058,0,1,growth hormone secretagogue receptor activity,MF,
553,GO:0001621,1,0.978578686470203,0,1,ADP receptor activity,MF,
554,GO:0001626,1,0.979069128376569,0,1,nociceptin receptor activity,MF,
555,GO:0001631,1,0.978969879079343,0,1,cysteinyl leukotriene receptor activity,MF,
556,GO:0001632,1,0.958099408732073,0,2,leukotriene B4 receptor activity,MF,
557,GO:0001635,1,0.959013481747993,0,2,calcitonin gene-related peptide receptor activity,MF,
558,GO:0001637,1,0.611612369058491,0,23,G-protein coupled chemoattractant receptor activity,MF,
559,GO:0001640,1,0.904310254739583,0,5,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
560,GO:0001641,1,0.95861640956725,0,2,group II metabotropic glutamate receptor activity,MF,
561,GO:0001642,1,0.979161052397716,0,1,group III metabotropic glutamate receptor activity,MF,
564,GO:0001651,1,0.978515364646893,0,1,dense fibrillar component,CC,
565,GO:0001652,1,0.917470626065079,0,4,granular component,CC,
573,GO:0001660,1,0.809342735030324,0,10,fever generation,BP,
574,GO:0001661,1,0.881677852342522,0,6,conditioned taste aversion,BP,
575,GO:0001662,1,0.532407077280892,0,30,behavioral fear response,BP,
577,GO:0001665,1,0.879454407981473,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
581,GO:0001671,1,0.611793544616687,0,23,ATPase activator activity,MF,
582,GO:0001672,1,0.832297606498359,0,9,regulation of chromatin assembly or disassembly,BP,
583,GO:0001673,1,0.74346002537891,0,14,male germ cell nucleus,CC,
584,GO:0001674,1,0.938269575715149,0,3,female germ cell nucleus,CC,
585,GO:0001675,1,0.778833743404147,0,12,acrosome assembly,BP,
588,GO:0001680,1,0.97887180099538,0,1,tRNA 3'-terminal CCA addition,BP,
589,GO:0001681,1,0.979041789436899,0,1,sialate O-acetylesterase activity,MF,
590,GO:0001682,1,0.789624483781629,0,11,tRNA 5'-leader removal,BP,
591,GO:0001692,1,0.917337725737228,0,4,histamine metabolic process,BP,
592,GO:0001694,1,0.957858846115353,0,2,histamine biosynthetic process,BP,
593,GO:0001695,1,0.978485347627933,0,1,histamine catabolic process,BP,
594,GO:0001696,1,0.6955910013232,0,17,gastric acid secretion,BP,
595,GO:0001697,1,0.979038212366522,0,1,histamine-induced gastric acid secretion,BP,
596,GO:0001698,1,0.95795530309699,0,2,gastrin-induced gastric acid secretion,BP,
606,GO:0001711,1,0.712176872943428,0,16,endodermal cell fate commitment,BP,
608,GO:0001714,1,0.824774218225787,0,9,endodermal cell fate specification,BP,
610,GO:0001716,1,0.978780843455415,0,1,L-amino-acid oxidase activity,MF,
611,GO:0001725,1,0.363485100494561,0,49,stress fiber,CC,
613,GO:0001727,1,0.901700716946698,0,5,lipid kinase activity,MF,
614,GO:0001729,1,0.958746206884968,0,2,ceramide kinase activity,MF,
615,GO:0001730,1,0.939710991335875,0,3,2'-5'-oligoadenylate synthetase activity,MF,
616,GO:0001731,1,0.847906327454712,0,8,formation of translation preinitiation complex,BP,
617,GO:0001732,1,0.958963210923607,0,2,formation of cytoplasmic translation initiation complex,BP,
618,GO:0001733,1,0.917928056566557,0,4,galactosylceramide sulfotransferase activity,MF,
619,GO:0001735,1,0.959230748640624,0,2,prenylcysteine oxidase activity,MF,
622,GO:0001739,1,0.880021200008745,0,6,sex chromatin,CC,
623,GO:0001740,1,0.901496130589274,0,5,Barr body,CC,
631,GO:0001758,1,0.860632731376577,0,7,retinal dehydrogenase activity,MF,
633,GO:0001760,1,0.978529078223452,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
636,GO:0001765,1,0.807898722658076,0,10,membrane raft assembly,BP,
637,GO:0001766,1,0.825900123621143,0,9,membrane raft polarization,BP,
638,GO:0001767,1,0.830406290002939,0,9,establishment of lymphocyte polarity,BP,
639,GO:0001768,1,0.846382753742133,0,8,establishment of T cell polarity,BP,
640,GO:0001770,1,0.98113233662853,0,1,establishment of natural killer cell polarity,BP,
642,GO:0001772,1,0.49842917040943,0,33,immunological synapse,CC,
644,GO:0001774,1,0.682810276511797,0,18,microglial cell activation,BP,
647,GO:0001777,1,0.917249025779656,0,4,T cell homeostatic proliferation,BP,
648,GO:0001778,1,0.850979171400176,0,8,plasma membrane repair,BP,
651,GO:0001781,1,0.862758343912043,0,7,neutrophil apoptotic process,BP,
652,GO:0001782,1,0.55862694256269,0,28,B cell homeostasis,BP,
653,GO:0001783,1,0.615453621143251,0,23,B cell apoptotic process,BP,
655,GO:0001785,1,0.958468040170624,0,2,prostaglandin J receptor activity,MF,
657,GO:0001787,1,0.774504652048904,0,12,natural killer cell proliferation,BP,
658,GO:0001791,1,0.978547199529346,0,1,IgM binding,MF,
659,GO:0001792,1,0.979188509437629,0,1,polymeric immunoglobulin receptor activity,MF,
660,GO:0001794,1,0.958567384699582,0,2,type IIa hypersensitivity,BP,
661,GO:0001796,1,0.958567384699582,0,2,regulation of type IIa hypersensitivity,BP,
662,GO:0001798,1,0.958567384699582,0,2,positive regulation of type IIa hypersensitivity,BP,
663,GO:0001802,1,0.957914086111682,0,2,type III hypersensitivity,BP,
664,GO:0001803,1,0.957914086111682,0,2,regulation of type III hypersensitivity,BP,
665,GO:0001805,1,0.957914086111682,0,2,positive regulation of type III hypersensitivity,BP,
666,GO:0001806,1,0.919888865032771,0,4,type IV hypersensitivity,BP,
667,GO:0001807,1,0.939563045562234,0,3,regulation of type IV hypersensitivity,BP,
668,GO:0001808,1,0.960154619097974,0,2,negative regulation of type IV hypersensitivity,BP,
669,GO:0001809,1,0.978556248914701,0,1,positive regulation of type IV hypersensitivity,BP,
670,GO:0001810,1,0.937330841176849,0,3,regulation of type I hypersensitivity,BP,
671,GO:0001812,1,0.937330841176849,0,3,positive regulation of type I hypersensitivity,BP,
676,GO:0001820,1,0.790557835589019,0,11,serotonin secretion,BP,
681,GO:0001825,1,0.554957827748985,0,28,blastocyst formation,BP,
682,GO:0001826,1,0.848383463368149,0,8,inner cell mass cell differentiation,BP,
683,GO:0001827,1,0.939482552896965,0,3,inner cell mass cell fate commitment,BP,
684,GO:0001828,1,0.939535550014345,0,3,inner cell mass cellular morphogenesis,BP,
685,GO:0001829,1,0.744280272769176,0,14,trophectodermal cell differentiation,BP,
686,GO:0001831,1,0.960107384769395,0,2,trophectodermal cellular morphogenesis,BP,
689,GO:0001834,1,0.981257942545542,0,1,trophectodermal cell proliferation,BP,
690,GO:0001835,1,0.979068924577401,0,1,blastocyst hatching,BP,
701,GO:0001846,1,0.781931939420219,0,12,opsonin binding,MF,
702,GO:0001847,1,0.92162611680594,0,4,opsonin receptor activity,MF,
704,GO:0001849,1,0.846865337049799,0,8,complement component C1q binding,MF,
705,GO:0001850,1,0.978689052924822,0,1,complement component C3a binding,MF,
706,GO:0001851,1,0.961801318241998,0,2,complement component C3b binding,MF,
707,GO:0001855,1,0.961719529900421,0,2,complement component C4b binding,MF,
708,GO:0001856,1,0.978896289404227,0,1,complement component C5a binding,MF,
709,GO:0001861,1,0.982745541009455,0,1,complement component C4b receptor activity,MF,
710,GO:0001865,1,0.844828270665755,0,8,NK T cell differentiation,BP,
711,GO:0001866,1,0.879310415955551,0,6,NK T cell proliferation,BP,
712,GO:0001867,1,0.807406619236089,0,10,complement activation, lectin pathway,BP,
713,GO:0001868,1,0.958528451098761,0,2,regulation of complement activation, lectin pathway,BP,
714,GO:0001869,1,0.958528451098761,0,2,negative regulation of complement activation, lectin pathway,BP,
715,GO:0001871,1,0.641970609327725,0,21,pattern binding,MF,
716,GO:0001872,1,0.978731256153011,0,1,(1->3)-beta-D-glucan binding,MF,
717,GO:0001875,1,0.899978788046911,0,5,lipopolysaccharide receptor activity,MF,
718,GO:0001878,1,0.879253073949703,0,6,response to yeast,BP,
719,GO:0001880,1,0.920116829530309,0,4,Mullerian duct regression,BP,
720,GO:0001881,1,0.511989416734547,0,32,receptor recycling,BP,
723,GO:0001884,1,0.959410279906985,0,2,pyrimidine nucleoside binding,MF,
725,GO:0001886,1,0.815376082786747,0,10,endothelial cell morphogenesis,BP,
726,GO:0001887,1,0.918565924695205,0,4,selenium compound metabolic process,BP,
727,GO:0001888,1,0.959896786368392,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
730,GO:0001891,1,0.685080993301342,0,18,phagocytic cup,CC,
735,GO:0001897,1,0.958318823202868,0,2,cytolysis by symbiont of host cells,BP,
736,GO:0001905,1,0.941467342279248,0,3,activation of membrane attack complex,BP,
738,GO:0001907,1,0.918506859886608,0,4,killing by symbiont of host cells,BP,
741,GO:0001911,1,0.757700377312325,0,13,negative regulation of leukocyte mediated cytotoxicity,BP,
745,GO:0001915,1,0.899729605138164,0,5,negative regulation of T cell mediated cytotoxicity,BP,
748,GO:0001918,1,0.979032887119095,0,1,farnesylated protein binding,MF,
749,GO:0001919,1,0.629328579595169,0,22,regulation of receptor recycling,BP,
750,GO:0001920,1,0.918441214360915,0,4,negative regulation of receptor recycling,BP,
751,GO:0001921,1,0.761767408476686,0,13,positive regulation of receptor recycling,BP,
752,GO:0001922,1,0.939646041869105,0,3,B-1 B cell homeostasis,BP,
753,GO:0001923,1,0.938544070294631,0,3,B-1 B cell differentiation,BP,
762,GO:0001937,1,0.524827232793089,0,31,negative regulation of endothelial cell proliferation,BP,
764,GO:0001939,1,0.850051505701019,0,8,female pronucleus,CC,
765,GO:0001940,1,0.906286215125997,0,5,male pronucleus,CC,
770,GO:0001946,1,0.721949241565469,0,16,lymphangiogenesis,BP,
773,GO:0001949,1,0.978929803067708,0,1,sebaceous gland cell differentiation,BP,
774,GO:0001951,1,0.919247753998365,0,4,intestinal D-glucose absorption,BP,
778,GO:0001955,1,0.846641789145453,0,8,blood vessel maturation,BP,
779,GO:0001956,1,0.797201598959056,0,11,positive regulation of neurotransmitter secretion,BP,
786,GO:0001964,1,0.600332030996811,0,25,startle response,BP,
787,GO:0001965,1,0.669053791877285,0,19,G-protein alpha-subunit binding,MF,
788,GO:0001966,1,0.978549586521007,0,1,thigmotaxis,BP,
789,GO:0001967,1,0.761154835244777,0,13,suckling behavior,BP,
791,GO:0001969,1,0.941467342279248,0,3,regulation of activation of membrane attack complex,BP,
792,GO:0001970,1,0.959158806191121,0,2,positive regulation of activation of membrane attack complex,BP,
793,GO:0001971,1,0.981557308903287,0,1,negative regulation of activation of membrane attack complex,BP,
797,GO:0001975,1,0.568327966578532,0,27,response to amphetamine,BP,
798,GO:0001976,1,0.762034475039114,0,13,neurological system process involved in regulation of systemic arterial blood pressure,BP,
800,GO:0001978,1,0.957765751228504,0,2,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
801,GO:0001979,1,0.978642378978139,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
802,GO:0001980,1,0.978480665719765,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
803,GO:0001983,1,0.957765751228504,0,2,baroreceptor response to increased systemic arterial blood pressure,BP,
804,GO:0001984,1,0.978477747451873,0,1,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,BP,
805,GO:0001985,1,0.978833670896506,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
807,GO:0001991,1,0.668230002397941,0,19,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
808,GO:0001992,1,0.898901627821295,0,5,regulation of systemic arterial blood pressure by vasopressin,BP,
809,GO:0001993,1,0.827765300386585,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
810,GO:0001994,1,0.918235390764196,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
811,GO:0001996,1,0.92089579741484,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
812,GO:0001997,1,0.958319780837155,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
813,GO:0001999,1,0.899580618226947,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
814,GO:0002001,1,0.899580618226947,0,5,renin secretion into blood stream,BP,
815,GO:0002002,1,0.758797013511728,0,13,regulation of angiotensin levels in blood,BP,
816,GO:0002003,1,0.77456429663909,0,12,angiotensin maturation,BP,
817,GO:0002005,1,0.938994671322477,0,3,angiotensin catabolic process in blood,BP,
818,GO:0002007,1,0.978642378978139,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
821,GO:0002016,1,0.825060023970229,0,9,regulation of blood volume by renin-angiotensin,BP,
822,GO:0002017,1,0.958208127780342,0,2,regulation of blood volume by renal aldosterone,BP,
823,GO:0002018,1,0.918129576842853,0,4,renin-angiotensin regulation of aldosterone production,BP,
824,GO:0002019,1,0.937852359719809,0,3,regulation of renal output by angiotensin,BP,
826,GO:0002021,1,0.629814960341288,0,22,response to dietary excess,BP,
827,GO:0002023,1,0.93765669908967,0,3,reduction of food intake in response to dietary excess,BP,
828,GO:0002024,1,0.825941002834553,0,9,diet induced thermogenesis,BP,
829,GO:0002025,1,0.938133460119786,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
833,GO:0002029,1,0.740936408066725,0,14,desensitization of G-protein coupled receptor protein signaling pathway,BP,
834,GO:0002031,1,0.773448082848671,0,12,G-protein coupled receptor internalization,BP,
835,GO:0002032,1,0.95794286639077,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
836,GO:0002033,1,0.979048985363861,0,1,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
837,GO:0002034,1,0.918404905584574,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
838,GO:0002035,1,0.918760522256064,0,4,brain renin-angiotensin system,BP,
839,GO:0002036,1,0.920636440719203,0,4,regulation of L-glutamate transport,BP,
840,GO:0002037,1,0.978809387012283,0,1,negative regulation of L-glutamate transport,BP,
841,GO:0002038,1,0.978867379319807,0,1,positive regulation of L-glutamate transport,BP,
842,GO:0002039,1,0.244935531139372,0,68,p53 binding,MF,
844,GO:0002041,1,0.978877796132037,0,1,intussusceptive angiogenesis,BP,
847,GO:0002046,1,0.937061934001623,0,3,opsin binding,MF,
848,GO:0002051,1,0.924000811170853,0,4,osteoblast fate commitment,BP,
852,GO:0002055,1,0.97847448486958,0,1,adenine binding,MF,
853,GO:0002058,1,0.97881063633701,0,1,uracil binding,MF,
854,GO:0002059,1,0.97881063633701,0,1,thymine binding,MF,
856,GO:0002061,1,0.97881063633701,0,1,pyrimidine nucleobase binding,MF,
866,GO:0002071,1,0.958022834602883,0,2,glandular epithelial cell maturation,BP,
868,GO:0002074,1,0.902762715174091,0,5,extraocular skeletal muscle development,BP,
869,GO:0002076,1,0.688639755573447,0,18,osteoblast development,BP,
870,GO:0002077,1,0.978551486324063,0,1,acrosome matrix dispersal,BP,
871,GO:0002079,1,0.920840929706197,0,4,inner acrosomal membrane,CC,
873,GO:0002081,1,0.920444120010484,0,4,outer acrosomal membrane,CC,
875,GO:0002083,1,0.978623097728073,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
878,GO:0002086,1,0.957993056591361,0,2,diaphragm contraction,BP,
882,GO:0002090,1,0.488796844401653,0,34,regulation of receptor internalization,BP,
883,GO:0002091,1,0.86338395485249,0,7,negative regulation of receptor internalization,BP,
884,GO:0002092,1,0.630273180760531,0,22,positive regulation of receptor internalization,BP,
886,GO:0002094,1,0.958138571486032,0,2,polyprenyltransferase activity,MF,
887,GO:0002097,1,0.759940562280079,0,13,tRNA wobble base modification,BP,
888,GO:0002098,1,0.826341827943251,0,9,tRNA wobble uridine modification,BP,
889,GO:0002100,1,0.980502499122696,0,1,tRNA wobble adenosine to inosine editing,BP,
890,GO:0002101,1,0.937975690922904,0,3,tRNA wobble cytosine modification,BP,
891,GO:0002102,1,0.53656384865943,0,30,podosome,CC,
892,GO:0002113,1,0.97887580233541,0,1,interleukin-33 binding,MF,
893,GO:0002114,1,0.958399103842022,0,2,interleukin-33 receptor activity,MF,
894,GO:0002115,1,0.813405868855782,0,10,store-operated calcium entry,BP,
895,GO:0002116,1,0.874129303144933,0,7,semaphorin receptor complex,CC,
896,GO:0002118,1,0.824889587914706,0,9,aggressive behavior,BP,
897,GO:0002121,1,0.958573830953602,0,2,inter-male aggressive behavior,BP,
898,GO:0002125,1,0.917454336111176,0,4,maternal aggressive behavior,BP,
899,GO:0002127,1,0.978566525805943,0,1,wobble base cytosine methylation,BP,
900,GO:0002133,1,0.965826830139463,0,2,polycystin complex,CC,
901,GO:0002134,1,0.959410279906985,0,2,UTP binding,MF,
902,GO:0002135,1,0.978970198177957,0,1,CTP binding,MF,
903,GO:0002138,1,0.842814261602202,0,8,retinoic acid biosynthetic process,BP,
906,GO:0002141,1,0.964051619402985,0,2,stereocilia ankle link,CC,
907,GO:0002142,1,0.984964667602565,0,1,stereocilia ankle link complex,CC,
908,GO:0002143,1,0.937665770173871,0,3,tRNA wobble position uridine thiolation,BP,
909,GO:0002148,1,0.979068592210635,0,1,hypochlorous acid metabolic process,BP,
910,GO:0002149,1,0.979068592210635,0,1,hypochlorous acid biosynthetic process,BP,
911,GO:0002151,1,0.871537958048814,0,7,G-quadruplex RNA binding,MF,
912,GO:0002152,1,0.979069350881823,0,1,bile acid conjugation,BP,
913,GO:0002153,1,0.978927433339487,0,1,steroid receptor RNA activator RNA binding,MF,
914,GO:0002154,1,0.903106780511683,0,5,thyroid hormone mediated signaling pathway,BP,
915,GO:0002155,1,0.919745810270724,0,4,regulation of thyroid hormone mediated signaling pathway,BP,
916,GO:0002158,1,0.843078055834685,0,8,osteoclast proliferation,BP,
918,GO:0002161,1,0.792142529114887,0,11,aminoacyl-tRNA editing activity,MF,
919,GO:0002162,1,0.835981871751028,0,9,dystroglycan binding,MF,
920,GO:0002169,1,0.958483655038194,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
921,GO:0002174,1,0.97905368115129,0,1,mammary stem cell proliferation,BP,
922,GO:0002175,1,0.923740604383483,0,4,protein localization to paranode region of axon,BP,
923,GO:0002176,1,0.878981156648806,0,6,male germ cell proliferation,BP,
924,GO:0002177,1,0.879359228770979,0,6,manchette,CC,
925,GO:0002178,1,0.792514741854981,0,11,palmitoyltransferase complex,CC,
926,GO:0002181,1,0.370049265457578,0,47,cytoplasmic translation,BP,
927,GO:0002182,1,0.960580495967173,0,2,cytoplasmic translational elongation,BP,
928,GO:0002183,1,0.628991956342882,0,22,cytoplasmic translational initiation,BP,
929,GO:0002184,1,0.960618177429744,0,2,cytoplasmic translational termination,BP,
930,GO:0002188,1,0.942970052127725,0,3,translation reinitiation,BP,
931,GO:0002189,1,0.937837696287348,0,3,ribose phosphate diphosphokinase complex,CC,
932,GO:0002190,1,0.729131110769467,0,15,cap-independent translational initiation,BP,
933,GO:0002191,1,0.938495667524854,0,3,cap-dependent translational initiation,BP,
934,GO:0002192,1,0.777497529845092,0,12,IRES-dependent translational initiation,BP,
936,GO:0002194,1,0.979063884651254,0,1,hepatocyte cell migration,BP,
937,GO:0002196,1,0.978716601309991,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
938,GO:0002199,1,0.824958495893285,0,9,zona pellucida receptor complex,CC,
942,GO:0002209,1,0.532407077280892,0,30,behavioral defense response,BP,
943,GO:0002215,1,0.937898681334436,0,3,defense response to nematode,BP,
949,GO:0002225,1,0.897245930748699,0,5,positive regulation of antimicrobial peptide production,BP,
950,GO:0002227,1,0.63433184615354,0,21,innate immune response in mucosa,BP,
952,GO:0002230,1,0.671987931495874,0,19,positive regulation of defense response to virus by host,BP,
953,GO:0002232,1,0.937569457409176,0,3,leukocyte chemotaxis involved in inflammatory response,BP,
954,GO:0002236,1,0.978887691543403,0,1,detection of misfolded protein,BP,
956,GO:0002238,1,0.938804282849802,0,3,response to molecule of fungal origin,BP,
958,GO:0002246,1,0.87972281637681,0,6,wound healing involved in inflammatory response,BP,
959,GO:0002248,1,0.898969952106504,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
960,GO:0002249,1,0.882399693854485,0,6,lymphocyte anergy,BP,
965,GO:0002254,1,0.937809474417479,0,3,kinin cascade,BP,
969,GO:0002264,1,0.978689435515459,0,1,endothelial cell activation involved in immune response,BP,
970,GO:0002266,1,0.95821255000764,0,2,follicular dendritic cell activation,BP,
971,GO:0002268,1,0.95821255000764,0,2,follicular dendritic cell differentiation,BP,
974,GO:0002276,1,0.978803762288996,0,1,basophil activation involved in immune response,BP,
976,GO:0002278,1,0.879376863244601,0,6,eosinophil activation involved in immune response,BP,
979,GO:0002282,1,0.958500716151438,0,2,microglial cell activation involved in immune response,BP,
984,GO:0002290,1,0.979044870566797,0,1,gamma-delta T cell activation involved in immune response,BP,
985,GO:0002291,1,0.843285155932488,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
990,GO:0002296,1,0.958041095112228,0,2,T-helper 1 cell lineage commitment,BP,
991,GO:0002298,1,0.957612548502402,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
992,GO:0002299,1,0.978599179600061,0,1,alpha-beta intraepithelial T cell differentiation,BP,
993,GO:0002300,1,0.978599179600061,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
994,GO:0002302,1,0.957992899432111,0,2,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
995,GO:0002304,1,0.958003937489118,0,2,gamma-delta intraepithelial T cell differentiation,BP,
996,GO:0002305,1,0.958003937489118,0,2,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
997,GO:0002309,1,0.89848519811882,0,5,T cell proliferation involved in immune response,BP,
1000,GO:0002314,1,0.937903681310844,0,3,germinal center B cell differentiation,BP,
1002,GO:0002316,1,0.979184544493128,0,1,follicular B cell differentiation,BP,
1003,GO:0002317,1,0.917298971819698,0,4,plasma cell differentiation,BP,
1006,GO:0002322,1,0.901197304439057,0,5,B cell proliferation involved in immune response,BP,
1008,GO:0002325,1,0.917046826839484,0,4,natural killer cell differentiation involved in immune response,BP,
1009,GO:0002326,1,0.924919685871785,0,4,B cell lineage commitment,BP,
1010,GO:0002327,1,0.853952604845492,0,8,immature B cell differentiation,BP,
1012,GO:0002329,1,0.906882617257535,0,5,pre-B cell differentiation,BP,
1013,GO:0002331,1,0.94467478333727,0,3,pre-B cell allelic exclusion,BP,
1014,GO:0002332,1,0.980032138912288,0,1,transitional stage B cell differentiation,BP,
1015,GO:0002333,1,0.980032138912288,0,1,transitional one stage B cell differentiation,BP,
1017,GO:0002337,1,0.958105637392489,0,2,B-1a B cell differentiation,BP,
1018,GO:0002339,1,0.937649728121789,0,3,B cell selection,BP,
1019,GO:0002343,1,0.978994232370442,0,1,peripheral B cell selection,BP,
1020,GO:0002344,1,0.978994232370442,0,1,B cell affinity maturation,BP,
1021,GO:0002347,1,0.711018853699744,0,16,response to tumor cell,BP,
1022,GO:0002349,1,0.879820291809512,0,6,histamine production involved in inflammatory response,BP,
1023,GO:0002351,1,0.938412098539341,0,3,serotonin production involved in inflammatory response,BP,
1024,GO:0002352,1,0.95777077822484,0,2,B cell negative selection,BP,
1025,GO:0002353,1,0.937809474417479,0,3,plasma kallikrein-kinin cascade,BP,
1026,GO:0002355,1,0.97892907535424,0,1,detection of tumor cell,BP,
1027,GO:0002357,1,0.958377522247281,0,2,defense response to tumor cell,BP,
1028,GO:0002358,1,0.957854153161641,0,2,B cell homeostatic proliferation,BP,
1030,GO:0002361,1,0.898358273074424,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1031,GO:0002362,1,0.978895123442552,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1035,GO:0002368,1,0.958324221448394,0,2,B cell cytokine production,BP,
1036,GO:0002369,1,0.539378157498427,0,29,T cell cytokine production,BP,
1037,GO:0002370,1,0.958697275649406,0,2,natural killer cell cytokine production,BP,
1038,GO:0002371,1,0.882625271085752,0,6,dendritic cell cytokine production,BP,
1039,GO:0002373,1,0.97848826210521,0,1,plasmacytoid dendritic cell cytokine production,BP,
1043,GO:0002378,1,0.93911582438897,0,3,immunoglobulin biosynthetic process,BP,
1044,GO:0002380,1,0.979281032514676,0,1,immunoglobulin secretion involved in immune response,BP,
1046,GO:0002384,1,0.958105967012985,0,2,hepatic immune response,BP,
1049,GO:0002396,1,0.897307303778832,0,5,MHC protein complex assembly,BP,
1050,GO:0002397,1,0.978723197588854,0,1,MHC class I protein complex assembly,BP,
1051,GO:0002399,1,0.916818841972371,0,4,MHC class II protein complex assembly,BP,
1053,GO:0002408,1,0.91832798584399,0,4,myeloid dendritic cell chemotaxis,BP,
1056,GO:0002416,1,0.978664600510852,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1057,GO:0002418,1,0.758178985457689,0,13,immune response to tumor cell,BP,
1058,GO:0002420,1,0.843793683929179,0,8,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1059,GO:0002423,1,0.843793683929179,0,8,natural killer cell mediated immune response to tumor cell,BP,
1060,GO:0002424,1,0.95839775695311,0,2,T cell mediated immune response to tumor cell,BP,
1061,GO:0002426,1,0.957825227517369,0,2,immunoglobulin production in mucosal tissue,BP,
1062,GO:0002428,1,0.937585360203247,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1064,GO:0002430,1,0.79341474271151,0,11,complement receptor mediated signaling pathway,BP,
1066,GO:0002432,1,0.979243270561779,0,1,granuloma formation,BP,
1068,GO:0002434,1,0.957881942599099,0,2,immune complex clearance,BP,
1069,GO:0002436,1,0.957881942599099,0,2,immune complex clearance by monocytes and macrophages,BP,
1071,GO:0002438,1,0.653681175632243,0,20,acute inflammatory response to antigenic stimulus,BP,
1072,GO:0002439,1,0.917375280496966,0,4,chronic inflammatory response to antigenic stimulus,BP,
1074,GO:0002441,1,0.879820291809512,0,6,histamine secretion involved in inflammatory response,BP,
1075,GO:0002442,1,0.938412098539341,0,3,serotonin secretion involved in inflammatory response,BP,
1078,GO:0002445,1,0.958567384699582,0,2,type II hypersensitivity,BP,
1080,GO:0002447,1,0.879376863244601,0,6,eosinophil mediated immunity,BP,
1083,GO:0002455,1,0.409540297200376,0,42,humoral immune response mediated by circulating immunoglobulin,BP,
1085,GO:0002457,1,0.899757016689161,0,5,T cell antigen processing and presentation,BP,
1086,GO:0002458,1,0.95814666880587,0,2,peripheral T cell tolerance induction,BP,
1088,GO:0002461,1,0.93791790697089,0,3,tolerance induction dependent upon immune response,BP,
1089,GO:0002465,1,0.95814666880587,0,2,peripheral tolerance induction,BP,
1090,GO:0002467,1,0.732137417654651,0,15,germinal center formation,BP,
1091,GO:0002468,1,0.843928080488192,0,8,dendritic cell antigen processing and presentation,BP,
1093,GO:0002475,1,0.807864606737643,0,10,antigen processing and presentation via MHC class Ib,BP,
1094,GO:0002476,1,0.958195917908222,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1095,GO:0002477,1,0.978492721278899,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1098,GO:0002480,1,0.841471672441653,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1099,GO:0002481,1,0.978492721278899,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1100,GO:0002483,1,0.844527997601537,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1101,GO:0002488,1,0.979115455454884,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1102,GO:0002489,1,0.979115455454884,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1104,GO:0002501,1,0.917017533214462,0,4,peptide antigen assembly with MHC protein complex,BP,
1105,GO:0002502,1,0.978723197588854,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1106,GO:0002503,1,0.936956468771243,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1108,GO:0002505,1,0.957499897015503,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1109,GO:0002506,1,0.957499897015503,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1110,GO:0002507,1,0.603085835679384,0,24,tolerance induction,BP,
1111,GO:0002508,1,0.958246677085353,0,2,central tolerance induction,BP,
1112,GO:0002509,1,0.978805429268348,0,1,central tolerance induction to self antigen,BP,
1113,GO:0002510,1,0.978997291477967,0,1,central B cell tolerance induction,BP,
1114,GO:0002513,1,0.899281497514853,0,5,tolerance induction to self antigen,BP,
1115,GO:0002514,1,0.958795997588321,0,2,B cell tolerance induction,BP,
1116,GO:0002517,1,0.760131324705684,0,13,T cell tolerance induction,BP,
1117,GO:0002518,1,0.978520430518689,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1118,GO:0002519,1,0.957973038600144,0,2,natural killer cell tolerance induction,BP,
1121,GO:0002522,1,0.958193003538148,0,2,leukocyte migration involved in immune response,BP,
1123,GO:0002524,1,0.826792672636537,0,9,hypersensitivity,BP,
1124,GO:0002525,1,0.937808464817501,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1126,GO:0002528,1,0.961239533827705,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1127,GO:0002532,1,0.376532356897007,0,46,production of molecular mediator involved in inflammatory response,BP,
1128,GO:0002534,1,0.563445316507971,0,27,cytokine production involved in inflammatory response,BP,
1129,GO:0002536,1,0.917191878058702,0,4,respiratory burst involved in inflammatory response,BP,
1130,GO:0002537,1,0.961893134042721,0,2,nitric oxide production involved in inflammatory response,BP,
1131,GO:0002538,1,0.958480984946453,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1132,GO:0002540,1,0.958480984946453,0,2,leukotriene production involved in inflammatory response,BP,
1133,GO:0002541,1,0.937876444442851,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1134,GO:0002542,1,0.958092906390443,0,2,Factor XII activation,BP,
1135,GO:0002543,1,0.958769397594377,0,2,activation of blood coagulation via clotting cascade,BP,
1137,GO:0002545,1,0.958222364474553,0,2,chronic inflammatory response to non-antigenic stimulus,BP,
1140,GO:0002553,1,0.879820291809512,0,6,histamine secretion by mast cell,BP,
1141,GO:0002554,1,0.938412098539341,0,3,serotonin secretion by platelet,BP,
1143,GO:0002566,1,0.778865831432909,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1144,GO:0002568,1,0.907916610447321,0,5,somatic diversification of T cell receptor genes,BP,
1145,GO:0002572,1,0.958605073244314,0,2,pro-T cell differentiation,BP,
1149,GO:0002578,1,0.880647055586113,0,6,negative regulation of antigen processing and presentation,BP,
1152,GO:0002581,1,0.939060389122803,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1155,GO:0002584,1,0.917704138060455,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1158,GO:0002587,1,0.95806934221135,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1160,GO:0002589,1,0.957872991495338,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1161,GO:0002590,1,0.957872991495338,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1162,GO:0002604,1,0.843928080488192,0,8,regulation of dendritic cell antigen processing and presentation,BP,
1163,GO:0002605,1,0.980161398536727,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1164,GO:0002606,1,0.86101633996388,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1165,GO:0002625,1,0.957879348796777,0,2,regulation of T cell antigen processing and presentation,BP,
1166,GO:0002626,1,0.978735715216539,0,1,negative regulation of T cell antigen processing and presentation,BP,
1167,GO:0002634,1,0.830654046532281,0,9,regulation of germinal center formation,BP,
1168,GO:0002635,1,0.963230817868614,0,2,negative regulation of germinal center formation,BP,
1169,GO:0002636,1,0.936965834317689,0,3,positive regulation of germinal center formation,BP,
1171,GO:0002638,1,0.848985177493268,0,8,negative regulation of immunoglobulin production,BP,
1173,GO:0002640,1,0.97897493185122,0,1,regulation of immunoglobulin biosynthetic process,BP,
1174,GO:0002642,1,0.97897493185122,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1175,GO:0002643,1,0.700359185360353,0,17,regulation of tolerance induction,BP,
1176,GO:0002644,1,0.958264969054473,0,2,negative regulation of tolerance induction,BP,
1177,GO:0002645,1,0.829207795075585,0,9,positive regulation of tolerance induction,BP,
1178,GO:0002646,1,0.978997291477967,0,1,regulation of central tolerance induction,BP,
1179,GO:0002648,1,0.978997291477967,0,1,positive regulation of central tolerance induction,BP,
1180,GO:0002649,1,0.979366503073909,0,1,regulation of tolerance induction to self antigen,BP,
1181,GO:0002651,1,0.979366503073909,0,1,positive regulation of tolerance induction to self antigen,BP,
1182,GO:0002652,1,0.958229505465953,0,2,regulation of tolerance induction dependent upon immune response,BP,
1183,GO:0002654,1,0.978895123442552,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1184,GO:0002658,1,0.978895123442552,0,1,regulation of peripheral tolerance induction,BP,
1185,GO:0002660,1,0.978895123442552,0,1,positive regulation of peripheral tolerance induction,BP,
1186,GO:0002661,1,0.958795997588321,0,2,regulation of B cell tolerance induction,BP,
1187,GO:0002663,1,0.958795997588321,0,2,positive regulation of B cell tolerance induction,BP,
1188,GO:0002664,1,0.793272486018887,0,11,regulation of T cell tolerance induction,BP,
1189,GO:0002665,1,0.979017437383628,0,1,negative regulation of T cell tolerance induction,BP,
1190,GO:0002666,1,0.862555622483234,0,7,positive regulation of T cell tolerance induction,BP,
1191,GO:0002667,1,0.882399693854485,0,6,regulation of T cell anergy,BP,
1192,GO:0002668,1,0.979017437383628,0,1,negative regulation of T cell anergy,BP,
1193,GO:0002669,1,0.939358963965694,0,3,positive regulation of T cell anergy,BP,
1197,GO:0002676,1,0.789805929669943,0,11,regulation of chronic inflammatory response,BP,
1198,GO:0002677,1,0.88004022617997,0,6,negative regulation of chronic inflammatory response,BP,
1199,GO:0002678,1,0.917201622193451,0,4,positive regulation of chronic inflammatory response,BP,
1201,GO:0002681,1,0.907916610447321,0,5,somatic recombination of T cell receptor gene segments,BP,
1209,GO:0002689,1,0.742670259884191,0,14,negative regulation of leukocyte chemotaxis,BP,
1212,GO:0002692,1,0.846296441794221,0,8,negative regulation of cellular extravasation,BP,
1218,GO:0002698,1,0.115998255046109,0,102,negative regulation of immune effector process,BP,
1221,GO:0002701,1,0.531966690017184,0,30,negative regulation of production of molecular mediator of immune response,BP,
1224,GO:0002704,1,0.393642523649505,0,44,negative regulation of leukocyte mediated immunity,BP,
1227,GO:0002707,1,0.496369434995253,0,33,negative regulation of lymphocyte mediated immunity,BP,
1230,GO:0002710,1,0.711460508460105,0,16,negative regulation of T cell mediated immunity,BP,
1233,GO:0002713,1,0.828449703137874,0,9,negative regulation of B cell mediated immunity,BP,
1235,GO:0002715,1,0.496202247737655,0,33,regulation of natural killer cell mediated immunity,BP,
1236,GO:0002716,1,0.790513032140624,0,11,negative regulation of natural killer cell mediated immunity,BP,
1237,GO:0002717,1,0.655140149708018,0,20,positive regulation of natural killer cell mediated immunity,BP,
1239,GO:0002719,1,0.613476374360653,0,23,negative regulation of cytokine production involved in immune response,BP,
1241,GO:0002721,1,0.978994232370442,0,1,regulation of B cell cytokine production,BP,
1242,GO:0002724,1,0.626107095097845,0,22,regulation of T cell cytokine production,BP,
1243,GO:0002725,1,0.86013399571208,0,7,negative regulation of T cell cytokine production,BP,
1244,GO:0002726,1,0.743587101883611,0,14,positive regulation of T cell cytokine production,BP,
1245,GO:0002727,1,0.958697275649406,0,2,regulation of natural killer cell cytokine production,BP,
1246,GO:0002728,1,0.979265393820919,0,1,negative regulation of natural killer cell cytokine production,BP,
1247,GO:0002729,1,0.978997566456369,0,1,positive regulation of natural killer cell cytokine production,BP,
1248,GO:0002730,1,0.900923180524282,0,5,regulation of dendritic cell cytokine production,BP,
1249,GO:0002731,1,0.958810327910692,0,2,negative regulation of dendritic cell cytokine production,BP,
1250,GO:0002732,1,0.979277721136309,0,1,positive regulation of dendritic cell cytokine production,BP,
1251,GO:0002736,1,0.97848826210521,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1252,GO:0002737,1,0.97848826210521,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1254,GO:0002740,1,0.879030337753687,0,6,negative regulation of cytokine secretion involved in immune response,BP,
1256,GO:0002752,1,0.95776592116323,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1257,GO:0002753,1,0.332224505256996,0,53,cytoplasmic pattern recognition receptor signaling pathway,BP,
1258,GO:0002755,1,0.468941540262308,0,36,MyD88-dependent toll-like receptor signaling pathway,BP,
1262,GO:0002759,1,0.859740939703107,0,7,regulation of antimicrobial humoral response,BP,
1263,GO:0002760,1,0.897245930748699,0,5,positive regulation of antimicrobial humoral response,BP,
1268,GO:0002765,1,0.879654245085818,0,6,immune response-inhibiting signal transduction,BP,
1269,GO:0002767,1,0.898735182412969,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1271,GO:0002769,1,0.978610737723817,0,1,natural killer cell inhibitory signaling pathway,BP,
1272,GO:0002774,1,0.938465312812414,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1273,GO:0002775,1,0.859610727892374,0,7,antimicrobial peptide production,BP,
1274,GO:0002777,1,0.957392980198556,0,2,antimicrobial peptide biosynthetic process,BP,
1275,GO:0002778,1,0.859610727892374,0,7,antibacterial peptide production,BP,
1276,GO:0002780,1,0.957392980198556,0,2,antibacterial peptide biosynthetic process,BP,
1277,GO:0002784,1,0.878463988354768,0,6,regulation of antimicrobial peptide production,BP,
1278,GO:0002785,1,0.979073235249225,0,1,negative regulation of antimicrobial peptide production,BP,
1279,GO:0002786,1,0.878463988354768,0,6,regulation of antibacterial peptide production,BP,
1280,GO:0002787,1,0.979073235249225,0,1,negative regulation of antibacterial peptide production,BP,
1285,GO:0002803,1,0.897245930748699,0,5,positive regulation of antibacterial peptide production,BP,
1286,GO:0002805,1,0.957392980198556,0,2,regulation of antimicrobial peptide biosynthetic process,BP,
1287,GO:0002807,1,0.957392980198556,0,2,positive regulation of antimicrobial peptide biosynthetic process,BP,
1288,GO:0002808,1,0.957392980198556,0,2,regulation of antibacterial peptide biosynthetic process,BP,
1289,GO:0002815,1,0.957392980198556,0,2,biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1290,GO:0002816,1,0.957392980198556,0,2,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1292,GO:0002820,1,0.448788525068958,0,38,negative regulation of adaptive immune response,BP,
1295,GO:0002823,1,0.478462842847794,0,35,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1297,GO:0002825,1,0.625412649575181,0,22,regulation of T-helper 1 type immune response,BP,
1298,GO:0002826,1,0.862066487980884,0,7,negative regulation of T-helper 1 type immune response,BP,
1299,GO:0002827,1,0.725593137091924,0,15,positive regulation of T-helper 1 type immune response,BP,
1300,GO:0002828,1,0.561755877981285,0,27,regulation of type 2 immune response,BP,
1301,GO:0002829,1,0.790873920092924,0,11,negative regulation of type 2 immune response,BP,
1302,GO:0002830,1,0.725897852159386,0,15,positive regulation of type 2 immune response,BP,
1304,GO:0002832,1,0.487465250028662,0,34,negative regulation of response to biotic stimulus,BP,
1306,GO:0002834,1,0.791470652926472,0,11,regulation of response to tumor cell,BP,
1307,GO:0002835,1,0.958400169676065,0,2,negative regulation of response to tumor cell,BP,
1308,GO:0002836,1,0.843506361875263,0,8,positive regulation of response to tumor cell,BP,
1309,GO:0002837,1,0.791470652926472,0,11,regulation of immune response to tumor cell,BP,
1310,GO:0002838,1,0.958400169676065,0,2,negative regulation of immune response to tumor cell,BP,
1311,GO:0002839,1,0.843506361875263,0,8,positive regulation of immune response to tumor cell,BP,
1312,GO:0002840,1,0.95839775695311,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1313,GO:0002842,1,0.978887691543403,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1314,GO:0002849,1,0.978895123442552,0,1,regulation of peripheral T cell tolerance induction,BP,
1315,GO:0002851,1,0.978895123442552,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1316,GO:0002855,1,0.843793683929179,0,8,regulation of natural killer cell mediated immune response to tumor cell,BP,
1317,GO:0002856,1,0.958400169676065,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1318,GO:0002857,1,0.880431944577445,0,6,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1319,GO:0002858,1,0.843793683929179,0,8,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1320,GO:0002859,1,0.958400169676065,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1321,GO:0002860,1,0.880431944577445,0,6,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1322,GO:0002861,1,0.639504548382022,0,21,regulation of inflammatory response to antigenic stimulus,BP,
1323,GO:0002862,1,0.808698748518286,0,10,negative regulation of inflammatory response to antigenic stimulus,BP,
1324,GO:0002863,1,0.790889547000784,0,11,positive regulation of inflammatory response to antigenic stimulus,BP,
1325,GO:0002864,1,0.776040979249405,0,12,regulation of acute inflammatory response to antigenic stimulus,BP,
1326,GO:0002865,1,0.920021658422654,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1327,GO:0002866,1,0.843535557587204,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1328,GO:0002870,1,0.882399693854485,0,6,T cell anergy,BP,
1329,GO:0002874,1,0.93717353941053,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1330,GO:0002875,1,0.978619319389108,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1331,GO:0002876,1,0.957651160083083,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1332,GO:0002877,1,0.937808464817501,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1333,GO:0002878,1,0.97906763508215,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1334,GO:0002879,1,0.957861089550601,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1335,GO:0002880,1,0.958222364474553,0,2,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1336,GO:0002881,1,0.979067851859155,0,1,negative regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1337,GO:0002882,1,0.978710056728387,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1338,GO:0002883,1,0.84448094786291,0,8,regulation of hypersensitivity,BP,
1339,GO:0002884,1,0.960154619097974,0,2,negative regulation of hypersensitivity,BP,
1340,GO:0002885,1,0.879538509712587,0,6,positive regulation of hypersensitivity,BP,
1341,GO:0002886,1,0.447138327254604,0,38,regulation of myeloid leukocyte mediated immunity,BP,
1342,GO:0002887,1,0.809805723987122,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1343,GO:0002888,1,0.681954584527749,0,18,positive regulation of myeloid leukocyte mediated immunity,BP,
1345,GO:0002890,1,0.828449703137874,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1347,GO:0002892,1,0.958567384699582,0,2,regulation of type II hypersensitivity,BP,
1348,GO:0002894,1,0.958567384699582,0,2,positive regulation of type II hypersensitivity,BP,
1349,GO:0002895,1,0.978997291477967,0,1,regulation of central B cell tolerance induction,BP,
1350,GO:0002897,1,0.978997291477967,0,1,positive regulation of central B cell tolerance induction,BP,
1351,GO:0002901,1,0.917351028125435,0,4,mature B cell apoptotic process,BP,
1352,GO:0002902,1,0.684093816877756,0,18,regulation of B cell apoptotic process,BP,
1353,GO:0002903,1,0.775594348109424,0,12,negative regulation of B cell apoptotic process,BP,
1354,GO:0002904,1,0.939124506920895,0,3,positive regulation of B cell apoptotic process,BP,
1355,GO:0002905,1,0.917351028125435,0,4,regulation of mature B cell apoptotic process,BP,
1356,GO:0002906,1,0.917351028125435,0,4,negative regulation of mature B cell apoptotic process,BP,
1357,GO:0002911,1,0.882399693854485,0,6,regulation of lymphocyte anergy,BP,
1358,GO:0002912,1,0.979017437383628,0,1,negative regulation of lymphocyte anergy,BP,
1359,GO:0002913,1,0.939358963965694,0,3,positive regulation of lymphocyte anergy,BP,
1361,GO:0002921,1,0.796424702938211,0,11,negative regulation of humoral immune response,BP,
1362,GO:0002922,1,0.723997656754049,0,15,positive regulation of humoral immune response,BP,
1363,GO:0002923,1,0.827248606624177,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1364,GO:0002924,1,0.902019030027302,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1365,GO:0002925,1,0.917130006165739,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1366,GO:0002930,1,0.958851148200421,0,2,trabecular meshwork development,BP,
1368,GO:0002933,1,0.898561472962146,0,5,lipid hydroxylation,BP,
1370,GO:0002940,1,0.978835942084345,0,1,tRNA N2-guanine methylation,BP,
1371,GO:0002943,1,0.937571602122059,0,3,tRNA dihydrouridine synthesis,BP,
1372,GO:0002944,1,0.961254438381919,0,2,cyclin K-CDK12 complex,CC,
1373,GO:0002945,1,0.960254951901982,0,2,cyclin K-CDK13 complex,CC,
1374,GO:0002946,1,0.978566525805943,0,1,tRNA C5-cytosine methylation,BP,
1375,GO:0002947,1,0.97913951205522,0,1,tumor necrosis factor receptor superfamily complex,CC,
1376,GO:0002949,1,0.937522439229067,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1377,GO:0002950,1,0.939347655431536,0,3,ceramide phosphoethanolamine synthase activity,MF,
1383,GO:0003010,1,0.901525527762418,0,5,voluntary skeletal muscle contraction,BP,
1384,GO:0003011,1,0.938442124011328,0,3,involuntary skeletal muscle contraction,BP,
1390,GO:0003017,1,0.982632524900655,0,1,lymph circulation,BP,
1392,GO:0003025,1,0.92243376005174,0,4,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1393,GO:0003026,1,0.97897493185122,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1394,GO:0003027,1,0.978642378978139,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1395,GO:0003029,1,0.978642378978139,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1396,GO:0003032,1,0.958372949875429,0,2,detection of oxygen,BP,
1398,GO:0003050,1,0.959036501467038,0,2,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1399,GO:0003051,1,0.938424843607692,0,3,angiotensin-mediated drinking behavior,BP,
1400,GO:0003056,1,0.885519190049754,0,6,regulation of vascular smooth muscle contraction,BP,
1401,GO:0003057,1,0.898714154505881,0,5,regulation of the force of heart contraction by chemical signal,BP,
1402,GO:0003058,1,0.978526838284668,0,1,hormonal regulation of the force of heart contraction,BP,
1405,GO:0003065,1,0.97867471453196,0,1,positive regulation of heart rate by epinephrine,BP,
1406,GO:0003068,1,0.978496709782108,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1407,GO:0003069,1,0.978496709782108,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1408,GO:0003070,1,0.978496709782108,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1410,GO:0003072,1,0.918404905584574,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1412,GO:0003081,1,0.587547638861784,0,25,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1413,GO:0003083,1,0.978472181035402,0,1,negative regulation of renal output by angiotensin,BP,
1414,GO:0003084,1,0.828478271442005,0,9,positive regulation of systemic arterial blood pressure,BP,
1419,GO:0003095,1,0.937865410214145,0,3,pressure natriuresis,BP,
1421,GO:0003097,1,0.880279778346114,0,6,renal water transport,BP,
1422,GO:0003099,1,0.93773926464783,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1425,GO:0003105,1,0.879267113791279,0,6,negative regulation of glomerular filtration,BP,
1426,GO:0003106,1,0.978472181035402,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1427,GO:0003127,1,0.962520010555177,0,2,detection of nodal flow,BP,
1431,GO:0003131,1,0.97903951762157,0,1,mesodermal-endodermal cell signaling,BP,
1434,GO:0003136,1,0.979053151914992,0,1,negative regulation of heart induction by canonical Wnt signaling pathway,BP,
1435,GO:0003137,1,0.978513746666424,0,1,Notch signaling pathway involved in heart induction,BP,
1436,GO:0003138,1,0.980538518891428,0,1,primary heart field specification,BP,
1438,GO:0003140,1,0.846110388814068,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1439,GO:0003142,1,0.978899388215034,0,1,cardiogenic plate morphogenesis,BP,
1441,GO:0003144,1,0.978654375421452,0,1,embryonic heart tube formation,BP,
1442,GO:0003147,1,0.978499297466388,0,1,neural crest cell migration involved in heart formation,BP,
1445,GO:0003150,1,0.901530558834134,0,5,muscular septum morphogenesis,BP,
1454,GO:0003163,1,0.939112529118476,0,3,sinoatrial node development,BP,
1455,GO:0003164,1,0.900056384434703,0,5,His-Purkinje system development,BP,
1456,GO:0003165,1,0.959199776337897,0,2,Purkinje myocyte development,BP,
1457,GO:0003166,1,0.918381481961636,0,4,bundle of His development,BP,
1458,GO:0003167,1,0.979417049411772,0,1,atrioventricular bundle cell differentiation,BP,
1459,GO:0003168,1,0.978725608204797,0,1,Purkinje myocyte differentiation,BP,
1463,GO:0003172,1,0.980538518891428,0,1,sinoatrial valve development,BP,
1473,GO:0003185,1,0.980538518891428,0,1,sinoatrial valve morphogenesis,BP,
1478,GO:0003193,1,0.958124296840337,0,2,pulmonary valve formation,BP,
1482,GO:0003199,1,0.918405234776734,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1489,GO:0003210,1,0.978513746666424,0,1,cardiac atrium formation,BP,
1494,GO:0003218,1,0.958172466097081,0,2,cardiac left ventricle formation,BP,
1496,GO:0003220,1,0.96986374741062,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1497,GO:0003221,1,0.94265716585548,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1499,GO:0003223,1,0.871674328673881,0,7,ventricular compact myocardium morphogenesis,BP,
1500,GO:0003226,1,0.983536776242703,0,1,right ventricular compact myocardium morphogenesis,BP,
1505,GO:0003235,1,0.978513746666424,0,1,sinus venosus development,BP,
1506,GO:0003236,1,0.978513746666424,0,1,sinus venosus morphogenesis,BP,
1508,GO:0003245,1,0.95813121252774,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1509,GO:0003247,1,0.978622147444102,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1510,GO:0003249,1,0.967228507468134,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1511,GO:0003250,1,0.967228507468134,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1512,GO:0003251,1,0.982356041621774,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1513,GO:0003252,1,0.984601507677694,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1514,GO:0003253,1,0.917561765326483,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1515,GO:0003254,1,0.42772782598457,0,41,regulation of membrane depolarization,BP,
1517,GO:0003257,1,0.920697878406429,0,4,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1518,GO:0003259,1,0.978513746666424,0,1,cardioblast anterior-lateral migration,BP,
1519,GO:0003260,1,0.978513746666424,0,1,cardioblast migration,BP,
1520,GO:0003263,1,0.825441083569729,0,9,cardioblast proliferation,BP,
1527,GO:0003275,1,0.93870172374835,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1528,GO:0003278,1,0.880342991001458,0,6,apoptotic process involved in heart morphogenesis,BP,
1533,GO:0003285,1,0.958239049743984,0,2,septum secundum development,BP,
1535,GO:0003290,1,0.979069341946278,0,1,atrial septum secundum morphogenesis,BP,
1536,GO:0003292,1,0.959244064262877,0,2,cardiac septum cell differentiation,BP,
1537,GO:0003294,1,0.979067462538613,0,1,atrial ventricular junction remodeling,BP,
1539,GO:0003299,1,0.677522421160923,0,19,muscle hypertrophy in response to stress,BP,
1546,GO:0003310,1,0.863256628123209,0,7,pancreatic A cell differentiation,BP,
1547,GO:0003311,1,0.979069625660436,0,1,pancreatic D cell differentiation,BP,
1548,GO:0003312,1,0.958227021528646,0,2,pancreatic PP cell differentiation,BP,
1549,GO:0003318,1,0.978513746666424,0,1,cell migration to the midline involved in heart development,BP,
1550,GO:0003321,1,0.863875190812773,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1551,GO:0003322,1,0.98098640850695,0,1,pancreatic A cell development,BP,
1553,GO:0003326,1,0.958227021528646,0,2,pancreatic A cell fate commitment,BP,
1554,GO:0003327,1,0.978788130990152,0,1,type B pancreatic cell fate commitment,BP,
1555,GO:0003329,1,0.958227021528646,0,2,pancreatic PP cell fate commitment,BP,
1556,GO:0003330,1,0.93792180018427,0,3,regulation of extracellular matrix constituent secretion,BP,
1557,GO:0003331,1,0.93792180018427,0,3,positive regulation of extracellular matrix constituent secretion,BP,
1559,GO:0003334,1,0.80011997921497,0,11,keratinocyte development,BP,
1560,GO:0003335,1,0.957962467186038,0,2,corneocyte development,BP,
1561,GO:0003336,1,0.978969559546176,0,1,corneocyte desquamation,BP,
1565,GO:0003340,1,0.937951849829779,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1566,GO:0003341,1,0.371257043059907,0,48,cilium movement,BP,
1567,GO:0003342,1,0.958230749208404,0,2,proepicardium development,BP,
1568,GO:0003343,1,0.958230749208404,0,2,septum transversum development,BP,
1570,GO:0003345,1,0.979089445023866,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1572,GO:0003350,1,0.938576307002084,0,3,pulmonary myocardium development,BP,
1573,GO:0003351,1,0.669016223363267,0,19,epithelial cilium movement,BP,
1574,GO:0003352,1,0.797665081840308,0,11,regulation of cilium movement,BP,
1575,GO:0003353,1,0.979059812685125,0,1,positive regulation of cilium movement,BP,
1576,GO:0003356,1,0.814735219479911,0,10,regulation of cilium beat frequency,BP,
1577,GO:0003357,1,0.864910089306092,0,7,noradrenergic neuron differentiation,BP,
1578,GO:0003358,1,0.938354741863969,0,3,noradrenergic neuron development,BP,
1579,GO:0003359,1,0.978946517601127,0,1,noradrenergic neuron fate commitment,BP,
1580,GO:0003360,1,0.868323763804411,0,7,brainstem development,BP,
1581,GO:0003363,1,0.980298455410041,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1583,GO:0003366,1,0.959825330700505,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1584,GO:0003373,1,0.866080181580409,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1585,GO:0003374,1,0.866080181580409,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1586,GO:0003376,1,0.774286395500576,0,12,sphingosine-1-phosphate signaling pathway,BP,
1588,GO:0003383,1,0.94222930382929,0,3,apical constriction,BP,
1589,GO:0003400,1,0.978827671348179,0,1,regulation of COPII vesicle coating,BP,
1592,GO:0003404,1,0.958470172087125,0,2,optic vesicle morphogenesis,BP,
1593,GO:0003406,1,0.921550296802723,0,4,retinal pigment epithelium development,BP,
1594,GO:0003407,1,0.30835884831997,0,57,neural retina development,BP,
1596,GO:0003409,1,0.979069237372578,0,1,optic cup structural organization,BP,
1598,GO:0003414,1,0.979084737167589,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1599,GO:0003415,1,0.919208743805985,0,4,chondrocyte hypertrophy,BP,
1604,GO:0003420,1,0.958455606383576,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1605,GO:0003421,1,0.979089880969185,0,1,growth plate cartilage axis specification,BP,
1606,GO:0003422,1,0.958610792090056,0,2,growth plate cartilage morphogenesis,BP,
1607,GO:0003429,1,0.979084737167589,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1608,GO:0003430,1,0.958838212572783,0,2,growth plate cartilage chondrocyte growth,BP,
1609,GO:0003431,1,0.919804495429036,0,4,growth plate cartilage chondrocyte development,BP,
1610,GO:0003433,1,0.881502470025013,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1614,GO:0003678,1,0.378267263015264,0,47,DNA helicase activity,MF,
1615,GO:0003680,1,0.843810001391964,0,8,AT DNA binding,MF,
1617,GO:0003684,1,0.272967321598281,0,62,damaged DNA binding,MF,
1618,GO:0003688,1,0.758689914907291,0,13,DNA replication origin binding,MF,
1619,GO:0003689,1,0.843168242036882,0,8,DNA clamp loader activity,MF,
1621,GO:0003691,1,0.826693515687592,0,9,double-stranded telomeric DNA binding,MF,
1622,GO:0003692,1,0.978834497088139,0,1,left-handed Z-DNA binding,MF,
1624,GO:0003697,1,0.146176303738429,0,91,single-stranded DNA binding,MF,
1626,GO:0003705,1,0.139725725887155,0,94,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1628,GO:0003708,1,0.863217278791496,0,7,retinoic acid receptor activity,MF,
1632,GO:0003720,1,0.86606506723548,0,7,telomerase activity,MF,
1633,GO:0003721,1,0.979110885702327,0,1,telomerase RNA reverse transcriptase activity,MF,
1635,GO:0003724,1,0.238331642046831,0,68,RNA helicase activity,MF,
1637,GO:0003726,1,0.940314681262143,0,3,double-stranded RNA adenosine deaminase activity,MF,
1638,GO:0003727,1,0.218221281159409,0,72,single-stranded RNA binding,MF,
1642,GO:0003743,1,0.34635132742243,0,50,translation initiation factor activity,MF,
1644,GO:0003747,1,0.882061803709443,0,6,translation release factor activity,MF,
1645,GO:0003755,1,0.444613266360977,0,38,peptidyl-prolyl cis-trans isomerase activity,MF,
1646,GO:0003756,1,0.682962912962193,0,18,protein disulfide isomerase activity,MF,
1648,GO:0003777,1,0.228665709433371,0,76,microtubule motor activity,MF,
1650,GO:0003785,1,0.578245319922962,0,26,actin monomer binding,MF,
1651,GO:0003796,1,0.787286404177758,0,11,lysozyme activity,MF,
1652,GO:0003810,1,0.826059534885786,0,9,protein-glutamine gamma-glutamyltransferase activity,MF,
1653,GO:0003823,1,0.25403476076241,0,64,antigen binding,MF,
1655,GO:0003826,1,0.958113585589135,0,2,alpha-ketoacid dehydrogenase activity,MF,
1656,GO:0003827,1,0.979052057934143,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1657,GO:0003828,1,0.888561894157351,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1658,GO:0003829,1,0.939188402409524,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1659,GO:0003830,1,0.979584767624086,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1660,GO:0003831,1,0.844201302193875,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1661,GO:0003835,1,0.960489761359539,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1662,GO:0003836,1,0.881695610577136,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1663,GO:0003837,1,0.978787297703884,0,1,beta-ureidopropionase activity,MF,
1664,GO:0003839,1,0.917291164145134,0,4,gamma-glutamylcyclotransferase activity,MF,
1665,GO:0003840,1,0.879355504618441,0,6,gamma-glutamyltransferase activity,MF,
1667,GO:0003842,1,0.979068924577401,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1668,GO:0003844,1,0.979065745481601,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1669,GO:0003845,1,0.957725123834675,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1670,GO:0003846,1,0.878965700674065,0,6,2-acylglycerol O-acyltransferase activity,MF,
1671,GO:0003847,1,0.89790264847318,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1675,GO:0003860,1,0.978729033555592,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1676,GO:0003863,1,0.958113585589135,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1677,GO:0003865,1,0.938124532939593,0,3,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1678,GO:0003867,1,0.979516224791057,0,1,4-aminobutyrate transaminase activity,MF,
1679,GO:0003868,1,0.978632151080609,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1680,GO:0003870,1,0.958112935985906,0,2,5-aminolevulinate synthase activity,MF,
1681,GO:0003872,1,0.93843717731824,0,3,6-phosphofructokinase activity,MF,
1684,GO:0003875,1,0.958189059344874,0,2,ADP-ribosylarginine hydrolase activity,MF,
1685,GO:0003876,1,0.938515153660378,0,3,AMP deaminase activity,MF,
1686,GO:0003878,1,0.97921950544183,0,1,ATP citrate synthase activity,MF,
1687,GO:0003880,1,0.958427198504933,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1688,GO:0003881,1,0.978706903502128,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1689,GO:0003882,1,0.978938433158511,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1690,GO:0003883,1,0.958513479051569,0,2,CTP synthase activity,MF,
1691,GO:0003884,1,0.957683119090276,0,2,D-amino-acid oxidase activity,MF,
1692,GO:0003886,1,0.939414713406759,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1693,GO:0003887,1,0.585602689131675,0,26,DNA-directed DNA polymerase activity,MF,
1694,GO:0003896,1,0.938650368795165,0,3,DNA primase activity,MF,
1695,GO:0003899,1,0.427061328043924,0,40,DNA-directed 5'-3' RNA polymerase activity,MF,
1696,GO:0003905,1,0.978504121567352,0,1,alkylbase DNA N-glycosylase activity,MF,
1697,GO:0003906,1,0.740191124734339,0,14,DNA-(apurinic or apyrimidinic site) lyase activity,MF,
1698,GO:0003908,1,0.978531192925023,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1699,GO:0003909,1,0.86173226858893,0,7,DNA ligase activity,MF,
1700,GO:0003910,1,0.880398527977369,0,6,DNA ligase (ATP) activity,MF,
1701,GO:0003912,1,0.978775437117353,0,1,DNA nucleotidylexotransferase activity,MF,
1702,GO:0003916,1,0.863237163698187,0,7,DNA topoisomerase activity,MF,
1703,GO:0003917,1,0.918609354462244,0,4,DNA topoisomerase type I activity,MF,
1704,GO:0003918,1,0.939735236764853,0,3,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1705,GO:0003919,1,0.978746526553592,0,1,FMN adenylyltransferase activity,MF,
1706,GO:0003920,1,0.957751632362377,0,2,GMP reductase activity,MF,
1707,GO:0003921,1,0.97894337658284,0,1,GMP synthase activity,MF,
1708,GO:0003922,1,0.97894337658284,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1709,GO:0003923,1,0.899058994589324,0,5,GPI-anchor transamidase activity,MF,
1711,GO:0003933,1,0.978738765552603,0,1,GTP cyclohydrolase activity,MF,
1712,GO:0003934,1,0.978738765552603,0,1,GTP cyclohydrolase I activity,MF,
1713,GO:0003937,1,0.978798551701089,0,1,IMP cyclohydrolase activity,MF,
1714,GO:0003938,1,0.95804882639502,0,2,IMP dehydrogenase activity,MF,
1715,GO:0003939,1,0.978965040994655,0,1,L-iditol 2-dehydrogenase activity,MF,
1717,GO:0003941,1,0.937466097238571,0,3,L-serine ammonia-lyase activity,MF,
1718,GO:0003943,1,0.958486470493741,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1719,GO:0003944,1,0.978843766023198,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1720,GO:0003945,1,0.918209460030739,0,4,N-acetyllactosamine synthase activity,MF,
1721,GO:0003947,1,0.979060651139411,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1722,GO:0003948,1,0.978794799674675,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1723,GO:0003950,1,0.631724703318549,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1724,GO:0003951,1,0.717252082684722,0,16,NAD+ kinase activity,MF,
1725,GO:0003952,1,0.978935935955106,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1726,GO:0003953,1,0.937075811774384,0,3,NAD+ nucleosidase activity,MF,
1727,GO:0003954,1,0.438536606514466,0,38,NADH dehydrogenase activity,MF,
1728,GO:0003955,1,0.958460124577502,0,2,NAD(P)H dehydrogenase (quinone) activity,MF,
1729,GO:0003956,1,0.897343218437509,0,5,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1730,GO:0003957,1,0.979372546615969,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1731,GO:0003958,1,0.882926483077901,0,6,NADPH-hemoprotein reductase activity,MF,
1732,GO:0003960,1,0.91748773251307,0,4,NADPH:quinone reductase activity,MF,
1733,GO:0003962,1,0.97865811077371,0,1,cystathionine gamma-synthase activity,MF,
1734,GO:0003963,1,0.97897493185122,0,1,RNA-3'-phosphate cyclase activity,MF,
1735,GO:0003964,1,0.86606506723548,0,7,RNA-directed DNA polymerase activity,MF,
1736,GO:0003968,1,0.960279199070421,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1737,GO:0003973,1,0.957722339473154,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1738,GO:0003974,1,0.978614375640949,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1739,GO:0003975,1,0.978818125495465,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1740,GO:0003976,1,0.938667332110938,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1741,GO:0003977,1,0.958403497308567,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1742,GO:0003978,1,0.978614375640949,0,1,UDP-glucose 4-epimerase activity,MF,
1743,GO:0003979,1,0.979068173992693,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1744,GO:0003980,1,0.963690810921366,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1745,GO:0003983,1,0.97881770979122,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1748,GO:0003987,1,0.938687881935183,0,3,acetate-CoA ligase activity,MF,
1750,GO:0003989,1,0.966077948500083,0,2,acetyl-CoA carboxylase activity,MF,
1751,GO:0003990,1,0.958358435868916,0,2,acetylcholinesterase activity,MF,
1753,GO:0003994,1,0.958533772243124,0,2,aconitate hydratase activity,MF,
1756,GO:0003997,1,0.882158178693723,0,6,acyl-CoA oxidase activity,MF,
1757,GO:0003998,1,0.95745491989436,0,2,acylphosphatase activity,MF,
1758,GO:0003999,1,0.97847448486958,0,1,adenine phosphoribosyltransferase activity,MF,
1759,GO:0004000,1,0.811088964164771,0,10,adenosine deaminase activity,MF,
1760,GO:0004001,1,0.978780635386742,0,1,adenosine kinase activity,MF,
1761,GO:0004003,1,0.502301361696131,0,33,ATP-dependent DNA helicase activity,MF,
1762,GO:0004004,1,0.243448208276253,0,67,ATP-dependent RNA helicase activity,MF,
1763,GO:0004008,1,0.963080193661701,0,2,copper-exporting ATPase activity,MF,
1764,GO:0004012,1,0.689344899133792,0,19,phospholipid-translocating ATPase activity,MF,
1765,GO:0004013,1,0.978878194325947,0,1,adenosylhomocysteinase activity,MF,
1766,GO:0004014,1,0.979069037868997,0,1,adenosylmethionine decarboxylase activity,MF,
1767,GO:0004016,1,0.820700576224504,0,10,adenylate cyclase activity,MF,
1768,GO:0004017,1,0.862769774050735,0,7,adenylate kinase activity,MF,
1769,GO:0004018,1,0.978577289981347,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1770,GO:0004019,1,0.95814847069592,0,2,adenylosuccinate synthase activity,MF,
1771,GO:0004020,1,0.958497218961017,0,2,adenylylsulfate kinase activity,MF,
1772,GO:0004021,1,0.958253608077895,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1773,GO:0004022,1,0.824363682135472,0,9,alcohol dehydrogenase (NAD) activity,MF,
1774,GO:0004024,1,0.879112852965948,0,6,alcohol dehydrogenase activity, zinc-dependent,MF,
1775,GO:0004027,1,0.957471780189303,0,2,alcohol sulfotransferase activity,MF,
1776,GO:0004028,1,0.899046329908142,0,5,3-chloroallyl aldehyde dehydrogenase activity,MF,
1777,GO:0004029,1,0.74465195181391,0,14,aldehyde dehydrogenase (NAD) activity,MF,
1778,GO:0004030,1,0.861490012395723,0,7,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1780,GO:0004032,1,0.859366036400841,0,7,alditol:NADP+ 1-oxidoreductase activity,MF,
1782,GO:0004034,1,0.978949972742984,0,1,aldose 1-epimerase activity,MF,
1783,GO:0004035,1,0.918560747551289,0,4,alkaline phosphatase activity,MF,
1784,GO:0004037,1,0.97856963137963,0,1,allantoicase activity,MF,
1785,GO:0004040,1,0.937822738565227,0,3,amidase activity,MF,
1786,GO:0004042,1,0.978788130990152,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1787,GO:0004043,1,0.979070337096472,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1788,GO:0004044,1,0.979077713043123,0,1,amidophosphoribosyltransferase activity,MF,
1789,GO:0004045,1,0.93728617911855,0,3,aminoacyl-tRNA hydrolase activity,MF,
1790,GO:0004046,1,0.897870366078639,0,5,aminoacylase activity,MF,
1791,GO:0004047,1,0.957824650426833,0,2,aminomethyltransferase activity,MF,
1792,GO:0004051,1,0.978974619387183,0,1,arachidonate 5-lipoxygenase activity,MF,
1793,GO:0004052,1,0.938192278618038,0,3,arachidonate 12-lipoxygenase activity,MF,
1794,GO:0004053,1,0.957774061790297,0,2,arginase activity,MF,
1795,GO:0004055,1,0.978688479522968,0,1,argininosuccinate synthase activity,MF,
1796,GO:0004056,1,0.978754947980044,0,1,argininosuccinate lyase activity,MF,
1797,GO:0004057,1,0.97884704898118,0,1,arginyltransferase activity,MF,
1798,GO:0004058,1,0.978766308543155,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1799,GO:0004059,1,0.978574531263958,0,1,aralkylamine N-acetyltransferase activity,MF,
1800,GO:0004060,1,0.937236815999874,0,3,arylamine N-acetyltransferase activity,MF,
1801,GO:0004061,1,0.978641526874056,0,1,arylformamidase activity,MF,
1802,GO:0004062,1,0.788724753867654,0,11,aryl sulfotransferase activity,MF,
1803,GO:0004063,1,0.957637842074573,0,2,aryldialkylphosphatase activity,MF,
1805,GO:0004065,1,0.775846992876004,0,12,arylsulfatase activity,MF,
1806,GO:0004066,1,0.95828109412722,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1807,GO:0004067,1,0.958060013647912,0,2,asparaginase activity,MF,
1808,GO:0004068,1,0.979073153012333,0,1,aspartate 1-decarboxylase activity,MF,
1809,GO:0004069,1,0.937643961738581,0,3,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1810,GO:0004070,1,0.981172412228562,0,1,aspartate carbamoyltransferase activity,MF,
1811,GO:0004074,1,0.957446243178105,0,2,biliverdin reductase activity,MF,
1812,GO:0004075,1,0.906503304706702,0,5,biotin carboxylase activity,MF,
1813,GO:0004077,1,0.980322128492799,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1814,GO:0004078,1,0.980322128492799,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1815,GO:0004079,1,0.980322128492799,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1816,GO:0004080,1,0.980322128492799,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1817,GO:0004081,1,0.957969774302333,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1818,GO:0004082,1,0.917193371948543,0,4,bisphosphoglycerate mutase activity,MF,
1819,GO:0004084,1,0.960994661689076,0,2,branched-chain-amino-acid transaminase activity,MF,
1820,GO:0004085,1,0.978725608204797,0,1,butyryl-CoA dehydrogenase activity,MF,
1821,GO:0004087,1,0.980121478494524,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1822,GO:0004088,1,0.961667153614187,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1823,GO:0004089,1,0.756997187793218,0,13,carbonate dehydratase activity,MF,
1824,GO:0004090,1,0.91691897799854,0,4,carbonyl reductase (NADPH) activity,MF,
1825,GO:0004092,1,0.979038624266357,0,1,carnitine O-acetyltransferase activity,MF,
1827,GO:0004096,1,0.937491861282197,0,3,catalase activity,MF,
1828,GO:0004098,1,0.978718794539972,0,1,cerebroside-sulfatase activity,MF,
1829,GO:0004102,1,0.978944426846825,0,1,choline O-acetyltransferase activity,MF,
1830,GO:0004103,1,0.958081157752452,0,2,choline kinase activity,MF,
1831,GO:0004104,1,0.938242548233306,0,3,cholinesterase activity,MF,
1832,GO:0004105,1,0.958956780031846,0,2,choline-phosphate cytidylyltransferase activity,MF,
1833,GO:0004108,1,0.979058019567663,0,1,citrate (Si)-synthase activity,MF,
1834,GO:0004109,1,0.958412761134268,0,2,coproporphyrinogen oxidase activity,MF,
1835,GO:0004111,1,0.880657186120056,0,6,creatine kinase activity,MF,
1837,GO:0004113,1,0.979721830064264,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1840,GO:0004117,1,0.938246045559142,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1841,GO:0004118,1,0.944067124902991,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1842,GO:0004119,1,0.959935464118918,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1843,GO:0004122,1,0.978987637002078,0,1,cystathionine beta-synthase activity,MF,
1844,GO:0004123,1,0.97865811077371,0,1,cystathionine gamma-lyase activity,MF,
1845,GO:0004126,1,0.841579499782559,0,8,cytidine deaminase activity,MF,
1846,GO:0004127,1,0.91867849553286,0,4,cytidylate kinase activity,MF,
1847,GO:0004128,1,0.861106582005906,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1849,GO:0004131,1,0.978484299630964,0,1,cytosine deaminase activity,MF,
1850,GO:0004132,1,0.978770454199024,0,1,dCMP deaminase activity,MF,
1851,GO:0004133,1,0.981219837109701,0,1,glycogen debranching enzyme activity,MF,
1852,GO:0004134,1,0.981219837109701,0,1,4-alpha-glucanotransferase activity,MF,
1853,GO:0004135,1,0.981219837109701,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1854,GO:0004137,1,0.95902048914971,0,2,deoxycytidine kinase activity,MF,
1855,GO:0004138,1,0.978495412165919,0,1,deoxyguanosine kinase activity,MF,
1857,GO:0004140,1,0.958103275290816,0,2,dephospho-CoA kinase activity,MF,
1858,GO:0004142,1,0.938080701027819,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1859,GO:0004143,1,0.797486547296123,0,11,diacylglycerol kinase activity,MF,
1860,GO:0004144,1,0.898138050907278,0,5,diacylglycerol O-acyltransferase activity,MF,
1861,GO:0004145,1,0.93717927224581,0,3,diamine N-acetyltransferase activity,MF,
1862,GO:0004146,1,0.979095613080179,0,1,dihydrofolate reductase activity,MF,
1863,GO:0004148,1,0.979070772639521,0,1,dihydrolipoyl dehydrogenase activity,MF,
1864,GO:0004149,1,0.979043139771547,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1865,GO:0004151,1,0.981172412228562,0,1,dihydroorotase activity,MF,
1866,GO:0004152,1,0.978786464509949,0,1,dihydroorotate dehydrogenase activity,MF,
1867,GO:0004155,1,0.978626292916885,0,1,6,7-dihydropteridine reductase activity,MF,
1868,GO:0004157,1,0.958553313612321,0,2,dihydropyrimidinase activity,MF,
1869,GO:0004161,1,0.958063540882306,0,2,dimethylallyltranstransferase activity,MF,
1870,GO:0004163,1,0.978678448688209,0,1,diphosphomevalonate decarboxylase activity,MF,
1871,GO:0004164,1,0.978675459035838,0,1,diphthine synthase activity,MF,
1873,GO:0004167,1,0.937197893777667,0,3,dopachrome isomerase activity,MF,
1874,GO:0004168,1,0.978840476122935,0,1,dolichol kinase activity,MF,
1875,GO:0004169,1,0.898433120963109,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1876,GO:0004170,1,0.978706510299768,0,1,dUTP diphosphatase activity,MF,
1879,GO:0004176,1,0.918873043488337,0,4,ATP-dependent peptidase activity,MF,
1883,GO:0004185,1,0.901065133252177,0,5,serine-type carboxypeptidase activity,MF,
1884,GO:0004190,1,0.599429078145536,0,24,aspartic-type endopeptidase activity,MF,
1886,GO:0004198,1,0.667200686329322,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1887,GO:0004222,1,0.0956351236591949,0,112,metalloendopeptidase activity,MF,
1891,GO:0004301,1,0.898176989294739,0,5,epoxide hydrolase activity,MF,
1893,GO:0004304,1,0.957876593952469,0,2,estrone sulfotransferase activity,MF,
1894,GO:0004305,1,0.918353452335493,0,4,ethanolamine kinase activity,MF,
1895,GO:0004306,1,0.978700638551432,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1896,GO:0004307,1,0.957812444168265,0,2,ethanolaminephosphotransferase activity,MF,
1897,GO:0004308,1,0.879555317221329,0,6,exo-alpha-sialidase activity,MF,
1898,GO:0004310,1,0.978802720300017,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1899,GO:0004311,1,0.918543951568504,0,4,farnesyltranstransferase activity,MF,
1909,GO:0004322,1,0.883214676445763,0,6,ferroxidase activity,MF,
1910,GO:0004324,1,0.978716402207837,0,1,ferredoxin-NADP+ reductase activity,MF,
1911,GO:0004325,1,0.981267183805823,0,1,ferrochelatase activity,MF,
1912,GO:0004326,1,0.978952368998314,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1913,GO:0004329,1,0.958577871763324,0,2,formate-tetrahydrofolate ligase activity,MF,
1915,GO:0004332,1,0.937496178625876,0,3,fructose-bisphosphate aldolase activity,MF,
1916,GO:0004333,1,0.978675459035838,0,1,fumarate hydratase activity,MF,
1917,GO:0004334,1,0.97857132942134,0,1,fumarylacetoacetase activity,MF,
1918,GO:0004335,1,0.958065625892239,0,2,galactokinase activity,MF,
1919,GO:0004336,1,0.9790507988319,0,1,galactosylceramidase activity,MF,
1920,GO:0004337,1,0.958063540882306,0,2,geranyltranstransferase activity,MF,
1921,GO:0004339,1,0.980708924807722,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1922,GO:0004340,1,0.901455582617272,0,5,glucokinase activity,MF,
1924,GO:0004342,1,0.958052338890153,0,2,glucosamine-6-phosphate deaminase activity,MF,
1925,GO:0004343,1,0.979097119133339,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1926,GO:0004345,1,0.961858090058694,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1927,GO:0004346,1,0.9380687195904,0,3,glucose-6-phosphatase activity,MF,
1928,GO:0004347,1,0.978794382798285,0,1,glucose-6-phosphate isomerase activity,MF,
1929,GO:0004348,1,0.937955920247027,0,3,glucosylceramidase activity,MF,
1930,GO:0004349,1,0.979069454243021,0,1,glutamate 5-kinase activity,MF,
1931,GO:0004350,1,0.979069454243021,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1932,GO:0004351,1,0.93843180806661,0,3,glutamate decarboxylase activity,MF,
1933,GO:0004352,1,0.958402899924685,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1934,GO:0004353,1,0.958402899924685,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1935,GO:0004356,1,0.959507843292867,0,2,glutamate-ammonia ligase activity,MF,
1936,GO:0004357,1,0.95857741030419,0,2,glutamate-cysteine ligase activity,MF,
1937,GO:0004359,1,0.938453116002801,0,3,glutaminase activity,MF,
1938,GO:0004360,1,0.961701424020883,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1939,GO:0004361,1,0.9786466750349,0,1,glutaryl-CoA dehydrogenase activity,MF,
1940,GO:0004362,1,0.97886939171856,0,1,glutathione-disulfide reductase activity,MF,
1941,GO:0004363,1,0.978719993210773,0,1,glutathione synthase activity,MF,
1943,GO:0004365,1,0.957580611332765,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1944,GO:0004366,1,0.96005149886148,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1945,GO:0004367,1,0.958578402219599,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1946,GO:0004368,1,0.959713408847975,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1947,GO:0004370,1,0.942386390252689,0,3,glycerol kinase activity,MF,
1948,GO:0004372,1,0.958242974601567,0,2,glycine hydroxymethyltransferase activity,MF,
1949,GO:0004373,1,0.95857318237996,0,2,glycogen (starch) synthase activity,MF,
1951,GO:0004376,1,0.918382189233467,0,4,glycolipid mannosyltransferase activity,MF,
1952,GO:0004377,1,0.978966987752712,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1953,GO:0004378,1,0.979050326243143,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1955,GO:0004380,1,0.978604806211776,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1956,GO:0004381,1,0.978604806211776,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1957,GO:0004382,1,0.958293882399762,0,2,guanosine-diphosphatase activity,MF,
1959,GO:0004385,1,0.766131929634282,0,13,guanylate kinase activity,MF,
1960,GO:0004386,1,0.0480276732767926,0,147,helicase activity,MF,
1961,GO:0004392,1,0.957708755755053,0,2,heme oxygenase (decyclizing) activity,MF,
1962,GO:0004394,1,0.979151613693977,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1963,GO:0004395,1,0.978531371205572,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1964,GO:0004396,1,0.901455582617272,0,5,hexokinase activity,MF,
1965,GO:0004397,1,0.979067237834846,0,1,histidine ammonia-lyase activity,MF,
1966,GO:0004398,1,0.978923946020535,0,1,histidine decarboxylase activity,MF,
1967,GO:0004402,1,0.327116407016993,0,54,histone acetyltransferase activity,MF,
1969,GO:0004408,1,0.978876600415521,0,1,holocytochrome-c synthase activity,MF,
1970,GO:0004411,1,0.978728428225461,0,1,homogentisate 1,2-dioxygenase activity,MF,
1971,GO:0004415,1,0.880198619780551,0,6,hyalurononglucosaminidase activity,MF,
1972,GO:0004416,1,0.958105664655775,0,2,hydroxyacylglutathione hydrolase activity,MF,
1973,GO:0004418,1,0.978574531263958,0,1,hydroxymethylbilane synthase activity,MF,
1974,GO:0004419,1,0.957994306378557,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1975,GO:0004420,1,0.979288686738532,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1977,GO:0004422,1,0.978562097860833,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1978,GO:0004423,1,0.980166002668205,0,1,iduronate-2-sulfatase activity,MF,
1979,GO:0004427,1,0.937131304753332,0,3,inorganic diphosphatase activity,MF,
1980,GO:0004430,1,0.919363803479736,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1981,GO:0004435,1,0.569669332030377,0,27,phosphatidylinositol phospholipase C activity,MF,
1982,GO:0004438,1,0.751775615906772,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1983,GO:0004439,1,0.848083714638397,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1984,GO:0004441,1,0.97879584188831,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1985,GO:0004445,1,0.899790104363528,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1986,GO:0004446,1,0.979042395172386,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1987,GO:0004447,1,0.960850896564907,0,2,iodide peroxidase activity,MF,
1989,GO:0004449,1,0.93754982450673,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1991,GO:0004452,1,0.957816178621932,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1995,GO:0004459,1,0.89783551304804,0,5,L-lactate dehydrogenase activity,MF,
1996,GO:0004461,1,0.937769710630202,0,3,lactose synthase activity,MF,
1997,GO:0004462,1,0.978776476198651,0,1,lactoylglutathione lyase activity,MF,
1998,GO:0004463,1,0.978788547665482,0,1,leukotriene-A4 hydrolase activity,MF,
2000,GO:0004465,1,0.842594228352787,0,8,lipoprotein lipase activity,MF,
2003,GO:0004468,1,0.882981763517124,0,6,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
2005,GO:0004471,1,0.938533397266462,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
2006,GO:0004473,1,0.938533397266462,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
2007,GO:0004474,1,0.980136066809812,0,1,malate synthase activity,MF,
2008,GO:0004475,1,0.978611943742488,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
2009,GO:0004476,1,0.978668801600268,0,1,mannose-6-phosphate isomerase activity,MF,
2010,GO:0004477,1,0.918510411459053,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
2011,GO:0004478,1,0.958545208060057,0,2,methionine adenosyltransferase activity,MF,
2012,GO:0004479,1,0.979024817940894,0,1,methionyl-tRNA formyltransferase activity,MF,
2013,GO:0004482,1,0.980469854211249,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2014,GO:0004484,1,0.979269311676231,0,1,mRNA guanylyltransferase activity,MF,
2015,GO:0004485,1,0.958483655038194,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2016,GO:0004486,1,0.979069458245616,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2017,GO:0004487,1,0.938147781306868,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2018,GO:0004488,1,0.918510411459053,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2019,GO:0004489,1,0.981180568946713,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2020,GO:0004490,1,0.978607751495977,0,1,methylglutaconyl-CoA hydratase activity,MF,
2021,GO:0004491,1,0.978834703582196,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2022,GO:0004492,1,0.978806054310493,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2023,GO:0004493,1,0.978482532684248,0,1,methylmalonyl-CoA epimerase activity,MF,
2024,GO:0004494,1,0.979056340786129,0,1,methylmalonyl-CoA mutase activity,MF,
2025,GO:0004496,1,0.978788339325216,0,1,mevalonate kinase activity,MF,
2027,GO:0004498,1,0.978952368998314,0,1,calcidiol 1-monooxygenase activity,MF,
2028,GO:0004499,1,0.899373486397301,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2029,GO:0004500,1,0.958529149180282,0,2,dopamine beta-monooxygenase activity,MF,
2030,GO:0004502,1,0.979585435496322,0,1,kynurenine 3-monooxygenase activity,MF,
2031,GO:0004503,1,0.978784381979683,0,1,monophenol monooxygenase activity,MF,
2032,GO:0004504,1,0.979076438871909,0,1,peptidylglycine monooxygenase activity,MF,
2034,GO:0004506,1,0.979058921951333,0,1,squalene monooxygenase activity,MF,
2035,GO:0004507,1,0.958560703769763,0,2,steroid 11-beta-monooxygenase activity,MF,
2037,GO:0004509,1,0.978769417163709,0,1,steroid 21-monooxygenase activity,MF,
2038,GO:0004510,1,0.958041443843079,0,2,tryptophan 5-monooxygenase activity,MF,
2039,GO:0004511,1,0.978719593470848,0,1,tyrosine 3-monooxygenase activity,MF,
2040,GO:0004512,1,0.978866573201486,0,1,inositol-3-phosphate synthase activity,MF,
2041,GO:0004513,1,0.978885328268719,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2042,GO:0004514,1,0.958360301301477,0,2,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2043,GO:0004515,1,0.920273815458771,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2044,GO:0004517,1,0.940504738203817,0,3,nitric-oxide synthase activity,MF,
2047,GO:0004520,1,0.344931725190413,0,50,endodeoxyribonuclease activity,MF,
2049,GO:0004522,1,0.916749638113414,0,4,ribonuclease A activity,MF,
2050,GO:0004523,1,0.878837400754178,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2051,GO:0004525,1,0.92262677174542,0,4,ribonuclease III activity,MF,
2052,GO:0004526,1,0.806882333262813,0,10,ribonuclease P activity,MF,
2053,GO:0004527,1,0.217693906144296,0,73,exonuclease activity,MF,
2054,GO:0004528,1,0.901232219248012,0,5,phosphodiesterase I activity,MF,
2055,GO:0004529,1,0.66867047315745,0,19,exodeoxyribonuclease activity,MF,
2056,GO:0004530,1,0.979065380633116,0,1,deoxyribonuclease I activity,MF,
2057,GO:0004531,1,0.957727213036485,0,2,deoxyribonuclease II activity,MF,
2058,GO:0004532,1,0.514951909321097,0,32,exoribonuclease activity,MF,
2059,GO:0004534,1,0.962703886147737,0,2,5'-3' exoribonuclease activity,MF,
2060,GO:0004535,1,0.781652353899871,0,12,poly(A)-specific ribonuclease activity,MF,
2061,GO:0004536,1,0.230214826408615,0,69,deoxyribonuclease activity,MF,
2063,GO:0004549,1,0.725026282273768,0,15,tRNA-specific ribonuclease activity,MF,
2064,GO:0004550,1,0.709458050158581,0,16,nucleoside diphosphate kinase activity,MF,
2065,GO:0004551,1,0.743578146820569,0,14,nucleotide diphosphatase activity,MF,
2067,GO:0004555,1,0.978702590235847,0,1,alpha,alpha-trehalase activity,MF,
2068,GO:0004556,1,0.897968080292516,0,5,alpha-amylase activity,MF,
2070,GO:0004558,1,0.921855786475924,0,4,alpha-1,4-glucosidase activity,MF,
2071,GO:0004559,1,0.764151408206137,0,13,alpha-mannosidase activity,MF,
2072,GO:0004560,1,0.958052749877667,0,2,alpha-L-fucosidase activity,MF,
2073,GO:0004561,1,0.979031207162614,0,1,alpha-N-acetylglucosaminidase activity,MF,
2075,GO:0004564,1,0.98034959648456,0,1,beta-fructofuranosidase activity,MF,
2076,GO:0004565,1,0.880162485994178,0,6,beta-galactosidase activity,MF,
2077,GO:0004566,1,0.938425924335589,0,3,beta-glucuronidase activity,MF,
2078,GO:0004567,1,0.979069296344645,0,1,beta-mannosidase activity,MF,
2079,GO:0004568,1,0.937863995022683,0,3,chitinase activity,MF,
2080,GO:0004569,1,0.97931791579165,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2081,GO:0004571,1,0.865479887665244,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2082,GO:0004572,1,0.960589780948754,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2083,GO:0004573,1,0.979020827607816,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2084,GO:0004574,1,0.959830947948436,0,2,oligo-1,6-glucosidase activity,MF,
2085,GO:0004575,1,0.98034959648456,0,1,sucrose alpha-glucosidase activity,MF,
2087,GO:0004577,1,0.958012128486524,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2088,GO:0004578,1,0.979099001044529,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2089,GO:0004579,1,0.824687732302395,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2092,GO:0004583,1,0.922396436337023,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2093,GO:0004584,1,0.978905920942834,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2094,GO:0004585,1,0.978626292916885,0,1,ornithine carbamoyltransferase activity,MF,
2095,GO:0004586,1,0.978786464509949,0,1,ornithine decarboxylase activity,MF,
2096,GO:0004587,1,0.978750628870034,0,1,ornithine-oxo-acid transaminase activity,MF,
2097,GO:0004588,1,0.979002954577381,0,1,orotate phosphoribosyltransferase activity,MF,
2098,GO:0004590,1,0.979002954577381,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2099,GO:0004591,1,0.939251769305944,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2100,GO:0004594,1,0.918369543912089,0,4,pantothenate kinase activity,MF,
2101,GO:0004595,1,0.978880579451014,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2102,GO:0004596,1,0.792397132508069,0,11,peptide alpha-N-acetyltransferase activity,MF,
2103,GO:0004597,1,0.979071974080889,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2104,GO:0004598,1,0.979076438871909,0,1,peptidylamidoglycolate lyase activity,MF,
2108,GO:0004605,1,0.938592521746231,0,3,phosphatidate cytidylyltransferase activity,MF,
2109,GO:0004607,1,0.978548543131946,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2110,GO:0004608,1,0.978493531868126,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2111,GO:0004609,1,0.958265078382057,0,2,phosphatidylserine decarboxylase activity,MF,
2112,GO:0004610,1,0.978757833489532,0,1,phosphoacetylglucosamine mutase activity,MF,
2113,GO:0004611,1,0.958199327940803,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2114,GO:0004613,1,0.958199327940803,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2115,GO:0004614,1,0.938093579438209,0,3,phosphoglucomutase activity,MF,
2116,GO:0004615,1,0.957878117849522,0,2,phosphomannomutase activity,MF,
2117,GO:0004616,1,0.93788982862376,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2118,GO:0004617,1,0.978766515663216,0,1,phosphoglycerate dehydrogenase activity,MF,
2119,GO:0004618,1,0.958001185211482,0,2,phosphoglycerate kinase activity,MF,
2120,GO:0004619,1,0.917193371948543,0,4,phosphoglycerate mutase activity,MF,
2122,GO:0004621,1,0.978877198485586,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2126,GO:0004630,1,0.880528722085581,0,6,phospholipase D activity,MF,
2127,GO:0004631,1,0.978537245387061,0,1,phosphomevalonate kinase activity,MF,
2128,GO:0004632,1,0.978530926098884,0,1,phosphopantothenate--cysteine ligase activity,MF,
2129,GO:0004633,1,0.978848687701964,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2130,GO:0004634,1,0.91782900054146,0,4,phosphopyruvate hydratase activity,MF,
2131,GO:0004637,1,0.979069379954725,0,1,phosphoribosylamine-glycine ligase activity,MF,
2132,GO:0004638,1,0.979069327431988,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2133,GO:0004639,1,0.979069327431988,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2134,GO:0004641,1,0.979069379954725,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2135,GO:0004642,1,0.979857736123937,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2136,GO:0004643,1,0.978798551701089,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2137,GO:0004644,1,0.979069379954725,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2138,GO:0004645,1,0.880752640064162,0,6,phosphorylase activity,MF,
2139,GO:0004647,1,0.937533774928922,0,3,phosphoserine phosphatase activity,MF,
2140,GO:0004648,1,0.978807929148039,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2141,GO:0004649,1,0.958266084205425,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2142,GO:0004651,1,0.958334696474245,0,2,polynucleotide 5'-phosphatase activity,MF,
2143,GO:0004652,1,0.847876555785293,0,8,polynucleotide adenylyltransferase activity,MF,
2144,GO:0004653,1,0.670087942889041,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2145,GO:0004654,1,0.979332324557987,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2146,GO:0004655,1,0.97906803949153,0,1,porphobilinogen synthase activity,MF,
2147,GO:0004656,1,0.91837379645498,0,4,procollagen-proline 4-dioxygenase activity,MF,
2148,GO:0004657,1,0.957936142789167,0,2,proline dehydrogenase activity,MF,
2149,GO:0004658,1,0.958080356104156,0,2,propionyl-CoA carboxylase activity,MF,
2150,GO:0004659,1,0.72957300056513,0,15,prenyltransferase activity,MF,
2151,GO:0004660,1,0.958097424448221,0,2,protein farnesyltransferase activity,MF,
2152,GO:0004661,1,0.898527716087449,0,5,protein geranylgeranyltransferase activity,MF,
2153,GO:0004662,1,0.958079579092876,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2154,GO:0004663,1,0.917786675563648,0,4,Rab geranylgeranyltransferase activity,MF,
2155,GO:0004666,1,0.9593001854942,0,2,prostaglandin-endoperoxide synthase activity,MF,
2156,GO:0004667,1,0.9575530346407,0,2,prostaglandin-D synthase activity,MF,
2157,GO:0004668,1,0.899451305808371,0,5,protein-arginine deiminase activity,MF,
2158,GO:0004671,1,0.979451105560986,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2163,GO:0004676,1,0.981102615067043,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2164,GO:0004677,1,0.949400190805637,0,3,DNA-dependent protein kinase activity,MF,
2165,GO:0004679,1,0.866153857733202,0,7,AMP-activated protein kinase activity,MF,
2166,GO:0004683,1,0.557215417164114,0,28,calmodulin-dependent protein kinase activity,MF,
2167,GO:0004686,1,0.981377846582927,0,1,elongation factor-2 kinase activity,MF,
2168,GO:0004687,1,0.924676634775477,0,4,myosin light chain kinase activity,MF,
2169,GO:0004689,1,0.901961124918243,0,5,phosphorylase kinase activity,MF,
2172,GO:0004692,1,0.958589673571617,0,2,cGMP-dependent protein kinase activity,MF,
2173,GO:0004693,1,0.567580528436577,0,27,cyclin-dependent protein serine/threonine kinase activity,MF,
2174,GO:0004694,1,0.920112472422607,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2176,GO:0004698,1,0.922109971473395,0,4,calcium-dependent protein kinase C activity,MF,
2177,GO:0004699,1,0.939318913436738,0,3,calcium-independent protein kinase C activity,MF,
2179,GO:0004703,1,0.898703131313455,0,5,G-protein coupled receptor kinase activity,MF,
2180,GO:0004704,1,0.881472915937765,0,6,NF-kappaB-inducing kinase activity,MF,
2181,GO:0004705,1,0.93819270979862,0,3,JUN kinase activity,MF,
2182,GO:0004706,1,0.939410840788,0,3,JUN kinase kinase kinase activity,MF,
2184,GO:0004708,1,0.761913138828699,0,13,MAP kinase kinase activity,MF,
2186,GO:0004711,1,0.938823136748532,0,3,ribosomal protein S6 kinase activity,MF,
2190,GO:0004715,1,0.34949267198108,0,50,non-membrane spanning protein tyrosine kinase activity,MF,
2192,GO:0004719,1,0.938215821359074,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2193,GO:0004720,1,0.938544075370395,0,3,protein-lysine 6-oxidase activity,MF,
2195,GO:0004722,1,0.245564437185002,0,67,protein serine/threonine phosphatase activity,MF,
2196,GO:0004723,1,0.884095336738296,0,6,calcium-dependent protein serine/threonine phosphatase activity,MF,
2198,GO:0004726,1,0.844570019796666,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2199,GO:0004727,1,0.957771356456655,0,2,prenylated protein tyrosine phosphatase activity,MF,
2200,GO:0004728,1,0.978984390211124,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2201,GO:0004729,1,0.978658468487151,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2204,GO:0004733,1,0.979069432095634,0,1,pyridoxamine-phosphate oxidase activity,MF,
2205,GO:0004735,1,0.93766689211862,0,3,pyrroline-5-carboxylate reductase activity,MF,
2206,GO:0004736,1,0.979113967725448,0,1,pyruvate carboxylase activity,MF,
2207,GO:0004738,1,0.879972665167519,0,6,pyruvate dehydrogenase activity,MF,
2208,GO:0004739,1,0.937557277228832,0,3,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2210,GO:0004741,1,0.941247926053857,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2211,GO:0004742,1,0.979216875884261,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2212,GO:0004743,1,0.958476093318075,0,2,pyruvate kinase activity,MF,
2213,GO:0004744,1,0.978991968506644,0,1,retinal isomerase activity,MF,
2215,GO:0004747,1,0.978520114324081,0,1,ribokinase activity,MF,
2216,GO:0004748,1,0.93893651880209,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2217,GO:0004749,1,0.898312358718965,0,5,ribose phosphate diphosphokinase activity,MF,
2218,GO:0004750,1,0.978880976289735,0,1,ribulose-phosphate 3-epimerase activity,MF,
2219,GO:0004751,1,0.978692505414605,0,1,ribose-5-phosphate isomerase activity,MF,
2220,GO:0004753,1,0.980224261402928,0,1,saccharopine dehydrogenase activity,MF,
2221,GO:0004756,1,0.958296407796226,0,2,selenide, water dikinase activity,MF,
2222,GO:0004757,1,0.978571573481459,0,1,sepiapterin reductase activity,MF,
2223,GO:0004758,1,0.901132675132292,0,5,serine C-palmitoyltransferase activity,MF,
2224,GO:0004760,1,0.978611339907467,0,1,serine-pyruvate transaminase activity,MF,
2225,GO:0004766,1,0.978533171522588,0,1,spermidine synthase activity,MF,
2226,GO:0004767,1,0.880459492113147,0,6,sphingomyelin phosphodiesterase activity,MF,
2227,GO:0004768,1,0.939225654804269,0,3,stearoyl-CoA 9-desaturase activity,MF,
2229,GO:0004771,1,0.918481061158784,0,4,sterol esterase activity,MF,
2230,GO:0004772,1,0.958303938025404,0,2,sterol O-acyltransferase activity,MF,
2231,GO:0004773,1,0.980598707268517,0,1,steryl-sulfatase activity,MF,
2232,GO:0004774,1,0.937643147726964,0,3,succinate-CoA ligase activity,MF,
2233,GO:0004775,1,0.957853089848278,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2234,GO:0004776,1,0.957926637870707,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2235,GO:0004777,1,0.979675135376631,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2236,GO:0004778,1,0.978619007265527,0,1,succinyl-CoA hydrolase activity,MF,
2237,GO:0004779,1,0.958497218961017,0,2,sulfate adenylyltransferase activity,MF,
2238,GO:0004781,1,0.958497218961017,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2239,GO:0004782,1,0.958526347041849,0,2,sulfinoalanine decarboxylase activity,MF,
2240,GO:0004784,1,0.897494621881894,0,5,superoxide dismutase activity,MF,
2241,GO:0004788,1,0.9789047734206,0,1,thiamine diphosphokinase activity,MF,
2242,GO:0004790,1,0.978973993112912,0,1,thioether S-methyltransferase activity,MF,
2243,GO:0004791,1,0.806370000854722,0,10,thioredoxin-disulfide reductase activity,MF,
2244,GO:0004792,1,0.937375611961479,0,3,thiosulfate sulfurtransferase activity,MF,
2245,GO:0004793,1,0.958242974601567,0,2,threonine aldolase activity,MF,
2246,GO:0004794,1,0.957627861389037,0,2,L-threonine ammonia-lyase activity,MF,
2247,GO:0004796,1,0.978804595812789,0,1,thromboxane-A synthase activity,MF,
2248,GO:0004797,1,0.958649224355686,0,2,thymidine kinase activity,MF,
2249,GO:0004798,1,0.9580181451805,0,2,thymidylate kinase activity,MF,
2250,GO:0004799,1,0.978605979430292,0,1,thymidylate synthase activity,MF,
2251,GO:0004800,1,0.939305664221382,0,3,thyroxine 5'-deiodinase activity,MF,
2252,GO:0004801,1,0.978527693561829,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2253,GO:0004802,1,0.938153262406939,0,3,transketolase activity,MF,
2254,GO:0004803,1,0.938672074087348,0,3,transposase activity,MF,
2255,GO:0004806,1,0.637740218918836,0,21,triglyceride lipase activity,MF,
2256,GO:0004807,1,0.978572307892198,0,1,triose-phosphate isomerase activity,MF,
2257,GO:0004809,1,0.937880011505297,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2258,GO:0004810,1,0.97887180099538,0,1,tRNA adenylyltransferase activity,MF,
2259,GO:0004812,1,0.391986524888107,0,44,aminoacyl-tRNA ligase activity,MF,
2260,GO:0004813,1,0.938529337102963,0,3,alanine-tRNA ligase activity,MF,
2261,GO:0004814,1,0.917530633187718,0,4,arginine-tRNA ligase activity,MF,
2262,GO:0004815,1,0.95840425865588,0,2,aspartate-tRNA ligase activity,MF,
2263,GO:0004816,1,0.958360177258325,0,2,asparagine-tRNA ligase activity,MF,
2264,GO:0004817,1,0.958153428239005,0,2,cysteine-tRNA ligase activity,MF,
2265,GO:0004818,1,0.959118624727625,0,2,glutamate-tRNA ligase activity,MF,
2266,GO:0004819,1,0.978937364976446,0,1,glutamine-tRNA ligase activity,MF,
2267,GO:0004820,1,0.958083267095272,0,2,glycine-tRNA ligase activity,MF,
2268,GO:0004821,1,0.958146432366142,0,2,histidine-tRNA ligase activity,MF,
2269,GO:0004822,1,0.958778245196915,0,2,isoleucine-tRNA ligase activity,MF,
2270,GO:0004823,1,0.959083899484164,0,2,leucine-tRNA ligase activity,MF,
2271,GO:0004824,1,0.978803762288996,0,1,lysine-tRNA ligase activity,MF,
2272,GO:0004825,1,0.958535360926919,0,2,methionine-tRNA ligase activity,MF,
2273,GO:0004826,1,0.898681732389015,0,5,phenylalanine-tRNA ligase activity,MF,
2274,GO:0004827,1,0.958924731799399,0,2,proline-tRNA ligase activity,MF,
2275,GO:0004828,1,0.957956168483073,0,2,serine-tRNA ligase activity,MF,
2276,GO:0004829,1,0.938336860182497,0,3,threonine-tRNA ligase activity,MF,
2277,GO:0004830,1,0.958488561468512,0,2,tryptophan-tRNA ligase activity,MF,
2278,GO:0004831,1,0.95833235335867,0,2,tyrosine-tRNA ligase activity,MF,
2279,GO:0004832,1,0.939042359299409,0,3,valine-tRNA ligase activity,MF,
2280,GO:0004833,1,0.937472848571958,0,3,tryptophan 2,3-dioxygenase activity,MF,
2281,GO:0004835,1,0.979679341783126,0,1,tubulin-tyrosine ligase activity,MF,
2282,GO:0004838,1,0.979027894596221,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2283,GO:0004839,1,0.920702762650446,0,4,ubiquitin activating enzyme activity,MF,
2285,GO:0004843,1,0.223032705005372,0,73,thiol-dependent ubiquitin-specific protease activity,MF,
2286,GO:0004844,1,0.898016259638453,0,5,uracil DNA N-glycosylase activity,MF,
2287,GO:0004849,1,0.898431292884595,0,5,uridine kinase activity,MF,
2288,GO:0004850,1,0.958055164949394,0,2,uridine phosphorylase activity,MF,
2289,GO:0004852,1,0.978549168135041,0,1,uroporphyrinogen-III synthase activity,MF,
2290,GO:0004853,1,0.978555589480674,0,1,uroporphyrinogen decarboxylase activity,MF,
2292,GO:0004855,1,0.980116871680728,0,1,xanthine oxidase activity,MF,
2293,GO:0004856,1,0.979074614309529,0,1,xylulokinase activity,MF,
2299,GO:0004864,1,0.500653270092362,0,33,protein phosphatase inhibitor activity,MF,
2300,GO:0004865,1,0.842367742610984,0,8,protein serine/threonine phosphatase inhibitor activity,MF,
2306,GO:0004873,1,0.957605109662001,0,2,asialoglycoprotein receptor activity,MF,
2307,GO:0004874,1,0.960342607261384,0,2,aryl hydrocarbon receptor activity,MF,
2308,GO:0004875,1,0.810545429633489,0,10,complement receptor activity,MF,
2309,GO:0004876,1,0.97873815485712,0,1,complement component C3a receptor activity,MF,
2310,GO:0004877,1,0.982745541009455,0,1,complement component C3b receptor activity,MF,
2311,GO:0004878,1,0.958313744906075,0,2,complement component C5a receptor activity,MF,
2313,GO:0004882,1,0.937983070516766,0,3,androgen receptor activity,MF,
2314,GO:0004883,1,0.980777414568203,0,1,glucocorticoid receptor activity,MF,
2315,GO:0004886,1,0.938808822898238,0,3,9-cis retinoic acid receptor activity,MF,
2316,GO:0004887,1,0.863875602485114,0,7,thyroid hormone receptor activity,MF,
2318,GO:0004890,1,0.674244171037512,0,19,GABA-A receptor activity,MF,
2320,GO:0004897,1,0.922641381092845,0,4,ciliary neurotrophic factor receptor activity,MF,
2321,GO:0004900,1,0.978697915840328,0,1,erythropoietin receptor activity,MF,
2322,GO:0004904,1,0.899893828871509,0,5,interferon receptor activity,MF,
2323,GO:0004905,1,0.959365471158743,0,2,type I interferon receptor activity,MF,
2324,GO:0004906,1,0.958105475313755,0,2,interferon-gamma receptor activity,MF,
2325,GO:0004908,1,0.861842286463733,0,7,interleukin-1 receptor activity,MF,
2326,GO:0004909,1,0.958692201922944,0,2,interleukin-1, Type I, activating receptor activity,MF,
2327,GO:0004910,1,0.958072010773801,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2328,GO:0004911,1,0.938100060083413,0,3,interleukin-2 receptor activity,MF,
2329,GO:0004912,1,0.958560613317362,0,2,interleukin-3 receptor activity,MF,
2330,GO:0004913,1,0.957958252870519,0,2,interleukin-4 receptor activity,MF,
2331,GO:0004914,1,0.958677047858791,0,2,interleukin-5 receptor activity,MF,
2332,GO:0004915,1,0.958645227653617,0,2,interleukin-6 receptor activity,MF,
2333,GO:0004917,1,0.957727840898024,0,2,interleukin-7 receptor activity,MF,
2334,GO:0004918,1,0.958417044128013,0,2,interleukin-8 receptor activity,MF,
2335,GO:0004919,1,0.978823939821561,0,1,interleukin-9 receptor activity,MF,
2336,GO:0004920,1,0.900058089464389,0,5,interleukin-10 receptor activity,MF,
2337,GO:0004921,1,0.979068192413853,0,1,interleukin-11 receptor activity,MF,
2338,GO:0004923,1,0.962757704543779,0,2,leukemia inhibitory factor receptor activity,MF,
2339,GO:0004924,1,0.942607459933624,0,3,oncostatin-M receptor activity,MF,
2340,GO:0004925,1,0.984416151264322,0,1,prolactin receptor activity,MF,
2342,GO:0004931,1,0.860950456800896,0,7,extracellular ATP-gated cation channel activity,MF,
2345,GO:0004937,1,0.938022667359592,0,3,alpha1-adrenergic receptor activity,MF,
2347,GO:0004939,1,0.938133460119786,0,3,beta-adrenergic receptor activity,MF,
2348,GO:0004940,1,0.979043725475798,0,1,beta1-adrenergic receptor activity,MF,
2349,GO:0004941,1,0.978773152273754,0,1,beta2-adrenergic receptor activity,MF,
2350,GO:0004945,1,0.91763390021763,0,4,angiotensin type II receptor activity,MF,
2351,GO:0004946,1,0.957567137061658,0,2,bombesin receptor activity,MF,
2352,GO:0004947,1,0.958140903897437,0,2,bradykinin receptor activity,MF,
2353,GO:0004948,1,0.938433747159612,0,3,calcitonin receptor activity,MF,
2354,GO:0004949,1,0.939190395375812,0,3,cannabinoid receptor activity,MF,
2355,GO:0004950,1,0.611612369058491,0,23,chemokine receptor activity,MF,
2356,GO:0004951,1,0.957895313509217,0,2,cholecystokinin receptor activity,MF,
2357,GO:0004952,1,0.771690045757822,0,12,dopamine neurotransmitter receptor activity,MF,
2358,GO:0004953,1,0.726364391281904,0,15,icosanoid receptor activity,MF,
2359,GO:0004954,1,0.791411577667034,0,11,prostanoid receptor activity,MF,
2360,GO:0004955,1,0.808505749263962,0,10,prostaglandin receptor activity,MF,
2361,GO:0004956,1,0.958468040170624,0,2,prostaglandin D receptor activity,MF,
2362,GO:0004957,1,0.879890818264067,0,6,prostaglandin E receptor activity,MF,
2363,GO:0004958,1,0.959244832602326,0,2,prostaglandin F receptor activity,MF,
2364,GO:0004960,1,0.978869190667263,0,1,thromboxane receptor activity,MF,
2365,GO:0004961,1,0.978869190667263,0,1,thromboxane A2 receptor activity,MF,
2366,GO:0004962,1,0.958708809482148,0,2,endothelin receptor activity,MF,
2367,GO:0004963,1,0.958525730167023,0,2,follicle-stimulating hormone receptor activity,MF,
2368,GO:0004964,1,0.979064947188827,0,1,luteinizing hormone receptor activity,MF,
2369,GO:0004965,1,0.939785035181932,0,3,G-protein coupled GABA receptor activity,MF,
2370,GO:0004966,1,0.85958690475001,0,7,galanin receptor activity,MF,
2371,GO:0004967,1,0.93781348199572,0,3,glucagon receptor activity,MF,
2372,GO:0004968,1,0.959718640577683,0,2,gonadotropin-releasing hormone receptor activity,MF,
2373,GO:0004969,1,0.880544379853149,0,6,histamine receptor activity,MF,
2376,GO:0004972,1,0.872731137653932,0,7,NMDA glutamate receptor activity,MF,
2377,GO:0004974,1,0.91785880361761,0,4,leukotriene receptor activity,MF,
2378,GO:0004977,1,0.878979640825751,0,6,melanocortin receptor activity,MF,
2379,GO:0004978,1,0.979072536374696,0,1,corticotropin receptor activity,MF,
2380,GO:0004979,1,0.978703372485861,0,1,beta-endorphin receptor activity,MF,
2381,GO:0004980,1,0.937480817935992,0,3,melanocyte-stimulating hormone receptor activity,MF,
2382,GO:0004982,1,0.917422363338801,0,4,N-formyl peptide receptor activity,MF,
2383,GO:0004983,1,0.842658076898316,0,8,neuropeptide Y receptor activity,MF,
2384,GO:0004984,1,0.000258465219141648,0,376,olfactory receptor activity,MF,
2385,GO:0004985,1,0.842528651347978,0,8,opioid receptor activity,MF,
2386,GO:0004990,1,0.979218491485834,0,1,oxytocin receptor activity,MF,
2387,GO:0004991,1,0.958274823823066,0,2,parathyroid hormone receptor activity,MF,
2388,GO:0004992,1,0.939106371493364,0,3,platelet activating factor receptor activity,MF,
2389,GO:0004993,1,0.571370084206062,0,26,G-protein coupled serotonin receptor activity,MF,
2390,GO:0004994,1,0.89865920538142,0,5,somatostatin receptor activity,MF,
2391,GO:0004995,1,0.937980443819993,0,3,tachykinin receptor activity,MF,
2392,GO:0004996,1,0.95806492675124,0,2,thyroid-stimulating hormone receptor activity,MF,
2393,GO:0004997,1,0.978544656088171,0,1,thyrotropin-releasing hormone receptor activity,MF,
2394,GO:0004998,1,0.959157435280935,0,2,transferrin receptor activity,MF,
2395,GO:0004999,1,0.938082485003259,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2396,GO:0005000,1,0.861311671415589,0,7,vasopressin receptor activity,MF,
2397,GO:0005001,1,0.72712967450572,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2398,GO:0005003,1,0.672963626773445,0,19,ephrin receptor activity,MF,
2399,GO:0005004,1,0.867536570986183,0,7,GPI-linked ephrin receptor activity,MF,
2400,GO:0005005,1,0.84764930716235,0,8,transmembrane-ephrin receptor activity,MF,
2401,GO:0005006,1,0.95843595618071,0,2,epidermal growth factor-activated receptor activity,MF,
2402,GO:0005007,1,0.90067792225457,0,5,fibroblast growth factor-activated receptor activity,MF,
2403,GO:0005008,1,0.980812726071875,0,1,hepatocyte growth factor-activated receptor activity,MF,
2404,GO:0005009,1,0.98255538360392,0,1,insulin-activated receptor activity,MF,
2405,GO:0005010,1,0.947605668816183,0,3,insulin-like growth factor-activated receptor activity,MF,
2406,GO:0005011,1,0.958972933810045,0,2,macrophage colony-stimulating factor receptor activity,MF,
2407,GO:0005017,1,0.9406545551878,0,3,platelet-derived growth factor-activated receptor activity,MF,
2408,GO:0005018,1,0.980757862310052,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2409,GO:0005019,1,0.959112001598869,0,2,platelet-derived growth factor beta-receptor activity,MF,
2410,GO:0005020,1,0.979695539311739,0,1,stem cell factor receptor activity,MF,
2411,GO:0005021,1,0.86644203362513,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2414,GO:0005026,1,0.958508127336809,0,2,transforming growth factor beta receptor activity, type II,MF,
2415,GO:0005030,1,0.922630722985754,0,4,neurotrophin receptor activity,MF,
2416,GO:0005031,1,0.598285710280354,0,24,tumor necrosis factor-activated receptor activity,MF,
2417,GO:0005034,1,0.979067305686981,0,1,osmosensor activity,MF,
2418,GO:0005035,1,0.598285710280354,0,24,death receptor activity,MF,
2419,GO:0005041,1,0.779200395889512,0,13,low-density lipoprotein receptor activity,MF,
2420,GO:0005042,1,0.962792412326697,0,2,netrin receptor activity,MF,
2421,GO:0005044,1,0.424366278712971,0,41,scavenger receptor activity,MF,
2422,GO:0005046,1,0.95806685605553,0,2,KDEL sequence binding,MF,
2423,GO:0005047,1,0.918313422677968,0,4,signal recognition particle binding,MF,
2424,GO:0005048,1,0.406153359490978,0,43,signal sequence binding,MF,
2425,GO:0005049,1,0.868021731067977,0,7,nuclear export signal receptor activity,MF,
2426,GO:0005052,1,0.958575570770808,0,2,peroxisome matrix targeting signal-1 binding,MF,
2427,GO:0005053,1,0.978578813992385,0,1,peroxisome matrix targeting signal-2 binding,MF,
2428,GO:0005055,1,0.957894930872764,0,2,laminin receptor activity,MF,
2431,GO:0005070,1,0.30259738416928,0,57,SH3/SH2 adaptor activity,MF,
2432,GO:0005072,1,0.818944571043195,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2433,GO:0005078,1,0.872187313249832,0,7,MAP-kinase scaffold activity,MF,
2436,GO:0005086,1,0.683819699210591,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2437,GO:0005087,1,0.917742077003024,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2439,GO:0005089,1,0.207989343344732,0,78,Rho guanyl-nucleotide exchange factor activity,MF,
2440,GO:0005090,1,0.978827671348179,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2442,GO:0005093,1,0.958293814893367,0,2,Rab GDP-dissociation inhibitor activity,MF,
2443,GO:0005094,1,0.937078036834277,0,3,Rho GDP-dissociation inhibitor activity,MF,
2444,GO:0005095,1,0.746613267728945,0,14,GTPase inhibitor activity,MF,
2454,GO:0005114,1,0.865050726801818,0,7,type II transforming growth factor beta receptor binding,MF,
2456,GO:0005119,1,0.941060386723376,0,3,smoothened binding,MF,
2458,GO:0005124,1,0.97880438743795,0,1,scavenger receptor binding,MF,
2462,GO:0005128,1,0.958060049550948,0,2,erythropoietin receptor binding,MF,
2463,GO:0005129,1,0.978476686491623,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
2464,GO:0005130,1,0.978586907180765,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2465,GO:0005131,1,0.900135214712845,0,5,growth hormone receptor binding,MF,
2466,GO:0005132,1,0.690942942617659,0,17,type I interferon receptor binding,MF,
2467,GO:0005133,1,0.978521707286252,0,1,interferon-gamma receptor binding,MF,
2468,GO:0005134,1,0.898143409059817,0,5,interleukin-2 receptor binding,MF,
2469,GO:0005135,1,0.95800519434007,0,2,interleukin-3 receptor binding,MF,
2470,GO:0005136,1,0.937557573165572,0,3,interleukin-4 receptor binding,MF,
2471,GO:0005137,1,0.95776057225288,0,2,interleukin-5 receptor binding,MF,
2473,GO:0005139,1,0.978790214558818,0,1,interleukin-7 receptor binding,MF,
2474,GO:0005140,1,0.978468779604703,0,1,interleukin-9 receptor binding,MF,
2475,GO:0005141,1,0.978619319389108,0,1,interleukin-10 receptor binding,MF,
2476,GO:0005142,1,0.97890247147664,0,1,interleukin-11 receptor binding,MF,
2477,GO:0005143,1,0.899343453749186,0,5,interleukin-12 receptor binding,MF,
2478,GO:0005144,1,0.978534083677148,0,1,interleukin-13 receptor binding,MF,
2480,GO:0005147,1,0.978701418544787,0,1,oncostatin-M receptor binding,MF,
2481,GO:0005148,1,0.957452833817073,0,2,prolactin receptor binding,MF,
2482,GO:0005149,1,0.696307416609463,0,17,interleukin-1 receptor binding,MF,
2483,GO:0005150,1,0.958188098914885,0,2,interleukin-1, Type I receptor binding,MF,
2484,GO:0005151,1,0.958914796372193,0,2,interleukin-1, Type II receptor binding,MF,
2485,GO:0005152,1,0.939833486719729,0,3,interleukin-1 receptor antagonist activity,MF,
2486,GO:0005153,1,0.97906630252243,0,1,interleukin-8 receptor binding,MF,
2488,GO:0005157,1,0.937531592969459,0,3,macrophage colony-stimulating factor receptor binding,MF,
2493,GO:0005163,1,0.978499413013945,0,1,nerve growth factor receptor binding,MF,
2496,GO:0005166,1,0.937373111979651,0,3,neurotrophin p75 receptor binding,MF,
2499,GO:0005169,1,0.959337570994625,0,2,neurotrophin TRKB receptor binding,MF,
2500,GO:0005170,1,0.979803728624371,0,1,neurotrophin TRKC receptor binding,MF,
2501,GO:0005171,1,0.957987779339395,0,2,hepatocyte growth factor receptor binding,MF,
2504,GO:0005174,1,0.958013766956208,0,2,CD40 receptor binding,MF,
2505,GO:0005175,1,0.978471487333462,0,1,CD27 receptor binding,MF,
2506,GO:0005176,1,0.937993029933606,0,3,ErbB-2 class receptor binding,MF,
2509,GO:0005183,1,0.9786466750349,0,1,gonadotropin hormone-releasing hormone activity,MF,
2510,GO:0005184,1,0.556737965823296,0,27,neuropeptide hormone activity,MF,
2511,GO:0005185,1,0.957398779405388,0,2,neurohypophyseal hormone activity,MF,
2513,GO:0005199,1,0.979069338479917,0,1,structural constituent of cell wall,MF,
2516,GO:0005212,1,0.648166224123862,0,20,structural constituent of eye lens,MF,
2519,GO:0005217,1,0.578033857774407,0,28,intracellular ligand-gated ion channel activity,MF,
2520,GO:0005219,1,0.940641151622989,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2521,GO:0005220,1,0.951632517335867,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2522,GO:0005221,1,0.828886099544868,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2523,GO:0005222,1,0.92161500698768,0,4,intracellular cAMP activated cation channel activity,MF,
2524,GO:0005223,1,0.918978811487991,0,4,intracellular cGMP activated cation channel activity,MF,
2526,GO:0005227,1,0.530523114448421,0,30,calcium activated cation channel activity,MF,
2527,GO:0005229,1,0.715338158718114,0,16,intracellular calcium activated chloride channel activity,MF,
2531,GO:0005237,1,0.882105233406034,0,6,inhibitory extracellular ligand-gated ion channel activity,MF,
2537,GO:0005247,1,0.779843558071134,0,12,voltage-gated chloride channel activity,MF,
2538,GO:0005248,1,0.63953681479104,0,23,voltage-gated sodium channel activity,MF,
2542,GO:0005252,1,0.979104971336723,0,1,open rectifier potassium channel activity,MF,
2545,GO:0005260,1,0.980425004267237,0,1,intracellular ATPase-gated chloride channel activity,MF,
2549,GO:0005272,1,0.404753749106965,0,45,sodium channel activity,MF,
2550,GO:0005275,1,0.938105571399985,0,3,amine transmembrane transporter activity,MF,
2551,GO:0005276,1,0.978978646038796,0,1,vesicular hydrogen:amino acid antiporter activity,MF,
2552,GO:0005277,1,0.937912092779444,0,3,acetylcholine transmembrane transporter activity,MF,
2553,GO:0005280,1,0.881373287809604,0,6,hydrogen:amino acid symporter activity,MF,
2554,GO:0005283,1,0.799057351851968,0,11,sodium:amino acid symporter activity,MF,
2555,GO:0005287,1,0.981485146893144,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2556,GO:0005289,1,0.981485146893144,0,1,high-affinity arginine transmembrane transporter activity,MF,
2557,GO:0005290,1,0.958414065007485,0,2,L-histidine transmembrane transporter activity,MF,
2558,GO:0005292,1,0.981485146893144,0,1,high-affinity lysine transmembrane transporter activity,MF,
2559,GO:0005294,1,0.942229410969091,0,3,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2560,GO:0005298,1,0.95872970683687,0,2,proline:sodium symporter activity,MF,
2561,GO:0005302,1,0.979067237834846,0,1,L-tyrosine transmembrane transporter activity,MF,
2562,GO:0005307,1,0.97966814258702,0,1,choline:sodium symporter activity,MF,
2563,GO:0005308,1,0.958845604361552,0,2,creatine transmembrane transporter activity,MF,
2564,GO:0005309,1,0.979070025842343,0,1,creatine:sodium symporter activity,MF,
2568,GO:0005315,1,0.921562001304897,0,4,inorganic phosphate transmembrane transporter activity,MF,
2569,GO:0005316,1,0.97906918223649,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2572,GO:0005325,1,0.979073318659778,0,1,peroxisomal fatty-acyl-CoA transporter activity,MF,
2573,GO:0005326,1,0.590953226650577,0,25,neurotransmitter transporter activity,MF,
2574,GO:0005328,1,0.672053984398448,0,19,neurotransmitter:sodium symporter activity,MF,
2575,GO:0005329,1,0.900304923706065,0,5,dopamine transmembrane transporter activity,MF,
2576,GO:0005330,1,0.958832475844441,0,2,dopamine:sodium symporter activity,MF,
2577,GO:0005332,1,0.918553785211769,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2578,GO:0005333,1,0.93804999778482,0,3,norepinephrine transmembrane transporter activity,MF,
2579,GO:0005334,1,0.979069336529951,0,1,norepinephrine:sodium symporter activity,MF,
2580,GO:0005335,1,0.97930137485841,0,1,serotonin:sodium symporter activity,MF,
2581,GO:0005337,1,0.825463159139762,0,9,nucleoside transmembrane transporter activity,MF,
2582,GO:0005338,1,0.827714450862607,0,9,nucleotide-sugar transmembrane transporter activity,MF,
2584,GO:0005343,1,0.595721955301267,0,25,organic acid:sodium symporter activity,MF,
2585,GO:0005344,1,0.73952344686755,0,14,oxygen transporter activity,MF,
2586,GO:0005345,1,0.879567555825328,0,6,purine nucleobase transmembrane transporter activity,MF,
2587,GO:0005346,1,0.790657977848439,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2588,GO:0005347,1,0.825332143214777,0,9,ATP transmembrane transporter activity,MF,
2589,GO:0005350,1,0.938010106545246,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2591,GO:0005353,1,0.978889655064775,0,1,fructose transmembrane transporter activity,MF,
2593,GO:0005362,1,0.958384479121222,0,2,low-affinity glucose:sodium symporter activity,MF,
2594,GO:0005365,1,0.965636277753464,0,2,myo-inositol transmembrane transporter activity,MF,
2595,GO:0005366,1,0.981068397446429,0,1,myo-inositol:proton symporter activity,MF,
2596,GO:0005367,1,0.984270904233013,0,1,myo-inositol:sodium symporter activity,MF,
2597,GO:0005368,1,0.980698373787216,0,1,taurine transmembrane transporter activity,MF,
2598,GO:0005369,1,0.980698373787216,0,1,taurine:sodium symporter activity,MF,
2599,GO:0005372,1,0.774249825098633,0,12,water transmembrane transporter activity,MF,
2602,GO:0005384,1,0.918497358684861,0,4,manganese ion transmembrane transporter activity,MF,
2603,GO:0005385,1,0.628838330803475,0,22,zinc ion transmembrane transporter activity,MF,
2604,GO:0005388,1,0.755820625239249,0,14,calcium-transporting ATPase activity,MF,
2605,GO:0005391,1,0.808772466971768,0,10,sodium:potassium-exchanging ATPase activity,MF,
2606,GO:0005395,1,0.981336582636444,0,1,eye pigment precursor transporter activity,MF,
2608,GO:0005412,1,0.880368222333486,0,6,glucose:sodium symporter activity,MF,
2609,GO:0005415,1,0.937901011066572,0,3,nucleoside:sodium symporter activity,MF,
2610,GO:0005416,1,0.704213404763818,0,17,cation:amino acid symporter activity,MF,
2611,GO:0005427,1,0.958579123753418,0,2,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2612,GO:0005432,1,0.901531080443159,0,5,calcium:sodium antiporter activity,MF,
2613,GO:0005436,1,0.808152862005087,0,10,sodium:phosphate symporter activity,MF,
2614,GO:0005451,1,0.745326347234888,0,14,monovalent cation:proton antiporter activity,MF,
2615,GO:0005452,1,0.604664610559309,0,24,inorganic anion exchanger activity,MF,
2616,GO:0005456,1,0.978683724190989,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2617,GO:0005457,1,0.940200850030415,0,3,GDP-fucose transmembrane transporter activity,MF,
2618,GO:0005459,1,0.957626944989284,0,2,UDP-galactose transmembrane transporter activity,MF,
2619,GO:0005461,1,0.980664434249937,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2620,GO:0005462,1,0.960152739692197,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2621,GO:0005464,1,0.980928878352256,0,1,UDP-xylose transmembrane transporter activity,MF,
2622,GO:0005471,1,0.937705695405564,0,3,ATP:ADP antiporter activity,MF,
2623,GO:0005476,1,0.97870572453966,0,1,carnitine:acyl carnitine antiporter activity,MF,
2624,GO:0005477,1,0.979069987524751,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2625,GO:0005483,1,0.938178331655841,0,3,soluble NSF attachment protein activity,MF,
2627,GO:0005487,1,0.560422028317909,0,28,nucleocytoplasmic transporter activity,MF,
2630,GO:0005497,1,0.917532011236957,0,4,androgen binding,MF,
2633,GO:0005502,1,0.937973028099821,0,3,11-cis retinal binding,MF,
2634,GO:0005503,1,0.978750012806252,0,1,all-trans retinal binding,MF,
2643,GO:0005519,1,0.979105517424451,0,1,cytoskeletal regulatory protein binding,MF,
2650,GO:0005527,1,0.74072035410781,0,14,macrolide binding,MF,
2651,GO:0005528,1,0.74072035410781,0,14,FK506 binding,MF,
2652,GO:0005534,1,0.917961265115506,0,4,galactose binding,MF,
2653,GO:0005536,1,0.793405760425548,0,11,glucose binding,MF,
2654,GO:0005537,1,0.698545907624945,0,17,mannose binding,MF,
2657,GO:0005542,1,0.807582450436944,0,10,folic acid binding,MF,
2660,GO:0005545,1,0.688450479616263,0,18,1-phosphatidylinositol binding,MF,
2664,GO:0005549,1,0.160363478060772,0,84,odorant binding,MF,
2665,GO:0005550,1,0.978467163129138,0,1,pheromone binding,MF,
2668,GO:0005577,1,0.828844435016831,0,9,fibrinogen complex,CC,
2670,GO:0005579,1,0.862188294633852,0,7,membrane attack complex,CC,
2671,GO:0005581,1,0.162133737551705,0,88,collagen trimer,CC,
2672,GO:0005582,1,0.979786148514273,0,1,collagen type XV trimer,CC,
2673,GO:0005583,1,0.787095043494191,0,12,fibrillar collagen trimer,CC,
2674,GO:0005584,1,0.960578883278037,0,2,collagen type I trimer,CC,
2675,GO:0005585,1,0.979590118181362,0,1,collagen type II trimer,CC,
2676,GO:0005586,1,0.979954779198019,0,1,collagen type III trimer,CC,
2677,GO:0005587,1,0.893010271637073,0,6,collagen type IV trimer,CC,
2678,GO:0005588,1,0.944740838427924,0,3,collagen type V trimer,CC,
2679,GO:0005589,1,0.941310821697456,0,3,collagen type VI trimer,CC,
2680,GO:0005590,1,0.982713299996025,0,1,collagen type VII trimer,CC,
2681,GO:0005591,1,0.978994653205006,0,1,collagen type VIII trimer,CC,
2682,GO:0005592,1,0.962079878607137,0,2,collagen type XI trimer,CC,
2683,GO:0005593,1,0.886665447973619,0,6,FACIT collagen trimer,CC,
2684,GO:0005594,1,0.93837978017496,0,3,collagen type IX trimer,CC,
2685,GO:0005595,1,0.983133161208394,0,1,collagen type XII trimer,CC,
2686,GO:0005596,1,0.980685556764124,0,1,collagen type XIV trimer,CC,
2687,GO:0005597,1,0.980041705811129,0,1,collagen type XVI trimer,CC,
2688,GO:0005598,1,0.978994653205006,0,1,short-chain collagen trimer,CC,
2689,GO:0005600,1,0.979063404813261,0,1,collagen type XIII trimer,CC,
2690,GO:0005602,1,0.957464921475916,0,2,complement component C1 complex,CC,
2694,GO:0005607,1,0.960243672783288,0,2,laminin-2 complex,CC,
2697,GO:0005614,1,0.76465267496924,0,13,interstitial matrix,CC,
2704,GO:0005638,1,0.918704144383649,0,4,lamin filament,CC,
2705,GO:0005639,1,0.742662271108028,0,14,integral component of nuclear inner membrane,CC,
2708,GO:0005642,1,0.905196797009753,0,5,annulate lamellae,CC,
2709,GO:0005643,1,0.226516543449063,0,72,nuclear pore,CC,
2710,GO:0005652,1,0.847307564203864,0,8,nuclear lamina,CC,
2712,GO:0005655,1,0.860525119421068,0,7,nucleolar ribonuclease P complex,CC,
2713,GO:0005656,1,0.95814743093924,0,2,nuclear pre-replicative complex,CC,
2714,GO:0005657,1,0.252722208720557,0,65,replication fork,CC,
2715,GO:0005658,1,0.880814138459026,0,6,alpha DNA polymerase:primase complex,CC,
2716,GO:0005662,1,0.728451213639539,0,15,DNA replication factor A complex,CC,
2717,GO:0005663,1,0.87934738714252,0,6,DNA replication factor C complex,CC,
2718,GO:0005664,1,0.825938687923209,0,9,nuclear origin of replication recognition complex,CC,
2719,GO:0005665,1,0.684699155324753,0,18,DNA-directed RNA polymerase II, core complex,CC,
2720,GO:0005666,1,0.695307283628834,0,17,DNA-directed RNA polymerase III complex,CC,
2722,GO:0005668,1,0.957868512377909,0,2,RNA polymerase transcription factor SL1 complex,CC,
2723,GO:0005669,1,0.477299413387186,0,35,transcription factor TFIID complex,CC,
2724,GO:0005671,1,0.762490807065734,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2725,GO:0005672,1,0.89751890123229,0,5,transcription factor TFIIA complex,CC,
2726,GO:0005673,1,0.978592601272244,0,1,transcription factor TFIIE complex,CC,
2727,GO:0005674,1,0.957994816817709,0,2,transcription factor TFIIF complex,CC,
2728,GO:0005675,1,0.773207546994905,0,12,holo TFIIH complex,CC,
2729,GO:0005677,1,0.836517359536866,0,9,chromatin silencing complex,CC,
2730,GO:0005680,1,0.640077789692925,0,21,anaphase-promoting complex,CC,
2731,GO:0005681,1,0.0247738431376223,0,174,spliceosomal complex,CC,
2732,GO:0005682,1,0.661499954872063,0,20,U5 snRNP,CC,
2733,GO:0005683,1,0.859330443461836,0,7,U7 snRNP,CC,
2734,GO:0005684,1,0.49438540583821,0,33,U2-type spliceosomal complex,CC,
2735,GO:0005685,1,0.665980425386473,0,19,U1 snRNP,CC,
2736,GO:0005686,1,0.693555273738085,0,17,U2 snRNP,CC,
2737,GO:0005687,1,0.805525172036998,0,10,U4 snRNP,CC,
2738,GO:0005688,1,0.878443236075531,0,6,U6 snRNP,CC,
2739,GO:0005689,1,0.585736548984282,0,25,U12-type spliceosomal complex,CC,
2740,GO:0005690,1,0.978837592154686,0,1,U4atac snRNP,CC,
2741,GO:0005691,1,0.979229612128656,0,1,U6atac snRNP,CC,
2743,GO:0005697,1,0.64575633901857,0,21,telomerase holoenzyme complex,CC,
2744,GO:0005712,1,0.961031539169837,0,2,chiasma,CC,
2745,GO:0005713,1,0.958452853152486,0,2,recombination nodule,CC,
2746,GO:0005715,1,0.978944776214029,0,1,late recombination nodule,CC,
2747,GO:0005719,1,0.601671008581015,0,24,nuclear euchromatin,CC,
2748,GO:0005720,1,0.502653443677883,0,33,nuclear heterochromatin,CC,
2749,GO:0005721,1,0.692558145813259,0,18,pericentric heterochromatin,CC,
2750,GO:0005724,1,0.978622147444102,0,1,nuclear telomeric heterochromatin,CC,
2751,GO:0005726,1,0.938636017349152,0,3,perichromatin fibrils,CC,
2753,GO:0005731,1,0.978648757804161,0,1,nucleolus organizer region,CC,
2754,GO:0005732,1,0.708437972936042,0,16,small nucleolar ribonucleoprotein complex,CC,
2755,GO:0005736,1,0.792025795756241,0,11,DNA-directed RNA polymerase I complex,CC,
2760,GO:0005742,1,0.823711682085707,0,9,mitochondrial outer membrane translocase complex,CC,
2762,GO:0005744,1,0.806530695697753,0,10,mitochondrial inner membrane presequence translocase complex,CC,
2763,GO:0005745,1,0.958509426848138,0,2,m-AAA complex,CC,
2764,GO:0005746,1,0.188574900287712,0,77,mitochondrial respiratory chain,CC,
2765,GO:0005747,1,0.402094908512984,0,42,mitochondrial respiratory chain complex I,CC,
2766,GO:0005749,1,0.917663598579391,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2767,GO:0005750,1,0.788719112251135,0,11,mitochondrial respiratory chain complex III,CC,
2768,GO:0005751,1,0.770125736192478,0,12,mitochondrial respiratory chain complex IV,CC,
2769,GO:0005753,1,0.648182340538465,0,20,mitochondrial proton-transporting ATP synthase complex,CC,
2770,GO:0005754,1,0.978695978101801,0,1,mitochondrial proton-transporting ATP synthase, catalytic core,CC,
2771,GO:0005757,1,0.978478550887233,0,1,mitochondrial permeability transition pore complex,CC,
2774,GO:0005760,1,0.958941429055791,0,2,gamma DNA polymerase complex,CC,
2777,GO:0005763,1,0.569113293447374,0,26,mitochondrial small ribosomal subunit,CC,
2781,GO:0005767,1,0.743834171400947,0,14,secondary lysosome,CC,
2792,GO:0005779,1,0.74130075577816,0,14,integral component of peroxisomal membrane,CC,
2795,GO:0005784,1,0.917098187508047,0,4,Sec61 translocon complex,CC,
2796,GO:0005785,1,0.879325001266103,0,6,signal recognition particle receptor complex,CC,
2797,GO:0005786,1,0.879071799225165,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2798,GO:0005787,1,0.898277372036091,0,5,signal peptidase complex,CC,
2805,GO:0005795,1,0.0814914990799001,0,120,Golgi stack,CC,
2807,GO:0005797,1,0.91894777246241,0,4,Golgi medial cisterna,CC,
2813,GO:0005814,1,0.114796131361955,0,105,centriole,CC,
2815,GO:0005818,1,0.904398655404739,0,5,aster,CC,
2817,GO:0005826,1,0.922463343659282,0,4,actomyosin contractile ring,CC,
2818,GO:0005827,1,0.901142068515825,0,5,polar microtubule,CC,
2819,GO:0005828,1,0.886868868717112,0,6,kinetochore microtubule,CC,
2821,GO:0005832,1,0.790418334234715,0,11,chaperonin-containing T-complex,CC,
2822,GO:0005833,1,0.770540406663596,0,12,hemoglobin complex,CC,
2823,GO:0005834,1,0.474483947773917,0,35,heterotrimeric G-protein complex,CC,
2824,GO:0005838,1,0.635950932882775,0,21,proteasome regulatory particle,CC,
2827,GO:0005844,1,0.397833214580921,0,44,polysome,CC,
2828,GO:0005845,1,0.760915571720578,0,13,mRNA cap binding complex,CC,
2829,GO:0005846,1,0.959070707929768,0,2,nuclear cap binding complex,CC,
2830,GO:0005847,1,0.742542808435984,0,14,mRNA cleavage and polyadenylation specificity factor complex,CC,
2831,GO:0005849,1,0.669765986822867,0,19,mRNA cleavage factor complex,CC,
2832,GO:0005850,1,0.918881448713745,0,4,eukaryotic translation initiation factor 2 complex,CC,
2833,GO:0005851,1,0.879374355080469,0,6,eukaryotic translation initiation factor 2B complex,CC,
2834,GO:0005852,1,0.695422011919741,0,17,eukaryotic translation initiation factor 3 complex,CC,
2835,GO:0005853,1,0.917489188696874,0,4,eukaryotic translation elongation factor 1 complex,CC,
2837,GO:0005858,1,0.817410066788695,0,12,axonemal dynein complex,CC,
2839,GO:0005861,1,0.841957104761539,0,8,troponin complex,CC,
2840,GO:0005862,1,0.918126812463531,0,4,muscle thin filament tropomyosin,CC,
2841,GO:0005863,1,0.939612783602723,0,3,striated muscle myosin thick filament,CC,
2843,GO:0005868,1,0.63663884100969,0,22,cytoplasmic dynein complex,CC,
2844,GO:0005869,1,0.842761639302907,0,8,dynactin complex,CC,
2845,GO:0005871,1,0.346192085881852,0,52,kinesin complex,CC,
2846,GO:0005873,1,0.960271917384568,0,2,plus-end kinesin complex,CC,
2848,GO:0005875,1,0.0579732561914364,0,141,microtubule associated complex,CC,
2850,GO:0005879,1,0.942590762899741,0,3,axonemal microtubule,CC,
2853,GO:0005883,1,0.851182301887775,0,8,neurofilament,CC,
2855,GO:0005885,1,0.788933168587193,0,11,Arp2/3 protein complex,CC,
2858,GO:0005889,1,0.958578167055932,0,2,hydrogen:potassium-exchanging ATPase complex,CC,
2861,GO:0005892,1,0.698118153003112,0,17,acetylcholine-gated channel complex,CC,
2862,GO:0005895,1,0.978827257004211,0,1,interleukin-5 receptor complex,CC,
2863,GO:0005896,1,0.938048763542431,0,3,interleukin-6 receptor complex,CC,
2864,GO:0005898,1,0.979111896935302,0,1,interleukin-13 receptor complex,CC,
2865,GO:0005899,1,0.946167919903246,0,3,insulin receptor complex,CC,
2866,GO:0005900,1,0.958577504483157,0,2,oncostatin-M receptor complex,CC,
2874,GO:0005914,1,0.979069326547467,0,1,spot adherens junction,CC,
2882,GO:0005927,1,0.938309595726477,0,3,muscle tendon junction,CC,
2884,GO:0005930,1,0.18353907272672,0,84,axoneme,CC,
2886,GO:0005940,1,0.979059508874851,0,1,septin ring,CC,
2890,GO:0005945,1,0.958573165933775,0,2,6-phosphofructokinase complex,CC,
2891,GO:0005947,1,0.902787528314874,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2893,GO:0005953,1,0.958079579092876,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2894,GO:0005954,1,0.978947558039316,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2895,GO:0005955,1,0.923111550949503,0,4,calcineurin complex,CC,
2896,GO:0005956,1,0.957979629217579,0,2,protein kinase CK2 complex,CC,
2897,GO:0005958,1,0.944332267485504,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2899,GO:0005964,1,0.901961124918243,0,5,phosphorylase kinase complex,CC,
2900,GO:0005965,1,0.958097424448221,0,2,protein farnesyltransferase complex,CC,
2901,GO:0005967,1,0.938710231621354,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2902,GO:0005968,1,0.920129090722872,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2903,GO:0005969,1,0.981817670480053,0,1,serine-pyruvate aminotransferase complex,CC,
2904,GO:0005971,1,0.95857459676509,0,2,ribonucleoside-diphosphate reductase complex,CC,
2910,GO:0005980,1,0.579949911966913,0,26,glycogen catabolic process,BP,
2911,GO:0005981,1,0.881018800504144,0,6,regulation of glycogen catabolic process,BP,
2912,GO:0005982,1,0.980708924807722,0,1,starch metabolic process,BP,
2913,GO:0005983,1,0.980708924807722,0,1,starch catabolic process,BP,
2915,GO:0005985,1,0.937546183353873,0,3,sucrose metabolic process,BP,
2916,GO:0005986,1,0.957589737571636,0,2,sucrose biosynthetic process,BP,
2917,GO:0005988,1,0.938031239213334,0,3,lactose metabolic process,BP,
2918,GO:0005989,1,0.938031239213334,0,3,lactose biosynthetic process,BP,
2919,GO:0005991,1,0.978702590235847,0,1,trehalose metabolic process,BP,
2920,GO:0005993,1,0.978702590235847,0,1,trehalose catabolic process,BP,
2922,GO:0005997,1,0.917557060880151,0,4,xylulose metabolic process,BP,
2923,GO:0005998,1,0.979074614309529,0,1,xylulose catabolic process,BP,
2924,GO:0005999,1,0.95778517091673,0,2,xylulose biosynthetic process,BP,
2927,GO:0006002,1,0.827594476591446,0,9,fructose 6-phosphate metabolic process,BP,
2929,GO:0006004,1,0.732689246926037,0,15,fucose metabolic process,BP,
2934,GO:0006013,1,0.845200170319827,0,8,mannose metabolic process,BP,
2935,GO:0006014,1,0.937097435006034,0,3,D-ribose metabolic process,BP,
2936,GO:0006015,1,0.917974240546835,0,4,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2937,GO:0006020,1,0.799525102399125,0,11,inositol metabolic process,BP,
2938,GO:0006021,1,0.920243058562269,0,4,inositol biosynthetic process,BP,
2945,GO:0006030,1,0.937863995022683,0,3,chitin metabolic process,BP,
2946,GO:0006032,1,0.937863995022683,0,3,chitin catabolic process,BP,
2947,GO:0006037,1,0.978582423287099,0,1,cell wall chitin metabolic process,BP,
2948,GO:0006040,1,0.488251264510456,0,34,amino sugar metabolic process,BP,
2949,GO:0006041,1,0.938055631113151,0,3,glucosamine metabolic process,BP,
2950,GO:0006043,1,0.978879387759788,0,1,glucosamine catabolic process,BP,
2951,GO:0006044,1,0.728699060838328,0,15,N-acetylglucosamine metabolic process,BP,
2952,GO:0006045,1,0.959282653582911,0,2,N-acetylglucosamine biosynthetic process,BP,
2953,GO:0006047,1,0.744516040379119,0,14,UDP-N-acetylglucosamine metabolic process,BP,
2954,GO:0006048,1,0.827788511942993,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2955,GO:0006049,1,0.979052057934143,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2956,GO:0006050,1,0.957637089025373,0,2,mannosamine metabolic process,BP,
2957,GO:0006051,1,0.957637089025373,0,2,N-acetylmannosamine metabolic process,BP,
2958,GO:0006054,1,0.827052935257989,0,9,N-acetylneuraminate metabolic process,BP,
2959,GO:0006055,1,0.978526838284668,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2960,GO:0006056,1,0.978668801600268,0,1,mannoprotein metabolic process,BP,
2961,GO:0006057,1,0.978668801600268,0,1,mannoprotein biosynthetic process,BP,
2962,GO:0006059,1,0.937423062621832,0,3,hexitol metabolic process,BP,
2963,GO:0006060,1,0.957973769382675,0,2,sorbitol metabolic process,BP,
2964,GO:0006061,1,0.978558918485875,0,1,sorbitol biosynthetic process,BP,
2965,GO:0006062,1,0.978965040994655,0,1,sorbitol catabolic process,BP,
2966,GO:0006063,1,0.625363197307411,0,22,uronic acid metabolic process,BP,
2967,GO:0006064,1,0.898093325838692,0,5,glucuronate catabolic process,BP,
2968,GO:0006065,1,0.939796139740596,0,3,UDP-glucuronate biosynthetic process,BP,
2970,GO:0006067,1,0.637540312976429,0,21,ethanol metabolic process,BP,
2971,GO:0006068,1,0.772779420211721,0,12,ethanol catabolic process,BP,
2972,GO:0006069,1,0.774041547876222,0,12,ethanol oxidation,BP,
2973,GO:0006071,1,0.713781356399343,0,16,glycerol metabolic process,BP,
2974,GO:0006072,1,0.866937761438647,0,7,glycerol-3-phosphate metabolic process,BP,
2978,GO:0006083,1,0.939275335733158,0,3,acetate metabolic process,BP,
2993,GO:0006104,1,0.918179344576577,0,4,succinyl-CoA metabolic process,BP,
2995,GO:0006106,1,0.937760295898061,0,3,fumarate metabolic process,BP,
3003,GO:0006114,1,0.918562660978552,0,4,glycerol biosynthetic process,BP,
3004,GO:0006116,1,0.938043839057597,0,3,NADH oxidation,BP,
3005,GO:0006117,1,0.978980630239622,0,1,acetaldehyde metabolic process,BP,
3007,GO:0006120,1,0.369270942436238,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
3008,GO:0006121,1,0.937342626997064,0,3,mitochondrial electron transport, succinate to ubiquinone,BP,
3009,GO:0006122,1,0.757588173321141,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
3010,GO:0006123,1,0.693953217827797,0,17,mitochondrial electron transport, cytochrome c to oxygen,BP,
3011,GO:0006127,1,0.979046657681476,0,1,glycerophosphate shuttle,BP,
3016,GO:0006147,1,0.979880888857312,0,1,guanine catabolic process,BP,
3019,GO:0006154,1,0.978592601272244,0,1,adenosine catabolic process,BP,
3020,GO:0006157,1,0.978592601272244,0,1,deoxyadenosine catabolic process,BP,
3024,GO:0006166,1,0.898448452962439,0,5,purine ribonucleoside salvage,BP,
3025,GO:0006167,1,0.860447794739326,0,7,AMP biosynthetic process,BP,
3026,GO:0006168,1,0.957496814988344,0,2,adenine salvage,BP,
3027,GO:0006169,1,0.978780635386742,0,1,adenosine salvage,BP,
3029,GO:0006172,1,0.95838734808711,0,2,ADP biosynthetic process,BP,
3030,GO:0006173,1,0.979071007692936,0,1,dADP biosynthetic process,BP,
3031,GO:0006175,1,0.978780635386742,0,1,dATP biosynthetic process,BP,
3032,GO:0006177,1,0.937873222746104,0,3,GMP biosynthetic process,BP,
3033,GO:0006178,1,0.978562097860833,0,1,guanine salvage,BP,
3035,GO:0006183,1,0.788630145077432,0,11,GTP biosynthetic process,BP,
3036,GO:0006185,1,0.978493226101955,0,1,dGDP biosynthetic process,BP,
3037,GO:0006188,1,0.8089149897951,0,10,IMP biosynthetic process,BP,
3038,GO:0006189,1,0.880820911005825,0,6,'de novo' IMP biosynthetic process,BP,
3039,GO:0006193,1,0.978505974722881,0,1,ITP catabolic process,BP,
3041,GO:0006196,1,0.958768508306672,0,2,AMP catabolic process,BP,
3043,GO:0006203,1,0.937646685086872,0,3,dGTP catabolic process,BP,
3044,GO:0006206,1,0.673409147771862,0,19,pyrimidine nucleobase metabolic process,BP,
3045,GO:0006207,1,0.88626036372655,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3046,GO:0006208,1,0.938033921028589,0,3,pyrimidine nucleobase catabolic process,BP,
3047,GO:0006210,1,0.938033921028589,0,3,thymine catabolic process,BP,
3048,GO:0006211,1,0.982829462550365,0,1,5-methylcytosine catabolic process,BP,
3049,GO:0006212,1,0.958319361836809,0,2,uracil catabolic process,BP,
3050,GO:0006213,1,0.364922079655258,0,47,pyrimidine nucleoside metabolic process,BP,
3051,GO:0006214,1,0.97906633745935,0,1,thymidine catabolic process,BP,
3052,GO:0006216,1,0.823482766568907,0,9,cytidine catabolic process,BP,
3053,GO:0006218,1,0.978682589154527,0,1,uridine catabolic process,BP,
3054,GO:0006220,1,0.381004118421094,0,45,pyrimidine nucleotide metabolic process,BP,
3055,GO:0006221,1,0.526037773932228,0,30,pyrimidine nucleotide biosynthetic process,BP,
3056,GO:0006222,1,0.809235254648626,0,10,UMP biosynthetic process,BP,
3057,GO:0006226,1,0.978706510299768,0,1,dUMP biosynthetic process,BP,
3058,GO:0006227,1,0.9580181451805,0,2,dUDP biosynthetic process,BP,
3059,GO:0006228,1,0.807674821608728,0,10,UTP biosynthetic process,BP,
3060,GO:0006231,1,0.957996575709428,0,2,dTMP biosynthetic process,BP,
3061,GO:0006233,1,0.9580181451805,0,2,dTDP biosynthetic process,BP,
3062,GO:0006235,1,0.917398443731461,0,4,dTTP biosynthetic process,BP,
3063,GO:0006238,1,0.978527865550976,0,1,CMP salvage,BP,
3064,GO:0006241,1,0.739577209856333,0,14,CTP biosynthetic process,BP,
3065,GO:0006244,1,0.772570666097755,0,12,pyrimidine nucleotide catabolic process,BP,
3066,GO:0006253,1,0.978508018657599,0,1,dCTP catabolic process,BP,
3067,GO:0006256,1,0.979053258701536,0,1,UDP catabolic process,BP,
3072,GO:0006264,1,0.809350078512581,0,10,mitochondrial DNA replication,BP,
3073,GO:0006265,1,0.827350499385801,0,9,DNA topological change,BP,
3074,GO:0006266,1,0.598884958361375,0,24,DNA ligation,BP,
3075,GO:0006267,1,0.95814743093924,0,2,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3076,GO:0006268,1,0.861796298902828,0,7,DNA unwinding involved in DNA replication,BP,
3077,GO:0006269,1,0.919000442347082,0,4,DNA replication, synthesis of RNA primer,BP,
3078,GO:0006270,1,0.437368738592313,0,39,DNA replication initiation,BP,
3079,GO:0006271,1,0.713137282878593,0,16,DNA strand elongation involved in DNA replication,BP,
3080,GO:0006272,1,0.961985177424594,0,2,leading strand elongation,BP,
3081,GO:0006273,1,0.844178335650233,0,8,lagging strand elongation,BP,
3082,GO:0006274,1,0.97897493185122,0,1,DNA replication termination,BP,
3084,GO:0006278,1,0.273785511642131,0,62,RNA-dependent DNA biosynthetic process,BP,
3087,GO:0006283,1,0.211680324365853,0,73,transcription-coupled nucleotide-excision repair,BP,
3088,GO:0006284,1,0.423996512763255,0,41,base-excision repair,BP,
3089,GO:0006285,1,0.806538928090614,0,10,base-excision repair, AP site formation,BP,
3090,GO:0006286,1,0.957570446084182,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3091,GO:0006287,1,0.901662913431951,0,5,base-excision repair, gap-filling,BP,
3092,GO:0006288,1,0.937741228388094,0,3,base-excision repair, DNA ligation,BP,
3093,GO:0006289,1,0.0888904016313019,0,114,nucleotide-excision repair,BP,
3094,GO:0006290,1,0.865535480787161,0,7,pyrimidine dimer repair,BP,
3095,GO:0006293,1,0.64210582610085,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3096,GO:0006294,1,0.539179724543072,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3097,GO:0006295,1,0.64210582610085,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3098,GO:0006296,1,0.455497996963927,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3099,GO:0006297,1,0.613321289116298,0,23,nucleotide-excision repair, DNA gap filling,BP,
3100,GO:0006298,1,0.520491703393877,0,31,mismatch repair,BP,
3101,GO:0006301,1,0.350609374731279,0,50,postreplication repair,BP,
3102,GO:0006302,1,0.0152501910235883,0,199,double-strand break repair,BP,
3103,GO:0006303,1,0.247525619678147,0,67,double-strand break repair via nonhomologous end joining,BP,
3107,GO:0006307,1,0.808035908788203,0,10,DNA dealkylation involved in DNA repair,BP,
3109,GO:0006309,1,0.669390351420721,0,19,apoptotic DNA fragmentation,BP,
3111,GO:0006311,1,0.938430798961102,0,3,meiotic gene conversion,BP,
3112,GO:0006312,1,0.374630945862213,0,47,mitotic recombination,BP,
3113,GO:0006313,1,0.958530448882214,0,2,transposition, DNA-mediated,BP,
3114,GO:0006323,1,0.0197536522240529,0,185,DNA packaging,BP,
3116,GO:0006333,1,0.0244926756624831,0,174,chromatin assembly or disassembly,BP,
3117,GO:0006334,1,0.058651990984211,0,132,nucleosome assembly,BP,
3118,GO:0006335,1,0.501195504746103,0,32,DNA replication-dependent nucleosome assembly,BP,
3119,GO:0006336,1,0.36019196821004,0,48,DNA replication-independent nucleosome assembly,BP,
3120,GO:0006337,1,0.68683605876893,0,18,nucleosome disassembly,BP,
3121,GO:0006338,1,0.0444235731787651,0,149,chromatin remodeling,BP,
3122,GO:0006342,1,0.0889781912395941,0,114,chromatin silencing,BP,
3123,GO:0006343,1,0.979086067712906,0,1,establishment of chromatin silencing,BP,
3124,GO:0006344,1,0.923191099314441,0,4,maintenance of chromatin silencing,BP,
3125,GO:0006346,1,0.655429896735601,0,20,methylation-dependent chromatin silencing,BP,
3126,GO:0006348,1,0.828490881356013,0,9,chromatin silencing at telomere,BP,
3127,GO:0006349,1,0.717579761077592,0,16,regulation of gene expression by genetic imprinting,BP,
3130,GO:0006353,1,0.109395481261995,0,104,DNA-templated transcription, termination,BP,
3133,GO:0006356,1,0.525326925199869,0,31,regulation of transcription from RNA polymerase I promoter,BP,
3136,GO:0006360,1,0.289816711012954,0,59,transcription from RNA polymerase I promoter,BP,
3137,GO:0006361,1,0.505884103577303,0,32,transcription initiation from RNA polymerase I promoter,BP,
3138,GO:0006362,1,0.517976057567496,0,31,transcription elongation from RNA polymerase I promoter,BP,
3139,GO:0006363,1,0.527974443329002,0,30,termination of RNA polymerase I transcription,BP,
3144,GO:0006369,1,0.230898660523066,0,69,termination of RNA polymerase II transcription,BP,
3145,GO:0006370,1,0.528581038529433,0,30,7-methylguanosine mRNA capping,BP,
3147,GO:0006378,1,0.440043529401497,0,39,mRNA polyadenylation,BP,
3148,GO:0006379,1,0.587435981042252,0,25,mRNA cleavage,BP,
3149,GO:0006382,1,0.921728795571121,0,4,adenosine to inosine editing,BP,
3151,GO:0006384,1,0.849809605972262,0,8,transcription initiation from RNA polymerase III promoter,BP,
3152,GO:0006388,1,0.739881012846273,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3153,GO:0006390,1,0.864659196750774,0,7,transcription from mitochondrial promoter,BP,
3154,GO:0006391,1,0.937819343831782,0,3,transcription initiation from mitochondrial promoter,BP,
3157,GO:0006398,1,0.899684915060849,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3162,GO:0006403,1,0.0102114221752409,0,218,RNA localization,BP,
3163,GO:0006404,1,0.941910113439763,0,3,RNA import into nucleus,BP,
3164,GO:0006405,1,0.0561310995916318,0,137,RNA export from nucleus,BP,
3165,GO:0006406,1,0.104072715576359,0,108,mRNA export from nucleus,BP,
3166,GO:0006407,1,0.961141731368821,0,2,rRNA export from nucleus,BP,
3167,GO:0006408,1,0.957906748930096,0,2,snRNA export from nucleus,BP,
3168,GO:0006409,1,0.528217545396734,0,31,tRNA export from nucleus,BP,
3170,GO:0006413,1,0.0176523944117117,0,188,translational initiation,BP,
3174,GO:0006418,1,0.359313393379013,0,48,tRNA aminoacylation for protein translation,BP,
3175,GO:0006419,1,0.938529337102963,0,3,alanyl-tRNA aminoacylation,BP,
3176,GO:0006420,1,0.917530633187718,0,4,arginyl-tRNA aminoacylation,BP,
3177,GO:0006421,1,0.938298762891941,0,3,asparaginyl-tRNA aminoacylation,BP,
3178,GO:0006422,1,0.978894344971556,0,1,aspartyl-tRNA aminoacylation,BP,
3179,GO:0006423,1,0.958153428239005,0,2,cysteinyl-tRNA aminoacylation,BP,
3180,GO:0006424,1,0.959118624727625,0,2,glutamyl-tRNA aminoacylation,BP,
3181,GO:0006425,1,0.978937364976446,0,1,glutaminyl-tRNA aminoacylation,BP,
3182,GO:0006426,1,0.958083267095272,0,2,glycyl-tRNA aminoacylation,BP,
3183,GO:0006427,1,0.958146432366142,0,2,histidyl-tRNA aminoacylation,BP,
3184,GO:0006428,1,0.958778245196915,0,2,isoleucyl-tRNA aminoacylation,BP,
3185,GO:0006429,1,0.959083899484164,0,2,leucyl-tRNA aminoacylation,BP,
3186,GO:0006430,1,0.978803762288996,0,1,lysyl-tRNA aminoacylation,BP,
3187,GO:0006431,1,0.958535360926919,0,2,methionyl-tRNA aminoacylation,BP,
3188,GO:0006432,1,0.91796238709159,0,4,phenylalanyl-tRNA aminoacylation,BP,
3189,GO:0006433,1,0.958924731799399,0,2,prolyl-tRNA aminoacylation,BP,
3190,GO:0006434,1,0.957956168483073,0,2,seryl-tRNA aminoacylation,BP,
3191,GO:0006435,1,0.938336860182497,0,3,threonyl-tRNA aminoacylation,BP,
3192,GO:0006436,1,0.958488561468512,0,2,tryptophanyl-tRNA aminoacylation,BP,
3193,GO:0006437,1,0.95833235335867,0,2,tyrosyl-tRNA aminoacylation,BP,
3194,GO:0006438,1,0.939042359299409,0,3,valyl-tRNA aminoacylation,BP,
3195,GO:0006446,1,0.227800560474062,0,70,regulation of translational initiation,BP,
3196,GO:0006447,1,0.939122248599877,0,3,regulation of translational initiation by iron,BP,
3197,GO:0006448,1,0.575614578694586,0,26,regulation of translational elongation,BP,
3198,GO:0006449,1,0.845027767881002,0,8,regulation of translational termination,BP,
3199,GO:0006450,1,0.71078430300255,0,16,regulation of translational fidelity,BP,
3200,GO:0006451,1,0.828594342314179,0,9,translational readthrough,BP,
3201,GO:0006452,1,0.938865028858175,0,3,translational frameshifting,BP,
3203,GO:0006458,1,0.508185626495024,0,32,'de novo' protein folding,BP,
3205,GO:0006463,1,0.979077372912769,0,1,steroid hormone receptor complex assembly,BP,
3211,GO:0006471,1,0.628751349267906,0,22,protein ADP-ribosylation,BP,
3213,GO:0006474,1,0.718557168660791,0,16,N-terminal protein amino acid acetylation,BP,
3216,GO:0006477,1,0.864109823029993,0,7,protein sulfation,BP,
3217,GO:0006478,1,0.957965528870048,0,2,peptidyl-tyrosine sulfation,BP,
3219,GO:0006480,1,0.95791418651886,0,2,N-terminal protein amino acid methylation,BP,
3220,GO:0006481,1,0.958427198504933,0,2,C-terminal protein methylation,BP,
3221,GO:0006482,1,0.567783357716607,0,28,protein demethylation,BP,
3224,GO:0006488,1,0.656459474100433,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3225,GO:0006489,1,0.861622789421542,0,7,dolichyl diphosphate biosynthetic process,BP,
3226,GO:0006490,1,0.642636478747061,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3227,GO:0006491,1,0.69185755481189,0,18,N-glycan processing,BP,
3232,GO:0006500,1,0.957948501285821,0,2,N-terminal protein palmitoylation,BP,
3236,GO:0006507,1,0.978877198485586,0,1,GPI anchor release,BP,
3238,GO:0006509,1,0.440445315580569,0,39,membrane protein ectodomain proteolysis,BP,
3240,GO:0006513,1,0.306278704190045,0,57,protein monoubiquitination,BP,
3241,GO:0006515,1,0.616004248347734,0,23,misfolded or incompletely synthesized protein catabolic process,BP,
3242,GO:0006516,1,0.70003177358195,0,17,glycoprotein catabolic process,BP,
3243,GO:0006517,1,0.492915248975934,0,34,protein deglycosylation,BP,
3247,GO:0006522,1,0.898291157589865,0,5,alanine metabolic process,BP,
3248,GO:0006524,1,0.898291157589865,0,5,alanine catabolic process,BP,
3249,GO:0006525,1,0.698578651906801,0,17,arginine metabolic process,BP,
3250,GO:0006526,1,0.917530976318758,0,4,arginine biosynthetic process,BP,
3251,GO:0006527,1,0.829760638943227,0,9,arginine catabolic process,BP,
3252,GO:0006528,1,0.898373126716911,0,5,asparagine metabolic process,BP,
3253,GO:0006529,1,0.95828109412722,0,2,asparagine biosynthetic process,BP,
3254,GO:0006530,1,0.958060013647912,0,2,asparagine catabolic process,BP,
3255,GO:0006531,1,0.790615230179281,0,11,aspartate metabolic process,BP,
3256,GO:0006532,1,0.937643961738581,0,3,aspartate biosynthetic process,BP,
3257,GO:0006533,1,0.937644795564082,0,3,aspartate catabolic process,BP,
3258,GO:0006534,1,0.758220363715596,0,13,cysteine metabolic process,BP,
3259,GO:0006535,1,0.978987637002078,0,1,cysteine biosynthetic process from serine,BP,
3262,GO:0006538,1,0.86178021117912,0,7,glutamate catabolic process,BP,
3263,GO:0006540,1,0.958346865548066,0,2,glutamate decarboxylation to succinate,BP,
3264,GO:0006541,1,0.605996022284656,0,24,glutamine metabolic process,BP,
3265,GO:0006542,1,0.959507843292867,0,2,glutamine biosynthetic process,BP,
3266,GO:0006543,1,0.938589045534225,0,3,glutamine catabolic process,BP,
3268,GO:0006545,1,0.89872636479202,0,5,glycine biosynthetic process,BP,
3270,GO:0006547,1,0.825371939950453,0,9,histidine metabolic process,BP,
3271,GO:0006548,1,0.861199552487302,0,7,histidine catabolic process,BP,
3274,GO:0006551,1,0.863849518118785,0,7,leucine metabolic process,BP,
3275,GO:0006552,1,0.898922271598323,0,5,leucine catabolic process,BP,
3276,GO:0006553,1,0.792279254980126,0,11,lysine metabolic process,BP,
3277,GO:0006554,1,0.809247039079676,0,10,lysine catabolic process,BP,
3279,GO:0006556,1,0.938215346673771,0,3,S-adenosylmethionine biosynthetic process,BP,
3280,GO:0006557,1,0.979069037868997,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3283,GO:0006560,1,0.82466313865125,0,9,proline metabolic process,BP,
3284,GO:0006561,1,0.879712861407905,0,6,proline biosynthetic process,BP,
3285,GO:0006562,1,0.917819090377405,0,4,proline catabolic process,BP,
3286,GO:0006563,1,0.807316137071472,0,10,L-serine metabolic process,BP,
3287,GO:0006564,1,0.879337291358571,0,6,L-serine biosynthetic process,BP,
3288,GO:0006565,1,0.937870482241225,0,3,L-serine catabolic process,BP,
3289,GO:0006566,1,0.957825266135624,0,2,threonine metabolic process,BP,
3290,GO:0006567,1,0.978605685514806,0,1,threonine catabolic process,BP,
3291,GO:0006568,1,0.759448618394577,0,13,tryptophan metabolic process,BP,
3292,GO:0006569,1,0.790133589619033,0,11,tryptophan catabolic process,BP,
3293,GO:0006570,1,0.826349676029377,0,9,tyrosine metabolic process,BP,
3294,GO:0006572,1,0.897934341211234,0,5,tyrosine catabolic process,BP,
3296,GO:0006574,1,0.917810450440507,0,4,valine catabolic process,BP,
3300,GO:0006578,1,0.861736206010124,0,7,amino-acid betaine biosynthetic process,BP,
3301,GO:0006579,1,0.938285859602601,0,3,amino-acid betaine catabolic process,BP,
3302,GO:0006580,1,0.979012464794399,0,1,ethanolamine metabolic process,BP,
3303,GO:0006581,1,0.958480536499977,0,2,acetylcholine catabolic process,BP,
3305,GO:0006583,1,0.958131561371945,0,2,melanin biosynthetic process from tyrosine,BP,
3307,GO:0006585,1,0.978719593470848,0,1,dopamine biosynthetic process from tyrosine,BP,
3308,GO:0006586,1,0.681861903033144,0,18,indolalkylamine metabolic process,BP,
3309,GO:0006589,1,0.958529149180282,0,2,octopamine biosynthetic process,BP,
3310,GO:0006590,1,0.718067104200886,0,16,thyroid hormone generation,BP,
3311,GO:0006591,1,0.860667657594019,0,7,ornithine metabolic process,BP,
3312,GO:0006592,1,0.979069454243021,0,1,ornithine biosynthetic process,BP,
3313,GO:0006593,1,0.978626292916885,0,1,ornithine catabolic process,BP,
3314,GO:0006595,1,0.72394526258972,0,15,polyamine metabolic process,BP,
3315,GO:0006596,1,0.772499987235795,0,12,polyamine biosynthetic process,BP,
3316,GO:0006597,1,0.958155096096242,0,2,spermine biosynthetic process,BP,
3317,GO:0006598,1,0.878410272206318,0,6,polyamine catabolic process,BP,
3318,GO:0006599,1,0.978598469313653,0,1,phosphagen metabolic process,BP,
3320,GO:0006601,1,0.957929134122802,0,2,creatine biosynthetic process,BP,
3321,GO:0006603,1,0.978598469313653,0,1,phosphocreatine metabolic process,BP,
3324,GO:0006607,1,0.641608858292638,0,22,NLS-bearing protein import into nucleus,BP,
3325,GO:0006610,1,0.848235105783358,0,8,ribosomal protein import into nucleus,BP,
3328,GO:0006613,1,0.125289015393332,0,96,cotranslational protein targeting to membrane,BP,
3329,GO:0006614,1,0.138644896532405,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3330,GO:0006616,1,0.878650042126232,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3331,GO:0006617,1,0.957796176474387,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3332,GO:0006620,1,0.882367329864498,0,6,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3333,GO:0006621,1,0.825934781170236,0,9,protein retention in ER lumen,BP,
3334,GO:0006622,1,0.706142474771728,0,17,protein targeting to lysosome,BP,
3335,GO:0006623,1,0.559278708324393,0,28,protein targeting to vacuole,BP,
3336,GO:0006624,1,0.957726168444717,0,2,vacuolar protein processing,BP,
3337,GO:0006625,1,0.69712525289562,0,17,protein targeting to peroxisome,BP,
3338,GO:0006626,1,0.0496655278938704,0,141,protein targeting to mitochondrion,BP,
3339,GO:0006627,1,0.863360056491092,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3349,GO:0006642,1,0.925863407172156,0,4,triglyceride mobilization,BP,
3352,GO:0006646,1,0.776465549199664,0,12,phosphatidylethanolamine biosynthetic process,BP,
3353,GO:0006649,1,0.960793112350475,0,2,phospholipid transfer to membrane,BP,
3356,GO:0006654,1,0.482089910437277,0,35,phosphatidic acid biosynthetic process,BP,
3357,GO:0006655,1,0.826117672203242,0,9,phosphatidylglycerol biosynthetic process,BP,
3359,GO:0006657,1,0.861852610057867,0,7,CDP-choline pathway,BP,
3361,GO:0006659,1,0.91842809857481,0,4,phosphatidylserine biosynthetic process,BP,
3362,GO:0006660,1,0.978671748385357,0,1,phosphatidylserine catabolic process,BP,
3365,GO:0006663,1,0.918807417971055,0,4,platelet activating factor biosynthetic process,BP,
3368,GO:0006666,1,0.979708294243052,0,1,3-keto-sphinganine metabolic process,BP,
3369,GO:0006667,1,0.939755532751176,0,3,sphinganine metabolic process,BP,
3370,GO:0006668,1,0.958562876202339,0,2,sphinganine-1-phosphate metabolic process,BP,
3371,GO:0006669,1,0.979056433026731,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3372,GO:0006670,1,0.80955506446476,0,10,sphingosine metabolic process,BP,
3373,GO:0006671,1,0.979233401567836,0,1,phytosphingosine metabolic process,BP,
3376,GO:0006678,1,0.862524574520194,0,7,glucosylceramide metabolic process,BP,
3377,GO:0006679,1,0.958699138093099,0,2,glucosylceramide biosynthetic process,BP,
3378,GO:0006680,1,0.938335191892605,0,3,glucosylceramide catabolic process,BP,
3379,GO:0006681,1,0.899462814773627,0,5,galactosylceramide metabolic process,BP,
3380,GO:0006682,1,0.958170196171657,0,2,galactosylceramide biosynthetic process,BP,
3381,GO:0006683,1,0.9790507988319,0,1,galactosylceramide catabolic process,BP,
3382,GO:0006684,1,0.744629509804308,0,14,sphingomyelin metabolic process,BP,
3383,GO:0006685,1,0.880815726229828,0,6,sphingomyelin catabolic process,BP,
3384,GO:0006686,1,0.88268879978764,0,6,sphingomyelin biosynthetic process,BP,
3386,GO:0006688,1,0.733548081203436,0,15,glycosphingolipid biosynthetic process,BP,
3394,GO:0006696,1,0.957845747348868,0,2,ergosterol biosynthetic process,BP,
3397,GO:0006701,1,0.86261238151084,0,7,progesterone biosynthetic process,BP,
3403,GO:0006707,1,0.792533051786253,0,11,cholesterol catabolic process,BP,
3405,GO:0006711,1,0.957923324526455,0,2,estrogen catabolic process,BP,
3406,GO:0006713,1,0.978674342721681,0,1,glucocorticoid catabolic process,BP,
3407,GO:0006714,1,0.957593049659306,0,2,sesquiterpenoid metabolic process,BP,
3410,GO:0006722,1,0.978922284447464,0,1,triterpenoid metabolic process,BP,
3412,GO:0006726,1,0.918558470730941,0,4,eye pigment biosynthetic process,BP,
3414,GO:0006730,1,0.49671664889452,0,33,one-carbon metabolic process,BP,
3422,GO:0006741,1,0.938111655003005,0,3,NADP biosynthetic process,BP,
3423,GO:0006742,1,0.958007555891013,0,2,NADP catabolic process,BP,
3424,GO:0006743,1,0.740181148120861,0,14,ubiquinone metabolic process,BP,
3425,GO:0006744,1,0.755847562085556,0,13,ubiquinone biosynthetic process,BP,
3426,GO:0006747,1,0.978746526553592,0,1,FAD biosynthetic process,BP,
3429,GO:0006751,1,0.842032830962206,0,8,glutathione catabolic process,BP,
3431,GO:0006754,1,0.406588636937921,0,42,ATP biosynthetic process,BP,
3433,GO:0006760,1,0.590228627063021,0,25,folic acid-containing compound metabolic process,BP,
3436,GO:0006768,1,0.798451712730972,0,11,biotin metabolic process,BP,
3438,GO:0006772,1,0.918175018434511,0,4,thiamine metabolic process,BP,
3440,GO:0006776,1,0.84322284134039,0,8,vitamin A metabolic process,BP,
3441,GO:0006777,1,0.880211457480748,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3443,GO:0006779,1,0.604305103833601,0,24,porphyrin-containing compound biosynthetic process,BP,
3444,GO:0006780,1,0.957830198363003,0,2,uroporphyrinogen III biosynthetic process,BP,
3445,GO:0006781,1,0.978828085621426,0,1,succinyl-CoA pathway,BP,
3446,GO:0006782,1,0.842166240521563,0,8,protoporphyrinogen IX biosynthetic process,BP,
3447,GO:0006783,1,0.656113359320043,0,20,heme biosynthetic process,BP,
3448,GO:0006784,1,0.960570939252975,0,2,heme a biosynthetic process,BP,
3449,GO:0006787,1,0.859825879827315,0,7,porphyrin-containing compound catabolic process,BP,
3450,GO:0006788,1,0.957708755755053,0,2,heme oxidation,BP,
3451,GO:0006789,1,0.958257465764168,0,2,bilirubin conjugation,BP,
3455,GO:0006797,1,0.979042395172386,0,1,polyphosphate metabolic process,BP,
3459,GO:0006808,1,0.937720558020261,0,3,regulation of nitrogen utilization,BP,
3467,GO:0006817,1,0.605598858012321,0,24,phosphate ion transport,BP,
3471,GO:0006824,1,0.898301330650442,0,5,cobalt ion transport,BP,
3474,GO:0006828,1,0.793153966902098,0,11,manganese ion transport,BP,
3475,GO:0006829,1,0.578551398745382,0,26,zinc II ion transport,BP,
3476,GO:0006833,1,0.667434384142817,0,19,water transport,BP,
3479,GO:0006837,1,0.712108333065207,0,16,serotonin transport,BP,
3481,GO:0006842,1,0.918554608635583,0,4,tricarboxylic acid transport,BP,
3482,GO:0006843,1,0.978611339907467,0,1,mitochondrial citrate transport,BP,
3483,GO:0006844,1,0.958061124992007,0,2,acyl carnitine transport,BP,
3484,GO:0006848,1,0.918597486718416,0,4,pyruvate transport,BP,
3485,GO:0006850,1,0.938238199096648,0,3,mitochondrial pyruvate transport,BP,
3486,GO:0006851,1,0.84339274711237,0,8,mitochondrial calcium ion transport,BP,
3489,GO:0006857,1,0.827928227365689,0,9,oligopeptide transport,BP,
3490,GO:0006858,1,0.959528080119782,0,2,extracellular transport,BP,
3491,GO:0006860,1,0.978728024873514,0,1,extracellular amino acid transport,BP,
3493,GO:0006863,1,0.860708536469599,0,7,purine nucleobase transport,BP,
3494,GO:0006864,1,0.958377835580009,0,2,pyrimidine nucleotide transport,BP,
3496,GO:0006867,1,0.958414065007485,0,2,asparagine transport,BP,
3497,GO:0006868,1,0.899278800305208,0,5,glutamine transport,BP,
3502,GO:0006876,1,0.979088056130525,0,1,cellular cadmium ion homeostasis,BP,
3505,GO:0006880,1,0.897221323377827,0,5,intracellular sequestering of iron ion,BP,
3506,GO:0006882,1,0.590593134175257,0,25,cellular zinc ion homeostasis,BP,
3507,GO:0006883,1,0.762888159281153,0,13,cellular sodium ion homeostasis,BP,
3508,GO:0006884,1,0.701601995145558,0,17,cell volume homeostasis,BP,
3516,GO:0006893,1,0.396120042327189,0,45,Golgi to plasma membrane transport,BP,
3517,GO:0006895,1,0.701187204537906,0,18,Golgi to endosome transport,BP,
3518,GO:0006896,1,0.810923034911072,0,10,Golgi to vacuole transport,BP,
3521,GO:0006900,1,0.101478304301115,0,109,membrane budding,BP,
3522,GO:0006901,1,0.262319149553194,0,64,vesicle coating,BP,
3523,GO:0006903,1,0.188083079183189,0,80,vesicle targeting,BP,
3534,GO:0006921,1,0.531818391347371,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3536,GO:0006925,1,0.697613431502627,0,17,inflammatory cell apoptotic process,BP,
3538,GO:0006929,1,0.574737855757839,0,27,substrate-dependent cell migration,BP,
3539,GO:0006930,1,0.84930463412245,0,8,substrate-dependent cell migration, cell extension,BP,
3540,GO:0006931,1,0.922536336172942,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3541,GO:0006933,1,0.918402898928833,0,4,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3549,GO:0006948,1,0.979065666430272,0,1,induction by virus of host cell-cell fusion,BP,
3550,GO:0006949,1,0.36187378602848,0,49,syncytium formation,BP,
3553,GO:0006953,1,0.374534180948341,0,46,acute-phase response,BP,
3558,GO:0006958,1,0.50808223573857,0,32,complement activation, classical pathway,BP,
3560,GO:0006963,1,0.957392980198556,0,2,positive regulation of antibacterial peptide biosynthetic process,BP,
3561,GO:0006965,1,0.957392980198556,0,2,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
3562,GO:0006968,1,0.283461836480698,0,59,cellular defense response,BP,
3564,GO:0006971,1,0.850418041901961,0,8,hypotonic response,BP,
3571,GO:0006982,1,0.937085568013967,0,3,response to lipid hydroperoxide,BP,
3572,GO:0006983,1,0.811321369716477,0,10,ER overload response,BP,
3573,GO:0006984,1,0.412123016954367,0,42,ER-nucleus signaling pathway,BP,
3575,GO:0006987,1,0.843743408759894,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3576,GO:0006990,1,0.921132228559564,0,4,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3577,GO:0006991,1,0.82626650211984,0,9,response to sterol depletion,BP,
3578,GO:0006995,1,0.920187318897993,0,4,cellular response to nitrogen starvation,BP,
3580,GO:0006997,1,0.0594268667645452,0,136,nucleus organization,BP,
3581,GO:0006998,1,0.184326586549852,0,81,nuclear envelope organization,BP,
3582,GO:0006999,1,0.752390815164147,0,14,nuclear pore organization,BP,
3583,GO:0007000,1,0.880689370959942,0,6,nucleolus organization,BP,
3584,GO:0007004,1,0.284361587969773,0,60,telomere maintenance via telomerase,BP,
3587,GO:0007007,1,0.680728644358983,0,18,inner mitochondrial membrane organization,BP,
3588,GO:0007008,1,0.841952734988616,0,8,outer mitochondrial membrane organization,BP,
3591,GO:0007014,1,0.979075551884441,0,1,actin ubiquitination,BP,
3595,GO:0007018,1,0.00775991465949041,0,237,microtubule-based movement,BP,
3596,GO:0007019,1,0.545851211218509,0,29,microtubule depolymerization,BP,
3598,GO:0007021,1,0.87897558244672,0,6,tubulin complex assembly,BP,
3599,GO:0007023,1,0.917754958085012,0,4,post-chaperonin tubulin folding pathway,BP,
3600,GO:0007026,1,0.703576907867524,0,17,negative regulation of microtubule depolymerization,BP,
3601,GO:0007028,1,0.81823073495357,0,10,cytoplasm organization,BP,
3608,GO:0007035,1,0.688805556645188,0,18,vacuolar acidification,BP,
3609,GO:0007037,1,0.98003558222434,0,1,vacuolar phosphate transport,BP,
3610,GO:0007039,1,0.843264586569402,0,8,protein catabolic process in the vacuole,BP,
3613,GO:0007042,1,0.879082210095244,0,6,lysosomal lumen acidification,BP,
3621,GO:0007056,1,0.937621542838432,0,3,spindle assembly involved in female meiosis,BP,
3622,GO:0007057,1,0.958130999716379,0,2,spindle assembly involved in female meiosis I,BP,
3624,GO:0007060,1,0.938296086708679,0,3,male meiosis chromosome segregation,BP,
3625,GO:0007062,1,0.0912975082202965,0,115,sister chromatid cohesion,BP,
3626,GO:0007063,1,0.705525740257134,0,17,regulation of sister chromatid cohesion,BP,
3627,GO:0007064,1,0.684570888934207,0,19,mitotic sister chromatid cohesion,BP,
3628,GO:0007066,1,0.95744322872232,0,2,female meiosis sister chromatid cohesion,BP,
3630,GO:0007068,1,0.959667222306231,0,2,negative regulation of transcription during mitotic cell cycle,BP,
3631,GO:0007070,1,0.959667222306231,0,2,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
3632,GO:0007072,1,0.978648757804161,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3633,GO:0007076,1,0.761939220083669,0,14,mitotic chromosome condensation,BP,
3634,GO:0007077,1,0.419831477689528,0,42,mitotic nuclear envelope disassembly,BP,
3635,GO:0007079,1,0.94166678856169,0,3,mitotic chromosome movement towards spindle pole,BP,
3637,GO:0007084,1,0.80738310868846,0,10,mitotic nuclear envelope reassembly,BP,
3639,GO:0007089,1,0.920592796924011,0,4,traversing start control point of mitotic cell cycle,BP,
3640,GO:0007091,1,0.386255682999521,0,46,metaphase/anaphase transition of mitotic cell cycle,BP,
3642,GO:0007094,1,0.573641952141003,0,27,mitotic spindle assembly checkpoint,BP,
3644,GO:0007096,1,0.682691340614348,0,18,regulation of exit from mitosis,BP,
3645,GO:0007097,1,0.834202657747892,0,9,nuclear migration,BP,
3647,GO:0007099,1,0.569036808725917,0,27,centriole replication,BP,
3648,GO:0007100,1,0.765634069926651,0,13,mitotic centrosome separation,BP,
3649,GO:0007113,1,0.937546308354762,0,3,endomitotic cell cycle,BP,
3651,GO:0007127,1,0.141062003995244,0,93,meiosis I,BP,
3652,GO:0007129,1,0.457392550961989,0,37,synapsis,BP,
3653,GO:0007130,1,0.671318685816146,0,19,synaptonemal complex assembly,BP,
3654,GO:0007131,1,0.405787541253759,0,43,reciprocal meiotic recombination,BP,
3655,GO:0007135,1,0.842556487175175,0,8,meiosis II,BP,
3657,GO:0007141,1,0.69892863826959,0,17,male meiosis I,BP,
3658,GO:0007143,1,0.606322962088938,0,24,female meiotic division,BP,
3659,GO:0007144,1,0.882365780294582,0,6,female meiosis I,BP,
3660,GO:0007146,1,0.97897493185122,0,1,meiotic recombination nodule assembly,BP,
3661,GO:0007147,1,0.979071895117419,0,1,female meiosis II,BP,
3666,GO:0007158,1,0.735142776513157,0,15,neuron cell-cell adhesion,BP,
3669,GO:0007161,1,0.928146971632416,0,4,calcium-independent cell-matrix adhesion,BP,
3678,GO:0007171,1,0.764282168509457,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3679,GO:0007172,1,0.843766982465624,0,8,signal complex assembly,BP,
3681,GO:0007174,1,0.978854407687914,0,1,epidermal growth factor catabolic process,BP,
3682,GO:0007175,1,0.79851035102459,0,11,negative regulation of epidermal growth factor-activated receptor activity,BP,
3686,GO:0007181,1,0.939506142129903,0,3,transforming growth factor beta receptor complex assembly,BP,
3688,GO:0007183,1,0.751558539934881,0,14,SMAD protein complex assembly,BP,
3690,GO:0007185,1,0.873687475716089,0,7,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3695,GO:0007190,1,0.452371607794151,0,38,activation of adenylate cyclase activity,BP,
3696,GO:0007191,1,0.807976255310843,0,10,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3698,GO:0007194,1,0.555049478548915,0,28,negative regulation of adenylate cyclase activity,BP,
3699,GO:0007195,1,0.791607240351427,0,11,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3700,GO:0007196,1,0.83482569439049,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3701,GO:0007197,1,0.898988107853558,0,5,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3702,GO:0007198,1,0.917696228162043,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3703,GO:0007199,1,0.958468966759684,0,2,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3708,GO:0007206,1,0.961268627933081,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3709,GO:0007207,1,0.879936274782962,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3710,GO:0007208,1,0.958912856093585,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3711,GO:0007210,1,0.571370084206062,0,26,serotonin receptor signaling pathway,BP,
3712,GO:0007212,1,0.38627505428882,0,45,dopamine receptor signaling pathway,BP,
3713,GO:0007213,1,0.728795443708738,0,15,G-protein coupled acetylcholine receptor signaling pathway,BP,
3714,GO:0007214,1,0.622286143512208,0,23,gamma-aminobutyric acid signaling pathway,BP,
3716,GO:0007216,1,0.751870499849886,0,14,G-protein coupled glutamate receptor signaling pathway,BP,
3717,GO:0007217,1,0.860243041334549,0,7,tachykinin receptor signaling pathway,BP,
3718,GO:0007218,1,0.122120853225802,0,98,neuropeptide signaling pathway,BP,
3724,GO:0007225,1,0.979411538762677,0,1,patched ligand maturation,BP,
3725,GO:0007227,1,0.918895852169952,0,4,signal transduction downstream of smoothened,BP,
3726,GO:0007228,1,0.938513547445779,0,3,positive regulation of hh target transcription factor activity,BP,
3728,GO:0007231,1,0.937741982249068,0,3,osmosensory signaling pathway,BP,
3730,GO:0007250,1,0.683054621633334,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3732,GO:0007253,1,0.789952087580496,0,11,cytoplasmic sequestering of NF-kappaB,BP,
3734,GO:0007256,1,0.886855855002208,0,6,activation of JNKK activity,BP,
3736,GO:0007258,1,0.918546561935054,0,4,JUN phosphorylation,BP,
3739,GO:0007262,1,0.84978199209587,0,8,STAT protein import into nucleus,BP,
3748,GO:0007271,1,0.477134890130874,0,35,synaptic transmission, cholinergic,BP,
3750,GO:0007274,1,0.542773443213826,0,29,neuromuscular synaptic transmission,BP,
3755,GO:0007284,1,0.97931995338201,0,1,spermatogonial cell division,BP,
3757,GO:0007288,1,0.84344382723269,0,8,sperm axoneme assembly,BP,
3758,GO:0007289,1,0.702776110360956,0,17,spermatid nucleus differentiation,BP,
3759,GO:0007290,1,0.917774179650256,0,4,spermatid nucleus elongation,BP,
3760,GO:0007291,1,0.978492123346419,0,1,sperm individualization,BP,
3762,GO:0007296,1,0.92467114353896,0,4,vitellogenesis,BP,
3763,GO:0007308,1,0.958487301088312,0,2,oocyte construction,BP,
3764,GO:0007309,1,0.958487301088312,0,2,oocyte axis specification,BP,
3765,GO:0007314,1,0.958487301088312,0,2,oocyte anterior/posterior axis specification,BP,
3766,GO:0007315,1,0.958487301088312,0,2,pole plasm assembly,BP,
3767,GO:0007320,1,0.757729232161565,0,13,insemination,BP,
3768,GO:0007321,1,0.97848305880818,0,1,sperm displacement,BP,
3770,GO:0007339,1,0.484373410444149,0,34,binding of sperm to zona pellucida,BP,
3771,GO:0007340,1,0.477202277916075,0,35,acrosome reaction,BP,
3774,GO:0007343,1,0.900222992120143,0,5,egg activation,BP,
3775,GO:0007344,1,0.978659005690316,0,1,pronuclear fusion,BP,
3777,GO:0007349,1,0.978492123346419,0,1,cellularization,BP,
3780,GO:0007352,1,0.942180253691999,0,3,zygotic specification of dorsal/ventral axis,BP,
3785,GO:0007371,1,0.979077239482383,0,1,ventral midline determination,BP,
3788,GO:0007387,1,0.979016510368233,0,1,anterior compartment pattern formation,BP,
3789,GO:0007388,1,0.979016510368233,0,1,posterior compartment specification,BP,
3793,GO:0007400,1,0.978946517601127,0,1,neuroblast fate determination,BP,
3794,GO:0007402,1,0.957818614857246,0,2,ganglion mother cell fate determination,BP,
3795,GO:0007403,1,0.979069351318695,0,1,glial cell fate determination,BP,
3797,GO:0007406,1,0.904702071356621,0,5,negative regulation of neuroblast proliferation,BP,
3800,GO:0007412,1,0.937521064802783,0,3,axon target recognition,BP,
3801,GO:0007413,1,0.656218797903941,0,21,axonal fasciculation,BP,
3804,GO:0007418,1,0.920146799628075,0,4,ventral midline development,BP,
3808,GO:0007424,1,0.978974306474141,0,1,open tracheal system development,BP,
3811,GO:0007439,1,0.958470007852081,0,2,ectodermal digestive tract development,BP,
3814,GO:0007468,1,0.937847222602596,0,3,regulation of rhodopsin gene expression,BP,
3816,GO:0007493,1,0.958409432743231,0,2,endodermal cell fate determination,BP,
3818,GO:0007495,1,0.979067958179433,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3819,GO:0007497,1,0.959121168055594,0,2,posterior midgut development,BP,
3821,GO:0007499,1,0.97935160886836,0,1,ectoderm and mesoderm interaction,BP,
3823,GO:0007501,1,0.742420494758399,0,14,mesodermal cell fate specification,BP,
3824,GO:0007506,1,0.860200031789734,0,7,gonadal mesoderm development,BP,
3826,GO:0007509,1,0.960100756129069,0,2,mesoderm migration involved in gastrulation,BP,
3827,GO:0007512,1,0.782368292752038,0,12,adult heart development,BP,
3829,GO:0007518,1,0.958036456741814,0,2,myoblast fate determination,BP,
3831,GO:0007520,1,0.452605237300171,0,38,myoblast fusion,BP,
3832,GO:0007521,1,0.960014111398342,0,2,muscle cell fate determination,BP,
3833,GO:0007522,1,0.980290814964822,0,1,visceral muscle development,BP,
3834,GO:0007525,1,0.971317406590045,0,2,somatic muscle development,BP,
3835,GO:0007528,1,0.436362144398035,0,41,neuromuscular junction development,BP,
3836,GO:0007529,1,0.979082291523524,0,1,establishment of synaptic specificity at neuromuscular junction,BP,
3838,GO:0007538,1,0.939303722672144,0,3,primary sex determination,BP,
3839,GO:0007542,1,0.959390608103266,0,2,primary sex determination, germ-line,BP,
3841,GO:0007549,1,0.834463749477337,0,9,dosage compensation,BP,
3847,GO:0007571,1,0.960087405950105,0,2,age-dependent general metabolic decline,BP,
3848,GO:0007576,1,0.978970516840979,0,1,nucleolar fragmentation,BP,
3856,GO:0007597,1,0.668749383984045,0,19,blood coagulation, intrinsic pathway,BP,
3870,GO:0007614,1,0.827159531580394,0,9,short-term memory,BP,
3871,GO:0007616,1,0.544192950331657,0,30,long-term memory,BP,
3875,GO:0007620,1,0.653342067613011,0,20,copulation,BP,
3876,GO:0007621,1,0.920158316777504,0,4,negative regulation of female receptivity,BP,
3879,GO:0007624,1,0.979145143860974,0,1,ultradian rhythm,BP,
3880,GO:0007625,1,0.682932447473318,0,18,grooming behavior,BP,
3884,GO:0007632,1,0.35767641091493,0,50,visual behavior,BP,
3885,GO:0007634,1,0.978934860638939,0,1,optokinetic behavior,BP,
3886,GO:0007635,1,0.704132494306157,0,17,chemosensory behavior,BP,
3893,GO:0008020,1,0.918158169087784,0,4,G-protein coupled photoreceptor activity,MF,
3896,GO:0008023,1,0.391919564361237,0,45,transcription elongation factor complex,CC,
3897,GO:0008024,1,0.848429268305932,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3898,GO:0008026,1,0.125557258941403,0,99,ATP-dependent helicase activity,MF,
3899,GO:0008028,1,0.456518946776443,0,37,monocarboxylic acid transmembrane transporter activity,MF,
3901,GO:0008035,1,0.824598012651184,0,9,high-density lipoprotein particle binding,MF,
3903,GO:0008038,1,0.503943042419846,0,34,neuron recognition,BP,
3904,GO:0008039,1,0.978587710071679,0,1,synaptic target recognition,BP,
3905,GO:0008043,1,0.957467957691734,0,2,intracellular ferritin complex,CC,
3907,GO:0008046,1,0.867390074115553,0,7,axon guidance receptor activity,MF,
3909,GO:0008048,1,0.897525285122115,0,5,calcium sensitive guanylate cyclase activator activity,MF,
3911,GO:0008050,1,0.960729066499782,0,2,female courtship behavior,BP,
3912,GO:0008052,1,0.978493634270525,0,1,sensory organ boundary specification,BP,
3913,GO:0008053,1,0.667665188361206,0,19,mitochondrial fusion,BP,
3914,GO:0008057,1,0.981396984542995,0,1,eye pigment granule organization,BP,
3915,GO:0008061,1,0.842781282908695,0,8,chitin binding,MF,
3916,GO:0008063,1,0.881371168314678,0,6,Toll signaling pathway,BP,
3920,GO:0008068,1,0.979058019567663,0,1,extracellular-glutamate-gated chloride channel activity,MF,
3921,GO:0008073,1,0.93708212687037,0,3,ornithine decarboxylase inhibitor activity,MF,
3925,GO:0008079,1,0.882061803709443,0,6,translation termination factor activity,MF,
3926,GO:0008080,1,0.176039496352966,0,83,N-acetyltransferase activity,MF,
3929,GO:0008088,1,0.395224377367945,0,45,axo-dendritic transport,BP,
3930,GO:0008089,1,0.533677188595393,0,30,anterograde axonal transport,BP,
3931,GO:0008090,1,0.833796181851835,0,9,retrograde axonal transport,BP,
3934,GO:0008093,1,0.796108173060056,0,11,cytoskeletal adaptor activity,MF,
3935,GO:0008094,1,0.215725039131442,0,74,DNA-dependent ATPase activity,MF,
3936,GO:0008097,1,0.878230361408672,0,6,5S rRNA binding,MF,
3939,GO:0008106,1,0.708180843582667,0,16,alcohol dehydrogenase (NADP+) activity,MF,
3940,GO:0008107,1,0.958675477768454,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3942,GO:0008109,1,0.938510727850436,0,3,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3943,GO:0008111,1,0.978747346101117,0,1,alpha-methylacyl-CoA racemase activity,MF,
3946,GO:0008115,1,0.978925417777675,0,1,sarcosine oxidase activity,MF,
3947,GO:0008116,1,0.980008063103152,0,1,prostaglandin-I synthase activity,MF,
3948,GO:0008117,1,0.980139137883569,0,1,sphinganine-1-phosphate aldolase activity,MF,
3949,GO:0008118,1,0.978850937793233,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3950,GO:0008119,1,0.979068915208737,0,1,thiopurine S-methyltransferase activity,MF,
3951,GO:0008120,1,0.978620572088332,0,1,ceramide glucosyltransferase activity,MF,
3952,GO:0008121,1,0.841192282869693,0,8,ubiquinol-cytochrome-c reductase activity,MF,
3953,GO:0008123,1,0.979046388604153,0,1,cholesterol 7-alpha-monooxygenase activity,MF,
3955,GO:0008126,1,0.979041789436899,0,1,acetylesterase activity,MF,
3956,GO:0008127,1,0.978537434295704,0,1,quercetin 2,3-dioxygenase activity,MF,
3957,GO:0008131,1,0.899564782976222,0,5,primary amine oxidase activity,MF,
3960,GO:0008137,1,0.438536606514466,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3962,GO:0008139,1,0.584257731941178,0,26,nuclear localization sequence binding,MF,
3963,GO:0008140,1,0.845504400641895,0,8,cAMP response element binding protein binding,MF,
3964,GO:0008142,1,0.904149329530891,0,5,oxysterol binding,MF,
3965,GO:0008143,1,0.778536019299188,0,12,poly(A) binding,MF,
3967,GO:0008146,1,0.334477923167994,0,52,sulfotransferase activity,MF,
3968,GO:0008147,1,0.957400734251505,0,2,structural constituent of bone,MF,
3972,GO:0008156,1,0.493301061020602,0,34,negative regulation of DNA replication,BP,
3973,GO:0008157,1,0.688820516733428,0,18,protein phosphatase 1 binding,MF,
3974,GO:0008158,1,0.940501042823028,0,3,hedgehog receptor activity,MF,
3975,GO:0008160,1,0.978991683240079,0,1,protein tyrosine phosphatase activator activity,MF,
3977,GO:0008169,1,0.938117595117915,0,3,C-methyltransferase activity,MF,
3979,GO:0008171,1,0.72620606477233,0,15,O-methyltransferase activity,MF,
3980,GO:0008172,1,0.864948337319521,0,7,S-methyltransferase activity,MF,
3981,GO:0008173,1,0.384581059074244,0,45,RNA methyltransferase activity,MF,
3982,GO:0008174,1,0.939282837106409,0,3,mRNA methyltransferase activity,MF,
3983,GO:0008175,1,0.588869350943962,0,25,tRNA methyltransferase activity,MF,
3984,GO:0008176,1,0.95766767954939,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3985,GO:0008177,1,0.93733394451385,0,3,succinate dehydrogenase (ubiquinone) activity,MF,
3986,GO:0008179,1,0.783125874478515,0,12,adenylate cyclase binding,MF,
3988,GO:0008184,1,0.938550537331462,0,3,glycogen phosphorylase activity,MF,
3989,GO:0008186,1,0.238340636158166,0,68,RNA-dependent ATPase activity,MF,
3990,GO:0008187,1,0.642793105865968,0,21,poly-pyrimidine tract binding,MF,
3991,GO:0008188,1,0.390366168466977,0,44,neuropeptide receptor activity,MF,
3992,GO:0008190,1,0.829780356771933,0,9,eukaryotic initiation factor 4E binding,MF,
3993,GO:0008191,1,0.728344298710556,0,15,metalloendopeptidase inhibitor activity,MF,
3994,GO:0008192,1,0.938256587879643,0,3,RNA guanylyltransferase activity,MF,
3995,GO:0008193,1,0.958121395039795,0,2,tRNA guanylyltransferase activity,MF,
3997,GO:0008195,1,0.94075738949047,0,3,phosphatidate phosphatase activity,MF,
4004,GO:0008204,1,0.957845747348868,0,2,ergosterol metabolic process,BP,
4012,GO:0008214,1,0.567783357716607,0,28,protein dealkylation,BP,
4013,GO:0008215,1,0.86012507255502,0,7,spermine metabolic process,BP,
4014,GO:0008216,1,0.841593007099282,0,8,spermidine metabolic process,BP,
4016,GO:0008218,1,0.938110736720323,0,3,bioluminescence,BP,
4019,GO:0008228,1,0.776523923623375,0,12,opsonization,BP,
4026,GO:0008239,1,0.825163075156464,0,9,dipeptidyl-peptidase activity,MF,
4027,GO:0008240,1,0.938830659663021,0,3,tripeptidyl-peptidase activity,MF,
4028,GO:0008241,1,0.958120193286528,0,2,peptidyl-dipeptidase activity,MF,
4029,GO:0008242,1,0.775955267559917,0,12,omega peptidase activity,MF,
4030,GO:0008250,1,0.772924419949873,0,12,oligosaccharyltransferase complex,CC,
4031,GO:0008251,1,0.959931816368363,0,2,tRNA-specific adenosine deaminase activity,MF,
4032,GO:0008252,1,0.761682445863209,0,13,nucleotidase activity,MF,
4033,GO:0008253,1,0.792971009168467,0,11,5'-nucleotidase activity,MF,
4034,GO:0008254,1,0.981230200878353,0,1,3'-nucleotidase activity,MF,
4035,GO:0008260,1,0.958201327969378,0,2,3-oxoacid CoA-transferase activity,MF,
4036,GO:0008263,1,0.958454570606059,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
4037,GO:0008265,1,0.979022036188469,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
4038,GO:0008266,1,0.684969082631055,0,18,poly(U) RNA binding,MF,
4039,GO:0008267,1,0.981816945571376,0,1,poly-glutamine tract binding,MF,
4040,GO:0008269,1,0.958008482162725,0,2,JAK pathway signal transduction adaptor activity,MF,
4042,GO:0008271,1,0.761991344889425,0,13,secondary active sulfate transmembrane transporter activity,MF,
4043,GO:0008272,1,0.730137513019918,0,15,sulfate transport,BP,
4044,GO:0008273,1,0.900175241833575,0,5,calcium, potassium:sodium antiporter activity,MF,
4045,GO:0008274,1,0.865061341025235,0,7,gamma-tubulin ring complex,CC,
4046,GO:0008275,1,0.939132147405327,0,3,gamma-tubulin small complex,CC,
4047,GO:0008276,1,0.247977549891392,0,67,protein methyltransferase activity,MF,
4049,GO:0008278,1,0.829343505072956,0,9,cohesin complex,CC,
4050,GO:0008281,1,0.959383656570333,0,2,sulfonylurea receptor activity,MF,
4051,GO:0008282,1,0.919484504454073,0,4,ATP-sensitive potassium channel complex,CC,
4056,GO:0008287,1,0.387644707124708,0,45,protein serine/threonine phosphatase complex,CC,
4058,GO:0008290,1,0.842891320906339,0,8,F-actin capping protein complex,CC,
4059,GO:0008291,1,0.919268737594455,0,4,acetylcholine metabolic process,BP,
4060,GO:0008292,1,0.959094253404072,0,2,acetylcholine biosynthetic process,BP,
4061,GO:0008294,1,0.964332515168445,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4062,GO:0008295,1,0.917742783398535,0,4,spermidine biosynthetic process,BP,
4063,GO:0008296,1,0.809343452305201,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4064,GO:0008297,1,0.863890920262287,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4065,GO:0008298,1,0.773996022712899,0,12,intracellular mRNA localization,BP,
4067,GO:0008300,1,0.842426272210907,0,8,isoprenoid catabolic process,BP,
4068,GO:0008301,1,0.67010861291069,0,19,DNA binding, bending,MF,
4070,GO:0008306,1,0.224519701488474,0,72,associative learning,BP,
4072,GO:0008308,1,0.685148060695469,0,18,voltage-gated anion channel activity,MF,
4073,GO:0008309,1,0.91790356064919,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4074,GO:0008310,1,0.901322290071025,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4075,GO:0008311,1,0.957782460197769,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4076,GO:0008312,1,0.860464234607526,0,7,7S RNA binding,MF,
4077,GO:0008318,1,0.864946982372583,0,7,protein prenyltransferase activity,MF,
4078,GO:0008320,1,0.693506390026986,0,17,protein transmembrane transporter activity,MF,
4079,GO:0008321,1,0.940427450624872,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4081,GO:0008327,1,0.642260661531464,0,21,methyl-CpG binding,MF,
4083,GO:0008329,1,0.697290193644652,0,17,signaling pattern recognition receptor activity,MF,
4084,GO:0008330,1,0.937788410243839,0,3,protein tyrosine/threonine phosphatase activity,MF,
4085,GO:0008331,1,0.796002077316738,0,12,high voltage-gated calcium channel activity,MF,
4086,GO:0008332,1,0.947507408896241,0,3,low voltage-gated calcium channel activity,MF,
4088,GO:0008334,1,0.609462623749743,0,24,histone mRNA metabolic process,BP,
4089,GO:0008336,1,0.978713223128666,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4090,GO:0008340,1,0.786967853834102,0,12,determination of adult lifespan,BP,
4091,GO:0008343,1,0.80818168795788,0,10,adult feeding behavior,BP,
4094,GO:0008348,1,0.979073235249225,0,1,negative regulation of antimicrobial humoral response,BP,
4095,GO:0008349,1,0.919039077197287,0,4,MAP kinase kinase kinase kinase activity,MF,
4096,GO:0008352,1,0.979004006340802,0,1,katanin complex,CC,
4097,GO:0008353,1,0.713274965393236,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4098,GO:0008354,1,0.863739324623123,0,7,germ cell migration,BP,
4099,GO:0008355,1,0.958859704121695,0,2,olfactory learning,BP,
4100,GO:0008356,1,0.701050973617861,0,17,asymmetric cell division,BP,
4101,GO:0008358,1,0.958487301088312,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4105,GO:0008373,1,0.647497490865833,0,21,sialyltransferase activity,MF,
4108,GO:0008376,1,0.487381263714857,0,34,acetylgalactosaminyltransferase activity,MF,
4110,GO:0008379,1,0.897072726132426,0,5,thioredoxin peroxidase activity,MF,
4112,GO:0008381,1,0.843845138964552,0,8,mechanically-gated ion channel activity,MF,
4113,GO:0008384,1,0.938537485980537,0,3,IkappaB kinase activity,MF,
4116,GO:0008387,1,0.978873003281332,0,1,steroid 7-alpha-hydroxylase activity,MF,
4117,GO:0008389,1,0.957780369038832,0,2,coumarin 7-hydroxylase activity,MF,
4118,GO:0008391,1,0.709509545125769,0,16,arachidonic acid monooxygenase activity,MF,
4119,GO:0008392,1,0.709509545125769,0,16,arachidonic acid epoxygenase activity,MF,
4121,GO:0008396,1,0.958235590670336,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4122,GO:0008397,1,0.979099809606227,0,1,sterol 12-alpha-hydroxylase activity,MF,
4123,GO:0008398,1,0.979064189724897,0,1,sterol 14-demethylase activity,MF,
4124,GO:0008401,1,0.918344257450781,0,4,retinoic acid 4-hydroxylase activity,MF,
4125,GO:0008403,1,0.979067705667554,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4126,GO:0008404,1,0.978701418544787,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4127,GO:0008405,1,0.978701418544787,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4129,GO:0008408,1,0.367007006847873,0,48,3'-5' exonuclease activity,MF,
4130,GO:0008409,1,0.778517414254454,0,12,5'-3' exonuclease activity,MF,
4131,GO:0008410,1,0.937777702200843,0,3,CoA-transferase activity,MF,
4132,GO:0008413,1,0.957695261884059,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4133,GO:0008417,1,0.764465608002309,0,13,fucosyltransferase activity,MF,
4134,GO:0008418,1,0.978507751231891,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4135,GO:0008419,1,0.979001627641986,0,1,RNA lariat debranching enzyme activity,MF,
4136,GO:0008420,1,0.880087176609644,0,6,CTD phosphatase activity,MF,
4137,GO:0008422,1,0.900797910477727,0,5,beta-glucosidase activity,MF,
4138,GO:0008424,1,0.979069191768179,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4139,GO:0008425,1,0.978531371205572,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4140,GO:0008426,1,0.937449319897392,0,3,protein kinase C inhibitor activity,MF,
4141,GO:0008427,1,0.937295268911599,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4142,GO:0008428,1,0.938255705880178,0,3,ribonuclease inhibitor activity,MF,
4144,GO:0008430,1,0.900116909555508,0,5,selenium binding,MF,
4145,GO:0008431,1,0.938137178861004,0,3,vitamin E binding,MF,
4146,GO:0008432,1,0.865981556745411,0,7,JUN kinase binding,MF,
4148,GO:0008437,1,0.978759897339402,0,1,thyrotropin-releasing hormone activity,MF,
4149,GO:0008440,1,0.808886939969168,0,10,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4150,GO:0008441,1,0.960567060618862,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4151,GO:0008442,1,0.978749191773758,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4153,GO:0008444,1,0.978838416629976,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4154,GO:0008445,1,0.978616217014486,0,1,D-aspartate oxidase activity,MF,
4155,GO:0008446,1,0.978634797865979,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4156,GO:0008448,1,0.978691928578039,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4157,GO:0008449,1,0.940111996487006,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4158,GO:0008453,1,0.957923977169014,0,2,alanine-glyoxylate transaminase activity,MF,
4159,GO:0008454,1,0.939358076070896,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4160,GO:0008455,1,0.979015220146453,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4161,GO:0008456,1,0.979076408025917,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4162,GO:0008457,1,0.979137597711037,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4163,GO:0008458,1,0.979068933807006,0,1,carnitine O-octanoyltransferase activity,MF,
4164,GO:0008459,1,0.960324987128705,0,2,chondroitin 6-sulfotransferase activity,MF,
4165,GO:0008460,1,0.978720393132309,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4166,GO:0008465,1,0.978526668160986,0,1,glycerate dehydrogenase activity,MF,
4167,GO:0008466,1,0.958195443543699,0,2,glycogenin glucosyltransferase activity,MF,
4168,GO:0008467,1,0.860867510067553,0,7,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4169,GO:0008469,1,0.861226807614436,0,7,histone-arginine N-methyltransferase activity,MF,
4170,GO:0008470,1,0.979345207147595,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4172,GO:0008475,1,0.938538365910562,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4173,GO:0008476,1,0.957965528870048,0,2,protein-tyrosine sulfotransferase activity,MF,
4174,GO:0008478,1,0.981349852562428,0,1,pyridoxal kinase activity,MF,
4175,GO:0008479,1,0.878314602912158,0,6,queuine tRNA-ribosyltransferase activity,MF,
4177,GO:0008481,1,0.95820464349785,0,2,sphinganine kinase activity,MF,
4178,GO:0008482,1,0.978894734322725,0,1,sulfite oxidase activity,MF,
4179,GO:0008483,1,0.70004320579678,0,17,transaminase activity,MF,
4180,GO:0008484,1,0.700075507465303,0,17,sulfuric ester hydrolase activity,MF,
4181,GO:0008486,1,0.918287180998757,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4182,GO:0008488,1,0.979067646984851,0,1,gamma-glutamyl carboxylase activity,MF,
4183,GO:0008489,1,0.979049906197958,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4184,GO:0008493,1,0.97870278571451,0,1,tetracycline transporter activity,MF,
4185,GO:0008494,1,0.863370990809926,0,7,translation activator activity,MF,
4186,GO:0008495,1,0.979059470450586,0,1,protoheme IX farnesyltransferase activity,MF,
4187,GO:0008496,1,0.979180295039753,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4189,GO:0008502,1,0.937256172346178,0,3,melatonin receptor activity,MF,
4190,GO:0008503,1,0.884497528427641,0,6,benzodiazepine receptor activity,MF,
4191,GO:0008504,1,0.826901102510975,0,9,monoamine transmembrane transporter activity,MF,
4193,GO:0008507,1,0.979070730532562,0,1,sodium:iodide symporter activity,MF,
4194,GO:0008508,1,0.878925981650765,0,6,bile acid:sodium symporter activity,MF,
4196,GO:0008510,1,0.924028962554165,0,4,sodium:bicarbonate symporter activity,MF,
4197,GO:0008511,1,0.96076780159771,0,2,sodium:potassium:chloride symporter activity,MF,
4198,GO:0008513,1,0.93782912191198,0,3,secondary active organic cation transmembrane transporter activity,MF,
4201,GO:0008517,1,0.881191391367242,0,6,folic acid transporter activity,MF,
4202,GO:0008518,1,0.979041174690571,0,1,reduced folate carrier activity,MF,
4203,GO:0008519,1,0.564296919387689,0,27,ammonium transmembrane transporter activity,MF,
4204,GO:0008520,1,0.960341204069287,0,2,L-ascorbate:sodium symporter activity,MF,
4205,GO:0008521,1,0.979003744219237,0,1,acetyl-CoA transporter activity,MF,
4206,GO:0008523,1,0.960502945374328,0,2,sodium-dependent multivitamin transmembrane transporter activity,MF,
4207,GO:0008525,1,0.886712798068581,0,6,phosphatidylcholine transporter activity,MF,
4208,GO:0008526,1,0.865436266642004,0,7,phosphatidylinositol transporter activity,MF,
4209,GO:0008527,1,0.582716929680911,0,25,taste receptor activity,MF,
4211,GO:0008531,1,0.979015220146453,0,1,riboflavin kinase activity,MF,
4213,GO:0008534,1,0.957681092072913,0,2,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4214,GO:0008535,1,0.653613608773114,0,20,respiratory chain complex IV assembly,BP,
4215,GO:0008536,1,0.52159972720838,0,32,Ran GTPase binding,MF,
4216,GO:0008537,1,0.937402292079425,0,3,proteasome activator complex,CC,
4217,GO:0008540,1,0.805932193702116,0,10,proteasome regulatory particle, base subcomplex,CC,
4218,GO:0008541,1,0.859780015109214,0,7,proteasome regulatory particle, lid subcomplex,CC,
4219,GO:0008542,1,0.395578119289802,0,45,visual learning,BP,
4222,GO:0008545,1,0.9790776442638,0,1,JUN kinase kinase activity,MF,
4223,GO:0008553,1,0.86118641066754,0,7,hydrogen-exporting ATPase activity, phosphorylative mechanism,MF,
4224,GO:0008554,1,0.979442107184009,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4225,GO:0008555,1,0.97983544917516,0,1,chloride-transporting ATPase activity,MF,
4226,GO:0008556,1,0.79143769105797,0,11,potassium-transporting ATPase activity,MF,
4227,GO:0008559,1,0.86522264699836,0,7,xenobiotic-transporting ATPase activity,MF,
4229,GO:0008568,1,0.846767843384618,0,8,microtubule-severing ATPase activity,MF,
4230,GO:0008569,1,0.931197109524523,0,4,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4231,GO:0008574,1,0.721455165616499,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4232,GO:0008579,1,0.979767937590631,0,1,JUN kinase phosphatase activity,MF,
4233,GO:0008582,1,0.902822754451711,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4236,GO:0008588,1,0.917956353278563,0,4,release of cytoplasmic sequestered NF-kappaB,BP,
4238,GO:0008592,1,0.979068802678644,0,1,regulation of Toll signaling pathway,BP,
4240,GO:0008594,1,0.979113548425636,0,1,photoreceptor cell morphogenesis,BP,
4242,GO:0008597,1,0.937957345297401,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4244,GO:0008607,1,0.919688467209099,0,4,phosphorylase kinase regulator activity,MF,
4245,GO:0008608,1,0.57978452858581,0,26,attachment of spindle microtubules to kinetochore,BP,
4246,GO:0008609,1,0.981565721895249,0,1,alkylglycerone-phosphate synthase activity,MF,
4248,GO:0008611,1,0.921343474610595,0,4,ether lipid biosynthetic process,BP,
4249,GO:0008612,1,0.91834326611659,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4250,GO:0008613,1,0.978472479553316,0,1,diuretic hormone activity,MF,
4251,GO:0008614,1,0.958319740397058,0,2,pyridoxine metabolic process,BP,
4252,GO:0008615,1,0.958319740397058,0,2,pyridoxine biosynthetic process,BP,
4253,GO:0008616,1,0.878314602912158,0,6,queuosine biosynthetic process,BP,
4254,GO:0008617,1,0.978495412165919,0,1,guanosine metabolic process,BP,
4255,GO:0008622,1,0.900825090722817,0,5,epsilon DNA polymerase complex,CC,
4256,GO:0008623,1,0.959644134959079,0,2,CHRAC,CC,
4258,GO:0008626,1,0.918783729132276,0,4,granzyme-mediated apoptotic signaling pathway,BP,
4259,GO:0008627,1,0.864575991968654,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4260,GO:0008628,1,0.91699766051048,0,4,hormone-mediated apoptotic signaling pathway,BP,
4263,GO:0008635,1,0.827624490328499,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4265,GO:0008641,1,0.810217131717188,0,10,small protein activating enzyme activity,MF,
4268,GO:0008649,1,0.757682702715532,0,13,rRNA methyltransferase activity,MF,
4270,GO:0008653,1,0.979099001044529,0,1,lipopolysaccharide metabolic process,BP,
4272,GO:0008655,1,0.790063382502203,0,11,pyrimidine-containing compound salvage,BP,
4274,GO:0008665,1,0.97849493469943,0,1,2'-phosphotransferase activity,MF,
4276,GO:0008689,1,0.978531371205572,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4277,GO:0008700,1,0.97897493185122,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4278,GO:0008705,1,0.983611382191265,0,1,methionine synthase activity,MF,
4280,GO:0008721,1,0.978948595150004,0,1,D-serine ammonia-lyase activity,MF,
4281,GO:0008725,1,0.978504121567352,0,1,DNA-3-methyladenine glycosylase activity,MF,
4282,GO:0008732,1,0.958242974601567,0,2,L-allo-threonine aldolase activity,MF,
4283,GO:0008745,1,0.917108070676324,0,4,N-acetylmuramoyl-L-alanine amidase activity,MF,
4284,GO:0008746,1,0.958318522259334,0,2,NAD(P)+ transhydrogenase activity,MF,
4285,GO:0008747,1,0.978598469313653,0,1,N-acetylneuraminate lyase activity,MF,
4286,GO:0008750,1,0.979372546615969,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4287,GO:0008753,1,0.979069394242042,0,1,NADPH dehydrogenase (quinone) activity,MF,
4289,GO:0008761,1,0.979779580335566,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4290,GO:0008768,1,0.978482236559889,0,1,UDP-sugar diphosphatase activity,MF,
4291,GO:0008775,1,0.978687906705008,0,1,acetate CoA-transferase activity,MF,
4292,GO:0008781,1,0.957641481116653,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4293,GO:0008783,1,0.978840064421984,0,1,agmatinase activity,MF,
4294,GO:0008785,1,0.978600178213438,0,1,alkyl hydroperoxide reductase activity,MF,
4295,GO:0008794,1,0.978485843550268,0,1,arsenate reductase (glutaredoxin) activity,MF,
4296,GO:0008796,1,0.957969774302333,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4297,GO:0008798,1,0.959435953979548,0,2,beta-aspartyl-peptidase activity,MF,
4298,GO:0008802,1,0.979070337096472,0,1,betaine-aldehyde dehydrogenase activity,MF,
4299,GO:0008803,1,0.978493023456071,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4300,GO:0008808,1,0.979081880848646,0,1,cardiolipin synthase activity,MF,
4301,GO:0008811,1,0.978480186120038,0,1,chloramphenicol O-acetyltransferase activity,MF,
4302,GO:0008812,1,0.979072393370562,0,1,choline dehydrogenase activity,MF,
4303,GO:0008817,1,0.97914342918865,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4304,GO:0008821,1,0.826344841019674,0,9,crossover junction endodeoxyribonuclease activity,MF,
4305,GO:0008823,1,0.940412605047703,0,3,cupric reductase activity,MF,
4306,GO:0008829,1,0.978686382069844,0,1,dCTP deaminase activity,MF,
4307,GO:0008832,1,0.9790682465105,0,1,dGTPase activity,MF,
4308,GO:0008843,1,0.978886510855663,0,1,endochitinase activity,MF,
4309,GO:0008852,1,0.979040235530268,0,1,exodeoxyribonuclease I activity,MF,
4310,GO:0008853,1,0.917943954200766,0,4,exodeoxyribonuclease III activity,MF,
4311,GO:0008859,1,0.97848981612342,0,1,exoribonuclease II activity,MF,
4312,GO:0008865,1,0.920819025148408,0,4,fructokinase activity,MF,
4313,GO:0008887,1,0.979068791560326,0,1,glycerate kinase activity,MF,
4314,GO:0008889,1,0.881274389018487,0,6,glycerophosphodiester phosphodiesterase activity,MF,
4315,GO:0008890,1,0.978605685514806,0,1,glycine C-acetyltransferase activity,MF,
4316,GO:0008891,1,0.978659723137941,0,1,glycolate oxidase activity,MF,
4317,GO:0008892,1,0.979880888857312,0,1,guanine deaminase activity,MF,
4318,GO:0008893,1,0.978498837827059,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4319,GO:0008894,1,0.979022253918837,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4320,GO:0008897,1,0.97904458756289,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4321,GO:0008898,1,0.983611382191265,0,1,S-adenosylmethionine-homocysteine S-methyltransferase activity,MF,
4322,GO:0008900,1,0.938041870588687,0,3,hydrogen:potassium-exchanging ATPase activity,MF,
4323,GO:0008903,1,0.978507087467741,0,1,hydroxypyruvate isomerase activity,MF,
4324,GO:0008905,1,0.978611943742488,0,1,mannose-phosphate guanylyltransferase activity,MF,
4325,GO:0008934,1,0.920431495574056,0,4,inositol monophosphate 1-phosphatase activity,MF,
4326,GO:0008940,1,0.93843911244104,0,3,nitrate reductase activity,MF,
4327,GO:0008941,1,0.958141991337,0,2,nitric oxide dioxygenase activity,MF,
4328,GO:0008948,1,0.918478951398371,0,4,oxaloacetate decarboxylase activity,MF,
4329,GO:0008955,1,0.979101470546785,0,1,peptidoglycan glycosyltransferase activity,MF,
4330,GO:0008962,1,0.978983045163613,0,1,phosphatidylglycerophosphatase activity,MF,
4331,GO:0008963,1,0.978818125495465,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4332,GO:0008967,1,0.958276394423003,0,2,phosphoglycolate phosphatase activity,MF,
4333,GO:0008969,1,0.937532574693535,0,3,phosphohistidine phosphatase activity,MF,
4335,GO:0008973,1,0.97906888625805,0,1,phosphopentomutase activity,MF,
4336,GO:0008988,1,0.95839073820654,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4337,GO:0008995,1,0.978984390211124,0,1,ribonuclease E activity,MF,
4338,GO:0009000,1,0.978943727030247,0,1,selenocysteine lyase activity,MF,
4339,GO:0009007,1,0.979073664205968,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4340,GO:0009008,1,0.900002443545055,0,5,DNA-methyltransferase activity,MF,
4341,GO:0009013,1,0.979675135376631,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4342,GO:0009019,1,0.919248354041805,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4343,GO:0009020,1,0.978741007376028,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4344,GO:0009032,1,0.978629530647796,0,1,thymidine phosphorylase activity,MF,
4345,GO:0009041,1,0.9379393328639,0,3,uridylate kinase activity,MF,
4346,GO:0009048,1,0.871054028901616,0,7,dosage compensation by inactivation of X chromosome,BP,
4347,GO:0009051,1,0.937476429748613,0,3,pentose-phosphate shunt, oxidative branch,BP,
4355,GO:0009061,1,0.978918756739653,0,1,anaerobic respiration,BP,
4359,GO:0009065,1,0.589999304038698,0,25,glutamine family amino acid catabolic process,BP,
4362,GO:0009068,1,0.696444555146554,0,17,aspartate family amino acid catabolic process,BP,
4364,GO:0009070,1,0.710327148095888,0,16,serine family amino acid biosynthetic process,BP,
4368,GO:0009078,1,0.898291157589865,0,5,pyruvate family amino acid metabolic process,BP,
4369,GO:0009080,1,0.898291157589865,0,5,pyruvate family amino acid catabolic process,BP,
4371,GO:0009082,1,0.960994661689076,0,2,branched-chain amino acid biosynthetic process,BP,
4374,GO:0009085,1,0.97904458756289,0,1,lysine biosynthetic process,BP,
4376,GO:0009087,1,0.9790693410655,0,1,methionine catabolic process,BP,
4377,GO:0009092,1,0.917937212253698,0,4,homoserine metabolic process,BP,
4378,GO:0009093,1,0.937556108650943,0,3,cysteine catabolic process,BP,
4379,GO:0009098,1,0.960994661689076,0,2,leucine biosynthetic process,BP,
4380,GO:0009099,1,0.960994661689076,0,2,valine biosynthetic process,BP,
4383,GO:0009103,1,0.979099001044529,0,1,lipopolysaccharide biosynthetic process,BP,
4384,GO:0009106,1,0.937538758060482,0,3,lipoate metabolic process,BP,
4385,GO:0009107,1,0.957582562630119,0,2,lipoate biosynthetic process,BP,
4389,GO:0009111,1,0.790527621405754,0,11,vitamin catabolic process,BP,
4391,GO:0009113,1,0.790679714835544,0,11,purine nucleobase biosynthetic process,BP,
4398,GO:0009124,1,0.162118842486369,0,85,nucleoside monophosphate biosynthetic process,BP,
4399,GO:0009125,1,0.790313925276784,0,11,nucleoside monophosphate catabolic process,BP,
4401,GO:0009127,1,0.248580832703586,0,65,purine nucleoside monophosphate biosynthetic process,BP,
4402,GO:0009128,1,0.824955218763609,0,9,purine nucleoside monophosphate catabolic process,BP,
4403,GO:0009129,1,0.742463182481868,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4404,GO:0009130,1,0.758706830651947,0,13,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4405,GO:0009131,1,0.978606273753634,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4407,GO:0009133,1,0.879371062506306,0,6,nucleoside diphosphate biosynthetic process,BP,
4408,GO:0009134,1,0.861837343530297,0,7,nucleoside diphosphate catabolic process,BP,
4410,GO:0009136,1,0.937773167616588,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4411,GO:0009137,1,0.918879805461351,0,4,purine nucleoside diphosphate catabolic process,BP,
4412,GO:0009138,1,0.937948466900679,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4413,GO:0009139,1,0.9580181451805,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4414,GO:0009140,1,0.979053258701536,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4416,GO:0009142,1,0.223045436963427,0,70,nucleoside triphosphate biosynthetic process,BP,
4417,GO:0009143,1,0.793020380318214,0,11,nucleoside triphosphate catabolic process,BP,
4419,GO:0009145,1,0.313640320708191,0,54,purine nucleoside triphosphate biosynthetic process,BP,
4420,GO:0009146,1,0.880178858580996,0,6,purine nucleoside triphosphate catabolic process,BP,
4421,GO:0009147,1,0.624041846401335,0,22,pyrimidine nucleoside triphosphate metabolic process,BP,
4422,GO:0009148,1,0.665652135043219,0,19,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4423,GO:0009149,1,0.978508018657599,0,1,pyrimidine nucleoside triphosphate catabolic process,BP,
4425,GO:0009151,1,0.807619870416981,0,10,purine deoxyribonucleotide metabolic process,BP,
4427,GO:0009153,1,0.937682368707701,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4429,GO:0009155,1,0.880252160432133,0,6,purine deoxyribonucleotide catabolic process,BP,
4430,GO:0009156,1,0.192514158494567,0,77,ribonucleoside monophosphate biosynthetic process,BP,
4431,GO:0009157,1,0.860998244023602,0,7,deoxyribonucleoside monophosphate biosynthetic process,BP,
4432,GO:0009158,1,0.8430839953834,0,8,ribonucleoside monophosphate catabolic process,BP,
4433,GO:0009159,1,0.958029810940089,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4435,GO:0009162,1,0.807098548352211,0,10,deoxyribonucleoside monophosphate metabolic process,BP,
4436,GO:0009163,1,0.364999195183276,0,47,nucleoside biosynthetic process,BP,
4441,GO:0009168,1,0.248580832703586,0,65,purine ribonucleoside monophosphate biosynthetic process,BP,
4442,GO:0009169,1,0.8430839953834,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4443,GO:0009170,1,0.978493226101955,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4444,GO:0009173,1,0.809235254648626,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4445,GO:0009174,1,0.809235254648626,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4446,GO:0009176,1,0.917532990571866,0,4,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4447,GO:0009177,1,0.937595126701771,0,3,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4448,GO:0009178,1,0.978606273753634,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4450,GO:0009180,1,0.937773167616588,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4451,GO:0009181,1,0.918879805461351,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4452,GO:0009182,1,0.937497266014464,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4453,GO:0009183,1,0.958013148873065,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4454,GO:0009184,1,0.97858744205237,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4456,GO:0009186,1,0.898132619477706,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4458,GO:0009188,1,0.937773167616588,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4459,GO:0009189,1,0.917789380527488,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4461,GO:0009191,1,0.880299754426298,0,6,ribonucleoside diphosphate catabolic process,BP,
4462,GO:0009192,1,0.97858744205237,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4463,GO:0009193,1,0.979053258701536,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4464,GO:0009195,1,0.979053258701536,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4465,GO:0009196,1,0.9580181451805,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4466,GO:0009197,1,0.9580181451805,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4468,GO:0009200,1,0.725354110824189,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4469,GO:0009201,1,0.282397539030261,0,59,ribonucleoside triphosphate biosynthetic process,BP,
4470,GO:0009202,1,0.897927308816386,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4471,GO:0009203,1,0.978505974722881,0,1,ribonucleoside triphosphate catabolic process,BP,
4472,GO:0009204,1,0.880180697651932,0,6,deoxyribonucleoside triphosphate catabolic process,BP,
4474,GO:0009206,1,0.32046118808817,0,53,purine ribonucleoside triphosphate biosynthetic process,BP,
4475,GO:0009207,1,0.978505974722881,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4476,GO:0009208,1,0.71038898024366,0,16,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4477,GO:0009209,1,0.725641402425373,0,15,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4478,GO:0009211,1,0.878556914385602,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4479,GO:0009212,1,0.917398443731461,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4480,GO:0009213,1,0.978508018657599,0,1,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4482,GO:0009215,1,0.84295105971826,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4483,GO:0009216,1,0.978780635386742,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4484,GO:0009217,1,0.899518652488845,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4485,GO:0009218,1,0.599055214372697,0,24,pyrimidine ribonucleotide metabolic process,BP,
4486,GO:0009219,1,0.693527789641219,0,17,pyrimidine deoxyribonucleotide metabolic process,BP,
4487,GO:0009220,1,0.625032265369166,0,22,pyrimidine ribonucleotide biosynthetic process,BP,
4488,GO:0009221,1,0.878946020455821,0,6,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4489,GO:0009222,1,0.979053258701536,0,1,pyrimidine ribonucleotide catabolic process,BP,
4490,GO:0009223,1,0.789110515538584,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4491,GO:0009224,1,0.978527865550976,0,1,CMP biosynthetic process,BP,
4493,GO:0009226,1,0.640786599866165,0,21,nucleotide-sugar biosynthetic process,BP,
4495,GO:0009229,1,0.9789047734206,0,1,thiamine diphosphate biosynthetic process,BP,
4496,GO:0009231,1,0.979015220146453,0,1,riboflavin biosynthetic process,BP,
4497,GO:0009233,1,0.938356756135538,0,3,menaquinone metabolic process,BP,
4498,GO:0009234,1,0.979072572809886,0,1,menaquinone biosynthetic process,BP,
4499,GO:0009235,1,0.645684751302612,0,21,cobalamin metabolic process,BP,
4500,GO:0009236,1,0.939703233364232,0,3,cobalamin biosynthetic process,BP,
4502,GO:0009240,1,0.897807837773187,0,5,isopentenyl diphosphate biosynthetic process,BP,
4503,GO:0009245,1,0.978471214322306,0,1,lipid A biosynthetic process,BP,
4505,GO:0009249,1,0.916799541067225,0,4,protein lipoylation,BP,
4507,GO:0009251,1,0.568745580027978,0,27,glucan catabolic process,BP,
4508,GO:0009253,1,0.859161291047345,0,7,peptidoglycan catabolic process,BP,
4509,GO:0009256,1,0.90166816313146,0,5,10-formyltetrahydrofolate metabolic process,BP,
4510,GO:0009257,1,0.958577871763324,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4511,GO:0009258,1,0.960910549710061,0,2,10-formyltetrahydrofolate catabolic process,BP,
4516,GO:0009263,1,0.773802162459373,0,12,deoxyribonucleotide biosynthetic process,BP,
4518,GO:0009265,1,0.824153544449458,0,9,2'-deoxyribonucleotide biosynthetic process,BP,
4521,GO:0009268,1,0.426370934645638,0,40,response to pH,BP,
4523,GO:0009298,1,0.917389485571583,0,4,GDP-mannose biosynthetic process,BP,
4524,GO:0009299,1,0.618094466968878,0,23,mRNA transcription,BP,
4525,GO:0009301,1,0.252754498422726,0,65,snRNA transcription,BP,
4527,GO:0009304,1,0.863590361222075,0,7,tRNA transcription,BP,
4528,GO:0009305,1,0.980322128492799,0,1,protein biotinylation,BP,
4531,GO:0009309,1,0.623051300222747,0,22,amine biosynthetic process,BP,
4534,GO:0009312,1,0.710136235913064,0,16,oligosaccharide biosynthetic process,BP,
4537,GO:0009328,1,0.937949010902953,0,3,phenylalanine-tRNA ligase complex,CC,
4538,GO:0009330,1,0.959592050938313,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4539,GO:0009331,1,0.939648260771138,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4540,GO:0009346,1,0.97921950544183,0,1,citrate lyase complex,CC,
4541,GO:0009353,1,0.978542659311075,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4542,GO:0009360,1,0.979013792235658,0,1,DNA polymerase III complex,CC,
4543,GO:0009368,1,0.957869485707962,0,2,endopeptidase Clp complex,CC,
4544,GO:0009372,1,0.979069145652555,0,1,quorum sensing,BP,
4545,GO:0009374,1,0.903974046088383,0,5,biotin binding,MF,
4546,GO:0009378,1,0.900845916149797,0,5,four-way junction helicase activity,MF,
4547,GO:0009383,1,0.958701950548361,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4548,GO:0009384,1,0.958814708807804,0,2,N-acylmannosamine kinase activity,MF,
4549,GO:0009386,1,0.957941635245395,0,2,translational attenuation,BP,
4550,GO:0009394,1,0.559987449219722,0,27,2'-deoxyribonucleotide metabolic process,BP,
4552,GO:0009396,1,0.807935831657211,0,10,folic acid-containing compound biosynthetic process,BP,
4553,GO:0009397,1,0.940232986470804,0,3,folic acid-containing compound catabolic process,BP,
4554,GO:0009398,1,0.979015220146453,0,1,FMN biosynthetic process,BP,
4555,GO:0009399,1,0.978509031324794,0,1,nitrogen fixation,BP,
4556,GO:0009400,1,0.97904224457962,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4557,GO:0009403,1,0.979066440660206,0,1,toxin biosynthetic process,BP,
4559,GO:0009405,1,0.960538093445983,0,2,pathogenesis,BP,
4564,GO:0009414,1,0.842998208111612,0,8,response to water deprivation,BP,
4565,GO:0009415,1,0.745800990363033,0,14,response to water,BP,
4568,GO:0009436,1,0.937781226689972,0,3,glyoxylate catabolic process,BP,
4570,GO:0009438,1,0.898129377634562,0,5,methylglyoxal metabolic process,BP,
4571,GO:0009439,1,0.957544333919167,0,2,cyanate metabolic process,BP,
4572,GO:0009440,1,0.957544333919167,0,2,cyanate catabolic process,BP,
4573,GO:0009441,1,0.939655797299939,0,3,glycolate metabolic process,BP,
4574,GO:0009443,1,0.981349852562428,0,1,pyridoxal 5'-phosphate salvage,BP,
4575,GO:0009444,1,0.979786513809616,0,1,pyruvate oxidation,BP,
4576,GO:0009445,1,0.879028743700726,0,6,putrescine metabolic process,BP,
4577,GO:0009446,1,0.918093272245237,0,4,putrescine biosynthetic process,BP,
4578,GO:0009447,1,0.937007779347431,0,3,putrescine catabolic process,BP,
4581,GO:0009450,1,0.959606578334108,0,2,gamma-aminobutyric acid catabolic process,BP,
4583,GO:0009452,1,0.484865434654969,0,34,7-methylguanosine RNA capping,BP,
4589,GO:0009590,1,0.978779387181551,0,1,detection of gravity,BP,
4591,GO:0009595,1,0.641368703217964,0,21,detection of biotic stimulus,BP,
4592,GO:0009597,1,0.8994139542757,0,5,detection of virus,BP,
4595,GO:0009608,1,0.958089483280355,0,2,response to symbiont,BP,
4596,GO:0009609,1,0.958089483280355,0,2,response to symbiotic bacterium,BP,
4602,GO:0009624,1,0.937383316731708,0,3,response to nematode,BP,
4604,GO:0009629,1,0.824741783607443,0,9,response to gravity,BP,
4605,GO:0009631,1,0.97964453895366,0,1,cold acclimation,BP,
4608,GO:0009637,1,0.95864799330687,0,2,response to blue light,BP,
4609,GO:0009642,1,0.776662687431568,0,12,response to light intensity,BP,
4610,GO:0009644,1,0.958979455887105,0,2,response to high light intensity,BP,
4611,GO:0009645,1,0.979069513730973,0,1,response to low light intensity stimulus,BP,
4612,GO:0009646,1,0.979069205329571,0,1,response to absence of light,BP,
4613,GO:0009648,1,0.614345748337543,0,23,photoperiodism,BP,
4614,GO:0009649,1,0.588866822532732,0,25,entrainment of circadian clock,BP,
4615,GO:0009650,1,0.759072659602528,0,13,UV protection,BP,
4618,GO:0009673,1,0.979073153012333,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4619,GO:0009692,1,0.978989672309085,0,1,ethylene metabolic process,BP,
4620,GO:0009698,1,0.860384619622719,0,7,phenylpropanoid metabolic process,BP,
4627,GO:0009730,1,0.918026830356171,0,4,detection of carbohydrate stimulus,BP,
4628,GO:0009732,1,0.918026830356171,0,4,detection of hexose stimulus,BP,
4629,GO:0009737,1,0.979217682648878,0,1,response to abscisic acid,BP,
4630,GO:0009738,1,0.979217682648878,0,1,abscisic acid-activated signaling pathway,BP,
4636,GO:0009751,1,0.978960440114079,0,1,response to salicylic acid,BP,
4637,GO:0009753,1,0.9168948804197,0,4,response to jasmonic acid,BP,
4639,GO:0009756,1,0.861562810952332,0,7,carbohydrate mediated signaling,BP,
4640,GO:0009757,1,0.898937439009475,0,5,hexose mediated signaling,BP,
4641,GO:0009758,1,0.982356752390083,0,1,carbohydrate utilization,BP,
4642,GO:0009785,1,0.95864799330687,0,2,blue light signaling pathway,BP,
4643,GO:0009786,1,0.942103949644279,0,3,regulation of asymmetric cell division,BP,
4644,GO:0009787,1,0.979217682648878,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4645,GO:0009789,1,0.979217682648878,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4649,GO:0009794,1,0.918335783187626,0,4,regulation of mitotic cell cycle, embryonic,BP,
4652,GO:0009804,1,0.860384619622719,0,7,coumarin metabolic process,BP,
4653,GO:0009810,1,0.97884417678277,0,1,stilbene metabolic process,BP,
4654,GO:0009812,1,0.774778779794453,0,12,flavonoid metabolic process,BP,
4655,GO:0009814,1,0.978841299221768,0,1,defense response, incompatible interaction,BP,
4656,GO:0009817,1,0.978841299221768,0,1,defense response to fungus, incompatible interaction,BP,
4657,GO:0009820,1,0.860840233566325,0,7,alkaloid metabolic process,BP,
4658,GO:0009822,1,0.93762369394405,0,3,alkaloid catabolic process,BP,
4659,GO:0009826,1,0.939229485064678,0,3,unidimensional cell growth,BP,
4660,GO:0009838,1,0.879926197108281,0,6,abscission,BP,
4661,GO:0009841,1,0.978904390398895,0,1,mitochondrial endopeptidase Clp complex,CC,
4664,GO:0009881,1,0.740838958651522,0,14,photoreceptor activity,MF,
4665,GO:0009882,1,0.95864799330687,0,2,blue light photoreceptor activity,MF,
4682,GO:0009917,1,0.978936293719533,0,1,sterol 5-alpha reductase activity,MF,
4686,GO:0009931,1,0.794885634734964,0,11,calcium-dependent protein serine/threonine kinase activity,MF,
4689,GO:0009949,1,0.978602768722672,0,1,polarity specification of anterior/posterior axis,BP,
4694,GO:0009955,1,0.978842533097552,0,1,adaxial/abaxial pattern specification,BP,
4695,GO:0009956,1,0.979094663941374,0,1,radial pattern formation,BP,
4696,GO:0009957,1,0.940901640403422,0,3,epidermal cell fate specification,BP,
4700,GO:0009972,1,0.823482766568907,0,9,cytidine deamination,BP,
4707,GO:0009992,1,0.978832430975698,0,1,cellular water homeostasis,BP,
4710,GO:0009997,1,0.979053151914992,0,1,negative regulation of cardioblast cell fate specification,BP,
4714,GO:0010009,1,0.95840013460975,0,2,cytoplasmic side of endosome membrane,CC,
4715,GO:0010015,1,0.978476629273923,0,1,root morphogenesis,BP,
4716,GO:0010021,1,0.979067210276894,0,1,amylopectin biosynthetic process,BP,
4717,GO:0010025,1,0.918539095730242,0,4,wax biosynthetic process,BP,
4718,GO:0010032,1,0.883389455791101,0,6,meiotic chromosome condensation,BP,
4720,GO:0010034,1,0.979069975076491,0,1,response to acetate,BP,
4722,GO:0010037,1,0.979065102314849,0,1,response to carbon dioxide,BP,
4725,GO:0010040,1,0.898779162313167,0,5,response to iron(II) ion,BP,
4726,GO:0010041,1,0.901453243629658,0,5,response to iron(III) ion,BP,
4727,GO:0010042,1,0.732067587340653,0,15,response to manganese ion,BP,
4729,GO:0010044,1,0.898911305619256,0,5,response to aluminum ion,BP,
4730,GO:0010045,1,0.981490281243391,0,1,response to nickel cation,BP,
4731,GO:0010046,1,0.918039465918835,0,4,response to mycotoxin,BP,
4732,GO:0010053,1,0.978476629273923,0,1,root epidermal cell differentiation,BP,
4733,GO:0010054,1,0.978476629273923,0,1,trichoblast differentiation,BP,
4734,GO:0010070,1,0.978925417777675,0,1,zygote asymmetric cell division,BP,
4735,GO:0010085,1,0.978792715368707,0,1,polarity specification of proximal/distal axis,BP,
4737,GO:0010106,1,0.978735715216539,0,1,cellular response to iron ion starvation,BP,
4738,GO:0010107,1,0.554341500132492,0,28,potassium ion import,BP,
4739,GO:0010124,1,0.978519172897859,0,1,phenylacetate catabolic process,BP,
4740,GO:0010133,1,0.937883186418159,0,3,proline catabolic process to glutamate,BP,
4741,GO:0010138,1,0.898058907261926,0,5,pyrimidine ribonucleotide salvage,BP,
4742,GO:0010155,1,0.695707988400735,0,17,regulation of proton transport,BP,
4743,GO:0010157,1,0.961040303874826,0,2,response to chlorate,BP,
4745,GO:0010160,1,0.978493634270525,0,1,formation of animal organ boundary,BP,
4746,GO:0010164,1,0.978615294453451,0,1,response to cesium ion,BP,
4748,GO:0010166,1,0.918539095730242,0,4,wax metabolic process,BP,
4750,GO:0010172,1,0.800806524981871,0,11,embryonic body morphogenesis,BP,
4751,GO:0010181,1,0.714701314250792,0,16,FMN binding,MF,
4752,GO:0010182,1,0.898937439009475,0,5,sugar mediated signaling pathway,BP,
4753,GO:0010189,1,0.97863496415373,0,1,vitamin E biosynthetic process,BP,
4756,GO:0010216,1,0.88227839260804,0,6,maintenance of DNA methylation,BP,
4758,GO:0010225,1,0.78459255816549,0,12,response to UV-C,BP,
4760,GO:0010232,1,0.97906633745935,0,1,vascular transport,BP,
4762,GO:0010248,1,0.758087968469945,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4763,GO:0010255,1,0.898937439009475,0,5,glucose mediated signaling pathway,BP,
4765,GO:0010257,1,0.304220575045312,0,55,NADH dehydrogenase complex assembly,BP,
4767,GO:0010260,1,0.97897803157895,0,1,animal organ senescence,BP,
4768,GO:0010265,1,0.881535599203241,0,6,SCF complex assembly,BP,
4769,GO:0010266,1,0.94011212168438,0,3,response to vitamin B1,BP,
4770,GO:0010269,1,0.885360129521722,0,6,response to selenium ion,BP,
4771,GO:0010273,1,0.961033241311551,0,2,detoxification of copper ion,BP,
4772,GO:0010286,1,0.937981729223756,0,3,heat acclimation,BP,
4774,GO:0010309,1,0.978633802264702,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4775,GO:0010310,1,0.757045080039058,0,13,regulation of hydrogen peroxide metabolic process,BP,
4776,GO:0010314,1,0.798039038044217,0,11,phosphatidylinositol-5-phosphate binding,MF,
4779,GO:0010335,1,0.979280084076002,0,1,response to non-ionic osmotic stress,BP,
4780,GO:0010340,1,0.89920492644358,0,5,carboxyl-O-methyltransferase activity,MF,
4781,GO:0010348,1,0.97897493185122,0,1,lithium:proton antiporter activity,MF,
4782,GO:0010359,1,0.901557572275767,0,5,regulation of anion channel activity,BP,
4783,GO:0010360,1,0.958808094438774,0,2,negative regulation of anion channel activity,BP,
4784,GO:0010369,1,0.747899693095531,0,14,chromocenter,CC,
4785,GO:0010370,1,0.958291692275157,0,2,perinucleolar chromocenter,CC,
4786,GO:0010383,1,0.978582423287099,0,1,cell wall polysaccharide metabolic process,BP,
4788,GO:0010387,1,0.938220442754234,0,3,COP9 signalosome assembly,BP,
4790,GO:0010390,1,0.617623812552329,0,23,histone monoubiquitination,BP,
4791,GO:0010420,1,0.978531371205572,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4792,GO:0010421,1,0.77673886093109,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4793,GO:0010428,1,0.980234981067365,0,1,methyl-CpNpG binding,MF,
4794,GO:0010430,1,0.958665601244173,0,2,fatty acid omega-oxidation,BP,
4795,GO:0010446,1,0.937675001034698,0,3,response to alkaline pH,BP,
4796,GO:0010447,1,0.626276165959481,0,22,response to acidic pH,BP,
4797,GO:0010452,1,0.83924176229794,0,9,histone H3-K36 methylation,BP,
4800,GO:0010455,1,0.826296443930283,0,9,positive regulation of cell fate commitment,BP,
4801,GO:0010457,1,0.834108313374864,0,9,centriole-centriole cohesion,BP,
4802,GO:0010458,1,0.530876648130147,0,30,exit from mitosis,BP,
4807,GO:0010465,1,0.960485112666202,0,2,nerve growth factor receptor activity,MF,
4813,GO:0010477,1,0.979068896050112,0,1,response to sulfur dioxide,BP,
4814,GO:0010481,1,0.958333273988905,0,2,epidermal cell division,BP,
4815,GO:0010482,1,0.958333273988905,0,2,regulation of epidermal cell division,BP,
4816,GO:0010484,1,0.943388882470966,0,3,H3 histone acetyltransferase activity,MF,
4817,GO:0010485,1,0.704648774293851,0,17,H4 histone acetyltransferase activity,MF,
4818,GO:0010494,1,0.448648381161339,0,39,cytoplasmic stress granule,CC,
4819,GO:0010496,1,0.978758658761031,0,1,intercellular transport,BP,
4821,GO:0010499,1,0.921523100215436,0,4,proteasomal ubiquitin-independent protein catabolic process,BP,
4822,GO:0010501,1,0.385557345180586,0,45,RNA secondary structure unwinding,BP,
4826,GO:0010509,1,0.979954779198019,0,1,polyamine homeostasis,BP,
4830,GO:0010513,1,0.918500986855285,0,4,positive regulation of phosphatidylinositol biosynthetic process,BP,
4833,GO:0010519,1,0.862267058007386,0,7,negative regulation of phospholipase activity,BP,
4834,GO:0010520,1,0.958508770795619,0,2,regulation of reciprocal meiotic recombination,BP,
4835,GO:0010521,1,0.937961014322395,0,3,telomerase inhibitor activity,MF,
4838,GO:0010524,1,0.387622180736756,0,45,positive regulation of calcium ion transport into cytosol,BP,
4839,GO:0010528,1,0.758049986608235,0,13,regulation of transposition,BP,
4840,GO:0010529,1,0.758049986608235,0,13,negative regulation of transposition,BP,
4841,GO:0010531,1,0.979066267315481,0,1,activation of JAK1 kinase activity,BP,
4842,GO:0010533,1,0.841789682855782,0,8,regulation of activation of Janus kinase activity,BP,
4843,GO:0010534,1,0.841789682855782,0,8,regulation of activation of JAK2 kinase activity,BP,
4844,GO:0010535,1,0.8789915838885,0,6,positive regulation of activation of JAK2 kinase activity,BP,
4845,GO:0010536,1,0.8789915838885,0,6,positive regulation of activation of Janus kinase activity,BP,
4852,GO:0010560,1,0.700575017533502,0,17,positive regulation of glycoprotein biosynthetic process,BP,
4859,GO:0010569,1,0.659552025033644,0,20,regulation of double-strand break repair via homologous recombination,BP,
4860,GO:0010571,1,0.887439407580964,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4861,GO:0010572,1,0.939413556423165,0,3,positive regulation of platelet activation,BP,
4862,GO:0010573,1,0.501571873959049,0,33,vascular endothelial growth factor production,BP,
4863,GO:0010574,1,0.511729666483185,0,32,regulation of vascular endothelial growth factor production,BP,
4864,GO:0010575,1,0.570158714293562,0,27,positive regulation of vascular endothelial growth factor production,BP,
4865,GO:0010578,1,0.880059259597965,0,6,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4866,GO:0010579,1,0.880059259597965,0,6,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4868,GO:0010587,1,0.882686560058339,0,6,miRNA catabolic process,BP,
4869,GO:0010591,1,0.559090409660637,0,28,regulation of lamellipodium assembly,BP,
4870,GO:0010592,1,0.702954834483112,0,17,positive regulation of lamellipodium assembly,BP,
4871,GO:0010593,1,0.919899657530129,0,4,negative regulation of lamellipodium assembly,BP,
4875,GO:0010603,1,0.850755195718472,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4878,GO:0010606,1,0.9064992650942,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4879,GO:0010607,1,0.978741823578443,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4881,GO:0010609,1,0.958363777962843,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4882,GO:0010610,1,0.982207436663827,0,1,regulation of mRNA stability involved in response to stress,BP,
4884,GO:0010612,1,0.884681517821733,0,6,regulation of cardiac muscle adaptation,BP,
4886,GO:0010614,1,0.718444355407643,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4887,GO:0010615,1,0.958860199812139,0,2,positive regulation of cardiac muscle adaptation,BP,
4888,GO:0010616,1,0.942822266003627,0,3,negative regulation of cardiac muscle adaptation,BP,
4889,GO:0010621,1,0.937519278529852,0,3,negative regulation of transcription by transcription factor localization,BP,
4891,GO:0010624,1,0.904127443214816,0,5,regulation of Schwann cell proliferation,BP,
4892,GO:0010626,1,0.904127443214816,0,5,negative regulation of Schwann cell proliferation,BP,
4899,GO:0010635,1,0.844830397972819,0,8,regulation of mitochondrial fusion,BP,
4900,GO:0010636,1,0.959984105149763,0,2,positive regulation of mitochondrial fusion,BP,
4901,GO:0010637,1,0.898926259711312,0,5,negative regulation of mitochondrial fusion,BP,
4905,GO:0010641,1,0.901724990945598,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4907,GO:0010643,1,0.938496238893509,0,3,cell communication by chemical coupling,BP,
4909,GO:0010645,1,0.958570825761194,0,2,regulation of cell communication by chemical coupling,BP,
4914,GO:0010650,1,0.96281055937691,0,2,positive regulation of cell communication by electrical coupling,BP,
4915,GO:0010652,1,0.958570825761194,0,2,positive regulation of cell communication by chemical coupling,BP,
4921,GO:0010661,1,0.711849062145221,0,16,positive regulation of muscle cell apoptotic process,BP,
4923,GO:0010663,1,0.844996429813177,0,8,positive regulation of striated muscle cell apoptotic process,BP,
4926,GO:0010666,1,0.844996429813177,0,8,positive regulation of cardiac muscle cell apoptotic process,BP,
4933,GO:0010692,1,0.835340672582056,0,9,regulation of alkaline phosphatase activity,BP,
4934,GO:0010693,1,0.938915450656119,0,3,negative regulation of alkaline phosphatase activity,BP,
4935,GO:0010694,1,0.889704666200208,0,6,positive regulation of alkaline phosphatase activity,BP,
4936,GO:0010698,1,0.957988561487427,0,2,acetyltransferase activator activity,MF,
4938,GO:0010701,1,0.918194673480308,0,4,positive regulation of norepinephrine secretion,BP,
4939,GO:0010705,1,0.958782514666385,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4940,GO:0010710,1,0.937917135036091,0,3,regulation of collagen catabolic process,BP,
4941,GO:0010711,1,0.978476345874716,0,1,negative regulation of collagen catabolic process,BP,
4943,GO:0010713,1,0.842639198037106,0,8,negative regulation of collagen metabolic process,BP,
4946,GO:0010716,1,0.918084444188401,0,4,negative regulation of extracellular matrix disassembly,BP,
4949,GO:0010719,1,0.574804750485567,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4952,GO:0010722,1,0.981188723353756,0,1,regulation of ferrochelatase activity,BP,
4954,GO:0010725,1,0.938033062700029,0,3,regulation of primitive erythrocyte differentiation,BP,
4955,GO:0010726,1,0.95827941425285,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4956,GO:0010727,1,0.879753040958224,0,6,negative regulation of hydrogen peroxide metabolic process,BP,
4957,GO:0010728,1,0.938488980207863,0,3,regulation of hydrogen peroxide biosynthetic process,BP,
4958,GO:0010729,1,0.978768587825754,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4959,GO:0010730,1,0.958849004489986,0,2,negative regulation of hydrogen peroxide biosynthetic process,BP,
4960,GO:0010731,1,0.978897259422962,0,1,protein glutathionylation,BP,
4961,GO:0010732,1,0.978897259422962,0,1,regulation of protein glutathionylation,BP,
4962,GO:0010734,1,0.978897259422962,0,1,negative regulation of protein glutathionylation,BP,
4963,GO:0010735,1,0.918890827204748,0,4,positive regulation of transcription via serum response element binding,BP,
4964,GO:0010736,1,0.958370342343667,0,2,serum response element binding,MF,
4965,GO:0010737,1,0.564129060307544,0,29,protein kinase A signaling,BP,
4966,GO:0010738,1,0.683180647200147,0,19,regulation of protein kinase A signaling,BP,
4967,GO:0010739,1,0.884245127930406,0,6,positive regulation of protein kinase A signaling,BP,
4970,GO:0010744,1,0.715225215131015,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4974,GO:0010749,1,0.922631198782553,0,4,regulation of nitric oxide mediated signal transduction,BP,
4975,GO:0010750,1,0.979267002891383,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4976,GO:0010751,1,0.942168311817035,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4977,GO:0010752,1,0.959788298872612,0,2,regulation of cGMP-mediated signaling,BP,
4978,GO:0010754,1,0.980161398536727,0,1,negative regulation of cGMP-mediated signaling,BP,
4979,GO:0010755,1,0.790845244820012,0,11,regulation of plasminogen activation,BP,
4980,GO:0010756,1,0.898127453102042,0,5,positive regulation of plasminogen activation,BP,
4981,GO:0010757,1,0.880581801776401,0,6,negative regulation of plasminogen activation,BP,
4982,GO:0010758,1,0.653400934251137,0,20,regulation of macrophage chemotaxis,BP,
4983,GO:0010759,1,0.72614485006679,0,15,positive regulation of macrophage chemotaxis,BP,
4984,GO:0010760,1,0.91900990096373,0,4,negative regulation of macrophage chemotaxis,BP,
4988,GO:0010764,1,0.844804896923705,0,8,negative regulation of fibroblast migration,BP,
4991,GO:0010767,1,0.94233842891136,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4992,GO:0010768,1,0.980613073878647,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4996,GO:0010792,1,0.88048067732284,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4997,GO:0010793,1,0.903260659194491,0,5,regulation of mRNA export from nucleus,BP,
4998,GO:0010795,1,0.978531371205572,0,1,regulation of ubiquinone biosynthetic process,BP,
4999,GO:0010796,1,0.937462055608095,0,3,regulation of multivesicular body size,BP,
5000,GO:0010797,1,0.978522515053256,0,1,regulation of multivesicular body size involved in endosome transport,BP,
5003,GO:0010801,1,0.744866637964581,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
5006,GO:0010805,1,0.978980782054902,0,1,regulation of lysine import,BP,
5007,GO:0010807,1,0.900700144103339,0,5,regulation of synaptic vesicle priming,BP,
5008,GO:0010808,1,0.980616097542003,0,1,positive regulation of synaptic vesicle priming,BP,
5012,GO:0010813,1,0.958668253725263,0,2,neuropeptide catabolic process,BP,
5013,GO:0010814,1,0.979657696042131,0,1,substance P catabolic process,BP,
5014,GO:0010815,1,0.899817363146619,0,5,bradykinin catabolic process,BP,
5015,GO:0010816,1,0.979657696042131,0,1,calcitonin catabolic process,BP,
5024,GO:0010825,1,0.882285124015107,0,6,positive regulation of centrosome duplication,BP,
5025,GO:0010826,1,0.811778601797941,0,10,negative regulation of centrosome duplication,BP,
5028,GO:0010829,1,0.729031765247739,0,15,negative regulation of glucose transport,BP,
5030,GO:0010831,1,0.528516318479751,0,30,positive regulation of myotube differentiation,BP,
5032,GO:0010833,1,0.225421800935179,0,71,telomere maintenance via telomere lengthening,BP,
5033,GO:0010835,1,0.899404350820309,0,5,regulation of protein ADP-ribosylation,BP,
5034,GO:0010836,1,0.978763617662823,0,1,negative regulation of protein ADP-ribosylation,BP,
5038,GO:0010840,1,0.878783660587828,0,6,regulation of circadian sleep/wake cycle, wakefulness,BP,
5039,GO:0010841,1,0.897929035938906,0,5,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
5040,GO:0010842,1,0.641276949517221,0,22,retina layer formation,BP,
5041,GO:0010845,1,0.958508770795619,0,2,positive regulation of reciprocal meiotic recombination,BP,
5042,GO:0010847,1,0.923145001469138,0,4,regulation of chromatin assembly,BP,
5043,GO:0010848,1,0.958727842758405,0,2,regulation of chromatin disassembly,BP,
5044,GO:0010849,1,0.978839240721593,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
5045,GO:0010851,1,0.823783187058576,0,9,cyclase regulator activity,MF,
5046,GO:0010852,1,0.978878592329253,0,1,cyclase inhibitor activity,MF,
5047,GO:0010853,1,0.859484587401341,0,7,cyclase activator activity,MF,
5048,GO:0010854,1,0.979161052397716,0,1,adenylate cyclase regulator activity,MF,
5049,GO:0010855,1,0.979161052397716,0,1,adenylate cyclase inhibitor activity,MF,
5050,GO:0010857,1,0.778186096553273,0,12,calcium-dependent protein kinase activity,MF,
5051,GO:0010858,1,0.937295268911599,0,3,calcium-dependent protein kinase regulator activity,MF,
5052,GO:0010859,1,0.979227108652633,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5058,GO:0010868,1,0.958899229134076,0,2,negative regulation of triglyceride biosynthetic process,BP,
5061,GO:0010871,1,0.886541648072006,0,6,negative regulation of receptor biosynthetic process,BP,
5067,GO:0010877,1,0.957837030053339,0,2,lipid transport involved in lipid storage,BP,
5069,GO:0010879,1,0.978867379319807,0,1,cholesterol transport involved in cholesterol storage,BP,
5074,GO:0010884,1,0.632380943607726,0,22,positive regulation of lipid storage,BP,
5076,GO:0010886,1,0.868198315100571,0,7,positive regulation of cholesterol storage,BP,
5079,GO:0010889,1,0.779139866185494,0,12,regulation of sequestering of triglyceride,BP,
5080,GO:0010890,1,0.86045410845414,0,7,positive regulation of sequestering of triglyceride,BP,
5081,GO:0010891,1,0.905535281400553,0,5,negative regulation of sequestering of triglyceride,BP,
5086,GO:0010898,1,0.842054475446985,0,8,positive regulation of triglyceride catabolic process,BP,
5089,GO:0010901,1,0.897119153353811,0,5,regulation of very-low-density lipoprotein particle remodeling,BP,
5090,GO:0010902,1,0.957654731150153,0,2,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5091,GO:0010903,1,0.936794887162959,0,3,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5092,GO:0010904,1,0.978834703582196,0,1,regulation of UDP-glucose catabolic process,BP,
5093,GO:0010905,1,0.978834703582196,0,1,negative regulation of UDP-glucose catabolic process,BP,
5096,GO:0010908,1,0.958612122858693,0,2,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5097,GO:0010909,1,0.958612122858693,0,2,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5098,GO:0010911,1,0.899619278762488,0,5,regulation of isomerase activity,BP,
5099,GO:0010912,1,0.899619278762488,0,5,positive regulation of isomerase activity,BP,
5103,GO:0010918,1,0.917634602252902,0,4,positive regulation of mitochondrial membrane potential,BP,
5104,GO:0010919,1,0.742021450580513,0,14,regulation of inositol phosphate biosynthetic process,BP,
5105,GO:0010920,1,0.979043579876824,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5109,GO:0010924,1,0.979043579876824,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5110,GO:0010925,1,0.979043579876824,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5112,GO:0010931,1,0.981978853201056,0,1,macrophage tolerance induction,BP,
5113,GO:0010932,1,0.981978853201056,0,1,regulation of macrophage tolerance induction,BP,
5114,GO:0010933,1,0.981978853201056,0,1,positive regulation of macrophage tolerance induction,BP,
5117,GO:0010936,1,0.902168042659985,0,5,negative regulation of macrophage cytokine production,BP,
5119,GO:0010940,1,0.878516213077919,0,6,positive regulation of necrotic cell death,BP,
5122,GO:0010944,1,0.828663252973606,0,9,negative regulation of transcription by competitive promoter binding,BP,
5124,GO:0010949,1,0.958470419588343,0,2,negative regulation of intestinal phytosterol absorption,BP,
5128,GO:0010954,1,0.686209164695116,0,18,positive regulation of protein processing,BP,
5130,GO:0010956,1,0.938405732744417,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5131,GO:0010957,1,0.898880801069552,0,5,negative regulation of vitamin D biosynthetic process,BP,
5132,GO:0010958,1,0.920517772447648,0,4,regulation of amino acid import,BP,
5134,GO:0010960,1,0.801456679458726,0,11,magnesium ion homeostasis,BP,
5135,GO:0010961,1,0.90237560217089,0,5,cellular magnesium ion homeostasis,BP,
5137,GO:0010963,1,0.95799989852805,0,2,regulation of L-arginine import,BP,
5138,GO:0010965,1,0.386255682999521,0,46,regulation of mitotic sister chromatid separation,BP,
5139,GO:0010966,1,0.901595048411865,0,5,regulation of phosphate transport,BP,
5140,GO:0010967,1,0.978641526874056,0,1,regulation of polyamine biosynthetic process,BP,
5141,GO:0010968,1,0.900445792548085,0,5,regulation of microtubule nucleation,BP,
5142,GO:0010970,1,0.0825225226423501,0,121,transport along microtubule,BP,
5143,GO:0010971,1,0.656618026678034,0,20,positive regulation of G2/M transition of mitotic cell cycle,BP,
5150,GO:0010982,1,0.937820513958327,0,3,regulation of high-density lipoprotein particle clearance,BP,
5151,GO:0010983,1,0.958461118518234,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5154,GO:0010986,1,0.918148900107632,0,4,positive regulation of lipoprotein particle clearance,BP,
5155,GO:0010987,1,0.978467310814307,0,1,negative regulation of high-density lipoprotein particle clearance,BP,
5156,GO:0010988,1,0.824447448664276,0,9,regulation of low-density lipoprotein particle clearance,BP,
5157,GO:0010989,1,0.918185010205463,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5158,GO:0010990,1,0.883019022815737,0,6,regulation of SMAD protein complex assembly,BP,
5159,GO:0010991,1,0.901864133385337,0,5,negative regulation of SMAD protein complex assembly,BP,
5160,GO:0010992,1,0.919762259129065,0,4,ubiquitin homeostasis,BP,
5161,GO:0010993,1,0.899045094974836,0,5,regulation of ubiquitin homeostasis,BP,
5162,GO:0010994,1,0.899045094974836,0,5,free ubiquitin chain polymerization,BP,
5164,GO:0010997,1,0.881129530157277,0,6,anaphase-promoting complex binding,MF,
5165,GO:0010998,1,0.793763850101831,0,11,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5166,GO:0010999,1,0.979268155798965,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5168,GO:0012502,1,0.958461169726698,0,2,induction of programmed cell death,BP,
5171,GO:0012507,1,0.304317018510411,0,56,ER to Golgi transport vesicle membrane,CC,
5172,GO:0012510,1,0.746611476657188,0,14,trans-Golgi network transport vesicle membrane,CC,
5174,GO:0014003,1,0.457804739094921,0,37,oligodendrocyte development,BP,
5178,GO:0014010,1,0.886287769427198,0,6,Schwann cell proliferation,BP,
5179,GO:0014011,1,0.97897493185122,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5180,GO:0014012,1,0.881347747727189,0,6,peripheral nervous system axon regeneration,BP,
5184,GO:0014016,1,0.938160966122807,0,3,neuroblast differentiation,BP,
5185,GO:0014017,1,0.978946517601127,0,1,neuroblast fate commitment,BP,
5187,GO:0014022,1,0.939200609987339,0,3,neural plate elongation,BP,
5188,GO:0014028,1,0.919255393121839,0,4,notochord formation,BP,
5189,GO:0014029,1,0.777897595193871,0,12,neural crest formation,BP,
5193,GO:0014034,1,0.937701968813541,0,3,neural crest cell fate commitment,BP,
5194,GO:0014036,1,0.978518088072341,0,1,neural crest cell fate specification,BP,
5196,GO:0014038,1,0.942179170492927,0,3,regulation of Schwann cell differentiation,BP,
5197,GO:0014040,1,0.962726823873672,0,2,positive regulation of Schwann cell differentiation,BP,
5198,GO:0014041,1,0.800487485517821,0,11,regulation of neuron maturation,BP,
5199,GO:0014042,1,0.923816029221986,0,4,positive regulation of neuron maturation,BP,
5200,GO:0014043,1,0.920585208598582,0,4,negative regulation of neuron maturation,BP,
5206,GO:0014049,1,0.843789189816595,0,8,positive regulation of glutamate secretion,BP,
5208,GO:0014051,1,0.851080077399759,0,8,gamma-aminobutyric acid secretion,BP,
5209,GO:0014052,1,0.900012161533987,0,5,regulation of gamma-aminobutyric acid secretion,BP,
5210,GO:0014053,1,0.979516224791057,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5211,GO:0014054,1,0.91883772433715,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5212,GO:0014055,1,0.938222949988036,0,3,acetylcholine secretion, neurotransmission,BP,
5213,GO:0014056,1,0.938222949988036,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5214,GO:0014057,1,0.958343536961437,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5218,GO:0014062,1,0.860972617546804,0,7,regulation of serotonin secretion,BP,
5219,GO:0014063,1,0.91818660901651,0,4,negative regulation of serotonin secretion,BP,
5220,GO:0014064,1,0.97930137485841,0,1,positive regulation of serotonin secretion,BP,
5223,GO:0014067,1,0.793661206290969,0,11,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5229,GO:0014075,1,0.452485938716529,0,38,response to amine,BP,
5232,GO:0014705,1,0.979176469848086,0,1,C zone,CC,
5234,GO:0014707,1,0.937877310143871,0,3,branchiomeric skeletal muscle development,BP,
5235,GO:0014717,1,0.937571124521394,0,3,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5236,GO:0014718,1,0.958072760474958,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5238,GO:0014721,1,0.901525527762418,0,5,twitch skeletal muscle contraction,BP,
5239,GO:0014722,1,0.900372441099527,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5240,GO:0014724,1,0.959838640264392,0,2,regulation of twitch skeletal muscle contraction,BP,
5245,GO:0014734,1,0.942744434448645,0,3,skeletal muscle hypertrophy,BP,
5248,GO:0014737,1,0.978656505269765,0,1,positive regulation of muscle atrophy,BP,
5249,GO:0014738,1,0.937799177413574,0,3,regulation of muscle hyperplasia,BP,
5250,GO:0014739,1,0.978470262767982,0,1,positive regulation of muscle hyperplasia,BP,
5251,GO:0014740,1,0.958436421970979,0,2,negative regulation of muscle hyperplasia,BP,
5252,GO:0014741,1,0.689634949800631,0,18,negative regulation of muscle hypertrophy,BP,
5255,GO:0014744,1,0.90198213235,0,5,positive regulation of muscle adaptation,BP,
5257,GO:0014801,1,0.978492821766151,0,1,longitudinal sarcoplasmic reticulum,CC,
5258,GO:0014802,1,0.924951314893318,0,4,terminal cisterna,CC,
5259,GO:0014804,1,0.978742231874347,0,1,terminal cisterna lumen,CC,
5260,GO:0014805,1,0.91728346813884,0,4,smooth muscle adaptation,BP,
5261,GO:0014806,1,0.957988805385761,0,2,smooth muscle hyperplasia,BP,
5264,GO:0014809,1,0.919647679212059,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5265,GO:0014810,1,0.978476859225323,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5267,GO:0014813,1,0.978866169897787,0,1,skeletal muscle satellite cell commitment,BP,
5268,GO:0014816,1,0.886579709315108,0,6,skeletal muscle satellite cell differentiation,BP,
5272,GO:0014822,1,0.978974306474141,0,1,detection of wounding,BP,
5276,GO:0014827,1,0.918203888786587,0,4,intestine smooth muscle contraction,BP,
5278,GO:0014831,1,0.862746116619488,0,7,gastro-intestinal system smooth muscle contraction,BP,
5279,GO:0014832,1,0.862850658515715,0,7,urinary bladder smooth muscle contraction,BP,
5281,GO:0014835,1,0.958511143467252,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5282,GO:0014839,1,0.957712479603304,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5283,GO:0014841,1,0.8122430267114,0,10,skeletal muscle satellite cell proliferation,BP,
5284,GO:0014842,1,0.827490497978444,0,9,regulation of skeletal muscle satellite cell proliferation,BP,
5285,GO:0014843,1,0.980893706680585,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5286,GO:0014846,1,0.959631955515148,0,2,esophagus smooth muscle contraction,BP,
5287,GO:0014848,1,0.862850658515715,0,7,urinary tract smooth muscle contraction,BP,
5288,GO:0014850,1,0.722493918838734,0,16,response to muscle activity,BP,
5289,GO:0014852,1,0.979045360617991,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5290,GO:0014853,1,0.979045360617991,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5293,GO:0014856,1,0.794853531282875,0,11,skeletal muscle cell proliferation,BP,
5294,GO:0014857,1,0.809775455058758,0,10,regulation of skeletal muscle cell proliferation,BP,
5295,GO:0014858,1,0.978602768722672,0,1,positive regulation of skeletal muscle cell proliferation,BP,
5296,GO:0014859,1,0.95854435924036,0,2,negative regulation of skeletal muscle cell proliferation,BP,
5297,GO:0014861,1,0.979838413645165,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5301,GO:0014873,1,0.958084714756922,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5305,GO:0014878,1,0.920176953556396,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5307,GO:0014886,1,0.958779797079044,0,2,transition between slow and fast fiber,BP,
5308,GO:0014887,1,0.677522421160923,0,19,cardiac muscle adaptation,BP,
5313,GO:0014895,1,0.978472181035402,0,1,smooth muscle hypertrophy,BP,
5316,GO:0014898,1,0.677522421160923,0,19,cardiac muscle hypertrophy in response to stress,BP,
5317,GO:0014900,1,0.917722987544883,0,4,muscle hyperplasia,BP,
5318,GO:0014901,1,0.937571124521394,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5320,GO:0014904,1,0.513236770070975,0,32,myotube cell development,BP,
5321,GO:0014905,1,0.97847906111944,0,1,myoblast fusion involved in skeletal muscle regeneration,BP,
5322,GO:0014908,1,0.93896182974494,0,3,myotube differentiation involved in skeletal muscle regeneration,BP,
5326,GO:0014912,1,0.662343699062299,0,20,negative regulation of smooth muscle cell migration,BP,
5327,GO:0014916,1,0.944622782861323,0,3,regulation of lung blood pressure,BP,
5330,GO:0015014,1,0.938546727369325,0,3,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5331,GO:0015015,1,0.90190639749041,0,5,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5332,GO:0015016,1,0.92262441562954,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5333,GO:0015018,1,0.937701627946246,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5334,GO:0015019,1,0.979725404150932,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5335,GO:0015020,1,0.516304744681294,0,31,glucuronosyltransferase activity,MF,
5336,GO:0015026,1,0.470415771415419,0,36,coreceptor activity,MF,
5337,GO:0015030,1,0.353376095696692,0,49,Cajal body,CC,
5339,GO:0015035,1,0.64002279523971,0,21,protein disulfide oxidoreductase activity,MF,
5340,GO:0015036,1,0.434725431849297,0,39,disulfide oxidoreductase activity,MF,
5341,GO:0015037,1,0.755996731404933,0,13,peptide disulfide oxidoreductase activity,MF,
5342,GO:0015038,1,0.897437035736078,0,5,glutathione disulfide oxidoreductase activity,MF,
5343,GO:0015039,1,0.978716402207837,0,1,NADPH-adrenodoxin reductase activity,MF,
5344,GO:0015052,1,0.978998661114604,0,1,beta3-adrenergic receptor activity,MF,
5345,GO:0015054,1,0.978807304253668,0,1,gastrin receptor activity,MF,
5346,GO:0015055,1,0.978689435515459,0,1,secretin receptor activity,MF,
5347,GO:0015056,1,0.958066240936387,0,2,corticotrophin-releasing factor receptor activity,MF,
5348,GO:0015057,1,0.899466087471498,0,5,thrombin-activated receptor activity,MF,
5350,GO:0015067,1,0.978983494587486,0,1,amidinotransferase activity,MF,
5351,GO:0015068,1,0.978983494587486,0,1,glycine amidinotransferase activity,MF,
5352,GO:0015074,1,0.812020973965047,0,10,DNA integration,BP,
5359,GO:0015086,1,0.97915312387682,0,1,cadmium ion transmembrane transporter activity,MF,
5360,GO:0015087,1,0.97915312387682,0,1,cobalt ion transmembrane transporter activity,MF,
5361,GO:0015088,1,0.979429643842571,0,1,copper uptake transmembrane transporter activity,MF,
5363,GO:0015093,1,0.938889762303193,0,3,ferrous iron transmembrane transporter activity,MF,
5364,GO:0015094,1,0.97915312387682,0,1,lead ion transmembrane transporter activity,MF,
5366,GO:0015098,1,0.978716601309991,0,1,molybdate ion transmembrane transporter activity,MF,
5367,GO:0015101,1,0.742232823424916,0,14,organic cation transmembrane transporter activity,MF,
5369,GO:0015105,1,0.978534450789495,0,1,arsenite transmembrane transporter activity,MF,
5370,GO:0015106,1,0.676107784539958,0,19,bicarbonate transmembrane transporter activity,MF,
5372,GO:0015111,1,0.939048533494933,0,3,iodide transmembrane transporter activity,MF,
5373,GO:0015112,1,0.979001894111168,0,1,nitrate transmembrane transporter activity,MF,
5374,GO:0015114,1,0.700623969642632,0,17,phosphate ion transmembrane transporter activity,MF,
5375,GO:0015116,1,0.745759117294062,0,14,sulfate transmembrane transporter activity,MF,
5376,GO:0015117,1,0.978713223128666,0,1,thiosulfate transmembrane transporter activity,MF,
5377,GO:0015119,1,0.93833255914652,0,3,hexose phosphate transmembrane transporter activity,MF,
5378,GO:0015125,1,0.759503887473232,0,13,bile acid transmembrane transporter activity,MF,
5379,GO:0015126,1,0.979442107184009,0,1,canalicular bile acid transmembrane transporter activity,MF,
5380,GO:0015127,1,0.979621893999958,0,1,bilirubin transmembrane transporter activity,MF,
5381,GO:0015129,1,0.900419582934008,0,5,lactate transmembrane transporter activity,MF,
5382,GO:0015130,1,0.979143855843724,0,1,mevalonate transmembrane transporter activity,MF,
5383,GO:0015131,1,0.978713223128666,0,1,oxaloacetate transmembrane transporter activity,MF,
5384,GO:0015132,1,0.979171362710354,0,1,prostaglandin transmembrane transporter activity,MF,
5385,GO:0015136,1,0.979069289906018,0,1,sialic acid transmembrane transporter activity,MF,
5386,GO:0015137,1,0.918554608635583,0,4,citrate transmembrane transporter activity,MF,
5387,GO:0015139,1,0.979044870566797,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5388,GO:0015140,1,0.957837048206783,0,2,malate transmembrane transporter activity,MF,
5389,GO:0015141,1,0.938219512103314,0,3,succinate transmembrane transporter activity,MF,
5390,GO:0015142,1,0.918554608635583,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5391,GO:0015143,1,0.807229500283578,0,10,urate transmembrane transporter activity,MF,
5395,GO:0015152,1,0.978802303481413,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5398,GO:0015165,1,0.882455489129194,0,6,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5399,GO:0015166,1,0.831471846844485,0,9,polyol transmembrane transporter activity,MF,
5400,GO:0015168,1,0.879635945434374,0,6,glycerol transmembrane transporter activity,MF,
5403,GO:0015173,1,0.938368148354364,0,3,aromatic amino acid transmembrane transporter activity,MF,
5404,GO:0015174,1,0.829461963447803,0,9,basic amino acid transmembrane transporter activity,MF,
5405,GO:0015175,1,0.521583987581158,0,31,neutral amino acid transmembrane transporter activity,MF,
5407,GO:0015180,1,0.863135586747368,0,7,L-alanine transmembrane transporter activity,MF,
5408,GO:0015181,1,0.922715095260228,0,4,arginine transmembrane transporter activity,MF,
5409,GO:0015182,1,0.958414065007485,0,2,L-asparagine transmembrane transporter activity,MF,
5410,GO:0015183,1,0.918471966180974,0,4,L-aspartate transmembrane transporter activity,MF,
5411,GO:0015184,1,0.918526485130887,0,4,L-cystine transmembrane transporter activity,MF,
5412,GO:0015185,1,0.899240118633614,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5413,GO:0015186,1,0.918508179082568,0,4,L-glutamine transmembrane transporter activity,MF,
5414,GO:0015187,1,0.844609579967218,0,8,glycine transmembrane transporter activity,MF,
5415,GO:0015189,1,0.940279327602099,0,3,L-lysine transmembrane transporter activity,MF,
5416,GO:0015190,1,0.979031017376563,0,1,L-leucine transmembrane transporter activity,MF,
5417,GO:0015191,1,0.979031017376563,0,1,L-methionine transmembrane transporter activity,MF,
5418,GO:0015193,1,0.863419930073368,0,7,L-proline transmembrane transporter activity,MF,
5419,GO:0015194,1,0.824956303264918,0,9,L-serine transmembrane transporter activity,MF,
5420,GO:0015195,1,0.979197954218797,0,1,L-threonine transmembrane transporter activity,MF,
5421,GO:0015196,1,0.978944776214029,0,1,L-tryptophan transmembrane transporter activity,MF,
5423,GO:0015198,1,0.901840635132546,0,5,oligopeptide transporter activity,MF,
5424,GO:0015199,1,0.918002279022098,0,4,amino-acid betaine transmembrane transporter activity,MF,
5425,GO:0015203,1,0.978482569930147,0,1,polyamine transmembrane transporter activity,MF,
5426,GO:0015204,1,0.918621019200229,0,4,urea transmembrane transporter activity,MF,
5427,GO:0015205,1,0.84467300783553,0,8,nucleobase transmembrane transporter activity,MF,
5428,GO:0015207,1,0.937705695405564,0,3,adenine transmembrane transporter activity,MF,
5429,GO:0015211,1,0.918350471026412,0,4,purine nucleoside transmembrane transporter activity,MF,
5430,GO:0015215,1,0.710962531594016,0,16,nucleotide transmembrane transporter activity,MF,
5431,GO:0015216,1,0.774306150759992,0,12,purine nucleotide transmembrane transporter activity,MF,
5432,GO:0015217,1,0.825332143214777,0,9,ADP transmembrane transporter activity,MF,
5433,GO:0015218,1,0.958377835580009,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5434,GO:0015220,1,0.881334723334943,0,6,choline transmembrane transporter activity,MF,
5435,GO:0015222,1,0.938371270133689,0,3,serotonin transmembrane transporter activity,MF,
5436,GO:0015226,1,0.918002279022098,0,4,carnitine transmembrane transporter activity,MF,
5437,GO:0015227,1,0.958061124992007,0,2,acyl carnitine transmembrane transporter activity,MF,
5438,GO:0015228,1,0.958375216158895,0,2,coenzyme A transmembrane transporter activity,MF,
5439,GO:0015229,1,0.960341204069287,0,2,L-ascorbic acid transporter activity,MF,
5440,GO:0015230,1,0.958369961268823,0,2,FAD transmembrane transporter activity,MF,
5442,GO:0015234,1,0.918178456923971,0,4,thiamine transmembrane transporter activity,MF,
5443,GO:0015235,1,0.939294237623536,0,3,cobalamin transporter activity,MF,
5446,GO:0015247,1,0.964794126877812,0,2,aminophospholipid transporter activity,MF,
5448,GO:0015250,1,0.790761759652578,0,11,water channel activity,MF,
5449,GO:0015252,1,0.880135004902636,0,6,hydrogen ion channel activity,MF,
5450,GO:0015254,1,0.917619651868604,0,4,glycerol channel activity,MF,
5451,GO:0015265,1,0.93818400690487,0,3,urea channel activity,MF,
5452,GO:0015266,1,0.788973341510569,0,11,protein channel activity,MF,
5454,GO:0015269,1,0.66864531876586,0,19,calcium-activated potassium channel activity,MF,
5456,GO:0015272,1,0.900029068039412,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5457,GO:0015275,1,0.938566714591349,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5459,GO:0015277,1,0.903208424396187,0,5,kainate selective glutamate receptor activity,MF,
5460,GO:0015278,1,0.711430036857159,0,18,calcium-release channel activity,MF,
5461,GO:0015279,1,0.796748848423674,0,11,store-operated calcium channel activity,MF,
5462,GO:0015280,1,0.828121644282448,0,9,ligand-gated sodium channel activity,MF,
5463,GO:0015288,1,0.879109646114181,0,6,porin activity,MF,
5465,GO:0015292,1,0.97897493185122,0,1,uniporter activity,MF,
5469,GO:0015296,1,0.360961818581872,0,49,anion:cation symporter activity,MF,
5470,GO:0015297,1,0.19053779341248,0,79,antiporter activity,MF,
5471,GO:0015298,1,0.510169024855199,0,32,solute:cation antiporter activity,MF,
5472,GO:0015299,1,0.669954865245593,0,19,solute:proton antiporter activity,MF,
5473,GO:0015301,1,0.522606934618317,0,31,anion:anion antiporter activity,MF,
5474,GO:0015307,1,0.937878938602896,0,3,drug:proton antiporter activity,MF,
5475,GO:0015315,1,0.93833255914652,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5476,GO:0015319,1,0.979058019567663,0,1,sodium:inorganic phosphate symporter activity,MF,
5477,GO:0015320,1,0.978636799951147,0,1,phosphate ion carrier activity,MF,
5478,GO:0015321,1,0.86167673743537,0,7,sodium-dependent phosphate transmembrane transporter activity,MF,
5479,GO:0015322,1,0.958579123753418,0,2,secondary active oligopeptide transmembrane transporter activity,MF,
5480,GO:0015327,1,0.982973597968147,0,1,cystine:glutamate antiporter activity,MF,
5481,GO:0015328,1,0.982973597968147,0,1,cystine secondary active transmembrane transporter activity,MF,
5482,GO:0015333,1,0.919347670279827,0,4,peptide:proton symporter activity,MF,
5483,GO:0015347,1,0.711558743202124,0,16,sodium-independent organic anion transmembrane transporter activity,MF,
5484,GO:0015349,1,0.899682226435595,0,5,thyroid hormone transmembrane transporter activity,MF,
5485,GO:0015350,1,0.960125288972702,0,2,methotrexate transporter activity,MF,
5486,GO:0015361,1,0.978931978465158,0,1,low-affinity sodium:dicarboxylate symporter activity,MF,
5487,GO:0015362,1,0.979123598204153,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5488,GO:0015367,1,0.978671009854582,0,1,oxoglutarate:malate antiporter activity,MF,
5489,GO:0015368,1,0.811511841150397,0,10,calcium:cation antiporter activity,MF,
5491,GO:0015373,1,0.979070730532562,0,1,monovalent anion:sodium symporter activity,MF,
5492,GO:0015375,1,0.958551973080917,0,2,glycine:sodium symporter activity,MF,
5493,GO:0015377,1,0.833265758475147,0,9,cation:chloride symporter activity,MF,
5494,GO:0015378,1,0.97999051875525,0,1,sodium:chloride symporter activity,MF,
5495,GO:0015379,1,0.885019615627168,0,6,potassium:chloride symporter activity,MF,
5496,GO:0015382,1,0.958568839382261,0,2,sodium:sulfate symporter activity,MF,
5497,GO:0015385,1,0.761272106574652,0,13,sodium:proton antiporter activity,MF,
5498,GO:0015386,1,0.794344499371348,0,11,potassium:proton antiporter activity,MF,
5499,GO:0015389,1,0.95807345739897,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5500,GO:0015390,1,0.978850324501421,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5502,GO:0015403,1,0.938237621260526,0,3,thiamine uptake transmembrane transporter activity,MF,
5504,GO:0015410,1,0.97909077167431,0,1,manganese-transporting ATPase activity,MF,
5505,GO:0015420,1,0.9806206324592,0,1,cobalamin-transporting ATPase activity,MF,
5506,GO:0015421,1,0.979069938689473,0,1,oligopeptide-transporting ATPase activity,MF,
5507,GO:0015431,1,0.9806206324592,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5508,GO:0015432,1,0.95894122958297,0,2,bile acid-exporting ATPase activity,MF,
5509,GO:0015433,1,0.958621043518678,0,2,peptide antigen-transporting ATPase activity,MF,
5510,GO:0015439,1,0.979058353496236,0,1,heme-transporting ATPase activity,MF,
5511,GO:0015440,1,0.918894100279574,0,4,peptide-transporting ATPase activity,MF,
5512,GO:0015450,1,0.841915419209337,0,8,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5513,GO:0015459,1,0.398205838021639,0,44,potassium channel regulator activity,MF,
5514,GO:0015464,1,0.62630196816235,0,22,acetylcholine receptor activity,MF,
5515,GO:0015467,1,0.810241949651419,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5517,GO:0015489,1,0.978482569930147,0,1,putrescine transmembrane transporter activity,MF,
5518,GO:0015491,1,0.55572121157514,0,28,cation:cation antiporter activity,MF,
5519,GO:0015495,1,0.978978646038796,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5520,GO:0015499,1,0.979002557919102,0,1,formate transmembrane transporter activity,MF,
5521,GO:0015501,1,0.963957192526421,0,2,glutamate:sodium symporter activity,MF,
5522,GO:0015526,1,0.93833255914652,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5523,GO:0015538,1,0.979069289906018,0,1,sialic acid:proton symporter activity,MF,
5524,GO:0015556,1,0.843328689872706,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5525,GO:0015562,1,0.901937465365667,0,5,efflux transmembrane transporter activity,MF,
5526,GO:0015563,1,0.918533645310494,0,4,uptake transmembrane transporter activity,MF,
5527,GO:0015578,1,0.978939852572812,0,1,mannose transmembrane transporter activity,MF,
5528,GO:0015605,1,0.667079808820083,0,19,organophosphate ester transmembrane transporter activity,MF,
5529,GO:0015607,1,0.979073318659778,0,1,fatty-acyl-CoA transporter activity,MF,
5530,GO:0015616,1,0.943226733580065,0,3,DNA translocase activity,MF,
5534,GO:0015633,1,0.978797301018103,0,1,zinc-transporting ATPase activity,MF,
5535,GO:0015635,1,0.978885722673793,0,1,short-chain fatty acid transporter activity,MF,
5536,GO:0015636,1,0.978885722673793,0,1,short-chain fatty acid uptake transporter activity,MF,
5537,GO:0015639,1,0.97915312387682,0,1,ferrous iron uptake transmembrane transporter activity,MF,
5538,GO:0015643,1,0.791826386199824,0,11,toxic substance binding,MF,
5540,GO:0015651,1,0.843772353747049,0,8,quaternary ammonium group transmembrane transporter activity,MF,
5541,GO:0015658,1,0.979031017376563,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5542,GO:0015659,1,0.979002557919102,0,1,formate uptake transmembrane transporter activity,MF,
5543,GO:0015660,1,0.979002557919102,0,1,formate efflux transmembrane transporter activity,MF,
5544,GO:0015662,1,0.465991206057197,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5545,GO:0015665,1,0.831471846844485,0,9,alcohol transmembrane transporter activity,MF,
5546,GO:0015669,1,0.664306293000613,0,19,gas transport,BP,
5547,GO:0015670,1,0.917732419127819,0,4,carbon dioxide transport,BP,
5548,GO:0015671,1,0.72391090720771,0,15,oxygen transport,BP,
5550,GO:0015677,1,0.887051754258149,0,6,copper ion import,BP,
5551,GO:0015679,1,0.982162731756738,0,1,plasma membrane copper ion transport,BP,
5552,GO:0015680,1,0.938822956447303,0,3,intracellular copper ion transport,BP,
5555,GO:0015688,1,0.937625972192459,0,3,iron chelate transport,BP,
5556,GO:0015689,1,0.978716601309991,0,1,molybdate ion transport,BP,
5557,GO:0015691,1,0.918671756472773,0,4,cadmium ion transport,BP,
5558,GO:0015692,1,0.97915312387682,0,1,lead ion transport,BP,
5560,GO:0015694,1,0.979621893999958,0,1,mercury ion transport,BP,
5561,GO:0015695,1,0.638692389803365,0,21,organic cation transport,BP,
5563,GO:0015697,1,0.808941462319823,0,10,quaternary ammonium group transport,BP,
5565,GO:0015701,1,0.396022562328473,0,44,bicarbonate transport,BP,
5566,GO:0015705,1,0.906012502679822,0,5,iodide transport,BP,
5567,GO:0015706,1,0.979001894111168,0,1,nitrate transport,BP,
5568,GO:0015707,1,0.979088056130525,0,1,nitrite transport,BP,
5569,GO:0015709,1,0.978713223128666,0,1,thiosulfate transport,BP,
5571,GO:0015712,1,0.879833249484983,0,6,hexose phosphate transport,BP,
5573,GO:0015721,1,0.531389271662634,0,30,bile acid and bile salt transport,BP,
5574,GO:0015722,1,0.939389048523432,0,3,canalicular bile acid transport,BP,
5575,GO:0015723,1,0.979621893999958,0,1,bilirubin transport,BP,
5576,GO:0015724,1,0.979002557919102,0,1,formate transport,BP,
5577,GO:0015727,1,0.88168593374972,0,6,lactate transport,BP,
5578,GO:0015728,1,0.979143855843724,0,1,mevalonate transport,BP,
5579,GO:0015729,1,0.978713223128666,0,1,oxaloacetate transport,BP,
5581,GO:0015734,1,0.980698373787216,0,1,taurine transport,BP,
5582,GO:0015739,1,0.979069289906018,0,1,sialic acid transport,BP,
5584,GO:0015742,1,0.937851476603131,0,3,alpha-ketoglutarate transport,BP,
5585,GO:0015743,1,0.978713223128666,0,1,malate transport,BP,
5586,GO:0015744,1,0.938219512103314,0,3,succinate transport,BP,
5587,GO:0015746,1,0.918554608635583,0,4,citrate transport,BP,
5588,GO:0015747,1,0.807453911144024,0,10,urate transport,BP,
5591,GO:0015755,1,0.958293063079837,0,2,fructose transport,BP,
5593,GO:0015760,1,0.879833249484983,0,6,glucose-6-phosphate transport,BP,
5594,GO:0015761,1,0.978939852572812,0,1,mannose transport,BP,
5598,GO:0015780,1,0.845805721824297,0,8,nucleotide-sugar transport,BP,
5599,GO:0015781,1,0.882455489129194,0,6,pyrimidine nucleotide-sugar transport,BP,
5600,GO:0015782,1,0.978683724190989,0,1,CMP-N-acetylneuraminate transport,BP,
5601,GO:0015783,1,0.940200850030415,0,3,GDP-fucose transport,BP,
5602,GO:0015785,1,0.957626944989284,0,2,UDP-galactose transport,BP,
5603,GO:0015787,1,0.980664434249937,0,1,UDP-glucuronic acid transport,BP,
5604,GO:0015788,1,0.960152739692197,0,2,UDP-N-acetylglucosamine transport,BP,
5605,GO:0015790,1,0.980928878352256,0,1,UDP-xylose transport,BP,
5606,GO:0015791,1,0.800957086239323,0,11,polyol transport,BP,
5607,GO:0015793,1,0.879635945434374,0,6,glycerol transport,BP,
5608,GO:0015797,1,0.979002557919102,0,1,mannitol transport,BP,
5609,GO:0015798,1,0.950165721065881,0,3,myo-inositol transport,BP,
5611,GO:0015801,1,0.899304662084032,0,5,aromatic amino acid transport,BP,
5612,GO:0015802,1,0.761412614456962,0,13,basic amino acid transport,BP,
5613,GO:0015803,1,0.920231351805688,0,4,branched-chain amino acid transport,BP,
5614,GO:0015804,1,0.478586728868181,0,35,neutral amino acid transport,BP,
5615,GO:0015805,1,0.978852367704527,0,1,S-adenosyl-L-methionine transport,BP,
5617,GO:0015808,1,0.863135586747368,0,7,L-alanine transport,BP,
5618,GO:0015809,1,0.847036269763429,0,8,arginine transport,BP,
5620,GO:0015811,1,0.918526485130887,0,4,L-cystine transport,BP,
5621,GO:0015812,1,0.781490192022959,0,12,gamma-aminobutyric acid transport,BP,
5623,GO:0015816,1,0.811525855324253,0,10,glycine transport,BP,
5624,GO:0015817,1,0.958414065007485,0,2,histidine transport,BP,
5625,GO:0015819,1,0.920512109461085,0,4,lysine transport,BP,
5626,GO:0015820,1,0.939944319836157,0,3,leucine transport,BP,
5627,GO:0015821,1,0.979031017376563,0,1,methionine transport,BP,
5628,GO:0015822,1,0.940380176930877,0,3,ornithine transport,BP,
5629,GO:0015824,1,0.829601385682542,0,9,proline transport,BP,
5630,GO:0015825,1,0.824956303264918,0,9,L-serine transport,BP,
5631,GO:0015826,1,0.979197954218797,0,1,threonine transport,BP,
5632,GO:0015827,1,0.938196719507831,0,3,tryptophan transport,BP,
5633,GO:0015828,1,0.979067237834846,0,1,tyrosine transport,BP,
5636,GO:0015838,1,0.880115702576891,0,6,amino-acid betaine transport,BP,
5637,GO:0015840,1,0.879686547658414,0,6,urea transport,BP,
5638,GO:0015842,1,0.917897047085177,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5640,GO:0015846,1,0.879423336608889,0,6,polyamine transport,BP,
5641,GO:0015847,1,0.978482569930147,0,1,putrescine transport,BP,
5644,GO:0015851,1,0.826560194347533,0,9,nucleobase transport,BP,
5645,GO:0015853,1,0.917603589168227,0,4,adenine transport,BP,
5646,GO:0015855,1,0.938010106545246,0,3,pyrimidine nucleobase transport,BP,
5648,GO:0015860,1,0.95824160838386,0,2,purine nucleoside transmembrane transport,BP,
5649,GO:0015862,1,0.97889356557901,0,1,uridine transport,BP,
5650,GO:0015864,1,0.958189094002354,0,2,pyrimidine nucleoside transport,BP,
5652,GO:0015866,1,0.825332143214777,0,9,ADP transport,BP,
5653,GO:0015867,1,0.79111820427684,0,11,ATP transport,BP,
5655,GO:0015870,1,0.899155350174542,0,5,acetylcholine transport,BP,
5656,GO:0015871,1,0.846686247021908,0,8,choline transport,BP,
5659,GO:0015876,1,0.979003744219237,0,1,acetyl-CoA transport,BP,
5660,GO:0015878,1,0.979069249607708,0,1,biotin transport,BP,
5661,GO:0015879,1,0.898540171680116,0,5,carnitine transport,BP,
5662,GO:0015880,1,0.958375216158895,0,2,coenzyme A transport,BP,
5663,GO:0015881,1,0.958845604361552,0,2,creatine transport,BP,
5664,GO:0015882,1,0.960341204069287,0,2,L-ascorbic acid transport,BP,
5665,GO:0015883,1,0.958369961268823,0,2,FAD transport,BP,
5666,GO:0015884,1,0.862222459623871,0,7,folic acid transport,BP,
5668,GO:0015887,1,0.979069249607708,0,1,pantothenate transmembrane transport,BP,
5669,GO:0015888,1,0.898937144877977,0,5,thiamine transport,BP,
5670,GO:0015889,1,0.848220222613102,0,8,cobalamin transport,BP,
5671,GO:0015891,1,0.937625972192459,0,3,siderophore transport,BP,
5673,GO:0015904,1,0.97870278571451,0,1,tetracycline transport,BP,
5676,GO:0015910,1,0.958396037851307,0,2,peroxisomal long-chain fatty acid import,BP,
5678,GO:0015912,1,0.978885722673793,0,1,short-chain fatty acid transport,BP,
5679,GO:0015913,1,0.978885722673793,0,1,short-chain fatty acid import,BP,
5681,GO:0015916,1,0.979003744219237,0,1,fatty-acyl-CoA transport,BP,
5682,GO:0015917,1,0.946768230842359,0,3,aminophospholipid transport,BP,
5684,GO:0015919,1,0.862291618163858,0,7,peroxisomal membrane transport,BP,
5685,GO:0015920,1,0.958146936885414,0,2,lipopolysaccharide transport,BP,
5686,GO:0015922,1,0.978616217014486,0,1,aspartate oxidase activity,MF,
5687,GO:0015923,1,0.748145576074421,0,14,mannosidase activity,MF,
5688,GO:0015924,1,0.831357964184464,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5690,GO:0015926,1,0.780994368370099,0,12,glucosidase activity,MF,
5691,GO:0015927,1,0.978702590235847,0,1,trehalase activity,MF,
5692,GO:0015928,1,0.958052749877667,0,2,fucosidase activity,MF,
5695,GO:0015932,1,0.466281650277183,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5697,GO:0015935,1,0.230181689866753,0,68,small ribosomal subunit,CC,
5702,GO:0015942,1,0.879718626242724,0,6,formate metabolic process,BP,
5703,GO:0015949,1,0.624684906637326,0,22,nucleobase-containing small molecule interconversion,BP,
5704,GO:0015959,1,0.861542645753118,0,7,diadenosine polyphosphate metabolic process,BP,
5705,GO:0015960,1,0.938220008959174,0,3,diadenosine polyphosphate biosynthetic process,BP,
5706,GO:0015961,1,0.918287180998757,0,4,diadenosine polyphosphate catabolic process,BP,
5707,GO:0015965,1,0.938220008959174,0,3,diadenosine tetraphosphate metabolic process,BP,
5708,GO:0015966,1,0.938220008959174,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5710,GO:0015985,1,0.583871319631367,0,25,energy coupled proton transport, down electrochemical gradient,BP,
5711,GO:0015986,1,0.583871319631367,0,25,ATP synthesis coupled proton transport,BP,
5712,GO:0015988,1,0.562943382571292,0,27,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5713,GO:0015991,1,0.562943382571292,0,27,ATP hydrolysis coupled proton transport,BP,
5715,GO:0015993,1,0.960158335201413,0,2,molecular hydrogen transport,BP,
5716,GO:0016004,1,0.791798428802733,0,11,phospholipase activator activity,MF,
5717,GO:0016005,1,0.958957390016436,0,2,phospholipase A2 activator activity,MF,
5718,GO:0016010,1,0.650334197735236,0,21,dystrophin-associated glycoprotein complex,CC,
5719,GO:0016011,1,0.865391453270017,0,7,dystroglycan complex,CC,
5720,GO:0016012,1,0.88298642651914,0,6,sarcoglycan complex,CC,
5721,GO:0016013,1,0.920181354570326,0,4,syntrophin complex,CC,
5722,GO:0016015,1,0.860474766332495,0,7,morphogen activity,MF,
5723,GO:0016018,1,0.809285610028674,0,10,cyclosporin A binding,MF,
5724,GO:0016019,1,0.897483949545353,0,5,peptidoglycan receptor activity,MF,
5727,GO:0016024,1,0.797588989594397,0,11,CDP-diacylglycerol biosynthetic process,BP,
5728,GO:0016028,1,0.979072220695289,0,1,rhabdomere,CC,
5729,GO:0016031,1,0.957988132385936,0,2,tRNA import into mitochondrion,BP,
5731,GO:0016034,1,0.978545059482444,0,1,maleylacetoacetate isomerase activity,MF,
5732,GO:0016035,1,0.947516323891735,0,3,zeta DNA polymerase complex,CC,
5733,GO:0016036,1,0.978869190667263,0,1,cellular response to phosphate starvation,BP,
5734,GO:0016037,1,0.979028492572226,0,1,light absorption,BP,
5735,GO:0016038,1,0.979028492572226,0,1,absorption of visible light,BP,
5738,GO:0016045,1,0.775859292911771,0,12,detection of bacterium,BP,
5739,GO:0016046,1,0.980039409153451,0,1,detection of fungus,BP,
5749,GO:0016062,1,0.958477094010263,0,2,adaptation of rhodopsin mediated signaling,BP,
5751,GO:0016068,1,0.937330841176849,0,3,type I hypersensitivity,BP,
5755,GO:0016073,1,0.195017818146039,0,77,snRNA metabolic process,BP,
5756,GO:0016074,1,0.756124422169427,0,13,snoRNA metabolic process,BP,
5757,GO:0016075,1,0.730488506969549,0,15,rRNA catabolic process,BP,
5758,GO:0016077,1,0.980330905715007,0,1,snoRNA catabolic process,BP,
5759,GO:0016078,1,0.938055540604411,0,3,tRNA catabolic process,BP,
5761,GO:0016080,1,0.921120915219771,0,4,synaptic vesicle targeting,BP,
5762,GO:0016081,1,0.849189009195433,0,8,synaptic vesicle docking,BP,
5763,GO:0016082,1,0.766369504911921,0,13,synaptic vesicle priming,BP,
5764,GO:0016093,1,0.842578373344978,0,8,polyprenol metabolic process,BP,
5765,GO:0016094,1,0.958944585129293,0,2,polyprenol biosynthetic process,BP,
5766,GO:0016095,1,0.937484832877258,0,3,polyprenol catabolic process,BP,
5767,GO:0016098,1,0.879170965534819,0,6,monoterpenoid metabolic process,BP,
5769,GO:0016102,1,0.842814261602202,0,8,diterpenoid biosynthetic process,BP,
5770,GO:0016103,1,0.917858529454904,0,4,diterpenoid catabolic process,BP,
5771,GO:0016107,1,0.957593049659306,0,2,sesquiterpenoid catabolic process,BP,
5772,GO:0016108,1,0.979044015025739,0,1,tetraterpenoid metabolic process,BP,
5773,GO:0016114,1,0.807453497439791,0,10,terpenoid biosynthetic process,BP,
5774,GO:0016115,1,0.878926056045738,0,6,terpenoid catabolic process,BP,
5775,GO:0016116,1,0.979044015025739,0,1,carotenoid metabolic process,BP,
5776,GO:0016119,1,0.979044015025739,0,1,carotene metabolic process,BP,
5777,GO:0016121,1,0.979044015025739,0,1,carotene catabolic process,BP,
5778,GO:0016122,1,0.979044015025739,0,1,xanthophyll metabolic process,BP,
5781,GO:0016127,1,0.792533051786253,0,11,sterol catabolic process,BP,
5788,GO:0016149,1,0.938299519905381,0,3,translation release factor activity, codon specific,MF,
5789,GO:0016151,1,0.95796208817031,0,2,nickel cation binding,MF,
5790,GO:0016153,1,0.979069338655521,0,1,urocanate hydratase activity,MF,
5791,GO:0016154,1,0.978629530647796,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5792,GO:0016155,1,0.960910549710061,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5793,GO:0016160,1,0.880640276045268,0,6,amylase activity,MF,
5794,GO:0016165,1,0.958343739176282,0,2,linoleate 13S-lipoxygenase activity,MF,
5795,GO:0016167,1,0.941478324596988,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5796,GO:0016174,1,0.883235759222156,0,6,NAD(P)H oxidase activity,MF,
5797,GO:0016175,1,0.825415258005798,0,9,superoxide-generating NADPH oxidase activity,MF,
5799,GO:0016180,1,0.684876106404348,0,18,snRNA processing,BP,
5800,GO:0016182,1,0.979459574969247,0,1,synaptic vesicle budding from endosome,BP,
5801,GO:0016185,1,0.960999752357493,0,2,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5802,GO:0016188,1,0.830132334722686,0,9,synaptic vesicle maturation,BP,
5803,GO:0016189,1,0.981817670480053,0,1,synaptic vesicle to endosome fusion,BP,
5804,GO:0016191,1,0.902551963234493,0,5,synaptic vesicle uncoating,BP,
5807,GO:0016198,1,0.865254186053851,0,7,axon choice point recognition,BP,
5808,GO:0016199,1,0.902980346200145,0,5,axon midline choice point recognition,BP,
5810,GO:0016203,1,0.981351326617653,0,1,muscle attachment,BP,
5811,GO:0016206,1,0.958373550293268,0,2,catechol O-methyltransferase activity,MF,
5812,GO:0016208,1,0.790505316289299,0,11,AMP binding,MF,
5814,GO:0016211,1,0.959507843292867,0,2,ammonia ligase activity,MF,
5815,GO:0016212,1,0.958233963409113,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5816,GO:0016213,1,0.979067265153926,0,1,linoleoyl-CoA desaturase activity,MF,
5817,GO:0016215,1,0.939225654804269,0,3,acyl-CoA desaturase activity,MF,
5818,GO:0016222,1,0.958465011604308,0,2,procollagen-proline 4-dioxygenase complex,CC,
5819,GO:0016226,1,0.680059835493256,0,18,iron-sulfur cluster assembly,BP,
5821,GO:0016230,1,0.958074183616173,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5822,GO:0016231,1,0.979659781208998,0,1,beta-N-acetylglucosaminidase activity,MF,
5823,GO:0016232,1,0.979037461697518,0,1,HNK-1 sulfotransferase activity,MF,
5824,GO:0016233,1,0.328761333670243,0,53,telomere capping,BP,
5825,GO:0016234,1,0.213286103698008,0,75,inclusion body,CC,
5826,GO:0016235,1,0.454285774390071,0,38,aggresome,CC,
5828,GO:0016237,1,0.958830273278206,0,2,lysosomal microautophagy,BP,
5830,GO:0016240,1,0.920129117410655,0,4,autophagosome docking,BP,
5833,GO:0016243,1,0.979110685393671,0,1,regulation of autophagosome size,BP,
5834,GO:0016246,1,0.813971349562983,0,10,RNA interference,BP,
5837,GO:0016250,1,0.979028888010301,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5838,GO:0016254,1,0.725606377593619,0,15,preassembly of GPI anchor in ER membrane,BP,
5839,GO:0016255,1,0.865685484328543,0,7,attachment of GPI anchor to protein,BP,
5840,GO:0016256,1,0.958982676165664,0,2,N-glycan processing to lysosome,BP,
5841,GO:0016259,1,0.938909443437666,0,3,selenocysteine metabolic process,BP,
5842,GO:0016260,1,0.978866169897787,0,1,selenocysteine biosynthetic process,BP,
5843,GO:0016262,1,0.938881403441003,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5844,GO:0016263,1,0.957865107320785,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5847,GO:0016267,1,0.957865107320785,0,2,O-glycan processing, core 1,BP,
5848,GO:0016269,1,0.978953050207788,0,1,O-glycan processing, core 3,BP,
5849,GO:0016272,1,0.858991044081573,0,7,prefoldin complex,CC,
5850,GO:0016273,1,0.790991124938273,0,11,arginine N-methyltransferase activity,MF,
5851,GO:0016274,1,0.790991124938273,0,11,protein-arginine N-methyltransferase activity,MF,
5852,GO:0016277,1,0.978921358707565,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5853,GO:0016278,1,0.41364238577568,0,43,lysine N-methyltransferase activity,MF,
5854,GO:0016279,1,0.42254712915413,0,42,protein-lysine N-methyltransferase activity,MF,
5855,GO:0016281,1,0.82749604167715,0,9,eukaryotic translation initiation factor 4F complex,CC,
5856,GO:0016282,1,0.979278664911986,0,1,eukaryotic 43S preinitiation complex,CC,
5857,GO:0016286,1,0.918201795958068,0,4,small conductance calcium-activated potassium channel activity,MF,
5858,GO:0016287,1,0.979011365643891,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5860,GO:0016290,1,0.806530643438758,0,10,palmitoyl-CoA hydrolase activity,MF,
5865,GO:0016300,1,0.918736644304053,0,4,tRNA (uracil) methyltransferase activity,MF,
5869,GO:0016308,1,0.864326073173891,0,7,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5870,GO:0016309,1,0.939517528219623,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5873,GO:0016312,1,0.920328212466597,0,4,inositol bisphosphate phosphatase activity,MF,
5874,GO:0016314,1,0.939394719364901,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5875,GO:0016316,1,0.960373323595959,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5876,GO:0016320,1,0.960842511155786,0,2,endoplasmic reticulum membrane fusion,BP,
5877,GO:0016321,1,0.938153685281742,0,3,female meiosis chromosome segregation,BP,
5878,GO:0016322,1,0.80965075156133,0,10,neuron remodeling,BP,
5885,GO:0016333,1,0.979054147488468,0,1,morphogenesis of follicular epithelium,BP,
5886,GO:0016334,1,0.979054147488468,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5890,GO:0016340,1,0.96172371799492,0,2,calcium-dependent cell-matrix adhesion,BP,
5892,GO:0016344,1,0.939994202023559,0,3,meiotic chromosome movement towards spindle pole,BP,
5895,GO:0016362,1,0.968987047219632,0,2,activin receptor activity, type II,MF,
5897,GO:0016401,1,0.958088648314953,0,2,palmitoyl-CoA oxidase activity,MF,
5898,GO:0016402,1,0.938162844106001,0,3,pristanoyl-CoA oxidase activity,MF,
5899,GO:0016403,1,0.958101060599798,0,2,dimethylargininase activity,MF,
5900,GO:0016404,1,0.958729597269,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5908,GO:0016412,1,0.978629204971283,0,1,serine O-acyltransferase activity,MF,
5909,GO:0016413,1,0.86205201804855,0,7,O-acetyltransferase activity,MF,
5910,GO:0016414,1,0.979068933807006,0,1,O-octanoyltransferase activity,MF,
5911,GO:0016415,1,0.958007872197996,0,2,octanoyltransferase activity,MF,
5917,GO:0016421,1,0.88714207790002,0,6,CoA carboxylase activity,MF,
5918,GO:0016422,1,0.957994782383719,0,2,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5919,GO:0016423,1,0.791626811303137,0,11,tRNA (guanine) methyltransferase activity,MF,
5920,GO:0016426,1,0.938059649488798,0,3,tRNA (adenine) methyltransferase activity,MF,
5921,GO:0016427,1,0.863084789090521,0,7,tRNA (cytosine) methyltransferase activity,MF,
5922,GO:0016428,1,0.920275662276157,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5923,GO:0016429,1,0.938059649488798,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5924,GO:0016433,1,0.879361813938897,0,6,rRNA (adenine) methyltransferase activity,MF,
5925,GO:0016434,1,0.958701950548361,0,2,rRNA (cytosine) methyltransferase activity,MF,
5926,GO:0016435,1,0.958796990139584,0,2,rRNA (guanine) methyltransferase activity,MF,
5928,GO:0016442,1,0.814070824384015,0,10,RISC complex,CC,
5931,GO:0016446,1,0.794185281924591,0,11,somatic hypermutation of immunoglobulin genes,BP,
5934,GO:0016454,1,0.901132675132292,0,5,C-palmitoyltransferase activity,MF,
5940,GO:0016469,1,0.371721636586591,0,46,proton-transporting two-sector ATPase complex,CC,
5941,GO:0016471,1,0.711456640088886,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5942,GO:0016476,1,0.939286531385571,0,3,regulation of embryonic cell shape,BP,
5944,GO:0016479,1,0.921257335902039,0,4,negative regulation of transcription from RNA polymerase I promoter,BP,
5948,GO:0016486,1,0.50559752986662,0,32,peptide hormone processing,BP,
5949,GO:0016487,1,0.957593049659306,0,2,farnesol metabolic process,BP,
5950,GO:0016488,1,0.957593049659306,0,2,farnesol catabolic process,BP,
5952,GO:0016492,1,0.958197811167479,0,2,G-protein coupled neurotensin receptor activity,MF,
5953,GO:0016493,1,0.790193515131456,0,11,C-C chemokine receptor activity,MF,
5954,GO:0016494,1,0.860856296973489,0,7,C-X-C chemokine receptor activity,MF,
5955,GO:0016495,1,0.979067851859155,0,1,C-X3-C chemokine receptor activity,MF,
5956,GO:0016496,1,0.979068951853317,0,1,substance P receptor activity,MF,
5957,GO:0016497,1,0.978925784945075,0,1,substance K receptor activity,MF,
5958,GO:0016499,1,0.957895916479675,0,2,orexin receptor activity,MF,
5959,GO:0016500,1,0.792211293170872,0,11,protein-hormone receptor activity,MF,
5960,GO:0016501,1,0.978792298535206,0,1,prostacyclin receptor activity,MF,
5962,GO:0016503,1,0.916788186625516,0,4,pheromone receptor activity,MF,
5965,GO:0016507,1,0.979062897628551,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5966,GO:0016508,1,0.938472451670355,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5967,GO:0016509,1,0.938187776591291,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5968,GO:0016514,1,0.733495859018955,0,15,SWI/SNF complex,CC,
5969,GO:0016517,1,0.978752272893443,0,1,interleukin-12 receptor activity,MF,
5970,GO:0016519,1,0.978771491623365,0,1,gastric inhibitory peptide receptor activity,MF,
5971,GO:0016520,1,0.917570114325491,0,4,growth hormone-releasing hormone receptor activity,MF,
5972,GO:0016521,1,0.97906763508215,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5976,GO:0016530,1,0.902771727468153,0,5,metallochaperone activity,MF,
5977,GO:0016531,1,0.920083570342952,0,4,copper chaperone activity,MF,
5978,GO:0016532,1,0.961033241311551,0,2,superoxide dismutase copper chaperone activity,MF,
5979,GO:0016533,1,0.937875387312298,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5980,GO:0016534,1,0.958472767983224,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5982,GO:0016539,1,0.957841934225913,0,2,intein-mediated protein splicing,BP,
5983,GO:0016540,1,0.793112054918411,0,11,protein autoprocessing,BP,
5984,GO:0016553,1,0.810722479392585,0,10,base conversion or substitution editing,BP,
5985,GO:0016554,1,0.918014076369734,0,4,cytidine to uridine editing,BP,
5987,GO:0016557,1,0.93758174667821,0,3,peroxisome membrane biogenesis,BP,
5988,GO:0016558,1,0.774885797669179,0,12,protein import into peroxisome matrix,BP,
5989,GO:0016559,1,0.824293734027527,0,9,peroxisome fission,BP,
5990,GO:0016560,1,0.938719023379564,0,3,protein import into peroxisome matrix, docking,BP,
5991,GO:0016561,1,0.95824212568591,0,2,protein import into peroxisome matrix, translocation,BP,
5995,GO:0016571,1,0.0819591281662308,0,121,histone methylation,BP,
5996,GO:0016572,1,0.491967258145699,0,34,histone phosphorylation,BP,
5998,GO:0016574,1,0.446271285618471,0,39,histone ubiquitination,BP,
6000,GO:0016576,1,0.881684716406022,0,6,histone dephosphorylation,BP,
6001,GO:0016577,1,0.592607555312734,0,26,histone demethylation,BP,
6002,GO:0016578,1,0.646459212665562,0,21,histone deubiquitination,BP,
6005,GO:0016581,1,0.708070200131037,0,17,NuRD complex,CC,
6006,GO:0016584,1,0.842591154165725,0,8,nucleosome positioning,BP,
6007,GO:0016586,1,0.979275839199062,0,1,RSC complex,CC,
6008,GO:0016589,1,0.868206197432284,0,7,NURF complex,CC,
6009,GO:0016590,1,0.980300365218903,0,1,ACF complex,CC,
6010,GO:0016591,1,0.121984610623276,0,100,DNA-directed RNA polymerase II, holoenzyme,CC,
6011,GO:0016592,1,0.485409332311717,0,35,mediator complex,CC,
6012,GO:0016593,1,0.863194448868274,0,7,Cdc73/Paf1 complex,CC,
6015,GO:0016596,1,0.97897493185122,0,1,thienylcyclohexylpiperidine binding,MF,
6017,GO:0016598,1,0.957987940407617,0,2,protein arginylation,BP,
6019,GO:0016601,1,0.537620976061728,0,30,Rac protein signal transduction,BP,
6020,GO:0016602,1,0.919370624122045,0,4,CCAAT-binding factor complex,CC,
6021,GO:0016603,1,0.957920717372721,0,2,glutaminyl-peptide cyclotransferase activity,MF,
6025,GO:0016608,1,0.957401499836759,0,2,growth hormone-releasing hormone activity,MF,
6029,GO:0016618,1,0.978526668160986,0,1,hydroxypyruvate reductase activity,MF,
6030,GO:0016620,1,0.475753239080636,0,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
6032,GO:0016624,1,0.843695258398849,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
6035,GO:0016634,1,0.827407820381599,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
6036,GO:0016635,1,0.917446309854057,0,4,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
6038,GO:0016639,1,0.937845149431137,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
6039,GO:0016641,1,0.742545063021297,0,14,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
6042,GO:0016646,1,0.714866405385573,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
6043,GO:0016647,1,0.937692409173877,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
6046,GO:0016652,1,0.958318522259334,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
6047,GO:0016653,1,0.776607388218472,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
6048,GO:0016655,1,0.331047771321875,0,51,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
6049,GO:0016657,1,0.957751632362377,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
6050,GO:0016661,1,0.89897051194906,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
6051,GO:0016662,1,0.978987637002078,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6053,GO:0016668,1,0.7245796011245,0,15,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
6054,GO:0016670,1,0.863149535738279,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
6056,GO:0016672,1,0.957517757905205,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
6059,GO:0016679,1,0.823510318134138,0,9,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
6060,GO:0016681,1,0.841192282869693,0,8,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
6062,GO:0016701,1,0.585633926080981,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6063,GO:0016702,1,0.598478295150064,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6066,GO:0016708,1,0.958141991337,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6067,GO:0016709,1,0.476855348250702,0,35,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6068,GO:0016711,1,0.978989672309085,0,1,flavonoid 3'-monooxygenase activity,MF,
6069,GO:0016712,1,0.586275987335397,0,25,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6072,GO:0016715,1,0.91887079133538,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6073,GO:0016716,1,0.95827452321199,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
6075,GO:0016721,1,0.897494621881894,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6077,GO:0016723,1,0.846016311477775,0,8,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6078,GO:0016724,1,0.883214676445763,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6081,GO:0016727,1,0.980116871680728,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6082,GO:0016728,1,0.93893651880209,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6083,GO:0016730,1,0.978716402207837,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6084,GO:0016731,1,0.978716402207837,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6087,GO:0016742,1,0.845478485950387,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6088,GO:0016743,1,0.960200045082201,0,2,carboxyl- or carbamoyltransferase activity,MF,
6089,GO:0016744,1,0.918005482781674,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6092,GO:0016748,1,0.938031581043846,0,3,succinyltransferase activity,MF,
6093,GO:0016749,1,0.958112935985906,0,2,N-succinyltransferase activity,MF,
6094,GO:0016751,1,0.979043139771547,0,1,S-succinyltransferase activity,MF,
6095,GO:0016755,1,0.624645573867042,0,22,transferase activity, transferring amino-acyl groups,MF,
6100,GO:0016768,1,0.978640168514796,0,1,spermine synthase activity,MF,
6101,GO:0016769,1,0.670594926340936,0,19,transferase activity, transferring nitrogenous groups,MF,
6104,GO:0016774,1,0.937947378385292,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6106,GO:0016776,1,0.440074858866921,0,39,phosphotransferase activity, phosphate group as acceptor,MF,
6107,GO:0016778,1,0.879356778345408,0,6,diphosphotransferase activity,MF,
6109,GO:0016780,1,0.683009487326809,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6110,GO:0016781,1,0.958296407796226,0,2,phosphotransferase activity, paired acceptors,MF,
6111,GO:0016782,1,0.231821030656224,0,69,transferase activity, transferring sulfur-containing groups,MF,
6112,GO:0016783,1,0.789122737043118,0,11,sulfurtransferase activity,MF,
6113,GO:0016784,1,0.978575904928287,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6114,GO:0016785,1,0.980041705811129,0,1,transferase activity, transferring selenium-containing groups,MF,
6119,GO:0016793,1,0.9790682465105,0,1,triphosphoric monoester hydrolase activity,MF,
6120,GO:0016794,1,0.978498837827059,0,1,diphosphoric monoester hydrolase activity,MF,
6121,GO:0016796,1,0.367112265195242,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6123,GO:0016799,1,0.624565548387919,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6124,GO:0016801,1,0.824587591494523,0,9,hydrolase activity, acting on ether bonds,MF,
6125,GO:0016802,1,0.978878194325947,0,1,trialkylsulfonium hydrolase activity,MF,
6126,GO:0016803,1,0.842388585813826,0,8,ether hydrolase activity,MF,
6130,GO:0016812,1,0.882477235219363,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6131,GO:0016813,1,0.790555256010709,0,11,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6132,GO:0016814,1,0.495894776872283,0,33,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6133,GO:0016815,1,0.978550427424545,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6137,GO:0016822,1,0.937147151775254,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6138,GO:0016823,1,0.937147151775254,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6139,GO:0016826,1,0.979028888010301,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6142,GO:0016831,1,0.505589871918689,0,32,carboxy-lyase activity,MF,
6144,GO:0016833,1,0.917775183413865,0,4,oxo-acid-lyase activity,MF,
6148,GO:0016840,1,0.824640211628296,0,9,carbon-nitrogen lyase activity,MF,
6149,GO:0016841,1,0.898299864115027,0,5,ammonia-lyase activity,MF,
6150,GO:0016842,1,0.937743524449618,0,3,amidine-lyase activity,MF,
6151,GO:0016843,1,0.97897493185122,0,1,amine-lyase activity,MF,
6152,GO:0016844,1,0.97897493185122,0,1,strictosidine synthase activity,MF,
6156,GO:0016854,1,0.761187820295104,0,13,racemase and epimerase activity,MF,
6157,GO:0016855,1,0.978948595150004,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6158,GO:0016857,1,0.829631215070176,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6159,GO:0016859,1,0.425893121141904,0,40,cis-trans isomerase activity,MF,
6162,GO:0016862,1,0.978467931885137,0,1,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6164,GO:0016864,1,0.682962912962193,0,18,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6166,GO:0016868,1,0.809438839128081,0,10,intramolecular transferase activity, phosphotransferases,MF,
6167,GO:0016872,1,0.978866573201486,0,1,intramolecular lyase activity,MF,
6169,GO:0016875,1,0.391986524888107,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6170,GO:0016876,1,0.391986524888107,0,44,ligase activity, forming aminoacyl-tRNA and related compounds,MF,
6173,GO:0016879,1,0.375122017476272,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6174,GO:0016880,1,0.959507843292867,0,2,acid-ammonia (or amide) ligase activity,MF,
6175,GO:0016881,1,0.69706994761183,0,17,acid-amino acid ligase activity,MF,
6176,GO:0016882,1,0.958002126083936,0,2,cyclo-ligase activity,MF,
6177,GO:0016884,1,0.829019297335979,0,9,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6179,GO:0016886,1,0.843607019946709,0,8,ligase activity, forming phosphoric ester bonds,MF,
6181,GO:0016888,1,0.808776369318909,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6182,GO:0016889,1,0.774500948749306,0,12,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6183,GO:0016890,1,0.958273223836182,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6184,GO:0016891,1,0.575827920914574,0,26,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6185,GO:0016892,1,0.82331132776125,0,9,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6186,GO:0016893,1,0.485878768452788,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6187,GO:0016894,1,0.637569068502265,0,21,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6188,GO:0016895,1,0.66867047315745,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6189,GO:0016896,1,0.537543152753971,0,30,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6191,GO:0016899,1,0.937683549919068,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6192,GO:0016900,1,0.957461149441119,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6193,GO:0016901,1,0.900588767913965,0,5,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6195,GO:0016907,1,0.898988107853558,0,5,G-protein coupled acetylcholine receptor activity,MF,
6196,GO:0016909,1,0.93819270979862,0,3,SAP kinase activity,MF,
6197,GO:0016913,1,0.97872440212719,0,1,follicle-stimulating hormone activity,MF,
6198,GO:0016917,1,0.633602277937076,0,22,GABA receptor activity,MF,
6200,GO:0016920,1,0.98112639476322,0,1,pyroglutamyl-peptidase activity,MF,
6201,GO:0016922,1,0.655359744281576,0,21,ligand-dependent nuclear receptor binding,MF,
6202,GO:0016925,1,0.159125935912352,0,88,protein sumoylation,BP,
6203,GO:0016926,1,0.865009105967386,0,7,protein desumoylation,BP,
6204,GO:0016929,1,0.865009105967386,0,7,SUMO-specific protease activity,MF,
6205,GO:0016933,1,0.898893452657479,0,5,extracellular-glycine-gated ion channel activity,MF,
6206,GO:0016934,1,0.898893452657479,0,5,extracellular-glycine-gated chloride channel activity,MF,
6207,GO:0016935,1,0.958571188169902,0,2,glycine-gated chloride channel complex,CC,
6209,GO:0016938,1,0.979055345589847,0,1,kinesin I complex,CC,
6210,GO:0016939,1,0.941150807193847,0,3,kinesin II complex,CC,
6212,GO:0016942,1,0.902084856344771,0,5,insulin-like growth factor binding protein complex,CC,
6213,GO:0016964,1,0.9864077942122,0,1,alpha-2 macroglobulin receptor activity,MF,
6214,GO:0016971,1,0.938574108623441,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6215,GO:0016972,1,0.919251362130152,0,4,thiol oxidase activity,MF,
6216,GO:0016973,1,0.742977631235289,0,14,poly(A)+ mRNA export from nucleus,BP,
6217,GO:0016979,1,0.957652316518619,0,2,lipoate-protein ligase activity,MF,
6218,GO:0016990,1,0.97887180099538,0,1,arginine deiminase activity,MF,
6219,GO:0016992,1,0.978634299609194,0,1,lipoate synthase activity,MF,
6220,GO:0016997,1,0.879555317221329,0,6,alpha-sialidase activity,MF,
6221,GO:0016998,1,0.936830163984976,0,3,cell wall macromolecule catabolic process,BP,
6222,GO:0016999,1,0.958697504893193,0,2,antibiotic metabolic process,BP,
6224,GO:0017003,1,0.978876600415521,0,1,protein-heme linkage,BP,
6225,GO:0017004,1,0.57459325083846,0,26,cytochrome complex assembly,BP,
6226,GO:0017005,1,0.979072393370562,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6227,GO:0017006,1,0.978876600415521,0,1,protein-tetrapyrrole linkage,BP,
6228,GO:0017014,1,0.780724548758582,0,12,protein nitrosylation,BP,
6232,GO:0017018,1,0.922834402371329,0,4,myosin phosphatase activity,MF,
6233,GO:0017020,1,0.979045360617991,0,1,myosin phosphatase regulator activity,MF,
6236,GO:0017025,1,0.617230955224736,0,23,TBP-class protein binding,MF,
6237,GO:0017034,1,0.904993833833421,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6240,GO:0017042,1,0.959579704354247,0,2,glycosylceramidase activity,MF,
6241,GO:0017045,1,0.978533171522588,0,1,corticotropin-releasing hormone activity,MF,
6244,GO:0017049,1,0.712765866076345,0,16,GTP-Rho binding,MF,
6245,GO:0017050,1,0.95820464349785,0,2,D-erythro-sphingosine kinase activity,MF,
6247,GO:0017055,1,0.958436669099126,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6248,GO:0017056,1,0.675496745799222,0,19,structural constituent of nuclear pore,MF,
6249,GO:0017057,1,0.961465473312784,0,2,6-phosphogluconolactonase activity,MF,
6250,GO:0017059,1,0.844798427387176,0,8,serine C-palmitoyltransferase complex,CC,
6251,GO:0017060,1,0.937985767031062,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6252,GO:0017061,1,0.97951877592604,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6253,GO:0017062,1,0.898328772976297,0,5,respiratory chain complex III assembly,BP,
6254,GO:0017064,1,0.958014877492613,0,2,fatty acid amide hydrolase activity,MF,
6255,GO:0017065,1,0.978601325517828,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6256,GO:0017069,1,0.494930291875813,0,33,snRNA binding,MF,
6257,GO:0017070,1,0.826454202484741,0,9,U6 snRNA binding,MF,
6258,GO:0017071,1,0.97907281640715,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6259,GO:0017075,1,0.67608186493642,0,19,syntaxin-1 binding,MF,
6261,GO:0017077,1,0.93736501210419,0,3,oxidative phosphorylation uncoupler activity,MF,
6264,GO:0017084,1,0.979069454243021,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6266,GO:0017089,1,0.937495597839851,0,3,glycolipid transporter activity,MF,
6267,GO:0017090,1,0.979053889572906,0,1,meprin A complex,CC,
6268,GO:0017091,1,0.614981137255848,0,23,AU-rich element binding,MF,
6269,GO:0017095,1,0.941221065400618,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6270,GO:0017096,1,0.978545059482444,0,1,acetylserotonin O-methyltransferase activity,MF,
6271,GO:0017098,1,0.958324122856778,0,2,sulfonylurea receptor binding,MF,
6272,GO:0017099,1,0.958034544799671,0,2,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6273,GO:0017101,1,0.792079105745758,0,11,aminoacyl-tRNA synthetase multienzyme complex,CC,
6274,GO:0017102,1,0.958487401004822,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6275,GO:0017108,1,0.88042366844301,0,6,5'-flap endonuclease activity,MF,
6276,GO:0017109,1,0.95857741030419,0,2,glutamate-cysteine ligase complex,CC,
6277,GO:0017110,1,0.761938927500199,0,13,nucleoside-diphosphatase activity,MF,
6280,GO:0017113,1,0.97906633745935,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6281,GO:0017116,1,0.958512399820088,0,2,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6282,GO:0017119,1,0.760239574767565,0,13,Golgi transport complex,CC,
6283,GO:0017121,1,0.775580862973661,0,12,phospholipid scrambling,BP,
6285,GO:0017125,1,0.979413565092023,0,1,deoxycytidyl transferase activity,MF,
6286,GO:0017126,1,0.979804095856282,0,1,nucleologenesis,BP,
6288,GO:0017128,1,0.80932300048678,0,10,phospholipid scramblase activity,MF,
6289,GO:0017129,1,0.958175559533727,0,2,triglyceride binding,MF,
6291,GO:0017134,1,0.621268071760484,0,23,fibroblast growth factor binding,MF,
6292,GO:0017136,1,0.730988687233617,0,15,NAD-dependent histone deacetylase activity,MF,
6295,GO:0017144,1,0.507220087710492,0,32,drug metabolic process,BP,
6297,GO:0017146,1,0.82045653385485,0,10,NMDA selective glutamate receptor complex,CC,
6300,GO:0017150,1,0.937571602122059,0,3,tRNA dihydrouridine synthase activity,MF,
6301,GO:0017151,1,0.846391417867947,0,8,DEAD/H-box RNA helicase binding,MF,
6302,GO:0017153,1,0.938429240456166,0,3,sodium:dicarboxylate symporter activity,MF,
6303,GO:0017154,1,0.807792104365682,0,11,semaphorin receptor activity,MF,
6307,GO:0017159,1,0.958277669118942,0,2,pantetheine hydrolase activity,MF,
6308,GO:0017160,1,0.764139126311432,0,13,Ral GTPase binding,MF,
6309,GO:0017161,1,0.960373323595959,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6310,GO:0017162,1,0.830474914347424,0,9,aryl hydrocarbon receptor binding,MF,
6311,GO:0017166,1,0.83852439917188,0,9,vinculin binding,MF,
6312,GO:0017168,1,0.979116537286167,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6313,GO:0017169,1,0.860819000642586,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6315,GO:0017172,1,0.978614070201798,0,1,cysteine dioxygenase activity,MF,
6316,GO:0017174,1,0.978501899002915,0,1,glycine N-methyltransferase activity,MF,
6317,GO:0017176,1,0.898158505147682,0,5,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6318,GO:0017177,1,0.979093878908121,0,1,glucosidase II complex,CC,
6319,GO:0017182,1,0.880040099048062,0,6,peptidyl-diphthamide metabolic process,BP,
6320,GO:0017183,1,0.880040099048062,0,6,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6321,GO:0017185,1,0.918892977738397,0,4,peptidyl-lysine hydroxylation,BP,
6322,GO:0017186,1,0.957920717372721,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6323,GO:0017187,1,0.789566109811803,0,11,peptidyl-glutamic acid carboxylation,BP,
6324,GO:0017188,1,0.980208941009651,0,1,aspartate N-acetyltransferase activity,MF,
6325,GO:0017196,1,0.881857406685384,0,6,N-terminal peptidyl-methionine acetylation,BP,
6326,GO:0017198,1,0.957528933456106,0,2,N-terminal peptidyl-serine acetylation,BP,
6327,GO:0018002,1,0.957528933456106,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6328,GO:0018003,1,0.957443265162459,0,2,peptidyl-lysine N6-acetylation,BP,
6330,GO:0018009,1,0.978814382527875,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6331,GO:0018011,1,0.97897493185122,0,1,N-terminal peptidyl-alanine methylation,BP,
6332,GO:0018012,1,0.97897493185122,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6333,GO:0018013,1,0.97897493185122,0,1,N-terminal peptidyl-glycine methylation,BP,
6334,GO:0018016,1,0.97897493185122,0,1,N-terminal peptidyl-proline dimethylation,BP,
6335,GO:0018022,1,0.122445629899234,0,102,peptidyl-lysine methylation,BP,
6336,GO:0018023,1,0.517997369682744,0,32,peptidyl-lysine trimethylation,BP,
6337,GO:0018024,1,0.490116929290831,0,35,histone-lysine N-methyltransferase activity,MF,
6338,GO:0018025,1,0.97897493185122,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6339,GO:0018026,1,0.881738508070848,0,6,peptidyl-lysine monomethylation,BP,
6340,GO:0018027,1,0.734264071731329,0,15,peptidyl-lysine dimethylation,BP,
6341,GO:0018032,1,0.979076438871909,0,1,protein amidation,BP,
6342,GO:0018057,1,0.979066474527347,0,1,peptidyl-lysine oxidation,BP,
6343,GO:0018063,1,0.978876600415521,0,1,cytochrome c-heme linkage,BP,
6344,GO:0018065,1,0.841006823811043,0,8,protein-cofactor linkage,BP,
6345,GO:0018076,1,0.92673043384693,0,4,N-terminal peptidyl-lysine acetylation,BP,
6346,GO:0018094,1,0.979069341627797,0,1,protein polyglycylation,BP,
6347,GO:0018095,1,0.844484619078674,0,8,protein polyglutamylation,BP,
6348,GO:0018101,1,0.899451305808371,0,5,protein citrullination,BP,
6351,GO:0018106,1,0.978474088890671,0,1,peptidyl-histidine phosphorylation,BP,
6354,GO:0018114,1,0.978948595150004,0,1,threonine racemase activity,MF,
6355,GO:0018117,1,0.978625650476873,0,1,protein adenylylation,BP,
6356,GO:0018119,1,0.780724548758582,0,12,peptidyl-cysteine S-nitrosylation,BP,
6358,GO:0018126,1,0.700877333068576,0,17,protein hydroxylation,BP,
6362,GO:0018153,1,0.958305144050237,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6363,GO:0018158,1,0.824372858159279,0,9,protein oxidation,BP,
6364,GO:0018160,1,0.978574531263958,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6365,GO:0018169,1,0.978588786045168,0,1,ribosomal S6-glutamic acid ligase activity,MF,
6366,GO:0018171,1,0.937834839899552,0,3,peptidyl-cysteine oxidation,BP,
6367,GO:0018175,1,0.978625650476873,0,1,protein nucleotidylation,BP,
6368,GO:0018190,1,0.978629204971283,0,1,protein octanoylation,BP,
6369,GO:0018191,1,0.978629204971283,0,1,peptidyl-serine octanoylation,BP,
6370,GO:0018192,1,0.978939498239432,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6372,GO:0018194,1,0.97897493185122,0,1,peptidyl-alanine modification,BP,
6373,GO:0018195,1,0.6122978442206,0,23,peptidyl-arginine modification,BP,
6375,GO:0018197,1,0.940402678437021,0,3,peptidyl-aspartic acid modification,BP,
6377,GO:0018199,1,0.917975772331244,0,4,peptidyl-glutamine modification,BP,
6378,GO:0018200,1,0.527414664225269,0,30,peptidyl-glutamic acid modification,BP,
6380,GO:0018202,1,0.844722454938249,0,8,peptidyl-histidine modification,BP,
6382,GO:0018206,1,0.775209122728613,0,12,peptidyl-methionine modification,BP,
6383,GO:0018208,1,0.345492473240014,0,50,peptidyl-proline modification,BP,
6388,GO:0018214,1,0.789566109811803,0,11,protein carboxylation,BP,
6389,GO:0018216,1,0.7264170162807,0,15,peptidyl-arginine methylation,BP,
6390,GO:0018217,1,0.979110685393671,0,1,peptidyl-aspartic acid phosphorylation,BP,
6391,GO:0018230,1,0.880440781753244,0,6,peptidyl-L-cysteine S-palmitoylation,BP,
6392,GO:0018231,1,0.880440781753244,0,6,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6393,GO:0018242,1,0.918975467702391,0,4,protein O-linked glycosylation via serine,BP,
6394,GO:0018243,1,0.919018245443182,0,4,protein O-linked glycosylation via threonine,BP,
6395,GO:0018262,1,0.958305144050237,0,2,isopeptide cross-linking,BP,
6396,GO:0018271,1,0.980322128492799,0,1,biotin-protein ligase activity,MF,
6397,GO:0018272,1,0.97865811077371,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6398,GO:0018277,1,0.958429485931531,0,2,protein deamination,BP,
6400,GO:0018282,1,0.960496356094681,0,2,metal incorporation into metallo-sulfur cluster,BP,
6401,GO:0018283,1,0.960496356094681,0,2,iron incorporation into metallo-sulfur cluster,BP,
6402,GO:0018293,1,0.978521226245419,0,1,protein-FAD linkage,BP,
6403,GO:0018298,1,0.756705678833842,0,13,protein-chromophore linkage,BP,
6404,GO:0018307,1,0.95787916536288,0,2,enzyme active site formation,BP,
6405,GO:0018312,1,0.958261965730761,0,2,peptidyl-serine ADP-ribosylation,BP,
6406,GO:0018315,1,0.979184544493128,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6408,GO:0018323,1,0.978487817470133,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6409,GO:0018342,1,0.813308446893811,0,10,protein prenylation,BP,
6410,GO:0018343,1,0.938006569600036,0,3,protein farnesylation,BP,
6411,GO:0018344,1,0.862991397170904,0,7,protein geranylgeranylation,BP,
6412,GO:0018345,1,0.604589754935785,0,24,protein palmitoylation,BP,
6413,GO:0018350,1,0.978916140448756,0,1,protein esterification,BP,
6414,GO:0018352,1,0.958015630625669,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6415,GO:0018364,1,0.957445124064711,0,2,peptidyl-glutamine methylation,BP,
6419,GO:0018395,1,0.979071682445459,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6420,GO:0018400,1,0.980803714402997,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6421,GO:0018401,1,0.901132425637984,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6424,GO:0018423,1,0.97853621221972,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6425,GO:0018444,1,0.960618177429744,0,2,translation release factor complex,CC,
6426,GO:0018455,1,0.978533717851927,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6427,GO:0018467,1,0.97899974731779,0,1,formaldehyde dehydrogenase activity,MF,
6428,GO:0018478,1,0.978834703582196,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6429,GO:0018479,1,0.957923324526455,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6430,GO:0018585,1,0.978825391606751,0,1,fluorene oxygenase activity,MF,
6431,GO:0018636,1,0.937026062370078,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6432,GO:0018675,1,0.957734308057819,0,2,(S)-limonene 6-monooxygenase activity,MF,
6433,GO:0018676,1,0.957734308057819,0,2,(S)-limonene 7-monooxygenase activity,MF,
6434,GO:0018685,1,0.91790567928183,0,4,alkane 1-monooxygenase activity,MF,
6435,GO:0018733,1,0.978519172897859,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6436,GO:0018738,1,0.978519642271121,0,1,S-formylglutathione hydrolase activity,MF,
6437,GO:0018773,1,0.978635797103521,0,1,acetylpyruvate hydrolase activity,MF,
6438,GO:0018872,1,0.978945125219278,0,1,arsonoacetate metabolic process,BP,
6439,GO:0018874,1,0.978782300195593,0,1,benzoate metabolic process,BP,
6441,GO:0018885,1,0.978632810325726,0,1,carbon tetrachloride metabolic process,BP,
6444,GO:0018910,1,0.978632810325726,0,1,benzene metabolic process,BP,
6445,GO:0018916,1,0.937530651100473,0,3,nitrobenzene metabolic process,BP,
6446,GO:0018917,1,0.978825391606751,0,1,fluorene metabolic process,BP,
6447,GO:0018931,1,0.957704807337109,0,2,naphthalene metabolic process,BP,
6450,GO:0018964,1,0.979188146250146,0,1,propylene metabolic process,BP,
6451,GO:0018969,1,0.979049233701702,0,1,thiocyanate metabolic process,BP,
6452,GO:0018979,1,0.978690201467065,0,1,trichloroethylene metabolic process,BP,
6453,GO:0018992,1,0.959390608103266,0,2,germ-line sex determination,BP,
6454,GO:0018993,1,0.958550876222108,0,2,somatic sex determination,BP,
6455,GO:0018995,1,0.743552796140294,0,14,host,CC,
6457,GO:0019002,1,0.9588714719595,0,2,GMP binding,MF,
6459,GO:0019005,1,0.347562102267433,0,50,SCF ubiquitin ligase complex,CC,
6460,GO:0019008,1,0.958159875997402,0,2,molybdopterin synthase complex,CC,
6461,GO:0019012,1,0.918508286851493,0,4,virion,CC,
6462,GO:0019028,1,0.97897493185122,0,1,viral capsid,CC,
6463,GO:0019031,1,0.938238199096648,0,3,viral envelope,CC,
6464,GO:0019034,1,0.959162747192094,0,2,viral replication complex,CC,
6465,GO:0019035,1,0.980099214300398,0,1,viral integration complex,CC,
6466,GO:0019042,1,0.794451412946388,0,11,viral latency,BP,
6467,GO:0019043,1,0.824888930253911,0,9,establishment of viral latency,BP,
6468,GO:0019045,1,0.963120082513549,0,2,latent virus replication,BP,
6469,GO:0019046,1,0.963120082513549,0,2,release from viral latency,BP,
6470,GO:0019048,1,0.484501729609356,0,35,modulation by virus of host morphology or physiology,BP,
6471,GO:0019049,1,0.939361584553954,0,3,evasion or tolerance of host defenses by virus,BP,
6472,GO:0019050,1,0.937806376967105,0,3,suppression by virus of host apoptotic process,BP,
6473,GO:0019054,1,0.629609244874022,0,22,modulation by virus of host process,BP,
6474,GO:0019056,1,0.979046253271142,0,1,modulation by virus of host transcription,BP,
6476,GO:0019060,1,0.898765012036251,0,5,intracellular transport of viral protein in host cell,BP,
6477,GO:0019061,1,0.97887139988167,0,1,uncoating of virus,BP,
6480,GO:0019065,1,0.938806879370618,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6481,GO:0019068,1,0.454568819180791,0,37,virion assembly,BP,
6482,GO:0019072,1,0.960009227900227,0,2,viral genome packaging,BP,
6483,GO:0019074,1,0.960009227900227,0,2,viral RNA genome packaging,BP,
6484,GO:0019075,1,0.95839073820654,0,2,virus maturation,BP,
6485,GO:0019076,1,0.47820701894983,0,35,viral release from host cell,BP,
6487,GO:0019080,1,0.0191111536785504,0,185,viral gene expression,BP,
6488,GO:0019081,1,0.808810891043372,0,10,viral translation,BP,
6489,GO:0019082,1,0.979158681339952,0,1,viral protein processing,BP,
6490,GO:0019083,1,0.0241893869045523,0,174,viral transcription,BP,
6491,GO:0019085,1,0.958804663721124,0,2,early viral transcription,BP,
6492,GO:0019086,1,0.91828358191056,0,4,late viral transcription,BP,
6493,GO:0019087,1,0.941189585151514,0,3,transformation of host cell by virus,BP,
6494,GO:0019088,1,0.978605979430292,0,1,immortalization of host cell by virus,BP,
6495,GO:0019089,1,0.980613073878647,0,1,transmission of virus,BP,
6497,GO:0019100,1,0.959390608103266,0,2,male germ-line sex determination,BP,
6498,GO:0019101,1,0.979051032160913,0,1,female somatic sex determination,BP,
6499,GO:0019102,1,0.97906239282777,0,1,male somatic sex determination,BP,
6500,GO:0019103,1,0.899127815562581,0,5,pyrimidine nucleotide binding,MF,
6501,GO:0019104,1,0.739801227042955,0,14,DNA N-glycosylase activity,MF,
6503,GO:0019113,1,0.957734308057819,0,2,limonene monooxygenase activity,MF,
6504,GO:0019115,1,0.978750012806252,0,1,benzaldehyde dehydrogenase activity,MF,
6505,GO:0019118,1,0.978550427424545,0,1,phenanthrene-epoxide hydrolase activity,MF,
6506,GO:0019119,1,0.978550427424545,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6507,GO:0019135,1,0.978711836239293,0,1,deoxyhypusine monooxygenase activity,MF,
6508,GO:0019136,1,0.918318685340412,0,4,deoxynucleoside kinase activity,MF,
6509,GO:0019144,1,0.957571780000042,0,2,ADP-sugar diphosphatase activity,MF,
6510,GO:0019145,1,0.978957440165652,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6511,GO:0019153,1,0.978609837539563,0,1,protein-disulfide reductase (glutathione) activity,MF,
6512,GO:0019158,1,0.920819025148408,0,4,mannokinase activity,MF,
6516,GO:0019185,1,0.958802853474317,0,2,snRNA-activating protein complex,CC,
6517,GO:0019187,1,0.979099001044529,0,1,beta-1,4-mannosyltransferase activity,MF,
6518,GO:0019198,1,0.72712967450572,0,16,transmembrane receptor protein phosphatase activity,MF,
6521,GO:0019201,1,0.606612377803308,0,24,nucleotide kinase activity,MF,
6522,GO:0019202,1,0.979069454243021,0,1,amino acid kinase activity,MF,
6524,GO:0019205,1,0.371676131679824,0,47,nucleobase-containing compound kinase activity,MF,
6525,GO:0019206,1,0.7577056287418,0,13,nucleoside kinase activity,MF,
6531,GO:0019212,1,0.479594317302076,0,35,phosphatase inhibitor activity,MF,
6542,GO:0019227,1,0.865890604084259,0,7,neuronal action potential propagation,BP,
6543,GO:0019228,1,0.518190280618172,0,33,neuronal action potential,BP,
6545,GO:0019230,1,0.921509589458993,0,4,proprioception,BP,
6547,GO:0019236,1,0.859546822582271,0,7,response to pheromone,BP,
6548,GO:0019237,1,0.901979556645633,0,5,centromeric DNA binding,MF,
6549,GO:0019238,1,0.879912181061413,0,6,cyclohydrolase activity,MF,
6550,GO:0019239,1,0.563587083982631,0,27,deaminase activity,MF,
6551,GO:0019240,1,0.905185483251228,0,5,citrulline biosynthetic process,BP,
6552,GO:0019242,1,0.978794382798285,0,1,methylglyoxal biosynthetic process,BP,
6553,GO:0019243,1,0.958105664655775,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6554,GO:0019244,1,0.978530129894086,0,1,lactate biosynthetic process from pyruvate,BP,
6555,GO:0019249,1,0.938884865929155,0,3,lactate biosynthetic process,BP,
6556,GO:0019254,1,0.938294107760539,0,3,carnitine metabolic process, CoA-linked,BP,
6557,GO:0019255,1,0.958024301399626,0,2,glucose 1-phosphate metabolic process,BP,
6558,GO:0019262,1,0.917167664373578,0,4,N-acetylneuraminate catabolic process,BP,
6559,GO:0019264,1,0.958242974601567,0,2,glycine biosynthetic process from serine,BP,
6560,GO:0019265,1,0.957923977169014,0,2,glycine biosynthetic process, by transamination of glyoxylate,BP,
6561,GO:0019276,1,0.938152031801483,0,3,UDP-N-acetylgalactosamine metabolic process,BP,
6562,GO:0019285,1,0.95857956979511,0,2,glycine betaine biosynthetic process from choline,BP,
6563,GO:0019287,1,0.937355910726181,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6565,GO:0019303,1,0.957501786335524,0,2,D-ribose catabolic process,BP,
6566,GO:0019310,1,0.978567951432417,0,1,inositol catabolic process,BP,
6567,GO:0019317,1,0.832445582757759,0,9,fucose catabolic process,BP,
6571,GO:0019321,1,0.772418692840325,0,12,pentose metabolic process,BP,
6572,GO:0019322,1,0.917629929366943,0,4,pentose biosynthetic process,BP,
6573,GO:0019323,1,0.8979307361843,0,5,pentose catabolic process,BP,
6574,GO:0019336,1,0.825766467414388,0,9,phenol-containing compound catabolic process,BP,
6575,GO:0019341,1,0.978989672309085,0,1,dibenzo-p-dioxin catabolic process,BP,
6576,GO:0019343,1,0.958092995633967,0,2,cysteine biosynthetic process via cystathionine,BP,
6577,GO:0019344,1,0.93788148885437,0,3,cysteine biosynthetic process,BP,
6578,GO:0019346,1,0.917937212253698,0,4,transsulfuration,BP,
6579,GO:0019348,1,0.898721542939217,0,5,dolichol metabolic process,BP,
6580,GO:0019355,1,0.939027367313167,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6584,GO:0019364,1,0.958007555891013,0,2,pyridine nucleotide catabolic process,BP,
6586,GO:0019368,1,0.898745187595703,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6591,GO:0019373,1,0.652086956946945,0,20,epoxygenase P450 pathway,BP,
6592,GO:0019374,1,0.880190904747817,0,6,galactolipid metabolic process,BP,
6593,GO:0019375,1,0.958170196171657,0,2,galactolipid biosynthetic process,BP,
6594,GO:0019376,1,0.958078426771655,0,2,galactolipid catabolic process,BP,
6597,GO:0019389,1,0.978998933460537,0,1,glucuronoside metabolic process,BP,
6598,GO:0019391,1,0.978998933460537,0,1,glucuronoside catabolic process,BP,
6600,GO:0019400,1,0.66907536867608,0,19,alditol metabolic process,BP,
6601,GO:0019401,1,0.898863175817535,0,5,alditol biosynthetic process,BP,
6602,GO:0019402,1,0.978550216681492,0,1,galactitol metabolic process,BP,
6603,GO:0019405,1,0.884956263573322,0,6,alditol catabolic process,BP,
6604,GO:0019406,1,0.978558918485875,0,1,hexitol biosynthetic process,BP,
6605,GO:0019407,1,0.978965040994655,0,1,hexitol catabolic process,BP,
6606,GO:0019408,1,0.979446296568416,0,1,dolichol biosynthetic process,BP,
6607,GO:0019413,1,0.958764304264903,0,2,acetate biosynthetic process,BP,
6608,GO:0019417,1,0.958603050175055,0,2,sulfur oxidation,BP,
6609,GO:0019418,1,0.937446496453152,0,3,sulfide oxidation,BP,
6610,GO:0019427,1,0.958764304264903,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6616,GO:0019441,1,0.86084973114339,0,7,tryptophan catabolic process to kynurenine,BP,
6617,GO:0019442,1,0.957677771193049,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6618,GO:0019448,1,0.937556108650943,0,3,L-cysteine catabolic process,BP,
6620,GO:0019470,1,0.91844409526791,0,4,4-hydroxyproline catabolic process,BP,
6621,GO:0019471,1,0.809805997017571,0,10,4-hydroxyproline metabolic process,BP,
6622,GO:0019474,1,0.919581708328093,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6623,GO:0019477,1,0.919581708328093,0,4,L-lysine catabolic process,BP,
6624,GO:0019478,1,0.957683119090276,0,2,D-amino acid catabolic process,BP,
6625,GO:0019481,1,0.978861723099495,0,1,L-alanine catabolic process, by transamination,BP,
6626,GO:0019482,1,0.918353395529677,0,4,beta-alanine metabolic process,BP,
6627,GO:0019483,1,0.95829651049153,0,2,beta-alanine biosynthetic process,BP,
6629,GO:0019510,1,0.978878194325947,0,1,S-adenosylhomocysteine catabolic process,BP,
6630,GO:0019511,1,0.794204114999818,0,11,peptidyl-proline hydroxylation,BP,
6631,GO:0019516,1,0.957964519652952,0,2,lactate oxidation,BP,
6632,GO:0019518,1,0.978605685514806,0,1,L-threonine catabolic process to glycine,BP,
6633,GO:0019519,1,0.978965040994655,0,1,pentitol metabolic process,BP,
6634,GO:0019520,1,0.958155742946867,0,2,aldonic acid metabolic process,BP,
6635,GO:0019521,1,0.958155742946867,0,2,D-gluconate metabolic process,BP,
6636,GO:0019527,1,0.978965040994655,0,1,pentitol catabolic process,BP,
6638,GO:0019531,1,0.794947095521375,0,11,oxalate transmembrane transporter activity,MF,
6639,GO:0019532,1,0.777933723414813,0,12,oxalate transport,BP,
6642,GO:0019541,1,0.958764304264903,0,2,propionate metabolic process,BP,
6643,GO:0019542,1,0.958764304264903,0,2,propionate biosynthetic process,BP,
6644,GO:0019546,1,0.97887180099538,0,1,arginine deiminase pathway,BP,
6645,GO:0019547,1,0.978569872846916,0,1,arginine catabolic process to ornithine,BP,
6646,GO:0019550,1,0.958195731342156,0,2,glutamate catabolic process to aspartate,BP,
6647,GO:0019551,1,0.958195731342156,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6648,GO:0019556,1,0.918291753374988,0,4,histidine catabolic process to glutamate and formamide,BP,
6649,GO:0019557,1,0.918291753374988,0,4,histidine catabolic process to glutamate and formate,BP,
6650,GO:0019563,1,0.903976551093241,0,5,glycerol catabolic process,BP,
6651,GO:0019566,1,0.97897493185122,0,1,arabinose metabolic process,BP,
6652,GO:0019585,1,0.625363197307411,0,22,glucuronate metabolic process,BP,
6653,GO:0019605,1,0.978782300195593,0,1,butyrate metabolic process,BP,
6654,GO:0019614,1,0.843661510383631,0,8,catechol-containing compound catabolic process,BP,
6655,GO:0019626,1,0.899709672592228,0,5,short-chain fatty acid catabolic process,BP,
6656,GO:0019627,1,0.757283031601788,0,13,urea metabolic process,BP,
6658,GO:0019640,1,0.898093325838692,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6662,GO:0019673,1,0.859621259306127,0,7,GDP-mannose metabolic process,BP,
6664,GO:0019676,1,0.958480449258161,0,2,ammonia assimilation cycle,BP,
6665,GO:0019677,1,0.979069535472492,0,1,NAD catabolic process,BP,
6671,GO:0019706,1,0.578802546701639,0,26,protein-cysteine S-palmitoyltransferase activity,MF,
6672,GO:0019707,1,0.578802546701639,0,26,protein-cysteine S-acyltransferase activity,MF,
6673,GO:0019720,1,0.880211457480748,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6678,GO:0019731,1,0.430959111515992,0,39,antibacterial humoral response,BP,
6679,GO:0019732,1,0.958326531028665,0,2,antifungal humoral response,BP,
6680,GO:0019740,1,0.918232985431744,0,4,nitrogen utilization,BP,
6681,GO:0019742,1,0.978922284447464,0,1,pentacyclic triterpenoid metabolic process,BP,
6682,GO:0019747,1,0.937427176604258,0,3,regulation of isoprenoid metabolic process,BP,
6684,GO:0019751,1,0.110090075267788,0,105,polyol metabolic process,BP,
6686,GO:0019755,1,0.80729265649119,0,10,one-carbon compound transport,BP,
6687,GO:0019763,1,0.897773078360399,0,5,immunoglobulin receptor activity,MF,
6688,GO:0019767,1,0.957445066919215,0,2,IgE receptor activity,MF,
6689,GO:0019770,1,0.978664600510852,0,1,IgG receptor activity,MF,
6690,GO:0019773,1,0.840599577137669,0,8,proteasome core complex, alpha-subunit complex,CC,
6691,GO:0019774,1,0.978475309295479,0,1,proteasome core complex, beta-subunit complex,CC,
6692,GO:0019776,1,0.93816897244827,0,3,Atg8 ligase activity,MF,
6693,GO:0019777,1,0.957883603514238,0,2,Atg12 transferase activity,MF,
6694,GO:0019778,1,0.979553690605078,0,1,Atg12 activating enzyme activity,MF,
6695,GO:0019780,1,0.980669716293126,0,1,FAT10 activating enzyme activity,MF,
6696,GO:0019781,1,0.957942540743932,0,2,NEDD8 activating enzyme activity,MF,
6697,GO:0019782,1,0.979069312250115,0,1,ISG15 activating enzyme activity,MF,
6698,GO:0019783,1,0.0855618084478673,0,119,ubiquitin-like protein-specific protease activity,MF,
6699,GO:0019784,1,0.879214328415884,0,6,NEDD8-specific protease activity,MF,
6700,GO:0019785,1,0.95834235614396,0,2,ISG15-specific protease activity,MF,
6702,GO:0019788,1,0.899809006559779,0,5,NEDD8 transferase activity,MF,
6703,GO:0019789,1,0.716805188131917,0,16,SUMO transferase activity,MF,
6704,GO:0019798,1,0.91837379645498,0,4,procollagen-proline dioxygenase activity,MF,
6705,GO:0019799,1,0.97897493185122,0,1,tubulin N-acetyltransferase activity,MF,
6706,GO:0019800,1,0.880140134205308,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6707,GO:0019805,1,0.938022166574441,0,3,quinolinate biosynthetic process,BP,
6708,GO:0019807,1,0.978554933214943,0,1,aspartoacylase activity,MF,
6709,GO:0019808,1,0.937733290341816,0,3,polyamine binding,MF,
6710,GO:0019809,1,0.957782939669673,0,2,spermidine binding,MF,
6711,GO:0019810,1,0.979069037868997,0,1,putrescine binding,MF,
6712,GO:0019811,1,0.97930137485841,0,1,cocaine binding,MF,
6713,GO:0019814,1,0.898479063440876,0,5,immunoglobulin complex,CC,
6714,GO:0019815,1,0.937968134137805,0,3,B cell receptor complex,CC,
6716,GO:0019826,1,0.940263049166904,0,3,oxygen sensor activity,MF,
6718,GO:0019828,1,0.958937606850728,0,2,aspartic-type endopeptidase inhibitor activity,MF,
6719,GO:0019829,1,0.266810281132493,0,63,cation-transporting ATPase activity,MF,
6720,GO:0019834,1,0.916975041016153,0,4,phospholipase A2 inhibitor activity,MF,
6721,GO:0019835,1,0.514372767542623,0,31,cytolysis,BP,
6722,GO:0019836,1,0.958318823202868,0,2,hemolysis by symbiont of host erythrocytes,BP,
6730,GO:0019855,1,0.845217818657606,0,8,calcium channel inhibitor activity,MF,
6731,GO:0019856,1,0.88626036372655,0,6,pyrimidine nucleobase biosynthetic process,BP,
6732,GO:0019857,1,0.982829462550365,0,1,5-methylcytosine metabolic process,BP,
6733,GO:0019858,1,0.941562470594763,0,3,cytosine metabolic process,BP,
6734,GO:0019859,1,0.938033921028589,0,3,thymine metabolic process,BP,
6735,GO:0019860,1,0.937814705629857,0,3,uracil metabolic process,BP,
6736,GO:0019862,1,0.957624995685961,0,2,IgA binding,MF,
6737,GO:0019863,1,0.897549614649188,0,5,IgE binding,MF,
6738,GO:0019864,1,0.789017803830739,0,11,IgG binding,MF,
6739,GO:0019865,1,0.638378801317617,0,21,immunoglobulin binding,MF,
6743,GO:0019870,1,0.867909969202625,0,7,potassium channel inhibitor activity,MF,
6744,GO:0019871,1,0.903408874211389,0,5,sodium channel inhibitor activity,MF,
6745,GO:0019878,1,0.97904458756289,0,1,lysine biosynthetic process via aminoadipic acid,BP,
6747,GO:0019883,1,0.792154362060146,0,11,antigen processing and presentation of endogenous antigen,BP,
6749,GO:0019885,1,0.862972324951422,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6752,GO:0019888,1,0.233217359908031,0,69,protein phosphatase regulator activity,MF,
6754,GO:0019896,1,0.846899116795451,0,8,axonal transport of mitochondrion,BP,
6764,GO:0019907,1,0.864661220230945,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6765,GO:0019908,1,0.717822028740766,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6766,GO:0019911,1,0.807655703838035,0,10,structural constituent of myelin sheath,MF,
6769,GO:0019918,1,0.938147926844816,0,3,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6770,GO:0019919,1,0.918150348574034,0,4,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6772,GO:0019933,1,0.37349360086877,0,48,cAMP-mediated signaling,BP,
6776,GO:0019948,1,0.958391749437266,0,2,SUMO activating enzyme activity,MF,
6779,GO:0019956,1,0.669610244404602,0,19,chemokine binding,MF,
6780,GO:0019957,1,0.861017294462894,0,7,C-C chemokine binding,MF,
6781,GO:0019958,1,0.899454094800811,0,5,C-X-C chemokine binding,MF,
6782,GO:0019959,1,0.938648787356941,0,3,interleukin-8 binding,MF,
6783,GO:0019960,1,0.903043403722559,0,5,C-X3-C chemokine binding,MF,
6784,GO:0019961,1,0.959863564109743,0,2,interferon binding,MF,
6785,GO:0019962,1,0.98038465800425,0,1,type I interferon binding,MF,
6786,GO:0019964,1,0.979069442775139,0,1,interferon-gamma binding,MF,
6787,GO:0019966,1,0.845192916504115,0,8,interleukin-1 binding,MF,
6788,GO:0019969,1,0.979075955999438,0,1,interleukin-10 binding,MF,
6789,GO:0019970,1,0.979068192413853,0,1,interleukin-11 binding,MF,
6790,GO:0019972,1,0.957918942197214,0,2,interleukin-12 binding,MF,
6791,GO:0019975,1,0.978566999549344,0,1,interleukin-17 binding,MF,
6792,GO:0019976,1,0.938100060083413,0,3,interleukin-2 binding,MF,
6793,GO:0019981,1,0.958645227653617,0,2,interleukin-6 binding,MF,
6794,GO:0019983,1,0.978823939821561,0,1,interleukin-9 binding,MF,
6795,GO:0019985,1,0.45162518195795,0,38,translesion synthesis,BP,
6796,GO:0019988,1,0.979024817940894,0,1,charged-tRNA amino acid modification,BP,
6797,GO:0019992,1,0.801758156937955,0,11,diacylglycerol binding,MF,
6798,GO:0020003,1,0.97902565244238,0,1,symbiont-containing vacuole,CC,
6799,GO:0020005,1,0.97902565244238,0,1,symbiont-containing vacuole membrane,CC,
6800,GO:0020012,1,0.979015691396219,0,1,evasion or tolerance of host immune response,BP,
6801,GO:0020016,1,0.93864066687967,0,3,ciliary pocket,CC,
6802,GO:0020018,1,0.93864066687967,0,3,ciliary pocket membrane,CC,
6803,GO:0020021,1,0.978605979430292,0,1,immortalization of host cell,BP,
6804,GO:0020027,1,0.728294378177172,0,15,hemoglobin metabolic process,BP,
6806,GO:0021501,1,0.978793549066336,0,1,prechordal plate formation,BP,
6808,GO:0021503,1,0.982125839710781,0,1,neural fold bending,BP,
6809,GO:0021508,1,0.980896701663796,0,1,floor plate formation,BP,
6810,GO:0021509,1,0.978754124420866,0,1,roof plate formation,BP,
6812,GO:0021511,1,0.61909776889347,0,23,spinal cord patterning,BP,
6813,GO:0021512,1,0.97918064611937,0,1,spinal cord anterior/posterior patterning,BP,
6814,GO:0021513,1,0.64237105226014,0,21,spinal cord dorsal/ventral patterning,BP,
6815,GO:0021514,1,0.715065784492147,0,16,ventral spinal cord interneuron differentiation,BP,
6817,GO:0021516,1,0.641119187810673,0,21,dorsal spinal cord development,BP,
6818,GO:0021517,1,0.401364951523667,0,44,ventral spinal cord development,BP,
6819,GO:0021519,1,0.978534083677148,0,1,spinal cord association neuron specification,BP,
6820,GO:0021520,1,0.777431527242574,0,12,spinal cord motor neuron cell fate specification,BP,
6821,GO:0021521,1,0.811588317443639,0,10,ventral spinal cord interneuron specification,BP,
6822,GO:0021522,1,0.515651707108182,0,32,spinal cord motor neuron differentiation,BP,
6823,GO:0021523,1,0.900412664216803,0,5,somatic motor neuron differentiation,BP,
6824,GO:0021524,1,0.937644193375028,0,3,visceral motor neuron differentiation,BP,
6825,GO:0021526,1,0.958067243389972,0,2,medial motor column neuron differentiation,BP,
6826,GO:0021527,1,0.744754193768463,0,14,spinal cord association neuron differentiation,BP,
6827,GO:0021528,1,0.97897493185122,0,1,commissural neuron differentiation in spinal cord,BP,
6828,GO:0021529,1,0.938008332101755,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6829,GO:0021530,1,0.938008332101755,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6832,GO:0021534,1,0.796936894076536,0,11,cell proliferation in hindbrain,BP,
6833,GO:0021535,1,0.75135590561987,0,14,cell migration in hindbrain,BP,
6836,GO:0021538,1,0.958589098762407,0,2,epithalamus development,BP,
6837,GO:0021539,1,0.957911793031225,0,2,subthalamus development,BP,
6838,GO:0021540,1,0.922966284963499,0,4,corpus callosum morphogenesis,BP,
6839,GO:0021541,1,0.979169855265786,0,1,ammon gyrus development,BP,
6840,GO:0021542,1,0.702317218081431,0,17,dentate gyrus development,BP,
6844,GO:0021546,1,0.860603311442799,0,7,rhombomere development,BP,
6845,GO:0021547,1,0.978793549066336,0,1,midbrain-hindbrain boundary initiation,BP,
6846,GO:0021548,1,0.808768936059382,0,10,pons development,BP,
6848,GO:0021550,1,0.958447577812344,0,2,medulla oblongata development,BP,
6849,GO:0021551,1,0.963700969446691,0,2,central nervous system morphogenesis,BP,
6850,GO:0021553,1,0.94333750581728,0,3,olfactory nerve development,BP,
6851,GO:0021554,1,0.78147931490191,0,12,optic nerve development,BP,
6852,GO:0021555,1,0.917993640707327,0,4,midbrain-hindbrain boundary morphogenesis,BP,
6853,GO:0021557,1,0.917432859415617,0,4,oculomotor nerve development,BP,
6854,GO:0021558,1,0.937049456518895,0,3,trochlear nerve development,BP,
6855,GO:0021559,1,0.793226806124873,0,11,trigeminal nerve development,BP,
6856,GO:0021560,1,0.958443926156887,0,2,abducens nerve development,BP,
6857,GO:0021561,1,0.810985648140531,0,10,facial nerve development,BP,
6858,GO:0021562,1,0.844843878199123,0,8,vestibulocochlear nerve development,BP,
6859,GO:0021563,1,0.903800296277583,0,5,glossopharyngeal nerve development,BP,
6860,GO:0021564,1,0.942585021571327,0,3,vagus nerve development,BP,
6861,GO:0021566,1,0.979533540189085,0,1,hypoglossal nerve development,BP,
6862,GO:0021568,1,0.957669120488224,0,2,rhombomere 2 development,BP,
6863,GO:0021569,1,0.937661031420075,0,3,rhombomere 3 development,BP,
6864,GO:0021570,1,0.957563717731689,0,2,rhombomere 4 development,BP,
6865,GO:0021571,1,0.93793541735171,0,3,rhombomere 5 development,BP,
6866,GO:0021572,1,0.979069334118858,0,1,rhombomere 6 development,BP,
6868,GO:0021576,1,0.978874203964035,0,1,hindbrain formation,BP,
6869,GO:0021577,1,0.958526376849712,0,2,hindbrain structural organization,BP,
6870,GO:0021578,1,0.882893215763919,0,6,hindbrain maturation,BP,
6871,GO:0021586,1,0.938522891663947,0,3,pons maturation,BP,
6873,GO:0021588,1,0.978874203964035,0,1,cerebellum formation,BP,
6874,GO:0021589,1,0.958526376849712,0,2,cerebellum structural organization,BP,
6875,GO:0021590,1,0.940736292264579,0,3,cerebellum maturation,BP,
6876,GO:0021591,1,0.593341305291144,0,26,ventricular system development,BP,
6877,GO:0021592,1,0.961683416792256,0,2,fourth ventricle development,BP,
6878,GO:0021593,1,0.958158852093715,0,2,rhombomere morphogenesis,BP,
6879,GO:0021594,1,0.979044230750363,0,1,rhombomere formation,BP,
6880,GO:0021598,1,0.958443926156887,0,2,abducens nerve morphogenesis,BP,
6881,GO:0021599,1,0.958443926156887,0,2,abducens nerve formation,BP,
6882,GO:0021602,1,0.567765647882621,0,27,cranial nerve morphogenesis,BP,
6883,GO:0021603,1,0.843981207231775,0,8,cranial nerve formation,BP,
6884,GO:0021604,1,0.81048917676371,0,10,cranial nerve structural organization,BP,
6885,GO:0021610,1,0.810985648140531,0,10,facial nerve morphogenesis,BP,
6886,GO:0021612,1,0.845698817729924,0,8,facial nerve structural organization,BP,
6887,GO:0021615,1,0.918686797843253,0,4,glossopharyngeal nerve morphogenesis,BP,
6888,GO:0021618,1,0.979533540189085,0,1,hypoglossal nerve morphogenesis,BP,
6889,GO:0021622,1,0.958156288283699,0,2,oculomotor nerve morphogenesis,BP,
6890,GO:0021623,1,0.958156288283699,0,2,oculomotor nerve formation,BP,
6891,GO:0021626,1,0.882893215763919,0,6,central nervous system maturation,BP,
6892,GO:0021631,1,0.884797469181324,0,6,optic nerve morphogenesis,BP,
6893,GO:0021633,1,0.958384824306772,0,2,optic nerve structural organization,BP,
6894,GO:0021634,1,0.979135713017116,0,1,optic nerve formation,BP,
6895,GO:0021636,1,0.902100007336359,0,5,trigeminal nerve morphogenesis,BP,
6896,GO:0021637,1,0.902100007336359,0,5,trigeminal nerve structural organization,BP,
6897,GO:0021639,1,0.978641186704773,0,1,trochlear nerve morphogenesis,BP,
6898,GO:0021642,1,0.978641186704773,0,1,trochlear nerve formation,BP,
6899,GO:0021644,1,0.958108549277767,0,2,vagus nerve morphogenesis,BP,
6900,GO:0021648,1,0.899702435294921,0,5,vestibulocochlear nerve morphogenesis,BP,
6901,GO:0021649,1,0.978950316202423,0,1,vestibulocochlear nerve structural organization,BP,
6902,GO:0021650,1,0.919052604555394,0,4,vestibulocochlear nerve formation,BP,
6903,GO:0021658,1,0.958158852093715,0,2,rhombomere 3 morphogenesis,BP,
6904,GO:0021660,1,0.979044230750363,0,1,rhombomere 3 formation,BP,
6905,GO:0021664,1,0.979044230750363,0,1,rhombomere 5 morphogenesis,BP,
6906,GO:0021666,1,0.979044230750363,0,1,rhombomere 5 formation,BP,
6907,GO:0021670,1,0.788804586041493,0,12,lateral ventricle development,BP,
6909,GO:0021678,1,0.940983759570471,0,3,third ventricle development,BP,
6913,GO:0021682,1,0.980080029216405,0,1,nerve maturation,BP,
6916,GO:0021685,1,0.981287873414398,0,1,cerebellar granular layer structural organization,BP,
6917,GO:0021686,1,0.978623733368141,0,1,cerebellar granular layer maturation,BP,
6920,GO:0021691,1,0.961287211992484,0,2,cerebellar Purkinje cell layer maturation,BP,
6923,GO:0021694,1,0.824377226032834,0,10,cerebellar Purkinje cell layer formation,BP,
6928,GO:0021699,1,0.940736292264579,0,3,cerebellar cortex maturation,BP,
6930,GO:0021702,1,0.824377226032834,0,10,cerebellar Purkinje cell differentiation,BP,
6931,GO:0021703,1,0.978641186704773,0,1,locus ceruleus development,BP,
6933,GO:0021718,1,0.958472767983224,0,2,superior olivary nucleus development,BP,
6934,GO:0021722,1,0.958472767983224,0,2,superior olivary nucleus maturation,BP,
6935,GO:0021723,1,0.979061405677543,0,1,medullary reticular formation development,BP,
6936,GO:0021730,1,0.96136112340266,0,2,trigeminal sensory nucleus development,BP,
6937,GO:0021732,1,0.978874203964035,0,1,midbrain-hindbrain boundary maturation,BP,
6938,GO:0021740,1,0.96136112340266,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6939,GO:0021747,1,0.939402235432279,0,3,cochlear nucleus development,BP,
6940,GO:0021750,1,0.978946517601127,0,1,vestibular nucleus development,BP,
6941,GO:0021754,1,0.978495412165919,0,1,facial nucleus development,BP,
6942,GO:0021756,1,0.718594225438714,0,16,striatum development,BP,
6943,GO:0021757,1,0.979072393370562,0,1,caudate nucleus development,BP,
6944,GO:0021758,1,0.979072393370562,0,1,putamen development,BP,
6945,GO:0021759,1,0.919091774646497,0,4,globus pallidus development,BP,
6946,GO:0021761,1,0.121207997869271,0,102,limbic system development,BP,
6947,GO:0021762,1,0.412608438964285,0,42,substantia nigra development,BP,
6948,GO:0021763,1,0.978855222752691,0,1,subthalamic nucleus development,BP,
6949,GO:0021764,1,0.925769097155218,0,4,amygdala development,BP,
6950,GO:0021766,1,0.208832370220162,0,76,hippocampus development,BP,
6951,GO:0021767,1,0.961580526856824,0,2,mammillary body development,BP,
6952,GO:0021768,1,0.979069611367795,0,1,nucleus accumbens development,BP,
6953,GO:0021769,1,0.9194657917268,0,4,orbitofrontal cortex development,BP,
6954,GO:0021771,1,0.980093073938868,0,1,lateral geniculate nucleus development,BP,
6956,GO:0021773,1,0.942722337165791,0,3,striatal medium spiny neuron differentiation,BP,
6957,GO:0021775,1,0.943459880692878,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6958,GO:0021776,1,0.943459880692878,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6959,GO:0021778,1,0.92156938896507,0,4,oligodendrocyte cell fate specification,BP,
6960,GO:0021779,1,0.92156938896507,0,4,oligodendrocyte cell fate commitment,BP,
6961,GO:0021780,1,0.92156938896507,0,4,glial cell fate specification,BP,
6962,GO:0021781,1,0.777787172647366,0,12,glial cell fate commitment,BP,
6964,GO:0021783,1,0.716243699471459,0,16,preganglionic parasympathetic fiber development,BP,
6966,GO:0021785,1,0.872373373225433,0,7,branchiomotor neuron axon guidance,BP,
6967,GO:0021793,1,0.9790693410655,0,1,chemorepulsion of branchiomotor axon,BP,
6968,GO:0021794,1,0.733264444384837,0,15,thalamus development,BP,
6969,GO:0021795,1,0.420278232740776,0,42,cerebral cortex cell migration,BP,
6970,GO:0021796,1,0.899444550115153,0,5,cerebral cortex regionalization,BP,
6973,GO:0021799,1,0.539087703494087,0,30,cerebral cortex radially oriented cell migration,BP,
6974,GO:0021800,1,0.852874792697492,0,8,cerebral cortex tangential migration,BP,
6975,GO:0021801,1,0.637806285423456,0,22,cerebral cortex radial glia guided migration,BP,
6976,GO:0021812,1,0.959613683987252,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6977,GO:0021813,1,0.978984687793569,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6978,GO:0021814,1,0.868347026727696,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6979,GO:0021815,1,0.905926816984988,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6980,GO:0021816,1,0.959686507286016,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6981,GO:0021817,1,0.943988138972199,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6982,GO:0021819,1,0.782097280369906,0,12,layer formation in cerebral cortex,BP,
6983,GO:0021822,1,0.978816254458648,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6984,GO:0021823,1,0.961323426090618,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6985,GO:0021824,1,0.959422263445639,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6986,GO:0021825,1,0.922310986989118,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6987,GO:0021826,1,0.810788452544905,0,10,substrate-independent telencephalic tangential migration,BP,
6988,GO:0021827,1,0.961323426090618,0,2,postnatal olfactory bulb interneuron migration,BP,
6989,GO:0021828,1,0.959422263445639,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6990,GO:0021830,1,0.828266639916449,0,9,interneuron migration from the subpallium to the cortex,BP,
6991,GO:0021831,1,0.958395341484553,0,2,embryonic olfactory bulb interneuron precursor migration,BP,
6992,GO:0021836,1,0.961323426090618,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6993,GO:0021840,1,0.958427256310014,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6994,GO:0021842,1,0.958427256310014,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6995,GO:0021843,1,0.810788452544905,0,10,substrate-independent telencephalic tangential interneuron migration,BP,
6997,GO:0021847,1,0.939334372745172,0,3,ventricular zone neuroblast division,BP,
6998,GO:0021849,1,0.958577499777579,0,2,neuroblast division in subventricular zone,BP,
6999,GO:0021852,1,0.958429507440463,0,2,pyramidal neuron migration,BP,
7000,GO:0021853,1,0.882689632197372,0,6,cerebral cortex GABAergic interneuron migration,BP,
7001,GO:0021854,1,0.626962809862821,0,22,hypothalamus development,BP,
7002,GO:0021855,1,0.919005445185953,0,4,hypothalamus cell migration,BP,
7003,GO:0021856,1,0.959422263445639,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
7004,GO:0021858,1,0.97849242124492,0,1,GABAergic neuron differentiation in basal ganglia,BP,
7005,GO:0021859,1,0.815643830479147,0,10,pyramidal neuron differentiation,BP,
7006,GO:0021860,1,0.831205848757747,0,9,pyramidal neuron development,BP,
7007,GO:0021861,1,0.920606226638673,0,4,forebrain radial glial cell differentiation,BP,
7008,GO:0021869,1,0.882069895646049,0,6,forebrain ventricular zone progenitor cell division,BP,
7009,GO:0021870,1,0.980378563287104,0,1,Cajal-Retzius cell differentiation,BP,
7012,GO:0021873,1,0.849133183084005,0,8,forebrain neuroblast division,BP,
7013,GO:0021874,1,0.979053151914992,0,1,Wnt signaling pathway involved in forebrain neuroblast division,BP,
7017,GO:0021882,1,0.958199159439563,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
7020,GO:0021886,1,0.959422263445639,0,2,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
7021,GO:0021888,1,0.959422263445639,0,2,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
7024,GO:0021892,1,0.776285533929766,0,12,cerebral cortex GABAergic interneuron differentiation,BP,
7025,GO:0021893,1,0.958199159439563,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
7026,GO:0021894,1,0.84548227096029,0,8,cerebral cortex GABAergic interneuron development,BP,
7027,GO:0021895,1,0.63164224601144,0,22,cerebral cortex neuron differentiation,BP,
7028,GO:0021896,1,0.964946925956086,0,2,forebrain astrocyte differentiation,BP,
7029,GO:0021897,1,0.964946925956086,0,2,forebrain astrocyte development,BP,
7031,GO:0021902,1,0.883353826967396,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
7034,GO:0021910,1,0.866849544347712,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7035,GO:0021912,1,0.957464744388613,0,2,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
7036,GO:0021913,1,0.937068222377312,0,3,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
7037,GO:0021914,1,0.918804078352666,0,4,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7039,GO:0021919,1,0.979070000134537,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
7040,GO:0021920,1,0.978534083677148,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
7041,GO:0021924,1,0.814127534683959,0,10,cell proliferation in external granule layer,BP,
7042,GO:0021930,1,0.814127534683959,0,10,cerebellar granule cell precursor proliferation,BP,
7043,GO:0021932,1,0.813467930500503,0,10,hindbrain radial glia guided cell migration,BP,
7044,GO:0021933,1,0.978623733368141,0,1,radial glia guided migration of cerebellar granule cell,BP,
7045,GO:0021934,1,0.963593547235152,0,2,hindbrain tangential cell migration,BP,
7046,GO:0021935,1,0.984202246515657,0,1,cerebellar granule cell precursor tangential migration,BP,
7047,GO:0021936,1,0.810116849385342,0,10,regulation of cerebellar granule cell precursor proliferation,BP,
7048,GO:0021937,1,0.881597101580215,0,6,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
7049,GO:0021938,1,0.920146799628075,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
7050,GO:0021940,1,0.845326627425604,0,8,positive regulation of cerebellar granule cell precursor proliferation,BP,
7051,GO:0021941,1,0.958366387510619,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
7052,GO:0021942,1,0.901784872034858,0,5,radial glia guided migration of Purkinje cell,BP,
7053,GO:0021943,1,0.921799448397184,0,4,formation of radial glial scaffolds,BP,
7058,GO:0021956,1,0.978757008585089,0,1,central nervous system interneuron axonogenesis,BP,
7059,GO:0021957,1,0.886263471808689,0,6,corticospinal tract morphogenesis,BP,
7060,GO:0021960,1,0.903144126910767,0,5,anterior commissure morphogenesis,BP,
7061,GO:0021965,1,0.944842447059275,0,3,spinal cord ventral commissure morphogenesis,BP,
7062,GO:0021966,1,0.958528992253952,0,2,corticospinal neuron axon guidance,BP,
7063,GO:0021972,1,0.979557623121372,0,1,corticospinal neuron axon guidance through spinal cord,BP,
7065,GO:0021979,1,0.881138793537356,0,6,hypothalamus cell differentiation,BP,
7068,GO:0021985,1,0.958572577401627,0,2,neurohypophysis development,BP,
7069,GO:0021986,1,0.958589098762407,0,2,habenula development,BP,
7072,GO:0021993,1,0.97976503385056,0,1,initiation of neural tube closure,BP,
7073,GO:0021997,1,0.962577854574402,0,2,neural plate axis specification,BP,
7074,GO:0021998,1,0.979071682445459,0,1,neural plate mediolateral regionalization,BP,
7076,GO:0022004,1,0.978874203964035,0,1,midbrain-hindbrain boundary maturation during brain development,BP,
7077,GO:0022007,1,0.939200609987339,0,3,convergent extension involved in neural plate elongation,BP,
7080,GO:0022010,1,0.72877502603823,0,15,central nervous system myelination,BP,
7082,GO:0022012,1,0.981959387761287,0,1,subpallium cell proliferation in forebrain,BP,
7083,GO:0022013,1,0.982207436663827,0,1,pallium cell proliferation in forebrain,BP,
7084,GO:0022018,1,0.981959387761287,0,1,lateral ganglionic eminence cell proliferation,BP,
7085,GO:0022027,1,0.910978823929799,0,5,interkinetic nuclear migration,BP,
7086,GO:0022028,1,0.868103337477005,0,7,tangential migration from the subventricular zone to the olfactory bulb,BP,
7087,GO:0022029,1,0.320858055747546,0,55,telencephalon cell migration,BP,
7088,GO:0022030,1,0.637806285423456,0,22,telencephalon glial cell migration,BP,
7090,GO:0022038,1,0.74852307492921,0,14,corpus callosum development,BP,
7092,GO:0022401,1,0.740936408066725,0,14,negative adaptation of signaling pathway,BP,
7104,GO:0022417,1,0.859648787333196,0,7,protein maturation by protein folding,BP,
7106,GO:0022601,1,0.958749411061404,0,2,menstrual cycle phase,BP,
7110,GO:0022605,1,0.880487115033924,0,6,oogenesis stage,BP,
7116,GO:0022615,1,0.861477395940987,0,7,protein to membrane docking,BP,
7117,GO:0022616,1,0.630042589089266,0,22,DNA strand elongation,BP,
7120,GO:0022622,1,0.978476629273923,0,1,root system development,BP,
7121,GO:0022624,1,0.59609432466995,0,24,proteasome accessory complex,CC,
7122,GO:0022625,1,0.278263061130176,0,59,cytosolic large ribosomal subunit,CC,
7123,GO:0022626,1,0.0907251721038648,0,111,cytosolic ribosome,CC,
7124,GO:0022627,1,0.387752563118403,0,44,cytosolic small ribosomal subunit,CC,
7127,GO:0022820,1,0.885019615627168,0,6,potassium ion symporter activity,MF,
7128,GO:0022821,1,0.715002051814822,0,16,potassium ion antiporter activity,MF,
7132,GO:0022833,1,0.843845138964552,0,8,mechanically gated channel activity,MF,
7137,GO:0022839,1,0.387172653252648,0,45,ion gated channel activity,MF,
7138,GO:0022840,1,0.863207037809985,0,7,leak channel activity,MF,
7139,GO:0022841,1,0.918290593053284,0,4,potassium ion leak channel activity,MF,
7140,GO:0022842,1,0.863207037809985,0,7,narrow pore channel activity,MF,
7142,GO:0022848,1,0.711931915757599,0,16,acetylcholine-gated cation-selective channel activity,MF,
7143,GO:0022850,1,0.897950403535985,0,5,serotonin-gated cation-selective channel activity,MF,
7144,GO:0022851,1,0.90041348925297,0,5,GABA-gated chloride ion channel activity,MF,
7145,GO:0022852,1,0.958577731370659,0,2,glycine-gated chloride ion channel activity,MF,
7146,GO:0022853,1,0.0747834037855782,0,124,active ion transmembrane transporter activity,MF,
7148,GO:0022858,1,0.863135586747368,0,7,alanine transmembrane transporter activity,MF,
7149,GO:0022865,1,0.979058435939385,0,1,transmembrane electron transfer carrier,MF,
7150,GO:0022884,1,0.651914347057187,0,20,macromolecule transmembrane transporter activity,MF,
7151,GO:0022889,1,0.824956303264918,0,9,serine transmembrane transporter activity,MF,
7155,GO:0022897,1,0.919347670279827,0,4,proton-dependent peptide secondary active transmembrane transporter activity,MF,
7160,GO:0023016,1,0.942360468846778,0,3,signal transduction by trans-phosphorylation,BP,
7162,GO:0023021,1,0.938162623140646,0,3,termination of signal transduction,BP,
7163,GO:0023023,1,0.650684392805817,0,20,MHC protein complex binding,MF,
7164,GO:0023024,1,0.937515085379891,0,3,MHC class I protein complex binding,MF,
7165,GO:0023025,1,0.95835239040278,0,2,MHC class Ib protein complex binding,MF,
7166,GO:0023026,1,0.709113702719937,0,16,MHC class II protein complex binding,MF,
7167,GO:0023029,1,0.899431479327249,0,5,MHC class Ib protein binding,MF,
7168,GO:0023030,1,0.95835239040278,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7169,GO:0023035,1,0.843577290242035,0,8,CD40 signaling pathway,BP,
7170,GO:0023041,1,0.882736519344335,0,6,neuronal signal transduction,BP,
7175,GO:0023058,1,0.710145963524412,0,16,adaptation of signaling pathway,BP,
7178,GO:0030002,1,0.764412405852954,0,13,cellular anion homeostasis,BP,
7181,GO:0030007,1,0.84630773172273,0,8,cellular potassium ion homeostasis,BP,
7182,GO:0030008,1,0.843445919097319,0,8,TRAPP complex,CC,
7184,GO:0030011,1,0.721279498162088,0,16,maintenance of cell polarity,BP,
7185,GO:0030014,1,0.733636293988231,0,15,CCR4-NOT complex,CC,
7186,GO:0030015,1,0.94021870310957,0,3,CCR4-NOT core complex,CC,
7190,GO:0030020,1,0.88602881107455,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7191,GO:0030021,1,0.879788047101646,0,6,extracellular matrix structural constituent conferring compression resistance,MF,
7192,GO:0030023,1,0.910462344749298,0,5,extracellular matrix constituent conferring elasticity,MF,
7198,GO:0030033,1,0.734214599032392,0,15,microvillus assembly,BP,
7201,GO:0030037,1,0.979553036195516,0,1,actin filament reorganization involved in cell cycle,BP,
7205,GO:0030043,1,0.938076049161137,0,3,actin filament fragmentation,BP,
7207,GO:0030047,1,0.938837864066143,0,3,actin modification,BP,
7210,GO:0030050,1,0.924428170480017,0,4,vesicle transport along actin filament,BP,
7217,GO:0030062,1,0.883736383550958,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7218,GO:0030070,1,0.938318025301175,0,3,insulin processing,BP,
7219,GO:0030071,1,0.402615784395273,0,44,regulation of mitotic metaphase/anaphase transition,BP,
7228,GO:0030103,1,0.957985562360255,0,2,vasopressin secretion,BP,
7230,GO:0030107,1,0.979044870566797,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7231,GO:0030108,1,0.978575904928287,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7232,GO:0030109,1,0.958208426363033,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7233,GO:0030110,1,0.978611641618458,0,1,HLA-C specific inhibitory MHC class I receptor activity,MF,
7235,GO:0030117,1,0.148482408748964,0,91,membrane coat,CC,
7236,GO:0030118,1,0.369662553055764,0,48,clathrin coat,CC,
7237,GO:0030119,1,0.40682082817879,0,43,AP-type membrane coat adaptor complex,CC,
7238,GO:0030120,1,0.357869663728532,0,49,vesicle coat,CC,
7239,GO:0030121,1,0.882608976645931,0,6,AP-1 adaptor complex,CC,
7240,GO:0030122,1,0.763221649288088,0,13,AP-2 adaptor complex,CC,
7241,GO:0030123,1,0.810828306319021,0,10,AP-3 adaptor complex,CC,
7242,GO:0030125,1,0.607762586462918,0,24,clathrin vesicle coat,CC,
7243,GO:0030126,1,0.758333239389988,0,13,COPI vesicle coat,CC,
7244,GO:0030127,1,0.777007751009732,0,12,COPII vesicle coat,CC,
7245,GO:0030128,1,0.747463072802887,0,14,clathrin coat of endocytic vesicle,CC,
7246,GO:0030130,1,0.779647280850487,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7247,GO:0030131,1,0.53521701691576,0,30,clathrin adaptor complex,CC,
7248,GO:0030132,1,0.689425013606707,0,18,clathrin coat of coated pit,CC,
7250,GO:0030134,1,0.205546616235311,0,75,ER to Golgi transport vesicle,CC,
7253,GO:0030137,1,0.612606692658417,0,23,COPI-coated vesicle,CC,
7255,GO:0030140,1,0.549229581470359,0,29,trans-Golgi network transport vesicle,CC,
7257,GO:0030144,1,0.938335355828045,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7259,GO:0030148,1,0.202000614608772,0,76,sphingolipid biosynthetic process,BP,
7261,GO:0030150,1,0.708871436726646,0,16,protein import into mitochondrial matrix,BP,
7262,GO:0030151,1,0.918477228720969,0,4,molybdenum ion binding,MF,
7265,GO:0030156,1,0.978474434786005,0,1,benzodiazepine receptor binding,MF,
7267,GO:0030158,1,0.941952980919371,0,3,protein xylosyltransferase activity,MF,
7269,GO:0030160,1,0.9258308297645,0,4,GKAP/Homer scaffold activity,MF,
7274,GO:0030167,1,0.918902866987373,0,4,proteoglycan catabolic process,BP,
7276,GO:0030169,1,0.752113131045216,0,14,low-density lipoprotein particle binding,MF,
7278,GO:0030171,1,0.958042400311558,0,2,voltage-gated proton channel activity,MF,
7279,GO:0030172,1,0.936884147427128,0,3,troponin C binding,MF,
7280,GO:0030173,1,0.328622212715239,0,53,integral component of Golgi membrane,CC,
7281,GO:0030174,1,0.899474042476902,0,5,regulation of DNA-dependent DNA replication initiation,BP,
7288,GO:0030184,1,0.97902565244238,0,1,nitric oxide transmembrane transporter activity,MF,
7290,GO:0030186,1,0.957578047916578,0,2,melatonin metabolic process,BP,
7291,GO:0030187,1,0.957578047916578,0,2,melatonin biosynthetic process,BP,
7293,GO:0030194,1,0.60070902061798,0,24,positive regulation of blood coagulation,BP,
7295,GO:0030197,1,0.944778675417628,0,3,extracellular matrix constituent, lubricant activity,MF,
7297,GO:0030199,1,0.471027855466682,0,37,collagen fibril organization,BP,
7298,GO:0030200,1,0.938088461534604,0,3,heparan sulfate proteoglycan catabolic process,BP,
7300,GO:0030202,1,0.848360043553311,0,8,heparin metabolic process,BP,
7304,GO:0030206,1,0.597813136228436,0,25,chondroitin sulfate biosynthetic process,BP,
7306,GO:0030208,1,0.783648045947719,0,12,dermatan sulfate biosynthetic process,BP,
7308,GO:0030210,1,0.848360043553311,0,8,heparin biosynthetic process,BP,
7312,GO:0030215,1,0.818487449217748,0,10,semaphorin receptor binding,MF,
7318,GO:0030221,1,0.95858343451054,0,2,basophil differentiation,BP,
7319,GO:0030222,1,0.898133735795049,0,5,eosinophil differentiation,BP,
7320,GO:0030223,1,0.899049457102932,0,5,neutrophil differentiation,BP,
7323,GO:0030226,1,0.964794126877812,0,2,apolipoprotein receptor activity,MF,
7324,GO:0030228,1,0.731091502902448,0,16,lipoprotein particle receptor activity,MF,
7325,GO:0030229,1,0.919519173825664,0,4,very-low-density lipoprotein particle receptor activity,MF,
7326,GO:0030233,1,0.978624051824217,0,1,deoxynucleotide transmembrane transporter activity,MF,
7332,GO:0030240,1,0.917859987670624,0,5,skeletal muscle thin filament assembly,BP,
7334,GO:0030242,1,0.920943880337586,0,4,pexophagy,BP,
7336,GO:0030247,1,0.641970609327725,0,21,polysaccharide binding,MF,
7337,GO:0030249,1,0.841323654003071,0,8,guanylate cyclase regulator activity,MF,
7338,GO:0030250,1,0.859484587401341,0,7,guanylate cyclase activator activity,MF,
7339,GO:0030251,1,0.978878592329253,0,1,guanylate cyclase inhibitor activity,MF,
7340,GO:0030252,1,0.732147949558107,0,15,growth hormone secretion,BP,
7342,GO:0030259,1,0.879290753701364,0,6,lipid glycosylation,BP,
7344,GO:0030261,1,0.529701902389561,0,31,chromosome condensation,BP,
7345,GO:0030262,1,0.555120797048991,0,28,apoptotic nuclear changes,BP,
7346,GO:0030263,1,0.920191889508568,0,4,apoptotic chromosome condensation,BP,
7347,GO:0030264,1,0.979167039160309,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7348,GO:0030267,1,0.978526668160986,0,1,glyoxylate reductase (NADP) activity,MF,
7349,GO:0030272,1,0.978483595077724,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7350,GO:0030273,1,0.9789268845792,0,1,melanin-concentrating hormone receptor activity,MF,
7352,GO:0030275,1,0.702503436055277,0,17,LRR domain binding,MF,
7360,GO:0030284,1,0.920152033949822,0,4,estrogen receptor activity,MF,
7362,GO:0030286,1,0.402867620531762,0,47,dynein complex,CC,
7363,GO:0030289,1,0.937561184429869,0,3,protein phosphatase 4 complex,CC,
7364,GO:0030290,1,0.979070628890252,0,1,sphingolipid activator protein activity,MF,
7366,GO:0030292,1,0.938983113107749,0,3,protein tyrosine kinase inhibitor activity,MF,
7367,GO:0030294,1,0.978844382121592,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7370,GO:0030297,1,0.863259949489566,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7371,GO:0030298,1,0.978524318840582,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7372,GO:0030299,1,0.741591986821691,0,14,intestinal cholesterol absorption,BP,
7373,GO:0030300,1,0.860467052515236,0,7,regulation of intestinal cholesterol absorption,BP,
7375,GO:0030302,1,0.978624051824217,0,1,deoxynucleotide transport,BP,
7376,GO:0030305,1,0.958292782701847,0,2,heparanase activity,MF,
7377,GO:0030306,1,0.851607895925391,0,8,ADP-ribosylation factor binding,MF,
7382,GO:0030312,1,0.978860101482976,0,1,external encapsulating structure,CC,
7384,GO:0030315,1,0.418566749328286,0,44,T-tubule,CC,
7388,GO:0030320,1,0.764412405852954,0,13,cellular monovalent inorganic anion homeostasis,BP,
7389,GO:0030321,1,0.900491150318708,0,5,transepithelial chloride transport,BP,
7390,GO:0030322,1,0.978858071158219,0,1,stabilization of membrane potential,BP,
7395,GO:0030327,1,0.939149223776625,0,3,prenylated protein catabolic process,BP,
7396,GO:0030328,1,0.959230748640624,0,2,prenylcysteine catabolic process,BP,
7397,GO:0030329,1,0.959230748640624,0,2,prenylcysteine metabolic process,BP,
7399,GO:0030331,1,0.457356214324143,0,38,estrogen receptor binding,MF,
7404,GO:0030337,1,0.957969781486992,0,2,DNA polymerase processivity factor activity,MF,
7405,GO:0030342,1,0.979067705667554,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7406,GO:0030343,1,0.958092782641692,0,2,vitamin D3 25-hydroxylase activity,MF,
7407,GO:0030345,1,0.879788047101646,0,6,structural constituent of tooth enamel,MF,
7408,GO:0030346,1,0.88289981257974,0,6,protein phosphatase 2B binding,MF,
7409,GO:0030348,1,0.938597419375239,0,3,syntaxin-3 binding,MF,
7410,GO:0030350,1,0.960076951519212,0,2,iron-responsive element binding,MF,
7411,GO:0030351,1,0.979042395172386,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7412,GO:0030354,1,0.97847525648432,0,1,melanin-concentrating hormone activity,MF,
7413,GO:0030366,1,0.957646801409003,0,2,molybdopterin synthase activity,MF,
7414,GO:0030368,1,0.846685134036261,0,8,interleukin-17 receptor activity,MF,
7415,GO:0030369,1,0.938681180457235,0,3,ICAM-3 receptor activity,MF,
7416,GO:0030371,1,0.607951432556622,0,24,translation repressor activity,MF,
7417,GO:0030372,1,0.979443900513166,0,1,high molecular weight B cell growth factor receptor binding,MF,
7420,GO:0030377,1,0.978567236970161,0,1,urokinase plasminogen activator receptor activity,MF,
7421,GO:0030378,1,0.978948595150004,0,1,serine racemase activity,MF,
7422,GO:0030379,1,0.98108848660805,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7423,GO:0030380,1,0.978525402091846,0,1,interleukin-17E receptor binding,MF,
7424,GO:0030382,1,0.978657574839101,0,1,sperm mitochondrion organization,BP,
7425,GO:0030387,1,0.978566053524938,0,1,fructosamine-3-kinase activity,MF,
7426,GO:0030388,1,0.860048347787526,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7427,GO:0030389,1,0.978566053524938,0,1,fructosamine metabolic process,BP,
7428,GO:0030393,1,0.978566053524938,0,1,fructoselysine metabolic process,BP,
7429,GO:0030395,1,0.937447093684767,0,3,lactose binding,MF,
7430,GO:0030397,1,0.385952863485892,0,46,membrane disassembly,BP,
7431,GO:0030407,1,0.978716800459583,0,1,formimidoyltransferase activity,MF,
7432,GO:0030409,1,0.978716800459583,0,1,glutamate formimidoyltransferase activity,MF,
7433,GO:0030412,1,0.978716800459583,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7435,GO:0030421,1,0.978484698441343,0,1,defecation,BP,
7436,GO:0030422,1,0.922135688042304,0,4,production of siRNA involved in RNA interference,BP,
7437,GO:0030423,1,0.941783580839902,0,3,targeting of mRNA for destruction involved in RNA interference,BP,
7442,GO:0030429,1,0.978578941609564,0,1,kynureninase activity,MF,
7443,GO:0030430,1,0.918812167581223,0,4,host cell cytoplasm,CC,
7446,GO:0030433,1,0.223318963883837,0,71,ubiquitin-dependent ERAD pathway,BP,
7448,GO:0030450,1,0.941272508262715,0,3,regulation of complement activation, classical pathway,BP,
7449,GO:0030451,1,0.982745541009455,0,1,regulation of complement activation, alternative pathway,BP,
7450,GO:0030473,1,0.943988138972199,0,3,nuclear migration along microtubule,BP,
7451,GO:0030478,1,0.919199131791767,0,4,actin cap,CC,
7454,GO:0030490,1,0.3609285459709,0,48,maturation of SSU-rRNA,BP,
7455,GO:0030492,1,0.897002477660449,0,5,hemoglobin binding,MF,
7460,GO:0030502,1,0.711211702447495,0,16,negative regulation of bone mineralization,BP,
7461,GO:0030504,1,0.981952896225021,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7462,GO:0030505,1,0.963691935558515,0,2,inorganic diphosphate transport,BP,
7467,GO:0030511,1,0.59723407222098,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7474,GO:0030518,1,0.0748621903614421,0,124,intracellular steroid hormone receptor signaling pathway,BP,
7475,GO:0030520,1,0.36738740534145,0,48,intracellular estrogen receptor signaling pathway,BP,
7476,GO:0030521,1,0.258908544788278,0,65,androgen receptor signaling pathway,BP,
7478,GO:0030523,1,0.979216875884261,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7479,GO:0030526,1,0.979475482029509,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7481,GO:0030532,1,0.254144792310764,0,65,small nuclear ribonucleoprotein complex,CC,
7486,GO:0030544,1,0.501508707518745,0,33,Hsp70 protein binding,MF,
7489,GO:0030547,1,0.726961955075644,0,15,receptor inhibitor activity,MF,
7490,GO:0030548,1,0.879405899323825,0,6,acetylcholine receptor regulator activity,MF,
7491,GO:0030549,1,0.978512663412901,0,1,acetylcholine receptor activator activity,MF,
7492,GO:0030550,1,0.918369818276384,0,4,acetylcholine receptor inhibitor activity,MF,
7495,GO:0030553,1,0.7484746118944,0,14,cGMP binding,MF,
7497,GO:0030572,1,0.979081880848646,0,1,phosphatidyltransferase activity,MF,
7498,GO:0030573,1,0.937964007927774,0,3,bile acid catabolic process,BP,
7500,GO:0030575,1,0.821417194527144,0,10,nuclear body organization,BP,
7501,GO:0030576,1,0.958333133327467,0,2,Cajal body organization,BP,
7502,GO:0030578,1,0.925956782997129,0,4,PML body organization,BP,
7503,GO:0030579,1,0.88159229820519,0,6,ubiquitin-dependent SMAD protein catabolic process,BP,
7504,GO:0030580,1,0.978531371205572,0,1,quinone cofactor methyltransferase activity,MF,
7505,GO:0030581,1,0.898765012036251,0,5,symbiont intracellular protein transport in host,BP,
7506,GO:0030586,1,0.979069205329571,0,1,[methionine synthase] reductase activity,MF,
7510,GO:0030611,1,0.978485843550268,0,1,arsenate reductase activity,MF,
7511,GO:0030613,1,0.936915162072771,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7512,GO:0030614,1,0.936915162072771,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7513,GO:0030616,1,0.982356041621774,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7514,GO:0030617,1,0.958548561695573,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7515,GO:0030618,1,0.907457927409999,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7516,GO:0030619,1,0.87977483140181,0,6,U1 snRNA binding,MF,
7517,GO:0030620,1,0.897432953112531,0,5,U2 snRNA binding,MF,
7518,GO:0030621,1,0.900169299009974,0,5,U4 snRNA binding,MF,
7519,GO:0030622,1,0.959135057976621,0,2,U4atac snRNA binding,MF,
7520,GO:0030623,1,0.981310024262988,0,1,U5 snRNA binding,MF,
7521,GO:0030624,1,0.979229612128656,0,1,U6atac snRNA binding,MF,
7522,GO:0030626,1,0.95824305634552,0,2,U12 snRNA binding,MF,
7523,GO:0030627,1,0.958014768500009,0,2,pre-mRNA 5'-splice site binding,MF,
7524,GO:0030628,1,0.879281981733181,0,6,pre-mRNA 3'-splice site binding,MF,
7525,GO:0030638,1,0.841203215055338,0,8,polyketide metabolic process,BP,
7527,GO:0030643,1,0.831119745930143,0,9,cellular phosphate ion homeostasis,BP,
7528,GO:0030644,1,0.919776786364672,0,4,cellular chloride ion homeostasis,BP,
7529,GO:0030647,1,0.823414873634527,0,9,aminoglycoside antibiotic metabolic process,BP,
7530,GO:0030653,1,0.979621893999958,0,1,beta-lactam antibiotic metabolic process,BP,
7536,GO:0030663,1,0.710771953480194,0,16,COPI-coated vesicle membrane,CC,
7545,GO:0030676,1,0.735182034454387,0,15,Rac guanyl-nucleotide exchange factor activity,MF,
7548,GO:0030681,1,0.860525119421068,0,7,multimeric ribonuclease P complex,CC,
7549,GO:0030682,1,0.979015691396219,0,1,evasion or tolerance of host defense response,BP,
7550,GO:0030683,1,0.979015691396219,0,1,evasion or tolerance by virus of host immune response,BP,
7551,GO:0030684,1,0.24451146951793,0,67,preribosome,CC,
7552,GO:0030686,1,0.54473652432762,0,29,90S preribosome,CC,
7553,GO:0030687,1,0.631664648879593,0,22,preribosome, large subunit precursor,CC,
7554,GO:0030688,1,0.794471570981014,0,11,preribosome, small subunit precursor,CC,
7555,GO:0030689,1,0.938035650237185,0,3,Noc complex,CC,
7556,GO:0030690,1,0.97903695460595,0,1,Noc1p-Noc2p complex,CC,
7557,GO:0030691,1,0.97903695460595,0,1,Noc2p-Noc3p complex,CC,
7558,GO:0030692,1,0.958123145409786,0,2,Noc4p-Nop14p complex,CC,
7560,GO:0030696,1,0.979067436977794,0,1,tRNA (m5U54) methyltransferase activity,MF,
7561,GO:0030697,1,0.979067436977794,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7562,GO:0030705,1,0.0591940353227939,0,138,cytoskeleton-dependent intracellular transport,BP,
7563,GO:0030718,1,0.937857352001106,0,3,germ-line stem cell population maintenance,BP,
7564,GO:0030719,1,0.958487301088312,0,2,P granule organization,BP,
7566,GO:0030729,1,0.979069317821223,0,1,acetoacetate-CoA ligase activity,MF,
7567,GO:0030730,1,0.732251058540805,0,15,sequestering of triglyceride,BP,
7568,GO:0030731,1,0.978494881953364,0,1,guanidinoacetate N-methyltransferase activity,MF,
7570,GO:0030748,1,0.978973993112912,0,1,amine N-methyltransferase activity,MF,
7572,GO:0030791,1,0.978945125219278,0,1,arsenite methyltransferase activity,MF,
7573,GO:0030792,1,0.978945125219278,0,1,methylarsonite methyltransferase activity,MF,
7580,GO:0030805,1,0.94166557471359,0,3,regulation of cyclic nucleotide catabolic process,BP,
7581,GO:0030806,1,0.960579319436877,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7582,GO:0030807,1,0.980312203334817,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7586,GO:0030811,1,0.94166557471359,0,3,regulation of nucleotide catabolic process,BP,
7587,GO:0030812,1,0.960579319436877,0,2,negative regulation of nucleotide catabolic process,BP,
7588,GO:0030813,1,0.980312203334817,0,1,positive regulation of nucleotide catabolic process,BP,
7595,GO:0030820,1,0.94166557471359,0,3,regulation of cAMP catabolic process,BP,
7596,GO:0030821,1,0.960579319436877,0,2,negative regulation of cAMP catabolic process,BP,
7597,GO:0030822,1,0.980312203334817,0,1,positive regulation of cAMP catabolic process,BP,
7599,GO:0030824,1,0.957889389471787,0,2,negative regulation of cGMP metabolic process,BP,
7602,GO:0030827,1,0.957889389471787,0,2,negative regulation of cGMP biosynthetic process,BP,
7611,GO:0030842,1,0.979969207333289,0,1,regulation of intermediate filament depolymerization,BP,
7612,GO:0030844,1,0.979969207333289,0,1,positive regulation of intermediate filament depolymerization,BP,
7613,GO:0030845,1,0.979043579876824,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7614,GO:0030846,1,0.983914948881197,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7618,GO:0030852,1,0.743195367469169,0,14,regulation of granulocyte differentiation,BP,
7619,GO:0030853,1,0.844525343391653,0,8,negative regulation of granulocyte differentiation,BP,
7620,GO:0030854,1,0.861642713246297,0,7,positive regulation of granulocyte differentiation,BP,
7626,GO:0030860,1,0.959455778042988,0,2,regulation of polarized epithelial cell differentiation,BP,
7627,GO:0030862,1,0.959455778042988,0,2,positive regulation of polarized epithelial cell differentiation,BP,
7632,GO:0030867,1,0.640752717619922,0,21,rough endoplasmic reticulum membrane,CC,
7634,GO:0030870,1,0.900888830995191,0,5,Mre11 complex,CC,
7635,GO:0030874,1,0.978648757804161,0,1,nucleolar chromatin,CC,
7639,GO:0030880,1,0.0686600894906374,0,127,RNA polymerase complex,CC,
7640,GO:0030881,1,0.824206474938012,0,9,beta-2-microglobulin binding,MF,
7641,GO:0030882,1,0.898517324341504,0,5,lipid antigen binding,MF,
7642,GO:0030883,1,0.898517324341504,0,5,endogenous lipid antigen binding,MF,
7643,GO:0030884,1,0.898517324341504,0,5,exogenous lipid antigen binding,MF,
7644,GO:0030885,1,0.897610907406301,0,5,regulation of myeloid dendritic cell activation,BP,
7645,GO:0030886,1,0.937412791921237,0,3,negative regulation of myeloid dendritic cell activation,BP,
7646,GO:0030887,1,0.978590411725591,0,1,positive regulation of myeloid dendritic cell activation,BP,
7648,GO:0030889,1,0.733955357891204,0,15,negative regulation of B cell proliferation,BP,
7650,GO:0030891,1,0.898637981788749,0,5,VCB complex,CC,
7651,GO:0030893,1,0.884103177511282,0,6,meiotic cohesin complex,CC,
7652,GO:0030894,1,0.530074554215472,0,30,replisome,CC,
7653,GO:0030895,1,0.937857761508398,0,3,apolipoprotein B mRNA editing enzyme complex,CC,
7654,GO:0030896,1,0.879638640503572,0,6,checkpoint clamp complex,CC,
7655,GO:0030897,1,0.75192888916037,0,14,HOPS complex,CC,
7657,GO:0030899,1,0.96134693894448,0,2,calcium-dependent ATPase activity,MF,
7662,GO:0030904,1,0.658278855180373,0,20,retromer complex,CC,
7663,GO:0030905,1,0.920961925074755,0,4,retromer, tubulation complex,CC,
7664,GO:0030906,1,0.918267735039348,0,4,retromer, cargo-selective complex,CC,
7665,GO:0030908,1,0.957841934225913,0,2,protein splicing,BP,
7667,GO:0030911,1,0.880774212053007,0,6,TPR domain binding,MF,
7668,GO:0030913,1,0.868889239940472,0,7,paranodal junction assembly,BP,
7669,GO:0030914,1,0.762196973153158,0,13,STAGA complex,CC,
7670,GO:0030915,1,0.880576653260698,0,6,Smc5-Smc6 complex,CC,
7673,GO:0030920,1,0.957528933456106,0,2,peptidyl-serine acetylation,BP,
7674,GO:0030934,1,0.947475105400507,0,3,anchoring collagen complex,CC,
7675,GO:0030935,1,0.978994653205006,0,1,sheet-forming collagen trimer,CC,
7676,GO:0030936,1,0.979063404813261,0,1,transmembrane collagen trimer,CC,
7677,GO:0030942,1,0.937670174801382,0,3,endoplasmic reticulum signal peptide binding,MF,
7678,GO:0030943,1,0.937515935007629,0,3,mitochondrion targeting sequence binding,MF,
7680,GO:0030948,1,0.863130248595273,0,7,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7682,GO:0030950,1,0.922337576124889,0,4,establishment or maintenance of actin cytoskeleton polarity,BP,
7683,GO:0030951,1,0.940146370849476,0,3,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7684,GO:0030952,1,0.867120525187805,0,7,establishment or maintenance of cytoskeleton polarity,BP,
7685,GO:0030953,1,0.883902508771428,0,6,astral microtubule organization,BP,
7686,GO:0030955,1,0.748706543486703,0,14,potassium ion binding,MF,
7687,GO:0030956,1,0.958051876700826,0,2,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7689,GO:0030961,1,0.97897493185122,0,1,peptidyl-arginine hydroxylation,BP,
7690,GO:0030964,1,0.402094908512984,0,42,NADH dehydrogenase complex,CC,
7692,GO:0030969,1,0.938412521790174,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7693,GO:0030970,1,0.577762398698768,0,26,retrograde protein transport, ER to cytosol,BP,
7695,GO:0030974,1,0.978624051824217,0,1,thiamine pyrophosphate transport,BP,
7696,GO:0030975,1,0.9789047734206,0,1,thiamine binding,MF,
7698,GO:0030977,1,0.978682967226778,0,1,taurine binding,MF,
7699,GO:0030981,1,0.961136413707824,0,2,cortical microtubule cytoskeleton,CC,
7700,GO:0030983,1,0.777579348804477,0,12,mismatched DNA binding,MF,
7701,GO:0030984,1,0.978514772252312,0,1,kininogen binding,MF,
7702,GO:0030990,1,0.554222486636633,0,28,intraciliary transport particle,CC,
7703,GO:0030991,1,0.865159690750409,0,7,intraciliary transport particle A,CC,
7704,GO:0030992,1,0.682181779788375,0,18,intraciliary transport particle B,CC,
7705,GO:0030997,1,0.941124396519654,0,3,regulation of centriole-centriole cohesion,BP,
7707,GO:0031001,1,0.97897493185122,0,1,response to brefeldin A,BP,
7708,GO:0031002,1,0.97852925271556,0,1,actin rod,CC,
7709,GO:0031005,1,0.796016830614984,0,11,filamin binding,MF,
7710,GO:0031010,1,0.799907560633307,0,11,ISWI-type complex,CC,
7711,GO:0031011,1,0.741708428303336,0,14,Ino80 complex,CC,
7713,GO:0031013,1,0.897665654376353,0,5,troponin I binding,MF,
7714,GO:0031014,1,0.916654282578093,0,4,troponin T binding,MF,
7716,GO:0031017,1,0.882369426969298,0,6,exocrine pancreas development,BP,
7718,GO:0031021,1,0.937857296871659,0,3,interphase microtubule organizing center,CC,
7719,GO:0031022,1,0.964163899178464,0,2,nuclear migration along microfilament,BP,
7724,GO:0031038,1,0.978802720300017,0,1,myosin II filament organization,BP,
7727,GO:0031048,1,0.97897493185122,0,1,chromatin silencing by small RNA,BP,
7728,GO:0031049,1,0.97903951762157,0,1,programmed DNA elimination,BP,
7730,GO:0031052,1,0.97903951762157,0,1,chromosome breakage,BP,
7731,GO:0031053,1,0.831813590050307,0,9,primary miRNA processing,BP,
7732,GO:0031054,1,0.764581593180756,0,13,pre-miRNA processing,BP,
7733,GO:0031055,1,0.414367294716562,0,41,chromatin remodeling at centromere,BP,
7735,GO:0031057,1,0.445940021227845,0,39,negative regulation of histone modification,BP,
7737,GO:0031060,1,0.302013697307846,0,58,regulation of histone methylation,BP,
7738,GO:0031061,1,0.673844379536499,0,19,negative regulation of histone methylation,BP,
7739,GO:0031062,1,0.50479679600634,0,33,positive regulation of histone methylation,BP,
7740,GO:0031063,1,0.5942785581141,0,25,regulation of histone deacetylation,BP,
7741,GO:0031064,1,0.903796444189224,0,5,negative regulation of histone deacetylation,BP,
7742,GO:0031065,1,0.716565963187583,0,16,positive regulation of histone deacetylation,BP,
7744,GO:0031071,1,0.978912000994551,0,1,cysteine desulfurase activity,MF,
7746,GO:0031074,1,0.919198148076179,0,4,nucleocytoplasmic shuttling complex,CC,
7748,GO:0031077,1,0.864823339789569,0,7,post-embryonic camera-type eye development,BP,
7749,GO:0031078,1,0.796541963820798,0,11,histone deacetylase activity (H3-K14 specific),MF,
7750,GO:0031080,1,0.812188646099997,0,10,nuclear pore outer ring,CC,
7751,GO:0031081,1,0.979158367654368,0,1,nuclear pore distribution,BP,
7752,GO:0031082,1,0.666975343415051,0,19,BLOC complex,CC,
7753,GO:0031083,1,0.741052263968679,0,14,BLOC-1 complex,CC,
7754,GO:0031084,1,0.938953820625499,0,3,BLOC-2 complex,CC,
7755,GO:0031085,1,0.958643628134324,0,2,BLOC-3 complex,CC,
7756,GO:0031086,1,0.844739006790616,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7757,GO:0031087,1,0.862812751061648,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7758,GO:0031088,1,0.883849366022494,0,6,platelet dense granule membrane,CC,
7759,GO:0031089,1,0.756796330796676,0,13,platelet dense granule lumen,CC,
7762,GO:0031092,1,0.703791784767998,0,17,platelet alpha granule membrane,CC,
7765,GO:0031095,1,0.860152806296159,0,8,platelet dense tubular network membrane,CC,
7771,GO:0031104,1,0.979130365316507,0,1,dendrite regeneration,BP,
7772,GO:0031105,1,0.879861095694953,0,6,septin complex,CC,
7773,GO:0031106,1,0.979435559037729,0,1,septin ring organization,BP,
7776,GO:0031111,1,0.580981725268737,0,26,negative regulation of microtubule polymerization or depolymerization,BP,
7779,GO:0031114,1,0.688835178302748,0,18,regulation of microtubule depolymerization,BP,
7780,GO:0031115,1,0.808117378152042,0,10,negative regulation of microtubule polymerization,BP,
7782,GO:0031117,1,0.937873415060965,0,3,positive regulation of microtubule depolymerization,BP,
7783,GO:0031118,1,0.878309087798918,0,6,rRNA pseudouridine synthesis,BP,
7785,GO:0031120,1,0.917172961829315,0,4,snRNA pseudouridine synthesis,BP,
7787,GO:0031123,1,0.088902971472783,0,114,RNA 3'-end processing,BP,
7788,GO:0031124,1,0.151426424359034,0,89,mRNA 3'-end processing,BP,
7789,GO:0031125,1,0.806167908699692,0,10,rRNA 3'-end processing,BP,
7790,GO:0031126,1,0.859692765777466,0,7,snoRNA 3'-end processing,BP,
7791,GO:0031127,1,0.958675477768454,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7793,GO:0031129,1,0.979704035085566,0,1,inductive cell-cell signaling,BP,
7795,GO:0031134,1,0.958844614736414,0,2,sister chromatid biorientation,BP,
7799,GO:0031151,1,0.981402870556993,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7800,GO:0031161,1,0.97906698108992,0,1,phosphatidylinositol catabolic process,BP,
7801,GO:0031163,1,0.680059835493256,0,18,metallo-sulfur cluster assembly,BP,
7802,GO:0031166,1,0.93858894351641,0,3,integral component of vacuolar membrane,CC,
7803,GO:0031167,1,0.710141972188848,0,16,rRNA methylation,BP,
7806,GO:0031179,1,0.958229609826683,0,2,peptide modification,BP,
7808,GO:0031204,1,0.959582298996263,0,2,posttranslational protein targeting to membrane, translocation,BP,
7809,GO:0031205,1,0.940118736170895,0,3,endoplasmic reticulum Sec complex,CC,
7810,GO:0031208,1,0.960288265195878,0,2,POZ domain binding,MF,
7811,GO:0031209,1,0.845988626856327,0,8,SCAR complex,CC,
7813,GO:0031211,1,0.844798427387176,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7814,GO:0031213,1,0.959180498692831,0,2,RSF complex,CC,
7821,GO:0031228,1,0.29535272692662,0,58,intrinsic component of Golgi membrane,CC,
7822,GO:0031229,1,0.742662271108028,0,14,intrinsic component of nuclear inner membrane,CC,
7823,GO:0031231,1,0.74130075577816,0,14,intrinsic component of peroxisomal membrane,CC,
7825,GO:0031233,1,0.59131095833205,0,25,intrinsic component of external side of plasma membrane,CC,
7828,GO:0031247,1,0.958236265029134,0,2,actin rod assembly,BP,
7829,GO:0031248,1,0.158855444711559,0,88,protein acetyltransferase complex,CC,
7830,GO:0031249,1,0.978928346363165,0,1,denatured protein binding,MF,
7831,GO:0031251,1,0.960233660438247,0,2,PAN complex,CC,
7836,GO:0031257,1,0.97897493185122,0,1,cell trailing edge membrane,CC,
7837,GO:0031258,1,0.67811046455517,0,19,lamellipodium membrane,CC,
7838,GO:0031259,1,0.97897493185122,0,1,uropod membrane,CC,
7839,GO:0031260,1,0.978503745184368,0,1,pseudopodium membrane,CC,
7840,GO:0031261,1,0.898731686745437,0,5,DNA replication preinitiation complex,CC,
7841,GO:0031262,1,0.917269342931081,0,4,Ndc80 complex,CC,
7845,GO:0031268,1,0.715310622513911,0,16,pseudopodium organization,BP,
7846,GO:0031269,1,0.731038484462303,0,15,pseudopodium assembly,BP,
7847,GO:0031271,1,0.97897493185122,0,1,lateral pseudopodium assembly,BP,
7848,GO:0031272,1,0.761770431665427,0,13,regulation of pseudopodium assembly,BP,
7849,GO:0031274,1,0.778141987986958,0,12,positive regulation of pseudopodium assembly,BP,
7850,GO:0031275,1,0.97897493185122,0,1,regulation of lateral pseudopodium assembly,BP,
7851,GO:0031279,1,0.153600060203217,0,89,regulation of cyclase activity,BP,
7852,GO:0031280,1,0.531639290631451,0,30,negative regulation of cyclase activity,BP,
7853,GO:0031281,1,0.290420114962566,0,59,positive regulation of cyclase activity,BP,
7854,GO:0031282,1,0.757774786591332,0,13,regulation of guanylate cyclase activity,BP,
7855,GO:0031283,1,0.957889389471787,0,2,negative regulation of guanylate cyclase activity,BP,
7856,GO:0031284,1,0.79110971619188,0,11,positive regulation of guanylate cyclase activity,BP,
7857,GO:0031289,1,0.979062663236952,0,1,actin phosphorylation,BP,
7858,GO:0031290,1,0.647601562245065,0,21,retinal ganglion cell axon guidance,BP,
7859,GO:0031291,1,0.979167368337565,0,1,Ran protein signal transduction,BP,
7860,GO:0031293,1,0.712191715932478,0,16,membrane protein intracellular domain proteolysis,BP,
7863,GO:0031296,1,0.916733554525174,0,4,B cell costimulation,BP,
7864,GO:0031297,1,0.609549955012534,0,24,replication fork processing,BP,
7865,GO:0031298,1,0.879731476508422,0,6,replication fork protection complex,CC,
7868,GO:0031302,1,0.979657696042131,0,1,intrinsic component of endosome membrane,CC,
7871,GO:0031306,1,0.600408557960935,0,24,intrinsic component of mitochondrial outer membrane,CC,
7872,GO:0031307,1,0.613091640790306,0,23,integral component of mitochondrial outer membrane,CC,
7873,GO:0031308,1,0.97897493185122,0,1,intrinsic component of nuclear outer membrane,CC,
7874,GO:0031309,1,0.97897493185122,0,1,integral component of nuclear outer membrane,CC,
7875,GO:0031310,1,0.93858894351641,0,3,intrinsic component of vacuolar membrane,CC,
7876,GO:0031312,1,0.554625474952105,0,28,extrinsic component of organelle membrane,CC,
7877,GO:0031313,1,0.881001238753369,0,6,extrinsic component of endosome membrane,CC,
7878,GO:0031314,1,0.881298865461949,0,6,extrinsic component of mitochondrial inner membrane,CC,
7879,GO:0031315,1,0.960507046884536,0,2,extrinsic component of mitochondrial outer membrane,CC,
7880,GO:0031320,1,0.978965040994655,0,1,hexitol dehydrogenase activity,MF,
7890,GO:0031332,1,0.800548221651433,0,11,RNAi effector complex,CC,
7893,GO:0031335,1,0.958268776022346,0,2,regulation of sulfur amino acid metabolic process,BP,
7894,GO:0031337,1,0.978869190667263,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7896,GO:0031339,1,0.901118216265547,0,5,negative regulation of vesicle fusion,BP,
7897,GO:0031340,1,0.844427669155778,0,8,positive regulation of vesicle fusion,BP,
7899,GO:0031342,1,0.710189184002957,0,16,negative regulation of cell killing,BP,
7907,GO:0031362,1,0.658155774784322,0,20,anchored component of external side of plasma membrane,CC,
7909,GO:0031369,1,0.542493328024879,0,29,translation initiation factor binding,MF,
7910,GO:0031370,1,0.979414434917324,0,1,eukaryotic initiation factor 4G binding,MF,
7911,GO:0031371,1,0.824837501591175,0,9,ubiquitin conjugating enzyme complex,CC,
7912,GO:0031372,1,0.958008511605882,0,2,UBC13-MMS2 complex,CC,
7913,GO:0031379,1,0.958616150411998,0,2,RNA-directed RNA polymerase complex,CC,
7914,GO:0031380,1,0.979069205329571,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7915,GO:0031386,1,0.841500464641179,0,8,protein tag,MF,
7916,GO:0031389,1,0.979049357109579,0,1,Rad17 RFC-like complex,CC,
7917,GO:0031390,1,0.842816509946757,0,8,Ctf18 RFC-like complex,CC,
7918,GO:0031392,1,0.880063960730942,0,6,regulation of prostaglandin biosynthetic process,BP,
7919,GO:0031393,1,0.958588973797294,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7920,GO:0031394,1,0.918091749111373,0,4,positive regulation of prostaglandin biosynthetic process,BP,
7927,GO:0031402,1,0.76529105080756,0,13,sodium ion binding,MF,
7928,GO:0031403,1,0.960808508367196,0,2,lithium ion binding,MF,
7929,GO:0031404,1,0.826918803855035,0,9,chloride ion binding,MF,
7931,GO:0031407,1,0.978907066130447,0,1,oxylipin metabolic process,BP,
7933,GO:0031414,1,0.814236189729748,0,10,N-terminal protein acetyltransferase complex,CC,
7934,GO:0031415,1,0.899132074941558,0,5,NatA complex,CC,
7935,GO:0031416,1,0.959111567108024,0,2,NatB complex,CC,
7936,GO:0031417,1,0.944219807633378,0,3,NatC complex,CC,
7938,GO:0031419,1,0.833358444508064,0,9,cobalamin binding,MF,
7939,GO:0031420,1,0.676299310221857,0,19,alkali metal ion binding,MF,
7941,GO:0031427,1,0.918992030401273,0,4,response to methotrexate,BP,
7942,GO:0031428,1,0.917317676093168,0,4,box C/D snoRNP complex,CC,
7943,GO:0031429,1,0.897459207646562,0,5,box H/ACA snoRNP complex,CC,
7944,GO:0031430,1,0.567763899294487,0,29,M band,CC,
7946,GO:0031433,1,0.879394164176904,0,7,telethonin binding,MF,
7948,GO:0031435,1,0.714958900726617,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7949,GO:0031436,1,0.960542045886861,0,2,BRCA1-BARD1 complex,CC,
7950,GO:0031437,1,0.958432462614354,0,2,regulation of mRNA cleavage,BP,
7951,GO:0031438,1,0.979064139690432,0,1,negative regulation of mRNA cleavage,BP,
7952,GO:0031439,1,0.978928346363165,0,1,positive regulation of mRNA cleavage,BP,
7953,GO:0031440,1,0.655898962181229,0,20,regulation of mRNA 3'-end processing,BP,
7954,GO:0031441,1,0.844201007422124,0,8,negative regulation of mRNA 3'-end processing,BP,
7955,GO:0031442,1,0.845852053633091,0,8,positive regulation of mRNA 3'-end processing,BP,
7956,GO:0031443,1,0.960444793461478,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7957,GO:0031444,1,0.938660725998982,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7958,GO:0031445,1,0.962023236622658,0,2,regulation of heterochromatin assembly,BP,
7959,GO:0031446,1,0.979069898024736,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7960,GO:0031448,1,0.979069898024736,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7961,GO:0031449,1,0.980358746911986,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7962,GO:0031453,1,0.962023236622658,0,2,positive regulation of heterochromatin assembly,BP,
7963,GO:0031455,1,0.95857956979511,0,2,glycine betaine metabolic process,BP,
7964,GO:0031456,1,0.95857956979511,0,2,glycine betaine biosynthetic process,BP,
7965,GO:0031460,1,0.9795010231456,0,1,glycine betaine transport,BP,
7966,GO:0031461,1,0.0272536104016535,0,171,cullin-RING ubiquitin ligase complex,CC,
7967,GO:0031462,1,0.828073387303439,0,9,Cul2-RING ubiquitin ligase complex,CC,
7968,GO:0031463,1,0.231253223514995,0,70,Cul3-RING ubiquitin ligase complex,CC,
7969,GO:0031464,1,0.808969787210193,0,10,Cul4A-RING E3 ubiquitin ligase complex,CC,
7970,GO:0031465,1,0.899669301383562,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7971,GO:0031466,1,0.880765001017159,0,6,Cul5-RING ubiquitin ligase complex,CC,
7972,GO:0031467,1,0.919292560912498,0,4,Cul7-RING ubiquitin ligase complex,CC,
7973,GO:0031468,1,0.696032255793066,0,17,nuclear envelope reassembly,BP,
7974,GO:0031475,1,0.978587710071679,0,1,myosin V complex,CC,
7980,GO:0031493,1,0.938050631511669,0,3,nucleosomal histone binding,MF,
7981,GO:0031494,1,0.97897493185122,0,1,regulation of mating type switching,BP,
7982,GO:0031497,1,0.0412795098424126,0,149,chromatin assembly,BP,
7983,GO:0031498,1,0.658460425791447,0,20,chromatin disassembly,BP,
7986,GO:0031506,1,0.978668801600268,0,1,cell wall glycoprotein biosynthetic process,BP,
7987,GO:0031507,1,0.784090284133403,0,12,heterochromatin assembly,BP,
7988,GO:0031508,1,0.917752522985988,0,4,pericentric heterochromatin assembly,BP,
7989,GO:0031509,1,0.937482110033035,0,3,telomeric heterochromatin assembly,BP,
7990,GO:0031510,1,0.937851172191204,0,3,SUMO activating enzyme complex,CC,
7991,GO:0031514,1,0.0665074481424162,0,128,motile cilium,CC,
7992,GO:0031515,1,0.937976422429698,0,3,tRNA (m1A) methyltransferase complex,CC,
7993,GO:0031519,1,0.399513592708742,0,44,PcG protein complex,CC,
7994,GO:0031523,1,0.961579768283447,0,2,Myb complex,CC,
7995,GO:0031526,1,0.340589459436765,0,52,brush border membrane,CC,
7999,GO:0031531,1,0.936856596977151,0,3,thyrotropin-releasing hormone receptor binding,MF,
8001,GO:0031536,1,0.897922473091779,0,5,positive regulation of exit from mitosis,BP,
8002,GO:0031543,1,0.80975730962657,0,10,peptidyl-proline dioxygenase activity,MF,
8003,GO:0031544,1,0.979061405677543,0,1,peptidyl-proline 3-dioxygenase activity,MF,
8004,GO:0031545,1,0.827084155295032,0,9,peptidyl-proline 4-dioxygenase activity,MF,
8005,GO:0031547,1,0.904309434475583,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
8006,GO:0031548,1,0.959380254625434,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8007,GO:0031549,1,0.979847320371,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8008,GO:0031550,1,0.979113131693725,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8009,GO:0031554,1,0.983914948881197,0,1,regulation of DNA-templated transcription, termination,BP,
8010,GO:0031559,1,0.979181173777904,0,1,oxidosqualene cyclase activity,MF,
8014,GO:0031573,1,0.727046847562946,0,15,intra-S DNA damage checkpoint,BP,
8015,GO:0031577,1,0.484166390682585,0,35,spindle checkpoint,BP,
8016,GO:0031579,1,0.613441748144877,0,23,membrane raft organization,BP,
8017,GO:0031580,1,0.825900123621143,0,9,membrane raft distribution,BP,
8020,GO:0031584,1,0.880559448419155,0,6,activation of phospholipase D activity,BP,
8021,GO:0031585,1,0.930780387958769,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8022,GO:0031587,1,0.945250330997386,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8025,GO:0031590,1,0.958465242679122,0,2,wybutosine metabolic process,BP,
8026,GO:0031591,1,0.958465242679122,0,2,wybutosine biosynthetic process,BP,
8027,GO:0031592,1,0.981760344414355,0,1,centrosomal corona,CC,
8028,GO:0031593,1,0.44135607401737,0,39,polyubiquitin binding,MF,
8029,GO:0031594,1,0.322503475367428,0,55,neuromuscular junction,CC,
8030,GO:0031595,1,0.841447789043267,0,8,nuclear proteasome complex,CC,
8031,GO:0031597,1,0.806738142792173,0,10,cytosolic proteasome complex,CC,
8032,GO:0031616,1,0.824597715120998,0,9,spindle pole centrosome,CC,
8033,GO:0031618,1,0.854276575505497,0,8,nuclear pericentric heterochromatin,CC,
8034,GO:0031620,1,0.844285422366656,0,8,regulation of fever generation,BP,
8035,GO:0031622,1,0.862235103496387,0,7,positive regulation of fever generation,BP,
8036,GO:0031623,1,0.191059251559084,0,79,receptor internalization,BP,
8039,GO:0031626,1,0.979709004824952,0,1,beta-endorphin binding,MF,
8040,GO:0031627,1,0.938478522851891,0,3,telomeric loop formation,BP,
8041,GO:0031628,1,0.827381367743212,0,9,opioid receptor binding,MF,
8042,GO:0031629,1,0.72665417134004,0,15,synaptic vesicle fusion to presynaptic active zone membrane,BP,
8043,GO:0031630,1,0.93806903740718,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
8044,GO:0031635,1,0.958679853296709,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
8049,GO:0031642,1,0.862688803635999,0,7,negative regulation of myelination,BP,
8050,GO:0031643,1,0.796339824455683,0,11,positive regulation of myelination,BP,
8052,GO:0031645,1,0.71087441844714,0,16,negative regulation of neurological system process,BP,
8053,GO:0031646,1,0.63354846350475,0,22,positive regulation of neurological system process,BP,
8056,GO:0031649,1,0.697972852859704,0,17,heat generation,BP,
8057,GO:0031650,1,0.776170769873904,0,12,regulation of heat generation,BP,
8058,GO:0031651,1,0.979150416112237,0,1,negative regulation of heat generation,BP,
8059,GO:0031652,1,0.809564849280096,0,10,positive regulation of heat generation,BP,
8061,GO:0031658,1,0.979965407711975,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8063,GO:0031660,1,0.978795633443475,0,1,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8064,GO:0031662,1,0.978795633443475,0,1,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8067,GO:0031665,1,0.825118173463974,0,9,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
8073,GO:0031672,1,0.447564308913501,0,41,A band,CC,
8074,GO:0031673,1,0.987993939140494,0,1,H zone,CC,
8076,GO:0031681,1,0.825571270053819,0,9,G-protein beta-subunit binding,MF,
8077,GO:0031682,1,0.979062146418257,0,1,G-protein gamma-subunit binding,MF,
8079,GO:0031685,1,0.958625359656818,0,2,adenosine receptor binding,MF,
8080,GO:0031686,1,0.97906542233794,0,1,A1 adenosine receptor binding,MF,
8082,GO:0031691,1,0.958010170858856,0,2,alpha-1A adrenergic receptor binding,MF,
8083,GO:0031692,1,0.937974685620228,0,3,alpha-1B adrenergic receptor binding,MF,
8085,GO:0031695,1,0.978941442747065,0,1,alpha-2B adrenergic receptor binding,MF,
8086,GO:0031696,1,0.958469400962956,0,2,alpha-2C adrenergic receptor binding,MF,
8087,GO:0031697,1,0.942169152028958,0,3,beta-1 adrenergic receptor binding,MF,
8088,GO:0031698,1,0.922339495130396,0,4,beta-2 adrenergic receptor binding,MF,
8089,GO:0031699,1,0.958585778341532,0,2,beta-3 adrenergic receptor binding,MF,
8090,GO:0031700,1,0.978569390281618,0,1,adrenomedullin receptor binding,MF,
8091,GO:0031701,1,0.793765750395209,0,11,angiotensin receptor binding,MF,
8092,GO:0031702,1,0.81093323905094,0,10,type 1 angiotensin receptor binding,MF,
8093,GO:0031703,1,0.978980782054902,0,1,type 2 angiotensin receptor binding,MF,
8094,GO:0031704,1,0.979068564333656,0,1,apelin receptor binding,MF,
8098,GO:0031710,1,0.978496764623781,0,1,neuromedin B receptor binding,MF,
8099,GO:0031711,1,0.958401584775597,0,2,bradykinin receptor binding,MF,
8100,GO:0031714,1,0.979661868456895,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8101,GO:0031715,1,0.979661868456895,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8102,GO:0031716,1,0.957424985458324,0,2,calcitonin receptor binding,MF,
8103,GO:0031720,1,0.936784340081173,0,3,haptoglobin binding,MF,
8104,GO:0031721,1,0.978478804484797,0,1,hemoglobin alpha binding,MF,
8105,GO:0031724,1,0.978520430518689,0,1,CXCR5 chemokine receptor binding,MF,
8106,GO:0031726,1,0.896939348150626,0,5,CCR1 chemokine receptor binding,MF,
8107,GO:0031727,1,0.957881942599099,0,2,CCR2 chemokine receptor binding,MF,
8108,GO:0031728,1,0.936796501966726,0,3,CCR3 chemokine receptor binding,MF,
8109,GO:0031729,1,0.957454938222449,0,2,CCR4 chemokine receptor binding,MF,
8112,GO:0031732,1,0.957416933746333,0,2,CCR7 chemokine receptor binding,MF,
8113,GO:0031735,1,0.936850731876656,0,3,CCR10 chemokine receptor binding,MF,
8114,GO:0031737,1,0.979069070443444,0,1,CX3C chemokine receptor binding,MF,
8115,GO:0031739,1,0.978807304253668,0,1,cholecystokinin receptor binding,MF,
8116,GO:0031741,1,0.978807304253668,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8117,GO:0031748,1,0.844191609142229,0,8,D1 dopamine receptor binding,MF,
8118,GO:0031749,1,0.938093479099084,0,3,D2 dopamine receptor binding,MF,
8119,GO:0031750,1,0.958116080376268,0,2,D3 dopamine receptor binding,MF,
8120,GO:0031751,1,0.978632645360423,0,1,D4 dopamine receptor binding,MF,
8121,GO:0031752,1,0.939656948697755,0,3,D5 dopamine receptor binding,MF,
8122,GO:0031753,1,0.979033253615243,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8123,GO:0031755,1,0.979033253615243,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8124,GO:0031762,1,0.958010170858856,0,2,follicle-stimulating hormone receptor binding,MF,
8125,GO:0031763,1,0.978476629273923,0,1,galanin receptor binding,MF,
8126,GO:0031764,1,0.978476629273923,0,1,type 1 galanin receptor binding,MF,
8127,GO:0031765,1,0.978476629273923,0,1,type 2 galanin receptor binding,MF,
8128,GO:0031766,1,0.978476629273923,0,1,type 3 galanin receptor binding,MF,
8129,GO:0031768,1,0.978473282549746,0,1,ghrelin receptor binding,MF,
8130,GO:0031770,1,0.978465893763757,0,1,growth hormone-releasing hormone receptor binding,MF,
8131,GO:0031771,1,0.978468313671559,0,1,type 1 hypocretin receptor binding,MF,
8132,GO:0031772,1,0.978468313671559,0,1,type 2 hypocretin receptor binding,MF,
8133,GO:0031773,1,0.978473190777419,0,1,kisspeptin receptor binding,MF,
8134,GO:0031775,1,0.981975970300005,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8140,GO:0031798,1,0.981545599693415,0,1,type 1 metabotropic glutamate receptor binding,MF,
8141,GO:0031800,1,0.937906630945419,0,3,type 3 metabotropic glutamate receptor binding,MF,
8142,GO:0031802,1,0.960908416349787,0,2,type 5 metabotropic glutamate receptor binding,MF,
8143,GO:0031811,1,0.979092697858382,0,1,G-protein coupled nucleotide receptor binding,MF,
8144,GO:0031812,1,0.979092697858382,0,1,P2Y1 nucleotide receptor binding,MF,
8145,GO:0031821,1,0.862030889620562,0,7,G-protein coupled serotonin receptor binding,MF,
8146,GO:0031826,1,0.937500068763362,0,3,type 2A serotonin receptor binding,MF,
8147,GO:0031834,1,0.97851096345759,0,1,neurokinin receptor binding,MF,
8148,GO:0031835,1,0.97851096345759,0,1,substance P receptor binding,MF,
8149,GO:0031838,1,0.916683580661934,0,4,haptoglobin-hemoglobin complex,CC,
8150,GO:0031848,1,0.810275224642534,0,10,protection from non-homologous end joining at telomere,BP,
8152,GO:0031851,1,0.97847750656036,0,1,kappa-type opioid receptor binding,MF,
8153,GO:0031852,1,0.921660367087638,0,4,mu-type opioid receptor binding,MF,
8154,GO:0031854,1,0.978465384472324,0,1,orexigenic neuropeptide QRFP receptor binding,MF,
8155,GO:0031855,1,0.978466864386927,0,1,oxytocin receptor binding,MF,
8156,GO:0031856,1,0.978478614002885,0,1,parathyroid hormone receptor binding,MF,
8157,GO:0031857,1,0.978478614002885,0,1,type 1 parathyroid hormone receptor binding,MF,
8158,GO:0031858,1,0.97906763508215,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8159,GO:0031859,1,0.978719193913594,0,1,platelet activating factor receptor binding,MF,
8160,GO:0031860,1,0.939859968967888,0,3,telomeric 3' overhang formation,BP,
8161,GO:0031861,1,0.97846459563124,0,1,prolactin-releasing peptide receptor binding,MF,
8162,GO:0031862,1,0.959864359699037,0,2,prostanoid receptor binding,MF,
8163,GO:0031867,1,0.979085473211787,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8164,GO:0031870,1,0.98036941889174,0,1,thromboxane A2 receptor binding,MF,
8165,GO:0031871,1,0.939055352127135,0,3,proteinase activated receptor binding,MF,
8166,GO:0031877,1,0.98081047341397,0,1,somatostatin receptor binding,MF,
8167,GO:0031883,1,0.978799802356638,0,1,taste receptor binding,MF,
8168,GO:0031893,1,0.937790770690367,0,3,vasopressin receptor binding,MF,
8169,GO:0031894,1,0.958063907529748,0,2,V1A vasopressin receptor binding,MF,
8170,GO:0031895,1,0.978469531779789,0,1,V1B vasopressin receptor binding,MF,
8171,GO:0031896,1,0.97884191627682,0,1,V2 vasopressin receptor binding,MF,
8175,GO:0031904,1,0.544231205056557,0,29,endosome lumen,CC,
8176,GO:0031905,1,0.958165814053326,0,2,early endosome lumen,CC,
8177,GO:0031906,1,0.859598929233445,0,7,late endosome lumen,CC,
8179,GO:0031914,1,0.902969540504093,0,5,negative regulation of synaptic plasticity,BP,
8180,GO:0031915,1,0.829249891645328,0,9,positive regulation of synaptic plasticity,BP,
8182,GO:0031930,1,0.978572799360899,0,1,mitochondria-nucleus signaling pathway,BP,
8183,GO:0031931,1,0.867528675755383,0,7,TORC1 complex,CC,
8185,GO:0031933,1,0.942581832127632,0,3,telomeric heterochromatin,CC,
8186,GO:0031935,1,0.648459450381476,0,21,regulation of chromatin silencing,BP,
8187,GO:0031936,1,0.833863728722685,0,9,negative regulation of chromatin silencing,BP,
8188,GO:0031937,1,0.846682876686317,0,8,positive regulation of chromatin silencing,BP,
8189,GO:0031938,1,0.957802131938367,0,2,regulation of chromatin silencing at telomere,BP,
8190,GO:0031940,1,0.978622147444102,0,1,positive regulation of chromatin silencing at telomere,BP,
8199,GO:0031953,1,0.794289052174582,0,11,negative regulation of protein autophosphorylation,BP,
8202,GO:0031958,1,0.719935852109855,0,16,corticosteroid receptor signaling pathway,BP,
8203,GO:0031959,1,0.979781768218683,0,1,mineralocorticoid receptor signaling pathway,BP,
8205,GO:0031962,1,0.98023995676388,0,1,mineralocorticoid receptor binding,MF,
8217,GO:0031985,1,0.151734298355314,0,90,Golgi cisterna,CC,
8218,GO:0031987,1,0.83272345130025,0,9,locomotion involved in locomotory behavior,BP,
8219,GO:0031989,1,0.957567137061658,0,2,bombesin receptor signaling pathway,BP,
8220,GO:0031990,1,0.962286989694969,0,2,mRNA export from nucleus in response to heat stress,BP,
8222,GO:0031995,1,0.850015268851254,0,8,insulin-like growth factor II binding,MF,
8223,GO:0031996,1,0.742424492190073,0,14,thioesterase binding,MF,
8224,GO:0031997,1,0.937906630945419,0,3,N-terminal myristoylation domain binding,MF,
8227,GO:0032000,1,0.834816617528421,0,9,positive regulation of fatty acid beta-oxidation,BP,
8228,GO:0032002,1,0.938005412173743,0,3,interleukin-28 receptor complex,CC,
8229,GO:0032003,1,0.97897493185122,0,1,interleukin-28 receptor binding,MF,
8233,GO:0032009,1,0.846704499868945,0,8,early phagosome,CC,
8234,GO:0032010,1,0.898462055836137,0,5,phagolysosome,CC,
8235,GO:0032011,1,0.739708156899338,0,15,ARF protein signal transduction,BP,
8236,GO:0032012,1,0.739708156899338,0,15,regulation of ARF protein signal transduction,BP,
8237,GO:0032020,1,0.878952492213259,0,6,ISG15-protein conjugation,BP,
8238,GO:0032021,1,0.918508286851493,0,4,NELF complex,CC,
8239,GO:0032023,1,0.978873003281332,0,1,trypsinogen activation,BP,
8241,GO:0032025,1,0.827781520058543,0,9,response to cobalt ion,BP,
8243,GO:0032027,1,0.882150539869068,0,6,myosin light chain binding,MF,
8244,GO:0032028,1,0.978802303481413,0,1,myosin head/neck binding,MF,
8247,GO:0032038,1,0.957432947367393,0,2,myosin II heavy chain binding,MF,
8248,GO:0032039,1,0.796304438783215,0,11,integrator complex,CC,
8249,GO:0032040,1,0.53182131399447,0,30,small-subunit processome,CC,
8250,GO:0032041,1,0.796541963820798,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8252,GO:0032044,1,0.958102956142483,0,2,DSIF complex,CC,
8253,GO:0032045,1,0.782100588462115,0,12,guanyl-nucleotide exchange factor complex,CC,
8254,GO:0032048,1,0.743277359834354,0,14,cardiolipin metabolic process,BP,
8255,GO:0032049,1,0.861673540389125,0,7,cardiolipin biosynthetic process,BP,
8256,GO:0032050,1,0.901087042576248,0,5,clathrin heavy chain binding,MF,
8257,GO:0032051,1,0.885041766771745,0,6,clathrin light chain binding,MF,
8259,GO:0032053,1,0.939960171113112,0,3,ciliary basal body organization,BP,
8261,GO:0032056,1,0.881811605869385,0,6,positive regulation of translation in response to stress,BP,
8262,GO:0032057,1,0.86237327113346,0,7,negative regulation of translational initiation in response to stress,BP,
8263,GO:0032058,1,0.920430434311964,0,4,positive regulation of translational initiation in response to stress,BP,
8264,GO:0032059,1,0.863309523561661,0,7,bleb,CC,
8265,GO:0032060,1,0.812380704582529,0,10,bleb assembly,BP,
8266,GO:0032066,1,0.940044843972075,0,3,nucleolus to nucleoplasm transport,BP,
8270,GO:0032072,1,0.979069349634111,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8271,GO:0032074,1,0.861522355807141,0,7,negative regulation of nuclease activity,BP,
8273,GO:0032076,1,0.957951960905458,0,2,negative regulation of deoxyribonuclease activity,BP,
8275,GO:0032078,1,0.978484618254381,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8278,GO:0032089,1,0.95920682393296,0,2,NACHT domain binding,MF,
8282,GO:0032093,1,0.97897493185122,0,1,SAM domain binding,MF,
8284,GO:0032095,1,0.698928979652427,0,17,regulation of response to food,BP,
8285,GO:0032096,1,0.810118164359672,0,10,negative regulation of response to food,BP,
8286,GO:0032097,1,0.916855206924902,0,4,positive regulation of response to food,BP,
8287,GO:0032098,1,0.639452852483911,0,21,regulation of appetite,BP,
8288,GO:0032099,1,0.810118164359672,0,10,negative regulation of appetite,BP,
8289,GO:0032100,1,0.916855206924902,0,4,positive regulation of appetite,BP,
8293,GO:0032104,1,0.617289783980135,0,23,regulation of response to extracellular stimulus,BP,
8294,GO:0032105,1,0.776767282576019,0,12,negative regulation of response to extracellular stimulus,BP,
8295,GO:0032106,1,0.878530812804336,0,6,positive regulation of response to extracellular stimulus,BP,
8296,GO:0032107,1,0.617289783980135,0,23,regulation of response to nutrient levels,BP,
8297,GO:0032108,1,0.776767282576019,0,12,negative regulation of response to nutrient levels,BP,
8298,GO:0032109,1,0.878530812804336,0,6,positive regulation of response to nutrient levels,BP,
8299,GO:0032113,1,0.978521707286252,0,1,regulation of carbohydrate phosphatase activity,BP,
8300,GO:0032116,1,0.962643533145069,0,2,SMC loading complex,CC,
8301,GO:0032119,1,0.77712842089933,0,12,sequestering of zinc ion,BP,
8302,GO:0032127,1,0.95863353412428,0,2,dense core granule membrane,CC,
8303,GO:0032129,1,0.958154117972043,0,2,histone deacetylase activity (H3-K9 specific),MF,
8304,GO:0032133,1,0.898177365465483,0,5,chromosome passenger complex,CC,
8305,GO:0032135,1,0.880670553316976,0,6,DNA insertion or deletion binding,MF,
8306,GO:0032137,1,0.938519094702,0,3,guanine/thymine mispair binding,MF,
8307,GO:0032138,1,0.919227647662134,0,4,single base insertion or deletion binding,MF,
8308,GO:0032139,1,0.938275196273926,0,3,dinucleotide insertion or deletion binding,MF,
8309,GO:0032142,1,0.938908914602327,0,3,single guanine insertion binding,MF,
8310,GO:0032143,1,0.958707183752687,0,2,single thymine insertion binding,MF,
8311,GO:0032144,1,0.979516224791057,0,1,4-aminobutyrate transaminase complex,CC,
8312,GO:0032145,1,0.979516224791057,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8318,GO:0032156,1,0.861526989732883,0,7,septin cytoskeleton,CC,
8319,GO:0032173,1,0.979059508874851,0,1,septin collar,CC,
8320,GO:0032181,1,0.958849685652146,0,2,dinucleotide repeat insertion binding,MF,
8322,GO:0032183,1,0.722281256668067,0,16,SUMO binding,MF,
8323,GO:0032184,1,0.903296632814042,0,5,SUMO polymer binding,MF,
8324,GO:0032185,1,0.95884170596337,0,2,septin cytoskeleton organization,BP,
8326,GO:0032194,1,0.979072572809886,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8327,GO:0032196,1,0.711390173576708,0,16,transposition,BP,
8328,GO:0032197,1,0.979097581915923,0,1,transposition, RNA-mediated,BP,
8329,GO:0032200,1,0.0344934668414055,0,160,telomere organization,BP,
8330,GO:0032201,1,0.881354816298545,0,6,telomere maintenance via semi-conservative replication,BP,
8331,GO:0032202,1,0.918019950714891,0,4,telomere assembly,BP,
8332,GO:0032203,1,0.978700443695918,0,1,telomere formation via telomerase,BP,
8333,GO:0032204,1,0.228513942361489,0,71,regulation of telomere maintenance,BP,
8334,GO:0032205,1,0.52751178714276,0,31,negative regulation of telomere maintenance,BP,
8335,GO:0032206,1,0.366777196160636,0,48,positive regulation of telomere maintenance,BP,
8336,GO:0032207,1,0.979049480011355,0,1,regulation of telomere maintenance via recombination,BP,
8337,GO:0032208,1,0.979049480011355,0,1,negative regulation of telomere maintenance via recombination,BP,
8338,GO:0032210,1,0.37428381758607,0,47,regulation of telomere maintenance via telomerase,BP,
8339,GO:0032211,1,0.729558187236733,0,15,negative regulation of telomere maintenance via telomerase,BP,
8340,GO:0032212,1,0.501423839041089,0,33,positive regulation of telomere maintenance via telomerase,BP,
8341,GO:0032213,1,0.958540672598738,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8342,GO:0032214,1,0.958540672598738,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8345,GO:0032222,1,0.828187581885933,0,9,regulation of synaptic transmission, cholinergic,BP,
8346,GO:0032223,1,0.9789809337531,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8347,GO:0032224,1,0.864124765049052,0,7,positive regulation of synaptic transmission, cholinergic,BP,
8349,GO:0032226,1,0.861617751800791,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8350,GO:0032227,1,0.938932546159524,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8353,GO:0032230,1,0.759954412147249,0,13,positive regulation of synaptic transmission, GABAergic,BP,
8355,GO:0032232,1,0.624117882088369,0,23,negative regulation of actin filament bundle assembly,BP,
8357,GO:0032237,1,0.91917020117826,0,4,activation of store-operated calcium channel activity,BP,
8359,GO:0032240,1,0.963459473768088,0,2,negative regulation of nucleobase-containing compound transport,BP,
8365,GO:0032261,1,0.860709634478797,0,7,purine nucleotide salvage,BP,
8366,GO:0032262,1,0.898058907261926,0,5,pyrimidine nucleotide salvage,BP,
8367,GO:0032264,1,0.918391917146263,0,4,IMP salvage,BP,
8376,GO:0032275,1,0.830606300299933,0,9,luteinizing hormone secretion,BP,
8381,GO:0032280,1,0.921575021815033,0,4,symmetric synapse,CC,
8383,GO:0032286,1,0.919458580970408,0,4,central nervous system myelin maintenance,BP,
8385,GO:0032288,1,0.69251704206335,0,18,myelin assembly,BP,
8386,GO:0032289,1,0.938185539622267,0,3,central nervous system myelin formation,BP,
8387,GO:0032290,1,0.962721219840702,0,2,peripheral nervous system myelin formation,BP,
8388,GO:0032291,1,0.72877502603823,0,15,axon ensheathment in central nervous system,BP,
8390,GO:0032296,1,0.92262677174542,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8391,GO:0032298,1,0.978858274352849,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8392,GO:0032299,1,0.937492303357534,0,3,ribonuclease H2 complex,CC,
8393,GO:0032300,1,0.847716630551792,0,8,mismatch repair complex,CC,
8394,GO:0032301,1,0.958707183752687,0,2,MutSalpha complex,CC,
8395,GO:0032302,1,0.958849685652146,0,2,MutSbeta complex,CC,
8397,GO:0032304,1,0.938840948780774,0,3,negative regulation of icosanoid secretion,BP,
8404,GO:0032324,1,0.861391464751153,0,7,molybdopterin cofactor biosynthetic process,BP,
8405,GO:0032328,1,0.811406574363182,0,10,alanine transport,BP,
8406,GO:0032329,1,0.807608120917617,0,10,serine transport,BP,
8424,GO:0032356,1,0.844790273949354,0,8,oxidized DNA binding,MF,
8425,GO:0032357,1,0.844790273949354,0,8,oxidized purine DNA binding,MF,
8426,GO:0032358,1,0.978480527706844,0,1,oxidized pyrimidine DNA binding,MF,
8427,GO:0032361,1,0.978758658761031,0,1,pyridoxal phosphate catabolic process,BP,
8441,GO:0032377,1,0.863915587280276,0,7,regulation of intracellular lipid transport,BP,
8442,GO:0032378,1,0.979072323496065,0,1,negative regulation of intracellular lipid transport,BP,
8443,GO:0032379,1,0.937580751149318,0,3,positive regulation of intracellular lipid transport,BP,
8444,GO:0032380,1,0.863915587280276,0,7,regulation of intracellular sterol transport,BP,
8445,GO:0032381,1,0.979072323496065,0,1,negative regulation of intracellular sterol transport,BP,
8446,GO:0032382,1,0.937580751149318,0,3,positive regulation of intracellular sterol transport,BP,
8447,GO:0032383,1,0.863915587280276,0,7,regulation of intracellular cholesterol transport,BP,
8448,GO:0032384,1,0.979072323496065,0,1,negative regulation of intracellular cholesterol transport,BP,
8449,GO:0032385,1,0.937580751149318,0,3,positive regulation of intracellular cholesterol transport,BP,
8453,GO:0032389,1,0.919722442774054,0,4,MutLalpha complex,CC,
8455,GO:0032392,1,0.187268844324175,0,80,DNA geometric change,BP,
8456,GO:0032393,1,0.823825152376261,0,9,MHC class I receptor activity,MF,
8457,GO:0032394,1,0.958027516891685,0,2,MHC class Ib receptor activity,MF,
8458,GO:0032395,1,0.805472562287547,0,10,MHC class II receptor activity,MF,
8459,GO:0032396,1,0.918066106727833,0,4,inhibitory MHC class I receptor activity,MF,
8460,GO:0032397,1,0.978575904928287,0,1,activating MHC class I receptor activity,MF,
8461,GO:0032398,1,0.978635463621931,0,1,MHC class Ib protein complex,CC,
8462,GO:0032399,1,0.936934174092609,0,3,HECT domain binding,MF,
8467,GO:0032404,1,0.845653195565524,0,8,mismatch repair complex binding,MF,
8468,GO:0032405,1,0.901560750011609,0,5,MutLalpha complex binding,MF,
8469,GO:0032407,1,0.901435079806965,0,5,MutSalpha complex binding,MF,
8476,GO:0032415,1,0.879052419507889,0,6,regulation of sodium:proton antiporter activity,BP,
8477,GO:0032416,1,0.95782098849202,0,2,negative regulation of sodium:proton antiporter activity,BP,
8478,GO:0032417,1,0.917771989708519,0,4,positive regulation of sodium:proton antiporter activity,BP,
8480,GO:0032419,1,0.978854407687914,0,1,extrinsic component of lysosome membrane,CC,
8483,GO:0032422,1,0.958254090078713,0,2,purine-rich negative regulatory element binding,MF,
8484,GO:0032423,1,0.938607049160477,0,3,regulation of mismatch repair,BP,
8485,GO:0032425,1,0.958573155533255,0,2,positive regulation of mismatch repair,BP,
8488,GO:0032428,1,0.979070628890252,0,1,beta-N-acetylgalactosaminidase activity,MF,
8492,GO:0032432,1,0.319697086805916,0,55,actin filament bundle,CC,
8495,GO:0032435,1,0.615586832385118,0,23,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8497,GO:0032437,1,0.924564225783927,0,4,cuticular plate,CC,
8499,GO:0032439,1,0.922810657012002,0,4,endosome localization,BP,
8500,GO:0032440,1,0.978528904045192,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8501,GO:0032444,1,0.945711033912394,0,3,activin responsive factor complex,CC,
8502,GO:0032445,1,0.978889655064775,0,1,fructose import,BP,
8504,GO:0032448,1,0.978604806211776,0,1,DNA hairpin binding,MF,
8505,GO:0032449,1,0.939025167764545,0,3,CBM complex,CC,
8506,GO:0032450,1,0.940336854957939,0,3,maltose alpha-glucosidase activity,MF,
8507,GO:0032451,1,0.499575296334837,0,34,demethylase activity,MF,
8508,GO:0032452,1,0.618355490032962,0,24,histone demethylase activity,MF,
8509,GO:0032453,1,0.888738422367921,0,6,histone demethylase activity (H3-K4 specific),MF,
8510,GO:0032454,1,0.833675495682533,0,9,histone demethylase activity (H3-K9 specific),MF,
8511,GO:0032455,1,0.918411456954053,0,4,nerve growth factor processing,BP,
8513,GO:0032458,1,0.979089755776911,0,1,slow endocytic recycling,BP,
8515,GO:0032460,1,0.729354149890651,0,15,negative regulation of protein oligomerization,BP,
8517,GO:0032462,1,0.71100643960045,0,16,regulation of protein homooligomerization,BP,
8518,GO:0032463,1,0.808000633694244,0,10,negative regulation of protein homooligomerization,BP,
8519,GO:0032464,1,0.86157345873645,0,7,positive regulation of protein homooligomerization,BP,
8520,GO:0032465,1,0.252968922625749,0,66,regulation of cytokinesis,BP,
8521,GO:0032466,1,0.862468223705889,0,7,negative regulation of cytokinesis,BP,
8522,GO:0032467,1,0.460686480206099,0,37,positive regulation of cytokinesis,BP,
8523,GO:0032468,1,0.979069604403261,0,1,Golgi calcium ion homeostasis,BP,
8524,GO:0032469,1,0.658773971132334,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
8525,GO:0032470,1,0.961422103574836,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8526,GO:0032471,1,0.860667944513067,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8527,GO:0032472,1,0.958257183607719,0,2,Golgi calcium ion transport,BP,
8528,GO:0032473,1,0.982703479687859,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8529,GO:0032474,1,0.958944879833201,0,2,otolith morphogenesis,BP,
8533,GO:0032482,1,0.882266298359109,0,6,Rab protein signal transduction,BP,
8534,GO:0032483,1,0.920865338672379,0,4,regulation of Rab protein signal transduction,BP,
8535,GO:0032484,1,0.941031839801552,0,3,Ral protein signal transduction,BP,
8536,GO:0032485,1,0.941031839801552,0,3,regulation of Ral protein signal transduction,BP,
8537,GO:0032486,1,0.765593975705462,0,13,Rap protein signal transduction,BP,
8538,GO:0032487,1,0.940842200558333,0,3,regulation of Rap protein signal transduction,BP,
8539,GO:0032488,1,0.846646777074359,0,8,Cdc42 protein signal transduction,BP,
8540,GO:0032489,1,0.901594401921325,0,5,regulation of Cdc42 protein signal transduction,BP,
8541,GO:0032490,1,0.79394508428987,0,11,detection of molecule of bacterial origin,BP,
8542,GO:0032493,1,0.862722743079538,0,7,response to bacterial lipoprotein,BP,
8543,GO:0032494,1,0.845486778382548,0,8,response to peptidoglycan,BP,
8546,GO:0032497,1,0.918618432754689,0,4,detection of lipopolysaccharide,BP,
8547,GO:0032498,1,0.979277721136309,0,1,detection of muramyl dipeptide,BP,
8548,GO:0032499,1,0.958221942363368,0,2,detection of peptidoglycan,BP,
8549,GO:0032500,1,0.979277721136309,0,1,muramyl dipeptide binding,MF,
8555,GO:0032508,1,0.226849301317805,0,71,DNA duplex unwinding,BP,
8556,GO:0032509,1,0.780739157890633,0,12,endosome transport via multivesicular body sorting pathway,BP,
8557,GO:0032510,1,0.924761617333399,0,4,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8558,GO:0032511,1,0.879329510949971,0,6,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8560,GO:0032516,1,0.73443156657172,0,15,positive regulation of phosphoprotein phosphatase activity,BP,
8561,GO:0032525,1,0.812114214338486,0,10,somite rostral/caudal axis specification,BP,
8563,GO:0032527,1,0.460420272344796,0,37,protein exit from endoplasmic reticulum,BP,
8564,GO:0032528,1,0.62081507719074,0,23,microvillus organization,BP,
8565,GO:0032530,1,0.761639056336988,0,13,regulation of microvillus organization,BP,
8566,GO:0032532,1,0.861972107719088,0,7,regulation of microvillus length,BP,
8567,GO:0032534,1,0.88364484306506,0,6,regulation of microvillus assembly,BP,
8570,GO:0032541,1,0.918475633477774,0,4,cortical endoplasmic reticulum,CC,
8573,GO:0032545,1,0.958127745093055,0,2,CURI complex,CC,
8576,GO:0032551,1,0.959410279906985,0,2,pyrimidine ribonucleoside binding,MF,
8577,GO:0032552,1,0.879623638021885,0,6,deoxyribonucleotide binding,MF,
8579,GO:0032554,1,0.898949387353226,0,5,purine deoxyribonucleotide binding,MF,
8581,GO:0032556,1,0.978508018657599,0,1,pyrimidine deoxyribonucleotide binding,MF,
8582,GO:0032557,1,0.939085502672851,0,3,pyrimidine ribonucleotide binding,MF,
8583,GO:0032558,1,0.918172776906936,0,4,adenyl deoxyribonucleotide binding,MF,
8585,GO:0032560,1,0.9790682465105,0,1,guanyl deoxyribonucleotide binding,MF,
8587,GO:0032564,1,0.918172776906936,0,4,dATP binding,MF,
8588,GO:0032567,1,0.9790682465105,0,1,dGTP binding,MF,
8591,GO:0032574,1,0.979103016056253,0,1,5'-3' RNA helicase activity,MF,
8592,GO:0032575,1,0.979103016056253,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8593,GO:0032580,1,0.21586684417971,0,73,Golgi cisterna membrane,CC,
8594,GO:0032581,1,0.978695784656885,0,1,ER-dependent peroxisome organization,BP,
8595,GO:0032584,1,0.880665191773344,0,6,growth cone membrane,CC,
8598,GO:0032588,1,0.184972384179458,0,80,trans-Golgi network membrane,CC,
8600,GO:0032590,1,0.641957421945624,0,21,dendrite membrane,CC,
8601,GO:0032591,1,0.829981233522747,0,9,dendritic spine membrane,CC,
8603,GO:0032593,1,0.867790285035219,0,7,insulin-responsive compartment,CC,
8604,GO:0032594,1,0.825892030920769,0,9,protein transport within lipid bilayer,BP,
8605,GO:0032595,1,0.978830983471915,0,1,B cell receptor transport within lipid bilayer,BP,
8606,GO:0032596,1,0.881008388132889,0,6,protein transport into membrane raft,BP,
8607,GO:0032597,1,0.978830983471915,0,1,B cell receptor transport into membrane raft,BP,
8608,GO:0032599,1,0.978830983471915,0,1,protein transport out of membrane raft,BP,
8609,GO:0032600,1,0.978830983471915,0,1,chemokine receptor transport out of membrane raft,BP,
8610,GO:0032601,1,0.957479357890389,0,2,connective tissue growth factor production,BP,
8612,GO:0032603,1,0.978486010590288,0,1,fractalkine production,BP,
8613,GO:0032604,1,0.726344234632077,0,15,granulocyte macrophage colony-stimulating factor production,BP,
8623,GO:0032615,1,0.339726905241774,0,51,interleukin-12 production,BP,
8624,GO:0032616,1,0.638437819544899,0,21,interleukin-13 production,BP,
8625,GO:0032618,1,0.957762716063997,0,2,interleukin-15 production,BP,
8626,GO:0032620,1,0.586075699053262,0,25,interleukin-17 production,BP,
8627,GO:0032621,1,0.862111937356459,0,7,interleukin-18 production,BP,
8629,GO:0032625,1,0.9790703454707,0,1,interleukin-21 production,BP,
8630,GO:0032627,1,0.843445499051322,0,8,interleukin-23 production,BP,
8631,GO:0032632,1,0.918682327009427,0,4,interleukin-3 production,BP,
8633,GO:0032634,1,0.654359435416973,0,20,interleukin-5 production,BP,
8636,GO:0032639,1,0.958142987264862,0,2,TRAIL production,BP,
8638,GO:0032641,1,0.937889554408554,0,3,lymphotoxin A production,BP,
8640,GO:0032643,1,0.978534083677148,0,1,regulation of connective tissue growth factor production,BP,
8641,GO:0032644,1,0.978486010590288,0,1,regulation of fractalkine production,BP,
8642,GO:0032645,1,0.726344234632077,0,15,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8651,GO:0032655,1,0.354463676927324,0,49,regulation of interleukin-12 production,BP,
8652,GO:0032656,1,0.666809321584438,0,19,regulation of interleukin-13 production,BP,
8653,GO:0032658,1,0.978672488126168,0,1,regulation of interleukin-15 production,BP,
8654,GO:0032660,1,0.625035224628533,0,22,regulation of interleukin-17 production,BP,
8655,GO:0032661,1,0.899229185712738,0,5,regulation of interleukin-18 production,BP,
8657,GO:0032667,1,0.843445499051322,0,8,regulation of interleukin-23 production,BP,
8658,GO:0032672,1,0.938307530105986,0,3,regulation of interleukin-3 production,BP,
8660,GO:0032674,1,0.668735846432418,0,19,regulation of interleukin-5 production,BP,
8663,GO:0032679,1,0.958142987264862,0,2,regulation of TRAIL production,BP,
8665,GO:0032681,1,0.979017437383628,0,1,regulation of lymphotoxin A production,BP,
8666,GO:0032682,1,0.709905137367786,0,16,negative regulation of chemokine production,BP,
8667,GO:0032685,1,0.979069049003716,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8672,GO:0032690,1,0.978565582704007,0,1,negative regulation of interleukin-1 alpha production,BP,
8673,GO:0032691,1,0.773335587235227,0,12,negative regulation of interleukin-1 beta production,BP,
8676,GO:0032695,1,0.730752181596507,0,15,negative regulation of interleukin-12 production,BP,
8677,GO:0032696,1,0.898474247238798,0,5,negative regulation of interleukin-13 production,BP,
8678,GO:0032700,1,0.791381002223998,0,11,negative regulation of interleukin-17 production,BP,
8679,GO:0032701,1,0.958134693121237,0,2,negative regulation of interleukin-18 production,BP,
8680,GO:0032703,1,0.681001360602077,0,18,negative regulation of interleukin-2 production,BP,
8681,GO:0032707,1,0.959367871552457,0,2,negative regulation of interleukin-23 production,BP,
8682,GO:0032712,1,0.978890047116645,0,1,negative regulation of interleukin-3 production,BP,
8684,GO:0032714,1,0.861047602397784,0,7,negative regulation of interleukin-5 production,BP,
8686,GO:0032717,1,0.713192341031862,0,16,negative regulation of interleukin-8 production,BP,
8689,GO:0032723,1,0.978534083677148,0,1,positive regulation of connective tissue growth factor production,BP,
8690,GO:0032724,1,0.978486010590288,0,1,positive regulation of fractalkine production,BP,
8691,GO:0032725,1,0.758215354080798,0,13,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8692,GO:0032727,1,0.717009519695945,0,16,positive regulation of interferon-alpha production,BP,
8699,GO:0032735,1,0.505833092597055,0,32,positive regulation of interleukin-12 production,BP,
8700,GO:0032736,1,0.74222197024811,0,14,positive regulation of interleukin-13 production,BP,
8701,GO:0032738,1,0.978672488126168,0,1,positive regulation of interleukin-15 production,BP,
8702,GO:0032740,1,0.756872554617455,0,13,positive regulation of interleukin-17 production,BP,
8703,GO:0032741,1,0.958594394521462,0,2,positive regulation of interleukin-18 production,BP,
8705,GO:0032747,1,0.898190813170028,0,5,positive regulation of interleukin-23 production,BP,
8706,GO:0032752,1,0.958544672326242,0,2,positive regulation of interleukin-3 production,BP,
8707,GO:0032753,1,0.625490049447429,0,22,positive regulation of interleukin-4 production,BP,
8708,GO:0032754,1,0.793594729446119,0,11,positive regulation of interleukin-5 production,BP,
8711,GO:0032759,1,0.958142987264862,0,2,positive regulation of TRAIL production,BP,
8713,GO:0032761,1,0.979017437383628,0,1,positive regulation of lymphotoxin A production,BP,
8715,GO:0032763,1,0.899294434738765,0,5,regulation of mast cell cytokine production,BP,
8716,GO:0032764,1,0.958112642648936,0,2,negative regulation of mast cell cytokine production,BP,
8717,GO:0032765,1,0.938617273752855,0,3,positive regulation of mast cell cytokine production,BP,
8718,GO:0032767,1,0.940903197070463,0,3,copper-dependent protein binding,MF,
8722,GO:0032771,1,0.979191434566361,0,1,regulation of monophenol monooxygenase activity,BP,
8723,GO:0032773,1,0.979191434566361,0,1,positive regulation of monophenol monooxygenase activity,BP,
8725,GO:0032775,1,0.979073664205968,0,1,DNA methylation on adenine,BP,
8726,GO:0032776,1,0.919351219241947,0,4,DNA methylation on cytosine,BP,
8727,GO:0032777,1,0.918247466917401,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8730,GO:0032782,1,0.881087112255387,0,6,bile acid secretion,BP,
8731,GO:0032783,1,0.958216677313208,0,2,ELL-EAF complex,CC,
8734,GO:0032786,1,0.628935822699432,0,22,positive regulation of DNA-templated transcription, elongation,BP,
8736,GO:0032788,1,0.978619007265527,0,1,saturated monocarboxylic acid metabolic process,BP,
8737,GO:0032789,1,0.978619007265527,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8738,GO:0032790,1,0.846713775276036,0,8,ribosome disassembly,BP,
8739,GO:0032792,1,0.899837716574811,0,5,negative regulation of CREB transcription factor activity,BP,
8740,GO:0032793,1,0.750612723103496,0,14,positive regulation of CREB transcription factor activity,BP,
8743,GO:0032796,1,0.960476499794693,0,2,uropod organization,BP,
8744,GO:0032797,1,0.79115106061367,0,11,SMN complex,CC,
8745,GO:0032798,1,0.95839073820654,0,2,Swi5-Sfr1 complex,CC,
8746,GO:0032799,1,0.745025527035708,0,14,low-density lipoprotein receptor particle metabolic process,BP,
8749,GO:0032802,1,0.898787092921427,0,5,low-density lipoprotein particle receptor catabolic process,BP,
8750,GO:0032803,1,0.898787092921427,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8751,GO:0032804,1,0.958225028601218,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8752,GO:0032805,1,0.958037582874809,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8753,GO:0032806,1,0.60504115652207,0,24,carboxy-terminal domain protein kinase complex,CC,
8754,GO:0032807,1,0.937878792458037,0,3,DNA ligase IV complex,CC,
8756,GO:0032809,1,0.669947154672853,0,19,neuronal cell body membrane,CC,
8757,GO:0032810,1,0.958584056565391,0,2,sterol response element binding,MF,
8759,GO:0032812,1,0.978486094436377,0,1,positive regulation of epinephrine secretion,BP,
8762,GO:0032815,1,0.860055122761562,0,7,negative regulation of natural killer cell activation,BP,
8764,GO:0032817,1,0.825516395374911,0,9,regulation of natural killer cell proliferation,BP,
8765,GO:0032819,1,0.861213712697572,0,7,positive regulation of natural killer cell proliferation,BP,
8767,GO:0032824,1,0.937078727417848,0,3,negative regulation of natural killer cell differentiation,BP,
8769,GO:0032826,1,0.917046826839484,0,4,regulation of natural killer cell differentiation involved in immune response,BP,
8770,GO:0032827,1,0.937078727417848,0,3,negative regulation of natural killer cell differentiation involved in immune response,BP,
8771,GO:0032829,1,0.937399894858916,0,3,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8772,GO:0032831,1,0.937399894858916,0,3,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8773,GO:0032832,1,0.957612548502402,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8774,GO:0032834,1,0.957612548502402,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8777,GO:0032838,1,0.276147488151036,0,62,cell projection cytoplasm,CC,
8778,GO:0032839,1,0.632494587960408,0,22,dendrite cytoplasm,CC,
8779,GO:0032841,1,0.979071537988483,0,1,calcitonin binding,MF,
8783,GO:0032847,1,0.898345312373345,0,5,regulation of cellular pH reduction,BP,
8784,GO:0032848,1,0.979086398056303,0,1,negative regulation of cellular pH reduction,BP,
8785,GO:0032849,1,0.917538805611672,0,4,positive regulation of cellular pH reduction,BP,
8792,GO:0032875,1,0.868045312957829,0,7,regulation of DNA endoreduplication,BP,
8793,GO:0032876,1,0.923937393327324,0,4,negative regulation of DNA endoreduplication,BP,
8794,GO:0032877,1,0.959607723263591,0,2,positive regulation of DNA endoreduplication,BP,
8795,GO:0032878,1,0.662608595552689,0,20,regulation of establishment or maintenance of cell polarity,BP,
8801,GO:0032889,1,0.978964061931984,0,1,regulation of vacuole fusion, non-autophagic,BP,
8805,GO:0032897,1,0.601776914261559,0,24,negative regulation of viral transcription,BP,
8809,GO:0032901,1,0.97909142341218,0,1,positive regulation of neurotrophin production,BP,
8810,GO:0032902,1,0.958662986609347,0,2,nerve growth factor production,BP,
8811,GO:0032905,1,0.827437874014205,0,9,transforming growth factor beta1 production,BP,
8812,GO:0032906,1,0.848309818344114,0,8,transforming growth factor beta2 production,BP,
8813,GO:0032907,1,0.94321919747488,0,3,transforming growth factor beta3 production,BP,
8814,GO:0032908,1,0.827437874014205,0,9,regulation of transforming growth factor beta1 production,BP,
8815,GO:0032909,1,0.848309818344114,0,8,regulation of transforming growth factor beta2 production,BP,
8816,GO:0032910,1,0.94321919747488,0,3,regulation of transforming growth factor beta3 production,BP,
8817,GO:0032911,1,0.939360758849518,0,3,negative regulation of transforming growth factor beta1 production,BP,
8818,GO:0032912,1,0.958695382401037,0,2,negative regulation of transforming growth factor beta2 production,BP,
8819,GO:0032913,1,0.978830983471915,0,1,negative regulation of transforming growth factor beta3 production,BP,
8820,GO:0032914,1,0.880871126519123,0,6,positive regulation of transforming growth factor beta1 production,BP,
8821,GO:0032915,1,0.957984135328479,0,2,positive regulation of transforming growth factor beta2 production,BP,
8822,GO:0032916,1,0.963620128472087,0,2,positive regulation of transforming growth factor beta3 production,BP,
8823,GO:0032917,1,0.93717927224581,0,3,polyamine acetylation,BP,
8824,GO:0032918,1,0.93717927224581,0,3,spermidine acetylation,BP,
8825,GO:0032919,1,0.978490665620568,0,1,spermine acetylation,BP,
8826,GO:0032920,1,0.978490665620568,0,1,putrescine acetylation,BP,
8827,GO:0032922,1,0.353173722827005,0,51,circadian regulation of gene expression,BP,
8831,GO:0032927,1,0.852234560744554,0,8,positive regulation of activin receptor signaling pathway,BP,
8832,GO:0032928,1,0.75815464167253,0,13,regulation of superoxide anion generation,BP,
8833,GO:0032929,1,0.957791903245494,0,2,negative regulation of superoxide anion generation,BP,
8834,GO:0032930,1,0.808087390666656,0,10,positive regulation of superoxide anion generation,BP,
8835,GO:0032933,1,0.843943687828033,0,8,SREBP signaling pathway,BP,
8837,GO:0032937,1,0.938504082183821,0,3,SREBP-SCAP-Insig complex,CC,
8845,GO:0032954,1,0.960041874933944,0,2,regulation of cytokinetic process,BP,
8847,GO:0032957,1,0.827721875484048,0,9,inositol trisphosphate metabolic process,BP,
8848,GO:0032958,1,0.65562677180048,0,20,inositol phosphate biosynthetic process,BP,
8849,GO:0032959,1,0.862303322460303,0,7,inositol trisphosphate biosynthetic process,BP,
8850,GO:0032960,1,0.89940400168303,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8851,GO:0032962,1,0.918498759653245,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8855,GO:0032966,1,0.861182455810292,0,7,negative regulation of collagen biosynthetic process,BP,
8857,GO:0032968,1,0.760815837190251,0,13,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8859,GO:0032971,1,0.917846739899686,0,4,regulation of muscle filament sliding,BP,
8860,GO:0032972,1,0.957444789965666,0,2,regulation of muscle filament sliding speed,BP,
8861,GO:0032976,1,0.978478550887233,0,1,release of matrix enzymes from mitochondria,BP,
8862,GO:0032980,1,0.978926151801738,0,1,keratinocyte activation,BP,
8863,GO:0032981,1,0.304220575045312,0,55,mitochondrial respiratory chain complex I assembly,BP,
8865,GO:0032983,1,0.958555087173784,0,2,kainate selective glutamate receptor complex,CC,
8867,GO:0032986,1,0.657841038637577,0,20,protein-DNA complex disassembly,BP,
8868,GO:0032988,1,0.76189945477547,0,13,ribonucleoprotein complex disassembly,BP,
8872,GO:0032993,1,0.0177319031490604,0,188,protein-DNA complex,CC,
8874,GO:0032996,1,0.978704155624961,0,1,Bcl3-Bcl10 complex,CC,
8875,GO:0032997,1,0.957846749315146,0,2,Fc receptor complex,CC,
8876,GO:0032998,1,0.957846749315146,0,2,Fc-epsilon receptor I complex,CC,
8878,GO:0033003,1,0.456239208590293,0,37,regulation of mast cell activation,BP,
8879,GO:0033004,1,0.77442541671573,0,12,negative regulation of mast cell activation,BP,
8880,GO:0033005,1,0.727113427122068,0,15,positive regulation of mast cell activation,BP,
8881,GO:0033006,1,0.539836333960137,0,29,regulation of mast cell activation involved in immune response,BP,
8882,GO:0033007,1,0.842673979778408,0,8,negative regulation of mast cell activation involved in immune response,BP,
8883,GO:0033008,1,0.758059449038128,0,13,positive regulation of mast cell activation involved in immune response,BP,
8885,GO:0033011,1,0.917862991696498,0,4,perinuclear theca,CC,
8887,GO:0033014,1,0.567818945769451,0,27,tetrapyrrole biosynthetic process,BP,
8888,GO:0033015,1,0.859825879827315,0,7,tetrapyrrole catabolic process,BP,
8896,GO:0033029,1,0.901064811084603,0,5,regulation of neutrophil apoptotic process,BP,
8897,GO:0033030,1,0.980434892232374,0,1,negative regulation of neutrophil apoptotic process,BP,
8898,GO:0033031,1,0.919050226310655,0,4,positive regulation of neutrophil apoptotic process,BP,
8901,GO:0033034,1,0.845481257205679,0,8,positive regulation of myeloid cell apoptotic process,BP,
8903,GO:0033037,1,0.980118023373351,0,1,polysaccharide localization,BP,
8904,GO:0033038,1,0.676162138241634,0,18,bitter taste receptor activity,MF,
8905,GO:0033040,1,0.959207365765717,0,2,sour taste receptor activity,MF,
8906,GO:0033041,1,0.958378506568461,0,2,sweet taste receptor activity,MF,
8909,GO:0033045,1,0.283353396528991,0,61,regulation of sister chromatid segregation,BP,
8910,GO:0033046,1,0.510374613106799,0,33,negative regulation of sister chromatid segregation,BP,
8911,GO:0033047,1,0.350758068579789,0,51,regulation of mitotic sister chromatid segregation,BP,
8912,GO:0033048,1,0.520382850906598,0,32,negative regulation of mitotic sister chromatid segregation,BP,
8913,GO:0033058,1,0.965570417362612,0,2,directional locomotion,BP,
8915,GO:0033061,1,0.861428443990363,0,7,DNA recombinase mediator complex,CC,
8916,GO:0033063,1,0.898839115000845,0,5,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8917,GO:0033065,1,0.957927672769897,0,2,Rad51C-XRCC3 complex,CC,
8918,GO:0033076,1,0.937440071602245,0,3,isoquinoline alkaloid metabolic process,BP,
8920,GO:0033078,1,0.938107752690427,0,3,extrathymic T cell differentiation,BP,
8924,GO:0033082,1,0.95857994891167,0,2,regulation of extrathymic T cell differentiation,BP,
8930,GO:0033089,1,0.792826038200531,0,11,positive regulation of T cell differentiation in thymus,BP,
8931,GO:0033091,1,0.93781379028769,0,3,positive regulation of immature T cell proliferation,BP,
8932,GO:0033092,1,0.957948274224545,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8934,GO:0033106,1,0.978986757347795,0,1,cis-Golgi network membrane,CC,
8935,GO:0033108,1,0.189554796438478,0,77,mitochondrial respiratory chain complex assembly,BP,
8936,GO:0033116,1,0.248454804989847,0,66,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8937,GO:0033119,1,0.587131979317481,0,25,negative regulation of RNA splicing,BP,
8939,GO:0033121,1,0.94166557471359,0,3,regulation of purine nucleotide catabolic process,BP,
8940,GO:0033122,1,0.960579319436877,0,2,negative regulation of purine nucleotide catabolic process,BP,
8941,GO:0033123,1,0.980312203334817,0,1,positive regulation of purine nucleotide catabolic process,BP,
8942,GO:0033127,1,0.76158550701829,0,13,regulation of histone phosphorylation,BP,
8943,GO:0033128,1,0.937688720180032,0,3,negative regulation of histone phosphorylation,BP,
8944,GO:0033129,1,0.847565055822024,0,8,positive regulation of histone phosphorylation,BP,
8945,GO:0033130,1,0.848022256525543,0,8,acetylcholine receptor binding,MF,
8946,GO:0033131,1,0.842806082724679,0,8,regulation of glucokinase activity,BP,
8947,GO:0033132,1,0.917996623774756,0,4,negative regulation of glucokinase activity,BP,
8948,GO:0033133,1,0.918111077275783,0,4,positive regulation of glucokinase activity,BP,
8950,GO:0033136,1,0.843511944639688,0,8,serine phosphorylation of STAT3 protein,BP,
8951,GO:0033137,1,0.616735211390533,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8954,GO:0033140,1,0.958179924453369,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8956,GO:0033142,1,0.960233660660042,0,2,progesterone receptor binding,MF,
8957,GO:0033143,1,0.260299119146166,0,64,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8958,GO:0033144,1,0.521179882312508,0,31,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8959,GO:0033145,1,0.730201413376558,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8960,GO:0033146,1,0.533074454754387,0,30,regulation of intracellular estrogen receptor signaling pathway,BP,
8961,GO:0033147,1,0.762607355973492,0,13,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8962,GO:0033148,1,0.828646206318053,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8963,GO:0033149,1,0.960479411293933,0,2,FFAT motif binding,MF,
8964,GO:0033150,1,0.93766302585645,0,3,cytoskeletal calyx,CC,
8965,GO:0033151,1,0.770835382865971,0,13,V(D)J recombination,BP,
8966,GO:0033152,1,0.924582884576551,0,4,immunoglobulin V(D)J recombination,BP,
8967,GO:0033153,1,0.907916610447321,0,5,T cell receptor V(D)J recombination,BP,
8971,GO:0033160,1,0.786999601496137,0,12,positive regulation of protein import into nucleus, translocation,BP,
8973,GO:0033165,1,0.938282366032692,0,3,interphotoreceptor matrix,CC,
8974,GO:0033167,1,0.983398169013766,0,1,ARC complex,CC,
8975,GO:0033168,1,0.983398169013766,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8976,GO:0033169,1,0.816141138645619,0,10,histone H3-K9 demethylation,BP,
8977,GO:0033170,1,0.843168242036882,0,8,protein-DNA loading ATPase activity,MF,
8979,GO:0033176,1,0.612360803944537,0,23,proton-transporting V-type ATPase complex,CC,
8980,GO:0033177,1,0.637087777775319,0,21,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8981,GO:0033178,1,0.709774851029421,0,16,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8982,GO:0033179,1,0.808686238386157,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8983,GO:0033180,1,0.825928563890942,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8984,GO:0033182,1,0.83105636907371,0,9,regulation of histone ubiquitination,BP,
8985,GO:0033183,1,0.94350307621666,0,3,negative regulation of histone ubiquitination,BP,
8986,GO:0033184,1,0.899763816743503,0,5,positive regulation of histone ubiquitination,BP,
8988,GO:0033186,1,0.940902449560737,0,3,CAF-1 complex,CC,
8989,GO:0033188,1,0.939347655431536,0,3,sphingomyelin synthase activity,MF,
8990,GO:0033189,1,0.695308192412959,0,17,response to vitamin A,BP,
8991,GO:0033192,1,0.922312389017083,0,4,calmodulin-dependent protein phosphatase activity,MF,
8992,GO:0033193,1,0.979570143855121,0,1,Lsd1/2 complex,CC,
8993,GO:0033194,1,0.712134531695358,0,16,response to hydroperoxide,BP,
8994,GO:0033197,1,0.776114452306688,0,12,response to vitamin E,BP,
8995,GO:0033198,1,0.522314689966065,0,31,response to ATP,BP,
8996,GO:0033202,1,0.741708428303336,0,14,DNA helicase complex,CC,
8997,GO:0033204,1,0.978949800872022,0,1,ribonuclease P RNA binding,MF,
8998,GO:0033206,1,0.90177788534646,0,5,meiotic cytokinesis,BP,
9000,GO:0033210,1,0.826211355126501,0,9,leptin-mediated signaling pathway,BP,
9001,GO:0033211,1,0.880324718448713,0,6,adiponectin-activated signaling pathway,BP,
9002,GO:0033212,1,0.978909349397237,0,1,iron assimilation,BP,
9003,GO:0033214,1,0.978909349397237,0,1,iron assimilation by chelation and transport,BP,
9004,GO:0033216,1,0.90091916297985,0,5,ferric iron import,BP,
9006,GO:0033227,1,0.899767048005272,0,5,dsRNA transport,BP,
9007,GO:0033229,1,0.979076408025917,0,1,cysteine transmembrane transporter activity,MF,
9008,GO:0033231,1,0.979107757569395,0,1,carbohydrate export,BP,
9009,GO:0033233,1,0.642292186024402,0,21,regulation of protein sumoylation,BP,
9010,GO:0033234,1,0.809341772099593,0,10,negative regulation of protein sumoylation,BP,
9011,GO:0033235,1,0.793691268105493,0,11,positive regulation of protein sumoylation,BP,
9013,GO:0033239,1,0.922292679834554,0,4,negative regulation of cellular amine metabolic process,BP,
9014,GO:0033240,1,0.825249404248418,0,9,positive regulation of cellular amine metabolic process,BP,
9015,GO:0033241,1,0.982396170646631,0,1,regulation of cellular amine catabolic process,BP,
9016,GO:0033242,1,0.982396170646631,0,1,negative regulation of cellular amine catabolic process,BP,
9017,GO:0033256,1,0.861339166802166,0,7,I-kappaB/NF-kappaB complex,CC,
9018,GO:0033257,1,0.95821255000764,0,2,Bcl3/NF-kappaB2 complex,CC,
9019,GO:0033260,1,0.546525558222884,0,29,nuclear DNA replication,BP,
9020,GO:0033262,1,0.764758402968841,0,13,regulation of nuclear cell cycle DNA replication,BP,
9021,GO:0033263,1,0.919793028463732,0,4,CORVET complex,CC,
9022,GO:0033265,1,0.918957816507245,0,4,choline binding,MF,
9025,GO:0033269,1,0.918647881772217,0,4,internode region of axon,CC,
9028,GO:0033274,1,0.981180568946713,0,1,response to vitamin B2,BP,
9030,GO:0033276,1,0.746739835365703,0,14,transcription factor TFTC complex,CC,
9031,GO:0033277,1,0.95980734145032,0,2,abortive mitotic cell cycle,BP,
9034,GO:0033290,1,0.979151313417047,0,1,eukaryotic 48S preinitiation complex,CC,
9035,GO:0033291,1,0.978465094800763,0,1,eukaryotic 80S initiation complex,CC,
9036,GO:0033292,1,0.943506385488049,0,3,T-tubule organization,BP,
9038,GO:0033299,1,0.899486887953566,0,5,secretion of lysosomal enzymes,BP,
9039,GO:0033300,1,0.918740023696542,0,4,dehydroascorbic acid transporter activity,MF,
9040,GO:0033301,1,0.979075926569367,0,1,cell cycle comprising mitosis without cytokinesis,BP,
9042,GO:0033313,1,0.84290286603507,0,8,meiotic cell cycle checkpoint,BP,
9043,GO:0033314,1,0.825816530751465,0,9,mitotic DNA replication checkpoint,BP,
9044,GO:0033315,1,0.978493736913688,0,1,meiotic DNA replication checkpoint,BP,
9045,GO:0033316,1,0.979061701303031,0,1,meiotic spindle assembly checkpoint,BP,
9046,GO:0033319,1,0.978796467227212,0,1,UDP-D-xylose metabolic process,BP,
9047,GO:0033320,1,0.978796467227212,0,1,UDP-D-xylose biosynthetic process,BP,
9048,GO:0033326,1,0.938751064148514,0,3,cerebrospinal fluid secretion,BP,
9050,GO:0033328,1,0.979071495839486,0,1,peroxisome membrane targeting sequence binding,MF,
9051,GO:0033341,1,0.961068317674178,0,2,regulation of collagen binding,BP,
9052,GO:0033342,1,0.97896373474217,0,1,negative regulation of collagen binding,BP,
9053,GO:0033343,1,0.981721091545092,0,1,positive regulation of collagen binding,BP,
9055,GO:0033345,1,0.978912567452902,0,1,asparagine catabolic process via L-aspartate,BP,
9056,GO:0033353,1,0.91923614585642,0,4,S-adenosylmethionine cycle,BP,
9058,GO:0033364,1,0.964362017067126,0,2,mast cell secretory granule organization,BP,
9060,GO:0033366,1,0.978528556629144,0,1,protein localization to secretory granule,BP,
9061,GO:0033367,1,0.978528556629144,0,1,protein localization to mast cell secretory granule,BP,
9062,GO:0033368,1,0.978528556629144,0,1,protease localization to mast cell secretory granule,BP,
9063,GO:0033370,1,0.978528556629144,0,1,maintenance of protein location in mast cell secretory granule,BP,
9064,GO:0033371,1,0.978528556629144,0,1,T cell secretory granule organization,BP,
9065,GO:0033373,1,0.978528556629144,0,1,maintenance of protease location in mast cell secretory granule,BP,
9066,GO:0033374,1,0.978528556629144,0,1,protein localization to T cell secretory granule,BP,
9067,GO:0033375,1,0.978528556629144,0,1,protease localization to T cell secretory granule,BP,
9068,GO:0033377,1,0.978528556629144,0,1,maintenance of protein location in T cell secretory granule,BP,
9069,GO:0033379,1,0.978528556629144,0,1,maintenance of protease location in T cell secretory granule,BP,
9070,GO:0033380,1,0.978528556629144,0,1,granzyme B localization to T cell secretory granule,BP,
9071,GO:0033382,1,0.978528556629144,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
9072,GO:0033383,1,0.958063540882306,0,2,geranyl diphosphate metabolic process,BP,
9073,GO:0033384,1,0.958063540882306,0,2,geranyl diphosphate biosynthetic process,BP,
9074,GO:0033385,1,0.979036613574826,0,1,geranylgeranyl diphosphate metabolic process,BP,
9075,GO:0033386,1,0.979036613574826,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
9076,GO:0033387,1,0.958416172833564,0,2,putrescine biosynthetic process from ornithine,BP,
9077,GO:0033388,1,0.978840064421984,0,1,putrescine biosynthetic process from arginine,BP,
9078,GO:0033391,1,0.779139769314847,0,12,chromatoid body,CC,
9079,GO:0033477,1,0.978755359907925,0,1,S-methylmethionine metabolic process,BP,
9081,GO:0033484,1,0.938158017009269,0,3,nitric oxide homeostasis,BP,
9082,GO:0033488,1,0.979064189724897,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9085,GO:0033499,1,0.978949972742984,0,1,galactose catabolic process via UDP-galactose,BP,
9087,GO:0033503,1,0.898812564487944,0,5,HULC complex,CC,
9088,GO:0033504,1,0.863842338048166,0,7,floor plate development,BP,
9089,GO:0033505,1,0.960093463611115,0,2,floor plate morphogenesis,BP,
9090,GO:0033512,1,0.93938213207708,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9091,GO:0033514,1,0.978925417777675,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9092,GO:0033522,1,0.674340738918866,0,19,histone H2A ubiquitination,BP,
9093,GO:0033523,1,0.81032082151083,0,10,histone H2B ubiquitination,BP,
9095,GO:0033540,1,0.759628421419451,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9097,GO:0033552,1,0.97847473781867,0,1,response to vitamin B3,BP,
9098,GO:0033553,1,0.92162826482661,0,4,rDNA heterochromatin,CC,
9100,GO:0033555,1,0.251665528830552,0,66,multicellular organismal response to stress,BP,
9101,GO:0033557,1,0.938238199096648,0,3,Slx1-Slx4 complex,CC,
9104,GO:0033560,1,0.979095613080179,0,1,folate reductase activity,MF,
9107,GO:0033564,1,0.905173133507269,0,5,anterior/posterior axon guidance,BP,
9108,GO:0033565,1,0.939457645805403,0,3,ESCRT-0 complex,CC,
9109,GO:0033566,1,0.958343698494532,0,2,gamma-tubulin complex localization,BP,
9110,GO:0033567,1,0.918410311824753,0,4,DNA replication, Okazaki fragment processing,BP,
9111,GO:0033570,1,0.979683204643424,0,1,transferrin transmembrane transporter activity,MF,
9114,GO:0033577,1,0.958456773457822,0,2,protein glycosylation in endoplasmic reticulum,BP,
9115,GO:0033578,1,0.901135853161934,0,5,protein glycosylation in Golgi,BP,
9116,GO:0033588,1,0.881315197273162,0,6,Elongator holoenzyme complex,CC,
9117,GO:0033590,1,0.937891605284643,0,3,response to cobalamin,BP,
9118,GO:0033591,1,0.901356297875799,0,5,response to L-ascorbic acid,BP,
9119,GO:0033592,1,0.900401199141461,0,5,RNA strand annealing activity,MF,
9120,GO:0033593,1,0.984162547018007,0,1,BRCA2-MAGE-D1 complex,CC,
9121,GO:0033594,1,0.918022631773531,0,4,response to hydroxyisoflavone,BP,
9122,GO:0033595,1,0.958380393115192,0,2,response to genistein,BP,
9123,GO:0033596,1,0.942459948477858,0,3,TSC1-TSC2 complex,CC,
9125,GO:0033599,1,0.707562464421979,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9126,GO:0033600,1,0.90581378286145,0,5,negative regulation of mammary gland epithelial cell proliferation,BP,
9127,GO:0033601,1,0.869926643156114,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9128,GO:0033602,1,0.939926939402172,0,3,negative regulation of dopamine secretion,BP,
9132,GO:0033606,1,0.978830983471915,0,1,chemokine receptor transport within lipid bilayer,BP,
9133,GO:0033609,1,0.97897493185122,0,1,oxalate metabolic process,BP,
9136,GO:0033615,1,0.93788999335325,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9137,GO:0033617,1,0.741372556132595,0,14,mitochondrial respiratory chain complex IV assembly,BP,
9138,GO:0033619,1,0.313411721070423,0,55,membrane protein proteolysis,BP,
9139,GO:0033622,1,0.688904833690789,0,18,integrin activation,BP,
9140,GO:0033623,1,0.810634162485174,0,10,regulation of integrin activation,BP,
9141,GO:0033624,1,0.960747825926128,0,2,negative regulation of integrin activation,BP,
9142,GO:0033625,1,0.899064603025016,0,5,positive regulation of integrin activation,BP,
9143,GO:0033626,1,0.979075383855457,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9146,GO:0033629,1,0.828793815670937,0,9,negative regulation of cell adhesion mediated by integrin,BP,
9147,GO:0033630,1,0.697365682120074,0,17,positive regulation of cell adhesion mediated by integrin,BP,
9149,GO:0033632,1,0.844173827140644,0,8,regulation of cell-cell adhesion mediated by integrin,BP,
9150,GO:0033633,1,0.979474865996751,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9151,GO:0033634,1,0.918865930099828,0,4,positive regulation of cell-cell adhesion mediated by integrin,BP,
9152,GO:0033643,1,0.827350622976788,0,9,host cell part,CC,
9153,GO:0033644,1,0.979158054547778,0,1,host cell membrane,CC,
9154,GO:0033646,1,0.862743545342343,0,7,host intracellular part,CC,
9155,GO:0033647,1,0.899711733988024,0,5,host intracellular organelle,CC,
9156,GO:0033648,1,0.899711733988024,0,5,host intracellular membrane-bounded organelle,CC,
9157,GO:0033650,1,0.978661162038463,0,1,host cell mitochondrion,CC,
9158,GO:0033655,1,0.918812167581223,0,4,host cell cytoplasm part,CC,
9159,GO:0033668,1,0.91824490465937,0,4,negative regulation by symbiont of host apoptotic process,BP,
9162,GO:0033676,1,0.978559819719408,0,1,double-stranded DNA-dependent ATPase activity,MF,
9163,GO:0033677,1,0.958463922644454,0,2,DNA/RNA helicase activity,MF,
9164,GO:0033678,1,0.979004789414866,0,1,5'-3' DNA/RNA helicase activity,MF,
9165,GO:0033680,1,0.979004789414866,0,1,ATP-dependent DNA/RNA helicase activity,MF,
9166,GO:0033682,1,0.979004789414866,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9167,GO:0033683,1,0.43639269463606,0,39,nucleotide-excision repair, DNA incision,BP,
9168,GO:0033684,1,0.864518427916838,0,7,regulation of luteinizing hormone secretion,BP,
9169,GO:0033685,1,0.938310906264797,0,3,negative regulation of luteinizing hormone secretion,BP,
9170,GO:0033686,1,0.921369144230572,0,4,positive regulation of luteinizing hormone secretion,BP,
9173,GO:0033689,1,0.830001752561086,0,9,negative regulation of osteoblast proliferation,BP,
9175,GO:0033691,1,0.832619741562139,0,9,sialic acid binding,MF,
9177,GO:0033693,1,0.938496906786347,0,3,neurofilament bundle assembly,BP,
9178,GO:0033695,1,0.918159172829805,0,4,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9179,GO:0033699,1,0.978766515663216,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9181,GO:0033735,1,0.978488985228464,0,1,aspartate dehydrogenase activity,MF,
9182,GO:0033737,1,0.978957440165652,0,1,1-pyrroline dehydrogenase activity,MF,
9183,GO:0033743,1,0.91803140181667,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9184,GO:0033746,1,0.979071682445459,0,1,histone demethylase activity (H3-R2 specific),MF,
9185,GO:0033749,1,0.979071682445459,0,1,histone demethylase activity (H4-R3 specific),MF,
9186,GO:0033750,1,0.773488846066112,0,12,ribosome localization,BP,
9187,GO:0033753,1,0.773488846066112,0,12,establishment of ribosome localization,BP,
9188,GO:0033754,1,0.957934250859404,0,2,indoleamine 2,3-dioxygenase activity,MF,
9191,GO:0033765,1,0.938124532939593,0,3,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9192,GO:0033768,1,0.979063621405716,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9193,GO:0033778,1,0.979099809606227,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9194,GO:0033780,1,0.979030251935431,0,1,taurochenodeoxycholate 6alpha-hydroxylase activity,MF,
9195,GO:0033781,1,0.978793549066336,0,1,cholesterol 24-hydroxylase activity,MF,
9196,GO:0033787,1,0.979042395172386,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9197,GO:0033791,1,0.978888477600489,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9198,GO:0033798,1,0.978798551701089,0,1,thyroxine 5-deiodinase activity,MF,
9199,GO:0033814,1,0.978563019187997,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9200,GO:0033819,1,0.978489909589652,0,1,lipoyl(octanoyl) transferase activity,MF,
9201,GO:0033823,1,0.979058680792045,0,1,procollagen glucosyltransferase activity,MF,
9202,GO:0033829,1,0.937647640482681,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9203,GO:0033842,1,0.958575754052064,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9204,GO:0033857,1,0.960219987110271,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9205,GO:0033858,1,0.979067611109599,0,1,N-acetylgalactosamine kinase activity,MF,
9206,GO:0033860,1,0.841881241647093,0,8,regulation of NAD(P)H oxidase activity,BP,
9207,GO:0033861,1,0.937264964387768,0,3,negative regulation of NAD(P)H oxidase activity,BP,
9208,GO:0033862,1,0.979058435939385,0,1,UMP kinase activity,MF,
9209,GO:0033864,1,0.898248861153461,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9212,GO:0033867,1,0.978624370704789,0,1,Fas-activated serine/threonine kinase activity,MF,
9214,GO:0033871,1,0.978736121469041,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9215,GO:0033872,1,0.958178658587306,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9217,GO:0033878,1,0.979082664010256,0,1,hormone-sensitive lipase activity,MF,
9218,GO:0033882,1,0.978513892316237,0,1,choloyl-CoA hydrolase activity,MF,
9219,GO:0033883,1,0.957722770946371,0,2,pyridoxal phosphatase activity,MF,
9220,GO:0033885,1,0.97884417678277,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9221,GO:0033897,1,0.978528556629144,0,1,ribonuclease T2 activity,MF,
9222,GO:0033906,1,0.958026770792713,0,2,hyaluronoglucuronidase activity,MF,
9223,GO:0033919,1,0.979093878908121,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9224,GO:0033925,1,0.979280084076002,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9225,GO:0033961,1,0.978659543650307,0,1,cis-stilbene-oxide hydrolase activity,MF,
9226,GO:0033962,1,0.697967135864517,0,18,cytoplasmic mRNA processing body assembly,BP,
9227,GO:0033967,1,0.978515364646893,0,1,box C/D snoRNA metabolic process,BP,
9228,GO:0033979,1,0.978980630239622,0,1,box H/ACA snoRNA metabolic process,BP,
9229,GO:0033981,1,0.978470438250598,0,1,D-dopachrome decarboxylase activity,MF,
9230,GO:0033989,1,0.979011610910436,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9232,GO:0034014,1,0.978877198485586,0,1,response to triglyceride,BP,
9233,GO:0034021,1,0.957404495948504,0,2,response to silicon dioxide,BP,
9239,GO:0034035,1,0.669008162678273,0,19,purine ribonucleoside bisphosphate metabolic process,BP,
9240,GO:0034036,1,0.882697664112051,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9241,GO:0034038,1,0.978518242160399,0,1,deoxyhypusine synthase activity,MF,
9242,GO:0034039,1,0.978722996983945,0,1,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9245,GO:0034045,1,0.751071874682191,0,14,pre-autophagosomal structure membrane,CC,
9246,GO:0034046,1,0.903931744686526,0,5,poly(G) binding,MF,
9247,GO:0034056,1,0.920180917260533,0,4,estrogen response element binding,MF,
9248,GO:0034057,1,0.958516853059149,0,2,RNA strand-exchange activity,MF,
9249,GO:0034058,1,0.831321489603114,0,9,endosomal vesicle fusion,BP,
9251,GO:0034061,1,0.507063554504012,0,33,DNA polymerase activity,MF,
9252,GO:0034062,1,0.409265002524909,0,42,5'-3' RNA polymerase activity,MF,
9253,GO:0034063,1,0.817048599971151,0,10,stress granule assembly,BP,
9254,GO:0034066,1,0.978537623531215,0,1,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9255,GO:0034067,1,0.52184983501105,0,32,protein localization to Golgi apparatus,BP,
9256,GO:0034080,1,0.451586231018269,0,37,CENP-A containing nucleosome assembly,BP,
9257,GO:0034085,1,0.938433391299496,0,3,establishment of sister chromatid cohesion,BP,
9258,GO:0034086,1,0.838041344554216,0,9,maintenance of sister chromatid cohesion,BP,
9259,GO:0034088,1,0.838041344554216,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9260,GO:0034091,1,0.908048936408048,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9261,GO:0034092,1,0.967214898792141,0,2,negative regulation of maintenance of sister chromatid cohesion,BP,
9262,GO:0034093,1,0.93883392239167,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9264,GO:0034098,1,0.827638745603141,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9270,GO:0034110,1,0.63357697911304,0,22,regulation of homotypic cell-cell adhesion,BP,
9271,GO:0034111,1,0.761510596166936,0,13,negative regulation of homotypic cell-cell adhesion,BP,
9272,GO:0034112,1,0.921452679440187,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9275,GO:0034115,1,0.825270800361123,0,9,negative regulation of heterotypic cell-cell adhesion,BP,
9277,GO:0034117,1,0.97846783459069,0,1,erythrocyte aggregation,BP,
9278,GO:0034118,1,0.97846783459069,0,1,regulation of erythrocyte aggregation,BP,
9279,GO:0034120,1,0.97846783459069,0,1,positive regulation of erythrocyte aggregation,BP,
9282,GO:0034123,1,0.681769370070125,0,18,positive regulation of toll-like receptor signaling pathway,BP,
9283,GO:0034124,1,0.917847240259555,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9284,GO:0034125,1,0.957829498440294,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9287,GO:0034130,1,0.979042545206108,0,1,toll-like receptor 1 signaling pathway,BP,
9288,GO:0034134,1,0.808542589492929,0,10,toll-like receptor 2 signaling pathway,BP,
9289,GO:0034135,1,0.89885290142945,0,5,regulation of toll-like receptor 2 signaling pathway,BP,
9290,GO:0034136,1,0.958747203099698,0,2,negative regulation of toll-like receptor 2 signaling pathway,BP,
9291,GO:0034137,1,0.937535518450365,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
9292,GO:0034138,1,0.711938577350284,0,16,toll-like receptor 3 signaling pathway,BP,
9293,GO:0034139,1,0.826327233133687,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9294,GO:0034140,1,0.938730155145636,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9295,GO:0034141,1,0.861829094307771,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9296,GO:0034142,1,0.552586266536067,0,28,toll-like receptor 4 signaling pathway,BP,
9297,GO:0034143,1,0.742898721955681,0,14,regulation of toll-like receptor 4 signaling pathway,BP,
9298,GO:0034144,1,0.899851742910235,0,5,negative regulation of toll-like receptor 4 signaling pathway,BP,
9299,GO:0034145,1,0.825624521983932,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9300,GO:0034146,1,0.958865597476232,0,2,toll-like receptor 5 signaling pathway,BP,
9301,GO:0034147,1,0.979250290847645,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9302,GO:0034148,1,0.979250290847645,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9303,GO:0034150,1,0.980215070096986,0,1,toll-like receptor 6 signaling pathway,BP,
9304,GO:0034154,1,0.900104542215112,0,5,toll-like receptor 7 signaling pathway,BP,
9305,GO:0034155,1,0.979069704666405,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
9306,GO:0034157,1,0.979069704666405,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
9307,GO:0034158,1,0.979165076058203,0,1,toll-like receptor 8 signaling pathway,BP,
9308,GO:0034162,1,0.684763569138901,0,18,toll-like receptor 9 signaling pathway,BP,
9309,GO:0034163,1,0.940172049511422,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
9310,GO:0034164,1,0.980802963305771,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
9311,GO:0034165,1,0.958575970369321,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9312,GO:0034166,1,0.979069266786649,0,1,toll-like receptor 10 signaling pathway,BP,
9313,GO:0034182,1,0.908048936408048,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9314,GO:0034183,1,0.967214898792141,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9315,GO:0034184,1,0.93883392239167,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9316,GO:0034185,1,0.727927136589345,0,16,apolipoprotein binding,MF,
9317,GO:0034186,1,0.922325100156467,0,4,apolipoprotein A-I binding,MF,
9318,GO:0034188,1,0.964794126877812,0,2,apolipoprotein A-I receptor activity,MF,
9319,GO:0034189,1,0.958580399346712,0,2,very-low-density lipoprotein particle binding,MF,
9320,GO:0034190,1,0.882116901559411,0,6,apolipoprotein receptor binding,MF,
9321,GO:0034191,1,0.920810520286283,0,4,apolipoprotein A-I receptor binding,MF,
9322,GO:0034196,1,0.89846188127708,0,5,acylglycerol transport,BP,
9323,GO:0034197,1,0.89846188127708,0,5,triglyceride transport,BP,
9326,GO:0034201,1,0.899968003591197,0,5,response to oleic acid,BP,
9327,GO:0034203,1,0.979639713250977,0,1,glycolipid translocation,BP,
9328,GO:0034204,1,0.633724684750745,0,23,lipid translocation,BP,
9329,GO:0034205,1,0.749125152425584,0,14,beta-amyloid formation,BP,
9330,GO:0034211,1,0.982703479687859,0,1,GTP-dependent protein kinase activity,MF,
9331,GO:0034212,1,0.270256182746538,0,63,peptide N-acetyltransferase activity,MF,
9332,GO:0034213,1,0.978595373722464,0,1,quinolinate catabolic process,BP,
9333,GO:0034214,1,0.862155335375267,0,7,protein hexamerization,BP,
9336,GO:0034224,1,0.958060142200595,0,2,cellular response to zinc ion starvation,BP,
9337,GO:0034226,1,0.960854055934674,0,2,lysine import,BP,
9338,GO:0034227,1,0.898135285271464,0,5,tRNA thio-modification,BP,
9339,GO:0034230,1,0.979413275336528,0,1,enkephalin processing,BP,
9340,GO:0034231,1,0.979413275336528,0,1,islet amyloid polypeptide processing,BP,
9341,GO:0034235,1,0.861475978088458,0,7,GPI anchor binding,MF,
9343,GO:0034237,1,0.731654096658461,0,16,protein kinase A regulatory subunit binding,MF,
9344,GO:0034238,1,0.93836514846285,0,3,macrophage fusion,BP,
9345,GO:0034239,1,0.93836514846285,0,3,regulation of macrophage fusion,BP,
9346,GO:0034241,1,0.93836514846285,0,3,positive regulation of macrophage fusion,BP,
9347,GO:0034242,1,0.938855424809849,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9350,GO:0034245,1,0.979083236024535,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9351,GO:0034247,1,0.957547608755993,0,2,snoRNA splicing,BP,
9355,GO:0034255,1,0.978819787817556,0,1,regulation of urea metabolic process,BP,
9357,GO:0034271,1,0.958855934637693,0,2,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9358,GO:0034272,1,0.958855934637693,0,2,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9359,GO:0034274,1,0.93896807462088,0,3,Atg12-Atg5-Atg16 complex,CC,
9360,GO:0034275,1,0.978602190228797,0,1,kynurenic acid metabolic process,BP,
9361,GO:0034276,1,0.978602190228797,0,1,kynurenic acid biosynthetic process,BP,
9364,GO:0034287,1,0.918026830356171,0,4,detection of monosaccharide stimulus,BP,
9366,GO:0034309,1,0.978487817470133,0,1,primary alcohol biosynthetic process,BP,
9367,GO:0034310,1,0.724181365499266,0,15,primary alcohol catabolic process,BP,
9368,GO:0034311,1,0.792187444059424,0,11,diol metabolic process,BP,
9369,GO:0034312,1,0.845030361091023,0,8,diol biosynthetic process,BP,
9370,GO:0034314,1,0.508334686334384,0,32,Arp2/3 complex-mediated actin nucleation,BP,
9371,GO:0034315,1,0.712955287902409,0,16,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9372,GO:0034316,1,0.898775009645959,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9378,GO:0034334,1,0.959626442706071,0,2,adherens junction maintenance,BP,
9379,GO:0034337,1,0.979088233543195,0,1,RNA folding,BP,
9380,GO:0034338,1,0.979041789436899,0,1,short-chain carboxylesterase activity,MF,
9383,GO:0034342,1,0.958229480320348,0,2,response to type III interferon,BP,
9384,GO:0034343,1,0.938843184981053,0,3,type III interferon production,BP,
9385,GO:0034344,1,0.938843184981053,0,3,regulation of type III interferon production,BP,
9386,GO:0034346,1,0.979062177533081,0,1,positive regulation of type III interferon production,BP,
9390,GO:0034354,1,0.978529078223452,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9393,GO:0034359,1,0.985907125100618,0,1,mature chylomicron,CC,
9394,GO:0034360,1,0.985907125100618,0,1,chylomicron remnant,CC,
9396,GO:0034362,1,0.782803534493925,0,12,low-density lipoprotein particle,CC,
9397,GO:0034363,1,0.923627718975517,0,4,intermediate-density lipoprotein particle,CC,
9399,GO:0034365,1,0.957422250517517,0,2,discoidal high-density lipoprotein particle,CC,
9400,GO:0034366,1,0.840884892474725,0,8,spherical high-density lipoprotein particle,CC,
9404,GO:0034370,1,0.788179354286549,0,11,triglyceride-rich lipoprotein particle remodeling,BP,
9405,GO:0034371,1,0.937470007801043,0,3,chylomicron remodeling,BP,
9406,GO:0034372,1,0.788179354286549,0,11,very-low-density lipoprotein particle remodeling,BP,
9407,GO:0034373,1,0.978612549231058,0,1,intermediate-density lipoprotein particle remodeling,BP,
9411,GO:0034378,1,0.959043049577107,0,2,chylomicron assembly,BP,
9413,GO:0034380,1,0.811248279621449,0,10,high-density lipoprotein particle assembly,BP,
9416,GO:0034383,1,0.686180055485584,0,18,low-density lipoprotein particle clearance,BP,
9417,GO:0034384,1,0.82348543913282,0,9,high-density lipoprotein particle clearance,BP,
9419,GO:0034388,1,0.881701365645608,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9420,GO:0034389,1,0.72798000965823,0,15,lipid particle organization,BP,
9424,GO:0034393,1,0.842494766588972,0,8,positive regulation of smooth muscle cell apoptotic process,BP,
9426,GO:0034395,1,0.958112074854578,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9427,GO:0034397,1,0.763199028066035,0,13,telomere localization,BP,
9428,GO:0034398,1,0.881326960753041,0,6,telomere tethering at nuclear periphery,BP,
9430,GO:0034402,1,0.959576739315882,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9432,GO:0034414,1,0.958378248755042,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9433,GO:0034416,1,0.979042395172386,0,1,bisphosphoglycerate phosphatase activity,MF,
9434,GO:0034417,1,0.979042395172386,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9436,GO:0034421,1,0.938524876721736,0,3,post-translational protein acetylation,BP,
9437,GO:0034423,1,0.978996739951282,0,1,autophagosome lumen,CC,
9438,GO:0034427,1,0.860337044385941,0,7,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9439,GO:0034431,1,0.918287180998757,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9440,GO:0034432,1,0.918287180998757,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9446,GO:0034439,1,0.958027874128062,0,2,lipoprotein lipid oxidation,BP,
9448,GO:0034441,1,0.93708938652342,0,3,plasma lipoprotein oxidation,BP,
9449,GO:0034442,1,0.917314222444418,0,4,regulation of lipoprotein oxidation,BP,
9450,GO:0034443,1,0.936928181528854,0,3,negative regulation of lipoprotein oxidation,BP,
9451,GO:0034444,1,0.957507499692759,0,2,regulation of plasma lipoprotein oxidation,BP,
9452,GO:0034445,1,0.957507499692759,0,2,negative regulation of plasma lipoprotein oxidation,BP,
9455,GO:0034448,1,0.978685241370659,0,1,EGO complex,CC,
9456,GO:0034450,1,0.764175840334116,0,13,ubiquitin-ubiquitin ligase activity,MF,
9457,GO:0034451,1,0.600834010199865,0,25,centriolar satellite,CC,
9460,GO:0034454,1,0.893042414989205,0,6,microtubule anchoring at centrosome,BP,
9461,GO:0034455,1,0.960282227134233,0,2,t-UTP complex,CC,
9462,GO:0034456,1,0.958127745093055,0,2,UTP-C complex,CC,
9463,GO:0034457,1,0.937330723883857,0,3,Mpp10 complex,CC,
9464,GO:0034458,1,0.978949972742984,0,1,3'-5' RNA helicase activity,MF,
9465,GO:0034462,1,0.978861317919528,0,1,small-subunit processome assembly,BP,
9466,GO:0034463,1,0.978465094800763,0,1,90S preribosome assembly,BP,
9467,GO:0034464,1,0.825802869079152,0,9,BBSome,CC,
9468,GO:0034465,1,0.919258481251323,0,4,response to carbon monoxide,BP,
9469,GO:0034466,1,0.979028690611766,0,1,chromaffin granule lumen,CC,
9471,GO:0034471,1,0.941642422121791,0,3,ncRNA 5'-end processing,BP,
9472,GO:0034472,1,0.843890682283104,0,8,snRNA 3'-end processing,BP,
9473,GO:0034474,1,0.981076583603102,0,1,U2 snRNA 3'-end processing,BP,
9474,GO:0034475,1,0.897444435889933,0,5,U4 snRNA 3'-end processing,BP,
9475,GO:0034477,1,0.97897493185122,0,1,U6 snRNA 3'-end processing,BP,
9476,GO:0034481,1,0.882523632476528,0,6,chondroitin sulfotransferase activity,MF,
9477,GO:0034483,1,0.731921943625831,0,15,heparan sulfate sulfotransferase activity,MF,
9478,GO:0034485,1,0.919359812671895,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9479,GO:0034486,1,0.978771906698635,0,1,vacuolar transmembrane transport,BP,
9480,GO:0034497,1,0.865755876838053,0,7,protein localization to pre-autophagosomal structure,BP,
9481,GO:0034498,1,0.865556020449525,0,7,early endosome to Golgi transport,BP,
9482,GO:0034499,1,0.960869135132568,0,2,late endosome to Golgi transport,BP,
9483,GO:0034501,1,0.726440779013089,0,15,protein localization to kinetochore,BP,
9484,GO:0034502,1,0.2674797579083,0,63,protein localization to chromosome,BP,
9487,GO:0034506,1,0.979115455454884,0,1,chromosome, centromeric core domain,CC,
9488,GO:0034508,1,0.353671806972582,0,49,centromere complex assembly,BP,
9489,GO:0034511,1,0.901510103157363,0,5,U3 snoRNA binding,MF,
9490,GO:0034513,1,0.897459207646562,0,5,box H/ACA snoRNA binding,MF,
9491,GO:0034516,1,0.978578941609564,0,1,response to vitamin B6,BP,
9492,GO:0034518,1,0.760915571720578,0,13,RNA cap binding complex,CC,
9493,GO:0034545,1,0.978635797103521,0,1,fumarylpyruvate hydrolase activity,MF,
9494,GO:0034551,1,0.898328772976297,0,5,mitochondrial respiratory chain complex III assembly,BP,
9495,GO:0034552,1,0.95749122913801,0,2,respiratory chain complex II assembly,BP,
9496,GO:0034553,1,0.95749122913801,0,2,mitochondrial respiratory chain complex II assembly,BP,
9497,GO:0034584,1,0.938523971114355,0,3,piRNA binding,MF,
9498,GO:0034587,1,0.711904346673221,0,16,piRNA metabolic process,BP,
9499,GO:0034589,1,0.979197954218797,0,1,hydroxyproline transport,BP,
9500,GO:0034590,1,0.979197954218797,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9501,GO:0034593,1,0.584647429719967,0,26,phosphatidylinositol bisphosphate phosphatase activity,MF,
9502,GO:0034594,1,0.881733494109986,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9503,GO:0034595,1,0.76445720189963,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9504,GO:0034596,1,0.814068345330008,0,10,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9505,GO:0034597,1,0.920047100760158,0,4,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9507,GO:0034602,1,0.979198899061688,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9508,GO:0034603,1,0.879972665167519,0,6,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9509,GO:0034604,1,0.879972665167519,0,6,pyruvate dehydrogenase (NAD+) activity,MF,
9514,GO:0034616,1,0.746561665090944,0,14,response to laminar fluid shear stress,BP,
9515,GO:0034617,1,0.920487105094466,0,4,tetrahydrobiopterin binding,MF,
9516,GO:0034618,1,0.882005715784134,0,6,arginine binding,MF,
9519,GO:0034625,1,0.937519149984244,0,3,fatty acid elongation, monounsaturated fatty acid,BP,
9520,GO:0034626,1,0.91842365723149,0,4,fatty acid elongation, polyunsaturated fatty acid,BP,
9521,GO:0034627,1,0.918862165940321,0,4,'de novo' NAD biosynthetic process,BP,
9522,GO:0034628,1,0.939027367313167,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9526,GO:0034634,1,0.9806206324592,0,1,glutathione transmembrane transporter activity,MF,
9527,GO:0034635,1,0.959790645109948,0,2,glutathione transport,BP,
9531,GO:0034643,1,0.707975193811636,0,17,establishment of mitochondrion localization, microtubule-mediated,BP,
9534,GO:0034647,1,0.964757965052805,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9535,GO:0034648,1,0.924806113707175,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9536,GO:0034649,1,0.97909142341218,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9539,GO:0034653,1,0.917858529454904,0,4,retinoic acid catabolic process,BP,
9542,GO:0034656,1,0.861256238762595,0,7,nucleobase-containing small molecule catabolic process,BP,
9543,GO:0034657,1,0.939217954886403,0,3,GID complex,CC,
9545,GO:0034661,1,0.618980388565377,0,23,ncRNA catabolic process,BP,
9546,GO:0034663,1,0.808190993627729,0,10,endoplasmic reticulum chaperone complex,CC,
9547,GO:0034665,1,0.958962276052779,0,2,integrin alpha1-beta1 complex,CC,
9548,GO:0034666,1,0.941055569152285,0,3,integrin alpha2-beta1 complex,CC,
9550,GO:0034668,1,0.979097893275581,0,1,integrin alpha4-beta1 complex,CC,
9551,GO:0034669,1,0.959825330700505,0,2,integrin alpha4-beta7 complex,CC,
9552,GO:0034670,1,0.983046059898094,0,1,chemotaxis to arachidonic acid,BP,
9553,GO:0034673,1,0.940169732677519,0,3,inhibin-betaglycan-ActRII complex,CC,
9554,GO:0034676,1,0.980130308344298,0,1,integrin alpha6-beta4 complex,CC,
9555,GO:0034677,1,0.979078865721107,0,1,integrin alpha7-beta1 complex,CC,
9556,GO:0034678,1,0.938764827987755,0,3,integrin alpha8-beta1 complex,CC,
9557,GO:0034679,1,0.979106439920717,0,1,integrin alpha9-beta1 complex,CC,
9558,GO:0034680,1,0.959204993502341,0,2,integrin alpha10-beta1 complex,CC,
9559,GO:0034681,1,0.959091565806959,0,2,integrin alpha11-beta1 complex,CC,
9560,GO:0034683,1,0.960918254253845,0,2,integrin alphav-beta3 complex,CC,
9562,GO:0034685,1,0.960345078712923,0,2,integrin alphav-beta6 complex,CC,
9564,GO:0034687,1,0.959121804489236,0,2,integrin alphaL-beta2 complex,CC,
9565,GO:0034693,1,0.978942674614775,0,1,U11/U12 snRNP,CC,
9575,GO:0034706,1,0.672814559103234,0,20,sodium channel complex,CC,
9577,GO:0034708,1,0.17627500260572,0,83,methyltransferase complex,CC,
9578,GO:0034709,1,0.771257493587578,0,12,methylosome,CC,
9579,GO:0034711,1,0.899418359007065,0,5,inhibin binding,MF,
9580,GO:0034713,1,0.82994466911267,0,9,type I transforming growth factor beta receptor binding,MF,
9581,GO:0034714,1,0.938899101029987,0,3,type III transforming growth factor beta receptor binding,MF,
9582,GO:0034715,1,0.877961437315817,0,6,pICln-Sm protein complex,CC,
9583,GO:0034718,1,0.979872659751557,0,1,SMN-Gemin2 complex,CC,
9584,GO:0034719,1,0.69396986539871,0,17,SMN-Sm protein complex,CC,
9585,GO:0034720,1,0.888738422367921,0,6,histone H3-K4 demethylation,BP,
9586,GO:0034721,1,0.964757965052805,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9587,GO:0034722,1,0.978580351674024,0,1,gamma-glutamyl-peptidase activity,MF,
9588,GO:0034723,1,0.501195504746103,0,32,DNA replication-dependent nucleosome organization,BP,
9589,GO:0034724,1,0.352747272994107,0,49,DNA replication-independent nucleosome organization,BP,
9590,GO:0034727,1,0.958830273278206,0,2,piecemeal microautophagy of nucleus,BP,
9591,GO:0034728,1,0.0334898367623217,0,159,nucleosome organization,BP,
9592,GO:0034729,1,0.940351201653171,0,3,histone H3-K79 methylation,BP,
9593,GO:0034736,1,0.958303938025404,0,2,cholesterol O-acyltransferase activity,MF,
9594,GO:0034739,1,0.957837679302838,0,2,histone deacetylase activity (H4-K16 specific),MF,
9595,GO:0034750,1,0.959208196897048,0,2,Scrib-APC-beta-catenin complex,CC,
9596,GO:0034751,1,0.939266525207782,0,3,aryl hydrocarbon receptor complex,CC,
9597,GO:0034752,1,0.980502499122696,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9598,GO:0034753,1,0.980502499122696,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9601,GO:0034756,1,0.920341433328991,0,4,regulation of iron ion transport,BP,
9602,GO:0034757,1,0.961011371662238,0,2,negative regulation of iron ion transport,BP,
9603,GO:0034758,1,0.957684554525506,0,2,positive regulation of iron ion transport,BP,
9604,GO:0034759,1,0.961011371662238,0,2,regulation of iron ion transmembrane transport,BP,
9605,GO:0034760,1,0.961011371662238,0,2,negative regulation of iron ion transmembrane transport,BP,
9612,GO:0034769,1,0.958365608114136,0,2,basement membrane disassembly,BP,
9613,GO:0034770,1,0.891179597952804,0,6,histone H4-K20 methylation,BP,
9614,GO:0034773,1,0.922183479059962,0,4,histone H4-K20 trimethylation,BP,
9616,GO:0034775,1,0.9806206324592,0,1,glutathione transmembrane transport,BP,
9617,GO:0034776,1,0.812136443856191,0,10,response to histamine,BP,
9618,GO:0034875,1,0.918159172829805,0,4,caffeine oxidase activity,MF,
9619,GO:0034899,1,0.978791256503603,0,1,trimethylamine monooxygenase activity,MF,
9620,GO:0034959,1,0.979657696042131,0,1,endothelin maturation,BP,
9621,GO:0034963,1,0.978515364646893,0,1,box C/D snoRNA processing,BP,
9622,GO:0034964,1,0.978980630239622,0,1,box H/ACA snoRNA processing,BP,
9623,GO:0034968,1,0.139105261960316,0,96,histone lysine methylation,BP,
9624,GO:0034969,1,0.790934481915652,0,11,histone arginine methylation,BP,
9625,GO:0034970,1,0.958493911895576,0,2,histone H3-R2 methylation,BP,
9626,GO:0034971,1,0.958319846634719,0,2,histone H3-R17 methylation,BP,
9627,GO:0034972,1,0.97884417678277,0,1,histone H3-R26 methylation,BP,
9628,GO:0034975,1,0.775211491342453,0,12,protein folding in endoplasmic reticulum,BP,
9630,GO:0034979,1,0.730988687233617,0,15,NAD-dependent protein deacetylase activity,MF,
9631,GO:0034982,1,0.809510243697783,0,10,mitochondrial protein processing,BP,
9632,GO:0034983,1,0.864743214238647,0,7,peptidyl-lysine deacetylation,BP,
9633,GO:0034986,1,0.981188723353756,0,1,iron chaperone activity,MF,
9634,GO:0034987,1,0.882454509455633,0,6,immunoglobulin receptor binding,MF,
9635,GO:0034988,1,0.961499658896956,0,2,Fc-gamma receptor I complex binding,MF,
9636,GO:0034991,1,0.918499875695118,0,4,nuclear meiotic cohesin complex,CC,
9637,GO:0034992,1,0.875322504584481,0,7,microtubule organizing center attachment site,CC,
9638,GO:0034993,1,0.875322504584481,0,7,LINC complex,CC,
9639,GO:0034998,1,0.97897493185122,0,1,oligosaccharyltransferase I complex,CC,
9640,GO:0035003,1,0.978878592329253,0,1,subapical complex,CC,
9645,GO:0035020,1,0.784266588782938,0,12,regulation of Rac protein signal transduction,BP,
9646,GO:0035021,1,0.924638175516617,0,4,negative regulation of Rac protein signal transduction,BP,
9647,GO:0035022,1,0.959750626488599,0,2,positive regulation of Rac protein signal transduction,BP,
9650,GO:0035025,1,0.593166204607504,0,25,positive regulation of Rho protein signal transduction,BP,
9651,GO:0035026,1,0.958835601082681,0,2,leading edge cell differentiation,BP,
9652,GO:0035032,1,0.880636843465795,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9653,GO:0035033,1,0.938422829024415,0,3,histone deacetylase regulator activity,MF,
9654,GO:0035034,1,0.958304456924211,0,2,histone acetyltransferase regulator activity,MF,
9655,GO:0035035,1,0.586068698574778,0,26,histone acetyltransferase binding,MF,
9656,GO:0035036,1,0.382450449091897,0,45,sperm-egg recognition,BP,
9657,GO:0035037,1,0.979291587455191,0,1,sperm entry,BP,
9658,GO:0035038,1,0.958391971017601,0,2,female pronucleus assembly,BP,
9659,GO:0035039,1,0.95780603195713,0,2,male pronucleus assembly,BP,
9660,GO:0035041,1,0.978465289722523,0,1,sperm chromatin decondensation,BP,
9661,GO:0035042,1,0.978465289722523,0,1,fertilization, exchange of chromosomal proteins,BP,
9662,GO:0035048,1,0.979074123546179,0,1,splicing factor protein import into nucleus,BP,
9666,GO:0035061,1,0.940419179226154,0,3,interchromatin granule,CC,
9667,GO:0035063,1,0.964979893870182,0,2,nuclear speck organization,BP,
9668,GO:0035064,1,0.332580340175696,0,53,methylated histone binding,MF,
9671,GO:0035067,1,0.715425334686976,0,16,negative regulation of histone acetylation,BP,
9672,GO:0035068,1,0.882740819416653,0,6,micro-ribonucleoprotein complex,CC,
9673,GO:0035082,1,0.421018467773008,0,42,axoneme assembly,BP,
9674,GO:0035087,1,0.921979313151501,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9677,GO:0035090,1,0.777952362474579,0,12,maintenance of apical/basal cell polarity,BP,
9679,GO:0035092,1,0.847722789669108,0,8,sperm chromatin condensation,BP,
9680,GO:0035093,1,0.923425443408508,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9682,GO:0035095,1,0.867249049668514,0,7,behavioral response to nicotine,BP,
9683,GO:0035097,1,0.271720321925022,0,63,histone methyltransferase complex,CC,
9684,GO:0035098,1,0.701422044857618,0,17,ESC/E(Z) complex,CC,
9685,GO:0035101,1,0.93863426518809,0,3,FACT complex,CC,
9686,GO:0035102,1,0.779888705897568,0,12,PRC1 complex,CC,
9687,GO:0035105,1,0.979066829814998,0,1,sterol regulatory element binding protein import into nucleus,BP,
9688,GO:0035106,1,0.938371698088491,0,3,operant conditioning,BP,
9695,GO:0035120,1,0.983993427542176,0,1,post-embryonic appendage morphogenesis,BP,
9696,GO:0035127,1,0.983993427542176,0,1,post-embryonic limb morphogenesis,BP,
9697,GO:0035128,1,0.983993427542176,0,1,post-embryonic forelimb morphogenesis,BP,
9700,GO:0035145,1,0.655087064794034,0,20,exon-exon junction complex,CC,
9704,GO:0035166,1,0.938817196058443,0,3,post-embryonic hemopoiesis,BP,
9705,GO:0035173,1,0.718348782036501,0,16,histone kinase activity,MF,
9706,GO:0035174,1,0.883062812932358,0,6,histone serine kinase activity,MF,
9707,GO:0035175,1,0.978645983729744,0,1,histone kinase activity (H3-S10 specific),MF,
9708,GO:0035176,1,0.383356022724541,0,47,social behavior,BP,
9709,GO:0035184,1,0.883964994606173,0,6,histone threonine kinase activity,MF,
9710,GO:0035188,1,0.979068924577401,0,1,hatching,BP,
9711,GO:0035189,1,0.938587949296697,0,3,Rb-E2F complex,CC,
9715,GO:0035197,1,0.848862325206142,0,8,siRNA binding,MF,
9716,GO:0035198,1,0.743824337400869,0,14,miRNA binding,MF,
9717,GO:0035226,1,0.97906423943737,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9718,GO:0035227,1,0.97906423943737,0,1,regulation of glutamate-cysteine ligase activity,BP,
9719,GO:0035229,1,0.97906423943737,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9723,GO:0035240,1,0.755772983181341,0,13,dopamine binding,MF,
9724,GO:0035241,1,0.938135766763169,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9725,GO:0035242,1,0.918150348574034,0,4,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9726,GO:0035243,1,0.938147926844816,0,3,protein-arginine omega-N symmetric methyltransferase activity,MF,
9727,GO:0035246,1,0.790991124938273,0,11,peptidyl-arginine N-methylation,BP,
9728,GO:0035247,1,0.861348050181723,0,7,peptidyl-arginine omega-N-methylation,BP,
9729,GO:0035248,1,0.979045568620893,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9733,GO:0035252,1,0.885604279994333,0,6,UDP-xylosyltransferase activity,MF,
9734,GO:0035253,1,0.848995547240121,0,8,ciliary rootlet,CC,
9735,GO:0035254,1,0.507765837416228,0,33,glutamate receptor binding,MF,
9736,GO:0035255,1,0.637028237296265,0,22,ionotropic glutamate receptor binding,MF,
9737,GO:0035256,1,0.882044519351234,0,6,G-protein coupled glutamate receptor binding,MF,
9739,GO:0035258,1,0.173770998293114,0,84,steroid hormone receptor binding,MF,
9740,GO:0035259,1,0.763122148878571,0,13,glucocorticoid receptor binding,MF,
9741,GO:0035261,1,0.966877054418608,0,2,external genitalia morphogenesis,BP,
9742,GO:0035262,1,0.961607863756859,0,2,gonad morphogenesis,BP,
9745,GO:0035267,1,0.688177462445896,0,18,NuA4 histone acetyltransferase complex,CC,
9750,GO:0035276,1,0.938827323140002,0,3,ethanol binding,MF,
9751,GO:0035278,1,0.771514260136751,0,13,miRNA mediated inhibition of translation,BP,
9752,GO:0035279,1,0.958484708903163,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9753,GO:0035280,1,0.866848488387598,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9754,GO:0035281,1,0.958779484153016,0,2,pre-miRNA export from nucleus,BP,
9756,GO:0035283,1,0.938101638526933,0,3,central nervous system segmentation,BP,
9757,GO:0035284,1,0.938101638526933,0,3,brain segmentation,BP,
9758,GO:0035290,1,0.93933917726541,0,3,trunk segmentation,BP,
9761,GO:0035299,1,0.979240238994296,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9768,GO:0035312,1,0.88062186328887,0,6,5'-3' exodeoxyribonuclease activity,MF,
9771,GO:0035325,1,0.826495209272142,0,9,Toll-like receptor binding,MF,
9772,GO:0035326,1,0.134736671979686,0,96,enhancer binding,MF,
9773,GO:0035327,1,0.642422795868741,0,21,transcriptionally active chromatin,CC,
9775,GO:0035330,1,0.837044608555339,0,9,regulation of hippo signaling,BP,
9776,GO:0035331,1,0.887888958697845,0,6,negative regulation of hippo signaling,BP,
9777,GO:0035332,1,0.982311937364933,0,1,positive regulation of hippo signaling,BP,
9782,GO:0035339,1,0.917538466761928,0,4,SPOTS complex,CC,
9783,GO:0035349,1,0.958375216158895,0,2,coenzyme A transmembrane transport,BP,
9784,GO:0035350,1,0.958369961268823,0,2,FAD transmembrane transport,BP,
9785,GO:0035354,1,0.958549368026365,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9786,GO:0035355,1,0.980215070096986,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9787,GO:0035356,1,0.861169049451228,0,7,cellular triglyceride homeostasis,BP,
9788,GO:0035357,1,0.659422971357189,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9789,GO:0035358,1,0.777120694808067,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9790,GO:0035359,1,0.938009720874619,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9791,GO:0035360,1,0.864360790394067,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9792,GO:0035363,1,0.958174623626593,0,2,histone locus body,CC,
9793,GO:0035368,1,0.9001773629345,0,5,selenocysteine insertion sequence binding,MF,
9794,GO:0035370,1,0.958302708163306,0,2,UBC13-UEV1A complex,CC,
9795,GO:0035371,1,0.714789480037125,0,17,microtubule plus-end,CC,
9796,GO:0035372,1,0.833134471315305,0,9,protein localization to microtubule,BP,
9797,GO:0035373,1,0.945650976597313,0,3,chondroitin sulfate proteoglycan binding,MF,
9798,GO:0035374,1,0.884126116239244,0,6,chondroitin sulfate binding,MF,
9799,GO:0035375,1,0.981582540346865,0,1,zymogen binding,MF,
9800,GO:0035376,1,0.824700126951424,0,9,sterol import,BP,
9801,GO:0035377,1,0.95986013273245,0,2,transepithelial water transport,BP,
9802,GO:0035378,1,0.958199838609608,0,2,carbon dioxide transmembrane transport,BP,
9803,GO:0035379,1,0.958199838609608,0,2,carbon dioxide transmembrane transporter activity,MF,
9804,GO:0035381,1,0.844090542648352,0,8,ATP-gated ion channel activity,MF,
9807,GO:0035385,1,0.8686602602017,0,7,Roundabout signaling pathway,BP,
9808,GO:0035397,1,0.958273883677671,0,2,helper T cell enhancement of adaptive immune response,BP,
9809,GO:0035400,1,0.979781768218683,0,1,histone tyrosine kinase activity,MF,
9810,GO:0035401,1,0.979781768218683,0,1,histone kinase activity (H3-Y41 specific),MF,
9811,GO:0035402,1,0.958510024114882,0,2,histone kinase activity (H3-T11 specific),MF,
9812,GO:0035403,1,0.96254722487705,0,2,histone kinase activity (H3-T6 specific),MF,
9813,GO:0035404,1,0.811132918853119,0,10,histone-serine phosphorylation,BP,
9814,GO:0035405,1,0.883964994606173,0,6,histone-threonine phosphorylation,BP,
9815,GO:0035406,1,0.979781768218683,0,1,histone-tyrosine phosphorylation,BP,
9816,GO:0035407,1,0.958510024114882,0,2,histone H3-T11 phosphorylation,BP,
9817,GO:0035408,1,0.96254722487705,0,2,histone H3-T6 phosphorylation,BP,
9818,GO:0035409,1,0.979781768218683,0,1,histone H3-Y41 phosphorylation,BP,
9819,GO:0035410,1,0.978524484651327,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9822,GO:0035413,1,0.800975444602354,0,11,positive regulation of catenin import into nucleus,BP,
9823,GO:0035414,1,0.795869672453343,0,11,negative regulation of catenin import into nucleus,BP,
9825,GO:0035419,1,0.958777438835055,0,2,activation of MAPK activity involved in innate immune response,BP,
9826,GO:0035425,1,0.938174942385059,0,3,autocrine signaling,BP,
9827,GO:0035426,1,0.901969917014743,0,5,extracellular matrix-cell signaling,BP,
9830,GO:0035435,1,0.685695635219941,0,18,phosphate ion transmembrane transport,BP,
9831,GO:0035437,1,0.808666915230786,0,10,maintenance of protein localization in endoplasmic reticulum,BP,
9832,GO:0035438,1,0.978639153821845,0,1,cyclic-di-GMP binding,MF,
9833,GO:0035441,1,0.942433375458721,0,3,cell migration involved in vasculogenesis,BP,
9834,GO:0035442,1,0.958081860797864,0,2,dipeptide transmembrane transport,BP,
9835,GO:0035443,1,0.9806206324592,0,1,tripeptide transmembrane transport,BP,
9836,GO:0035445,1,0.979065975813621,0,1,borate transmembrane transport,BP,
9838,GO:0035456,1,0.624335440081047,0,22,response to interferon-beta,BP,
9840,GO:0035458,1,0.74192892831459,0,14,cellular response to interferon-beta,BP,
9841,GO:0035459,1,0.812542112350003,0,10,cargo loading into vesicle,BP,
9842,GO:0035461,1,0.828780155101101,0,9,vitamin transmembrane transport,BP,
9843,GO:0035469,1,0.900417109485993,0,5,determination of pancreatic left/right asymmetry,BP,
9844,GO:0035470,1,0.957769312112087,0,2,positive regulation of vascular wound healing,BP,
9845,GO:0035472,1,0.979064947188827,0,1,choriogonadotropin hormone receptor activity,MF,
9846,GO:0035473,1,0.886110038765721,0,6,lipase binding,MF,
9847,GO:0035478,1,0.978873003281332,0,1,chylomicron binding,MF,
9848,GO:0035480,1,0.978513746666424,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9849,GO:0035481,1,0.978513746666424,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9850,GO:0035482,1,0.937071689682279,0,3,gastric motility,BP,
9851,GO:0035483,1,0.957537099094847,0,2,gastric emptying,BP,
9852,GO:0035490,1,0.979067424110744,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9853,GO:0035491,1,0.979067424110744,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9855,GO:0035494,1,0.938137428660333,0,3,SNARE complex disassembly,BP,
9856,GO:0035497,1,0.763506825943458,0,13,cAMP response element binding,MF,
9857,GO:0035498,1,0.97910198034312,0,1,carnosine metabolic process,BP,
9858,GO:0035499,1,0.97910198034312,0,1,carnosine biosynthetic process,BP,
9859,GO:0035500,1,0.958555878609433,0,2,MH2 domain binding,MF,
9860,GO:0035501,1,0.97903951762157,0,1,MH1 domain binding,MF,
9862,GO:0035504,1,0.978582423287099,0,1,regulation of myosin light chain kinase activity,BP,
9863,GO:0035505,1,0.978582423287099,0,1,positive regulation of myosin light chain kinase activity,BP,
9864,GO:0035507,1,0.867409698626762,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9865,GO:0035508,1,0.980005009635267,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9866,GO:0035509,1,0.902323769801698,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9867,GO:0035510,1,0.606398014163111,0,24,DNA dealkylation,BP,
9868,GO:0035511,1,0.898698752227274,0,5,oxidative DNA demethylation,BP,
9869,GO:0035513,1,0.918460980174297,0,4,oxidative RNA demethylation,BP,
9870,GO:0035514,1,0.958129468837486,0,2,DNA demethylase activity,MF,
9871,GO:0035515,1,0.918460980174297,0,4,oxidative RNA demethylase activity,MF,
9872,GO:0035516,1,0.979194394457685,0,1,oxidative DNA demethylase activity,MF,
9873,GO:0035517,1,0.958628442143659,0,2,PR-DUB complex,CC,
9874,GO:0035518,1,0.777020554260102,0,12,histone H2A monoubiquitination,BP,
9875,GO:0035519,1,0.918765797587645,0,4,protein K29-linked ubiquitination,BP,
9876,GO:0035520,1,0.831193612424066,0,9,monoubiquitinated protein deubiquitination,BP,
9877,GO:0035521,1,0.918826745680123,0,4,monoubiquitinated histone deubiquitination,BP,
9878,GO:0035522,1,0.918826745680123,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9879,GO:0035523,1,0.922774321633729,0,4,protein K29-linked deubiquitination,BP,
9880,GO:0035524,1,0.863419930073368,0,7,proline transmembrane transport,BP,
9881,GO:0035525,1,0.978980630239622,0,1,NF-kappaB p50/p65 complex,CC,
9882,GO:0035526,1,0.959033046768711,0,2,retrograde transport, plasma membrane to Golgi,BP,
9883,GO:0035529,1,0.900972628593395,0,5,NADH pyrophosphatase activity,MF,
9884,GO:0035538,1,0.979068990482086,0,1,carbohydrate response element binding,MF,
9885,GO:0035539,1,0.957695261884059,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9886,GO:0035542,1,0.826659481325234,0,9,regulation of SNARE complex assembly,BP,
9887,GO:0035543,1,0.978604222043234,0,1,positive regulation of SNARE complex assembly,BP,
9888,GO:0035544,1,0.959050509272114,0,2,negative regulation of SNARE complex assembly,BP,
9889,GO:0035545,1,0.979098206915309,0,1,determination of left/right asymmetry in nervous system,BP,
9890,GO:0035546,1,0.979044870566797,0,1,interferon-beta secretion,BP,
9891,GO:0035547,1,0.979044870566797,0,1,regulation of interferon-beta secretion,BP,
9892,GO:0035548,1,0.979044870566797,0,1,negative regulation of interferon-beta secretion,BP,
9893,GO:0035552,1,0.938099387755211,0,3,oxidative single-stranded DNA demethylation,BP,
9894,GO:0035553,1,0.938182246699872,0,3,oxidative single-stranded RNA demethylation,BP,
9896,GO:0035561,1,0.656162779269239,0,20,regulation of chromatin binding,BP,
9897,GO:0035562,1,0.847035038150052,0,8,negative regulation of chromatin binding,BP,
9898,GO:0035563,1,0.791321180781934,0,11,positive regulation of chromatin binding,BP,
9899,GO:0035564,1,0.922284667083179,0,4,regulation of kidney size,BP,
9900,GO:0035565,1,0.979034695035522,0,1,regulation of pronephros size,BP,
9901,GO:0035566,1,0.958620660236088,0,2,regulation of metanephros size,BP,
9903,GO:0035568,1,0.97897493185122,0,1,N-terminal peptidyl-proline methylation,BP,
9904,GO:0035570,1,0.97897493185122,0,1,N-terminal peptidyl-serine methylation,BP,
9905,GO:0035572,1,0.97897493185122,0,1,N-terminal peptidyl-serine dimethylation,BP,
9906,GO:0035573,1,0.97897493185122,0,1,N-terminal peptidyl-serine trimethylation,BP,
9907,GO:0035574,1,0.980366370141383,0,1,histone H4-K20 demethylation,BP,
9908,GO:0035575,1,0.980366370141383,0,1,histone demethylase activity (H4-K20 specific),MF,
9913,GO:0035581,1,0.852460755489849,0,8,sequestering of extracellular ligand from receptor,BP,
9914,GO:0035582,1,0.922667492636039,0,4,sequestering of BMP in extracellular matrix,BP,
9915,GO:0035583,1,0.948727792790758,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9917,GO:0035585,1,0.985554031958493,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9924,GO:0035594,1,0.918373430772953,0,4,ganglioside binding,MF,
9925,GO:0035596,1,0.958280528539516,0,2,methylthiotransferase activity,MF,
9926,GO:0035597,1,0.978768173256155,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9927,GO:0035598,1,0.979069140003123,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9928,GO:0035600,1,0.958280528539516,0,2,tRNA methylthiolation,BP,
9930,GO:0035602,1,0.979132033086062,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9931,GO:0035603,1,0.979132033086062,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9932,GO:0035604,1,0.979132033086062,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9933,GO:0035605,1,0.978540307307745,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9934,GO:0035606,1,0.957469453153377,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9935,GO:0035607,1,0.95958311957853,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9936,GO:0035608,1,0.844073550710671,0,8,protein deglutamylation,BP,
9937,GO:0035609,1,0.899417615929163,0,5,C-terminal protein deglutamylation,BP,
9938,GO:0035610,1,0.899786729296031,0,5,protein side chain deglutamylation,BP,
9939,GO:0035611,1,0.979041865645296,0,1,protein branching point deglutamylation,BP,
9941,GO:0035613,1,0.796996254575388,0,11,RNA stem-loop binding,MF,
9942,GO:0035614,1,0.937540430364685,0,3,snRNA stem-loop binding,MF,
9943,GO:0035615,1,0.794658598380249,0,11,clathrin adaptor activity,MF,
9944,GO:0035616,1,0.939551185167858,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9945,GO:0035617,1,0.939314871451359,0,3,stress granule disassembly,BP,
9946,GO:0035620,1,0.959771786794044,0,2,ceramide transporter activity,MF,
9947,GO:0035621,1,0.959035031864736,0,2,ER to Golgi ceramide transport,BP,
9948,GO:0035622,1,0.979096509992481,0,1,intrahepatic bile duct development,BP,
9952,GO:0035627,1,0.903360277485306,0,5,ceramide transport,BP,
9954,GO:0035631,1,0.791388610605474,0,11,CD40 receptor complex,CC,
9955,GO:0035633,1,0.919382550090616,0,4,maintenance of permeability of blood-brain barrier,BP,
9956,GO:0035634,1,0.899222051040379,0,5,response to stilbenoid,BP,
9959,GO:0035638,1,0.979411538762677,0,1,signal maturation,BP,
9962,GO:0035641,1,0.782453129670815,0,12,locomotory exploration behavior,BP,
9963,GO:0035642,1,0.979057678939984,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9964,GO:0035643,1,0.978642208365672,0,1,L-DOPA receptor activity,MF,
9965,GO:0035644,1,0.979060036388473,0,1,phosphoanandamide dephosphorylation,BP,
9966,GO:0035645,1,0.979190700017812,0,1,enteric smooth muscle cell differentiation,BP,
9972,GO:0035662,1,0.936974857262906,0,3,Toll-like receptor 4 binding,MF,
9973,GO:0035663,1,0.939201480588636,0,3,Toll-like receptor 2 binding,MF,
9974,GO:0035664,1,0.978672488126168,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9975,GO:0035665,1,0.978672488126168,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9977,GO:0035668,1,0.959426594426854,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9978,GO:0035669,1,0.959426594426854,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9979,GO:0035671,1,0.898704227642732,0,5,enone reductase activity,MF,
9980,GO:0035672,1,0.881736033726812,0,6,oligopeptide transmembrane transport,BP,
9981,GO:0035673,1,0.920322796579326,0,4,oligopeptide transmembrane transporter activity,MF,
9982,GO:0035674,1,0.958126370844499,0,2,tricarboxylic acid transmembrane transport,BP,
9983,GO:0035684,1,0.97847473781867,0,1,helper T cell extravasation,BP,
9984,GO:0035686,1,0.860725489026538,0,7,sperm fibrous sheath,CC,
9986,GO:0035691,1,0.958197109309229,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9987,GO:0035692,1,0.958539759974524,0,2,macrophage migration inhibitory factor receptor complex,CC,
9988,GO:0035693,1,0.978540113466399,0,1,NOS2-CD74 complex,CC,
9989,GO:0035694,1,0.918566233711089,0,4,mitochondrial protein catabolic process,BP,
9990,GO:0035695,1,0.979198899061688,0,1,mitophagy by induced vacuole formation,BP,
9991,GO:0035696,1,0.940197816298418,0,3,monocyte extravasation,BP,
9994,GO:0035700,1,0.958074456316929,0,2,astrocyte chemotaxis,BP,
9996,GO:0035704,1,0.97895542225611,0,1,helper T cell chemotaxis,BP,
9997,GO:0035705,1,0.97895542225611,0,1,T-helper 17 cell chemotaxis,BP,
9998,GO:0035708,1,0.979069541176219,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9999,GO:0035709,1,0.958353728735635,0,2,memory T cell activation,BP,
10001,GO:0035711,1,0.958041162767911,0,2,T-helper 1 cell activation,BP,
10002,GO:0035712,1,0.958575563274472,0,2,T-helper 2 cell activation,BP,
10003,GO:0035713,1,0.979069541176219,0,1,response to nitrogen dioxide,BP,
10004,GO:0035714,1,0.979069541176219,0,1,cellular response to nitrogen dioxide,BP,
10005,GO:0035717,1,0.979007108794475,0,1,chemokine (C-C motif) ligand 7 binding,MF,
10006,GO:0035718,1,0.978540113466399,0,1,macrophage migration inhibitory factor binding,MF,
10007,GO:0035720,1,0.939454007679882,0,3,intraciliary anterograde transport,BP,
10008,GO:0035721,1,0.835663059457286,0,9,intraciliary retrograde transport,BP,
10009,GO:0035722,1,0.940650758002608,0,3,interleukin-12-mediated signaling pathway,BP,
10010,GO:0035723,1,0.939860761293963,0,3,interleukin-15-mediated signaling pathway,BP,
10011,GO:0035724,1,0.980906807466197,0,1,CD24 biosynthetic process,BP,
10013,GO:0035726,1,0.862882336036448,0,7,common myeloid progenitor cell proliferation,BP,
10014,GO:0035727,1,0.918415724540273,0,4,lysophosphatidic acid binding,MF,
10017,GO:0035730,1,0.978490191368942,0,1,S-nitrosoglutathione binding,MF,
10018,GO:0035731,1,0.978490191368942,0,1,dinitrosyl-iron complex binding,MF,
10019,GO:0035732,1,0.978490191368942,0,1,nitric oxide storage,BP,
10020,GO:0035733,1,0.862967700246566,0,7,hepatic stellate cell activation,BP,
10021,GO:0035735,1,0.455943816567422,0,38,intraciliary transport involved in cilium assembly,BP,
10022,GO:0035739,1,0.89898129610375,0,5,CD4-positive, alpha-beta T cell proliferation,BP,
10023,GO:0035740,1,0.917841418415224,0,4,CD8-positive, alpha-beta T cell proliferation,BP,
10024,GO:0035743,1,0.756749009377269,0,13,CD4-positive, alpha-beta T cell cytokine production,BP,
10025,GO:0035744,1,0.957737127039205,0,2,T-helper 1 cell cytokine production,BP,
10026,GO:0035745,1,0.789744203881314,0,11,T-helper 2 cell cytokine production,BP,
10027,GO:0035746,1,0.978523494370587,0,1,granzyme A production,BP,
10029,GO:0035748,1,0.882179230060952,0,6,myelin sheath abaxonal region,CC,
10030,GO:0035749,1,0.881870202694681,0,6,myelin sheath adaxonal region,CC,
10031,GO:0035750,1,0.979827308600298,0,1,protein localization to myelin sheath abaxonal region,BP,
10032,GO:0035751,1,0.810064852263592,0,10,regulation of lysosomal lumen pH,BP,
10033,GO:0035752,1,0.978718994203744,0,1,lysosomal lumen pH elevation,BP,
10035,GO:0035755,1,0.978978646038796,0,1,cardiolipin hydrolase activity,MF,
10036,GO:0035757,1,0.978828085621426,0,1,chemokine (C-C motif) ligand 19 binding,MF,
10037,GO:0035758,1,0.978828085621426,0,1,chemokine (C-C motif) ligand 21 binding,MF,
10038,GO:0035759,1,0.957950998480773,0,2,mesangial cell-matrix adhesion,BP,
10042,GO:0035769,1,0.978520430518689,0,1,B cell chemotaxis across high endothelial venule,BP,
10044,GO:0035771,1,0.880249030692384,0,6,interleukin-4-mediated signaling pathway,BP,
10045,GO:0035772,1,0.978663692803811,0,1,interleukin-13-mediated signaling pathway,BP,
10046,GO:0035773,1,0.314195829570413,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
10047,GO:0035774,1,0.587573578785785,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
10048,GO:0035782,1,0.978523494370587,0,1,mature natural killer cell chemotaxis,BP,
10049,GO:0035783,1,0.979069541176219,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
10050,GO:0035786,1,0.97897493185122,0,1,protein complex oligomerization,BP,
10054,GO:0035790,1,0.940383394088292,0,3,platelet-derived growth factor receptor-alpha signaling pathway,BP,
10059,GO:0035799,1,0.919328678525649,0,4,ureter maturation,BP,
10060,GO:0035800,1,0.958090577928674,0,2,deubiquitinase activator activity,MF,
10063,GO:0035803,1,0.957581395623103,0,2,egg coat formation,BP,
10064,GO:0035805,1,0.978860101482976,0,1,egg coat,CC,
10067,GO:0035811,1,0.898900129017595,0,5,negative regulation of urine volume,BP,
10073,GO:0035822,1,0.920274093658276,0,4,gene conversion,BP,
10074,GO:0035825,1,0.405787541253759,0,43,reciprocal DNA recombination,BP,
10075,GO:0035826,1,0.901614994108937,0,5,rubidium ion transport,BP,
10076,GO:0035838,1,0.94066569166153,0,3,growing cell tip,CC,
10077,GO:0035841,1,0.960690517298582,0,2,new growing cell tip,CC,
10079,GO:0035845,1,0.831353384491713,0,9,photoreceptor cell outer segment organization,BP,
10080,GO:0035846,1,0.978874603830838,0,1,oviduct epithelium development,BP,
10081,GO:0035847,1,0.978874603830838,0,1,uterine epithelium development,BP,
10082,GO:0035849,1,0.978874603830838,0,1,nephric duct elongation,BP,
10084,GO:0035851,1,0.979057066521638,0,1,Krueppel-associated box domain binding,MF,
10085,GO:0035852,1,0.978874603830838,0,1,horizontal cell localization,BP,
10086,GO:0035853,1,0.979274432670041,0,1,chromosome passenger complex localization to spindle midzone,BP,
10087,GO:0035854,1,0.958093330495049,0,2,eosinophil fate commitment,BP,
10090,GO:0035860,1,0.884546232898386,0,6,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10091,GO:0035861,1,0.544031307033922,0,29,site of double-strand break,CC,
10092,GO:0035862,1,0.980330905715007,0,1,dITP metabolic process,BP,
10093,GO:0035863,1,0.980330905715007,0,1,dITP catabolic process,BP,
10094,GO:0035864,1,0.778260324778072,0,12,response to potassium ion,BP,
10095,GO:0035865,1,0.865061846206533,0,7,cellular response to potassium ion,BP,
10096,GO:0035867,1,0.927876609809588,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10098,GO:0035870,1,0.959258519830558,0,2,dITP diphosphatase activity,MF,
10099,GO:0035871,1,0.817619598586072,0,10,protein K11-linked deubiquitination,BP,
10100,GO:0035872,1,0.4906224207972,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10101,GO:0035873,1,0.88168593374972,0,6,lactate transmembrane transport,BP,
10104,GO:0035879,1,0.938421600045297,0,3,plasma membrane lactate transport,BP,
10105,GO:0035880,1,0.937976401385677,0,3,embryonic nail plate morphogenesis,BP,
10106,GO:0035881,1,0.843468808380543,0,8,amacrine cell differentiation,BP,
10109,GO:0035887,1,0.97865811077371,0,1,aortic smooth muscle cell differentiation,BP,
10110,GO:0035890,1,0.47820701894983,0,35,exit from host,BP,
10111,GO:0035891,1,0.47820701894983,0,35,exit from host cell,BP,
10112,GO:0035897,1,0.879811424821212,0,6,proteolysis in other organism,BP,
10113,GO:0035898,1,0.939089919839939,0,3,parathyroid hormone secretion,BP,
10117,GO:0035905,1,0.919324195581742,0,4,ascending aorta development,BP,
10120,GO:0035910,1,0.919324195581742,0,4,ascending aorta morphogenesis,BP,
10123,GO:0035915,1,0.978775852712716,0,1,pore formation in membrane of other organism,BP,
10124,GO:0035921,1,0.978797717913849,0,1,desmosome disassembly,BP,
10125,GO:0035922,1,0.958124296840337,0,2,foramen ovale closure,BP,
10127,GO:0035925,1,0.794654307392146,0,11,mRNA 3'-UTR AU-rich region binding,MF,
10128,GO:0035926,1,0.918651644703013,0,4,chemokine (C-C motif) ligand 2 secretion,BP,
10129,GO:0035927,1,0.898271056029986,0,5,RNA import into mitochondrion,BP,
10130,GO:0035928,1,0.937671130515087,0,3,rRNA import into mitochondrion,BP,
10135,GO:0035933,1,0.843470041622808,0,8,glucocorticoid secretion,BP,
10136,GO:0035934,1,0.937371154994862,0,3,corticosterone secretion,BP,
10137,GO:0035935,1,0.979069122397277,0,1,androgen secretion,BP,
10138,GO:0035936,1,0.960447489606326,0,2,testosterone secretion,BP,
10139,GO:0035938,1,0.939735290212418,0,3,estradiol secretion,BP,
10141,GO:0035945,1,0.978949972742984,0,1,mitochondrial ncRNA surveillance,BP,
10142,GO:0035946,1,0.978949972742984,0,1,mitochondrial mRNA surveillance,BP,
10143,GO:0035947,1,0.881556408314902,0,6,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10144,GO:0035948,1,0.918726291840399,0,4,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10147,GO:0035964,1,0.919661944786051,0,4,COPI-coated vesicle budding,BP,
10148,GO:0035965,1,0.880158121098221,0,6,cardiolipin acyl-chain remodeling,BP,
10152,GO:0035971,1,0.978523494370587,0,1,peptidyl-histidine dephosphorylation,BP,
10153,GO:0035973,1,0.925271200394789,0,4,aggrephagy,BP,
10154,GO:0035976,1,0.89817179034095,0,5,transcription factor AP-1 complex,CC,
10155,GO:0035977,1,0.92139791505583,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10156,GO:0035978,1,0.97903951762157,0,1,histone H2A-S139 phosphorylation,BP,
10157,GO:0035981,1,0.95832986037582,0,2,tongue muscle cell differentiation,BP,
10158,GO:0035983,1,0.939875151265417,0,3,response to trichostatin A,BP,
10159,GO:0035984,1,0.939875151265417,0,3,cellular response to trichostatin A,BP,
10160,GO:0035985,1,0.917656001576194,0,4,senescence-associated heterochromatin focus,CC,
10161,GO:0035986,1,0.937640763477814,0,3,senescence-associated heterochromatin focus assembly,BP,
10169,GO:0035995,1,0.936951435318527,0,4,detection of muscle stretch,BP,
10170,GO:0035998,1,0.978738765552603,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10171,GO:0035999,1,0.826785652989254,0,9,tetrahydrofolate interconversion,BP,
10172,GO:0036002,1,0.563627046439271,0,27,pre-mRNA binding,MF,
10174,GO:0036004,1,0.978525653916765,0,1,GAF domain binding,MF,
10175,GO:0036005,1,0.808269228781754,0,10,response to macrophage colony-stimulating factor,BP,
10176,GO:0036006,1,0.808269228781754,0,10,cellular response to macrophage colony-stimulating factor stimulus,BP,
10177,GO:0036009,1,0.978515364646893,0,1,protein-glutamine N-methyltransferase activity,MF,
10179,GO:0036015,1,0.900743246598735,0,5,response to interleukin-3,BP,
10180,GO:0036016,1,0.900743246598735,0,5,cellular response to interleukin-3,BP,
10181,GO:0036017,1,0.878974778005549,0,6,response to erythropoietin,BP,
10182,GO:0036018,1,0.898325306442821,0,5,cellular response to erythropoietin,BP,
10183,GO:0036019,1,0.672525576548489,0,19,endolysosome,CC,
10184,GO:0036020,1,0.748349264978845,0,14,endolysosome membrane,CC,
10185,GO:0036021,1,0.918283067369369,0,4,endolysosome lumen,CC,
10186,GO:0036022,1,0.937803874555906,0,3,limb joint morphogenesis,BP,
10187,GO:0036023,1,0.937803874555906,0,3,embryonic skeletal limb joint morphogenesis,BP,
10195,GO:0036031,1,0.978512021153067,0,1,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex,BP,
10196,GO:0036033,1,0.929350300029567,0,4,mediator complex binding,MF,
10197,GO:0036034,1,0.958349767606808,0,2,mediator complex assembly,BP,
10199,GO:0036037,1,0.710684136175236,0,16,CD8-positive, alpha-beta T cell activation,BP,
10200,GO:0036038,1,0.776528730002825,0,12,MKS complex,CC,
10202,GO:0036042,1,0.936995768405318,0,3,long-chain fatty acyl-CoA binding,MF,
10203,GO:0036046,1,0.97906712615959,0,1,protein demalonylation,BP,
10204,GO:0036047,1,0.97906712615959,0,1,peptidyl-lysine demalonylation,BP,
10205,GO:0036048,1,0.97906712615959,0,1,protein desuccinylation,BP,
10206,GO:0036049,1,0.97906712615959,0,1,peptidyl-lysine desuccinylation,BP,
10207,GO:0036053,1,0.979017667638585,0,1,glomerular endothelium fenestra,CC,
10208,GO:0036054,1,0.97906712615959,0,1,protein-malonyllysine demalonylase activity,MF,
10209,GO:0036055,1,0.97906712615959,0,1,protein-succinyllysine desuccinylase activity,MF,
10210,GO:0036056,1,0.84954207284822,0,8,filtration diaphragm,CC,
10211,GO:0036057,1,0.84954207284822,0,8,slit diaphragm,CC,
10212,GO:0036058,1,0.979115994377593,0,1,filtration diaphragm assembly,BP,
10213,GO:0036060,1,0.979115994377593,0,1,slit diaphragm assembly,BP,
10215,GO:0036065,1,0.62280302408215,0,23,fucosylation,BP,
10216,GO:0036066,1,0.797821893230866,0,11,protein O-linked fucosylation,BP,
10217,GO:0036071,1,0.979069191768179,0,1,N-glycan fucosylation,BP,
10220,GO:0036079,1,0.940200850030415,0,3,purine nucleotide-sugar transport,BP,
10221,GO:0036080,1,0.940200850030415,0,3,purine nucleotide-sugar transmembrane transporter activity,MF,
10222,GO:0036085,1,0.97897493185122,0,1,GDP-fucose import into Golgi lumen,BP,
10223,GO:0036088,1,0.978610737723817,0,1,D-serine catabolic process,BP,
10225,GO:0036090,1,0.957979559320375,0,2,cleavage furrow ingression,BP,
10228,GO:0036093,1,0.878981156648806,0,6,germ cell proliferation,BP,
10230,GO:0036100,1,0.918222249959032,0,4,leukotriene catabolic process,BP,
10231,GO:0036101,1,0.918222249959032,0,4,leukotriene B4 catabolic process,BP,
10232,GO:0036102,1,0.918222249959032,0,4,leukotriene B4 metabolic process,BP,
10233,GO:0036105,1,0.979071495839486,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10235,GO:0036111,1,0.979011610910436,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10236,GO:0036112,1,0.937983693857978,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10237,GO:0036114,1,0.978590547835434,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10238,GO:0036115,1,0.978590547835434,0,1,fatty-acyl-CoA catabolic process,BP,
10239,GO:0036116,1,0.978590547835434,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10240,GO:0036117,1,0.958207565453374,0,2,hyaluranon cable,CC,
10242,GO:0036119,1,0.663971405178509,0,20,response to platelet-derived growth factor,BP,
10243,GO:0036120,1,0.678189942179075,0,19,cellular response to platelet-derived growth factor stimulus,BP,
10244,GO:0036122,1,0.829731135867478,0,9,BMP binding,MF,
10245,GO:0036123,1,0.861323504530949,0,7,histone H3-K9 dimethylation,BP,
10246,GO:0036124,1,0.719416108690978,0,16,histone H3-K9 trimethylation,BP,
10247,GO:0036125,1,0.979062897628551,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10248,GO:0036126,1,0.221679594624598,0,71,sperm flagellum,CC,
10249,GO:0036128,1,0.842940081971386,0,8,CatSper complex,CC,
10250,GO:0036130,1,0.978524484651327,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10251,GO:0036131,1,0.978524484651327,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10252,GO:0036132,1,0.938715314236267,0,3,13-prostaglandin reductase activity,MF,
10253,GO:0036134,1,0.978804595812789,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10254,GO:0036135,1,0.960597264710646,0,2,Schwann cell migration,BP,
10255,GO:0036137,1,0.958233963409113,0,2,kynurenine aminotransferase activity,MF,
10256,GO:0036138,1,0.980999840732479,0,1,peptidyl-histidine hydroxylation,BP,
10257,GO:0036139,1,0.980999840732479,0,1,peptidyl-histidine dioxygenase activity,MF,
10258,GO:0036140,1,0.980999840732479,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10259,GO:0036143,1,0.978481155008299,0,1,kringle domain binding,MF,
10260,GO:0036145,1,0.978671378968208,0,1,dendritic cell homeostasis,BP,
10261,GO:0036146,1,0.958520778545755,0,2,cellular response to mycotoxin,BP,
10262,GO:0036148,1,0.697795938633107,0,17,phosphatidylglycerol acyl-chain remodeling,BP,
10267,GO:0036153,1,0.97903627015796,0,1,triglyceride acyl-chain remodeling,BP,
10268,GO:0036155,1,0.861512044518301,0,7,acylglycerol acyl-chain remodeling,BP,
10269,GO:0036156,1,0.970375645898504,0,2,inner dynein arm,CC,
10270,GO:0036157,1,0.906370515065024,0,5,outer dynein arm,CC,
10271,GO:0036158,1,0.779534164033515,0,12,outer dynein arm assembly,BP,
10272,GO:0036159,1,0.835228654874274,0,9,inner dynein arm assembly,BP,
10273,GO:0036164,1,0.978505780391867,0,1,cell-abiotic substrate adhesion,BP,
10275,GO:0036179,1,0.979026271635056,0,1,osteoclast maturation,BP,
10276,GO:0036194,1,0.957635683214443,0,2,muscle cell projection,CC,
10277,GO:0036195,1,0.957635683214443,0,2,muscle cell projection membrane,CC,
10279,GO:0036215,1,0.939110419753859,0,3,response to stem cell factor,BP,
10280,GO:0036216,1,0.939110419753859,0,3,cellular response to stem cell factor stimulus,BP,
10281,GO:0036219,1,0.978473282549746,0,1,GTP diphosphatase activity,MF,
10282,GO:0036220,1,0.978505974722881,0,1,ITP diphosphatase activity,MF,
10283,GO:0036222,1,0.978505974722881,0,1,XTP diphosphatase activity,MF,
10284,GO:0036228,1,0.958541491303086,0,2,protein targeting to nuclear inner membrane,BP,
10286,GO:0036233,1,0.958299027893936,0,2,glycine import,BP,
10287,GO:0036245,1,0.9584877307609,0,2,cellular response to menadione,BP,
10288,GO:0036250,1,0.978728428225461,0,1,peroxisome transport along microtubule,BP,
10290,GO:0036258,1,0.52765610179573,0,30,multivesicular body assembly,BP,
10291,GO:0036260,1,0.484865434654969,0,34,RNA capping,BP,
10292,GO:0036261,1,0.979074665154177,0,1,7-methylguanosine cap hypermethylation,BP,
10293,GO:0036265,1,0.91874131233653,0,4,RNA (guanine-N7)-methylation,BP,
10294,GO:0036266,1,0.978971945409171,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10295,GO:0036269,1,0.959513352390923,0,2,swimming behavior,BP,
10296,GO:0036284,1,0.978583206465222,0,1,tubulobulbar complex,CC,
10297,GO:0036289,1,0.884816639410935,0,6,peptidyl-serine autophosphorylation,BP,
10298,GO:0036290,1,0.979114178337418,0,1,protein trans-autophosphorylation,BP,
10299,GO:0036292,1,0.958082500228738,0,2,DNA rewinding,BP,
10302,GO:0036295,1,0.863225428404962,0,7,cellular response to increased oxygen levels,BP,
10304,GO:0036297,1,0.404328621542667,0,43,interstrand cross-link repair,BP,
10305,GO:0036301,1,0.918597391363523,0,4,macrophage colony-stimulating factor production,BP,
10306,GO:0036302,1,0.870346771528802,0,7,atrioventricular canal development,BP,
10307,GO:0036303,1,0.696869318635161,0,18,lymph vessel morphogenesis,BP,
10309,GO:0036305,1,0.98006315745336,0,1,ameloblast differentiation,BP,
10310,GO:0036306,1,0.978610287168351,0,1,embryonic heart tube elongation,BP,
10311,GO:0036309,1,0.972410331433954,0,2,protein localization to M-band,BP,
10312,GO:0036310,1,0.844105062949012,0,8,annealing helicase activity,MF,
10314,GO:0036313,1,0.958439284326099,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10315,GO:0036314,1,0.615051806506714,0,24,response to sterol,BP,
10316,GO:0036315,1,0.724953519892098,0,16,cellular response to sterol,BP,
10317,GO:0036317,1,0.97897493185122,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10318,GO:0036323,1,0.979409517014211,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10319,GO:0036324,1,0.958229604757762,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10320,GO:0036326,1,0.979409517014211,0,1,VEGF-A-activated receptor activity,MF,
10321,GO:0036327,1,0.979409517014211,0,1,VEGF-B-activated receptor activity,MF,
10322,GO:0036332,1,0.979409517014211,0,1,placental growth factor-activated receptor activity,MF,
10323,GO:0036333,1,0.978996601743249,0,1,hepatocyte homeostasis,BP,
10324,GO:0036335,1,0.979748392907758,0,1,intestinal stem cell homeostasis,BP,
10326,GO:0036337,1,0.920543403114341,0,4,Fas signaling pathway,BP,
10327,GO:0036338,1,0.938238199096648,0,3,viral membrane,CC,
10329,GO:0036343,1,0.979095761173409,0,1,psychomotor behavior,BP,
10331,GO:0036345,1,0.958140931853597,0,2,platelet maturation,BP,
10332,GO:0036351,1,0.978887691543403,0,1,histone H2A-K13 ubiquitination,BP,
10333,GO:0036352,1,0.978887691543403,0,1,histone H2A-K15 ubiquitination,BP,
10334,GO:0036353,1,0.958634554989945,0,2,histone H2A-K119 monoubiquitination,BP,
10335,GO:0036361,1,0.978948595150004,0,1,racemase activity, acting on amino acids and derivatives,MF,
10336,GO:0036363,1,0.958725890220384,0,2,transforming growth factor beta activation,BP,
10337,GO:0036367,1,0.958477094010263,0,2,light adaption,BP,
10338,GO:0036369,1,0.963255124042224,0,2,transcription factor catabolic process,BP,
10339,GO:0036371,1,0.981887173695178,0,1,protein localization to T-tubule,BP,
10340,GO:0036372,1,0.97849172945727,0,1,opsin transport,BP,
10341,GO:0036374,1,0.879355504618441,0,6,glutathione hydrolase activity,MF,
10343,GO:0036378,1,0.937924872326536,0,3,calcitriol biosynthetic process from calciol,BP,
10345,GO:0036387,1,0.95814743093924,0,2,pre-replicative complex,CC,
10346,GO:0036388,1,0.95814743093924,0,2,pre-replicative complex assembly,BP,
10347,GO:0036392,1,0.979075551884441,0,1,chemokine (C-C motif) ligand 20 production,BP,
10348,GO:0036393,1,0.979049233701702,0,1,thiocyanate peroxidase activity,MF,
10349,GO:0036396,1,0.918216078769904,0,4,MIS complex,CC,
10350,GO:0036398,1,0.958442685831601,0,2,TCR signalosome,CC,
10351,GO:0036399,1,0.979069145652555,0,1,TCR signalosome assembly,BP,
10352,GO:0036402,1,0.878183620556348,0,6,proteasome-activating ATPase activity,MF,
10353,GO:0036403,1,0.978994793226151,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10354,GO:0036404,1,0.983398169013766,0,1,conversion of ds siRNA to ss siRNA,BP,
10355,GO:0036413,1,0.958534604141979,0,2,histone H3-R26 citrullination,BP,
10356,GO:0036414,1,0.899451305808371,0,5,histone citrullination,BP,
10357,GO:0036435,1,0.938017221557381,0,3,K48-linked polyubiquitin binding,MF,
10358,GO:0036438,1,0.918653570026778,0,4,maintenance of lens transparency,BP,
10359,GO:0036440,1,0.979058019567663,0,1,citrate synthase activity,MF,
10360,GO:0036442,1,0.625592554512015,0,22,hydrogen-exporting ATPase activity,MF,
10361,GO:0036444,1,0.918674375422164,0,4,mitochondrial calcium uptake,BP,
10362,GO:0036445,1,0.765416164420853,0,13,neuronal stem cell division,BP,
10363,GO:0036446,1,0.939469567090022,0,3,myofibroblast differentiation,BP,
10364,GO:0036449,1,0.927233420727461,0,4,microtubule minus-end,CC,
10365,GO:0036452,1,0.562028772978302,0,27,ESCRT complex,CC,
10366,GO:0036454,1,0.902084856344771,0,5,growth factor complex,CC,
10367,GO:0036455,1,0.978509031324794,0,1,iron-sulfur transferase activity,MF,
10368,GO:0036457,1,0.947404645990238,0,3,keratohyalin granule,CC,
10369,GO:0036458,1,0.978838416629976,0,1,hepatocyte growth factor binding,MF,
10370,GO:0036459,1,0.105657169989621,0,109,thiol-dependent ubiquitinyl hydrolase activity,MF,
10375,GO:0036466,1,0.959188370692306,0,2,synaptic vesicle recycling via endosome,BP,
10376,GO:0036468,1,0.978766308543155,0,1,L-dopa decarboxylase activity,MF,
10377,GO:0036470,1,0.978487817470133,0,1,tyrosine 3-monooxygenase activator activity,MF,
10378,GO:0036471,1,0.978487817470133,0,1,cellular response to glyoxal,BP,
10380,GO:0036474,1,0.617345516338761,0,23,cell death in response to hydrogen peroxide,BP,
10381,GO:0036475,1,0.699766861043655,0,17,neuron death in response to oxidative stress,BP,
10382,GO:0036476,1,0.938576942511285,0,3,neuron death in response to hydrogen peroxide,BP,
10384,GO:0036478,1,0.978487817470133,0,1,L-dopa decarboxylase activator activity,MF,
10385,GO:0036479,1,0.982703479687859,0,1,peroxidase inhibitor activity,MF,
10386,GO:0036480,1,0.861871561513224,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10387,GO:0036481,1,0.879341766371429,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10388,GO:0036482,1,0.957942545336479,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10389,GO:0036483,1,0.979311342074061,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10390,GO:0036484,1,0.93933917726541,0,3,trunk neural crest cell migration,BP,
10391,GO:0036486,1,0.93933917726541,0,3,ventral trunk neural crest cell migration,BP,
10392,GO:0036487,1,0.982396170646631,0,1,nitric-oxide synthase inhibitor activity,MF,
10393,GO:0036488,1,0.957633873425643,0,2,CHOP-C/EBP complex,CC,
10395,GO:0036491,1,0.864205336878985,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10396,GO:0036492,1,0.864205336878985,0,7,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10397,GO:0036493,1,0.938882502486652,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10398,GO:0036494,1,0.979993567599058,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10399,GO:0036496,1,0.957938249814367,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10400,GO:0036497,1,0.978912378702394,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10402,GO:0036499,1,0.654249299116772,0,20,PERK-mediated unfolded protein response,BP,
10403,GO:0036500,1,0.808368229420569,0,10,ATF6-mediated unfolded protein response,BP,
10404,GO:0036501,1,0.979232555932096,0,1,UFD1-NPL4 complex,CC,
10405,GO:0036502,1,0.979066607357875,0,1,Derlin-1-VIMP complex,CC,
10406,GO:0036503,1,0.159464982899198,0,87,ERAD pathway,BP,
10407,GO:0036505,1,0.958435166666792,0,2,prosaposin receptor activity,MF,
10408,GO:0036506,1,0.94073606828228,0,3,maintenance of unfolded protein,BP,
10409,GO:0036507,1,0.607986213800843,0,24,protein demannosylation,BP,
10410,GO:0036508,1,0.607986213800843,0,24,protein alpha-1,2-demannosylation,BP,
10411,GO:0036509,1,0.958192597871163,0,2,trimming of terminal mannose on B branch,BP,
10412,GO:0036510,1,0.939439650907374,0,3,trimming of terminal mannose on C branch,BP,
10413,GO:0036511,1,0.958192597871163,0,2,trimming of first mannose on A branch,BP,
10414,GO:0036512,1,0.958192597871163,0,2,trimming of second mannose on A branch,BP,
10415,GO:0036513,1,0.793273239883037,0,11,Derlin-1 retrotranslocation complex,CC,
10420,GO:0036520,1,0.978874203964035,0,1,astrocyte-dopaminergic neuron signaling,BP,
10421,GO:0036524,1,0.978487817470133,0,1,protein deglycase activity,MF,
10422,GO:0036525,1,0.978487817470133,0,1,protein deglycation,BP,
10423,GO:0036526,1,0.978487817470133,0,1,peptidyl-cysteine deglycation,BP,
10424,GO:0036527,1,0.978487817470133,0,1,peptidyl-arginine deglycation,BP,
10425,GO:0036528,1,0.978487817470133,0,1,peptidyl-lysine deglycation,BP,
10426,GO:0036529,1,0.978487817470133,0,1,protein deglycation, glyoxal removal,BP,
10427,GO:0036530,1,0.978487817470133,0,1,protein deglycation, methylglyoxal removal,BP,
10428,GO:0036531,1,0.978487817470133,0,1,glutathione deglycation,BP,
10430,GO:0038002,1,0.979822506489083,0,1,endocrine signaling,BP,
10431,GO:0038003,1,0.807541146746617,0,10,opioid receptor signaling pathway,BP,
10432,GO:0038007,1,0.923100977957696,0,4,netrin-activated signaling pathway,BP,
10433,GO:0038009,1,0.978551592690055,0,1,regulation of signal transduction by receptor internalization,BP,
10434,GO:0038016,1,0.958398632925058,0,2,insulin receptor internalization,BP,
10435,GO:0038018,1,0.960431831527818,0,2,Wnt receptor catabolic process,BP,
10436,GO:0038021,1,0.979182764222996,0,1,leptin receptor activity,MF,
10438,GO:0038024,1,0.282883906119231,0,61,cargo receptor activity,MF,
10439,GO:0038025,1,0.958675895228798,0,2,reelin receptor activity,MF,
10440,GO:0038026,1,0.924068768685345,0,4,reelin-mediated signaling pathway,BP,
10441,GO:0038027,1,0.907356731817111,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10445,GO:0038033,1,0.900287873097089,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10447,GO:0038036,1,0.843114206657196,0,8,sphingosine-1-phosphate receptor activity,MF,
10448,GO:0038037,1,0.941543042822927,0,3,G-protein coupled receptor dimeric complex,CC,
10449,GO:0038038,1,0.980990140303235,0,1,G-protein coupled receptor homodimeric complex,CC,
10450,GO:0038039,1,0.95979055009661,0,2,G-protein coupled receptor heterodimeric complex,CC,
10451,GO:0038042,1,0.980990140303235,0,1,dimeric G-protein coupled receptor signaling pathway,BP,
10452,GO:0038043,1,0.958677047858791,0,2,interleukin-5-mediated signaling pathway,BP,
10453,GO:0038044,1,0.904603972067451,0,5,transforming growth factor-beta secretion,BP,
10454,GO:0038046,1,0.978668067987227,0,1,enkephalin receptor activity,MF,
10455,GO:0038047,1,0.978703372485861,0,1,morphine receptor activity,MF,
10456,GO:0038048,1,0.979541955829297,0,1,dynorphin receptor activity,MF,
10457,GO:0038049,1,0.965272141016744,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10458,GO:0038051,1,0.980777414568203,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10459,GO:0038052,1,0.959920434864099,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10469,GO:0038085,1,0.920861471931958,0,4,vascular endothelial growth factor binding,MF,
10470,GO:0038086,1,0.941122312547342,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10471,GO:0038089,1,0.881754928639084,0,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10472,GO:0038091,1,0.941122312547342,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10473,GO:0038092,1,0.747632062220639,0,14,nodal signaling pathway,BP,
10478,GO:0038097,1,0.979786513809616,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10479,GO:0038098,1,0.958368898643963,0,2,sequestering of BMP from receptor via BMP binding,BP,
10480,GO:0038100,1,0.961177543377272,0,2,nodal binding,MF,
10481,GO:0038101,1,0.978652610134473,0,1,sequestering of nodal from receptor via nodal binding,BP,
10482,GO:0038106,1,0.979064947188827,0,1,choriogonadotropin hormone binding,MF,
10483,GO:0038107,1,0.864198933247389,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10484,GO:0038108,1,0.91865054338644,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10485,GO:0038109,1,0.939110419753859,0,3,Kit signaling pathway,BP,
10486,GO:0038110,1,0.899346651675344,0,5,interleukin-2-mediated signaling pathway,BP,
10487,GO:0038111,1,0.957727840898024,0,2,interleukin-7-mediated signaling pathway,BP,
10488,GO:0038112,1,0.958417044128013,0,2,interleukin-8-mediated signaling pathway,BP,
10489,GO:0038113,1,0.978823939821561,0,1,interleukin-9-mediated signaling pathway,BP,
10490,GO:0038114,1,0.979069056272352,0,1,interleukin-21-mediated signaling pathway,BP,
10491,GO:0038115,1,0.978828085621426,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10492,GO:0038116,1,0.978828085621426,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10493,GO:0038117,1,0.978828085621426,0,1,C-C motif chemokine 19 receptor activity,MF,
10494,GO:0038118,1,0.978499877763531,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10495,GO:0038121,1,0.978828085621426,0,1,C-C motif chemokine 21 receptor activity,MF,
10496,GO:0038123,1,0.938040934590349,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10497,GO:0038124,1,0.919239288639565,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10500,GO:0038129,1,0.937949092505124,0,3,ERBB3 signaling pathway,BP,
10501,GO:0038131,1,0.978722796422645,0,1,neuregulin receptor activity,MF,
10503,GO:0038133,1,0.978774813819462,0,1,ERBB2-ERBB3 signaling pathway,BP,
10504,GO:0038145,1,0.899036586833905,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10505,GO:0038154,1,0.979068192413853,0,1,interleukin-11-mediated signaling pathway,BP,
10506,GO:0038155,1,0.958234281147425,0,2,interleukin-23-mediated signaling pathway,BP,
10507,GO:0038156,1,0.958560613317362,0,2,interleukin-3-mediated signaling pathway,BP,
10508,GO:0038158,1,0.958142552283566,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10509,GO:0038161,1,0.904710212461182,0,5,prolactin signaling pathway,BP,
10510,GO:0038162,1,0.958824828370306,0,2,erythropoietin-mediated signaling pathway,BP,
10511,GO:0038163,1,0.937587003920884,0,3,thrombopoietin-mediated signaling pathway,BP,
10512,GO:0038164,1,0.97907260952095,0,1,thrombopoietin receptor activity,MF,
10513,GO:0038165,1,0.922528057647551,0,4,oncostatin-M-mediated signaling pathway,BP,
10515,GO:0038167,1,0.979823244871979,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10516,GO:0038168,1,0.979823244871979,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10517,GO:0038169,1,0.89865920538142,0,5,somatostatin receptor signaling pathway,BP,
10518,GO:0038170,1,0.89865920538142,0,5,somatostatin signaling pathway,BP,
10519,GO:0038171,1,0.882400605948782,0,6,cannabinoid signaling pathway,BP,
10520,GO:0038172,1,0.958399103842022,0,2,interleukin-33-mediated signaling pathway,BP,
10521,GO:0038178,1,0.958313744906075,0,2,complement component C5a signaling pathway,BP,
10523,GO:0038180,1,0.851696789653462,0,8,nerve growth factor signaling pathway,BP,
10525,GO:0038182,1,0.978580351674024,0,1,G-protein coupled bile acid receptor activity,MF,
10527,GO:0038184,1,0.978580351674024,0,1,cell surface bile acid receptor signaling pathway,BP,
10528,GO:0038185,1,0.978819787817556,0,1,intracellular bile acid receptor signaling pathway,BP,
10530,GO:0038187,1,0.697290193644652,0,17,pattern recognition receptor activity,MF,
10531,GO:0038188,1,0.957895313509217,0,2,cholecystokinin signaling pathway,BP,
10532,GO:0038189,1,0.958459488358843,0,2,neuropilin signaling pathway,BP,
10533,GO:0038190,1,0.958459488358843,0,2,VEGF-activated neuropilin signaling pathway,BP,
10534,GO:0038191,1,0.980053194345808,0,1,neuropilin binding,MF,
10535,GO:0038192,1,0.978771491623365,0,1,gastric inhibitory peptide signaling pathway,BP,
10536,GO:0038193,1,0.978869190667263,0,1,thromboxane A2 signaling pathway,BP,
10537,GO:0038194,1,0.95806492675124,0,2,thyroid-stimulating hormone signaling pathway,BP,
10538,GO:0038195,1,0.978567236970161,0,1,urokinase plasminogen activator signaling pathway,BP,
10542,GO:0039003,1,0.958660096857259,0,2,pronephric field specification,BP,
10543,GO:0039007,1,0.979967307283971,0,1,pronephric nephron morphogenesis,BP,
10544,GO:0039008,1,0.979967307283971,0,1,pronephric nephron tubule morphogenesis,BP,
10545,GO:0039017,1,0.958660096857259,0,2,pattern specification involved in pronephros development,BP,
10546,GO:0039019,1,0.939340146707982,0,3,pronephric nephron development,BP,
10547,GO:0039020,1,0.959420872469947,0,2,pronephric nephron tubule development,BP,
10548,GO:0039022,1,0.979967307283971,0,1,pronephric duct development,BP,
10549,GO:0039023,1,0.979967307283971,0,1,pronephric duct morphogenesis,BP,
10550,GO:0039506,1,0.959145458173215,0,2,modulation by virus of host molecular function,BP,
10551,GO:0039507,1,0.959145458173215,0,2,suppression by virus of host molecular function,BP,
10552,GO:0039513,1,0.979027290815123,0,1,suppression by virus of host catalytic activity,BP,
10553,GO:0039516,1,0.979027290815123,0,1,modulation by virus of host catalytic activity,BP,
10554,GO:0039519,1,0.959924661156242,0,2,modulation by virus of host autophagy,BP,
10555,GO:0039520,1,0.979962369403722,0,1,induction by virus of host autophagy,BP,
10556,GO:0039521,1,0.979553690605078,0,1,suppression by virus of host autophagy,BP,
10557,GO:0039526,1,0.937806376967105,0,3,modulation by virus of host apoptotic process,BP,
10558,GO:0039528,1,0.635783804380453,0,22,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10559,GO:0039529,1,0.707519860898292,0,17,RIG-I signaling pathway,BP,
10560,GO:0039530,1,0.829115683421057,0,9,MDA-5 signaling pathway,BP,
10561,GO:0039531,1,0.71830776231939,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10562,GO:0039532,1,0.845426587967732,0,8,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10563,GO:0039533,1,0.884157456548562,0,6,regulation of MDA-5 signaling pathway,BP,
10564,GO:0039534,1,0.93795282822634,0,3,negative regulation of MDA-5 signaling pathway,BP,
10565,GO:0039535,1,0.749552637665498,0,14,regulation of RIG-I signaling pathway,BP,
10566,GO:0039536,1,0.882184187734378,0,6,negative regulation of RIG-I signaling pathway,BP,
10567,GO:0039552,1,0.979928280833746,0,1,RIG-I binding,MF,
10568,GO:0039650,1,0.979027290815123,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10569,GO:0039656,1,0.938104232154571,0,3,modulation by virus of host gene expression,BP,
10571,GO:0039689,1,0.938272786028124,0,3,negative stranded viral RNA replication,BP,
10572,GO:0039692,1,0.808849880204812,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10573,GO:0039694,1,0.630156631131193,0,22,viral RNA genome replication,BP,
10574,GO:0039702,1,0.63856527664789,0,21,viral budding via host ESCRT complex,BP,
10575,GO:0039703,1,0.630156631131193,0,22,RNA replication,BP,
10577,GO:0039713,1,0.979069369180422,0,1,viral factory,CC,
10578,GO:0039714,1,0.979069369180422,0,1,cytoplasmic viral factory,CC,
10582,GO:0040009,1,0.959433815927246,0,2,regulation of growth rate,BP,
10587,GO:0040015,1,0.814885723989159,0,10,negative regulation of multicellular organism growth,BP,
10588,GO:0040016,1,0.845530274360429,0,8,embryonic cleavage,BP,
10593,GO:0040023,1,0.769463717548397,0,13,establishment of nucleus localization,BP,
10595,GO:0040030,1,0.957998870716456,0,2,regulation of molecular function, epigenetic,BP,
10596,GO:0040031,1,0.897929833715297,0,5,snRNA modification,BP,
10597,GO:0040032,1,0.978714215252225,0,1,post-embryonic body morphogenesis,BP,
10598,GO:0040033,1,0.771514260136751,0,13,negative regulation of translation, ncRNA-mediated,BP,
10602,GO:0040038,1,0.940776685143815,0,3,polar body extrusion after meiotic divisions,BP,
10603,GO:0040040,1,0.980364083375552,0,1,thermosensory behavior,BP,
10604,GO:0042000,1,0.978925601400141,0,1,translocation of peptides or proteins into host,BP,
10605,GO:0042007,1,0.978562557802841,0,1,interleukin-18 binding,MF,
10606,GO:0042008,1,0.979069807012897,0,1,interleukin-18 receptor activity,MF,
10607,GO:0042011,1,0.979065666430272,0,1,interleukin-16 binding,MF,
10608,GO:0042012,1,0.979065666430272,0,1,interleukin-16 receptor activity,MF,
10609,GO:0042015,1,0.9381989377101,0,3,interleukin-20 binding,MF,
10610,GO:0042017,1,0.979034872466804,0,1,interleukin-22 binding,MF,
10611,GO:0042018,1,0.979034872466804,0,1,interleukin-22 receptor activity,MF,
10612,GO:0042019,1,0.958234281147425,0,2,interleukin-23 binding,MF,
10613,GO:0042020,1,0.958234281147425,0,2,interleukin-23 receptor activity,MF,
10614,GO:0042022,1,0.978752272893443,0,1,interleukin-12 receptor complex,CC,
10615,GO:0042023,1,0.868045312957829,0,7,DNA endoreduplication,BP,
10616,GO:0042025,1,0.938990697358365,0,3,host cell nucleus,CC,
10617,GO:0042026,1,0.599474955073543,0,24,protein refolding,BP,
10618,GO:0042030,1,0.92049861013599,0,4,ATPase inhibitor activity,MF,
10622,GO:0042040,1,0.979184544493128,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10623,GO:0042043,1,0.780267300109012,0,12,neurexin family protein binding,MF,
10626,GO:0042048,1,0.852241085283877,0,8,olfactory behavior,BP,
10627,GO:0042053,1,0.696869585183727,0,17,regulation of dopamine metabolic process,BP,
10628,GO:0042054,1,0.379268569998667,0,47,histone methyltransferase activity,MF,
10634,GO:0042069,1,0.696869585183727,0,17,regulation of catecholamine metabolic process,BP,
10635,GO:0042073,1,0.393525220898544,0,45,intraciliary transport,BP,
10637,GO:0042078,1,0.917690585099026,0,4,germ-line stem cell division,BP,
10638,GO:0042083,1,0.978605979430292,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10639,GO:0042084,1,0.983611382191265,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10642,GO:0042090,1,0.844952517348872,0,8,interleukin-12 biosynthetic process,BP,
10643,GO:0042091,1,0.938853561796631,0,3,interleukin-10 biosynthetic process,BP,
10644,GO:0042092,1,0.483210697173122,0,34,type 2 immune response,BP,
10646,GO:0042094,1,0.639117090935753,0,21,interleukin-2 biosynthetic process,BP,
10651,GO:0042101,1,0.666417073848792,0,19,T cell receptor complex,CC,
10654,GO:0042105,1,0.897561820582418,0,5,alpha-beta T cell receptor complex,CC,
10657,GO:0042109,1,0.937889554408554,0,3,lymphotoxin A biosynthetic process,BP,
10661,GO:0042117,1,0.842505249076345,0,8,monocyte activation,BP,
10662,GO:0042118,1,0.812158234201101,0,10,endothelial cell activation,BP,
10664,GO:0042126,1,0.918417558718355,0,4,nitrate metabolic process,BP,
10666,GO:0042128,1,0.978894734322725,0,1,nitrate assimilation,BP,
10669,GO:0042131,1,0.978964551934234,0,1,thiamine phosphate phosphatase activity,MF,
10670,GO:0042132,1,0.957589737571636,0,2,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10671,GO:0042133,1,0.542368291586424,0,29,neurotransmitter metabolic process,BP,
10672,GO:0042134,1,0.957704574202212,0,2,rRNA primary transcript binding,MF,
10673,GO:0042135,1,0.792470164048036,0,11,neurotransmitter catabolic process,BP,
10674,GO:0042136,1,0.699829681771837,0,17,neurotransmitter biosynthetic process,BP,
10675,GO:0042137,1,0.958221687299544,0,2,sequestering of neurotransmitter,BP,
10676,GO:0042138,1,0.898214787238678,0,5,meiotic DNA double-strand break formation,BP,
10677,GO:0042140,1,0.97897493185122,0,1,late meiotic recombination nodule assembly,BP,
10678,GO:0042144,1,0.958885939055001,0,2,vacuole fusion, non-autophagic,BP,
10680,GO:0042148,1,0.844121890644397,0,8,strand invasion,BP,
10685,GO:0042160,1,0.897750939711832,0,5,lipoprotein modification,BP,
10686,GO:0042161,1,0.897750939711832,0,5,lipoprotein oxidation,BP,
10687,GO:0042162,1,0.513946109118302,0,32,telomeric DNA binding,MF,
10688,GO:0042163,1,0.978566999549344,0,1,interleukin-12 beta subunit binding,MF,
10689,GO:0042164,1,0.978900931820457,0,1,interleukin-12 alpha subunit binding,MF,
10690,GO:0042165,1,0.627354496864644,0,22,neurotransmitter binding,MF,
10691,GO:0042166,1,0.697310514332632,0,17,acetylcholine binding,MF,
10692,GO:0042167,1,0.859825879827315,0,7,heme catabolic process,BP,
10694,GO:0042169,1,0.539104368571519,0,30,SH2 domain binding,MF,
10698,GO:0042177,1,0.1253180434201,0,99,negative regulation of protein catabolic process,BP,
10699,GO:0042178,1,0.806713180143333,0,10,xenobiotic catabolic process,BP,
10702,GO:0042182,1,0.860856932021829,0,7,ketone catabolic process,BP,
10703,GO:0042196,1,0.957777128664522,0,2,chlorinated hydrocarbon metabolic process,BP,
10704,GO:0042197,1,0.957777128664522,0,2,halogenated hydrocarbon metabolic process,BP,
10705,GO:0042214,1,0.958208371213656,0,2,terpene metabolic process,BP,
10710,GO:0042223,1,0.958544672326242,0,2,interleukin-3 biosynthetic process,BP,
10711,GO:0042225,1,0.978468779604703,0,1,interleukin-5 biosynthetic process,BP,
10712,GO:0042226,1,0.681333203582822,0,18,interleukin-6 biosynthetic process,BP,
10713,GO:0042228,1,0.758285713129641,0,13,interleukin-8 biosynthetic process,BP,
10714,GO:0042231,1,0.958736513158647,0,2,interleukin-13 biosynthetic process,BP,
10715,GO:0042241,1,0.979068802678644,0,1,interleukin-18 biosynthetic process,BP,
10716,GO:0042245,1,0.958613396662093,0,2,RNA repair,BP,
10718,GO:0042247,1,0.979054147488468,0,1,establishment of planar polarity of follicular epithelium,BP,
10720,GO:0042253,1,0.898502588573816,0,5,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10722,GO:0042255,1,0.360410455071509,0,48,ribosome assembly,BP,
10723,GO:0042256,1,0.89906810449456,0,5,mature ribosome assembly,BP,
10724,GO:0042262,1,0.897673742109553,0,5,DNA protection,BP,
10725,GO:0042264,1,0.960468387733802,0,2,peptidyl-aspartic acid hydroxylation,BP,
10726,GO:0042265,1,0.980999840732479,0,1,peptidyl-asparagine hydroxylation,BP,
10728,GO:0042268,1,0.824303935960937,0,9,regulation of cytolysis,BP,
10729,GO:0042269,1,0.517635274574821,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10730,GO:0042270,1,0.937763720564002,0,3,protection from natural killer cell mediated cytotoxicity,BP,
10731,GO:0042271,1,0.939084577733814,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10732,GO:0042272,1,0.92284775073995,0,4,nuclear RNA export factor complex,CC,
10733,GO:0042273,1,0.291554286199796,0,58,ribosomal large subunit biogenesis,BP,
10734,GO:0042274,1,0.272530994033031,0,61,ribosomal small subunit biogenesis,BP,
10735,GO:0042275,1,0.978587978480329,0,1,error-free postreplication DNA repair,BP,
10736,GO:0042276,1,0.659688876315156,0,20,error-prone translesion synthesis,BP,
10739,GO:0042281,1,0.958162439960461,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10740,GO:0042282,1,0.979288686738532,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10741,GO:0042284,1,0.957713116879264,0,2,sphingolipid delta-4 desaturase activity,MF,
10742,GO:0042285,1,0.885604279994333,0,6,xylosyltransferase activity,MF,
10743,GO:0042287,1,0.539004371630304,0,29,MHC protein binding,MF,
10744,GO:0042288,1,0.666370151256952,0,19,MHC class I protein binding,MF,
10745,GO:0042289,1,0.898897705468946,0,5,MHC class II protein binding,MF,
10746,GO:0042292,1,0.978939498239432,0,1,URM1 activating enzyme activity,MF,
10747,GO:0042296,1,0.917505995120412,0,4,ISG15 transferase activity,MF,
10755,GO:0042309,1,0.957981672411987,0,2,homoiothermy,BP,
10759,GO:0042316,1,0.979621893999958,0,1,penicillin metabolic process,BP,
10760,GO:0042320,1,0.879111383882358,0,6,regulation of circadian sleep/wake cycle, REM sleep,BP,
10762,GO:0042322,1,0.957467333103241,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10764,GO:0042324,1,0.978468313671559,0,1,hypocretin receptor binding,MF,
10768,GO:0042328,1,0.958581965528354,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10770,GO:0042335,1,0.940661923959098,0,3,cuticle development,BP,
10774,GO:0042346,1,0.599539641187001,0,24,positive regulation of NF-kappaB import into nucleus,BP,
10777,GO:0042350,1,0.937622022278049,0,3,GDP-L-fucose biosynthetic process,BP,
10778,GO:0042351,1,0.957642278429082,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10779,GO:0042352,1,0.979096661434132,0,1,GDP-L-fucose salvage,BP,
10780,GO:0042354,1,0.832445582757759,0,9,L-fucose metabolic process,BP,
10781,GO:0042355,1,0.832445582757759,0,9,L-fucose catabolic process,BP,
10782,GO:0042356,1,0.978550427424545,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10783,GO:0042357,1,0.958029974561379,0,2,thiamine diphosphate metabolic process,BP,
10785,GO:0042360,1,0.91784522900928,0,4,vitamin E metabolic process,BP,
10786,GO:0042361,1,0.958416238861122,0,2,menaquinone catabolic process,BP,
10788,GO:0042363,1,0.825464204939106,0,9,fat-soluble vitamin catabolic process,BP,
10790,GO:0042365,1,0.957698073049933,0,2,water-soluble vitamin catabolic process,BP,
10792,GO:0042369,1,0.938387661797585,0,3,vitamin D catabolic process,BP,
10793,GO:0042371,1,0.979072572809886,0,1,vitamin K biosynthetic process,BP,
10794,GO:0042373,1,0.879136057017055,0,6,vitamin K metabolic process,BP,
10795,GO:0042374,1,0.937814598615085,0,3,phylloquinone metabolic process,BP,
10796,GO:0042376,1,0.937814598615085,0,3,phylloquinone catabolic process,BP,
10797,GO:0042377,1,0.958416238861122,0,2,vitamin K catabolic process,BP,
10799,GO:0042382,1,0.882038481188814,0,6,paraspeckles,CC,
10802,GO:0042392,1,0.958037753751773,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10803,GO:0042393,1,0.0228472808283357,0,180,histone binding,MF,
10804,GO:0042396,1,0.978598469313653,0,1,phosphagen biosynthetic process,BP,
10806,GO:0042401,1,0.636746224070965,0,21,cellular biogenic amine biosynthetic process,BP,
10808,GO:0042403,1,0.661127985304832,0,20,thyroid hormone metabolic process,BP,
10809,GO:0042404,1,0.978798551701089,0,1,thyroid hormone catabolic process,BP,
10810,GO:0042405,1,0.807168283446989,0,11,nuclear inclusion body,CC,
10811,GO:0042406,1,0.898501278123069,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10812,GO:0042407,1,0.773724414097679,0,12,cristae formation,BP,
10813,GO:0042412,1,0.958076872836173,0,2,taurine biosynthetic process,BP,
10814,GO:0042413,1,0.978953390235161,0,1,carnitine catabolic process,BP,
10816,GO:0042415,1,0.811456542438224,0,10,norepinephrine metabolic process,BP,
10817,GO:0042416,1,0.774654144859864,0,12,dopamine biosynthetic process,BP,
10820,GO:0042420,1,0.861710269483946,0,7,dopamine catabolic process,BP,
10821,GO:0042421,1,0.880254313772273,0,6,norepinephrine biosynthetic process,BP,
10823,GO:0042424,1,0.843661510383631,0,8,catecholamine catabolic process,BP,
10825,GO:0042427,1,0.937696337546721,0,3,serotonin biosynthetic process,BP,
10826,GO:0042428,1,0.804670598878836,0,11,serotonin metabolic process,BP,
10827,GO:0042430,1,0.583084135845671,0,26,indole-containing compound metabolic process,BP,
10828,GO:0042431,1,0.978863544526371,0,1,indole metabolic process,BP,
10829,GO:0042435,1,0.897910608181495,0,5,indole-containing compound biosynthetic process,BP,
10830,GO:0042436,1,0.790133589619033,0,11,indole-containing compound catabolic process,BP,
10832,GO:0042439,1,0.938409687842296,0,3,ethanolamine-containing compound metabolic process,BP,
10834,GO:0042441,1,0.918558470730941,0,4,eye pigment metabolic process,BP,
10839,GO:0042450,1,0.978754947980044,0,1,arginine biosynthetic process via ornithine,BP,
10840,GO:0042451,1,0.636583029245353,0,21,purine nucleoside biosynthetic process,BP,
10842,GO:0042455,1,0.433434227161617,0,39,ribonucleoside biosynthetic process,BP,
10848,GO:0042473,1,0.826478903779923,0,9,outer ear morphogenesis,BP,
10854,GO:0042483,1,0.920014245538074,0,4,negative regulation of odontogenesis,BP,
10856,GO:0042488,1,0.938777435630211,0,3,positive regulation of odontogenesis of dentin-containing tooth,BP,
10857,GO:0042489,1,0.958406598237282,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10862,GO:0042494,1,0.920332938907905,0,4,detection of bacterial lipoprotein,BP,
10863,GO:0042495,1,0.958549368026365,0,2,detection of triacyl bacterial lipopeptide,BP,
10864,GO:0042496,1,0.959697415313469,0,2,detection of diacyl bacterial lipopeptide,BP,
10865,GO:0042497,1,0.979069339559967,0,1,triacyl lipopeptide binding,MF,
10866,GO:0042500,1,0.900189925564186,0,5,aspartic endopeptidase activity, intramembrane cleaving,MF,
10868,GO:0042502,1,0.97897493185122,0,1,tyrosine phosphorylation of Stat2 protein,BP,
10870,GO:0042504,1,0.898453576237959,0,5,tyrosine phosphorylation of Stat4 protein,BP,
10871,GO:0042505,1,0.937585990043303,0,3,tyrosine phosphorylation of Stat6 protein,BP,
10877,GO:0042512,1,0.937531335709154,0,3,negative regulation of tyrosine phosphorylation of Stat1 protein,BP,
10880,GO:0042518,1,0.862648478741182,0,7,negative regulation of tyrosine phosphorylation of Stat3 protein,BP,
10881,GO:0042519,1,0.898453576237959,0,5,regulation of tyrosine phosphorylation of Stat4 protein,BP,
10882,GO:0042520,1,0.917668247505817,0,4,positive regulation of tyrosine phosphorylation of Stat4 protein,BP,
10883,GO:0042521,1,0.979066267315481,0,1,negative regulation of tyrosine phosphorylation of Stat4 protein,BP,
10886,GO:0042524,1,0.939196161583807,0,3,negative regulation of tyrosine phosphorylation of Stat5 protein,BP,
10887,GO:0042525,1,0.937585990043303,0,3,regulation of tyrosine phosphorylation of Stat6 protein,BP,
10888,GO:0042526,1,0.958048514685267,0,2,positive regulation of tyrosine phosphorylation of Stat6 protein,BP,
10889,GO:0042527,1,0.978643918776184,0,1,negative regulation of tyrosine phosphorylation of Stat6 protein,BP,
10891,GO:0042532,1,0.809176994769672,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10892,GO:0042533,1,0.669052347322659,0,19,tumor necrosis factor biosynthetic process,BP,
10893,GO:0042534,1,0.669052347322659,0,19,regulation of tumor necrosis factor biosynthetic process,BP,
10894,GO:0042535,1,0.79430529552066,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10895,GO:0042536,1,0.878978320573188,0,6,negative regulation of tumor necrosis factor biosynthetic process,BP,
10898,GO:0042539,1,0.96088722095183,0,2,hypotonic salinity response,BP,
10899,GO:0042541,1,0.824856128388375,0,9,hemoglobin biosynthetic process,BP,
10901,GO:0042543,1,0.978467622475152,0,1,protein N-linked glycosylation via arginine,BP,
10902,GO:0042546,1,0.978668801600268,0,1,cell wall biogenesis,BP,
10906,GO:0042555,1,0.791935462061261,0,11,MCM complex,CC,
10909,GO:0042560,1,0.940232986470804,0,3,pteridine-containing compound catabolic process,BP,
10911,GO:0042564,1,0.979218491485834,0,1,NLS-dependent protein nuclear import complex,CC,
10912,GO:0042565,1,0.958779484153016,0,2,RNA nuclear export complex,CC,
10913,GO:0042567,1,0.921918977760817,0,4,insulin-like growth factor ternary complex,CC,
10914,GO:0042568,1,0.978490761166356,0,1,insulin-like growth factor binary complex,CC,
10915,GO:0042571,1,0.957906534000973,0,2,immunoglobulin complex, circulating,CC,
10917,GO:0042573,1,0.624947941459818,0,22,retinoic acid metabolic process,BP,
10918,GO:0042574,1,0.791716658522704,0,11,retinal metabolic process,BP,
10919,GO:0042575,1,0.705998927853497,0,17,DNA polymerase complex,CC,
10920,GO:0042577,1,0.95835438187703,0,2,lipid phosphatase activity,MF,
10926,GO:0042584,1,0.885448926350554,0,6,chromaffin granule membrane,CC,
10927,GO:0042585,1,0.958485515274893,0,2,germinal vesicle,CC,
10928,GO:0042586,1,0.978513456226706,0,1,peptide deformylase activity,MF,
10931,GO:0042589,1,0.793822562670793,0,11,zymogen granule membrane,CC,
10936,GO:0042595,1,0.958020985252534,0,2,behavioral response to starvation,BP,
10937,GO:0042596,1,0.510280720135924,0,32,fear response,BP,
10938,GO:0042599,1,0.698343025620473,0,17,lamellar body,CC,
10939,GO:0042602,1,0.978481654082571,0,1,riboflavin reductase (NADPH) activity,MF,
10940,GO:0042605,1,0.61053674761736,0,23,peptide antigen binding,MF,
10941,GO:0042608,1,0.861654040221551,0,7,T cell receptor binding,MF,
10942,GO:0042609,1,0.863288143614049,0,7,CD4 receptor binding,MF,
10943,GO:0042610,1,0.958043977562321,0,2,CD8 receptor binding,MF,
10944,GO:0042611,1,0.594411514658956,0,24,MHC protein complex,CC,
10945,GO:0042612,1,0.840872901851014,0,8,MHC class I protein complex,CC,
10946,GO:0042613,1,0.707013934428225,0,16,MHC class II protein complex,CC,
10947,GO:0042622,1,0.712855682880012,0,16,photoreceptor outer segment membrane,CC,
10949,GO:0042624,1,0.978472181035402,0,1,ATPase activity, uncoupled,MF,
10950,GO:0042625,1,0.208086557095929,0,75,ATPase coupled ion transmembrane transporter activity,MF,
10953,GO:0042628,1,0.978865968185324,0,1,mating plug formation,BP,
10955,GO:0042631,1,0.938666127196034,0,3,cellular response to water deprivation,BP,
10960,GO:0042636,1,0.89976243654787,0,5,negative regulation of hair cycle,BP,
10961,GO:0042637,1,0.918804434011132,0,4,catagen,BP,
10963,GO:0042641,1,0.287216686234077,0,61,actomyosin,CC,
10964,GO:0042643,1,0.958565794040967,0,2,actomyosin, actin portion,CC,
10966,GO:0042658,1,0.978540113466399,0,1,MHC class II protein binding, via antigen binding groove,MF,
10968,GO:0042660,1,0.960346005562304,0,2,positive regulation of cell fate specification,BP,
10969,GO:0042661,1,0.861925998428547,0,7,regulation of mesodermal cell fate specification,BP,
10970,GO:0042662,1,0.917519458713045,0,4,negative regulation of mesodermal cell fate specification,BP,
10971,GO:0042663,1,0.917864917535857,0,4,regulation of endodermal cell fate specification,BP,
10972,GO:0042664,1,0.978513746666424,0,1,negative regulation of endodermal cell fate specification,BP,
10975,GO:0042667,1,0.978501057651594,0,1,auditory receptor cell fate specification,BP,
10976,GO:0042668,1,0.936978155783057,0,3,auditory receptor cell fate determination,BP,
10977,GO:0042670,1,0.828301299036142,0,9,retinal cone cell differentiation,BP,
10978,GO:0042684,1,0.979053151914992,0,1,cardioblast cell fate commitment,BP,
10979,GO:0042685,1,0.979053151914992,0,1,cardioblast cell fate specification,BP,
10980,GO:0042686,1,0.979053151914992,0,1,regulation of cardioblast cell fate specification,BP,
10983,GO:0042694,1,0.978479782672656,0,1,muscle cell fate specification,BP,
10986,GO:0042699,1,0.898731559426626,0,5,follicle-stimulating hormone signaling pathway,BP,
10987,GO:0042700,1,0.958842190007752,0,2,luteinizing hormone signaling pathway,BP,
10988,GO:0042701,1,0.919918842000378,0,4,progesterone secretion,BP,
10989,GO:0042703,1,0.979051032160913,0,1,menstruation,BP,
10990,GO:0042704,1,0.959196737105904,0,2,uterine wall breakdown,BP,
10991,GO:0042709,1,0.978903239804412,0,1,succinate-CoA ligase complex,CC,
10992,GO:0042710,1,0.958326531028665,0,2,biofilm formation,BP,
10993,GO:0042711,1,0.760096448132422,0,13,maternal behavior,BP,
10994,GO:0042713,1,0.881265758534994,0,6,sperm ejaculation,BP,
10995,GO:0042719,1,0.897635962000972,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10996,GO:0042720,1,0.957525070226155,0,2,mitochondrial inner membrane peptidase complex,CC,
10997,GO:0042721,1,0.978632480497762,0,1,mitochondrial inner membrane protein insertion complex,CC,
10998,GO:0042723,1,0.86132229684691,0,7,thiamine-containing compound metabolic process,BP,
11000,GO:0042727,1,0.958206556874786,0,2,flavin-containing compound biosynthetic process,BP,
11001,GO:0042728,1,0.979089260094394,0,1,flavin-containing compound catabolic process,BP,
11003,GO:0042731,1,0.919746221493548,0,4,PH domain binding,MF,
11004,GO:0042732,1,0.937407775306208,0,3,D-xylose metabolic process,BP,
11007,GO:0042737,1,0.742763289812923,0,14,drug catabolic process,BP,
11008,GO:0042738,1,0.79238116731475,0,11,exogenous drug catabolic process,BP,
11010,GO:0042743,1,0.408009329237038,0,42,hydrogen peroxide metabolic process,BP,
11011,GO:0042744,1,0.626454222544838,0,22,hydrogen peroxide catabolic process,BP,
11013,GO:0042746,1,0.878783660587828,0,6,circadian sleep/wake cycle, wakefulness,BP,
11018,GO:0042753,1,0.684774067121845,0,18,positive regulation of circadian rhythm,BP,
11020,GO:0042755,1,0.506423805376488,0,32,eating behavior,BP,
11021,GO:0042756,1,0.807238105683202,0,10,drinking behavior,BP,
11022,GO:0042758,1,0.861660912440831,0,7,long-chain fatty acid catabolic process,BP,
11024,GO:0042760,1,0.899960250633654,0,5,very long-chain fatty acid catabolic process,BP,
11027,GO:0042765,1,0.899058994589324,0,5,GPI-anchor transamidase complex,CC,
11028,GO:0042766,1,0.981997224601726,0,1,nucleosome mobilization,BP,
11029,GO:0042769,1,0.463452417883015,0,36,DNA damage response, detection of DNA damage,BP,
11033,GO:0042773,1,0.166462120357173,0,83,ATP synthesis coupled electron transport,BP,
11034,GO:0042774,1,0.97897493185122,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
11035,GO:0042775,1,0.170054643028013,0,82,mitochondrial ATP synthesis coupled electron transport,BP,
11036,GO:0042776,1,0.662338003225539,0,19,mitochondrial ATP synthesis coupled proton transport,BP,
11037,GO:0042779,1,0.958378248755042,0,2,tRNA 3'-trailer cleavage,BP,
11038,GO:0042780,1,0.898845384247408,0,5,tRNA 3'-end processing,BP,
11039,GO:0042781,1,0.958378248755042,0,2,3'-tRNA processing endoribonuclease activity,MF,
11041,GO:0042788,1,0.866827305886332,0,7,polysomal ribosome,CC,
11042,GO:0042789,1,0.686871549785929,0,18,mRNA transcription from RNA polymerase II promoter,BP,
11043,GO:0042790,1,0.760874382875211,0,13,transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
11044,GO:0042791,1,0.882056501465006,0,6,5S class rRNA transcription from RNA polymerase III type 1 promoter,BP,
11045,GO:0042795,1,0.252754498422726,0,65,snRNA transcription from RNA polymerase II promoter,BP,
11046,GO:0042796,1,0.918696063864725,0,4,snRNA transcription from RNA polymerase III promoter,BP,
11047,GO:0042797,1,0.882056501465006,0,6,tRNA transcription from RNA polymerase III promoter,BP,
11048,GO:0042799,1,0.984944178515762,0,1,histone methyltransferase activity (H4-K20 specific),MF,
11049,GO:0042800,1,0.765578317509266,0,13,histone methyltransferase activity (H3-K4 specific),MF,
11050,GO:0042801,1,0.980335102612572,0,1,polo kinase kinase activity,MF,
11053,GO:0042805,1,0.451528384314578,0,40,actinin binding,MF,
11054,GO:0042806,1,0.917995611514458,0,4,fucose binding,MF,
11055,GO:0042809,1,0.735978881782909,0,15,vitamin D receptor binding,MF,
11058,GO:0042819,1,0.940444879581321,0,3,vitamin B6 biosynthetic process,BP,
11059,GO:0042820,1,0.978758658761031,0,1,vitamin B6 catabolic process,BP,
11060,GO:0042822,1,0.940397535173755,0,3,pyridoxal phosphate metabolic process,BP,
11061,GO:0042823,1,0.960808598974023,0,2,pyridoxal phosphate biosynthetic process,BP,
11062,GO:0042824,1,0.918568615012923,0,4,MHC class I peptide loading complex,CC,
11063,GO:0042825,1,0.93854118414609,0,3,TAP complex,CC,
11064,GO:0042826,1,0.119373313057067,0,102,histone deacetylase binding,MF,
11065,GO:0042827,1,0.654904708434707,0,20,platelet dense granule,CC,
11067,GO:0042834,1,0.807332000166132,0,10,peptidoglycan binding,MF,
11068,GO:0042835,1,0.958941605924085,0,2,BRE binding,MF,
11069,GO:0042839,1,0.978575904928287,0,1,D-glucuronate metabolic process,BP,
11070,GO:0042840,1,0.978575904928287,0,1,D-glucuronate catabolic process,BP,
11071,GO:0042843,1,0.978503745184368,0,1,D-xylose catabolic process,BP,
11072,GO:0042851,1,0.917929523534882,0,4,L-alanine metabolic process,BP,
11073,GO:0042853,1,0.917929523534882,0,4,L-alanine catabolic process,BP,
11074,GO:0042866,1,0.898580901223519,0,5,pyruvate biosynthetic process,BP,
11075,GO:0042883,1,0.979076408025917,0,1,cysteine transport,BP,
11077,GO:0042887,1,0.494998095456909,0,33,amide transmembrane transporter activity,MF,
11078,GO:0042891,1,0.97870278571451,0,1,antibiotic transport,BP,
11079,GO:0042895,1,0.97870278571451,0,1,antibiotic transporter activity,MF,
11080,GO:0042903,1,0.958317218869144,0,2,tubulin deacetylase activity,MF,
11081,GO:0042904,1,0.918313057829733,0,4,9-cis-retinoic acid biosynthetic process,BP,
11082,GO:0042905,1,0.918313057829733,0,4,9-cis-retinoic acid metabolic process,BP,
11083,GO:0042908,1,0.81346307720839,0,10,xenobiotic transport,BP,
11084,GO:0042910,1,0.830751639700228,0,9,xenobiotic transporter activity,MF,
11085,GO:0042918,1,0.980698373787216,0,1,alkanesulfonate transport,BP,
11086,GO:0042921,1,0.734804663066513,0,15,glucocorticoid receptor signaling pathway,BP,
11087,GO:0042922,1,0.978478804484797,0,1,neuromedin U receptor binding,MF,
11088,GO:0042923,1,0.637489394354142,0,21,neuropeptide binding,MF,
11089,GO:0042924,1,0.978783965559314,0,1,neuromedin U binding,MF,
11090,GO:0042927,1,0.97897493185122,0,1,siderophore transporter activity,MF,
11091,GO:0042930,1,0.97897493185122,0,1,enterobactin transport,BP,
11092,GO:0042931,1,0.97897493185122,0,1,enterobactin transporter activity,MF,
11093,GO:0042936,1,0.9790668910779,0,1,dipeptide transporter activity,MF,
11094,GO:0042937,1,0.9806206324592,0,1,tripeptide transporter activity,MF,
11095,GO:0042938,1,0.938023913698526,0,3,dipeptide transport,BP,
11096,GO:0042939,1,0.959790645109948,0,2,tripeptide transport,BP,
11098,GO:0042941,1,0.97873815485712,0,1,D-alanine transport,BP,
11099,GO:0042942,1,0.958165541776681,0,2,D-serine transport,BP,
11100,GO:0042946,1,0.97897493185122,0,1,glucoside transport,BP,
11101,GO:0042947,1,0.97897493185122,0,1,glucoside transmembrane transporter activity,MF,
11103,GO:0042954,1,0.955871218334823,0,3,lipoprotein transporter activity,MF,
11104,GO:0042959,1,0.980698373787216,0,1,alkanesulfonate transporter activity,MF,
11106,GO:0042975,1,0.816043024435783,0,10,peroxisome proliferator activated receptor binding,MF,
11109,GO:0042978,1,0.963929009283958,0,2,ornithine decarboxylase activator activity,MF,
11110,GO:0042979,1,0.903274762152346,0,5,ornithine decarboxylase regulator activity,MF,
11113,GO:0042983,1,0.862886871233156,0,7,amyloid precursor protein biosynthetic process,BP,
11114,GO:0042984,1,0.862886871233156,0,7,regulation of amyloid precursor protein biosynthetic process,BP,
11115,GO:0042985,1,0.920042253378515,0,4,negative regulation of amyloid precursor protein biosynthetic process,BP,
11116,GO:0042986,1,0.958250934310592,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
11118,GO:0042988,1,0.979699429449801,0,1,X11-like protein binding,MF,
11119,GO:0042989,1,0.860451651331739,0,7,sequestering of actin monomers,BP,
11124,GO:0042994,1,0.629766458626498,0,22,cytoplasmic sequestering of transcription factor,BP,
11126,GO:0042996,1,0.880875465201509,0,6,regulation of Golgi to plasma membrane protein transport,BP,
11127,GO:0042997,1,0.918804141843285,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
11128,GO:0042998,1,0.958728844038696,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
11129,GO:0042999,1,0.979327397937968,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11130,GO:0043000,1,0.958338044423207,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11131,GO:0043001,1,0.53943341284603,0,30,Golgi to plasma membrane protein transport,BP,
11132,GO:0043002,1,0.979327397937968,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11133,GO:0043004,1,0.979327397937968,0,1,cytoplasmic sequestering of CFTR protein,BP,
11135,GO:0043006,1,0.958204386895062,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11136,GO:0043008,1,0.843710849675983,0,8,ATP-dependent protein binding,MF,
11139,GO:0043011,1,0.666749959325831,0,19,myeloid dendritic cell differentiation,BP,
11140,GO:0043012,1,0.978985281514428,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11143,GO:0043016,1,0.979017437383628,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11144,GO:0043017,1,0.979017437383628,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11145,GO:0043020,1,0.806919994775651,0,10,NADPH oxidase complex,CC,
11147,GO:0043022,1,0.389011399568057,0,45,ribosome binding,MF,
11148,GO:0043023,1,0.861226378092592,0,7,ribosomal large subunit binding,MF,
11149,GO:0043024,1,0.760764186954234,0,13,ribosomal small subunit binding,MF,
11155,GO:0043031,1,0.860239147496067,0,7,negative regulation of macrophage activation,BP,
11157,GO:0043033,1,0.981219837109701,0,1,isoamylase complex,CC,
11159,GO:0043035,1,0.979081128991428,0,1,chromatin insulator sequence binding,MF,
11160,GO:0043038,1,0.336974987493523,0,51,amino acid activation,BP,
11161,GO:0043039,1,0.34419968267281,0,50,tRNA aminoacylation,BP,
11162,GO:0043041,1,0.979070422957188,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11164,GO:0043044,1,0.233411586396641,0,69,ATP-dependent chromatin remodeling,BP,
11165,GO:0043045,1,0.866243379771742,0,7,DNA methylation involved in embryo development,BP,
11166,GO:0043046,1,0.653670023161437,0,20,DNA methylation involved in gamete generation,BP,
11167,GO:0043047,1,0.826893035434898,0,9,single-stranded telomeric DNA binding,MF,
11168,GO:0043048,1,0.978840476122935,0,1,dolichyl monophosphate biosynthetic process,BP,
11169,GO:0043049,1,0.979063884651254,0,1,otic placode formation,BP,
11170,GO:0043060,1,0.978944776214029,0,1,meiotic metaphase I plate congression,BP,
11172,GO:0043063,1,0.979501337987922,0,1,intercellular bridge organization,BP,
11178,GO:0043073,1,0.697530008869281,0,17,germ cell nucleus,CC,
11180,GO:0043084,1,0.826978759610986,0,9,penile erection,BP,
11185,GO:0043091,1,0.920594670413655,0,4,L-arginine import,BP,
11188,GO:0043095,1,0.978473190777419,0,1,regulation of GTP cyclohydrolase I activity,BP,
11189,GO:0043096,1,0.957496814988344,0,2,purine nucleobase salvage,BP,
11190,GO:0043097,1,0.790063382502203,0,11,pyrimidine nucleoside salvage,BP,
11193,GO:0043103,1,0.978562097860833,0,1,hypoxanthine salvage,BP,
11194,GO:0043105,1,0.978473190777419,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11195,GO:0043111,1,0.978534450789495,0,1,replication fork arrest,BP,
11199,GO:0043116,1,0.809625776159109,0,10,negative regulation of vascular permeability,BP,
11200,GO:0043117,1,0.825401230056043,0,9,positive regulation of vascular permeability,BP,
11201,GO:0043120,1,0.938504122730216,0,3,tumor necrosis factor binding,MF,
11202,GO:0043121,1,0.813353932004028,0,10,neurotrophin binding,MF,
11207,GO:0043126,1,0.978582423287099,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11208,GO:0043128,1,0.978582423287099,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11209,GO:0043129,1,0.864372538937659,0,7,surfactant homeostasis,BP,
11211,GO:0043132,1,0.958375462031632,0,2,NAD transport,BP,
11212,GO:0043133,1,0.957421128545549,0,2,hindgut contraction,BP,
11213,GO:0043134,1,0.957421128545549,0,2,regulation of hindgut contraction,BP,
11214,GO:0043136,1,0.979066574543881,0,1,glycerol-3-phosphatase activity,MF,
11215,GO:0043137,1,0.938051250471738,0,3,DNA replication, removal of RNA primer,BP,
11216,GO:0043138,1,0.776791409681917,0,12,3'-5' DNA helicase activity,MF,
11217,GO:0043139,1,0.861483527074163,0,7,5'-3' DNA helicase activity,MF,
11218,GO:0043140,1,0.882791379638069,0,6,ATP-dependent 3'-5' DNA helicase activity,MF,
11219,GO:0043141,1,0.898781299186383,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11220,GO:0043142,1,0.777765807888717,0,12,single-stranded DNA-dependent ATPase activity,MF,
11221,GO:0043143,1,0.978904007121587,0,1,regulation of translation by machinery localization,BP,
11222,GO:0043144,1,0.823182046329624,0,9,snoRNA processing,BP,
11224,GO:0043152,1,0.920533732358435,0,4,induction of bacterial agglutination,BP,
11225,GO:0043153,1,0.669050948476118,0,19,entrainment of circadian clock by photoperiod,BP,
11227,GO:0043159,1,0.937720485312959,0,3,acrosomal matrix,CC,
11228,GO:0043160,1,0.97897493185122,0,1,acrosomal lumen,CC,
11230,GO:0043162,1,0.682496735948694,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11231,GO:0043163,1,0.94213679482329,0,3,cell envelope organization,BP,
11236,GO:0043171,1,0.541592009113635,0,29,peptide catabolic process,BP,
11237,GO:0043173,1,0.756765865869312,0,13,nucleotide salvage,BP,
11238,GO:0043174,1,0.709782413337103,0,16,nucleoside salvage,BP,
11239,GO:0043175,1,0.531014678308857,0,30,RNA polymerase core enzyme binding,MF,
11240,GO:0043176,1,0.79101404268248,0,11,amine binding,MF,
11244,GO:0043181,1,0.979071190447851,0,1,vacuolar sequestering,BP,
11245,GO:0043183,1,0.958026818825213,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11247,GO:0043185,1,0.978791464903483,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11248,GO:0043186,1,0.71324005378679,0,16,P granule,CC,
11249,GO:0043189,1,0.688177462445896,0,18,H4/H2A histone acetyltransferase complex,CC,
11250,GO:0043190,1,0.848552492532604,0,8,ATP-binding cassette (ABC) transporter complex,CC,
11253,GO:0043196,1,0.842993343744815,0,8,varicosity,CC,
11256,GO:0043199,1,0.921333699580527,0,4,sulfate binding,MF,
11263,GO:0043208,1,0.843173253646723,0,8,glycosphingolipid binding,MF,
11265,GO:0043210,1,0.978682967226778,0,1,alkanesulfonate binding,MF,
11266,GO:0043215,1,0.979107757569395,0,1,daunorubicin transport,BP,
11269,GO:0043219,1,0.91926185250939,0,4,lateral loop,CC,
11271,GO:0043221,1,0.979088651858188,0,1,SMC family protein binding,MF,
11272,GO:0043225,1,0.76454374354331,0,13,ATPase-coupled anion transmembrane transporter activity,MF,
11284,GO:0043237,1,0.882217927498209,0,6,laminin-1 binding,MF,
11285,GO:0043240,1,0.845818669397577,0,8,Fanconi anaemia nuclear complex,CC,
11290,GO:0043247,1,0.779294138332915,0,12,telomere maintenance in response to DNA damage,BP,
11291,GO:0043248,1,0.757213441588848,0,13,proteasome assembly,BP,
11292,GO:0043249,1,0.790842524060449,0,11,erythrocyte maturation,BP,
11293,GO:0043250,1,0.978583206465222,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11294,GO:0043251,1,0.978583206465222,0,1,sodium-dependent organic anion transport,BP,
11295,GO:0043252,1,0.588877334289512,0,25,sodium-independent organic anion transport,BP,
11299,GO:0043257,1,0.980214304028837,0,1,laminin-8 complex,CC,
11302,GO:0043262,1,0.938049283826794,0,3,adenosine-diphosphatase activity,MF,
11303,GO:0043265,1,0.979066829814998,0,1,ectoplasm,CC,
11310,GO:0043273,1,0.979856991284043,0,1,CTPase activity,MF,
11311,GO:0043274,1,0.730555840289708,0,15,phospholipase binding,MF,
11318,GO:0043291,1,0.96793674831349,0,2,RAVE complex,CC,
11320,GO:0043293,1,0.960187313784325,0,2,apoptosome,CC,
11325,GO:0043300,1,0.438329338473736,0,39,regulation of leukocyte degranulation,BP,
11326,GO:0043301,1,0.792846408631196,0,11,negative regulation of leukocyte degranulation,BP,
11327,GO:0043302,1,0.682841779423505,0,18,positive regulation of leukocyte degranulation,BP,
11329,GO:0043304,1,0.539836333960137,0,29,regulation of mast cell degranulation,BP,
11330,GO:0043305,1,0.86070747541247,0,7,negative regulation of mast cell degranulation,BP,
11331,GO:0043306,1,0.758059449038128,0,13,positive regulation of mast cell degranulation,BP,
11332,GO:0043307,1,0.86065093055952,0,7,eosinophil activation,BP,
11333,GO:0043308,1,0.879376863244601,0,6,eosinophil degranulation,BP,
11334,GO:0043309,1,0.937887174485764,0,3,regulation of eosinophil degranulation,BP,
11335,GO:0043310,1,0.97895542225611,0,1,negative regulation of eosinophil degranulation,BP,
11336,GO:0043311,1,0.958051288161418,0,2,positive regulation of eosinophil degranulation,BP,
11338,GO:0043313,1,0.902334641117731,0,5,regulation of neutrophil degranulation,BP,
11339,GO:0043314,1,0.961112380730602,0,2,negative regulation of neutrophil degranulation,BP,
11340,GO:0043315,1,0.979143855843724,0,1,positive regulation of neutrophil degranulation,BP,
11342,GO:0043317,1,0.979069458245616,0,1,regulation of cytotoxic T cell degranulation,BP,
11343,GO:0043318,1,0.979069458245616,0,1,negative regulation of cytotoxic T cell degranulation,BP,
11345,GO:0043321,1,0.960328757798516,0,2,regulation of natural killer cell degranulation,BP,
11346,GO:0043323,1,0.960328757798516,0,2,positive regulation of natural killer cell degranulation,BP,
11347,GO:0043324,1,0.918558470730941,0,4,pigment metabolic process involved in developmental pigmentation,BP,
11349,GO:0043328,1,0.917451229712562,0,4,protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11352,GO:0043335,1,0.958077649791178,0,2,protein unfolding,BP,
11353,GO:0043337,1,0.979081880848646,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11354,GO:0043353,1,0.865339559807535,0,7,enucleate erythrocyte differentiation,BP,
11355,GO:0043366,1,0.958759780402893,0,2,beta selection,BP,
11359,GO:0043370,1,0.44674027235181,0,38,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11360,GO:0043371,1,0.730273208101514,0,15,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11361,GO:0043372,1,0.586023834599525,0,25,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11363,GO:0043374,1,0.791200779951938,0,11,CD8-positive, alpha-beta T cell differentiation,BP,
11364,GO:0043375,1,0.979086398056303,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11365,GO:0043376,1,0.958603371770614,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11366,GO:0043378,1,0.979095613080179,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11367,GO:0043379,1,0.828300368717007,0,9,memory T cell differentiation,BP,
11368,GO:0043380,1,0.843273021994435,0,8,regulation of memory T cell differentiation,BP,
11369,GO:0043381,1,0.97897493185122,0,1,negative regulation of memory T cell differentiation,BP,
11370,GO:0043382,1,0.879812011373183,0,6,positive regulation of memory T cell differentiation,BP,
11371,GO:0043383,1,0.76243779965698,0,13,negative T cell selection,BP,
11372,GO:0043385,1,0.97888453883524,0,1,mycotoxin metabolic process,BP,
11373,GO:0043388,1,0.357166186890549,0,49,positive regulation of DNA binding,BP,
11374,GO:0043390,1,0.97888453883524,0,1,aflatoxin B1 metabolic process,BP,
11377,GO:0043394,1,0.49642798878678,0,34,proteoglycan binding,MF,
11378,GO:0043395,1,0.689516357698995,0,18,heparan sulfate proteoglycan binding,MF,
11379,GO:0043396,1,0.938652245619141,0,3,corticotropin-releasing hormone secretion,BP,
11380,GO:0043397,1,0.938652245619141,0,3,regulation of corticotropin-releasing hormone secretion,BP,
11381,GO:0043398,1,0.938520453531445,0,3,HLH domain binding,MF,
11382,GO:0043400,1,0.899349161008055,0,5,cortisol secretion,BP,
11384,GO:0043402,1,0.94613272213083,0,3,glucocorticoid mediated signaling pathway,BP,
11395,GO:0043415,1,0.899069102766184,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11396,GO:0043416,1,0.879826780506832,0,6,regulation of skeletal muscle tissue regeneration,BP,
11397,GO:0043418,1,0.938296431676648,0,3,homocysteine catabolic process,BP,
11398,GO:0043420,1,0.978578941609564,0,1,anthranilate metabolic process,BP,
11399,GO:0043422,1,0.779590647092421,0,12,protein kinase B binding,MF,
11400,GO:0043423,1,0.979215669629585,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11401,GO:0043425,1,0.582517140923291,0,26,bHLH transcription factor binding,MF,
11402,GO:0043426,1,0.903224872899508,0,5,MRF binding,MF,
11405,GO:0043435,1,0.89973022285611,0,5,response to corticotropin-releasing hormone,BP,
11407,GO:0043438,1,0.97904679142788,0,1,acetoacetic acid metabolic process,BP,
11408,GO:0043449,1,0.958613915944777,0,2,cellular alkene metabolic process,BP,
11410,GO:0043456,1,0.917193371948543,0,4,regulation of pentose-phosphate shunt,BP,
11412,GO:0043461,1,0.917813182542972,0,4,proton-transporting ATP synthase complex assembly,BP,
11417,GO:0043471,1,0.790928252263879,0,11,regulation of cellular carbohydrate catabolic process,BP,
11419,GO:0043474,1,0.918558470730941,0,4,pigment metabolic process involved in pigmentation,BP,
11424,GO:0043486,1,0.359501650083554,0,48,histone exchange,BP,
11428,GO:0043490,1,0.958615640091802,0,2,malate-aspartate shuttle,BP,
11431,GO:0043495,1,0.868257970350525,0,7,protein anchor,MF,
11433,GO:0043497,1,0.845609133513805,0,8,regulation of protein heterodimerization activity,BP,
11437,GO:0043503,1,0.957715385082957,0,2,skeletal muscle fiber adaptation,BP,
11438,GO:0043504,1,0.938631289645583,0,3,mitochondrial DNA repair,BP,
11441,GO:0043508,1,0.742807424038654,0,14,negative regulation of JUN kinase activity,BP,
11442,GO:0043509,1,0.978828913951794,0,1,activin A complex,CC,
11443,GO:0043511,1,0.957844341549476,0,2,inhibin complex,CC,
11444,GO:0043512,1,0.957844341549476,0,2,inhibin A complex,CC,
11445,GO:0043513,1,0.978562788314866,0,1,inhibin B complex,CC,
11446,GO:0043514,1,0.957918942197214,0,2,interleukin-12 complex,CC,
11447,GO:0043515,1,0.923828419756236,0,4,kinetochore binding,MF,
11450,GO:0043518,1,0.743896937907557,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11451,GO:0043519,1,0.978802720300017,0,1,regulation of myosin II filament organization,BP,
11452,GO:0043522,1,0.793415491797527,0,11,leucine zipper domain binding,MF,
11455,GO:0043525,1,0.366212317549103,0,48,positive regulation of neuron apoptotic process,BP,
11456,GO:0043527,1,0.898262926869689,0,5,tRNA methyltransferase complex,CC,
11459,GO:0043533,1,0.905174681519296,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11464,GO:0043538,1,0.979062663236952,0,1,regulation of actin phosphorylation,BP,
11465,GO:0043539,1,0.589152507099822,0,25,protein serine/threonine kinase activator activity,MF,
11466,GO:0043540,1,0.978657217974508,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11467,GO:0043541,1,0.938499245646394,0,3,UDP-N-acetylglucosamine transferase complex,CC,
11470,GO:0043544,1,0.979070772639521,0,1,lipoamide binding,MF,
11471,GO:0043545,1,0.861391464751153,0,7,molybdopterin cofactor metabolic process,BP,
11479,GO:0043553,1,0.95864212217218,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11481,GO:0043558,1,0.697904388872335,0,17,regulation of translational initiation in response to stress,BP,
11484,GO:0043562,1,0.920187318897993,0,4,cellular response to nitrogen levels,BP,
11485,GO:0043564,1,0.937701248386833,0,3,Ku70:Ku80 complex,CC,
11488,GO:0043568,1,0.764570399208184,0,13,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11490,GO:0043570,1,0.919258173323526,0,4,maintenance of DNA repeat elements,BP,
11491,GO:0043574,1,0.682522538751896,0,18,peroxisomal transport,BP,
11493,GO:0043578,1,0.947877166571972,0,3,nuclear matrix organization,BP,
11497,GO:0043586,1,0.662821308837566,0,20,tongue development,BP,
11498,GO:0043587,1,0.828284031263019,0,9,tongue morphogenesis,BP,
11500,GO:0043589,1,0.831837173761504,0,9,skin morphogenesis,BP,
11501,GO:0043596,1,0.402909464371437,0,43,nuclear replication fork,CC,
11502,GO:0043601,1,0.541716313878265,0,29,nuclear replisome,CC,
11503,GO:0043602,1,0.978958443763373,0,1,nitrate catabolic process,BP,
11506,GO:0043605,1,0.937398347467554,0,3,cellular amide catabolic process,BP,
11507,GO:0043606,1,0.918291753374988,0,4,formamide metabolic process,BP,
11508,GO:0043610,1,0.982356752390083,0,1,regulation of carbohydrate utilization,BP,
11509,GO:0043614,1,0.959365647745108,0,2,multi-eIF complex,CC,
11516,GO:0043622,1,0.92023188840365,0,4,cortical microtubule organization,BP,
11519,GO:0043625,1,0.917915954953634,0,4,delta DNA polymerase complex,CC,
11520,GO:0043626,1,0.978544958507303,0,1,PCNA complex,CC,
11522,GO:0043628,1,0.652631496049498,0,20,ncRNA 3'-end processing,BP,
11523,GO:0043631,1,0.430812662038531,0,40,RNA polyadenylation,BP,
11525,GO:0043633,1,0.898695911918028,0,5,polyadenylation-dependent RNA catabolic process,BP,
11526,GO:0043634,1,0.917666336135772,0,4,polyadenylation-dependent ncRNA catabolic process,BP,
11527,GO:0043647,1,0.245076711654076,0,67,inositol phosphate metabolic process,BP,
11529,GO:0043649,1,0.727253576299976,0,15,dicarboxylic acid catabolic process,BP,
11532,GO:0043652,1,0.866565026263177,0,7,engulfment of apoptotic cell,BP,
11533,GO:0043653,1,0.847006128532704,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
11534,GO:0043654,1,0.863402601727921,0,7,recognition of apoptotic cell,BP,
11535,GO:0043656,1,0.862743545342343,0,7,intracellular region of host,CC,
11536,GO:0043657,1,0.743552796140294,0,14,host cell,CC,
11539,GO:0043682,1,0.963080193661701,0,2,copper-transporting ATPase activity,MF,
11540,GO:0043686,1,0.937833837564059,0,3,co-translational protein modification,BP,
11545,GO:0043733,1,0.978504121567352,0,1,DNA-3-methylbase glycosylase activity,MF,
11546,GO:0043734,1,0.917916187654468,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11547,GO:0043739,1,0.979068896050112,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11548,GO:0043754,1,0.983770024290829,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11550,GO:0043795,1,0.978558918485875,0,1,glyceraldehyde oxidoreductase activity,MF,
11551,GO:0043812,1,0.940492276813311,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11552,GO:0043813,1,0.904890925123906,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11553,GO:0043843,1,0.978974619387183,0,1,ADP-specific glucokinase activity,MF,
11554,GO:0043849,1,0.979051776946609,0,1,Ras palmitoyltransferase activity,MF,
11555,GO:0043855,1,0.828886099544868,0,9,cyclic nucleotide-gated ion channel activity,MF,
11556,GO:0043865,1,0.979031017376563,0,1,methionine transmembrane transporter activity,MF,
11557,GO:0043874,1,0.978763617662823,0,1,acireductone synthase activity,MF,
11558,GO:0043890,1,0.978908969517427,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11559,GO:0043891,1,0.957580611332765,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11564,GO:0043914,1,0.979096813437444,0,1,NADPH:sulfur oxidoreductase activity,MF,
11565,GO:0043916,1,0.978504121567352,0,1,DNA-7-methylguanine glycosylase activity,MF,
11566,GO:0043921,1,0.5923946617064,0,25,modulation by host of viral transcription,BP,
11567,GO:0043922,1,0.774009255083433,0,12,negative regulation by host of viral transcription,BP,
11568,GO:0043923,1,0.733919355958348,0,15,positive regulation by host of viral transcription,BP,
11569,GO:0043924,1,0.987283951635937,0,1,suramin binding,MF,
11570,GO:0043928,1,0.49887980044172,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11572,GO:0043932,1,0.917987429663737,0,4,ossification involved in bone remodeling,BP,
11574,GO:0043946,1,0.978658826538303,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11575,GO:0043947,1,0.978658826538303,0,1,positive regulation by host of symbiont catalytic activity,BP,
11576,GO:0043949,1,0.64347237275814,0,21,regulation of cAMP-mediated signaling,BP,
11577,GO:0043950,1,0.825953652593267,0,9,positive regulation of cAMP-mediated signaling,BP,
11578,GO:0043951,1,0.882109362381115,0,6,negative regulation of cAMP-mediated signaling,BP,
11581,GO:0043967,1,0.301286244058893,0,58,histone H4 acetylation,BP,
11582,GO:0043968,1,0.733828832669854,0,15,histone H2A acetylation,BP,
11583,GO:0043969,1,0.982363148461466,0,1,histone H2B acetylation,BP,
11584,GO:0043970,1,0.796556945158675,0,11,histone H3-K9 acetylation,BP,
11585,GO:0043973,1,0.97884273865187,0,1,histone H3-K4 acetylation,BP,
11587,GO:0043981,1,0.778505837213822,0,12,histone H4-K5 acetylation,BP,
11588,GO:0043982,1,0.778505837213822,0,12,histone H4-K8 acetylation,BP,
11589,GO:0043983,1,0.918066375505936,0,4,histone H4-K12 acetylation,BP,
11590,GO:0043984,1,0.702872738145432,0,17,histone H4-K16 acetylation,BP,
11591,GO:0043985,1,0.880013045685907,0,6,histone H4-R3 methylation,BP,
11592,GO:0043987,1,0.918202140562969,0,4,histone H3-S10 phosphorylation,BP,
11593,GO:0043988,1,0.937982941084456,0,3,histone H3-S28 phosphorylation,BP,
11594,GO:0043990,1,0.979065124172936,0,1,histone H2A-S1 phosphorylation,BP,
11595,GO:0043995,1,0.830256816546503,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11596,GO:0043996,1,0.830256816546503,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11597,GO:0043997,1,0.97906630252243,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11598,GO:0043998,1,0.979069320292298,0,1,H2A histone acetyltransferase activity,MF,
11599,GO:0044003,1,0.409106095715556,0,43,modification by symbiont of host morphology or physiology,BP,
11600,GO:0044004,1,0.918506859886608,0,4,disruption by symbiont of host cell,BP,
11601,GO:0044007,1,0.980613073878647,0,1,dissemination or transmission of symbiont from host,BP,
11602,GO:0044010,1,0.958326531028665,0,2,single-species biofilm formation,BP,
11603,GO:0044020,1,0.918055616070965,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11604,GO:0044026,1,0.940016586734783,0,3,DNA hypermethylation,BP,
11605,GO:0044027,1,0.960103484080935,0,2,hypermethylation of CpG island,BP,
11609,GO:0044033,1,0.0114677409731807,0,209,multi-organism metabolic process,BP,
11610,GO:0044034,1,0.938272786028124,0,3,multi-organism biosynthetic process,BP,
11611,GO:0044035,1,0.978621989433484,0,1,multi-organism catabolic process,BP,
11612,GO:0044036,1,0.897201793359207,0,5,cell wall macromolecule metabolic process,BP,
11613,GO:0044038,1,0.978668801600268,0,1,cell wall macromolecule biosynthetic process,BP,
11615,GO:0044053,1,0.978925601400141,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11621,GO:0044068,1,0.592073703032312,0,25,modulation by symbiont of host cellular process,BP,
11631,GO:0044094,1,0.959162747192094,0,2,host cell nuclear part,CC,
11633,GO:0044107,1,0.898380595437991,0,5,cellular alcohol metabolic process,BP,
11634,GO:0044108,1,0.898380595437991,0,5,cellular alcohol biosynthetic process,BP,
11635,GO:0044110,1,0.664852176227589,0,19,growth involved in symbiotic interaction,BP,
11636,GO:0044111,1,0.959648410335656,0,2,development involved in symbiotic interaction,BP,
11637,GO:0044115,1,0.978621989433484,0,1,development of symbiont involved in interaction with host,BP,
11638,GO:0044116,1,0.664852176227589,0,19,growth of symbiont involved in interaction with host,BP,
11639,GO:0044117,1,0.679494700678501,0,18,growth of symbiont in host,BP,
11640,GO:0044126,1,0.725161453251336,0,15,regulation of growth of symbiont in host,BP,
11641,GO:0044128,1,0.979631468267195,0,1,positive regulation of growth of symbiont in host,BP,
11642,GO:0044130,1,0.74025152567032,0,14,negative regulation of growth of symbiont in host,BP,
11643,GO:0044133,1,0.978473282549746,0,1,growth of symbiont on or near host,BP,
11644,GO:0044139,1,0.978473282549746,0,1,modulation of growth of symbiont on or near host,BP,
11645,GO:0044140,1,0.978473282549746,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11646,GO:0044144,1,0.709537587328701,0,16,modulation of growth of symbiont involved in interaction with host,BP,
11647,GO:0044145,1,0.978621989433484,0,1,modulation of development of symbiont involved in interaction with host,BP,
11648,GO:0044146,1,0.724303423928465,0,15,negative regulation of growth of symbiont involved in interaction with host,BP,
11649,GO:0044147,1,0.978621989433484,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11650,GO:0044148,1,0.979631468267195,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11651,GO:0044154,1,0.861763907236142,0,7,histone H3-K14 acetylation,BP,
11652,GO:0044179,1,0.958318823202868,0,2,hemolysis in other organism,BP,
11653,GO:0044183,1,0.563017463209575,0,27,protein binding involved in protein folding,MF,
11654,GO:0044190,1,0.978661162038463,0,1,host cell mitochondrial envelope,CC,
11655,GO:0044194,1,0.918254664930747,0,4,cytolytic granule,CC,
11656,GO:0044205,1,0.940190345012879,0,3,'de novo' UMP biosynthetic process,BP,
11657,GO:0044206,1,0.898058907261926,0,5,UMP salvage,BP,
11658,GO:0044207,1,0.979151313417047,0,1,translation initiation ternary complex,CC,
11659,GO:0044208,1,0.937619969356175,0,3,'de novo' AMP biosynthetic process,BP,
11660,GO:0044209,1,0.957710660651651,0,2,AMP salvage,BP,
11661,GO:0044210,1,0.958513479051569,0,2,'de novo' CTP biosynthetic process,BP,
11662,GO:0044211,1,0.937384107377102,0,3,CTP salvage,BP,
11664,GO:0044213,1,0.792244201332426,0,11,intronic transcription regulatory region DNA binding,MF,
11665,GO:0044214,1,0.943914079431972,0,3,spanning component of plasma membrane,CC,
11666,GO:0044215,1,0.668740247165047,0,19,other organism,CC,
11667,GO:0044216,1,0.668740247165047,0,19,other organism cell,CC,
11668,GO:0044217,1,0.668740247165047,0,19,other organism part,CC,
11669,GO:0044218,1,0.938387773493567,0,3,other organism cell membrane,CC,
11670,GO:0044220,1,0.979467499828946,0,1,host cell perinuclear region of cytoplasm,CC,
11671,GO:0044221,1,0.979158054547778,0,1,host cell synapse,CC,
11672,GO:0044224,1,0.818613314613531,0,10,juxtaparanode region of axon,CC,
11673,GO:0044228,1,0.979406349274381,0,1,host cell surface,CC,
11674,GO:0044231,1,0.979158054547778,0,1,host cell presynaptic membrane,CC,
11680,GO:0044240,1,0.917126697917582,0,4,multicellular organismal lipid catabolic process,BP,
11681,GO:0044241,1,0.560285915609164,0,27,lipid digestion,BP,
11684,GO:0044245,1,0.922554288986936,0,4,polysaccharide digestion,BP,
11686,GO:0044247,1,0.568745580027978,0,27,cellular polysaccharide catabolic process,BP,
11689,GO:0044252,1,0.825062410404205,0,9,negative regulation of multicellular organismal metabolic process,BP,
11691,GO:0044254,1,0.919335257484825,0,4,multicellular organismal protein catabolic process,BP,
11693,GO:0044256,1,0.919335257484825,0,4,protein digestion,BP,
11695,GO:0044258,1,0.978916140448756,0,1,intestinal lipid catabolic process,BP,
11701,GO:0044266,1,0.919335257484825,0,4,multicellular organismal macromolecule catabolic process,BP,
11703,GO:0044268,1,0.903762219493008,0,5,multicellular organismal protein metabolic process,BP,
11708,GO:0044275,1,0.388435467964115,0,45,cellular carbohydrate catabolic process,BP,
11709,GO:0044279,1,0.938387773493567,0,3,other organism membrane,CC,
11713,GO:0044284,1,0.978484940281113,0,1,mitochondrial crista junction,CC,
11715,GO:0044292,1,0.82850876835287,0,9,dendrite terminus,CC,
11716,GO:0044294,1,0.902704928559569,0,5,dendritic growth cone,CC,
11717,GO:0044295,1,0.718793215224392,0,16,axonal growth cone,CC,
11719,GO:0044298,1,0.669947154672853,0,19,cell body membrane,CC,
11720,GO:0044299,1,0.97847473781867,0,1,C-fiber,CC,
11721,GO:0044300,1,0.902429762916106,0,5,cerebellar mossy fiber,CC,
11722,GO:0044301,1,0.958298775335346,0,2,climbing fiber,CC,
11723,GO:0044302,1,0.958570121611042,0,2,dentate gyrus mossy fiber,CC,
11725,GO:0044305,1,0.92681718019831,0,4,calyx of Held,CC,
11727,GO:0044307,1,0.984871679797812,0,1,dendritic branch,CC,
11728,GO:0044308,1,0.942443294609188,0,3,axonal spine,CC,
11730,GO:0044313,1,0.942661544968078,0,3,protein K6-linked deubiquitination,BP,
11731,GO:0044314,1,0.91731917357636,0,4,protein K27-linked ubiquitination,BP,
11732,GO:0044316,1,0.958493194352539,0,2,cone cell pedicle,CC,
11733,GO:0044317,1,0.978552125821345,0,1,rod spherule,CC,
11737,GO:0044322,1,0.59529508638039,0,25,endoplasmic reticulum quality control compartment,CC,
11738,GO:0044323,1,0.920116197424214,0,4,retinoic acid-responsive element binding,MF,
11739,GO:0044324,1,0.95752740275144,0,2,regulation of transcription involved in anterior/posterior axis specification,BP,
11741,GO:0044326,1,0.942249797736101,0,3,dendritic spine neck,CC,
11742,GO:0044327,1,0.883698901242294,0,6,dendritic spine head,CC,
11744,GO:0044332,1,0.870879574645769,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11745,GO:0044333,1,0.978708872698114,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11746,GO:0044334,1,0.958612122858693,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11747,GO:0044335,1,0.96221938738694,0,2,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11748,GO:0044336,1,0.938295932133591,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11749,GO:0044337,1,0.981140504695955,0,1,canonical Wnt signaling pathway involved in positive regulation of apoptotic process,BP,
11753,GO:0044341,1,0.826020563811219,0,9,sodium-dependent phosphate transport,BP,
11754,GO:0044342,1,0.698065183462587,0,17,type B pancreatic cell proliferation,BP,
11755,GO:0044343,1,0.958751486977511,0,2,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11757,GO:0044345,1,0.979265164430661,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11759,GO:0044349,1,0.978651906489294,0,1,DNA excision,BP,
11761,GO:0044352,1,0.919933572991364,0,4,pinosome,CC,
11762,GO:0044354,1,0.919933572991364,0,4,macropinosome,CC,
11763,GO:0044355,1,0.978568429576654,0,1,clearance of foreign intracellular DNA,BP,
11764,GO:0044356,1,0.978568429576654,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11765,GO:0044359,1,0.860796902720043,0,7,modulation of molecular function in other organism,BP,
11766,GO:0044362,1,0.860796902720043,0,7,negative regulation of molecular function in other organism,BP,
11768,GO:0044374,1,0.979076594448839,0,1,sequence-specific DNA binding, bending,MF,
11769,GO:0044375,1,0.936995704094256,0,3,regulation of peroxisome size,BP,
11770,GO:0044376,1,0.937185457436469,0,3,RNA polymerase II complex import to nucleus,BP,
11771,GO:0044377,1,0.979076594448839,0,1,RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending,MF,
11772,GO:0044378,1,0.959424776030908,0,2,non-sequence-specific DNA binding, bending,MF,
11773,GO:0044380,1,0.482434884032543,0,36,protein localization to cytoskeleton,BP,
11775,GO:0044387,1,0.845331279578917,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11776,GO:0044388,1,0.89795668666458,0,5,small protein activating enzyme binding,MF,
11780,GO:0044393,1,0.938485442853971,0,3,microspike,CC,
11781,GO:0044395,1,0.978985577650819,0,1,protein targeting to vacuolar membrane,BP,
11784,GO:0044407,1,0.958326531028665,0,2,single-species biofilm formation in or on host organism,BP,
11786,GO:0044413,1,0.939361584553954,0,3,avoidance of host defenses,BP,
11787,GO:0044415,1,0.939361584553954,0,3,evasion or tolerance of host defenses,BP,
11788,GO:0044416,1,0.957871401892734,0,2,induction by symbiont of host defense response,BP,
11789,GO:0044417,1,0.978925601400141,0,1,translocation of molecules into host,BP,
11794,GO:0044423,1,0.918508286851493,0,4,virion part,CC,
11812,GO:0044447,1,0.66802400410697,0,22,axoneme part,CC,
11818,GO:0044453,1,0.727035219056276,0,15,nuclear membrane part,CC,
11822,GO:0044458,1,0.652946545442994,0,20,motile cilium assembly,BP,
11826,GO:0044467,1,0.958460014095821,0,2,glial cell-derived neurotrophic factor secretion,BP,
11827,GO:0044501,1,0.979069134244812,0,1,modulation of signal transduction in other organism,BP,
11828,GO:0044524,1,0.97865811077371,0,1,protein sulfhydration,BP,
11829,GO:0044530,1,0.940548429117663,0,3,supraspliceosomal complex,CC,
11830,GO:0044531,1,0.899432040751791,0,5,modulation of programmed cell death in other organism,BP,
11831,GO:0044532,1,0.899432040751791,0,5,modulation of apoptotic process in other organism,BP,
11832,GO:0044533,1,0.958461169726698,0,2,positive regulation of apoptotic process in other organism,BP,
11833,GO:0044537,1,0.978672118104979,0,1,regulation of circulating fibrinogen levels,BP,
11835,GO:0044540,1,0.97865811077371,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11836,GO:0044546,1,0.794349455704315,0,11,NLRP3 inflammasome complex assembly,BP,
11837,GO:0044547,1,0.899534033191424,0,5,DNA topoisomerase binding,MF,
11839,GO:0044549,1,0.978473190777419,0,1,GTP cyclohydrolase binding,MF,
11842,GO:0044558,1,0.979576774463753,0,1,uterine smooth muscle relaxation,BP,
11843,GO:0044565,1,0.958076045442357,0,2,dendritic cell proliferation,BP,
11844,GO:0044571,1,0.917130711965254,0,4,[2Fe-2S] cluster assembly,BP,
11845,GO:0044594,1,0.979011610910436,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11846,GO:0044595,1,0.978531371205572,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11847,GO:0044596,1,0.978531371205572,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11848,GO:0044597,1,0.841203215055338,0,8,daunorubicin metabolic process,BP,
11849,GO:0044598,1,0.841203215055338,0,8,doxorubicin metabolic process,BP,
11850,GO:0044599,1,0.97897493185122,0,1,AP-5 adaptor complex,CC,
11851,GO:0044609,1,0.978814382527875,0,1,DBIRD complex,CC,
11852,GO:0044610,1,0.978867379319807,0,1,FMN transmembrane transporter activity,MF,
11853,GO:0044611,1,0.941028431886172,0,3,nuclear pore inner ring,CC,
11854,GO:0044613,1,0.880894217320856,0,6,nuclear pore central transport channel,CC,
11855,GO:0044614,1,0.924435592992747,0,4,nuclear pore cytoplasmic filaments,CC,
11856,GO:0044615,1,0.891841984776113,0,6,nuclear pore nuclear basket,CC,
11857,GO:0044620,1,0.978471214322306,0,1,ACP phosphopantetheine attachment site binding,MF,
11859,GO:0044665,1,0.570710133156404,0,27,MLL1/2 complex,CC,
11860,GO:0044666,1,0.862638425867326,0,7,MLL3/4 complex,CC,
11861,GO:0044691,1,0.943469696232713,0,3,tooth eruption,BP,
11866,GO:0044704,1,0.978865968185324,0,1,single-organism reproductive behavior,BP,
11873,GO:0044713,1,0.978473282549746,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11874,GO:0044714,1,0.978473282549746,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11875,GO:0044715,1,0.957567671740093,0,2,8-oxo-dGDP phosphatase activity,MF,
11876,GO:0044716,1,0.97858744205237,0,1,8-oxo-GDP phosphatase activity,MF,
11877,GO:0044717,1,0.97858744205237,0,1,8-hydroxy-dADP phosphatase activity,MF,
11878,GO:0044721,1,0.978728428225461,0,1,protein import into peroxisome matrix, substrate release,BP,
11879,GO:0044722,1,0.979089880969185,0,1,renal phosphate excretion,BP,
11882,GO:0044725,1,0.962723749392601,0,2,chromatin reprogramming in the zygote,BP,
11883,GO:0044726,1,0.978497930733547,0,1,protection of DNA demethylation of female pronucleus,BP,
11884,GO:0044727,1,0.98388013751242,0,1,DNA demethylation of male pronucleus,BP,
11887,GO:0044736,1,0.918508286851493,0,4,acid-sensing ion channel activity,MF,
11888,GO:0044743,1,0.406568452639186,0,42,protein transmembrane import into intracellular organelle,BP,
11890,GO:0044745,1,0.981485146893144,0,1,amino acid transmembrane import,BP,
11892,GO:0044753,1,0.962114838405547,0,2,amphisome,CC,
11893,GO:0044754,1,0.828176867373155,0,9,autolysosome,CC,
11899,GO:0044769,1,0.514666667641509,0,31,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11901,GO:0044771,1,0.898468787044719,0,5,meiotic cell cycle phase transition,BP,
11905,GO:0044778,1,0.917450880320375,0,4,meiotic DNA integrity checkpoint,BP,
11906,GO:0044779,1,0.979061701303031,0,1,meiotic spindle checkpoint,BP,
11909,GO:0044784,1,0.37792915460137,0,47,metaphase/anaphase transition of cell cycle,BP,
11910,GO:0044785,1,0.958008869044639,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11911,GO:0044786,1,0.474298267716467,0,36,cell cycle DNA replication,BP,
11912,GO:0044788,1,0.656934128762825,0,20,modulation by host of viral process,BP,
11913,GO:0044789,1,0.901515173554811,0,5,modulation by host of viral release from host cell,BP,
11914,GO:0044791,1,0.901515173554811,0,5,positive regulation by host of viral release from host cell,BP,
11915,GO:0044793,1,0.86367154173799,0,7,negative regulation by host of viral process,BP,
11916,GO:0044794,1,0.76209931856148,0,13,positive regulation by host of viral process,BP,
11917,GO:0044795,1,0.978513601303345,0,1,trans-Golgi network to recycling endosome transport,BP,
11918,GO:0044796,1,0.978544958507303,0,1,DNA polymerase processivity factor complex,CC,
11924,GO:0044804,1,0.763407077294004,0,13,nucleophagy,BP,
11925,GO:0044805,1,0.958830273278206,0,2,late nucleophagy,BP,
11926,GO:0044806,1,0.882098213382536,0,6,G-quadruplex DNA unwinding,BP,
11927,GO:0044815,1,0.096503102168856,0,108,DNA packaging complex,CC,
11930,GO:0044821,1,0.899561054899537,0,5,meiotic telomere tethering at nuclear periphery,BP,
11931,GO:0044827,1,0.796498617573021,0,11,modulation by host of viral genome replication,BP,
11932,GO:0044828,1,0.921287959063943,0,4,negative regulation by host of viral genome replication,BP,
11933,GO:0044829,1,0.8661525302114,0,7,positive regulation by host of viral genome replication,BP,
11934,GO:0044830,1,0.979225863789439,0,1,modulation by host of viral RNA genome replication,BP,
11935,GO:0044837,1,0.939420341287481,0,3,actomyosin contractile ring organization,BP,
11939,GO:0044849,1,0.728236072735377,0,15,estrous cycle,BP,
11942,GO:0044854,1,0.898502232394193,0,5,plasma membrane raft assembly,BP,
11943,GO:0044855,1,0.979021927090507,0,1,plasma membrane raft distribution,BP,
11944,GO:0044856,1,0.979021927090507,0,1,plasma membrane raft localization,BP,
11945,GO:0044857,1,0.898502232394193,0,5,plasma membrane raft organization,BP,
11946,GO:0044858,1,0.979021927090507,0,1,plasma membrane raft polarization,BP,
11947,GO:0044860,1,0.919452504964515,0,4,protein localization to plasma membrane raft,BP,
11948,GO:0044861,1,0.959322503027638,0,2,protein transport into plasma membrane raft,BP,
11949,GO:0044866,1,0.957674876301617,0,2,modulation by host of viral exo-alpha-sialidase activity,BP,
11950,GO:0044867,1,0.957674876301617,0,2,modulation by host of viral catalytic activity,BP,
11951,GO:0044868,1,0.939146853804713,0,3,modulation by host of viral molecular function,BP,
11952,GO:0044869,1,0.957674876301617,0,2,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11953,GO:0044870,1,0.957674876301617,0,2,modulation by host of viral glycoprotein metabolic process,BP,
11954,GO:0044871,1,0.957674876301617,0,2,negative regulation by host of viral glycoprotein metabolic process,BP,
11957,GO:0045002,1,0.861740259953634,0,7,double-strand break repair via single-strand annealing,BP,
11958,GO:0045003,1,0.808050622448838,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11959,GO:0045004,1,0.961165684130594,0,2,DNA replication proofreading,BP,
11960,GO:0045005,1,0.56098253858288,0,28,DNA-dependent DNA replication maintenance of fidelity,BP,
11961,GO:0045006,1,0.805717083392239,0,10,DNA deamination,BP,
11962,GO:0045007,1,0.937277459387314,0,3,depurination,BP,
11963,GO:0045008,1,0.842218241695587,0,8,depyrimidination,BP,
11965,GO:0045010,1,0.41349230321419,0,42,actin nucleation,BP,
11966,GO:0045013,1,0.958266640511486,0,2,carbon catabolite repression of transcription,BP,
11967,GO:0045014,1,0.958266640511486,0,2,negative regulation of transcription by glucose,BP,
11968,GO:0045016,1,0.979069329835597,0,1,mitochondrial magnesium ion transport,BP,
11973,GO:0045025,1,0.958716191718372,0,2,mitochondrial degradosome,CC,
11975,GO:0045027,1,0.978799802356638,0,1,DNA end binding,MF,
11978,GO:0045030,1,0.978621200964744,0,1,UTP-activated nucleotide receptor activity,MF,
11979,GO:0045031,1,0.958255093357417,0,2,ATP-activated adenosine receptor activity,MF,
11980,GO:0045032,1,0.97906542233794,0,1,ADP-activated adenosine receptor activity,MF,
11981,GO:0045039,1,0.897300229450318,0,5,protein import into mitochondrial inner membrane,BP,
11982,GO:0045040,1,0.878889221889229,0,6,protein import into mitochondrial outer membrane,BP,
11983,GO:0045041,1,0.957925342726238,0,2,protein import into mitochondrial intermembrane space,BP,
11984,GO:0045046,1,0.880728657805819,0,6,protein import into peroxisome membrane,BP,
11985,GO:0045047,1,0.114375357845694,0,100,protein targeting to ER,BP,
11986,GO:0045048,1,0.900545787704853,0,5,protein insertion into ER membrane,BP,
11987,GO:0045053,1,0.963214089376532,0,2,protein retention in Golgi apparatus,BP,
11992,GO:0045059,1,0.809662809525221,0,10,positive thymic T cell selection,BP,
11993,GO:0045060,1,0.778733144291792,0,12,negative thymic T cell selection,BP,
11995,GO:0045062,1,0.978645638634916,0,1,extrathymic T cell selection,BP,
11996,GO:0045063,1,0.696496357516731,0,17,T-helper 1 cell differentiation,BP,
11997,GO:0045064,1,0.710225404394788,0,16,T-helper 2 cell differentiation,BP,
11998,GO:0045065,1,0.938066164115284,0,3,cytotoxic T cell differentiation,BP,
11999,GO:0045066,1,0.638872262707403,0,21,regulatory T cell differentiation,BP,
12005,GO:0045074,1,0.938853561796631,0,3,regulation of interleukin-10 biosynthetic process,BP,
12006,GO:0045075,1,0.844952517348872,0,8,regulation of interleukin-12 biosynthetic process,BP,
12007,GO:0045076,1,0.681646726252813,0,18,regulation of interleukin-2 biosynthetic process,BP,
12008,GO:0045077,1,0.917975306189515,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
12010,GO:0045079,1,0.937005788438558,0,3,negative regulation of chemokine biosynthetic process,BP,
12012,GO:0045081,1,0.979071552159237,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
12013,GO:0045082,1,0.958924635616091,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
12014,GO:0045083,1,0.979132941847173,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
12015,GO:0045084,1,0.880469624447995,0,6,positive regulation of interleukin-12 biosynthetic process,BP,
12016,GO:0045085,1,0.917516016353576,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
12017,GO:0045086,1,0.775831398137731,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
12021,GO:0045091,1,0.844184742117809,0,8,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12022,GO:0045092,1,0.979071165345968,0,1,interleukin-18 receptor complex,CC,
12023,GO:0045095,1,0.137280270271137,0,92,keratin filament,CC,
12024,GO:0045098,1,0.958064496229343,0,2,type III intermediate filament,CC,
12027,GO:0045105,1,0.959458068882408,0,2,intermediate filament polymerization or depolymerization,BP,
12028,GO:0045106,1,0.979969207333289,0,1,intermediate filament depolymerization,BP,
12029,GO:0045108,1,0.979969207333289,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
12033,GO:0045112,1,0.883130622996052,0,6,integrin biosynthetic process,BP,
12034,GO:0045113,1,0.899179287932987,0,5,regulation of integrin biosynthetic process,BP,
12035,GO:0045116,1,0.728896271294337,0,15,protein neddylation,BP,
12037,GO:0045118,1,0.879986453678988,0,6,azole transporter activity,MF,
12038,GO:0045120,1,0.751186965210943,0,14,pronucleus,CC,
12043,GO:0045127,1,0.978603639498859,0,1,N-acetylglucosamine kinase activity,MF,
12044,GO:0045130,1,0.97901778254051,0,1,keratan sulfotransferase activity,MF,
12045,GO:0045131,1,0.979058103675276,0,1,pre-mRNA branch point binding,MF,
12046,GO:0045132,1,0.230033976098731,0,70,meiotic chromosome segregation,BP,
12047,GO:0045134,1,0.918533351066522,0,4,uridine-diphosphatase activity,MF,
12050,GO:0045141,1,0.795794103801082,0,11,meiotic telomere clustering,BP,
12051,GO:0045142,1,0.979099646733073,0,1,triplex DNA binding,MF,
12052,GO:0045143,1,0.364873700348095,0,48,homologous chromosome segregation,BP,
12053,GO:0045144,1,0.86057396036126,0,7,meiotic sister chromatid segregation,BP,
12054,GO:0045145,1,0.95848211331736,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
12055,GO:0045153,1,0.978522029486734,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
12056,GO:0045155,1,0.958882478102093,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
12057,GO:0045159,1,0.898737777847027,0,5,myosin II binding,MF,
12058,GO:0045160,1,0.979420255089006,0,1,myosin I complex,CC,
12061,GO:0045163,1,0.944667130642125,0,3,clustering of voltage-gated potassium channels,BP,
12065,GO:0045174,1,0.957517757905205,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12066,GO:0045176,1,0.804762559129567,0,11,apical protein localization,BP,
12069,GO:0045179,1,0.864448844164686,0,7,apical cortex,CC,
12070,GO:0045180,1,0.906556890092415,0,5,basal cortex,CC,
12071,GO:0045182,1,0.462956015740813,0,37,translation regulator activity,MF,
12074,GO:0045186,1,0.981436691500388,0,1,zonula adherens assembly,BP,
12077,GO:0045189,1,0.978484658321254,0,1,connective tissue growth factor biosynthetic process,BP,
12080,GO:0045196,1,0.940291619484863,0,3,establishment or maintenance of neuroblast polarity,BP,
12083,GO:0045199,1,0.777952362474579,0,12,maintenance of epithelial cell apical/basal polarity,BP,
12084,GO:0045200,1,0.940291619484863,0,3,establishment of neuroblast polarity,BP,
12086,GO:0045204,1,0.939228071640818,0,3,MAPK export from nucleus,BP,
12087,GO:0045208,1,0.979070405406062,0,1,MAPK phosphatase export from nucleus,BP,
12088,GO:0045209,1,0.979070405406062,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
12091,GO:0045212,1,0.9789809337531,0,1,neurotransmitter receptor biosynthetic process,BP,
12092,GO:0045213,1,0.937835873958017,0,3,neurotransmitter receptor metabolic process,BP,
12097,GO:0045219,1,0.979890632634475,0,1,regulation of FasL biosynthetic process,BP,
12098,GO:0045221,1,0.979890632634475,0,1,negative regulation of FasL biosynthetic process,BP,
12099,GO:0045222,1,0.978513892316237,0,1,CD4 biosynthetic process,BP,
12100,GO:0045223,1,0.978513892316237,0,1,regulation of CD4 biosynthetic process,BP,
12101,GO:0045225,1,0.978513892316237,0,1,negative regulation of CD4 biosynthetic process,BP,
12102,GO:0045226,1,0.938189082133873,0,3,extracellular polysaccharide biosynthetic process,BP,
12103,GO:0045229,1,0.94213679482329,0,3,external encapsulating structure organization,BP,
12104,GO:0045234,1,0.978673229069386,0,1,protein palmitoleylation,BP,
12105,GO:0045236,1,0.724660731740247,0,15,CXCR chemokine receptor binding,MF,
12106,GO:0045239,1,0.778636034715718,0,12,tricarboxylic acid cycle enzyme complex,CC,
12107,GO:0045240,1,0.812768944099161,0,10,dihydrolipoyl dehydrogenase complex,CC,
12108,GO:0045244,1,0.978903239804412,0,1,succinate-CoA ligase complex (GDP-forming),CC,
12110,GO:0045252,1,0.880990721784074,0,6,oxoglutarate dehydrogenase complex,CC,
12111,GO:0045254,1,0.843561016192208,0,8,pyruvate dehydrogenase complex,CC,
12112,GO:0045257,1,0.917663598579391,0,4,succinate dehydrogenase complex (ubiquinone),CC,
12113,GO:0045259,1,0.634267065605174,0,21,proton-transporting ATP synthase complex,CC,
12114,GO:0045261,1,0.897360179969233,0,5,proton-transporting ATP synthase complex, catalytic core F(1),CC,
12115,GO:0045263,1,0.787914570727419,0,11,proton-transporting ATP synthase complex, coupling factor F(o),CC,
12116,GO:0045265,1,0.978468652759428,0,1,proton-transporting ATP synthase, stator stalk,CC,
12117,GO:0045267,1,0.978695978101801,0,1,proton-transporting ATP synthase, catalytic core,CC,
12118,GO:0045271,1,0.402094908512984,0,42,respiratory chain complex I,CC,
12119,GO:0045273,1,0.917663598579391,0,4,respiratory chain complex II,CC,
12120,GO:0045275,1,0.788719112251135,0,11,respiratory chain complex III,CC,
12121,GO:0045277,1,0.737292349948076,0,14,respiratory chain complex IV,CC,
12122,GO:0045281,1,0.917663598579391,0,4,succinate dehydrogenase complex,CC,
12123,GO:0045283,1,0.917663598579391,0,4,fumarate reductase complex,CC,
12124,GO:0045292,1,0.697756992089641,0,17,mRNA cis splicing, via spliceosome,BP,
12125,GO:0045293,1,0.918216078769904,0,4,mRNA editing complex,CC,
12129,GO:0045297,1,0.978865968185324,0,1,post-mating behavior,BP,
12130,GO:0045298,1,0.938962581388792,0,3,tubulin complex,CC,
12131,GO:0045299,1,0.982451117615527,0,1,otolith mineralization,BP,
12134,GO:0045322,1,0.979056797625357,0,1,unmethylated CpG binding,MF,
12135,GO:0045323,1,0.9381192891431,0,3,interleukin-1 receptor complex,CC,
12136,GO:0045324,1,0.729680997735861,0,15,late endosome to vacuole transport,BP,
12137,GO:0045329,1,0.898983048833009,0,5,carnitine biosynthetic process,BP,
12138,GO:0045332,1,0.646911482895253,0,22,phospholipid translocation,BP,
12142,GO:0045337,1,0.958063540882306,0,2,farnesyl diphosphate biosynthetic process,BP,
12143,GO:0045338,1,0.937752855300486,0,3,farnesyl diphosphate metabolic process,BP,
12144,GO:0045340,1,0.978487817470133,0,1,mercury ion binding,MF,
12145,GO:0045341,1,0.863667031758092,0,7,MHC class I biosynthetic process,BP,
12146,GO:0045342,1,0.759021066956576,0,13,MHC class II biosynthetic process,BP,
12147,GO:0045343,1,0.863667031758092,0,7,regulation of MHC class I biosynthetic process,BP,
12148,GO:0045345,1,0.882668278379101,0,6,positive regulation of MHC class I biosynthetic process,BP,
12149,GO:0045346,1,0.775244057359352,0,12,regulation of MHC class II biosynthetic process,BP,
12150,GO:0045347,1,0.89978334266679,0,5,negative regulation of MHC class II biosynthetic process,BP,
12151,GO:0045348,1,0.843197070214327,0,8,positive regulation of MHC class II biosynthetic process,BP,
12155,GO:0045352,1,0.978671748385357,0,1,interleukin-1 Type I receptor antagonist activity,MF,
12156,GO:0045353,1,0.978671748385357,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12159,GO:0045356,1,0.919426568411427,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12165,GO:0045366,1,0.979791266402129,0,1,regulation of interleukin-13 biosynthetic process,BP,
12166,GO:0045368,1,0.979791266402129,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12167,GO:0045381,1,0.979068802678644,0,1,regulation of interleukin-18 biosynthetic process,BP,
12168,GO:0045399,1,0.958544672326242,0,2,regulation of interleukin-3 biosynthetic process,BP,
12169,GO:0045401,1,0.958544672326242,0,2,positive regulation of interleukin-3 biosynthetic process,BP,
12172,GO:0045404,1,0.95923160288651,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12173,GO:0045405,1,0.978468779604703,0,1,regulation of interleukin-5 biosynthetic process,BP,
12174,GO:0045407,1,0.978468779604703,0,1,positive regulation of interleukin-5 biosynthetic process,BP,
12175,GO:0045408,1,0.711173874852106,0,16,regulation of interleukin-6 biosynthetic process,BP,
12176,GO:0045409,1,0.898853466614397,0,5,negative regulation of interleukin-6 biosynthetic process,BP,
12177,GO:0045410,1,0.84423497995189,0,8,positive regulation of interleukin-6 biosynthetic process,BP,
12178,GO:0045414,1,0.774338429132803,0,12,regulation of interleukin-8 biosynthetic process,BP,
12179,GO:0045415,1,0.917805479396597,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12180,GO:0045416,1,0.843725580644931,0,8,positive regulation of interleukin-8 biosynthetic process,BP,
12181,GO:0045423,1,0.91823807316258,0,4,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12182,GO:0045425,1,0.93843831861795,0,3,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12188,GO:0045448,1,0.918335783187626,0,4,mitotic cell cycle, embryonic,BP,
12190,GO:0045454,1,0.233400363045935,0,68,cell redox homeostasis,BP,
12192,GO:0045472,1,0.778435083720625,0,12,response to ether,BP,
12193,GO:0045475,1,0.799046191097244,0,11,locomotor rhythm,BP,
12196,GO:0045495,1,0.71324005378679,0,16,pole plasm,CC,
12197,GO:0045499,1,0.830725169795346,0,9,chemorepellent activity,MF,
12198,GO:0045503,1,0.918648664453409,0,4,dynein light chain binding,MF,
12199,GO:0045504,1,0.918343846394602,0,4,dynein heavy chain binding,MF,
12201,GO:0045509,1,0.958574195332492,0,2,interleukin-27 receptor activity,MF,
12202,GO:0045513,1,0.978566999549344,0,1,interleukin-27 binding,MF,
12203,GO:0045517,1,0.978525653916765,0,1,interleukin-20 receptor binding,MF,
12204,GO:0045518,1,0.957498164431837,0,2,interleukin-22 receptor binding,MF,
12205,GO:0045519,1,0.957851991382485,0,2,interleukin-23 receptor binding,MF,
12206,GO:0045523,1,0.957469701949,0,2,interleukin-27 receptor binding,MF,
12208,GO:0045541,1,0.898318806005976,0,5,negative regulation of cholesterol biosynthetic process,BP,
12210,GO:0045545,1,0.887216560500797,0,6,syndecan binding,MF,
12211,GO:0045550,1,0.957593049659306,0,2,geranylgeranyl reductase activity,MF,
12212,GO:0045553,1,0.979061372367106,0,1,TRAIL biosynthetic process,BP,
12213,GO:0045554,1,0.979061372367106,0,1,regulation of TRAIL biosynthetic process,BP,
12214,GO:0045556,1,0.979061372367106,0,1,positive regulation of TRAIL biosynthetic process,BP,
12215,GO:0045569,1,0.918050037312288,0,4,TRAIL binding,MF,
12216,GO:0045575,1,0.957741241677485,0,2,basophil activation,BP,
12218,GO:0045577,1,0.603986975142963,0,24,regulation of B cell differentiation,BP,
12219,GO:0045578,1,0.917857732821001,0,4,negative regulation of B cell differentiation,BP,
12220,GO:0045579,1,0.76023105110548,0,13,positive regulation of B cell differentiation,BP,
12224,GO:0045583,1,0.958147684156442,0,2,regulation of cytotoxic T cell differentiation,BP,
12225,GO:0045585,1,0.958147684156442,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12226,GO:0045586,1,0.90083848186966,0,5,regulation of gamma-delta T cell differentiation,BP,
12227,GO:0045588,1,0.939585502096547,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12228,GO:0045589,1,0.666663265100274,0,19,regulation of regulatory T cell differentiation,BP,
12229,GO:0045590,1,0.938181043375824,0,3,negative regulation of regulatory T cell differentiation,BP,
12230,GO:0045591,1,0.772994413097207,0,12,positive regulation of regulatory T cell differentiation,BP,
12238,GO:0045602,1,0.866736273424693,0,7,negative regulation of endothelial cell differentiation,BP,
12245,GO:0045609,1,0.978501057651594,0,1,positive regulation of auditory receptor cell differentiation,BP,
12247,GO:0045617,1,0.843466064698692,0,8,negative regulation of keratinocyte differentiation,BP,
12252,GO:0045622,1,0.529903708172791,0,30,regulation of T-helper cell differentiation,BP,
12253,GO:0045623,1,0.745897676840613,0,14,negative regulation of T-helper cell differentiation,BP,
12254,GO:0045624,1,0.666325346133488,0,19,positive regulation of T-helper cell differentiation,BP,
12255,GO:0045625,1,0.808358261750055,0,10,regulation of T-helper 1 cell differentiation,BP,
12256,GO:0045626,1,0.939149894996798,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12257,GO:0045627,1,0.879676601436974,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12258,GO:0045628,1,0.77420114408723,0,12,regulation of T-helper 2 cell differentiation,BP,
12259,GO:0045629,1,0.918381666206053,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12260,GO:0045630,1,0.843039275999783,0,8,positive regulation of T-helper 2 cell differentiation,BP,
12263,GO:0045633,1,0.978501057651594,0,1,positive regulation of mechanoreceptor differentiation,BP,
12269,GO:0045643,1,0.957999898522629,0,2,regulation of eosinophil differentiation,BP,
12270,GO:0045645,1,0.957999898522629,0,2,positive regulation of eosinophil differentiation,BP,
12272,GO:0045647,1,0.845340525378866,0,8,negative regulation of erythrocyte differentiation,BP,
12273,GO:0045648,1,0.617575596540205,0,23,positive regulation of erythrocyte differentiation,BP,
12275,GO:0045650,1,0.861186653563896,0,7,negative regulation of macrophage differentiation,BP,
12277,GO:0045652,1,0.547024584751521,0,28,regulation of megakaryocyte differentiation,BP,
12278,GO:0045653,1,0.676601577123817,0,18,negative regulation of megakaryocyte differentiation,BP,
12279,GO:0045654,1,0.860965629903631,0,7,positive regulation of megakaryocyte differentiation,BP,
12280,GO:0045655,1,0.685746962841726,0,18,regulation of monocyte differentiation,BP,
12281,GO:0045656,1,0.866521900585564,0,7,negative regulation of monocyte differentiation,BP,
12282,GO:0045657,1,0.825941462061827,0,9,positive regulation of monocyte differentiation,BP,
12283,GO:0045658,1,0.958974804712871,0,2,regulation of neutrophil differentiation,BP,
12284,GO:0045659,1,0.958974804712871,0,2,negative regulation of neutrophil differentiation,BP,
12287,GO:0045663,1,0.646907715938507,0,21,positive regulation of myoblast differentiation,BP,
12296,GO:0045672,1,0.604233964460533,0,24,positive regulation of osteoclast differentiation,BP,
12303,GO:0045703,1,0.978524484651327,0,1,ketoreductase activity,MF,
12304,GO:0045713,1,0.81168294946616,0,10,low-density lipoprotein particle receptor biosynthetic process,BP,
12305,GO:0045714,1,0.82935679223847,0,9,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12306,GO:0045715,1,0.941042324050471,0,3,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12307,GO:0045716,1,0.917896082858454,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12309,GO:0045719,1,0.903677755604788,0,5,negative regulation of glycogen biosynthetic process,BP,
12310,GO:0045720,1,0.958190497569662,0,2,negative regulation of integrin biosynthetic process,BP,
12311,GO:0045721,1,0.758250473484328,0,13,negative regulation of gluconeogenesis,BP,
12312,GO:0045722,1,0.814756253789518,0,10,positive regulation of gluconeogenesis,BP,
12314,GO:0045724,1,0.664779125963939,0,20,positive regulation of cilium assembly,BP,
12316,GO:0045726,1,0.938990675282339,0,3,positive regulation of integrin biosynthetic process,BP,
12318,GO:0045728,1,0.978823939821561,0,1,respiratory burst after phagocytosis,BP,
12323,GO:0045738,1,0.705561923353077,0,17,negative regulation of DNA repair,BP,
12328,GO:0045743,1,0.882385483974194,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12333,GO:0045751,1,0.979068802678644,0,1,negative regulation of Toll signaling pathway,BP,
12334,GO:0045759,1,0.862641302886616,0,7,negative regulation of action potential,BP,
12335,GO:0045760,1,0.797368622612472,0,11,positive regulation of action potential,BP,
12336,GO:0045761,1,0.211702448800119,0,74,regulation of adenylate cyclase activity,BP,
12337,GO:0045762,1,0.38340352127143,0,46,positive regulation of adenylate cyclase activity,BP,
12338,GO:0045763,1,0.962351873827961,0,2,negative regulation of cellular amino acid metabolic process,BP,
12339,GO:0045764,1,0.937521382954235,0,3,positive regulation of cellular amino acid metabolic process,BP,
12342,GO:0045769,1,0.98383051313392,0,1,negative regulation of asymmetric cell division,BP,
12343,GO:0045773,1,0.457740536873369,0,39,positive regulation of axon extension,BP,
12348,GO:0045780,1,0.762290122826914,0,13,positive regulation of bone resorption,BP,
12354,GO:0045794,1,0.903280780598175,0,5,negative regulation of cell volume,BP,
12355,GO:0045795,1,0.980975210244642,0,1,positive regulation of cell volume,BP,
12356,GO:0045796,1,0.958470419588343,0,2,negative regulation of intestinal cholesterol absorption,BP,
12357,GO:0045799,1,0.942367185733233,0,3,positive regulation of chromatin assembly or disassembly,BP,
12360,GO:0045814,1,0.0636025242426226,0,130,negative regulation of gene expression, epigenetic,BP,
12361,GO:0045815,1,0.187313645604966,0,79,positive regulation of gene expression, epigenetic,BP,
12362,GO:0045818,1,0.978466075387628,0,1,negative regulation of glycogen catabolic process,BP,
12363,GO:0045819,1,0.979098049809899,0,1,positive regulation of glycogen catabolic process,BP,
12365,GO:0045821,1,0.766478476360554,0,13,positive regulation of glycolytic process,BP,
12369,GO:0045827,1,0.978524484651327,0,1,negative regulation of isoprenoid metabolic process,BP,
12370,GO:0045829,1,0.918461232397415,0,4,negative regulation of isotype switching,BP,
12377,GO:0045838,1,0.827836933735248,0,9,positive regulation of membrane potential,BP,
12380,GO:0045841,1,0.538052361600377,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
12381,GO:0045842,1,0.883788493242418,0,6,positive regulation of mitotic metaphase/anaphase transition,BP,
12384,GO:0045848,1,0.978819787817556,0,1,positive regulation of nitrogen utilization,BP,
12386,GO:0045852,1,0.88151910738308,0,6,pH elevation,BP,
12391,GO:0045869,1,0.861332848892125,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12392,GO:0045870,1,0.980099214300398,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12393,GO:0045872,1,0.957974714582927,0,2,positive regulation of rhodopsin gene expression,BP,
12394,GO:0045875,1,0.9486441093324,0,3,negative regulation of sister chromatid cohesion,BP,
12395,GO:0045876,1,0.862491221922394,0,7,positive regulation of sister chromatid cohesion,BP,
12397,GO:0045880,1,0.570467557612222,0,27,positive regulation of smoothened signaling pathway,BP,
12398,GO:0045887,1,0.981323306537097,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12401,GO:0045896,1,0.940544873366923,0,3,regulation of transcription during mitotic cell cycle,BP,
12402,GO:0045897,1,0.980076193654385,0,1,positive regulation of transcription during mitotic cell cycle,BP,
12403,GO:0045898,1,0.762389880011184,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12404,GO:0045899,1,0.812239520250665,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12405,GO:0045900,1,0.919952247540605,0,4,negative regulation of translational elongation,BP,
12406,GO:0045901,1,0.89940229009067,0,5,positive regulation of translational elongation,BP,
12407,GO:0045903,1,0.957697199387178,0,2,positive regulation of translational fidelity,BP,
12408,GO:0045905,1,0.938865028858175,0,3,positive regulation of translational termination,BP,
12409,GO:0045906,1,0.871523118234024,0,7,negative regulation of vasoconstriction,BP,
12411,GO:0045910,1,0.644137348311953,0,21,negative regulation of DNA recombination,BP,
12415,GO:0045914,1,0.958377916731128,0,2,negative regulation of catecholamine metabolic process,BP,
12416,GO:0045915,1,0.880127390096153,0,6,positive regulation of catecholamine metabolic process,BP,
12417,GO:0045916,1,0.84886689694953,0,8,negative regulation of complement activation,BP,
12418,GO:0045917,1,0.93871592619069,0,3,positive regulation of complement activation,BP,
12419,GO:0045918,1,0.917273932453256,0,4,negative regulation of cytolysis,BP,
12420,GO:0045919,1,0.898667917650443,0,5,positive regulation of cytolysis,BP,
12425,GO:0045924,1,0.846363858470925,0,8,regulation of female receptivity,BP,
12426,GO:0045925,1,0.939641198375215,0,3,positive regulation of female receptivity,BP,
12437,GO:0045938,1,0.859741628269539,0,7,positive regulation of circadian sleep/wake cycle, sleep,BP,
12440,GO:0045943,1,0.646683839498544,0,21,positive regulation of transcription from RNA polymerase I promoter,BP,
12442,GO:0045945,1,0.832964288553241,0,9,positive regulation of transcription from RNA polymerase III promoter,BP,
12443,GO:0045947,1,0.644410692766994,0,21,negative regulation of translational initiation,BP,
12444,GO:0045948,1,0.615068372374893,0,23,positive regulation of translational initiation,BP,
12445,GO:0045950,1,0.91852929063915,0,4,negative regulation of mitotic recombination,BP,
12446,GO:0045953,1,0.807260934815436,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12447,GO:0045954,1,0.683856822787169,0,18,positive regulation of natural killer cell mediated cytotoxicity,BP,
12449,GO:0045956,1,0.647424302852,0,21,positive regulation of calcium ion-dependent exocytosis,BP,
12450,GO:0045957,1,0.982745541009455,0,1,negative regulation of complement activation, alternative pathway,BP,
12451,GO:0045959,1,0.941272508262715,0,3,negative regulation of complement activation, classical pathway,BP,
12452,GO:0045963,1,0.958377916731128,0,2,negative regulation of dopamine metabolic process,BP,
12453,GO:0045964,1,0.880127390096153,0,6,positive regulation of dopamine metabolic process,BP,
12454,GO:0045974,1,0.771514260136751,0,13,regulation of translation, ncRNA-mediated,BP,
12455,GO:0045976,1,0.958600622682417,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12456,GO:0045977,1,0.978570356890495,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12463,GO:0045990,1,0.881593469403188,0,6,carbon catabolite regulation of transcription,BP,
12464,GO:0045991,1,0.900602977933804,0,5,carbon catabolite activation of transcription,BP,
12466,GO:0045993,1,0.979268155798965,0,1,negative regulation of translational initiation by iron,BP,
12467,GO:0045994,1,0.959006465625876,0,2,positive regulation of translational initiation by iron,BP,
12469,GO:0046005,1,0.93682519249346,0,3,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12471,GO:0046007,1,0.812257029518765,0,10,negative regulation of activated T cell proliferation,BP,
12472,GO:0046010,1,0.937444704815582,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12473,GO:0046013,1,0.937427332422486,0,3,regulation of T cell homeostatic proliferation,BP,
12474,GO:0046015,1,0.879470588383457,0,6,regulation of transcription by glucose,BP,
12475,GO:0046016,1,0.918054295455661,0,4,positive regulation of transcription by glucose,BP,
12476,GO:0046021,1,0.940544873366923,0,3,regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12477,GO:0046022,1,0.980076193654385,0,1,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12478,GO:0046030,1,0.7960943914609,0,11,inositol trisphosphate phosphatase activity,MF,
12480,GO:0046032,1,0.978591640247889,0,1,ADP catabolic process,BP,
12481,GO:0046033,1,0.774079462487613,0,12,AMP metabolic process,BP,
12483,GO:0046035,1,0.978527865550976,0,1,CMP metabolic process,BP,
12484,GO:0046036,1,0.739577209856333,0,14,CTP metabolic process,BP,
12485,GO:0046037,1,0.660228674080719,0,20,GMP metabolic process,BP,
12486,GO:0046038,1,0.978562097860833,0,1,GMP catabolic process,BP,
12488,GO:0046040,1,0.759372960423139,0,13,IMP metabolic process,BP,
12489,GO:0046041,1,0.957955102264844,0,2,ITP metabolic process,BP,
12490,GO:0046048,1,0.979053258701536,0,1,UDP metabolic process,BP,
12491,GO:0046049,1,0.809235254648626,0,10,UMP metabolic process,BP,
12492,GO:0046051,1,0.790703020463766,0,11,UTP metabolic process,BP,
12493,GO:0046054,1,0.978493226101955,0,1,dGMP metabolic process,BP,
12494,GO:0046056,1,0.958105398124343,0,2,dADP metabolic process,BP,
12495,GO:0046057,1,0.97858744205237,0,1,dADP catabolic process,BP,
12497,GO:0046060,1,0.897845404008093,0,5,dATP metabolic process,BP,
12498,GO:0046061,1,0.937480454686771,0,3,dATP catabolic process,BP,
12499,GO:0046065,1,0.978508018657599,0,1,dCTP metabolic process,BP,
12500,GO:0046066,1,0.957539956037265,0,2,dGDP metabolic process,BP,
12501,GO:0046067,1,0.97858744205237,0,1,dGDP catabolic process,BP,
12503,GO:0046069,1,0.868576920884461,0,7,cGMP catabolic process,BP,
12504,GO:0046070,1,0.917479482032112,0,4,dGTP metabolic process,BP,
12505,GO:0046072,1,0.9580181451805,0,2,dTDP metabolic process,BP,
12506,GO:0046073,1,0.957996575709428,0,2,dTMP metabolic process,BP,
12507,GO:0046075,1,0.917398443731461,0,4,dTTP metabolic process,BP,
12508,GO:0046077,1,0.9580181451805,0,2,dUDP metabolic process,BP,
12509,GO:0046078,1,0.937274245328949,0,3,dUMP metabolic process,BP,
12510,GO:0046079,1,0.978606273753634,0,1,dUMP catabolic process,BP,
12511,GO:0046080,1,0.978706510299768,0,1,dUTP metabolic process,BP,
12512,GO:0046083,1,0.957496814988344,0,2,adenine metabolic process,BP,
12513,GO:0046084,1,0.957496814988344,0,2,adenine biosynthetic process,BP,
12514,GO:0046085,1,0.861761073912097,0,7,adenosine metabolic process,BP,
12515,GO:0046086,1,0.958344881330318,0,2,adenosine biosynthetic process,BP,
12516,GO:0046087,1,0.823482766568907,0,9,cytidine metabolic process,BP,
12517,GO:0046090,1,0.978592601272244,0,1,deoxyadenosine metabolic process,BP,
12518,GO:0046092,1,0.979604582537683,0,1,deoxycytidine metabolic process,BP,
12519,GO:0046098,1,0.938796595531993,0,3,guanine metabolic process,BP,
12520,GO:0046099,1,0.978562097860833,0,1,guanine biosynthetic process,BP,
12521,GO:0046100,1,0.937330786234155,0,3,hypoxanthine metabolic process,BP,
12522,GO:0046101,1,0.937330786234155,0,3,hypoxanthine biosynthetic process,BP,
12524,GO:0046103,1,0.978592601272244,0,1,inosine biosynthetic process,BP,
12525,GO:0046104,1,0.938578900115956,0,3,thymidine metabolic process,BP,
12526,GO:0046108,1,0.958055164949394,0,2,uridine metabolic process,BP,
12528,GO:0046111,1,0.978592601272244,0,1,xanthine biosynthetic process,BP,
12529,GO:0046112,1,0.70069390131742,0,17,nucleobase biosynthetic process,BP,
12531,GO:0046116,1,0.878314602912158,0,6,queuosine metabolic process,BP,
12533,GO:0046122,1,0.957547143976403,0,2,purine deoxyribonucleoside metabolic process,BP,
12534,GO:0046124,1,0.978592601272244,0,1,purine deoxyribonucleoside catabolic process,BP,
12535,GO:0046125,1,0.938578900115956,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12536,GO:0046127,1,0.97906633745935,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12538,GO:0046129,1,0.636583029245353,0,21,purine ribonucleoside biosynthetic process,BP,
12540,GO:0046131,1,0.503740097702295,0,32,pyrimidine ribonucleoside metabolic process,BP,
12541,GO:0046132,1,0.638409710631702,0,21,pyrimidine ribonucleoside biosynthetic process,BP,
12542,GO:0046133,1,0.789027859318851,0,11,pyrimidine ribonucleoside catabolic process,BP,
12543,GO:0046134,1,0.537708475343657,0,29,pyrimidine nucleoside biosynthetic process,BP,
12544,GO:0046135,1,0.650353973540707,0,20,pyrimidine nucleoside catabolic process,BP,
12545,GO:0046136,1,0.937098523408545,0,3,positive regulation of vitamin metabolic process,BP,
12546,GO:0046137,1,0.87957132741208,0,6,negative regulation of vitamin metabolic process,BP,
12547,GO:0046144,1,0.978610737723817,0,1,D-alanine family amino acid metabolic process,BP,
12550,GO:0046149,1,0.859825879827315,0,7,pigment catabolic process,BP,
12551,GO:0046160,1,0.960570939252975,0,2,heme a metabolic process,BP,
12552,GO:0046164,1,0.378164248443885,0,46,alcohol catabolic process,BP,
12554,GO:0046166,1,0.957828842049013,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12555,GO:0046167,1,0.942386390252689,0,3,glycerol-3-phosphate biosynthetic process,BP,
12556,GO:0046168,1,0.958578402219599,0,2,glycerol-3-phosphate catabolic process,BP,
12557,GO:0046173,1,0.429542794080964,0,40,polyol biosynthetic process,BP,
12558,GO:0046174,1,0.688243157112758,0,18,polyol catabolic process,BP,
12559,GO:0046176,1,0.97897493185122,0,1,aldonic acid catabolic process,BP,
12560,GO:0046177,1,0.97897493185122,0,1,D-gluconate catabolic process,BP,
12562,GO:0046185,1,0.789951473068161,0,11,aldehyde catabolic process,BP,
12564,GO:0046203,1,0.957617363850045,0,2,spermidine catabolic process,BP,
12565,GO:0046204,1,0.978490665620568,0,1,nor-spermidine metabolic process,BP,
12566,GO:0046208,1,0.917438119031289,0,4,spermine catabolic process,BP,
12568,GO:0046210,1,0.978958443763373,0,1,nitric oxide catabolic process,BP,
12569,GO:0046218,1,0.790133589619033,0,11,indolalkylamine catabolic process,BP,
12570,GO:0046219,1,0.897910608181495,0,5,indolalkylamine biosynthetic process,BP,
12571,GO:0046222,1,0.97888453883524,0,1,aflatoxin metabolic process,BP,
12572,GO:0046226,1,0.957642457859658,0,2,coumarin catabolic process,BP,
12573,GO:0046247,1,0.979044015025739,0,1,terpene catabolic process,BP,
12574,GO:0046271,1,0.957642457859658,0,2,phenylpropanoid catabolic process,BP,
12575,GO:0046272,1,0.97884417678277,0,1,stilbene catabolic process,BP,
12576,GO:0046292,1,0.938260381789933,0,3,formaldehyde metabolic process,BP,
12577,GO:0046293,1,0.979428759681036,0,1,formaldehyde biosynthetic process,BP,
12578,GO:0046294,1,0.957969279949908,0,2,formaldehyde catabolic process,BP,
12579,GO:0046295,1,0.978487817470133,0,1,glycolate biosynthetic process,BP,
12580,GO:0046296,1,0.978659723137941,0,1,glycolate catabolic process,BP,
12581,GO:0046305,1,0.958076872836173,0,2,alkanesulfonate biosynthetic process,BP,
12582,GO:0046314,1,0.978598469313653,0,1,phosphocreatine biosynthetic process,BP,
12583,GO:0046316,1,0.97897493185122,0,1,gluconokinase activity,MF,
12584,GO:0046317,1,0.97964453895366,0,1,regulation of glucosylceramide biosynthetic process,BP,
12585,GO:0046318,1,0.97964453895366,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12587,GO:0046321,1,0.752095342702839,0,14,positive regulation of fatty acid oxidation,BP,
12591,GO:0046325,1,0.776613164115814,0,12,negative regulation of glucose import,BP,
12593,GO:0046327,1,0.97900988198517,0,1,glycerol biosynthetic process from pyruvate,BP,
12599,GO:0046333,1,0.958529149180282,0,2,octopamine metabolic process,BP,
12600,GO:0046337,1,0.728647943533294,0,15,phosphatidylethanolamine metabolic process,BP,
12601,GO:0046338,1,0.958526837526601,0,2,phosphatidylethanolamine catabolic process,BP,
12603,GO:0046340,1,0.938961139438173,0,3,diacylglycerol catabolic process,BP,
12604,GO:0046341,1,0.780595492947604,0,12,CDP-diacylglycerol metabolic process,BP,
12605,GO:0046348,1,0.824344777596708,0,9,amino sugar catabolic process,BP,
12606,GO:0046349,1,0.79406615294932,0,11,amino sugar biosynthetic process,BP,
12607,GO:0046351,1,0.898242304787678,0,5,disaccharide biosynthetic process,BP,
12608,GO:0046352,1,0.978702590235847,0,1,disaccharide catabolic process,BP,
12610,GO:0046360,1,0.978805637620653,0,1,2-oxobutyrate biosynthetic process,BP,
12611,GO:0046361,1,0.978805637620653,0,1,2-oxobutyrate metabolic process,BP,
12614,GO:0046368,1,0.917993428057708,0,4,GDP-L-fucose metabolic process,BP,
12615,GO:0046370,1,0.957973769382675,0,2,fructose biosynthetic process,BP,
12616,GO:0046373,1,0.97897493185122,0,1,L-arabinose metabolic process,BP,
12617,GO:0046379,1,0.938189082133873,0,3,extracellular polysaccharide metabolic process,BP,
12618,GO:0046380,1,0.979081215841271,0,1,N-acetylneuraminate biosynthetic process,BP,
12619,GO:0046381,1,0.978526838284668,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12620,GO:0046385,1,0.824153544449458,0,9,deoxyribose phosphate biosynthetic process,BP,
12623,GO:0046391,1,0.917974240546835,0,4,5-phosphoribose 1-diphosphate metabolic process,BP,
12626,GO:0046398,1,0.920152493594203,0,4,UDP-glucuronate metabolic process,BP,
12627,GO:0046403,1,0.978651906489294,0,1,polynucleotide 3'-phosphatase activity,MF,
12628,GO:0046404,1,0.93950108193437,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12630,GO:0046416,1,0.937520194655341,0,3,D-amino acid metabolic process,BP,
12632,GO:0046426,1,0.35539937855596,0,49,negative regulation of JAK-STAT cascade,BP,
12635,GO:0046436,1,0.978610737723817,0,1,D-alanine metabolic process,BP,
12636,GO:0046437,1,0.978948595150004,0,1,D-amino acid biosynthetic process,BP,
12637,GO:0046439,1,0.861822712792595,0,7,L-cysteine metabolic process,BP,
12638,GO:0046440,1,0.919581708328093,0,4,L-lysine metabolic process,BP,
12639,GO:0046443,1,0.978746526553592,0,1,FAD metabolic process,BP,
12640,GO:0046444,1,0.979015220146453,0,1,FMN metabolic process,BP,
12641,GO:0046448,1,0.978935935955106,0,1,tropane alkaloid metabolic process,BP,
12643,GO:0046452,1,0.958336186071685,0,2,dihydrofolate metabolic process,BP,
12646,GO:0046459,1,0.758989625515965,0,13,short-chain fatty acid metabolic process,BP,
12649,GO:0046462,1,0.958093912555592,0,2,monoacylglycerol metabolic process,BP,
12652,GO:0046465,1,0.861622789421542,0,7,dolichyl diphosphate metabolic process,BP,
12655,GO:0046469,1,0.88123915565881,0,6,platelet activating factor metabolic process,BP,
12657,GO:0046471,1,0.518602702779755,0,31,phosphatidylglycerol metabolic process,BP,
12658,GO:0046473,1,0.482089910437277,0,35,phosphatidic acid metabolic process,BP,
12661,GO:0046476,1,0.91859243039761,0,4,glycosylceramide biosynthetic process,BP,
12669,GO:0046490,1,0.897807837773187,0,5,isopentenyl diphosphate metabolic process,BP,
12670,GO:0046491,1,0.978482532684248,0,1,L-methylmalonyl-CoA metabolic process,BP,
12671,GO:0046493,1,0.978471214322306,0,1,lipid A metabolic process,BP,
12674,GO:0046498,1,0.880113574219232,0,6,S-adenosylhomocysteine metabolic process,BP,
12675,GO:0046499,1,0.979069037868997,0,1,S-adenosylmethioninamine metabolic process,BP,
12676,GO:0046500,1,0.759639806060773,0,13,S-adenosylmethionine metabolic process,BP,
12677,GO:0046501,1,0.809241520849832,0,10,protoporphyrinogen IX metabolic process,BP,
12678,GO:0046502,1,0.957830198363003,0,2,uroporphyrinogen III metabolic process,BP,
12680,GO:0046504,1,0.921343474610595,0,4,glycerol ether biosynthetic process,BP,
12681,GO:0046511,1,0.960348693330123,0,2,sphinganine biosynthetic process,BP,
12682,GO:0046512,1,0.845030361091023,0,8,sphingosine biosynthetic process,BP,
12683,GO:0046513,1,0.371473047745195,0,47,ceramide biosynthetic process,BP,
12685,GO:0046519,1,0.75986078914708,0,13,sphingoid metabolic process,BP,
12686,GO:0046520,1,0.827350229215848,0,9,sphingoid biosynthetic process,BP,
12687,GO:0046521,1,0.978703372485861,0,1,sphingoid catabolic process,BP,
12689,GO:0046525,1,0.978651555199687,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12690,GO:0046526,1,0.978965040994655,0,1,D-xylulose reductase activity,MF,
12695,GO:0046534,1,0.979264248064071,0,1,positive regulation of photoreceptor cell differentiation,BP,
12696,GO:0046538,1,0.917193371948543,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12697,GO:0046539,1,0.978485347627933,0,1,histamine N-methyltransferase activity,MF,
12698,GO:0046540,1,0.668212897975113,0,19,U4/U6 x U5 tri-snRNP complex,CC,
12701,GO:0046544,1,0.979641779965089,0,1,development of secondary male sexual characteristics,BP,
12704,GO:0046548,1,0.83046869286436,0,9,retinal rod cell development,BP,
12705,GO:0046549,1,0.828301299036142,0,9,retinal cone cell development,BP,
12706,GO:0046554,1,0.978538957355817,0,1,malate dehydrogenase (NADP+) activity,MF,
12707,GO:0046556,1,0.97897493185122,0,1,alpha-L-arabinofuranosidase activity,MF,
12708,GO:0046570,1,0.978530306275397,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12710,GO:0046577,1,0.979079054860775,0,1,long-chain-alcohol oxidase activity,MF,
12714,GO:0046581,1,0.883640735124439,0,6,intercellular canaliculus,CC,
12715,GO:0046586,1,0.957995039769114,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12716,GO:0046587,1,0.979060220110392,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12717,GO:0046588,1,0.978485512071337,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12718,GO:0046592,1,0.957881707201612,0,2,polyamine oxidase activity,MF,
12719,GO:0046596,1,0.538965943392633,0,29,regulation of viral entry into host cell,BP,
12720,GO:0046597,1,0.667503140978502,0,19,negative regulation of viral entry into host cell,BP,
12721,GO:0046598,1,0.824877127807936,0,9,positive regulation of viral entry into host cell,BP,
12722,GO:0046599,1,0.73108790387071,0,15,regulation of centriole replication,BP,
12723,GO:0046600,1,0.884054487342597,0,6,negative regulation of centriole replication,BP,
12724,GO:0046601,1,0.938523626640641,0,3,positive regulation of centriole replication,BP,
12725,GO:0046602,1,0.832468104886461,0,9,regulation of mitotic centrosome separation,BP,
12726,GO:0046604,1,0.905855828592843,0,5,positive regulation of mitotic centrosome separation,BP,
12728,GO:0046606,1,0.811778601797941,0,10,negative regulation of centrosome cycle,BP,
12729,GO:0046607,1,0.799196126393737,0,11,positive regulation of centrosome cycle,BP,
12730,GO:0046618,1,0.899176203154968,0,5,drug export,BP,
12731,GO:0046619,1,0.960424269686799,0,2,optic placode formation involved in camera-type eye formation,BP,
12735,GO:0046623,1,0.979502282993324,0,1,sphingolipid-translocating ATPase activity,MF,
12736,GO:0046624,1,0.900298586429954,0,5,sphingolipid transporter activity,MF,
12737,GO:0046625,1,0.742508659227011,0,14,sphingolipid binding,MF,
12739,GO:0046627,1,0.534497423457721,0,30,negative regulation of insulin receptor signaling pathway,BP,
12740,GO:0046628,1,0.780536877963122,0,12,positive regulation of insulin receptor signaling pathway,BP,
12744,GO:0046633,1,0.575847615510302,0,26,alpha-beta T cell proliferation,BP,
12747,GO:0046636,1,0.567246000159246,0,27,negative regulation of alpha-beta T cell activation,BP,
12750,GO:0046639,1,0.686829588788026,0,18,negative regulation of alpha-beta T cell differentiation,BP,
12751,GO:0046640,1,0.613002401247002,0,23,regulation of alpha-beta T cell proliferation,BP,
12752,GO:0046641,1,0.666425074144912,0,19,positive regulation of alpha-beta T cell proliferation,BP,
12753,GO:0046642,1,0.899758767100862,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12754,GO:0046643,1,0.863673649182183,0,7,regulation of gamma-delta T cell activation,BP,
12755,GO:0046645,1,0.900826484261214,0,5,positive regulation of gamma-delta T cell activation,BP,
12758,GO:0046653,1,0.699022589186025,0,17,tetrahydrofolate metabolic process,BP,
12759,GO:0046654,1,0.880275458299458,0,6,tetrahydrofolate biosynthetic process,BP,
12760,GO:0046655,1,0.685698800205586,0,18,folic acid metabolic process,BP,
12761,GO:0046657,1,0.978483595077724,0,1,folic acid catabolic process,BP,
12762,GO:0046658,1,0.394153693707526,0,44,anchored component of plasma membrane,CC,
12765,GO:0046666,1,0.917642841174619,0,4,retinal cell programmed cell death,BP,
12766,GO:0046668,1,0.958242840936315,0,2,regulation of retinal cell programmed cell death,BP,
12767,GO:0046671,1,0.979086398056303,0,1,negative regulation of retinal cell programmed cell death,BP,
12770,GO:0046680,1,0.978795633443475,0,1,response to DDT,BP,
12772,GO:0046684,1,0.918168392461937,0,4,response to pyrethroid,BP,
12775,GO:0046687,1,0.978505201044607,0,1,response to chromate,BP,
12776,GO:0046688,1,0.588419248606892,0,25,response to copper ion,BP,
12777,GO:0046689,1,0.790849676515821,0,11,response to mercury ion,BP,
12778,GO:0046690,1,0.979069513730973,0,1,response to tellurium ion,BP,
12779,GO:0046691,1,0.979044302385337,0,1,intracellular canaliculus,CC,
12780,GO:0046692,1,0.97848305880818,0,1,sperm competition,BP,
12781,GO:0046696,1,0.881019661459536,0,6,lipopolysaccharide receptor complex,CC,
12784,GO:0046703,1,0.823296634788621,0,9,natural killer cell lectin-like receptor binding,MF,
12785,GO:0046707,1,0.959342504795163,0,2,IDP metabolic process,BP,
12786,GO:0046709,1,0.959342504795163,0,2,IDP catabolic process,BP,
12787,GO:0046710,1,0.749715300950392,0,14,GDP metabolic process,BP,
12788,GO:0046711,1,0.978493226101955,0,1,GDP biosynthetic process,BP,
12789,GO:0046712,1,0.97858744205237,0,1,GDP catabolic process,BP,
12790,GO:0046713,1,0.979065975813621,0,1,borate transport,BP,
12791,GO:0046715,1,0.979065975813621,0,1,borate transmembrane transporter activity,MF,
12792,GO:0046716,1,0.697712251946808,0,17,muscle cell cellular homeostasis,BP,
12795,GO:0046719,1,0.826111427515398,0,9,regulation by virus of viral protein levels in host cell,BP,
12796,GO:0046724,1,0.958061807580931,0,2,oxalic acid secretion,BP,
12797,GO:0046725,1,0.979070476763863,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12798,GO:0046726,1,0.938838177910511,0,3,positive regulation by virus of viral protein levels in host cell,BP,
12799,GO:0046730,1,0.957871401892734,0,2,induction of host immune response by virus,BP,
12800,GO:0046732,1,0.957871401892734,0,2,active induction of host immune response by virus,BP,
12801,GO:0046745,1,0.97897493185122,0,1,viral capsid secondary envelopment,BP,
12802,GO:0046755,1,0.598956135085793,0,24,viral budding,BP,
12804,GO:0046778,1,0.958184090829974,0,2,modification by virus of host mRNA processing,BP,
12805,GO:0046782,1,0.258489925791861,0,64,regulation of viral transcription,BP,
12806,GO:0046784,1,0.843391273486927,0,8,viral mRNA export from host cell nucleus,BP,
12808,GO:0046786,1,0.979512407411805,0,1,viral replication complex formation and maintenance,BP,
12810,GO:0046790,1,0.849079429807024,0,8,virion binding,MF,
12812,GO:0046811,1,0.958983185543149,0,2,histone deacetylase inhibitor activity,MF,
12815,GO:0046817,1,0.978524318840582,0,1,chemokine receptor antagonist activity,MF,
12820,GO:0046826,1,0.861327053098,0,7,negative regulation of protein export from nucleus,BP,
12822,GO:0046831,1,0.799645882503573,0,11,regulation of RNA export from nucleus,BP,
12823,GO:0046832,1,0.963459473768088,0,2,negative regulation of RNA export from nucleus,BP,
12824,GO:0046833,1,0.938186787591084,0,3,positive regulation of RNA export from nucleus,BP,
12827,GO:0046836,1,0.879800020302208,0,6,glycolipid transport,BP,
12828,GO:0046838,1,0.812197041639562,0,10,phosphorylated carbohydrate dephosphorylation,BP,
12829,GO:0046839,1,0.596777436736921,0,25,phospholipid dephosphorylation,BP,
12831,GO:0046848,1,0.936790333777171,0,3,hydroxyapatite binding,MF,
12835,GO:0046852,1,0.762290122826914,0,13,positive regulation of bone remodeling,BP,
12837,GO:0046855,1,0.829572760196721,0,9,inositol phosphate dephosphorylation,BP,
12838,GO:0046856,1,0.609693216735994,0,24,phosphatidylinositol dephosphorylation,BP,
12841,GO:0046870,1,0.881371418692564,0,6,cadmium ion binding,MF,
12844,GO:0046874,1,0.898227111327029,0,5,quinolinate metabolic process,BP,
12847,GO:0046878,1,0.917734765475553,0,4,positive regulation of saliva secretion,BP,
12860,GO:0046898,1,0.922265436349002,0,4,response to cycloheximide,BP,
12861,GO:0046899,1,0.958414236497751,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12862,GO:0046900,1,0.978952368998314,0,1,tetrahydrofolylpolyglutamate metabolic process,BP,
12863,GO:0046901,1,0.978952368998314,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12866,GO:0046904,1,0.978566525805943,0,1,calcium oxalate binding,MF,
12869,GO:0046909,1,0.978996186337913,0,1,intermembrane transport,BP,
12870,GO:0046911,1,0.978516865961842,0,1,metal chelating activity,MF,
12875,GO:0046920,1,0.849715193905774,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12876,GO:0046921,1,0.979069191768179,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12877,GO:0046922,1,0.958570751370771,0,2,peptide-O-fucosyltransferase activity,MF,
12878,GO:0046923,1,0.917744486429248,0,4,ER retention sequence binding,MF,
12879,GO:0046928,1,0.347939733890866,0,51,regulation of neurotransmitter secretion,BP,
12880,GO:0046929,1,0.800301522781316,0,11,negative regulation of neurotransmitter secretion,BP,
12881,GO:0046930,1,0.695774639228625,0,17,pore complex,CC,
12882,GO:0046931,1,0.733252077268466,0,15,pore complex assembly,BP,
12883,GO:0046933,1,0.707180058771631,0,16,proton-transporting ATP synthase activity, rotational mechanism,MF,
12887,GO:0046940,1,0.937859326578893,0,3,nucleoside monophosphate phosphorylation,BP,
12890,GO:0046946,1,0.938538365910562,0,3,hydroxylysine metabolic process,BP,
12891,GO:0046947,1,0.938538365910562,0,3,hydroxylysine biosynthetic process,BP,
12896,GO:0046958,1,0.883779268630451,0,6,nonassociative learning,BP,
12897,GO:0046959,1,0.922131336492483,0,4,habituation,BP,
12898,GO:0046960,1,0.958418579808408,0,2,sensitization,BP,
12899,GO:0046961,1,0.667644848859225,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12900,GO:0046963,1,0.958009119288288,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12901,GO:0046964,1,0.958009119288288,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12903,GO:0046966,1,0.578237988373331,0,27,thyroid hormone receptor binding,MF,
12904,GO:0046967,1,0.958607477224323,0,2,cytosol to ER transport,BP,
12905,GO:0046968,1,0.93828679240081,0,3,peptide antigen transport,BP,
12906,GO:0046969,1,0.958154117972043,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12907,GO:0046970,1,0.978736121469041,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12908,GO:0046972,1,0.830256816546503,0,9,histone acetyltransferase activity (H4-K16 specific),MF,
12909,GO:0046974,1,0.900710478573994,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12910,GO:0046975,1,0.892857614385998,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12911,GO:0046976,1,0.938486700416174,0,3,histone methyltransferase activity (H3-K27 specific),MF,
12912,GO:0046977,1,0.918391784547693,0,4,TAP binding,MF,
12913,GO:0046978,1,0.918391784547693,0,4,TAP1 binding,MF,
12914,GO:0046979,1,0.937984545790016,0,3,TAP2 binding,MF,
12915,GO:0046980,1,0.979115455454884,0,1,tapasin binding,MF,
12918,GO:0046984,1,0.91834712180408,0,4,regulation of hemoglobin biosynthetic process,BP,
12919,GO:0046985,1,0.937792660068078,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12920,GO:0046986,1,0.979268155798965,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12922,GO:0047006,1,0.957578544547403,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12923,GO:0047012,1,0.978610437250493,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12925,GO:0047016,1,0.978835529339059,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12926,GO:0047017,1,0.957949736971968,0,2,prostaglandin-F synthase activity,MF,
12927,GO:0047020,1,0.978524484651327,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12928,GO:0047021,1,0.97852735051818,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12929,GO:0047023,1,0.936967430381456,0,3,androsterone dehydrogenase activity,MF,
12930,GO:0047025,1,0.95801186941463,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12932,GO:0047042,1,0.978554280109784,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12934,GO:0047057,1,0.957461149441119,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12935,GO:0047066,1,0.978488441531257,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12936,GO:0047086,1,0.937026062370078,0,3,ketosteroid monooxygenase activity,MF,
12937,GO:0047105,1,0.978957440165652,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12938,GO:0047115,1,0.916879981880308,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12940,GO:0047127,1,0.978552446742385,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12941,GO:0047130,1,0.980224261402928,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12942,GO:0047131,1,0.980224261402928,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12943,GO:0047134,1,0.860151348259456,0,7,protein-disulfide reductase activity,MF,
12945,GO:0047150,1,0.978956096470896,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12946,GO:0047159,1,0.979101133648772,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12947,GO:0047166,1,0.978723598928971,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12948,GO:0047173,1,0.979495996559671,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12949,GO:0047179,1,0.957482442174529,0,2,platelet-activating factor acetyltransferase activity,MF,
12950,GO:0047184,1,0.89954601966774,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12951,GO:0047191,1,0.979101133648772,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12952,GO:0047192,1,0.93895644334746,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12953,GO:0047196,1,0.957822008712442,0,2,long-chain-alcohol O-fatty-acyltransferase activity,MF,
12954,GO:0047198,1,0.978502141739047,0,1,cysteine-S-conjugate N-acetyltransferase activity,MF,
12955,GO:0047220,1,0.979032146699424,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12956,GO:0047223,1,0.938323966023854,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12957,GO:0047224,1,0.978953050207788,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12958,GO:0047225,1,0.978848687701964,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
12959,GO:0047237,1,0.938524193409469,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12960,GO:0047238,1,0.899867964564982,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12961,GO:0047256,1,0.979137597711037,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12962,GO:0047263,1,0.979049906197958,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12963,GO:0047273,1,0.979069282852216,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12964,GO:0047275,1,0.958338447205147,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12965,GO:0047277,1,0.978736934402059,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12966,GO:0047280,1,0.979323535932765,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12967,GO:0047288,1,0.957722362729107,0,2,monosialoganglioside sialyltransferase activity,MF,
12968,GO:0047290,1,0.978625009740256,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12969,GO:0047291,1,0.978885328268719,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12970,GO:0047293,1,0.978623097728073,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12971,GO:0047298,1,0.979516224791057,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12972,GO:0047305,1,0.978861723099495,0,1,(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,MF,
12973,GO:0047322,1,0.962758882997041,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12974,GO:0047323,1,0.978812717910157,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12975,GO:0047325,1,0.979068969355821,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12976,GO:0047326,1,0.978676204711141,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12977,GO:0047341,1,0.979069350455509,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12978,GO:0047372,1,0.81180660969396,0,10,acylglycerol lipase activity,MF,
12979,GO:0047374,1,0.937715883596168,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12980,GO:0047389,1,0.9593945848287,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12981,GO:0047390,1,0.979098681668221,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12982,GO:0047391,1,0.958572097625946,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12983,GO:0047394,1,0.978856647806514,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12984,GO:0047395,1,0.97905368115129,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12985,GO:0047408,1,0.978659364246395,0,1,alkenylglycerophosphocholine hydrolase activity,MF,
12986,GO:0047409,1,0.978659364246395,0,1,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12987,GO:0047429,1,0.827399153456346,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12989,GO:0047444,1,0.978526838284668,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12991,GO:0047464,1,0.979598176220583,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12992,GO:0047484,1,0.826021691775023,0,9,regulation of response to osmotic stress,BP,
12994,GO:0047493,1,0.939347655431536,0,3,ceramide cholinephosphotransferase activity,MF,
12995,GO:0047496,1,0.474936545840809,0,36,vesicle transport along microtubule,BP,
12996,GO:0047497,1,0.707975193811636,0,17,mitochondrion transport along microtubule,BP,
12997,GO:0047498,1,0.843407487148411,0,8,calcium-dependent phospholipase A2 activity,MF,
12998,GO:0047499,1,0.879907165044475,0,6,calcium-independent phospholipase A2 activity,MF,
12999,GO:0047522,1,0.938715314236267,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
13000,GO:0047536,1,0.978850937793233,0,1,2-aminoadipate transaminase activity,MF,
13001,GO:0047545,1,0.98038465800425,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
13002,GO:0047555,1,0.749875411214638,0,14,3',5'-cyclic-GMP phosphodiesterase activity,MF,
13003,GO:0047560,1,0.979708294243052,0,1,3-dehydrosphinganine reductase activity,MF,
13005,GO:0047617,1,0.694475404453358,0,17,acyl-CoA hydrolase activity,MF,
13006,GO:0047620,1,0.97905368115129,0,1,acylglycerol kinase activity,MF,
13007,GO:0047621,1,0.978635797103521,0,1,acylpyruvate hydrolase activity,MF,
13008,GO:0047623,1,0.938515153660378,0,3,adenosine-phosphate deaminase activity,MF,
13009,GO:0047631,1,0.917261369629708,0,4,ADP-ribose diphosphatase activity,MF,
13010,GO:0047635,1,0.958253608077895,0,2,alanine-oxo-acid transaminase activity,MF,
13011,GO:0047638,1,0.979030251935431,0,1,albendazole monooxygenase activity,MF,
13012,GO:0047658,1,0.978641526874056,0,1,alpha-amino-acid esterase activity,MF,
13013,GO:0047661,1,0.978948595150004,0,1,amino-acid racemase activity,MF,
13015,GO:0047685,1,0.978584124547743,0,1,amine sulfotransferase activity,MF,
13016,GO:0047693,1,0.978473282549746,0,1,ATP diphosphatase activity,MF,
13017,GO:0047696,1,0.958472506005404,0,2,beta-adrenergic receptor kinase activity,MF,
13018,GO:0047704,1,0.978752889837797,0,1,bile-salt sulfotransferase activity,MF,
13019,GO:0047708,1,0.957754079733954,0,2,biotinidase activity,MF,
13020,GO:0047710,1,0.958319616085411,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
13021,GO:0047714,1,0.978580094441819,0,1,galactolipase activity,MF,
13022,GO:0047718,1,0.937054379980068,0,3,indanol dehydrogenase activity,MF,
13023,GO:0047726,1,0.978958443763373,0,1,iron-cytochrome-c reductase activity,MF,
13024,GO:0047730,1,0.97910198034312,0,1,carnosine synthase activity,MF,
13025,GO:0047734,1,0.97897493185122,0,1,CDP-glycerol diphosphatase activity,MF,
13026,GO:0047743,1,0.978519642271121,0,1,chlordecone reductase activity,MF,
13027,GO:0047747,1,0.978908589370483,0,1,cholate-CoA ligase activity,MF,
13029,GO:0047751,1,0.938124532939593,0,3,cholestenone 5-alpha-reductase activity,MF,
13030,GO:0047756,1,0.918992916843546,0,4,chondroitin 4-sulfotransferase activity,MF,
13031,GO:0047757,1,0.962184604206328,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
13033,GO:0047783,1,0.958560703769763,0,2,corticosterone 18-monooxygenase activity,MF,
13034,GO:0047787,1,0.95798682196414,0,2,delta4-3-oxosteroid 5beta-reductase activity,MF,
13035,GO:0047800,1,0.979075809721853,0,1,cysteamine dioxygenase activity,MF,
13036,GO:0047801,1,0.978811885381927,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
13037,GO:0047837,1,0.978503745184368,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
13038,GO:0047840,1,0.978508018657599,0,1,dCTP diphosphatase activity,MF,
13039,GO:0047844,1,0.937206167660751,0,3,deoxycytidine deaminase activity,MF,
13040,GO:0047856,1,0.978519172897859,0,1,dihydrocoumarin hydrolase activity,MF,
13042,GO:0047865,1,0.979065036287471,0,1,dimethylglycine dehydrogenase activity,MF,
13043,GO:0047874,1,0.978804804183332,0,1,dolichyldiphosphatase activity,MF,
13044,GO:0047888,1,0.978737341080633,0,1,fatty acid peroxidase activity,MF,
13045,GO:0047894,1,0.937083702343917,0,3,flavonol 3-sulfotransferase activity,MF,
13046,GO:0047915,1,0.978636465269064,0,1,ganglioside galactosyltransferase activity,MF,
13047,GO:0047933,1,0.982166310851926,0,1,glucose-1,6-bisphosphate synthase activity,MF,
13048,GO:0047936,1,0.982594510598072,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
13049,GO:0047939,1,0.978575904928287,0,1,L-glucuronate reductase activity,MF,
13050,GO:0047946,1,0.978786881094886,0,1,glutamine N-acyltransferase activity,MF,
13051,GO:0047961,1,0.917441184360645,0,4,glycine N-acyltransferase activity,MF,
13052,GO:0047962,1,0.97861013718915,0,1,glycine N-benzoyltransferase activity,MF,
13053,GO:0047963,1,0.979069350881823,0,1,glycine N-choloyltransferase activity,MF,
13054,GO:0047969,1,0.978659723137941,0,1,glyoxylate oxidase activity,MF,
13055,GO:0047977,1,0.958358996890799,0,2,hepoxilin-epoxide hydrolase activity,MF,
13056,GO:0047982,1,0.97865811077371,0,1,homocysteine desulfhydrase activity,MF,
13057,GO:0047988,1,0.978717996347308,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
13059,GO:0048003,1,0.861666321865896,0,7,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
13060,GO:0048006,1,0.979080283666296,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
13061,GO:0048007,1,0.861666321865896,0,7,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
13068,GO:0048014,1,0.939648309661667,0,3,Tie signaling pathway,BP,
13073,GO:0048019,1,0.808552415268084,0,10,receptor antagonist activity,MF,
13077,GO:0048023,1,0.921740341385557,0,4,positive regulation of melanin biosynthetic process,BP,
13078,GO:0048024,1,0.237344506969665,0,68,regulation of mRNA splicing, via spliceosome,BP,
13079,GO:0048025,1,0.653588235327363,0,20,negative regulation of mRNA splicing, via spliceosome,BP,
13080,GO:0048026,1,0.727037987994119,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
13081,GO:0048027,1,0.642001771749386,0,21,mRNA 5'-UTR binding,MF,
13083,GO:0048030,1,0.917413307139895,0,4,disaccharide binding,MF,
13084,GO:0048033,1,0.979059470450586,0,1,heme o metabolic process,BP,
13085,GO:0048034,1,0.979059470450586,0,1,heme O biosynthetic process,BP,
13089,GO:0048040,1,0.978796467227212,0,1,UDP-glucuronate decarboxylase activity,MF,
13092,GO:0048050,1,0.883801316843359,0,6,post-embryonic eye morphogenesis,BP,
13093,GO:0048058,1,0.979069286457784,0,1,compound eye corneal lens development,BP,
13095,GO:0048069,1,0.843999375889695,0,8,eye pigmentation,BP,
13097,GO:0048073,1,0.958850002574698,0,2,regulation of eye pigmentation,BP,
13098,GO:0048075,1,0.979200417773211,0,1,positive regulation of eye pigmentation,BP,
13100,GO:0048096,1,0.831987914165229,0,9,chromatin-mediated maintenance of transcription,BP,
13101,GO:0048101,1,0.958359310592526,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
13102,GO:0048102,1,0.881891728797791,0,6,autophagic cell death,BP,
13104,GO:0048104,1,0.924649575260725,0,4,establishment of body hair or bristle planar orientation,BP,
13105,GO:0048105,1,0.924649575260725,0,4,establishment of body hair planar orientation,BP,
13106,GO:0048133,1,0.917690585099026,0,4,male germ-line stem cell asymmetric division,BP,
13107,GO:0048137,1,0.97897493185122,0,1,spermatocyte division,BP,
13108,GO:0048143,1,0.900109095912184,0,5,astrocyte activation,BP,
13114,GO:0048149,1,0.743745924428563,0,14,behavioral response to ethanol,BP,
13116,GO:0048160,1,0.979346004083926,0,1,primary follicle stage,BP,
13117,GO:0048162,1,0.937621452110082,0,3,multi-layer follicle stage,BP,
13118,GO:0048165,1,0.95973080078005,0,2,fused antrum stage,BP,
13122,GO:0048170,1,0.92164845207537,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
13123,GO:0048172,1,0.75158322134114,0,14,regulation of short-term neuronal synaptic plasticity,BP,
13124,GO:0048174,1,0.979130747882954,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
13129,GO:0048180,1,0.978828913951794,0,1,activin complex,CC,
13131,GO:0048188,1,0.767581316927374,0,13,Set1C/COMPASS complex,CC,
13133,GO:0048194,1,0.832188345949938,0,9,Golgi vesicle budding,BP,
13134,GO:0048199,1,0.246204036914539,0,67,vesicle targeting, to, from or within Golgi,BP,
13135,GO:0048200,1,0.919661944786051,0,4,Golgi transport vesicle coating,BP,
13136,GO:0048203,1,0.958218628112245,0,2,vesicle targeting, trans-Golgi to endosome,BP,
13137,GO:0048205,1,0.919661944786051,0,4,COPI coating of Golgi vesicle,BP,
13138,GO:0048207,1,0.273404991190972,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
13139,GO:0048208,1,0.273404991190972,0,62,COPII vesicle coating,BP,
13140,GO:0048209,1,0.958975594878125,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
13141,GO:0048210,1,0.957961496919576,0,2,Golgi vesicle fusion to target membrane,BP,
13142,GO:0048211,1,0.979086342699834,0,1,Golgi vesicle docking,BP,
13143,GO:0048213,1,0.958149007611141,0,2,Golgi vesicle prefusion complex stabilization,BP,
13144,GO:0048227,1,0.845237411942593,0,8,plasma membrane to endosome transport,BP,
13147,GO:0048239,1,0.958297558389211,0,2,negative regulation of DNA recombination at telomere,BP,
13148,GO:0048240,1,0.640414301602692,0,21,sperm capacitation,BP,
13153,GO:0048245,1,0.788602025446403,0,11,eosinophil chemotaxis,BP,
13154,GO:0048246,1,0.537773710357613,0,29,macrophage chemotaxis,BP,
13156,GO:0048248,1,0.897517040063268,0,5,CXCR3 chemokine receptor binding,MF,
13157,GO:0048250,1,0.957753876364428,0,2,mitochondrial iron ion transport,BP,
13159,GO:0048254,1,0.918797870978261,0,4,snoRNA localization,BP,
13161,GO:0048256,1,0.843813317546337,0,8,flap endonuclease activity,MF,
13162,GO:0048257,1,0.958340099310583,0,2,3'-flap endonuclease activity,MF,
13168,GO:0048264,1,0.979060146914743,0,1,determination of ventral identity,BP,
13169,GO:0048265,1,0.536605404113875,0,30,response to pain,BP,
13170,GO:0048266,1,0.74779038927022,0,14,behavioral response to pain,BP,
13171,GO:0048268,1,0.719135132932138,0,16,clathrin coat assembly,BP,
13172,GO:0048269,1,0.958274977969162,0,2,methionine adenosyltransferase complex,CC,
13173,GO:0048270,1,0.978793340638455,0,1,methionine adenosyltransferase regulator activity,MF,
13174,GO:0048273,1,0.902020873863529,0,5,mitogen-activated protein kinase p38 binding,MF,
13176,GO:0048280,1,0.807705637376069,0,10,vesicle fusion with Golgi apparatus,BP,
13181,GO:0048290,1,0.880046405751868,0,6,isotype switching to IgA isotypes,BP,
13182,GO:0048291,1,0.74261273966416,0,14,isotype switching to IgG isotypes,BP,
13184,GO:0048294,1,0.938344838114496,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13186,GO:0048296,1,0.898865677557663,0,5,regulation of isotype switching to IgA isotypes,BP,
13187,GO:0048297,1,0.97881355029476,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13188,GO:0048298,1,0.918326217861461,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13189,GO:0048302,1,0.758641338630865,0,13,regulation of isotype switching to IgG isotypes,BP,
13190,GO:0048304,1,0.808519370039864,0,10,positive regulation of isotype switching to IgG isotypes,BP,
13193,GO:0048308,1,0.7447303513613,0,14,organelle inheritance,BP,
13194,GO:0048311,1,0.766899582987901,0,13,mitochondrion distribution,BP,
13195,GO:0048312,1,0.851042491545302,0,8,intracellular distribution of mitochondria,BP,
13196,GO:0048313,1,0.7447303513613,0,14,Golgi inheritance,BP,
13200,GO:0048321,1,0.978792715368707,0,1,axial mesodermal cell differentiation,BP,
13201,GO:0048322,1,0.978792715368707,0,1,axial mesodermal cell fate commitment,BP,
13202,GO:0048327,1,0.978792715368707,0,1,axial mesodermal cell fate specification,BP,
13205,GO:0048337,1,0.979053151914992,0,1,positive regulation of mesodermal cell fate specification,BP,
13206,GO:0048338,1,0.979071682445459,0,1,mesoderm structural organization,BP,
13210,GO:0048342,1,0.958133639869187,0,2,paraxial mesodermal cell differentiation,BP,
13211,GO:0048343,1,0.958133639869187,0,2,paraxial mesodermal cell fate commitment,BP,
13212,GO:0048352,1,0.979071682445459,0,1,paraxial mesoderm structural organization,BP,
13213,GO:0048364,1,0.978476629273923,0,1,root development,BP,
13214,GO:0048365,1,0.404729420094507,0,44,Rac GTPase binding,MF,
13215,GO:0048368,1,0.729833336996445,0,15,lateral mesoderm development,BP,
13216,GO:0048369,1,0.919251313523124,0,4,lateral mesoderm morphogenesis,BP,
13217,GO:0048370,1,0.919251313523124,0,4,lateral mesoderm formation,BP,
13218,GO:0048371,1,0.939347066000318,0,3,lateral mesodermal cell differentiation,BP,
13219,GO:0048372,1,0.959523970654068,0,2,lateral mesodermal cell fate commitment,BP,
13220,GO:0048377,1,0.959523970654068,0,2,lateral mesodermal cell fate specification,BP,
13221,GO:0048378,1,0.959523970654068,0,2,regulation of lateral mesodermal cell fate specification,BP,
13223,GO:0048384,1,0.52907407967271,0,30,retinoic acid receptor signaling pathway,BP,
13224,GO:0048385,1,0.712142080095759,0,16,regulation of retinoic acid receptor signaling pathway,BP,
13225,GO:0048386,1,0.918648254379879,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13226,GO:0048387,1,0.80995943732702,0,10,negative regulation of retinoic acid receptor signaling pathway,BP,
13227,GO:0048388,1,0.937717405872905,0,3,endosomal lumen acidification,BP,
13232,GO:0048403,1,0.941275322950588,0,3,brain-derived neurotrophic factor binding,MF,
13233,GO:0048406,1,0.882619027149334,0,6,nerve growth factor binding,MF,
13235,GO:0048408,1,0.937843276843345,0,3,epidermal growth factor binding,MF,
13239,GO:0048475,1,0.148482408748964,0,91,coated membrane,CC,
13240,GO:0048476,1,0.898230493077712,0,5,Holliday junction resolvase complex,CC,
13242,GO:0048478,1,0.884708081408979,0,6,replication fork protection,BP,
13247,GO:0048487,1,0.488547508077131,0,34,beta-tubulin binding,MF,
13250,GO:0048490,1,0.697050345241952,0,17,anterograde synaptic vesicle transport,BP,
13251,GO:0048495,1,0.905214408017901,0,5,Roundabout binding,MF,
13252,GO:0048496,1,0.925139873858476,0,4,maintenance of animal organ identity,BP,
13253,GO:0048499,1,0.958823852590905,0,2,synaptic vesicle membrane organization,BP,
13254,GO:0048500,1,0.824521278395548,0,9,signal recognition particle,CC,
13276,GO:0048539,1,0.862449472382761,0,7,bone marrow development,BP,
13280,GO:0048548,1,0.826693020588518,0,9,regulation of pinocytosis,BP,
13281,GO:0048549,1,0.919480889768765,0,4,positive regulation of pinocytosis,BP,
13282,GO:0048550,1,0.899108556183335,0,5,negative regulation of pinocytosis,BP,
13284,GO:0048560,1,0.958129055092867,0,2,establishment of anatomical structure orientation,BP,
13285,GO:0048561,1,0.978849506345678,0,1,establishment of animal organ orientation,BP,
13290,GO:0048567,1,0.978974306474141,0,1,ectodermal digestive tract morphogenesis,BP,
13294,GO:0048571,1,0.978475792408847,0,1,long-day photoperiodism,BP,
13303,GO:0048597,1,0.937212170485136,0,3,post-embryonic camera-type eye morphogenesis,BP,
13308,GO:0048611,1,0.958470007852081,0,2,embryonic ectodermal digestive tract development,BP,
13309,GO:0048613,1,0.978974306474141,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13310,GO:0048617,1,0.83646878477735,0,9,embryonic foregut morphogenesis,BP,
13311,GO:0048619,1,0.93832396736913,0,3,embryonic hindgut morphogenesis,BP,
13312,GO:0048621,1,0.978795633443475,0,1,post-embryonic digestive tract morphogenesis,BP,
13313,GO:0048625,1,0.899580493179851,0,5,myoblast fate commitment,BP,
13314,GO:0048627,1,0.958072784870403,0,2,myoblast development,BP,
13317,GO:0048632,1,0.960328414871551,0,2,negative regulation of skeletal muscle tissue growth,BP,
13336,GO:0048664,1,0.806685374835458,0,10,neuron fate determination,BP,
13343,GO:0048671,1,0.834954123647811,0,9,negative regulation of collateral sprouting,BP,
13345,GO:0048673,1,0.978605392006663,0,1,collateral sprouting of intact axon in response to injury,BP,
13347,GO:0048677,1,0.940172397170108,0,3,axon extension involved in regeneration,BP,
13349,GO:0048679,1,0.630881203147604,0,22,regulation of axon regeneration,BP,
13350,GO:0048680,1,0.879777941507012,0,6,positive regulation of axon regeneration,BP,
13351,GO:0048681,1,0.778399153971233,0,12,negative regulation of axon regeneration,BP,
13352,GO:0048682,1,0.940172397170108,0,3,sprouting of injured axon,BP,
13353,GO:0048683,1,0.978605392006663,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13354,GO:0048685,1,0.978605392006663,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13355,GO:0048686,1,0.959182777237013,0,2,regulation of sprouting of injured axon,BP,
13356,GO:0048687,1,0.979046253271142,0,1,positive regulation of sprouting of injured axon,BP,
13357,GO:0048688,1,0.979712560808074,0,1,negative regulation of sprouting of injured axon,BP,
13358,GO:0048690,1,0.959182777237013,0,2,regulation of axon extension involved in regeneration,BP,
13359,GO:0048691,1,0.979046253271142,0,1,positive regulation of axon extension involved in regeneration,BP,
13360,GO:0048692,1,0.979712560808074,0,1,negative regulation of axon extension involved in regeneration,BP,
13363,GO:0048698,1,0.979552709099307,0,1,negative regulation of collateral sprouting in absence of injury,BP,
13366,GO:0048702,1,0.866344554104494,0,7,embryonic neurocranium morphogenesis,BP,
13367,GO:0048703,1,0.798862171381343,0,11,embryonic viscerocranium morphogenesis,BP,
13375,GO:0048712,1,0.779150745497669,0,12,negative regulation of astrocyte differentiation,BP,
13377,GO:0048714,1,0.714804019093214,0,16,positive regulation of oligodendrocyte differentiation,BP,
13383,GO:0048733,1,0.869468291069242,0,7,sebaceous gland development,BP,
13387,GO:0048741,1,0.545963346701637,0,29,skeletal muscle fiber development,BP,
13388,GO:0048742,1,0.81060972039096,0,10,regulation of skeletal muscle fiber development,BP,
13389,GO:0048743,1,0.860777889560425,0,7,positive regulation of skeletal muscle fiber development,BP,
13392,GO:0048749,1,0.958620389476446,0,2,compound eye development,BP,
13396,GO:0048755,1,0.833235060524913,0,9,branching morphogenesis of a nerve,BP,
13399,GO:0048763,1,0.94171963206815,0,4,calcium-induced calcium release activity,MF,
13400,GO:0048764,1,0.978476629273923,0,1,trichoblast maturation,BP,
13401,GO:0048765,1,0.978476629273923,0,1,root hair cell differentiation,BP,
13402,GO:0048767,1,0.978476629273923,0,1,root hair elongation,BP,
13403,GO:0048769,1,0.960682224736489,0,3,sarcomerogenesis,BP,
13407,GO:0048787,1,0.919488882780547,0,4,presynaptic active zone membrane,CC,
13408,GO:0048788,1,0.975671938601356,0,2,cytoskeleton of presynaptic active zone,CC,
13409,GO:0048789,1,0.97951749973897,0,1,cytoskeletal matrix organization at active zone,BP,
13410,GO:0048790,1,0.978582683962392,0,1,maintenance of presynaptic active zone structure,BP,
13412,GO:0048792,1,0.979069359855704,0,1,spontaneous exocytosis of neurotransmitter,BP,
13413,GO:0048793,1,0.846996258724691,0,8,pronephros development,BP,
13421,GO:0048817,1,0.959291804219955,0,2,negative regulation of hair follicle maturation,BP,
13425,GO:0048821,1,0.617026099293282,0,23,erythrocyte development,BP,
13426,GO:0048822,1,0.961107278048995,0,2,enucleate erythrocyte development,BP,
13428,GO:0048840,1,0.902813876563686,0,5,otolith development,BP,
13430,GO:0048842,1,0.877741412095446,0,7,positive regulation of axon extension involved in axon guidance,BP,
13439,GO:0048855,1,0.980594168999297,0,1,adenohypophysis morphogenesis,BP,
13441,GO:0048857,1,0.270804166940802,0,62,neural nucleus development,BP,
13443,GO:0048859,1,0.900928250089307,0,5,formation of anatomical boundary,BP,
13447,GO:0048865,1,0.842279350344058,0,8,stem cell fate commitment,BP,
13448,GO:0048866,1,0.937409525525494,0,3,stem cell fate specification,BP,
13449,GO:0048867,1,0.937650855182828,0,3,stem cell fate determination,BP,
13454,GO:0048873,1,0.531687885957146,0,30,homeostasis of number of cells within a tissue,BP,
13455,GO:0048874,1,0.979069145652555,0,1,homeostasis of number of cells in a free-living population,BP,
13456,GO:0048875,1,0.828332007125278,0,9,chemical homeostasis within a tissue,BP,
13458,GO:0048880,1,0.919741664422566,0,4,sensory system development,BP,
13459,GO:0048892,1,0.979061405677543,0,1,lateral line nerve development,BP,
13460,GO:0048894,1,0.979061405677543,0,1,efferent axon development in a lateral line nerve,BP,
13461,GO:0048925,1,0.979061405677543,0,1,lateral line system development,BP,
13462,GO:0048934,1,0.768251864652832,0,13,peripheral nervous system neuron differentiation,BP,
13463,GO:0048935,1,0.768251864652832,0,13,peripheral nervous system neuron development,BP,
13464,GO:0048936,1,0.938145371477592,0,3,peripheral nervous system neuron axonogenesis,BP,
13466,GO:0050023,1,0.978702199446616,0,1,L-fuconate dehydratase activity,MF,
13467,GO:0050031,1,0.978925417777675,0,1,L-pipecolate oxidase activity,MF,
13468,GO:0050038,1,0.978479916375834,0,1,L-xylulose reductase (NADP+) activity,MF,
13469,GO:0050051,1,0.918222249959032,0,4,leukotriene-B4 20-monooxygenase activity,MF,
13470,GO:0050062,1,0.958991966474447,0,2,long-chain-fatty-acyl-CoA reductase activity,MF,
13471,GO:0050072,1,0.865491832917451,0,7,m7G(5')pppN diphosphatase activity,MF,
13472,GO:0050080,1,0.978838004439744,0,1,malonyl-CoA decarboxylase activity,MF,
13473,GO:0050104,1,0.978582683962392,0,1,L-gulonate 3-dehydrogenase activity,MF,
13474,GO:0050113,1,0.978567951432417,0,1,inositol oxygenase activity,MF,
13475,GO:0050115,1,0.979495996559671,0,1,myosin-light-chain-phosphatase activity,MF,
13476,GO:0050119,1,0.961316578475735,0,2,N-acetylglucosamine deacetylase activity,MF,
13477,GO:0050121,1,0.978576281538565,0,1,N-acylglucosamine 2-epimerase activity,MF,
13478,GO:0050124,1,0.979081215841271,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13479,GO:0050129,1,0.979068264157219,0,1,N-formylglutamate deformylase activity,MF,
13480,GO:0050135,1,0.957616534359577,0,2,NAD(P)+ nucleosidase activity,MF,
13481,GO:0050136,1,0.438536606514466,0,38,NADH dehydrogenase (quinone) activity,MF,
13482,GO:0050144,1,0.97897493185122,0,1,nucleoside deoxyribosyltransferase activity,MF,
13483,GO:0050145,1,0.937859326578893,0,3,nucleoside phosphate kinase activity,MF,
13484,GO:0050146,1,0.979797491726723,0,1,nucleoside phosphotransferase activity,MF,
13485,GO:0050152,1,0.978532990053877,0,1,omega-amidase activity,MF,
13486,GO:0050178,1,0.978467931885137,0,1,phenylpyruvate tautomerase activity,MF,
13487,GO:0050197,1,0.978887298193496,0,1,phytanate-CoA ligase activity,MF,
13488,GO:0050201,1,0.979096661434132,0,1,fucokinase activity,MF,
13489,GO:0050211,1,0.979058680792045,0,1,procollagen galactosyltransferase activity,MF,
13491,GO:0050221,1,0.97852735051818,0,1,prostaglandin-E2 9-reductase activity,MF,
13492,GO:0050252,1,0.938143665319588,0,3,retinol O-fatty-acyltransferase activity,MF,
13493,GO:0050253,1,0.959144055825785,0,2,retinyl-palmitate esterase activity,MF,
13494,GO:0050254,1,0.937647988568076,0,3,rhodopsin kinase activity,MF,
13495,GO:0050262,1,0.95839073820654,0,2,ribosylnicotinamide kinase activity,MF,
13496,GO:0050265,1,0.940508528954858,0,3,RNA uridylyltransferase activity,MF,
13498,GO:0050290,1,0.979412696105281,0,1,sphingomyelin phosphodiesterase D activity,MF,
13499,GO:0050291,1,0.861546224876466,0,7,sphingosine N-acyltransferase activity,MF,
13500,GO:0050294,1,0.917175685969822,0,4,steroid sulfotransferase activity,MF,
13502,GO:0050309,1,0.9380687195904,0,3,sugar-terminal-phosphatase activity,MF,
13503,GO:0050313,1,0.978490665620568,0,1,sulfur dioxygenase activity,MF,
13505,GO:0050333,1,0.97867657798566,0,1,thiamin-triphosphatase activity,MF,
13506,GO:0050346,1,0.97897493185122,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13507,GO:0050347,1,0.958133986410002,0,2,trans-octaprenyltranstransferase activity,MF,
13508,GO:0050353,1,0.979044015025739,0,1,trimethyllysine dioxygenase activity,MF,
13509,GO:0050355,1,0.979269311676231,0,1,triphosphatase activity,MF,
13510,GO:0050379,1,0.979598176220583,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13511,GO:0050405,1,0.962758882997041,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13512,GO:0050421,1,0.978987637002078,0,1,nitrite reductase (NO-forming) activity,MF,
13513,GO:0050427,1,0.669008162678273,0,19,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13514,GO:0050428,1,0.882697664112051,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13515,GO:0050429,1,0.980661415516129,0,1,calcium-dependent phospholipase C activity,MF,
13519,GO:0050434,1,0.421327806555429,0,41,positive regulation of viral transcription,BP,
13520,GO:0050435,1,0.583738197411983,0,26,beta-amyloid metabolic process,BP,
13521,GO:0050436,1,0.959216099971548,0,2,microfibril binding,MF,
13522,GO:0050444,1,0.979069205329571,0,1,aquacobalamin reductase (NADPH) activity,MF,
13523,GO:0050462,1,0.978526838284668,0,1,N-acetylneuraminate synthase activity,MF,
13524,GO:0050473,1,0.938583717089642,0,3,arachidonate 15-lipoxygenase activity,MF,
13525,GO:0050479,1,0.97897493185122,0,1,glyceryl-ether monooxygenase activity,MF,
13526,GO:0050480,1,0.978815630576651,0,1,imidazolonepropionase activity,MF,
13527,GO:0050482,1,0.537800018982945,0,29,arachidonic acid secretion,BP,
13528,GO:0050497,1,0.958280528539516,0,2,transferase activity, transferring alkylthio groups,MF,
13529,GO:0050501,1,0.918251268631276,0,4,hyaluronan synthase activity,MF,
13531,GO:0050509,1,0.958581965528354,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13532,GO:0050510,1,0.919105842680804,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13533,GO:0050512,1,0.978794799674675,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13534,GO:0050528,1,0.97891688940261,0,1,acyloxyacyl hydrolase activity,MF,
13535,GO:0050542,1,0.878469914252312,0,6,icosanoid binding,MF,
13537,GO:0050544,1,0.897628541767447,0,5,arachidonic acid binding,MF,
13538,GO:0050560,1,0.979069336529951,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13539,GO:0050561,1,0.979095761173409,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13540,GO:0050567,1,0.958051876700826,0,2,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13541,GO:0050571,1,0.978613460569343,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13542,GO:0050577,1,0.978550427424545,0,1,GDP-L-fucose synthase activity,MF,
13543,GO:0050591,1,0.979030251935431,0,1,quinine 3-monooxygenase activity,MF,
13544,GO:0050610,1,0.957517757905205,0,2,methylarsonate reductase activity,MF,
13545,GO:0050613,1,0.958134772067978,0,2,delta14-sterol reductase activity,MF,
13546,GO:0050614,1,0.97919254046201,0,1,delta24-sterol reductase activity,MF,
13547,GO:0050632,1,0.978563019187997,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13548,GO:0050646,1,0.978662606227995,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13549,GO:0050647,1,0.978662606227995,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13550,GO:0050648,1,0.978662606227995,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13551,GO:0050649,1,0.979030251935431,0,1,testosterone 6-beta-hydroxylase activity,MF,
13552,GO:0050650,1,0.548446371294679,0,29,chondroitin sulfate proteoglycan biosynthetic process,BP,
13553,GO:0050651,1,0.735082395431712,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13554,GO:0050652,1,0.979076104465156,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13555,GO:0050653,1,0.958613687138802,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13558,GO:0050656,1,0.882776486879487,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13559,GO:0050657,1,0.0202190352091698,0,186,nucleic acid transport,BP,
13560,GO:0050658,1,0.0202190352091698,0,186,RNA transport,BP,
13561,GO:0050659,1,0.959901212787924,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13566,GO:0050664,1,0.744463084378706,0,14,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13567,GO:0050665,1,0.826440783323904,0,9,hydrogen peroxide biosynthetic process,BP,
13568,GO:0050666,1,0.958268776022346,0,2,regulation of homocysteine metabolic process,BP,
13569,GO:0050667,1,0.744551411288727,0,14,homocysteine metabolic process,BP,
13570,GO:0050668,1,0.978869190667263,0,1,positive regulation of homocysteine metabolic process,BP,
13581,GO:0050681,1,0.41864683532988,0,42,androgen receptor binding,MF,
13582,GO:0050682,1,0.963705620760662,0,2,AF-2 domain binding,MF,
13583,GO:0050683,1,0.979135980439007,0,1,AF-1 domain binding,MF,
13584,GO:0050684,1,0.120301172945157,0,100,regulation of mRNA processing,BP,
13585,GO:0050685,1,0.614298297989546,0,23,positive regulation of mRNA processing,BP,
13586,GO:0050686,1,0.540083664070604,0,29,negative regulation of mRNA processing,BP,
13587,GO:0050687,1,0.655830605372284,0,20,negative regulation of defense response to virus,BP,
13588,GO:0050688,1,0.163586232842097,0,86,regulation of defense response to virus,BP,
13589,GO:0050689,1,0.917811977569673,0,4,negative regulation of defense response to virus by host,BP,
13590,GO:0050690,1,0.553167641808979,0,28,regulation of defense response to virus by virus,BP,
13591,GO:0050691,1,0.519930106428749,0,31,regulation of defense response to virus by host,BP,
13592,GO:0050692,1,0.938992804673113,0,3,DBD domain binding,MF,
13593,GO:0050693,1,0.882921789413444,0,6,LBD domain binding,MF,
13594,GO:0050694,1,0.917928056566557,0,4,galactose 3-O-sulfotransferase activity,MF,
13595,GO:0050698,1,0.958476282206236,0,2,proteoglycan sulfotransferase activity,MF,
13597,GO:0050700,1,0.867167334651696,0,7,CARD domain binding,MF,
13600,GO:0050703,1,0.898051159607463,0,5,interleukin-1 alpha secretion,BP,
13602,GO:0050705,1,0.917817041230989,0,4,regulation of interleukin-1 alpha secretion,BP,
13609,GO:0050712,1,0.978565582704007,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13610,GO:0050713,1,0.898582546128948,0,5,negative regulation of interleukin-1 beta secretion,BP,
13614,GO:0050717,1,0.937924375224458,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13617,GO:0050720,1,0.937380267311193,0,3,interleukin-1 beta biosynthetic process,BP,
13619,GO:0050722,1,0.958001745957425,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13620,GO:0050725,1,0.958001745957425,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13627,GO:0050732,1,0.423927690014825,0,41,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13628,GO:0050733,1,0.863526990232778,0,7,RS domain binding,MF,
13629,GO:0050746,1,0.744957265861888,0,14,regulation of lipoprotein metabolic process,BP,
13630,GO:0050747,1,0.900990664495516,0,5,positive regulation of lipoprotein metabolic process,BP,
13631,GO:0050748,1,0.881108435785096,0,6,negative regulation of lipoprotein metabolic process,BP,
13632,GO:0050750,1,0.715710418822643,0,16,low-density lipoprotein particle receptor binding,MF,
13633,GO:0050751,1,0.978486010590288,0,1,fractalkine biosynthetic process,BP,
13634,GO:0050752,1,0.978486010590288,0,1,regulation of fractalkine biosynthetic process,BP,
13635,GO:0050754,1,0.978486010590288,0,1,positive regulation of fractalkine biosynthetic process,BP,
13637,GO:0050756,1,0.978486010590288,0,1,fractalkine metabolic process,BP,
13638,GO:0050757,1,0.957957095426808,0,2,thymidylate synthase biosynthetic process,BP,
13639,GO:0050758,1,0.957957095426808,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13640,GO:0050760,1,0.978998251605262,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13642,GO:0050765,1,0.791610783098726,0,11,negative regulation of phagocytosis,BP,
13651,GO:0050774,1,0.732690331129158,0,15,negative regulation of dendrite morphogenesis,BP,
13652,GO:0050775,1,0.50851024332286,0,33,positive regulation of dendrite morphogenesis,BP,
13656,GO:0050779,1,0.668179360944215,0,20,RNA destabilization,BP,
13657,GO:0050780,1,0.728900514259214,0,15,dopamine receptor binding,MF,
13658,GO:0050783,1,0.978935935955106,0,1,cocaine metabolic process,BP,
13660,GO:0050787,1,0.958546919616814,0,2,detoxification of mercury ion,BP,
13678,GO:0050811,1,0.748804418144053,0,14,GABA receptor binding,MF,
13680,GO:0050815,1,0.881564885465953,0,6,phosphoserine binding,MF,
13681,GO:0050816,1,0.939444510533106,0,3,phosphothreonine binding,MF,
13685,GO:0050820,1,0.588906019361991,0,25,positive regulation of coagulation,BP,
13687,GO:0050822,1,0.979069632990704,0,1,peptide stabilization,BP,
13688,GO:0050823,1,0.979069632990704,0,1,peptide antigen stabilization,BP,
13689,GO:0050828,1,0.97897493185122,0,1,regulation of liquid surface tension,BP,
13693,GO:0050833,1,0.918597486718416,0,4,pyruvate transmembrane transporter activity,MF,
13696,GO:0050847,1,0.923537222588872,0,4,progesterone receptor signaling pathway,BP,
13699,GO:0050850,1,0.449427545737873,0,38,positive regulation of calcium-mediated signaling,BP,
13703,GO:0050854,1,0.387964439959086,0,45,regulation of antigen receptor-mediated signaling pathway,BP,
13704,GO:0050855,1,0.744054538529256,0,14,regulation of B cell receptor signaling pathway,BP,
13705,GO:0050856,1,0.499482499663306,0,33,regulation of T cell receptor signaling pathway,BP,
13706,GO:0050857,1,0.685288768726252,0,18,positive regulation of antigen receptor-mediated signaling pathway,BP,
13707,GO:0050858,1,0.638993038438886,0,21,negative regulation of antigen receptor-mediated signaling pathway,BP,
13708,GO:0050859,1,0.918048314824553,0,4,negative regulation of B cell receptor signaling pathway,BP,
13709,GO:0050860,1,0.681366097444099,0,18,negative regulation of T cell receptor signaling pathway,BP,
13710,GO:0050861,1,0.863814839424314,0,7,positive regulation of B cell receptor signaling pathway,BP,
13711,GO:0050862,1,0.809935428361796,0,10,positive regulation of T cell receptor signaling pathway,BP,
13718,GO:0050869,1,0.532894402100944,0,30,negative regulation of B cell activation,BP,
13728,GO:0050882,1,0.913635009936742,0,5,voluntary musculoskeletal movement,BP,
13729,GO:0050883,1,0.958004031191078,0,2,musculoskeletal movement, spinal reflex action,BP,
13730,GO:0050884,1,0.718334734647917,0,16,neuromuscular process controlling posture,BP,
13736,GO:0050893,1,0.91993811499234,0,4,sensory processing,BP,
13737,GO:0050894,1,0.98081047341397,0,1,determination of affect,BP,
13739,GO:0050897,1,0.980330905715007,0,1,cobalt ion binding,MF,
13741,GO:0050901,1,0.641177427599361,0,21,leukocyte tethering or rolling,BP,
13742,GO:0050902,1,0.958473537043266,0,2,leukocyte adhesive activation,BP,
13743,GO:0050904,1,0.93925435035868,0,3,diapedesis,BP,
13746,GO:0050907,1,0.000100104155506793,0,419,detection of chemical stimulus involved in sensory perception,BP,
13747,GO:0050908,1,0.700140516938505,0,17,detection of light stimulus involved in visual perception,BP,
13748,GO:0050909,1,0.264051121041824,0,62,sensory perception of taste,BP,
13749,GO:0050910,1,0.780126365545235,0,12,detection of mechanical stimulus involved in sensory perception of sound,BP,
13750,GO:0050911,1,0.000258465219141648,0,376,detection of chemical stimulus involved in sensory perception of smell,BP,
13751,GO:0050912,1,0.421283159356139,0,40,detection of chemical stimulus involved in sensory perception of taste,BP,
13752,GO:0050913,1,0.441072991559458,0,38,sensory perception of bitter taste,BP,
13753,GO:0050915,1,0.899958479390287,0,5,sensory perception of sour taste,BP,
13754,GO:0050916,1,0.882996885627051,0,6,sensory perception of sweet taste,BP,
13755,GO:0050917,1,0.883104644786993,0,6,sensory perception of umami taste,BP,
13761,GO:0050923,1,0.922596070119203,0,4,regulation of negative chemotaxis,BP,
13762,GO:0050924,1,0.979557623121372,0,1,positive regulation of negative chemotaxis,BP,
13763,GO:0050925,1,0.96199008723534,0,2,negative regulation of negative chemotaxis,BP,
13766,GO:0050928,1,0.979754170184832,0,1,negative regulation of positive chemotaxis,BP,
13767,GO:0050929,1,0.979557623121372,0,1,induction of negative chemotaxis,BP,
13775,GO:0050955,1,0.940125047001756,0,3,thermoception,BP,
13777,GO:0050960,1,0.97914272108427,0,1,detection of temperature stimulus involved in thermoception,BP,
13779,GO:0050962,1,0.700140516938505,0,17,detection of light stimulus involved in sensory perception,BP,
13781,GO:0050966,1,0.85154501075683,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13782,GO:0050968,1,0.939108209446473,0,3,detection of chemical stimulus involved in sensory perception of pain,BP,
13783,GO:0050974,1,0.609802074688551,0,24,detection of mechanical stimulus involved in sensory perception,BP,
13784,GO:0050975,1,0.940271643648398,0,3,sensory perception of touch,BP,
13785,GO:0050976,1,0.960852746491895,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13786,GO:0050982,1,0.43339739564267,0,42,detection of mechanical stimulus,BP,
13787,GO:0050992,1,0.957816178621932,0,2,dimethylallyl diphosphate biosynthetic process,BP,
13788,GO:0050993,1,0.957816178621932,0,2,dimethylallyl diphosphate metabolic process,BP,
13793,GO:0050998,1,0.71957546350399,0,16,nitric-oxide synthase binding,MF,
13799,GO:0051006,1,0.80694720019119,0,10,positive regulation of lipoprotein lipase activity,BP,
13800,GO:0051010,1,0.810507376324453,0,11,microtubule plus-end binding,MF,
13802,GO:0051012,1,0.95875944495641,0,2,microtubule sliding,BP,
13803,GO:0051013,1,0.882914009113098,0,6,microtubule severing,BP,
13804,GO:0051014,1,0.828812710333645,0,9,actin filament severing,BP,
13806,GO:0051016,1,0.711246470694237,0,16,barbed-end actin filament capping,BP,
13809,GO:0051019,1,0.621775391153291,0,23,mitogen-activated protein kinase binding,MF,
13811,GO:0051021,1,0.93954999021748,0,3,GDP-dissociation inhibitor binding,MF,
13812,GO:0051022,1,0.93954999021748,0,3,Rho GDP-dissociation inhibitor binding,MF,
13815,GO:0051025,1,0.958502637211041,0,2,negative regulation of immunoglobulin secretion,BP,
13816,GO:0051026,1,0.880447932302953,0,6,chiasma assembly,BP,
13817,GO:0051028,1,0.0506432870630174,0,143,mRNA transport,BP,
13818,GO:0051029,1,0.901228586475699,0,5,rRNA transport,BP,
13819,GO:0051030,1,0.937445932515217,0,3,snRNA transport,BP,
13820,GO:0051031,1,0.505988333398555,0,33,tRNA transport,BP,
13821,GO:0051032,1,0.940084403408322,0,3,nucleic acid transmembrane transporter activity,MF,
13822,GO:0051033,1,0.940084403408322,0,3,RNA transmembrane transporter activity,MF,
13823,GO:0051036,1,0.89893514102381,0,5,regulation of endosome size,BP,
13824,GO:0051037,1,0.958803888708758,0,2,regulation of transcription involved in meiotic cell cycle,BP,
13825,GO:0051038,1,0.979302858549776,0,1,negative regulation of transcription involved in meiotic cell cycle,BP,
13826,GO:0051039,1,0.979068973647465,0,1,positive regulation of transcription involved in meiotic cell cycle,BP,
13828,GO:0051041,1,0.979069070443444,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13830,GO:0051043,1,0.640737610933136,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13831,GO:0051044,1,0.74230521286022,0,14,positive regulation of membrane protein ectodomain proteolysis,BP,
13832,GO:0051045,1,0.863275825956939,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
13846,GO:0051059,1,0.554125466857442,0,28,NF-kappaB binding,MF,
13847,GO:0051066,1,0.957818278577029,0,2,dihydrobiopterin metabolic process,BP,
13848,GO:0051068,1,0.979070772639521,0,1,dihydrolipoamide metabolic process,BP,
13849,GO:0051081,1,0.385952863485892,0,46,nuclear envelope disassembly,BP,
13850,GO:0051082,1,0.109462624754231,0,104,unfolded protein binding,MF,
13851,GO:0051083,1,0.957950776804402,0,2,'de novo' cotranslational protein folding,BP,
13852,GO:0051084,1,0.71378042443632,0,16,'de novo' posttranslational protein folding,BP,
13853,GO:0051085,1,0.773969618312015,0,12,chaperone mediated protein folding requiring cofactor,BP,
13854,GO:0051086,1,0.978743457528968,0,1,chaperone mediated protein folding independent of cofactor,BP,
13855,GO:0051087,1,0.163697997194622,0,86,chaperone binding,MF,
13856,GO:0051088,1,0.938575264179405,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13857,GO:0051089,1,0.979098681668221,0,1,constitutive protein ectodomain proteolysis,BP,
13863,GO:0051095,1,0.826059928195236,0,9,regulation of helicase activity,BP,
13864,GO:0051096,1,0.880596706911366,0,6,positive regulation of helicase activity,BP,
13865,GO:0051097,1,0.938089155862805,0,3,negative regulation of helicase activity,BP,
13870,GO:0051102,1,0.979121485859726,0,1,DNA ligation involved in DNA recombination,BP,
13871,GO:0051103,1,0.790120440509009,0,11,DNA ligation involved in DNA repair,BP,
13872,GO:0051105,1,0.899278490201472,0,5,regulation of DNA ligation,BP,
13873,GO:0051106,1,0.918526622611223,0,4,positive regulation of DNA ligation,BP,
13874,GO:0051107,1,0.979049357109579,0,1,negative regulation of DNA ligation,BP,
13877,GO:0051120,1,0.938297574259468,0,3,hepoxilin A3 synthase activity,MF,
13878,GO:0051121,1,0.899253090567763,0,5,hepoxilin metabolic process,BP,
13879,GO:0051122,1,0.899253090567763,0,5,hepoxilin biosynthetic process,BP,
13880,GO:0051123,1,0.532681687606027,0,30,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13881,GO:0051124,1,0.867834903560542,0,7,synaptic growth at neuromuscular junction,BP,
13882,GO:0051125,1,0.605161784327664,0,24,regulation of actin nucleation,BP,
13883,GO:0051126,1,0.879551941424264,0,6,negative regulation of actin nucleation,BP,
13884,GO:0051127,1,0.765340942686077,0,13,positive regulation of actin nucleation,BP,
13888,GO:0051131,1,0.680296477868333,0,18,chaperone-mediated protein complex assembly,BP,
13889,GO:0051132,1,0.807210216260625,0,10,NK T cell activation,BP,
13890,GO:0051133,1,0.842411073447465,0,8,regulation of NK T cell activation,BP,
13891,GO:0051134,1,0.978712826625149,0,1,negative regulation of NK T cell activation,BP,
13892,GO:0051135,1,0.86074122661346,0,7,positive regulation of NK T cell activation,BP,
13893,GO:0051136,1,0.881291527334501,0,6,regulation of NK T cell differentiation,BP,
13894,GO:0051138,1,0.919380869748388,0,4,positive regulation of NK T cell differentiation,BP,
13895,GO:0051139,1,0.979088056130525,0,1,metal ion:proton antiporter activity,MF,
13896,GO:0051140,1,0.917646294960523,0,4,regulation of NK T cell proliferation,BP,
13897,GO:0051142,1,0.917646294960523,0,4,positive regulation of NK T cell proliferation,BP,
13905,GO:0051152,1,0.809630523474549,0,10,positive regulation of smooth muscle cell differentiation,BP,
13910,GO:0051160,1,0.978965040994655,0,1,L-xylitol catabolic process,BP,
13911,GO:0051164,1,0.978965040994655,0,1,L-xylitol metabolic process,BP,
13912,GO:0051167,1,0.898093325838692,0,5,xylulose 5-phosphate metabolic process,BP,
13920,GO:0051176,1,0.901689893846131,0,5,positive regulation of sulfur metabolic process,BP,
13921,GO:0051177,1,0.86057396036126,0,7,meiotic sister chromatid cohesion,BP,
13925,GO:0051182,1,0.880345064149053,0,6,coenzyme transport,BP,
13928,GO:0051185,1,0.91840543078279,0,4,coenzyme transporter activity,MF,
13932,GO:0051189,1,0.861391464751153,0,7,prosthetic group metabolic process,BP,
13933,GO:0051192,1,0.978471214322306,0,1,prosthetic group binding,MF,
13951,GO:0051225,1,0.175322131769803,0,84,spindle assembly,BP,
13952,GO:0051228,1,0.979689539940314,0,1,mitotic spindle disassembly,BP,
13953,GO:0051230,1,0.979689539940314,0,1,spindle disassembly,BP,
13954,GO:0051231,1,0.792176482182542,0,11,spindle elongation,BP,
13955,GO:0051232,1,0.978910487424136,0,1,meiotic spindle elongation,BP,
13959,GO:0051236,1,0.019116219888633,0,189,establishment of RNA localization,BP,
13973,GO:0051255,1,0.809154260420667,0,10,spindle midzone assembly,BP,
13974,GO:0051256,1,0.826566746129012,0,9,mitotic spindle midzone assembly,BP,
13975,GO:0051257,1,0.978944776214029,0,1,meiotic spindle midzone assembly,BP,
13981,GO:0051264,1,0.97903627015796,0,1,mono-olein transacylation activity,MF,
13982,GO:0051265,1,0.97903627015796,0,1,diolein transacylation activity,MF,
13983,GO:0051267,1,0.979068866243211,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13990,GO:0051281,1,0.490855430530758,0,34,positive regulation of release of sequestered calcium ion into cytosol,BP,
13994,GO:0051286,1,0.864805473043751,0,7,cell tip,CC,
13997,GO:0051290,1,0.397299447681281,0,43,protein heterotetramerization,BP,
13999,GO:0051292,1,0.833495048074206,0,9,nuclear pore complex assembly,BP,
14002,GO:0051295,1,0.903477083163017,0,5,establishment of meiotic spindle localization,BP,
14003,GO:0051296,1,0.978498155989432,0,1,establishment of meiotic spindle orientation,BP,
14006,GO:0051299,1,0.74960381997705,0,14,centrosome separation,BP,
14010,GO:0051304,1,0.254242665437213,0,66,chromosome separation,BP,
14011,GO:0051305,1,0.885152342698785,0,6,chromosome movement towards spindle pole,BP,
14012,GO:0051306,1,0.370154540700046,0,48,mitotic sister chromatid separation,BP,
14013,GO:0051307,1,0.717138789906286,0,16,meiotic chromosome separation,BP,
14014,GO:0051308,1,0.97897493185122,0,1,male meiosis chromosome separation,BP,
14016,GO:0051311,1,0.978944776214029,0,1,meiotic metaphase plate congression,BP,
14017,GO:0051315,1,0.828567998570715,0,9,attachment of mitotic spindle microtubules to kinetochore,BP,
14021,GO:0051339,1,0.150530035870306,0,90,regulation of lyase activity,BP,
14025,GO:0051343,1,0.918265338294056,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14031,GO:0051349,1,0.29092099966507,0,59,positive regulation of lyase activity,BP,
14032,GO:0051350,1,0.50929463794957,0,32,negative regulation of lyase activity,BP,
14033,GO:0051351,1,0.879069975439862,0,6,positive regulation of ligase activity,BP,
14037,GO:0051355,1,0.979082570228003,0,1,proprioception involved in equilibrioception,BP,
14038,GO:0051365,1,0.938331219221506,0,3,cellular response to potassium ion starvation,BP,
14039,GO:0051371,1,0.703978630890381,0,18,muscle alpha-actinin binding,MF,
14041,GO:0051377,1,0.938902417965019,0,3,mannose-ethanolamine phosphotransferase activity,MF,
14042,GO:0051378,1,0.79101404268248,0,11,serotonin binding,MF,
14044,GO:0051380,1,0.918512560241419,0,4,norepinephrine binding,MF,
14045,GO:0051382,1,0.799964870434354,0,11,kinetochore assembly,BP,
14046,GO:0051383,1,0.736217814927186,0,15,kinetochore organization,BP,
14049,GO:0051386,1,0.79325465199187,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
14050,GO:0051387,1,0.918373157317687,0,4,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
14051,GO:0051388,1,0.901192162064413,0,5,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
14052,GO:0051389,1,0.984062347172257,0,1,inactivation of MAPKK activity,BP,
14053,GO:0051391,1,0.979101555141531,0,1,tRNA acetylation,BP,
14054,GO:0051392,1,0.979101555141531,0,1,tRNA N-acetyltransferase activity,MF,
14055,GO:0051393,1,0.533936143829061,0,32,alpha-actinin binding,MF,
14056,GO:0051394,1,0.978551592690055,0,1,regulation of nerve growth factor receptor activity,BP,
14057,GO:0051400,1,0.807713354534474,0,10,BH domain binding,MF,
14060,GO:0051409,1,0.811857079506812,0,10,response to nitrosative stress,BP,
14061,GO:0051410,1,0.898513981971312,0,5,detoxification of nitrogen compound,BP,
14063,GO:0051414,1,0.902808006032709,0,5,response to cortisol,BP,
14064,GO:0051415,1,0.881869171698195,0,6,interphase microtubule nucleation by interphase microtubule organizing center,BP,
14065,GO:0051418,1,0.864948389262888,0,7,microtubule nucleation by microtubule organizing center,BP,
14066,GO:0051424,1,0.978693275402233,0,1,corticotropin-releasing hormone binding,MF,
14067,GO:0051425,1,0.92251673230789,0,4,PTB domain binding,MF,
14070,GO:0051429,1,0.878794118947269,0,6,corticotropin-releasing hormone receptor binding,MF,
14071,GO:0051430,1,0.917799669794883,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
14072,GO:0051431,1,0.916776902812964,0,4,corticotropin-releasing hormone receptor 2 binding,MF,
14073,GO:0051433,1,0.979304843081212,0,1,BH2 domain binding,MF,
14074,GO:0051434,1,0.918223130221845,0,4,BH3 domain binding,MF,
14079,GO:0051440,1,0.979071895117419,0,1,regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14080,GO:0051441,1,0.979071895117419,0,1,positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14086,GO:0051450,1,0.7438777376422,0,14,myoblast proliferation,BP,
14087,GO:0051451,1,0.810449728861483,0,10,myoblast migration,BP,
14090,GO:0051454,1,0.88151910738308,0,6,intracellular pH elevation,BP,
14091,GO:0051457,1,0.734460767840797,0,15,maintenance of protein location in nucleus,BP,
14092,GO:0051458,1,0.860779610598002,0,7,corticotropin secretion,BP,
14093,GO:0051459,1,0.879271953101839,0,6,regulation of corticotropin secretion,BP,
14094,GO:0051460,1,0.978693275402233,0,1,negative regulation of corticotropin secretion,BP,
14095,GO:0051461,1,0.898419863635315,0,5,positive regulation of corticotropin secretion,BP,
14096,GO:0051462,1,0.899349161008055,0,5,regulation of cortisol secretion,BP,
14097,GO:0051463,1,0.98053283445274,0,1,negative regulation of cortisol secretion,BP,
14098,GO:0051464,1,0.917208782173951,0,4,positive regulation of cortisol secretion,BP,
14099,GO:0051466,1,0.958382802616415,0,2,positive regulation of corticotropin-releasing hormone secretion,BP,
14101,GO:0051481,1,0.74979635912689,0,14,negative regulation of cytosolic calcium ion concentration,BP,
14104,GO:0051490,1,0.937979849061329,0,3,negative regulation of filopodium assembly,BP,
14111,GO:0051497,1,0.662807652869406,0,20,negative regulation of stress fiber assembly,BP,
14112,GO:0051499,1,0.957975549381653,0,2,D-aminoacyl-tRNA deacylase activity,MF,
14113,GO:0051500,1,0.957975549381653,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
14114,GO:0051503,1,0.757877695657272,0,13,adenine nucleotide transport,BP,
14115,GO:0051510,1,0.97852925271556,0,1,regulation of unidimensional cell growth,BP,
14116,GO:0051511,1,0.97852925271556,0,1,negative regulation of unidimensional cell growth,BP,
14117,GO:0051525,1,0.90293263849921,0,5,NFAT protein binding,MF,
14119,GO:0051532,1,0.735279688986658,0,15,regulation of NFAT protein import into nucleus,BP,
14120,GO:0051533,1,0.812195546957939,0,10,positive regulation of NFAT protein import into nucleus,BP,
14121,GO:0051534,1,0.905349925641484,0,5,negative regulation of NFAT protein import into nucleus,BP,
14124,GO:0051538,1,0.937934604747667,0,3,3 iron, 4 sulfur cluster binding,MF,
14133,GO:0051548,1,0.9617838116484,0,2,negative regulation of keratinocyte migration,BP,
14135,GO:0051552,1,0.881402746869955,0,6,flavone metabolic process,BP,
14136,GO:0051560,1,0.71166474061927,0,16,mitochondrial calcium ion homeostasis,BP,
14137,GO:0051561,1,0.842780486613335,0,8,positive regulation of mitochondrial calcium ion concentration,BP,
14138,GO:0051562,1,0.958006988051392,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
14139,GO:0051563,1,0.959857624109324,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
14140,GO:0051567,1,0.517818685259085,0,32,histone H3-K9 methylation,BP,
14141,GO:0051568,1,0.380158663289706,0,47,histone H3-K4 methylation,BP,
14142,GO:0051569,1,0.606057981747551,0,24,regulation of histone H3-K4 methylation,BP,
14143,GO:0051570,1,0.623416463435423,0,23,regulation of histone H3-K9 methylation,BP,
14144,GO:0051571,1,0.748720159991387,0,14,positive regulation of histone H3-K4 methylation,BP,
14145,GO:0051572,1,0.921930779259155,0,4,negative regulation of histone H3-K4 methylation,BP,
14146,GO:0051573,1,0.777916682227805,0,12,negative regulation of histone H3-K9 methylation,BP,
14147,GO:0051574,1,0.814682540381915,0,10,positive regulation of histone H3-K9 methylation,BP,
14148,GO:0051575,1,0.902327571592335,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
14150,GO:0051581,1,0.940124137777195,0,3,negative regulation of neurotransmitter uptake,BP,
14151,GO:0051582,1,0.937493228020187,0,3,positive regulation of neurotransmitter uptake,BP,
14154,GO:0051585,1,0.979067586913297,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
14155,GO:0051586,1,0.937493228020187,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
14157,GO:0051589,1,0.752354552228256,0,14,negative regulation of neurotransmitter transport,BP,
14158,GO:0051590,1,0.747341297429142,0,14,positive regulation of neurotransmitter transport,BP,
14161,GO:0051593,1,0.79172631288098,0,11,response to folic acid,BP,
14162,GO:0051594,1,0.918026830356171,0,4,detection of glucose,BP,
14163,GO:0051595,1,0.95980471134024,0,2,response to methylglyoxal,BP,
14164,GO:0051596,1,0.958105664655775,0,2,methylglyoxal catabolic process,BP,
14166,GO:0051598,1,0.958484188900028,0,2,meiotic recombination checkpoint,BP,
14167,GO:0051599,1,0.884751009538858,0,6,response to hydrostatic pressure,BP,
14175,GO:0051610,1,0.920661619604591,0,4,serotonin uptake,BP,
14176,GO:0051611,1,0.940124137777195,0,3,regulation of serotonin uptake,BP,
14177,GO:0051612,1,0.940124137777195,0,3,negative regulation of serotonin uptake,BP,
14178,GO:0051615,1,0.98002563738937,0,1,histamine uptake,BP,
14179,GO:0051620,1,0.979067586913297,0,1,norepinephrine uptake,BP,
14180,GO:0051621,1,0.979067586913297,0,1,regulation of norepinephrine uptake,BP,
14181,GO:0051622,1,0.979067586913297,0,1,negative regulation of norepinephrine uptake,BP,
14185,GO:0051642,1,0.661508537600336,0,21,centrosome localization,BP,
14186,GO:0051643,1,0.963990159656475,0,2,endoplasmic reticulum localization,BP,
14187,GO:0051645,1,0.782294546050072,0,12,Golgi localization,BP,
14188,GO:0051646,1,0.456751235408511,0,38,mitochondrion localization,BP,
14189,GO:0051647,1,0.657138706480947,0,21,nucleus localization,BP,
14195,GO:0051654,1,0.692841049179813,0,18,establishment of mitochondrion localization,BP,
14197,GO:0051657,1,0.820885280757914,0,10,maintenance of organelle location,BP,
14198,GO:0051659,1,0.958374452853917,0,2,maintenance of mitochondrion location,BP,
14199,GO:0051660,1,0.920252296815539,0,4,establishment of centrosome localization,BP,
14200,GO:0051661,1,0.910215602035095,0,5,maintenance of centrosome location,BP,
14201,GO:0051664,1,0.979158367654368,0,1,nuclear pore localization,BP,
14202,GO:0051665,1,0.808574753946199,0,10,membrane raft localization,BP,
14204,GO:0051673,1,0.957809858552439,0,2,membrane disruption in other organism,BP,
14206,GO:0051683,1,0.862959388154984,0,7,establishment of Golgi localization,BP,
14207,GO:0051684,1,0.941131013529631,0,3,maintenance of Golgi location,BP,
14208,GO:0051685,1,0.97897493185122,0,1,maintenance of ER location,BP,
14209,GO:0051691,1,0.95760631237613,0,2,cellular oligosaccharide metabolic process,BP,
14210,GO:0051692,1,0.95760631237613,0,2,cellular oligosaccharide catabolic process,BP,
14214,GO:0051697,1,0.917922150409449,0,4,protein delipidation,BP,
14216,GO:0051702,1,0.269987517993818,0,62,interaction with symbiont,BP,
14217,GO:0051703,1,0.383356022724541,0,47,intraspecies interaction between organisms,BP,
14219,GO:0051705,1,0.273264973631767,0,63,multi-organism behavior,BP,
14221,GO:0051708,1,0.898765012036251,0,5,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14222,GO:0051709,1,0.861432101008534,0,7,regulation of killing of cells of other organism,BP,
14223,GO:0051712,1,0.879856590875126,0,6,positive regulation of killing of cells of other organism,BP,
14224,GO:0051715,1,0.958318823202868,0,2,cytolysis in other organism,BP,
14226,GO:0051717,1,0.959426558889782,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14228,GO:0051722,1,0.978941971221998,0,1,protein C-terminal methylesterase activity,MF,
14229,GO:0051723,1,0.978941971221998,0,1,protein methylesterase activity,MF,
14230,GO:0051724,1,0.978867379319807,0,1,NAD transporter activity,MF,
14231,GO:0051725,1,0.918257967787069,0,4,protein de-ADP-ribosylation,BP,
14233,GO:0051728,1,0.979058680792045,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14234,GO:0051729,1,0.979058680792045,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14235,GO:0051731,1,0.921508946804196,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14236,GO:0051732,1,0.978659005690316,0,1,polyribonucleotide kinase activity,MF,
14237,GO:0051733,1,0.93950108193437,0,3,polydeoxyribonucleotide kinase activity,MF,
14238,GO:0051734,1,0.93950108193437,0,3,ATP-dependent polynucleotide kinase activity,MF,
14239,GO:0051736,1,0.978659005690316,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14240,GO:0051747,1,0.978488712361713,0,1,cytosine C-5 DNA demethylase activity,MF,
14241,GO:0051748,1,0.97881770979122,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14242,GO:0051754,1,0.938366451823073,0,3,meiotic sister chromatid cohesion, centromeric,BP,
14243,GO:0051758,1,0.980641031006178,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14244,GO:0051764,1,0.778189959684887,0,12,actin crosslink formation,BP,
14245,GO:0051765,1,0.958190312932894,0,2,inositol tetrakisphosphate kinase activity,MF,
14246,GO:0051766,1,0.79194641921772,0,11,inositol trisphosphate kinase activity,MF,
14251,GO:0051775,1,0.79778605519501,0,11,response to redox state,BP,
14252,GO:0051780,1,0.979143855843724,0,1,behavioral response to nutrient,BP,
14254,GO:0051782,1,0.717787394674501,0,16,negative regulation of cell division,BP,
14258,GO:0051786,1,0.979069282852216,0,1,all-trans-retinol 13,14-reductase activity,MF,
14259,GO:0051787,1,0.759835433535809,0,13,misfolded protein binding,MF,
14260,GO:0051788,1,0.629053340270664,0,22,response to misfolded protein,BP,
14261,GO:0051790,1,0.918292785828015,0,4,short-chain fatty acid biosynthetic process,BP,
14262,GO:0051791,1,0.898341235885621,0,5,medium-chain fatty acid metabolic process,BP,
14263,GO:0051792,1,0.957582087640733,0,2,medium-chain fatty acid biosynthetic process,BP,
14264,GO:0051793,1,0.978991111195043,0,1,medium-chain fatty acid catabolic process,BP,
14265,GO:0051794,1,0.918804434011132,0,4,regulation of timing of catagen,BP,
14266,GO:0051795,1,0.938333151862517,0,3,positive regulation of timing of catagen,BP,
14267,GO:0051796,1,0.979191434566361,0,1,negative regulation of timing of catagen,BP,
14270,GO:0051799,1,0.919002121121301,0,4,negative regulation of hair follicle development,BP,
14271,GO:0051800,1,0.959082530647169,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14272,GO:0051801,1,0.958318823202868,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14273,GO:0051805,1,0.979015691396219,0,1,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14275,GO:0051807,1,0.979015691396219,0,1,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14276,GO:0051808,1,0.978925601400141,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14277,GO:0051817,1,0.141592315316682,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14278,GO:0051818,1,0.77278133945416,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14279,GO:0051821,1,0.980613073878647,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14280,GO:0051823,1,0.833958118811259,0,9,regulation of synapse structural plasticity,BP,
14282,GO:0051832,1,0.939361584553954,0,3,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14283,GO:0051834,1,0.939361584553954,0,3,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14284,GO:0051835,1,0.923045315297229,0,4,positive regulation of synapse structural plasticity,BP,
14285,GO:0051836,1,0.978925601400141,0,1,translocation of molecules into other organism involved in symbiotic interaction,BP,
14286,GO:0051851,1,0.293186553047963,0,58,modification by host of symbiont morphology or physiology,BP,
14287,GO:0051852,1,0.841378860318606,0,8,disruption by host of symbiont cells,BP,
14288,GO:0051861,1,0.66656258737744,0,19,glycolipid binding,MF,
14289,GO:0051864,1,0.903523638591871,0,5,histone demethylase activity (H3-K36 specific),MF,
14290,GO:0051865,1,0.332547766206379,0,53,protein autoubiquitination,BP,
14291,GO:0051866,1,0.958049668701845,0,2,general adaptation syndrome,BP,
14292,GO:0051867,1,0.978531639221901,0,1,general adaptation syndrome, behavioral process,BP,
14293,GO:0051870,1,0.937451192724539,0,3,methotrexate binding,MF,
14294,GO:0051873,1,0.841378860318606,0,8,killing by host of symbiont cells,BP,
14296,GO:0051877,1,0.958492956489676,0,2,pigment granule aggregation in cell center,BP,
14297,GO:0051878,1,0.979069722034358,0,1,lateral element assembly,BP,
14298,GO:0051879,1,0.519644455854057,0,31,Hsp90 protein binding,MF,
14299,GO:0051880,1,0.868239209919375,0,7,G-quadruplex DNA binding,MF,
14301,GO:0051882,1,0.628437662151567,0,22,mitochondrial depolarization,BP,
14302,GO:0051883,1,0.77278133945416,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14305,GO:0051886,1,0.979678640160998,0,1,negative regulation of timing of anagen,BP,
14306,GO:0051890,1,0.862692471785358,0,7,regulation of cardioblast differentiation,BP,
14307,GO:0051891,1,0.899897296950107,0,5,positive regulation of cardioblast differentiation,BP,
14308,GO:0051892,1,0.958668219021593,0,2,negative regulation of cardioblast differentiation,BP,
14311,GO:0051895,1,0.748103677334932,0,14,negative regulation of focal adhesion assembly,BP,
14314,GO:0051898,1,0.493551444909505,0,34,negative regulation of protein kinase B signaling,BP,
14316,GO:0051900,1,0.669799451285897,0,19,regulation of mitochondrial depolarization,BP,
14317,GO:0051901,1,0.825759951493313,0,9,positive regulation of mitochondrial depolarization,BP,
14318,GO:0051902,1,0.879946916374033,0,6,negative regulation of mitochondrial depolarization,BP,
14319,GO:0051903,1,0.97899974731779,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14322,GO:0051908,1,0.979068264157219,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14323,GO:0051916,1,0.979056752430998,0,1,granulocyte colony-stimulating factor binding,MF,
14324,GO:0051917,1,0.742262129760116,0,14,regulation of fibrinolysis,BP,
14325,GO:0051918,1,0.808280950846393,0,10,negative regulation of fibrinolysis,BP,
14326,GO:0051919,1,0.918250060071488,0,4,positive regulation of fibrinolysis,BP,
14327,GO:0051920,1,0.840983844437716,0,8,peroxiredoxin activity,MF,
14328,GO:0051923,1,0.712002179572637,0,16,sulfation,BP,
14335,GO:0051933,1,0.923236501525473,0,4,amino acid neurotransmitter reuptake,BP,
14337,GO:0051935,1,0.923236501525473,0,4,glutamate reuptake,BP,
14340,GO:0051939,1,0.979283411742694,0,1,gamma-aminobutyric acid import,BP,
14342,GO:0051941,1,0.960879088673025,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14343,GO:0051944,1,0.937493228020187,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14344,GO:0051945,1,0.979067586913297,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14345,GO:0051946,1,0.960879088673025,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14351,GO:0051957,1,0.72719592911205,0,15,positive regulation of amino acid transport,BP,
14352,GO:0051958,1,0.960125288972702,0,2,methotrexate transport,BP,
14353,GO:0051959,1,0.793224602429473,0,12,dynein light intermediate chain binding,MF,
14362,GO:0051968,1,0.663787451223724,0,20,positive regulation of synaptic transmission, glutamatergic,BP,
14363,GO:0051969,1,0.712105188117505,0,16,regulation of transmission of nerve impulse,BP,
14364,GO:0051970,1,0.897905145899772,0,5,negative regulation of transmission of nerve impulse,BP,
14365,GO:0051971,1,0.863472980758654,0,7,positive regulation of transmission of nerve impulse,BP,
14366,GO:0051972,1,0.394217059643437,0,44,regulation of telomerase activity,BP,
14367,GO:0051973,1,0.477003345720278,0,35,positive regulation of telomerase activity,BP,
14368,GO:0051974,1,0.82566312844534,0,9,negative regulation of telomerase activity,BP,
14369,GO:0051977,1,0.957784130801056,0,2,lysophospholipid transport,BP,
14370,GO:0051978,1,0.978836561032953,0,1,lysophospholipid transporter activity,MF,
14371,GO:0051983,1,0.190650629430088,0,80,regulation of chromosome segregation,BP,
14372,GO:0051984,1,0.672283398054649,0,19,positive regulation of chromosome segregation,BP,
14373,GO:0051985,1,0.499380704143706,0,34,negative regulation of chromosome segregation,BP,
14374,GO:0051987,1,0.918102631179519,0,4,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14375,GO:0051988,1,0.795069833314424,0,11,regulation of attachment of spindle microtubules to kinetochore,BP,
14377,GO:0051996,1,0.978802720300017,0,1,squalene synthase activity,MF,
14378,GO:0051998,1,0.89920492644358,0,5,protein carboxyl O-methyltransferase activity,MF,
14379,GO:0052026,1,0.979046253271142,0,1,modulation by symbiont of host transcription,BP,
14380,GO:0052027,1,0.979069134244812,0,1,modulation by symbiont of host signal transduction pathway,BP,
14381,GO:0052031,1,0.957871401892734,0,2,modulation by symbiont of host defense response,BP,
14382,GO:0052040,1,0.899432040751791,0,5,modulation by symbiont of host programmed cell death,BP,
14383,GO:0052041,1,0.91824490465937,0,4,negative regulation by symbiont of host programmed cell death,BP,
14384,GO:0052042,1,0.958461169726698,0,2,positive regulation by symbiont of host programmed cell death,BP,
14385,GO:0052047,1,0.961371852155606,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14386,GO:0052053,1,0.979027290815123,0,1,negative regulation by symbiont of host catalytic activity,BP,
14387,GO:0052055,1,0.898937676588302,0,5,modulation by symbiont of host molecular function,BP,
14388,GO:0052056,1,0.959145458173215,0,2,negative regulation by symbiont of host molecular function,BP,
14389,GO:0052066,1,0.981023704923529,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14390,GO:0052097,1,0.979069145652555,0,1,interspecies quorum sensing,BP,
14391,GO:0052106,1,0.979069145652555,0,1,quorum sensing involved in interaction with host,BP,
14392,GO:0052126,1,0.47820701894983,0,35,movement in host environment,BP,
14393,GO:0052148,1,0.979027290815123,0,1,modulation by symbiont of host catalytic activity,BP,
14394,GO:0052150,1,0.899432040751791,0,5,modulation by symbiont of host apoptotic process,BP,
14395,GO:0052151,1,0.958461169726698,0,2,positive regulation by symbiont of host apoptotic process,BP,
14396,GO:0052173,1,0.880982217630622,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
14397,GO:0052182,1,0.978909729008923,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14398,GO:0052190,1,0.981023704923529,0,1,modulation by symbiont of host phagocytosis,BP,
14399,GO:0052191,1,0.981023704923529,0,1,positive regulation by symbiont of host phagocytosis,BP,
14400,GO:0052192,1,0.47820701894983,0,35,movement in environment of other organism involved in symbiotic interaction,BP,
14401,GO:0052199,1,0.937587498405873,0,3,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14402,GO:0052200,1,0.880982217630622,0,6,response to host defenses,BP,
14403,GO:0052203,1,0.917574806275358,0,4,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14404,GO:0052204,1,0.860796902720043,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14405,GO:0052205,1,0.860796902720043,0,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14406,GO:0052212,1,0.978909729008923,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14407,GO:0052213,1,0.978909729008923,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14408,GO:0052214,1,0.978621989433484,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14409,GO:0052227,1,0.978621989433484,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14410,GO:0052229,1,0.978621989433484,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14411,GO:0052231,1,0.981023704923529,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14412,GO:0052248,1,0.899432040751791,0,5,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14413,GO:0052250,1,0.979069134244812,0,1,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14414,GO:0052251,1,0.957871401892734,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14415,GO:0052255,1,0.957871401892734,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14416,GO:0052312,1,0.579964239026857,0,26,modulation of transcription in other organism involved in symbiotic interaction,BP,
14417,GO:0052314,1,0.957936559015546,0,2,phytoalexin metabolic process,BP,
14418,GO:0052330,1,0.958461169726698,0,2,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14419,GO:0052331,1,0.958318823202868,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14420,GO:0052360,1,0.978621989433484,0,1,catabolism by host of symbiont macromolecule,BP,
14421,GO:0052361,1,0.978621989433484,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14422,GO:0052362,1,0.978621989433484,0,1,catabolism by host of symbiont protein,BP,
14423,GO:0052363,1,0.978621989433484,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14424,GO:0052364,1,0.978621989433484,0,1,catabolism by host of substance in symbiont,BP,
14425,GO:0052370,1,0.981023704923529,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14426,GO:0052381,1,0.978812717910157,0,1,tRNA dimethylallyltransferase activity,MF,
14427,GO:0052403,1,0.957674876301617,0,2,negative regulation by host of symbiont catalytic activity,BP,
14428,GO:0052405,1,0.897473348754258,0,5,negative regulation by host of symbiont molecular function,BP,
14429,GO:0052416,1,0.978621989433484,0,1,metabolism by host of symbiont macromolecule,BP,
14430,GO:0052417,1,0.978621989433484,0,1,metabolism by host of symbiont protein,BP,
14431,GO:0052418,1,0.978621989433484,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14432,GO:0052419,1,0.978621989433484,0,1,metabolism by host of substance in symbiont,BP,
14433,GO:0052422,1,0.917574806275358,0,4,modulation by host of symbiont catalytic activity,BP,
14434,GO:0052428,1,0.878645412874815,0,6,modification by host of symbiont molecular function,BP,
14435,GO:0052433,1,0.899432040751791,0,5,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14436,GO:0052472,1,0.5923946617064,0,25,modulation by host of symbiont transcription,BP,
14437,GO:0052490,1,0.91824490465937,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14438,GO:0052501,1,0.958461169726698,0,2,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14439,GO:0052509,1,0.957871401892734,0,2,positive regulation by symbiont of host defense response,BP,
14440,GO:0052510,1,0.957871401892734,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14441,GO:0052522,1,0.981023704923529,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14444,GO:0052550,1,0.978635797103521,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14445,GO:0052551,1,0.979318933713604,0,1,response to defense-related nitric oxide production by other organism involved in symbiotic interaction,BP,
14446,GO:0052552,1,0.957871401892734,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14447,GO:0052553,1,0.957871401892734,0,2,modulation by symbiont of host immune response,BP,
14448,GO:0052564,1,0.898746607042406,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
14449,GO:0052565,1,0.979318933713604,0,1,response to defense-related host nitric oxide production,BP,
14450,GO:0052567,1,0.978635797103521,0,1,response to defense-related host reactive oxygen species production,BP,
14451,GO:0052572,1,0.898746607042406,0,5,response to host immune response,BP,
14452,GO:0052590,1,0.9802541138829,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14453,GO:0052591,1,0.9802541138829,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14454,GO:0052593,1,0.958544997252236,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14455,GO:0052594,1,0.958544997252236,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14456,GO:0052595,1,0.958544997252236,0,2,aliphatic-amine oxidase activity,MF,
14457,GO:0052596,1,0.958544997252236,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14458,GO:0052629,1,0.800326251350904,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14459,GO:0052642,1,0.958095107318244,0,2,lysophosphatidic acid phosphatase activity,MF,
14460,GO:0052646,1,0.84845043356874,0,8,alditol phosphate metabolic process,BP,
14461,GO:0052650,1,0.824015333054343,0,9,NADP-retinol dehydrogenase activity,MF,
14462,GO:0052651,1,0.958093912555592,0,2,monoacylglycerol catabolic process,BP,
14464,GO:0052654,1,0.960994661689076,0,2,L-leucine transaminase activity,MF,
14465,GO:0052655,1,0.960994661689076,0,2,L-valine transaminase activity,MF,
14466,GO:0052656,1,0.960994661689076,0,2,L-isoleucine transaminase activity,MF,
14467,GO:0052657,1,0.978562097860833,0,1,guanine phosphoribosyltransferase activity,MF,
14468,GO:0052658,1,0.883172686291799,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14469,GO:0052659,1,0.829476260312455,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14470,GO:0052666,1,0.978741007376028,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14473,GO:0052695,1,0.696396992743625,0,17,cellular glucuronidation,BP,
14474,GO:0052696,1,0.898871395510549,0,5,flavonoid glucuronidation,BP,
14475,GO:0052697,1,0.825277216511789,0,9,xenobiotic glucuronidation,BP,
14476,GO:0052723,1,0.900761433003902,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14477,GO:0052724,1,0.900761433003902,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14478,GO:0052725,1,0.979068969355821,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14479,GO:0052726,1,0.979068969355821,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14480,GO:0052731,1,0.978802511892268,0,1,phosphocholine phosphatase activity,MF,
14481,GO:0052732,1,0.978802511892268,0,1,phosphoethanolamine phosphatase activity,MF,
14484,GO:0052741,1,0.957734308057819,0,2,(R)-limonene 6-monooxygenase activity,MF,
14486,GO:0052743,1,0.795804751503931,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14487,GO:0052744,1,0.751775615906772,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
14488,GO:0052745,1,0.674043670023284,0,19,inositol phosphate phosphatase activity,MF,
14489,GO:0052746,1,0.979240238994296,0,1,inositol phosphorylation,BP,
14490,GO:0052794,1,0.917873136168162,0,4,exo-alpha-(2->3)-sialidase activity,MF,
14491,GO:0052795,1,0.917873136168162,0,4,exo-alpha-(2->6)-sialidase activity,MF,
14492,GO:0052796,1,0.917873136168162,0,4,exo-alpha-(2->8)-sialidase activity,MF,
14493,GO:0052798,1,0.978798551701089,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14494,GO:0052803,1,0.790439453477569,0,11,imidazole-containing compound metabolic process,BP,
14495,GO:0052805,1,0.861199552487302,0,7,imidazole-containing compound catabolic process,BP,
14496,GO:0052810,1,0.958519751706088,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14497,GO:0052811,1,0.90103955642264,0,5,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14498,GO:0052812,1,0.938972971443465,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14500,GO:0052815,1,0.958031762387306,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14501,GO:0052816,1,0.979069350881823,0,1,long-chain acyl-CoA hydrolase activity,MF,
14502,GO:0052817,1,0.979069350881823,0,1,very long chain acyl-CoA hydrolase activity,MF,
14503,GO:0052821,1,0.978504121567352,0,1,DNA-7-methyladenine glycosylase activity,MF,
14504,GO:0052822,1,0.978504121567352,0,1,DNA-3-methylguanine glycosylase activity,MF,
14505,GO:0052825,1,0.979068969355821,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14506,GO:0052826,1,0.979042395172386,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14507,GO:0052827,1,0.958548858658972,0,2,inositol pentakisphosphate phosphatase activity,MF,
14508,GO:0052828,1,0.960373323595959,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14509,GO:0052829,1,0.97879584188831,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14510,GO:0052830,1,0.979068969355821,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14511,GO:0052831,1,0.979068969355821,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14512,GO:0052832,1,0.920431495574056,0,4,inositol monophosphate 3-phosphatase activity,MF,
14513,GO:0052833,1,0.920431495574056,0,4,inositol monophosphate 4-phosphatase activity,MF,
14514,GO:0052834,1,0.920431495574056,0,4,inositol monophosphate phosphatase activity,MF,
14515,GO:0052835,1,0.979068969355821,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14516,GO:0052836,1,0.938084830212143,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14517,GO:0052839,1,0.938084830212143,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14518,GO:0052840,1,0.918287180998757,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14519,GO:0052841,1,0.918287180998757,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14520,GO:0052842,1,0.918287180998757,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14521,GO:0052843,1,0.918287180998757,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14522,GO:0052844,1,0.918287180998757,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14523,GO:0052845,1,0.918287180998757,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14524,GO:0052846,1,0.918287180998757,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14525,GO:0052847,1,0.918287180998757,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14526,GO:0052848,1,0.918287180998757,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14527,GO:0052851,1,0.940412605047703,0,3,ferric-chelate reductase (NADPH) activity,MF,
14528,GO:0052852,1,0.957722339473154,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14529,GO:0052853,1,0.957722339473154,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14530,GO:0052854,1,0.957722339473154,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14531,GO:0052858,1,0.979070551236452,0,1,peptidyl-lysine acetyltransferase activity,MF,
14532,GO:0052866,1,0.549061312461856,0,29,phosphatidylinositol phosphate phosphatase activity,MF,
14533,GO:0052869,1,0.978907828278979,0,1,arachidonic acid omega-hydroxylase activity,MF,
14534,GO:0052870,1,0.958407420394983,0,2,tocopherol omega-hydroxylase activity,MF,
14535,GO:0052871,1,0.958407420394983,0,2,alpha-tocopherol omega-hydroxylase activity,MF,
14536,GO:0052872,1,0.978907828278979,0,1,tocotrienol omega-hydroxylase activity,MF,
14537,GO:0052884,1,0.978991968506644,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14538,GO:0052885,1,0.978991968506644,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14539,GO:0052890,1,0.978725608204797,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14540,GO:0052894,1,0.978788339325216,0,1,norspermine:oxygen oxidoreductase activity,MF,
14541,GO:0052895,1,0.978788339325216,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14542,GO:0052899,1,0.978641526874056,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14543,GO:0052901,1,0.957881707201612,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14544,GO:0052902,1,0.978641526874056,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14545,GO:0052903,1,0.978641526874056,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14546,GO:0052904,1,0.978641526874056,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14547,GO:0052906,1,0.979763583038675,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14548,GO:0052907,1,0.97897493185122,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14549,GO:0052909,1,0.97897493185122,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14550,GO:0052917,1,0.978910866225711,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14551,GO:0052918,1,0.980534729386184,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14552,GO:0052925,1,0.978587308188659,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14553,GO:0052926,1,0.980534729386184,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14554,GO:0052927,1,0.97887180099538,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14555,GO:0052928,1,0.97887180099538,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14556,GO:0052929,1,0.97887180099538,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14560,GO:0055005,1,0.938974976078079,0,3,ventricular cardiac myofibril assembly,BP,
14566,GO:0055011,1,0.937199844148182,0,3,atrial cardiac muscle cell differentiation,BP,
14567,GO:0055012,1,0.686503707467633,0,18,ventricular cardiac muscle cell differentiation,BP,
14569,GO:0055014,1,0.937199844148182,0,3,atrial cardiac muscle cell development,BP,
14570,GO:0055015,1,0.75990342886626,0,13,ventricular cardiac muscle cell development,BP,
14580,GO:0055029,1,0.0731876781770628,0,124,nuclear DNA-directed RNA polymerase complex,CC,
14583,GO:0055048,1,0.981215394349312,0,1,anastral spindle assembly,BP,
14585,GO:0055057,1,0.765416164420853,0,13,neuroblast division,BP,
14586,GO:0055059,1,0.901450558165794,0,5,asymmetric neuroblast division,BP,
14587,GO:0055062,1,0.780822576624143,0,12,phosphate ion homeostasis,BP,
14588,GO:0055064,1,0.900551731119943,0,5,chloride ion homeostasis,BP,
14591,GO:0055069,1,0.578320560602351,0,26,zinc ion homeostasis,BP,
14594,GO:0055073,1,0.958005569323721,0,2,cadmium ion homeostasis,BP,
14598,GO:0055077,1,0.918382468205829,0,4,gap junction hemi-channel activity,MF,
14603,GO:0055083,1,0.703121433085372,0,17,monovalent inorganic anion homeostasis,BP,
14606,GO:0055087,1,0.938673404581256,0,3,Ski complex,CC,
14608,GO:0055089,1,0.762340262362637,0,13,fatty acid homeostasis,BP,
14614,GO:0055095,1,0.938262819629974,0,3,lipoprotein particle mediated signaling,BP,
14615,GO:0055096,1,0.938262819629974,0,3,low-density lipoprotein particle mediated signaling,BP,
14616,GO:0055098,1,0.715351085954718,0,16,response to low-density lipoprotein particle,BP,
14618,GO:0055100,1,0.93831161301939,0,3,adiponectin binding,MF,
14620,GO:0055103,1,0.979068866243211,0,1,ligase regulator activity,MF,
14621,GO:0055105,1,0.897182797232277,0,5,ubiquitin-protein transferase inhibitor activity,MF,
14622,GO:0055106,1,0.709432029286606,0,16,ubiquitin-protein transferase regulator activity,MF,
14623,GO:0055108,1,0.978748781425082,0,1,Golgi to transport vesicle transport,BP,
14624,GO:0055111,1,0.98004094021772,0,1,ingression involved in gastrulation with mouth forming second,BP,
14625,GO:0055113,1,0.983891523582187,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14630,GO:0055120,1,0.978499297466388,0,1,striated muscle dense body,CC,
14632,GO:0055129,1,0.917827229786343,0,4,L-proline biosynthetic process,BP,
14633,GO:0055130,1,0.978610737723817,0,1,D-alanine catabolic process,BP,
14635,GO:0060001,1,0.982296270135723,0,1,minus-end directed microfilament motor activity,MF,
14636,GO:0060002,1,0.944500543475277,0,3,plus-end directed microfilament motor activity,MF,
14637,GO:0060003,1,0.963080193661701,0,2,copper ion export,BP,
14638,GO:0060004,1,0.687091603145218,0,18,reflex,BP,
14639,GO:0060005,1,0.919613982808841,0,4,vestibular reflex,BP,
14640,GO:0060007,1,0.979154648689585,0,1,linear vestibuloocular reflex,BP,
14641,GO:0060008,1,0.68829699604,0,18,Sertoli cell differentiation,BP,
14642,GO:0060009,1,0.749644806564935,0,14,Sertoli cell development,BP,
14643,GO:0060010,1,0.979069291021107,0,1,Sertoli cell fate commitment,BP,
14644,GO:0060011,1,0.918616170643989,0,4,Sertoli cell proliferation,BP,
14645,GO:0060012,1,0.861625498870979,0,7,synaptic transmission, glycinergic,BP,
14646,GO:0060013,1,0.848847708882054,0,8,righting reflex,BP,
14647,GO:0060014,1,0.958029562155406,0,2,granulosa cell differentiation,BP,
14648,GO:0060016,1,0.978529953828418,0,1,granulosa cell development,BP,
14649,GO:0060017,1,0.863727998313494,0,7,parathyroid gland development,BP,
14650,GO:0060018,1,0.919312872529641,0,4,astrocyte fate commitment,BP,
14652,GO:0060020,1,0.863464676416615,0,7,Bergmann glial cell differentiation,BP,
14654,GO:0060022,1,0.884014800329422,0,6,hard palate development,BP,
14655,GO:0060023,1,0.903862626293103,0,5,soft palate development,BP,
14657,GO:0060025,1,0.960245531671959,0,2,regulation of synaptic activity,BP,
14663,GO:0060032,1,0.960364977996983,0,2,notochord regression,BP,
14664,GO:0060033,1,0.794474338185173,0,11,anatomical structure regression,BP,
14665,GO:0060034,1,0.97910198034312,0,1,notochord cell differentiation,BP,
14666,GO:0060035,1,0.97910198034312,0,1,notochord cell development,BP,
14670,GO:0060040,1,0.917715841041853,0,4,retinal bipolar neuron differentiation,BP,
14676,GO:0060046,1,0.667882168908541,0,19,regulation of acrosome reaction,BP,
14679,GO:0060049,1,0.699644920991002,0,17,regulation of protein glycosylation,BP,
14680,GO:0060050,1,0.84560654252748,0,8,positive regulation of protein glycosylation,BP,
14681,GO:0060051,1,0.937781637519036,0,3,negative regulation of protein glycosylation,BP,
14682,GO:0060052,1,0.828246027905283,0,9,neurofilament cytoskeleton organization,BP,
14683,GO:0060053,1,0.960292848822429,0,2,neurofilament cytoskeleton,CC,
14685,GO:0060055,1,0.682722960233213,0,18,angiogenesis involved in wound healing,BP,
14690,GO:0060060,1,0.960625358071287,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14699,GO:0060072,1,0.960003191763389,0,2,large conductance calcium-activated potassium channel activity,MF,
14700,GO:0060073,1,0.864213917670326,0,7,micturition,BP,
14701,GO:0060074,1,0.709502476609488,0,17,synapse maturation,BP,
14704,GO:0060077,1,0.777532573092498,0,12,inhibitory synapse,CC,
14707,GO:0060080,1,0.748953132998822,0,14,inhibitory postsynaptic potential,BP,
14708,GO:0060081,1,0.777963935022454,0,12,membrane hyperpolarization,BP,
14709,GO:0060083,1,0.93996862871053,0,3,smooth muscle contraction involved in micturition,BP,
14710,GO:0060084,1,0.939305227435006,0,3,synaptic transmission involved in micturition,BP,
14711,GO:0060086,1,0.958533157672934,0,2,circadian temperature homeostasis,BP,
14716,GO:0060091,1,0.826149915263421,0,9,kinocilium,CC,
14717,GO:0060099,1,0.795074980383966,0,11,regulation of phagocytosis, engulfment,BP,
14718,GO:0060100,1,0.829803931969677,0,9,positive regulation of phagocytosis, engulfment,BP,
14719,GO:0060101,1,0.978712826625149,0,1,negative regulation of phagocytosis, engulfment,BP,
14720,GO:0060112,1,0.957624286730621,0,2,generation of ovulation cycle rhythm,BP,
14722,GO:0060114,1,0.978493023456071,0,1,vestibular receptor cell differentiation,BP,
14724,GO:0060118,1,0.978493023456071,0,1,vestibular receptor cell development,BP,
14728,GO:0060123,1,0.796956055200497,0,11,regulation of growth hormone secretion,BP,
14729,GO:0060124,1,0.842904726572897,0,8,positive regulation of growth hormone secretion,BP,
14730,GO:0060125,1,0.961340872580902,0,2,negative regulation of growth hormone secretion,BP,
14732,GO:0060127,1,0.978855222752691,0,1,prolactin secreting cell differentiation,BP,
14735,GO:0060133,1,0.957549007438875,0,2,somatotropin secreting cell development,BP,
14736,GO:0060134,1,0.764274036204204,0,13,prepulse inhibition,BP,
14740,GO:0060139,1,0.958461169726698,0,2,positive regulation of apoptotic process by virus,BP,
14741,GO:0060142,1,0.573217903056753,0,26,regulation of syncytium formation by plasma membrane fusion,BP,
14742,GO:0060143,1,0.598564103091463,0,24,positive regulation of syncytium formation by plasma membrane fusion,BP,
14745,GO:0060149,1,0.783253734865473,0,12,negative regulation of posttranscriptional gene silencing,BP,
14746,GO:0060151,1,0.958953014878686,0,2,peroxisome localization,BP,
14747,GO:0060152,1,0.958953014878686,0,2,microtubule-based peroxisome localization,BP,
14748,GO:0060154,1,0.938275389775796,0,3,cellular process regulating host cell cycle in response to virus,BP,
14751,GO:0060158,1,0.756037267310929,0,13,phospholipase C-activating dopamine receptor signaling pathway,BP,
14752,GO:0060159,1,0.812007493761315,0,10,regulation of dopamine receptor signaling pathway,BP,
14753,GO:0060160,1,0.937972859734772,0,3,negative regulation of dopamine receptor signaling pathway,BP,
14754,GO:0060161,1,0.902415124601462,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14755,GO:0060163,1,0.957919212295888,0,2,subpallium neuron fate commitment,BP,
14756,GO:0060164,1,0.917718931060403,0,4,regulation of timing of neuron differentiation,BP,
14757,GO:0060165,1,0.978946517601127,0,1,regulation of timing of subpallium neuron differentiation,BP,
14758,GO:0060166,1,0.937906646106967,0,3,olfactory pit development,BP,
14759,GO:0060167,1,0.940325136347602,0,3,regulation of adenosine receptor signaling pathway,BP,
14760,GO:0060168,1,0.960897668310456,0,2,positive regulation of adenosine receptor signaling pathway,BP,
14761,GO:0060169,1,0.978592601272244,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14763,GO:0060171,1,0.964693514399668,0,2,stereocilium membrane,CC,
14766,GO:0060175,1,0.98115238139334,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14767,GO:0060177,1,0.758797013511728,0,13,regulation of angiotensin metabolic process,BP,
14770,GO:0060180,1,0.828560996181954,0,9,female mating behavior,BP,
14771,GO:0060184,1,0.979058680792045,0,1,cell cycle switching,BP,
14772,GO:0060187,1,0.959602927515971,0,2,cell pole,CC,
14777,GO:0060198,1,0.774566039678931,0,12,clathrin-sculpted vesicle,CC,
14778,GO:0060199,1,0.918522698212286,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14779,GO:0060200,1,0.938272151450166,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14780,GO:0060201,1,0.938272151450166,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14781,GO:0060203,1,0.918522698212286,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14783,GO:0060211,1,0.803890043908368,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14784,GO:0060212,1,0.978686382069844,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14785,GO:0060213,1,0.803890043908368,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14786,GO:0060214,1,0.917854471476303,0,4,endocardium formation,BP,
14789,GO:0060217,1,0.979570143855121,0,1,hemangioblast cell differentiation,BP,
14790,GO:0060218,1,0.699232386679599,0,17,hematopoietic stem cell differentiation,BP,
14791,GO:0060219,1,0.718591535101969,0,16,camera-type eye photoreceptor cell differentiation,BP,
14792,GO:0060221,1,0.938074090590508,0,3,retinal rod cell differentiation,BP,
14794,GO:0060229,1,0.758285232710998,0,13,lipase activator activity,MF,
14795,GO:0060230,1,0.937082626106744,0,3,lipoprotein lipase activator activity,MF,
14797,GO:0060232,1,0.958475914804624,0,2,delamination,BP,
14800,GO:0060242,1,0.827501517319041,0,9,contact inhibition,BP,
14801,GO:0060243,1,0.979173730319897,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14802,GO:0060244,1,0.918818425174812,0,4,negative regulation of cell proliferation involved in contact inhibition,BP,
14803,GO:0060245,1,0.979077239482383,0,1,detection of cell density,BP,
14804,GO:0060246,1,0.979077239482383,0,1,detection of cell density by contact stimulus,BP,
14805,GO:0060248,1,0.979077239482383,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14808,GO:0060252,1,0.813235224518698,0,10,positive regulation of glial cell proliferation,BP,
14810,GO:0060254,1,0.978683724190989,0,1,regulation of N-terminal protein palmitoylation,BP,
14812,GO:0060259,1,0.655966139416625,0,20,regulation of feeding behavior,BP,
14815,GO:0060262,1,0.978683724190989,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14816,GO:0060263,1,0.793668270575901,0,11,regulation of respiratory burst,BP,
14817,GO:0060264,1,0.917191878058702,0,4,regulation of respiratory burst involved in inflammatory response,BP,
14818,GO:0060265,1,0.957629378174862,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14819,GO:0060266,1,0.937165458379157,0,3,negative regulation of respiratory burst involved in inflammatory response,BP,
14820,GO:0060267,1,0.901089892685467,0,5,positive regulation of respiratory burst,BP,
14821,GO:0060268,1,0.91933050765192,0,4,negative regulation of respiratory burst,BP,
14826,GO:0060280,1,0.978889655064775,0,1,negative regulation of ovulation,BP,
14828,GO:0060282,1,0.920172739726635,0,4,positive regulation of oocyte development,BP,
14831,GO:0060285,1,0.636088620653914,0,23,cilium-dependent cell motility,BP,
14832,GO:0060287,1,0.844145205329948,0,8,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14833,GO:0060290,1,0.845976807854979,0,8,transdifferentiation,BP,
14836,GO:0060293,1,0.71324005378679,0,16,germ plasm,CC,
14837,GO:0060294,1,0.740474779115405,0,14,cilium movement involved in cell motility,BP,
14838,GO:0060295,1,0.899262418896982,0,5,regulation of cilium movement involved in cell motility,BP,
14839,GO:0060296,1,0.899262418896982,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14842,GO:0060299,1,0.978551592690055,0,1,negative regulation of sarcomere organization,BP,
14843,GO:0060300,1,0.918073790872441,0,4,regulation of cytokine activity,BP,
14844,GO:0060301,1,0.978950316202423,0,1,positive regulation of cytokine activity,BP,
14845,GO:0060302,1,0.957785679292546,0,2,negative regulation of cytokine activity,BP,
14846,GO:0060304,1,0.979062052533437,0,1,regulation of phosphatidylinositol dephosphorylation,BP,
14847,GO:0060305,1,0.979043579876824,0,1,regulation of cell diameter,BP,
14850,GO:0060309,1,0.957427906173702,0,2,elastin catabolic process,BP,
14851,GO:0060310,1,0.978476345874716,0,1,regulation of elastin catabolic process,BP,
14852,GO:0060311,1,0.978476345874716,0,1,negative regulation of elastin catabolic process,BP,
14853,GO:0060312,1,0.828645597950358,0,9,regulation of blood vessel remodeling,BP,
14854,GO:0060313,1,0.940423517899914,0,3,negative regulation of blood vessel remodeling,BP,
14857,GO:0060316,1,0.846777468664701,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14866,GO:0060327,1,0.979025236461441,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14867,GO:0060330,1,0.641907418515728,0,21,regulation of response to interferon-gamma,BP,
14868,GO:0060331,1,0.91741148787277,0,4,negative regulation of response to interferon-gamma,BP,
14869,GO:0060332,1,0.922874809303622,0,4,positive regulation of response to interferon-gamma,BP,
14871,GO:0060334,1,0.655646493863273,0,20,regulation of interferon-gamma-mediated signaling pathway,BP,
14872,GO:0060335,1,0.922874809303622,0,4,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14873,GO:0060336,1,0.91741148787277,0,4,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14876,GO:0060339,1,0.883074950424486,0,6,negative regulation of type I interferon-mediated signaling pathway,BP,
14879,GO:0060342,1,0.958183454333339,0,2,photoreceptor inner segment membrane,CC,
14881,GO:0060345,1,0.979069335039327,0,1,spleen trabecula formation,BP,
14882,GO:0060346,1,0.817445147926376,0,10,bone trabecula formation,BP,
14888,GO:0060352,1,0.861778425741271,0,7,cell adhesion molecule production,BP,
14889,GO:0060353,1,0.898235184571976,0,5,regulation of cell adhesion molecule production,BP,
14890,GO:0060354,1,0.978484698441343,0,1,negative regulation of cell adhesion molecule production,BP,
14891,GO:0060355,1,0.917990582322287,0,4,positive regulation of cell adhesion molecule production,BP,
14892,GO:0060356,1,0.978866976342433,0,1,leucine import,BP,
14895,GO:0060364,1,0.921146041441137,0,4,frontal suture morphogenesis,BP,
14896,GO:0060366,1,0.981959387761287,0,1,lambdoid suture morphogenesis,BP,
14897,GO:0060367,1,0.981959387761287,0,1,sagittal suture morphogenesis,BP,
14898,GO:0060368,1,0.862859794307475,0,7,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14899,GO:0060369,1,0.919714656678276,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14900,GO:0060370,1,0.959049713850959,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14901,GO:0060371,1,0.869169191172404,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14902,GO:0060372,1,0.888132650280628,0,6,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14903,GO:0060373,1,0.884147269528259,0,6,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14907,GO:0060378,1,0.981640961123948,0,1,regulation of brood size,BP,
14909,GO:0060380,1,0.978783965559314,0,1,regulation of single-stranded telomeric DNA binding,BP,
14910,GO:0060381,1,0.978783965559314,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14911,GO:0060382,1,0.960189256387123,0,2,regulation of DNA strand elongation,BP,
14912,GO:0060383,1,0.979131260122671,0,1,positive regulation of DNA strand elongation,BP,
14913,GO:0060384,1,0.600187804148053,0,25,innervation,BP,
14914,GO:0060385,1,0.901044330522602,0,5,axonogenesis involved in innervation,BP,
14915,GO:0060386,1,0.980102284795924,0,1,synapse assembly involved in innervation,BP,
14919,GO:0060392,1,0.937617579302739,0,3,negative regulation of SMAD protein import into nucleus,BP,
14921,GO:0060394,1,0.80825797542569,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14925,GO:0060398,1,0.920419945010414,0,4,regulation of growth hormone receptor signaling pathway,BP,
14926,GO:0060399,1,0.939827866344525,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14927,GO:0060400,1,0.979352950077623,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14930,GO:0060404,1,0.979072835636165,0,1,axonemal microtubule depolymerization,BP,
14931,GO:0060405,1,0.881046272914506,0,6,regulation of penile erection,BP,
14932,GO:0060406,1,0.91854728854042,0,4,positive regulation of penile erection,BP,
14933,GO:0060407,1,0.978592601272244,0,1,negative regulation of penile erection,BP,
14937,GO:0060414,1,0.941677014926982,0,3,aorta smooth muscle tissue morphogenesis,BP,
14943,GO:0060422,1,0.978879387759788,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14954,GO:0060434,1,0.958774098114,0,2,bronchus morphogenesis,BP,
14966,GO:0060446,1,0.978974306474141,0,1,branching involved in open tracheal system development,BP,
14968,GO:0060448,1,0.943641208660338,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14970,GO:0060450,1,0.978466864386927,0,1,positive regulation of hindgut contraction,BP,
14972,GO:0060453,1,0.807827853246806,0,10,regulation of gastric acid secretion,BP,
14973,GO:0060454,1,0.958647245841816,0,2,positive regulation of gastric acid secretion,BP,
14974,GO:0060455,1,0.897818432488277,0,5,negative regulation of gastric acid secretion,BP,
14975,GO:0060456,1,0.789804108059608,0,11,positive regulation of digestive system process,BP,
14977,GO:0060458,1,0.958025767379644,0,2,right lung development,BP,
14978,GO:0060459,1,0.937592217314593,0,3,left lung development,BP,
14979,GO:0060460,1,0.958095165818374,0,2,left lung morphogenesis,BP,
14980,GO:0060461,1,0.978974306474141,0,1,right lung morphogenesis,BP,
14983,GO:0060465,1,0.95857564119712,0,2,pharynx development,BP,
14984,GO:0060466,1,0.980906807466197,0,1,activation of meiosis involved in egg activation,BP,
14985,GO:0060467,1,0.879000719702927,0,6,negative regulation of fertilization,BP,
14986,GO:0060468,1,0.957863060265922,0,2,prevention of polyspermy,BP,
14987,GO:0060473,1,0.978537434295704,0,1,cortical granule,CC,
14988,GO:0060474,1,0.917214082437637,0,4,positive regulation of flagellated sperm motility involved in capacitation,BP,
14989,GO:0060478,1,0.91801950333519,0,4,acrosomal vesicle exocytosis,BP,
14991,GO:0060480,1,0.916994111447855,0,4,lung goblet cell differentiation,BP,
14992,GO:0060481,1,0.897819365606572,0,5,lobar bronchus epithelium development,BP,
14994,GO:0060484,1,0.808840593596891,0,10,lung-associated mesenchyme development,BP,
14996,GO:0060486,1,0.921185339319605,0,4,Clara cell differentiation,BP,
14998,GO:0060488,1,0.964302545158949,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14999,GO:0060489,1,0.964302545158949,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
15000,GO:0060490,1,0.964302545158949,0,2,lateral sprouting involved in lung morphogenesis,BP,
15008,GO:0060509,1,0.907530470501816,0,5,Type I pneumocyte differentiation,BP,
15012,GO:0060514,1,0.97906239282777,0,1,prostate induction,BP,
15013,GO:0060515,1,0.97906239282777,0,1,prostate field specification,BP,
15014,GO:0060516,1,0.958145362905025,0,2,primary prostatic bud elongation,BP,
15015,GO:0060517,1,0.979096509992481,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
15016,GO:0060520,1,0.97906239282777,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
15017,GO:0060523,1,0.939561946622156,0,3,prostate epithelial cord elongation,BP,
15019,GO:0060526,1,0.883914367950973,0,6,prostate glandular acinus morphogenesis,BP,
15020,GO:0060527,1,0.883914367950973,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
15022,GO:0060529,1,0.958913382061665,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
15023,GO:0060532,1,0.958733550804863,0,2,bronchus cartilage development,BP,
15031,GO:0060542,1,0.980137602358416,0,1,regulation of strand invasion,BP,
15033,GO:0060545,1,0.958259644868172,0,2,positive regulation of necroptotic process,BP,
15037,GO:0060549,1,0.978521707286252,0,1,regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15038,GO:0060550,1,0.978521707286252,0,1,positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15039,GO:0060551,1,0.978521707286252,0,1,regulation of fructose 1,6-bisphosphate metabolic process,BP,
15040,GO:0060552,1,0.978521707286252,0,1,positive regulation of fructose 1,6-bisphosphate metabolic process,BP,
15042,GO:0060557,1,0.937098523408545,0,3,positive regulation of vitamin D biosynthetic process,BP,
15044,GO:0060559,1,0.937098523408545,0,3,positive regulation of calcidiol 1-monooxygenase activity,BP,
15049,GO:0060566,1,0.983914948881197,0,1,positive regulation of DNA-templated transcription, termination,BP,
15052,GO:0060573,1,0.811588317443639,0,10,cell fate specification involved in pattern specification,BP,
15056,GO:0060577,1,0.957916584955855,0,2,pulmonary vein morphogenesis,BP,
15057,GO:0060578,1,0.978855222752691,0,1,superior vena cava morphogenesis,BP,
15058,GO:0060579,1,0.745394395989809,0,14,ventral spinal cord interneuron fate commitment,BP,
15059,GO:0060580,1,0.978788130990152,0,1,ventral spinal cord interneuron fate determination,BP,
15060,GO:0060581,1,0.745394395989809,0,14,cell fate commitment involved in pattern specification,BP,
15061,GO:0060582,1,0.978788130990152,0,1,cell fate determination involved in pattern specification,BP,
15065,GO:0060587,1,0.958027874128062,0,2,regulation of lipoprotein lipid oxidation,BP,
15066,GO:0060588,1,0.978509921581045,0,1,negative regulation of lipoprotein lipid oxidation,BP,
15068,GO:0060590,1,0.445301604893758,0,38,ATPase regulator activity,MF,
15069,GO:0060591,1,0.900478996398234,0,5,chondroblast differentiation,BP,
15073,GO:0060596,1,0.938847903726366,0,3,mammary placode formation,BP,
15074,GO:0060598,1,0.978526159648071,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
15076,GO:0060600,1,0.818940830058617,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
15080,GO:0060605,1,0.901376277096767,0,5,tube lumen cavitation,BP,
15082,GO:0060611,1,0.978930529495848,0,1,mammary gland fat development,BP,
15084,GO:0060613,1,0.920273766386471,0,4,fat pad development,BP,
15086,GO:0060620,1,0.937264288542072,0,3,regulation of cholesterol import,BP,
15087,GO:0060621,1,0.957395965871561,0,2,negative regulation of cholesterol import,BP,
15088,GO:0060623,1,0.93764832214505,0,3,regulation of chromosome condensation,BP,
15090,GO:0060628,1,0.779010233650703,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
15091,GO:0060629,1,0.958200453492878,0,2,regulation of homologous chromosome segregation,BP,
15092,GO:0060631,1,0.861766300174435,0,7,regulation of meiosis I,BP,
15093,GO:0060632,1,0.701826365314578,0,17,regulation of microtubule-based movement,BP,
15094,GO:0060633,1,0.899998995348316,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
15099,GO:0060662,1,0.901376277096767,0,5,salivary gland cavitation,BP,
15102,GO:0060666,1,0.906077172214447,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
15104,GO:0060668,1,0.979071566390724,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
15106,GO:0060670,1,0.792899642398088,0,11,branching involved in labyrinthine layer morphogenesis,BP,
15107,GO:0060671,1,0.938743021298436,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
15108,GO:0060672,1,0.938743021298436,0,3,epithelial cell morphogenesis involved in placental branching,BP,
15113,GO:0060678,1,0.978866169897787,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15115,GO:0060683,1,0.979029476369352,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
15121,GO:0060689,1,0.940864059936447,0,3,cell differentiation involved in salivary gland development,BP,
15122,GO:0060690,1,0.978680891239982,0,1,epithelial cell differentiation involved in salivary gland development,BP,
15123,GO:0060691,1,0.978680891239982,0,1,epithelial cell maturation involved in salivary gland development,BP,
15125,GO:0060694,1,0.957624091612095,0,2,regulation of cholesterol transporter activity,BP,
15126,GO:0060695,1,0.978466210066378,0,1,negative regulation of cholesterol transporter activity,BP,
15128,GO:0060697,1,0.95795668276735,0,2,positive regulation of phospholipid catabolic process,BP,
15129,GO:0060698,1,0.958662189546017,0,2,endoribonuclease inhibitor activity,MF,
15130,GO:0060699,1,0.918326693561582,0,4,regulation of endoribonuclease activity,BP,
15131,GO:0060700,1,0.900683134617233,0,5,regulation of ribonuclease activity,BP,
15132,GO:0060701,1,0.958662189546017,0,2,negative regulation of ribonuclease activity,BP,
15133,GO:0060702,1,0.958662189546017,0,2,negative regulation of endoribonuclease activity,BP,
15134,GO:0060703,1,0.979017090875596,0,1,deoxyribonuclease inhibitor activity,MF,
15143,GO:0060715,1,0.960164056072353,0,2,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
15145,GO:0060717,1,0.883736849260165,0,6,chorion development,BP,
15146,GO:0060718,1,0.902628406874711,0,5,chorionic trophoblast cell differentiation,BP,
15147,GO:0060720,1,0.960732500930503,0,2,spongiotrophoblast cell proliferation,BP,
15148,GO:0060721,1,0.960732500930503,0,2,regulation of spongiotrophoblast cell proliferation,BP,
15149,GO:0060722,1,0.960732500930503,0,2,cell proliferation involved in embryonic placenta development,BP,
15150,GO:0060723,1,0.960732500930503,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
15151,GO:0060729,1,0.900065878779162,0,5,intestinal epithelial structure maintenance,BP,
15152,GO:0060730,1,0.95850214875034,0,2,regulation of intestinal epithelial structure maintenance,BP,
15153,GO:0060731,1,0.979069145652555,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
15154,GO:0060732,1,0.774015038619944,0,12,positive regulation of inositol phosphate biosynthetic process,BP,
15155,GO:0060733,1,0.959459106529243,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
15156,GO:0060734,1,0.95870855941571,0,2,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
15157,GO:0060735,1,0.978550849946611,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
15158,GO:0060736,1,0.796304504782831,0,11,prostate gland growth,BP,
15159,GO:0060737,1,0.91991852101354,0,4,prostate gland morphogenetic growth,BP,
15160,GO:0060738,1,0.958115059426555,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
15161,GO:0060739,1,0.981522532977102,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
15163,GO:0060741,1,0.937763241748888,0,3,prostate gland stromal morphogenesis,BP,
15165,GO:0060743,1,0.938406695164268,0,3,epithelial cell maturation involved in prostate gland development,BP,
15168,GO:0060746,1,0.760096448132422,0,13,parental behavior,BP,
15173,GO:0060752,1,0.958470419588343,0,2,intestinal phytosterol absorption,BP,
15174,GO:0060753,1,0.879581486285903,0,6,regulation of mast cell chemotaxis,BP,
15175,GO:0060754,1,0.898845428750033,0,5,positive regulation of mast cell chemotaxis,BP,
15180,GO:0060763,1,0.939300851484112,0,3,mammary duct terminal end bud growth,BP,
15181,GO:0060764,1,0.958644440411229,0,2,cell-cell signaling involved in mammary gland development,BP,
15182,GO:0060765,1,0.579155698083869,0,26,regulation of androgen receptor signaling pathway,BP,
15183,GO:0060766,1,0.775487886623353,0,12,negative regulation of androgen receptor signaling pathway,BP,
15186,GO:0060769,1,0.938055755450395,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15187,GO:0060770,1,0.879586512210431,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15189,GO:0060781,1,0.978602768722672,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15190,GO:0060782,1,0.978602768722672,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15191,GO:0060783,1,0.978602768722672,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15192,GO:0060784,1,0.979096509992481,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15194,GO:0060789,1,0.862106102270811,0,7,hair follicle placode formation,BP,
15196,GO:0060796,1,0.95792974837463,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15197,GO:0060800,1,0.939500575892859,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15198,GO:0060802,1,0.978792715368707,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15199,GO:0060803,1,0.978579581120576,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15201,GO:0060806,1,0.978638479315528,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15202,GO:0060807,1,0.978899388215034,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15204,GO:0060816,1,0.983618492057181,0,1,random inactivation of X chromosome,BP,
15205,GO:0060817,1,0.97884417678277,0,1,inactivation of paternal X chromosome,BP,
15206,GO:0060821,1,0.982311937364933,0,1,inactivation of X chromosome by DNA methylation,BP,
15208,GO:0060825,1,0.957796312499749,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15209,GO:0060827,1,0.979125761205231,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15211,GO:0060829,1,0.979125761205231,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15212,GO:0060830,1,0.938209770888308,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15214,GO:0060836,1,0.871081688527535,0,7,lymphatic endothelial cell differentiation,BP,
15216,GO:0060838,1,0.95859505756059,0,2,lymphatic endothelial cell fate commitment,BP,
15225,GO:0060849,1,0.95859505756059,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15226,GO:0060850,1,0.731638419442453,0,15,regulation of transcription involved in cell fate commitment,BP,
15229,GO:0060857,1,0.978872201933914,0,1,establishment of glial blood-brain barrier,BP,
15231,GO:0060873,1,0.981959387761287,0,1,anterior semicircular canal development,BP,
15232,GO:0060875,1,0.981959387761287,0,1,lateral semicircular canal development,BP,
15238,GO:0060901,1,0.979191434566361,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15239,GO:0060903,1,0.918606706229683,0,4,positive regulation of meiosis I,BP,
15240,GO:0060904,1,0.979103718563012,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15243,GO:0060912,1,0.938240758677733,0,3,cardiac cell fate specification,BP,
15244,GO:0060913,1,0.937763722169114,0,3,cardiac cell fate determination,BP,
15247,GO:0060916,1,0.901885544873721,0,5,mesenchymal cell proliferation involved in lung development,BP,
15248,GO:0060920,1,0.900831700987659,0,5,cardiac pacemaker cell differentiation,BP,
15249,GO:0060921,1,0.939112529118476,0,3,sinoatrial node cell differentiation,BP,
15250,GO:0060922,1,0.959244064262877,0,2,atrioventricular node cell differentiation,BP,
15252,GO:0060926,1,0.920616714776473,0,4,cardiac pacemaker cell development,BP,
15253,GO:0060927,1,0.978725608204797,0,1,cardiac pacemaker cell fate commitment,BP,
15254,GO:0060928,1,0.959244064262877,0,2,atrioventricular node cell development,BP,
15255,GO:0060929,1,0.978725608204797,0,1,atrioventricular node cell fate commitment,BP,
15256,GO:0060931,1,0.959735942979183,0,2,sinoatrial node cell development,BP,
15257,GO:0060932,1,0.958579379255912,0,2,His-Purkinje system cell differentiation,BP,
15258,GO:0060935,1,0.939873728151028,0,3,cardiac fibroblast cell differentiation,BP,
15259,GO:0060936,1,0.939873728151028,0,3,cardiac fibroblast cell development,BP,
15260,GO:0060938,1,0.939873728151028,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15261,GO:0060939,1,0.939873728151028,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15262,GO:0060940,1,0.958435979684801,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15268,GO:0060965,1,0.815708037239358,0,10,negative regulation of gene silencing by miRNA,BP,
15270,GO:0060967,1,0.783253734865473,0,12,negative regulation of gene silencing by RNA,BP,
15272,GO:0060969,1,0.653047784053627,0,21,negative regulation of gene silencing,BP,
15273,GO:0060971,1,0.922721931605461,0,4,embryonic heart tube left/right pattern formation,BP,
15276,GO:0060974,1,0.957473782721341,0,2,cell migration involved in heart formation,BP,
15277,GO:0060975,1,0.978513746666424,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15280,GO:0060978,1,0.940840233732196,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15282,GO:0060980,1,0.979072572809886,0,1,cell migration involved in coronary vasculogenesis,BP,
15283,GO:0060981,1,0.980103820112071,0,1,cell migration involved in coronary angiogenesis,BP,
15286,GO:0060987,1,0.978889655064775,0,1,lipid tube,CC,
15287,GO:0060988,1,0.938430493244448,0,3,lipid tube assembly,BP,
15288,GO:0060989,1,0.979070038942469,0,1,lipid tube assembly involved in organelle fusion,BP,
15292,GO:0060995,1,0.959235059202472,0,2,cell-cell signaling involved in kidney development,BP,
15295,GO:0060998,1,0.294445491461363,0,60,regulation of dendritic spine development,BP,
15296,GO:0060999,1,0.469675289566469,0,37,positive regulation of dendritic spine development,BP,
15297,GO:0061000,1,0.782733810373977,0,12,negative regulation of dendritic spine development,BP,
15298,GO:0061001,1,0.503883803285802,0,34,regulation of dendritic spine morphogenesis,BP,
15299,GO:0061002,1,0.883815874960041,0,6,negative regulation of dendritic spine morphogenesis,BP,
15300,GO:0061003,1,0.709171405995802,0,17,positive regulation of dendritic spine morphogenesis,BP,
15304,GO:0061009,1,0.898526900044193,0,5,common bile duct development,BP,
15305,GO:0061010,1,0.942028065290468,0,3,gall bladder development,BP,
15306,GO:0061011,1,0.978662244688169,0,1,hepatic duct development,BP,
15309,GO:0061015,1,0.978642549686137,0,1,snRNA import into nucleus,BP,
15310,GO:0061017,1,0.958143099453077,0,2,hepatoblast differentiation,BP,
15313,GO:0061026,1,0.984500198799258,0,1,cardiac muscle tissue regeneration,BP,
15317,GO:0061030,1,0.917857266313884,0,4,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15318,GO:0061031,1,0.937643446906785,0,3,endodermal digestive tract morphogenesis,BP,
15321,GO:0061034,1,0.959323985485479,0,2,olfactory bulb mitral cell layer development,BP,
15326,GO:0061040,1,0.982356041621774,0,1,female gonad morphogenesis,BP,
15328,GO:0061042,1,0.825632778305939,0,9,vascular wound healing,BP,
15329,GO:0061043,1,0.918257643784331,0,4,regulation of vascular wound healing,BP,
15330,GO:0061044,1,0.979067424110744,0,1,negative regulation of vascular wound healing,BP,
15334,GO:0061048,1,0.97863116530353,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15338,GO:0061052,1,0.898780513969784,0,5,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15341,GO:0061055,1,0.920148235416716,0,4,myotome development,BP,
15342,GO:0061056,1,0.917870741818808,0,4,sclerotome development,BP,
15345,GO:0061073,1,0.939344442566218,0,3,ciliary body morphogenesis,BP,
15346,GO:0061074,1,0.879872313493638,0,6,regulation of neural retina development,BP,
15347,GO:0061075,1,0.958199159439563,0,2,positive regulation of neural retina development,BP,
15348,GO:0061076,1,0.979066704239959,0,1,negative regulation of neural retina development,BP,
15349,GO:0061077,1,0.267006159126718,0,62,chaperone-mediated protein folding,BP,
15350,GO:0061078,1,0.978467931885137,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15353,GO:0061083,1,0.918874003326853,0,4,regulation of protein refolding,BP,
15354,GO:0061084,1,0.918874003326853,0,4,negative regulation of protein refolding,BP,
15355,GO:0061085,1,0.82778998995112,0,9,regulation of histone H3-K27 methylation,BP,
15356,GO:0061086,1,0.919499188476942,0,4,negative regulation of histone H3-K27 methylation,BP,
15357,GO:0061087,1,0.881305997107134,0,6,positive regulation of histone H3-K27 methylation,BP,
15358,GO:0061088,1,0.811730514931274,0,10,regulation of sequestering of zinc ion,BP,
15359,GO:0061090,1,0.978920616769008,0,1,positive regulation of sequestering of zinc ion,BP,
15360,GO:0061091,1,0.941859914501637,0,3,regulation of phospholipid translocation,BP,
15361,GO:0061092,1,0.941859914501637,0,3,positive regulation of phospholipid translocation,BP,
15364,GO:0061099,1,0.620413228854276,0,23,negative regulation of protein tyrosine kinase activity,BP,
15365,GO:0061100,1,0.978946517601127,0,1,lung neuroendocrine cell differentiation,BP,
15367,GO:0061102,1,0.957966840329145,0,2,stomach neuroendocrine cell differentiation,BP,
15368,GO:0061103,1,0.978946517601127,0,1,carotid body glomus cell differentiation,BP,
15369,GO:0061104,1,0.958425113906484,0,2,adrenal chromaffin cell differentiation,BP,
15370,GO:0061105,1,0.978570356890495,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15371,GO:0061106,1,0.978570356890495,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15373,GO:0061108,1,0.978865968185324,0,1,seminal vesicle epithelium development,BP,
15375,GO:0061113,1,0.918775089501731,0,4,pancreas morphogenesis,BP,
15376,GO:0061114,1,0.979063884651254,0,1,branching involved in pancreas morphogenesis,BP,
15379,GO:0061133,1,0.878632399287255,0,6,endopeptidase activator activity,MF,
15385,GO:0061141,1,0.940654954529848,0,3,lung ciliated cell differentiation,BP,
15387,GO:0061144,1,0.979065545692908,0,1,alveolar secondary septum development,BP,
15388,GO:0061145,1,0.958733550804863,0,2,lung smooth muscle development,BP,
15393,GO:0061152,1,0.958035763528456,0,2,trachea submucosa development,BP,
15394,GO:0061153,1,0.958035763528456,0,2,trachea gland development,BP,
15398,GO:0061157,1,0.682475740959139,0,19,mRNA destabilization,BP,
15399,GO:0061158,1,0.786624700332591,0,12,3'-UTR-mediated mRNA destabilization,BP,
15401,GO:0061168,1,0.978478932421333,0,1,regulation of hair follicle placode formation,BP,
15402,GO:0061170,1,0.978478932421333,0,1,negative regulation of hair follicle placode formation,BP,
15403,GO:0061178,1,0.356355011244805,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15404,GO:0061179,1,0.842068938170085,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15406,GO:0061181,1,0.979173390402267,0,1,regulation of chondrocyte development,BP,
15409,GO:0061185,1,0.978752889837797,0,1,negative regulation of dermatome development,BP,
15410,GO:0061187,1,0.960587233825062,0,2,regulation of chromatin silencing at rDNA,BP,
15411,GO:0061188,1,0.960587233825062,0,2,negative regulation of chromatin silencing at rDNA,BP,
15412,GO:0061189,1,0.978602768722672,0,1,positive regulation of sclerotome development,BP,
15413,GO:0061190,1,0.978602768722672,0,1,regulation of sclerotome development,BP,
15414,GO:0061193,1,0.978493634270525,0,1,taste bud development,BP,
15415,GO:0061196,1,0.883138731557382,0,6,fungiform papilla development,BP,
15416,GO:0061197,1,0.902208230559482,0,5,fungiform papilla morphogenesis,BP,
15417,GO:0061198,1,0.93991388283277,0,3,fungiform papilla formation,BP,
15418,GO:0061200,1,0.84345294820718,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15419,GO:0061202,1,0.84345294820718,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15421,GO:0061206,1,0.979034695035522,0,1,mesonephros morphogenesis,BP,
15424,GO:0061215,1,0.979034695035522,0,1,mesonephric nephron development,BP,
15429,GO:0061228,1,0.979034695035522,0,1,mesonephric nephron morphogenesis,BP,
15430,GO:0061235,1,0.979034695035522,0,1,mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis,BP,
15432,GO:0061289,1,0.959235059202472,0,2,Wnt signaling pathway involved in kidney development,BP,
15433,GO:0061290,1,0.959235059202472,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15434,GO:0061295,1,0.979034695035522,0,1,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15435,GO:0061296,1,0.979034695035522,0,1,negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15438,GO:0061300,1,0.960330788027634,0,2,cerebellum vasculature development,BP,
15439,GO:0061301,1,0.981344692769172,0,1,cerebellum vasculature morphogenesis,BP,
15442,GO:0061304,1,0.923708947324663,0,4,retinal blood vessel morphogenesis,BP,
15443,GO:0061307,1,0.843434410746516,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
15444,GO:0061308,1,0.843434410746516,0,8,cardiac neural crest cell development involved in heart development,BP,
15445,GO:0061309,1,0.880214917465413,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15449,GO:0061316,1,0.898653632156185,0,5,canonical Wnt signaling pathway involved in heart development,BP,
15450,GO:0061317,1,0.917869678496506,0,4,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15453,GO:0061324,1,0.979069351318695,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15468,GO:0061355,1,0.93802343521589,0,3,Wnt protein secretion,BP,
15469,GO:0061356,1,0.93802343521589,0,3,regulation of Wnt protein secretion,BP,
15470,GO:0061357,1,0.958437251535452,0,2,positive regulation of Wnt protein secretion,BP,
15471,GO:0061358,1,0.978703372485861,0,1,negative regulation of Wnt protein secretion,BP,
15472,GO:0061360,1,0.979135713017116,0,1,optic chiasma development,BP,
15473,GO:0061364,1,0.940856919066163,0,3,apoptotic process involved in luteolysis,BP,
15474,GO:0061365,1,0.789655411431403,0,11,positive regulation of triglyceride lipase activity,BP,
15475,GO:0061366,1,0.939246296396222,0,3,behavioral response to chemical pain,BP,
15476,GO:0061368,1,0.939246296396222,0,3,behavioral response to formalin induced pain,BP,
15480,GO:0061373,1,0.961580526856824,0,2,mammillary axonal complex development,BP,
15481,GO:0061374,1,0.97857132942134,0,1,mammillothalamic axonal tract development,BP,
15483,GO:0061378,1,0.957800165078516,0,2,corpora quadrigemina development,BP,
15484,GO:0061379,1,0.957800165078516,0,2,inferior colliculus development,BP,
15485,GO:0061381,1,0.97857132942134,0,1,cell migration in diencephalon,BP,
15488,GO:0061386,1,0.963126315843833,0,2,closure of optic fissure,BP,
15490,GO:0061394,1,0.957877004273589,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15491,GO:0061395,1,0.978648583736127,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15492,GO:0061402,1,0.958393373509071,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15493,GO:0061408,1,0.978823939821561,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15496,GO:0061428,1,0.919969830291572,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15497,GO:0061430,1,0.785497498419661,0,12,bone trabecula morphogenesis,BP,
15498,GO:0061433,1,0.978736121469041,0,1,cellular response to caloric restriction,BP,
15504,GO:0061441,1,0.958991357567803,0,2,renal artery morphogenesis,BP,
15506,GO:0061444,1,0.980316021090211,0,1,endocardial cushion cell development,BP,
15509,GO:0061450,1,0.844762723586829,0,8,trophoblast cell migration,BP,
15510,GO:0061451,1,0.979061405677543,0,1,retrotrapezoid nucleus development,BP,
15511,GO:0061452,1,0.979061405677543,0,1,retrotrapezoid nucleus neuron differentiation,BP,
15513,GO:0061459,1,0.981485146893144,0,1,L-arginine transmembrane transporter activity,MF,
15514,GO:0061461,1,0.960854055934674,0,2,L-lysine import,BP,
15516,GO:0061467,1,0.979080449385717,0,1,basolateral protein localization,BP,
15517,GO:0061469,1,0.827013919974334,0,9,regulation of type B pancreatic cell proliferation,BP,
15518,GO:0061470,1,0.923030124766202,0,4,T follicular helper cell differentiation,BP,
15519,GO:0061474,1,0.978969879079343,0,1,phagolysosome membrane,CC,
15520,GO:0061476,1,0.979065102314849,0,1,response to anticoagulant,BP,
15521,GO:0061481,1,0.978480527706844,0,1,response to TNF agonist,BP,
15522,GO:0061484,1,0.88547199533839,0,6,hematopoietic stem cell homeostasis,BP,
15523,GO:0061485,1,0.981430077527535,0,1,memory T cell proliferation,BP,
15524,GO:0061501,1,0.97897493185122,0,1,cyclic-GMP-AMP synthase activity,MF,
15525,GO:0061502,1,0.925840339754686,0,4,early endosome to recycling endosome transport,BP,
15526,GO:0061505,1,0.939735236764853,0,3,DNA topoisomerase II activity,MF,
15527,GO:0061507,1,0.978639153821845,0,1,cyclic-GMP-AMP binding,MF,
15528,GO:0061511,1,0.920285774351006,0,4,centriole elongation,BP,
15529,GO:0061512,1,0.527655278949008,0,31,protein localization to cilium,BP,
15530,GO:0061513,1,0.93833255914652,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15532,GO:0061517,1,0.958481200696779,0,2,macrophage proliferation,BP,
15533,GO:0061518,1,0.958481200696779,0,2,microglial cell proliferation,BP,
15534,GO:0061519,1,0.979070926691736,0,1,macrophage homeostasis,BP,
15535,GO:0061523,1,0.979072835636165,0,1,cilium disassembly,BP,
15537,GO:0061526,1,0.918517150556547,0,4,acetylcholine secretion,BP,
15538,GO:0061528,1,0.979516224791057,0,1,aspartate secretion,BP,
15539,GO:0061534,1,0.984818926876515,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15540,GO:0061535,1,0.964662334933449,0,2,glutamate secretion, neurotransmission,BP,
15541,GO:0061536,1,0.979068564333656,0,1,glycine secretion,BP,
15542,GO:0061537,1,0.979068564333656,0,1,glycine secretion, neurotransmission,BP,
15543,GO:0061542,1,0.978531371205572,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15544,GO:0061547,1,0.95857318237996,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15545,GO:0061548,1,0.761640898597971,0,13,ganglion development,BP,
15546,GO:0061549,1,0.827877170619998,0,9,sympathetic ganglion development,BP,
15547,GO:0061550,1,0.901656051151183,0,5,cranial ganglion development,BP,
15548,GO:0061551,1,0.920936123444182,0,4,trigeminal ganglion development,BP,
15549,GO:0061552,1,0.978950316202423,0,1,ganglion morphogenesis,BP,
15552,GO:0061574,1,0.938396555784617,0,3,ASAP complex,CC,
15553,GO:0061575,1,0.917007782869255,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15554,GO:0061577,1,0.819773139789817,0,10,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15555,GO:0061578,1,0.831454184948187,0,9,Lys63-specific deubiquitinase activity,MF,
15556,GO:0061580,1,0.97913868799948,0,1,colon epithelial cell migration,BP,
15557,GO:0061582,1,0.96007654799351,0,2,intestinal epithelial cell migration,BP,
15558,GO:0061588,1,0.901023213080156,0,5,calcium activated phospholipid scrambling,BP,
15559,GO:0061589,1,0.919155795963947,0,4,calcium activated phosphatidylserine scrambling,BP,
15560,GO:0061590,1,0.901023213080156,0,5,calcium activated phosphatidylcholine scrambling,BP,
15561,GO:0061591,1,0.901023213080156,0,5,calcium activated galactosylceramide scrambling,BP,
15562,GO:0061598,1,0.979184544493128,0,1,molybdopterin adenylyltransferase activity,MF,
15563,GO:0061599,1,0.979184544493128,0,1,molybdopterin molybdotransferase activity,MF,
15564,GO:0061604,1,0.978939498239432,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15565,GO:0061605,1,0.978939498239432,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15566,GO:0061609,1,0.978930892225506,0,1,fructose-1-phosphate aldolase activity,MF,
15567,GO:0061611,1,0.978668801600268,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15570,GO:0061617,1,0.878805693843597,0,6,MICOS complex,CC,
15571,GO:0061618,1,0.984205221343562,0,1,sublamina densa,CC,
15574,GO:0061622,1,0.958066457907988,0,2,glycolytic process through glucose-1-phosphate,BP,
15575,GO:0061623,1,0.978550216681492,0,1,glycolytic process from galactose,BP,
15578,GO:0061627,1,0.978755359907925,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15579,GO:0061628,1,0.944497657938871,0,3,H3K27me3 modified histone binding,MF,
15580,GO:0061629,1,0.978558918485875,0,1,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15582,GO:0061631,1,0.544190811243794,0,29,ubiquitin conjugating enzyme activity,MF,
15583,GO:0061635,1,0.879624865236431,0,6,regulation of protein complex stability,BP,
15585,GO:0061641,1,0.451586231018269,0,37,CENP-A containing chromatin organization,BP,
15588,GO:0061646,1,0.979533540189085,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15589,GO:0061647,1,0.429474166579276,0,41,histone H3-K9 modification,BP,
15590,GO:0061649,1,0.979345472688626,0,1,ubiquitinated histone binding,MF,
15591,GO:0061650,1,0.532482646145456,0,30,ubiquitin-like protein conjugating enzyme activity,MF,
15592,GO:0061656,1,0.978520430518689,0,1,SUMO conjugating enzyme activity,MF,
15594,GO:0061663,1,0.981337320016502,0,1,NEDD8 ligase activity,MF,
15595,GO:0061665,1,0.899388872095814,0,5,SUMO ligase activity,MF,
15596,GO:0061668,1,0.920181685839185,0,4,mitochondrial ribosome assembly,BP,
15597,GO:0061669,1,0.943543998581771,0,3,spontaneous neurotransmitter secretion,BP,
15598,GO:0061670,1,0.978582683962392,0,1,evoked neurotransmitter secretion,BP,
15599,GO:0061673,1,0.96058421794247,0,2,mitotic spindle astral microtubule,CC,
15600,GO:0061676,1,0.918792912415537,0,4,importin-alpha family protein binding,MF,
15601,GO:0061682,1,0.978897453248995,0,1,seminal vesicle morphogenesis,BP,
15602,GO:0061684,1,0.791209412834194,0,11,chaperone-mediated autophagy,BP,
15603,GO:0061687,1,0.921451308711112,0,4,detoxification of inorganic compound,BP,
15604,GO:0061689,1,0.920924999266028,0,4,tricellular tight junction,CC,
15605,GO:0061690,1,0.978515513469385,0,1,lipoamidase activity,MF,
15607,GO:0061697,1,0.97906712615959,0,1,protein-glutaryllysine deglutarylase activity,MF,
15608,GO:0061698,1,0.97906712615959,0,1,protein deglutarylation,BP,
15609,GO:0061699,1,0.97906712615959,0,1,peptidyl-lysine deglutarylation,BP,
15612,GO:0061709,1,0.980825112600823,0,1,reticulophagy,BP,
15613,GO:0061711,1,0.9579363958607,0,2,N(6)-L-threonylcarbamoyladenine synthase,MF,
15614,GO:0061712,1,0.979069140003123,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15615,GO:0061713,1,0.978499297466388,0,1,anterior neural tube closure,BP,
15616,GO:0061714,1,0.957468836491468,0,2,folic acid receptor activity,MF,
15618,GO:0061723,1,0.960165621596834,0,2,glycophagy,BP,
15620,GO:0061726,1,0.199987123600749,0,77,mitochondrion disassembly,BP,
15621,GO:0061727,1,0.958105664655775,0,2,methylglyoxal catabolic process to lactate,BP,
15622,GO:0061731,1,0.93893651880209,0,3,ribonucleoside-diphosphate reductase activity,MF,
15623,GO:0061732,1,0.880133469133654,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15624,GO:0061733,1,0.32021800916728,0,55,peptide-lysine-N-acetyltransferase activity,MF,
15625,GO:0061734,1,0.906091550309588,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15626,GO:0061736,1,0.980088853007181,0,1,engulfment of target by autophagosome,BP,
15627,GO:0061737,1,0.898174373138494,0,5,leukotriene signaling pathway,BP,
15628,GO:0061738,1,0.937998092906589,0,3,late endosomal microautophagy,BP,
15629,GO:0061739,1,0.979068866243211,0,1,protein lipidation involved in autophagosome assembly,BP,
15630,GO:0061740,1,0.958340563248147,0,2,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15631,GO:0061741,1,0.978771906698635,0,1,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15632,GO:0061743,1,0.918026442677244,0,4,motor learning,BP,
15633,GO:0061744,1,0.959055995268603,0,2,motor behavior,BP,
15634,GO:0061749,1,0.959849972449445,0,2,forked DNA-dependent helicase activity,MF,
15635,GO:0061750,1,0.978891613116959,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15636,GO:0061752,1,0.958207220849625,0,2,telomeric repeat-containing RNA binding,MF,
15637,GO:0061753,1,0.980088853007181,0,1,substrate localization to autophagosome,BP,
15638,GO:0061756,1,0.602064495626271,0,24,leukocyte adhesion to vascular endothelial cell,BP,
15639,GO:0061757,1,0.958130733463383,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15640,GO:0061762,1,0.943329955422761,0,3,CAMKK-AMPK signaling cascade,BP,
15641,GO:0061763,1,0.958410456876422,0,2,multivesicular body-lysosome fusion,BP,
15642,GO:0061767,1,0.98023995676388,0,1,negative regulation of lung blood pressure,BP,
15643,GO:0061768,1,0.9794798036043,0,1,magnesium:sodium antiporter activity,MF,
15644,GO:0061769,1,0.95839073820654,0,2,ribosylnicotinate kinase activity,MF,
15645,GO:0061770,1,0.978823939821561,0,1,translation elongation factor binding,MF,
15646,GO:0061771,1,0.978736121469041,0,1,response to caloric restriction,BP,
15648,GO:0061778,1,0.715338158718114,0,16,intracellular chloride channel activity,MF,
15649,GO:0061782,1,0.979130747882954,0,1,vesicle fusion with vesicle,BP,
15650,GO:0061783,1,0.721986008259235,0,15,peptidoglycan muralytic activity,MF,
15651,GO:0061792,1,0.939821694265056,0,3,secretory granule maturation,BP,
15652,GO:0061798,1,0.979150416112237,0,1,GTP 3',8'-cyclase activity,MF,
15653,GO:0061799,1,0.979150416112237,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15654,GO:0061809,1,0.957616534359577,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15655,GO:0061811,1,0.978578050281878,0,1,ADP-ribosyl cyclase activity,MF,
15656,GO:0061812,1,0.978578050281878,0,1,cyclic ADP-ribose hydrolase,MF,
15657,GO:0061819,1,0.940001358942251,0,3,telomeric DNA-containing double minutes formation,BP,
15658,GO:0061820,1,0.827507770313794,0,9,telomeric D-loop disassembly,BP,
15659,GO:0061821,1,0.92015728684745,0,4,telomeric D-loop binding,MF,
15660,GO:0061825,1,0.979097272827943,0,1,podosome core,CC,
15661,GO:0061827,1,0.978970198177957,0,1,sperm head,CC,
15662,GO:0061833,1,0.958500500546627,0,2,protein localization to tricellular tight junction,BP,
15663,GO:0061842,1,0.647435541741256,0,22,microtubule organizing center localization,BP,
15664,GO:0061844,1,0.859610727892374,0,7,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15665,GO:0061845,1,0.979068969355821,0,1,neuron projection branch point,CC,
15666,GO:0061846,1,0.979068969355821,0,1,dendritic spine cytoplasm,CC,
15667,GO:0061847,1,0.97888453883524,0,1,response to cholecystokinin,BP,
15668,GO:0061849,1,0.959849972449445,0,2,telomeric G-quadruplex DNA binding,MF,
15669,GO:0061850,1,0.978483828037327,0,1,growth cone leading edge,CC,
15670,GO:0065001,1,0.920437937389386,0,4,specification of axis polarity,BP,
15671,GO:0065002,1,0.322443561537799,0,53,intracellular protein transmembrane transport,BP,
15673,GO:0065004,1,0.00782803165344368,0,227,protein-DNA complex assembly,BP,
15675,GO:0065006,1,0.957499897015503,0,2,protein-carbohydrate complex assembly,BP,
15679,GO:0065010,1,0.938128308569332,0,3,extracellular membrane-bounded organelle,CC,
15680,GO:0070001,1,0.586546040535256,0,25,aspartic-type peptidase activity,MF,
15681,GO:0070002,1,0.978537434295704,0,1,glutamic-type peptidase activity,MF,
15683,GO:0070006,1,0.685095486081098,0,18,metalloaminopeptidase activity,MF,
15684,GO:0070008,1,0.828765444808539,0,9,serine-type exopeptidase activity,MF,
15685,GO:0070009,1,0.97906918223649,0,1,serine-type aminopeptidase activity,MF,
15687,GO:0070012,1,0.978915014878921,0,1,oligopeptidase activity,MF,
15690,GO:0070022,1,0.920810707891314,0,4,transforming growth factor beta receptor complex,CC,
15691,GO:0070025,1,0.978987637002078,0,1,carbon monoxide binding,MF,
15692,GO:0070026,1,0.957928595405462,0,2,nitric oxide binding,MF,
15693,GO:0070032,1,0.917871395133477,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15694,GO:0070033,1,0.938319956601036,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15695,GO:0070034,1,0.70144577297864,0,17,telomerase RNA binding,MF,
15696,GO:0070035,1,0.125557258941403,0,99,purine NTP-dependent helicase activity,MF,
15697,GO:0070037,1,0.978499761191661,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15698,GO:0070039,1,0.958796990139584,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15699,GO:0070044,1,0.937659897984907,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15701,GO:0070051,1,0.939472942149702,0,3,fibrinogen binding,MF,
15702,GO:0070052,1,0.93901817077892,0,3,collagen V binding,MF,
15704,GO:0070054,1,0.938412521790174,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15705,GO:0070055,1,0.938412521790174,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15707,GO:0070060,1,0.982608596316148,0,1,'de novo' actin filament nucleation,BP,
15708,GO:0070061,1,0.898893001364043,0,5,fructose binding,MF,
15710,GO:0070063,1,0.395818247056234,0,44,RNA polymerase binding,MF,
15712,GO:0070069,1,0.546644912849107,0,28,cytochrome complex,CC,
15713,GO:0070070,1,0.836294509444294,0,9,proton-transporting V-type ATPase complex assembly,BP,
15714,GO:0070071,1,0.767530033975943,0,13,proton-transporting two-sector ATPase complex assembly,BP,
15715,GO:0070072,1,0.836294509444294,0,9,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15717,GO:0070076,1,0.629344080962261,0,23,histone lysine demethylation,BP,
15718,GO:0070077,1,0.979071682445459,0,1,histone arginine demethylation,BP,
15719,GO:0070078,1,0.979071682445459,0,1,histone H3-R2 demethylation,BP,
15720,GO:0070079,1,0.979071682445459,0,1,histone H4-R3 demethylation,BP,
15722,GO:0070081,1,0.898957651652024,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15723,GO:0070083,1,0.898957651652024,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15725,GO:0070086,1,0.919325443384046,0,4,ubiquitin-dependent endocytosis,BP,
15726,GO:0070087,1,0.889294214408924,0,6,chromo shadow domain binding,MF,
15727,GO:0070091,1,0.860758316666566,0,7,glucagon secretion,BP,
15728,GO:0070092,1,0.879662211355506,0,6,regulation of glucagon secretion,BP,
15729,GO:0070093,1,0.937436848018279,0,3,negative regulation of glucagon secretion,BP,
15730,GO:0070094,1,0.97847323658306,0,1,positive regulation of glucagon secretion,BP,
15731,GO:0070095,1,0.937894136185967,0,3,fructose-6-phosphate binding,MF,
15732,GO:0070096,1,0.957988132385936,0,2,mitochondrial outer membrane translocase complex assembly,BP,
15733,GO:0070097,1,0.887238514059887,0,6,delta-catenin binding,MF,
15736,GO:0070100,1,0.902574711046079,0,5,negative regulation of chemokine-mediated signaling pathway,BP,
15738,GO:0070102,1,0.813909092216675,0,10,interleukin-6-mediated signaling pathway,BP,
15739,GO:0070103,1,0.958105167318035,0,2,regulation of interleukin-6-mediated signaling pathway,BP,
15740,GO:0070104,1,0.978643918776184,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15741,GO:0070105,1,0.979014270558424,0,1,positive regulation of interleukin-6-mediated signaling pathway,BP,
15742,GO:0070106,1,0.958574195332492,0,2,interleukin-27-mediated signaling pathway,BP,
15743,GO:0070110,1,0.938274073958298,0,3,ciliary neurotrophic factor receptor complex,CC,
15744,GO:0070119,1,0.979141595897396,0,1,ciliary neurotrophic factor binding,MF,
15745,GO:0070120,1,0.902996323975369,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15746,GO:0070121,1,0.979967307283971,0,1,Kupffer's vesicle development,BP,
15747,GO:0070122,1,0.97909416246885,0,1,isopeptidase activity,MF,
15748,GO:0070123,1,0.980634988455833,0,1,transforming growth factor beta receptor activity, type III,MF,
15749,GO:0070124,1,0.957974485745294,0,2,mitochondrial translational initiation,BP,
15752,GO:0070127,1,0.899624826647945,0,5,tRNA aminoacylation for mitochondrial protein translation,BP,
15754,GO:0070130,1,0.97897493185122,0,1,negative regulation of mitochondrial translation,BP,
15755,GO:0070131,1,0.860828347775716,0,7,positive regulation of mitochondrial translation,BP,
15756,GO:0070137,1,0.940248212543536,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15757,GO:0070138,1,0.97909416246885,0,1,ubiquitin-like protein-specific isopeptidase activity,MF,
15758,GO:0070139,1,0.940248212543536,0,3,SUMO-specific endopeptidase activity,MF,
15759,GO:0070140,1,0.97909416246885,0,1,SUMO-specific isopeptidase activity,MF,
15761,GO:0070142,1,0.921252138603181,0,4,synaptic vesicle budding,BP,
15762,GO:0070143,1,0.979442704606068,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15763,GO:0070145,1,0.979069336529951,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15764,GO:0070159,1,0.978913886765427,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15770,GO:0070165,1,0.958486800615531,0,2,positive regulation of adiponectin secretion,BP,
15771,GO:0070166,1,0.748602479305116,0,14,enamel mineralization,BP,
15776,GO:0070171,1,0.959946021056637,0,2,negative regulation of tooth mineralization,BP,
15778,GO:0070173,1,0.918885811343166,0,4,regulation of enamel mineralization,BP,
15779,GO:0070175,1,0.95898502361638,0,2,positive regulation of enamel mineralization,BP,
15780,GO:0070176,1,0.978678073973614,0,1,DRM complex,CC,
15781,GO:0070178,1,0.958008406451285,0,2,D-serine metabolic process,BP,
15782,GO:0070179,1,0.978948595150004,0,1,D-serine biosynthetic process,BP,
15783,GO:0070180,1,0.957404878800779,0,2,large ribosomal subunit rRNA binding,MF,
15784,GO:0070181,1,0.841929523163718,0,8,small ribosomal subunit rRNA binding,MF,
15785,GO:0070182,1,0.729075805073799,0,15,DNA polymerase binding,MF,
15786,GO:0070184,1,0.978823939821561,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15787,GO:0070187,1,0.880045009496106,0,6,shelterin complex,CC,
15788,GO:0070189,1,0.842711869593396,0,8,kynurenine metabolic process,BP,
15789,GO:0070191,1,0.97897493185122,0,1,methionine-R-sulfoxide reductase activity,MF,
15790,GO:0070192,1,0.309922044025474,0,56,chromosome organization involved in meiotic cell cycle,BP,
15791,GO:0070193,1,0.643274451929001,0,21,synaptonemal complex organization,BP,
15792,GO:0070194,1,0.978830155892562,0,1,synaptonemal complex disassembly,BP,
15794,GO:0070197,1,0.899561054899537,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15795,GO:0070198,1,0.574047825273305,0,27,protein localization to chromosome, telomeric region,BP,
15796,GO:0070199,1,0.641465235578761,0,21,establishment of protein localization to chromosome,BP,
15797,GO:0070200,1,0.730171875453057,0,15,establishment of protein localization to telomere,BP,
15799,GO:0070202,1,0.807713554802939,0,10,regulation of establishment of protein localization to chromosome,BP,
15800,GO:0070203,1,0.807713554802939,0,10,regulation of establishment of protein localization to telomere,BP,
15801,GO:0070206,1,0.377873817427224,0,46,protein trimerization,BP,
15802,GO:0070207,1,0.576554198786591,0,26,protein homotrimerization,BP,
15803,GO:0070208,1,0.777281706502119,0,12,protein heterotrimerization,BP,
15804,GO:0070212,1,0.942268989249728,0,3,protein poly-ADP-ribosylation,BP,
15805,GO:0070213,1,0.923788802746484,0,4,protein auto-ADP-ribosylation,BP,
15806,GO:0070217,1,0.978670272541697,0,1,transcription factor TFIIIB complex assembly,BP,
15807,GO:0070221,1,0.937446496453152,0,3,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15818,GO:0070237,1,0.979705099176087,0,1,positive regulation of activation-induced cell death of T cells,BP,
15819,GO:0070238,1,0.978633140563537,0,1,activated T cell autonomous cell death,BP,
15820,GO:0070239,1,0.978633140563537,0,1,regulation of activated T cell autonomous cell death,BP,
15821,GO:0070241,1,0.978633140563537,0,1,positive regulation of activated T cell autonomous cell death,BP,
15826,GO:0070246,1,0.978536868549282,0,1,natural killer cell apoptotic process,BP,
15827,GO:0070247,1,0.978536868549282,0,1,regulation of natural killer cell apoptotic process,BP,
15828,GO:0070251,1,0.978887298193496,0,1,pristanate-CoA ligase activity,MF,
15830,GO:0070253,1,0.917185430678614,0,4,somatostatin secretion,BP,
15834,GO:0070257,1,0.880916832502203,0,6,positive regulation of mucus secretion,BP,
15835,GO:0070259,1,0.958486155940359,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15836,GO:0070260,1,0.97897493185122,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15837,GO:0070262,1,0.775997247390914,0,12,peptidyl-serine dephosphorylation,BP,
15840,GO:0070267,1,0.979070794007844,0,1,oncosis,BP,
15842,GO:0070269,1,0.878601148499264,0,6,pyroptosis,BP,
15844,GO:0070272,1,0.917813182542972,0,4,proton-transporting ATP synthase complex biogenesis,BP,
15845,GO:0070273,1,0.660993275538487,0,20,phosphatidylinositol-4-phosphate binding,MF,
15846,GO:0070274,1,0.957804519766794,0,2,RES complex,CC,
15849,GO:0070283,1,0.978634299609194,0,1,radical SAM enzyme activity,MF,
15850,GO:0070286,1,0.651826384355533,0,21,axonemal dynein complex assembly,BP,
15851,GO:0070287,1,0.979071895117419,0,1,ferritin receptor activity,MF,
15852,GO:0070288,1,0.957467957691734,0,2,ferritin complex,CC,
15853,GO:0070290,1,0.900564763668426,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15854,GO:0070292,1,0.979064625669121,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
15857,GO:0070295,1,0.937926754848571,0,3,renal water absorption,BP,
15859,GO:0070300,1,0.733985011507891,0,15,phosphatidic acid binding,MF,
15864,GO:0070305,1,0.865825553254522,0,7,response to cGMP,BP,
15867,GO:0070309,1,0.898909715046727,0,5,lens fiber cell morphogenesis,BP,
15868,GO:0070314,1,0.845825181819571,0,8,G1 to G0 transition,BP,
15869,GO:0070315,1,0.938202974954394,0,3,G1 to G0 transition involved in cell differentiation,BP,
15873,GO:0070320,1,0.979006725358829,0,1,inward rectifier potassium channel inhibitor activity,MF,
15874,GO:0070324,1,0.881334658729427,0,6,thyroid hormone binding,MF,
15875,GO:0070325,1,0.650921181748382,0,21,lipoprotein particle receptor binding,MF,
15876,GO:0070326,1,0.922819466183394,0,4,very-low-density lipoprotein particle receptor binding,MF,
15877,GO:0070327,1,0.82580432541766,0,9,thyroid hormone transport,BP,
15879,GO:0070330,1,0.625279798358984,0,22,aromatase activity,MF,
15880,GO:0070335,1,0.981172412228562,0,1,aspartate binding,MF,
15881,GO:0070336,1,0.959529027340626,0,2,flap-structured DNA binding,MF,
15882,GO:0070337,1,0.980137602358416,0,1,3'-flap-structured DNA binding,MF,
15883,GO:0070339,1,0.880770425382892,0,6,response to bacterial lipopeptide,BP,
15884,GO:0070340,1,0.939582368835214,0,3,detection of bacterial lipopeptide,BP,
15886,GO:0070342,1,0.978464917941881,0,1,brown fat cell proliferation,BP,
15889,GO:0070345,1,0.881941048204894,0,6,negative regulation of fat cell proliferation,BP,
15891,GO:0070347,1,0.978464917941881,0,1,regulation of brown fat cell proliferation,BP,
15892,GO:0070349,1,0.978464917941881,0,1,positive regulation of brown fat cell proliferation,BP,
15894,GO:0070351,1,0.978484658321254,0,1,negative regulation of white fat cell proliferation,BP,
15896,GO:0070358,1,0.941988070527901,0,3,actin polymerization-dependent cell motility,BP,
15897,GO:0070361,1,0.97906623183746,0,1,mitochondrial light strand promoter anti-sense binding,MF,
15898,GO:0070362,1,0.97906623183746,0,1,mitochondrial heavy strand promoter anti-sense binding,MF,
15899,GO:0070363,1,0.978732065538147,0,1,mitochondrial light strand promoter sense binding,MF,
15900,GO:0070365,1,0.761122852040256,0,13,hepatocyte differentiation,BP,
15901,GO:0070366,1,0.957741362412901,0,2,regulation of hepatocyte differentiation,BP,
15902,GO:0070367,1,0.978772737024802,0,1,negative regulation of hepatocyte differentiation,BP,
15903,GO:0070368,1,0.978513746666424,0,1,positive regulation of hepatocyte differentiation,BP,
15904,GO:0070369,1,0.958612122858693,0,2,beta-catenin-TCF7L2 complex,CC,
15905,GO:0070370,1,0.937981729223756,0,3,cellular heat acclimation,BP,
15910,GO:0070375,1,0.939134360397866,0,3,ERK5 cascade,BP,
15911,GO:0070376,1,0.97904910978681,0,1,regulation of ERK5 cascade,BP,
15912,GO:0070377,1,0.97904910978681,0,1,negative regulation of ERK5 cascade,BP,
15913,GO:0070381,1,0.979069340392895,0,1,endosome to plasma membrane transport vesicle,CC,
15915,GO:0070383,1,0.878815707608892,0,6,DNA cytosine deamination,BP,
15917,GO:0070389,1,0.86156954789481,0,7,chaperone cofactor-dependent protein refolding,BP,
15918,GO:0070390,1,0.97864702124328,0,1,transcription export complex 2,CC,
15920,GO:0070392,1,0.978499877763531,0,1,detection of lipoteichoic acid,BP,
15921,GO:0070401,1,0.957936185039436,0,2,NADP+ binding,MF,
15923,GO:0070403,1,0.757247800810247,0,13,NAD+ binding,MF,
15924,GO:0070404,1,0.957578272772137,0,2,NADH binding,MF,
15926,GO:0070407,1,0.97906623183746,0,1,oxidation-dependent protein catabolic process,BP,
15927,GO:0070408,1,0.980121478494524,0,1,carbamoyl phosphate metabolic process,BP,
15928,GO:0070409,1,0.980121478494524,0,1,carbamoyl phosphate biosynthetic process,BP,
15929,GO:0070410,1,0.806356642732262,0,11,co-SMAD binding,MF,
15931,GO:0070412,1,0.628629339841681,0,23,R-SMAD binding,MF,
15932,GO:0070417,1,0.882937952176421,0,6,cellular response to cold,BP,
15933,GO:0070418,1,0.979689187518853,0,1,DNA-dependent protein kinase complex,CC,
15934,GO:0070419,1,0.848573297938294,0,8,nonhomologous end joining complex,CC,
15935,GO:0070423,1,0.501281516153799,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15936,GO:0070424,1,0.847710972014037,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15937,GO:0070425,1,0.958743666131237,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15938,GO:0070426,1,0.939200528888305,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15939,GO:0070427,1,0.919422859489818,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15940,GO:0070428,1,0.959702770293192,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15941,GO:0070429,1,0.979250290847645,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15942,GO:0070430,1,0.980039409153451,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15943,GO:0070431,1,0.826999207654691,0,9,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15944,GO:0070432,1,0.900446072782291,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15945,GO:0070433,1,0.958743666131237,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15946,GO:0070434,1,0.939200528888305,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15947,GO:0070435,1,0.958483748492866,0,2,Shc-EGFR complex,CC,
15948,GO:0070436,1,0.95872193604753,0,2,Grb2-EGFR complex,CC,
15949,GO:0070442,1,0.9785540631091,0,1,integrin alphaIIb-beta3 complex,CC,
15952,GO:0070446,1,0.978736121469041,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15953,GO:0070447,1,0.979063648103242,0,1,positive regulation of oligodendrocyte progenitor proliferation,BP,
15954,GO:0070449,1,0.978706117311954,0,1,elongin complex,CC,
15955,GO:0070458,1,0.937530651100473,0,3,cellular detoxification of nitrogen compound,BP,
15956,GO:0070459,1,0.880102590892249,0,6,prolactin secretion,BP,
15957,GO:0070460,1,0.979089260094394,0,1,thyroid-stimulating hormone secretion,BP,
15958,GO:0070461,1,0.556606939772588,0,28,SAGA-type complex,CC,
15959,GO:0070462,1,0.979072835636165,0,1,plus-end specific microtubule depolymerization,BP,
15960,GO:0070463,1,0.979069466527203,0,1,tubulin-dependent ATPase activity,MF,
15961,GO:0070469,1,0.169496232862868,0,82,respiratory chain,CC,
15965,GO:0070474,1,0.880287935110308,0,6,positive regulation of uterine smooth muscle contraction,BP,
15966,GO:0070475,1,0.898269520131193,0,5,rRNA base methylation,BP,
15967,GO:0070476,1,0.978468393293054,0,1,rRNA (guanine-N7)-methylation,BP,
15968,GO:0070478,1,0.979159310446349,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15969,GO:0070481,1,0.97905149292972,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15971,GO:0070483,1,0.979067958179433,0,1,detection of hypoxia,BP,
15974,GO:0070488,1,0.957396129730586,0,2,neutrophil aggregation,BP,
15975,GO:0070489,1,0.978734497326609,0,1,T cell aggregation,BP,
15976,GO:0070491,1,0.297831410130207,0,58,repressing transcription factor binding,MF,
15977,GO:0070492,1,0.790421532884619,0,11,oligosaccharide binding,MF,
15978,GO:0070493,1,0.777679196079221,0,12,thrombin-activated receptor signaling pathway,BP,
15979,GO:0070494,1,0.939743898175657,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15980,GO:0070495,1,0.939743898175657,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15981,GO:0070498,1,0.65630342612272,0,20,interleukin-1-mediated signaling pathway,BP,
15982,GO:0070506,1,0.958453164601741,0,2,high-density lipoprotein particle receptor activity,MF,
15984,GO:0070508,1,0.824700126951424,0,9,cholesterol import,BP,
15986,GO:0070510,1,0.981160172817578,0,1,regulation of histone H4-K20 methylation,BP,
15987,GO:0070512,1,0.981160172817578,0,1,positive regulation of histone H4-K20 methylation,BP,
15989,GO:0070522,1,0.920234468771172,0,4,ERCC4-ERCC1 complex,CC,
15990,GO:0070524,1,0.978560612989008,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15994,GO:0070530,1,0.702409136427553,0,17,K63-linked polyubiquitin binding,MF,
15995,GO:0070531,1,0.863596372489143,0,7,BRCA1-A complex,CC,
15996,GO:0070534,1,0.422444406467021,0,41,protein K63-linked ubiquitination,BP,
15997,GO:0070535,1,0.905058871261827,0,5,histone H2A K63-linked ubiquitination,BP,
15998,GO:0070536,1,0.571052284486973,0,27,protein K63-linked deubiquitination,BP,
15999,GO:0070537,1,0.93840290059427,0,3,histone H2A K63-linked deubiquitination,BP,
16001,GO:0070539,1,0.979069730920932,0,1,linoleic acid binding,MF,
16002,GO:0070541,1,0.96072628940809,0,2,response to platinum ion,BP,
16004,GO:0070543,1,0.95854317413732,0,2,response to linoleic acid,BP,
16005,GO:0070544,1,0.903523638591871,0,5,histone H3-K36 demethylation,BP,
16006,GO:0070545,1,0.918604982167292,0,4,PeBoW complex,CC,
16007,GO:0070546,1,0.938098036191125,0,3,L-phenylalanine aminotransferase activity,MF,
16008,GO:0070547,1,0.979027894596221,0,1,L-tyrosine aminotransferase activity,MF,
16009,GO:0070548,1,0.961701424020883,0,2,L-glutamine aminotransferase activity,MF,
16010,GO:0070551,1,0.97897493185122,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
16011,GO:0070552,1,0.898978015264712,0,5,BRISC complex,CC,
16012,GO:0070553,1,0.97897493185122,0,1,nicotinic acid receptor activity,MF,
16013,GO:0070554,1,0.958636379899889,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
16016,GO:0070560,1,0.979043579876824,0,1,protein secretion by platelet,BP,
16018,GO:0070562,1,0.883300927252348,0,6,regulation of vitamin D receptor signaling pathway,BP,
16019,GO:0070563,1,0.95885520129839,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
16020,GO:0070564,1,0.958209839866977,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
16021,GO:0070566,1,0.618138665092611,0,23,adenylyltransferase activity,MF,
16022,GO:0070567,1,0.826591566461138,0,9,cytidylyltransferase activity,MF,
16023,GO:0070568,1,0.898963012089264,0,5,guanylyltransferase activity,MF,
16025,GO:0070570,1,0.591791585700699,0,25,regulation of neuron projection regeneration,BP,
16026,GO:0070571,1,0.761977864800529,0,13,negative regulation of neuron projection regeneration,BP,
16027,GO:0070572,1,0.86108637104973,0,7,positive regulation of neuron projection regeneration,BP,
16028,GO:0070573,1,0.938009087931296,0,3,metallodipeptidase activity,MF,
16029,GO:0070574,1,0.918671756472773,0,4,cadmium ion transmembrane transport,BP,
16030,GO:0070576,1,0.938394282682234,0,3,vitamin D 24-hydroxylase activity,MF,
16031,GO:0070577,1,0.713366944410817,0,17,lysine-acetylated histone binding,MF,
16032,GO:0070578,1,0.846580764013332,0,8,RISC-loading complex,CC,
16033,GO:0070579,1,0.930497167674264,0,4,methylcytosine dioxygenase activity,MF,
16034,GO:0070584,1,0.655641721198935,0,20,mitochondrion morphogenesis,BP,
16036,GO:0070586,1,0.80794292304469,0,10,cell-cell adhesion involved in gastrulation,BP,
16037,GO:0070587,1,0.825270800361123,0,9,regulation of cell-cell adhesion involved in gastrulation,BP,
16039,GO:0070589,1,0.978668801600268,0,1,cellular component macromolecule biosynthetic process,BP,
16040,GO:0070593,1,0.981165736830969,0,1,dendrite self-avoidance,BP,
16041,GO:0070601,1,0.862320417354741,0,7,centromeric sister chromatid cohesion,BP,
16042,GO:0070602,1,0.938620760600963,0,3,regulation of centromeric sister chromatid cohesion,BP,
16043,GO:0070603,1,0.223109741940268,0,73,SWI/SNF superfamily-type complex,CC,
16044,GO:0070611,1,0.978997566456369,0,1,histone methyltransferase activity (H3-R2 specific),MF,
16045,GO:0070612,1,0.978997566456369,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
16047,GO:0070615,1,0.979128848906504,0,1,nucleosome-dependent ATPase activity,MF,
16048,GO:0070618,1,0.979010873384126,0,1,Grb2-Sos complex,CC,
16049,GO:0070625,1,0.978791464903483,0,1,zymogen granule exocytosis,BP,
16050,GO:0070626,1,0.978577289981347,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
16052,GO:0070628,1,0.783256025294631,0,12,proteasome binding,MF,
16054,GO:0070634,1,0.939660034145557,0,3,transepithelial ammonium transport,BP,
16057,GO:0070640,1,0.919196510024618,0,4,vitamin D3 metabolic process,BP,
16058,GO:0070643,1,0.958092782641692,0,2,vitamin D 25-hydroxylase activity,MF,
16062,GO:0070649,1,0.940776685143815,0,3,formin-nucleated actin cable assembly,BP,
16063,GO:0070651,1,0.97905149292972,0,1,nonfunctional rRNA decay,BP,
16064,GO:0070652,1,0.844915249020083,0,8,HAUS complex,CC,
16065,GO:0070653,1,0.936794887162959,0,3,high-density lipoprotein particle receptor binding,MF,
16072,GO:0070667,1,0.979063648103242,0,1,negative regulation of mast cell proliferation,BP,
16074,GO:0070669,1,0.827032440332022,0,9,response to interleukin-2,BP,
16076,GO:0070671,1,0.901589859705193,0,5,response to interleukin-12,BP,
16079,GO:0070676,1,0.937439368839269,0,3,intralumenal vesicle formation,BP,
16080,GO:0070679,1,0.83269038761894,0,9,inositol 1,4,5 trisphosphate binding,MF,
16081,GO:0070681,1,0.958051876700826,0,2,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
16082,GO:0070682,1,0.937880565880305,0,3,proteasome regulatory particle assembly,BP,
16083,GO:0070684,1,0.978510614413643,0,1,seminal clot liquefaction,BP,
16084,GO:0070685,1,0.978804179058961,0,1,macropinocytic cup,CC,
16085,GO:0070694,1,0.97897493185122,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
16086,GO:0070695,1,0.906866895996506,0,5,FHF complex,CC,
16088,GO:0070697,1,0.920154398946182,0,4,activin receptor binding,MF,
16089,GO:0070698,1,0.958282288142379,0,2,type I activin receptor binding,MF,
16090,GO:0070699,1,0.960216785109666,0,2,type II activin receptor binding,MF,
16092,GO:0070701,1,0.970615488263393,0,2,mucus layer,CC,
16093,GO:0070702,1,0.982279168254636,0,1,inner mucus layer,CC,
16094,GO:0070703,1,0.982279168254636,0,1,outer mucus layer,CC,
16096,GO:0070715,1,0.979069145652555,0,1,sodium-dependent organic cation transport,BP,
16097,GO:0070717,1,0.689038903033292,0,18,poly-purine tract binding,MF,
16098,GO:0070722,1,0.979069590832577,0,1,Tle3-Aes complex,CC,
16099,GO:0070723,1,0.652291484371129,0,21,response to cholesterol,BP,
16103,GO:0070733,1,0.978625650476873,0,1,protein adenylyltransferase activity,MF,
16104,GO:0070734,1,0.687098977278673,0,18,histone H3-K27 methylation,BP,
16105,GO:0070735,1,0.979069341627797,0,1,protein-glycine ligase activity,MF,
16106,GO:0070736,1,0.979069341627797,0,1,protein-glycine ligase activity, initiating,MF,
16107,GO:0070739,1,0.880381674725292,0,6,protein-glutamic acid ligase activity,MF,
16108,GO:0070740,1,0.938058736154159,0,3,tubulin-glutamic acid ligase activity,MF,
16109,GO:0070741,1,0.521108683320974,0,31,response to interleukin-6,BP,
16111,GO:0070743,1,0.957851991382485,0,2,interleukin-23 complex,CC,
16112,GO:0070761,1,0.88046551071405,0,6,pre-snoRNP complex,CC,
16113,GO:0070765,1,0.881276422037259,0,6,gamma-secretase complex,CC,
16114,GO:0070772,1,0.979065666430272,0,1,PAS complex,CC,
16115,GO:0070773,1,0.978547302371095,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
16116,GO:0070774,1,0.979233401567836,0,1,phytoceramidase activity,MF,
16117,GO:0070775,1,0.864164405372267,0,7,H3 histone acetyltransferase complex,CC,
16118,GO:0070776,1,0.864164405372267,0,7,MOZ/MORF histone acetyltransferase complex,CC,
16120,GO:0070778,1,0.918471966180974,0,4,L-aspartate transport,BP,
16122,GO:0070780,1,0.958037753751773,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
16123,GO:0070781,1,0.959367887548077,0,2,response to biotin,BP,
16124,GO:0070782,1,0.978822694827793,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
16125,GO:0070813,1,0.900441741140415,0,5,hydrogen sulfide metabolic process,BP,
16126,GO:0070814,1,0.920239923639006,0,4,hydrogen sulfide biosynthetic process,BP,
16127,GO:0070815,1,0.918892977738397,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
16128,GO:0070816,1,0.729972741346705,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
16129,GO:0070818,1,0.978658468487151,0,1,protoporphyrinogen oxidase activity,MF,
16133,GO:0070826,1,0.97915312387682,0,1,paraferritin complex,CC,
16134,GO:0070827,1,0.941543172040233,0,3,chromatin maintenance,BP,
16135,GO:0070828,1,0.738965758327858,0,15,heterochromatin organization,BP,
16136,GO:0070829,1,0.981180568946713,0,1,heterochromatin maintenance,BP,
16138,GO:0070831,1,0.835610189300419,0,9,basement membrane assembly,BP,
16139,GO:0070836,1,0.918068838822053,0,4,caveola assembly,BP,
16140,GO:0070837,1,0.918740023696542,0,4,dehydroascorbic acid transport,BP,
16142,GO:0070839,1,0.958593924437946,0,2,divalent metal ion export,BP,
16143,GO:0070840,1,0.681178993869712,0,19,dynein complex binding,MF,
16144,GO:0070841,1,0.648547115635103,0,21,inclusion body assembly,BP,
16145,GO:0070842,1,0.918461007170421,0,4,aggresome assembly,BP,
16146,GO:0070843,1,0.97913868799948,0,1,misfolded protein transport,BP,
16147,GO:0070844,1,0.97913868799948,0,1,polyubiquitinated protein transport,BP,
16148,GO:0070845,1,0.97913868799948,0,1,polyubiquitinated misfolded protein transport,BP,
16149,GO:0070846,1,0.97913868799948,0,1,Hsp90 deacetylation,BP,
16150,GO:0070847,1,0.880450719297392,0,6,core mediator complex,CC,
16155,GO:0070853,1,0.963197748882101,0,2,myosin VI binding,MF,
16156,GO:0070856,1,0.980373991437376,0,1,myosin VI light chain binding,MF,
16158,GO:0070858,1,0.938020067944876,0,3,negative regulation of bile acid biosynthetic process,BP,
16160,GO:0070860,1,0.978884143808707,0,1,RNA polymerase I core factor complex,CC,
16161,GO:0070861,1,0.646356505420736,0,21,regulation of protein exit from endoplasmic reticulum,BP,
16162,GO:0070862,1,0.826937173648648,0,9,negative regulation of protein exit from endoplasmic reticulum,BP,
16163,GO:0070863,1,0.813899105405667,0,10,positive regulation of protein exit from endoplasmic reticulum,BP,
16165,GO:0070874,1,0.884212713522424,0,6,negative regulation of glycogen metabolic process,BP,
16167,GO:0070876,1,0.918800006687368,0,4,SOSS complex,CC,
16168,GO:0070877,1,0.958667318683626,0,2,microprocessor complex,CC,
16169,GO:0070878,1,0.84927664286456,0,8,primary miRNA binding,MF,
16170,GO:0070883,1,0.922651126307161,0,4,pre-miRNA binding,MF,
16173,GO:0070886,1,0.831295976811535,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16175,GO:0070888,1,0.478304161965495,0,35,E-box binding,MF,
16176,GO:0070889,1,0.958341557847825,0,2,platelet alpha granule organization,BP,
16177,GO:0070890,1,0.960341204069287,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16178,GO:0070891,1,0.917539675690766,0,4,lipoteichoic acid binding,MF,
16179,GO:0070892,1,0.978787714335958,0,1,lipoteichoic acid receptor activity,MF,
16180,GO:0070893,1,0.959302888331537,0,2,transposon integration,BP,
16181,GO:0070894,1,0.959302888331537,0,2,regulation of transposon integration,BP,
16182,GO:0070895,1,0.959302888331537,0,2,negative regulation of transposon integration,BP,
16183,GO:0070897,1,0.470941932638587,0,36,DNA-templated transcriptional preinitiation complex assembly,BP,
16184,GO:0070898,1,0.963233370983411,0,2,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16185,GO:0070899,1,0.979059850215379,0,1,mitochondrial tRNA wobble uridine modification,BP,
16189,GO:0070903,1,0.97874509348896,0,1,mitochondrial tRNA thio-modification,BP,
16190,GO:0070904,1,0.960341204069287,0,2,transepithelial L-ascorbic acid transport,BP,
16191,GO:0070905,1,0.938222027507493,0,3,serine binding,MF,
16192,GO:0070911,1,0.507964167672448,0,32,global genome nucleotide-excision repair,BP,
16193,GO:0070914,1,0.792949123256624,0,11,UV-damage excision repair,BP,
16197,GO:0070922,1,0.848341952229515,0,8,small RNA loading onto RISC,BP,
16199,GO:0070926,1,0.979088772500531,0,1,regulation of ATP:ADP antiporter activity,BP,
16200,GO:0070931,1,0.980104971626652,0,1,Golgi-associated vesicle lumen,CC,
16201,GO:0070932,1,0.65917479336532,0,20,histone H3 deacetylation,BP,
16202,GO:0070933,1,0.831449213505331,0,9,histone H4 deacetylation,BP,
16203,GO:0070934,1,0.905737687504653,0,5,CRD-mediated mRNA stabilization,BP,
16204,GO:0070935,1,0.810070975080005,0,10,3'-UTR-mediated mRNA stabilization,BP,
16206,GO:0070937,1,0.886839512816604,0,6,CRD-mediated mRNA stability complex,CC,
16207,GO:0070938,1,0.801592470328431,0,11,contractile ring,CC,
16208,GO:0070939,1,0.940625322778041,0,3,Dsl1/NZR complex,CC,
16209,GO:0070940,1,0.899262467252692,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16210,GO:0070942,1,0.878285762930325,0,6,neutrophil mediated cytotoxicity,BP,
16211,GO:0070943,1,0.878285762930325,0,6,neutrophil mediated killing of symbiont cell,BP,
16212,GO:0070944,1,0.897601613267313,0,5,neutrophil mediated killing of bacterium,BP,
16213,GO:0070945,1,0.937514184406203,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16214,GO:0070946,1,0.978486944922499,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16215,GO:0070947,1,0.978486858885798,0,1,neutrophil mediated killing of fungus,BP,
16216,GO:0070948,1,0.979046924647433,0,1,regulation of neutrophil mediated cytotoxicity,BP,
16217,GO:0070949,1,0.979046924647433,0,1,regulation of neutrophil mediated killing of symbiont cell,BP,
16218,GO:0070950,1,0.979046924647433,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16219,GO:0070951,1,0.979046924647433,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16220,GO:0070960,1,0.979046924647433,0,1,positive regulation of neutrophil mediated cytotoxicity,BP,
16221,GO:0070961,1,0.979046924647433,0,1,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16222,GO:0070962,1,0.979046924647433,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16223,GO:0070963,1,0.979046924647433,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16224,GO:0070966,1,0.93988324203989,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16226,GO:0070971,1,0.801027342804989,0,11,endoplasmic reticulum exit site,CC,
16227,GO:0070972,1,0.0668226129924194,0,126,protein localization to endoplasmic reticulum,BP,
16228,GO:0070973,1,0.92079061869422,0,4,protein localization to endoplasmic reticulum exit site,BP,
16229,GO:0070974,1,0.97906239282777,0,1,POU domain binding,MF,
16230,GO:0070975,1,0.981343218371094,0,1,FHA domain binding,MF,
16231,GO:0070976,1,0.97901639381874,0,1,TIR domain binding,MF,
16233,GO:0070979,1,0.574271126932647,0,26,protein K11-linked ubiquitination,BP,
16234,GO:0070980,1,0.978903623589795,0,1,biphenyl catabolic process,BP,
16235,GO:0070981,1,0.978892394779349,0,1,L-asparagine biosynthetic process,BP,
16236,GO:0070982,1,0.978892394779349,0,1,L-asparagine metabolic process,BP,
16237,GO:0070984,1,0.979152216008561,0,1,SET domain binding,MF,
16238,GO:0070985,1,0.957600545198903,0,2,TFIIK complex,CC,
16240,GO:0070987,1,0.682948389214466,0,18,error-free translesion synthesis,BP,
16241,GO:0070988,1,0.308986138338782,0,57,demethylation,BP,
16242,GO:0070989,1,0.773664384147088,0,12,oxidative demethylation,BP,
16243,GO:0070990,1,0.841115157389671,0,8,snRNP binding,MF,
16244,GO:0070991,1,0.958500068448034,0,2,medium-chain-acyl-CoA dehydrogenase activity,MF,
16245,GO:0070992,1,0.957978324662907,0,2,translation initiation complex,CC,
16246,GO:0070993,1,0.958860838181783,0,2,translation preinitiation complex,CC,
16247,GO:0070994,1,0.97931791579165,0,1,detection of oxidative stress,BP,
16248,GO:0070995,1,0.938861728572343,0,3,NADPH oxidation,BP,
16251,GO:0071000,1,0.958051179717893,0,2,response to magnetism,BP,
16252,GO:0071001,1,0.938052427886192,0,3,U4/U6 snRNP,CC,
16253,GO:0071004,1,0.712215817741377,0,16,U2-type prespliceosome,CC,
16254,GO:0071006,1,0.938187067438768,0,3,U2-type catalytic step 1 spliceosome,CC,
16255,GO:0071007,1,0.978901317107128,0,1,U2-type catalytic step 2 spliceosome,CC,
16256,GO:0071008,1,0.918232158728634,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16257,GO:0071010,1,0.667341501185676,0,19,prespliceosome,CC,
16258,GO:0071011,1,0.61616620705317,0,23,precatalytic spliceosome,CC,
16259,GO:0071012,1,0.918167541648435,0,4,catalytic step 1 spliceosome,CC,
16260,GO:0071013,1,0.134946245455673,0,95,catalytic step 2 spliceosome,CC,
16261,GO:0071014,1,0.860804496263796,0,7,post-mRNA release spliceosomal complex,CC,
16262,GO:0071020,1,0.957765162596719,0,2,post-spliceosomal complex,CC,
16263,GO:0071021,1,0.978645638634916,0,1,U2-type post-spliceosomal complex,CC,
16264,GO:0071025,1,0.776042970016426,0,12,RNA surveillance,BP,
16265,GO:0071026,1,0.978949972742984,0,1,cytoplasmic RNA surveillance,BP,
16266,GO:0071027,1,0.809712557125764,0,10,nuclear RNA surveillance,BP,
16267,GO:0071028,1,0.809712557125764,0,10,nuclear mRNA surveillance,BP,
16268,GO:0071029,1,0.917666336135772,0,4,nuclear ncRNA surveillance,BP,
16269,GO:0071030,1,0.958124528655662,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16270,GO:0071031,1,0.957805349554748,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16271,GO:0071033,1,0.898092191725892,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16272,GO:0071034,1,0.920384871653384,0,4,CUT catabolic process,BP,
16273,GO:0071035,1,0.917666336135772,0,4,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16274,GO:0071038,1,0.957805349554748,0,2,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16275,GO:0071042,1,0.979332324557987,0,1,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16276,GO:0071043,1,0.920384871653384,0,4,CUT metabolic process,BP,
16277,GO:0071044,1,0.804847459249275,0,11,histone mRNA catabolic process,BP,
16278,GO:0071045,1,0.978624051824217,0,1,nuclear histone mRNA catabolic process,BP,
16279,GO:0071046,1,0.917666336135772,0,4,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16280,GO:0071047,1,0.979332324557987,0,1,polyadenylation-dependent mRNA catabolic process,BP,
16281,GO:0071048,1,0.958124528655662,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16282,GO:0071049,1,0.957805349554748,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16283,GO:0071051,1,0.897444435889933,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16285,GO:0071065,1,0.958560905501228,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16289,GO:0071074,1,0.959285609648447,0,2,eukaryotic initiation factor eIF2 binding,MF,
16290,GO:0071077,1,0.958375216158895,0,2,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16291,GO:0071103,1,0.00361939800716029,0,265,DNA conformation change,BP,
16292,GO:0071104,1,0.938502323306347,0,3,response to interleukin-9,BP,
16293,GO:0071105,1,0.958361071310929,0,2,response to interleukin-11,BP,
16294,GO:0071106,1,0.958375216158895,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16295,GO:0071107,1,0.796952650279252,0,11,response to parathyroid hormone,BP,
16296,GO:0071108,1,0.602890619896051,0,25,protein K48-linked deubiquitination,BP,
16297,GO:0071109,1,0.96460681923566,0,2,superior temporal gyrus development,BP,
16298,GO:0071110,1,0.980322128492799,0,1,histone biotinylation,BP,
16299,GO:0071133,1,0.979067097635795,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16300,GO:0071139,1,0.959938848133421,0,2,resolution of recombination intermediates,BP,
16301,GO:0071140,1,0.959938848133421,0,2,resolution of mitotic recombination intermediates,BP,
16302,GO:0071141,1,0.836374253079286,0,9,SMAD protein complex,CC,
16303,GO:0071144,1,0.96408318893857,0,2,SMAD2-SMAD3 protein complex,CC,
16304,GO:0071146,1,0.978812717910157,0,1,SMAD3-SMAD4 protein complex,CC,
16305,GO:0071148,1,0.962944884536327,0,2,TEAD-1-YAP complex,CC,
16306,GO:0071149,1,0.95902984427932,0,2,TEAD-2-YAP complex,CC,
16310,GO:0071159,1,0.957912277895895,0,2,NF-kappaB complex,CC,
16311,GO:0071163,1,0.937598895600197,0,3,DNA replication preinitiation complex assembly,BP,
16312,GO:0071164,1,0.979074665154177,0,1,RNA trimethylguanosine synthase activity,MF,
16313,GO:0071166,1,0.0693667848950102,0,127,ribonucleoprotein complex localization,BP,
16314,GO:0071167,1,0.979074665154177,0,1,ribonucleoprotein complex import into nucleus,BP,
16315,GO:0071168,1,0.72704344661146,0,15,protein localization to chromatin,BP,
16316,GO:0071169,1,0.878610124700009,0,6,establishment of protein localization to chromatin,BP,
16317,GO:0071170,1,0.97897493185122,0,1,site-specific DNA replication termination,BP,
16318,GO:0071171,1,0.97897493185122,0,1,site-specific DNA replication termination at RTS1 barrier,BP,
16319,GO:0071173,1,0.561474949776273,0,28,spindle assembly checkpoint,BP,
16320,GO:0071174,1,0.549568824199635,0,29,mitotic spindle checkpoint,BP,
16321,GO:0071203,1,0.922649531989617,0,4,WASH complex,CC,
16322,GO:0071204,1,0.881284813973804,0,6,histone pre-mRNA 3'end processing complex,CC,
16323,GO:0071205,1,0.92916137022467,0,4,protein localization to juxtaparanode region of axon,BP,
16324,GO:0071206,1,0.981545965679784,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16325,GO:0071207,1,0.958432304035844,0,2,histone pre-mRNA stem-loop binding,MF,
16326,GO:0071208,1,0.916906431795375,0,4,histone pre-mRNA DCP binding,MF,
16327,GO:0071209,1,0.937362205701321,0,3,U7 snRNA binding,MF,
16328,GO:0071211,1,0.939256712127954,0,3,protein targeting to vacuole involved in autophagy,BP,
16330,GO:0071215,1,0.979217682648878,0,1,cellular response to abscisic acid stimulus,BP,
16332,GO:0071217,1,0.979107757569395,0,1,cellular response to external biotic stimulus,BP,
16333,GO:0071218,1,0.670654931253755,0,19,cellular response to misfolded protein,BP,
16335,GO:0071220,1,0.880770425382892,0,6,cellular response to bacterial lipoprotein,BP,
16336,GO:0071221,1,0.880770425382892,0,6,cellular response to bacterial lipopeptide,BP,
16339,GO:0071224,1,0.957934609959614,0,2,cellular response to peptidoglycan,BP,
16340,GO:0071225,1,0.900010873057959,0,5,cellular response to muramyl dipeptide,BP,
16341,GO:0071226,1,0.938804282849802,0,3,cellular response to molecule of fungal origin,BP,
16342,GO:0071228,1,0.979052828720985,0,1,cellular response to tumor cell,BP,
16345,GO:0071231,1,0.957468836491468,0,2,cellular response to folic acid,BP,
16349,GO:0071242,1,0.315321764686175,0,55,cellular response to ammonium ion,BP,
16350,GO:0071243,1,0.72602795951558,0,15,cellular response to arsenic-containing substance,BP,
16351,GO:0071245,1,0.979072306195535,0,1,cellular response to carbon monoxide,BP,
16352,GO:0071247,1,0.978505201044607,0,1,cellular response to chromate,BP,
16354,GO:0071250,1,0.980557080498592,0,1,cellular response to nitrite,BP,
16355,GO:0071253,1,0.880276848502867,0,6,connexin binding,MF,
16356,GO:0071256,1,0.917098187508047,0,4,translocon complex,CC,
16357,GO:0071257,1,0.777268176550396,0,12,cellular response to electrical stimulus,BP,
16358,GO:0071258,1,0.979143855843724,0,1,cellular response to gravity,BP,
16359,GO:0071259,1,0.958051179717893,0,2,cellular response to magnetism,BP,
16361,GO:0071262,1,0.959459106529243,0,2,regulation of translational initiation in response to starvation,BP,
16362,GO:0071264,1,0.959459106529243,0,2,positive regulation of translational initiation in response to starvation,BP,
16364,GO:0071266,1,0.97865811077371,0,1,'de novo' L-methionine biosynthetic process,BP,
16366,GO:0071268,1,0.978878194325947,0,1,homocysteine biosynthetic process,BP,
16367,GO:0071275,1,0.978820203269567,0,1,cellular response to aluminum ion,BP,
16370,GO:0071279,1,0.940559338881302,0,3,cellular response to cobalt ion,BP,
16371,GO:0071280,1,0.776733874372741,0,12,cellular response to copper ion,BP,
16373,GO:0071283,1,0.957743187436224,0,2,cellular response to iron(III) ion,BP,
16376,GO:0071286,1,0.893876954640806,0,6,cellular response to magnesium ion,BP,
16377,GO:0071287,1,0.829369784820949,0,9,cellular response to manganese ion,BP,
16378,GO:0071288,1,0.937988459211274,0,3,cellular response to mercury ion,BP,
16379,GO:0071294,1,0.681335916636423,0,18,cellular response to zinc ion,BP,
16381,GO:0071298,1,0.979069350455509,0,1,cellular response to L-ascorbic acid,BP,
16383,GO:0071301,1,0.981337320016502,0,1,cellular response to vitamin B1,BP,
16385,GO:0071306,1,0.959406942920692,0,2,cellular response to vitamin E,BP,
16390,GO:0071314,1,0.937602167628645,0,3,cellular response to cocaine,BP,
16391,GO:0071315,1,0.918459531678041,0,4,cellular response to morphine,BP,
16392,GO:0071316,1,0.842748847740124,0,8,cellular response to nicotine,BP,
16393,GO:0071317,1,0.918459531678041,0,4,cellular response to isoquinoline alkaloid,BP,
16394,GO:0071318,1,0.765168792963888,0,13,cellular response to ATP,BP,
16396,GO:0071321,1,0.884788599516948,0,6,cellular response to cGMP,BP,
16398,GO:0071324,1,0.979572130115318,0,1,cellular response to disaccharide stimulus,BP,
16400,GO:0071329,1,0.979572130115318,0,1,cellular response to sucrose stimulus,BP,
16402,GO:0071332,1,0.900354243334414,0,5,cellular response to fructose stimulus,BP,
16407,GO:0071339,1,0.570710133156404,0,27,MLL1 complex,CC,
16408,GO:0071340,1,0.793179370794976,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16409,GO:0071344,1,0.957604773107657,0,2,diphosphate metabolic process,BP,
16413,GO:0071348,1,0.97943348461879,0,1,cellular response to interleukin-11,BP,
16414,GO:0071349,1,0.940650758002608,0,3,cellular response to interleukin-12,BP,
16415,GO:0071350,1,0.939860761293963,0,3,cellular response to interleukin-15,BP,
16417,GO:0071352,1,0.880509144197384,0,6,cellular response to interleukin-2,BP,
16419,GO:0071354,1,0.567872519393795,0,27,cellular response to interleukin-6,BP,
16420,GO:0071355,1,0.978823939821561,0,1,cellular response to interleukin-9,BP,
16425,GO:0071361,1,0.782335705276121,0,12,cellular response to ethanol,BP,
16426,GO:0071362,1,0.883315125445131,0,6,cellular response to ether,BP,
16432,GO:0071374,1,0.847914228507789,0,8,cellular response to parathyroid hormone stimulus,BP,
16434,GO:0071376,1,0.89973022285611,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16442,GO:0071386,1,0.942476504753955,0,3,cellular response to corticosterone stimulus,BP,
16443,GO:0071387,1,0.979709004824952,0,1,cellular response to cortisol stimulus,BP,
16445,GO:0071391,1,0.778283145254869,0,12,cellular response to estrogen stimulus,BP,
16446,GO:0071392,1,0.478689544549599,0,35,cellular response to estradiol stimulus,BP,
16447,GO:0071393,1,0.97912160187868,0,1,cellular response to progesterone stimulus,BP,
16449,GO:0071395,1,0.9168948804197,0,4,cellular response to jasmonic acid stimulus,BP,
16451,GO:0071397,1,0.768827179662969,0,13,cellular response to cholesterol,BP,
16453,GO:0071400,1,0.959478857819339,0,2,cellular response to oleic acid,BP,
16454,GO:0071401,1,0.978877198485586,0,1,cellular response to triglyceride,BP,
16455,GO:0071402,1,0.711092158075168,0,16,cellular response to lipoprotein particle stimulus,BP,
16456,GO:0071403,1,0.97847473781867,0,1,cellular response to high density lipoprotein particle stimulus,BP,
16457,GO:0071404,1,0.75898427303431,0,13,cellular response to low-density lipoprotein particle stimulus,BP,
16459,GO:0071409,1,0.9421077253705,0,3,cellular response to cycloheximide,BP,
16460,GO:0071412,1,0.978874203964035,0,1,cellular response to genistein,BP,
16461,GO:0071413,1,0.978874203964035,0,1,cellular response to hydroxyisoflavone,BP,
16464,GO:0071418,1,0.978549168135041,0,1,cellular response to amine stimulus,BP,
16465,GO:0071420,1,0.866295270595902,0,7,cellular response to histamine,BP,
16466,GO:0071421,1,0.899244125987894,0,5,manganese ion transmembrane transport,BP,
16467,GO:0071422,1,0.938219512103314,0,3,succinate transmembrane transport,BP,
16468,GO:0071423,1,0.978713223128666,0,1,malate transmembrane transport,BP,
16470,GO:0071426,1,0.0724032878168496,0,125,ribonucleoprotein complex export from nucleus,BP,
16471,GO:0071427,1,0.104072715576359,0,108,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16472,GO:0071428,1,0.743411769666273,0,14,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16473,GO:0071431,1,0.528217545396734,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16478,GO:0071439,1,0.847563250347519,0,8,clathrin complex,CC,
16479,GO:0071440,1,0.899247331448882,0,5,regulation of histone H3-K14 acetylation,BP,
16480,GO:0071441,1,0.979086067712906,0,1,negative regulation of histone H3-K14 acetylation,BP,
16481,GO:0071442,1,0.918460354074968,0,4,positive regulation of histone H3-K14 acetylation,BP,
16482,GO:0071444,1,0.978464532445689,0,1,cellular response to pheromone,BP,
16483,GO:0071447,1,0.845056860418176,0,8,cellular response to hydroperoxide,BP,
16484,GO:0071449,1,0.978486262782228,0,1,cellular response to lipid hydroperoxide,BP,
16488,GO:0071454,1,0.981377846582927,0,1,cellular response to anoxia,BP,
16489,GO:0071455,1,0.863225428404962,0,7,cellular response to hyperoxia,BP,
16491,GO:0071458,1,0.88056968899029,0,6,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16492,GO:0071459,1,0.681641194552665,0,18,protein localization to chromosome, centromeric region,BP,
16493,GO:0071460,1,0.957537905726099,0,2,cellular response to cell-matrix adhesion,BP,
16494,GO:0071461,1,0.958007288840114,0,2,cellular response to redox state,BP,
16495,GO:0071462,1,0.900091772931339,0,5,cellular response to water stimulus,BP,
16496,GO:0071464,1,0.95891207857809,0,2,cellular response to hydrostatic pressure,BP,
16498,GO:0071467,1,0.653476104643778,0,20,cellular response to pH,BP,
16499,GO:0071468,1,0.792565709784229,0,11,cellular response to acidic pH,BP,
16500,GO:0071469,1,0.958275987555691,0,2,cellular response to alkaline pH,BP,
16501,GO:0071470,1,0.544863942977696,0,29,cellular response to osmotic stress,BP,
16502,GO:0071471,1,0.979280084076002,0,1,cellular response to non-ionic osmotic stress,BP,
16503,GO:0071472,1,0.846097972786489,0,8,cellular response to salt stress,BP,
16504,GO:0071474,1,0.843682393383997,0,8,cellular hyperosmotic response,BP,
16505,GO:0071475,1,0.93830412047997,0,3,cellular hyperosmotic salinity response,BP,
16506,GO:0071476,1,0.866258450424322,0,7,cellular hypotonic response,BP,
16507,GO:0071477,1,0.96088722095183,0,2,cellular hypotonic salinity response,BP,
16511,GO:0071481,1,0.769473198883547,0,13,cellular response to X-ray,BP,
16513,GO:0071483,1,0.95864799330687,0,2,cellular response to blue light,BP,
16514,GO:0071484,1,0.95924954683515,0,2,cellular response to light intensity,BP,
16515,GO:0071485,1,0.979069205329571,0,1,cellular response to absence of light,BP,
16516,GO:0071486,1,0.979757786914629,0,1,cellular response to high light intensity,BP,
16517,GO:0071492,1,0.939006218482084,0,3,cellular response to UV-A,BP,
16519,GO:0071494,1,0.943604765129867,0,3,cellular response to UV-C,BP,
16522,GO:0071498,1,0.683826002438113,0,18,cellular response to fluid shear stress,BP,
16523,GO:0071499,1,0.861522708949112,0,7,cellular response to laminar fluid shear stress,BP,
16524,GO:0071500,1,0.883707190104333,0,6,cellular response to nitrosative stress,BP,
16525,GO:0071501,1,0.843943687828033,0,8,cellular response to sterol depletion,BP,
16526,GO:0071502,1,0.89970100230572,0,5,cellular response to temperature stimulus,BP,
16527,GO:0071503,1,0.900096614933107,0,5,response to heparin,BP,
16528,GO:0071504,1,0.919527871105409,0,4,cellular response to heparin,BP,
16532,GO:0071515,1,0.97897493185122,0,1,genetic imprinting at mating-type locus,BP,
16533,GO:0071516,1,0.97897493185122,0,1,establishment of imprinting at mating-type locus,BP,
16534,GO:0071526,1,0.631077665757608,0,23,semaphorin-plexin signaling pathway,BP,
16535,GO:0071527,1,0.978906684662316,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16536,GO:0071528,1,0.97909103080811,0,1,tRNA re-export from nucleus,BP,
16537,GO:0071529,1,0.978981992351213,0,1,cementum mineralization,BP,
16538,GO:0071532,1,0.903928601329112,0,5,ankyrin repeat binding,MF,
16539,GO:0071535,1,0.918349277120409,0,4,RING-like zinc finger domain binding,MF,
16540,GO:0071538,1,0.97888453883524,0,1,SH2 domain-mediated complex assembly,BP,
16541,GO:0071539,1,0.631128740502807,0,23,protein localization to centrosome,BP,
16542,GO:0071540,1,0.979794194510604,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16543,GO:0071541,1,0.860830279821759,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16545,GO:0071543,1,0.918287180998757,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16546,GO:0071544,1,0.978547302371095,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16547,GO:0071545,1,0.794824736587119,0,11,inositol phosphate catabolic process,BP,
16548,GO:0071546,1,0.862350946257571,0,7,pi-body,CC,
16549,GO:0071547,1,0.899479230675345,0,5,piP-body,CC,
16554,GO:0071554,1,0.897201793359207,0,5,cell wall organization or biogenesis,BP,
16555,GO:0071556,1,0.547290399765646,0,28,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16556,GO:0071557,1,0.923212338544609,0,4,histone H3-K27 demethylation,BP,
16557,GO:0071558,1,0.923212338544609,0,4,histone demethylase activity (H3-K27 specific),MF,
16560,GO:0071561,1,0.979604920367337,0,1,nucleus-vacuole junction,CC,
16561,GO:0071564,1,0.779568013305367,0,12,npBAF complex,CC,
16562,GO:0071565,1,0.749543967438302,0,14,nBAF complex,CC,
16563,GO:0071566,1,0.97905490398132,0,1,UFM1 activating enzyme activity,MF,
16564,GO:0071567,1,0.957855515358288,0,2,UFM1 hydrolase activity,MF,
16565,GO:0071568,1,0.957934408200897,0,2,UFM1 transferase activity,MF,
16566,GO:0071569,1,0.879309484298993,0,6,protein ufmylation,BP,
16567,GO:0071573,1,0.97905352361093,0,1,shelterin complex assembly,BP,
16568,GO:0071575,1,0.979071165345968,0,1,integral component of external side of plasma membrane,CC,
16569,GO:0071577,1,0.616394238628576,0,23,zinc II ion transmembrane transport,BP,
16570,GO:0071578,1,0.844391289194221,0,8,zinc II ion transmembrane import,BP,
16571,GO:0071579,1,0.958251023652281,0,2,regulation of zinc ion transport,BP,
16572,GO:0071580,1,0.978764031435996,0,1,regulation of zinc ion transmembrane transport,BP,
16573,GO:0071581,1,0.978764031435996,0,1,regulation of zinc ion transmembrane import,BP,
16574,GO:0071582,1,0.978764031435996,0,1,negative regulation of zinc ion transport,BP,
16575,GO:0071583,1,0.978764031435996,0,1,negative regulation of zinc ion transmembrane transport,BP,
16576,GO:0071584,1,0.978764031435996,0,1,negative regulation of zinc ion transmembrane import,BP,
16577,GO:0071585,1,0.978764031435996,0,1,detoxification of cadmium ion,BP,
16578,GO:0071586,1,0.937591250544998,0,3,CAAX-box protein processing,BP,
16579,GO:0071593,1,0.938926685562862,0,3,lymphocyte aggregation,BP,
16580,GO:0071595,1,0.95839073820654,0,2,Nem1-Spo7 phosphatase complex,CC,
16581,GO:0071596,1,0.94427695193576,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16582,GO:0071598,1,0.938087636420497,0,3,neuronal ribonucleoprotein granule,CC,
16585,GO:0071602,1,0.979233401567836,0,1,phytosphingosine biosynthetic process,BP,
16586,GO:0071603,1,0.919351156257031,0,4,endothelial cell-cell adhesion,BP,
16587,GO:0071604,1,0.557322150931766,0,28,transforming growth factor beta production,BP,
16588,GO:0071605,1,0.773504163766746,0,12,monocyte chemotactic protein-1 production,BP,
16589,GO:0071608,1,0.958573898911676,0,2,macrophage inflammatory protein-1 alpha production,BP,
16590,GO:0071609,1,0.848678021837467,0,8,chemokine (C-C motif) ligand 5 production,BP,
16591,GO:0071611,1,0.938237758651291,0,3,granulocyte colony-stimulating factor production,BP,
16592,GO:0071612,1,0.984395174738673,0,1,IP-10 production,BP,
16593,GO:0071613,1,0.957933936525323,0,2,granzyme B production,BP,
16594,GO:0071614,1,0.978701418544787,0,1,linoleic acid epoxygenase activity,MF,
16595,GO:0071615,1,0.979066440660206,0,1,oxidative deethylation,BP,
16598,GO:0071619,1,0.97887079788465,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16601,GO:0071623,1,0.958961210344584,0,2,negative regulation of granulocyte chemotaxis,BP,
16603,GO:0071625,1,0.71300794901499,0,17,vocalization behavior,BP,
16604,GO:0071626,1,0.957617234357243,0,2,mastication,BP,
16605,GO:0071629,1,0.978624051824217,0,1,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome,BP,
16606,GO:0071630,1,0.941571872249473,0,3,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome,BP,
16607,GO:0071633,1,0.957997061425897,0,2,dihydroceramidase activity,MF,
16608,GO:0071634,1,0.569108072710721,0,27,regulation of transforming growth factor beta production,BP,
16609,GO:0071635,1,0.862469210636724,0,7,negative regulation of transforming growth factor beta production,BP,
16610,GO:0071636,1,0.700413246085674,0,17,positive regulation of transforming growth factor beta production,BP,
16611,GO:0071637,1,0.773504163766746,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16612,GO:0071638,1,0.898532577721143,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16613,GO:0071639,1,0.860890258133533,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16614,GO:0071640,1,0.958573898911676,0,2,regulation of macrophage inflammatory protein 1 alpha production,BP,
16615,GO:0071641,1,0.979069632990704,0,1,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16616,GO:0071642,1,0.979067305686981,0,1,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16617,GO:0071649,1,0.867212441731787,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
16618,GO:0071650,1,0.958008251789204,0,2,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16619,GO:0071651,1,0.90523493790813,0,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16620,GO:0071655,1,0.938237758651291,0,3,regulation of granulocyte colony-stimulating factor production,BP,
16621,GO:0071656,1,0.978890047116645,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16622,GO:0071657,1,0.958473400161402,0,2,positive regulation of granulocyte colony-stimulating factor production,BP,
16623,GO:0071658,1,0.984395174738673,0,1,regulation of IP-10 production,BP,
16624,GO:0071660,1,0.984395174738673,0,1,positive regulation of IP-10 production,BP,
16625,GO:0071661,1,0.957933936525323,0,2,regulation of granzyme B production,BP,
16626,GO:0071663,1,0.957933936525323,0,2,positive regulation of granzyme B production,BP,
16627,GO:0071664,1,0.938545450440906,0,3,catenin-TCF7L2 complex,CC,
16628,GO:0071665,1,0.979069338479917,0,1,gamma-catenin-TCF7L2 complex,CC,
16629,GO:0071670,1,0.844315974491382,0,8,smooth muscle cell chemotaxis,BP,
16630,GO:0071671,1,0.879888723165182,0,6,regulation of smooth muscle cell chemotaxis,BP,
16631,GO:0071672,1,0.917889426013636,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16632,GO:0071673,1,0.937968413270921,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16634,GO:0071675,1,0.425904218294205,0,40,regulation of mononuclear cell migration,BP,
16635,GO:0071676,1,0.882390552337264,0,6,negative regulation of mononuclear cell migration,BP,
16636,GO:0071677,1,0.62268635880339,0,22,positive regulation of mononuclear cell migration,BP,
16637,GO:0071678,1,0.981584002346345,0,1,olfactory bulb axon guidance,BP,
16638,GO:0071679,1,0.866027607584599,0,7,commissural neuron axon guidance,BP,
16641,GO:0071682,1,0.669067897562716,0,19,endocytic vesicle lumen,CC,
16642,GO:0071684,1,0.979068924577401,0,1,organism emergence from protective structure,BP,
16644,GO:0071691,1,0.98101923188129,0,1,cardiac muscle thin filament assembly,BP,
16645,GO:0071692,1,0.889234433773402,0,6,protein localization to extracellular region,BP,
16646,GO:0071694,1,0.889234433773402,0,6,maintenance of protein location in extracellular region,BP,
16652,GO:0071701,1,0.979476715098243,0,1,regulation of MAPK export from nucleus,BP,
16657,GO:0071707,1,0.978531728719585,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16659,GO:0071711,1,0.665565613206473,0,20,basement membrane organization,BP,
16660,GO:0071712,1,0.807949292916644,0,10,ER-associated misfolded protein catabolic process,BP,
16661,GO:0071714,1,0.979171362710354,0,1,icosanoid transmembrane transporter activity,MF,
16663,GO:0071723,1,0.808533816115482,0,10,lipopeptide binding,MF,
16664,GO:0071724,1,0.919239288639565,0,4,response to diacyl bacterial lipopeptide,BP,
16665,GO:0071725,1,0.938040934590349,0,3,response to triacyl bacterial lipopeptide,BP,
16666,GO:0071726,1,0.919239288639565,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16667,GO:0071727,1,0.938040934590349,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16671,GO:0071763,1,0.899444817184466,0,5,nuclear membrane organization,BP,
16672,GO:0071765,1,0.979167039160309,0,1,nuclear inner membrane organization,BP,
16678,GO:0071787,1,0.918448792986146,0,4,endoplasmic reticulum tubular network formation,BP,
16679,GO:0071791,1,0.958515240679331,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16680,GO:0071796,1,0.978535932155181,0,1,K6-linked polyubiquitin binding,MF,
16681,GO:0071797,1,0.938087935552322,0,3,LUBAC complex,CC,
16682,GO:0071798,1,0.901630562954057,0,5,response to prostaglandin D,BP,
16683,GO:0071799,1,0.901630562954057,0,5,cellular response to prostaglandin D stimulus,BP,
16686,GO:0071802,1,0.979160258438739,0,1,negative regulation of podosome assembly,BP,
16690,GO:0071806,1,0.277144037296725,0,60,protein transmembrane transport,BP,
16691,GO:0071812,1,0.958380723692272,0,2,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16692,GO:0071813,1,0.607631713988072,0,24,lipoprotein particle binding,MF,
16693,GO:0071814,1,0.607631713988072,0,24,protein-lipid complex binding,MF,
16694,GO:0071816,1,0.917889369533987,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16695,GO:0071817,1,0.898425478702028,0,5,MMXD complex,CC,
16696,GO:0071818,1,0.937977841421191,0,3,BAT3 complex,CC,
16697,GO:0071819,1,0.978468157715739,0,1,DUBm complex,CC,
16698,GO:0071820,1,0.978570356890495,0,1,N-box binding,MF,
16699,GO:0071821,1,0.981171670594124,0,1,FANCM-MHF complex,CC,
16701,GO:0071823,1,0.957499897015503,0,2,protein-carbohydrate complex subunit organization,BP,
16702,GO:0071824,1,0.00426531682476093,0,256,protein-DNA complex subunit organization,BP,
16707,GO:0071837,1,0.699590019081161,0,17,HMG box domain binding,MF,
16708,GO:0071838,1,0.880569825745448,0,6,cell proliferation in bone marrow,BP,
16709,GO:0071839,1,0.898275120470332,0,5,apoptotic process in bone marrow,BP,
16711,GO:0071846,1,0.978470986066789,0,1,actin filament debranching,BP,
16713,GO:0071848,1,0.958380723692272,0,2,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16716,GO:0071863,1,0.880626229955157,0,6,regulation of cell proliferation in bone marrow,BP,
16717,GO:0071864,1,0.880626229955157,0,6,positive regulation of cell proliferation in bone marrow,BP,
16718,GO:0071865,1,0.898449722911928,0,5,regulation of apoptotic process in bone marrow,BP,
16719,GO:0071866,1,0.898449722911928,0,5,negative regulation of apoptotic process in bone marrow,BP,
16726,GO:0071873,1,0.939813293288086,0,3,response to norepinephrine,BP,
16727,GO:0071874,1,0.958450504675233,0,2,cellular response to norepinephrine stimulus,BP,
16729,GO:0071877,1,0.885092425457185,0,6,regulation of adrenergic receptor signaling pathway,BP,
16730,GO:0071878,1,0.943743669334679,0,3,negative regulation of adrenergic receptor signaling pathway,BP,
16731,GO:0071879,1,0.940381168096525,0,3,positive regulation of adrenergic receptor signaling pathway,BP,
16733,GO:0071881,1,0.979088772500531,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16734,GO:0071882,1,0.979088772500531,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16736,GO:0071884,1,0.980409024504204,0,1,vitamin D receptor activator activity,MF,
16737,GO:0071885,1,0.95791418651886,0,2,N-terminal protein N-methyltransferase activity,MF,
16738,GO:0071886,1,0.958912856093585,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16740,GO:0071888,1,0.844010426546509,0,8,macrophage apoptotic process,BP,
16742,GO:0071890,1,0.979721115841685,0,1,bicarbonate binding,MF,
16744,GO:0071894,1,0.979069349634111,0,1,histone H2B conserved C-terminal lysine ubiquitination,BP,
16745,GO:0071895,1,0.938387814040664,0,3,odontoblast differentiation,BP,
16746,GO:0071896,1,0.925452940395827,0,4,protein localization to adherens junction,BP,
16748,GO:0071898,1,0.938042463264487,0,3,regulation of estrogen receptor binding,BP,
16749,GO:0071899,1,0.938042463264487,0,3,negative regulation of estrogen receptor binding,BP,
16753,GO:0071907,1,0.866881148161557,0,7,determination of digestive tract left/right asymmetry,BP,
16754,GO:0071908,1,0.979846577391115,0,1,determination of intestine left/right asymmetry,BP,
16755,GO:0071909,1,0.979846577391115,0,1,determination of stomach left/right asymmetry,BP,
16756,GO:0071910,1,0.882055153598056,0,6,determination of liver left/right asymmetry,BP,
16757,GO:0071914,1,0.97908568773558,0,1,prominosome,CC,
16758,GO:0071918,1,0.918621019200229,0,4,urea transmembrane transport,BP,
16759,GO:0071920,1,0.958231446185863,0,2,cleavage body,CC,
16760,GO:0071921,1,0.938433391299496,0,3,cohesin loading,BP,
16761,GO:0071922,1,0.938433391299496,0,3,regulation of cohesin loading,BP,
16762,GO:0071926,1,0.939543271213529,0,3,endocannabinoid signaling pathway,BP,
16763,GO:0071929,1,0.958480192818391,0,2,alpha-tubulin acetylation,BP,
16764,GO:0071930,1,0.939815160024574,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16765,GO:0071931,1,0.978549586521007,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16766,GO:0071933,1,0.847481458517379,0,8,Arp2/3 complex binding,MF,
16767,GO:0071934,1,0.918178456923971,0,4,thiamine transmembrane transport,BP,
16768,GO:0071936,1,0.850316146766661,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16769,GO:0071941,1,0.725344532322566,0,15,nitrogen cycle metabolic process,BP,
16770,GO:0071942,1,0.938038344024639,0,3,XPC complex,CC,
16772,GO:0071947,1,0.920925580268931,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16773,GO:0071949,1,0.69998357838503,0,17,FAD binding,MF,
16774,GO:0071951,1,0.979024817940894,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16775,GO:0071953,1,0.918351160169206,0,4,elastic fiber,CC,
16776,GO:0071954,1,0.979069541176219,0,1,chemokine (C-C motif) ligand 11 production,BP,
16778,GO:0071962,1,0.979070551236452,0,1,mitotic sister chromatid cohesion, centromeric,BP,
16780,GO:0071964,1,0.97852925271556,0,1,establishment of cell polarity regulating cell shape,BP,
16782,GO:0071976,1,0.979069218032502,0,1,cell gliding,BP,
16784,GO:0071986,1,0.880276625167937,0,6,Ragulator complex,CC,
16785,GO:0071987,1,0.940898396110301,0,3,WD40-repeat domain binding,MF,
16786,GO:0071997,1,0.9806206324592,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16788,GO:0072003,1,0.938116593754202,0,3,kidney rudiment formation,BP,
16789,GO:0072004,1,0.958660096857259,0,2,kidney field specification,BP,
16795,GO:0072011,1,0.937540585912525,0,3,glomerular endothelium development,BP,
16799,GO:0072016,1,0.978997291477967,0,1,glomerular parietal epithelial cell development,BP,
16802,GO:0072021,1,0.925171320196833,0,4,ascending thin limb development,BP,
16803,GO:0072023,1,0.95790991561643,0,2,thick ascending limb development,BP,
16804,GO:0072024,1,0.97858190308725,0,1,macula densa development,BP,
16805,GO:0072025,1,0.898986895612466,0,5,distal convoluted tubule development,BP,
16806,GO:0072027,1,0.978967633275564,0,1,connecting tubule development,BP,
16810,GO:0072036,1,0.979077239482383,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16815,GO:0072046,1,0.978573045654478,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16816,GO:0072047,1,0.898245679140732,0,5,proximal/distal pattern formation involved in nephron development,BP,
16820,GO:0072051,1,0.97858190308725,0,1,juxtaglomerular apparatus development,BP,
16823,GO:0072055,1,0.979613047728332,0,1,renal cortex development,BP,
16824,GO:0072059,1,0.979613047728332,0,1,cortical collecting duct development,BP,
16827,GO:0072069,1,0.938125085967165,0,3,DCT cell differentiation,BP,
16829,GO:0072071,1,0.957738920452794,0,2,kidney interstitial fibroblast differentiation,BP,
16838,GO:0072081,1,0.898245679140732,0,5,specification of nephron tubule identity,BP,
16839,GO:0072086,1,0.917786549242095,0,4,specification of loop of Henle identity,BP,
16844,GO:0072092,1,0.946742404980693,0,3,ureteric bud invasion,BP,
16845,GO:0072093,1,0.926931012694842,0,4,metanephric renal vesicle formation,BP,
16863,GO:0072114,1,0.959420872469947,0,2,pronephros morphogenesis,BP,
16867,GO:0072127,1,0.978866169897787,0,1,renal capsule development,BP,
16868,GO:0072128,1,0.978866169897787,0,1,renal capsule morphogenesis,BP,
16869,GO:0072129,1,0.978866169897787,0,1,renal capsule formation,BP,
16870,GO:0072130,1,0.978866169897787,0,1,renal capsule specification,BP,
16877,GO:0072137,1,0.931082692920262,0,4,condensed mesenchymal cell proliferation,BP,
16879,GO:0072139,1,0.938238902433559,0,3,glomerular parietal epithelial cell differentiation,BP,
16880,GO:0072141,1,0.957738920452794,0,2,renal interstitial fibroblast development,BP,
16890,GO:0072165,1,0.978713619830335,0,1,anterior mesonephric tubule development,BP,
16892,GO:0072167,1,0.978713619830335,0,1,specification of mesonephric tubule identity,BP,
16893,GO:0072168,1,0.978713619830335,0,1,specification of anterior mesonephric tubule identity,BP,
16894,GO:0072169,1,0.978713619830335,0,1,specification of posterior mesonephric tubule identity,BP,
16902,GO:0072177,1,0.849279944035257,0,8,mesonephric duct development,BP,
16905,GO:0072180,1,0.917852485282651,0,4,mesonephric duct morphogenesis,BP,
16906,GO:0072181,1,0.958055765623887,0,2,mesonephric duct formation,BP,
16908,GO:0072183,1,0.958228422363663,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16909,GO:0072184,1,0.978713619830335,0,1,renal vesicle progenitor cell differentiation,BP,
16910,GO:0072185,1,0.95806698606471,0,2,metanephric cap development,BP,
16911,GO:0072186,1,0.95806698606471,0,2,metanephric cap morphogenesis,BP,
16917,GO:0072194,1,0.938242347530578,0,3,kidney smooth muscle tissue development,BP,
16918,GO:0072195,1,0.978602768722672,0,1,kidney smooth muscle cell differentiation,BP,
16926,GO:0072204,1,0.959235059202472,0,2,cell-cell signaling involved in metanephros development,BP,
16928,GO:0072206,1,0.97858190308725,0,1,metanephric juxtaglomerular apparatus development,BP,
16930,GO:0072208,1,0.958759474109813,0,2,metanephric smooth muscle tissue development,BP,
16933,GO:0072213,1,0.978866169897787,0,1,metanephric capsule development,BP,
16934,GO:0072214,1,0.979613047728332,0,1,metanephric cortex development,BP,
16938,GO:0072218,1,0.925171320196833,0,4,metanephric ascending thin limb development,BP,
16939,GO:0072219,1,0.979613047728332,0,1,metanephric cortical collecting duct development,BP,
16940,GO:0072221,1,0.898986895612466,0,5,metanephric distal convoluted tubule development,BP,
16943,GO:0072227,1,0.97858190308725,0,1,metanephric macula densa development,BP,
16945,GO:0072233,1,0.95790991561643,0,2,metanephric thick ascending limb development,BP,
16947,GO:0072235,1,0.86825688391316,0,7,metanephric distal tubule development,BP,
16951,GO:0072240,1,0.938125085967165,0,3,metanephric DCT cell differentiation,BP,
16953,GO:0072244,1,0.939466725453545,0,3,metanephric glomerular epithelium development,BP,
16954,GO:0072248,1,0.939466725453545,0,3,metanephric glomerular visceral epithelial cell differentiation,BP,
16955,GO:0072249,1,0.939466725453545,0,3,metanephric glomerular visceral epithelial cell development,BP,
16959,GO:0072258,1,0.978713619830335,0,1,metanephric interstitial fibroblast differentiation,BP,
16960,GO:0072259,1,0.978713619830335,0,1,metanephric interstitial fibroblast development,BP,
16962,GO:0072265,1,0.978866169897787,0,1,metanephric capsule morphogenesis,BP,
16963,GO:0072266,1,0.978866169897787,0,1,metanephric capsule formation,BP,
16964,GO:0072267,1,0.978866169897787,0,1,metanephric capsule specification,BP,
16965,GO:0072268,1,0.917934255104654,0,4,pattern specification involved in metanephros development,BP,
16966,GO:0072272,1,0.958154045972611,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16968,GO:0072274,1,0.980182878551802,0,1,metanephric glomerular basement membrane development,BP,
16969,GO:0072275,1,0.940916056361305,0,3,metanephric glomerulus morphogenesis,BP,
16970,GO:0072276,1,0.940916056361305,0,3,metanephric glomerulus vasculature morphogenesis,BP,
16971,GO:0072277,1,0.940916056361305,0,3,metanephric glomerular capillary formation,BP,
16973,GO:0072282,1,0.849996100808379,0,8,metanephric nephron tubule morphogenesis,BP,
16976,GO:0072285,1,0.979077239482383,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16977,GO:0072286,1,0.978967633275564,0,1,metanephric connecting tubule development,BP,
16978,GO:0072287,1,0.985927662683354,0,1,metanephric distal tubule morphogenesis,BP,
16979,GO:0072289,1,0.918962890667956,0,4,metanephric nephron tubule formation,BP,
16982,GO:0072300,1,0.900294767875889,0,5,positive regulation of metanephric glomerulus development,BP,
16985,GO:0072303,1,0.979066574543881,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16986,GO:0072304,1,0.958660096857259,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16987,GO:0072305,1,0.958660096857259,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16989,GO:0072308,1,0.979070476763863,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16990,GO:0072309,1,0.958660096857259,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16993,GO:0072312,1,0.939466725453545,0,3,metanephric glomerular epithelial cell differentiation,BP,
16994,GO:0072313,1,0.939466725453545,0,3,metanephric glomerular epithelial cell development,BP,
16995,GO:0072318,1,0.883387209213654,0,6,clathrin coat disassembly,BP,
16996,GO:0072319,1,0.864682345747395,0,7,vesicle uncoating,BP,
16998,GO:0072321,1,0.823903624341023,0,9,chaperone-mediated protein transport,BP,
17003,GO:0072334,1,0.957626944989284,0,2,UDP-galactose transmembrane transport,BP,
17004,GO:0072337,1,0.577024653732126,0,26,modified amino acid transport,BP,
17006,GO:0072340,1,0.978641526874056,0,1,cellular lactam catabolic process,BP,
17008,GO:0072343,1,0.957690523316162,0,2,pancreatic stellate cell proliferation,BP,
17009,GO:0072344,1,0.979068315955253,0,1,rescue of stalled ribosome,BP,
17010,GO:0072345,1,0.919317150873033,0,4,NAADP-sensitive calcium-release channel activity,MF,
17011,GO:0072348,1,0.488658224078355,0,34,sulfur compound transport,BP,
17012,GO:0072349,1,0.686224773150833,0,18,modified amino acid transmembrane transporter activity,MF,
17014,GO:0072354,1,0.958125409109935,0,2,histone kinase activity (H3-T3 specific),MF,
17015,GO:0072355,1,0.958125409109935,0,2,histone H3-T3 phosphorylation,BP,
17016,GO:0072356,1,0.958585063064087,0,2,chromosome passenger complex localization to kinetochore,BP,
17017,GO:0072357,1,0.86351867865965,0,7,PTW/PP1 phosphatase complex,CC,
17020,GO:0072361,1,0.965290590510417,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
17021,GO:0072362,1,0.981766154959249,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17022,GO:0072363,1,0.983219280991359,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17023,GO:0072364,1,0.965787657535938,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17024,GO:0072365,1,0.982271682782049,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17025,GO:0072366,1,0.983219280991359,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17026,GO:0072367,1,0.925413572041533,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
17027,GO:0072368,1,0.961347443889579,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
17028,GO:0072369,1,0.962625293712893,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
17030,GO:0072377,1,0.97905336501738,0,1,blood coagulation, common pathway,BP,
17032,GO:0072379,1,0.937977841421191,0,3,ER membrane insertion complex,CC,
17033,GO:0072383,1,0.854239499421845,0,8,plus-end-directed vesicle transport along microtubule,BP,
17034,GO:0072384,1,0.257287557408302,0,66,organelle transport along microtubule,BP,
17035,GO:0072385,1,0.939349131221303,0,3,minus-end-directed organelle transport along microtubule,BP,
17036,GO:0072386,1,0.837260112203539,0,9,plus-end-directed organelle transport along microtubule,BP,
17037,GO:0072387,1,0.958279027323971,0,2,flavin adenine dinucleotide metabolic process,BP,
17038,GO:0072388,1,0.978746526553592,0,1,flavin adenine dinucleotide biosynthetic process,BP,
17039,GO:0072389,1,0.979089260094394,0,1,flavin adenine dinucleotide catabolic process,BP,
17040,GO:0072393,1,0.856803353444107,0,8,microtubule anchoring at microtubule organizing center,BP,
17042,GO:0072396,1,0.885840528217402,0,6,response to cell cycle checkpoint signaling,BP,
17044,GO:0072402,1,0.885840528217402,0,6,response to DNA integrity checkpoint signaling,BP,
17046,GO:0072414,1,0.981120451674498,0,1,response to mitotic cell cycle checkpoint signaling,BP,
17048,GO:0072423,1,0.885840528217402,0,6,response to DNA damage checkpoint signaling,BP,
17049,GO:0072425,1,0.963355706349915,0,2,signal transduction involved in G2 DNA damage checkpoint,BP,
17050,GO:0072428,1,0.978704547525532,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17051,GO:0072429,1,0.918477311619665,0,4,response to intra-S DNA damage checkpoint signaling,BP,
17053,GO:0072432,1,0.981120451674498,0,1,response to G1 DNA damage checkpoint signaling,BP,
17054,GO:0072434,1,0.963355706349915,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17055,GO:0072487,1,0.918735881262099,0,4,MSL complex,CC,
17056,GO:0072488,1,0.683047899365824,0,18,ammonium transmembrane transport,BP,
17057,GO:0072492,1,0.978661162038463,0,1,host cell mitochondrial intermembrane space,CC,
17060,GO:0072501,1,0.831119745930143,0,9,cellular divalent inorganic anion homeostasis,BP,
17061,GO:0072502,1,0.831119745930143,0,9,cellular trivalent inorganic anion homeostasis,BP,
17063,GO:0072505,1,0.780822576624143,0,12,divalent inorganic anion homeostasis,BP,
17064,GO:0072506,1,0.780822576624143,0,12,trivalent inorganic anion homeostasis,BP,
17070,GO:0072513,1,0.918281169061439,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
17071,GO:0072517,1,0.979069369180422,0,1,host cell viral assembly compartment,CC,
17072,GO:0072518,1,0.980635743842012,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17073,GO:0072520,1,0.815526656412338,0,10,seminiferous tubule development,BP,
17080,GO:0072527,1,0.201869666358321,0,75,pyrimidine-containing compound metabolic process,BP,
17081,GO:0072528,1,0.435952028520743,0,39,pyrimidine-containing compound biosynthetic process,BP,
17082,GO:0072529,1,0.515459252414999,0,31,pyrimidine-containing compound catabolic process,BP,
17083,GO:0072530,1,0.825328606794517,0,9,purine-containing compound transmembrane transport,BP,
17084,GO:0072531,1,0.744195376081443,0,14,pyrimidine-containing compound transmembrane transport,BP,
17085,GO:0072534,1,0.962008687382047,0,2,perineuronal net,CC,
17086,GO:0072535,1,0.937829246583444,0,3,tumor necrosis factor (ligand) superfamily member 11 production,BP,
17087,GO:0072536,1,0.958234281147425,0,2,interleukin-23 receptor complex,CC,
17088,GO:0072537,1,0.809499341637645,0,10,fibroblast activation,BP,
17089,GO:0072538,1,0.641951437564794,0,21,T-helper 17 type immune response,BP,
17090,GO:0072539,1,0.669932756779296,0,19,T-helper 17 cell differentiation,BP,
17091,GO:0072540,1,0.774169512119925,0,12,T-helper 17 cell lineage commitment,BP,
17092,GO:0072542,1,0.862378782515061,0,7,protein phosphatase activator activity,MF,
17093,GO:0072544,1,0.978642208365672,0,1,L-DOPA binding,MF,
17094,GO:0072545,1,0.95791721640763,0,2,tyrosine binding,MF,
17095,GO:0072546,1,0.680755421074884,0,18,ER membrane protein complex,CC,
17096,GO:0072553,1,0.88243974579388,0,6,terminal button organization,BP,
17097,GO:0072554,1,0.958413909352658,0,2,blood vessel lumenization,BP,
17098,GO:0072556,1,0.979158054547778,0,1,other organism presynaptic membrane,CC,
17102,GO:0072560,1,0.958022834602883,0,2,type B pancreatic cell maturation,BP,
17104,GO:0072563,1,0.958125457282822,0,2,endothelial microparticle,CC,
17105,GO:0072564,1,0.957870953174939,0,2,blood microparticle formation,BP,
17106,GO:0072566,1,0.958185045657319,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
17107,GO:0072567,1,0.80734434293752,0,10,chemokine (C-X-C motif) ligand 2 production,BP,
17108,GO:0072572,1,0.978816046508867,0,1,poly-ADP-D-ribose binding,MF,
17109,GO:0072573,1,0.979250290847645,0,1,tolerance induction to lipopolysaccharide,BP,
17114,GO:0072578,1,0.850553181328421,0,8,neurotransmitter-gated ion channel clustering,BP,
17115,GO:0072579,1,0.979184544493128,0,1,glycine receptor clustering,BP,
17118,GO:0072586,1,0.979285323464443,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
17119,GO:0072587,1,0.979285323464443,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
17120,GO:0072588,1,0.897459207646562,0,5,box H/ACA RNP complex,CC,
17121,GO:0072589,1,0.917136164246567,0,4,box H/ACA scaRNP complex,CC,
17122,GO:0072590,1,0.96410603161333,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
17123,GO:0072591,1,0.980181344768279,0,1,citrate-L-glutamate ligase activity,MF,
17124,GO:0072592,1,0.89907144617336,0,5,oxygen metabolic process,BP,
17128,GO:0072599,1,0.106227161881161,0,104,establishment of protein localization to endoplasmic reticulum,BP,
17129,GO:0072600,1,0.644321558096542,0,22,establishment of protein localization to Golgi,BP,
17131,GO:0072603,1,0.879787953763811,0,6,interleukin-5 secretion,BP,
17135,GO:0072610,1,0.825280475188995,0,9,interleukin-12 secretion,BP,
17136,GO:0072611,1,0.842447056271804,0,8,interleukin-13 secretion,BP,
17137,GO:0072615,1,0.978819787817556,0,1,interleukin-17 secretion,BP,
17138,GO:0072616,1,0.9791099893852,0,1,interleukin-18 secretion,BP,
17139,GO:0072619,1,0.9790703454707,0,1,interleukin-21 secretion,BP,
17140,GO:0072641,1,0.938141658558781,0,3,type I interferon secretion,BP,
17141,GO:0072642,1,0.958223669528091,0,2,interferon-alpha secretion,BP,
17142,GO:0072643,1,0.697541587585034,0,17,interferon-gamma secretion,BP,
17146,GO:0072658,1,0.983176257208993,0,1,maintenance of protein location in membrane,BP,
17148,GO:0072660,1,0.983176257208993,0,1,maintenance of protein location in plasma membrane,BP,
17150,GO:0072662,1,0.69712525289562,0,17,protein localization to peroxisome,BP,
17151,GO:0072663,1,0.69712525289562,0,17,establishment of protein localization to peroxisome,BP,
17153,GO:0072666,1,0.524887639791786,0,31,establishment of protein localization to vacuole,BP,
17154,GO:0072669,1,0.859789777219875,0,7,tRNA-splicing ligase complex,CC,
17155,GO:0072671,1,0.978971945409171,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17157,GO:0072673,1,0.748439880017314,0,14,lamellipodium morphogenesis,BP,
17158,GO:0072674,1,0.926904983178279,0,4,multinuclear osteoclast differentiation,BP,
17159,GO:0072675,1,0.946814766009648,0,3,osteoclast fusion,BP,
17161,GO:0072677,1,0.724274598280815,0,15,eosinophil migration,BP,
17164,GO:0072680,1,0.979067097635795,0,1,extracellular matrix-dependent thymocyte migration,BP,
17165,GO:0072681,1,0.979067097635795,0,1,fibronectin-dependent thymocyte migration,BP,
17166,GO:0072682,1,0.979069342662988,0,1,eosinophil extravasation,BP,
17168,GO:0072684,1,0.979083528070418,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17169,GO:0072686,1,0.262353143358648,0,65,mitotic spindle,CC,
17170,GO:0072687,1,0.84680632800475,0,8,meiotic spindle,CC,
17171,GO:0072695,1,0.958297558389211,0,2,regulation of DNA recombination at telomere,BP,
17172,GO:0072697,1,0.958041592568738,0,2,protein localization to cell cortex,BP,
17173,GO:0072698,1,0.513506405328234,0,33,protein localization to microtubule cytoskeleton,BP,
17174,GO:0072702,1,0.980027549251446,0,1,response to methyl methanesulfonate,BP,
17175,GO:0072703,1,0.980027549251446,0,1,cellular response to methyl methanesulfonate,BP,
17176,GO:0072706,1,0.978977877676387,0,1,response to sodium dodecyl sulfate,BP,
17177,GO:0072707,1,0.978977877676387,0,1,cellular response to sodium dodecyl sulfate,BP,
17178,GO:0072708,1,0.91838253437554,0,4,response to sorbitol,BP,
17179,GO:0072709,1,0.958226554705464,0,2,cellular response to sorbitol,BP,
17180,GO:0072710,1,0.867328842035934,0,7,response to hydroxyurea,BP,
17181,GO:0072711,1,0.885962344591776,0,6,cellular response to hydroxyurea,BP,
17182,GO:0072714,1,0.978656505269765,0,1,response to selenite ion,BP,
17183,GO:0072715,1,0.978656505269765,0,1,cellular response to selenite ion,BP,
17184,GO:0072716,1,0.920256996602633,0,4,response to actinomycin D,BP,
17185,GO:0072717,1,0.940024369359144,0,3,cellular response to actinomycin D,BP,
17186,GO:0072718,1,0.828208124640686,0,9,response to cisplatin,BP,
17187,GO:0072719,1,0.880989876985086,0,6,cellular response to cisplatin,BP,
17188,GO:0072720,1,0.95839073820654,0,2,response to dithiothreitol,BP,
17189,GO:0072721,1,0.97897493185122,0,1,cellular response to dithiothreitol,BP,
17190,GO:0072733,1,0.91806954920626,0,4,response to staurosporine,BP,
17191,GO:0072734,1,0.91806954920626,0,4,cellular response to staurosporine,BP,
17192,GO:0072737,1,0.958249380472876,0,2,response to diamide,BP,
17193,GO:0072738,1,0.958249380472876,0,2,cellular response to diamide,BP,
17194,GO:0072739,1,0.97897493185122,0,1,response to anisomycin,BP,
17195,GO:0072750,1,0.978534819191145,0,1,cellular response to leptomycin B,BP,
17196,GO:0072752,1,0.980766888043651,0,1,cellular response to rapamycin,BP,
17197,GO:0072755,1,0.979078642013519,0,1,cellular response to benomyl,BP,
17198,GO:0072757,1,0.938535023609827,0,3,cellular response to camptothecin,BP,
17199,GO:0075136,1,0.880982217630622,0,6,response to host,BP,
17200,GO:0075509,1,0.938806879370618,0,3,endocytosis involved in viral entry into host cell,BP,
17201,GO:0075519,1,0.978472479553316,0,1,microtubule-dependent intracellular transport of viral material,BP,
17202,GO:0075521,1,0.978472479553316,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17203,GO:0075522,1,0.861822344063636,0,7,IRES-dependent viral translational initiation,BP,
17204,GO:0075525,1,0.899167136202574,0,5,viral translational termination-reinitiation,BP,
17205,GO:0075528,1,0.957871401892734,0,2,modulation by virus of host immune response,BP,
17206,GO:0075606,1,0.978472479553316,0,1,transport of viral material towards nucleus,BP,
17207,GO:0075713,1,0.842808234118661,0,8,establishment of integrated proviral latency,BP,
17208,GO:0075732,1,0.959769676357603,0,2,viral penetration into host nucleus,BP,
17210,GO:0080008,1,0.581141939094633,0,26,Cul4-RING E3 ubiquitin ligase complex,CC,
17211,GO:0080009,1,0.918216078769904,0,4,mRNA methylation,BP,
17212,GO:0080019,1,0.958991966474447,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17213,GO:0080025,1,0.66137760330852,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
17214,GO:0080033,1,0.980557080498592,0,1,response to nitrite,BP,
17215,GO:0080048,1,0.97897493185122,0,1,GDP-D-glucose phosphorylase activity,MF,
17216,GO:0080058,1,0.978549586521007,0,1,protein deglutathionylation,BP,
17217,GO:0080084,1,0.905683864934098,0,5,5S rDNA binding,MF,
17219,GO:0080101,1,0.978493531868126,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17220,GO:0080111,1,0.688927417806366,0,18,DNA demethylation,BP,
17221,GO:0080120,1,0.937591250544998,0,3,CAAX-box protein maturation,BP,
17222,GO:0080121,1,0.958375216158895,0,2,AMP transport,BP,
17223,GO:0080122,1,0.958375216158895,0,2,AMP transmembrane transporter activity,MF,
17224,GO:0080129,1,0.978504881541008,0,1,proteasome core complex assembly,BP,
17225,GO:0080130,1,0.938098036191125,0,3,L-phenylalanine:2-oxoglutarate aminotransferase activity,MF,
17226,GO:0080132,1,0.978929803067708,0,1,fatty acid alpha-hydroxylase activity,MF,
17229,GO:0080144,1,0.97871243032062,0,1,amino acid homeostasis,BP,
17230,GO:0080146,1,0.97865811077371,0,1,L-cysteine desulfhydrase activity,MF,
17231,GO:0080147,1,0.978476629273923,0,1,root hair cell development,BP,
17232,GO:0080154,1,0.586970445087901,0,25,regulation of fertilization,BP,
17233,GO:0080163,1,0.97891745036386,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17235,GO:0080182,1,0.767896345008157,0,13,histone H3-K4 trimethylation,BP,
17236,GO:0080184,1,0.898633328768983,0,5,response to phenylpropanoid,BP,
17237,GO:0085018,1,0.97902565244238,0,1,maintenance of symbiont-containing vacuole by host,BP,
17238,GO:0085020,1,0.862653860926549,0,7,protein K6-linked ubiquitination,BP,
17240,GO:0085032,1,0.979069134244812,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17246,GO:0086006,1,0.903602634653248,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17247,GO:0086007,1,0.910289547633955,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17252,GO:0086012,1,0.645258205004583,0,22,membrane depolarization during cardiac muscle cell action potential,BP,
17254,GO:0086014,1,0.702470462531424,0,18,atrial cardiac muscle cell action potential,BP,
17255,GO:0086015,1,0.845676592779674,0,9,SA node cell action potential,BP,
17256,GO:0086016,1,0.827286905132343,0,10,AV node cell action potential,BP,
17257,GO:0086017,1,0.921307974803454,0,4,Purkinje myocyte action potential,BP,
17258,GO:0086018,1,0.845676592779674,0,9,SA node cell to atrial cardiac muscle cell signalling,BP,
17260,GO:0086020,1,0.960988649341372,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17261,GO:0086021,1,0.960988649341372,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17263,GO:0086024,1,0.981892957769005,0,1,adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17264,GO:0086026,1,0.702470462531424,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17265,GO:0086027,1,0.827286905132343,0,10,AV node cell to bundle of His cell signaling,BP,
17266,GO:0086028,1,0.865615332409236,0,7,bundle of His cell to Purkinje myocyte signaling,BP,
17270,GO:0086037,1,0.979070388045509,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17271,GO:0086039,1,0.981975970300005,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17272,GO:0086040,1,0.97931995338201,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17273,GO:0086041,1,0.981234641348364,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17275,GO:0086043,1,0.865615332409236,0,7,bundle of His cell action potential,BP,
17276,GO:0086044,1,0.979067462538613,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
17277,GO:0086045,1,0.910826153885122,0,5,membrane depolarization during AV node cell action potential,BP,
17278,GO:0086046,1,0.911673515395243,0,5,membrane depolarization during SA node cell action potential,BP,
17279,GO:0086047,1,0.941008909601297,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17280,GO:0086048,1,0.941541485349484,0,3,membrane depolarization during bundle of His cell action potential,BP,
17281,GO:0086050,1,0.979044302385337,0,1,membrane repolarization during bundle of His cell action potential,BP,
17282,GO:0086052,1,0.979044302385337,0,1,membrane repolarization during SA node cell action potential,BP,
17283,GO:0086053,1,0.960988649341372,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
17284,GO:0086054,1,0.979067462538613,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
17285,GO:0086055,1,0.979067462538613,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
17286,GO:0086056,1,0.947150660663309,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17287,GO:0086057,1,0.979087472781623,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17288,GO:0086059,1,0.963446512376644,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17289,GO:0086060,1,0.982157004226488,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17290,GO:0086061,1,0.982157004226488,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17291,GO:0086062,1,0.961072720196432,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17292,GO:0086063,1,0.982157004226488,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17293,GO:0086064,1,0.627468518362238,0,23,cell communication by electrical coupling involved in cardiac conduction,BP,
17295,GO:0086066,1,0.702470462531424,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17296,GO:0086067,1,0.812003804747608,0,11,AV node cell to bundle of His cell communication,BP,
17299,GO:0086070,1,0.830054693758774,0,10,SA node cell to atrial cardiac muscle cell communication,BP,
17300,GO:0086072,1,0.978945822139972,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17302,GO:0086075,1,0.940869477620679,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17303,GO:0086076,1,0.979067462538613,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
17304,GO:0086077,1,0.960988649341372,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17305,GO:0086078,1,0.979067462538613,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
17306,GO:0086079,1,0.979067462538613,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
17308,GO:0086082,1,0.978945822139972,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17310,GO:0086087,1,0.979044302385337,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17311,GO:0086089,1,0.918797763105486,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17312,GO:0086090,1,0.979044302385337,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17314,GO:0086092,1,0.958406361355805,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17316,GO:0086098,1,0.958565463980753,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17317,GO:0086100,1,0.958708809482148,0,2,endothelin receptor signaling pathway,BP,
17319,GO:0089700,1,0.919969439420676,0,4,protein kinase D signaling,BP,
17320,GO:0089701,1,0.898083929485221,0,5,U2AF,CC,
17321,GO:0089709,1,0.958414065007485,0,2,L-histidine transmembrane transport,BP,
17323,GO:0089712,1,0.918471966180974,0,4,L-aspartate transmembrane transport,BP,
17324,GO:0089717,1,0.943914079431972,0,3,spanning component of membrane,CC,
17325,GO:0089718,1,0.981485146893144,0,1,amino acid import across plasma membrane,BP,
17332,GO:0090010,1,0.978792715368707,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17335,GO:0090024,1,0.958961210344584,0,2,negative regulation of neutrophil chemotaxis,BP,
17336,GO:0090025,1,0.623896884895368,0,22,regulation of monocyte chemotaxis,BP,
17337,GO:0090026,1,0.69345569165525,0,17,positive regulation of monocyte chemotaxis,BP,
17338,GO:0090027,1,0.919032881706657,0,4,negative regulation of monocyte chemotaxis,BP,
17342,GO:0090034,1,0.9581950336202,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17343,GO:0090035,1,0.9581950336202,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17346,GO:0090038,1,0.958597053467809,0,2,negative regulation of protein kinase C signaling,BP,
17347,GO:0090042,1,0.868463873322929,0,7,tubulin deacetylation,BP,
17348,GO:0090043,1,0.906248768694869,0,5,regulation of tubulin deacetylation,BP,
17349,GO:0090044,1,0.978611339907467,0,1,positive regulation of tubulin deacetylation,BP,
17350,GO:0090045,1,0.863038860532733,0,7,positive regulation of deacetylase activity,BP,
17352,GO:0090050,1,0.861630044513711,0,7,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17354,GO:0090063,1,0.91989174751896,0,4,positive regulation of microtubule nucleation,BP,
17355,GO:0090065,1,0.979110885702327,0,1,regulation of production of siRNA involved in RNA interference,BP,
17358,GO:0090069,1,0.812277137579761,0,10,regulation of ribosome biogenesis,BP,
17359,GO:0090070,1,0.882191083182101,0,6,positive regulation of ribosome biogenesis,BP,
17360,GO:0090071,1,0.920775629507825,0,4,negative regulation of ribosome biogenesis,BP,
17361,GO:0090073,1,0.845559220022061,0,8,positive regulation of protein homodimerization activity,BP,
17362,GO:0090074,1,0.902992168856294,0,5,negative regulation of protein homodimerization activity,BP,
17364,GO:0090076,1,0.959329169159593,0,2,relaxation of skeletal muscle,BP,
17366,GO:0090079,1,0.659564840814626,0,20,translation regulator activity, nucleic acid binding,MF,
17367,GO:0090080,1,0.901625279033723,0,5,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17368,GO:0090081,1,0.957650196418089,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17369,GO:0090082,1,0.957650196418089,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17370,GO:0090083,1,0.720508564230311,0,16,regulation of inclusion body assembly,BP,
17371,GO:0090084,1,0.801484106162982,0,11,negative regulation of inclusion body assembly,BP,
17372,GO:0090085,1,0.84403365860786,0,8,regulation of protein deubiquitination,BP,
17373,GO:0090086,1,0.937115838549622,0,3,negative regulation of protein deubiquitination,BP,
17375,GO:0090088,1,0.958081860797864,0,2,regulation of oligopeptide transport,BP,
17376,GO:0090089,1,0.958081860797864,0,2,regulation of dipeptide transport,BP,
17378,GO:0090091,1,0.904685743462633,0,5,positive regulation of extracellular matrix disassembly,BP,
17380,GO:0090094,1,0.95806698606471,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17381,GO:0090095,1,0.978905538693577,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17382,GO:0090096,1,0.978905538693577,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17387,GO:0090104,1,0.979069625660436,0,1,pancreatic epsilon cell differentiation,BP,
17388,GO:0090107,1,0.942006506657393,0,3,regulation of high-density lipoprotein particle assembly,BP,
17389,GO:0090108,1,0.978787297703884,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17391,GO:0090110,1,0.902510230484866,0,5,cargo loading into COPII-coated vesicle,BP,
17392,GO:0090113,1,0.978827671348179,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17393,GO:0090114,1,0.252364696192974,0,66,COPII-coated vesicle budding,BP,
17394,GO:0090116,1,0.939414713406759,0,3,C-5 methylation of cytosine,BP,
17395,GO:0090118,1,0.903709184699468,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17396,GO:0090119,1,0.95850034116522,0,2,vesicle-mediated cholesterol transport,BP,
17397,GO:0090122,1,0.978764445286454,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17398,GO:0090128,1,0.800343054889036,0,11,regulation of synapse maturation,BP,
17399,GO:0090129,1,0.852163897202945,0,8,positive regulation of synapse maturation,BP,
17405,GO:0090135,1,0.938867949190827,0,3,actin filament branching,BP,
17408,GO:0090140,1,0.679724479376792,0,19,regulation of mitochondrial fission,BP,
17409,GO:0090141,1,0.780355219765378,0,12,positive regulation of mitochondrial fission,BP,
17410,GO:0090148,1,0.797022232906577,0,11,membrane fission,BP,
17411,GO:0090149,1,0.958632515072556,0,2,mitochondrial membrane fission,BP,
17413,GO:0090151,1,0.724053647280013,0,15,establishment of protein localization to mitochondrial membrane,BP,
17414,GO:0090152,1,0.978997015975946,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17415,GO:0090153,1,0.758269580631566,0,13,regulation of sphingolipid biosynthetic process,BP,
17416,GO:0090154,1,0.843743153989572,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17417,GO:0090155,1,0.918415620435431,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17418,GO:0090156,1,0.937502232466921,0,3,cellular sphingolipid homeostasis,BP,
17419,GO:0090158,1,0.938290005894318,0,3,endoplasmic reticulum membrane organization,BP,
17420,GO:0090160,1,0.90194079311908,0,5,Golgi to lysosome transport,BP,
17421,GO:0090161,1,0.797406450925048,0,11,Golgi ribbon formation,BP,
17423,GO:0090164,1,0.960899780652874,0,2,asymmetric Golgi ribbon formation,BP,
17424,GO:0090166,1,0.881046370503224,0,6,Golgi disassembly,BP,
17425,GO:0090168,1,0.92079514108492,0,4,Golgi reassembly,BP,
17426,GO:0090169,1,0.715060348548965,0,16,regulation of spindle assembly,BP,
17427,GO:0090170,1,0.918059463494168,0,4,regulation of Golgi inheritance,BP,
17428,GO:0090171,1,0.979084737167589,0,1,chondrocyte morphogenesis,BP,
17431,GO:0090176,1,0.980017993004911,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17436,GO:0090182,1,0.957838819002678,0,2,regulation of secretion of lysosomal enzymes,BP,
17441,GO:0090187,1,0.957709777302794,0,2,positive regulation of pancreatic juice secretion,BP,
17452,GO:0090198,1,0.979046924647433,0,1,negative regulation of chemokine secretion,BP,
17457,GO:0090204,1,0.939548211659347,0,3,protein localization to nuclear pore,BP,
17459,GO:0090206,1,0.898318806005976,0,5,negative regulation of cholesterol metabolic process,BP,
17463,GO:0090210,1,0.958575821203142,0,2,regulation of establishment of blood-brain barrier,BP,
17464,GO:0090212,1,0.958575821203142,0,2,negative regulation of establishment of blood-brain barrier,BP,
17465,GO:0090214,1,0.940083264269031,0,3,spongiotrophoblast layer developmental growth,BP,
17467,GO:0090219,1,0.938572236202769,0,3,negative regulation of lipid kinase activity,BP,
17468,GO:0090220,1,0.77899539032919,0,12,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17469,GO:0090222,1,0.980819107664006,0,1,centrosome-templated microtubule nucleation,BP,
17471,GO:0090230,1,0.882020512519664,0,6,regulation of centromere complex assembly,BP,
17472,GO:0090231,1,0.715783652396901,0,16,regulation of spindle checkpoint,BP,
17473,GO:0090232,1,0.84781508359676,0,8,positive regulation of spindle checkpoint,BP,
17474,GO:0090233,1,0.979008629917437,0,1,negative regulation of spindle checkpoint,BP,
17475,GO:0090234,1,0.94006562461384,0,3,regulation of kinetochore assembly,BP,
17476,GO:0090235,1,0.958280749019811,0,2,regulation of metaphase plate congression,BP,
17477,GO:0090237,1,0.88073859036257,0,6,regulation of arachidonic acid secretion,BP,
17478,GO:0090238,1,0.899092109408281,0,5,positive regulation of arachidonic acid secretion,BP,
17479,GO:0090239,1,0.776363836327866,0,12,regulation of histone H4 acetylation,BP,
17480,GO:0090240,1,0.863600398884282,0,7,positive regulation of histone H4 acetylation,BP,
17481,GO:0090241,1,0.898535040113323,0,5,negative regulation of histone H4 acetylation,BP,
17482,GO:0090244,1,0.922334032900251,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17483,GO:0090245,1,0.905429957036244,0,5,axis elongation involved in somitogenesis,BP,
17484,GO:0090246,1,0.979265164430661,0,1,convergent extension involved in somitogenesis,BP,
17485,GO:0090247,1,0.978984390211124,0,1,cell motility involved in somitogenic axis elongation,BP,
17486,GO:0090249,1,0.978984390211124,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17487,GO:0090251,1,0.984169830152526,0,1,protein localization involved in establishment of planar polarity,BP,
17489,GO:0090258,1,0.94089356876332,0,3,negative regulation of mitochondrial fission,BP,
17490,GO:0090259,1,0.900006105104114,0,5,regulation of retinal ganglion cell axon guidance,BP,
17491,GO:0090260,1,0.95909939675054,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17492,GO:0090261,1,0.917642885009831,0,4,positive regulation of inclusion body assembly,BP,
17494,GO:0090264,1,0.957881942599099,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17495,GO:0090265,1,0.957881942599099,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17496,GO:0090266,1,0.761694769119902,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17497,GO:0090267,1,0.865947090515819,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17498,GO:0090269,1,0.88458073117728,0,6,fibroblast growth factor production,BP,
17499,GO:0090270,1,0.88458073117728,0,6,regulation of fibroblast growth factor production,BP,
17500,GO:0090271,1,0.942037574079384,0,3,positive regulation of fibroblast growth factor production,BP,
17501,GO:0090272,1,0.939017528126836,0,3,negative regulation of fibroblast growth factor production,BP,
17502,GO:0090273,1,0.9579840939042,0,2,regulation of somatostatin secretion,BP,
17503,GO:0090274,1,0.9579840939042,0,2,positive regulation of somatostatin secretion,BP,
17510,GO:0090283,1,0.94016081345678,0,3,regulation of protein glycosylation in Golgi,BP,
17511,GO:0090284,1,0.981246479243017,0,1,positive regulation of protein glycosylation in Golgi,BP,
17512,GO:0090285,1,0.958131223817988,0,2,negative regulation of protein glycosylation in Golgi,BP,
17513,GO:0090286,1,0.856232477803264,0,8,cytoskeletal anchoring at nuclear membrane,BP,
17516,GO:0090289,1,0.898703792812844,0,5,regulation of osteoclast proliferation,BP,
17517,GO:0090290,1,0.937306047148455,0,3,positive regulation of osteoclast proliferation,BP,
17518,GO:0090291,1,0.958822853806664,0,2,negative regulation of osteoclast proliferation,BP,
17519,GO:0090292,1,0.947877166571972,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17520,GO:0090293,1,0.978819787817556,0,1,nitrogen catabolite regulation of transcription,BP,
17521,GO:0090294,1,0.978819787817556,0,1,nitrogen catabolite activation of transcription,BP,
17522,GO:0090296,1,0.918765118031655,0,4,regulation of mitochondrial DNA replication,BP,
17523,GO:0090297,1,0.978533535421311,0,1,positive regulation of mitochondrial DNA replication,BP,
17524,GO:0090298,1,0.938923918136733,0,3,negative regulation of mitochondrial DNA replication,BP,
17525,GO:0090299,1,0.978630183258409,0,1,regulation of neural crest formation,BP,
17526,GO:0090301,1,0.978630183258409,0,1,negative regulation of neural crest formation,BP,
17530,GO:0090306,1,0.90325646515864,0,5,spindle assembly involved in meiosis,BP,
17531,GO:0090307,1,0.336296042073414,0,52,mitotic spindle assembly,BP,
17532,GO:0090308,1,0.830351126319813,0,9,regulation of methylation-dependent chromatin silencing,BP,
17533,GO:0090309,1,0.919937271426538,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17534,GO:0090310,1,0.941611899098732,0,3,negative regulation of methylation-dependent chromatin silencing,BP,
17535,GO:0090311,1,0.485193136013135,0,35,regulation of protein deacetylation,BP,
17536,GO:0090312,1,0.643782553353959,0,21,positive regulation of protein deacetylation,BP,
17537,GO:0090313,1,0.564885475132553,0,27,regulation of protein targeting to membrane,BP,
17538,GO:0090314,1,0.628423814079206,0,22,positive regulation of protein targeting to membrane,BP,
17539,GO:0090315,1,0.898747921788051,0,5,negative regulation of protein targeting to membrane,BP,
17542,GO:0090320,1,0.978873003281332,0,1,regulation of chylomicron remnant clearance,BP,
17543,GO:0090321,1,0.978873003281332,0,1,positive regulation of chylomicron remnant clearance,BP,
17545,GO:0090323,1,0.978467931885137,0,1,prostaglandin secretion involved in immune response,BP,
17547,GO:0090325,1,0.918443646351178,0,4,regulation of locomotion involved in locomotory behavior,BP,
17548,GO:0090326,1,0.979069213891897,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17549,GO:0090327,1,0.979150416112237,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17551,GO:0090330,1,0.732828513413822,0,15,regulation of platelet aggregation,BP,
17552,GO:0090331,1,0.811536359854035,0,10,negative regulation of platelet aggregation,BP,
17553,GO:0090335,1,0.76345851107772,0,13,regulation of brown fat cell differentiation,BP,
17554,GO:0090336,1,0.863991820380212,0,7,positive regulation of brown fat cell differentiation,BP,
17555,GO:0090340,1,0.978787297703884,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17556,GO:0090341,1,0.978598753127655,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17557,GO:0090342,1,0.483197789938898,0,35,regulation of cell aging,BP,
17558,GO:0090343,1,0.825263267968528,0,9,positive regulation of cell aging,BP,
17559,GO:0090344,1,0.706306459728668,0,17,negative regulation of cell aging,BP,
17560,GO:0090345,1,0.958013386526991,0,2,cellular organohalogen metabolic process,BP,
17561,GO:0090346,1,0.958013386526991,0,2,cellular organofluorine metabolic process,BP,
17562,GO:0090347,1,0.978605979430292,0,1,regulation of cellular organohalogen metabolic process,BP,
17563,GO:0090348,1,0.978605979430292,0,1,regulation of cellular organofluorine metabolic process,BP,
17564,GO:0090349,1,0.978605979430292,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17565,GO:0090350,1,0.978605979430292,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17566,GO:0090357,1,0.978529078223452,0,1,regulation of tryptophan metabolic process,BP,
17567,GO:0090360,1,0.938183103858346,0,3,platelet-derived growth factor production,BP,
17568,GO:0090361,1,0.938183103858346,0,3,regulation of platelet-derived growth factor production,BP,
17569,GO:0090362,1,0.958520226365613,0,2,positive regulation of platelet-derived growth factor production,BP,
17570,GO:0090365,1,0.957771962916212,0,2,regulation of mRNA modification,BP,
17571,GO:0090366,1,0.978484299630964,0,1,positive regulation of mRNA modification,BP,
17572,GO:0090367,1,0.978833464295311,0,1,negative regulation of mRNA modification,BP,
17573,GO:0090370,1,0.918415454312254,0,4,negative regulation of cholesterol efflux,BP,
17574,GO:0090381,1,0.937588103520492,0,3,regulation of heart induction,BP,
17578,GO:0090386,1,0.981544867706304,0,1,phagosome maturation involved in apoptotic cell clearance,BP,
17579,GO:0090387,1,0.981544867706304,0,1,phagolysosome assembly involved in apoptotic cell clearance,BP,
17580,GO:0090389,1,0.981544867706304,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17581,GO:0090394,1,0.831288462680785,0,9,negative regulation of excitatory postsynaptic potential,BP,
17585,GO:0090402,1,0.958231944576543,0,2,oncogene-induced cell senescence,BP,
17586,GO:0090403,1,0.919236501346316,0,4,oxidative stress-induced premature senescence,BP,
17588,GO:0090409,1,0.978876999175852,0,1,malonyl-CoA synthetase activity,MF,
17589,GO:0090410,1,0.978876999175852,0,1,malonate catabolic process,BP,
17590,GO:0090416,1,0.978976487401161,0,1,nicotinate transporter activity,MF,
17591,GO:0090420,1,0.957704807337109,0,2,naphthalene-containing compound metabolic process,BP,
17592,GO:0090422,1,0.978624051824217,0,1,thiamine pyrophosphate transporter activity,MF,
17593,GO:0090425,1,0.979063884651254,0,1,acinar cell differentiation,BP,
17594,GO:0090427,1,0.939727589283753,0,3,activation of meiosis,BP,
17595,GO:0090435,1,0.863031694518162,0,7,protein localization to nuclear envelope,BP,
17596,GO:0090467,1,0.920594670413655,0,4,arginine import,BP,
17597,GO:0090472,1,0.979158681339952,0,1,dibasic protein processing,BP,
17598,GO:0090480,1,0.97897493185122,0,1,purine nucleotide-sugar transmembrane transport,BP,
17599,GO:0090481,1,0.9016813398859,0,5,pyrimidine nucleotide-sugar transmembrane transport,BP,
17600,GO:0090482,1,0.846557478932312,0,8,vitamin transmembrane transporter activity,MF,
17604,GO:0090498,1,0.939796191894709,0,3,extrinsic component of Golgi membrane,CC,
17605,GO:0090500,1,0.899177778839011,0,5,endocardial cushion to mesenchymal transition,BP,
17608,GO:0090503,1,0.493316824486215,0,34,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17611,GO:0090520,1,0.774286395500576,0,12,sphingolipid mediated signaling pathway,BP,
17612,GO:0090521,1,0.920045890048332,0,4,glomerular visceral epithelial cell migration,BP,
17614,GO:0090527,1,0.8901161146189,0,6,actin filament reorganization,BP,
17615,GO:0090529,1,0.978697140030716,0,1,cell septum assembly,BP,
17617,GO:0090534,1,0.978645983729744,0,1,calcium ion-transporting ATPase complex,CC,
17618,GO:0090537,1,0.959585245261233,0,2,CERF complex,CC,
17619,GO:0090541,1,0.958639668053858,0,2,MIT domain binding,MF,
17620,GO:0090543,1,0.860775144046168,0,7,Flemming body,CC,
17621,GO:0090544,1,0.622164553995974,0,23,BAF-type complex,CC,
17622,GO:0090545,1,0.708070200131037,0,17,CHD-type complex,CC,
17623,GO:0090554,1,0.925269614053331,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17624,GO:0090555,1,0.961220399638594,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17625,GO:0090556,1,0.964794126877812,0,2,phosphatidylserine-translocating ATPase activity,MF,
17627,GO:0090558,1,0.978476629273923,0,1,plant epidermis development,BP,
17629,GO:0090560,1,0.978822902364384,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17630,GO:0090568,1,0.532245430315779,0,31,nuclear transcriptional repressor complex,CC,
17631,GO:0090571,1,0.918097345613026,0,4,RNA polymerase II transcription repressor complex,CC,
17633,GO:0090576,1,0.849736089377792,0,8,RNA polymerase III transcription factor complex,CC,
17635,GO:0090594,1,0.87972281637681,0,6,inflammatory response to wounding,BP,
17638,GO:0090599,1,0.885623847960981,0,6,alpha-glucosidase activity,MF,
17639,GO:0090600,1,0.979093878908121,0,1,alpha-1,3-glucosidase activity,MF,
17640,GO:0090611,1,0.899528498306393,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17641,GO:0090615,1,0.979332324557987,0,1,mitochondrial mRNA processing,BP,
17642,GO:0090616,1,0.979332324557987,0,1,mitochondrial mRNA 3'-end processing,BP,
17643,GO:0090619,1,0.978903623589795,0,1,meiotic spindle pole,CC,
17644,GO:0090624,1,0.97897493185122,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17645,GO:0090625,1,0.97897493185122,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17646,GO:0090627,1,0.978476629273923,0,1,plant epidermal cell differentiation,BP,
17648,GO:0090631,1,0.958779484153016,0,2,pre-miRNA transporter activity,MF,
17649,GO:0090634,1,0.978586640327867,0,1,microglial cell mediated cytotoxicity,BP,
17651,GO:0090648,1,0.980494910467042,0,1,response to environmental enrichment,BP,
17652,GO:0090649,1,0.906799022340024,0,5,response to oxygen-glucose deprivation,BP,
17653,GO:0090650,1,0.906799022340024,0,5,cellular response to oxygen-glucose deprivation,BP,
17654,GO:0090651,1,0.980881723678527,0,1,apical cytoplasm,CC,
17655,GO:0090656,1,0.729223009032794,0,15,t-circle formation,BP,
17656,GO:0090657,1,0.79334950167728,0,11,telomeric loop disassembly,BP,
17658,GO:0090661,1,0.917136164246567,0,4,box H/ACA telomerase RNP complex,CC,
17659,GO:0090662,1,0.212783773948168,0,74,ATP hydrolysis coupled transmembrane transport,BP,
17660,GO:0090665,1,0.650334197735236,0,21,glycoprotein complex,CC,
17661,GO:0090666,1,0.917914985715153,0,4,scaRNA localization to Cajal body,BP,
17662,GO:0090669,1,0.938041864622271,0,3,telomerase RNA stabilization,BP,
17663,GO:0090670,1,0.709367448020596,0,16,RNA localization to Cajal body,BP,
17664,GO:0090671,1,0.709367448020596,0,16,telomerase RNA localization to Cajal body,BP,
17665,GO:0090672,1,0.709367448020596,0,16,telomerase RNA localization,BP,
17666,GO:0090675,1,0.95867796541488,0,2,intermicrovillar adhesion,BP,
17667,GO:0090676,1,0.979053151914992,0,1,calcium ion transmembrane transport via low voltage-gated calcium channel,BP,
17670,GO:0090713,1,0.828300368717007,0,9,immunological memory process,BP,
17671,GO:0090715,1,0.828300368717007,0,9,immunological memory formation process,BP,
17672,GO:0090722,1,0.920437438466141,0,4,receptor-receptor interaction,MF,
17673,GO:0090723,1,0.71565359602926,0,16,growth cone part,CC,
17674,GO:0090724,1,0.899976943046383,0,5,central region of growth cone,CC,
17675,GO:0090725,1,0.958025372872464,0,2,peripheral region of growth cone,CC,
17676,GO:0090731,1,0.978516865961842,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17677,GO:0090732,1,0.97852925271556,0,1,cofilin-actin rod,CC,
17678,GO:0090734,1,0.544031307033922,0,29,site of DNA damage,CC,
17679,GO:0090735,1,0.808050622448838,0,10,DNA repair complex assembly,BP,
17680,GO:0090737,1,0.729223009032794,0,15,telomere maintenance via telomere trimming,BP,
17681,GO:0093001,1,0.97906846131447,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17682,GO:0095500,1,0.642359938159788,0,21,acetylcholine receptor signaling pathway,BP,
17683,GO:0097001,1,0.86194549285171,0,7,ceramide binding,MF,
17684,GO:0097003,1,0.958358022085193,0,2,adipokinetic hormone receptor activity,MF,
17687,GO:0097010,1,0.939086581668732,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17690,GO:0097013,1,0.93723806600043,0,3,phagocytic vesicle lumen,CC,
17691,GO:0097014,1,0.18353907272672,0,84,ciliary plasm,CC,
17692,GO:0097016,1,0.938865951952401,0,3,L27 domain binding,MF,
17695,GO:0097020,1,0.979069338014745,0,1,COPII adaptor activity,MF,
17697,GO:0097022,1,0.978828085621426,0,1,lymphocyte migration into lymph node,BP,
17698,GO:0097025,1,0.940013412245074,0,3,MPP7-DLG1-LIN7 complex,CC,
17699,GO:0097026,1,0.920164864462269,0,4,dendritic cell dendrite assembly,BP,
17700,GO:0097027,1,0.842733797891576,0,8,ubiquitin-protein transferase activator activity,MF,
17702,GO:0097029,1,0.917515315019238,0,4,mature conventional dendritic cell differentiation,BP,
17703,GO:0097031,1,0.304220575045312,0,55,mitochondrial respiratory chain complex I biogenesis,BP,
17704,GO:0097032,1,0.95749122913801,0,2,mitochondrial respiratory chain complex II biogenesis,BP,
17705,GO:0097033,1,0.898328772976297,0,5,mitochondrial respiratory chain complex III biogenesis,BP,
17706,GO:0097034,1,0.741372556132595,0,14,mitochondrial respiratory chain complex IV biogenesis,BP,
17707,GO:0097035,1,0.470408938237123,0,37,regulation of membrane lipid distribution,BP,
17708,GO:0097037,1,0.979069362481193,0,1,heme export,BP,
17710,GO:0097039,1,0.921290922432062,0,4,protein linear polyubiquitination,BP,
17711,GO:0097045,1,0.979434965897342,0,1,phosphatidylserine exposure on blood platelet,BP,
17714,GO:0097050,1,0.798223532188644,0,11,type B pancreatic cell apoptotic process,BP,
17715,GO:0097051,1,0.941133624209368,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17716,GO:0097052,1,0.937705218081733,0,3,L-kynurenine metabolic process,BP,
17717,GO:0097053,1,0.978578941609564,0,1,L-kynurenine catabolic process,BP,
17718,GO:0097055,1,0.978840064421984,0,1,agmatine biosynthetic process,BP,
17719,GO:0097056,1,0.918781861304731,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17720,GO:0097057,1,0.957817595924291,0,2,TRAF2-GSTP1 complex,CC,
17726,GO:0097065,1,0.958114953080563,0,2,anterior head development,BP,
17727,GO:0097066,1,0.603379558297844,0,24,response to thyroid hormone,BP,
17728,GO:0097067,1,0.731295312270306,0,15,cellular response to thyroid hormone stimulus,BP,
17729,GO:0097068,1,0.899670551614529,0,5,response to thyroxine,BP,
17730,GO:0097069,1,0.95857741030419,0,2,cellular response to thyroxine stimulus,BP,
17733,GO:0097086,1,0.979072992026655,0,1,amniotic stem cell differentiation,BP,
17735,GO:0097090,1,0.817751870104334,0,10,presynaptic membrane organization,BP,
17738,GO:0097100,1,0.898637380522839,0,5,supercoiled DNA binding,MF,
17742,GO:0097105,1,0.851433542310517,0,8,presynaptic membrane assembly,BP,
17744,GO:0097107,1,0.907505642210707,0,5,postsynaptic density assembly,BP,
17745,GO:0097108,1,0.941060986212166,0,3,hedgehog family protein binding,MF,
17746,GO:0097109,1,0.904504964486409,0,5,neuroligin family protein binding,MF,
17748,GO:0097111,1,0.961986254525073,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17749,GO:0097112,1,0.958681806981659,0,2,gamma-aminobutyric acid receptor clustering,BP,
17750,GO:0097113,1,0.901373365239468,0,5,AMPA glutamate receptor clustering,BP,
17751,GO:0097114,1,0.925675948803451,0,4,NMDA glutamate receptor clustering,BP,
17752,GO:0097115,1,0.97951749973897,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17753,GO:0097116,1,0.943823584344468,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17754,GO:0097117,1,0.98118501709157,0,1,guanylate kinase-associated protein clustering,BP,
17757,GO:0097120,1,0.749983588521811,0,14,receptor localization to synapse,BP,
17758,GO:0097123,1,0.958026572862211,0,2,cyclin A1-CDK2 complex,CC,
17759,GO:0097124,1,0.958335030023053,0,2,cyclin A2-CDK2 complex,CC,
17760,GO:0097125,1,0.957905955091097,0,2,cyclin B1-CDK1 complex,CC,
17761,GO:0097129,1,0.959686000938209,0,2,cyclin D2-CDK4 complex,CC,
17762,GO:0097134,1,0.958012804213394,0,2,cyclin E1-CDK2 complex,CC,
17763,GO:0097135,1,0.958321346551663,0,2,cyclin E2-CDK2 complex,CC,
17764,GO:0097136,1,0.899395908627759,0,5,Bcl-2 family protein complex,CC,
17765,GO:0097144,1,0.978478550887233,0,1,BAX complex,CC,
17766,GO:0097149,1,0.938536563745418,0,3,centralspindlin complex,CC,
17768,GO:0097151,1,0.867719405767879,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17771,GO:0097154,1,0.727911024242632,0,15,GABAergic neuron differentiation,BP,
17772,GO:0097155,1,0.944696592261551,0,3,fasciculation of sensory neuron axon,BP,
17773,GO:0097156,1,0.960165094354437,0,2,fasciculation of motor neuron axon,BP,
17774,GO:0097157,1,0.864311996409214,0,7,pre-mRNA intronic binding,MF,
17775,GO:0097158,1,0.978623733368141,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17777,GO:0097160,1,0.978465551700127,0,1,polychlorinated biphenyl binding,MF,
17778,GO:0097161,1,0.980582820291316,0,1,DH domain binding,MF,
17779,GO:0097162,1,0.979069122397277,0,1,MADS box domain binding,MF,
17781,GO:0097165,1,0.899543668054347,0,5,nuclear stress granule,CC,
17782,GO:0097166,1,0.961434799798501,0,2,lens epithelial cell proliferation,BP,
17783,GO:0097167,1,0.919944134830957,0,4,circadian regulation of translation,BP,
17784,GO:0097168,1,0.958578988808043,0,2,mesenchymal stem cell proliferation,BP,
17786,GO:0097176,1,0.978907066130447,0,1,epoxide metabolic process,BP,
17787,GO:0097177,1,0.957623094812057,0,2,mitochondrial ribosome binding,MF,
17795,GO:0097187,1,0.938021973330911,0,3,dentinogenesis,BP,
17801,GO:0097195,1,0.938263663361036,0,3,pilomotor reflex,BP,
17802,GO:0097196,1,0.958154353001204,0,2,Shu complex,CC,
17804,GO:0097198,1,0.961554704641947,0,2,histone H3-K36 trimethylation,BP,
17805,GO:0097199,1,0.959584107511851,0,2,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17807,GO:0097201,1,0.75954230689785,0,13,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17810,GO:0097208,1,0.881354619383056,0,6,alveolar lamellar body,CC,
17811,GO:0097209,1,0.921061043481514,0,4,epidermal lamellar body,CC,
17812,GO:0097210,1,0.900780130988987,0,5,response to gonadotropin-releasing hormone,BP,
17813,GO:0097211,1,0.900780130988987,0,5,cellular response to gonadotropin-releasing hormone,BP,
17814,GO:0097212,1,0.957673580670111,0,2,lysosomal membrane organization,BP,
17815,GO:0097213,1,0.9784684469879,0,1,regulation of lysosomal membrane permeability,BP,
17816,GO:0097214,1,0.9784684469879,0,1,positive regulation of lysosomal membrane permeability,BP,
17817,GO:0097222,1,0.979332324557987,0,1,mitochondrial mRNA polyadenylation,BP,
17819,GO:0097224,1,0.978659005690316,0,1,sperm connecting piece,CC,
17820,GO:0097225,1,0.726136995665991,0,15,sperm midpiece,CC,
17821,GO:0097226,1,0.978875403017503,0,1,sperm mitochondrial sheath,CC,
17822,GO:0097227,1,0.881109988991197,0,6,sperm annulus,CC,
17823,GO:0097228,1,0.655913314927337,0,20,sperm principal piece,CC,
17824,GO:0097229,1,0.978543453992033,0,1,sperm end piece,CC,
17825,GO:0097231,1,0.97864806207989,0,1,cell motility in response to calcium ion,BP,
17826,GO:0097232,1,0.960273021078715,0,2,lamellar body membrane,CC,
17827,GO:0097233,1,0.960273021078715,0,2,alveolar lamellar body membrane,CC,
17828,GO:0097237,1,0.847027074391759,0,8,cellular response to toxic substance,BP,
17829,GO:0097238,1,0.978558918485875,0,1,cellular response to methylglyoxal,BP,
17830,GO:0097240,1,0.899561054899537,0,5,chromosome attachment to the nuclear envelope,BP,
17832,GO:0097242,1,0.871329038453529,0,7,beta-amyloid clearance,BP,
17834,GO:0097254,1,0.978805429268348,0,1,renal tubular secretion,BP,
17835,GO:0097255,1,0.898097333363408,0,5,R2TP complex,CC,
17836,GO:0097258,1,0.958407420394983,0,2,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17837,GO:0097259,1,0.958407420394983,0,2,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17838,GO:0097260,1,0.979010378828671,0,1,eoxin A4 synthase activity,MF,
17839,GO:0097264,1,0.843720117022263,0,8,self proteolysis,BP,
17840,GO:0097267,1,0.826111663337679,0,9,omega-hydroxylase P450 pathway,BP,
17841,GO:0097272,1,0.959184289467386,0,2,ammonia homeostasis,BP,
17842,GO:0097273,1,0.980134531240677,0,1,creatinine homeostasis,BP,
17843,GO:0097274,1,0.959618645161934,0,2,urea homeostasis,BP,
17844,GO:0097275,1,0.980134531240677,0,1,cellular ammonia homeostasis,BP,
17845,GO:0097276,1,0.980134531240677,0,1,cellular creatinine homeostasis,BP,
17846,GO:0097277,1,0.980134531240677,0,1,cellular urea homeostasis,BP,
17848,GO:0097283,1,0.879986471003538,0,6,keratinocyte apoptotic process,BP,
17851,GO:0097291,1,0.978759484391737,0,1,renal phosphate ion absorption,BP,
17853,GO:0097298,1,0.979097272827943,0,1,regulation of nucleus size,BP,
17857,GO:0097319,1,0.978889655064775,0,1,carbohydrate import into cell,BP,
17858,GO:0097320,1,0.69961258020729,0,17,plasma membrane tubulation,BP,
17859,GO:0097322,1,0.86295603177935,0,7,7SK snRNA binding,MF,
17860,GO:0097324,1,0.962685269556847,0,2,melanocyte migration,BP,
17862,GO:0097326,1,0.979695539311739,0,1,melanocyte adhesion,BP,
17863,GO:0097327,1,0.898783431016236,0,5,response to antineoplastic agent,BP,
17864,GO:0097332,1,0.958012687904521,0,2,response to antipsychotic drug,BP,
17869,GO:0097343,1,0.921544625665942,0,4,ripoptosome assembly,BP,
17870,GO:0097344,1,0.979064064032629,0,1,Rix1 complex,CC,
17872,GO:0097346,1,0.646345920940941,0,21,INO80-type complex,CC,
17873,GO:0097350,1,0.918703324943449,0,4,neutrophil clearance,BP,
17874,GO:0097352,1,0.488951288902199,0,34,autophagosome maturation,BP,
17875,GO:0097354,1,0.813308446893811,0,10,prenylation,BP,
17876,GO:0097356,1,0.981447711364207,0,1,perinucleolar compartment,CC,
17877,GO:0097359,1,0.963690810921366,0,2,UDP-glucosylation,BP,
17878,GO:0097360,1,0.923126400808139,0,4,chorionic trophoblast cell proliferation,BP,
17879,GO:0097361,1,0.91809994328824,0,4,CIA complex,CC,
17880,GO:0097362,1,0.958458395341654,0,2,MCM8-MCM9 complex,CC,
17881,GO:0097363,1,0.979915451378249,0,1,protein O-GlcNAc transferase activity,MF,
17883,GO:0097368,1,0.920368647447121,0,4,establishment of Sertoli cell barrier,BP,
17884,GO:0097369,1,0.747030743688615,0,14,sodium ion import,BP,
17885,GO:0097371,1,0.884851325640321,0,6,MDM2/MDM4 family protein binding,MF,
17886,GO:0097372,1,0.978648757804161,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17887,GO:0097374,1,0.957942284488181,0,2,sensory neuron axon guidance,BP,
17888,GO:0097376,1,0.978562788314866,0,1,interneuron axon guidance,BP,
17890,GO:0097382,1,0.980330905715007,0,1,deoxynucleoside-diphosphatase activity,MF,
17891,GO:0097383,1,0.980330905715007,0,1,dIDP diphosphatase activity,MF,
17892,GO:0097384,1,0.882496442766637,0,6,cellular lipid biosynthetic process,BP,
17894,GO:0097393,1,0.983993427542176,0,1,telomeric repeat-containing RNA transcription,BP,
17895,GO:0097394,1,0.983993427542176,0,1,telomeric repeat-containing RNA transcription from RNA pol II promoter,BP,
17896,GO:0097396,1,0.979075551884441,0,1,response to interleukin-17,BP,
17897,GO:0097398,1,0.979075551884441,0,1,cellular response to interleukin-17,BP,
17898,GO:0097400,1,0.979075551884441,0,1,interleukin-17-mediated signaling pathway,BP,
17899,GO:0097401,1,0.979058019567663,0,1,synaptic vesicle lumen acidification,BP,
17900,GO:0097402,1,0.978961762897448,0,1,neuroblast migration,BP,
17901,GO:0097403,1,0.979060861464536,0,1,cellular response to raffinose,BP,
17902,GO:0097409,1,0.9787408034073,0,1,glial cytoplasmic inclusion,CC,
17903,GO:0097411,1,0.901548077219221,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17904,GO:0097413,1,0.879941272418494,0,6,Lewy body,CC,
17905,GO:0097414,1,0.9787408034073,0,1,classical Lewy body,CC,
17906,GO:0097418,1,0.900575342148267,0,5,neurofibrillary tangle,CC,
17908,GO:0097422,1,0.899492876711206,0,5,tubular endosome,CC,
17910,GO:0097427,1,0.958706481496998,0,2,microtubule bundle,CC,
17911,GO:0097428,1,0.859098441024914,0,7,protein maturation by iron-sulfur cluster transfer,BP,
17912,GO:0097431,1,0.769361095262135,0,13,mitotic spindle pole,CC,
17913,GO:0097433,1,0.880062242534374,0,6,dense body,CC,
17915,GO:0097440,1,0.781760304065754,0,12,apical dendrite,CC,
17916,GO:0097441,1,0.939386965615007,0,3,basilar dendrite,CC,
17917,GO:0097442,1,0.979999668316469,0,1,CA3 pyramidal cell dendrite,CC,
17918,GO:0097443,1,0.88321945427737,0,6,sorting endosome,CC,
17919,GO:0097444,1,0.97966221653319,0,1,spine apparatus,CC,
17920,GO:0097447,1,0.958010655594447,0,2,dendritic tree,CC,
17922,GO:0097450,1,0.938036710290391,0,3,astrocyte end-foot,CC,
17923,GO:0097451,1,0.958680946914983,0,2,glial limiting end-foot,CC,
17924,GO:0097452,1,0.920054647439453,0,4,GAIT complex,CC,
17925,GO:0097453,1,0.978923208303036,0,1,mesaxon,CC,
17926,GO:0097454,1,0.942022304584385,0,3,Schwann cell microvillus,CC,
17927,GO:0097457,1,0.979069898024736,0,1,hippocampal mossy fiber,CC,
17931,GO:0097461,1,0.92072587941118,0,4,ferric iron import into cell,BP,
17932,GO:0097462,1,0.9787408034073,0,1,Lewy neurite,CC,
17933,GO:0097466,1,0.92139791505583,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17934,GO:0097468,1,0.77673886093109,0,12,programmed cell death in response to reactive oxygen species,BP,
17935,GO:0097470,1,0.904187850085104,0,5,ribbon synapse,CC,
17936,GO:0097472,1,0.555662845497864,0,28,cyclin-dependent protein kinase activity,MF,
17937,GO:0097473,1,0.979757786914629,0,1,retinal rod cell apoptotic process,BP,
17938,GO:0097475,1,0.868335536336775,0,7,motor neuron migration,BP,
17939,GO:0097476,1,0.923296058002841,0,4,spinal cord motor neuron migration,BP,
17940,GO:0097477,1,0.94326087514063,0,3,lateral motor column neuron migration,BP,
17943,GO:0097484,1,0.572324472442673,0,27,dendrite extension,BP,
17945,GO:0097486,1,0.859598929233445,0,7,multivesicular body lumen,CC,
17946,GO:0097487,1,0.941351757231706,0,3,multivesicular body, internal vesicle,CC,
17947,GO:0097489,1,0.978975555428151,0,1,multivesicular body, internal vesicle lumen,CC,
17948,GO:0097490,1,0.920396018177121,0,4,sympathetic neuron projection extension,BP,
17949,GO:0097491,1,0.920396018177121,0,4,sympathetic neuron projection guidance,BP,
17950,GO:0097493,1,0.72672392958963,0,17,structural molecule activity conferring elasticity,MF,
17951,GO:0097494,1,0.961240001200203,0,2,regulation of vesicle size,BP,
17952,GO:0097497,1,0.979067305686981,0,1,blood vessel endothelial cell delamination,BP,
17953,GO:0097498,1,0.959355929280595,0,2,endothelial tube lumen extension,BP,
17954,GO:0097499,1,0.828016350028511,0,9,protein localization to non-motile cilium,BP,
17955,GO:0097500,1,0.900179000090775,0,5,receptor localization to non-motile cilium,BP,
17956,GO:0097501,1,0.920963822403127,0,4,stress response to metal ion,BP,
17958,GO:0097503,1,0.647497490865833,0,21,sialylation,BP,
17959,GO:0097504,1,0.809226122083557,0,10,Gemini of coiled bodies,CC,
17960,GO:0097505,1,0.980114568324444,0,1,Rad6-Rad18 complex,CC,
17961,GO:0097506,1,0.898016259638453,0,5,deaminated base DNA N-glycosylase activity,MF,
17962,GO:0097510,1,0.978779179182881,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17963,GO:0097512,1,0.861667351942572,0,7,cardiac myofibril,CC,
17964,GO:0097513,1,0.944998562676131,0,3,myosin II filament,CC,
17965,GO:0097517,1,0.363485100494561,0,49,contractile actin filament bundle,CC,
17966,GO:0097524,1,0.882687342518198,0,6,sperm plasma membrane,CC,
17967,GO:0097525,1,0.299683429523141,0,57,spliceosomal snRNP complex,CC,
17968,GO:0097526,1,0.599392814127747,0,24,spliceosomal tri-snRNP complex,CC,
17973,GO:0097534,1,0.97901331157068,0,1,lymphoid lineage cell migration,BP,
17974,GO:0097535,1,0.97901331157068,0,1,lymphoid lineage cell migration into thymus,BP,
17975,GO:0097536,1,0.958262358525396,0,2,thymus epithelium morphogenesis,BP,
17976,GO:0097539,1,0.834524075241576,0,9,ciliary transition fiber,CC,
17977,GO:0097541,1,0.97897493185122,0,1,axonemal basal plate,CC,
17978,GO:0097542,1,0.402130568874889,0,44,ciliary tip,CC,
17979,GO:0097543,1,0.959312913290304,0,2,ciliary inversin compartment,CC,
17981,GO:0097550,1,0.880500261079529,0,6,transcriptional preinitiation complex,CC,
17983,GO:0097573,1,0.978549586521007,0,1,glutathione oxidoreductase activity,MF,
17984,GO:0097576,1,0.46905490750155,0,36,vacuole fusion,BP,
17985,GO:0097577,1,0.897221323377827,0,5,sequestering of iron ion,BP,
17987,GO:0097598,1,0.959251385113703,0,2,sperm cytoplasmic droplet,CC,
17988,GO:0097602,1,0.746329350461886,0,14,cullin family protein binding,MF,
17989,GO:0097603,1,0.938827740360107,0,3,temperature-gated ion channel activity,MF,
17990,GO:0097604,1,0.958828562281147,0,2,temperature-gated cation channel activity,MF,
17992,GO:0097617,1,0.759996375814223,0,13,annealing activity,MF,
17994,GO:0097625,1,0.981485146893144,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17995,GO:0097626,1,0.981485146893144,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17996,GO:0097627,1,0.981485146893144,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17997,GO:0097629,1,0.939060872361496,0,3,extrinsic component of omegasome membrane,CC,
17998,GO:0097630,1,0.97897493185122,0,1,intrinsic component of omegasome membrane,CC,
17999,GO:0097631,1,0.97897493185122,0,1,integral component of omegasome membrane,CC,
18000,GO:0097632,1,0.959138109457881,0,2,extrinsic component of pre-autophagosomal structure membrane,CC,
18001,GO:0097635,1,0.959516958283876,0,2,extrinsic component of autophagosome membrane,CC,
18002,GO:0097636,1,0.958616057849502,0,2,intrinsic component of autophagosome membrane,CC,
18003,GO:0097637,1,0.958616057849502,0,2,integral component of autophagosome membrane,CC,
18004,GO:0097638,1,0.981485146893144,0,1,L-arginine import across plasma membrane,BP,
18005,GO:0097639,1,0.981485146893144,0,1,L-lysine import across plasma membrane,BP,
18006,GO:0097640,1,0.981485146893144,0,1,L-ornithine import across plasma membrane,BP,
18007,GO:0097642,1,0.91873620777828,0,4,calcitonin family receptor activity,MF,
18008,GO:0097644,1,0.979071537988483,0,1,calcitonin family binding,MF,
18009,GO:0097648,1,0.941543042822927,0,3,G-protein coupled receptor complex,CC,
18012,GO:0097676,1,0.946340081305862,0,3,histone H3-K36 dimethylation,BP,
18013,GO:0097677,1,0.937776246884363,0,3,STAT family protein binding,MF,
18014,GO:0097680,1,0.938911359964806,0,3,double-strand break repair via classical nonhomologous end joining,BP,
18015,GO:0097681,1,0.968164270205873,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
18016,GO:0097688,1,0.901373365239468,0,5,glutamate receptor clustering,BP,
18017,GO:0097689,1,0.979069335039327,0,1,iron channel activity,MF,
18018,GO:0097692,1,0.980501740343927,0,1,histone H3-K4 monomethylation,BP,
18019,GO:0097694,1,0.946018349175451,0,3,establishment of RNA localization to telomere,BP,
18020,GO:0097695,1,0.946018349175451,0,3,establishment of macromolecular complex localization to telomere,BP,
18022,GO:0097699,1,0.979263790598097,0,1,vascular endothelial cell response to fluid shear stress,BP,
18024,GO:0097709,1,0.88040985197088,0,6,connective tissue replacement,BP,
18026,GO:0097718,1,0.531522854344845,0,31,disordered domain specific binding,MF,
18029,GO:0097724,1,0.978689626907284,0,1,sperm flagellum movement,BP,
18030,GO:0097726,1,0.978508624393034,0,1,LEM domain binding,MF,
18031,GO:0097729,1,0.221679594624598,0,71,9+2 motile cilium,CC,
18034,GO:0097732,1,0.826149915263421,0,9,9+2 non-motile cilium,CC,
18037,GO:0097742,1,0.919672029071258,0,4,de novo centriole assembly,BP,
18039,GO:0097747,1,0.409265002524909,0,42,RNA polymerase activity,MF,
18042,GO:0098501,1,0.898073364534665,0,5,polynucleotide dephosphorylation,BP,
18043,GO:0098502,1,0.93712575474235,0,3,DNA dephosphorylation,BP,
18044,GO:0098503,1,0.978651906489294,0,1,DNA 3' dephosphorylation,BP,
18045,GO:0098504,1,0.978651906489294,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
18046,GO:0098505,1,0.843607914031013,0,8,G-rich strand telomeric DNA binding,MF,
18047,GO:0098506,1,0.978651906489294,0,1,polynucleotide 3' dephosphorylation,BP,
18048,GO:0098507,1,0.958334696474245,0,2,polynucleotide 5' dephosphorylation,BP,
18049,GO:0098518,1,0.937873731469565,0,3,polynucleotide phosphatase activity,MF,
18050,GO:0098519,1,0.89999988999892,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
18051,GO:0098528,1,0.900577170898418,0,5,skeletal muscle fiber differentiation,BP,
18052,GO:0098530,1,0.980137602358416,0,1,positive regulation of strand invasion,BP,
18054,GO:0098532,1,0.865856210297687,0,7,histone H3-K27 trimethylation,BP,
18056,GO:0098534,1,0.545026865068468,0,29,centriole assembly,BP,
18057,GO:0098535,1,0.919672029071258,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
18058,GO:0098536,1,0.91901779704967,0,4,deuterosome,CC,
18060,GO:0098543,1,0.760362073068867,0,13,detection of other organism,BP,
18061,GO:0098547,1,0.978861317919528,0,1,lumenal side of Golgi membrane,CC,
18063,GO:0098553,1,0.547290399765646,0,28,lumenal side of endoplasmic reticulum membrane,CC,
18064,GO:0098554,1,0.825646567112297,0,9,cytoplasmic side of endoplasmic reticulum membrane,CC,
18065,GO:0098556,1,0.9786466750349,0,1,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
18066,GO:0098559,1,0.95840013460975,0,2,cytoplasmic side of early endosome membrane,CC,
18070,GO:0098574,1,0.95821039321281,0,2,cytoplasmic side of lysosomal membrane,CC,
18071,GO:0098575,1,0.958079968468282,0,2,lumenal side of lysosomal membrane,CC,
18072,GO:0098576,1,0.918192387682744,0,4,lumenal side of membrane,CC,
18073,GO:0098581,1,0.683442792334834,0,18,detection of external biotic stimulus,BP,
18074,GO:0098582,1,0.959753615925797,0,2,innate vocalization behavior,BP,
18075,GO:0098583,1,0.957617234357243,0,2,learned vocalization behavior,BP,
18076,GO:0098586,1,0.433487265609382,0,40,cellular response to virus,BP,
18080,GO:0098592,1,0.938507264743338,0,3,cytoplasmic side of apical plasma membrane,CC,
18081,GO:0098594,1,0.978474535121621,0,1,mucin granule,CC,
18082,GO:0098595,1,0.978860101482976,0,1,perivitelline space,CC,
18087,GO:0098601,1,0.9790693410655,0,1,selenomethionine adenosyltransferase activity,MF,
18090,GO:0098619,1,0.97871759753029,0,1,selenocysteine-tRNA ligase activity,MF,
18091,GO:0098621,1,0.980041705811129,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
18092,GO:0098625,1,0.979081926044166,0,1,methylselenol reductase activity,MF,
18093,GO:0098626,1,0.979081926044166,0,1,methylseleninic acid reductase activity,MF,
18096,GO:0098633,1,0.978966340526484,0,1,collagen fibril binding,MF,
18097,GO:0098634,1,0.865625573894686,0,7,protein binding involved in cell-matrix adhesion,MF,
18099,GO:0098637,1,0.979097893275581,0,1,protein complex involved in cell-matrix adhesion,CC,
18100,GO:0098639,1,0.903488164026833,0,5,collagen binding involved in cell-matrix adhesion,MF,
18101,GO:0098640,1,0.958104221124091,0,2,integrin binding involved in cell-matrix adhesion,MF,
18103,GO:0098642,1,0.874246551167247,0,7,network-forming collagen trimer,CC,
18104,GO:0098643,1,0.787095043494191,0,12,banded collagen fibril,CC,
18105,GO:0098644,1,0.676148428146708,0,20,complex of collagen trimers,CC,
18106,GO:0098645,1,0.874246551167247,0,7,collagen network,CC,
18107,GO:0098646,1,0.978994653205006,0,1,collagen sheet,CC,
18108,GO:0098647,1,0.941310821697456,0,3,collagen beaded filament,CC,
18109,GO:0098648,1,0.982713299996025,0,1,collagen anchoring fibril,CC,
18110,GO:0098651,1,0.856568245823723,0,8,basement membrane collagen trimer,CC,
18111,GO:0098652,1,0.982713299996025,0,1,collagen type VII anchoring fibril,CC,
18119,GO:0098664,1,0.571370084206062,0,26,G-protein coupled serotonin receptor signaling pathway,BP,
18120,GO:0098665,1,0.957992296447262,0,2,serotonin receptor complex,CC,
18122,GO:0098679,1,0.965290590510417,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18123,GO:0098680,1,0.979110885702327,0,1,template-free RNA nucleotidyltransferase,MF,
18124,GO:0098687,1,0.000931456473429406,0,331,chromosomal region,CC,
18125,GO:0098700,1,0.861377041087971,0,7,neurotransmitter loading into synaptic vesicle,BP,
18126,GO:0098703,1,0.866091566524677,0,7,calcium ion import across plasma membrane,BP,
18127,GO:0098704,1,0.978889655064775,0,1,carbohydrate import across plasma membrane,BP,
18128,GO:0098706,1,0.979069331885983,0,1,ferric iron import across plasma membrane,BP,
18129,GO:0098711,1,0.979069331885983,0,1,iron ion import across plasma membrane,BP,
18130,GO:0098719,1,0.762024253553157,0,13,sodium ion import across plasma membrane,BP,
18131,GO:0098722,1,0.827232598429023,0,9,asymmetric stem cell division,BP,
18133,GO:0098728,1,0.917690585099026,0,4,germline stem cell asymmetric division,BP,
18136,GO:0098735,1,0.909990925952258,0,5,positive regulation of the force of heart contraction,BP,
18137,GO:0098736,1,0.982396170646631,0,1,negative regulation of the force of heart contraction,BP,
18138,GO:0098739,1,0.534989621922528,0,30,import across plasma membrane,BP,
18141,GO:0098745,1,0.978657217974508,0,1,Dcp1-Dcp2 complex,CC,
18142,GO:0098746,1,0.979452311309029,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18143,GO:0098748,1,0.794658598380249,0,11,endocytic adaptor activity,MF,
18144,GO:0098749,1,0.979343351289233,0,1,cerebellar neuron development,BP,
18147,GO:0098756,1,0.979069056272352,0,1,response to interleukin-21,BP,
18148,GO:0098757,1,0.979069056272352,0,1,cellular response to interleukin-21,BP,
18149,GO:0098758,1,0.938351795108583,0,3,response to interleukin-8,BP,
18150,GO:0098759,1,0.938351795108583,0,3,cellular response to interleukin-8,BP,
18151,GO:0098760,1,0.937607690425049,0,3,response to interleukin-7,BP,
18152,GO:0098761,1,0.937607690425049,0,3,cellular response to interleukin-7,BP,
18153,GO:0098770,1,0.963736500627104,0,2,FBXO family protein binding,MF,
18157,GO:0098779,1,0.831497582725998,0,9,positive regulation of macromitophagy in response to mitochondrial depolarization,BP,
18158,GO:0098780,1,0.688143053771459,0,18,response to mitochondrial depolarisation,BP,
18160,GO:0098782,1,0.978682589154527,0,1,mechanically-gated potassium channel activity,MF,
18161,GO:0098787,1,0.775153908753643,0,12,mRNA cleavage involved in mRNA processing,BP,
18162,GO:0098789,1,0.826054163452738,0,9,pre-mRNA cleavage required for polyadenylation,BP,
18164,GO:0098792,1,0.844062832513407,0,8,xenophagy,BP,
18167,GO:0098795,1,0.958484708903163,0,2,mRNA cleavage involved in gene silencing,BP,
18171,GO:0098799,1,0.772639874288561,0,12,outer mitochondrial membrane protein complex,CC,
18172,GO:0098800,1,0.0939594108287504,0,109,inner mitochondrial membrane protein complex,CC,
18175,GO:0098803,1,0.218898318807232,0,70,respiratory chain complex,CC,
18177,GO:0098808,1,0.958161319820854,0,2,mRNA cap binding,MF,
18178,GO:0098809,1,0.978987637002078,0,1,nitrite reductase activity,MF,
18182,GO:0098814,1,0.943543998581771,0,3,spontaneous synaptic transmission,BP,
18184,GO:0098821,1,0.90504545741366,0,5,BMP receptor activity,MF,
18185,GO:0098822,1,0.978939498239432,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18187,GO:0098828,1,0.867719405767879,0,7,modulation of inhibitory postsynaptic potential,BP,
18188,GO:0098829,1,0.980680277550159,0,1,intestinal folate absorption,BP,
18189,GO:0098830,1,0.979459574969247,0,1,presynaptic endosome,CC,
18190,GO:0098831,1,0.975671938601356,0,2,presynaptic active zone cytoplasmic component,CC,
18191,GO:0098833,1,0.979537418067763,0,1,presynaptic endocytic zone,CC,
18192,GO:0098835,1,0.979537418067763,0,1,presynaptic endocytic zone membrane,CC,
18193,GO:0098837,1,0.958207586587224,0,2,postsynaptic recycling endosome,CC,
18194,GO:0098838,1,0.979041174690571,0,1,reduced folate transmembrane transport,BP,
18195,GO:0098839,1,0.871272236973391,0,7,postsynaptic density membrane,CC,
18196,GO:0098840,1,0.385037037455912,0,46,protein transport along microtubule,BP,
18197,GO:0098843,1,0.981545599693415,0,1,postsynaptic endocytic zone,CC,
18198,GO:0098844,1,0.981545599693415,0,1,postsynaptic endocytic zone membrane,CC,
18199,GO:0098845,1,0.918506316355296,0,4,postsynaptic endosome,CC,
18200,GO:0098847,1,0.792090168777823,0,11,sequence-specific single stranded DNA binding,MF,
18201,GO:0098850,1,0.978736121469041,0,1,extrinsic component of synaptic vesicle membrane,CC,
18203,GO:0098855,1,0.941317341379764,0,3,HCN channel complex,CC,
18204,GO:0098856,1,0.741591986821691,0,14,intestinal lipid absorption,BP,
18210,GO:0098870,1,0.865890604084259,0,7,action potential propagation,BP,
18211,GO:0098871,1,0.978640507524207,0,1,postsynaptic actin cytoskeleton,CC,
18212,GO:0098875,1,0.979408651956856,0,1,epididymosome,CC,
18213,GO:0098876,1,0.244064042039418,0,68,vesicle-mediated transport to the plasma membrane,BP,
18214,GO:0098877,1,0.792220242379223,0,11,neurotransmitter receptor transport to plasma membrane,BP,
18216,GO:0098881,1,0.918647776819416,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18217,GO:0098883,1,0.978679574538984,0,1,synapse disassembly,BP,
18218,GO:0098884,1,0.981545599693415,0,1,postsynaptic neurotransmitter receptor internalization,BP,
18219,GO:0098885,1,0.963120163406989,0,2,modification of postsynaptic actin cytoskeleton,BP,
18220,GO:0098886,1,0.959063610417413,0,2,modification of dendritic spine,BP,
18221,GO:0098887,1,0.899903933842545,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18222,GO:0098888,1,0.981260530398882,0,1,extrinsic component of presynaptic membrane,CC,
18223,GO:0098890,1,0.981260530398882,0,1,extrinsic component of postsynaptic membrane,CC,
18224,GO:0098895,1,0.979159941864044,0,1,postsynaptic endosome membrane,CC,
18227,GO:0098902,1,0.885180526496794,0,6,regulation of membrane depolarization during action potential,BP,
18228,GO:0098903,1,0.847539561909688,0,8,regulation of membrane repolarization during action potential,BP,
18229,GO:0098904,1,0.946263684393228,0,3,regulation of AV node cell action potential,BP,
18230,GO:0098905,1,0.95799645183526,0,2,regulation of bundle of His cell action potential,BP,
18231,GO:0098906,1,0.979067462538613,0,1,regulation of Purkinje myocyte action potential,BP,
18232,GO:0098907,1,0.969400825841695,0,2,regulation of SA node cell action potential,BP,
18233,GO:0098908,1,0.898796287622725,0,5,regulation of neuronal action potential,BP,
18234,GO:0098909,1,0.852559953255566,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18235,GO:0098910,1,0.893660496722259,0,6,regulation of atrial cardiac muscle cell action potential,BP,
18237,GO:0098912,1,0.947794118787294,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18238,GO:0098914,1,0.883248833073033,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18241,GO:0098917,1,0.922317855160211,0,4,retrograde trans-synaptic signaling,BP,
18242,GO:0098918,1,0.978681833834384,0,1,structural constituent of synapse,MF,
18243,GO:0098920,1,0.980130692247812,0,1,retrograde trans-synaptic signaling by lipid,BP,
18244,GO:0098921,1,0.980130692247812,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
18245,GO:0098923,1,0.981175378575318,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18246,GO:0098924,1,0.981175378575318,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18248,GO:0098928,1,0.975671938601356,0,2,presynaptic signal transduction,BP,
18249,GO:0098930,1,0.455903890128201,0,38,axonal transport,BP,
18250,GO:0098935,1,0.940125768658999,0,3,dendritic transport,BP,
18251,GO:0098936,1,0.889679112571141,0,6,intrinsic component of postsynaptic membrane,CC,
18252,GO:0098937,1,0.940125768658999,0,3,anterograde dendritic transport,BP,
18253,GO:0098939,1,0.980717212250347,0,1,dendritic transport of mitochondrion,BP,
18254,GO:0098942,1,0.97951749973897,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18255,GO:0098943,1,0.958493162763402,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18256,GO:0098948,1,0.947242669397752,0,3,intrinsic component of postsynaptic specialization membrane,CC,
18257,GO:0098953,1,0.978595094694415,0,1,receptor diffusion trapping,BP,
18258,GO:0098957,1,0.979488183888889,0,1,anterograde axonal transport of mitochondrion,BP,
18259,GO:0098960,1,0.656736225698239,0,20,postsynaptic neurotransmitter receptor activity,MF,
18260,GO:0098967,1,0.918647776819416,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18261,GO:0098968,1,0.979715409260696,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18262,GO:0098969,1,0.809166402312923,0,10,neurotransmitter receptor transport to postsynaptic membrane,BP,
18263,GO:0098970,1,0.978595094694415,0,1,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18264,GO:0098971,1,0.958612602167039,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18265,GO:0098972,1,0.980717212250347,0,1,anterograde dendritic transport of mitochondrion,BP,
18266,GO:0098973,1,0.978681833834384,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18267,GO:0098974,1,0.978681833834384,0,1,postsynaptic actin cytoskeleton organization,BP,
18268,GO:0098976,1,0.978936651145214,0,1,excitatory chemical synaptic transmission,BP,
18269,GO:0098982,1,0.979062603763866,0,1,GABA-ergic synapse,CC,
18271,GO:0098988,1,0.904310254739583,0,5,G-protein coupled glutamate receptor activity,MF,
18272,GO:0098989,1,0.960213774167117,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18273,GO:0098992,1,0.978945473861581,0,1,neuronal dense core vesicle,CC,
18274,GO:0098993,1,0.937609955936958,0,3,anchored component of synaptic vesicle membrane,CC,
18275,GO:0098999,1,0.979159941864044,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18277,GO:0099004,1,0.943329955422761,0,3,calmodulin dependent kinase signaling pathway,BP,
18278,GO:0099010,1,0.923689542337694,0,4,modification of postsynaptic structure,BP,
18279,GO:0099011,1,0.924883545664206,0,4,neuronal dense core vesicle exocytosis,BP,
18282,GO:0099038,1,0.979502282993324,0,1,ceramide-translocating ATPase activity,MF,
18283,GO:0099039,1,0.979502282993324,0,1,sphingolipid translocation,BP,
18284,GO:0099040,1,0.979502282993324,0,1,ceramide translocation,BP,
18285,GO:0099046,1,0.978568429576654,0,1,clearance of foreign intracellular nucleic acids,BP,
18286,GO:0099053,1,0.939047437864915,0,3,activating signal cointegrator 1 complex,CC,
18288,GO:0099055,1,0.889679112571141,0,6,integral component of postsynaptic membrane,CC,
18289,GO:0099060,1,0.947242669397752,0,3,integral component of postsynaptic specialization membrane,CC,
18290,GO:0099061,1,0.947242669397752,0,3,integral component of postsynaptic density membrane,CC,
18292,GO:0099072,1,0.882384804167711,0,6,regulation of postsynaptic specialization membrane neurotransmitter receptor levels,BP,
18293,GO:0099073,1,0.958806067095809,0,2,mitochondrion-derived vesicle,CC,
18294,GO:0099074,1,0.958511766775537,0,2,mitochondrion to lysosome transport,BP,
18295,GO:0099075,1,0.958511766775537,0,2,mitochondrion-derived vesicle mediated transport,BP,
18296,GO:0099078,1,0.917378124476875,0,4,BORC complex,CC,
18299,GO:0099082,1,0.979130747882954,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
18301,GO:0099086,1,0.510352731987791,0,32,synaptonemal structure,CC,
18303,GO:0099095,1,0.776871224178071,0,12,ligand-gated anion channel activity,MF,
18305,GO:0099111,1,0.0825225226423501,0,121,microtubule-based transport,BP,
18306,GO:0099118,1,0.385037037455912,0,46,microtubule-based protein transport,BP,
18307,GO:0099122,1,0.958843570994622,0,2,RNA polymerase II C-terminal domain binding,MF,
18308,GO:0099131,1,0.242029259921329,0,68,ATP hydrolysis coupled ion transmembrane transport,BP,
18309,GO:0099132,1,0.310300148195995,0,56,ATP hydrolysis coupled cation transmembrane transport,BP,
18310,GO:0099133,1,0.76454374354331,0,13,ATP hydrolysis coupled anion transmembrane transport,BP,
18311,GO:0099142,1,0.980425004267237,0,1,intracellular ATP-gated ion channel activity,MF,
18312,GO:0099400,1,0.982703479687859,0,1,caveola neck,CC,
18313,GO:0099402,1,0.978476629273923,0,1,plant organ development,BP,
18314,GO:0099403,1,0.967214898792141,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18315,GO:0099404,1,0.967214898792141,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18316,GO:0099500,1,0.72665417134004,0,15,vesicle fusion to plasma membrane,BP,
18320,GO:0099509,1,0.978967633275564,0,1,regulation of presynaptic cytosolic calcium ion concentration,BP,
18323,GO:0099514,1,0.697050345241952,0,17,synaptic vesicle cytoskeletal transport,BP,
18324,GO:0099515,1,0.891293287322051,0,6,actin filament-based transport,BP,
18325,GO:0099516,1,0.290121680636294,0,59,ion antiporter activity,MF,
18326,GO:0099517,1,0.697050345241952,0,17,synaptic vesicle transport along microtubule,BP,
18327,GO:0099518,1,0.438974587895004,0,40,vesicle cytoskeletal trafficking,BP,
18328,GO:0099525,1,0.924883545664206,0,4,presynaptic dense core vesicle exocytosis,BP,
18329,GO:0099526,1,0.975671938601356,0,2,presynapse to nucleus signaling pathway,BP,
18330,GO:0099528,1,0.898988107853558,0,5,G-protein coupled neurotransmitter receptor activity,MF,
18331,GO:0099529,1,0.668977209638712,0,19,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18332,GO:0099530,1,0.981721818951905,0,1,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18334,GO:0099532,1,0.961649718578961,0,2,synaptic vesicle endosomal processing,BP,
18337,GO:0099538,1,0.979130747882954,0,1,synaptic signaling via neuropeptide,BP,
18338,GO:0099540,1,0.979130747882954,0,1,trans-synaptic signaling by neuropeptide,BP,
18339,GO:0099541,1,0.940592863766944,0,3,trans-synaptic signaling by lipid,BP,
18340,GO:0099542,1,0.940592863766944,0,3,trans-synaptic signaling by endocannabinoid,BP,
18341,GO:0099543,1,0.981175378575318,0,1,trans-synaptic signaling by soluble gas,BP,
18342,GO:0099545,1,0.959427138744915,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18343,GO:0099548,1,0.981175378575318,0,1,trans-synaptic signaling by nitric oxide,BP,
18344,GO:0099550,1,0.939978599487548,0,3,trans-synaptic signalling, modulating synaptic transmission,BP,
18345,GO:0099552,1,0.959662819240807,0,2,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18346,GO:0099553,1,0.959662819240807,0,2,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18347,GO:0099557,1,0.979490678420023,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18348,GO:0099558,1,0.957621575139758,0,2,maintenance of synapse structure,BP,
18349,GO:0099563,1,0.885197627392023,0,6,modification of synaptic structure,BP,
18351,GO:0099566,1,0.962195114531415,0,2,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18353,GO:0099569,1,0.975671938601356,0,2,presynaptic cytoskeleton,CC,
18354,GO:0099571,1,0.978640507524207,0,1,postsynaptic cytoskeleton,CC,
18356,GO:0099580,1,0.960482626647614,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18357,GO:0099583,1,0.962195114531415,0,2,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18359,GO:0099589,1,0.535510800883077,0,29,serotonin receptor activity,MF,
18360,GO:0099590,1,0.921460063646974,0,4,neurotransmitter receptor internalization,BP,
18362,GO:0099601,1,0.493824548494318,0,34,regulation of neurotransmitter receptor activity,BP,
18363,GO:0099602,1,0.879405899323825,0,6,neurotransmitter receptor regulator activity,MF,
18364,GO:0099604,1,0.711430036857159,0,18,ligand-gated calcium channel activity,MF,
18365,GO:0099607,1,0.982270613259847,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18366,GO:0099609,1,0.960762971493226,0,2,microtubule lateral binding,MF,
18367,GO:0099612,1,0.872742229499215,0,7,protein localization to axon,BP,
18368,GO:0099617,1,0.979069339343476,0,1,matrix side of mitochondrial inner membrane,CC,
18371,GO:0099624,1,0.833198706436502,0,9,atrial cardiac muscle cell membrane repolarization,BP,
18373,GO:0099628,1,0.978595094694415,0,1,neurotransmitter receptor diffusion trapping,BP,
18374,GO:0099634,1,0.834365209781745,0,9,postsynaptic specialization membrane,CC,
18375,GO:0099637,1,0.745077457911286,0,14,neurotransmitter receptor transport,BP,
18376,GO:0099638,1,0.862616754884011,0,7,endosome to plasma membrane protein transport,BP,
18377,GO:0099639,1,0.881062880603922,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18378,GO:0099640,1,0.978484538280191,0,1,axo-dendritic protein transport,BP,
18379,GO:0099641,1,0.978484538280191,0,1,anterograde axonal protein transport,BP,
18381,GO:0099738,1,0.73221820918608,0,16,cell cortex region,CC,
18382,GO:0100001,1,0.979838413645165,0,1,regulation of skeletal muscle contraction by action potential,BP,
18384,GO:0100012,1,0.937588103520492,0,3,regulation of heart induction by canonical Wnt signaling pathway,BP,
18385,GO:0100057,1,0.981525096876413,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18388,GO:0101005,1,0.101178086072746,0,111,ubiquitinyl hydrolase activity,MF,
18389,GO:0101020,1,0.898561472962146,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18390,GO:0101023,1,0.978622147444102,0,1,vascular endothelial cell proliferation,BP,
18391,GO:0101030,1,0.978545059482444,0,1,tRNA-guanine transglycosylation,BP,
18392,GO:0101031,1,0.77351939413739,0,12,chaperone complex,CC,
18393,GO:0102005,1,0.978585047353106,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18395,GO:0102008,1,0.979578769049646,0,1,cytosolic dipeptidase activity,MF,
18397,GO:0102076,1,0.979044015025739,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18398,GO:0102077,1,0.958014877492613,0,2,oleamide hydrolase activity,MF,
18399,GO:0102084,1,0.958373550293268,0,2,L-dopa O-methyltransferase activity,MF,
18401,GO:0102279,1,0.979495996559671,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18402,GO:0102320,1,0.979030251935431,0,1,1,8-cineole 2-exo-monooxygenase activity,MF,
18406,GO:0102339,1,0.978969239579433,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18407,GO:0102340,1,0.978969239579433,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18408,GO:0102341,1,0.978969239579433,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18409,GO:0102342,1,0.978969239579433,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18410,GO:0102390,1,0.978998933460537,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18412,GO:0102483,1,0.978637302720666,0,1,scopolin beta-glucosidase activity,MF,
18413,GO:0102490,1,0.943865958558025,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18414,GO:0102522,1,0.97884622891961,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18415,GO:0102549,1,0.978580094441819,0,1,1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity,MF,
18416,GO:0102571,1,0.979659781208998,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18417,GO:0102704,1,0.979050326243143,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18418,GO:0102867,1,0.979022036188469,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18419,GO:0102991,1,0.860082573076379,0,7,myristoyl-CoA hydrolase activity,MF,
18420,GO:0103046,1,0.979578769049646,0,1,alanylglutamate dipeptidase activity,MF,
18421,GO:0103053,1,0.957922507248007,0,2,1-ethyladenine demethylase activity,MF,
18422,GO:0103073,1,0.958014877492613,0,2,anandamide amidohydrolase activity,MF,
18423,GO:0103095,1,0.957822008712442,0,2,wax ester synthase activity,MF,
18424,GO:0106001,1,0.919247753998365,0,4,intestinal hexose absorption,BP,
18427,GO:1900003,1,0.758595006258639,0,13,regulation of serine-type endopeptidase activity,BP,
18428,GO:1900004,1,0.792013682323513,0,11,negative regulation of serine-type endopeptidase activity,BP,
18429,GO:1900005,1,0.941302857456563,0,3,positive regulation of serine-type endopeptidase activity,BP,
18431,GO:1900010,1,0.978693275402233,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18432,GO:1900011,1,0.978693275402233,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18433,GO:1900015,1,0.600616024794285,0,24,regulation of cytokine production involved in inflammatory response,BP,
18434,GO:1900016,1,0.826511942264893,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18435,GO:1900017,1,0.807481718716964,0,10,positive regulation of cytokine production involved in inflammatory response,BP,
18438,GO:1900024,1,0.414781843564538,0,42,regulation of substrate adhesion-dependent cell spreading,BP,
18439,GO:1900025,1,0.792880467239315,0,11,negative regulation of substrate adhesion-dependent cell spreading,BP,
18440,GO:1900026,1,0.534445694643368,0,30,positive regulation of substrate adhesion-dependent cell spreading,BP,
18442,GO:1900028,1,0.898830623221319,0,5,negative regulation of ruffle assembly,BP,
18444,GO:1900034,1,0.216245034314578,0,74,regulation of cellular response to heat,BP,
18445,GO:1900035,1,0.979017667638585,0,1,negative regulation of cellular response to heat,BP,
18446,GO:1900036,1,0.978895512330051,0,1,positive regulation of cellular response to heat,BP,
18447,GO:1900037,1,0.808206688875034,0,10,regulation of cellular response to hypoxia,BP,
18448,GO:1900038,1,0.899383526433673,0,5,negative regulation of cellular response to hypoxia,BP,
18449,GO:1900039,1,0.958034366693648,0,2,positive regulation of cellular response to hypoxia,BP,
18450,GO:1900040,1,0.866517260310372,0,7,regulation of interleukin-2 secretion,BP,
18451,GO:1900041,1,0.918794504707332,0,4,negative regulation of interleukin-2 secretion,BP,
18452,GO:1900042,1,0.943115112988492,0,3,positive regulation of interleukin-2 secretion,BP,
18453,GO:1900044,1,0.869176888198474,0,7,regulation of protein K63-linked ubiquitination,BP,
18454,GO:1900045,1,0.923752266031135,0,4,negative regulation of protein K63-linked ubiquitination,BP,
18457,GO:1900048,1,0.60070902061798,0,24,positive regulation of hemostasis,BP,
18458,GO:1900052,1,0.978524484651327,0,1,regulation of retinoic acid biosynthetic process,BP,
18459,GO:1900053,1,0.978524484651327,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18460,GO:1900060,1,0.918415620435431,0,4,negative regulation of ceramide biosynthetic process,BP,
18461,GO:1900062,1,0.979075637054212,0,1,regulation of replicative cell aging,BP,
18462,GO:1900063,1,0.943548127133302,0,3,regulation of peroxisome organization,BP,
18463,GO:1900073,1,0.978603784982831,0,1,regulation of neuromuscular synaptic transmission,BP,
18464,GO:1900075,1,0.978603784982831,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18466,GO:1900077,1,0.512571152279745,0,32,negative regulation of cellular response to insulin stimulus,BP,
18468,GO:1900081,1,0.982396170646631,0,1,regulation of arginine catabolic process,BP,
18469,GO:1900082,1,0.982396170646631,0,1,negative regulation of arginine catabolic process,BP,
18470,GO:1900084,1,0.883228187465177,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18471,GO:1900085,1,0.979006725358829,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18472,GO:1900086,1,0.902173011678374,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18473,GO:1900087,1,0.569542073505176,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18474,GO:1900094,1,0.864198933247389,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18475,GO:1900095,1,0.983618492057181,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18476,GO:1900098,1,0.978680891239982,0,1,regulation of plasma cell differentiation,BP,
18477,GO:1900100,1,0.978680891239982,0,1,positive regulation of plasma cell differentiation,BP,
18479,GO:1900102,1,0.844280421393764,0,8,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18483,GO:1900107,1,0.864549196055119,0,7,regulation of nodal signaling pathway,BP,
18484,GO:1900108,1,0.937569327122025,0,3,negative regulation of nodal signaling pathway,BP,
18485,GO:1900109,1,0.917484221793282,0,4,regulation of histone H3-K9 dimethylation,BP,
18486,GO:1900110,1,0.957625963590627,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18487,GO:1900111,1,0.95808686248003,0,2,positive regulation of histone H3-K9 dimethylation,BP,
18488,GO:1900112,1,0.796599705224793,0,11,regulation of histone H3-K9 trimethylation,BP,
18489,GO:1900113,1,0.880215957621024,0,6,negative regulation of histone H3-K9 trimethylation,BP,
18490,GO:1900114,1,0.939471738615711,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18491,GO:1900115,1,0.749462757911705,0,14,extracellular regulation of signal transduction,BP,
18492,GO:1900116,1,0.749462757911705,0,14,extracellular negative regulation of signal transduction,BP,
18493,GO:1900117,1,0.615580577517199,0,23,regulation of execution phase of apoptosis,BP,
18494,GO:1900118,1,0.84419275043216,0,8,negative regulation of execution phase of apoptosis,BP,
18495,GO:1900119,1,0.775666976381734,0,12,positive regulation of execution phase of apoptosis,BP,
18496,GO:1900120,1,0.641554518963285,0,21,regulation of receptor binding,BP,
18497,GO:1900121,1,0.776194659871101,0,12,negative regulation of receptor binding,BP,
18498,GO:1900122,1,0.844418473246291,0,8,positive regulation of receptor binding,BP,
18500,GO:1900126,1,0.941322593666694,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18502,GO:1900130,1,0.979071495839486,0,1,regulation of lipid binding,BP,
18503,GO:1900131,1,0.979071495839486,0,1,negative regulation of lipid binding,BP,
18504,GO:1900133,1,0.918816444899461,0,4,regulation of renin secretion into blood stream,BP,
18505,GO:1900134,1,0.979082291523524,0,1,negative regulation of renin secretion into blood stream,BP,
18506,GO:1900135,1,0.958516505755239,0,2,positive regulation of renin secretion into blood stream,BP,
18507,GO:1900138,1,0.938246290709293,0,3,negative regulation of phospholipase A2 activity,BP,
18508,GO:1900139,1,0.979596830552551,0,1,negative regulation of arachidonic acid secretion,BP,
18511,GO:1900145,1,0.90213814448694,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18512,GO:1900146,1,0.957630196530656,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18513,GO:1900147,1,0.960597264710646,0,2,regulation of Schwann cell migration,BP,
18514,GO:1900148,1,0.97897493185122,0,1,negative regulation of Schwann cell migration,BP,
18515,GO:1900149,1,0.981228720568987,0,1,positive regulation of Schwann cell migration,BP,
18516,GO:1900151,1,0.722577091880031,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18517,GO:1900152,1,0.978686382069844,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18518,GO:1900153,1,0.722577091880031,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18519,GO:1900154,1,0.958225424850323,0,2,regulation of bone trabecula formation,BP,
18520,GO:1900155,1,0.958225424850323,0,2,negative regulation of bone trabecula formation,BP,
18521,GO:1900157,1,0.937858637202297,0,3,regulation of bone mineralization involved in bone maturation,BP,
18522,GO:1900158,1,0.958067231425673,0,2,negative regulation of bone mineralization involved in bone maturation,BP,
18523,GO:1900159,1,0.978909349397237,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18524,GO:1900161,1,0.979032978974685,0,1,regulation of phospholipid scramblase activity,BP,
18525,GO:1900163,1,0.979032978974685,0,1,positive regulation of phospholipid scramblase activity,BP,
18526,GO:1900164,1,0.864198933247389,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18528,GO:1900166,1,0.958460014095821,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18529,GO:1900168,1,0.958460014095821,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18530,GO:1900169,1,0.964678134364496,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18531,GO:1900170,1,0.97897493185122,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18532,GO:1900175,1,0.90213814448694,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18533,GO:1900176,1,0.957630196530656,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18538,GO:1900190,1,0.958326531028665,0,2,regulation of single-species biofilm formation,BP,
18539,GO:1900191,1,0.958326531028665,0,2,negative regulation of single-species biofilm formation,BP,
18542,GO:1900195,1,0.958040164151913,0,2,positive regulation of oocyte maturation,BP,
18543,GO:1900200,1,0.938559207888959,0,3,mesenchymal cell apoptotic process involved in metanephros development,BP,
18544,GO:1900204,1,0.958660096857259,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18545,GO:1900205,1,0.958660096857259,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18546,GO:1900208,1,0.978533535421311,0,1,regulation of cardiolipin metabolic process,BP,
18547,GO:1900210,1,0.978533535421311,0,1,positive regulation of cardiolipin metabolic process,BP,
18548,GO:1900211,1,0.938559207888959,0,3,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18549,GO:1900212,1,0.938559207888959,0,3,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18550,GO:1900214,1,0.958660096857259,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18551,GO:1900215,1,0.958660096857259,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18552,GO:1900217,1,0.958660096857259,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18553,GO:1900218,1,0.958660096857259,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18554,GO:1900220,1,0.960938742728362,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18555,GO:1900221,1,0.883339627143689,0,6,regulation of beta-amyloid clearance,BP,
18556,GO:1900222,1,0.939969180374381,0,3,negative regulation of beta-amyloid clearance,BP,
18557,GO:1900223,1,0.980958031202852,0,1,positive regulation of beta-amyloid clearance,BP,
18558,GO:1900224,1,0.962659737724007,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18559,GO:1900225,1,0.811239715481022,0,10,regulation of NLRP3 inflammasome complex assembly,BP,
18560,GO:1900226,1,0.919439687086988,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18561,GO:1900227,1,0.901262625037469,0,5,positive regulation of NLRP3 inflammasome complex assembly,BP,
18562,GO:1900228,1,0.958326531028665,0,2,regulation of single-species biofilm formation in or on host organism,BP,
18563,GO:1900229,1,0.958326531028665,0,2,negative regulation of single-species biofilm formation in or on host organism,BP,
18564,GO:1900234,1,0.979082570228003,0,1,regulation of Kit signaling pathway,BP,
18565,GO:1900235,1,0.979082570228003,0,1,negative regulation of Kit signaling pathway,BP,
18569,GO:1900242,1,0.847471289412708,0,8,regulation of synaptic vesicle endocytosis,BP,
18570,GO:1900243,1,0.979741187992227,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18571,GO:1900244,1,0.938908232715368,0,3,positive regulation of synaptic vesicle endocytosis,BP,
18572,GO:1900245,1,0.922851599846218,0,4,positive regulation of MDA-5 signaling pathway,BP,
18573,GO:1900246,1,0.867773584724918,0,7,positive regulation of RIG-I signaling pathway,BP,
18574,GO:1900247,1,0.960580495967173,0,2,regulation of cytoplasmic translational elongation,BP,
18575,GO:1900248,1,0.960580495967173,0,2,negative regulation of cytoplasmic translational elongation,BP,
18576,GO:1900259,1,0.978714811114327,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18577,GO:1900260,1,0.978714811114327,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18578,GO:1900262,1,0.879243445411242,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18579,GO:1900264,1,0.879243445411242,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18580,GO:1900271,1,0.675617506999144,0,20,regulation of long-term synaptic potentiation,BP,
18581,GO:1900272,1,0.922248015337592,0,4,negative regulation of long-term synaptic potentiation,BP,
18582,GO:1900273,1,0.810138783823371,0,11,positive regulation of long-term synaptic potentiation,BP,
18584,GO:1900275,1,0.959518332021495,0,2,negative regulation of phospholipase C activity,BP,
18585,GO:1900276,1,0.979069369180422,0,1,regulation of proteinase activated receptor activity,BP,
18586,GO:1900279,1,0.979069541176219,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18587,GO:1900281,1,0.979069541176219,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18588,GO:1900363,1,0.809628834772541,0,10,regulation of mRNA polyadenylation,BP,
18589,GO:1900364,1,0.862328304515537,0,7,negative regulation of mRNA polyadenylation,BP,
18590,GO:1900365,1,0.959433602746594,0,2,positive regulation of mRNA polyadenylation,BP,
18591,GO:1900368,1,0.940879416853943,0,3,regulation of RNA interference,BP,
18592,GO:1900369,1,0.960234984657812,0,2,negative regulation of RNA interference,BP,
18593,GO:1900370,1,0.979845091838559,0,1,positive regulation of RNA interference,BP,
18599,GO:1900378,1,0.921740341385557,0,4,positive regulation of secondary metabolite biosynthetic process,BP,
18600,GO:1900383,1,0.979069034095098,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18601,GO:1900387,1,0.978797717913849,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18602,GO:1900390,1,0.957684554525506,0,2,regulation of iron ion import,BP,
18603,GO:1900402,1,0.833781930350605,0,9,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18607,GO:1900424,1,0.744122709989224,0,14,regulation of defense response to bacterium,BP,
18608,GO:1900425,1,0.920441420372149,0,4,negative regulation of defense response to bacterium,BP,
18609,GO:1900426,1,0.825054315558137,0,9,positive regulation of defense response to bacterium,BP,
18610,GO:1900449,1,0.496058537723297,0,34,regulation of glutamate receptor signaling pathway,BP,
18611,GO:1900451,1,0.890613859875698,0,6,positive regulation of glutamate receptor signaling pathway,BP,
18614,GO:1900454,1,0.962707619714834,0,2,positive regulation of long term synaptic depression,BP,
18615,GO:1900477,1,0.978790214558818,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18616,GO:1900483,1,0.978985577650819,0,1,regulation of protein targeting to vacuolar membrane,BP,
18617,GO:1900533,1,0.978590547835434,0,1,palmitic acid metabolic process,BP,
18618,GO:1900535,1,0.978590547835434,0,1,palmitic acid biosynthetic process,BP,
18622,GO:1900619,1,0.919268737594455,0,4,acetate ester metabolic process,BP,
18623,GO:1900620,1,0.959094253404072,0,2,acetate ester biosynthetic process,BP,
18624,GO:1900623,1,0.939669875378335,0,3,regulation of monocyte aggregation,BP,
18625,GO:1900625,1,0.939669875378335,0,3,positive regulation of monocyte aggregation,BP,
18626,GO:1900673,1,0.938331338883844,0,3,olefin metabolic process,BP,
18627,GO:1900719,1,0.979576774463753,0,1,regulation of uterine smooth muscle relaxation,BP,
18628,GO:1900721,1,0.979576774463753,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18630,GO:1900737,1,0.979069369180422,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18637,GO:1900747,1,0.919269220221205,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18638,GO:1900748,1,0.941301705261527,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18640,GO:1900756,1,0.960872886882366,0,2,protein processing in phagocytic vesicle,BP,
18641,GO:1900757,1,0.978491145677098,0,1,regulation of D-amino-acid oxidase activity,BP,
18642,GO:1900758,1,0.978491145677098,0,1,negative regulation of D-amino-acid oxidase activity,BP,
18643,GO:1900825,1,0.902545451401121,0,5,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18644,GO:1900826,1,0.978551592690055,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18645,GO:1900827,1,0.983176257208993,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18647,GO:1900920,1,0.960879088673025,0,2,regulation of L-glutamate import,BP,
18648,GO:1901004,1,0.978532628076482,0,1,ubiquinone-6 metabolic process,BP,
18649,GO:1901006,1,0.978532628076482,0,1,ubiquinone-6 biosynthetic process,BP,
18656,GO:1901026,1,0.921544625665942,0,4,ripoptosome assembly involved in necroptotic process,BP,
18658,GO:1901029,1,0.860984394868389,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18661,GO:1901032,1,0.715510330763989,0,16,negative regulation of response to reactive oxygen species,BP,
18663,GO:1901042,1,0.978980782054902,0,1,positive regulation of L-arginine import,BP,
18667,GO:1901069,1,0.95760735692214,0,2,guanosine-containing compound catabolic process,BP,
18668,GO:1901070,1,0.755398526946756,0,13,guanosine-containing compound biosynthetic process,BP,
18669,GO:1901071,1,0.668851359117353,0,19,glucosamine-containing compound metabolic process,BP,
18670,GO:1901072,1,0.918052308279046,0,4,glucosamine-containing compound catabolic process,BP,
18671,GO:1901073,1,0.959282653582911,0,2,glucosamine-containing compound biosynthetic process,BP,
18672,GO:1901074,1,0.960367025479951,0,2,regulation of engulfment of apoptotic cell,BP,
18673,GO:1901076,1,0.980958031202852,0,1,positive regulation of engulfment of apoptotic cell,BP,
18677,GO:1901080,1,0.979576774463753,0,1,regulation of relaxation of smooth muscle,BP,
18678,GO:1901082,1,0.979576774463753,0,1,positive regulation of relaxation of smooth muscle,BP,
18679,GO:1901086,1,0.979621893999958,0,1,benzylpenicillin metabolic process,BP,
18680,GO:1901090,1,0.958240373645941,0,2,regulation of protein tetramerization,BP,
18681,GO:1901091,1,0.958240373645941,0,2,negative regulation of protein tetramerization,BP,
18682,GO:1901093,1,0.958240373645941,0,2,regulation of protein homotetramerization,BP,
18683,GO:1901094,1,0.958240373645941,0,2,negative regulation of protein homotetramerization,BP,
18684,GO:1901096,1,0.833403649932038,0,9,regulation of autophagosome maturation,BP,
18685,GO:1901097,1,0.958285541438419,0,2,negative regulation of autophagosome maturation,BP,
18686,GO:1901098,1,0.888282254716379,0,6,positive regulation of autophagosome maturation,BP,
18688,GO:1901128,1,0.978863544526371,0,1,gentamycin metabolic process,BP,
18692,GO:1901142,1,0.881226844652007,0,6,insulin metabolic process,BP,
18693,GO:1901143,1,0.959202030923065,0,2,insulin catabolic process,BP,
18695,GO:1901146,1,0.979034695035522,0,1,mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
18696,GO:1901147,1,0.958660096857259,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18697,GO:1901159,1,0.898093325838692,0,5,xylulose 5-phosphate biosynthetic process,BP,
18698,GO:1901160,1,0.771092695917112,0,13,primary amino compound metabolic process,BP,
18699,GO:1901162,1,0.917851303390374,0,4,primary amino compound biosynthetic process,BP,
18700,GO:1901163,1,0.844762723586829,0,8,regulation of trophoblast cell migration,BP,
18701,GO:1901164,1,0.900983026006956,0,5,negative regulation of trophoblast cell migration,BP,
18702,GO:1901165,1,0.937618313382509,0,3,positive regulation of trophoblast cell migration,BP,
18703,GO:1901166,1,0.919667416367428,0,4,neural crest cell migration involved in autonomic nervous system development,BP,
18707,GO:1901187,1,0.959902212257656,0,2,regulation of ephrin receptor signaling pathway,BP,
18708,GO:1901189,1,0.978904198792155,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18709,GO:1901193,1,0.978509509232932,0,1,regulation of formation of translation preinitiation complex,BP,
18710,GO:1901194,1,0.978509509232932,0,1,negative regulation of formation of translation preinitiation complex,BP,
18712,GO:1901202,1,0.978901702146056,0,1,negative regulation of extracellular matrix assembly,BP,
18713,GO:1901203,1,0.834124833806662,0,9,positive regulation of extracellular matrix assembly,BP,
18714,GO:1901204,1,0.96390204539563,0,2,regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18715,GO:1901205,1,0.96390204539563,0,2,negative regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18716,GO:1901206,1,0.981175378575318,0,1,positive regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18717,GO:1901207,1,0.95861066816257,0,2,regulation of heart looping,BP,
18718,GO:1901208,1,0.979069339138296,0,1,negative regulation of heart looping,BP,
18719,GO:1901210,1,0.979069339138296,0,1,regulation of cardiac chamber formation,BP,
18720,GO:1901211,1,0.979069339138296,0,1,negative regulation of cardiac chamber formation,BP,
18724,GO:1901216,1,0.246433375112373,0,67,positive regulation of neuron death,BP,
18725,GO:1901219,1,0.979069339138296,0,1,regulation of cardiac chamber morphogenesis,BP,
18726,GO:1901220,1,0.979069339138296,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18727,GO:1901222,1,0.33439728954913,0,52,regulation of NIK/NF-kappaB signaling,BP,
18728,GO:1901223,1,0.809769352667499,0,10,negative regulation of NIK/NF-kappaB signaling,BP,
18729,GO:1901224,1,0.439409309657461,0,39,positive regulation of NIK/NF-kappaB signaling,BP,
18730,GO:1901228,1,0.920697878406429,0,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18731,GO:1901229,1,0.978984390211124,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18732,GO:1901231,1,0.978984390211124,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18733,GO:1901232,1,0.978984390211124,0,1,regulation of convergent extension involved in axis elongation,BP,
18734,GO:1901233,1,0.978984390211124,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18735,GO:1901246,1,0.957981015613534,0,2,regulation of lung ciliated cell differentiation,BP,
18736,GO:1901247,1,0.978534083677148,0,1,negative regulation of lung ciliated cell differentiation,BP,
18737,GO:1901248,1,0.978997291477967,0,1,positive regulation of lung ciliated cell differentiation,BP,
18738,GO:1901249,1,0.978534083677148,0,1,regulation of lung goblet cell differentiation,BP,
18739,GO:1901251,1,0.978534083677148,0,1,positive regulation of lung goblet cell differentiation,BP,
18740,GO:1901252,1,0.93789114987435,0,3,regulation of intracellular transport of viral material,BP,
18741,GO:1901253,1,0.957790738516505,0,2,negative regulation of intracellular transport of viral material,BP,
18742,GO:1901254,1,0.979225863789439,0,1,positive regulation of intracellular transport of viral material,BP,
18743,GO:1901255,1,0.959903690272847,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18744,GO:1901256,1,0.918597391363523,0,4,regulation of macrophage colony-stimulating factor production,BP,
18745,GO:1901257,1,0.978890047116645,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18746,GO:1901258,1,0.958473400161402,0,2,positive regulation of macrophage colony-stimulating factor production,BP,
18749,GO:1901269,1,0.978471214322306,0,1,lipooligosaccharide metabolic process,BP,
18750,GO:1901271,1,0.978471214322306,0,1,lipooligosaccharide biosynthetic process,BP,
18751,GO:1901291,1,0.978722996983945,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18754,GO:1901295,1,0.958032345657546,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18755,GO:1901296,1,0.978679574538984,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18756,GO:1901297,1,0.978904198792155,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18757,GO:1901298,1,0.81097466854721,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18758,GO:1901299,1,0.881336980294115,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18759,GO:1901300,1,0.920190475307239,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18760,GO:1901301,1,0.958786530756105,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18761,GO:1901303,1,0.979017090875596,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18762,GO:1901304,1,0.978641526874056,0,1,regulation of spermidine biosynthetic process,BP,
18763,GO:1901307,1,0.978641526874056,0,1,positive regulation of spermidine biosynthetic process,BP,
18764,GO:1901314,1,0.94350307621666,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18765,GO:1901315,1,0.94350307621666,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18768,GO:1901320,1,0.979053151914992,0,1,negative regulation of heart induction,BP,
18769,GO:1901321,1,0.957650196418089,0,2,positive regulation of heart induction,BP,
18770,GO:1901337,1,0.979003744219237,0,1,thioester transport,BP,
18772,GO:1901339,1,0.881147928288762,0,6,regulation of store-operated calcium channel activity,BP,
18773,GO:1901340,1,0.979140758303424,0,1,negative regulation of store-operated calcium channel activity,BP,
18774,GO:1901341,1,0.91917020117826,0,4,positive regulation of store-operated calcium channel activity,BP,
18777,GO:1901344,1,0.978534819191145,0,1,response to leptomycin B,BP,
18778,GO:1901350,1,0.981111906341021,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18779,GO:1901355,1,0.959996614288428,0,2,response to rapamycin,BP,
18784,GO:1901373,1,0.978563019187997,0,1,lipid hydroperoxide transport,BP,
18785,GO:1901374,1,0.861475554776838,0,7,acetate ester transport,BP,
18786,GO:1901375,1,0.937912092779444,0,3,acetate ester transmembrane transporter activity,MF,
18787,GO:1901376,1,0.97888453883524,0,1,organic heteropentacyclic compound metabolic process,BP,
18791,GO:1901382,1,0.923126400808139,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18792,GO:1901383,1,0.961469703543431,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18794,GO:1901386,1,0.772778370142943,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18795,GO:1901387,1,0.861377193658605,0,7,positive regulation of voltage-gated calcium channel activity,BP,
18796,GO:1901388,1,0.978970198177957,0,1,regulation of transforming growth factor beta activation,BP,
18797,GO:1901389,1,0.978970198177957,0,1,negative regulation of transforming growth factor beta activation,BP,
18798,GO:1901407,1,0.825596385817693,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18799,GO:1901409,1,0.842865099866391,0,8,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18800,GO:1901419,1,0.979217682648878,0,1,regulation of response to alcohol,BP,
18801,GO:1901421,1,0.979217682648878,0,1,positive regulation of response to alcohol,BP,
18802,GO:1901474,1,0.879986453678988,0,6,azole transmembrane transporter activity,MF,
18803,GO:1901475,1,0.918597486718416,0,4,pyruvate transmembrane transport,BP,
18805,GO:1901490,1,0.901889795850007,0,5,regulation of lymphangiogenesis,BP,
18806,GO:1901491,1,0.939753792667098,0,3,negative regulation of lymphangiogenesis,BP,
18807,GO:1901492,1,0.95971528429398,0,2,positive regulation of lymphangiogenesis,BP,
18808,GO:1901503,1,0.921343474610595,0,4,ether biosynthetic process,BP,
18810,GO:1901509,1,0.918809938759666,0,4,regulation of endothelial tube morphogenesis,BP,
18812,GO:1901523,1,0.898912124486911,0,5,icosanoid catabolic process,BP,
18813,GO:1901524,1,0.782624089565413,0,12,regulation of macromitophagy,BP,
18814,GO:1901525,1,0.941251010921668,0,3,negative regulation of macromitophagy,BP,
18815,GO:1901526,1,0.831497582725998,0,9,positive regulation of macromitophagy,BP,
18816,GO:1901529,1,0.940296542643622,0,3,positive regulation of anion channel activity,BP,
18819,GO:1901534,1,0.958610524086474,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18820,GO:1901535,1,0.937944834026357,0,3,regulation of DNA demethylation,BP,
18821,GO:1901536,1,0.937944834026357,0,3,negative regulation of DNA demethylation,BP,
18822,GO:1901538,1,0.866243379771742,0,7,changes to DNA methylation involved in embryo development,BP,
18823,GO:1901545,1,0.979060861464536,0,1,response to raffinose,BP,
18825,GO:1901551,1,0.979162169984871,0,1,negative regulation of endothelial cell development,BP,
18827,GO:1901555,1,0.981025195784456,0,1,response to paclitaxel,BP,
18828,GO:1901557,1,0.979107757569395,0,1,response to fenofibrate,BP,
18829,GO:1901558,1,0.959670543723539,0,2,response to metformin,BP,
18830,GO:1901561,1,0.979078642013519,0,1,response to benomyl,BP,
18831,GO:1901563,1,0.919427441140002,0,4,response to camptothecin,BP,
18835,GO:1901567,1,0.878469914252312,0,6,fatty acid derivative binding,MF,
18837,GO:1901569,1,0.898912124486911,0,5,fatty acid derivative catabolic process,BP,
18842,GO:1901580,1,0.983993427542176,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18843,GO:1901581,1,0.983993427542176,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18844,GO:1901582,1,0.983993427542176,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18845,GO:1901585,1,0.979038788003417,0,1,regulation of acid-sensing ion channel activity,BP,
18846,GO:1901594,1,0.97914272108427,0,1,response to capsazepine,BP,
18850,GO:1901608,1,0.97854365350071,0,1,regulation of vesicle transport along microtubule,BP,
18851,GO:1901609,1,0.97854365350071,0,1,negative regulation of vesicle transport along microtubule,BP,
18852,GO:1901611,1,0.861772608146245,0,7,phosphatidylglycerol binding,MF,
18853,GO:1901612,1,0.899288672236314,0,5,cardiolipin binding,MF,
18855,GO:1901616,1,0.268851803808231,0,62,organic hydroxy compound catabolic process,BP,
18860,GO:1901622,1,0.978981992351213,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18862,GO:1901624,1,0.91792542695835,0,4,negative regulation of lymphocyte chemotaxis,BP,
18863,GO:1901625,1,0.97897493185122,0,1,cellular response to ergosterol,BP,
18865,GO:1901627,1,0.978895900984278,0,1,negative regulation of postsynaptic membrane organization,BP,
18866,GO:1901628,1,0.920341470425273,0,4,positive regulation of postsynaptic membrane organization,BP,
18867,GO:1901629,1,0.960714172382133,0,2,regulation of presynaptic membrane organization,BP,
18868,GO:1901630,1,0.978516865961842,0,1,negative regulation of presynaptic membrane organization,BP,
18869,GO:1901631,1,0.981807520037875,0,1,positive regulation of presynaptic membrane organization,BP,
18870,GO:1901639,1,0.980330905715007,0,1,XDP catabolic process,BP,
18871,GO:1901640,1,0.980330905715007,0,1,XTP binding,MF,
18872,GO:1901641,1,0.980330905715007,0,1,ITP binding,MF,
18873,GO:1901642,1,0.861330114682819,0,7,nucleoside transmembrane transport,BP,
18878,GO:1901656,1,0.958520778545755,0,2,glycoside transport,BP,
18881,GO:1901659,1,0.34979824007408,0,49,glycosyl compound biosynthetic process,BP,
18882,GO:1901660,1,0.887160554919906,0,6,calcium ion export,BP,
18883,GO:1901661,1,0.523813676875546,0,30,quinone metabolic process,BP,
18884,GO:1901662,1,0.937814598615085,0,3,quinone catabolic process,BP,
18885,GO:1901663,1,0.755847562085556,0,13,quinone biosynthetic process,BP,
18886,GO:1901664,1,0.95783164304588,0,2,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18887,GO:1901666,1,0.95783164304588,0,2,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18890,GO:1901673,1,0.744679219674095,0,14,regulation of mitotic spindle assembly,BP,
18892,GO:1901675,1,0.980835993416474,0,1,negative regulation of histone H3-K27 acetylation,BP,
18894,GO:1901677,1,0.685695635219941,0,18,phosphate transmembrane transporter activity,MF,
18896,GO:1901679,1,0.861474033556356,0,7,nucleotide transmembrane transport,BP,
18897,GO:1901680,1,0.982973597968147,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
18899,GO:1901682,1,0.534226101799726,0,30,sulfur compound transmembrane transporter activity,MF,
18900,GO:1901684,1,0.978863544526371,0,1,arsenate ion transmembrane transport,BP,
18907,GO:1901702,1,0.807229500283578,0,10,salt transmembrane transporter activity,MF,
18908,GO:1901706,1,0.978983793607148,0,1,mesenchymal cell differentiation involved in bone development,BP,
18909,GO:1901707,1,0.978534819191145,0,1,leptomycin B binding,MF,
18913,GO:1901725,1,0.868156665055862,0,7,regulation of histone deacetylase activity,BP,
18914,GO:1901726,1,0.983828499224743,0,1,negative regulation of histone deacetylase activity,BP,
18915,GO:1901727,1,0.901233535391458,0,5,positive regulation of histone deacetylase activity,BP,
18916,GO:1901738,1,0.979069339138296,0,1,regulation of vitamin A metabolic process,BP,
18917,GO:1901739,1,0.650523608080883,0,20,regulation of myoblast fusion,BP,
18918,GO:1901740,1,0.957712880075966,0,2,negative regulation of myoblast fusion,BP,
18919,GO:1901741,1,0.679277938040413,0,18,positive regulation of myoblast fusion,BP,
18920,GO:1901748,1,0.97895542225611,0,1,leukotriene D4 metabolic process,BP,
18921,GO:1901750,1,0.97895542225611,0,1,leukotriene D4 biosynthetic process,BP,
18922,GO:1901751,1,0.978907066130447,0,1,leukotriene A4 metabolic process,BP,
18924,GO:1901797,1,0.56326764342881,0,27,negative regulation of signal transduction by p53 class mediator,BP,
18926,GO:1901799,1,0.520465635138763,0,31,negative regulation of proteasomal protein catabolic process,BP,
18928,GO:1901804,1,0.978921358707565,0,1,beta-glucoside metabolic process,BP,
18929,GO:1901805,1,0.978921358707565,0,1,beta-glucoside catabolic process,BP,
18930,GO:1901834,1,0.978657217974508,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18931,GO:1901835,1,0.978657217974508,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18932,GO:1901836,1,0.811206336743032,0,10,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18933,GO:1901837,1,0.958008571019184,0,2,negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18934,GO:1901838,1,0.846779596147723,0,8,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18936,GO:1901843,1,0.938576672827008,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
18937,GO:1901844,1,0.828264306139118,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18938,GO:1901846,1,0.979286762104831,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18939,GO:1901856,1,0.938293198476247,0,3,negative regulation of cellular respiration,BP,
18940,GO:1901857,1,0.880435304693846,0,6,positive regulation of cellular respiration,BP,
18941,GO:1901858,1,0.882032628369298,0,6,regulation of mitochondrial DNA metabolic process,BP,
18942,GO:1901859,1,0.938923918136733,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
18943,GO:1901860,1,0.95950687215042,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
18947,GO:1901873,1,0.980803714402997,0,1,regulation of post-translational protein modification,BP,
18948,GO:1901874,1,0.980803714402997,0,1,negative regulation of post-translational protein modification,BP,
18949,GO:1901876,1,0.957577996418309,0,2,regulation of calcium ion binding,BP,
18950,GO:1901877,1,0.957577996418309,0,2,negative regulation of calcium ion binding,BP,
18955,GO:1901889,1,0.674958682721615,0,19,negative regulation of cell junction assembly,BP,
18958,GO:1901895,1,0.958179868572487,0,2,negative regulation of calcium-transporting ATPase activity,BP,
18963,GO:1901906,1,0.918287180998757,0,4,diadenosine pentaphosphate metabolic process,BP,
18964,GO:1901907,1,0.918287180998757,0,4,diadenosine pentaphosphate catabolic process,BP,
18965,GO:1901908,1,0.918287180998757,0,4,diadenosine hexaphosphate metabolic process,BP,
18966,GO:1901909,1,0.918287180998757,0,4,diadenosine hexaphosphate catabolic process,BP,
18967,GO:1901910,1,0.918287180998757,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
18968,GO:1901911,1,0.918287180998757,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
18969,GO:1901962,1,0.978852367704527,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
18972,GO:1901970,1,0.883788493242418,0,6,positive regulation of mitotic sister chromatid separation,BP,
18974,GO:1901977,1,0.898828759379502,0,5,negative regulation of cell cycle checkpoint,BP,
18975,GO:1901978,1,0.830057225370759,0,9,positive regulation of cell cycle checkpoint,BP,
18976,GO:1901979,1,0.957935269673253,0,2,regulation of inward rectifier potassium channel activity,BP,
18979,GO:1901984,1,0.629854753610806,0,22,negative regulation of protein acetylation,BP,
18981,GO:1901986,1,0.978559143259173,0,1,response to ketamine,BP,
18984,GO:1901989,1,0.24997996428997,0,66,positive regulation of cell cycle phase transition,BP,
18987,GO:1901992,1,0.290085575376226,0,59,positive regulation of mitotic cell cycle phase transition,BP,
18988,GO:1901993,1,0.898468787044719,0,5,regulation of meiotic cell cycle phase transition,BP,
18989,GO:1901994,1,0.917769414835777,0,4,negative regulation of meiotic cell cycle phase transition,BP,
18990,GO:1901995,1,0.97897493185122,0,1,positive regulation of meiotic cell cycle phase transition,BP,
18993,GO:1902003,1,0.814985560575182,0,10,regulation of beta-amyloid formation,BP,
18994,GO:1902004,1,0.90020411556131,0,5,positive regulation of beta-amyloid formation,BP,
18996,GO:1902017,1,0.420098864672126,0,42,regulation of cilium assembly,BP,
18997,GO:1902018,1,0.826673219932589,0,9,negative regulation of cilium assembly,BP,
18998,GO:1902019,1,0.899262418896982,0,5,regulation of cilium-dependent cell motility,BP,
18999,GO:1902022,1,0.920512109461085,0,4,L-lysine transport,BP,
19000,GO:1902023,1,0.920594670413655,0,4,L-arginine transport,BP,
19001,GO:1902024,1,0.958414065007485,0,2,L-histidine transport,BP,
19002,GO:1902031,1,0.879400631344018,0,6,regulation of NADP metabolic process,BP,
19005,GO:1902036,1,0.882050878026847,0,6,regulation of hematopoietic stem cell differentiation,BP,
19006,GO:1902037,1,0.938378976667434,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19007,GO:1902038,1,0.979069373403245,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19011,GO:1902044,1,0.958660563468499,0,2,regulation of Fas signaling pathway,BP,
19012,GO:1902045,1,0.978903239804412,0,1,negative regulation of Fas signaling pathway,BP,
19013,GO:1902047,1,0.91757748776653,0,4,polyamine transmembrane transport,BP,
19014,GO:1902065,1,0.82888001072252,0,9,response to L-glutamate,BP,
19015,GO:1902071,1,0.978516563366486,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19016,GO:1902073,1,0.978516563366486,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19018,GO:1902075,1,0.898461958112578,0,5,cellular response to salt,BP,
19019,GO:1902076,1,0.984306146966229,0,1,regulation of lateral motor column neuron migration,BP,
19020,GO:1902078,1,0.984306146966229,0,1,positive regulation of lateral motor column neuron migration,BP,
19021,GO:1902080,1,0.958008574682515,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19022,GO:1902081,1,0.958008574682515,0,2,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19023,GO:1902083,1,0.924177330317876,0,4,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19024,GO:1902093,1,0.859694152167004,0,7,positive regulation of flagellated sperm motility,BP,
19026,GO:1902099,1,0.393937550901909,0,45,regulation of metaphase/anaphase transition of cell cycle,BP,
19027,GO:1902100,1,0.526463902615673,0,31,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19028,GO:1902101,1,0.883788493242418,0,6,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19029,GO:1902102,1,0.958008869044639,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19030,GO:1902103,1,0.958008869044639,0,2,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19038,GO:1902116,1,0.547083968499027,0,29,negative regulation of organelle assembly,BP,
19040,GO:1902118,1,0.978673229069386,0,1,calcidiol binding,MF,
19042,GO:1902122,1,0.978819787817556,0,1,chenodeoxycholic acid binding,MF,
19043,GO:1902159,1,0.959323103990108,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19044,GO:1902161,1,0.980425004267237,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19045,GO:1902162,1,0.957818353755465,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19046,GO:1902164,1,0.957818353755465,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19047,GO:1902165,1,0.724799434317387,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19048,GO:1902166,1,0.756621023742037,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19049,GO:1902167,1,0.978468501176454,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19051,GO:1902172,1,0.879986471003538,0,6,regulation of keratinocyte apoptotic process,BP,
19052,GO:1902173,1,0.979067895018549,0,1,negative regulation of keratinocyte apoptotic process,BP,
19053,GO:1902174,1,0.938057233353144,0,3,positive regulation of keratinocyte apoptotic process,BP,
19056,GO:1902177,1,0.879653049259774,0,6,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19057,GO:1902178,1,0.979196261958767,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19058,GO:1902186,1,0.520982927188092,0,31,regulation of viral release from host cell,BP,
19059,GO:1902187,1,0.731371184826716,0,15,negative regulation of viral release from host cell,BP,
19060,GO:1902188,1,0.727929880013424,0,15,positive regulation of viral release from host cell,BP,
19061,GO:1902202,1,0.918627589843814,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19062,GO:1902203,1,0.979551728245356,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19063,GO:1902204,1,0.978762170078875,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19064,GO:1902205,1,0.978643918776184,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19065,GO:1902206,1,0.978643918776184,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19066,GO:1902211,1,0.958066666538956,0,2,regulation of prolactin signaling pathway,BP,
19067,GO:1902212,1,0.978643918776184,0,1,negative regulation of prolactin signaling pathway,BP,
19068,GO:1902213,1,0.97897493185122,0,1,positive regulation of prolactin signaling pathway,BP,
19069,GO:1902214,1,0.957762056994744,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
19070,GO:1902215,1,0.978643918776184,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19071,GO:1902216,1,0.978663692803811,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
19072,GO:1902217,1,0.978543055981436,0,1,erythrocyte apoptotic process,BP,
19073,GO:1902218,1,0.898984182133575,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19074,GO:1902219,1,0.918736754158517,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19075,GO:1902220,1,0.978505201044607,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19079,GO:1902225,1,0.97897493185122,0,1,negative regulation of acrosome reaction,BP,
19080,GO:1902226,1,0.937506344069037,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19081,GO:1902227,1,0.957686645764958,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19082,GO:1902228,1,0.978930529495848,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19083,GO:1902229,1,0.47319168116055,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19084,GO:1902230,1,0.573916541891956,0,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19085,GO:1902231,1,0.842387770451603,0,8,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19086,GO:1902232,1,0.958104228757069,0,2,regulation of positive thymic T cell selection,BP,
19087,GO:1902233,1,0.978643918776184,0,1,negative regulation of positive thymic T cell selection,BP,
19089,GO:1902236,1,0.699477278921732,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19091,GO:1902238,1,0.979159941864044,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19092,GO:1902239,1,0.979159941864044,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19093,GO:1902250,1,0.978543055981436,0,1,regulation of erythrocyte apoptotic process,BP,
19094,GO:1902251,1,0.978543055981436,0,1,negative regulation of erythrocyte apoptotic process,BP,
19095,GO:1902253,1,0.599481745498688,0,24,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19096,GO:1902254,1,0.68254717583115,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19097,GO:1902255,1,0.91688011081455,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19098,GO:1902256,1,0.93870172374835,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19099,GO:1902257,1,0.958149515675832,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19100,GO:1902259,1,0.732772621782067,0,15,regulation of delayed rectifier potassium channel activity,BP,
19101,GO:1902260,1,0.864599534938194,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19102,GO:1902261,1,0.922670571540762,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19103,GO:1902262,1,0.898950395291073,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19105,GO:1902267,1,0.91757748776653,0,4,regulation of polyamine transmembrane transport,BP,
19106,GO:1902268,1,0.93708212687037,0,3,negative regulation of polyamine transmembrane transport,BP,
19107,GO:1902269,1,0.979189419794692,0,1,positive regulation of polyamine transmembrane transport,BP,
19111,GO:1902283,1,0.979114178337418,0,1,negative regulation of primary amine oxidase activity,BP,
19113,GO:1902285,1,0.883905844462852,0,6,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19114,GO:1902287,1,0.902100007336359,0,5,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19115,GO:1902292,1,0.978517017698347,0,1,cell cycle DNA replication initiation,BP,
19116,GO:1902294,1,0.97897493185122,0,1,cell cycle DNA replication termination,BP,
19117,GO:1902296,1,0.97906919638579,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19118,GO:1902298,1,0.963353953966265,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19119,GO:1902299,1,0.95814743093924,0,2,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19122,GO:1902304,1,0.958357545686413,0,2,positive regulation of potassium ion export,BP,
19124,GO:1902306,1,0.796117025971511,0,11,negative regulation of sodium ion transmembrane transport,BP,
19126,GO:1902308,1,0.90037367463337,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19127,GO:1902309,1,0.939868121429973,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19128,GO:1902310,1,0.957985684937584,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19130,GO:1902315,1,0.978517017698347,0,1,nuclear cell cycle DNA replication initiation,BP,
19131,GO:1902317,1,0.97897493185122,0,1,nuclear DNA replication termination,BP,
19132,GO:1902319,1,0.97906919638579,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19133,GO:1902336,1,0.958459488358843,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19137,GO:1902340,1,0.957963686201023,0,2,negative regulation of chromosome condensation,BP,
19138,GO:1902356,1,0.978713223128666,0,1,oxaloacetate(2-) transmembrane transport,BP,
19139,GO:1902358,1,0.761729460224431,0,13,sulfate transmembrane transport,BP,
19140,GO:1902359,1,0.958262431282259,0,2,Notch signaling pathway involved in somitogenesis,BP,
19141,GO:1902361,1,0.938238199096648,0,3,mitochondrial pyruvate transmembrane transport,BP,
19142,GO:1902362,1,0.979034695035522,0,1,melanocyte apoptotic process,BP,
19143,GO:1902366,1,0.958262431282259,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19144,GO:1902367,1,0.958262431282259,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19147,GO:1902378,1,0.978950316202423,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19149,GO:1902380,1,0.978928346363165,0,1,positive regulation of endoribonuclease activity,BP,
19150,GO:1902396,1,0.979094305064747,0,1,protein localization to bicellular tight junction,BP,
19154,GO:1902410,1,0.881211507929027,0,6,mitotic cytokinetic process,BP,
19155,GO:1902412,1,0.939668955622985,0,3,regulation of mitotic cytokinesis,BP,
19156,GO:1902414,1,0.850037338395232,0,8,protein localization to cell junction,BP,
19157,GO:1902415,1,0.825890389309239,0,9,regulation of mRNA binding,BP,
19158,GO:1902416,1,0.861969502235138,0,7,positive regulation of mRNA binding,BP,
19159,GO:1902423,1,0.978820203269567,0,1,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19160,GO:1902425,1,0.978820203269567,0,1,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19161,GO:1902426,1,0.979008629917437,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19162,GO:1902430,1,0.886090636628347,0,6,negative regulation of beta-amyloid formation,BP,
19163,GO:1902442,1,0.979077107537638,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19164,GO:1902443,1,0.979077107537638,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19165,GO:1902444,1,0.978518165079435,0,1,riboflavin binding,MF,
19166,GO:1902445,1,0.937184285683324,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19168,GO:1902459,1,0.900953263752145,0,5,positive regulation of stem cell population maintenance,BP,
19169,GO:1902460,1,0.979321997946626,0,1,regulation of mesenchymal stem cell proliferation,BP,
19170,GO:1902462,1,0.979321997946626,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19171,GO:1902463,1,0.937127200688626,0,3,protein localization to cell leading edge,BP,
19172,GO:1902464,1,0.979241535255677,0,1,regulation of histone H3-K27 trimethylation,BP,
19173,GO:1902466,1,0.979241535255677,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19178,GO:1902480,1,0.97892943937117,0,1,protein localization to mitotic spindle,BP,
19179,GO:1902488,1,0.982356752390083,0,1,cholangiocyte apoptotic process,BP,
19180,GO:1902490,1,0.978750012806252,0,1,regulation of sperm capacitation,BP,
19181,GO:1902493,1,0.158855444711559,0,88,acetyltransferase complex,CC,
19184,GO:1902498,1,0.926997331873908,0,4,regulation of protein autoubiquitination,BP,
19185,GO:1902499,1,0.9621073976142,0,2,positive regulation of protein autoubiquitination,BP,
19186,GO:1902504,1,0.979058353496236,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19187,GO:1902510,1,0.862193199329758,0,7,regulation of apoptotic DNA fragmentation,BP,
19188,GO:1902511,1,0.979017090875596,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19189,GO:1902512,1,0.937173952934423,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19190,GO:1902513,1,0.918302574739211,0,4,regulation of organelle transport along microtubule,BP,
19191,GO:1902514,1,0.867786993001343,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19192,GO:1902523,1,0.958574099803742,0,2,positive regulation of protein K63-linked ubiquitination,BP,
19194,GO:1902525,1,0.898175015617978,0,5,regulation of protein monoubiquitination,BP,
19195,GO:1902527,1,0.917375632794065,0,4,positive regulation of protein monoubiquitination,BP,
19196,GO:1902528,1,0.982097510052096,0,1,regulation of protein linear polyubiquitination,BP,
19197,GO:1902530,1,0.982097510052096,0,1,positive regulation of protein linear polyubiquitination,BP,
19201,GO:1902534,1,0.980088853007181,0,1,single-organism membrane invagination,BP,
19202,GO:1902544,1,0.957998649229002,0,2,regulation of DNA N-glycosylase activity,BP,
19203,GO:1902546,1,0.978480527706844,0,1,positive regulation of DNA N-glycosylase activity,BP,
19205,GO:1902548,1,0.90046748482469,0,5,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19208,GO:1902559,1,0.958009119288288,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19209,GO:1902560,1,0.957751632362377,0,2,GMP reductase complex,CC,
19210,GO:1902562,1,0.492294308571217,0,34,H4 histone acetyltransferase complex,CC,
19211,GO:1902563,1,0.88312116494505,0,6,regulation of neutrophil activation,BP,
19212,GO:1902564,1,0.940650826271636,0,3,negative regulation of neutrophil activation,BP,
19213,GO:1902565,1,0.979143855843724,0,1,positive regulation of neutrophil activation,BP,
19214,GO:1902566,1,0.917918757421636,0,4,regulation of eosinophil activation,BP,
19215,GO:1902567,1,0.958115034001759,0,2,negative regulation of eosinophil activation,BP,
19216,GO:1902568,1,0.958051288161418,0,2,positive regulation of eosinophil activation,BP,
19217,GO:1902569,1,0.978712826625149,0,1,negative regulation of activation of JAK2 kinase activity,BP,
19218,GO:1902570,1,0.862691519560857,0,7,protein localization to nucleolus,BP,
19219,GO:1902571,1,0.758595006258639,0,13,regulation of serine-type peptidase activity,BP,
19220,GO:1902572,1,0.792013682323513,0,11,negative regulation of serine-type peptidase activity,BP,
19221,GO:1902573,1,0.941302857456563,0,3,positive regulation of serine-type peptidase activity,BP,
19222,GO:1902576,1,0.918487352548015,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19229,GO:1902585,1,0.978758658761031,0,1,single-organism intercellular transport,BP,
19231,GO:1902590,1,0.598956135085793,0,24,multi-organism organelle organization,BP,
19232,GO:1902592,1,0.598956135085793,0,24,multi-organism membrane budding,BP,
19234,GO:1902594,1,0.959769676357603,0,2,multi-organism nuclear import,BP,
19235,GO:1902595,1,0.958020102071403,0,2,regulation of DNA replication origin binding,BP,
19236,GO:1902598,1,0.958845604361552,0,2,creatine transmembrane transport,BP,
19238,GO:1902603,1,0.918002279022098,0,4,carnitine transmembrane transport,BP,
19239,GO:1902605,1,0.979023333231083,0,1,heterotrimeric G-protein complex assembly,BP,
19240,GO:1902606,1,0.957474041937617,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19241,GO:1902608,1,0.957474041937617,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19244,GO:1902616,1,0.958061124992007,0,2,acyl carnitine transmembrane transport,BP,
19245,GO:1902617,1,0.921052613087413,0,4,response to fluoride,BP,
19246,GO:1902618,1,0.980287758244799,0,1,cellular response to fluoride,BP,
19248,GO:1902623,1,0.958961210344584,0,2,negative regulation of neutrophil migration,BP,
19250,GO:1902626,1,0.936916947066775,0,3,assembly of large subunit precursor of preribosome,BP,
19251,GO:1902630,1,0.961612937846663,0,2,regulation of membrane hyperpolarization,BP,
19252,GO:1902631,1,0.981046432232711,0,1,negative regulation of membrane hyperpolarization,BP,
19253,GO:1902636,1,0.957929240475514,0,2,kinociliary basal body,CC,
19257,GO:1902659,1,0.938293798369831,0,3,regulation of glucose mediated signaling pathway,BP,
19258,GO:1902661,1,0.938293798369831,0,3,positive regulation of glucose mediated signaling pathway,BP,
19261,GO:1902669,1,0.877741412095446,0,7,positive regulation of axon guidance,BP,
19264,GO:1902683,1,0.937929418128031,0,3,regulation of receptor localization to synapse,BP,
19265,GO:1902684,1,0.97854365350071,0,1,negative regulation of receptor localization to synapse,BP,
19266,GO:1902685,1,0.979187059968203,0,1,positive regulation of receptor localization to synapse,BP,
19270,GO:1902691,1,0.979065545692908,0,1,respiratory basal cell differentiation,BP,
19272,GO:1902710,1,0.688373138659203,0,18,GABA receptor complex,CC,
19273,GO:1902711,1,0.702322774329105,0,17,GABA-A receptor complex,CC,
19274,GO:1902713,1,0.809062459856688,0,10,regulation of interferon-gamma secretion,BP,
19275,GO:1902714,1,0.918199546310675,0,4,negative regulation of interferon-gamma secretion,BP,
19276,GO:1902715,1,0.862442515371327,0,7,positive regulation of interferon-gamma secretion,BP,
19277,GO:1902722,1,0.95892129098052,0,2,positive regulation of prolactin secretion,BP,
19278,GO:1902723,1,0.95854435924036,0,2,negative regulation of skeletal muscle satellite cell proliferation,BP,
19279,GO:1902725,1,0.959917854726864,0,2,negative regulation of satellite cell differentiation,BP,
19280,GO:1902728,1,0.959741982268872,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19281,GO:1902730,1,0.958612122858693,0,2,positive regulation of proteoglycan biosynthetic process,BP,
19282,GO:1902731,1,0.94460464756438,0,3,negative regulation of chondrocyte proliferation,BP,
19283,GO:1902732,1,0.937688973958253,0,3,positive regulation of chondrocyte proliferation,BP,
19284,GO:1902737,1,0.979225863789439,0,1,dendritic filopodium,CC,
19285,GO:1902739,1,0.958223669528091,0,2,regulation of interferon-alpha secretion,BP,
19286,GO:1902741,1,0.958223669528091,0,2,positive regulation of interferon-alpha secretion,BP,
19288,GO:1902743,1,0.473932585145416,0,36,regulation of lamellipodium organization,BP,
19289,GO:1902744,1,0.901200866287216,0,5,negative regulation of lamellipodium organization,BP,
19290,GO:1902745,1,0.608324986694019,0,24,positive regulation of lamellipodium organization,BP,
19291,GO:1902746,1,0.921390970756924,0,4,regulation of lens fiber cell differentiation,BP,
19292,GO:1902747,1,0.978747961067802,0,1,negative regulation of lens fiber cell differentiation,BP,
19293,GO:1902748,1,0.982638152020481,0,1,positive regulation of lens fiber cell differentiation,BP,
19296,GO:1902751,1,0.642518154635129,0,21,positive regulation of cell cycle G2/M phase transition,BP,
19297,GO:1902765,1,0.960854055934674,0,2,L-arginine import into cell,BP,
19298,GO:1902766,1,0.957723143966454,0,2,skeletal muscle satellite cell migration,BP,
19299,GO:1902769,1,0.983868746166216,0,1,regulation of choline O-acetyltransferase activity,BP,
19300,GO:1902771,1,0.983868746166216,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19301,GO:1902773,1,0.979062146418257,0,1,GTPase activator complex,CC,
19302,GO:1902774,1,0.884001981945825,0,6,late endosome to lysosome transport,BP,
19303,GO:1902775,1,0.940356858728235,0,3,mitochondrial large ribosomal subunit assembly,BP,
19304,GO:1902803,1,0.463179446070822,0,37,regulation of synaptic vesicle transport,BP,
19305,GO:1902804,1,0.844218376645368,0,8,negative regulation of synaptic vesicle transport,BP,
19306,GO:1902805,1,0.901429771545717,0,5,positive regulation of synaptic vesicle transport,BP,
19309,GO:1902808,1,0.512294789740851,0,32,positive regulation of cell cycle G1/S phase transition,BP,
19310,GO:1902809,1,0.93824810425444,0,3,regulation of skeletal muscle fiber differentiation,BP,
19311,GO:1902811,1,0.95832986037582,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19312,GO:1902822,1,0.921433545302191,0,4,regulation of late endosome to lysosome transport,BP,
19313,GO:1902823,1,0.962133753679253,0,2,negative regulation of late endosome to lysosome transport,BP,
19314,GO:1902824,1,0.957702329614183,0,2,positive regulation of late endosome to lysosome transport,BP,
19315,GO:1902826,1,0.978980782054902,0,1,regulation of L-arginine import into cell,BP,
19316,GO:1902828,1,0.978980782054902,0,1,positive regulation of L-arginine import into cell,BP,
19317,GO:1902837,1,0.868577733207791,0,7,amino acid import into cell,BP,
19318,GO:1902847,1,0.97904224457962,0,1,regulation of neuronal signal transduction,BP,
19320,GO:1902855,1,0.762527148681584,0,13,regulation of non-motile cilium assembly,BP,
19321,GO:1902856,1,0.939112040300438,0,3,negative regulation of non-motile cilium assembly,BP,
19322,GO:1902857,1,0.829458925685993,0,9,positive regulation of non-motile cilium assembly,BP,
19325,GO:1902861,1,0.979429643842571,0,1,copper ion import into cell,BP,
19326,GO:1902866,1,0.861496059893747,0,7,regulation of retina development in camera-type eye,BP,
19327,GO:1902867,1,0.979066704239959,0,1,negative regulation of retina development in camera-type eye,BP,
19328,GO:1902868,1,0.958199159439563,0,2,positive regulation of retina development in camera-type eye,BP,
19329,GO:1902869,1,0.938138584135485,0,3,regulation of amacrine cell differentiation,BP,
19330,GO:1902870,1,0.979066704239959,0,1,negative regulation of amacrine cell differentiation,BP,
19331,GO:1902871,1,0.958199159439563,0,2,positive regulation of amacrine cell differentiation,BP,
19335,GO:1902890,1,0.978476629273923,0,1,regulation of root hair elongation,BP,
19336,GO:1902891,1,0.978476629273923,0,1,negative regulation of root hair elongation,BP,
19340,GO:1902896,1,0.938471797891299,0,3,terminal web assembly,BP,
19342,GO:1902902,1,0.812877086658328,0,10,negative regulation of autophagosome assembly,BP,
19346,GO:1902908,1,0.958276882759767,0,2,regulation of melanosome transport,BP,
19347,GO:1902910,1,0.979191434566361,0,1,positive regulation of melanosome transport,BP,
19349,GO:1902913,1,0.978501057651594,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19351,GO:1902915,1,0.923752266031135,0,4,negative regulation of protein polyubiquitination,BP,
19354,GO:1902931,1,0.825298050789551,0,9,negative regulation of alcohol biosynthetic process,BP,
19357,GO:1902937,1,0.958528814779941,0,2,inward rectifier potassium channel complex,CC,
19358,GO:1902938,1,0.97904873498944,0,1,regulation of intracellular calcium activated chloride channel activity,BP,
19359,GO:1902939,1,0.97904873498944,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19360,GO:1902941,1,0.959976028352971,0,2,regulation of voltage-gated chloride channel activity,BP,
19361,GO:1902943,1,0.959976028352971,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19363,GO:1902947,1,0.942788193502945,0,3,regulation of tau-protein kinase activity,BP,
19364,GO:1902948,1,0.983868746166216,0,1,negative regulation of tau-protein kinase activity,BP,
19365,GO:1902949,1,0.97904224457962,0,1,positive regulation of tau-protein kinase activity,BP,
19366,GO:1902950,1,0.879741416882923,0,6,regulation of dendritic spine maintenance,BP,
19367,GO:1902951,1,0.937677715099203,0,3,negative regulation of dendritic spine maintenance,BP,
19368,GO:1902952,1,0.958283412566484,0,2,positive regulation of dendritic spine maintenance,BP,
19369,GO:1902953,1,0.923015927670825,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19370,GO:1902954,1,0.965671237857636,0,2,regulation of early endosome to recycling endosome transport,BP,
19371,GO:1902955,1,0.983868746166216,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19372,GO:1902956,1,0.918217314284188,0,4,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19373,GO:1902957,1,0.958535426488522,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19374,GO:1902958,1,0.957942545336479,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19375,GO:1902959,1,0.963287024569368,0,2,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19376,GO:1902960,1,0.983868746166216,0,1,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19377,GO:1902961,1,0.979081745911418,0,1,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19378,GO:1902962,1,0.963287024569368,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19379,GO:1902963,1,0.963287024569368,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19382,GO:1902969,1,0.813012216485997,0,10,mitotic DNA replication,BP,
19383,GO:1902975,1,0.978517017698347,0,1,mitotic DNA replication initiation,BP,
19384,GO:1902977,1,0.978726413098834,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19385,GO:1902979,1,0.97897493185122,0,1,mitotic DNA replication termination,BP,
19386,GO:1902983,1,0.97906919638579,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19387,GO:1902988,1,0.94410825729554,0,3,neurofibrillary tangle assembly,BP,
19388,GO:1902990,1,0.938420356804076,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19389,GO:1902991,1,0.767536324681632,0,13,regulation of amyloid precursor protein catabolic process,BP,
19390,GO:1902992,1,0.849321494268546,0,8,negative regulation of amyloid precursor protein catabolic process,BP,
19391,GO:1902993,1,0.90020411556131,0,5,positive regulation of amyloid precursor protein catabolic process,BP,
19392,GO:1902994,1,0.959882885490926,0,2,regulation of phospholipid efflux,BP,
19393,GO:1902995,1,0.959882885490926,0,2,positive regulation of phospholipid efflux,BP,
19394,GO:1902996,1,0.963248158770503,0,2,regulation of neurofibrillary tangle assembly,BP,
19395,GO:1902997,1,0.983868746166216,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19396,GO:1902998,1,0.97904224457962,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19397,GO:1903000,1,0.978516865961842,0,1,regulation of lipid transport across blood brain barrier,BP,
19398,GO:1903002,1,0.978516865961842,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19399,GO:1903003,1,0.918499277449366,0,4,positive regulation of protein deubiquitination,BP,
19400,GO:1903004,1,0.979089260094394,0,1,regulation of protein K63-linked deubiquitination,BP,
19401,GO:1903006,1,0.979089260094394,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19402,GO:1903007,1,0.979089260094394,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19403,GO:1903008,1,0.131338228104711,0,97,organelle disassembly,BP,
19406,GO:1903012,1,0.86186627851646,0,7,positive regulation of bone development,BP,
19407,GO:1903015,1,0.937213974002269,0,3,regulation of exo-alpha-sialidase activity,BP,
19408,GO:1903016,1,0.957674876301617,0,2,negative regulation of exo-alpha-sialidase activity,BP,
19409,GO:1903017,1,0.978637302720666,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19412,GO:1903020,1,0.671227921745961,0,19,positive regulation of glycoprotein metabolic process,BP,
19414,GO:1903026,1,0.880557781260998,0,6,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19415,GO:1903027,1,0.940084129503653,0,3,regulation of opsonization,BP,
19416,GO:1903028,1,0.981504945683275,0,1,positive regulation of opsonization,BP,
19417,GO:1903031,1,0.95814579159903,0,2,regulation of microtubule plus-end binding,BP,
19418,GO:1903033,1,0.95814579159903,0,2,positive regulation of microtubule plus-end binding,BP,
19425,GO:1903044,1,0.82638459913416,0,9,protein localization to membrane raft,BP,
19426,GO:1903045,1,0.980053194345808,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19430,GO:1903051,1,0.412687265112325,0,42,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19433,GO:1903054,1,0.879801361415328,0,6,negative regulation of extracellular matrix organization,BP,
19434,GO:1903055,1,0.734454509835273,0,15,positive regulation of extracellular matrix organization,BP,
19435,GO:1903056,1,0.961650178436223,0,2,regulation of melanosome organization,BP,
19436,GO:1903059,1,0.90116583136855,0,5,regulation of protein lipidation,BP,
19437,GO:1903060,1,0.978683724190989,0,1,negative regulation of protein lipidation,BP,
19438,GO:1903061,1,0.920798185685091,0,4,positive regulation of protein lipidation,BP,
19439,GO:1903069,1,0.825446252352291,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19440,GO:1903070,1,0.937909055629244,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19441,GO:1903071,1,0.861526116043555,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19442,GO:1903072,1,0.978487817470133,0,1,regulation of death-inducing signaling complex assembly,BP,
19443,GO:1903073,1,0.978487817470133,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19447,GO:1903080,1,0.978499877763531,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19448,GO:1903082,1,0.978499877763531,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19449,GO:1903093,1,0.957484258219011,0,2,regulation of protein K48-linked deubiquitination,BP,
19450,GO:1903094,1,0.957484258219011,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19451,GO:1903095,1,0.958667318683626,0,2,ribonuclease III complex,CC,
19452,GO:1903096,1,0.979061701303031,0,1,protein localization to meiotic spindle midzone,BP,
19454,GO:1903116,1,0.938787634188795,0,3,positive regulation of actin filament-based movement,BP,
19455,GO:1903118,1,0.978906684662316,0,1,urate homeostasis,BP,
19456,GO:1903121,1,0.919677413804434,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19457,GO:1903122,1,0.978487817470133,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19458,GO:1903123,1,0.982703479687859,0,1,regulation of thioredoxin peroxidase activity,BP,
19459,GO:1903124,1,0.982703479687859,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19460,GO:1903125,1,0.982703479687859,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19461,GO:1903126,1,0.978813134120898,0,1,negative regulation of centriole-centriole cohesion,BP,
19463,GO:1903135,1,0.937945437058894,0,3,cupric ion binding,MF,
19464,GO:1903136,1,0.881993242917531,0,6,cuprous ion binding,MF,
19466,GO:1903141,1,0.979162169984871,0,1,negative regulation of establishment of endothelial barrier,BP,
19468,GO:1903146,1,0.359698280865121,0,49,regulation of mitophagy,BP,
19469,GO:1903147,1,0.901646662970166,0,5,negative regulation of mitophagy,BP,
19470,GO:1903165,1,0.979012464794399,0,1,response to polycyclic arene,BP,
19471,GO:1903167,1,0.978487817470133,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19472,GO:1903168,1,0.978487817470133,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19476,GO:1903176,1,0.978487817470133,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19477,GO:1903178,1,0.978487817470133,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19478,GO:1903179,1,0.958006097829785,0,2,regulation of dopamine biosynthetic process,BP,
19479,GO:1903181,1,0.958006097829785,0,2,positive regulation of dopamine biosynthetic process,BP,
19480,GO:1903182,1,0.978520430518689,0,1,regulation of SUMO transferase activity,BP,
19481,GO:1903184,1,0.978487817470133,0,1,L-dopa metabolic process,BP,
19482,GO:1903185,1,0.978487817470133,0,1,L-dopa biosynthetic process,BP,
19483,GO:1903189,1,0.978487817470133,0,1,glyoxal metabolic process,BP,
19484,GO:1903195,1,0.978487817470133,0,1,regulation of L-dopa biosynthetic process,BP,
19485,GO:1903197,1,0.978487817470133,0,1,positive regulation of L-dopa biosynthetic process,BP,
19486,GO:1903198,1,0.978487817470133,0,1,regulation of L-dopa decarboxylase activity,BP,
19487,GO:1903200,1,0.978487817470133,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19490,GO:1903203,1,0.715148142797644,0,16,regulation of oxidative stress-induced neuron death,BP,
19491,GO:1903204,1,0.761986576630928,0,13,negative regulation of oxidative stress-induced neuron death,BP,
19492,GO:1903205,1,0.644573249286713,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19493,GO:1903206,1,0.715510330763989,0,16,negative regulation of hydrogen peroxide-induced cell death,BP,
19494,GO:1903207,1,0.938576942511285,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
19495,GO:1903208,1,0.938576942511285,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
19496,GO:1903209,1,0.775591347491424,0,12,positive regulation of oxidative stress-induced cell death,BP,
19497,GO:1903210,1,0.980557080498592,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19498,GO:1903214,1,0.146074710449709,0,91,regulation of protein targeting to mitochondrion,BP,
19499,GO:1903215,1,0.921566054780949,0,4,negative regulation of protein targeting to mitochondrion,BP,
19500,GO:1903216,1,0.961589605246334,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19501,GO:1903217,1,0.961589605246334,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19502,GO:1903223,1,0.958602653552632,0,2,positive regulation of oxidative stress-induced neuron death,BP,
19503,GO:1903224,1,0.884393547571931,0,6,regulation of endodermal cell differentiation,BP,
19504,GO:1903225,1,0.942836836816421,0,3,negative regulation of endodermal cell differentiation,BP,
19506,GO:1903233,1,0.961877410933762,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19507,GO:1903236,1,0.861206789692848,0,7,regulation of leukocyte tethering or rolling,BP,
19508,GO:1903237,1,0.916891093431251,0,4,negative regulation of leukocyte tethering or rolling,BP,
19509,GO:1903238,1,0.939282265568408,0,3,positive regulation of leukocyte tethering or rolling,BP,
19510,GO:1903242,1,0.884681517821733,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
19511,GO:1903243,1,0.942822266003627,0,3,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19512,GO:1903244,1,0.958860199812139,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19513,GO:1903248,1,0.982396170646631,0,1,regulation of citrulline biosynthetic process,BP,
19514,GO:1903249,1,0.982396170646631,0,1,negative regulation of citrulline biosynthetic process,BP,
19515,GO:1903251,1,0.880870583895163,0,6,multi-ciliated epithelial cell differentiation,BP,
19516,GO:1903261,1,0.918884238639393,0,4,regulation of serine phosphorylation of STAT3 protein,BP,
19517,GO:1903262,1,0.958179924453369,0,2,negative regulation of serine phosphorylation of STAT3 protein,BP,
19518,GO:1903263,1,0.958993915274654,0,2,positive regulation of serine phosphorylation of STAT3 protein,BP,
19519,GO:1903265,1,0.898968006687814,0,5,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19524,GO:1903279,1,0.939207600169701,0,3,regulation of calcium:sodium antiporter activity,BP,
19525,GO:1903280,1,0.979907165507507,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19526,GO:1903281,1,0.958468146313637,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19527,GO:1903282,1,0.979067586913297,0,1,regulation of glutathione peroxidase activity,BP,
19528,GO:1903284,1,0.979067586913297,0,1,positive regulation of glutathione peroxidase activity,BP,
19529,GO:1903285,1,0.979067586913297,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19530,GO:1903286,1,0.918659657173978,0,4,regulation of potassium ion import,BP,
19531,GO:1903288,1,0.937809830642153,0,3,positive regulation of potassium ion import,BP,
19532,GO:1903293,1,0.387644707124708,0,45,phosphatase complex,CC,
19533,GO:1903294,1,0.979533540189085,0,1,regulation of glutamate secretion, neurotransmission,BP,
19534,GO:1903296,1,0.979533540189085,0,1,positive regulation of glutamate secretion, neurotransmission,BP,
19535,GO:1903297,1,0.918663640944717,0,4,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19536,GO:1903298,1,0.918663640944717,0,4,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19537,GO:1903299,1,0.842806082724679,0,8,regulation of hexokinase activity,BP,
19538,GO:1903300,1,0.917996623774756,0,4,negative regulation of hexokinase activity,BP,
19539,GO:1903301,1,0.918111077275783,0,4,positive regulation of hexokinase activity,BP,
19546,GO:1903314,1,0.978819787817556,0,1,regulation of nitrogen cycle metabolic process,BP,
19549,GO:1903319,1,0.671818289804502,0,19,positive regulation of protein maturation,BP,
19553,GO:1903332,1,0.861775125068403,0,7,regulation of protein folding,BP,
19554,GO:1903333,1,0.899084235049977,0,5,negative regulation of protein folding,BP,
19555,GO:1903335,1,0.902065878582631,0,5,regulation of vacuolar transport,BP,
19556,GO:1903336,1,0.962133753679253,0,2,negative regulation of vacuolar transport,BP,
19557,GO:1903337,1,0.957702329614183,0,2,positive regulation of vacuolar transport,BP,
19558,GO:1903347,1,0.921593356868429,0,4,negative regulation of bicellular tight junction assembly,BP,
19560,GO:1903349,1,0.919313706552109,0,4,omegasome membrane,CC,
19561,GO:1903350,1,0.764884752862491,0,13,response to dopamine,BP,
19562,GO:1903351,1,0.764884752862491,0,13,cellular response to dopamine,BP,
19563,GO:1903352,1,0.940380176930877,0,3,L-ornithine transmembrane transport,BP,
19564,GO:1903358,1,0.808338612814494,0,10,regulation of Golgi organization,BP,
19565,GO:1903361,1,0.898394773452723,0,5,protein localization to basolateral plasma membrane,BP,
19567,GO:1903363,1,0.34059355998907,0,51,negative regulation of cellular protein catabolic process,BP,
19569,GO:1903365,1,0.89943366537937,0,5,regulation of fear response,BP,
19570,GO:1903367,1,0.89943366537937,0,5,positive regulation of fear response,BP,
19571,GO:1903371,1,0.943550238797926,0,3,regulation of endoplasmic reticulum tubular network organization,BP,
19572,GO:1903373,1,0.961244573203866,0,2,positive regulation of endoplasmic reticulum tubular network organization,BP,
19573,GO:1903375,1,0.959422263445639,0,2,facioacoustic ganglion development,BP,
19574,GO:1903376,1,0.861871561513224,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19575,GO:1903377,1,0.918289988934595,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19576,GO:1903378,1,0.958602653552632,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19577,GO:1903381,1,0.979311342074061,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19578,GO:1903382,1,0.979311342074061,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19579,GO:1903383,1,0.957942545336479,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19580,GO:1903384,1,0.957942545336479,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19581,GO:1903385,1,0.959258311511541,0,2,regulation of homophilic cell adhesion,BP,
19582,GO:1903387,1,0.97976648536885,0,1,positive regulation of homophilic cell adhesion,BP,
19584,GO:1903392,1,0.732590894548193,0,15,negative regulation of adherens junction organization,BP,
19586,GO:1903394,1,0.978901702146056,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19587,GO:1903400,1,0.981485146893144,0,1,L-arginine transmembrane transport,BP,
19588,GO:1903401,1,0.940279327602099,0,3,L-lysine transmembrane transport,BP,
19589,GO:1903402,1,0.979089880969185,0,1,regulation of renal phosphate excretion,BP,
19590,GO:1903403,1,0.979089880969185,0,1,negative regulation of renal phosphate excretion,BP,
19591,GO:1903405,1,0.824851327405115,0,9,protein localization to nuclear body,BP,
19592,GO:1903406,1,0.979072306195535,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19593,GO:1903408,1,0.979072306195535,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19595,GO:1903410,1,0.960854055934674,0,2,L-lysine import into cell,BP,
19596,GO:1903411,1,0.981485146893144,0,1,L-ornithine import into cell,BP,
19597,GO:1903412,1,0.937505172382035,0,3,response to bile acid,BP,
19598,GO:1903413,1,0.937505172382035,0,3,cellular response to bile acid,BP,
19599,GO:1903414,1,0.979069335039327,0,1,iron cation export,BP,
19600,GO:1903416,1,0.88106898485208,0,6,response to glycoside,BP,
19601,GO:1903420,1,0.980622143944159,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19602,GO:1903421,1,0.746143823203522,0,14,regulation of synaptic vesicle recycling,BP,
19603,GO:1903422,1,0.939402799414327,0,3,negative regulation of synaptic vesicle recycling,BP,
19604,GO:1903423,1,0.91925252457495,0,4,positive regulation of synaptic vesicle recycling,BP,
19610,GO:1903431,1,0.885044663423142,0,6,positive regulation of cell maturation,BP,
19613,GO:1903434,1,0.97908782131278,0,1,negative regulation of constitutive secretory pathway,BP,
19615,GO:1903436,1,0.960041874933944,0,2,regulation of mitotic cytokinetic process,BP,
19616,GO:1903438,1,0.960041874933944,0,2,positive regulation of mitotic cytokinetic process,BP,
19617,GO:1903441,1,0.86285251818337,0,7,protein localization to ciliary membrane,BP,
19618,GO:1903444,1,0.979067305686981,0,1,negative regulation of brown fat cell differentiation,BP,
19619,GO:1903445,1,0.937460362766717,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19620,GO:1903450,1,0.982255635514078,0,1,regulation of G1 to G0 transition,BP,
19621,GO:1903452,1,0.982255635514078,0,1,positive regulation of G1 to G0 transition,BP,
19622,GO:1903461,1,0.979065586228144,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19623,GO:1903463,1,0.939086502353655,0,3,regulation of mitotic cell cycle DNA replication,BP,
19624,GO:1903464,1,0.958218989825018,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19625,GO:1903465,1,0.98003558222434,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19626,GO:1903487,1,0.957639889161198,0,2,regulation of lactation,BP,
19627,GO:1903488,1,0.978501899002915,0,1,negative regulation of lactation,BP,
19628,GO:1903489,1,0.978680891239982,0,1,positive regulation of lactation,BP,
19629,GO:1903490,1,0.960041874933944,0,2,positive regulation of mitotic cytokinesis,BP,
19630,GO:1903504,1,0.761694769119902,0,13,regulation of mitotic spindle checkpoint,BP,
19636,GO:1903513,1,0.577762398698768,0,26,endoplasmic reticulum to cytosol transport,BP,
19638,GO:1903515,1,0.981975970300005,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19639,GO:1903516,1,0.979049480011355,0,1,regulation of single strand break repair,BP,
19640,GO:1903517,1,0.979049480011355,0,1,negative regulation of single strand break repair,BP,
19646,GO:1903525,1,0.902450294836743,0,5,regulation of membrane tubulation,BP,
19647,GO:1903526,1,0.958752229696559,0,2,negative regulation of membrane tubulation,BP,
19648,GO:1903527,1,0.941282365215693,0,3,positive regulation of membrane tubulation,BP,
19653,GO:1903537,1,0.978910487424136,0,1,meiotic cell cycle process involved in oocyte maturation,BP,
19654,GO:1903538,1,0.978910487424136,0,1,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19655,GO:1903539,1,0.809166402312923,0,10,protein localization to postsynaptic membrane,BP,
19656,GO:1903540,1,0.809166402312923,0,10,establishment of protein localization to postsynaptic membrane,BP,
19658,GO:1903542,1,0.958365157672031,0,2,negative regulation of exosomal secretion,BP,
19662,GO:1903546,1,0.864352990082895,0,7,protein localization to photoreceptor outer segment,BP,
19663,GO:1903547,1,0.957497707339593,0,2,regulation of growth hormone activity,BP,
19670,GO:1903564,1,0.944044493730747,0,3,regulation of protein localization to cilium,BP,
19671,GO:1903565,1,0.979069340210104,0,1,negative regulation of protein localization to cilium,BP,
19672,GO:1903566,1,0.964228416037589,0,2,positive regulation of protein localization to cilium,BP,
19673,GO:1903567,1,0.979069340210104,0,1,regulation of protein localization to ciliary membrane,BP,
19674,GO:1903568,1,0.979069340210104,0,1,negative regulation of protein localization to ciliary membrane,BP,
19675,GO:1903570,1,0.979069772614041,0,1,regulation of protein kinase D signaling,BP,
19676,GO:1903572,1,0.979069772614041,0,1,positive regulation of protein kinase D signaling,BP,
19677,GO:1903573,1,0.458414567855618,0,37,negative regulation of response to endoplasmic reticulum stress,BP,
19678,GO:1903575,1,0.958090152975621,0,2,cornified envelope assembly,BP,
19679,GO:1903576,1,0.978786464509949,0,1,response to L-arginine,BP,
19683,GO:1903584,1,0.979229612128656,0,1,regulation of histone deubiquitination,BP,
19684,GO:1903586,1,0.979229612128656,0,1,positive regulation of histone deubiquitination,BP,
19685,GO:1903587,1,0.91966202323226,0,4,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19686,GO:1903588,1,0.937997969199718,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19687,GO:1903589,1,0.980455418346562,0,1,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19688,GO:1903593,1,0.937760227221199,0,3,regulation of histamine secretion by mast cell,BP,
19689,GO:1903595,1,0.937760227221199,0,3,positive regulation of histamine secretion by mast cell,BP,
19690,GO:1903596,1,0.918721219699428,0,4,regulation of gap junction assembly,BP,
19691,GO:1903597,1,0.979069337494231,0,1,negative regulation of gap junction assembly,BP,
19692,GO:1903598,1,0.938365193504502,0,3,positive regulation of gap junction assembly,BP,
19693,GO:1903599,1,0.677759435468794,0,19,positive regulation of mitophagy,BP,
19694,GO:1903608,1,0.863785619095413,0,7,protein localization to cytoplasmic stress granule,BP,
19697,GO:1903613,1,0.979815867730665,0,1,regulation of protein tyrosine phosphatase activity,BP,
19698,GO:1903615,1,0.979815867730665,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19699,GO:1903618,1,0.979110885702327,0,1,regulation of transdifferentiation,BP,
19700,GO:1903620,1,0.979110885702327,0,1,positive regulation of transdifferentiation,BP,
19701,GO:1903621,1,0.978735512144216,0,1,protein localization to photoreceptor connecting cilium,BP,
19704,GO:1903626,1,0.937173952934423,0,3,positive regulation of DNA catabolic process,BP,
19709,GO:1903632,1,0.978523003345303,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19712,GO:1903636,1,0.978467931885137,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19713,GO:1903638,1,0.978467931885137,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19714,GO:1903639,1,0.978466922233803,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19715,GO:1903640,1,0.978466922233803,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19716,GO:1903644,1,0.957892529035172,0,2,regulation of chaperone-mediated protein folding,BP,
19717,GO:1903645,1,0.978467931885137,0,1,negative regulation of chaperone-mediated protein folding,BP,
19719,GO:1903650,1,0.957492001565336,0,2,negative regulation of cytoplasmic transport,BP,
19721,GO:1903659,1,0.937341398796323,0,3,regulation of complement-dependent cytotoxicity,BP,
19722,GO:1903660,1,0.937341398796323,0,3,negative regulation of complement-dependent cytotoxicity,BP,
19726,GO:1903673,1,0.978724803983263,0,1,mitotic cleavage furrow formation,BP,
19727,GO:1903674,1,0.97872199461599,0,1,regulation of cap-dependent translational initiation,BP,
19728,GO:1903676,1,0.97872199461599,0,1,positive regulation of cap-dependent translational initiation,BP,
19729,GO:1903677,1,0.93783347953873,0,3,regulation of cap-independent translational initiation,BP,
19730,GO:1903679,1,0.93783347953873,0,3,positive regulation of cap-independent translational initiation,BP,
19731,GO:1903689,1,0.874212991752053,0,7,regulation of wound healing, spreading of epidermal cells,BP,
19732,GO:1903690,1,0.925470396031167,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19733,GO:1903691,1,0.964869188763417,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19734,GO:1903697,1,0.979069333611148,0,1,negative regulation of microvillus assembly,BP,
19735,GO:1903699,1,0.98441811686448,0,1,tarsal gland development,BP,
19736,GO:1903701,1,0.979705099176087,0,1,substantia propria of cornea development,BP,
19737,GO:1903704,1,0.979110885702327,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19741,GO:1903709,1,0.98441811686448,0,1,uterine gland development,BP,
19742,GO:1903712,1,0.979076408025917,0,1,cysteine transmembrane transport,BP,
19744,GO:1903717,1,0.980121478494524,0,1,response to ammonia,BP,
19745,GO:1903718,1,0.980121478494524,0,1,cellular response to ammonia,BP,
19748,GO:1903722,1,0.958003802121922,0,2,regulation of centriole elongation,BP,
19749,GO:1903723,1,0.978485347627933,0,1,negative regulation of centriole elongation,BP,
19750,GO:1903724,1,0.979069339153274,0,1,positive regulation of centriole elongation,BP,
19755,GO:1903742,1,0.97854365350071,0,1,regulation of anterograde synaptic vesicle transport,BP,
19756,GO:1903743,1,0.97854365350071,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19758,GO:1903748,1,0.865408463235904,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19760,GO:1903750,1,0.918086551059836,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19761,GO:1903751,1,0.918086551059836,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19762,GO:1903753,1,0.919338232844522,0,4,negative regulation of p38MAPK cascade,BP,
19763,GO:1903755,1,0.978520430518689,0,1,positive regulation of SUMO transferase activity,BP,
19764,GO:1903756,1,0.95867445302214,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19765,GO:1903758,1,0.95867445302214,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19766,GO:1903759,1,0.979067305686981,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19767,GO:1903760,1,0.939226500274246,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19768,GO:1903762,1,0.958804212547253,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19769,GO:1903763,1,0.940869477620679,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19770,GO:1903764,1,0.938433056843786,0,3,regulation of potassium ion export across plasma membrane,BP,
19771,GO:1903765,1,0.97906372769701,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19772,GO:1903766,1,0.978481225703226,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19773,GO:1903767,1,0.958378506568461,0,2,sweet taste receptor complex,CC,
19774,GO:1903768,1,0.958378506568461,0,2,taste receptor complex,CC,
19775,GO:1903770,1,0.979049480011355,0,1,negative regulation of beta-galactosidase activity,BP,
19776,GO:1903772,1,0.898339755071902,0,5,regulation of viral budding via host ESCRT complex,BP,
19777,GO:1903774,1,0.937782310016672,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19778,GO:1903775,1,0.979069338941652,0,1,regulation of DNA double-strand break processing,BP,
19779,GO:1903778,1,0.959987940607069,0,2,protein localization to vacuolar membrane,BP,
19781,GO:1903781,1,0.938806578783788,0,3,positive regulation of cardiac conduction,BP,
19782,GO:1903786,1,0.979022687514597,0,1,regulation of glutathione biosynthetic process,BP,
19783,GO:1903788,1,0.979022687514597,0,1,positive regulation of glutathione biosynthetic process,BP,
19784,GO:1903789,1,0.958227145597026,0,2,regulation of amino acid transmembrane transport,BP,
19787,GO:1903795,1,0.903757128283586,0,5,regulation of inorganic anion transmembrane transport,BP,
19788,GO:1903796,1,0.961774146104334,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19789,GO:1903797,1,0.939683302899425,0,3,positive regulation of inorganic anion transmembrane transport,BP,
19791,GO:1903799,1,0.868894728802143,0,7,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19793,GO:1903802,1,0.903974209790183,0,5,L-glutamate(1-) import into cell,BP,
19794,GO:1903814,1,0.978481225703226,0,1,regulation of collecting lymphatic vessel constriction,BP,
19795,GO:1903815,1,0.978481225703226,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19796,GO:1903817,1,0.864599534938194,0,7,negative regulation of voltage-gated potassium channel activity,BP,
19797,GO:1903818,1,0.903822568950187,0,5,positive regulation of voltage-gated potassium channel activity,BP,
19798,GO:1903823,1,0.979049480011355,0,1,telomere single strand break repair,BP,
19799,GO:1903824,1,0.979049480011355,0,1,negative regulation of telomere single strand break repair,BP,
19801,GO:1903826,1,0.922715095260228,0,4,arginine transmembrane transport,BP,
19806,GO:1903831,1,0.642359938159788,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19807,GO:1903837,1,0.978946517601127,0,1,regulation of mRNA 3'-UTR binding,BP,
19808,GO:1903839,1,0.978946517601127,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19811,GO:1903846,1,0.59723407222098,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19814,GO:1903850,1,0.979004267914554,0,1,regulation of cristae formation,BP,
19815,GO:1903852,1,0.979004267914554,0,1,positive regulation of cristae formation,BP,
19816,GO:1903859,1,0.691722491444898,0,18,regulation of dendrite extension,BP,
19817,GO:1903860,1,0.958015954171848,0,2,negative regulation of dendrite extension,BP,
19818,GO:1903861,1,0.722064003275702,0,16,positive regulation of dendrite extension,BP,
19819,GO:1903862,1,0.860308183297099,0,7,positive regulation of oxidative phosphorylation,BP,
19821,GO:1903874,1,0.938889762303193,0,3,ferrous iron transmembrane transport,BP,
19822,GO:1903881,1,0.979075551884441,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19823,GO:1903883,1,0.979075551884441,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19824,GO:1903884,1,0.979075551884441,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19825,GO:1903886,1,0.979075551884441,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19826,GO:1903888,1,0.978476629273923,0,1,regulation of plant epidermal cell differentiation,BP,
19827,GO:1903889,1,0.978476629273923,0,1,negative regulation of plant epidermal cell differentiation,BP,
19828,GO:1903891,1,0.958612085415158,0,2,regulation of ATF6-mediated unfolded protein response,BP,
19829,GO:1903892,1,0.979072220695289,0,1,negative regulation of ATF6-mediated unfolded protein response,BP,
19830,GO:1903894,1,0.776683815697202,0,12,regulation of IRE1-mediated unfolded protein response,BP,
19831,GO:1903895,1,0.958563857983205,0,2,negative regulation of IRE1-mediated unfolded protein response,BP,
19832,GO:1903896,1,0.845703094176725,0,8,positive regulation of IRE1-mediated unfolded protein response,BP,
19833,GO:1903897,1,0.810515858972477,0,10,regulation of PERK-mediated unfolded protein response,BP,
19834,GO:1903898,1,0.899621746417322,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19835,GO:1903899,1,0.920212243979741,0,4,positive regulation of PERK-mediated unfolded protein response,BP,
19839,GO:1903903,1,0.958458908961625,0,2,regulation of establishment of T cell polarity,BP,
19840,GO:1903905,1,0.978997566456369,0,1,positive regulation of establishment of T cell polarity,BP,
19841,GO:1903906,1,0.979021927090507,0,1,regulation of plasma membrane raft polarization,BP,
19842,GO:1903909,1,0.882301902782785,0,6,regulation of receptor clustering,BP,
19843,GO:1903910,1,0.978895900984278,0,1,negative regulation of receptor clustering,BP,
19844,GO:1903911,1,0.920646665736645,0,4,positive regulation of receptor clustering,BP,
19845,GO:1903912,1,0.900471216584761,0,5,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19846,GO:1903916,1,0.978912378702394,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19847,GO:1903917,1,0.978912378702394,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19848,GO:1903918,1,0.981463131983759,0,1,regulation of actin filament severing,BP,
19849,GO:1903919,1,0.981463131983759,0,1,negative regulation of actin filament severing,BP,
19850,GO:1903921,1,0.960872886882366,0,2,regulation of protein processing in phagocytic vesicle,BP,
19851,GO:1903923,1,0.960872886882366,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19852,GO:1903924,1,0.978850733393808,0,1,estradiol binding,MF,
19853,GO:1903925,1,0.978704547525532,0,1,response to bisphenol A,BP,
19854,GO:1903926,1,0.978704547525532,0,1,cellular response to bisphenol A,BP,
19855,GO:1903935,1,0.898931798280677,0,5,response to sodium arsenite,BP,
19856,GO:1903936,1,0.918152463206324,0,4,cellular response to sodium arsenite,BP,
19857,GO:1903937,1,0.959039736066596,0,2,response to acrylamide,BP,
19858,GO:1903939,1,0.979069326547467,0,1,regulation of TORC2 signaling,BP,
19859,GO:1903943,1,0.978741415412062,0,1,regulation of hepatocyte apoptotic process,BP,
19860,GO:1903944,1,0.978741415412062,0,1,negative regulation of hepatocyte apoptotic process,BP,
19861,GO:1903946,1,0.97906372769701,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19862,GO:1903947,1,0.958804212547253,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19863,GO:1903949,1,0.958665914377467,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19864,GO:1903952,1,0.97910515275087,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19865,GO:1903954,1,0.97910515275087,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19866,GO:1903955,1,0.176571741654672,0,82,positive regulation of protein targeting to mitochondrion,BP,
19869,GO:1903961,1,0.920418707606649,0,4,positive regulation of anion transmembrane transport,BP,
19870,GO:1903963,1,0.537800018982945,0,29,arachidonate transport,BP,
19871,GO:1903969,1,0.937506344069037,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19872,GO:1903970,1,0.957686645764958,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19873,GO:1903971,1,0.978930529495848,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19874,GO:1903972,1,0.937506344069037,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19875,GO:1903973,1,0.957686645764958,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19876,GO:1903974,1,0.978930529495848,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19877,GO:1903975,1,0.826418626840185,0,9,regulation of glial cell migration,BP,
19878,GO:1903976,1,0.917694763186904,0,4,negative regulation of glial cell migration,BP,
19879,GO:1903977,1,0.940337052517965,0,3,positive regulation of glial cell migration,BP,
19880,GO:1903978,1,0.95755120502349,0,2,regulation of microglial cell activation,BP,
19881,GO:1903979,1,0.978505522229819,0,1,negative regulation of microglial cell activation,BP,
19882,GO:1903980,1,0.95755120502349,0,2,positive regulation of microglial cell activation,BP,
19883,GO:1903984,1,0.939900093929929,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19884,GO:1903988,1,0.979069335039327,0,1,ferrous iron export across plasma membrane,BP,
19885,GO:1903989,1,0.957684554525506,0,2,regulation of ferrous iron import into cell,BP,
19886,GO:1903991,1,0.957684554525506,0,2,positive regulation of ferrous iron import into cell,BP,
19887,GO:1903995,1,0.978586640327867,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19888,GO:1903997,1,0.978586640327867,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19889,GO:1903998,1,0.962429788989792,0,2,regulation of eating behavior,BP,
19890,GO:1903999,1,0.979716121879881,0,1,negative regulation of eating behavior,BP,
19891,GO:1904000,1,0.982356752390083,0,1,positive regulation of eating behavior,BP,
19892,GO:1904008,1,0.978559143259173,0,1,response to monosodium glutamate,BP,
19893,GO:1904009,1,0.978559143259173,0,1,cellular response to monosodium glutamate,BP,
19894,GO:1904010,1,0.978559143259173,0,1,response to Aroclor 1254,BP,
19895,GO:1904016,1,0.961809294313163,0,2,response to Thyroglobulin triiodothyronine,BP,
19896,GO:1904017,1,0.961809294313163,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
19899,GO:1904020,1,0.979069343063311,0,1,regulation of G-protein coupled receptor internalization,BP,
19900,GO:1904021,1,0.979069343063311,0,1,negative regulation of G-protein coupled receptor internalization,BP,
19903,GO:1904026,1,0.978966340526484,0,1,regulation of collagen fibril organization,BP,
19904,GO:1904027,1,0.978966340526484,0,1,negative regulation of collagen fibril organization,BP,
19910,GO:1904037,1,0.605339668360079,0,24,positive regulation of epithelial cell apoptotic process,BP,
19911,GO:1904041,1,0.979069205329571,0,1,regulation of cystathionine beta-synthase activity,BP,
19912,GO:1904042,1,0.979069205329571,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19913,GO:1904044,1,0.918258674847919,0,4,response to aldosterone,BP,
19914,GO:1904045,1,0.978845408400923,0,1,cellular response to aldosterone,BP,
19915,GO:1904046,1,0.978483828037327,0,1,negative regulation of vascular endothelial growth factor production,BP,
19916,GO:1904047,1,0.938112083242464,0,3,S-adenosyl-L-methionine binding,MF,
19917,GO:1904048,1,0.96293117697268,0,2,regulation of spontaneous neurotransmitter secretion,BP,
19918,GO:1904049,1,0.983280765401125,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
19919,GO:1904050,1,0.979305340332325,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19920,GO:1904054,1,0.982356752390083,0,1,regulation of cholangiocyte proliferation,BP,
19921,GO:1904056,1,0.982356752390083,0,1,positive regulation of cholangiocyte proliferation,BP,
19922,GO:1904057,1,0.958054730734685,0,2,negative regulation of sensory perception of pain,BP,
19923,GO:1904058,1,0.921527944211095,0,4,positive regulation of sensory perception of pain,BP,
19924,GO:1904059,1,0.965436428534711,0,2,regulation of locomotor rhythm,BP,
19928,GO:1904071,1,0.961693808273415,0,2,presynaptic active zone assembly,BP,
19929,GO:1904073,1,0.981257942545542,0,1,regulation of trophectodermal cell proliferation,BP,
19930,GO:1904075,1,0.981257942545542,0,1,positive regulation of trophectodermal cell proliferation,BP,
19931,GO:1904098,1,0.938510674197642,0,3,regulation of protein O-linked glycosylation,BP,
19932,GO:1904100,1,0.938510674197642,0,3,positive regulation of protein O-linked glycosylation,BP,
19933,GO:1904106,1,0.958515166634792,0,2,protein localization to microvillus,BP,
19934,GO:1904115,1,0.456145731465436,0,38,axon cytoplasm,CC,
19935,GO:1904116,1,0.939858936106298,0,3,response to vasopressin,BP,
19936,GO:1904117,1,0.939858936106298,0,3,cellular response to vasopressin,BP,
19937,GO:1904118,1,0.979065745481601,0,1,regulation of otic vesicle morphogenesis,BP,
19938,GO:1904120,1,0.979065745481601,0,1,positive regulation of otic vesicle morphogenesis,BP,
19939,GO:1904121,1,0.961220399638594,0,2,phosphatidylethanolamine transporter activity,MF,
19940,GO:1904124,1,0.93744384658676,0,3,microglial cell migration,BP,
19941,GO:1904139,1,0.93744384658676,0,3,regulation of microglial cell migration,BP,
19942,GO:1904140,1,0.978586640327867,0,1,negative regulation of microglial cell migration,BP,
19943,GO:1904141,1,0.978930529495848,0,1,positive regulation of microglial cell migration,BP,
19944,GO:1904149,1,0.978586640327867,0,1,regulation of microglial cell mediated cytotoxicity,BP,
19945,GO:1904151,1,0.978586640327867,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
19946,GO:1904152,1,0.760226203728576,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
19947,GO:1904153,1,0.826937173648648,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
19948,GO:1904154,1,0.939025067710317,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
19949,GO:1904155,1,0.979069326995122,0,1,DN2 thymocyte differentiation,BP,
19950,GO:1904156,1,0.979069326995122,0,1,DN3 thymocyte differentiation,BP,
19951,GO:1904158,1,0.943987105057973,0,3,axonemal central apparatus assembly,BP,
19952,GO:1904167,1,0.983546283884205,0,1,regulation of thyroid hormone receptor activity,BP,
19953,GO:1904168,1,0.983546283884205,0,1,negative regulation of thyroid hormone receptor activity,BP,
19954,GO:1904170,1,0.9790668910779,0,1,regulation of bleb assembly,BP,
19955,GO:1904172,1,0.9790668910779,0,1,positive regulation of bleb assembly,BP,
19957,GO:1904179,1,0.921110568687698,0,4,positive regulation of adipose tissue development,BP,
19958,GO:1904180,1,0.861066951882378,0,7,negative regulation of membrane depolarization,BP,
19959,GO:1904181,1,0.794903878708673,0,11,positive regulation of membrane depolarization,BP,
19960,GO:1904182,1,0.978515513469385,0,1,regulation of pyruvate dehydrogenase activity,BP,
19961,GO:1904192,1,0.982356752390083,0,1,regulation of cholangiocyte apoptotic process,BP,
19962,GO:1904193,1,0.982356752390083,0,1,negative regulation of cholangiocyte apoptotic process,BP,
19963,GO:1904195,1,0.982356752390083,0,1,regulation of granulosa cell proliferation,BP,
19964,GO:1904197,1,0.982356752390083,0,1,positive regulation of granulosa cell proliferation,BP,
19965,GO:1904199,1,0.979125761205231,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19966,GO:1904200,1,0.982356752390083,0,1,iodide transmembrane transport,BP,
19967,GO:1904201,1,0.982356752390083,0,1,regulation of iodide transport,BP,
19968,GO:1904202,1,0.982356752390083,0,1,negative regulation of iodide transport,BP,
19969,GO:1904204,1,0.963190399282698,0,2,regulation of skeletal muscle hypertrophy,BP,
19970,GO:1904205,1,0.980490356347428,0,1,negative regulation of skeletal muscle hypertrophy,BP,
19971,GO:1904206,1,0.982356752390083,0,1,positive regulation of skeletal muscle hypertrophy,BP,
19972,GO:1904207,1,0.958376403362318,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19973,GO:1904209,1,0.958376403362318,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19974,GO:1904210,1,0.978555151618616,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19975,GO:1904211,1,0.958678871514037,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
19976,GO:1904212,1,0.982356752390083,0,1,regulation of iodide transmembrane transport,BP,
19977,GO:1904213,1,0.982356752390083,0,1,negative regulation of iodide transmembrane transport,BP,
19978,GO:1904217,1,0.937887510662248,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19979,GO:1904219,1,0.937887510662248,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19980,GO:1904220,1,0.918164953263497,0,4,regulation of serine C-palmitoyltransferase activity,BP,
19981,GO:1904222,1,0.937887510662248,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
19982,GO:1904226,1,0.978834703582196,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19983,GO:1904227,1,0.978834703582196,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19984,GO:1904229,1,0.960074945497492,0,2,regulation of succinate dehydrogenase activity,BP,
19985,GO:1904231,1,0.960074945497492,0,2,positive regulation of succinate dehydrogenase activity,BP,
19986,GO:1904232,1,0.960074945497492,0,2,regulation of aconitate hydratase activity,BP,
19987,GO:1904234,1,0.960074945497492,0,2,positive regulation of aconitate hydratase activity,BP,
19988,GO:1904235,1,0.982085308500429,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19989,GO:1904237,1,0.982085308500429,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19991,GO:1904239,1,0.978555151618616,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19992,GO:1904240,1,0.978555151618616,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19993,GO:1904245,1,0.95816714167877,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
19994,GO:1904246,1,0.978657217974508,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
19995,GO:1904247,1,0.979064288828823,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
19997,GO:1904252,1,0.938020067944876,0,3,negative regulation of bile acid metabolic process,BP,
19999,GO:1904259,1,0.90698913613954,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20000,GO:1904261,1,0.90698913613954,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20002,GO:1904263,1,0.861986250803822,0,7,positive regulation of TORC1 signaling,BP,
20003,GO:1904264,1,0.778205130068093,0,12,ubiquitin protein ligase activity involved in ERAD pathway,MF,
20004,GO:1904265,1,0.980509327263079,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20005,GO:1904266,1,0.981228720568987,0,1,regulation of Schwann cell chemotaxis,BP,
20006,GO:1904268,1,0.981228720568987,0,1,positive regulation of Schwann cell chemotaxis,BP,
20007,GO:1904274,1,0.978850324501421,0,1,tricellular tight junction assembly,BP,
20008,GO:1904282,1,0.978735715216539,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20009,GO:1904283,1,0.978735715216539,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20010,GO:1904288,1,0.921240323887416,0,4,BAT3 complex binding,MF,
20011,GO:1904289,1,0.979058353496236,0,1,regulation of mitotic DNA damage checkpoint,BP,
20012,GO:1904292,1,0.567511725173947,0,27,regulation of ERAD pathway,BP,
20013,GO:1904293,1,0.75968844767925,0,13,negative regulation of ERAD pathway,BP,
20014,GO:1904294,1,0.762903103648893,0,13,positive regulation of ERAD pathway,BP,
20015,GO:1904298,1,0.979143855843724,0,1,regulation of transcytosis,BP,
20016,GO:1904300,1,0.979143855843724,0,1,positive regulation of transcytosis,BP,
20017,GO:1904301,1,0.979143855843724,0,1,regulation of maternal process involved in parturition,BP,
20018,GO:1904303,1,0.979143855843724,0,1,positive regulation of maternal process involved in parturition,BP,
20019,GO:1904304,1,0.979143855843724,0,1,regulation of gastro-intestinal system smooth muscle contraction,BP,
20020,GO:1904306,1,0.979143855843724,0,1,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20021,GO:1904313,1,0.958106007150109,0,2,response to methamphetamine hydrochloride,BP,
20022,GO:1904315,1,0.668977209638712,0,19,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20023,GO:1904316,1,0.979143855843724,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20024,GO:1904317,1,0.979143855843724,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20025,GO:1904321,1,0.836098564333719,0,9,response to forskolin,BP,
20026,GO:1904322,1,0.836098564333719,0,9,cellular response to forskolin,BP,
20027,GO:1904327,1,0.96022819403272,0,2,protein localization to cytosolic proteasome complex,BP,
20028,GO:1904338,1,0.811209192983046,0,10,regulation of dopaminergic neuron differentiation,BP,
20029,GO:1904339,1,0.940031503020167,0,3,negative regulation of dopaminergic neuron differentiation,BP,
20030,GO:1904340,1,0.917625264012452,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20031,GO:1904350,1,0.899041239172483,0,5,regulation of protein catabolic process in the vacuole,BP,
20032,GO:1904351,1,0.958615962668869,0,2,negative regulation of protein catabolic process in the vacuole,BP,
20033,GO:1904352,1,0.958057204370338,0,2,positive regulation of protein catabolic process in the vacuole,BP,
20034,GO:1904353,1,0.58478024758091,0,26,regulation of telomere capping,BP,
20035,GO:1904354,1,0.852252548699999,0,8,negative regulation of telomere capping,BP,
20036,GO:1904355,1,0.700375581289761,0,17,positive regulation of telomere capping,BP,
20037,GO:1904356,1,0.323241220478446,0,54,regulation of telomere maintenance via telomere lengthening,BP,
20038,GO:1904357,1,0.633516042362342,0,22,negative regulation of telomere maintenance via telomere lengthening,BP,
20039,GO:1904358,1,0.480740169958501,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
20040,GO:1904373,1,0.978594537828936,0,1,response to kainic acid,BP,
20044,GO:1904378,1,0.94073606828228,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20045,GO:1904379,1,0.96022819403272,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20046,GO:1904380,1,0.659993916129879,0,20,endoplasmic reticulum mannose trimming,BP,
20047,GO:1904381,1,0.93932487245946,0,3,Golgi apparatus mannose trimming,BP,
20048,GO:1904382,1,0.92139791505583,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20049,GO:1904383,1,0.938243840686424,0,3,response to sodium phosphate,BP,
20051,GO:1904386,1,0.899670551614529,0,5,response to L-phenylalanine derivative,BP,
20052,GO:1904387,1,0.95857741030419,0,2,cellular response to L-phenylalanine derivative,BP,
20053,GO:1904389,1,0.978594537828936,0,1,rod bipolar cell differentiation,BP,
20054,GO:1904391,1,0.978594537828936,0,1,response to ciliary neurotrophic factor,BP,
20055,GO:1904393,1,0.94051163088398,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20056,GO:1904394,1,0.978895900984278,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20057,GO:1904395,1,0.96079043490389,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20058,GO:1904396,1,0.849100782613461,0,8,regulation of neuromuscular junction development,BP,
20059,GO:1904397,1,0.957940977531003,0,2,negative regulation of neuromuscular junction development,BP,
20060,GO:1904398,1,0.942844105511755,0,3,positive regulation of neuromuscular junction development,BP,
20061,GO:1904399,1,0.978594537828936,0,1,heparan sulfate binding,MF,
20062,GO:1904400,1,0.979065102314849,0,1,response to Thyroid stimulating hormone,BP,
20063,GO:1904404,1,0.981337320016502,0,1,response to formaldehyde,BP,
20066,GO:1904408,1,0.978511455072996,0,1,melatonin binding,MF,
20067,GO:1904412,1,0.979071682445459,0,1,regulation of cardiac ventricle development,BP,
20068,GO:1904414,1,0.979071682445459,0,1,positive regulation of cardiac ventricle development,BP,
20069,GO:1904415,1,0.880571830386394,0,6,regulation of xenophagy,BP,
20070,GO:1904417,1,0.880571830386394,0,6,positive regulation of xenophagy,BP,
20071,GO:1904424,1,0.900896113154945,0,5,regulation of GTP binding,BP,
20072,GO:1904425,1,0.979079401590507,0,1,negative regulation of GTP binding,BP,
20073,GO:1904426,1,0.959163797803409,0,2,positive regulation of GTP binding,BP,
20075,GO:1904428,1,0.983737702995487,0,1,negative regulation of tubulin deacetylation,BP,
20076,GO:1904429,1,0.862302869790326,0,7,regulation of t-circle formation,BP,
20077,GO:1904430,1,0.938731188139241,0,3,negative regulation of t-circle formation,BP,
20078,GO:1904431,1,0.918596820709858,0,4,positive regulation of t-circle formation,BP,
20079,GO:1904432,1,0.957684554525506,0,2,regulation of ferrous iron binding,BP,
20080,GO:1904434,1,0.957684554525506,0,2,positive regulation of ferrous iron binding,BP,
20081,GO:1904435,1,0.957684554525506,0,2,regulation of transferrin receptor binding,BP,
20082,GO:1904437,1,0.957684554525506,0,2,positive regulation of transferrin receptor binding,BP,
20083,GO:1904447,1,0.980680277550159,0,1,folic acid import into cell,BP,
20084,GO:1904448,1,0.979516224791057,0,1,regulation of aspartate secretion,BP,
20085,GO:1904450,1,0.979516224791057,0,1,positive regulation of aspartate secretion,BP,
20086,GO:1904454,1,0.981760344414355,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20087,GO:1904455,1,0.960467542196861,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20088,GO:1904456,1,0.97870572453966,0,1,negative regulation of neuronal action potential,BP,
20089,GO:1904457,1,0.978921358707565,0,1,positive regulation of neuronal action potential,BP,
20090,GO:1904464,1,0.97865472952949,0,1,regulation of matrix metallopeptidase secretion,BP,
20091,GO:1904465,1,0.97865472952949,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20092,GO:1904467,1,0.862419470949105,0,7,regulation of tumor necrosis factor secretion,BP,
20093,GO:1904468,1,0.938864489100152,0,3,negative regulation of tumor necrosis factor secretion,BP,
20094,GO:1904469,1,0.918590564198449,0,4,positive regulation of tumor necrosis factor secretion,BP,
20095,GO:1904478,1,0.824299543153129,0,9,regulation of intestinal absorption,BP,
20096,GO:1904479,1,0.918195173984514,0,4,negative regulation of intestinal absorption,BP,
20097,GO:1904481,1,0.978941266412219,0,1,response to tetrahydrofolate,BP,
20098,GO:1904482,1,0.978941266412219,0,1,cellular response to tetrahydrofolate,BP,
20099,GO:1904491,1,0.902833877238892,0,5,protein localization to ciliary transition zone,BP,
20100,GO:1904492,1,0.978987344273391,0,1,Ac-Asp-Glu binding,MF,
20101,GO:1904493,1,0.978987344273391,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20102,GO:1904499,1,0.979069351318695,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20103,GO:1904501,1,0.979069351318695,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20106,GO:1904505,1,0.920559082371927,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20107,GO:1904506,1,0.920559082371927,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20108,GO:1904515,1,0.979069326547467,0,1,positive regulation of TORC2 signaling,BP,
20109,GO:1904526,1,0.881037293646031,0,6,regulation of microtubule binding,BP,
20110,GO:1904527,1,0.958498568140274,0,2,negative regulation of microtubule binding,BP,
20111,GO:1904528,1,0.919123525842997,0,4,positive regulation of microtubule binding,BP,
20112,GO:1904529,1,0.959514361055073,0,2,regulation of actin filament binding,BP,
20113,GO:1904530,1,0.979065317522414,0,1,negative regulation of actin filament binding,BP,
20114,GO:1904531,1,0.980032138912288,0,1,positive regulation of actin filament binding,BP,
20115,GO:1904533,1,0.938715987922295,0,3,regulation of telomeric loop disassembly,BP,
20116,GO:1904534,1,0.958540672598738,0,2,negative regulation of telomeric loop disassembly,BP,
20117,GO:1904535,1,0.979320208571654,0,1,positive regulation of telomeric loop disassembly,BP,
20118,GO:1904542,1,0.979004267914554,0,1,regulation of free ubiquitin chain polymerization,BP,
20119,GO:1904544,1,0.979004267914554,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20120,GO:1904562,1,0.963104649843375,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20121,GO:1904565,1,0.979066354826871,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20122,GO:1904566,1,0.979066354826871,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20123,GO:1904567,1,0.979060220110392,0,1,response to wortmannin,BP,
20124,GO:1904568,1,0.979060220110392,0,1,cellular response to wortmannin,BP,
20125,GO:1904569,1,0.957581626778655,0,2,regulation of selenocysteine incorporation,BP,
20126,GO:1904570,1,0.978656505269765,0,1,negative regulation of selenocysteine incorporation,BP,
20127,GO:1904571,1,0.978466751492011,0,1,positive regulation of selenocysteine incorporation,BP,
20128,GO:1904572,1,0.978656505269765,0,1,negative regulation of mRNA binding,BP,
20129,GO:1904573,1,0.978656505269765,0,1,regulation of selenocysteine insertion sequence binding,BP,
20130,GO:1904574,1,0.978656505269765,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20131,GO:1904576,1,0.958115918738967,0,2,response to tunicamycin,BP,
20132,GO:1904577,1,0.958115918738967,0,2,cellular response to tunicamycin,BP,
20133,GO:1904578,1,0.938139039551234,0,3,response to thapsigargin,BP,
20134,GO:1904579,1,0.938139039551234,0,3,cellular response to thapsigargin,BP,
20135,GO:1904580,1,0.958163787273031,0,2,regulation of intracellular mRNA localization,BP,
20136,GO:1904582,1,0.958163787273031,0,2,positive regulation of intracellular mRNA localization,BP,
20137,GO:1904585,1,0.97882352488438,0,1,response to putrescine,BP,
20138,GO:1904586,1,0.97882352488438,0,1,cellular response to putrescine,BP,
20139,GO:1904587,1,0.901609169163485,0,5,response to glycoprotein,BP,
20140,GO:1904588,1,0.978527865550976,0,1,cellular response to glycoprotein,BP,
20144,GO:1904594,1,0.983914948881197,0,1,regulation of termination of RNA polymerase II transcription,BP,
20145,GO:1904595,1,0.983914948881197,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20146,GO:1904596,1,0.978545667108812,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20147,GO:1904597,1,0.978545667108812,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20148,GO:1904599,1,0.978545667108812,0,1,advanced glycation end-product binding,MF,
20149,GO:1904602,1,0.957992296447262,0,2,serotonin-activated cation-selective channel complex,CC,
20150,GO:1904603,1,0.978545667108812,0,1,regulation of advanced glycation end-product receptor activity,BP,
20151,GO:1904604,1,0.978545667108812,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20152,GO:1904606,1,0.979069350455509,0,1,fat cell apoptotic process,BP,
20153,GO:1904612,1,0.979065102314849,0,1,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20154,GO:1904616,1,0.959514361055073,0,2,regulation of actin binding,BP,
20155,GO:1904617,1,0.979065317522414,0,1,negative regulation of actin binding,BP,
20156,GO:1904618,1,0.980032138912288,0,1,positive regulation of actin binding,BP,
20157,GO:1904627,1,0.903948883051309,0,5,response to phorbol 13-acetate 12-myristate,BP,
20158,GO:1904628,1,0.903948883051309,0,5,cellular response to phorbol 13-acetate 12-myristate,BP,
20159,GO:1904631,1,0.978857461361443,0,1,response to glucoside,BP,
20160,GO:1904633,1,0.980557080498592,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20161,GO:1904635,1,0.980557080498592,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20162,GO:1904636,1,0.920408448991943,0,4,response to ionomycin,BP,
20163,GO:1904637,1,0.920408448991943,0,4,cellular response to ionomycin,BP,
20164,GO:1904638,1,0.980557080498592,0,1,response to resveratrol,BP,
20165,GO:1904639,1,0.980557080498592,0,1,cellular response to resveratrol,BP,
20166,GO:1904640,1,0.939316592511714,0,3,response to methionine,BP,
20169,GO:1904647,1,0.982620211412088,0,1,response to rotenone,BP,
20170,GO:1904649,1,0.979069350455509,0,1,regulation of fat cell apoptotic process,BP,
20171,GO:1904651,1,0.979069350455509,0,1,positive regulation of fat cell apoptotic process,BP,
20178,GO:1904674,1,0.958836643742647,0,2,positive regulation of somatic stem cell population maintenance,BP,
20179,GO:1904675,1,0.97905368115129,0,1,regulation of somatic stem cell division,BP,
20180,GO:1904677,1,0.97905368115129,0,1,positive regulation of somatic stem cell division,BP,
20181,GO:1904680,1,0.562347882077398,0,27,peptide transmembrane transporter activity,MF,
20182,GO:1904681,1,0.979012464794399,0,1,response to 3-methylcholanthrene,BP,
20183,GO:1904683,1,0.886297952707052,0,6,regulation of metalloendopeptidase activity,BP,
20184,GO:1904684,1,0.924347024400517,0,4,negative regulation of metalloendopeptidase activity,BP,
20185,GO:1904685,1,0.958845456082986,0,2,positive regulation of metalloendopeptidase activity,BP,
20186,GO:1904688,1,0.917675492502157,0,4,regulation of cytoplasmic translational initiation,BP,
20187,GO:1904689,1,0.978509509232932,0,1,negative regulation of cytoplasmic translational initiation,BP,
20188,GO:1904690,1,0.93783347953873,0,3,positive regulation of cytoplasmic translational initiation,BP,
20189,GO:1904691,1,0.978811469066312,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20190,GO:1904692,1,0.979072500214175,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20191,GO:1904693,1,0.941391595967952,0,3,midbrain morphogenesis,BP,
20192,GO:1904694,1,0.943644658096102,0,3,negative regulation of vascular smooth muscle contraction,BP,
20193,GO:1904700,1,0.978986757347795,0,1,granulosa cell apoptotic process,BP,
20194,GO:1904701,1,0.978679574538984,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20196,GO:1904706,1,0.843729057449127,0,8,negative regulation of vascular smooth muscle cell proliferation,BP,
20198,GO:1904708,1,0.978986757347795,0,1,regulation of granulosa cell apoptotic process,BP,
20199,GO:1904711,1,0.978679574538984,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20200,GO:1904713,1,0.962041098114726,0,2,beta-catenin destruction complex binding,MF,
20201,GO:1904714,1,0.843278292497719,0,8,regulation of chaperone-mediated autophagy,BP,
20202,GO:1904715,1,0.93798066790515,0,3,negative regulation of chaperone-mediated autophagy,BP,
20203,GO:1904716,1,0.978907447336373,0,1,positive regulation of chaperone-mediated autophagy,BP,
20204,GO:1904717,1,0.978936651145214,0,1,regulation of AMPA glutamate receptor clustering,BP,
20205,GO:1904719,1,0.978936651145214,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20206,GO:1904720,1,0.958432462614354,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20207,GO:1904721,1,0.979064139690432,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20208,GO:1904722,1,0.978928346363165,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20209,GO:1904723,1,0.978679574538984,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20211,GO:1904729,1,0.860467052515236,0,7,regulation of intestinal lipid absorption,BP,
20212,GO:1904730,1,0.958470419588343,0,2,negative regulation of intestinal lipid absorption,BP,
20213,GO:1904732,1,0.961011360825573,0,2,regulation of electron carrier activity,BP,
20214,GO:1904734,1,0.978465540667257,0,1,positive regulation of electron carrier activity,BP,
20216,GO:1904742,1,0.923413259535569,0,4,regulation of telomeric DNA binding,BP,
20217,GO:1904743,1,0.964164210812899,0,2,negative regulation of telomeric DNA binding,BP,
20218,GO:1904744,1,0.957738546931217,0,2,positive regulation of telomeric DNA binding,BP,
20222,GO:1904749,1,0.900358110670592,0,5,regulation of protein localization to nucleolus,BP,
20223,GO:1904750,1,0.980812726071875,0,1,negative regulation of protein localization to nucleolus,BP,
20224,GO:1904751,1,0.917975631989239,0,4,positive regulation of protein localization to nucleolus,BP,
20226,GO:1904753,1,0.939864990188947,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
20228,GO:1904760,1,0.939469567090022,0,3,regulation of myofibroblast differentiation,BP,
20229,GO:1904761,1,0.959516005623121,0,2,negative regulation of myofibroblast differentiation,BP,
20230,GO:1904762,1,0.979110088332993,0,1,positive regulation of myofibroblast differentiation,BP,
20231,GO:1904764,1,0.978771906698635,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20232,GO:1904772,1,0.978996601743249,0,1,response to tetrachloromethane,BP,
20233,GO:1904779,1,0.888995706625421,0,6,regulation of protein localization to centrosome,BP,
20234,GO:1904780,1,0.981140504695955,0,1,negative regulation of protein localization to centrosome,BP,
20235,GO:1904781,1,0.925597939972582,0,4,positive regulation of protein localization to centrosome,BP,
20236,GO:1904783,1,0.97852925271556,0,1,positive regulation of NMDA glutamate receptor activity,BP,
20237,GO:1904790,1,0.97905352361093,0,1,regulation of shelterin complex assembly,BP,
20238,GO:1904792,1,0.97905352361093,0,1,positive regulation of shelterin complex assembly,BP,
20239,GO:1904793,1,0.979069351318695,0,1,regulation of euchromatin binding,BP,
20240,GO:1904796,1,0.862598748452671,0,7,regulation of core promoter binding,BP,
20241,GO:1904797,1,0.980378563287104,0,1,negative regulation of core promoter binding,BP,
20242,GO:1904798,1,0.879869007862325,0,6,positive regulation of core promoter binding,BP,
20243,GO:1904799,1,0.979101809816413,0,1,regulation of neuron remodeling,BP,
20244,GO:1904800,1,0.979101809816413,0,1,negative regulation of neuron remodeling,BP,
20245,GO:1904803,1,0.978468501176454,0,1,regulation of translation involved in cellular response to UV,BP,
20246,GO:1904806,1,0.95839073820654,0,2,regulation of protein oxidation,BP,
20247,GO:1904808,1,0.95839073820654,0,2,positive regulation of protein oxidation,BP,
20248,GO:1904812,1,0.979101555141531,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20250,GO:1904814,1,0.758977981950654,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20251,GO:1904815,1,0.958223961013058,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20252,GO:1904816,1,0.79208889229952,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20253,GO:1904823,1,0.938010106545246,0,3,purine nucleobase transmembrane transport,BP,
20254,GO:1904826,1,0.981525096876413,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20255,GO:1904828,1,0.981525096876413,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20256,GO:1904829,1,0.97865811077371,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20257,GO:1904831,1,0.97865811077371,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20259,GO:1904835,1,0.978950316202423,0,1,dorsal root ganglion morphogenesis,BP,
20261,GO:1904842,1,0.978823939821561,0,1,response to nitroglycerin,BP,
20262,GO:1904843,1,0.978823939821561,0,1,cellular response to nitroglycerin,BP,
20263,GO:1904844,1,0.937833173733724,0,3,response to L-glutamine,BP,
20264,GO:1904845,1,0.937833173733724,0,3,cellular response to L-glutamine,BP,
20266,GO:1904848,1,0.978520430518689,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20268,GO:1904850,1,0.97905352361093,0,1,negative regulation of establishment of protein localization to telomere,BP,
20269,GO:1904851,1,0.825003432944279,0,9,positive regulation of establishment of protein localization to telomere,BP,
20270,GO:1904854,1,0.978909729008923,0,1,proteasome core complex binding,MF,
20273,GO:1904863,1,0.979081971348199,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20274,GO:1904864,1,0.979081971348199,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20275,GO:1904867,1,0.824851327405115,0,9,protein localization to Cajal body,BP,
20276,GO:1904868,1,0.966259968151251,0,2,telomerase catalytic core complex assembly,BP,
20277,GO:1904869,1,0.842811104176058,0,8,regulation of protein localization to Cajal body,BP,
20278,GO:1904871,1,0.842811104176058,0,8,positive regulation of protein localization to Cajal body,BP,
20279,GO:1904872,1,0.724819168401473,0,15,regulation of telomerase RNA localization to Cajal body,BP,
20280,GO:1904874,1,0.724819168401473,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20281,GO:1904875,1,0.979049357109579,0,1,regulation of DNA ligase activity,BP,
20282,GO:1904876,1,0.979049357109579,0,1,negative regulation of DNA ligase activity,BP,
20283,GO:1904878,1,0.983525905957674,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20284,GO:1904879,1,0.958496120481692,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20285,GO:1904882,1,0.966259968151251,0,2,regulation of telomerase catalytic core complex assembly,BP,
20286,GO:1904884,1,0.966259968151251,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20289,GO:1904887,1,0.982703479687859,0,1,Wnt signalosome assembly,BP,
20294,GO:1904893,1,0.35539937855596,0,49,negative regulation of STAT cascade,BP,
20296,GO:1904895,1,0.97863116530353,0,1,ESCRT complex assembly,BP,
20297,GO:1904896,1,0.807939873863903,0,10,ESCRT complex disassembly,BP,
20298,GO:1904897,1,0.979069293200516,0,1,regulation of hepatic stellate cell proliferation,BP,
20299,GO:1904899,1,0.979069293200516,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20300,GO:1904902,1,0.97863116530353,0,1,ESCRT III complex assembly,BP,
20301,GO:1904903,1,0.807939873863903,0,10,ESCRT III complex disassembly,BP,
20302,GO:1904907,1,0.967214898792141,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20303,GO:1904908,1,0.967214898792141,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20304,GO:1904910,1,0.97905352361093,0,1,regulation of establishment of RNA localization to telomere,BP,
20305,GO:1904911,1,0.97905352361093,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20306,GO:1904913,1,0.97905352361093,0,1,regulation of establishment of macromolecular complex localization to telomere,BP,
20307,GO:1904914,1,0.97905352361093,0,1,negative regulation of establishment of macromolecular complex localization to telomere,BP,
20308,GO:1904923,1,0.764927825782835,0,13,regulation of mitophagy in response to mitochondrial depolarization,BP,
20309,GO:1904924,1,0.963978534174015,0,2,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20310,GO:1904925,1,0.764927825782835,0,13,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
20311,GO:1904928,1,0.963285198606189,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20312,GO:1904929,1,0.882736468922793,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20315,GO:1904935,1,0.978555370373739,0,1,positive regulation of cell proliferation in midbrain,BP,
20316,GO:1904936,1,0.882689632197372,0,6,interneuron migration,BP,
20318,GO:1904947,1,0.979061271876645,0,1,folic acid import into mitochondrion,BP,
20326,GO:1904956,1,0.898830256819434,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20327,GO:1904958,1,0.937795355030966,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20328,GO:1904959,1,0.961011360825573,0,2,regulation of cytochrome-c oxidase activity,BP,
20329,GO:1904960,1,0.978465540667257,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20330,GO:1904970,1,0.901331039561137,0,5,brush border assembly,BP,
20331,GO:1904975,1,0.95920325097549,0,2,response to bleomycin,BP,
20332,GO:1904976,1,0.95920325097549,0,2,cellular response to bleomycin,BP,
20333,GO:1904978,1,0.940616084808035,0,3,regulation of endosome organization,BP,
20334,GO:1904979,1,0.978854407687914,0,1,negative regulation of endosome organization,BP,
20335,GO:1904980,1,0.981133821903718,0,1,positive regulation of endosome organization,BP,
20336,GO:1904990,1,0.978934321848921,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20337,GO:1904992,1,0.978934321848921,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20338,GO:1904994,1,0.791421458714635,0,11,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20339,GO:1904995,1,0.897680623125438,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20340,GO:1904996,1,0.881661872294642,0,6,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20341,GO:1904997,1,0.958130733463383,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20342,GO:1904998,1,0.979053151914992,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20343,GO:1904999,1,0.97863116530353,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20344,GO:1905000,1,0.982188133153268,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20345,GO:1905003,1,0.978529078223452,0,1,picolinic acid metabolic process,BP,
20346,GO:1905004,1,0.978529078223452,0,1,picolinic acid biosynthetic process,BP,
20348,GO:1905006,1,0.95884840580116,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20350,GO:1905008,1,0.978980782054902,0,1,regulation of L-lysine import into cell,BP,
20351,GO:1905010,1,0.978980782054902,0,1,positive regulation of L-lysine import into cell,BP,
20352,GO:1905012,1,0.978529078223452,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20353,GO:1905024,1,0.919559274040297,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20354,GO:1905025,1,0.97906372769701,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20355,GO:1905026,1,0.958804212547253,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20356,GO:1905030,1,0.63953681479104,0,23,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20357,GO:1905031,1,0.903176490211049,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20358,GO:1905032,1,0.97906372769701,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20359,GO:1905033,1,0.958804212547253,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20361,GO:1905038,1,0.758269580631566,0,13,regulation of membrane lipid metabolic process,BP,
20363,GO:1905040,1,0.978950316202423,0,1,otic placode development,BP,
20364,GO:1905041,1,0.981447711364207,0,1,regulation of epithelium regeneration,BP,
20365,GO:1905044,1,0.97897493185122,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20366,GO:1905045,1,0.97897493185122,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20367,GO:1905048,1,0.762871592964048,0,13,regulation of metallopeptidase activity,BP,
20368,GO:1905049,1,0.885523677889889,0,6,negative regulation of metallopeptidase activity,BP,
20369,GO:1905050,1,0.861534595968343,0,7,positive regulation of metallopeptidase activity,BP,
20370,GO:1905051,1,0.957605707625593,0,2,regulation of base-excision repair,BP,
20371,GO:1905053,1,0.957605707625593,0,2,positive regulation of base-excision repair,BP,
20372,GO:1905062,1,0.979015691396219,0,1,positive regulation of cardioblast proliferation,BP,
20375,GO:1905065,1,0.920804109734465,0,4,positive regulation of vascular smooth muscle cell differentiation,BP,
20376,GO:1905066,1,0.958032345657546,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20377,GO:1905067,1,0.978679574538984,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20378,GO:1905068,1,0.978904198792155,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20380,GO:1905071,1,0.9600568746681,0,2,occluding junction disassembly,BP,
20381,GO:1905073,1,0.9600568746681,0,2,regulation of occluding junction disassembly,BP,
20382,GO:1905075,1,0.9600568746681,0,2,positive regulation of occluding junction disassembly,BP,
20383,GO:1905089,1,0.984735370183364,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20384,GO:1905090,1,0.984735370183364,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20385,GO:1905097,1,0.903900639440845,0,5,regulation of guanyl-nucleotide exchange factor activity,BP,
20386,GO:1905098,1,0.939824270738699,0,3,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20387,GO:1905099,1,0.980582820291316,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20388,GO:1905103,1,0.979110685393671,0,1,integral component of lysosomal membrane,CC,
20390,GO:1905122,1,0.979110685393671,0,1,polyamine import,BP,
20391,GO:1905123,1,0.958956266309084,0,2,regulation of glucosylceramidase activity,BP,
20392,GO:1905132,1,0.958008869044639,0,2,regulation of meiotic chromosome separation,BP,
20393,GO:1905133,1,0.958008869044639,0,2,negative regulation of meiotic chromosome separation,BP,
20394,GO:1905143,1,0.978597056243655,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20395,GO:1905144,1,0.642359938159788,0,21,response to acetylcholine,BP,
20396,GO:1905145,1,0.642359938159788,0,21,cellular response to acetylcholine,BP,
20397,GO:1905146,1,0.91881635954573,0,4,lysosomal protein catabolic process,BP,
20398,GO:1905150,1,0.939806818575023,0,3,regulation of voltage-gated sodium channel activity,BP,
20399,GO:1905152,1,0.980239574047083,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20400,GO:1905153,1,0.778957736435985,0,12,regulation of membrane invagination,BP,
20401,GO:1905154,1,0.95888411667752,0,2,negative regulation of membrane invagination,BP,
20402,GO:1905155,1,0.829803931969677,0,9,positive regulation of membrane invagination,BP,
20403,GO:1905161,1,0.979741187992227,0,1,protein localization to phagocytic vesicle,BP,
20404,GO:1905162,1,0.979741187992227,0,1,regulation of phagosome maturation,BP,
20405,GO:1905165,1,0.938407338494083,0,3,regulation of lysosomal protein catabolic process,BP,
20406,GO:1905166,1,0.958615962668869,0,2,negative regulation of lysosomal protein catabolic process,BP,
20407,GO:1905169,1,0.979741187992227,0,1,regulation of protein localization to phagocytic vesicle,BP,
20408,GO:1905171,1,0.979741187992227,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20411,GO:1905202,1,0.958483655038194,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20412,GO:1905203,1,0.958347270102707,0,2,regulation of connective tissue replacement,BP,
20413,GO:1905204,1,0.978545667108812,0,1,negative regulation of connective tissue replacement,BP,
20414,GO:1905205,1,0.979359965811981,0,1,positive regulation of connective tissue replacement,BP,
20415,GO:1905206,1,0.900943846860256,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20419,GO:1905214,1,0.793576347619246,0,11,regulation of RNA binding,BP,
20420,GO:1905215,1,0.978656505269765,0,1,negative regulation of RNA binding,BP,
20421,GO:1905216,1,0.844593466967988,0,8,positive regulation of RNA binding,BP,
20422,GO:1905217,1,0.979065102314849,0,1,response to astaxanthin,BP,
20423,GO:1905222,1,0.9790666882547,0,1,atrioventricular canal morphogenesis,BP,
20424,GO:1905223,1,0.980583577006769,0,1,epicardium morphogenesis,BP,
20425,GO:1905224,1,0.959466611309635,0,2,clathrin-coated pit assembly,BP,
20426,GO:1905225,1,0.958041286337187,0,2,response to thyrotropin-releasing hormone,BP,
20427,GO:1905229,1,0.978527865550976,0,1,cellular response to thyrotropin-releasing hormone,BP,
20428,GO:1905230,1,0.979107757569395,0,1,response to borneol,BP,
20429,GO:1905231,1,0.979107757569395,0,1,cellular response to borneol,BP,
20430,GO:1905232,1,0.938577299703784,0,3,cellular response to L-glutamate,BP,
20431,GO:1905233,1,0.979107757569395,0,1,response to codeine,BP,
20432,GO:1905235,1,0.979107757569395,0,1,response to quercetin,BP,
20433,GO:1905237,1,0.958031007411143,0,2,response to cyclosporin A,BP,
20434,GO:1905239,1,0.979584100023671,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20435,GO:1905240,1,0.979584100023671,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20436,GO:1905242,1,0.97900963270787,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
20437,GO:1905243,1,0.97900963270787,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20438,GO:1905244,1,0.960687829035717,0,2,regulation of modification of synaptic structure,BP,
20439,GO:1905245,1,0.963287024569368,0,2,regulation of aspartic-type peptidase activity,BP,
20440,GO:1905246,1,0.983868746166216,0,1,negative regulation of aspartic-type peptidase activity,BP,
20441,GO:1905247,1,0.979081745911418,0,1,positive regulation of aspartic-type peptidase activity,BP,
20442,GO:1905255,1,0.980655377124509,0,1,regulation of RNA binding transcription factor activity,BP,
20443,GO:1905258,1,0.957540791977671,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20444,GO:1905259,1,0.957540791977671,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20445,GO:1905267,1,0.958378248755042,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20446,GO:1905268,1,0.371704277859621,0,48,negative regulation of chromatin organization,BP,
20448,GO:1905271,1,0.978469855833082,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20449,GO:1905273,1,0.978469855833082,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20450,GO:1905274,1,0.981228720568987,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20452,GO:1905277,1,0.979063806545174,0,1,negative regulation of epithelial tube formation,BP,
20454,GO:1905279,1,0.982703479687859,0,1,regulation of retrograde transport, endosome to Golgi,BP,
20455,GO:1905285,1,0.979071682445459,0,1,fibrous ring of heart morphogenesis,BP,
20456,GO:1905286,1,0.938203967022779,0,3,serine-type peptidase complex,CC,
20457,GO:1905289,1,0.982703479687859,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20458,GO:1905301,1,0.979305340332325,0,1,regulation of macropinocytosis,BP,
20459,GO:1905302,1,0.979305340332325,0,1,negative regulation of macropinocytosis,BP,
20460,GO:1905304,1,0.982356041621774,0,1,regulation of cardiac myofibril assembly,BP,
20461,GO:1905305,1,0.982356041621774,0,1,negative regulation of cardiac myofibril assembly,BP,
20462,GO:1905313,1,0.978841299221768,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20464,GO:1905323,1,0.88708852999099,0,6,telomerase holoenzyme complex assembly,BP,
20465,GO:1905327,1,0.978602768722672,0,1,tracheoesophageal septum formation,BP,
20469,GO:1905333,1,0.978629530647796,0,1,regulation of gastric motility,BP,
20470,GO:1905335,1,0.985530953689311,0,1,regulation of aggrephagy,BP,
20471,GO:1905337,1,0.985530953689311,0,1,positive regulation of aggrephagy,BP,
20472,GO:1905340,1,0.918106100079441,0,4,regulation of protein localization to kinetochore,BP,
20473,GO:1905341,1,0.979008629917437,0,1,negative regulation of protein localization to kinetochore,BP,
20474,GO:1905342,1,0.918106100079441,0,4,positive regulation of protein localization to kinetochore,BP,
20475,GO:1905344,1,0.97897493185122,0,1,prostaglandin catabolic process,BP,
20477,GO:1905354,1,0.626173135770431,0,22,exoribonuclease complex,CC,
20478,GO:1905355,1,0.97966221653319,0,1,spine apparatus assembly,BP,
20479,GO:1905359,1,0.979061701303031,0,1,protein localization to meiotic spindle,BP,
20480,GO:1905360,1,0.474483947773917,0,35,GTPase complex,CC,
20481,GO:1905361,1,0.824956303264918,0,9,L-serine transporter activity,MF,
20482,GO:1905365,1,0.978854407687914,0,1,regulation of intralumenal vesicle formation,BP,
20483,GO:1905366,1,0.978854407687914,0,1,negative regulation of intralumenal vesicle formation,BP,
20486,GO:1905370,1,0.978922284447464,0,1,serine-type endopeptidase complex,CC,
20487,GO:1905371,1,0.959422602315851,0,2,ceramide phosphoethanolamine metabolic process,BP,
20488,GO:1905373,1,0.959422602315851,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20492,GO:1905392,1,0.978476629273923,0,1,plant organ morphogenesis,BP,
20493,GO:1905394,1,0.939827264975292,0,3,retromer complex binding,MF,
20494,GO:1905395,1,0.938201822710606,0,3,response to flavonoid,BP,
20495,GO:1905397,1,0.978593152597655,0,1,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20496,GO:1905402,1,0.978593152597655,0,1,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20497,GO:1905404,1,0.978593152597655,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20498,GO:1905407,1,0.958227145597026,0,2,regulation of creatine transmembrane transporter activity,BP,
20499,GO:1905408,1,0.958227145597026,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20500,GO:1905419,1,0.978689626907284,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20501,GO:1905421,1,0.978476629273923,0,1,regulation of plant organ morphogenesis,BP,
20502,GO:1905422,1,0.978476629273923,0,1,negative regulation of plant organ morphogenesis,BP,
20503,GO:1905424,1,0.958227522647635,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20504,GO:1905426,1,0.958227522647635,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20505,GO:1905432,1,0.979130747882954,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20506,GO:1905433,1,0.979130747882954,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20508,GO:1905443,1,0.979281507431748,0,1,regulation of clathrin coat assembly,BP,
20509,GO:1905445,1,0.979281507431748,0,1,positive regulation of clathrin coat assembly,BP,
20510,GO:1905446,1,0.879557040986135,0,6,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20511,GO:1905447,1,0.958535426488522,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20512,GO:1905448,1,0.917614250005344,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20513,GO:1905449,1,0.959540197138371,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20514,GO:1905451,1,0.959540197138371,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20515,GO:1905453,1,0.979068578357292,0,1,regulation of myeloid progenitor cell differentiation,BP,
20518,GO:1905458,1,0.979104971336723,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20519,GO:1905462,1,0.979131260122671,0,1,regulation of DNA duplex unwinding,BP,
20520,GO:1905464,1,0.979131260122671,0,1,positive regulation of DNA duplex unwinding,BP,
20521,GO:1905468,1,0.979741187992227,0,1,regulation of clathrin-coated pit assembly,BP,
20522,GO:1905469,1,0.979741187992227,0,1,negative regulation of clathrin-coated pit assembly,BP,
20527,GO:1905483,1,0.984306146966229,0,1,regulation of motor neuron migration,BP,
20528,GO:1905485,1,0.984306146966229,0,1,positive regulation of motor neuron migration,BP,
20529,GO:1905508,1,0.631128740502807,0,23,protein localization to microtubule organizing center,BP,
20530,GO:1905515,1,0.376973761099106,0,47,non-motile cilium assembly,BP,
20531,GO:1905516,1,0.828565044199368,0,9,positive regulation of fertilization,BP,
20532,GO:1905517,1,0.504430616207401,0,32,macrophage migration,BP,
20533,GO:1905518,1,0.97951749973897,0,1,regulation of presynaptic active zone assembly,BP,
20534,GO:1905520,1,0.97951749973897,0,1,positive regulation of presynaptic active zone assembly,BP,
20535,GO:1905521,1,0.625989639176306,0,22,regulation of macrophage migration,BP,
20536,GO:1905522,1,0.91900990096373,0,4,negative regulation of macrophage migration,BP,
20537,GO:1905523,1,0.710933531613927,0,16,positive regulation of macrophage migration,BP,
20538,GO:1905524,1,0.981574863603851,0,1,negative regulation of protein autoubiquitination,BP,
20539,GO:1905535,1,0.979731132909452,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20540,GO:1905537,1,0.979731132909452,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20541,GO:1905546,1,0.978874203964035,0,1,cellular response to phenylpropanoid,BP,
20542,GO:1905547,1,0.978622147444102,0,1,regulation of telomeric heterochromatin assembly,BP,
20543,GO:1905549,1,0.978622147444102,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20544,GO:1905550,1,0.957915552460573,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20545,GO:1905552,1,0.957915552460573,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20546,GO:1905553,1,0.978622147444102,0,1,regulation of blood vessel branching,BP,
20547,GO:1905555,1,0.978622147444102,0,1,positive regulation blood vessel branching,BP,
20548,GO:1905562,1,0.978622147444102,0,1,regulation of vascular endothelial cell proliferation,BP,
20549,GO:1905564,1,0.978622147444102,0,1,positive regulation of vascular endothelial cell proliferation,BP,
20550,GO:1905572,1,0.979040707677425,0,1,ganglioside GM1 transport to membrane,BP,
20551,GO:1905573,1,0.9582082700588,0,2,ganglioside GM1 binding,MF,
20552,GO:1905574,1,0.979040707677425,0,1,ganglioside GM2 binding,MF,
20553,GO:1905575,1,0.979040707677425,0,1,ganglioside GM3 binding,MF,
20554,GO:1905576,1,0.938009990045439,0,3,ganglioside GT1b binding,MF,
20555,GO:1905577,1,0.979040707677425,0,1,ganglioside GP1c binding,MF,
20556,GO:1905578,1,0.978935577852832,0,1,regulation of ERBB3 signaling pathway,BP,
20557,GO:1905580,1,0.978935577852832,0,1,positive regulation of ERBB3 signaling pathway,BP,
20558,GO:1905581,1,0.978621989433484,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20559,GO:1905590,1,0.979066474527347,0,1,fibronectin fibril organization,BP,
20560,GO:1905594,1,0.978511455072996,0,1,resveratrol binding,MF,
20561,GO:1905595,1,0.958140512097775,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20562,GO:1905596,1,0.979072323496065,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20563,GO:1905597,1,0.978621989433484,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20564,GO:1905598,1,0.979072323496065,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20565,GO:1905599,1,0.978621989433484,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20566,GO:1905600,1,0.938068782067692,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20567,GO:1905601,1,0.979072323496065,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20568,GO:1905602,1,0.958122369465709,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20569,GO:1905603,1,0.979576774463753,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20570,GO:1905605,1,0.979576774463753,0,1,positive regulation of maintenance of permeability of blood-brain barrier,BP,
20571,GO:1905606,1,0.939572394804878,0,3,regulation of presynapse assembly,BP,
20572,GO:1905608,1,0.97951749973897,0,1,positive regulation of presynapse assembly,BP,
20573,GO:1905610,1,0.979731132909452,0,1,regulation of mRNA cap binding,BP,
20574,GO:1905612,1,0.979731132909452,0,1,positive regulation of mRNA cap binding,BP,
20575,GO:1905616,1,0.959131081607648,0,2,regulation of miRNA mediated inhibition of translation,BP,
20576,GO:1905618,1,0.959131081607648,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20577,GO:1905634,1,0.938433391299496,0,3,regulation of protein localization to chromatin,BP,
20578,GO:1905636,1,0.978528904045192,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20579,GO:1905642,1,0.97864615641684,0,1,negative regulation of DNA methylation,BP,
20580,GO:1905643,1,0.97864615641684,0,1,positive regulation of DNA methylation,BP,
20583,GO:1905661,1,0.958339720095412,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20584,GO:1905663,1,0.958339720095412,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20585,GO:1905664,1,0.95825451960015,0,2,regulation of calcium ion import across plasma membrane,BP,
20588,GO:1905671,1,0.958671747633211,0,2,regulation of lysosome organization,BP,
20589,GO:1905672,1,0.978820203269567,0,1,negative regulation of lysosome organization,BP,
20590,GO:1905687,1,0.980131843954398,0,1,regulation of diacylglycerol kinase activity,BP,
20591,GO:1905689,1,0.980131843954398,0,1,positive regulation of diacylglycerol kinase activity,BP,
20592,GO:1905693,1,0.978819787817556,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20593,GO:1905695,1,0.978819787817556,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20594,GO:1905696,1,0.979731132909452,0,1,regulation of polysome binding,BP,
20595,GO:1905705,1,0.981025195784456,0,1,cellular response to paclitaxel,BP,
20598,GO:1905711,1,0.979081880848646,0,1,response to phosphatidylethanolamine,BP,
20599,GO:1905715,1,0.978969559546176,0,1,regulation of cornification,BP,
20600,GO:1905716,1,0.978969559546176,0,1,negative regulation of cornification,BP,
20601,GO:1905747,1,0.957617234357243,0,2,negative regulation of saliva secretion,BP,
20602,GO:1905748,1,0.957617234357243,0,2,hard palate morphogenesis,BP,
20603,GO:1905764,1,0.940001358942251,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20604,GO:1905765,1,0.940001358942251,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20605,GO:1905767,1,0.980889962520051,0,1,regulation of double-stranded telomeric DNA binding,BP,
20606,GO:1905768,1,0.980889962520051,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20607,GO:1905770,1,0.861925998428547,0,7,regulation of mesodermal cell differentiation,BP,
20608,GO:1905771,1,0.917519458713045,0,4,negative regulation of mesodermal cell differentiation,BP,
20609,GO:1905772,1,0.979053151914992,0,1,positive regulation of mesodermal cell differentiation,BP,
20610,GO:1905774,1,0.979131260122671,0,1,regulation of DNA helicase activity,BP,
20611,GO:1905776,1,0.979131260122671,0,1,positive regulation of DNA helicase activity,BP,
20612,GO:1905777,1,0.958540672598738,0,2,regulation of exonuclease activity,BP,
20613,GO:1905778,1,0.958540672598738,0,2,negative regulation of exonuclease activity,BP,
20614,GO:1905793,1,0.963865748828773,0,2,protein localization to pericentriolar material,BP,
20615,GO:1905794,1,0.98328556800265,0,1,response to puromycin,BP,
20616,GO:1905795,1,0.98328556800265,0,1,cellular response to puromycin,BP,
20617,GO:1905802,1,0.979043139771547,0,1,regulation of cellular response to manganese ion,BP,
20619,GO:1905818,1,0.37792915460137,0,47,regulation of chromosome separation,BP,
20620,GO:1905819,1,0.526463902615673,0,31,negative regulation of chromosome separation,BP,
20621,GO:1905820,1,0.883788493242418,0,6,positive regulation of chromosome separation,BP,
20622,GO:1905838,1,0.958540672598738,0,2,regulation of telomeric D-loop disassembly,BP,
20623,GO:1905839,1,0.958540672598738,0,2,negative regulation of telomeric D-loop disassembly,BP,
20624,GO:1905853,1,0.978516865961842,0,1,regulation of heparan sulfate binding,BP,
20625,GO:1905855,1,0.978516865961842,0,1,positive regulation of heparan sulfate binding,BP,
20626,GO:1905858,1,0.978516865961842,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20627,GO:1905860,1,0.978516865961842,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20629,GO:1905871,1,0.97852925271556,0,1,regulation of protein localization to cell leading edge,BP,
20630,GO:1905873,1,0.97852925271556,0,1,positive regulation of protein localization to cell leading edge,BP,
20632,GO:1905875,1,0.97852925271556,0,1,negative regulation of postsynaptic density organization,BP,
20635,GO:1905881,1,0.920172739726635,0,4,positive regulation of oogenesis,BP,
20636,GO:1905890,1,0.978516865961842,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20637,GO:1905891,1,0.97904224457962,0,1,regulation of cellular response to thapsigargin,BP,
20638,GO:1905892,1,0.97904224457962,0,1,negative regulation of cellular response to thapsigargin,BP,
20639,GO:1905894,1,0.97904224457962,0,1,regulation of cellular response to tunicamycin,BP,
20640,GO:1905895,1,0.97904224457962,0,1,negative regulation of cellular response to tunicamycin,BP,
20643,GO:1905899,1,0.978602768722672,0,1,regulation of smooth muscle tissue development,BP,
20644,GO:1905900,1,0.978602768722672,0,1,negative regulation of smooth muscle tissue development,BP,
20645,GO:1905901,1,0.978602768722672,0,1,positive regulation of smooth muscle tissue development,BP,
20646,GO:1905902,1,0.861925998428547,0,7,regulation of mesoderm formation,BP,
20647,GO:1905903,1,0.917519458713045,0,4,negative regulation of mesoderm formation,BP,
20648,GO:1905904,1,0.979053151914992,0,1,positive regulation of mesoderm formation,BP,
20649,GO:1905906,1,0.937676575966526,0,3,regulation of amyloid fibril formation,BP,
20650,GO:1905907,1,0.957964438885912,0,2,negative regulation of amyloid fibril formation,BP,
20651,GO:1905912,1,0.978694818338773,0,1,regulation of calcium ion export from cell,BP,
20652,GO:1905913,1,0.978694818338773,0,1,negative regulation of calcium ion export from cell,BP,
20653,GO:1905918,1,0.978824354696714,0,1,regulation of CoA-transferase activity,BP,
20654,GO:1905920,1,0.978824354696714,0,1,positive regulation of CoA-transferase activity,BP,
20655,GO:1905936,1,0.917260199715532,0,4,regulation of germ cell proliferation,BP,
20656,GO:1905937,1,0.937425841671245,0,3,negative regulation of germ cell proliferation,BP,
20657,GO:1905938,1,0.978492024520221,0,1,positive regulation of germ cell proliferation,BP,
20665,GO:1905957,1,0.979217682648878,0,1,regulation of cellular response to alcohol,BP,
20666,GO:1905959,1,0.979217682648878,0,1,positive regulation of cellular response to alcohol,BP,
20667,GO:1990000,1,0.793380273406482,0,11,amyloid fibril formation,BP,
20669,GO:1990005,1,0.9786466750349,0,1,granular vesicle,CC,
20670,GO:1990008,1,0.9786466750349,0,1,neurosecretory vesicle,CC,
20671,GO:1990009,1,0.959254797111391,0,2,retinal cell apoptotic process,BP,
20672,GO:1990015,1,0.978923208303036,0,1,ensheathing process,CC,
20673,GO:1990022,1,0.937185457436469,0,3,RNA polymerase III complex localization to nucleus,BP,
20674,GO:1990023,1,0.814260051734095,0,10,mitotic spindle midzone,CC,
20675,GO:1990026,1,0.979069898024736,0,1,hippocampal mossy fiber expansion,CC,
20676,GO:1990029,1,0.979067462538613,0,1,vasomotion,BP,
20677,GO:1990030,1,0.979094953506347,0,1,pericellular basket,CC,
20678,GO:1990031,1,0.979067385161909,0,1,pinceau fiber,CC,
20679,GO:1990032,1,0.979274666797977,0,1,parallel fiber,CC,
20680,GO:1990034,1,0.903062297865328,0,5,calcium ion export from cell,BP,
20681,GO:1990035,1,0.796294155906127,0,11,calcium ion import into cell,BP,
20682,GO:1990036,1,0.940739396539324,0,3,calcium ion import into sarcoplasmic reticulum,BP,
20683,GO:1990037,1,0.937563162462624,0,3,Lewy body core,CC,
20684,GO:1990038,1,0.9787408034073,0,1,Lewy body corona,CC,
20685,GO:1990046,1,0.978533535421311,0,1,stress-induced mitochondrial fusion,BP,
20686,GO:1990047,1,0.978873403688345,0,1,spindle matrix,CC,
20687,GO:1990050,1,0.957495827982146,0,2,phosphatidic acid transporter activity,MF,
20688,GO:1990051,1,0.959518313669577,0,2,activation of protein kinase C activity,BP,
20689,GO:1990071,1,0.98105276290046,0,1,TRAPPII protein complex,CC,
20690,GO:1990072,1,0.97897493185122,0,1,TRAPPIII protein complex,CC,
20691,GO:1990074,1,0.979069739943941,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20692,GO:1990075,1,0.924412449939946,0,4,periciliary membrane compartment,CC,
20693,GO:1990079,1,0.978493942923075,0,1,cartilage homeostasis,BP,
20694,GO:1990081,1,0.978511737547494,0,1,trimethylamine receptor activity,MF,
20695,GO:1990086,1,0.91958322581421,0,4,lens fiber cell apoptotic process,BP,
20698,GO:1990108,1,0.982233510373185,0,1,protein linear deubiquitination,BP,
20700,GO:1990117,1,0.978478550887233,0,1,B cell receptor apoptotic signaling pathway,BP,
20701,GO:1990118,1,0.762024253553157,0,13,sodium ion import into cell,BP,
20702,GO:1990123,1,0.903974209790183,0,5,L-glutamate import into cell,BP,
20704,GO:1990126,1,0.686119811805111,0,18,retrograde transport, endosome to plasma membrane,BP,
20705,GO:1990127,1,0.979159941864044,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20706,GO:1990130,1,0.918732410314167,0,4,GATOR1 complex,CC,
20708,GO:1990136,1,0.978959443754869,0,1,linoleate 9S-lipoxygenase activity,MF,
20710,GO:1990144,1,0.898992188842311,0,5,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20711,GO:1990145,1,0.979069140003123,0,1,maintenance of translational fidelity,BP,
20712,GO:1990164,1,0.958542276384544,0,2,histone H2A phosphorylation,BP,
20713,GO:1990166,1,0.978905347471897,0,1,protein localization to site of double-strand break,BP,
20714,GO:1990167,1,0.94103671233189,0,3,protein K27-linked deubiquitination,BP,
20715,GO:1990168,1,0.93992103050405,0,3,protein K33-linked deubiquitination,BP,
20716,GO:1990169,1,0.961033241311551,0,2,stress response to copper ion,BP,
20717,GO:1990170,1,0.978764031435996,0,1,stress response to cadmium ion,BP,
20719,GO:1990173,1,0.824851327405115,0,9,protein localization to nucleoplasm,BP,
20720,GO:1990174,1,0.979087472781623,0,1,phosphodiesterase decapping endonuclease activity,MF,
20721,GO:1990175,1,0.979097581915923,0,1,EH domain binding,MF,
20722,GO:1990180,1,0.97887180099538,0,1,mitochondrial tRNA 3'-end processing,BP,
20724,GO:1990183,1,0.978481225703226,0,1,lymphatic vascular process in circulatory system,BP,
20725,GO:1990186,1,0.978481225703226,0,1,regulation of lymphatic vessel size,BP,
20726,GO:1990188,1,0.978994372777001,0,1,euchromatin binding,MF,
20727,GO:1990189,1,0.937484857616317,0,3,peptide-serine-N-acetyltransferase activity,MF,
20728,GO:1990190,1,0.957528933456106,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20729,GO:1990192,1,0.978481225703226,0,1,collecting lymphatic vessel constriction,BP,
20731,GO:1990226,1,0.879908399078469,0,6,histone methyltransferase binding,MF,
20733,GO:1990239,1,0.901474401639789,0,5,steroid hormone binding,MF,
20734,GO:1990246,1,0.95839073820654,0,2,uniplex complex,CC,
20735,GO:1990247,1,0.865427304222642,0,7,N6-methyladenosine-containing RNA binding,MF,
20736,GO:1990253,1,0.885134308283298,0,6,cellular response to leucine starvation,BP,
20737,GO:1990254,1,0.89981964865325,0,5,keratin filament binding,MF,
20738,GO:1990256,1,0.984437763920119,0,1,signal clustering,BP,
20739,GO:1990258,1,0.978515364646893,0,1,histone glutamine methylation,BP,
20740,GO:1990259,1,0.978515364646893,0,1,histone-glutamine methyltransferase activity,MF,
20742,GO:1990264,1,0.979069289906018,0,1,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20744,GO:1990267,1,0.979068592210635,0,1,response to transition metal nanoparticle,BP,
20745,GO:1990268,1,0.979068592210635,0,1,response to gold nanoparticle,BP,
20746,GO:1990269,1,0.958843570994622,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20747,GO:1990272,1,0.978703372485861,0,1,anti-Mullerian hormone receptor activity,MF,
20748,GO:1990275,1,0.979047777805675,0,1,preribosome binding,MF,
20749,GO:1990314,1,0.869241492607636,0,7,cellular response to insulin-like growth factor stimulus,BP,
20751,GO:1990332,1,0.979114178337418,0,1,Ire1 complex,CC,
20752,GO:1990349,1,0.978758658761031,0,1,gap junction-mediated intercellular transport,BP,
20754,GO:1990356,1,0.978520430518689,0,1,sumoylated E2 ligase complex,CC,
20755,GO:1990357,1,0.937722958677914,0,3,terminal web,CC,
20756,GO:1990379,1,0.957806872112557,0,2,lipid transport across blood brain barrier,BP,
20757,GO:1990380,1,0.869444393733501,0,7,Lys48-specific deubiquitinase activity,MF,
20758,GO:1990381,1,0.77662705590319,0,12,ubiquitin-specific protease binding,MF,
20759,GO:1990384,1,0.978533717851927,0,1,hyaloid vascular plexus regression,BP,
20760,GO:1990386,1,0.978748781425082,0,1,mitotic cleavage furrow ingression,BP,
20761,GO:1990390,1,0.979069442775139,0,1,protein K33-linked ubiquitination,BP,
20762,GO:1990391,1,0.465283106132321,0,37,DNA repair complex,CC,
20763,GO:1990393,1,0.90148890507167,0,5,3M complex,CC,
20764,GO:1990399,1,0.981447711364207,0,1,epithelium regeneration,BP,
20765,GO:1990401,1,0.979029476369352,0,1,embryonic lung development,BP,
20766,GO:1990402,1,0.978841299221768,0,1,embryonic liver development,BP,
20767,GO:1990403,1,0.828330300340709,0,9,embryonic brain development,BP,
20768,GO:1990404,1,0.958261965730761,0,2,protein ADP-ribosylase activity,MF,
20769,GO:1990405,1,0.905410580720587,0,5,protein antigen binding,MF,
20770,GO:1990414,1,0.958373361286653,0,2,replication-born double-strand break repair via sister chromatid exchange,BP,
20771,GO:1990415,1,0.95818263314549,0,2,Pex17p-Pex14p docking complex,CC,
20772,GO:1990416,1,0.865775401566814,0,7,cellular response to brain-derived neurotrophic factor stimulus,BP,
20774,GO:1990421,1,0.983993427542176,0,1,subtelomeric heterochromatin,CC,
20775,GO:1990423,1,0.94041795848507,0,3,RZZ complex,CC,
20776,GO:1990425,1,0.981175378575318,0,1,ryanodine receptor complex,CC,
20777,GO:1990426,1,0.963353953966265,0,2,mitotic recombination-dependent replication fork processing,BP,
20779,GO:1990428,1,0.979074243250457,0,1,miRNA transport,BP,
20780,GO:1990429,1,0.95818263314549,0,2,peroxisomal importomer complex,CC,
20783,GO:1990439,1,0.979054854347874,0,1,MAP kinase threonine phosphatase activity,MF,
20784,GO:1990440,1,0.79086601082416,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20785,GO:1990441,1,0.898985349382525,0,5,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20786,GO:1990442,1,0.936937542715297,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20787,GO:1990446,1,0.878172385469386,0,6,U1 snRNP binding,MF,
20788,GO:1990450,1,0.978795216556702,0,1,linear polyubiquitin binding,MF,
20789,GO:1990451,1,0.978942323095997,0,1,cellular stress response to acidic pH,BP,
20790,GO:1990452,1,0.958582516783649,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20791,GO:1990454,1,0.889163236925956,0,6,L-type voltage-gated calcium channel complex,CC,
20793,GO:1990460,1,0.940816286337622,0,3,leptin receptor binding,MF,
20794,GO:1990462,1,0.979069340046258,0,1,omegasome,CC,
20795,GO:1990478,1,0.978729235412385,0,1,response to ultrasound,BP,
20797,GO:1990498,1,0.982232082324955,0,1,mitotic spindle microtubule,CC,
20798,GO:1990502,1,0.95985537167019,0,2,dense core granule maturation,BP,
20799,GO:1990504,1,0.906723713137226,0,5,dense core granule exocytosis,BP,
20800,GO:1990505,1,0.963353953966265,0,2,mitotic DNA replication maintenance of fidelity,BP,
20801,GO:1990511,1,0.979041329225599,0,1,piRNA biosynthetic process,BP,
20802,GO:1990512,1,0.979068994608312,0,1,Cry-Per complex,CC,
20803,GO:1990519,1,0.958377835580009,0,2,mitochondrial pyrimidine nucleotide import,BP,
20804,GO:1990523,1,0.918622309020086,0,4,bone regeneration,BP,
20805,GO:1990539,1,0.978889655064775,0,1,fructose import across plasma membrane,BP,
20807,GO:1990564,1,0.898439165018677,0,5,protein polyufmylation,BP,
20808,GO:1990565,1,0.978633802264702,0,1,HSP90-CDC37 chaperone complex,CC,
20809,GO:1990569,1,0.960152739692197,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
20810,GO:1990572,1,0.979110885702327,0,1,TERT-RMRP complex,CC,
20811,GO:1990573,1,0.828175456418542,0,9,potassium ion import across plasma membrane,BP,
20813,GO:1990579,1,0.979114178337418,0,1,peptidyl-serine trans-autophosphorylation,BP,
20814,GO:1990583,1,0.978748781425082,0,1,phospholipase D activator activity,MF,
20815,GO:1990584,1,0.936838801919199,0,3,cardiac Troponin complex,CC,
20816,GO:1990589,1,0.962055664695195,0,2,ATF4-CREB1 transcription factor complex,CC,
20817,GO:1990590,1,0.958031664343539,0,2,ATF1-ATF4 transcription factor complex,CC,
20818,GO:1990592,1,0.898439165018677,0,5,protein K69-linked ufmylation,BP,
20819,GO:1990595,1,0.978770246760339,0,1,mast cell secretagogue receptor activity,MF,
20820,GO:1990597,1,0.938562412094552,0,3,AIP1-IRE1 complex,CC,
20821,GO:1990599,1,0.940001358942251,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
20822,GO:1990603,1,0.979069205329571,0,1,dark adaptation,BP,
20823,GO:1990604,1,0.919335205146875,0,4,IRE1-TRAF2-ASK1 complex,CC,
20824,GO:1990613,1,0.979069807012897,0,1,mitochondrial membrane fusion,BP,
20825,GO:1990614,1,0.979069329835597,0,1,mitochondrial magnesium ion transmembrane transport,BP,
20826,GO:1990617,1,0.957592398222049,0,2,CHOP-ATF4 complex,CC,
20827,GO:1990619,1,0.958154117972043,0,2,histone H3-K9 deacetylation,BP,
20828,GO:1990622,1,0.957717546342368,0,2,CHOP-ATF3 complex,CC,
20829,GO:1990630,1,0.979114178337418,0,1,IRE1-RACK1-PP2A complex,CC,
20830,GO:1990635,1,0.940803010177311,0,3,proximal dendrite,CC,
20831,GO:1990637,1,0.920104366696879,0,4,response to prolactin,BP,
20832,GO:1990641,1,0.957657961181309,0,2,response to iron ion starvation,BP,
20833,GO:1990646,1,0.958026334821273,0,2,cellular response to prolactin,BP,
20834,GO:1990654,1,0.979516543411674,0,1,sebum secreting cell proliferation,BP,
20835,GO:1990666,1,0.95925543821799,0,2,PCSK9-LDLR complex,CC,
20836,GO:1990667,1,0.958140512097775,0,2,PCSK9-AnxA2 complex,CC,
20837,GO:1990668,1,0.879702946536108,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
20838,GO:1990682,1,0.958480167730842,0,2,CSF1-CSF1R complex,CC,
20839,GO:1990696,1,0.964051619402985,0,2,USH2 complex,CC,
20840,GO:1990697,1,0.978849915485079,0,1,protein depalmitoleylation,BP,
20841,GO:1990698,1,0.958219458088146,0,2,palmitoleoyltransferase activity,MF,
20842,GO:1990699,1,0.978849915485079,0,1,palmitoleyl hydrolase activity,MF,
20843,GO:1990700,1,0.979099646733073,0,1,nucleolar chromatin organization,BP,
20844,GO:1990705,1,0.982356752390083,0,1,cholangiocyte proliferation,BP,
20845,GO:1990707,1,0.983993427542176,0,1,nuclear subtelomeric heterochromatin,CC,
20846,GO:1990708,1,0.979541955829297,0,1,conditioned place preference,BP,
20847,GO:1990709,1,0.941094738264697,0,3,presynaptic active zone organization,BP,
20849,GO:1990715,1,0.958324804846967,0,2,mRNA CDS binding,MF,
20850,GO:1990716,1,0.943929206474299,0,3,axonemal central apparatus,CC,
20851,GO:1990718,1,0.983017653993518,0,1,axonemal central pair projection,CC,
20852,GO:1990723,1,0.979061668824759,0,1,cytoplasmic periphery of the nuclear pore complex,CC,
20853,GO:1990726,1,0.917024185219953,0,4,Lsm1-7-Pat1 complex,CC,
20854,GO:1990729,1,0.978741415412062,0,1,primary miRNA modification,BP,
20855,GO:1990730,1,0.958595901027296,0,2,VCP-NSFL1C complex,CC,
20856,GO:1990736,1,0.979125761205231,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
20857,GO:1990737,1,0.938465480287698,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
20858,GO:1990739,1,0.982356752390083,0,1,granulosa cell proliferation,BP,
20859,GO:1990742,1,0.958967979077942,0,2,microvesicle,CC,
20860,GO:1990743,1,0.983315049864253,0,1,protein sialylation,BP,
20861,GO:1990744,1,0.978741415412062,0,1,primary miRNA methylation,BP,
20862,GO:1990745,1,0.93996267828559,0,3,EARP complex,CC,
20864,GO:1990751,1,0.981228720568987,0,1,Schwann cell chemotaxis,BP,
20865,GO:1990752,1,0.648781338812145,0,22,microtubule end,CC,
20866,GO:1990755,1,0.97897493185122,0,1,mitotic spindle microtubule depolymerization,BP,
20867,GO:1990761,1,0.94247879899932,0,3,growth cone lamellipodium,CC,
20868,GO:1990763,1,0.962357646334119,0,2,arrestin family protein binding,MF,
20870,GO:1990771,1,0.980383896232286,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
20871,GO:1990773,1,0.97865472952949,0,1,matrix metallopeptidase secretion,BP,
20872,GO:1990774,1,0.84436126615039,0,8,tumor necrosis factor secretion,BP,
20877,GO:1990784,1,0.97911785649481,0,1,response to dsDNA,BP,
20879,GO:1990786,1,0.97911785649481,0,1,cellular response to dsDNA,BP,
20880,GO:1990790,1,0.978555370373739,0,1,response to glial cell derived neurotrophic factor,BP,
20881,GO:1990791,1,0.938393073589233,0,3,dorsal root ganglion development,BP,
20882,GO:1990792,1,0.978555370373739,0,1,cellular response to glial cell derived neurotrophic factor,BP,
20883,GO:1990796,1,0.979054604473511,0,1,photoreceptor cell terminal bouton,CC,
20884,GO:1990809,1,0.978867379319807,0,1,endoplasmic reticulum tubular network membrane organization,BP,
20885,GO:1990812,1,0.938591715313119,0,3,growth cone filopodium,CC,
20886,GO:1990822,1,0.8819444986041,0,6,basic amino acid transmembrane transport,BP,
20887,GO:1990823,1,0.97943348461879,0,1,response to leukemia inhibitory factor,BP,
20888,GO:1990825,1,0.843426214861599,0,8,sequence-specific mRNA binding,MF,
20889,GO:1990828,1,0.97882352488438,0,1,hepatocyte dedifferentiation,BP,
20890,GO:1990829,1,0.95825172595645,0,2,C-rich single-stranded DNA binding,MF,
20891,GO:1990830,1,0.97943348461879,0,1,cellular response to leukemia inhibitory factor,BP,
20892,GO:1990834,1,0.938154940301243,0,3,response to odorant,BP,
20894,GO:1990839,1,0.97888453883524,0,1,response to endothelin,BP,
20896,GO:1990843,1,0.980557080498592,0,1,subsarcolemmal mitochondrion,CC,
20897,GO:1990844,1,0.980557080498592,0,1,interfibrillar mitochondrion,CC,
20898,GO:1990845,1,0.759385644637078,0,13,adaptive thermogenesis,BP,
20900,GO:1990859,1,0.97888453883524,0,1,cellular response to endothelin,BP,
20901,GO:1990868,1,0.958524704545467,0,2,response to chemokine,BP,
20902,GO:1990869,1,0.958524704545467,0,2,cellular response to chemokine,BP,
20904,GO:1990876,1,0.980787937326398,0,1,cytoplasmic side of nuclear pore,CC,
20905,GO:1990879,1,0.95839073820654,0,2,CST complex,CC,
20906,GO:1990882,1,0.979101555141531,0,1,rRNA acetylation,BP,
20907,GO:1990883,1,0.979101555141531,0,1,rRNA cytidine N-acetyltransferase activity,MF,
20908,GO:1990884,1,0.979101555141531,0,1,RNA acetylation,BP,
20909,GO:1990889,1,0.978702590235847,0,1,H4K20me3 modified histone binding,MF,
20911,GO:1990907,1,0.938545725766386,0,3,beta-catenin-TCF complex,CC,
20913,GO:1990910,1,0.937929831236066,0,3,response to hypobaric hypoxia,BP,
20914,GO:1990911,1,0.978823939821561,0,1,response to psychosocial stress,BP,
20915,GO:1990913,1,0.978970198177957,0,1,sperm head plasma membrane,CC,
20916,GO:1990917,1,0.978970198177957,0,1,ooplasm,CC,
20917,GO:1990918,1,0.938272741576364,0,3,double-strand break repair involved in meiotic recombination,BP,
20918,GO:1990922,1,0.979069293200516,0,1,hepatic stellate cell proliferation,BP,
20919,GO:1990923,1,0.938076975291798,0,3,PET complex,CC,
20920,GO:1990926,1,0.958516604518091,0,2,short-term synaptic potentiation,BP,
20921,GO:1990927,1,0.959456915615142,0,2,calcium ion regulated lysosome exocytosis,BP,
20922,GO:1990928,1,0.93959379549107,0,3,response to amino acid starvation,BP,
20923,GO:1990930,1,0.978602768722672,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
20924,GO:1990931,1,0.979194394457685,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
20925,GO:1990932,1,0.936802626629601,0,3,5.8S rRNA binding,MF,
20927,GO:1990938,1,0.979110685393671,0,1,peptidyl-aspartic acid autophosphorylation,BP,
20928,GO:1990939,1,0.66008636338837,0,21,ATP-dependent microtubule motor activity,MF,
20929,GO:1990948,1,0.916642116910308,0,4,ubiquitin ligase inhibitor activity,MF,
20930,GO:1990955,1,0.979131260122671,0,1,G-rich single-stranded DNA binding,MF,
20931,GO:1990962,1,0.979107757569395,0,1,drug transport across blood-brain barrier,BP,
20932,GO:1990963,1,0.979107757569395,0,1,establishment of blood-retinal barrier,BP,
20933,GO:1990966,1,0.918503522802672,0,4,ATP generation from poly-ADP-D-ribose,BP,
20935,GO:1990968,1,0.980655377124509,0,1,modulation by host of RNA binding by virus,BP,
20936,GO:1990969,1,0.980655377124509,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
20937,GO:1990971,1,0.979097893275581,0,1,EMILIN complex,CC,
20938,GO:1990983,1,0.978982895117617,0,1,tRNA demethylation,BP,
20939,GO:1990984,1,0.978982895117617,0,1,tRNA demethylase activity,MF,
20940,GO:2000001,1,0.758136541011164,0,13,regulation of DNA damage checkpoint,BP,
20941,GO:2000002,1,0.918105490608982,0,4,negative regulation of DNA damage checkpoint,BP,
20948,GO:2000010,1,0.781244379346052,0,12,positive regulation of protein localization to cell surface,BP,
20949,GO:2000011,1,0.978842533097552,0,1,regulation of adaxial/abaxial pattern formation,BP,
20951,GO:2000016,1,0.978485677378034,0,1,negative regulation of determination of dorsal identity,BP,
20959,GO:2000035,1,0.898593564296729,0,5,regulation of stem cell division,BP,
20961,GO:2000040,1,0.958457434528656,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
20962,GO:2000041,1,0.958457434528656,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
20963,GO:2000042,1,0.88499528417195,0,6,negative regulation of double-strand break repair via homologous recombination,BP,
20964,GO:2000043,1,0.958393352615361,0,2,regulation of cardiac cell fate specification,BP,
20965,GO:2000044,1,0.979053151914992,0,1,negative regulation of cardiac cell fate specification,BP,
20968,GO:2000048,1,0.917706613521519,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
20971,GO:2000051,1,0.887244638375659,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
20973,GO:2000053,1,0.94255284134337,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20974,GO:2000054,1,0.95858209460715,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20975,GO:2000055,1,0.98328007924134,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20976,GO:2000056,1,0.978708872698114,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20977,GO:2000057,1,0.978708872698114,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20979,GO:2000059,1,0.759967957704183,0,13,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
20981,GO:2000061,1,0.978602768722672,0,1,regulation of ureter smooth muscle cell differentiation,BP,
20982,GO:2000062,1,0.978602768722672,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
20983,GO:2000063,1,0.978602768722672,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
20987,GO:2000067,1,0.978476629273923,0,1,regulation of root morphogenesis,BP,
20988,GO:2000074,1,0.845582299018783,0,8,regulation of type B pancreatic cell development,BP,
20989,GO:2000077,1,0.960373308175353,0,2,negative regulation of type B pancreatic cell development,BP,
20990,GO:2000078,1,0.937427947203638,0,3,positive regulation of type B pancreatic cell development,BP,
20991,GO:2000079,1,0.958751486977511,0,2,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20992,GO:2000080,1,0.979265164430661,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20993,GO:2000081,1,0.979053151914992,0,1,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20994,GO:2000095,1,0.777232833506782,0,12,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20995,GO:2000096,1,0.863527384992336,0,7,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20997,GO:2000098,1,0.95802598907268,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
20998,GO:2000101,1,0.97905368115129,0,1,regulation of mammary stem cell proliferation,BP,
20999,GO:2000103,1,0.97905368115129,0,1,positive regulation of mammary stem cell proliferation,BP,
21000,GO:2000104,1,0.689691447476201,0,18,negative regulation of DNA-dependent DNA replication,BP,
21005,GO:2000109,1,0.862461261972159,0,7,regulation of macrophage apoptotic process,BP,
21006,GO:2000110,1,0.937879251842919,0,3,negative regulation of macrophage apoptotic process,BP,
21007,GO:2000111,1,0.939400788325835,0,3,positive regulation of macrophage apoptotic process,BP,
21010,GO:2000114,1,0.691017909657011,0,18,regulation of establishment of cell polarity,BP,
21013,GO:2000118,1,0.938371957069041,0,3,regulation of sodium-dependent phosphate transport,BP,
21014,GO:2000119,1,0.979057243633339,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21015,GO:2000120,1,0.978863544526371,0,1,positive regulation of sodium-dependent phosphate transport,BP,
21017,GO:2000124,1,0.958592004781246,0,2,regulation of endocannabinoid signaling pathway,BP,
21023,GO:2000143,1,0.881166298482139,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21028,GO:2000152,1,0.917351998633204,0,4,regulation of ubiquitin-specific protease activity,BP,
21029,GO:2000156,1,0.958572396059888,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21030,GO:2000157,1,0.957484258219011,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21031,GO:2000158,1,0.958090577928674,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21032,GO:2000167,1,0.979846577391115,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21033,GO:2000169,1,0.886064679434495,0,6,regulation of peptidyl-cysteine S-nitrosylation,BP,
21034,GO:2000170,1,0.958769137908903,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21035,GO:2000171,1,0.575100631297524,0,27,negative regulation of dendrite development,BP,
21036,GO:2000172,1,0.922176406164667,0,4,regulation of branching morphogenesis of a nerve,BP,
21037,GO:2000173,1,0.979101809816413,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21038,GO:2000174,1,0.979104971336723,0,1,regulation of pro-T cell differentiation,BP,
21039,GO:2000176,1,0.979104971336723,0,1,positive regulation of pro-T cell differentiation,BP,
21044,GO:2000182,1,0.940211830118859,0,3,regulation of progesterone biosynthetic process,BP,
21045,GO:2000184,1,0.980557080498592,0,1,positive regulation of progesterone biosynthetic process,BP,
21046,GO:2000185,1,0.978863544526371,0,1,regulation of phosphate transmembrane transport,BP,
21047,GO:2000187,1,0.978863544526371,0,1,positive regulation of phosphate transmembrane transport,BP,
21048,GO:2000188,1,0.78012994521481,0,12,regulation of cholesterol homeostasis,BP,
21049,GO:2000189,1,0.919782368640118,0,4,positive regulation of cholesterol homeostasis,BP,
21055,GO:2000196,1,0.957483070193138,0,2,positive regulation of female gonad development,BP,
21056,GO:2000197,1,0.884345975397309,0,6,regulation of ribonucleoprotein complex localization,BP,
21057,GO:2000199,1,0.979065296337448,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21058,GO:2000200,1,0.979065296337448,0,1,regulation of ribosomal subunit export from nucleus,BP,
21059,GO:2000202,1,0.979065296337448,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21060,GO:2000206,1,0.979065296337448,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21061,GO:2000208,1,0.979065296337448,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21063,GO:2000210,1,0.860568753382132,0,7,positive regulation of anoikis,BP,
21064,GO:2000211,1,0.958848267209376,0,2,regulation of glutamate metabolic process,BP,
21065,GO:2000212,1,0.979597503254171,0,1,negative regulation of glutamate metabolic process,BP,
21066,GO:2000213,1,0.978819787817556,0,1,positive regulation of glutamate metabolic process,BP,
21069,GO:2000226,1,0.978570356890495,0,1,regulation of pancreatic A cell differentiation,BP,
21070,GO:2000227,1,0.978570356890495,0,1,negative regulation of pancreatic A cell differentiation,BP,
21071,GO:2000229,1,0.957690523316162,0,2,regulation of pancreatic stellate cell proliferation,BP,
21072,GO:2000230,1,0.978700443695918,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21073,GO:2000231,1,0.978534083677148,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21074,GO:2000232,1,0.846702021472829,0,8,regulation of rRNA processing,BP,
21075,GO:2000233,1,0.959785146944349,0,2,negative regulation of rRNA processing,BP,
21076,GO:2000234,1,0.882191083182101,0,6,positive regulation of rRNA processing,BP,
21082,GO:2000252,1,0.860614186153472,0,7,negative regulation of feeding behavior,BP,
21083,GO:2000253,1,0.883110104383209,0,6,positive regulation of feeding behavior,BP,
21084,GO:2000254,1,0.917260199715532,0,4,regulation of male germ cell proliferation,BP,
21085,GO:2000255,1,0.937425841671245,0,3,negative regulation of male germ cell proliferation,BP,
21086,GO:2000256,1,0.978492024520221,0,1,positive regulation of male germ cell proliferation,BP,
21088,GO:2000258,1,0.84886689694953,0,8,negative regulation of protein activation cascade,BP,
21089,GO:2000259,1,0.93871592619069,0,3,positive regulation of protein activation cascade,BP,
21090,GO:2000266,1,0.978610437250493,0,1,regulation of blood coagulation, intrinsic pathway,BP,
21093,GO:2000271,1,0.863887139113904,0,7,positive regulation of fibroblast apoptotic process,BP,
21096,GO:2000275,1,0.917470855903031,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21097,GO:2000276,1,0.957919781219186,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21098,GO:2000277,1,0.978487817470133,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21101,GO:2000280,1,0.978476629273923,0,1,regulation of root development,BP,
21102,GO:2000282,1,0.961261671569581,0,2,regulation of cellular amino acid biosynthetic process,BP,
21103,GO:2000283,1,0.982396170646631,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21104,GO:2000284,1,0.978487817470133,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21105,GO:2000286,1,0.938362286357104,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21106,GO:2000287,1,0.978858883721889,0,1,positive regulation of myotome development,BP,
21107,GO:2000288,1,0.87984676060383,0,6,positive regulation of myoblast proliferation,BP,
21108,GO:2000290,1,0.978858883721889,0,1,regulation of myotome development,BP,
21109,GO:2000291,1,0.807586763777679,0,10,regulation of myoblast proliferation,BP,
21110,GO:2000295,1,0.937431100908646,0,3,regulation of hydrogen peroxide catabolic process,BP,
21111,GO:2000296,1,0.957475725775255,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21112,GO:2000297,1,0.939265753101455,0,3,negative regulation of synapse maturation,BP,
21113,GO:2000298,1,0.958427430888037,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21114,GO:2000299,1,0.979069337116743,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21115,GO:2000300,1,0.571066056836409,0,27,regulation of synaptic vesicle exocytosis,BP,
21116,GO:2000301,1,0.918402027988619,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21117,GO:2000302,1,0.940649096765266,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21118,GO:2000303,1,0.758269580631566,0,13,regulation of ceramide biosynthetic process,BP,
21119,GO:2000304,1,0.843743153989572,0,8,positive regulation of ceramide biosynthetic process,BP,
21120,GO:2000307,1,0.937829246583444,0,3,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21121,GO:2000308,1,0.978909349397237,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21122,GO:2000309,1,0.958037209235339,0,2,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21123,GO:2000310,1,0.71951105278834,0,16,regulation of NMDA receptor activity,BP,
21124,GO:2000311,1,0.675648590378926,0,19,regulation of AMPA receptor activity,BP,
21125,GO:2000312,1,0.940491262950254,0,3,regulation of kainate selective glutamate receptor activity,BP,
21126,GO:2000313,1,0.957796312499749,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21127,GO:2000314,1,0.978630183258409,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21128,GO:2000316,1,0.757011524741234,0,13,regulation of T-helper 17 type immune response,BP,
21129,GO:2000317,1,0.87903483470277,0,6,negative regulation of T-helper 17 type immune response,BP,
21130,GO:2000318,1,0.861230099170975,0,7,positive regulation of T-helper 17 type immune response,BP,
21131,GO:2000319,1,0.789992933549543,0,11,regulation of T-helper 17 cell differentiation,BP,
21132,GO:2000320,1,0.87903483470277,0,6,negative regulation of T-helper 17 cell differentiation,BP,
21133,GO:2000321,1,0.898738630536961,0,5,positive regulation of T-helper 17 cell differentiation,BP,
21134,GO:2000322,1,0.844991698748149,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21135,GO:2000323,1,0.881774349124469,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21136,GO:2000324,1,0.958299638601659,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21137,GO:2000325,1,0.980448577872618,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21138,GO:2000327,1,0.980448577872618,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21139,GO:2000328,1,0.879275363032156,0,6,regulation of T-helper 17 cell lineage commitment,BP,
21140,GO:2000329,1,0.957990761271592,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21141,GO:2000330,1,0.917842020912558,0,4,positive regulation of T-helper 17 cell lineage commitment,BP,
21142,GO:2000331,1,0.958602231475315,0,2,regulation of terminal button organization,BP,
21143,GO:2000332,1,0.957870953174939,0,2,regulation of blood microparticle formation,BP,
21144,GO:2000334,1,0.957870953174939,0,2,positive regulation of blood microparticle formation,BP,
21145,GO:2000338,1,0.958185045657319,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21146,GO:2000340,1,0.958185045657319,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21147,GO:2000341,1,0.842268446187456,0,8,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21148,GO:2000342,1,0.958400309778771,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21149,GO:2000343,1,0.878840533378342,0,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21150,GO:2000344,1,0.828565044199368,0,9,positive regulation of acrosome reaction,BP,
21153,GO:2000347,1,0.863702781520311,0,7,positive regulation of hepatocyte proliferation,BP,
21154,GO:2000348,1,0.880384706598444,0,6,regulation of CD40 signaling pathway,BP,
21155,GO:2000349,1,0.958448525673512,0,2,negative regulation of CD40 signaling pathway,BP,
21156,GO:2000350,1,0.978499877763531,0,1,positive regulation of CD40 signaling pathway,BP,
21159,GO:2000353,1,0.761664287346348,0,13,positive regulation of endothelial cell apoptotic process,BP,
21160,GO:2000354,1,0.918223500722421,0,4,regulation of ovarian follicle development,BP,
21161,GO:2000355,1,0.978765273215093,0,1,negative regulation of ovarian follicle development,BP,
21162,GO:2000356,1,0.978602768722672,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21163,GO:2000357,1,0.978602768722672,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21164,GO:2000358,1,0.978602768722672,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21165,GO:2000359,1,0.917267530106142,0,4,regulation of binding of sperm to zona pellucida,BP,
21166,GO:2000360,1,0.917267530106142,0,4,negative regulation of binding of sperm to zona pellucida,BP,
21167,GO:2000361,1,0.979277721136309,0,1,regulation of prostaglandin-E synthase activity,BP,
21168,GO:2000363,1,0.979277721136309,0,1,positive regulation of prostaglandin-E synthase activity,BP,
21169,GO:2000364,1,0.943184186140719,0,3,regulation of STAT protein import into nucleus,BP,
21170,GO:2000366,1,0.943184186140719,0,3,positive regulation of STAT protein import into nucleus,BP,
21171,GO:2000367,1,0.978556248914701,0,1,regulation of acrosomal vesicle exocytosis,BP,
21172,GO:2000368,1,0.978556248914701,0,1,positive regulation of acrosomal vesicle exocytosis,BP,
21174,GO:2000370,1,0.881576175345698,0,6,positive regulation of clathrin-dependent endocytosis,BP,
21175,GO:2000371,1,0.918660370484933,0,4,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21176,GO:2000373,1,0.918660370484933,0,4,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21177,GO:2000374,1,0.957700070591457,0,2,regulation of oxygen metabolic process,BP,
21178,GO:2000376,1,0.9784684469879,0,1,positive regulation of oxygen metabolic process,BP,
21182,GO:2000380,1,0.71593607294239,0,16,regulation of mesoderm development,BP,
21183,GO:2000381,1,0.844956667272069,0,8,negative regulation of mesoderm development,BP,
21184,GO:2000382,1,0.902441973709826,0,5,positive regulation of mesoderm development,BP,
21187,GO:2000386,1,0.978556248914701,0,1,positive regulation of ovarian follicle development,BP,
21188,GO:2000387,1,0.978556248914701,0,1,regulation of antral ovarian follicle growth,BP,
21189,GO:2000388,1,0.978556248914701,0,1,positive regulation of antral ovarian follicle growth,BP,
21190,GO:2000389,1,0.938916573285444,0,3,regulation of neutrophil extravasation,BP,
21191,GO:2000391,1,0.938916573285444,0,3,positive regulation of neutrophil extravasation,BP,
21192,GO:2000392,1,0.847906969283702,0,8,regulation of lamellipodium morphogenesis,BP,
21193,GO:2000393,1,0.979677588142812,0,1,negative regulation of lamellipodium morphogenesis,BP,
21194,GO:2000394,1,0.865502933131034,0,7,positive regulation of lamellipodium morphogenesis,BP,
21195,GO:2000395,1,0.957546510952669,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21196,GO:2000397,1,0.957546510952669,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21198,GO:2000402,1,0.86104977523915,0,7,negative regulation of lymphocyte migration,BP,
21201,GO:2000405,1,0.978509921581045,0,1,negative regulation of T cell migration,BP,
21205,GO:2000410,1,0.937731388756395,0,3,regulation of thymocyte migration,BP,
21206,GO:2000412,1,0.958038959008453,0,2,positive regulation of thymocyte migration,BP,
21207,GO:2000413,1,0.979067097635795,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21208,GO:2000415,1,0.979067097635795,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21209,GO:2000416,1,0.87933344405858,0,6,regulation of eosinophil migration,BP,
21210,GO:2000417,1,0.958226535694387,0,2,negative regulation of eosinophil migration,BP,
21211,GO:2000418,1,0.91767676367862,0,4,positive regulation of eosinophil migration,BP,
21212,GO:2000419,1,0.979069342662988,0,1,regulation of eosinophil extravasation,BP,
21213,GO:2000420,1,0.979069342662988,0,1,negative regulation of eosinophil extravasation,BP,
21214,GO:2000422,1,0.95793208592399,0,2,regulation of eosinophil chemotaxis,BP,
21215,GO:2000424,1,0.95793208592399,0,2,positive regulation of eosinophil chemotaxis,BP,
21217,GO:2000426,1,0.978663692803811,0,1,negative regulation of apoptotic cell clearance,BP,
21219,GO:2000434,1,0.95742882454759,0,2,regulation of protein neddylation,BP,
21220,GO:2000435,1,0.95742882454759,0,2,negative regulation of protein neddylation,BP,
21221,GO:2000437,1,0.940197816298418,0,3,regulation of monocyte extravasation,BP,
21222,GO:2000438,1,0.980906807466197,0,1,negative regulation of monocyte extravasation,BP,
21223,GO:2000439,1,0.958500751002983,0,2,positive regulation of monocyte extravasation,BP,
21224,GO:2000446,1,0.97921207898215,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21229,GO:2000458,1,0.958074456316929,0,2,regulation of astrocyte chemotaxis,BP,
21231,GO:2000464,1,0.97895542225611,0,1,positive regulation of astrocyte chemotaxis,BP,
21232,GO:2000465,1,0.848233439111243,0,8,regulation of glycogen (starch) synthase activity,BP,
21233,GO:2000466,1,0.940269123681929,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21234,GO:2000467,1,0.901931124640309,0,5,positive regulation of glycogen (starch) synthase activity,BP,
21235,GO:2000468,1,0.962132154768,0,2,regulation of peroxidase activity,BP,
21236,GO:2000469,1,0.982703479687859,0,1,negative regulation of peroxidase activity,BP,
21237,GO:2000470,1,0.979067586913297,0,1,positive regulation of peroxidase activity,BP,
21238,GO:2000471,1,0.958981470982939,0,2,regulation of hematopoietic stem cell migration,BP,
21239,GO:2000473,1,0.958981470982939,0,2,positive regulation of hematopoietic stem cell migration,BP,
21240,GO:2000474,1,0.958492189252912,0,2,regulation of opioid receptor signaling pathway,BP,
21241,GO:2000477,1,0.97931791579165,0,1,regulation of metanephric glomerular visceral epithelial cell development,BP,
21242,GO:2000478,1,0.97931791579165,0,1,positive regulation of metanephric glomerular visceral epithelial cell development,BP,
21245,GO:2000481,1,0.923999929760575,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21247,GO:2000483,1,0.881931912224462,0,6,negative regulation of interleukin-8 secretion,BP,
21249,GO:2000485,1,0.958451593001539,0,2,regulation of glutamine transport,BP,
21250,GO:2000486,1,0.979069350455509,0,1,negative regulation of glutamine transport,BP,
21251,GO:2000487,1,0.978942674614775,0,1,positive regulation of glutamine transport,BP,
21252,GO:2000489,1,0.881427332135149,0,6,regulation of hepatic stellate cell activation,BP,
21253,GO:2000490,1,0.958257334019102,0,2,negative regulation of hepatic stellate cell activation,BP,
21254,GO:2000491,1,0.91983213642543,0,4,positive regulation of hepatic stellate cell activation,BP,
21255,GO:2000492,1,0.979058353496236,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21256,GO:2000494,1,0.979058353496236,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21257,GO:2000501,1,0.822945031293343,0,9,regulation of natural killer cell chemotaxis,BP,
21258,GO:2000502,1,0.93740334119576,0,3,negative regulation of natural killer cell chemotaxis,BP,
21259,GO:2000503,1,0.877918674689146,0,6,positive regulation of natural killer cell chemotaxis,BP,
21260,GO:2000504,1,0.938506942817452,0,3,positive regulation of blood vessel remodeling,BP,
21262,GO:2000506,1,0.9579417636787,0,2,negative regulation of energy homeostasis,BP,
21263,GO:2000507,1,0.882003705710026,0,6,positive regulation of energy homeostasis,BP,
21266,GO:2000511,1,0.978523494370587,0,1,regulation of granzyme A production,BP,
21267,GO:2000513,1,0.978523494370587,0,1,positive regulation of granzyme A production,BP,
21268,GO:2000514,1,0.393057119255561,0,44,regulation of CD4-positive, alpha-beta T cell activation,BP,
21269,GO:2000515,1,0.684649463705029,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21270,GO:2000516,1,0.538257953305148,0,29,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21271,GO:2000517,1,0.978523494370587,0,1,regulation of T-helper 1 cell activation,BP,
21272,GO:2000518,1,0.978523494370587,0,1,negative regulation of T-helper 1 cell activation,BP,
21273,GO:2000520,1,0.937618090848602,0,3,regulation of immunological synapse formation,BP,
21274,GO:2000521,1,0.957901040428381,0,2,negative regulation of immunological synapse formation,BP,
21275,GO:2000522,1,0.978828085621426,0,1,positive regulation of immunological synapse formation,BP,
21276,GO:2000523,1,0.958339582862484,0,2,regulation of T cell costimulation,BP,
21277,GO:2000525,1,0.958339582862484,0,2,positive regulation of T cell costimulation,BP,
21278,GO:2000526,1,0.978828085621426,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21279,GO:2000527,1,0.97848305880818,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21280,GO:2000529,1,0.97848305880818,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21283,GO:2000534,1,0.97931791579165,0,1,positive regulation of renal albumin absorption,BP,
21284,GO:2000535,1,0.901649866861589,0,5,regulation of entry of bacterium into host cell,BP,
21285,GO:2000536,1,0.981023704923529,0,1,negative regulation of entry of bacterium into host cell,BP,
21286,GO:2000537,1,0.958184348522352,0,2,regulation of B cell chemotaxis,BP,
21287,GO:2000538,1,0.958184348522352,0,2,positive regulation of B cell chemotaxis,BP,
21288,GO:2000539,1,0.978956769109952,0,1,regulation of protein geranylgeranylation,BP,
21289,GO:2000541,1,0.978956769109952,0,1,positive regulation of protein geranylgeranylation,BP,
21291,GO:2000543,1,0.879834275558371,0,6,positive regulation of gastrulation,BP,
21293,GO:2000545,1,0.978520430518689,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21295,GO:2000547,1,0.937144207485596,0,3,regulation of dendritic cell dendrite assembly,BP,
21296,GO:2000548,1,0.97848305880818,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21297,GO:2000549,1,0.978471890074619,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21298,GO:2000551,1,0.842233132465815,0,8,regulation of T-helper 2 cell cytokine production,BP,
21299,GO:2000552,1,0.957452425981076,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21300,GO:2000553,1,0.87967391275345,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21301,GO:2000554,1,0.978523494370587,0,1,regulation of T-helper 1 cell cytokine production,BP,
21302,GO:2000556,1,0.978523494370587,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21303,GO:2000557,1,0.978523494370587,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21304,GO:2000558,1,0.978523494370587,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21305,GO:2000559,1,0.980906807466197,0,1,regulation of CD24 biosynthetic process,BP,
21306,GO:2000560,1,0.980906807466197,0,1,positive regulation of CD24 biosynthetic process,BP,
21307,GO:2000561,1,0.89898129610375,0,5,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21308,GO:2000562,1,0.937576880310386,0,3,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21309,GO:2000563,1,0.918196092064038,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21310,GO:2000564,1,0.917841418415224,0,4,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21311,GO:2000566,1,0.937465752183362,0,3,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21312,GO:2000567,1,0.958353728735635,0,2,regulation of memory T cell activation,BP,
21313,GO:2000568,1,0.958353728735635,0,2,positive regulation of memory T cell activation,BP,
21314,GO:2000569,1,0.958575563274472,0,2,regulation of T-helper 2 cell activation,BP,
21315,GO:2000570,1,0.958575563274472,0,2,positive regulation of T-helper 2 cell activation,BP,
21316,GO:2000571,1,0.979069541176219,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21317,GO:2000572,1,0.979069541176219,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21319,GO:2000574,1,0.939272287894978,0,3,regulation of microtubule motor activity,BP,
21320,GO:2000583,1,0.958835534295363,0,2,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21321,GO:2000584,1,0.958835534295363,0,2,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21324,GO:2000588,1,0.960929253040365,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21326,GO:2000590,1,0.97931791579165,0,1,negative regulation of metanephric mesenchymal cell migration,BP,
21328,GO:2000592,1,0.958660096857259,0,2,regulation of metanephric DCT cell differentiation,BP,
21329,GO:2000594,1,0.958660096857259,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21330,GO:2000595,1,0.979135713017116,0,1,regulation of optic nerve formation,BP,
21331,GO:2000597,1,0.979135713017116,0,1,positive regulation of optic nerve formation,BP,
21332,GO:2000601,1,0.863776806204698,0,7,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21333,GO:2000606,1,0.979063806545174,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21334,GO:2000607,1,0.979063806545174,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21335,GO:2000609,1,0.898592575882444,0,5,regulation of thyroid hormone generation,BP,
21336,GO:2000611,1,0.938257289318709,0,3,positive regulation of thyroid hormone generation,BP,
21337,GO:2000612,1,0.979089260094394,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21338,GO:2000615,1,0.830734019162297,0,9,regulation of histone H3-K9 acetylation,BP,
21339,GO:2000616,1,0.979691655599005,0,1,negative regulation of histone H3-K9 acetylation,BP,
21340,GO:2000617,1,0.866149814257702,0,7,positive regulation of histone H3-K9 acetylation,BP,
21341,GO:2000618,1,0.902169126762067,0,5,regulation of histone H4-K16 acetylation,BP,
21342,GO:2000619,1,0.938006829524549,0,3,negative regulation of histone H4-K16 acetylation,BP,
21343,GO:2000620,1,0.961800310064993,0,2,positive regulation of histone H4-K16 acetylation,BP,
21344,GO:2000622,1,0.921092567765469,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21345,GO:2000623,1,0.921092567765469,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21346,GO:2000625,1,0.958782152688243,0,2,regulation of miRNA catabolic process,BP,
21347,GO:2000627,1,0.958782152688243,0,2,positive regulation of miRNA catabolic process,BP,
21350,GO:2000631,1,0.979068866243211,0,1,regulation of pre-miRNA processing,BP,
21351,GO:2000632,1,0.979068866243211,0,1,negative regulation of pre-miRNA processing,BP,
21353,GO:2000638,1,0.979077107537638,0,1,regulation of SREBP signaling pathway,BP,
21354,GO:2000639,1,0.979077107537638,0,1,negative regulation of SREBP signaling pathway,BP,
21356,GO:2000642,1,0.957492001565336,0,2,negative regulation of early endosome to late endosome transport,BP,
21358,GO:2000644,1,0.861841395912146,0,7,regulation of receptor catabolic process,BP,
21359,GO:2000645,1,0.93848940617831,0,3,negative regulation of receptor catabolic process,BP,
21360,GO:2000646,1,0.937982858711487,0,3,positive regulation of receptor catabolic process,BP,
21361,GO:2000647,1,0.813676321035132,0,10,negative regulation of stem cell proliferation,BP,
21364,GO:2000650,1,0.813641915170133,0,10,negative regulation of sodium ion transmembrane transporter activity,BP,
21365,GO:2000651,1,0.767418463142312,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21367,GO:2000654,1,0.979086067712906,0,1,regulation of cellular response to testosterone stimulus,BP,
21368,GO:2000655,1,0.979086067712906,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21369,GO:2000656,1,0.978708872698114,0,1,regulation of apolipoprotein binding,BP,
21370,GO:2000657,1,0.978708872698114,0,1,negative regulation of apolipoprotein binding,BP,
21371,GO:2000659,1,0.879387261020333,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
21372,GO:2000660,1,0.917287864576011,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
21373,GO:2000661,1,0.979512407411805,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21374,GO:2000662,1,0.879787953763811,0,6,regulation of interleukin-5 secretion,BP,
21375,GO:2000663,1,0.958031577323609,0,2,negative regulation of interleukin-5 secretion,BP,
21376,GO:2000664,1,0.918337901827715,0,4,positive regulation of interleukin-5 secretion,BP,
21377,GO:2000665,1,0.842447056271804,0,8,regulation of interleukin-13 secretion,BP,
21378,GO:2000666,1,0.958031577323609,0,2,negative regulation of interleukin-13 secretion,BP,
21379,GO:2000667,1,0.879365280734382,0,6,positive regulation of interleukin-13 secretion,BP,
21382,GO:2000670,1,0.939880865882118,0,3,positive regulation of dendritic cell apoptotic process,BP,
21383,GO:2000671,1,0.918513815202309,0,4,regulation of motor neuron apoptotic process,BP,
21384,GO:2000672,1,0.938145072725628,0,3,negative regulation of motor neuron apoptotic process,BP,
21385,GO:2000674,1,0.808510549195267,0,10,regulation of type B pancreatic cell apoptotic process,BP,
21386,GO:2000675,1,0.880734421515574,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21387,GO:2000676,1,0.918023029832008,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
21390,GO:2000679,1,0.627353300283701,0,22,positive regulation of transcription regulatory region DNA binding,BP,
21391,GO:2000680,1,0.901614994108937,0,5,regulation of rubidium ion transport,BP,
21392,GO:2000681,1,0.938744013111731,0,3,negative regulation of rubidium ion transport,BP,
21393,GO:2000682,1,0.981563527443779,0,1,positive regulation of rubidium ion transport,BP,
21394,GO:2000683,1,0.958540986302839,0,2,regulation of cellular response to X-ray,BP,
21395,GO:2000685,1,0.97903951762157,0,1,positive regulation of cellular response to X-ray,BP,
21396,GO:2000686,1,0.921433927154777,0,4,regulation of rubidium ion transmembrane transporter activity,BP,
21397,GO:2000687,1,0.938744013111731,0,3,negative regulation of rubidium ion transmembrane transporter activity,BP,
21398,GO:2000688,1,0.981563527443779,0,1,positive regulation of rubidium ion transmembrane transporter activity,BP,
21399,GO:2000690,1,0.979180119707855,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21400,GO:2000691,1,0.979180119707855,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21402,GO:2000697,1,0.917982803558978,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21404,GO:2000699,1,0.979063806545174,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21405,GO:2000701,1,0.979063806545174,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21406,GO:2000702,1,0.979063806545174,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21407,GO:2000703,1,0.979063806545174,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21409,GO:2000706,1,0.979072992026655,0,1,negative regulation of dense core granule biogenesis,BP,
21411,GO:2000721,1,0.940535280704118,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21412,GO:2000722,1,0.960331111954073,0,2,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21413,GO:2000723,1,0.97900659726781,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21414,GO:2000724,1,0.980925138698575,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21418,GO:2000729,1,0.958060339702423,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21419,GO:2000733,1,0.979063806545174,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21420,GO:2000734,1,0.979063806545174,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21423,GO:2000738,1,0.731920136419867,0,15,positive regulation of stem cell differentiation,BP,
21424,GO:2000739,1,0.885762498371432,0,6,regulation of mesenchymal stem cell differentiation,BP,
21425,GO:2000740,1,0.979072992026655,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21426,GO:2000741,1,0.922454145397065,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21427,GO:2000742,1,0.958114953080563,0,2,regulation of anterior head development,BP,
21428,GO:2000744,1,0.958114953080563,0,2,positive regulation of anterior head development,BP,
21429,GO:2000751,1,0.979032887119095,0,1,histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore,BP,
21430,GO:2000752,1,0.979032978974685,0,1,regulation of glucosylceramide catabolic process,BP,
21431,GO:2000753,1,0.979032978974685,0,1,positive regulation of glucosylceramide catabolic process,BP,
21432,GO:2000754,1,0.979032978974685,0,1,regulation of sphingomyelin catabolic process,BP,
21433,GO:2000755,1,0.979032978974685,0,1,positive regulation of sphingomyelin catabolic process,BP,
21435,GO:2000757,1,0.672101086944717,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21437,GO:2000759,1,0.97948724978707,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21438,GO:2000761,1,0.97948724978707,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21439,GO:2000763,1,0.978906684662316,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21440,GO:2000764,1,0.978906684662316,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21441,GO:2000765,1,0.762150707816137,0,13,regulation of cytoplasmic translation,BP,
21442,GO:2000766,1,0.847988960403731,0,8,negative regulation of cytoplasmic translation,BP,
21443,GO:2000767,1,0.9181989306088,0,4,positive regulation of cytoplasmic translation,BP,
21444,GO:2000768,1,0.938121309135104,0,3,positive regulation of nephron tubule epithelial cell differentiation,BP,
21445,GO:2000769,1,0.97852925271556,0,1,regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21446,GO:2000771,1,0.97852925271556,0,1,positive regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21447,GO:2000772,1,0.560387189818609,0,28,regulation of cellular senescence,BP,
21448,GO:2000773,1,0.80185759253791,0,11,negative regulation of cellular senescence,BP,
21449,GO:2000774,1,0.842916308511161,0,8,positive regulation of cellular senescence,BP,
21450,GO:2000775,1,0.978795633443475,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21451,GO:2000777,1,0.958090882445688,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21453,GO:2000779,1,0.445874328629794,0,39,regulation of double-strand break repair,BP,
21454,GO:2000780,1,0.736536707679737,0,15,negative regulation of double-strand break repair,BP,
21455,GO:2000781,1,0.847859668525872,0,8,positive regulation of double-strand break repair,BP,
21456,GO:2000782,1,0.97852925271556,0,1,regulation of establishment of cell polarity regulating cell shape,BP,
21457,GO:2000784,1,0.97852925271556,0,1,positive regulation of establishment of cell polarity regulating cell shape,BP,
21460,GO:2000790,1,0.961379505144752,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21461,GO:2000791,1,0.961379505144752,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21462,GO:2000793,1,0.946556519047039,0,3,cell proliferation involved in heart valve development,BP,
21464,GO:2000795,1,0.981916081977069,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21465,GO:2000797,1,0.979072992026655,0,1,regulation of amniotic stem cell differentiation,BP,
21466,GO:2000798,1,0.979072992026655,0,1,negative regulation of amniotic stem cell differentiation,BP,
21467,GO:2000800,1,0.978629530647796,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21468,GO:2000802,1,0.978629530647796,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21469,GO:2000804,1,0.983914948881197,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21470,GO:2000806,1,0.983914948881197,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21472,GO:2000808,1,0.979965407711975,0,1,negative regulation of synaptic vesicle clustering,BP,
21476,GO:2000812,1,0.958067512638062,0,2,regulation of barbed-end actin filament capping,BP,
21477,GO:2000814,1,0.97852925271556,0,1,positive regulation of barbed-end actin filament capping,BP,
21478,GO:2000816,1,0.538052361600377,0,30,negative regulation of mitotic sister chromatid separation,BP,
21479,GO:2000818,1,0.958162774756031,0,2,negative regulation of myoblast proliferation,BP,
21480,GO:2000819,1,0.958526106563251,0,2,regulation of nucleotide-excision repair,BP,
21482,GO:2000821,1,0.922139039963189,0,4,regulation of grooming behavior,BP,
21483,GO:2000822,1,0.89943366537937,0,5,regulation of behavioral fear response,BP,
21484,GO:2000823,1,0.881355411361056,0,6,regulation of androgen receptor activity,BP,
21485,GO:2000824,1,0.958408671656273,0,2,negative regulation of androgen receptor activity,BP,
21486,GO:2000825,1,0.919611840130879,0,4,positive regulation of androgen receptor activity,BP,
21488,GO:2000827,1,0.978949972742984,0,1,mitochondrial RNA surveillance,BP,
21489,GO:2000828,1,0.959173621435878,0,2,regulation of parathyroid hormone secretion,BP,
21490,GO:2000830,1,0.98003558222434,0,1,positive regulation of parathyroid hormone secretion,BP,
21492,GO:2000832,1,0.960008253877792,0,2,negative regulation of steroid hormone secretion,BP,
21494,GO:2000834,1,0.979069122397277,0,1,regulation of androgen secretion,BP,
21495,GO:2000836,1,0.979069122397277,0,1,positive regulation of androgen secretion,BP,
21496,GO:2000843,1,0.960447489606326,0,2,regulation of testosterone secretion,BP,
21497,GO:2000845,1,0.960447489606326,0,2,positive regulation of testosterone secretion,BP,
21499,GO:2000847,1,0.960008253877792,0,2,negative regulation of corticosteroid hormone secretion,BP,
21501,GO:2000849,1,0.843470041622808,0,8,regulation of glucocorticoid secretion,BP,
21502,GO:2000850,1,0.960008253877792,0,2,negative regulation of glucocorticoid secretion,BP,
21503,GO:2000851,1,0.897494260120155,0,5,positive regulation of glucocorticoid secretion,BP,
21504,GO:2000852,1,0.937371154994862,0,3,regulation of corticosterone secretion,BP,
21505,GO:2000854,1,0.957504207231201,0,2,positive regulation of corticosterone secretion,BP,
21510,GO:2000864,1,0.939735290212418,0,3,regulation of estradiol secretion,BP,
21511,GO:2000866,1,0.958312538416908,0,2,positive regulation of estradiol secretion,BP,
21512,GO:2000870,1,0.957687200054661,0,2,regulation of progesterone secretion,BP,
21513,GO:2000872,1,0.978466288137151,0,1,positive regulation of progesterone secretion,BP,
21514,GO:2000878,1,0.958081860797864,0,2,positive regulation of oligopeptide transport,BP,
21515,GO:2000880,1,0.958081860797864,0,2,positive regulation of dipeptide transport,BP,
21516,GO:2000896,1,0.979067210276894,0,1,amylopectin metabolic process,BP,
21517,GO:2000909,1,0.937264288542072,0,3,regulation of sterol import,BP,
21518,GO:2000910,1,0.957395965871561,0,2,negative regulation of sterol import,BP,
21519,GO:2000969,1,0.925786356792048,0,4,positive regulation of AMPA receptor activity,BP,
21520,GO:2000970,1,0.978924682514653,0,1,regulation of detection of glucose,BP,
21521,GO:2000971,1,0.978924682514653,0,1,negative regulation of detection of glucose,BP,
21524,GO:2000977,1,0.917890895279464,0,4,regulation of forebrain neuron differentiation,BP,
21525,GO:2000978,1,0.957567243347927,0,2,negative regulation of forebrain neuron differentiation,BP,
21526,GO:2000979,1,0.979063884651254,0,1,positive regulation of forebrain neuron differentiation,BP,
21529,GO:2000982,1,0.978501057651594,0,1,positive regulation of inner ear receptor cell differentiation,BP,
21530,GO:2000983,1,0.957456461000372,0,2,regulation of ATP citrate synthase activity,BP,
21531,GO:2000984,1,0.957456461000372,0,2,negative regulation of ATP citrate synthase activity,BP,
21532,GO:2000987,1,0.89943366537937,0,5,positive regulation of behavioral fear response,BP,
21534,GO:2001013,1,0.921340867945043,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21537,GO:2001016,1,0.900719075497207,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21539,GO:2001021,1,0.301704172962674,0,57,negative regulation of response to DNA damage stimulus,BP,
21541,GO:2001023,1,0.905837277093572,0,5,regulation of response to drug,BP,
21542,GO:2001025,1,0.979107757569395,0,1,positive regulation of response to drug,BP,
21546,GO:2001029,1,0.97994947093804,0,1,regulation of cellular glucuronidation,BP,
21547,GO:2001031,1,0.97994947093804,0,1,positive regulation of cellular glucuronidation,BP,
21548,GO:2001032,1,0.864499173998989,0,7,regulation of double-strand break repair via nonhomologous end joining,BP,
21549,GO:2001033,1,0.938226699525995,0,3,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21550,GO:2001034,1,0.941162221176501,0,3,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21551,GO:2001035,1,0.95832986037582,0,2,regulation of tongue muscle cell differentiation,BP,
21552,GO:2001037,1,0.95832986037582,0,2,positive regulation of tongue muscle cell differentiation,BP,
21553,GO:2001038,1,0.960432163208614,0,2,regulation of cellular response to drug,BP,
21555,GO:2001045,1,0.959956823234501,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21557,GO:2001049,1,0.978754124420866,0,1,regulation of tendon cell differentiation,BP,
21558,GO:2001051,1,0.978754124420866,0,1,positive regulation of tendon cell differentiation,BP,
21561,GO:2001055,1,0.958021394965742,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21564,GO:2001065,1,0.95750073601385,0,2,mannan binding,MF,
21565,GO:2001069,1,0.93797046513697,0,3,glycogen binding,MF,
21566,GO:2001070,1,0.959266958017707,0,2,starch binding,MF,
21569,GO:2001106,1,0.961782570331229,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21570,GO:2001108,1,0.980582820291316,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21571,GO:2001109,1,0.961434799798501,0,2,regulation of lens epithelial cell proliferation,BP,
21572,GO:2001111,1,0.961434799798501,0,2,positive regulation of lens epithelial cell proliferation,BP,
21573,GO:2001112,1,0.979551728245356,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21574,GO:2001113,1,0.979551728245356,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21576,GO:2001136,1,0.979069331885983,0,1,negative regulation of endocytic recycling,BP,
21578,GO:2001138,1,0.847475328042206,0,8,regulation of phospholipid transport,BP,
21579,GO:2001140,1,0.847475328042206,0,8,positive regulation of phospholipid transport,BP,
21581,GO:2001142,1,0.978976487401161,0,1,nicotinate transport,BP,
21582,GO:2001144,1,0.978833464295311,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21583,GO:2001145,1,0.978833464295311,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21584,GO:2001148,1,0.958081860797864,0,2,regulation of dipeptide transmembrane transport,BP,
21585,GO:2001150,1,0.958081860797864,0,2,positive regulation of dipeptide transmembrane transport,BP,
21586,GO:2001151,1,0.979068564333656,0,1,regulation of renal water transport,BP,
21587,GO:2001153,1,0.979068564333656,0,1,positive regulation of renal water transport,BP,
21588,GO:2001160,1,0.958172517644194,0,2,regulation of histone H3-K79 methylation,BP,
21589,GO:2001162,1,0.958172517644194,0,2,positive regulation of histone H3-K79 methylation,BP,
21590,GO:2001163,1,0.97887079788465,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21591,GO:2001165,1,0.97887079788465,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21592,GO:2001166,1,0.919007886418726,0,4,regulation of histone H2B ubiquitination,BP,
21593,GO:2001168,1,0.919007886418726,0,4,positive regulation of histone H2B ubiquitination,BP,
21594,GO:2001169,1,0.827350706114699,0,9,regulation of ATP biosynthetic process,BP,
21595,GO:2001170,1,0.938449460860427,0,3,negative regulation of ATP biosynthetic process,BP,
21596,GO:2001171,1,0.863128261330609,0,7,positive regulation of ATP biosynthetic process,BP,
21597,GO:2001176,1,0.958349767606808,0,2,regulation of mediator complex assembly,BP,
21598,GO:2001178,1,0.958349767606808,0,2,positive regulation of mediator complex assembly,BP,
21600,GO:2001180,1,0.938145893486388,0,3,negative regulation of interleukin-10 secretion,BP,
21602,GO:2001182,1,0.861697728421399,0,7,regulation of interleukin-12 secretion,BP,
21603,GO:2001183,1,0.938235067842109,0,3,negative regulation of interleukin-12 secretion,BP,
21604,GO:2001184,1,0.938074669785849,0,3,positive regulation of interleukin-12 secretion,BP,
21605,GO:2001185,1,0.843069436095331,0,8,regulation of CD8-positive, alpha-beta T cell activation,BP,
21606,GO:2001186,1,0.958224993390129,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21607,GO:2001187,1,0.917865193958592,0,4,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21608,GO:2001188,1,0.898092135935538,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21609,GO:2001189,1,0.937825772935688,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21610,GO:2001190,1,0.957639424129637,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21611,GO:2001191,1,0.979044870566797,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21612,GO:2001193,1,0.979044870566797,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21613,GO:2001197,1,0.90698913613954,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21616,GO:2001200,1,0.918109102781103,0,4,positive regulation of dendritic cell differentiation,BP,
21617,GO:2001201,1,0.941963427591471,0,3,regulation of transforming growth factor-beta secretion,BP,
21618,GO:2001202,1,0.961504579035932,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21619,GO:2001203,1,0.979678640160998,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21622,GO:2001206,1,0.918307379858637,0,4,positive regulation of osteoclast development,BP,
21623,GO:2001207,1,0.979082570228003,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21624,GO:2001208,1,0.979082570228003,0,1,negative regulation of transcription elongation from RNA polymerase I promoter,BP,
21626,GO:2001213,1,0.980116871680728,0,1,negative regulation of vasculogenesis,BP,
21627,GO:2001214,1,0.811587964858535,0,10,positive regulation of vasculogenesis,BP,
21628,GO:2001222,1,0.579880701289301,0,27,regulation of neuron migration,BP,
21629,GO:2001223,1,0.850822622032797,0,8,negative regulation of neuron migration,BP,
21630,GO:2001224,1,0.837413371621263,0,9,positive regulation of neuron migration,BP,
21631,GO:2001225,1,0.845112745436121,0,8,regulation of chloride transport,BP,
21632,GO:2001226,1,0.938487911685472,0,3,negative regulation of chloride transport,BP,
21633,GO:2001228,1,0.985534073788592,0,1,regulation of response to gamma radiation,BP,
21634,GO:2001229,1,0.985534073788592,0,1,negative regulation of response to gamma radiation,BP,
21643,GO:2001241,1,0.746548222861127,0,14,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21648,GO:2001246,1,0.979101133648772,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21649,GO:2001247,1,0.979203096075372,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21650,GO:2001248,1,0.978819787817556,0,1,regulation of ammonia assimilation cycle,BP,
21651,GO:2001250,1,0.978819787817556,0,1,positive regulation of ammonia assimilation cycle,BP,
21652,GO:2001251,1,0.0965436672239828,0,113,negative regulation of chromosome organization,BP,
21654,GO:2001253,1,0.979060146914743,0,1,regulation of histone H3-K36 trimethylation,BP,
21655,GO:2001256,1,0.881174944499962,0,6,regulation of store-operated calcium entry,BP,
21659,GO:2001260,1,0.978906684662316,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21660,GO:2001262,1,0.978906684662316,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21661,GO:2001263,1,0.9784689967334,0,1,regulation of C-C chemokine binding,BP,
21662,GO:2001264,1,0.9784689967334,0,1,negative regulation of C-C chemokine binding,BP,
21664,GO:2001268,1,0.89791393789711,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21666,GO:2001270,1,0.919369106245105,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21667,GO:2001271,1,0.939592026255168,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21668,GO:2001272,1,0.978480527706844,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21670,GO:2001274,1,0.938920453248669,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21672,GO:2001279,1,0.880063960730942,0,6,regulation of unsaturated fatty acid biosynthetic process,BP,
21673,GO:2001280,1,0.918091749111373,0,4,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21676,GO:2001288,1,0.961032055469381,0,2,positive regulation of caveolin-mediated endocytosis,BP,
21677,GO:2001293,1,0.945631905053725,0,3,malonyl-CoA metabolic process,BP,
21678,GO:2001294,1,0.978838004439744,0,1,malonyl-CoA catabolic process,BP,
21679,GO:2001295,1,0.966077948500083,0,2,malonyl-CoA biosynthetic process,BP,
21680,GO:2001300,1,0.879403119999703,0,6,lipoxin metabolic process,BP,
21681,GO:2001301,1,0.958358996890799,0,2,lipoxin biosynthetic process,BP,
21682,GO:2001302,1,0.958358996890799,0,2,lipoxin A4 metabolic process,BP,
21683,GO:2001303,1,0.958358996890799,0,2,lipoxin A4 biosynthetic process,BP,
21684,GO:2001304,1,0.978907066130447,0,1,lipoxin B4 metabolic process,BP,
21685,GO:2001306,1,0.978907066130447,0,1,lipoxin B4 biosynthetic process,BP,
21686,GO:2001311,1,0.978683345572611,0,1,lysobisphosphatidic acid metabolic process,BP,
9940,GO:0035612,1.00000000000007,0.87511770108055,0,7,AP-2 adaptor complex binding,MF,
1612,GO:0003676,1.0000000000006,0,29,3818,nucleic acid binding,MF,POU3F1;NOTCH1;FASN;GADD45A;MRPL14;MRPL16;ZFPM1;SALL4;EBF1;ARL6IP4;FOXO4;HSD17B10;WNT5A;RNASEL;ANG;TSFM;WT1;HMGN5;MSN;NOL3;NUDT7;FAM46A;PUS1;ZCCHC12;LZTS1;RBMS3;HNF1A;VDR;HEY1
